FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Fields, B
   Liu, J
   Arunkumar, G
   Schaad, N
   Qi, XP
   Sawatwong, P
   Osoro, E
   Boncy, J
   Luyai, A
   Lopez, MR
   Henao, O
   Rama, S
   Yang, ZH
   Bhengrisi, S
   Ngeno, E
   Journel, I
   Devadiga, S
   Marwanga, D
   Verani, J
   Dely, P
   Bigogo, G
   Ramachandran, S
   Operario, D
   Amon, D
   Gratz, J
   Joseph, G
   Robin, S
   Papanna, M
   Ke, C
   Ochieng, M
   Alboth, JA
   Zhang, YZ
   Wu, SY
   Antoine, M
   Juin, S
   Castellanos, MBL
   Bryan, J
   Mansour, H
   ElSoud, HA
   Hunsperger, E
   Rainey, J
   Whistler, T
   Laserson, K
   Houpt, E
   Montgomery, J
AF Fields, Barry
   Liu, Jie
   Arunkumar, Govindakarnavar
   Schaad, Nicholas
   Qi, Xiaopong
   Sawatwong, Pongpun
   Osoro, Eric
   Boncy, Jaques
   Luyai, Anthony
   Renee Lopez, Maria
   Henao, Olga
   Rama, Sima
   Yang, Zhonghua
   Bhengrisi, Saithip
   Ngeno, Eric
   Journel, Ito
   Devadiga, Santhosha
   Marwanga, Doris
   Verani, Jennifer
   Dely, Patrick
   Bigogo, Godfrey
   Ramachandran, Sanjay
   Operario, Darwin
   Amon, Derrick
   Gratz, Jean
   Joseph, Gersard
   Robin, S.
   Papanna, Mohan
   Ke, Changwen
   Ochieng, Melvin
   Alboth, Jocelyne
   Zhang, Yuzhi
   Wu, Shuyu
   Antoine, Mayer
   Juin, Stanley
   Lopez Castellanos, Maria
   Bryan, Joseph
   Mansour, Hoda
   ElSoud, Hanaa
   Hunsperger, Elizabeth
   Rainey, Jeanette
   Whistler, Toni
   Laserson, Kayla
   Houpt, Eric
   Montgomery, Joel
TI A MULTI-COUNTRY EVALUATION OF DIAGNOSTIC ASSAYS FOR ZIKA INFECTIONS AND
   ACUTE FEBRILE ILLNESS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Fields, Barry; Schaad, Nicholas; Luyai, Anthony; Henao, Olga; Montgomery, Joel] Ctr Dis Control & Prevent, Atlanta, GA USA.
   [Liu, Jie; Operario, Darwin; Gratz, Jean; Houpt, Eric] Univ Virginia, Charlottesville, VA USA.
   [Arunkumar, Govindakarnavar; Devadiga, Santhosha; Ramachandran, Sanjay; Robin, S.] Manipal Univ, Manipal, Karnataka, India.
   [Qi, Xiaopong] China CDC, Beijing, Peoples R China.
   [Sawatwong, Pongpun; Bhengrisi, Saithip; Whistler, Toni] Thailand MOPH US CDC Collaborat, Bangkok, Thailand.
   [Osoro, Eric; Ngeno, Eric] Washington State Univ, Nairobi, Kenya.
   [Boncy, Jaques; Journel, Ito; Dely, Patrick; Joseph, Gersard; Alboth, Jocelyne] Minist Sante Publ & Populat, Port Au Prince, Haiti.
   [Renee Lopez, Maria] Univ Valle Guatemala, Guatemala City, Guatemala.
   [Rama, Sima] Northrup Grumman Corp, Atlanta, GA USA.
   [Yang, Zhonghua] Yunnan Inst Parasit Dis, Puer, Yunnan, Peoples R China.
   [Marwanga, Doris; Amon, Derrick; Ochieng, Melvin] Kenya Govt Med Res Ctr, Nairobi, Kenya.
   [Verani, Jennifer; Hunsperger, Elizabeth] Ctr Dis Control & Prevent Kenya, Nairobi, Kenya.
   [Bigogo, Godfrey] Kenya Govt Med Res Ctr, Kisumu, Kenya.
   [Papanna, Mohan; Laserson, Kayla] Ctr Dis Control & Prevent India, New Delhi, India.
   [Ke, Changwen] Guangdong Prov CDC, Guangzhou, Guangdong, Peoples R China.
   [Zhang, Yuzhi; Wu, Shuyu; Rainey, Jeanette] Ctr Dis Control & Prevent China, Beijing, Peoples R China.
   [Antoine, Mayer; Juin, Stanley] Ctr Dis Control & Prevent Haiti, Port Au Prince, Haiti.
   [Lopez Castellanos, Maria; Bryan, Joseph] Ctr Dis Control & Prevent Guatemala, Guatemala City, Guatemala.
   [Mansour, Hoda] Training Programs Epidemiol & Publ Hlth Intervent, Cairo, Egypt.
   [ElSoud, Hanaa] Minist Hlth & Populat, Cairo, Egypt.
RI Bigogo, Godfrey/W-3591-2019
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 208
BP 65
EP 65
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386602209
DA 2020-07-08
ER

PT J
AU Buekens, P
   Alger, J
   Cafferata, ML
   Berrueta, AM
   Bock, H
   Bustillo, C
   Calderon, A
   Callejas, A
   Castillo, M
   Ciganda, A
   Fuentes, I
   Funes, J
   Garcia, J
   Garcia, K
   Gilboa, S
   Harville, E
   Lopez, W
   Lorenzana, I
   Luque, MT
   Maldonado, C
   Oberhelman, R
   Ochoa, C
   Pastrana, K
   Parham, L
   Rodriguez, H
   Tong, V
   Valencia, D
   Varela, D
   Ward, M
   Wesson, D
   Zuniga, C
AF Buekens, Pierre
   Alger, Jackeline
   Luisa Cafferata, Maria
   Berrueta, Amanda
   Bock, Harry
   Bustillo, Carolina
   Calderon, Alejandra
   Callejas, Allison
   Castillo, Mario
   Ciganda, Alvaro
   Fuentes, Itzel
   Funes, Jenny
   Garcia, Jorge
   Garcia, Kimberly
   Gilboa, Suzanne
   Harville, Emily
   Lopez, Wendy
   Lorenzana, Ivette
   Tulio Luque, Marco
   Maldonado, Carlos
   Oberhelman, Richard
   Ochoa, Carlos
   Pastrana, Karla
   Parham, Leda
   Rodriguez, Heriberto
   Tong, Van
   Valencia, Diana
   Varela, Douglas
   Ward, Matthew
   Wesson, Dawn
   Zuniga, Concepcion
TI THE ZIKA VIRUS INFECTION IN PREGNANT WOMEN IN HONDURAS (ZIPH) COHORT
   STUDY
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Buekens, Pierre; Harville, Emily; Oberhelman, Richard; Ward, Matthew; Wesson, Dawn] Tulane Univ, New Orleans, LA 70118 USA.
   [Alger, Jackeline; Garcia, Jorge; Lopez, Wendy] Hosp Escuela Univ, Dept Lab Clin, Tegucigalpa, Honduras.
   [Luisa Cafferata, Maria; Berrueta, Amanda; Ciganda, Alvaro] Inst Efectividad Clin & Sanitaria, Buenos Aires, DF, Argentina.
   [Bock, Harry] Secretaria Salud Honduras, Reg Sanitaria Metropolitana Dist Cent, Tegucigalpa, Honduras.
   [Bustillo, Carolina; Fuentes, Itzel; Pastrana, Karla] Hosp Escuela Univ, Dept Ginecol & Obstet, Tegucigalpa, Honduras.
   [Calderon, Alejandra] Secretaria Salud Honduras, Ctr Salud Alonso Suazo, Tegucigalpa, Honduras.
   [Callejas, Allison; Castillo, Mario; Funes, Jenny] Hosp Escuela Univ, Dept Pediat, Neonatol, Tegucigalpa, Honduras.
   [Garcia, Kimberly; Lorenzana, Ivette] Univ Nacl Autonoma Honduras, Ctr Invest Genet, Escuela Microbiol, Tegucigalpa, Honduras.
   [Gilboa, Suzanne; Tong, Van; Valencia, Diana] Ctr Dis Control & Prevent, Div Congenital & Dev Disorders, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA USA.
   [Tulio Luque, Marco] Hosp Escuela Univ, Dept Pediat, Infectol, Tegucigalpa, Honduras.
   [Maldonado, Carlos] Hosp Escuela Univ, Dept Pediat, Oftalmol, Tegucigalpa, Honduras.
   [Ochoa, Carlos; Rodriguez, Heriberto] Hosp Gen San Felipe, Tegucigalpa, Honduras.
   [Parham, Leda] Escuela Microbiol, Ctr Invest Genet, New Orleans, LA USA.
   [Varela, Douglas] Hosp Escuela Univ, Dept Pediat, Neurol, Tegucigalpa, Honduras.
   [Zuniga, Concepcion] Hosp Escuela Univ, Dept Vigilancia Salud, Tegucigalpa, Honduras.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 212
BP 66
EP 66
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386602213
DA 2020-07-08
ER

PT J
AU Asad, S
   Feitosa-Suntheimer, F
   Gold, A
   Colpitts, TM
AF Asad, Sultan
   Feitosa-Suntheimer, Fabiana
   Gold, Alexander
   Colpitts, Tonya
TI <it>AEDES AEGYPTI</it> SALIVA PROTEIN INTERACTIONS WITH ZIKA VIRUS AND
   THEIR ROLE IN MAMMALIAN INFECTION
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Asad, Sultan; Feitosa-Suntheimer, Fabiana; Gold, Alexander; Colpitts, Tonya] Boston Univ, Sch Med, Boston, MA 02118 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 214
BP 67
EP 67
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386602215
DA 2020-07-08
ER

PT J
AU Faical, AV
   de Oliveira, JM
   de Almeida, BL
   Leao, EK
   Oliveira, JV
   Andrade, I
   Cabral, MB
   Ferreira, NS
   Reis, LO
   Salles, C
   Costa, BG
   Francisco, MV
   Santos, CS
   D'Agostinho, E
   Vianna, MI
   Duarte, AO
   Acosta, AX
   de Siqueira, IC
AF Faical, Adriana
   de Oliveira, Juliana
   de Almeida, Breno
   Leao, Emila
   Oliveira, Joao
   Andrade, Iluska
   Cabral, Maria
   Ferreira, Nelfa
   Reis, Lucas
   Salles, Cristina
   Costa, Bernardo
   Francisco, Marcus
   Santos, Cleiton
   D'Agostinho, Erica
   Vianna, Maria
   Duarte, Alan
   Acosta, Angelina
   de Siqueira, Isadora
TI NEURODEVELOPMENTAL DELAYS ARISING FROM <it>IN UTERO</it> EXPOSURE TO
   ZIKA VIRUS IN SALVADOR, BRAZIL
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Faical, Adriana; Leao, Emila; Andrade, Iluska; Salles, Cristina; Acosta, Angelina] Univ Fed Bahia, Salvador, BA, Brazil.
   [de Oliveira, Juliana; de Almeida, Breno; Oliveira, Joao; Ferreira, Nelfa; Reis, Lucas; Costa, Bernardo; Francisco, Marcus; Santos, Cleiton; Duarte, Alan; de Siqueira, Isadora] Fiocruz MS, Inst Goncalo Moniz, Salvador, BA, Brazil.
   [Cabral, Maria; D'Agostinho, Erica; Vianna, Maria] Univ Fed Bahia, Fac Odontol, Salvador, BA, Brazil.
RI de Siqueira, Isadora Cristina/R-9953-2016
OI de Siqueira, Isadora Cristina/0000-0002-2520-4099
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 215
BP 67
EP 67
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386602216
DA 2020-07-08
ER

PT J
AU Pauvolid-Correa, A
   Dezengrini-Slhessarenko, R
   Herrera, H
   Porfirio, G
   Sabino-Santos, G
   Maia, L
   Dias, H
   Miranda, E
   Lima, S
   Morgado, T
   Netto, C
   Hannon, E
   Figueiredo, L
   Santos, F
   de Filippis, AB
   Montgomery, J
   Slayer, S
   Komar, N
AF Pauvolid-Correa, Alex
   Dezengrini-Slhessarenko, Renata
   Herrera, Heitor
   Porfirio, Grasiela
   Sabino-Santos, Gilberto
   Maia, Laura
   Dias, Helver
   Miranda, Emily
   Lima, Sheila
   Morgado, Thais
   Netto, Claudia
   Hannon, Emily
   Figueiredo, Luis
   Santos, Flavia
   de Filippis, Ana
   Montgomery, Joel
   Slayer, Stephanie
   Komar, Nick
TI HUMAN-ANIMAL INTERFACE AND VECTOR SURVEILLANCE IN ZIKA VIRUS PRONE
   TRANSMISSION AREAS IN BRAZIL
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Pauvolid-Correa, Alex; de Filippis, Ana] Fiocruz MS, Lab Flavivirus, Inst Oswaldo Cruz, Rio De Janeiro, RJ, Brazil.
   [Dezengrini-Slhessarenko, Renata; Maia, Laura] Univ Fed Mato Grosso, Lab Virol, Fac Med, Cuiaba, MT, Brazil.
   [Herrera, Heitor; Porfirio, Grasiela] Univ Catolica Dom Bosco, Lab Biol Parasitaria, Campo Grande, MS, Brazil.
   [Sabino-Santos, Gilberto; Figueiredo, Luis] Univ Sao Paulo, Ctr Pesquisa Virol, Fac Med, Ribeirao Preto, SP, Brazil.
   [Dias, Helver; Santos, Flavia] Fiocruz MS, Lab Imunol Viral, Inst Oswaldo Cruz, Rio De Janeiro, RJ, Brazil.
   [Miranda, Emily; Lima, Sheila] Fiocruz MS, Lab Tecnol Virol, Biomanguinhos, Rio De Janeiro, RJ, Brazil.
   [Morgado, Thais] Univ Fed Mato Grosso, Hosp Vet, Zool, Cuiaba, MT, Brazil.
   [Netto, Claudia] Imasul, Ctr Reabilitacao Anim Silvestres, Campo Grande, MS, Brazil.
   [Hannon, Emily; Komar, Nick] Ctr Dis Control & Prevent, Arbovirus Dis Branch, Div Vector Borne Dis, Natl Ctr Emerging & Zoonot Infect Dis, Ft Collins, CO USA.
   [Montgomery, Joel; Slayer, Stephanie] Ctr Dis Control & Prevent, EISL Branch, Div Global Hlth Protect, Ctr Global Hlth, Atlanta, GA USA.
RI Pauvolid-Correa, Alex/D-3643-2017
OI Pauvolid-Correa, Alex/0000-0002-6924-157X
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 217
BP 67
EP 68
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386602218
DA 2020-07-08
ER

PT J
AU Ruckert, C
   Robison, A
   Donkoh, J
   Ebel, GD
AF Ruckert, Claudia
   Robison, Alexis
   Donkoh, Jasmine
   Ebel, Gregory
TI SERIAL PASSAGING OF ZIKA VIRUS RESULTS IN ENHANCED REPLICATION IN
   <it>CULEX</it> CELLS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Ruckert, Claudia; Robison, Alexis; Donkoh, Jasmine; Ebel, Gregory] Colorado State Univ, Ft Collins, CO 80523 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 216
BP 67
EP 67
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386602217
DA 2020-07-08
ER

PT J
AU Glaessner, AG
   Leguia, M
AF Garcia Glaessner, Alejandra
   Leguia, Mariana
TI OPTIMIZATION OF QUANTITATIVE RT-PCR PROTOCOL FOR ZIKA VIRUS DETECTION IN
   LOW VIRAL SAMPLE CONCENTRATIONS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Garcia Glaessner, Alejandra; Leguia, Mariana] Pontificia Univ Catolica Peru, Lima, Peru.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 219
BP 68
EP 68
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386602220
DA 2020-07-08
ER

PT J
AU Haller, SL
   Saldana, MA
   Hegde, S
   Roundy, CM
   Weaver, SC
   Hughes, GL
AF Haller, Sherry
   Saldana, Miguel
   Hegde, Shivanand
   Roundy, Christopher
   Weaver, Scott
   Hughes, Grant
TI THE EFFECTS OF MOSQUITO MICROBIOTA ON ZIKV INFECTION AND TRANSMISSION IN
   <it>AEDES AEGYPTI</it>
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Haller, Sherry; Saldana, Miguel; Hegde, Shivanand; Roundy, Christopher; Weaver, Scott; Hughes, Grant] Univ Texas Med Branch, Galveston, TX 77555 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 220
BP 68
EP 69
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386602221
DA 2020-07-08
ER

PT J
AU Sy, AK
   Igoy, MAU
   Privaldos, KJ
AF Sy, Ava
   Igoy, Mary
   Joy Privaldos, Kristine
TI GENETIC ANALYSIS OF ZIKA VIRUS INFECTIONS FROM AUTOCHTHONOUS
   TRANSMISSION IN THE PHILIPPINES, 2016-2017
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Sy, Ava; Igoy, Mary; Joy Privaldos, Kristine] Res Inst Trop Med, Manila, Philippines.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 218
BP 68
EP 68
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386602219
DA 2020-07-08
ER

PT J
AU Bernatchez, JA
   Coste, M
   Wells, GA
   Zhu, Z
   Beck, S
   Clark, AE
   Sohl, CD
   Purse, BW
   Siqueira-Neto, JL
AF Bernatchez, Jean
   Coste, Michael
   Wells, Grace
   Zhu, Zhe
   Beck, Sungjun
   Clark, Alex
   Sohl, Christal
   Purse, Byron
   Siqueira-Neto, Jair
TI <it>IN VITRO</it> ACTIVITY OF A 2'-C-METHYLURIDINE PROTIDE AGAINST THE
   ZIKA VIRUS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Bernatchez, Jean; Zhu, Zhe; Beck, Sungjun; Clark, Alex; Siqueira-Neto, Jair] Univ Calif San Diego, San Diego, CA 92103 USA.
   [Coste, Michael; Wells, Grace; Sohl, Christal; Purse, Byron] San Diego State Univ, San Diego, CA 92182 USA.
RI Siqueira-Neto, Jair L/D-6040-2012
OI Siqueira-Neto, Jair L/0000-0001-9574-8174
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 222
BP 69
EP 69
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386602223
DA 2020-07-08
ER

PT J
AU Burkel, V
   Mercado, M
   Rodriguez, HM
   Valencia, D
   Tong, V
   Gonzalez, M
   Merchan, MBO
   Gilboa, SM
   Johnson, CY
   Gomez, YO
   Rodriguez, JM
   Kim, SY
   Latorre, HMB
   Ailes, E
   Honein, MA
   Martinez, MLO
AF Burkel, Veronica
   Mercado, Marcela
   Rodriguez, Helena
   Valencia, Diana
   Tong, Van
   Gonzalez, Maritza
   Osorio Merchan, May
   Gilboa, Suzanne
   Johnson, Candice
   Ortiz Gomez, Yamileth
   Martin Rodriguez, Jorge
   Kim, Shin
   Baquero Latorre, Hernando
   Ailes, Elizabeth
   Honein, Margaret
   Ospina Martinez, Martha
TI OVERVIEW OF ZIKA EN EMBARAZADAS Y NINOS EN COLOMBIA (ZEN): A PROSPECTIVE
   COHORT STUDY EXAMINING ZIKA VIRUS INFECTION DURING PREGNANCY AND RISK OF
   ADVERSE PREGNANCY, BIRTH, AND INFANT OUTCOMES
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Burkel, Veronica; Valencia, Diana; Tong, Van; Gilboa, Suzanne; Kim, Shin; Ailes, Elizabeth; Honein, Margaret] Ctr Dis Control & Prevent, Atlanta, GA USA.
   [Mercado, Marcela; Rodriguez, Helena; Gonzalez, Maritza; Osorio Merchan, May; Ortiz Gomez, Yamileth; Martin Rodriguez, Jorge; Ospina Martinez, Martha] Inst Nacl Salud, Bogota, Colombia.
   [Johnson, Candice] NIOSH, Cincinnati, OH 45226 USA.
   [Baquero Latorre, Hernando] Univ Norte, Barranquilla, Colombia.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 224
BP 69
EP 70
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386602225
DA 2020-07-08
ER

PT J
AU Huang, CYH
   Stovall, J
   Livengood, J
   Baldwin, W
   Giebler, H
   Boroughs, K
   Egan, M
   Dean, H
AF Huang, Claire
   Stovall, Janae
   Livengood, Jill
   Baldwin, Whitney
   Giebler, Holli
   Boroughs, Karen
   Egan, Michael
   Dean, Hansi
TI DEVELOPMENT OF A LIVE-ATTENUATED DENV-2-BASED CHIMERIC VACCINE AGAINST
   ZIKA VIRUS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Huang, Claire; Stovall, Janae; Baldwin, Whitney; Giebler, Holli; Boroughs, Karen] Ctr Dis Control & Prevent, Ft Collins, CO USA.
   [Livengood, Jill; Egan, Michael; Dean, Hansi] Takeda Vaccine, Cambridge, MA USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 223
BP 69
EP 69
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386602224
DA 2020-07-08
ER

PT J
AU Montoya, M
   Chua, CL
   Chan, YF
   Pastor, A
   Harris, E
   Sam, JIC
AF Montoya, Magelda
   Chua, Chong
   Chan, Yoke
   Pastor, Andrew
   Harris, Eva
   Sam, Jamal
TI LOW ZIKA VIRUS SEROPREVALENCE IN KUALA LUMPUR, MALAYSIA
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Montoya, Magelda; Pastor, Andrew; Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
   [Chua, Chong; Chan, Yoke; Sam, Jamal] Univ Malaya, Dept Med Microbiol, Fac Med, Kuala Lumpur, Malaysia.
RI Chan, Yoke Fun/B-5351-2010; Sam, Jamal I-Ching/B-8688-2010
OI Chan, Yoke Fun/0000-0001-7089-0510; Sam, Jamal
   I-Ching/0000-0002-1296-7898
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 227
BP 70
EP 71
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386602228
DA 2020-07-08
ER

PT J
AU Ospina, ML
   Mercado, M
   Galang, R
   Moore, C
   Gonzalez, M
   Valencia, D
   Cuevas, L
   Pacheco, O
   Bermudez, A
   Tong, V
   Dominguez, M
   Gilboa, S
   Rozo, N
   Honein, M
   Prieto, F
AF Ospina, Martha
   Mercado, Marcela
   Galang, Romeo
   Moore, Cynthia
   Gonzalez, Maritza
   Valencia, Diana
   Cuevas, Lilliana
   Pacheco, Oscar
   Bermudez, Antonio
   Tong, Van
   Dominguez, Molly
   Gilboa, Suzanne
   Rozo, Nataly
   Honein, Margaret
   Prieto, Franklyn
TI SURVEILLANCE OF MICROCEPHALY AND OTHER CONGENITAL CENTRAL NERVOUS SYSTEM
   MALFORMATIONS: THE COLOMBIAN EXPERIENCE DURING THE 2015-2016 ZIKA VIRUS
   EPIDEMIC
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Ospina, Martha; Mercado, Marcela; Gonzalez, Maritza; Cuevas, Lilliana; Pacheco, Oscar; Bermudez, Antonio; Rozo, Nataly; Prieto, Franklyn] Inst Nacl Salud, Bogota, Colombia.
   [Galang, Romeo; Moore, Cynthia; Valencia, Diana; Tong, Van; Dominguez, Molly; Gilboa, Suzanne; Honein, Margaret] Ctr Dis Control & Prevent, Atlanta, GA USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 225
BP 70
EP 70
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386602226
DA 2020-07-08
ER

PT J
AU Suthangkornkul, R
   Hunsawong, T
   Ong-ajchaowlerd, P
   Sirikajornpan, K
   Thaisomboonsuk, B
   Klungthong, C
   Anderson, KB
   Weg, AL
   Macareo, LR
   Ellison, DW
AF Suthangkornkul, Rungarun
   Hunsawong, Taweewun
   Ong-ajchaowlerd, Prapapun
   Sirikajornpan, Kanittha
   Thaisomboonsuk, Butsaya
   Klungthong, Chonticha
   Anderson, Kathryn
   Weg, Alden
   Macareo, Louis
   Ellison, Damon
TI DENGUE VIRUS CROSS-NEUTRALIZING ANTIBODIES AGAINST ZIKA VIRUS INFECTION
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Suthangkornkul, Rungarun; Hunsawong, Taweewun; Ong-ajchaowlerd, Prapapun; Sirikajornpan, Kanittha; Thaisomboonsuk, Butsaya; Klungthong, Chonticha; Anderson, Kathryn; Weg, Alden; Macareo, Louis; Ellison, Damon] Armed Forces Res Inst Med Sci, US Army Med Directorate, Bangkok, Thailand.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 229
BP 71
EP 71
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386602230
DA 2020-07-08
ER

PT J
AU Towle, TM
   Shifflett, J
   Rashid, S
AF Towle, Teresa
   Shifflett, Jessica
   Rashid, Sujatha
TI FACTORS AFFECTING YIELD DURING THE PRODUCTION OF PURIFIED ZIKA VIRUS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Towle, Teresa; Shifflett, Jessica; Rashid, Sujatha] BEI Resources, Manassas, VA USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 228
BP 71
EP 71
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386602229
DA 2020-07-08
ER

PT J
AU Aubry, F
   Martynow, D
   Baidaliuk, A
   Merkling, SH
   Dickson, LB
   Romero-Vivas, CM
   Vega-Rua, A
   Dusfour, I
   Jiolle, D
   Paupy, C
   Mayanja, MN
   Lutwama, JJ
   Kohl, A
   Duong, V
   Ponlawat, A
   Cao-Lormeau, VM
   Jarman, RG
   Diagne, CT
   Faye, O
   Faye, O
   Sall, AA
   Lambrechts, L
AF Aubry, Fabien
   Martynow, Daria
   Baidaliuk, Artem
   Merkling, Sarah
   Dickson, Laura
   Romero-Vivas, Claudia
   Vega-Rua, Anubis
   Dusfour, Isabelle
   Jiolle, Davy
   Paupy, Christophe
   Mayanja, Martin
   Lutwama, Julius
   Kohl, Alain
   Duong, Veasna
   Ponlawat, Alongkot
   Cao-Lormeau, Van-Mai
   Jarman, Richard
   Diagne, Cheikh
   Faye, Oumar
   Faye, Ousmane
   Sall, Amadou
   Lambrechts, Louis
TI A WORLDWIDE SURVEY OF AEDES AEGYPTI SUSCEPTIBILITY TO ZIKA VIRUS SHEDS
   LIGHT ON THE AFRICAN EXCEPTION TO ZIKA EMERGENCE
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Aubry, Fabien; Martynow, Daria; Baidaliuk, Artem; Merkling, Sarah; Dickson, Laura; Lambrechts, Louis] Pasteur Inst, Paris, France.
   [Romero-Vivas, Claudia] Univ Norte, Barranquilla, Colombia.
   [Vega-Rua, Anubis] Pasteur Inst, Les Abymes, Guadeloupe, France.
   [Dusfour, Isabelle] Pasteur Inst, Cayenne, French Guiana.
   [Jiolle, Davy] Malad Infect & Vecteurs Ecol Genet Evolut & Contr, Montpellier, France.
   [Paupy, Christophe] Ctr Int Rech Med Franceville, Franceville, Gabon.
   [Mayanja, Martin; Lutwama, Julius] Uganda Virus Res Inst, Entebbe, Uganda.
   [Kohl, Alain] Univ Glasgow, MRC, Ctr Virus Res, Glasgow, Lanark, Scotland.
   [Duong, Veasna] Pasteur Inst, Bogota, Colombia.
   [Ponlawat, Alongkot] Armed Forces Res Inst Med Sci, Bangkok, Thailand.
   [Cao-Lormeau, Van-Mai] Inst Louis Malarde, Tahiti, French Polynesi, France.
   [Jarman, Richard] Walter Reed Army Inst Res, Silver Spring, MD USA.
   [Diagne, Cheikh; Faye, Oumar; Faye, Ousmane; Sall, Amadou] Pasteur Inst, Dakar, Senegal.
RI Faye, Oumar/T-7168-2019
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 231
BP 72
EP 72
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386602232
DA 2020-07-08
ER

PT J
AU Ward, MJ
   Alger, J
   Berrueta, M
   Bock, H
   Buekens, P
   Cafferata, ML
   Ciganda, A
   Garcia, J
   Garcia, K
   Lorenzana, I
   Lopez, W
   Parham, L
   Wesson, DM
AF Ward, Matthew
   Alger, Jackeline
   Berrueta, Mabel
   Bock, Harry
   Buekens, Pierre
   Luisa Cafferata, Maria
   Ciganda, Alvaro
   Garcia, Jorge
   Garcia, Kimberly
   Lorenzana, Ivette
   Lopez, Wendy
   Parham, Leda
   Wesson, Dawn
TI ZIKA VIRUS AND THE WORLD HEALTH ORGANIZATION CRITERIA FOR DETERMINING
   RECENT INFECTION USING PLAQUE REDUCTION NEUTRALIZATION TESTING
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Ward, Matthew; Buekens, Pierre; Wesson, Dawn] Tulane Sch Publ Hlth & Trop Med, New Orleans, LA USA.
   [Alger, Jackeline; Garcia, Jorge; Lopez, Wendy] Hosp Escuela Univ, Dept Lab Clin, Tegucigalpa, Honduras.
   [Alger, Jackeline; Garcia, Jorge; Lopez, Wendy] Inst Enfermedades Infecciosas & Parasitol Antonio, Tegucigalpa, Honduras.
   [Berrueta, Mabel; Luisa Cafferata, Maria; Ciganda, Alvaro] Inst Efectividad Clin & Sanitaria, Buenos Aires, DF, Argentina.
   [Bock, Harry] Reg Sanitaria Metropolitana Dist Cent, Secretaria Salud Honduras, Tegucigalpa, Honduras.
   [Garcia, Kimberly; Lorenzana, Ivette; Parham, Leda] UNAH, Escuela Microbiol, CIG, Inst Invest Microbiol, Tegucigalpa, Honduras.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 234
BP 73
EP 73
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386602235
DA 2020-07-08
ER

PT J
AU Krystosik, AR
   LaBeaud, AD
   Davalos, D
   Bhatta, MP
   Curtis, A
   Pacheco, R
   Buritica, P
   Alvarez, AA
   Palacios, JHR
   James, MA
AF Krystosik, Amy
   LaBeaud, Angelle
   Davalos, Diana
   Bhatta, Madhav
   Curtis, Andrew
   Pacheco, Robinson
   Buritica, Paola
   Alvarez, Alvaro
   Palacios, Jorge
   James, Mark
TI NEED FOR REAL TIME ARBOVIRAL SURVEILLANCE DATA TO PREVENT OUTBREAKS. A
   RETROSPECTIVE STUDY OF ZIKA, CHIKUNGUNYA, AND DENGUE OUTBREAKS IN CALI
   COLOMBIA 2014 TO 2016
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Krystosik, Amy; LaBeaud, Angelle] Stanford Univ, Dept Pediat, Div Infect Dis, Stanford, CA 94305 USA.
   [Davalos, Diana; Pacheco, Robinson] Univ ICESI, Dept Publ Hlth & Community Med, Cali, Valle Del Cauca, Colombia.
   [Bhatta, Madhav] Kent State Univ, Coll Publ Hlth, Dept Biostat Environm Hlth Sci & Epidemiol, Kent, OH 44242 USA.
   [Curtis, Andrew] Kent State Univ, Dept Geog, GIS Hlth & Hazards Lab, Kent, OH 44242 USA.
   [Buritica, Paola] Univ Libre, Fac Salud, Cali, Valle Del Cauca, Colombia.
   [Alvarez, Alvaro] Caucaseco Sci Res Ctr, Cali, Valle Del Cauca, Colombia.
   [Palacios, Jorge] Secretaria Salud Cali, Cali, Valle Del Cauca, Colombia.
   [James, Mark] Coll Publ Hlth, Dept Biostat Environm Hlth Sci & Epidemiol, Kent, OH USA.
RI Curtis, Andrew/U-8674-2019
NR 0
TC 0
Z9 0
U1 1
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 239
BP 74
EP 75
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386602240
DA 2020-07-08
ER

PT J
AU Vielot, NA
   Stamm, L
   Herrington, J
   Squires, L
   Kelly, B
   McCormack, L
   Becker-Dreps, S
AF Vielot, Nadja
   Stamm, Lola
   Herrington, James
   Squires, Linda
   Kelly, Bridget
   McCormack, Lauren
   Becker-Dreps, Sylvia
TI US TRAVELERS' CONCERN ABOUT ZIKA INFECTION AND WILLINGNESS TO RECEIVE A
   HYPOTHETICAL ZIKA VACCINE
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Vielot, Nadja; Becker-Dreps, Sylvia] Univ N Carolina, Dept Family Med, Chapel Hill, NC 27515 USA.
   [Stamm, Lola] UNC Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC USA.
   [Herrington, James] UNC Gillings Sch Global Publ Hlth, Dept Hlth Behav, Chapel Hill, NC USA.
   [Squires, Linda; Kelly, Bridget; McCormack, Lauren] RTI Int, Res Triangle Pk, NC USA.
RI Vielot, Nadja/AAK-7532-2020; Vielot, Nadja/AAI-3632-2020
OI Vielot, Nadja/0000-0002-9004-0609; 
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 490
BP 154
EP 154
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386602495
DA 2020-07-08
ER

PT J
AU McDermott, EG
   Olowolayemo, HT
   Garver, LS
AF McDermott, Emily
   Olowolayemo, H.
   Garver, Lindsey
TI SUPERINFECTION EXCLUSION BETWEEN DENGUE AND ZIKA VIRUSES IN
   <it>AEDES</it> MOSQUITOES
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [McDermott, Emily; Olowolayemo, H.; Garver, Lindsey] Walter Reed Army Inst Res, Silver Spring, MD USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 666
BP 208
EP 208
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386602672
DA 2020-07-08
ER

PT J
AU Guezala, MC
   Quevedo, TP
   Albujar, CB
   Dupont, JC
   Astete, H
   Komar, N
   Salyer, SJ
   Montgomery, JM
   Mores, CM
AF Claudia Guezala, Maria
   Quevedo, Tatiana
   Albujar, Christian
   Dupont T, J.
   Astete, Helvio
   Komar, Nicholas
   Salyer, Stephanie
   Montgomery, Joel
   Mores, Christopher
TI SURVEILLANCE AT THE HUMAN-ANIMAL INTERFACE DURING ZIKA VIRUS
   TRANSMISSION - PERU
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Claudia Guezala, Maria; Albujar, Christian; Dupont T, J.; Astete, Helvio; Mores, Christopher] Naval Med Res Unit 6, Lima, Peru.
   [Quevedo, Tatiana] Vysnova Partners Inc, Lima, Peru.
   [Komar, Nicholas] Ctr Dis Control & Prevent, Arbovirus Dis Branch, Div Vector Borne Dis, Ft Collins, CO USA.
   [Salyer, Stephanie; Montgomery, Joel] Ctr Dis Control & Prevent, EISL Branch, Div Global Hlth Protect, Ctr Global Hlth, Atlanta, GA USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 708
BP 222
EP 222
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386603042
DA 2020-07-08
ER

PT J
AU Pinchoff, J
   Silva, M
   Stolow, J
   Hewett, P
   Moses, LM
AF Pinchoff, Jessie
   Silva, Martha
   Stolow, Jeni
   Hewett, Paul
   Moses, Lina
TI SPATIAL PATTERNS OF WATER STORAGE PRACTICES AND UPTAKE OF VECTOR CONTROL
   BEHAVIORS FOR ZIKA TO IMPROVE PREDICTIVE MAPPING OF <it>AEDES
   AEGYPTI</it> IN CENTRAL AMERICA
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Pinchoff, Jessie] Populat Council, 1230 York Ave, New York, NY 10021 USA.
   [Silva, Martha; Stolow, Jeni; Moses, Lina] Tulane Univ, New Orleans, LA 70118 USA.
   [Hewett, Paul] Populat Council, Washington, DC USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 812
BP 255
EP 255
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386603146
DA 2020-07-08
ER

PT J
AU Masters, J
   Drury, A
   Dean, C
   Yee, DA
   King, JG
AF Masters, Jillian
   Drury, Austin
   Dean, Catherine
   Yee, Donald
   King, Jonas
TI EFFECT OF LARVAL DIET, AGING, AND ZIKV INFECTION ON IMMUNE GENE
   REGULATION IN AEDES AEGYPTI
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Masters, Jillian; Drury, Austin; King, Jonas] Mississippi State Univ, Mississippi State, MS 39762 USA.
   [Dean, Catherine; Yee, Donald] Univ Southern Mississippi, Hattiesburg, MS 39406 USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 888
BP 279
EP 279
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386603224
DA 2020-07-08
ER

PT J
AU Masters, J
   Drury, A
   Dean, C
   Yee, DA
   King, JG
AF Masters, Jillian
   Drury, Austin
   Dean, Catherine
   Yee, Donald
   King, Jonas
TI EFFECT OF LARVAL DIET, AGING, AND ZIKV INFECTION ON IMMUNE GENE
   REGULATION IN AEDES AEGYPTI
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Masters, Jillian; Drury, Austin; King, Jonas] Mississippi State Univ, Mississippi State, MS 39762 USA.
   [Dean, Catherine; Yee, Donald] Univ Southern Mississippi, Hattiesburg, MS 39406 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 888
BP 279
EP 279
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386603223
DA 2020-07-08
ER

PT J
AU Boroughs, KL
   Ong, YT
   Anderson, KM
   Stovall, JL
   Dietrich, EA
   Huang, CYH
AF Boroughs, Karen
   Ong, Yee
   Anderson, Kimberly
   Stovall, Janae
   Dietrich, Elizabeth
   Huang, Claire
TI HIGH THROUGHPUT LIVE-IMAGE CYTOMETRY-BASED NEUTRALIZATION ASSAYS FOR
   DENGUE AND ZIKA VIRUSES
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Boroughs, Karen; Ong, Yee; Anderson, Kimberly; Stovall, Janae; Dietrich, Elizabeth; Huang, Claire] Ctr Dis Control & Prevent, Ft Collins, CO USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 901
BP 283
EP 283
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386603237
DA 2020-07-08
ER

PT J
AU Mugabe, VA
   Borja, LS
   Cardoso, CW
   Kitron, UC
   dos Reis, MG
   Ribeiro, GS
AF Mugabe, Vanio
   Borja, Lairton
   Cardoso, Cristiane
   Kitron, Uriel
   dos Reis, Mitermayer
   Ribeiro, Guilherme
TI HERD IMMUNITY TO ZIKA VIRUS MAY CAUSE CHANGES IN THE DYNAMICS OF DENGUE
   INCIDENCE IN THE AMERICAS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Mugabe, Vanio] Univ Fed Bahia, Inst Saude Coletiva, Salvador, BA, Brazil.
   [Borja, Lairton; dos Reis, Mitermayer; Ribeiro, Guilherme] Oswaldo Cruz Fdn FIOCRUZ, Salvador, BA, Brazil.
   [Cardoso, Cristiane] Secretaria Municipal Saude Salvador, Salvador, BA, Brazil.
   [Kitron, Uriel] Emory Univ, Atlanta, GA 30322 USA.
RI Ribeiro, Guilherme/B-6624-2008
OI Ribeiro, Guilherme/0000-0002-6798-2059
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 905
BP 284
EP 285
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386603241
DA 2020-07-08
ER

PT J
AU Herrington, J
   Squiers, L
   Lynch, M
   Dolina, S
   Ray, S
   Kelly, B
   Turner, M
   Chawla, D
   Becker-Dreps, S
   Stamm, L
   McCormack, L
AF Herrington, James
   Squiers, Linda
   Lynch, Molly
   Dolina, Suzanne
   Ray, Sarah
   Kelly, Bridget
   Turner, Mallory
   Chawla, Devika
   Becker-Dreps, Sylvia
   Stamm, Lola
   McCormack, Lauren
TI ZIKA VIRUS AND TRAVEL IN THE NEWS - A MEDIA CONTENT ANALYSIS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Herrington, James; Turner, Mallory; Chawla, Devika; Becker-Dreps, Sylvia; Stamm, Lola] Univ N Carolina, Chapel Hill, NC 27515 USA.
   [Squiers, Linda; Lynch, Molly; Dolina, Suzanne; Ray, Sarah; Kelly, Bridget; McCormack, Lauren] RTI Int, Res Triangle Pk, NC USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 920
BP 289
EP 289
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386603256
DA 2020-07-08
ER

PT J
AU Lusk, R
   Zimmerman, J
   VanMaldeghem, K
   Kim, S
   Roth, N
   Lavinder, J
   Fulton, A
   Raycraft, M
   Galang, R
AF Lusk, Richard
   Zimmerman, John
   VanMaldeghem, Kelley
   Kim, Suzanna
   Roth, Nicole
   Lavinder, James
   Fulton, Anna
   Raycraft, Meghan
   Galang, Romeo
TI USE OF MACHINE LEARNING IN SURVEILLANCE CASE IDENTIFICATION FOR THE ZIKA
   EMERGENCY RESPONSE
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Lusk, Richard; Zimmerman, John; VanMaldeghem, Kelley; Kim, Suzanna; Lavinder, James; Raycraft, Meghan] Deloitte, Atlanta, GA USA.
   [Roth, Nicole; Fulton, Anna] Eagle Med Serv, Atlanta, GA USA.
   [Galang, Romeo] Ctr Dis Control & Prevent, Atlanta, GA USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 921
BP 289
EP 290
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386603257
DA 2020-07-08
ER

PT J
AU Escalante-Maldonado, O
   Garcia, MP
   Cabezas, C
   Gavilan, RG
   Yamazaki, W
AF Escalante-Maldonado, Oscar
   Paquita Garcia, Maria
   Cabezas, Cesar
   Gustavo Gavilan, Ronnie
   Yamazaki, Wataru
TI DEVELOPMENT OF A POINT OF CARE METHOD FOR DETECTION OF ZIKA VIRUS BASED
   ON LOOP-MEDIATED ISOTHERMAL AMPLIFICATION
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Escalante-Maldonado, Oscar; Paquita Garcia, Maria; Cabezas, Cesar; Gustavo Gavilan, Ronnie] Natl Inst Hlth, Lima, Peru.
   [Yamazaki, Wataru] Univ Miyazaki, Miyazaki, Japan.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 923
BP 290
EP 290
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386603259
DA 2020-07-08
ER

PT J
AU Lopez, CA
   Schaefer, AM
   Lai, SK
   Lazear, HM
AF Lopez, Cesar
   Schaefer, Alison
   Lai, Sam
   Lazear, Helen
TI THE ROLE OF CROSS-REACTIVE DENGUE VIRUS ANTIBODIES IN SEXUAL
   TRANSMISSION OF ZIKA VIRUS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Lopez, Cesar; Schaefer, Alison; Lai, Sam; Lazear, Helen] Univ N Carolina, Chapel Hill, NC 27515 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 924
BP 290
EP 291
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386603260
DA 2020-07-08
ER

PT J
AU Henderson, RR
   Bardosh, K
   Ibarra, AMS
AF Henderson, Rebecca
   Bardosh, Kevin
   Ibarra, Anna
TI IMAGINING ZIKA: EPIDEMIOLOGY, GLOBAL HEALTH, AND UNCERTAINTY
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Henderson, Rebecca; Bardosh, Kevin] Univ Florida, Gainesville, FL USA.
   [Ibarra, Anna] SUNY Upstate Med Univ, Syracuse, NY 13210 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 926
BP 291
EP 291
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386603262
DA 2020-07-08
ER

PT J
AU McDonald, EM
   Duggal, NK
   Ritter, JM
   Brault, AC
AF McDonald, Erin
   Duggal, Nisha
   Ritter, Jana
   Brault, Aaron
TI STRUCTURAL PROTEINS PRME DICTATE SEXUAL TRANSMISSION POTENTIAL OF ZIKV
   IN AN IMMUNOCOMPETENT MOUSE MODEL
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [McDonald, Erin; Brault, Aaron] Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO USA.
   [Duggal, Nisha] Virginia Maryland Coll Vet Med, Dept Biomed Sci & Pathobiol, Blacksburg, VA USA.
   [Ritter, Jana] Ctr Dis Control & Prevent, Div Highconsequence Pathogens & Pathol, Atlanta, GA USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 927
BP 291
EP 291
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386603263
DA 2020-07-08
ER

PT J
AU MIller, MR
   Bowen, R
   Schountz, T
   Foy, B
AF MIller, Megan
   Bowen, Richard
   Schountz, Tony
   Foy, Brian
TI DETERMINING AN IMMUNOCOMPETENT, SMALL ANIMAL SEXUAL TRANSMISSION MODEL
   FOR ZIKA VIRUS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [MIller, Megan; Bowen, Richard; Schountz, Tony; Foy, Brian] Colorado State Univ, Ft Collins, CO 80523 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 925
BP 291
EP 291
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386603261
DA 2020-07-08
ER

PT J
AU Strange, DP
   Zarandi, NP
   Trivedi, G
   Atala, A
   Bishop, CE
   Sadri-Ardekani, H
   Verma, S
AF Strange, Daniel
   Zarandi, Nima
   Trivedi, Goral
   Atala, Anthony
   Bishop, Colin
   Sadri-Ardekani, Hooman
   Verma, Saguna
TI HUMAN TESTICULAR ORGANOID MODEL AS AN <it>IN VITRO</it> SYSTEM TO
   INVESTIGATE ZIKA VIRUS PATHOGENESIS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Strange, Daniel; Trivedi, Goral; Verma, Saguna] Univ Hawaii Manoa, John A Burns Sch Med, Dept Trop Med Med Microbiol & Pharmacol, Honolulu, HI 96822 USA.
   [Zarandi, Nima; Atala, Anthony; Bishop, Colin; Sadri-Ardekani, Hooman] WFIRM, Salem, NC USA.
   [Atala, Anthony; Sadri-Ardekani, Hooman] Wake Forest Sch Med, Dept Urol, Salem, NC USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 928
BP 291
EP 292
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386603264
DA 2020-07-08
ER

PT J
AU Lozier, MJ
   Rosenberg, E
   Doyle, K
   Munoz-Jordan, JL
   Little, E
   Klein, L
   Beltran, M
   Adams, L
   Alvarado, LI
   Paz-Bailey, G
   Sharp, TM
AF Lozier, Matthew
   Rosenberg, Eli
   Doyle, Kate
   Munoz-Jordan, Jorge
   Little, Emma
   Klein, Liore
   Beltran, Manuela
   Adams, Laura
   Alvarado, Luisa
   Paz-Bailey, Gabriela
   Sharp, Tyler
TI DURATION OF DETECTION OF ANTI-ZIKA VIRUS IGM ANTIBODY IN A PROSPECTIVE
   COHORT STUDY
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Lozier, Matthew; Munoz-Jordan, Jorge; Beltran, Manuela; Adams, Laura; Paz-Bailey, Gabriela; Sharp, Tyler] Ctr Dis Control & Prevent, San Juan, PR USA.
   [Rosenberg, Eli] SUNY Albany, Albany, NY 12222 USA.
   [Doyle, Kate] Ctr Dis Control & Prevent, Atlanta, GA USA.
   [Little, Emma; Klein, Liore] Oak Ridge Inst Sci & Educ, Oak Ridge, TN USA.
   [Alvarado, Luisa] Ponce Hlth Sci Univ, Ponce, PR USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 931
BP 292
EP 293
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386603267
DA 2020-07-08
ER

PT J
AU McCracken, MK
   Sanborn, MA
   Lewis, BS
   Putnak, JR
   Jarman, RG
   Gromowski, GD
   Berry, IM
   Rutvisuttinunt, W
AF McCracken, Michael
   Sanborn, Mark
   Lewis, Bridget
   Putnak, J.
   Jarman, Richard
   Gromowski, Gregory
   Berry, Irina
   Rutvisuttinunt, Wiriya
TI LONG TERM PERSISTENCE OF ZIKA VIRUS IN RHESUS MACAQUE TISSUES
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [McCracken, Michael; Sanborn, Mark; Lewis, Bridget; Putnak, J.; Jarman, Richard; Gromowski, Gregory; Berry, Irina; Rutvisuttinunt, Wiriya] Walter Reed Army Inst Res, Silver Spring, MD USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 930
BP 292
EP 292
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386603266
DA 2020-07-08
ER

PT J
AU Moore, S
   Soda, J
   Raybaud, B
   Wenger, E
   Welkhoff, P
   Perkins, A
AF Moore, Sean
   Soda, James
   Raybaud, Benoit
   Wenger, Edward
   Welkhoff, Philip
   Perkins, Alex
TI LOCAL AND REGIONAL DYNAMICS OF ZIKA VIRUS TRANSMISSION IN THE AMERICAS:
   THE ROLE OF MISMATCHED SPATIAL HETEROGENEITY
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Moore, Sean; Soda, James; Perkins, Alex] Univ Notre Dame, Notre Dame, IN 46556 USA.
   [Raybaud, Benoit; Wenger, Edward] Inst Dis Modeling, Bellevue, WA USA.
   [Welkhoff, Philip] Bill & Melinda Gates Fdn, Seattle, WA USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 929
BP 292
EP 292
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386603265
DA 2020-07-08
ER

PT J
AU Ellision, DW
   Klungthong, C
   Chinnawirotpisan, P
   Manasatienkij, W
   Poolpanichupatam, Y
   Hussem, K
   Thaisomboonsuk, B
   Lohachanakul, J
   Nisalak, A
   Buddhari, D
   Khuntirat, B
   Suntarattiwong, P
   Watanaveeradej, V
   Suwanpakdee, D
   Simasathien, S
   Chuenchitra, T
   Chusri, S
   Buathong, R
   Weg, AL
   Anderson, K
   Macareo, LR
AF Ellision, Damon
   Klungthong, Chonticha
   Chinnawirotpisan, Piyawan
   Manasatienkij, Wudtichai
   Poolpanichupatam, Yongyuth
   Hussem, Kittinun
   Thaisomboonsuk, Butsaya
   Lohachanakul, Jindarat
   Nisalak, Ananda
   Buddhari, Darunee
   Khuntirat, Benjawan
   Suntarattiwong, Piyarat
   Watanaveeradej, Veerachai
   Suwanpakdee, Detchvijitr
   Simasathien, Sriluck
   Chuenchitra, Thippawan
   Chusri, Sarunyou
   Buathong, Rome
   Weg, Alden
   Anderson, Katie
   Macareo, Louis
TI DETECTION AND MOLECULAR CHARACTERIZATION OF ZIKA VIRUS IN SPECIMENS
   COLLECTED DURING 1998 TO 2017 FROM THAILAND
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Ellision, Damon; Klungthong, Chonticha; Chinnawirotpisan, Piyawan; Manasatienkij, Wudtichai; Poolpanichupatam, Yongyuth; Hussem, Kittinun; Thaisomboonsuk, Butsaya; Lohachanakul, Jindarat; Nisalak, Ananda; Buddhari, Darunee; Khuntirat, Benjawan; Weg, Alden; Anderson, Katie; Macareo, Louis] Armed Forces Res Inst Med Sci, US Army Med Directorate, Dept Virol, Bangkok, Thailand.
   [Suntarattiwong, Piyarat] Queen Sirikit Natl Inst Child Hlth, Dept Pediat, Bangkok, Thailand.
   [Watanaveeradej, Veerachai] Phramongkutklao Coll Med, Dept Microbiol, Bangkok, Thailand.
   [Suwanpakdee, Detchvijitr; Simasathien, Sriluck] Phramongkutklao Hosp, Dept Pediat, Bangkok, Thailand.
   [Chuenchitra, Thippawan] Armed Forces Res Inst Med Sci, Bangkok, Thailand.
   [Chusri, Sarunyou] Prince Songkla Univ, Dept Internal Med, Fac Med, Hat Yai, Thailand.
   [Buathong, Rome] Minist Publ Hlth, Bur Epidemiol, Dept Dis Control, Nonthaburi, Thailand.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 934
BP 293
EP 294
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386603270
DA 2020-07-08
ER

PT J
AU Mayton, EH
   Christofferson, RC
AF Mayton, E.
   Christofferson, Rebecca
TI EFFECTS OF AGE, BLOOD MEAL ACQUISITION, AND MORTALITY ON THE
   TRANSMISSION POTENTIAL OF ZIKA VIRUS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Mayton, E.; Christofferson, Rebecca] Louisiana State Univ, Sch Vet Med, Baton Rouge, LA 70803 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 932
BP 293
EP 293
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386603268
DA 2020-07-08
ER

PT J
AU Bustos, F
   Zambrana, JV
   Burger-Calderon, R
   Collado, D
   Sanchez, N
   Ojeda, S
   Monterrey, JC
   Plazaola, M
   Lopez, B
   Arguello, S
   Elizondo, D
   Avlies, W
   Coloma, J
   Kuan, G
   Balmaseda, A
   Gordon, A
   Harris, E
AF Bustos, Fausto
   Victor Zambrana, Jose
   Burger-Calderon, Raquel
   Collado, Damaris
   Sanchez, Nery
   Ojeda, Sergio
   Monterrey, Jairo
   Plazaola, Miguel
   Lopez, Brenda
   Arguello, Sonia
   Elizondo, Douglas
   Avlies, William
   Coloma, Josefina
   Kuan, Guillermina
   Balmaseda, Angel
   Gordon, Aubree
   Harris, Eva
TI SEROPREVALENCE, RISK FACTOR, AND SPATIAL ANALYSES OF ZIKA VIRUS
   INFECTION AFTER THE 2016 EPIDEMIC IN MANAGUA, NICARAGUA
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Bustos, Fausto; Burger-Calderon, Raquel; Coloma, Josefina; Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
   [Victor Zambrana, Jose; Collado, Damaris; Sanchez, Nery; Ojeda, Sergio; Monterrey, Jairo; Plazaola, Miguel; Lopez, Brenda; Arguello, Sonia; Elizondo, Douglas; Avlies, William] Sustainable Sci Inst, Managua, Nicaragua.
   [Kuan, Guillermina] Minist Hlth, Ctr Salud Socrates Flores Vivas, Managua, Nicaragua.
   [Balmaseda, Angel] Minist Hlth, Ctr Nacl Diagnost & Referencia, Lab Nacl Virol, Managua, Nicaragua.
   [Gordon, Aubree] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 937
BP 294
EP 295
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386603273
DA 2020-07-08
ER

PT J
AU Hunsperger, EA
   Odhiambo, D
   Makio, A
   Alando, M
   Ochieng, M
   Omballa, V
   Bigogo, G
   Munyua, P
   Widdowson, MA
AF Hunsperger, Elizabeth
   Odhiambo, Dennis
   Makio, Albina
   Alando, Moshe
   Ochieng, Melvin
   Omballa, Victor
   Bigogo, Godfrey
   Munyua, Peninah
   Widdowson, Marc-Alain
TI A RETROSPECTIVE STUDY USING A SEROSURVEY TO DETECT ZIKA VIRUS IN
   MOMBASA, KENYA
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Hunsperger, Elizabeth; Munyua, Peninah; Widdowson, Marc-Alain] Ctr Dis Control & Prevent, Nairobi, Kenya.
   [Odhiambo, Dennis; Makio, Albina; Alando, Moshe; Ochieng, Melvin; Omballa, Victor; Bigogo, Godfrey] KEMRI, Nairobi, Kenya.
RI Bigogo, Godfrey/W-3591-2019
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 936
BP 294
EP 294
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386603272
DA 2020-07-08
ER

PT J
AU Davidson, E
   Whitbeck, C
   Thomas, A
   Bryan, A
   Sullivan, T
   Stafford, LJ
   Sapparapu, G
   Crowe, J
   Doranz, BJ
AF Davidson, Edgar
   Whitbeck, Chuck
   Thomas, Anu
   Bryan, Aubrey
   Sullivan, Tabb
   Stafford, Lewis
   Sapparapu, Gopal
   Crowe, James, Jr.
   Doranz, Benjamin
TI CHARACTERIZING THE IMMUNE RESPONSE TO ZIKA VIRUS USING EPITOPE MAPPING,
   REPORTER VIRUS PARTICLES, AND ANTI-ZIKV ANTIBODIES
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Davidson, Edgar; Whitbeck, Chuck; Thomas, Anu; Bryan, Aubrey; Sullivan, Tabb; Stafford, Lewis; Doranz, Benjamin] Integral Mol Inc, Philadelphia, PA USA.
   [Sapparapu, Gopal; Crowe, James, Jr.] Vanderbilt Univ, 221 Kirkland Hall, Nashville, TN 37235 USA.
RI Crowe, James E./B-5549-2009
OI Crowe, James E./0000-0002-0049-1079
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 940
BP 295
EP 296
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386603276
DA 2020-07-08
ER

PT J
AU Marban-Castro, E
   Salvia, D
   Gonce, A
   Esteve, C
   Martinez, MJ
   Alejo-Cancho, I
   Lopez, M
   Garcia, L
   Salazar, L
   Fuente-Moreno, M
   Casellas, A
   Fortuny, C
   Menendez, C
   Bardaji, A
   Fumado, V
AF Marban-Castro, Elena
   Salvia, Dolors
   Gonce, Anna
   Esteve, Carolina
   Martinez, Miguel
   Alejo-Cancho, Izaskun
   Lopez, Marta
   Garcia, Laura
   Salazar, Laura
   Fuente-Moreno, Marina
   Casellas, Aina
   Fortuny, Claudia
   Menendez, Clara
   Bardaji, Azucena
   Fumado, Victoria
TI NEUROLOGICAL ASSESSMENT OF CHILDREN BORN TO PREGNANT WOMEN RETURNING
   FROM ZIKA AFFECTED AREAS: RESULTS FROM SURVEILLANCE IN A NON-ENDEMIC
   AREA
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Marban-Castro, Elena; Martinez, Miguel; Fuente-Moreno, Marina; Casellas, Aina; Menendez, Clara; Bardaji, Azucena; Fumado, Victoria] Univ Barcelona, Hosp Clin, ISGlobal, Barcelona, Spain.
   [Salvia, Dolors; Gonce, Anna; Esteve, Carolina; Lopez, Marta; Garcia, Laura; Salazar, Laura; Fortuny, Claudia] BCNatal Barcelona Ctr Maternal Fetal & Neonatal M, Dept Maternal Fetal Med, Barcelona, Spain.
   [Alejo-Cancho, Izaskun] Hosp Clin Barcelona, Dept Clin Microbiol, Barcelona, Spain.
RI Bardaji, Azucena/AAE-9145-2019
OI Bardaji, Azucena/0000-0002-5135-0540
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 939
BP 295
EP 295
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386603275
DA 2020-07-08
ER

PT J
AU Rosenberg, E
   Doyle, K
   Adams, L
   Munoz, J
   Klein, L
   Lozier, M
   Sharp, TM
   Paz-Bailey, G
AF Rosenberg, Eli
   Doyle, Kate
   Adams, Laura
   Munoz, Jorge
   Klein, Liore
   Lozier, Matthew
   Sharp, Tyler
   Paz-Bailey, Gabriela
TI CHANGES IN BEHAVIORS ASSOCIATED WITH TRANSMISSION AMONG A COHORT OF ZIKA
   VIRUS INFECTED PARTICIPANTS IN PUERTO RICO
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Rosenberg, Eli] SUNY Albany, Sch Publ Hlth, Rensselaer, NY USA.
   [Doyle, Kate; Adams, Laura; Munoz, Jorge; Lozier, Matthew; Sharp, Tyler; Paz-Bailey, Gabriela] Ctr Dis Control & Prevent, San Juan, PR USA.
   [Klein, Liore] Oak Ridge Inst Sci & Educ, San Juan, PR USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 938
BP 295
EP 295
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386603274
DA 2020-07-08
ER

PT J
AU Nouvellet, P
   Cucunuba, ZM
   Rodriguez-Barraquer, I
   Vanhomwegen, J
   Montoya, MC
   Correa, AT
   Burgos, EC
   Estupinan, MI
   Lozano, A
   Gelves, M
   Herrera, M
   Manuguerra, JC
   Basanez, MG
   Donnely, CA
   Osorio, J
   Villar, LA
   Ferguson, NM
AF Nouvellet, Pierre
   Cucunuba, Zulma
   Rodriguez-Barraquer, Isabel
   Vanhomwegen, Jessica
   Montoya, Maria-Consuelo
   Trujillo Correa, Andrea
   Camacho Burgos, Erwin
   Estupinan, Maria
   Lozano, Anyela
   Gelves, Margarita
   Herrera, Mauricio
   Manuguerra, Jean-Claude
   Basanez, Maria-Gloria
   Donnely, Christl
   Osorio, Jorge
   Villar, Luis
   Ferguson, Neil
TI CHARACTERIZATION OF POPULATION EXPOSURE (SEROPREVALENCE) TO ARBOVIRUSES
   AFTER RECENT OUTBREAKS IN COLOMBIA: DENGUE, CHIKUNGUNYA AND ZIKA
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Nouvellet, Pierre; Cucunuba, Zulma; Camacho Burgos, Erwin; Basanez, Maria-Gloria; Donnely, Christl; Ferguson, Neil] Imperial Coll London, London, England.
   [Rodriguez-Barraquer, Isabel] Univ Calif San Francisco, San Francisco, CA 94143 USA.
   [Vanhomwegen, Jessica; Manuguerra, Jean-Claude] Inst Paster, Paris, France.
   [Montoya, Maria-Consuelo; Estupinan, Maria; Lozano, Anyela; Gelves, Margarita; Villar, Luis] Univ Ind Santander, Pidecuesta, Colombia.
   [Trujillo Correa, Andrea] Univ Antioquia, Medellin, Colombia.
   [Camacho Burgos, Erwin] Univ Sucre, Sincelejo, Colombia.
   [Herrera, Mauricio] Univ Autonoma Bucaramanga, Bucaramanga, Colombia.
   [Osorio, Jorge] Univ Wisconsin, Madison, WI USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 941
BP 296
EP 296
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386603277
DA 2020-07-08
ER

PT J
AU Rosinger, A
   Ellington, S
   Perez-Padilla, J
   Olson, S
   Simeone, R
   Pedati, C
   Schroeder, B
   Munoz-Jordan, JL
   Adams, LE
   Galang, R
   Valencia-Prado, M
   Colon, C
   Goodwin, M
   Meaney-Delman, D
   Petersen, L
   Jamieson, D
   Deseda, C
   Honein, M
   Rivera-Garcia, B
   Shapiro-Mendoza, C
AF Rosinger, Asher
   Ellington, Sascha
   Perez-Padilla, Janice
   Olson, Samantha
   Simeone, Regina
   Pedati, Caitlin
   Schroeder, Betsy
   Munoz-Jordan, Jorge
   Adams, Laura
   Galang, Romeo
   Valencia-Prado, Miguel
   Colon, Candimar
   Goodwin, Mary
   Meaney-Delman, Dana
   Petersen, Lyle
   Jamieson, Denise
   Deseda, Carmen
   Honein, Margaret
   Rivera-Garcia, Brenda
   Shapiro-Mendoza, Carrie
TI EVALUATING DIFFERENCES IN ZIKA VIRUS DIAGNOSTIC TEST RESULTS BY SPECIMEN
   TYPE AMONG PREGNANT WOMEN DURING THE ZIKA VIRUS OUTBREAK, PUERTO RICO
   2016
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Rosinger, Asher] Penn State Univ, State Coll, PA USA.
   [Ellington, Sascha; Olson, Samantha; Simeone, Regina; Galang, Romeo; Goodwin, Mary; Meaney-Delman, Dana; Honein, Margaret; Shapiro-Mendoza, Carrie] Ctr Dis Control & Prevent, Atlanta, GA USA.
   [Perez-Padilla, Janice; Munoz-Jordan, Jorge; Adams, Laura; Colon, Candimar] Ctr Dis Control & Prevent, San Juan, PR USA.
   [Pedati, Caitlin] Nebraska Dept Hlth & Human Serv, Nebraska City, NE USA.
   [Schroeder, Betsy] Indiana State Dept Hlth, Indianapolis, IN 46202 USA.
   [Valencia-Prado, Miguel; Rivera-Garcia, Brenda] Puerto Rico Dept Hlth, San Juan, PR USA.
   [Petersen, Lyle] Ctr Dis Control & Prevent, Ft Collins, CO USA.
   [Jamieson, Denise] Emory Univ, Atlanta, GA 30322 USA.
   [Deseda, Carmen] Puerto Rico Dept Hlth, Atlanta, GA USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 942
BP 296
EP 296
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386603278
DA 2020-07-08
ER

PT J
AU Chung, H
   Espana, G
   Siraj, A
   Soda, J
   Perkins, A
AF Chung, Henri
   Espana, Guido
   Siraj, Amir
   Soda, James
   Perkins, Alex
TI FORECASTING ZIKA INCIDENCE USING DENGUE SURVEILLANCE DATA FROM COLOMBIA
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Chung, Henri; Espana, Guido; Siraj, Amir; Soda, James; Perkins, Alex] Univ Notre Dame, South Bend, IN USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 946
BP 297
EP 298
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386603282
DA 2020-07-08
ER

PT J
AU Lebov, JF
   Brown, LM
   Rivera, TA
   Pugh, N
   Hooper, SR
AF Lebov, Jill
   Brown, Linda
   Aleman Rivera, Teresa
   Pugh, Norma
   Hooper, Stephen
TI NEUROLOGICAL SEQUELAE ASSOCIATED WITH ACQUIRED ZIKA VIRUS INFECTION IN
   CHILDREN
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Lebov, Jill; Brown, Linda; Pugh, Norma] RTI Int, Res Triangle Pk, NC USA.
   [Aleman Rivera, Teresa] Univ Nacl Autonoma Nicaragua, Leon, Nicaragua.
   [Hooper, Stephen] Univ N Carolina, Chapel Hill, NC 27515 USA.
RI Hooper, Stephen/X-8171-2019
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 944
BP 297
EP 297
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386603280
DA 2020-07-08
ER

PT J
AU Loeffler, F
   Lins, R
   Fischer, N
   Viana, I
   Cataldi, C
   Leite, B
   Magalhaes, T
   Cordeiro, MT
   Marques, ET
   Jaenisch, T
AF Loeffler, Felix
   Lins, Roberto
   Fischer, Nico
   Viana, Isabelle
   Cataldi, Catarina
   Leite, Bruno
   Magalhaes, Tereza
   Cordeiro, Marli
   Marques, Ernesto
   Jaenisch, Thomas
TI UNEXPECTED PROPERTIES OF A ZIKA NS2B EPITOPE SUGGEST ITS POTENTIAL AS A
   BIOMARKER FOR DIAGNOSIS AND PROGNOSIS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Loeffler, Felix] Max Planck Inst Colloids & Interfaces, Potsdam, Germany.
   [Lins, Roberto; Viana, Isabelle; Cataldi, Catarina; Leite, Bruno; Cordeiro, Marli] Fundacao Oswaldo Cruz, Recife, PE, Brazil.
   [Fischer, Nico; Jaenisch, Thomas] Heidelberg Univ Hosp, Heidelberg, Germany.
   [Magalhaes, Tereza] Colorado State Univ, Ft Collins, CO 80523 USA.
   [Marques, Ernesto] Univ Pittsburgh, Pittsburgh, PA USA.
RI Marques, Ernesto T. A/L-4967-2013
OI Marques, Ernesto T. A/0000-0003-3826-9358
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 943
BP 297
EP 297
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386603279
DA 2020-07-08
ER

PT J
AU Medina, FA
   Torres, G
   Acevedo, J
   Fonseca, S
   Casiano, L
   De Leon, C
   Santiago, GA
   Doyle, K
   Sharp, TM
   Paz-Bailey, G
   Munoz-Jordan, JL
AF Medina, Freddy
   Torres, Giselle
   Acevedo, Jenny
   Fonseca, Sharon
   Casiano, Leslie
   De Leon, Carlos
   Santiago, Gilberto
   Doyle, Katherine
   Sharp, Tyler
   Paz-Bailey, Gabriela
   Munoz-Jordan, Jorge
TI DURATION OF INFECTIOUS ZIKA VIRUS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Medina, Freddy; Torres, Giselle; Acevedo, Jenny; Fonseca, Sharon; Casiano, Leslie; De Leon, Carlos; Santiago, Gilberto; Doyle, Katherine; Sharp, Tyler; Paz-Bailey, Gabriela; Munoz-Jordan, Jorge] Ctr Dis Control, San Juan, PR USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 947
BP 298
EP 298
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386603283
DA 2020-07-08
ER

PT J
AU Husain, T
   Pike, B
   Khor, CS
   Mohd-Rahim, NF
   Hassan, H
   Nore, SS
   Johari, J
   Loong, SK
   Abd-Jamil, J
   Zandi, K
   Khoo, JJ
   Lee, HY
   Lim, YAL
   AbuBakar, S
AF Husain, Tupur
   Pike, Brian
   Khor, Chee-Sieng
   Mohd-Rahim, Nurul-Farhana
   Hassan, Habibi
   Nore, Siti-Sarah
   Johari, Jefree
   Loong, Shih-Keng
   Abd-Jamil, Juraina
   Zandi, Keivan
   Khoo, Jing-Jing
   Lee, Hai-Yen
   Lim, Yvonne
   AbuBakar, Sazaly
TI PREVALENCE OF DENGUE VIRUS, CHIKUNGUNYA VIRUS, AND ZIKA VIRUS DETERMINED
   THROUGH ENHANCED SURVEILLANCE OF EMERGING INFECTIOUS DISEASES IN
   MALAYSIA
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Husain, Tupur; Pike, Brian] Naval Med Res Unit 2, FPO, AE USA.
   [Khor, Chee-Sieng; Mohd-Rahim, Nurul-Farhana; Hassan, Habibi; Nore, Siti-Sarah; Johari, Jefree; Loong, Shih-Keng; Abd-Jamil, Juraina; Zandi, Keivan; Khoo, Jing-Jing; Lee, Hai-Yen; AbuBakar, Sazaly] Univ Malaya, TIDREC, Kuala Lumpur, Malaysia.
   [Lim, Yvonne] Univ Malaya, Dept Parasitol, Fac Med, Kuala Lumpur, Malaysia.
RI Khoo, Jing Jing/G-6198-2013; LIM, YVONNE AL/B-5276-2010
OI Khoo, Jing Jing/0000-0003-1285-6052; LIM, YVONNE AL/0000-0003-4050-6332
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 962
BP 302
EP 302
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386603298
DA 2020-07-08
ER

PT J
AU Kaneechit, W
   Lohachanakul, J
   Thaisomboonsuk, B
   Klungthong, C
   Poolpanichupatam, Y
   Khiankaew, T
   Tawilert, C
   Buathong, R
   Alera, M
   Chusri, S
   Buddhari, D
   Watanaveeradej, V
   Chuenchitra, T
   Hinjoy, S
   Thanajirasak, S
   Jarman, RG
   Fernandez, S
   Yoon, IK
   Anderson, KB
   Nisalak, A
   Srikiatkhachorn, A
   Ellison, DW
   Weg, AL
   Macareo, LR
AF Kaneechit, Winai
   Lohachanakul, Jindarat
   Thaisomboonsuk, Butsaya
   Klungthong, Chonticha
   Poolpanichupatam, Yongyuth
   Khiankaew, Thongchai
   Tawilert, Chutithorn
   Buathong, Rome
   Alera, Maria
   Chusri, Sarunyou
   Buddhari, Darunee
   Watanaveeradej, Veerachai
   Chuenchitra, Thippawan
   Hinjoy, Soawapak
   Thanajirasak, Suppakrit
   Jarman, Richard
   Fernandez, Stefan
   Yoon, In-Kyu
   Anderson, Kathryn
   Nisalak, Ananda
   Srikiatkhachorn, Anon
   Ellison, Damon
   Weg, Alden
   Macareo, Louis
TI EVALUATION OF ZIKA VIRUS ISOLATION PROCEDURES USING MOSQUITO INOCULATION
   COMPARED TO <it>IN VITRO</it> C6/36 CELL CULTURE
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Kaneechit, Winai; Lohachanakul, Jindarat; Thaisomboonsuk, Butsaya; Klungthong, Chonticha; Poolpanichupatam, Yongyuth; Khiankaew, Thongchai; Tawilert, Chutithorn; Buddhari, Darunee; Anderson, Kathryn; Nisalak, Ananda; Ellison, Damon; Weg, Alden; Macareo, Louis] AFRIMS, Dept Virol, Bangkok, Thailand.
   [Buathong, Rome; Hinjoy, Soawapak; Thanajirasak, Suppakrit] Minist Publ Hlth, Bur Epidemiol, Dept Dis Control, Bangkok, Thailand.
   [Alera, Maria] Philippines Armed Forces Res Inst Med Sci, Cebu, Philippines.
   [Chusri, Sarunyou] PSU, Dept Internal Med, Fac Med, Hat Yai, Thailand.
   [Watanaveeradej, Veerachai] Phramongkutklao Hosp, Bangkok, Thailand.
   [Chuenchitra, Thippawan] Royal Thai Army RTA AFRIMS, Bangkok, Thailand.
   [Jarman, Richard] Walter Reed Army Inst Res, Bethesda, MD USA.
   [Fernandez, Stefan] US Army, Med Mat Dev Act, Ft Detrick, MD USA.
   [Yoon, In-Kyu] Int Vaccine Inst, Soul, South Korea.
   [Srikiatkhachorn, Anon] Univ Rhode Isl, 825 Chalkstone Ave, Providence, RI 02908 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 961
BP 302
EP 302
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386603297
DA 2020-07-08
ER

PT J
AU Charniga, KA
   Cucunuba, ZM
   Mercado, M
   Prieto, F
   Ospina, M
   Ferguson, NM
   Nouvellet, P
   Donnelly, CA
AF Charniga, Kelly
   Cucunuba, Zulma
   Mercado, Marcela
   Prieto, Franklyn
   Ospina, Martha
   Ferguson, Neil
   Nouvellet, Pierre
   Donnelly, Christl
TI SPATIAL AND TEMPORAL SPREAD OF ZIKA AND CHIKUNGUNYA VIRUSES IN COLOMBIA,
   A GRAVITY-MODEL BASED APPROACH
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Charniga, Kelly; Cucunuba, Zulma; Ferguson, Neil; Donnelly, Christl] Imperial Coll London, London, England.
   [Mercado, Marcela; Prieto, Franklyn; Ospina, Martha] Natl Inst Hlth Colombia, Bogota, Colombia.
   [Nouvellet, Pierre] Univ Sussex, Brighton, E Sussex, England.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 971
BP 305
EP 305
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386603307
DA 2020-07-08
ER

PT J
AU Michlmayr, D
   Suarez-Farinas, M
   Kim, EY
   Rahman, A
   Kim-Schulze, S
   Kuan, G
   Balmaseda, A
   Wolinsky, SM
   Kasarskis, A
   Harris, E
AF Michlmayr, Daniela
   Suarez-Farinas, Mayte
   Kim, Eun-young
   Rahman, Adeeb
   Kim-Schulze, Seunghee
   Kuan, Guillermina
   Balmaseda, Angel
   Wolinsky, Steven
   Kasarskis, Andrew
   Harris, Eva
TI COMPREHENSIVE INNATE IMMUNE PROFILING OF ZIKA CASES REVEALS A KEY ROLE
   OF MONOCYTES IN THE ACUTE PHASE OF INFECTION AND NO EFFECT OF PRIOR
   DENGUE VIRUS INFECTION ON THE INNATE IMMUNE RESPONSE
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Michlmayr, Daniela; Harris, Eva] Univ Calif Berkeley, Berkeley, CA 94720 USA.
   [Suarez-Farinas, Mayte; Kasarskis, Andrew] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA.
   [Kim, Eun-young; Wolinsky, Steven] Northwestern Univ, Feinberg Sch Med, Div Infect Dis, Chicago, IL 60611 USA.
   [Rahman, Adeeb; Kim-Schulze, Seunghee] Icahn Sch Med Mt Sinai, Tisch Canc Inst, Dept Oncol Sci, New York, NY 10029 USA.
   [Rahman, Adeeb; Kim-Schulze, Seunghee] Icahn Sch Med Mt Sinai, Immunol Inst, New York, NY 10029 USA.
   [Kuan, Guillermina] Minist Hlth, Ctr Salud Socrates Flores Vivas, Managua, Nicaragua.
   [Balmaseda, Angel] Minist Hlth, Ctr Nacl Diagnost & Referencia, Lab Nacl Virol, Managua, Nicaragua.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 1418
BP 446
EP 447
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386604118
DA 2020-07-08
ER

PT J
AU Andrade, P
   Gimblet-Ochieng, C
   Modirian, F
   Collins, M
   Cardenas, M
   Montoya, M
   Michlmayr, D
   Kuan, G
   Balmaseda, A
   Coloma, J
   de Silva, A
   Harris, E
AF Andrade, Paulina
   Gimblet-Ochieng, Ciara
   Modirian, Faraz
   Collins, Matthew
   Cardenas, Maritza
   Montoya, Magelda
   Michlmayr, Daniela
   Kuan, Guillermina
   Balmaseda, Angel
   Coloma, Josefina
   de Silva, Aravinda
   Harris, Eva
TI HOW CLOSE IS CLOSE? CHARACTERIZATION OF ZIKA AND DENGUE VIRUS
   CROSS-REACTIVE MEMORY B CELLS AND SERUM RESPONSES
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Andrade, Paulina; Modirian, Faraz; Cardenas, Maritza; Montoya, Magelda; Michlmayr, Daniela; Coloma, Josefina; Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA.
   [Gimblet-Ochieng, Ciara; Collins, Matthew; de Silva, Aravinda] Univ N Carolina, Div Infect Dis, Chapel Hill, NC 27515 USA.
   [Kuan, Guillermina] Minist Hlth, Ctr Salud Socrates Flores Vivas, Managua, Nicaragua.
   [Balmaseda, Angel] Minist Hlth, Ctr Nacl Diagnost & Referencia, Lab Nacl Virol, Managua, Nicaragua.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 1421
BP 447
EP 448
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386604121
DA 2020-07-08
ER

PT J
AU Collins, MH
   Tu, H
   Gimblet-Ochieng, C
   Liou, GJA
   Jadi, R
   Metz, S
   Thomas, A
   McElvany, B
   Bowman, N
   Becker-Dreps, S
   Bucardo, F
   Lazear, H
   Diehl, S
   de Silva, A
AF Collins, Matthew
   Tu, Huy
   Gimblet-Ochieng, Ciara
   Liou, Guei-Jiun
   Jadi, Ramesh
   Metz, Stefan
   Thomas, Ashlie
   McElvany, Benjamin
   Bowman, Natalie
   Becker-Dreps, Sylvia
   Bucardo, Filemon
   Lazear, Helen
   Diehl, Sean
   de Silva, Aravinda
TI EPITOPE TARGETS OF THE HUMAN ANTIBODY RESPONSE TO PRIMARY ZIKA VIRUS
   INFECTION
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Collins, Matthew] Emory Univ, Atlanta, GA 30322 USA.
   [Tu, Huy; McElvany, Benjamin; Diehl, Sean] Univ Vermont, Burlington, VT USA.
   [Gimblet-Ochieng, Ciara; Liou, Guei-Jiun; Jadi, Ramesh; Metz, Stefan; Thomas, Ashlie; Bowman, Natalie; Becker-Dreps, Sylvia; Lazear, Helen; de Silva, Aravinda] Univ N Carolina, Chapel Hill, NC 27515 USA.
   [Bucardo, Filemon] Univ Nacl Autonoma Nicaragua Leon, Leon, Nicaragua.
RI Diehl, Sean/AAE-2779-2020
OI Diehl, Sean/0000-0001-9700-235X
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 1420
BP 447
EP 447
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386604120
DA 2020-07-08
ER

PT J
AU Gordon, A
   Gresh, L
   Ojeda, S
   Katzelnick, LC
   Sanchez, N
   Mercado, JC
   Lopez, B
   Elizondo, D
   Burger-Calderon, R
   Coloma, J
   Kuan, G
   Balmaseda, A
   Harris, E
AF Gordon, Aubree
   Gresh, Lionel
   Ojeda, Sergio
   Katzelnick, Leah
   Sanchez, Nery
   Mercado, Juan
   Lopez, Brenda
   Elizondo, Douglas
   Burger-Calderon, Raquel
   Coloma, Josefina
   Kuan, Guillermina
   Balmaseda, Angel
   Harris, Eva
TI RECENT PRIOR DENGUE VIRUS INFECTION PROTECTS AGAINST ZIKA IN A PEDIATRIC
   COHORT IN NICARAGUA
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Gordon, Aubree] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA.
   [Gresh, Lionel; Ojeda, Sergio; Sanchez, Nery; Lopez, Brenda; Elizondo, Douglas] Sustainable Sci Inst, Managua, Nicaragua.
   [Katzelnick, Leah; Burger-Calderon, Raquel; Coloma, Josefina; Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
   [Mercado, Juan; Balmaseda, Angel] Minist Hlth, Ctr Nacl Diagnost & Referencia, Lab Nacl Virol, Managua, Nicaragua.
   [Kuan, Guillermina] Minist Hlth, Ctr Salud Socrates Flores Vivas, Managua, Nicaragua.
RI Gordon, Aubree/X-1113-2019
OI Gordon, Aubree/0000-0002-9352-7877
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 1419
BP 447
EP 447
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386604119
DA 2020-07-08
ER

PT J
AU Aguilar, JP
   Costa, F
   Nery, N
   Lim, J
   Gambrah, C
   Sacramento, G
   Freitas, B
   Bouzon, J
   Oliveira, J
   Adhikarla, H
   Montoya, M
   Wunder, EA
   Chin, A
   Reis, M
   Harris, E
   Ko, A
AF Aguilar, Juan
   Costa, Federico
   Nery, Nivison, Jr.
   Lim, Joseph
   Gambrah, Claudia
   Sacramento, Gielson
   Freitas, Bruno
   Bouzon, Joseane
   Oliveira-Filho, Jamary
   Adhikarla, Haritha
   Montoya, Magelda
   Wunder, Elsio, Jr.
   Chin, Athena
   Reis, Mitermayer
   Harris, Eva
   Ko, Albert
TI PROSPECTIVE INVESTIGATION OF A COMMUNITY-BASED COHORT OF PREGNANT WOMEN
   BEFORE AND DURING THE ZIKA EPIDEMIC IN NORTHEAST BRAZIL: SILENT
   TRANSMISSION AND INFANT OUTCOMES
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Aguilar, Juan; Costa, Federico; Nery, Nivison, Jr.; Bouzon, Joseane; Oliveira-Filho, Jamary] Univ Fed Bahia, Salvador, BA, Brazil.
   [Lim, Joseph; Gambrah, Claudia; Adhikarla, Haritha; Wunder, Elsio, Jr.; Ko, Albert] Yale Sch Publ Hlth, New Haven, CT USA.
   [Sacramento, Gielson; Reis, Mitermayer] Fundacao Oswaldo Cruz, Salvador, BA, Brazil.
   [Freitas, Bruno] Hosp Geral Roberto Santos, Salvador, BA, Brazil.
   [Montoya, Magelda; Chin, Athena; Harris, Eva] Univ Calif Berkeley, Berkeley, CA 94720 USA.
RI Ko, Albert Icksang/P-2343-2015; Oliveira-Filho, Jamary/B-6441-2016;
   Reis, Mitermayer/AAO-9742-2020
OI Ko, Albert Icksang/0000-0001-9023-2339; Oliveira-Filho,
   Jamary/0000-0003-1915-0423; Reis, Mitermayer/0000-0002-3051-9060
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 1422
BP 448
EP 448
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386604122
DA 2020-07-08
ER

PT J
AU Henderson, A
   Kama, M
   Cao-Lormeau, VM
   Lau, C
   Edmunds, J
   Watson, C
   Kucharski, A
AF Henderson, Alasdair
   Kama, Mike
   Cao-Lormeau, Van-Mai
   Lau, Colleen
   Edmunds, John
   Watson, Conall
   Kucharski, Adam
TI EVIDENCE OF SHORT-TERM CROSS-IMMUNITY BETWEEN DENGUE AND ZIKA VIRUSES
   INFERRED USING LONGITUDINAL SEROLOGICAL AND SURVEILLANCE DATA FROM FIJI,
   2013-2017
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Henderson, Alasdair; Edmunds, John; Watson, Conall; Kucharski, Adam] London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, London, England.
   [Kama, Mike] Minist Hlth, Communicable Dis Control, Suva, Fiji.
   [Cao-Lormeau, Van-Mai] Inst Louis Malarde, Tahiti, French Polynesi, France.
   [Lau, Colleen] Univ Queensland, Brisbane, Qld, Australia.
RI Lau, Colleen L/F-5974-2012
OI Lau, Colleen L/0000-0001-8288-4169
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 1423
BP 448
EP 448
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386604123
DA 2020-07-08
ER

PT J
AU Tu, HA
   Collins, MH
   Liou, GJ
   Jadi, RS
   De Silva, AM
   Diehl, SA
AF Tu, Huy
   Collins, Matthew
   Liou, Guei-Jiun
   Jadi, Ramesh
   De Silva, Aravinda
   Diehl, Sean
TI MAPPING REACTIVITY TO ZIKA VIRUS IN MEMORY B CELLS FOLLOWING DISTINCT
   ANTECEDENT FLAVIVIRUS EXPOSURES
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Tu, Huy; Diehl, Sean] Univ Vermont, Burlington, VT USA.
   [Collins, Matthew; Liou, Guei-Jiun; Jadi, Ramesh; De Silva, Aravinda] Univ N Carolina, Chapel Hill, NC 27515 USA.
RI Diehl, Sean/AAE-2779-2020
OI Diehl, Sean/0000-0001-9700-235X
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 1424
BP 448
EP 449
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386604124
DA 2020-07-08
ER

PT J
AU Murrieta, R
   Garcia-Luna, S
   Ruckert, C
   Halladay, G
   Weger-Lucarelli, J
   Fauver, J
   Gendernalik, A
   Murrieta, D
   Young, M
   Ebel, G
AF Murrieta, Reyes
   Garcia-Luna, Selene
   Ruckert, Claudia
   Halladay, Gareth
   Weger-Lucarelli, James
   Fauver, Joseph
   Gendernalik, Alex
   Murrieta, Deedra
   Young, Michael
   Ebel, Gregory
TI IMPACT OF EXTRINSIC INCUBATION TEMPERATURE ON ZIKA VIRUS POPULATION
   DIVERSITY IN AEDES MOSQUITOES
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Murrieta, Reyes; Garcia-Luna, Selene; Ruckert, Claudia; Halladay, Gareth; Weger-Lucarelli, James; Fauver, Joseph; Gendernalik, Alex; Murrieta, Deedra; Young, Michael; Ebel, Gregory] Colorado State Univ, Ft Collins, CO 80523 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 1473
BP 464
EP 465
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386604173
DA 2020-07-08
ER

PT J
AU Grubaugh, ND
   Saraf, S
   Tan, AL
   Gangavarapu, K
   Morrison, A
   Stanek, D
   Scott, B
   Ramadugu, K
   Landis, V
   Watts, A
   Wiley, M
   White, S
   Prieto, K
   Oliveira, G
   Matteson, NL
   Palacios, G
   Gardner, L
   Khan, K
   Ladner, JT
   Isern, S
   Michael, SF
   Andersen, KG
AF Grubaugh, Nathan
   Saraf, Sharada
   Tan, Amanda
   Gangavarapu, Karthik
   Morrison, Andrea
   Stanek, Danielle
   Scott, Blake
   Ramadugu, Kirtana
   Landis, Vanessa
   Watts, Alexander
   Wiley, Michael
   White, Stephen
   Prieto, Karla
   Oliveira, Glenn
   Matteson, Nathaniel
   Palacios, Gustavo
   Gardner, Lauren
   Khan, Kamran
   Ladner, Jason
   Isern, Sharon
   Michael, Scott
   Andersen, Kristian
TI INTERNATIONAL TRAVELERS AND VIRUS GENOMES REVEAL 'HIDDEN' ZIKA VIRUS
   TRANSMISSION DURING THE EPIDEMIC
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Grubaugh, Nathan] Yale Univ, New Haven, CT USA.
   [Saraf, Sharada; Gangavarapu, Karthik; Oliveira, Glenn; Matteson, Nathaniel; Andersen, Kristian] Scripps Res Inst, San Diego, CA USA.
   [Tan, Amanda; Isern, Sharon; Michael, Scott] Florida Gulf Coast Univ, Ft Myers, FL USA.
   [Morrison, Andrea; Stanek, Danielle; Scott, Blake; Ramadugu, Kirtana; Landis, Vanessa; White, Stephen] Florida Dept Hlth, Miami, FL USA.
   [Watts, Alexander; Khan, Kamran] St Michaels Hosp, Toronto, ON, Canada.
   [Wiley, Michael; Prieto, Karla; Palacios, Gustavo] US Army, Res Inst Infect Dis, Frederick, MD USA.
   [Gardner, Lauren] Univ New South Wales, Sydney, NSW, Australia.
   [Ladner, Jason] No Arizona Univ, Flagstaff, AZ 86011 USA.
RI Palacios, Gustavo/I-7773-2015
OI Palacios, Gustavo/0000-0001-5062-1938
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 1476
BP 465
EP 466
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386604176
DA 2020-07-08
ER

PT J
AU Lemos, DE
   Grubaugh, ND
   Singapuri, A
   Tsetsarkin, K
   Van Rompay, KK
   Chiu, CY
   Andersen, KG
   Coffey, LL
AF Lemos, Danilo
   Grubaugh, Nathan
   Singapuri, Anil
   Tsetsarkin, Konstantin
   Van Rompay, Koen
   Chiu, Charles
   Andersen, Kristian
   Coffey, Lark
TI A ZIKA VIRUS MUTATION THAT ASSOCIATES WITH FETAL DEATH IN RHESUS
   MACAQUES REDUCES TRANSMISSION BY <it>AEDES AEGYPTI</it> MOSQUITOES
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Lemos, Danilo; Singapuri, Anil; Coffey, Lark] Univ Calif Davis, Sch Vet Med, Davis, CA 95616 USA.
   [Grubaugh, Nathan; Andersen, Kristian] Scripps Res Inst, San Diego, CA USA.
   [Tsetsarkin, Konstantin] NIAID, 9000 Rockville Pike, Bethesda, MD 20892 USA.
   [Van Rompay, Koen] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA.
   [Chiu, Charles] Univ Calif San Francisco, Sch Med, San Francisco, CA USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 1475
BP 465
EP 465
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386604175
DA 2020-07-08
ER

PT J
AU Sessions, OM
   Burger-Calderon, R
   de Sessions, PF
   Chu, CW
   Wilm, A
   Phu, R
   Ho, E
   Ong, XM
   Kuan, G
   Balmaseda, A
   Ooi, EE
   Harris, E
AF Sessions, October
   Burger-Calderon, Raquel
   de Sessions, Paola
   Chu, Collins
   Wilm, Andreas
   Phu, Rachel
   Ho, Eliza
   Ong, Xin
   Kuan, Guillermina
   Balmaseda, Angel
   Ooi, Eng
   Harris, Eva
TI INTRAHOST DIVERSITY OF ZIKA VIRUS IN BLOOD, URINE AND SALIVA OVER TIME
   IN AN INDEX CLUSTER STUDY IN NICARAGUA
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Sessions, October; Ong, Xin; Ooi, Eng] Duke Nus, Singapore, Singapore.
   [Burger-Calderon, Raquel] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
   [de Sessions, Paola; Chu, Collins; Wilm, Andreas; Ho, Eliza] ASTAR, Genome Inst Singapore, Singapore, Singapore.
   [Phu, Rachel] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore.
   [Kuan, Guillermina] Minist Hlth, Hlth Ctr Socrates Flores Vivas, Managua, Nicaragua.
   [Balmaseda, Angel] Minist Hlth, Ctr Nacl Diagnost & Referencia, Lab Nacl Virol, Managua, Nicaragua.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 1474
BP 465
EP 465
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386604174
DA 2020-07-08
ER

PT J
AU Dimitrova, M
   Puerta-Guardo, H
   Tabata, T
   Pettit, M
   Wang, CL
   Corti, D
   Pereira, L
   Harris, E
AF Dimitrova, Milena
   Puerta-Guardo, Henry
   Tabata, Takako
   Pettit, Matthew
   Wang, Chunling
   Corti, Davide
   Pereira, Lenore
   Harris, Eva
TI ANTI-ZIKA VIRUS ANTIBODIES MODULATE VIRUS TRANSPORT ACROSS PLACENTAL
   CELL MONOLAYERS AND SUBSEQUENT INFECTION OF FC-GAMMA RECEPTOR-BEARING
   CELLS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Dimitrova, Milena; Puerta-Guardo, Henry; Wang, Chunling; Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
   [Tabata, Takako; Pettit, Matthew; Pereira, Lenore] Univ Calif San Francisco, Sch Dent, Dept Cell & Tissue Biol, San Francisco, CA USA.
   [Corti, Davide] Humabs SA, Bellinzona, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 1478
BP 466
EP 466
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386604178
DA 2020-07-08
ER

PT J
AU Jaeger, AS
   Murrieta, RM
   Simmons, HA
   Mejia, A
   Fritsch, M
   Goren, L
   Ebel, GD
   Friedrich, TC
   Aliota, MT
AF Jaeger, Anna
   Murrieta, Reyes
   Simmons, Heather
   Mejia, Andres
   Fritsch, Michael
   Goren, Lea
   Ebel, Gregory
   Friedrich, Thomas
   Aliota, Matthew
TI ZIKA VIRUS OF BOTH AFRICAN AND ASIAN LINEAGES CAUSE FETAL HARM IN A
   VERTICAL TRANSMISSION MODEL
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Jaeger, Anna; Simmons, Heather; Mejia, Andres; Fritsch, Michael; Goren, Lea; Friedrich, Thomas; Aliota, Matthew] Univ Wisconsin, Madison, WI USA.
   [Murrieta, Reyes; Ebel, Gregory] Colorado State Univ, Ft Collins, CO 80523 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 1477
BP 466
EP 466
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386604177
DA 2020-07-08
ER

PT J
AU Nery, NR
   Costa, F
   Aromolaran, A
   Cruz, JS
   Sarno, M
   Freitas, B
   Mattos, A
   Baltazar, G
   Pimentel, K
   Khouri, R
   Maltez, JR
   Oliveira, J
   Oliveira, DB
   Durigon, EL
   Henriques, DF
   Vasconcelos, PF
   Vasilakis, N
   Almeida, AR
   Reis, MG
   Ko, AI
AF Nery, Nivison, Jr.
   Costa, Federico
   Aromolaran, Adeolu
   Cruz, Jaqueline
   Sarno, Manoel
   Freitas, Bruno
   Mattos, Adriana
   Baltazar, Gustavo
   Pimentel, Kleber
   Khouri, Ricardo
   Maltez, Joao
   Oliveira-Filho, Jamary
   Oliveira, Danielle
   Durigon, Edison
   Henriques, Daniele
   Vasconcelos, Pedro
   Vasilakis, Nikos
   Almeida, Antonio
   Reis, Mitermayer
   Ko, Albert
TI MATERNAL DENGUE ANTIBODIES AND RISK FOR CONGENITAL ZIKA
   SYNDROME-ASSOCIATED MICROCEPHALY
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Nery, Nivison, Jr.; Costa, Federico; Oliveira-Filho, Jamary; Almeida, Antonio] Univ Fed Bahia, Salvador, BA, Brazil.
   [Aromolaran, Adeolu; Ko, Albert] Yale Sch Publ Hlth, New Haven, CT USA.
   [Cruz, Jaqueline; Khouri, Ricardo; Reis, Mitermayer] Brazilian Minist Hlth, Oswaldo Cruz Fdn, Salvador, BA, Brazil.
   [Sarno, Manoel; Freitas, Bruno; Mattos, Adriana; Baltazar, Gustavo; Pimentel, Kleber; Maltez, Joao] Hosp Geral Roberto Santos, Salvador, BA, Brazil.
   [Oliveira, Danielle; Durigon, Edison] Univ Sao Paulo, Sao Paulo, Brazil.
   [Henriques, Daniele; Vasconcelos, Pedro] Evandro Chagas Inst, Ananindeua, Brazil.
   [Vasilakis, Nikos] Univ Texas Med Branch, Galveston, TX 77555 USA.
RI Khouri, Ricardo/M-3184-2018; Reis, Mitermayer/AAO-9742-2020;
   Vasconcelos, Pedro/AAH-3142-2019; Oliveira-Filho, Jamary/B-6441-2016;
   Ko, Albert Icksang/P-2343-2015
OI Khouri, Ricardo/0000-0001-5664-4436; Reis,
   Mitermayer/0000-0002-3051-9060; Oliveira-Filho,
   Jamary/0000-0003-1915-0423; Ko, Albert Icksang/0000-0001-9023-2339
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 1479
BP 466
EP 467
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386604179
DA 2020-07-08
ER

PT J
AU Pollock, M
   Ayers, J
   Fuentes, JI
   Suarez, C
   Kalamar, A
   Sorgi, A
AF Pollock, Mathias
   Ayers, James
   Ivan Fuentes, Jose
   Suarez, Carmen
   Kalamar, Amanda
   Sorgi, Ashley
TI ADAPTING THE POPULAR OPINION LEADERS (POL) MODEL TO PROMOTE FAMILY
   PLANNING AND ZIKA PREVENTION BEHAVIORS AMONG ADOLESCENTS IN SANTA ANA,
   EL SALVADOR
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Pollock, Mathias; Ayers, James; Kalamar, Amanda; Sorgi, Ashley] Populat Serv Int, Washington, DC USA.
   [Ivan Fuentes, Jose] Pan Amer Social Mkt Org, San Salvador, El Salvador.
   [Suarez, Carmen] Populat Serv Int, San Salvador, El Salvador.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 1495
BP 472
EP 472
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386604195
DA 2020-07-08
ER

PT J
AU Pinchoff, J
   Merritt, AP
   Serino, A
   Silva, M
   Parikh, P
   Hunter, G
   Hewett, P
AF Pinchoff, Jessie
   Merritt, Alice
   Serino, Arianna
   Silva, Martha
   Parikh, Priya
   Hunter, Gabrielle
   Hewett, Paul
TI FOCUSING BEHAVIOR CHANGE EFFORTS TO MAXIMIZE USAID-LED ZIKA PREVENTION
   EFFORTS IN CENTRAL AMERICA AND THE CARIBBEAN: LESSONS FOR FUTURE PUBLIC
   HEALTH EMERGENCIES
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Pinchoff, Jessie] Populat Council, 1230 York Ave, New York, NY 10021 USA.
   [Merritt, Alice; Parikh, Priya; Hunter, Gabrielle] Johns Hopkins Ctr Commun Programs, Baltimore, MD USA.
   [Serino, Arianna] US Agcy Int Dev, Washington, DC 20523 USA.
   [Silva, Martha] Tulane Univ, New Orleans, LA 70118 USA.
   [Hewett, Paul] Populat Council, Washington, DC USA.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 1510
BP 476
EP 477
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386604210
DA 2020-07-08
ER

PT J
AU Hugo, LE
   Stassen, L
   Devine, GJ
   Frentiu, FD
AF Hugo, Leon
   Stassen, Liesel
   Devine, Gregor
   Frentiu, Francesca
TI RELATIVE VECTOR COMPETENCE OF <it>AEDES AEGYPTI</it> AND <it>AE</it>.
   <it>ALBOPICTUS</it> FOR AN EPIDEMIC STRAIN OF ZIKA VIRUS UNDER SIMULATED
   FIELD CONDITIONS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Hugo, Leon; Devine, Gregor] QIMR Berghofer Med Res Inst, Herston, Qld, Australia.
   [Stassen, Liesel; Frentiu, Francesca] Queensland Univ Technol, Brisbane, Qld, Australia.
RI Devine, Gregor J/H-1141-2014
OI Devine, Gregor J/0000-0001-6312-0390
NR 0
TC 0
Z9 0
U1 1
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 1539
BP 485
EP 485
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386604239
DA 2020-07-08
ER

PT J
AU MacLeod, HJ
   Anglero-Rodriguez, YI
   Dimopoulos, G
AF MacLeod, Hannah
   Anglero-Rodriguez, Yesseinia
   Dimopoulos, George
TI THE ROLE OF THE MIDGUT BARRIER IN DETERMINING MOSQUITO COMPETENCE FOR
   ZIKA VIRUS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [MacLeod, Hannah; Anglero-Rodriguez, Yesseinia; Dimopoulos, George] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 1572
BP 495
EP 496
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386604272
DA 2020-07-08
ER

PT J
AU Gutierrez, CT
   Dengela, D
   Murillo, M
   Cortez, T
   Orellana, G
   Urrutia, O
   Chanquin, S
   Menes, M
   Jean, L
   Escobar, D
   Morales, Z
   Romero, E
   Lemoine, JF
   Wood, P
   Belemvire, A
   Grisales, N
AF Gutierrez, Carolina
   Dengela, Dereje
   Murillo, Melany
   Cortez, Tanya
   Orellana, Gabriel
   Urrutia, Orlando
   Chanquin, Sayra
   Menes, Marianela
   Jean, Lorence
   Escobar, Denis
   Morales, Zoraida
   Romero, Eduardo
   Lemoine, Jean
   Wood, Paula
   Belemvire, Allison
   Grisales, Nelson
TI THE ZIKA AIRS PROJECT (ZAP): FIRST YEAR OF ENTOMOLOGICAL SURVEILLANCE
   AND VECTOR CONTROL USING A BIOLARVICIDE IN COUNTRIES OF LATIN AMERICA
   AND THE CARIBBEAN
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Gutierrez, Carolina; Dengela, Dereje; Murillo, Melany; Cortez, Tanya; Orellana, Gabriel; Urrutia, Orlando; Chanquin, Sayra; Menes, Marianela; Jean, Lorence; Wood, Paula; Grisales, Nelson] Abt Associates Inc, Rockville, MD USA.
   [Escobar, Denis] Secretaria Salud Honduras, Tegucigalpa, Honduras.
   [Morales, Zoraida] Minist Salud Publ & Asistencia Social Guatemala, Ciudad De Guatemala, Guatemala.
   [Romero, Eduardo] Minist Salud El Salvador, San Salvador, El Salvador.
   [Lemoine, Jean] Minist Sante Publ & Populat, Port Au Prince, Haiti.
   [Belemvire, Allison] US Agcy Int Dev, Arlington, VA USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 1581
BP 498
EP 498
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386604281
DA 2020-07-08
ER

PT J
AU McKenzie, BA
   Zohdy, S
   Wilson, A
AF McKenzie, Benjamin
   Zohdy, Sarah
   Wilson, Alan
TI VECTOR COMPETENCE OF AEDES ALBOPICTUS FOR ZIKA VIRUS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [McKenzie, Benjamin; Zohdy, Sarah] Auburn Univ, Sch Forestry & Wildlife Sci, Auburn, AL 36849 USA.
   [Wilson, Alan] Auburn Univ, Sch Fisheries, Auburn, AL 36849 USA.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 1583
BP 499
EP 499
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386604283
DA 2020-07-08
ER

PT J
AU Tesla, B
   Demakovsky, LR
   Mordecai, EA
   Bonds, MH
   Ngonghala, CN
   Brindley, MA
   Murdock, CC
AF Tesla, Blanka
   Demakovsky, Leah
   Mordecai, Erin
   Bonds, Matthew
   Ngonghala, Calistus
   Brindley, Melinda
   Murdock, Courtney
TI IMPACTS OF TEMPERATURE ON ZIKA VIRUS TRANSMISSION POTENTIAL
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Tesla, Blanka; Demakovsky, Leah; Brindley, Melinda; Murdock, Courtney] Univ Georgia, Athens, GA 30602 USA.
   [Mordecai, Erin] Stanford Univ, Stanford, CA 94305 USA.
   [Bonds, Matthew] Harvard Mediacl Sch, Boston, MA USA.
   [Ngonghala, Calistus] Univ Florida, Gainesville, FL USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 1594
BP 502
EP 502
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386604294
DA 2020-07-08
ER

PT J
AU Vang, L
   Guenther, B
   Uranga, C
   Mendy, J
   Betancourt, E
   Thompson, D
   Aruri, J
   Smith, J
   Alexander, J
AF Vang, Lo
   Guenther, Ben
   Uranga, Carla
   Mendy, Jason
   Betancourt, Elena
   Thompson, Danielle
   Aruri, Jayavani
   Smith, Jonathan
   Alexander, Jeffery
TI PRECLINICAL DEVELOPMENT OF A COMBINATION ZIKA AND CHIKUNGUNYA VIRUS-LIKE
   PARTICLE VACCINE
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Vang, Lo; Guenther, Ben; Uranga, Carla; Mendy, Jason; Betancourt, Elena; Thompson, Danielle; Aruri, Jayavani; Smith, Jonathan; Alexander, Jeffery] PaxVax Inc, San Diego, CA USA.
RI Uranga, Carla/AAL-4748-2020
OI Uranga, Carla/0000-0003-1437-3521
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 1600
BP 504
EP 504
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386604300
DA 2020-07-08
ER

PT J
AU Santiago, GA
   Vazquez, J
   Munoz-Jordan, JL
AF Santiago, Gilberto
   Vazquez, Jesus
   Munoz-Jordan, Jorge
TI CLINICAL AND ANALYTICAL PERFORMANCE OF THE TRIOPLEX REAL TIME RT-PCR
   ASSAY DURING THE 2016 ZIKA EPIDEMIC IN PUERTO RICO
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Santiago, Gilberto; Vazquez, Jesus; Munoz-Jordan, Jorge] Ctr Dis Control & Prevent, San Juan, PR USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 1620
BP 510
EP 510
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386604320
DA 2020-07-08
ER

PT J
AU Medina, FA
   Vila, F
   Munoz-Jordan, JL
AF Medina, Freddy
   Vila, Frances
   Munoz-Jordan, Jorge
TI SEROLOGICAL DISCRIMINATION OF DENGUE AND ZIKA INFECTIONS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Medina, Freddy; Vila, Frances; Munoz-Jordan, Jorge] Ctr Dis Control, San Juan, PR USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 1624
BP 511
EP 511
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386604324
DA 2020-07-08
ER

PT J
AU Kobres, PY
   Chretien, JP
   Viboud, C
   Biggerstaff, M
   Quandelacy, T
   Whung, PY
   Morgan, J
   Johansson, M
   Pollett, S
AF Kobres, Pei-Ying
   Chretien, Jean-Paul
   Viboud, Cecile
   Biggerstaff, Matthew
   Quandelacy, Talia
   Whung, Pai-Yei
   Morgan, Jeffrey
   Johansson, Michael
   Pollett, Simon
TI ZIKA VIRUS FORECASTING AND PREDICTION STUDIES: A SYSTEMATIC REVIEW AND
   EVALUATION OF THEIR UTILITY DURING A GLOBAL HEALTH EMERGENCY
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Kobres, Pei-Ying] George Washington Univ, Washington, DC USA.
   [Chretien, Jean-Paul] Dept Def, Frederick, MD USA.
   [Viboud, Cecile] NIH, Bldg 10, Bethesda, MD 20892 USA.
   [Biggerstaff, Matthew; Johansson, Michael] Ctr Dis Control & Prevent, Atlanta, GA USA.
   [Quandelacy, Talia] Johns Hopkins Univ, Baltimore, MD USA.
   [Whung, Pai-Yei] US EPA, Washington, DC 20460 USA.
   [Morgan, Jeffrey] Joint Res & Dev Inc, Stafford, VA USA.
   [Pollett, Simon] Walter Reed Army Inst Res, Silver Spring, MD USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 1634
BP 514
EP 514
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386604334
DA 2020-07-08
ER

PT J
AU Winokur, OC
   Main, BJ
   Nicholson, J
   Barker, CM
AF Winokur, Olivia
   Main, Bradley
   Nicholson, Jay
   Barker, Christopher
TI EFFECT OF TEMPERATURE ON THE EXTRINSIC INCUBATION PERIOD OF ZIKA VIRUS
   IN <it>AEDES AEGYPTI</it>
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Winokur, Olivia; Main, Bradley; Nicholson, Jay; Barker, Christopher] Univ Calif Davis, Davis, CA 95616 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 1635
BP 514
EP 515
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386604335
DA 2020-07-08
ER

PT J
AU Densathaporn, T
   Nakthungtao, S
   Chongsuvivatwong, V
   Sangthong, R
   Thompson, M
AF Densathaporn, Theerut
   Nakthungtao, Somchai
   Chongsuvivatwong, Virasakdi
   Sangthong, Rassamee
   Thompson, Mekkla
TI THE EFFECT OF TIMELY INTENSIVE SPACE SPRAY ON DISEASE CONTROL IN TWO
   ZIKA VIRUS OUTBREAKS IN SOUTHERN THAILAND
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Densathaporn, Theerut; Chongsuvivatwong, Virasakdi; Sangthong, Rassamee] Prince Songkla Univ, Fac Med, Epidemiol Unit, Hat Yai, Songklha, Thailand.
   [Nakthungtao, Somchai] Ban Na San Dist Hlth Off, Ban Na San, Suratthani, Thailand.
   [Thompson, Mekkla] WESTAT Corp, Rockville, MD 20850 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 1637
BP 515
EP 515
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386604337
DA 2020-07-08
ER

PT J
AU Stone, C
   Schwab, S
   Fonseca, D
   Fefferman, N
AF Stone, Chris
   Schwab, Samantha
   Fonseca, Dina
   Fefferman, Nina
TI CONTRASTING THE VALUE OF TARGETED VERSUS AREA-WIDE MOSQUITO CONTROL
   SCENARIOS TO LIMIT ZIKA VIRUS TRANSMISSION FOR DIFFERENT TROPICAL URBAN
   POPULATION CENTERS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Stone, Chris] Univ Illinois, Champaign, IL USA.
   [Schwab, Samantha; Fonseca, Dina] Rutgers State Univ, New Brunswick, NJ USA.
   [Fefferman, Nina] Univ Tennessee, Knoxville, TN USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 1636
BP 515
EP 515
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386604336
DA 2020-07-08
ER

PT J
AU Puerta-Guardo, H
   Tabata, T
   Pettit, M
   Dimitrova, M
   Pereira, L
   Harris, E
AF Puerta-Guardo, Henry
   Tabata, Takako
   Pettit, Matthew
   Dimitrova, Milena
   Pereira, Lenore
   Harris, Eva
TI ZIKA VIRUS NS1 PROTEIN MODULATES THE BARRIER FUNCTION OF HUMAN PLACENTAL
   EXPLANTS AND HUMAN TROPHOBLAST CELL LINES
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Puerta-Guardo, Henry; Dimitrova, Milena; Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
   [Tabata, Takako; Pettit, Matthew; Pereira, Lenore] Univ Calif San Francisco, Sch Dent, Dept Cell & Tissue Biol, San Francisco, CA USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 1642
BP 516
EP 517
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386604342
DA 2020-07-08
ER

PT J
AU Silva, ME
   Ampuero, JS
   Guerrero, D
   Gladys, C
   Guevara, C
   Aguilar, Y
   Popuche, D
   Huaman, A
   Siles, C
   Wong, J
   Mores, C
AF Silva, Maria
   Ampuero, Julia
   Guerrero, David
   Gladys, Carrion
   Guevara, Carolina
   Aguilar, Yojani
   Popuche, Dina
   Huaman, Alfredo
   Siles, Crystyan
   Wong, Juan
   Mores, Christopher
TI ZIKA VIRUS PERSISTENCE AND VIRAL LOAD IN BODY FLUIDS OBTAINED FROM
   INFECTED PATIENTS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Silva, Maria; Ampuero, Julia; Gladys, Carrion; Guevara, Carolina; Popuche, Dina; Huaman, Alfredo; Siles, Crystyan; Mores, Christopher] Naval Med Res Unit 6, Bellavista, Peru.
   [Guerrero, David] VYSNOVA Partners, San Isidro, Peru.
   [Aguilar, Yojani] Hosp Santa Gema, Yurimaguas, Peru.
   [Wong, Juan] UPCH, San Martin De Porres, Peru.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 1641
BP 516
EP 516
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386604341
DA 2020-07-08
ER

PT J
AU Capasso, A
   Vieira, DL
   Tozan, Y
AF Capasso, Ariadna
   Vieira, Dorice
   Tozan, Yesim
TI INCIDENCE OF GUILLAIN-BARRE SYNDROME IN LATIN AMERICA AND THE CARIBBEAN
   FOLLOWING THE 2015-2016 ZIKA EPIDEMIC
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Capasso, Ariadna; Tozan, Yesim] NYU, Coll Global Publ Hlth, New York, NY USA.
   [Vieira, Dorice] NYU, Sch Med, Langone Med Ctr, New York, NY USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 1645
BP 517
EP 518
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386604345
DA 2020-07-08
ER

PT J
AU Gonzalez, C
   Link, A
   Leon, C
   Rondon, S
   Hoyos, J
   Komar, N
   Salyer, SJ
   Montgomery, J
AF Gonzalez, Camila
   Link, Andres
   Leon, Cielo
   Rondon, Silvia
   Hoyos, Juliana
   Komar, Nick
   Salyer, Stephanie
   Montgomery, Joel
TI EVALUATION OF ZIKV POTENTIAL TO INFECT VERTEBRATES AND MOSQUITOES IN AN
   URBAN-SYLVATIC INTERFACE IN COLOMBIA
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Gonzalez, Camila; Leon, Cielo; Rondon, Silvia; Hoyos, Juliana] Univ Los Andes, Ctr Res Trop Microbiol & Parasitol CIMPAT, Dept Biol Sci, Bogota, Colombia.
   [Link, Andres] Univ Los Andes, Dept Biol Sci, Bogota, Colombia.
   [Link, Andres] Univ Los Andes, Sch Management, Bogota, Colombia.
   [Komar, Nick] Ctr Dis Control & Prevent, Arbovirus Dis Branch, Div Vector Borne Dis, Natl Ctr Emerging & Zoonot Infect Dis, Ft Collins, CO USA.
   [Salyer, Stephanie; Montgomery, Joel] CDC Atlanta, Ctr Global Hlth, EISL Branch, Div Global Hlth Protect, Atlanta, GA USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 1644
BP 517
EP 517
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386604344
DA 2020-07-08
ER

PT J
AU Jadi, R
   Collins, MCM
   Guerra, EGE
   Corbett, KSCKS
   De Silva, DDD
   Tissera, HTH
   De Silva, AMD
AF Jadi, Ramesh
   Collins, Matt
   Guerra, Enrique
   Corbett, Kizzmekia
   De Silva, Dharshan
   Tissera, Hasitha
   De Silva, Aravinda
TI ZIKA VIRUS TRANSMISSION IN SRI LANKA
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Jadi, Ramesh; Guerra, Enrique; De Silva, Aravinda] Univ N Carolina, Chapel Hill, NC 27515 USA.
   [Collins, Matt] Emory Univ, Sch Med, Atlanta, GA USA.
   [Corbett, Kizzmekia] NIH, Vaccine Res Ctr, Bldg 10, Bethesda, MD 20892 USA.
   [De Silva, Dharshan] Kotalawela Def Acad, Colombo, Sri Lanka.
   [Tissera, Hasitha] Minist Hlth, Epidemiol Unit, Colombo, Sri Lanka.
RI Tissera, Hasitha/AAQ-2516-2020
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 1643
BP 517
EP 517
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386604343
DA 2020-07-08
ER

PT J
AU Ampuero, JS
   Aguilar, Y
   Guerrero, D
   Siles, C
   Silva, M
   Guevara, C
   Jenkins, S
   Wong, J
   Campbell, W
   Montgomery, J
   Mores, C
AF Ampuero, Julia
   Aguilar, Yojani
   Guerrero, David
   Siles, Crystyan
   Silva, Maria
   Guevara, Carolina
   Jenkins, Sarah
   Wong, Juan
   Campbell, Wesley
   Montgomery, Joel
   Mores, Christopher
TI ZIKA VIRUS INFECTION IN OLIGOSYMPTOMATIC AND ASYMPTOMATIC CLOSE CONTACTS
   IN PERU
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Ampuero, Julia; Silva, Maria; Guevara, Carolina; Jenkins, Sarah; Campbell, Wesley; Mores, Christopher] US Naval Med Res Unit 6 NAMRU 6, Lima, Peru.
   [Aguilar, Yojani] Minist Salud Peru, Hosp Santa Gema Yurimaguas, Yurimaguas, Peru.
   [Guerrero, David] VYSNOVA Partners, Lima, Peru.
   [Siles, Crystyan] US Naval Med Res Unit 6 NAMRU 6, Iquitos, Peru.
   [Wong, Juan] UPCH, Lima, Peru.
   [Montgomery, Joel] Ctr Dis Control & Prevent, Atlanta, GA USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 1646
BP 518
EP 518
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386604346
DA 2020-07-08
ER

PT J
AU Oidtman, RJ
   Espana, G
   Perkins, A
AF Oidtman, Rachel
   Espana, Guido
   Perkins, Alex
TI CO-CIRCULATION AND CLINICAL MISDIAGNOSIS OF ZIKA, DENGUE, AND
   CHIKUNGUNYA LED TO UNDERESTIMATION OF THE 2015-2016 ZIKA EPIDEMIC IN THE
   AMERICAS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Oidtman, Rachel; Espana, Guido; Perkins, Alex] Univ Notre Dame, Notre Dame, IN 46556 USA.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 1648
BP 518
EP 518
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386604348
DA 2020-07-08
ER

PT J
AU Oliveira, G
   Saraf, S
   Ontiveros, C
   Agarwal, R
   Ebel, GD
   Grubaugh, ND
   Andersen, KG
AF Oliveira, Glenn
   Saraf, Sharada
   Ontiveros, Carlos
   Agarwal, Rimjhim
   Ebel, Greg
   Grubaugh, Nathan
   Andersen, Kristian
TI FITNESS OF ZIKA VIRUS MUTATIONS CIRCULATING IN THE AMERICAS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Oliveira, Glenn; Saraf, Sharada; Ontiveros, Carlos; Agarwal, Rimjhim; Andersen, Kristian] Scripps Res Inst, Encinitas, CA USA.
   [Ebel, Greg] Colorado State Univ, Colorado Springs, CO USA.
   [Grubaugh, Nathan] Yale, New Haven, CT USA.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 1656
BP 521
EP 521
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386604356
DA 2020-07-08
ER

PT J
AU Pereira, L
   Petitt, M
   Gajewski, A
   Fang-Hoover, J
   Llufrio, L
   Schwartz, D
   Balmaseda, A
   Harris, E
AF Pereira, Lenore
   Petitt, Matthew
   Gajewski, Anna
   Fang-Hoover, June
   Llufrio, Liliam
   Schwartz, David
   Balmaseda, Angel
   Harris, Eva
TI COINFECTION OF PLACENTAS FROM CONGENITAL ZIKA VIRUS INFECTION WITH HUMAN
   CYTOMEGALOVIRUS IN BABIES WITH AND WITHOUT MICROCEPHALY
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Pereira, Lenore; Petitt, Matthew; Fang-Hoover, June] Univ Calif San Francisco, Sch Dent, Dept Cell & Tissue Biol, San Francisco, CA USA.
   [Gajewski, Anna; Llufrio, Liliam] Sustainable Sci Inst, Managua, Nicaragua.
   [Schwartz, David] Augusta Univ, Med Coll Georgia, Augusta, GA USA.
   [Balmaseda, Angel] Minist Hlth, Lab Nacl Virol, Ctr Nacl Diagnost & Referencia, Managua, Nicaragua.
   [Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 1658
BP 521
EP 521
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386604358
DA 2020-07-08
ER

PT J
AU Adhikarla, H
   Montoya, M
   Nery, N
   Aromolaran, A
   Cruz, JS
   Pastor, A
   Petrone, M
   Wunder, EA
   Costa, F
   Harris, E
   Ko, AI
AF Adhikarla, Haritha
   Montoya, Magelda
   Jr Nery, Nivison
   Aromolaran, Adeolu
   Cruz, Jaqueline
   Pastor, Andrew
   Petrone, Mary
   Wunder, Elsio
   Costa, Federico
   Harris, Eva
   Ko, Albert
TI KINETICS OF ANTI ZIKA-IGG ANTIBODIES DURING FOLLOW-UP OF INFANTS EXPOSED
   TO ZIKA VIRUS <it>IN UTERO</it>
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Adhikarla, Haritha; Aromolaran, Adeolu; Petrone, Mary; Wunder, Elsio; Costa, Federico; Ko, Albert] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Montoya, Magelda; Pastor, Andrew; Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
   [Jr Nery, Nivison; Cruz, Jaqueline] Univ Fed Bahia, Oswaldo Cruz Fdn, Brazilian Minist Hlth, Salvador, BA, Brazil.
RI Ko, Albert Icksang/P-2343-2015
OI Ko, Albert Icksang/0000-0001-9023-2339
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 1660
BP 522
EP 522
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386604360
DA 2020-07-08
ER

PT J
AU Gambrah-Sampaney, CO
   Aguilar, P
   Nery, N
   Freitas, B
   Bouzon, J
   Guerra, A
   Oliveira, J
   Adhikarla, H
   Montoya, M
   Wunder, EA
   Harris, E
   Reis, M
   Costa, F
   Ko, A
AF Gambrah-Sampaney, Claudia
   Aguilar, Pablo
   Nery, Nivison, Jr.
   Freitas, Bruno
   Bouzon, Joseane
   Guerra, Ailema
   Oliveira-Filho, Jamary
   Adhikarla, Haritha
   Montoya, Magelda
   Wunder, Elsio, Jr.
   Harris, Eva
   Reis, Mitermayer
   Costa, Federico
   Ko, Albert
TI GROWTH AND DEVELOPMENTAL OUTCOMES OF CONGENITAL ZIKA INFECTION DURING
   FOLLOW-UP OF A CHILD COHORT FROM SALVADOR, BRAZIL
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Gambrah-Sampaney, Claudia; Adhikarla, Haritha; Wunder, Elsio, Jr.; Ko, Albert] Yale Sch Publ Hlth, New Haven, CT USA.
   [Aguilar, Pablo; Bouzon, Joseane; Oliveira-Filho, Jamary] Univ Fed Bahia, Salvador, BA, Brazil.
   [Nery, Nivison, Jr.; Guerra, Ailema; Reis, Mitermayer; Costa, Federico] Fundacao Oswaldo Cruz, Salvador, BA, Brazil.
   [Freitas, Bruno] Hosp Geral Roberto Santos, Salvador, BA, Brazil.
   [Montoya, Magelda; Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA.
RI Oliveira-Filho, Jamary/B-6441-2016; Reis, Mitermayer/AAO-9742-2020; Ko,
   Albert Icksang/P-2343-2015
OI Oliveira-Filho, Jamary/0000-0003-1915-0423; Reis,
   Mitermayer/0000-0002-3051-9060; Ko, Albert Icksang/0000-0001-9023-2339
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 1659
BP 522
EP 522
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386604359
DA 2020-07-08
ER

PT J
AU Pujols, SMO
   Rosales, ELM
   Goldman, BD
   Collins, M
   Torrez, MC
   Quintana, LR
   Reyes, Y
   Zepeda, O
   de Silva, A
   Bucardo, F
   Becker-Dreps, S
   Stringer, E
   Bowman, N
AF Pujols, Shiara
   Martinez Rosales, Eveling
   Goldman, Barbara
   Collins, Matt
   Chavarria Torrez, Meylin
   Rosales Quintana, Leyla
   Reyes, Yaoska
   Zepeda, Omar
   de Silva, Aravinda
   Bucardo, Filemon
   Becker-Dreps, Sylvia
   Stringer, Elizabeth
   Bowman, Natalie
TI IMPLICATIONS OF CONGENITALLY ACQUIRED AND EARLY EXPOSURE TO ZIKA VIRUS
   INFECTION ON CHILD NEURODEVELOPMENT
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Pujols, Shiara; Collins, Matt; de Silva, Aravinda; Becker-Dreps, Sylvia; Stringer, Elizabeth; Bowman, Natalie] Univ N Carolina, Chapel Hill, NC 27515 USA.
   [Martinez Rosales, Eveling; Chavarria Torrez, Meylin; Rosales Quintana, Leyla; Reyes, Yaoska; Zepeda, Omar; Bucardo, Filemon] UNAN, Leon, Nicaragua.
   [Goldman, Barbara] Univ N Carolina, Frank Porter Graham Child Dev Inst, Chapel Hill, NC 27515 USA.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 1661
BP 522
EP 522
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386604361
DA 2020-07-08
ER

PT J
AU Escalante-Maldonado, O
   Garcia, MP
   Marcelo, A
   Cabezas, C
   Gavilan, RG
AF Escalante-Maldonado, Oscar
   Paquita Garcia, Maria
   Marcelo, Adolfo
   Cabezas, Cesar
   Gustavo Gavilan, Ronnie
TI STANDARDIZATION OF A FOUR-PLEX FORMAT REVERSE TRANSCRIPTION REAL TIME
   PCR FOR THE SIMULTANEOUS DETECTION OF ZIKA, CHIKUNGUNYA, DENGUE AND
   YELLOW FEVER IN PERU
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Escalante-Maldonado, Oscar; Paquita Garcia, Maria; Marcelo, Adolfo; Cabezas, Cesar; Gustavo Gavilan, Ronnie] Natl Inst Hlth, Lima, Peru.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 1663
BP 523
EP 523
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386604363
DA 2020-07-08
ER

PT J
AU McHale, TC
   Romero-Vivas, C
   Fronterre, C
   Falconar, AK
   Walker, N
   Nix, C
   Cano, J
AF McHale, Thomas
   Romero-Vivas, Claudia
   Fronterre, Claudio
   Falconar, Andrew
   Walker, Naomi
   Nix, Chad
   Cano, Jorge
TI SPATIOTEMPORAL HETEROGENEITY IN THE DISTRIBUTION OF CHIKUNGUNYA AND ZIKA
   VIRUS CASE INCIDENCES AND RISK FACTORS DURING THEIR EPIDEMICS IN
   BARRANQUILLA (COLOMBIA) BETWEEN 2014 AND 2016
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [McHale, Thomas; Fronterre, Claudio; Walker, Naomi; Nix, Chad; Cano, Jorge] London Sch Hyg & Trop Med, London, England.
   [Romero-Vivas, Claudia; Falconar, Andrew] Univ Norte, Barranquilla, Colombia.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 1665
BP 523
EP 524
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386604365
DA 2020-07-08
ER

PT B
AU Ju, XY
   Garcia, IR
   Silva, LD
   Mossey, P
   Al-Rudainy, D
   Ayoub, A
   de Mattos, AM
AF Ju, Xiangyang
   Garcia Junior, Idelmo Rangel
   Silva, Leonardo de Freitas
   Mossey, Peter
   Al-Rudainy, Dhelal
   Ayoub, Ashraf
   de Mattos, Adriana Marques
BE Li, W
   Li, Q
   Wang, L
TI 3D Head Shape Analysis of Suspected Zika Infected Infants
SO 2018 11TH INTERNATIONAL CONGRESS ON IMAGE AND SIGNAL PROCESSING,
   BIOMEDICAL ENGINEERING AND INFORMATICS (CISP-BMEI 2018)
LA English
DT Proceedings Paper
CT 11th International Congress on Image and Signal Processing, BioMedical
   Engineering and Informatics (CISP-BMEI)
CY OCT 13-15, 2018
CL Beijing, PEOPLES R CHINA
SP IEEE, IEEE Engn Med & Biol Soc, Beijing Univ Chem Technol, Beijing Inst Technol, E China Normal Univ
DE 3D imaging; shape analysis; Zika
AB The babies infected from Zika before they are born are at risk for problems with brain development and microcephaly. 3D head images of 43 Zika cases and 43 controls were collected aiming to extract shape characteristics for diagnosis purposes. Principal component analysis (PCA) has been applied on the vaults and faces of the collected 3D images and the scores on the second principal components of the vaults and faces showed significant differences between the control and Zika groups. The shape variations from -2s to 2s illustrated the typical characteristics of microcephaly of the Zika babies. Canonical correlation analysis (CCA) showed a significant correlation in the first CCA variates of face and vault which indicated the potential of 3D facial imaging for Zika surveillance. Further head circumferences and distances from ear to ear were measured from the 3D images and preliminary results showed the adding ear to ear distances for classifying control and Zika children strengthened the abilities of tested classification models.
C1 [Ju, Xiangyang] NHS Greater Glasgow & Clyde, Med Devices Unit, Glasgow, Lanark, Scotland.
   [Garcia Junior, Idelmo Rangel] Sao Paulo State Univ, UNESP Sch Dent Aracatuba, Aracatuba, SP, Brazil.
   [Silva, Leonardo de Freitas] Univ Estadual Paulista, Aracatuba Dent Sch, Aracatuba, SP, Brazil.
   [Mossey, Peter] Univ Dundee, Sch Dent, Dundee, Scotland.
   [Al-Rudainy, Dhelal; Ayoub, Ashraf] Univ Glasgow, Coll MVLS, Sch Dent, Glasgow, Lanark, Scotland.
   [de Mattos, Adriana Marques] Roberto Santos Gen Hosp, Salvador, BA, Brazil.
RP Ju, XY (corresponding author), NHS Greater Glasgow & Clyde, Med Devices Unit, Glasgow, Lanark, Scotland.
RI Al-Rudainy, Dhelal Hatem/R-6085-2018
OI Al-Rudainy, Dhelal Hatem/0000-0001-8965-5502
CR Almukhtar A, 2017, JPRAS OPEN, V14, P39
   Dryden I.L., 1998, STAT SHAPE ANAL
   Hammond P, 2004, AM J MED GENET A, V126A, P339, DOI 10.1002/ajmg.a.20665
   Ju X, P 6 NUM 3 D SCANN 20
   Martini M., HEAD FACE MED, V201814, P3
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
NR 7
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-5386-7604-2
PY 2018
PG 4
WC Engineering, Biomedical; Engineering, Electrical & Electronic; Imaging
   Science & Photographic Technology
SC Engineering; Imaging Science & Photographic Technology
GA BM3IZ
UT WOS:000462163500103
DA 2020-07-08
ER

PT J
AU Yen, PS
   James, A
   Li, JC
   Chen, CH
   Failloux, AB
AF Yen, Pei-Shi
   James, Anthony
   Li, Jian-Chiuan
   Chen, Chun-Hong
   Failloux, Anna-Bella
TI Synthetic miRNAs induce dual arboviral-resistance phenotypes in the
   vector mosquito Aedes aegypti
SO COMMUNICATIONS BIOLOGY
LA English
DT Article
ID YELLOW-FEVER MOSQUITO; DENGUE VIRUS; CHIKUNGUNYA VIRUS; RNA
   INTERFERENCE; GENE-EXPRESSION; COINFECTION; MICRORNAS; INFECTION;
   SEPTEMBER; OUTBREAK
AB Mosquito-borne arboviruses are responsible for recent dengue, chikungunya, and Zika pandemics. The yellow-fever mosquito, Aedes aegypti, plays an important role in the transmission of all three viruses. We developed a miRNA-based approach that results in a dual resistance phenotype in mosquitoes to dengue serotype 3 (DENV-3) and chikungunya (CHIKV) viruses. The target viruses are from two distinct arboviral families and the antiviral mechanism is designed to function through the endogenous miRNA pathway in infected mosquitoes. Challenge experiments showed reductions in viral transmission efficiency of transgenic mosquitoes. Several components of mosquito fitness were examined, and transgenic mosquitoes with the PUb promoter showed minor fitness costs at all developing stages. Further development of these strains with gene editing tools could make them candidates for releases in population replacement strategies for sustainable control of multiple arbovirus diseases.
C1 [Yen, Pei-Shi; Failloux, Anna-Bella] Inst Pasteur, Dept Virol, Unit Arboviruses & Insect Vectors, F-75015 Paris, France.
   [James, Anthony] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92697 USA.
   [James, Anthony] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA.
   [Li, Jian-Chiuan; Chen, Chun-Hong] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Miaoli 35053, Taiwan.
RP Failloux, AB (corresponding author), Inst Pasteur, Dept Virol, Unit Arboviruses & Insect Vectors, F-75015 Paris, France.; Chen, CH (corresponding author), Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Miaoli 35053, Taiwan.
EM chunhong@nhri.org.tw; anna-bella.failloux@pasteur.fr
OI CHEN, CHUN-HONG/0000-0002-3028-5508; FAILLOUX,
   Anna-Bella/0000-0001-6890-0820; James, Anthony/0000-0001-5577-3308; Yen,
   Pei-Shi/0000-0002-2113-7394
FU Institut Pasteur; French Government's Investissement d'Avenir program,
   Laboratoire d'Excellence "Integrative Biology of Emerging Infectious
   Diseases"French National Research Agency (ANR) [ANR-10-LABX-62-IBEID];
   Ministry of Science and Technology, TaiwanMinistry of Science and
   Technology, Taiwan [MOST 105-2325-B-400-006, MOHW105-TDU-M-212-000006];
   Pasteur-Paris University (PPU) program
FX This study was funded by the Institut Pasteur and the French
   Government's Investissement d'Avenir program, Laboratoire d'Excellence
   "Integrative Biology of Emerging Infectious Diseases" (Grant No.
   ANR-10-LABX-62-IBEID) and the Ministry of Science and Technology, Taiwan
   (Grant No. MOST 105-2325-B-400-006; MOHW105-TDU-M-212-000006). P.-S.Y.
   was supported by the Pasteur-Paris University (PPU) program. We are
   grateful Herve Blanc and Carla Saleh for technical advice and, Marie
   Vazeille and Laurence Mousson for technical help.
CR Adelman ZN, 2002, MOL BIOCHEM PARASIT, V121, P1, DOI 10.1016/S0166-6851(02)00028-2
   Anderson MAE, 2010, INSECT MOL BIOL, V19, P441, DOI 10.1111/j.1365-2583.2010.01005.x
   Angelini R., 2007, EUROSURVEILLANCE, V12, DOI [DOI 10.2807/ESW.12.36.03260-EN, 10.2807/esw.12.36.03260-en]
   Arvey A, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.24
   Bonizzoni M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050512
   Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   Carter JR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139899
   Carter JR, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-111
   Chahar HS, 2009, EMERG INFECT DIS, V15, P1077, DOI 10.3201/eid1507.080638
   Champer J, 2016, NAT REV GENET, V17, P146, DOI 10.1038/nrg.2015.34
   Chang SF, 2010, J CLIN MICROBIOL, V48, P4586, DOI 10.1128/JCM.01228-10
   Chen XG, 2008, ADV GENET, V64, P19, DOI 10.1016/S0065-2660(08)00802-X
   Chipwaza B, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003335
   Clem RJ, 2016, J GEN VIROL, V97, P1033, DOI 10.1099/jgv.0.000429
   Delisle E, 2015, EUROSURVEILLANCE, V20, P8, DOI 10.2807/1560-7917.ES2015.20.17.21108
   Dubrulle M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005895
   Edwards MJ, 2000, INSECT MOL BIOL, V9, P33, DOI 10.1046/j.1365-2583.2000.00159.x
   Forstemann K, 2007, CELL, V130, P287, DOI 10.1016/j.cell.2007.05.056
   Frantz S, 2006, NAT REV DRUG DISCOV, V5, P528, DOI 10.1038/nrd2104
   Franz AWE, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002833
   Franz AWE, 2006, P NATL ACAD SCI USA, V103, P4198, DOI 10.1073/pnas.0600479103
   Furuya-Kanamori L, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1519-x
   Gantz VM, 2015, P NATL ACAD SCI USA, V112, pE6736, DOI 10.1073/pnas.1521077112
   Ghildiyal M, 2010, RNA, V16, P43, DOI 10.1261/rna.1972910
   Gjenero-Margan I, 2011, EUROSURVEILLANCE, V16, P2
   Grandadam M, 2011, EMERG INFECT DIS, V17, P910, DOI 10.3201/eid1705.101873
   Hapuarachchi H. A. C., 2008, CEYLON MEDICAL JOURNAL, V53, P104
   Irvin N, 2004, P NATL ACAD SCI USA, V101, P891, DOI 10.1073/pnas.0305511101
   Joga MR, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00553
   Lam S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046396
   Laoprasopwattana K, 2012, PEDIATR INFECT DIS J, V31, P459, DOI 10.1097/INF.0b013e31824bb06d
   Li ZH, 2014, NAT REV DRUG DISCOV, V13, P622, DOI 10.1038/nrd4359
   Lobo NF, 2006, NAT PROTOC, V1, P1312, DOI 10.1038/nprot.2006.221
   Lourenco J, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003083
   Marchand E, 2013, EUROSURVEILLANCE, V18, P3, DOI 10.2807/1560-7917.ES2013.18.50.20661
   Martin Estelle, 2010, BMC Ecology, V10, P8, DOI 10.1186/1472-6785-10-8
   Mathur G, 2010, INSECT MOL BIOL, V19, P753, DOI 10.1111/j.1365-2583.2010.01032.x
   McFarlane M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002994
   Mercado M, 2016, EUROSURVEILLANCE, V21, P33, DOI 10.2807/1560-7917.ES.2016.21.22.30244
   Messina JP, 2014, TRENDS MICROBIOL, V22, P138, DOI 10.1016/j.tim.2013.12.011
   Mishra P, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8060163
   Moreira LA, 2000, P NATL ACAD SCI USA, V97, P10895, DOI 10.1073/pnas.97.20.10895
   Nayar S K, 2007, Med J Malaysia, V62, P335
   Ohmichi T, 2000, NUCLEIC ACIDS RES, V28, P776, DOI 10.1093/nar/28.3.776
   Omarjee R, 2013, EUROSURVEILLANCE, P19, DOI DOI 10.2807/1560-
   Parreira R., 2014, Eurosurveillance, V19, P20730, DOI 10.2807/1560-7917.ES2014.19.10.20730
   Ratsitorahina M, 2008, EMERG INFECT DIS, V14, P1135, DOI 10.3201/eid1407.071521
   Raut CG, 2015, EMERG INFECT DIS, V21, P908, DOI 10.3201/eid2105.141804
   Rezza G, 2014, EMERG INFECT DIS, V20, P1351, DOI 10.3201/eid2008.131615
   Sanchez-Vargas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000299
   Scherer LJ, 2003, NAT BIOTECHNOL, V21, P1457, DOI 10.1038/nbt915
   Schilling S, 2009, J CLIN VIROL, V45, P163, DOI 10.1016/j.jcv.2009.04.001
   Selck FW, 2014, VECTOR-BORNE ZOONOT, V14, P824, DOI 10.1089/vbz.2013.1528
   Sigoillot FD, 2012, NAT METHODS, V9, P363, DOI [10.1038/NMETH.1898, 10.1038/nmeth.1898]
   Sim S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002295
   Succo T, 2016, EUROSURVEILLANCE, V21, P5, DOI 10.2807/1560-7917.ES.2016.21.21.30240
   Sun W, 2006, J INFECT DIS, V193, P1658, DOI 10.1086/503372
   Thiboutot MM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000623
   Travanty EA, 2004, INSECT BIOCHEM MOLEC, V34, P607, DOI 10.1016/j.ibmb.2004.03.013
   Tun MMN, 2014, EMERG INFECT DIS, V20, P1378, DOI 10.3201/eid2008.131431
   Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168
   Vazeille M, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000706
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   Wang H, 2012, J VIROL, V86, P6546, DOI 10.1128/JVI.00125-12
   Wilczynska A, 2015, CELL DEATH DIFFER, V22, P22, DOI 10.1038/cdd.2014.112
   WILSON C, 1990, ANNU REV CELL BIOL, V6, P679, DOI 10.1146/annurev.cb.06.110190.003335
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310, DOI 10.4269/ajtmh.2001.64.310
   Yang JS, 2014, NUCLEIC ACIDS RES, V42, P1987, DOI 10.1093/nar/gkt1038
   Ye YXH, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003894
   Zouache K, 2015, CURR OPIN INSECT SCI, V10, P14, DOI 10.1016/j.cois.2015.04.010
NR 70
TC 16
Z9 16
U1 3
U2 6
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
EI 2399-3642
J9 COMMUN BIOL
JI Commun. Biol.
PY 2018
VL 1
AR 11
DI 10.1038/s42003-017-0011-5
PG 9
WC Biology; Multidisciplinary Sciences
SC Life Sciences & Biomedicine - Other Topics; Science & Technology - Other
   Topics
GA HO7LC
UT WOS:000461126500011
PM 30271898
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Tchetgna, HS
   Ouilibona, RS
   Nkili-Meyong, AA
   Caron, M
   Labouba, I
   Selekon, B
   Njouom, R
   Leroy, EM
   Nakoune, E
   Berthet, N
AF Tchetgna, Huguette Simo
   Ouilibona, Rita Sem
   Nkili-Meyong, Andriniaina Andy
   Caron, Melanie
   Labouba, Ingrid
   Selekon, Benjamin
   Njouom, Richard
   Leroy, Eric M.
   Nakoune, Emmanuel
   Berthet, Nicolas
TI Viral Exploration of Negative Acute Febrile Cases Observed during
   Chikungunya Outbreaks in Gabon
SO INTERVIROLOGY
LA English
DT Article
DE Gabon; Virus isolation; Emerging viruses; Next-generation sequencing;
   Chikungunya virus
ID WEST-NILE-VIRUS; ZIKA VIRUS; DENGUE VIRUS; YELLOW-FEVER;
   HEMORRHAGIC-FEVER; AEDES-ALBOPICTUS; EBOLA-VIRUS; IDENTIFICATION;
   INFECTION; EPIDEMIC
AB Non-malarial febrile illness outbreaks were documented in 2007 and 2010 in Gabon. After investigation, these outbreaks were attributed to the chikungunya and dengue viruses (CHIKV and DENV). However, for more than half of the samples analyzed, the causative agent was not identified. Given the geographical and ecological position of Gabon, where there is a great animal and microbial diversity, the circulation of other emerging viruses was suspected in these samples lacking aetiology. A total of 436 undiagnosed samples, collected between 2007 and 2013, and originating from 14 urban, suburban, and rural Gabonese locations were selected. These samples were used for viral isolation on newborn mice and VERO cells. In samples with signs of viral replication, cell supernatants and brain suspensions were used to extract nucleic acids and perform real-time RT-PCR targeting specific arboviruses, i.e., CHIKV, DENV, yellow fever, Rift Valley fever, and West Nile and Zika viruses. Virus isolation was conclusive for 43 samples either on newborn mice or by cell culture. Virus identification by RT-PCR led to the identification of CHIKV in 37 isolates. A total of 18 complete genomes and 19 partial sequences containing the E2 and E1 genes of CHIKV were sequenced using next-generation sequencing technology or the Sanger method. Phylogenetic analysis of the complete genomes showed that all the sequences belong to the East Central South Africa lineage. Furthermore, we identified 2 distinct clusters. The first cluster was made up of sequences from the western part of Gabon, whereas the second cluster was made up of sequences from the southern regions, reflecting the way CHIKV spread across the country following its initial introduction in 2007. Similar results were obtained when analyzing the CHIKV genes of the E2 and E1 structural proteins. Moreover, study of the mutations found in the E2 and E1 structural proteins revealed the presence of several mutations that facilitate the adaptation to the Aedes albopictus mosquito, such as E2 I211T and E1 A226V, in all the Gabonese CHIKV strains. Finally, sequencing of 6 additional viral isolates failed to lead to any conclusive identification. (c) 2019 S. Karger AG, Basel
C1 [Tchetgna, Huguette Simo; Nkili-Meyong, Andriniaina Andy; Caron, Melanie; Labouba, Ingrid; Leroy, Eric M.; Berthet, Nicolas] CIRMF, BP 769, Franceville, Gabon.
   [Ouilibona, Rita Sem; Selekon, Benjamin; Nakoune, Emmanuel] Inst Pasteur, Bangui, Cent Afr Republ.
   [Njouom, Richard] Ctr Pasteur Cameroun, Yaounde, Cameroon.
   [Leroy, Eric M.] Inst Rech Dev, Unite Mixte Rech Malad Infectieuses & Vecteurs Ec, IRD 224, CNRS 5290,UM1 UM2, Montpellier, France.
   [Berthet, Nicolas] Inst Pasteur, Cellule Intervent Biol Urgence, Unite Environm & Risques Infect, Paris, France.
   [Berthet, Nicolas] CNRS, UMR3569, Paris, France.
RP Berthet, N (corresponding author), CIRMF, BP 769, Franceville, Gabon.
EM nicolas.berthet@pasteur.fr
RI Nakoune, Emmanuel/W-2710-2019; LEROY, Eric/I-4347-2016
OI LEROY, Eric/0000-0003-0022-0890
FU Institut Pasteur de Bangui; CIRMF (Gabonese Government); LMI ZOOFAC at
   IRD; French Foreign Ministry; Total Gabon
FX We acknowledge Dr Carolyn Engel-Gautier for improving English usage in
   the manuscript. This study was supported by the Institut Pasteur de
   Bangui, the CIRMF (funded by the Gabonese Government), Total Gabon, the
   LMI ZOOFAC at IRD, and the French Foreign Ministry. The funders had no
   role in study design, data analysis, or preparation of the manuscript.
CR Amblard J, 1997, LANCET, V349, P181, DOI 10.1016/S0140-6736(05)60984-1
   Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021
   Barzon L, 2013, J INFECT DIS, V208, P1086, DOI 10.1093/infdis/jit290
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Caron M, 2012, CLIN INFECT DIS, V55, pE45, DOI 10.1093/cid/cis530
   Coffey LL, 2014, VIROLOGY, V448, P146, DOI 10.1016/j.virol.2013.09.026
   da Silva SR, 2016, J MED VIROL, V88, P1291, DOI 10.1002/jmv.24563
   Dixon MG, 2014, MMWR-MORBID MORTAL W, V63, P548
   Drosten C, 2002, J CLIN MICROBIOL, V40, P2323, DOI 10.1128/JCM.40.7.2323-2330.2002
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grobbelaar AA, 2016, EMERG INFECT DIS, V22, P1854, DOI 10.3201/eid2210.160818
   Hirayama T, 2012, J CLIN MICROBIOL, V50, P2047, DOI 10.1128/JCM.06557-11
   Hontz RD, 2015, EMERG INFECT DIS, V21, P781, DOI 10.3201/eid2105.141368
   Ip HS, 2014, J VIROL METHODS, V206, P42, DOI 10.1016/j.jviromet.2014.05.018
   Ishii A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6651
   Jaffar-Bandjee MC, 2009, MICROBES INFECT, V11, P1206, DOI 10.1016/j.micinf.2009.10.001
   Kuniholm MH, 2006, AM J TROP MED HYG, V74, P1078, DOI 10.4269/ajtmh.2006.74.1078
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Leparc-Goffart I, 2009, J CLIN VIROL, V45, P61, DOI 10.1016/j.jcv.2009.02.010
   Leroy EM, 2004, J INFECT DIS, V190, P1895, DOI 10.1086/425421
   Leroy EM, 2002, LANCET, V359, P712, DOI 10.1016/S0140-6736(02)07796-6
   Leroy EM, 2009, EMERG INFECT DIS, V15, P591, DOI 10.3201/eid1504.080664
   Linke S, 2007, J VIROL METHODS, V146, P355, DOI 10.1016/j.jviromet.2007.05.021
   Lo Presti A, 2016, INFECT GENET EVOL, V41, P270, DOI 10.1016/j.meegid.2016.04.006
   Morens DM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003467
   Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759
   MORSE SS, 1995, EMERG INFECT DIS, V1, P7, DOI 10.3201/eid0101.950102
   Mostashari F, 2001, LANCET, V358, P261, DOI 10.1016/S0140-6736(01)05480-0
   Moyen N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115938
   Musso D, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0556-9
   Nkoghe D, 2005, Bull Soc Pathol Exot, V98, P224
   Nur YA, 1999, AM J TROP MED HYG, V61, P885, DOI 10.4269/ajtmh.1999.61.885
   Ocan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092323
   Pages F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004691
   Pastorino B, 2005, J VIROL METHODS, V124, P65, DOI 10.1016/j.jviromet.2004.11.002
   Paupy C, 2012, VECTOR-BORNE ZOONOT, V12, P167, DOI 10.1089/vbz.2011.0736
   Peyrefitte CN, 2008, J MED VIROL, V80, P430, DOI 10.1002/jmv.21090
   Peyrefitte CN, 2007, EMERG INFECT DIS, V13, P768, DOI 10.3201/eid1305.061500
   Pourrut X, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000763
   Pourrut X, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-132
   Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029
   Rossini G, 2017, J INFECTION, V75, P242, DOI 10.1016/j.jinf.2017.05.021
   Santiago GA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03772-1
   Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Stapleford KA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004402
   Thonnon J, 1998, AM J TROP MED HYG, V59, P108, DOI 10.4269/ajtmh.1998.59.108
   Tsetsarkin KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006835
   Vazeille M, 2008, TROP MED INT HEALTH, V13, P1176, DOI 10.1111/j.1365-3156.2008.02123.x
   Volk SM, 2010, J VIROL, V84, P6497, DOI 10.1128/JVI.01603-09
   Wasonga C, 2015, VIRUS GENES, V51, P323, DOI 10.1007/s11262-015-1243-4
   Weaver SC, 2015, ANTIVIR RES, V120, P32, DOI 10.1016/j.antiviral.2015.04.016
   Woodall JP, 2016, PAN AFR MED J, V24, DOI 10.11604/pamj.2016.24.107.9921
   Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721
NR 56
TC 1
Z9 1
U1 0
U2 1
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0300-5526
EI 1423-0100
J9 INTERVIROLOGY
JI Intervirology
PY 2018
VL 61
IS 4
BP 174
EP 184
DI 10.1159/000495136
PG 11
WC Virology
SC Virology
GA HO5MA
UT WOS:000460969900003
PM 30625488
OA Bronze
DA 2020-07-08
ER

PT S
AU Jain, A
   Meena, GG
   Parks, JW
   Stambaugh, A
   Patterson, JL
   Hawkins, AR
   Schmidt, H
AF Jain, A.
   Meena, G. G.
   Parks, J. W.
   Stambaugh, A.
   Patterson, J. L.
   Hawkins, A. R.
   Schmidt, H.
BE Winzer, P
   Tsang, HK
   Capmany, J
   Yao, J
   Fontaine, N
   Dutta, N
TI All-in-one optofluidic platform for differential diagnostics of multiple
   biomarkers with single molecule sensitivity
SO 2018 IEEE PHOTONICS CONFERENCE (IPC)
SE IEEE Photonics Conference
LA English
DT Proceedings Paper
CT 31st Annual IEEE Photonics Conference (IPC) of the
   IEEE-Photonics-Society
CY SEP 30-OCT 04, 2018
CL Reston, VA
SP IEEE Photon Soc, IEEE
ID EBOLA
AB Amplification-free and high throughput single nucleic acid detection, with minimal user input, is achieved by integrating optical waveguides with programmable valve array on a single microfluidic platform. Automated preparation and analysis of a dual protein-nucleic acid assay for Zika viral diagnostics is demonstrated.
C1 [Jain, A.; Meena, G. G.; Parks, J. W.; Stambaugh, A.; Schmidt, H.] Univ Calif Santa Cruz, Sch Engn, 1156 High St, Santa Cruz, CA 95064 USA.
   [Patterson, J. L.] Texas Biomed Res Inst, Dept Virol & Immunol, 7620 NW Loop 410, San Antonio, TX 78227 USA.
   [Hawkins, A. R.] Brigham Young Univ, ECEn Dept, 459 Clyde Bldg, Provo, UT 84602 USA.
RP Schmidt, H (corresponding author), Univ Calif Santa Cruz, Sch Engn, 1156 High St, Santa Cruz, CA 95064 USA.
EM hschmidt@soe.ucsc.edu
CR Ashley EA, 2016, NAT REV GENET, V17, P507, DOI 10.1038/nrg.2016.86
   Cai H, 2015, SCI REP-UK, V5, DOI 10.1038/srep14494
   Osterholm MT, 2016, SCIENCE, V353, P1073, DOI 10.1126/science.aai9078
   Parks JW, 2016, SCI REP-UK, V6, DOI 10.1038/srep33008
NR 4
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 2374-0140
BN 978-1-5386-5358-6
J9 IEEE PHOTON CONF
PY 2018
PG 2
WC Engineering, Electrical & Electronic; Optics; Physics, Applied
SC Engineering; Optics; Physics
GA BM1TN
UT WOS:000460542800197
DA 2020-07-08
ER

PT B
AU Mandal, S
   Rath, M
   Wang, YW
   Patra, BG
AF Mandal, Soumik
   Rath, Manasa
   Wang, Yiwei
   Patra, Braja Gopal
GP Assoc Comp Machinery
TI Predicting Zika Prevention Techniques Discussed on Twitter: An
   Exploratory Study
SO CHIIR'18: PROCEEDINGS OF THE 2018 CONFERENCE ON HUMAN INFORMATION
   INTERACTION & RETRIEVAL
LA English
DT Proceedings Paper
CT 3rd ACM SIGIR Conference on Human Information Interaction and Retrieval
   (CHIIR)
CY MAR 11-15, 2018
CL New Brunswick, NJ
SP Assoc Comp Machinery, ACM SIGIR, ACM SIGCHI
DE Zika prevention; Health analytics; Social media; Logistic regression
AB Social media platforms are widely seen as a valuable medium to spread a wide range of information including charitable causes and health awareness. But given the flexibility provided by the social media platforms, it is important to ensure that the right kind of information is delivered to the right audience when needed. The pilot study presented in this paper considered a sample of Zika related tweets that were classified into different prevention techniques. The classification categories were drawn from the guidelines by CDC. Training a logistic regression model on the annotated data we found the accuracy to be 72%. The findings are significant in studying the effectiveness of social media platforms in spreading the right kind of information in time. This in turn can be useful in informing health care officials to take necessary steps with the help of real-time communication for such unfortunate events in future.
C1 [Mandal, Soumik; Rath, Manasa; Wang, Yiwei] Rutgers State Univ, New Brunswick, NJ 08901 USA.
   [Patra, Braja Gopal] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA.
RP Mandal, S (corresponding author), Rutgers State Univ, New Brunswick, NJ 08901 USA.
EM soumik.mandal@rutgers.edu; manasa.rath@rutgers.edu;
   yiwei.wang@rutgers.edu; brajagopal.cse@gmail.com
RI Patra, Braja Gopal/P-7126-2018
OI Patra, Braja Gopal/0000-0003-2997-5314
CR Asur S, 2010, Proceedings 2010 IEEE/ACM International Conference on Web Intelligence-Intelligent Agent Technology (WI-IAT), P492, DOI 10.1109/WI-IAT.2010.63
   Chen KY, 2003, INFORM SYST FRONT, V5, P47, DOI 10.1023/A:1022041805438
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Dredze M, 2016, VACCINE, V34, P3441, DOI 10.1016/j.vaccine.2016.05.008
   Glowacki EM, 2016, AM J INFECT CONTROL, V44, P1709, DOI 10.1016/j.ajic.2016.05.025
   Holmes G., 1994, Proceedings of the 1994 Second Australian and New Zealand Conference on Intelligent Information Systems (Cat. No.94TH8019), P357, DOI 10.1109/ANZIIS.1994.396988
   Kaplan AM, 2010, BUS HORIZONS, V53, P59, DOI 10.1016/j.bushor.2009.09.003
   Kilgarriff A., 2000, WORDNET ELECT LEXICA
   Manning C.D., 2009, INTRO INFORM RETRIEV
   Miller M., 2017, ARXIV170107490
   Oyeyemi SO, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6178
   Pennington Jeffrey, 2014, P EMNLP C, P1532, DOI DOI 10.3115/V1/D14-1162
   Perrin A., 2015, SOCIAL MEDIA USAGE
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Sadilek A., 2012, P 6 INT AAAI C WEBL, P322
NR 15
TC 3
Z9 3
U1 0
U2 1
PU ASSOC COMPUTING MACHINERY
PI NEW YORK
PA 1515 BROADWAY, NEW YORK, NY 10036-9998 USA
BN 978-1-4503-4925-3
PY 2018
BP 269
EP 272
DI 10.1145/3176349.3176874
PG 4
WC Computer Science, Cybernetics; Computer Science, Information Systems
SC Computer Science
GA BM1PZ
UT WOS:000460388100037
DA 2020-07-08
ER

PT B
AU Beltran, JD
   Boscor, A
   dos Santos, WP
   Massoni, T
   Kostkova, P
AF Beltran, Juan D.
   Boscor, Andrei
   dos Santos, Wellington P.
   Massoni, Tiago
   Kostkova, Patty
GP Assoc Comp Machinery
TI ZIKA: A New System to Empower Health Workers and Local Communities to
   Improve Surveillance Protocols by E-learning and to Forecast Zika Virus
   in Real Time in Brazil
SO DH '18: PROCEEDINGS OF THE 2018 INTERNATIONAL CONFERENCE ON DIGITAL
   HEALTH
LA English
DT Proceedings Paper
CT 8th International Conference on Digital Health (DH)
CY APR 23-26, 2018
CL Lyon, FRANCE
SP ACM Special Interest Grp Knowledge Discovery & Data Mining, ICPS, Digital Biomarkers, Frost & Sullivan, WEB Conference, Int Journal Environm Res & Publ Hlth, Invest Lyon, UCL IRDR, UCL European Inst, Maddyness
DE Zika virus; big data; surveillance; forecasting; e-learning
ID TRANSMISSION; INFECTION; AMERICA; BRAIN
AB The devastating consequences of neonates infected with the Zika virus makes it necessary to fight and stop the spread of this virus and its vectors (Aedes mosquitoes). An essential part of the fight against mosquitoes is the use of mobile technology to support routine surveillance and risk assessment by community health workers (health agents). In addition, to improve early warning systems, the public health authorities need to forecast more accurately where an outbreak of the virus and its vector is likely to occur. The ZIK. system aims to develop a novel comprehensive framework that combines e-learning to empower health agents, community-based participatory surveillance, and forecasting of occurrences and distribution of the Zika virus and its vectors in real time. This system is currently being implemented in Brazil, in the cities of Campina Grande, Recife, Jaboatao dos Guararapes, and Olinda, the State of Pernambuco and Paraiba with the highest prevalence of the Zika virus disease. In this paper, we present the ZIKA system which helps health agents to learn new techniques and good practices to improve the surveillance of the virus and offer a real time distribution forecast of the virus and the vector. The forecast model is recalibrated in real time with information coming from health agents, governmental institutions, and weather stations to predict the areas with higher risk of a Zika virus outbreak in an interactive map. This mapping and alert system will help governmental institutions to make fast decisions and use their resources more efficiently to stop the spread of the Zika virus. The ZIKA app was developed and built in Ionic which allows for easy cross-platform rendering for both iOS and Android. The system presented in the current paper is one of the first systems combining public health surveillance, citizen-driven participatory reporting and weather data-based prediction. The implementation of the ZIKA system will reduce the devastating consequences of Zika virus in neonates and improve the life quality of vulnerable people in Brazil.
C1 [Beltran, Juan D.; Boscor, Andrei; Kostkova, Patty] UCL, Inst Risk & Disaster Reduct, London, England.
   [dos Santos, Wellington P.] Univ Fed Pernambuco, Dept Biomed Engn, Recife, PE, Brazil.
   [Massoni, Tiago] Univ Fed Campina Grande, Dept Syst & Comp, Campina Grande, Paraiba, Brazil.
RP Beltran, JD (corresponding author), UCL, Inst Risk & Disaster Reduct, London, England.
EM juan.beltran@ucl.ac.uk; andrei.boscor.14@ucl.ac.uk;
   wellington.santos@ufpe.br; massoni@computacao.ufcg.edu.br;
   p.kostkova@ucl.ac.uk
RI Massoni, Tiago/AAE-9376-2020; Santos, Wellington P/F-9052-2012
OI Massoni, Tiago/0000-0002-9423-7556; Santos, Wellington
   P/0000-0003-2558-6602
FU British Council Newton Fund [280860230]
FX This work was supported by the British Council Newton Fund No.
   280860230.
CR Afsahi S, 2018, BIOSENS BIOELECTRON, V100, P85, DOI 10.1016/j.bios.2017.08.051
   Alam A, 2017, BIOMED PHARMACOTHER, V91, P1152, DOI 10.1016/j.biopha.2017.05.045
   Attar N., 2016, NAT REV MICROBIOL, V14, P62, DOI DOI 10.1038/NRMICR0.2015.28
   Barata G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190482
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Carlson CJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004968
   de Quincey E, 2009, ELECT HEALTHCARE, P21, DOI [10.1007/978-3-642-11745-9_4, DOI 10.1007/978-3-642-11745-9_4]
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i595
   Javed F, 2017, J BASIC MICROB, V2017, P3
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P86
   Kostkova P, 2017, ACM P DIG HLTH 2017, V1
   Kostkova P, 2014, ACM TRANS MANAG INF, V5, DOI 10.1145/2597892
   Kostkova P, 2015, FRONT PUBLIC HEALTH, V3, DOI 10.3389/fpubh.2015.00134
   Kostkova Patty, 2013, P 22 INT C WORLD WID, P687
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   McGough SF, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005295
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Paz S, 2016, LANCET, V387, P745, DOI 10.1016/S0140-6736(16)00256-7
   Samy AM, 2016, MEM I OSWALDO CRUZ, V111, P559, DOI 10.1590/0074-02760160149
   Szomszor M, 2010, LECT NOTES I COMPUTE, P18, DOI DOI 10.1007/978-3-642-23635-8_3
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 25
TC 4
Z9 4
U1 0
U2 1
PU ASSOC COMPUTING MACHINERY
PI NEW YORK
PA 1515 BROADWAY, NEW YORK, NY 10036-9998 USA
BN 978-1-4503-6493-5
PY 2018
BP 90
EP 94
DI 10.1145/3194658.3194683
PG 5
WC Computer Science, Interdisciplinary Applications; Public, Environmental
   & Occupational Health; Medical Informatics
SC Computer Science; Public, Environmental & Occupational Health; Medical
   Informatics
GA BM1RY
UT WOS:000460466600015
DA 2020-07-08
ER

PT J
AU Vianna, P
   Gomes, JD
   Boquett, JA
   Fraga, LR
   Schuch, JB
   Vianna, FSL
   Schuler-Faccini, L
AF Vianna, Priscila
   Gomes, Julia do Amaral
   Boquett, Juliano Andre
   Fraga, Lucas Rosa
   Schuch, Jaqueline Bohrer
   Luiz Vianna, Fernanda Sales
   Schuler-Faccini, Lavinia
TI Zika Virus as a Possible Risk Factor for Autism Spectrum Disorder:
   Neuroimmunological Aspects
SO NEUROIMMUNOMODULATION
LA English
DT Review
DE Zika virus; Neuroimmunomodulation; Inflammation; Autism
ID PRENATAL INFECTION; MOUSE MODEL; BRAIN; ACTIVATION; BRAZIL; INHIBITION;
   MECHANISMS; EXPRESSION; MIGRATION; BIRTH
AB The recent outbreak of the Zika virus (ZIKV) and the discovery that perinatal Zika exposure can lead to the Congenital Zika Syndrome has promoted a call for prevention measures. Due to the increased number of babies born with microcephaly, structural brain abnormalities, and neurological alterations in regions affected by ZIKV, investigations were carried out in order to better understand this process. The maternal immune system directly influences the fetal central nervous system, and complications during pregnancy have been associated with neurodevelopmental disorders. Autism spectrum disorder (ASD), a neurodevelopmental disorder commonly manifested in the first years of life, is a disease with multifactorial etiology and is manifested typically by social and communication impairments, as well as stereotyped behaviors. Brain abnormalities, including both anatomically and functionally, can be observed in this disorder, suggesting delays in neuronal maturation and altered brain connectivity. It is known that some viral congenital infections, such as rubella, and cytomegalovirus can interfere with brain development, being associated with brain calcification, microcephaly, and ASD. Here, we reviewed a range of studies evaluating the aspects concerning brain development, immunological status during pregnancy, and neuroimmunomodulation in congenital viral infections, and we discuss if the fetal brain infection caused by ZIKV could predispose to ASD. Finally, we suggest a mechanism encompassing neurological and immunological pathways that could play a role in the development of ASD in infants after ZIKV infection in pregnancy. (C) 2019 S. Karger AG, Basel
C1 [Vianna, Priscila; Gomes, Julia do Amaral; Boquett, Juliano Andre; Luiz Vianna, Fernanda Sales; Schuler-Faccini, Lavinia] Univ Fed Rio Grande do Sul, Inst Biosci, Dept Genet, Porto Alegre, RS, Brazil.
   [Vianna, Priscila; Gomes, Julia do Amaral; Boquett, Juliano Andre; Fraga, Lucas Rosa; Luiz Vianna, Fernanda Sales; Schuler-Faccini, Lavinia] Natl Inst Populat Med Genet INAGEMP, Porto Alegre, RS, Brazil.
   [Fraga, Lucas Rosa; Luiz Vianna, Fernanda Sales; Schuler-Faccini, Lavinia] HCPA, Brazilian Teratogen Informat Serv SIAT, Med Genet Serv, Porto Alegre, RS, Brazil.
   [Gomes, Julia do Amaral; Luiz Vianna, Fernanda Sales] HCPA, Genom Med Lab, Porto Alegre, RS, Brazil.
   [Schuch, Jaqueline Bohrer] Pontificia Univ Catolica Rio Grande Sul PUCRS, Grad Program Biomed Gerontol, Porto Alegre, RS, Brazil.
   [Fraga, Lucas Rosa] Univ Fed Rio Grande do Sul, Inst Hlth Sci, Dept Morphol Sci, Porto Alegre, RS, Brazil.
RP Schuler-Faccini, L (corresponding author), Univ Fed Rio Grande do Sul, Dept Genet, Av Bento Goncalves 9500, BR-91501970 Porto Alegre, RS, Brazil.
EM lavinia.faccini@ufrgs.br
RI Schuch, Jaqueline Bohrer/L-1249-2015; Boquett, Juliano
   Andre/F-6893-2018; SCHULER-FACCINI, LAVINIA/C-8309-2013; Vianna,
   Fernanda Sales Luiz/O-4337-2019; Fraga, Lucas/L-1538-2015
OI Schuch, Jaqueline Bohrer/0000-0002-2195-4407; Boquett, Juliano
   Andre/0000-0002-6437-789X; SCHULER-FACCINI, LAVINIA/0000-0002-2428-0460;
   
FU National Institute of Population Medical Genetics (INAGEMP) [CNPq
   573993/2008-4]; Coordenacao de Aperfeicoamento Pessoal de Nivel Superior
   (CAPES)CAPES [001]; CNPq/CAPES/MS [14/2016]
FX This work was supported by National Institute of Population Medical
   Genetics (INAGEMP) grants CNPq 573993/2008-4; CNPq/CAPES/MS (No. 14/2016
   - Preventing and Combating the Zika Virus) and Coordenacao de
   Aperfeicoamento Pessoal de Nivel Superior (CAPES, Finance Code 001).
CR Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599
   Ahmad SF, 2017, PROG NEURO-PSYCHOPH, V79, P184, DOI 10.1016/j.pnpbp.2017.06.034
   Ansari MA, 2017, MOL CELL NEUROSCI, V82, P76, DOI 10.1016/j.mcn.2017.04.012
   Ansari MA, 2017, CELL SIGNAL, V36, P14, DOI 10.1016/j.cellsig.2017.04.014
   Ashkar AA, 2000, J EXP MED, V192, P259, DOI 10.1084/jem.192.2.259
   Ashwood P, 2011, BRAIN BEHAV IMMUN, V25, P40, DOI 10.1016/j.bbi.2010.08.003
   Avitsur R, 2015, STRESS, V18, P289, DOI 10.3109/10253890.2015.1017464
   Blom B, 1998, CRIT REV IMMUNOL, V18, P371, DOI 10.1615/CritRevImmunol.v18.i4.50
   Boldenow E, 2013, PLACENTA, V34, P480, DOI 10.1016/j.placenta.2013.02.010
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Businaro R, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-015-0466-6
   Campbell DE, 2015, CLIN EXP ALLERGY, V45, P844, DOI 10.1111/cea.12531
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Challis JR, 2009, REPROD SCI, V16, P206, DOI 10.1177/1933719108329095
   Chatterjee A, 2001, J Perinatol, V21, P559, DOI 10.1038/sj.jp.7210573
   Chen R, 2011, PEDIATR RES, V69, p63R, DOI 10.1203/PDR.0b013e318212c2b3
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Souza IND, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aar2749
   del Campo M, 2017, AM J MED GENET A, V173, P841, DOI 10.1002/ajmg.a.38170
   Doherty GH, 2007, NEUROSCI RES, V57, P296, DOI 10.1016/j.neures.2006.10.019
   Fortier ME, 2007, BEHAV BRAIN RES, V181, P270, DOI 10.1016/j.bbr.2007.04.016
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Gottfried C, 2015, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00121
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hutton J, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00025
   Kalkbrenner AE, 2010, EPIDEMIOLOGY, V21, P631, DOI 10.1097/EDE.0b013e3181e65d76
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Labouesse MA, 2015, AM J PHYSIOL-REG I, V309, pR1, DOI 10.1152/ajpregu.00087.2015
   Li XH, 2009, J NEUROIMMUNOL, V207, P111, DOI 10.1016/j.jneuroim.2008.12.002
   Maeyama K, 2018, J AUTISM DEV DISORD, V48, P1483, DOI 10.1007/s10803-017-3412-x
   Malkova NV, 2012, BRAIN BEHAV IMMUN, V26, P607, DOI 10.1016/j.bbi.2012.01.011
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Mavigner M, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao6975
   McEwan M, 2009, CYTOKINE GROWTH F R, V20, P241, DOI 10.1016/j.cytogfr.2009.05.004
   MEDAWAR PB, 1953, SYM SOC EXP BIOL, V7, P320
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Michaelsson J, 2006, J IMMUNOL, V176, P5741, DOI 10.4049/jimmunol.176.10.5741
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mold JE, 2008, SCIENCE, V322, P1562, DOI 10.1126/science.1164511
   Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Moreau P, 1999, INT IMMUNOL, V11, P803, DOI 10.1093/intimm/11.5.803
   Morgan JT, 2010, BIOL PSYCHIAT, V68, P368, DOI 10.1016/j.biopsych.2010.05.024
   Nadarajah B, 2002, NAT REV NEUROSCI, V3, P423, DOI 10.1038/nrn845
   Olagnier D, 2016, DNA CELL BIOL, V35, P367, DOI 10.1089/dna.2016.3404
   Park MTM, 2018, J PSYCHIATR NEUROSCI, V43
   Patel AS, 2014, INT NEUROPSYCHIATR D, V2, P175, DOI [10.9734/INDJ/2014/7284, DOI 10.9734/INDJ/2014/7284]
   Patterson PH, 2011, TRENDS MOL MED, V17, P389, DOI 10.1016/j.molmed.2011.03.001
   RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rodriguez-Rojas R., 2015, TRANSLATIONAL APPROA, P95
   RUSSELL LJ, 1984, AM J MED GENET, V17, P509, DOI 10.1002/ajmg.1320170213
   Saito S, 2010, AM J REPROD IMMUNOL, V63, P601, DOI 10.1111/j.1600-0897.2010.00852.x
   Schuler-Faccini L, 2016, CLIN PHARMACOL THER, V100, P28, DOI 10.1002/cpt.386
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Slawinski BL, 2018, AM J REPROD IMMUNOL, V79, DOI 10.1111/aji.12840
   Smith SEP, 2007, J NEUROSCI, V27, P10695, DOI 10.1523/JNEUROSCI.2178-07.2007
   SPENCER J, 1986, CLIN EXP IMMUNOL, V65, P553
   Stiles J., 2008, FUNDAMENTALS BRAIN D
   Stiles J, 2010, NEUROPSYCHOL REV, V20, P327, DOI 10.1007/s11065-010-9148-4
   Tegethoff M, 2010, PSYCHOSOM MED, V72, P419, DOI 10.1097/PSY.0b013e3181d2f0b0
   Underwood Mark A, 2005, J Perinatol, V25, P341, DOI 10.1038/sj.jp.7211290
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Vohr BR, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2017-0453
   Waldorf KMA, 2018, NAT MED, V24, P368, DOI 10.1038/nm.4485
   Wegiel J, 2010, ACTA NEUROPATHOL, V119, P755, DOI 10.1007/s00401-010-0655-4
   Wei HG, 2016, BBA-MOL BASIS DIS, V1862, P1918, DOI 10.1016/j.bbadis.2016.07.013
   Wei HG, 2012, BBA-MOL BASIS DIS, V1822, P831, DOI 10.1016/j.bbadis.2012.01.011
   Wei HG, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-52
   Wodarz A, 2003, MECH DEVELOP, V120, P1297, DOI 10.1016/j.mod.2003.06.003
   Zin AA, 2017, JAMA PEDIATR, V171, P847, DOI 10.1001/jamapediatrics.2017.1474
NR 72
TC 3
Z9 3
U1 0
U2 1
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1021-7401
EI 1423-0216
J9 NEUROIMMUNOMODULAT
JI Neuroimmunomodulation
PY 2018
VL 25
IS 5-6
SI SI
BP 320
EP 327
DI 10.1159/000495660
PG 8
WC Endocrinology & Metabolism; Immunology; Neurosciences
SC Endocrinology & Metabolism; Immunology; Neurosciences & Neurology
GA HM5LD
UT WOS:000459516300007
PM 30630174
OA Bronze
DA 2020-07-08
ER

PT S
AU Santos, DAA
   Brandao, RF
   Duarte, GAC
   Totti, DR
   Furtado, V
   Rodrigues, JJPC
AF Santos, Diego A. A.
   Brandao, Renann F.
   Duarte, Gabriela A. C.
   Totti, Debora R.
   Furtado, Vasco
   Rodrigues, Joel J. P. C.
BE Velazquez, R
   Rodriguez, A
   Gutierrez, CA
TI A Fan-Based Smart Selective Trap for Flying Insects
SO 2018 IEEE 10TH LATIN-AMERICAN CONFERENCE ON COMMUNICATIONS (IEEE
   LATINCOM)
SE IEEE Latin American Conference on Communications
LA English
DT Proceedings Paper
CT 10th IEEE Latin-American Conference on Communications (IEEE LATINCOM)
CY NOV 14-16, 2018
CL Guadalajara, MEXICO
SP IEEE
DE Internet of Things; Electronic insect traps; mosquito; Aedes aegypti
ID DIPTERA; DENGUE
AB For several years, insect-borne diseases have been a major global concern. Countries with warmer climates are these disease vectors primary victims. However, due to rising global temperatures, countries with no history of insect-borne diseases have presented alarming statistics on the mosquitoes population lack control. Due to the importance of this subject, this paper proposes a smart and selective fan-based trap to capture the Aedes aegypti mosquito, main vector of diseases such as Yellow Fever, Dengue Fever, Zika, and Chikungunya. The central purpose of this study is the development of an electronic trap integrable to variable approaches of flying insects sensors. The trap is made up of a microcontroller that operates two DC fans arranged at the ends of an aerodynamic structure. The construction of a prototype validates the project through results evaluation and discussion.
C1 [Santos, Diego A. A.; Brandao, Renann F.; Duarte, Gabriela A. C.; Totti, Debora R.; Rodrigues, Joel J. P. C.] Natl Inst Telecommun Inatel, Santa Rita Do Sapucai, MG, Brazil.
   [Furtado, Vasco; Rodrigues, Joel J. P. C.] Univ Fortaleza UNIFOR, Fortaleza, CE, Brazil.
   [Rodrigues, Joel J. P. C.] Inst Telecomunicacoes, Lisbon, Portugal.
RP Santos, DAA (corresponding author), Natl Inst Telecommun Inatel, Santa Rita Do Sapucai, MG, Brazil.
EM diego.amorim@mtel.inatel.br; renannde@geb.inatel.br;
   gabrieladuarte@geb.inatel.br; deboratotti@geb.inatel.br;
   vasco@unifor.br; joeljr@ieee.org
RI Rodrigues, Joel J. P. C./A-8103-2013; Furtado, Vasco/AAB-8318-2019;
   Furtado, Vasco/C-3748-2013
OI Rodrigues, Joel J. P. C./0000-0001-8657-3800; Furtado,
   Vasco/0000-0001-8721-4308; Furtado, Vasco/0000-0001-8721-4308
FU National Funding from the FCT - Fundacao para a Ciencia e a Tecnologia
   [UID/EEA/50008/2013]; FinepCiencia Tecnologia e Inovacao (FINEP);
   Funttel under the Centro de Referencia em Radiocomunicacoes - CRR
   project of the Instituto Nacional de Telecomunicacoes (Inatel), Brazil
   [01.14.0231.00]; Finatel through the Inatel Smart Campus project;
   Brazilian National Council for Research and Development (CNPq)National
   Council for Scientific and Technological Development (CNPq)
   [309335/2017-5]; Minas Gerais State Agency for Research and Development
   (FAPMIG) [TEC - APQ-03283-17]
FX This work was supported by the National Funding from the FCT - Fundacao
   para a Ciencia e a Tecnologia through the UID/EEA/50008/2013 Project; by
   Finep, with resources from Funttel, Grant No. 01.14.0231.00, under the
   Centro de Referencia em Radiocomunicacoes - CRR project of the Instituto
   Nacional de Telecomunicacoes (Inatel), Brazil; by Finatel through the
   Inatel Smart Campus project; by Brazilian National Council for Research
   and Development (CNPq) via Grant No. 309335/2017-5; and by Minas Gerais
   State Agency for Research and Development (FAPMIG) via Grant No. TEC -
   APQ-03283-17.
CR Braga IA, 2004, MEM I OSWALDO CRUZ, V99, P199, DOI 10.1590/S0074-02762004000200015
   Chen YP, 2014, J INSECT BEHAV, V27, P657, DOI 10.1007/s10905-014-9454-4
   De Los Reyes AMM, 2016, PROCEEDINGS OF THE 2016 IEEE REGION 10 CONFERENCE (TENCON), P2342, DOI 10.1109/TENCON.2016.7848448
   Kaieski N, 2016, P ANN HICSS, P3063, DOI 10.1109/HICSS.2016.385
   Li K, 2017, INT CONF ACOUST SPEE, P2726, DOI 10.1109/ICASSP.2017.7952652
   Lukman A, 2017, 2017 INTERNATIONAL CONFERENCE ON SOFT COMPUTING, INTELLIGENT SYSTEM AND INFORMATION TECHNOLOGY (ICSIIT), P17, DOI 10.1109/ICSIIT.2017.28
   Mello CAB, 2008, IEEE ENG MED BIO, P3103, DOI 10.1109/IEMBS.2008.4649860
   Morais SM, 2006, J AM MOSQUITO CONTR, V22, P161, DOI 10.2987/8756-971X(2006)22[161:LAOEOF]2.0.CO;2
   Nevai AL, 2014, MATH MED BIOL, V31, P150, DOI 10.1093/imammb/dqt002
   Costa IMP, 2016, EPIDEMIOL SERV SAUDE, V25, P735, DOI [10.5123/S1679-49742016000400007, 10.5123/s1679-49742016000400007]
   Ponnusamy L, 2008, P NATL ACAD SCI USA, V105, P9262, DOI 10.1073/pnas.0802505105
   RUEDA LM, 1990, J MED ENTOMOL, V27, P892, DOI 10.1093/jmedent/27.5.892
   Santos D. A. A., 2018, 3 INT SMART SUST TEC
   Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8
   Tan Kah Bee, 2009, Proceedings of the 2009 Sixth International Conference on Fuzzy Systems and Knowledge Discovery (FSKD 2009), P61, DOI 10.1109/FSKD.2009.761
   Vega-Almeida R. L., 2018, SCIENTOMETRICS, P1
NR 16
TC 0
Z9 0
U1 0
U2 3
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 2330-989X
BN 978-1-5386-6754-5
J9 IEEE LATAMER CONF
PY 2018
PG 5
WC Engineering, Electrical & Electronic; Telecommunications
SC Engineering; Telecommunications
GA BL9UZ
UT WOS:000458428900039
DA 2020-07-08
ER

PT J
AU Lo, CC
   Laurent-Simpson, A
AF Lo, Celia C.
   Laurent-Simpson, Andrea
TI How SES May Figure in Perceptions of Zika Risks and in Preventive Action
SO SOCIOLOGICAL SPECTRUM
LA English
DT Article
ID FUNDAMENTAL CAUSES; INFECTIOUS-DISEASE; SOCIAL CONDITIONS; VACCINE
   REFUSAL; PUBLIC TRUST; HEALTH; SOCIETY; SCIENCE; VIRUS; MEDIA
AB The present study intended to determine how the socioeconomic status (SES) of citizens and public health communications help explain citizens' risk perception and actions taken during Zika virus outbreaks in 2016. We used data from a nationally representative study conducted in March 2016 by the Associated Press-National Opinion Research Center to analyze 831 American adult responses regarding Zika. We found that respondent risk perception and actions taken diminished as SES level rose. Risk perception was also found to mediate preventive actions' associations. To quell the global spread of emerging infectious diseases (EIDs) like Zika, health organizations worldwide must understand how SES contributes to Zika (and other future EIDs) risk perception and preventive action. A more compelling form of public health communications must be developed that takes into account the impact made on future outbreaks and infections by these higher-SES risk assessments.
C1 [Lo, Celia C.] Texas Womans Univ, Dept Sociol & Social Work, CFO 305,POB 425887, Denton, TX 76204 USA.
   [Laurent-Simpson, Andrea] Southern Methodist Univ, Dept Sociol, Dallas, TX USA.
RP Lo, CC (corresponding author), Texas Womans Univ, Dept Sociol & Social Work, CFO 305,POB 425887, Denton, TX 76204 USA.
EM clo@twu.edu
OI Lo, Celia/0000-0002-5785-6622; Laurent-Simpson,
   Andrea/0000-0002-7261-9860
CR Adam B, 2000, RISK SOC CRITICAL IS, P1, DOI DOI 10.4135/9781446219539
   Awadh Asma, 2017, PLOS CURRENTS, V9
   Bakir V, 2010, J RISK RES, V13, P5, DOI 10.1080/13669870903135953
   Bban A, 2014, INT J BEHAV MED, V21, P20, DOI [10.1007/s12529-013-9340-z, DOI 10.1007/s12529-013-9340-z]
   Beaubien Jason, 2016, NPR
   Beck U., 2000, RISK SOC CRITICAL IS, P211, DOI DOI 10.4135/9781446219539.N12
   Beck U., 1992, RISK SOC NEW MODERNI, V17
   Beck Ulrich, 1998, POLITICS RISK SOC, P9
   Berezin M, 2016, SOC SCI MED, V165, P233, DOI 10.1016/j.socscimed.2016.07.009
   Bohm R, 2016, J ECON BEHAV ORGAN, V131, P183, DOI 10.1016/j.jebo.2015.11.008
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cobb MD, 2005, SCI COMMUN, V27, P221, DOI 10.1177/1075547005281473
   Conrad P, 2016, HEALTH-LONDON, V20, P22, DOI 10.1177/1363459315611941
   Dredze M, 2016, AM J PREV MED, V50, P550, DOI 10.1016/j.amepre.2015.10.002
   Dubois D, 2015, J PERS SOC PSYCHOL, V108, P436, DOI 10.1037/pspi0000008
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Farmer PE, 2013, NEW ENGL J MED, V369, P2424, DOI 10.1056/NEJMsa1310472
   Fitzgerald ST, 2010, SOCIOL SPECTRUM, V30, P367, DOI 10.1080/02732171003641016
   Fox S., 2013, HLTH ONLINE 2013
   Gauchat G, 2012, AM SOCIOL REV, V77, P167, DOI 10.1177/0003122412438225
   Gesser-Edelsburg A, 2014, DISASTER MED PUBLIC, V8, P158, DOI 10.1017/dmp.2014.27
   Giddens A., 2011, RUNAWAY WORLD
   Giddens A, 1991, MODERNITY AND SELF I
   Harambam J, 2015, PUBLIC UNDERST SCI, V24, P466, DOI 10.1177/0963662514559891
   Holmes BJ, 2008, HEALTH RISK SOC, V10, P349, DOI 10.1080/13698570802166431
   Howard J, 2017, ANTIVACCINE GROUPS B
   Jensen M, 2008, CURR SOCIOL, V56, P757, DOI 10.1177/0011392108093834
   Joffe H, 2004, J HEALTH PSYCHOL, V9, P517, DOI 10.1177/1359105304044036
   Johnson BB, 2015, HEALTH RISK SOC, V17, P458, DOI 10.1080/13698575.2015.1113237
   Jones V, 2004, SOC CULT GEOGR, V5, P213, DOI 10.1080/14649360410001690222
   Kata A, 2012, VACCINE, V30, P3778, DOI 10.1016/j.vaccine.2011.11.112
   Kata A, 2010, VACCINE, V28, P1709, DOI 10.1016/j.vaccine.2009.12.022
   Laurent-Simpson Andrea, 2017, RISK SOC ONLIN UNPUB
   Leask J, 2006, VACCINE, V24, P7238, DOI 10.1016/j.vaccine.2006.05.010
   Lehmann BA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-547
   LINK BG, 1995, J HEALTH SOC BEHAV, V35, P80, DOI 10.2307/2626958
   Link BG, 2008, J HEALTH SOC BEHAV, V49, P72, DOI 10.1177/002214650804900106
   Lupton D, 2016, ROUT INT HANDB, P301
   McComas WF, 2015, AM BIOL TEACH, V77, P485, DOI 10.1525/abt.2015.77.7.2
   Melkote SR, 2000, J HEALTH COMMUN, V5, P17, DOI 10.1080/10810730050019537
   Meyer SB, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001389
   MMWR, 2001, MMWR            0601, V50, P430
   Mumah JN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100507
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   PEARLIN LI, 1989, J HEALTH SOC BEHAV, V30, P241, DOI 10.2307/2136956
   Perrin A., 2015, SOCIAL MEDIA USAGE
   Pew Research Center, 2017, INT BROADB FACT SHEE
   Phelan JC, 2005, J GERONTOL B-PSYCHOL, V60, P27
   Phelan JC, 2004, J HEALTH SOC BEHAV, V45, P265, DOI 10.1177/002214650404500303
   Phelan JC, 2005, J HEALTH SOC BEHAV, V46
   Phelan JC, 2010, J HEALTH SOC BEHAV, V51, pS28, DOI 10.1177/0022146510383498
   Porter CE, 2006, J BUS RES, V59, P999, DOI 10.1016/j.jbusres.2006.06.003
   Price AM, 2016, INT SOCIOL, V31, P57, DOI 10.1177/0268580915614593
   Rainie Lee, 2016, HALF OF AMERICANS SA
   Roundtable on Public Interfaces of the Life Sciences, 2015, THE NATIONAL ACADEMI
   Salathe M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002199
   Salmon DA, 2005, ARCH PEDIAT ADOL MED, V159, P470, DOI 10.1001/archpedi.159.5.470
   Shacham E, 2017, AM J PUBLIC HEALTH, V107, P724, DOI 10.2105/AJPH.2017.303670
   Sharma M, 2017, AM J INFECT CONTROL, V45, P301, DOI 10.1016/j.ajic.2016.08.022
   Sinha MS, 2016, AM J LAW MED, V42, P223, DOI 10.1177/0098858816658269
   Smith PJ, 2004, PEDIATRICS, V114, P187, DOI 10.1542/peds.114.1.187
   Sobo EJ, 2015, MED ANTHROPOL Q, V29, P381, DOI 10.1111/maq.12214
   Taylor-Gooby P, 2010, J RISK RES, V13, P731, DOI 10.1080/13669877.2010.488744
   The Associated Press and National Opinion Research Center, 2016, THE ZIKA VIRUS AMERI
   van Loon J, 2014, HEALTH RISK SOC, V16, P444, DOI 10.1080/13698575.2014.936833
   Vest KG, 2016, DISASTER MED PUBLIC, V10, P707, DOI 10.1017/dmp.2016.43
   Wilmut I, 2007, NATURE, V445, P485, DOI 10.1038/445485a
   Wylie BJ, 2016, OBSTET GYNECOL, V128, P1111, DOI 10.1097/AOG.0000000000001685
   Wynne B, 2006, COMMUNITY GENET, V9, P211, DOI 10.1159/000092659
   Yang YT, 2016, AM J PUBLIC HEALTH, V106, P172, DOI 10.2105/AJPH.2015.302926
NR 70
TC 0
Z9 0
U1 1
U2 1
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0273-2173
EI 1521-0707
J9 SOCIOL SPECTRUM
JI Sociol. Spectr.
PY 2018
VL 38
IS 5
BP 295
EP 311
DI 10.1080/02732173.2018.1502109
PG 17
WC Sociology
SC Sociology
GA HK9FD
UT WOS:000458294400001
DA 2020-07-08
ER

PT B
AU Dias, TM
   Alves, VC
   Alves, HM
   Pinheiro, LF
   Pontes, RSG
   Araujo, GM
   Lima, AA
   Prego, TM
AF Dias, T. M.
   Alves, V. C.
   Alves Junior, H. M.
   Pinheiro, L. F.
   Pontes, R. S. G.
   Araujo, G. M.
   Lima, A. A.
   Prego, T. M.
BE DoNascimento, TP
   Colombini, EL
   DeBrito, AV
   Garcia, LTD
   Sa, STD
   Goncalves, LMG
TI Autonomous Detection of Mosquito-breeding Habitats using an Unmanned
   Aerial Vehicle
SO 15TH LATIN AMERICAN ROBOTICS SYMPOSIUM 6TH BRAZILIAN ROBOTICS SYMPOSIUM
   9TH WORKSHOP ON ROBOTICS IN EDUCATION (LARS/SBR/WRE 2018)
LA English
DT Proceedings Paper
CT 15th Latin American Robotic Symposium (LARS) / 6th Brazilian Symposium
   on Robotics (SBR) / 9th Workshop on Robotics in Education (WRE)
CY NOV 06-10, 2018
CL Joao Pessoa, BRAZIL
SP Fed Univ Paraiba, IEEE Comp Soc, Fed Univ Rio Grande Norte, Fed Univ Paraiba, Laser Lab, Fed Univ Rio Grande Norte, Natalnet Associate Labs, CNPq, Paraiba State Govt, Joao Pessoa City Council, SEBRAE, FIEPb, Fecomercio, BRISA, ANID, GMI, Magazine Luiza, RoboEduc
DE Aedes aegypti; mosquito; detection; unmanned aerial vehicle; computer
   vision
AB Every year, thousands of people die from diseases such as dengue fever, chikungunya, and zika. This public health problem is more evident in developing countries. All these illnesses have the same source in common: a mosquito scientifically known as Aedes Aegypti. In cities, the majority of mosquito-breeding habitats are man-made: bottles, tires, barrels, pots or any stagnant water. This paper proposes an innovative system to aid in determining mosquito-breeding habitats location by employing computer vision tools on aerial images. Tires and regions with stagnant water were selected as objects of study. For this, a dataset was created containing video sequences and telemetry data from an unmanned aerial vehicle (UAV) and the respective manual annotation in different scenarios. The features extracted from the videos (through HSV color space, histograms, and edge detection) were used to train a random forest classifier, resulting in an accuracy higher than 99% in the test set. The system is also capable of automatically determining the GPS coordinates of the possible mosquito breeding location with similar precision to commercial GPS equipment.
C1 [Dias, T. M.; Alves Junior, H. M.; Pinheiro, L. F.; Pontes, R. S. G.; Araujo, G. M.] Fed Ctr Technol Educ Rio de Janeiro CEFET RJ, Dept Automat & Control Engn, Campus Nova Iguacu, Rio De Janeiro, Brazil.
   [Alves, V. C.] Fed Ctr Technol Educ Rio de Janeiro CEFET RJ, Dept Prod Engn, Campus Nova Iguacu, Rio De Janeiro, Brazil.
   [Pontes, R. S. G.] Pedro II Sch CPII, Informat Technol Adm, Rio De Janeiro, Brazil.
   [Lima, A. A.; Prego, T. M.] Fed Ctr Technol Educ Rio de Janeiro CEFET RJ, Dept Telecommun, Campus Nova Iguacu, Rio De Janeiro, Brazil.
RP Dias, TM (corresponding author), Fed Ctr Technol Educ Rio de Janeiro CEFET RJ, Dept Automat & Control Engn, Campus Nova Iguacu, Rio De Janeiro, Brazil.
EM mtayanaa@gmail.com; vivicardosoalves@gmail.com;
   henrique.menezesjr@gmail.com; lucasferreirapinheiro@gmail.com;
   robertosgpontes@gmail.com; gabriel.araujo@cefet-rj.br;
   amaro.lima@cefet-rj.br; thiago.prego@cefet-rj.br
CR Ackerman E., 2017, IEEE SPECTRUM
   [Anonymous], 2016, REV ECOLOGICO
   [Anonymous], 2016, VISTORIA AEREA COM D
   Blasberg M., 2016, AEDES AEGYPTI MOSQUI
   Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324
   Gates B, 2014, GATESNOTES
   Hastie T., 2009, ELEMENTS STAT LEARNI
   Hughes Ciaran, 2008, IET Irish Signals and Systems Conference. ISSC 2008, P162, DOI 10.1049/cp:20080656
   Jos C., 2013, 39 LAT AM COMP C, P1
   London A. G., 2016, BMJ, V352
   Ministerio da Saude, 2018, FEBR AM MIN SAUD AT
   Nunes ML, 2016, J PEDIAT-BRAZIL, V92, P230, DOI 10.1016/j.jped.2016.02.009
   Oliveira N., 2015, EBC
   Paules CI, 2017, NEW ENGL J MED, V376, P1397, DOI 10.1056/NEJMp1702172
   Pownuk A., 2017, DEP TECHNICAL REPORT
   Praseena M., 2015, 2015 IEEE 9th International Conference on Intelligent Systems and Control (ISCO), P1, DOI 10.1109/ISCO.2015.7282285
   Rede Brasil Atual, 2017, REV BRASIL
   Rodriguez-Galiano VF, 2012, ISPRS J PHOTOGRAMM, V67, P93, DOI 10.1016/j.isprsjprs.2011.11.002
   World Health Organization, 2017, PAHO WHO YELL FEV
NR 19
TC 0
Z9 0
U1 2
U2 5
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-5386-7761-2
PY 2018
BP 351
EP 356
DI 10.1109/LARS/SBR/WRE.2018.00070
PG 6
WC Computer Science, Artificial Intelligence; Robotics
SC Computer Science; Robotics
GA BL9LD
UT WOS:000457620800059
DA 2020-07-08
ER

PT J
AU Nourse, MB
   Engel, K
   Anekal, SG
   Bailey, JA
   Bhatta, P
   Bhave, DP
   Chandrasekaran, S
   Chen, YT
   Chow, S
   Das, U
   Galil, E
   Gong, XW
   Gessert, SF
   Ha, KD
   Hu, R
   Hyland, L
   Jammalamadaka, A
   Jayasurya, K
   Kemp, TM
   Kim, AN
   Lee, LS
   Liu, YL
   Nguyen, A
   O'Leary, J
   Pangarkar, CH
   Patel, PJ
   Quon, K
   Ramachandran, PL
   Rappaport, AR
   Roy, J
   Sapida, JF
   Sergeev, NV
   Shee, C
   Shenoy, R
   Sivaraman, S
   Sosa-Padilla, B
   Tran, L
   Trent, A
   Waggoner, TC
   Wodziak, D
   Yuan, A
   Zhao, P
   Young, DL
   Robertson, CR
   Holmes, EA
AF Nourse, Marilyn B.
   Engel, Kate
   Anekal, Samartha G.
   Bailey, Jocelyn A.
   Bhatta, Pradeep
   Bhave, Devayani P.
   Chandrasekaran, Shekar
   Chen, Yutao
   Chow, Steven
   Das, Ushati
   Galil, Erez
   Gong, Xinwei
   Gessert, Steven F.
   Ha, Kevin D.
   Hu, Ran
   Hyland, Laura
   Jammalamadaka, Arvind
   Jayasurya, Karthik
   Kemp, Timothy M.
   Kim, Andrew N.
   Lee, Lucie S.
   Liu, Yang Lily
   Nguyen, Alphonso
   O'Leary, Jared
   Pangarkar, Chinmay H.
   Patel, Paul J.
   Quon, Ken
   Ramachandran, Pradeep L.
   Rappaport, Amy R.
   Roy, Joy
   Sapida, Jerald F.
   Sergeev, Nikolay V.
   Shee, Chandan
   Shenoy, Renuka
   Sivaraman, Sharada
   Sosa-Padilla, Bernardo
   Tran, Lorraine
   Trent, Amanda
   Waggoner, Thomas C.
   Wodziak, Dariusz
   Yuan, Amy
   Zhao, Peter
   Young, Daniel L.
   Robertson, Channing R.
   Holmes, Elizabeth A.
TI Engineering of a miniaturized, robotic clinical laboratory
SO BIOENGINEERING & TRANSLATIONAL MEDICINE
LA English
DT Article
ID POINT-OF-CARE; HOSPITAL-ACQUIRED ANEMIA; BLOOD-LOSS; HOMOGENEOUS ASSAYS;
   LDL-CHOLESTEROL; HDL-CHOLESTEROL; PHLEBOTOMY; SYSTEM;
   ULTRACENTRIFUGATION; ANALYZER
AB The ability to perform laboratory testing near the patient and with smaller blood volumes would benefit patients and physicians alike. We describe our design of a miniaturized clinical laboratory system with three components: a hardware platform (i.e, the miniLab) that performs preanalytical and analytical processing steps using miniaturized sample manipulation and detection modules, an assay-configurable cartridge that provides consumable materials and assay reagents, and a server that communicates bidirectionally with the miniLab to manage assay-specific protocols and analyze, store, and report results (i.e., the virtual analyzer). The miniLab can detect analytes in blood using multiple methods, including molecular diagnostics, immunoassays, clinical chemistry, and hematology. Analytical performance results show that our qualitative Zika virus assay has a limit of detection of 55 genomic copies/ml. For our anti-herpes simplex virus type 2 immunoglobulin G, lipid panel, and lymphocyte subset panel assays, the miniLab has low imprecision, and method comparison results agree well with those from the United States Food and Drug Administration-cleared devices. With its small footprint and versatility, the miniLab has the potential to provide testing of a range of analytes in decentralized locations.
C1 [Nourse, Marilyn B.; Engel, Kate; Bailey, Jocelyn A.; Bhave, Devayani P.; Chen, Yutao; Das, Ushati; Gessert, Steven F.; Ha, Kevin D.; Hu, Ran; Hyland, Laura; Kim, Andrew N.; Lee, Lucie S.; Liu, Yang Lily; Pangarkar, Chinmay H.; Patel, Paul J.; Rappaport, Amy R.; Sapida, Jerald F.; Sergeev, Nikolay V.; Shee, Chandan; Sivaraman, Sharada; Tran, Lorraine; Trent, Amanda; Wodziak, Dariusz] Theranos, Assay Dev, 7373 Gateway Blvd, Newark, CA 94560 USA.
   [Anekal, Samartha G.; Nguyen, Alphonso; O'Leary, Jared; Yuan, Amy] Theranos, Syst Integrat, 7373 Gateway Blvd, Newark, CA 94560 USA.
   [Bhatta, Pradeep; Galil, Erez; Gong, Xinwei; Jammalamadaka, Arvind; Jayasurya, Karthik; Shenoy, Renuka; Sosa-Padilla, Bernardo; Young, Daniel L.] Theranos, Computat Biosci, 7373 Gateway Blvd, Newark, CA 94560 USA.
   [Chandrasekaran, Shekar; Kemp, Timothy M.; Quon, Ken] Theranos, Software Dev, 7373 Gateway Blvd, Newark, CA 94560 USA.
   [Chow, Steven; Roy, Joy; Waggoner, Thomas C.; Zhao, Peter] Theranos, Engn, 7373 Gateway Blvd, Newark, CA 94560 USA.
   [Ramachandran, Pradeep L.] Theranos, Reagent Dev, 7373 Gateway Blvd, Newark, CA 94560 USA.
   [Robertson, Channing R.; Holmes, Elizabeth A.] Theranos, 7373 Gateway Blvd, Newark, CA 94560 USA.
RP Young, DL; Robertson, CR (corresponding author), Theranos, 7373 Gateway Blvd, Newark, CA 94560 USA.
EM Daniel.Young@theranos.com; Channing.Robertson@theranos.com
OI Nourse, Marilyn/0000-0001-9306-7981
CR Ania BJ, 1997, J AM GERIATR SOC, V45, P825, DOI 10.1111/j.1532-5415.1997.tb01509.x
   Armbruster David A, 2014, Clin Biochem Rev, V35, P143
   BACHORIK PS, 1995, CLIN CHEM, V41, P1414
   Badrick Tony, 2013, Clin Biochem Rev, V34, P43
   Bateman ST, 2008, AM J RESP CRIT CARE, V178, P26, DOI 10.1164/rccm.200711-1637OC
   Becton Dickinson & Company, 2009, BD MULT 6 COL TBNK R
   Beneteau-Burnat B, 2008, CLIN CHEM LAB MED, V46, P271, DOI 10.1515/CCLM.2008.043
   BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8
   Blick KE, 2015, POINT CARE, V14, P143, DOI 10.1097/POC.0000000000000068
   Bloom BM, 2014, EUR J EMERG MED, V21, P310, DOI 10.1097/MEJ.0000000000000076
   Clinical and Laboratory Standards Institute (CLSI), 2014, EP05A3 CLSI
   CLSI, 2008, EP12A2 CLSI
   CLSI, 2013, EP09A3 CLSI
   Dale JC, 2003, ARCH PATHOL LAB MED, V127, P162
   ERICKSON KA, 1993, CLIN CHEM, V39, P283
   Gubala V, 2012, ANAL CHEM, V84, P487, DOI 10.1021/ac2030199
   Hicks JM, 1999, NEW ENGL J MED, V340, P1690, DOI 10.1056/NEJM199905273402119
   Huynh T, 2017, CUREUS, V9, DOI 10.7759/cureus.1965
   Jun W, 2017, J VIROL METHODS, V252, P65
   Koch CG, 2015, ANN THORAC SURG, V99, P779, DOI 10.1016/j.athoracsur.2014.09.062
   Koch CG, 2013, J HOSP MED, V8, P506, DOI 10.1002/jhm.2061
   Kurniali PC, 2014, ANEMIA, V2014, DOI 10.1155/2014/634582
   Laurence CO, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X483508
   Lin JC, 2000, PEDIATRICS, V106, part. no., DOI 10.1542/peds.106.2.e19
   LINNET K, 1990, STAT MED, V9, P1463, DOI 10.1002/sim.4780091210
   Madan Ashima, 2005, J Perinatol, V25, P21, DOI 10.1038/sj.jp.7211201
   Miida T, 2014, ATHEROSCLEROSIS, V233, P253, DOI 10.1016/j.atherosclerosis.2013.12.033
   Miller WG, 2010, CLIN CHEM, V56, P977, DOI 10.1373/clinchem.2009.142810
   Nauck M, 2002, CLIN CHEM, V48, P236
   Nayak S, 2017, ANAL CHEM, V89, P102, DOI 10.1021/acs.analchem.6b04630
   Ngo A, 2016, J APPL LAB MED, V2016
   Nichols JH, 2008, POINT CARE, V7, P7, DOI 10.1097/POC.0b013e3181634d02
   Nomura N, 2015, INT J LAB HEMATOL, V37, P466, DOI 10.1111/ijlh.12312
   PASSING H, 1983, J CLIN CHEM CLIN BIO, V21, P709
   Plebani M, 2010, ANN CLIN BIOCHEM, V47, P101, DOI 10.1258/acb.2009.009222
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Salisbury AC, 2011, ARCH INTERN MED, V171, P1646, DOI 10.1001/archinternmed.2011.361
   St John Andrew, 2010, Clin Biochem Rev, V31, P111
   Stotler BA, 2013, AM J CLIN PATHOL, V140, P715, DOI 10.1309/AJCP7QB3QQIBZPEK
   Streitberg GS, 2009, JALA-J ASSOC LAB AUT, V14, P94, DOI 10.1016/j.jala.2008.12.001
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Thompson WR, 1936, ANN MATH STAT, V7, P122, DOI 10.1214/aoms/1177732502
   US Food and Drug Administration, EM SIT MED DEV ZIK V
   US Food and Drug Administration. FDA, 510K US FDA
   Valentine SL, 2012, PEDIATR CRIT CARE ME, V13, P22, DOI 10.1097/PCC.0b013e318219681d
   Vermeer HJ, 2005, CLIN CHEM, V51, P244
   Vincent JL, 2002, JAMA-J AM MED ASSOC, V288, P1499, DOI 10.1001/jama.288.12.1499
   Warnick GR, 2001, CLIN CHEM, V47, P1579
   Wisser D, 2003, CLIN CHEM, V49, P1651, DOI 10.1373/49.10.1651
NR 49
TC 1
Z9 1
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
EI 2380-6761
J9 BIOENG TRANSL MED
JI Bioeng. Transl. Med.
PD JAN
PY 2018
VL 3
IS 1
BP 58
EP 70
DI 10.1002/btm2.10084
PG 13
WC Biotechnology & Applied Microbiology; Engineering, Biomedical;
   Pharmacology & Pharmacy
SC Biotechnology & Applied Microbiology; Engineering; Pharmacology &
   Pharmacy
GA FV3JM
UT WOS:000424464300006
PM 29376134
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Nandy, A
   Dey, S
   Roy, P
   Basak, SC
AF Nandy, Ashesh
   Dey, Sumanta
   Roy, Proyasha
   Basak, Subhash C.
TI Epidemics and Peptide Vaccine Response: A Brief Review
SO CURRENT TOPICS IN MEDICINAL CHEMISTRY
LA English
DT Review
DE Ebola vaccine; Nipah virus; Influenza virus; Peptide vaccines; Surface
   exposed conserved segments; MHC; Public health
ID IN-VIVO; VIRUS-INFECTION; NIPAH VIRUS; INFLUENZA; DESIGN; INDUCTION;
   PROTEIN; SURVEILLANCE; TRANSMISSION; STABILITY
AB We briefly review the situations arising out of epidemics that erupt rather suddenly, threatening life and livelihoods of humans. Ebola, Zika and the Nipah virus outbreaks are recent examples where the viral epidemics have led to considerably high degree of fatalities or debilitating consequences. The problems are accentuated by a lack of drugs or vaccines effective against the new and emergent viruses, and the inordinate amount of temporal and financial resources that are required to combat the novel pathogens. Progress in computational, biological and informational sciences have made it possible to consider design of synthetic vaccines that can be rapidly developed and deployed to help stem the damages. In this review, we consider the pros and cons of this new paradigm and suggest a new system where the manufacturing process can be decentralized to provide more targeted vaccines to meet the urgent needs of protection in case of a rampaging epidemic.
C1 [Nandy, Ashesh; Dey, Sumanta; Roy, Proyasha] Ctr Interdisciplinary Res & Educ, 404B Jodhpur Pk, Kolkata 700068, India.
   [Basak, Subhash C.] Univ Minnesota, Dept Chem & Biochem, 1802 Stanford Ave, Duluth, MN USA.
RP Nandy, A (corresponding author), Ctr Interdisciplinary Res & Educ, 404B Jodhpur Pk, Kolkata 700068, India.
EM anandy43@yahoo.com
CR [Anonymous], 2016, NIAID EMERGING INFEC
   Apellaniz B, 2015, J BIOL CHEM, V290, P12999, DOI 10.1074/jbc.M115.644351
   Barrett ADT, 2009, VACCINES FOR BIODEFENSE AND EMERGING AND NEGLECTED DISEASES, P1
   Basak SC, 2016, CURR COMPUT-AID DRUG, V12, P2, DOI 10.2174/1573409912999160315115502
   Bottger R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178943
   Braks M, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-192
   Brossart P, 2000, BLOOD, V96, P3102, DOI 10.1182/blood.V96.9.3102.h8003102_3102_3108
   CDC, 2009, BIOSAFETY MICROBIOLO, P200
   Chakraborty Sajib, 2010, In Silico Biology, V10, P235, DOI 10.3233/ISB-2010-0435
   Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782
   Chatterjee P, 2018, LANCET, V391, P2200, DOI 10.1016/S0140-6736(18)31252-2
   Cohen J., 2017, SCIENCE, V24, P821
   Dawood FS, 2012, LANCET INFECT DIS, V12, P687, DOI 10.1016/S1473-3099(12)70121-4
   De Brito RCF, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01043
   Deprez B, 1996, VACCINE, V14, P375, DOI 10.1016/0264-410X(95)00220-U
   Dey S, 2017, COMPUT BIOL CHEM, V68, P143, DOI 10.1016/j.compbiolchem.2017.03.002
   Dey S, 2016, CANCER INFORM, V15, P1, DOI 10.4137/CIN.S39071
   ECDC, 2015, MICR BRAZ POT LINK Z
   Freeman AJ, 2003, J HEPATOL, V38, P349, DOI 10.1016/S0168-8278(02)00424-5
   Ghosh A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040749
   Ghosh A, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-6
   Gorris HH, 2009, ANAL CHEM, V81, P1580, DOI 10.1021/ac802324f
   Hardy LW, 2003, CURRENT DRUG DISCOVE, V3, P15
   Hossein MU, 2018, FRONT CHEM, V6, DOI 10.3389/fchem.2018.00246
   Huber SR, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00171
   Islam R, 2012, FUTURE VIROL, V7, P1029, DOI 10.2217/FVL.12.95
   Jones LH, 2015, NAT CHEM, V7, P952, DOI [10.1038/NCHEM.2396, 10.1038/nchem.2396]
   Khan AM, 2017, BMC MED GENOMICS, V10, DOI 10.1186/s12920-017-0301-2
   Kim H, 2014, J ANTIMICROB CHEMOTH, V69, P121, DOI 10.1093/jac/dkt322
   Kleandrova VV, 2016, ACS COMB SCI, V18, P490, DOI 10.1021/acscombsci.6b00063
   LANGEVELD JPM, 1994, J VIROL, V68, P4506, DOI 10.1128/JVI.68.7.4506-4513.1994
   Larche M, 2007, ALLERGY, V62, P325, DOI 10.1111/j.1398-9995.2006.01309.x
   Li WD, 2014, VACCINES-BASEL, V2, P515, DOI 10.3390/vaccines2030515
   Liao SJ, 2013, J HUAZHONG U SCI-MED, V33, P735, DOI 10.1007/s11596-013-1189-5
   Luby SP, 2009, EMERG INFECT DIS, V15, P1229, DOI 10.3201/eid1508.081237
   Ludewig B, 2000, VACCINE, V19, P23, DOI 10.1016/S0264-410X(00)00163-8
   Mocellin S., 2009, COCHRANE DB SYST REV, V2
   Moisa AA, 2012, INSIGHT CONTROL INFE, P201
   Monso M, 2011, J PEPT SCI, V17, P24, DOI 10.1002/psc.1292
   Nagpal G, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1560-1
   Nandy A., 2017, J MOL PATHOL EPIDEMI, V2, pS1
   Nandy A, 2017, CURR COMPUT-AID DRUG, V13, P264, DOI 10.2174/157340991304171110160723
   Nava-Parada P, 2007, CURR OPIN MOL THER, V9, P490
   Oany AR, 2014, DRUG DES DEV THER, V8, P1139, DOI [10.2147/DDDT.567861, 10.2147/DDDT.S67861]
   Poland GA, 2016, CURR OPIN VIROL, V17, P116, DOI 10.1016/j.coviro.2016.03.003
   Poland GA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002344
   PR Tufts, COST DEV WIN MARK AP
   Purcell AW, 2007, NAT REV DRUG DISCOV, V6, P404, DOI 10.1038/nrd2224
   Rappuoli R, 2001, VACCINE, V19, P2688, DOI 10.1016/S0264-410X(00)00554-5
   Rojas-Caraballo J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105323
   Roy P., 2018, J BACTERIOL VACCIN R, V1, P1004
   Sarkar T, 2015, COMPUT BIOL CHEM, V59, P8, DOI 10.1016/j.compbiolchem.2015.08.003
   Satterfield BA, 2016, VACCINE, V34, P2971, DOI 10.1016/j.vaccine.2015.12.075
   Semenza J. C., 2018, FEMS MICROBIOL LETT, V365
   Shi M, 2016, NATURE, V540, P539, DOI 10.1038/nature20167
   Sirskyj D, 2011, IMMUNOL CELL BIOL, V89, P81, DOI 10.1038/icb.2010.65
   Skwarczynski M, 2016, CHEM SCI, V7, P842, DOI 10.1039/c5sc03892h
   Slingluff CL, 2011, CANCER J, V17, P343, DOI 10.1097/PPO.0b013e318233e5b2
   Sloan SR, 1997, WESTERN J MED, V167, P36
   Smith RD, 2006, SOC SCI MED, V63, P3113, DOI 10.1016/j.socscimed.2006.08.004
   Sobolev BN, 2005, CURR COMPUT-AID DRUG, V1, P207, DOI 10.2174/1573409053585681
   Sommer Simone, 2005, Frontiers in Zoology, V2, P1, DOI 10.1186/1742-9994-2-16
   Stapleford KA, 2014, CELL HOST MICROBE, V15, P706, DOI 10.1016/j.chom.2014.05.008
   Suzuki H, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-97
   Tamura SI, 2004, JPN J INFECT DIS, V57, P236
   Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979
   Tester I, 2005, J EXP MED, V201, P1725, DOI 10.1084/jem.20042284
   Tomar N, 2010, IMMUNOLOGY, V131, P153, DOI 10.1111/j.1365-2567.2010.03330.x
   Trifonov V, 2009, NEW ENGL J MED, V361, P115, DOI 10.1056/NEJMp0904572
   US FDA, 2015, PROD DEV AN RUL GUID
   Valenzuela JG, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006365
   Varghese JN, 1999, DRUG DEVELOP RES, V46, P176, DOI 10.1002/(SICI)1098-2299(199903/04)46:3/4<176::AID-DDR4>3.0.CO;2-6
   WANG RB, 1995, J IMMUNOL, V154, P2784
   WHO, 1999, GUID PROD QUAL CONTR
   WHO, 2016, FIN TRIAL RES CONF E
   WHO Biologicals, SYNTH PEPT VACC
   Wong SS, 2013, CLIN MICROBIOL REV, V26, P476, DOI 10.1128/CMR.00097-12
   World Health Organization, 2018, EB VIR DIS
NR 78
TC 2
Z9 2
U1 1
U2 1
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1568-0266
EI 1873-5294
J9 CURR TOP MED CHEM
JI Curr. Top. Med. Chem.
PY 2018
VL 18
IS 26
BP 2202
EP 2208
DI 10.2174/1568026618666181112144745
PG 7
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA HJ6UH
UT WOS:000457327500003
PM 30417788
DA 2020-07-08
ER

PT S
AU Pandey, MK
   Subbiah, K
AF Pandey, Manish Kumar
   Subbiah, Karthikeyan
BE Deka, GC
   Kaiwartya, O
   Vashisth, P
   Rathee, P
TI Performance Analysis of Time Series Forecasting Using Machine Learning
   Algorithms for Prediction of Ebola Casualties
SO APPLICATIONS OF COMPUTING AND COMMUNICATION TECHNOLOGIES, ICACCT 2018
SE Communications in Computer and Information Science
LA English
DT Proceedings Paper
CT 1st International Conference on Applications of Computing and
   Communication Technologies (ICACCT)
CY MAR09, 2018
CL Univ Delhi, Shyama Prasad Mukherji Coll, Delhi, INDIA
HO Univ Delhi, Shyama Prasad Mukherji Coll
DE SMAC; Epidemic Forecasting; Ebola; Time series forecasting; Random tree
AB There is an immense concern on our vigilance for controlling the spread of pandemics such as Ebola, Zika, and H1N1 etc. through state of art technology. The dynamics become very complex of epidemics in sweeping population. Efficient descriptive, predictive, preventive and prescriptive analyses on the huge data generated by SMAC are very crucial for valuable arrangement and associated responsive tactics. In this paper, we have proposed the use of machine learning techniques for performance evaluation of time series forecasting of Ebola casualties. By experimenting without lag creation, we achieved the best results in the MAE of 7.85%, RMSE value of 61.14%, and Direction Accuracy of 85.99% with Random Tree Classifier. Thus we can conclude that by using these models for forecasting epidemic spread and developing public health policies leads the health authorities to ensure the appropriate actions for the control of the outbreak.
C1 [Pandey, Manish Kumar; Subbiah, Karthikeyan] Banaras Hindu Univ, Inst Sci, Dept Comp Sci, Varanasi 221005, Uttar Pradesh, India.
RP Pandey, MK (corresponding author), Banaras Hindu Univ, Inst Sci, Dept Comp Sci, Varanasi 221005, Uttar Pradesh, India.
EM pandey.manish@live.com; karthinikita@gmail.com
OI Pandey, Manish/0000-0002-6943-6991
CR Bisset K., 2009, P 23 ACM INT C SUP I
   Brauer F, 2008, LECT NOTES MATH, V1945, DOI [10.1007/978-3-540-78911-6, DOI 10.1007/978-3-540-78911-6]
   Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324
   Buendia R. J. M., 2015, 2015 6 INT C INF INT, P1, DOI DOI 10.1109/IISA.2015.7388087
   Caruana R., 2004, INT C MACH LEARN ICM
   De S, 2014, 2014 6TH INTERNATIONAL CONFERENCE ON COMPUTATIONAL INTELLIGENCE AND COMMUNICATION NETWORKS, P262, DOI 10.1109/CICN.2014.67
   Gartner, 2012, NEX FORC SOC MOB CLO
   Hall IM, 2007, EPIDEMIOL INFECT, V135, P372, DOI 10.1017/S0950268806007084
   Hall M., 2009, SIGKDD EXPLORATIONS, V11, P1, DOI DOI 10.1145/1656274.1656278
   IDC, 2012, IDC PRED 2013 COMP 3
   Last J, 2001, DICT EPIDEMIOLOGY
   Liao YL, 2017, SCI REP-UK, V7, DOI 10.1038/srep40084
   Marathe M, 2015, INT PARALL DISTRIB P, P831, DOI 10.1109/IPDPS.2015.121
   Nishiura H, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-15
   Nsoesie EO, 2014, INFLUENZA OTHER RESP, V8, P309, DOI 10.1111/irv.12226
   Ohkusa Y, 2011, J INFECT CHEMOTHER, V17, P468, DOI 10.1007/s10156-010-0200-3
   Pandey M. K, 2017, P ITISE 201 GRAN 18
   Pandey MK, 2016, 2016 IEEE INTERNATIONAL CONFERENCE ON COMPUTER AND INFORMATION TECHNOLOGY (CIT), P578, DOI 10.1109/CIT.2016.86
   Pyne S, 2015, HDB STAT, V33, P171
   Ramadona AL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152688
   Ristic B, 2016, 2016 19TH INTERNATIONAL CONFERENCE ON INFORMATION FUSION (FUSION), P1983
   Salathe M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002616
   Shaman J, 2012, P NATL ACAD SCI USA, V109, P20425, DOI 10.1073/pnas.1208772109
   Shaman J, 2011, AM J EPIDEMIOL, V173, P127, DOI 10.1093/aje/kwq347
   Shaman J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000316
   Sharma S, 2015, 2015 1st International Conference on Next Generation Computing Technologies (NGCT), P639, DOI 10.1109/NGCT.2015.7375199
   Shevade SK, 2000, IEEE T NEURAL NETWOR, V11, P1188, DOI 10.1109/72.870050
   Smola A.J., 1998, TUTORIAL SUPPORT VEC
   Tizzoni M, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-165
   Wang YM, 2015, 2015 12TH INTERNATIONAL CONFERENCE ON FUZZY SYSTEMS AND KNOWLEDGE DISCOVERY (FSKD), P1096, DOI 10.1109/FSKD.2015.7382095
   WHO, 2018, EB VIR DIS FACT SHEE
NR 31
TC 0
Z9 0
U1 0
U2 2
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 1865-0929
EI 1865-0937
BN 978-981-13-2035-4; 978-981-13-2034-7
J9 COMM COM INF SC
PY 2018
VL 899
BP 320
EP 334
DI 10.1007/978-981-13-2035-4_28
PG 15
WC Computer Science, Theory & Methods; Engineering, Electrical &
   Electronic; Telecommunications
SC Computer Science; Engineering; Telecommunications
GA BL8HH
UT WOS:000456340700028
DA 2020-07-08
ER

PT J
AU Leite, RFP
   Santos, MSA
   Ribeiro, EM
   Pessoa, ALS
   Lewis, DR
   Giacheti, CM
   Cavalcanti, LPD
AF Pequeno Leite, Rebeka Ferreira
   Aragao Santos, Marinisi Sales
   Ribeiro, Erlane Marques
   Santos Pessoa, Andre Luiz
   Lewis, Doris Ruthy
   Giacheti, Celia Maria
   de Goes Cavalcanti, Luciano Pamplona
TI Hearing Screening in children with Congenital Zika Virus Syndrome in
   Fortaleza, Ceara, Brazil, 2016
SO EPIDEMIOLOGIA E SERVICOS DE SAUDE
LA English
DT Article
DE Epidemiology, Descriptive; Zika Virus Infection; Microcephaly;
   Arboviruses; Hearing Loss
ID INFECTION; OUTBREAK
AB Objective: to describe the results of hearing screening performed in children with Congenital Zika Virus Syndrome (CZS) in Fortaleza, Ceara, Brazil. Methods: this was a descriptive cross-sectional study involving children with CZS receiving health care in Fortaleza, 2016; the hearing screening tests performed were immittance audiometry, transient otoacoustic emissions (TOAE), acoustic reflexes, and cochleopalpebral reflex (CPR). Results: The study included 45 children with an average age of 10 months. 44 of them underwent tympanometric screening, with 16 of these having the right ear within the normal range and 22 having the left ear within the normal range. Among the 43 children evaluated by TOAE, 30 "passed" in both ears, nine "refered" in both ears and four "refered" just in ear; 13/43 "refered" and needed to repeat screening. 43 children evaluated by CPR, 37 showed responses. Conclusion: most of the children evaluated had completed cochlear function and middle ear results refer in compatible with their age range.
C1 [Pequeno Leite, Rebeka Ferreira; Aragao Santos, Marinisi Sales; Santos Pessoa, Andre Luiz] Hosp Infantil Albert Sabin, Secretaria Saude Estado Ceara, Fortaleza, CE, Brazil.
   [Ribeiro, Erlane Marques] Ctr Univ Christus, Fac Med, Fortaleza, CE, Brazil.
   [Lewis, Doris Ruthy] Pontificia Univ Catolica Sao Paulo, Programa Posgrad Fonoaudiol, Sao Paulo, Brazil.
   [Giacheti, Celia Maria] Univ Estadual Paulista, Dept Fonoaudiol, Sao Paulo, Brazil.
   [de Goes Cavalcanti, Luciano Pamplona] Univ Fed Ceara, Dept Saude Comunitaria, Rua Prof Costa Mendes 1608,5 Andar, BR-60430140 Fortaleza, CE, Brazil.
RP Cavalcanti, LPD (corresponding author), Univ Fed Ceara, Dept Saude Comunitaria, Rua Prof Costa Mendes 1608,5 Andar, BR-60430140 Fortaleza, CE, Brazil.
EM pamplona.luciano@gmail.com
RI Giacheti, Celia M/I-4863-2012; Cavalcanti, Luciano/N-4391-2015
OI Giacheti, Celia M/0000-0001-9691-4672; Cavalcanti,
   Luciano/0000-0002-3440-1182
CR American Academy of Pediatrics, 2007, PEDIATRICS
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cohen BE, 2014, TRENDS HEAR, V18, DOI 10.1177/2331216514541361
   de Carvalho Leal M, 2016, BRAZ J OTORHINOLAR, V30, P30127
   Di Francesco Renata Cantisani, 2016, Rev. paul. pediatr., V34, P148, DOI [10.1016/j.rpped.2015.08.005, 10.1016/j.rppede.2016.01.003]
   Eickmann SH, 2016, ZIKA VIRUS CONGENITA
   Garcia Michele Vargas, 2009, Braz J Otorhinolaryngol, V75, P80
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   JERGER J, 1970, ARCHIV OTOLARYNGOL, V92, P311
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Lewis DR, 2010, BRAZ J OTORHINOLAR, V76, P121, DOI 10.1590/S1808-86942010000100020
   Linares Ana Emilia, 2008, Braz J Otorhinolaryngol, V74, P410
   Ministerio da Saude, 2015, PROT VIG RESP OC MIC
   Ministerio da Saude (BR), 2017, B EP
   Ministerio da Saude (BR), 2015, MIN SAUD CONF REL EN
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   MOLLER AAGE R., 1962, JOUR ACOUSTICAL SOC AMER, V34, P1524, DOI 10.1121/1.1918384
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Redondo MC, 2015, MANUAL AUDIOLOGIA PE, P58
   Saes Sandra de O, 2005, J Pediatr (Rio J), V81, P133
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
NR 24
TC 1
Z9 1
U1 0
U2 2
PU MINISTERIO DA SAUDE
PI BRASILIA
PA ESPLANADA MINISTERIOS, BLOCO G, BRASILIA, DF 70058-900, BRAZIL
SN 1679-4974
EI 2237-9622
J9 EPIDEMIOL SERV SAUDE
JI Epidemiol. Serv. Saude
PY 2018
VL 27
IS 4
AR UNSP e2017553
DI 10.5123/S1679-49742018000400002
PG 9
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA HI8FE
UT WOS:000456689900012
PM 30427400
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Brito, KGD
   dos Santos, EB
   Lucas, LDM
   Orsini, M
   Fiorelli, R
   Teixeira, S
   Ayres, C
   Correia, L
   Bastos, VH
   Trajano, E
   Cardoso, CE
   de Freitas, MRG
   Catharino, AMD
AF da Silva Brito, Kattiucy Gabrielle
   dos Santos, Edarlan Barbosa
   Maia Lucas, Liliane dos Santos
   Orsini, Marco
   Fiorelli, Rossano
   Teixeira, Silmar
   Ayres, Carla
   Correia, Luan
   Bastos, Victor Hugo
   Trajano, Eduardo
   Cardoso, Carlos Eduardo
   de Freitas, Marcos R. G.
   da Silva Catharino, Antonio Marcos
TI Prevalence of neurological complications associated with Zika virus in a
   brazilian metropolis
SO NEUROLOGY INTERNATIONAL
LA English
DT Article
DE Zika virus; Guillain-Barre syndrome; microcephaly; infection
ID GUILLAIN-BARRE-SYNDROME; SEXUAL TRANSMISSION
AB The aim of this paper is to study the prevalence of Zika Virus (ZIKV) and the index of its neurological complications. This is a quantitative, cross-sectional epidemiological study. Data were collected through the compulsory notification of suspected ZIKV and its neurological alterations cases. 113 suspected ZIKV cases were reported, most of them in the summer, with a higher prevalence of females and in the fourth decade of life. Among the neurological changes, 15 Guillain-Barre Syndrome cases were reported, with one registered death. As neurological manifestations, most of them started 30 days after a ZIKV infection. No case has been confirmed laboratory. It is necessary to combat the vector, mainly in the summer, to reduce ZIKV infection and its neurological complications, besides instruction to the health professionals about these complications and serological tests requests for an accurate diagnosis.
C1 [da Silva Brito, Kattiucy Gabrielle; dos Santos, Edarlan Barbosa; Maia Lucas, Liliane dos Santos; da Silva Catharino, Antonio Marcos] Univ Iguacu UNIG, Sch Med, Nova Iguacu, RJ, Brazil.
   [Orsini, Marco; Fiorelli, Rossano; Trajano, Eduardo; Cardoso, Carlos Eduardo] Univ Severino Sombra, Masters Program Appl Sci Hlth, Vassouras, RJ, Brazil.
   [Orsini, Marco; Fiorelli, Rossano; Trajano, Eduardo; Cardoso, Carlos Eduardo] UNISUAM, Sci Rehabil Program, Rio De Janeiro, Brazil.
   [Orsini, Marco] Fed Univ Piaui UFPI, Lab Mapping & Cerebral Plast LAMPLACE, Teresina, Piaui, Brazil.
   [Teixeira, Silmar; Ayres, Carla; Correia, Luan; Bastos, Victor Hugo] Fed Univ Piaui UFPI, Lab Brain Mapping & Functional LAMCEF, Teresina, Piaui, Brazil.
   [de Freitas, Marcos R. G.] Rio de Janeiro Fed Univ UFRJ, Neurol Serv, Rio De Janeiro, Brazil.
   [da Silva Catharino, Antonio Marcos] Geral Hosp Nova Igoacu, Nova Iguacu, RJ, Brazil.
RP Brito, KGD (corresponding author), Rua Minist Lafaiete Andrade 1560,Bl 02 Ap 402, BR-26261220 Nova Iguacu, RJ, Brazil.
EM kattiucy_brito@hotmail.com
RI Trajano, Eduardo/X-4675-2019; Teixeira, Silmar/G-8881-2011
OI Trajano, Eduardo/0000-0001-7809-7138; Teixeira,
   Silmar/0000-0002-9240-1228
CR Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Caveiao C., 2016, SAUDE, V1, P3
   Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023
   Dourado ME, 2012, ACTA NEUROL SCAND, V125, P47, DOI 10.1111/j.1600-0404.2011.01503.x
   da Silva IRF, 2017, JAMA NEUROL, V74, P1190, DOI 10.1001/jamaneurol.2017.1703
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Kieseier BC, 2003, SEMIN NEUROL, V23, P159
   Ministerio da Sande Secretaria de Vigilancia em Sande, 2017, B EP, V48, P1
   Ministerio da Saude, 2015, PROT VIG RESP OC MIC
   Ministerio da Saude, 2015, B EPIDEMIOL, V46, P1
   Ministerio da Saude (BR), 2015, PROT CLIN DIR TER SI
   Ministerio da Saude (BR), 2015, PROT VIG DOS CAS MAN
   Ministerio da Saude (BR). Departamento De Vigilancia Das Doencas Transmissiveis, NOT INFR SVS MS QUE
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nhan T-X, 2014, REV FRANCOPH LAB, V467, P45
   Vucic S, 2009, J CLIN NEUROSCI, V16, P733, DOI 10.1016/j.jocn.2008.08.033
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P499, DOI 10.1016/j.apjtm.2016.03.036
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 20
TC 0
Z9 0
U1 0
U2 0
PU PAGEPRESS PUBL
PI PAVIA
PA MEDITGROUP, VIA G BELLI, 4, PAVIA, 27100, ITALY
SN 2035-8385
EI 2035-8377
J9 NEUROL INT
JI Neurol. Int.
PY 2018
VL 10
IS 2
BP 61
EP 64
DI 10.4081/ni.2018.7638
PG 4
WC Clinical Neurology
SC Neurosciences & Neurology
GA HI4RH
UT WOS:000456437700004
PM 30069289
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT S
AU Campos, RK
   Garcia-Blanco, MA
   Bradrick, SS
AF Campos, Rafael K.
   Garcia-Blanco, Mariano A.
   Bradrick, Shelton S.
BE Tripp, RA
   Tompkins, SM
TI Roles of Pro-viral Host Factors in Mosquito-Borne Flavivirus Infections
SO ROLES OF HOST GENE AND NON-CODING RNA EXPRESSION IN VIRUS INFECTION
SE Current Topics in Microbiology and Immunology
LA English
DT Review; Book Chapter
ID DENGUE-VIRUS-INFECTION; N-LINKED GLYCOSYLATION; SIGNAL RECOGNITION
   PROTEIN; RNA CHAPERONE ACTIVITY; HUMAN DENDRITIC CELLS;
   ENCEPHALITIS-VIRUS; ZIKA VIRUS; ENVELOPE PROTEIN; HEPARAN-SULFATE;
   ENDOPLASMIC-RETICULUM
AB Identification and analysis of viral host factors is a growing area of research which aims to understand the how viruses molecularly interface with the host cell. Investigations into flavivirus-host interactions has led to new discoveries in viral and cell biology, and will potentially bolster strategies to control the important diseases caused by these pathogens. Here, we address the current knowledge of prominent host factors required for the flavivirus life-cycle and mechanisms by which they promote infection.
C1 [Campos, Rafael K.] Duke Univ, Dept Mol Genet & Microbiol, Ctr RNA Biol, Durham, NC USA.
   [Campos, Rafael K.; Garcia-Blanco, Mariano A.; Bradrick, Shelton S.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
   [Garcia-Blanco, Mariano A.] Duke NUS Med Sch, Programme Emerging Infect Dis, Singapore, Singapore.
RP Garcia-Blanco, MA; Bradrick, SS (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
EM maragarc@utmb.edu; ssbradri@utmb.edu
RI Campos, Rafael Kroon/AAB-5135-2020
OI Campos, Rafael Kroon/0000-0002-4852-0449
CR Acosta EG, 2016, EXPERT REV VACCINES, V15, P467, DOI 10.1586/14760584.2016.1121814
   Acosta EG, 2009, CELL MICROBIOL, V11, P1533, DOI 10.1111/j.1462-5822.2009.01345.x
   Anwar A, 2009, J BIOL CHEM, V284, P17021, DOI 10.1074/jbc.M109.006239
   Artpradit C, 2013, VIRUS RES, V176, P69, DOI 10.1016/j.virusres.2013.04.017
   Ast T, 2013, CELL, V152, P1134, DOI 10.1016/j.cell.2013.02.003
   Avirutnan P, 2007, PLOS PATHOG, V3, P1798, DOI 10.1371/journal.ppat.0030183
   Agis-Juarez RA, 2009, J GEN VIROL, V90, P2893, DOI 10.1099/vir.0.013433-0
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Beasley DWC, 2005, J VIROL, V79, P8339, DOI 10.1128/JVI.79.13.8339-8347.2005
   Beatman E, 2012, VIROLOGY, V433, P262, DOI 10.1016/j.virol.2012.08.016
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   BLUMENTHAL T, 1979, ANNU REV BIOCHEM, V48, P525, DOI 10.1146/annurev.bi.48.070179.002521
   Byk LA, 2016, ANNU REV VIROL, V3, P263, DOI 10.1146/annurev-virology-110615-042334
   Byk LA, 2016, MBIO, V7, DOI 10.1128/mBio.00804-16
   Cabrera-Hernandez A, 2007, J MED VIROL, V79, P386, DOI 10.1002/jmv.20786
   Campos RK, 2017, J VIROL, V91, DOI 10.1128/JVI.01706-16
   Carnec X, 2016, J VIROL, V90, P92, DOI 10.1128/JVI.01849-15
   Cervantes-Salazar M, 2015, VIROLOGY, V484, P113, DOI 10.1016/j.virol.2015.05.017
   Chan KR, 2014, P NATL ACAD SCI USA, V111, P2722, DOI 10.1073/pnas.1317454111
   Chen ST, 2008, NATURE, V453, P672, DOI 10.1038/nature07013
   Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866
   Cheng G, 2010, CELL, V142, P714, DOI 10.1016/j.cell.2010.07.038
   Chiu WW, 2005, J VIROL, V79, P8303, DOI 10.1128/JVI.79.13.8303-8315.2005
   Choy MM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004058
   Clyde K, 2006, J VIROL, V80, P2170, DOI 10.1128/JVI.80.5.2170-2182.2006
   Courageot MP, 2000, J VIROL, V74, P564, DOI 10.1128/JVI.74.1.564-572.2000
   Crabtree MB, 2005, ARCH VIROL, V150, P771, DOI 10.1007/s00705-004-0430-8
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dalrymple N, 2011, J VIROL, V85, P9478, DOI 10.1128/JVI.05008-11
   Das S, 2009, VIROLOGY, V385, P47, DOI 10.1016/j.virol.2008.10.025
   Davis CW, 2006, J BIOL CHEM, V281, P37183, DOI 10.1074/jbc.M605429200
   Davis WG, 2007, J VIROL, V81, P10172, DOI 10.1128/JVI.00531-07
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dejnirattisai W, 2011, J INFECT DIS, V203, P1775, DOI 10.1093/infdis/jir173
   Devaux PF, 2008, BBA-BIOMEMBRANES, V1778, P1591, DOI 10.1016/j.bbamem.2008.03.007
   Diaz A, 2012, CURR OPIN MICROBIOL, V15, P519, DOI 10.1016/j.mib.2012.04.007
   Duan XQ, 2008, BIOCHEM BIOPH RES CO, V373, P319, DOI 10.1016/j.bbrc.2008.06.041
   Edgil D, 2006, J VIROL, V80, P2976, DOI 10.1128/JVI.80.6.2976-2986.2006
   EVANS EA, 1986, P NATL ACAD SCI USA, V83, P581, DOI 10.1073/pnas.83.3.581
   Evron T, 2012, TRENDS PHARMACOL SCI, V33, P154, DOI 10.1016/j.tips.2011.12.003
   Flamand M, 1999, J VIROL, V73, P6104, DOI 10.1128/JVI.73.7.6104-6110.1999
   FRIEDMAN DI, 1981, P NATL ACAD SCI-BIOL, V78, P1115, DOI 10.1073/pnas.78.2.1115
   Friedrich S, 2016, RNA, V22, P1574, DOI 10.1261/rna.055269.115
   Friedrich S, 2014, J VIROL, V88, P11586, DOI 10.1128/JVI.01283-14
   Gamarnik AV, 1998, GENE DEV, V12, P2293, DOI 10.1101/gad.12.15.2293
   Garcia-Blanco MA, 2016, ANTIVIR RES, V134, P244, DOI 10.1016/j.antiviral.2016.09.010
   Garcia-Montalvo BM, 2004, VIRUS RES, V102, P141, DOI 10.1016/j.virusres.2004.01.024
   Garske T, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001638
   Gomila RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016687
   GUIRAKHOO F, 1993, VIROLOGY, V194, P219, DOI 10.1006/viro.1993.1252
   Guo Y, 2004, NAT STRUCT MOL BIOL, V11, P591, DOI 10.1038/nsmb784
   Hackett BA, 2015, P NATL ACAD SCI USA, V112, P7797, DOI 10.1073/pnas.1424098112
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hanna SL, 2005, J VIROL, V79, P13262, DOI 10.1128/JVI.79.21.13262-13274.2005
   Harrower J, 2016, EMERG INFECT DIS, V22, P1855, DOI 10.3201/eid2210.160951
   Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006
   Heaton NS, 2010, P NATL ACAD SCI USA, V107, P17345, DOI 10.1073/pnas.1010811107
   Hirsch AJ, 2005, J VIROL, V79, P11943, DOI 10.1128/JVI.79.18.11943-11951.2005
   Huo Y, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004141
   Iglesias NG, 2015, TRAFFIC, V16, P962, DOI 10.1111/tra.12305
   Ivanov A, 2016, NUCLEIC ACIDS RES, V44, P7766, DOI 10.1093/nar/gkw635
   Ivanyi-Nagy R, 2008, NUCLEIC ACIDS RES, V36, P712, DOI 10.1093/nar/gkm1051
   Jan CH, 2014, SCIENCE, V346, P716, DOI 10.1126/science.1257521
   Jiang LB, 2009, BIOCHEM BIOPH RES CO, V385, P187, DOI 10.1016/j.bbrc.2009.05.036
   Jindadamrongwech S, 2004, ARCH VIROL, V149, P915, DOI 10.1007/s00705-003-0263-x
   Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983
   Junjhon J, 2014, J VIROL, V88, P4687, DOI 10.1128/JVI.00118-14
   Kahvejian A, 2005, GENE DEV, V19, P104, DOI 10.1101/gad.1262905
   Kalia M, 2013, J VIROL, V87, P148, DOI 10.1128/JVI.01399-12
   KIM J, 1995, J BIOL CHEM, V270, P13620, DOI 10.1074/jbc.270.23.13620
   Kim JM, 2008, J VIROL, V82, P7846, DOI 10.1128/JVI.00789-08
   Kobayashi N, 2007, IMMUNITY, V27, P927, DOI 10.1016/j.immuni.2007.11.011
   Kobayashi S, 2016, J BIOL CHEM, V291, P6559, DOI 10.1074/jbc.M115.712760
   Kobayashi S, 2014, VIRUS RES, V191, P83, DOI 10.1016/j.virusres.2014.07.016
   Kooijman EE, 2003, TRAFFIC, V4, P162, DOI 10.1034/j.1600-0854.2003.00086.x
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207
   Krishnan MN, 2007, J VIROL, V81, P4881, DOI 10.1128/JVI.02210-06
   Kroschewski H, 2003, VIROLOGY, V308, P92, DOI 10.1016/S0042-6822(02)00097-1
   Kudelko M, 2012, J BIOL CHEM, V287, P767, DOI 10.1074/jbc.M111.270579
   Kutay U, 1998, MOL CELL, V1, P359, DOI 10.1016/S1097-2765(00)80036-2
   Landry DM, 2009, GENE DEV, V23, P2753, DOI 10.1101/gad.1832209
   Le Sommer C, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001820
   Lee E, 2000, J VIROL, V74, P8867, DOI 10.1128/JVI.74.19.8867-8875.2000
   Li L, 2008, SCIENCE, V319, P1830, DOI 10.1126/science.1153263
   Li MY, 2015, CELL REP, V10, P1496, DOI 10.1016/j.celrep.2015.02.021
   Lindenbach BD, 2013, FIELDS VIROLOGY, P712
   Liu H, 2004, J MED VIROL, V72, P618, DOI 10.1002/jmv.20025
   Lobigs M, 2010, VIROLOGY, V401, P80, DOI 10.1016/j.virol.2010.02.008
   Louie RJ, 2012, GENOME MED, V4, DOI 10.1186/gm404
   Lozach PY, 2005, J BIOL CHEM, V280, P23698, DOI 10.1074/jbc.M504337200
   Luca VC, 2013, J VIROL, V87, P818, DOI 10.1128/JVI.01950-12
   Ma HM, 2015, CELL REP, V12, P673, DOI 10.1016/j.celrep.2015.06.049
   Marceau CD, 2016, NATURE, V535, P159, DOI 10.1038/nature18631
   Mateo R, 2013, J VIROL, V87, P1312, DOI 10.1128/JVI.02177-12
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Miller JL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040017
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Moller-Tank S, 2014, VIROLOGY, V468, P565, DOI 10.1016/j.virol.2014.09.009
   Mondotte JA, 2007, J VIROL, V81, P7136, DOI 10.1128/JVI.00116-07
   Mukhopadhyay S, 2003, SCIENCE, V302, P248, DOI 10.1126/science.1089316
   Muylaert IR, 1996, VIROLOGY, V222, P159, DOI 10.1006/viro.1996.0406
   Nagy PD, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005912
   Navarro-Sanchez E, 2003, EMBO REP, V4, P723, DOI 10.1038/sj.embor.embor866
   Nour AM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003585
   Okamoto K, 2012, J GEN VIROL, V93, P761, DOI 10.1099/vir.0.037853-0
   Padwad YS, 2010, VIRAL IMMUNOL, V23, P557, DOI 10.1089/vim.2010.0052
   Pena J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038202
   Perera R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002584
   Perera-Lecoin M, 2014, VIRUSES-BASEL, V6, P69, DOI 10.3390/v6010069
   Perreira JM, 2015, CELL REP, V12, P850, DOI 10.1016/j.celrep.2015.06.076
   Pokidysheva E, 2006, CELL, V124, P485, DOI 10.1016/j.cell.2005.11.042
   Polacek C, 2009, J GEN VIROL, V90, P687, DOI 10.1099/vir.0.007021-0
   Richard M, 2013, P NATL ACAD SCI USA, V110, pE1055, DOI 10.1073/pnas.1216154110
   Roehrig JT, 2013, VIROLOGY, V441, P114, DOI 10.1016/j.virol.2013.03.011
   Romero-Brey I, 2014, VIRUSES-BASEL, V6, P2826, DOI 10.3390/v6072826
   Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632
   Satoh T, 2015, ELIFE, V4, DOI 10.7554/eLife.06306
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Seitz HM, 2007, J IMMUNOL, V178, P5635, DOI 10.4049/jimmunol.178.9.5635
   Sessions OM, 2009, NATURE, V458, P1047, DOI 10.1038/nature07967
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Smit JM, 2011, VIRUSES-BASEL, V3, P160, DOI 10.3390/v3020160
   Somnuke P, 2011, VIROLOGY, V413, P253, DOI 10.1016/j.virol.2011.02.022
   Stadler K, 1997, J VIROL, V71, P8475, DOI 10.1128/JVI.71.11.8475-8481.1997
   Tabata K, 2016, CELL REP, V16, P2339, DOI 10.1016/j.celrep.2016.07.068
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Taguwa S, 2015, CELL, V163, P1108, DOI 10.1016/j.cell.2015.10.046
   Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840
   Thepparit C, 2004, J VIROL, V78, P12647, DOI 10.1128/JVI.78.22.12647-12656.2004
   Tio PH, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-25
   Tung YT, 2014, NANOMED-NANOTECHNOL, V10, P1335, DOI 10.1016/j.nano.2014.03.009
   Uchida L, 2014, SCI REP-UK, V4, DOI 10.1038/srep07395
   Valle JRD, 2005, J VIROL, V79, P4557, DOI 10.1128/JVI.79.8.4557-4567.2005
   Vashist S, 2009, J GEN VIROL, V90, P1343, DOI 10.1099/vir.0.010850-0
   WALTER P, 1981, J CELL BIOL, V91, P551, DOI 10.1083/jcb.91.2.551
   WALTER P, 1981, J CELL BIOL, V91, P557, DOI 10.1083/jcb.91.2.557
   WALTER P, 1981, J CELL BIOL, V91, P545, DOI 10.1083/jcb.91.2.545
   WALTER P, 1994, ANNU REV CELL BIOL, V10, P87, DOI 10.1146/annurev.cb.10.110194.000511
   Wang P, 2016, VIROLOGY, V488, P108, DOI 10.1016/j.virol.2015.11.006
   Ward AM, 2016, SCI REP-UK, V6, DOI 10.1038/srep34379
   Ward AM, 2011, RNA BIOL, V8, P1173, DOI 10.4161/rna.8.6.17836
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   Wilder-Smith A, 2016, LANCET INFECT DIS, V16, P629, DOI 10.1016/S1473-3099(16)00076-1
   Xu ZK, 2012, VIROLOGY, V433, P226, DOI 10.1016/j.virol.2012.08.011
   Ye J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075188
   Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264
   Zaitseva E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001131
   Zeisel MB, 2013, CURR TOP MICROBIOL, V369, P87, DOI 10.1007/978-3-642-27340-7_4
   Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625
   Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463
   Zhou X, 2015, J MOL CELL BIOL, V7, P92, DOI 10.1093/jmcb/mjv014
   ZHOURAVLEVA G, 1995, EMBO J, V14, P4065, DOI 10.1002/j.1460-2075.1995.tb00078.x
   Zybert IA, 2008, J GEN VIROL, V89, P3047, DOI 10.1099/vir.0.2008/002535-0
NR 156
TC 3
Z9 3
U1 0
U2 1
PU SPRINGER INTERNATIONAL PUBLISHING AG
PI CHAM
PA GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND
SN 0070-217X
EI 2196-9965
BN 978-3-030-05369-7; 978-3-030-05368-0
J9 CURR TOP MICROBIOL
JI Curr.Top.Microbiol.Immunol.
PY 2018
VL 419
BP 43
EP 67
DI 10.1007/82_2017_26
D2 10.1007/978-3-030-05369-7
PG 25
WC Immunology; Infectious Diseases; Microbiology; Virology
SC Immunology; Infectious Diseases; Microbiology; Virology
GA BL8GM
UT WOS:000456328600003
PM 28688087
DA 2020-07-08
ER

PT J
AU Andrew, SE
   Kennedy, EM
   Sum, MSH
AF Andrew, Sylvia Empiang
   Kennedy, Easther Manye
   Sum, Magdline Sia Henry
TI Overexpression of recombinant domain III envelope protein of Zika virus
SO MALAYSIAN JOURNAL OF MICROBIOLOGY
LA English
DT Article
DE Recombinant protein; domain III; Zika virus
ID INFECTION; FLAVIVIRUSES; STATE
AB Aims: Zika virus (ZIKV) is a member of the Flaviviridae family and is transmitted to humans by mosquitoes. In humans, it causes disease known as Zika fever. The severity of the infection ranged from asymptomatic to mild disease and to infection associated with neurological disorders and congenital anomaly. The common symptoms are maculopapular rash, fever, arthralgia, myalgia, headache and conjunctivitis. The flavivirus genome consists of structural and nonstructural proteins. The envelope (E) glycoprotein is the major structural protein which is responsible for virus entry and represents a major target for neutralizing antibodies. The E protein consists of three distinct domains: domain I, domain II and domain III. The domain III (DIII) of the E protein has shown to be useful as antigen for flavivirus serologic diagnosis and immunization in animal model. Hence, the aim of this work is to express the DIII of E protein (EDIII) of ZIKV for immunoreactivity study.
   Methodology and results: The EDIII of ZIKV was cloned into pET SUMO cloning vector and transformed into Mach-T1 competent E. coli cells. Positive clone was selected, verified and transformed into BL21 (DE3) competent E. coli for protein expression. The expression of the recombinant protein was analysed on SDS-PAGE and western blot. The recombinant fusion protein of EDIII/SUMOHIS (rEDIII) was successfully expressed at a molecular weight of approximately 38.2 kDa.
   Conclusion, significance and impact of study: The expression of the protein was confirmed by detection with anti-histidine and a flavivirus antiserum, HPR.
C1 [Andrew, Sylvia Empiang; Kennedy, Easther Manye; Sum, Magdline Sia Henry] Univ Malaysia Sarawak, Inst Hlth & Community Med, Kota Samarahan 94300, Malaysia.
RP Sum, MSH (corresponding author), Univ Malaysia Sarawak, Inst Hlth & Community Med, Kota Samarahan 94300, Malaysia.
EM shsmag@unimas.my
CR Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Cardosa M. J., 2002, BIOMEDICAL CENTRAL M, V2, P1
   Caron M, 2012, CLIN INFECT DIS, V55, pE45, DOI 10.1093/cid/cis530
   Cook S, 2006, ARCH VIROL, V151, P309, DOI 10.1007/s00705-005-0626-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Malakhov Michael P., 2004, Journal of Structural and Functional Genomics, V5, P75, DOI 10.1023/B:JSFG.0000029237.70316.52
   Mathengtheng L, 2014, VECTOR-BORNE ZOONOT, V14, P261, DOI 10.1089/vbz.2013.1407
   Musso D., 2014, CLIN MICROBIOL INFEC, V20, P596
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Oehler E, 2014, EUROSURVEILLANCE, V19, P4
   Olson J. G., 1990, T ROY SOC TROP MED H, V75, P389
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Smithburn K. C., 1969, AM J TROP MED HYG, V59, P157
   Sum M. S. H., 2015, BIOTECHNOLOGY INDIAN, V11, P109
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 24
TC 0
Z9 0
U1 0
U2 0
PU MALAYSIAN SOC MICROBIOLOGY
PI PENANG
PA UNIV SAINS MALAYSIA, SCHOOL BIOLOGICAL SCIENCES, PENANG, 11800, MALAYSIA
SN 1823-8262
EI 2231-7538
J9 MALAYS J MICROBIOL
JI Malays. J. Microbiol.
PY 2018
VL 14
IS 4
SI SI
BP 325
EP 328
DI 10.21161/mjm.144185
PG 4
WC Microbiology
SC Microbiology
GA HI0CC
UT WOS:000456108700005
OA DOAJ Gold, Green Accepted
DA 2020-07-08
ER

PT J
AU Moura, LKB
   Cordeiro, SMM
   Almeida, CAPL
   Marques, MDMP
   de Araujo, TME
   Moura, MEB
AF Batista Moura, Luana Kelle
   Melo Cordeiro, Sarah Maria
   Pinheiro Landim Almeida, Camila Aparecida
   Mendes Pinto Marques, Maria do Ceu
   Evangelista de Araujo, Telma Maria
   Batista Moura, Maria Eliete
TI Analysis of scientific production on Zika virus and pregnancy
SO REV RENE
LA English
DT Article
DE Pregnancy; Zika Virus; Bibliometrics
AB Objective: to analyze the international scientific production on Zika virus and pregnancy. Methods: a bibliometric survey was carried out in the ISI Web of Knowledge/Web of Science database, using the search terms "Pregnancy", "ZikV" and "Bibliometrics", from the export of this data to the HistCite (TM) bibliometric analysis software. Results: 355 publication records were identified and the 11 most cited articles were selected in the Web of Science (global) and those most cited in the selected articles (local) in 207 different journals indexed to the database in question, written by 2,435 authors who had links with 799 institutions, located in 59 countries. Conclusion: obscure aspects remain about the natural history of Zika virus in pregnant women, clinical profile, epidemiology, and lack clarity about the existence of cofactors associated with infection by Zika virus.
C1 [Batista Moura, Luana Kelle; Melo Cordeiro, Sarah Maria; Pinheiro Landim Almeida, Camila Aparecida] Ctr Univ UNINOVAFAPI, Teresina, PI, Brazil.
   [Batista Moura, Luana Kelle] Univ Fed Rio Grande do Norte, Ave Senador Salgado Filho 1-787, BR-59056000 Natal, RN, Brazil.
   [Mendes Pinto Marques, Maria do Ceu] Univ Evora, Escola Super Enfermagem Sao Joao de Deus, Evora, Portugal.
   [Evangelista de Araujo, Telma Maria; Batista Moura, Maria Eliete] Univ Fed Piaui, Teresina, PI, Brazil.
RP Moura, LKB (corresponding author), Univ Fed Rio Grande do Norte, Ave Senador Salgado Filho 1-787, BR-59056000 Natal, RN, Brazil.
EM luana_moura19@hotmail.com
RI Moura, Luana K B/M-1989-2017; Araujo, Telma M. E./F-5179-2018; Moura,
   Maria Eliete Batista/F-4162-2018; Marques, Maria/AAL-3257-2020;
   Rene/M-6342-2019
OI Moura, Luana K B/0000-0003-4917-7598; Araujo, Telma M.
   E./0000-0001-5628-9577; Moura, Maria Eliete Batista/0000-0003-3095-9506;
   Marques, Maria/0000-0003-2658-3550; Almeida, Camila Aparecida Pinheiro
   Landim/0000-0003-4843-4572
CR Ashwal S, 2009, NEUROLOGY, V73, P887, DOI 10.1212/WNL.0b013e3181b783f7
   Moura LKB, 2017, IRAN J PUBLIC HEALTH, V46, P1435
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brito VRS, 2010, REV RENE, V11, P29
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Diniz D, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00046316
   Donalisio MR, 2017, REV SAUDE PUBL, V51, DOI [10.1590/S1518-8787.2017051006889, 10.1590/s1518-8787.2017051006889]
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Ministerio da Saude (BR), 2018, MON CAS DENG FEBR CH, V49, P1
   Ministerio da Saude (BR). Secretaria de Atencao a Saude, 2015, PROT AT SAUD RESP OC
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Henriques CMP, 2016, EPIDEMIOL SERV SAUDE, V25, P7, DOI [10.5123/S1679-49742016000100001, 10.5123/s1679-49742016000100001]
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 20
TC 0
Z9 0
U1 0
U2 0
PU UNIV FEDERAL CEARA, DEPT ENFERMAGEM
PI CEARA
PA AVDA UNIVERSIDADE, CAIXA POSTAL 1000, FORTALEZA, CEARA, 00000, BRAZIL
SN 1517-3852
EI 2175-6783
J9 REV RENE
JI Rev Rene
PY 2018
VL 19
AR UNSP e33794
DI 10.15253/2175-6783.20181933794
PG 8
WC Nursing
SC Nursing
GA HH9BF
UT WOS:000456028000029
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Campos, MMMS
   de Sousa, TC
   Teixeira, GP
   Chaves, KYD
   Araujo, MVUM
   Sousa, MR
AF Martins Sampaio Campos, Mara Marusia
   de Sousa, Thaynara Campos
   Teixeira, Gianini Portela
   dos Santos Chaves, Kellen Yamille
   Uchoa Moraes Araujo, Maria Valdeleda
   Sousa, Marilia Rocha
TI Challenges and perspectives of mothers of children with microcephaly due
   to Zika virus infection
SO REV RENE
LA English
DT Article
DE Zika Virus; Mothers; Microcephaly; Child
ID BRAZIL
AB Objective: to understand the challenges and perspectives of mothers of children with microcephaly due to Zika virus infection. Methods: qualitative study carried out with twelve mothers of children with microcephaly due to Zika virus at a pediatric public hospital. Data were collected through a semi-structured interview and submitted to content analysis. Results: the speeches revealed the mothers were mostly unaware of the occurrence of Zika virus infection in pregnancy, and the moment of diagnosis was characterized by surprise and suffering, despite the observed overcoming. Many of them did not know the meaning of microcephaly and did not know what changes and limitations their children might have. In describing the difficulties in caring for the child, mothers attached to spirituality as a form of coping. Conclusion: microcephaly brought a new reality to the investigated women, who sometimes denied their own reality, demonstrating in the speeches many challenges and few perspectives.
C1 [Martins Sampaio Campos, Mara Marusia; de Sousa, Thaynara Campos; Teixeira, Gianini Portela; Uchoa Moraes Araujo, Maria Valdeleda; Sousa, Marilia Rocha] Ctr Univ Christus, Fortaleza, Ceara, Brazil.
   [dos Santos Chaves, Kellen Yamille] Maternidade Escola Assis Chateaubriand, Fortaleza, Ceara, Brazil.
RP Campos, MMMS (corresponding author), Rua Jonas Sampaio 550, BR-60830465 Fortaleza, Ceara, Brazil.
EM maramarusia@hotmail.com
RI Rene/M-6342-2019
OI Campos, Mara/0000-0002-6326-8499; Chaves, Kellen/0000-0003-0674-5890
CR Barros SMM, 2017, NOVA PERSPECT SIST, V26, P38
   Brunoni D, 2016, CIENC SAUDE COLETIVA, V21, P3296, DOI 10.1590/1413-812320152110.16832016
   Martins EMDS, 2013, REV REDE ENFERM NORD, V14, P42
   Cerqueira MMF, 2016, CIENC SAUDE COLETIVA, V21, P3222, DOI 10.1590/1413-812320152110.17242016
   Flor CJDRV, 2017, REV PESQ FISIO, V7, P313, DOI [10.17267/2238-2704rpf.v7i3.1386, DOI 10.17267/2238-2704RPF.V7I3.1386]
   Galli B, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00031116
   Goncalves AE, 2018, REV PESQUISA FISIOTE, V8, P155, DOI [10.17267/2238-2704rpf.v8i2.1865, DOI 10.17267/2238-2704RPF.V8I2.1865]
   Guerra Camilla de Sena, 2015, Texto contexto - enferm., V24, P459, DOI 10.1590/0104-07072015000992014
   Marinho F, 2016, EPIDEMIOL SERV SAUDE, V25, P701, DOI [10.5123/S1679-49742016000400004, 10.5123/s1679-49742016000400004]
   Medeiros VAB, 2018, CIEN BIOL SAUDE UNIT, V4, P67
   Minayo MCS, 2014, DESAFIO CONHECIMENTO
   Oliveira MC, 2017, REV PESQ FISIO, V7, P511, DOI DOI 10.17267/2238-2704RPF.V7I4.1602
   Pedroso CNLS, 2014, REV CIENC SAUDE, V7, P61, DOI DOI 10.15448/1983-652X.2014.2.16464
   Rego Sergio, 2016, Rev. Bioét., V24, P430, DOI 10.1590/1983-80422016243141
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Silva EHP, 2016, ESTUD PESQUI PSICOL, V16, P180
   Vargas A, 2016, EPIDEMIOL SERV SAUDE, V25, P691, DOI 10.5123/S1679-49742016000400003
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
NR 18
TC 0
Z9 0
U1 0
U2 0
PU UNIV FEDERAL CEARA, DEPT ENFERMAGEM
PI CEARA
PA AVDA UNIVERSIDADE, CAIXA POSTAL 1000, FORTALEZA, CEARA, 00000, BRAZIL
SN 1517-3852
EI 2175-6783
J9 REV RENE
JI Rev Rene
PY 2018
VL 19
AR UNSP e32839
DI 10.15253/2175-6783.20181932839
PG 8
WC Nursing
SC Nursing
GA HH9BF
UT WOS:000456028000014
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Haque, A
   Akcesme, FB
   Pant, AB
AF Haque, Azizul
   Akcesme, Faruk Berat
   Pant, Anudeep B.
TI A review of Zika virus: hurdles toward vaccine development and the way
   forward
SO ANTIVIRAL THERAPY
LA English
DT Review
ID T-CELLS; RESPONSES; OUTBREAK; IMMUNITY
AB The Zika virus (ZIKV) epidemic has recently emerged as a public health threat due to its teratogenic nature and association with the serious neurological condition Guillain-Barre syndrome (GBS). To date, no approved antiviral therapeutics to treat, nor vaccines to prevent, ZIKV infection are available. In order to develop effective anti-ZIKV vaccines, improved animal models and a better understanding of immunological correlates of protection against ZIKV are required. In this paper, we discuss the recent progress in developing vaccines against ZIKV and the hurdles to overcome in making efficacious anti-ZIKV vaccines. Here, we propose strategies to make efficacious and safe vaccines against ZIKV by using novel approaches including molecular attenuation of viruses and TLR-based nanoparticle vaccines. The question of exacerbating dengue virus infection or causing GBS through the production of cross-reactive immunity targeting viral or host proteins have been addressed in this paper. Challenges in implementing immunogenic and protective ZIKV vaccine trials in immunodepressed target populations (for example, pregnant women) have also been discussed.
C1 [Haque, Azizul] Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Lebanon, NH 03756 USA.
   [Akcesme, Faruk Berat] Univ Med Sci, Dept Biostat & Med Informat, Uskudar Istanbul, Turkey.
   [Pant, Anudeep B.] Tulane Univ, Sch Publ Hlth & Trop Med, New Orleans, LA USA.
RP Haque, A (corresponding author), Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Lebanon, NH 03756 USA.
EM Azizul.Haque@Dartmouth.Edu
RI amsalu, ribka/G-8780-2019
CR [Anonymous], 2016, WHO 1 M INT HLTH REG
   Boigard H, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005608
   Borhani K, 2017, INT IMMUNOPHARMACOL, V48, P231, DOI 10.1016/j.intimp.2017.05.007
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Centres for Disease Control and Prevention, 2017, WORLD MAP AR RISK ZI
   Charles Anu Susan, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.4ab8bc87c945eb41cd8a49e127082620
   Cunha-Neto E, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00640
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Haque A, 2017, J BIOANAL BIOMED, V4, P177
   Haque A, 2007, EMERG INFECT DIS, V13, P1512, DOI 10.3201/eid1310.061262
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Kasturi SP, 2011, NATURE, V470, P543, DOI 10.1038/nature09737
   Knudsen A. B., 1995, Parassitologia (Rome), V37, P91
   Levy O, 2006, BLOOD, V108, P1284, DOI 10.1182/blood-2005-12-4821
   Lucchese G, 2016, AUTOIMMUN REV, V15, P801, DOI 10.1016/j.autrev.2016.03.020
   Minor PD, 2015, VIROLOGY, V479, P379, DOI 10.1016/j.virol.2015.03.032
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Monath TP, 2005, EXPERT REV VACCINES, V4, P553, DOI 10.1586/14760584.4.4.553
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   National Institutes of Health, 2016, TEST INV IN ZIK VACC
   National Institutes of Health, ZIK VACC DOS FIND ST
   National Institutes of Health, 2017, NIH BEG STUD VACC PR
   Netland J, 2013, VIRUSES-BASEL, V5, P2573, DOI 10.3390/v5102573
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   PEDERSEN CE, 1972, AM J EPIDEMIOL, V95, P490, DOI 10.1093/oxfordjournals.aje.a121416
   Plotkin SA, 2015, J INFECT DIS, V212, pS12, DOI 10.1093/infdis/jiu568
   Prins RM, 2006, J IMMUNOL, V176, P157, DOI 10.4049/jimmunol.176.1.157
   Richner JM, 2017, CELL, V169, P176, DOI 10.1016/j.cell.2017.03.016
   Rochlin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060874
   Rubsamen RM, 2014, VACCINE, V32, P4111, DOI 10.1016/j.vaccine.2014.05.071
   Sahin U, 2014, NAT REV DRUG DISCOV, V13, P759, DOI 10.1038/nrd4278
   Seligman SJ, 2004, LANCET, V363, P2073, DOI 10.1016/S0140-6736(04)16459-3
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Shrestha B, 2004, J VIROL, V78, P8312, DOI 10.1128/jvi.78.15.8312-8321.2004
   Tsetsarkin KA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004852
   Vannice KS, 2016, VACCINE, V34, P2934, DOI 10.1016/j.vaccine.2015.12.073
   Weissman D, 2015, EXPERT REV VACCINES, V14, P265, DOI 10.1586/14760584.2015.973859
   Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36
   World Health Organization, 2017, SIT REP ZIK VIR MICR
   Xie XP, 2017, MBIO, V8, DOI [10.1128/mBio.02134-16, 10.1128/mbio.02134-16]
   Yang M, 2017, VACCINE, V35, P4287, DOI 10.1016/j.vaccine.2017.04.052
   Zanluca C, 2016, MICROBES INFECT, V18, P295, DOI 10.1016/j.micinf.2016.03.003
   Zhang YJ, 2016, PROTEIN CELL, V7, P461, DOI 10.1007/s13238-016-0274-5
NR 51
TC 2
Z9 2
U1 0
U2 2
PU INT MEDICAL PRESS LTD
PI LONDON
PA 2-4 IDOL LANE, LONDON EC3R 5DD, ENGLAND
SN 1359-6535
J9 ANTIVIR THER
JI Antivir. Ther.
PY 2018
VL 23
IS 4
BP 285
EP 293
DI 10.3851/IMP3215
PG 9
WC Infectious Diseases; Pharmacology & Pharmacy; Virology
SC Infectious Diseases; Pharmacology & Pharmacy; Virology
GA HG3QO
UT WOS:000454889600001
PM 29300166
DA 2020-07-08
ER

PT J
AU Beesetti, H
   Tyagi, P
   Medapi, B
   Krishna, VS
   Sriram, D
   Khanna, N
   Swaminathan, S
AF Beesetti, Hemalatha
   Tyagi, Poornima
   Medapi, Brahmam
   Krishna, Vagolu Siva
   Sriram, Dharmarajan
   Khanna, Navin
   Swaminathan, Sathyamangalam
TI A quinoline compound inhibits the replication of dengue virus serotypes
   1-4 in Vero cells
SO ANTIVIRAL THERAPY
LA English
DT Article
ID YELLOW-FEVER VIRUS; ZIKA VIRUS; PROTEIN; VACCINE; NS3; EFFICACY; BURDEN;
   DOMAIN; NS2B
AB Background: The global occurrence of dengue, a mosquito-borne viral disease caused by four distinct dengue viruses (DENV-1, -2, -3 and -4), is reported to have increased approximately 30-fold in the last 50 years, causing approximately 400 million infections a year. A limited use, sub-optimal live attenuated dengue vaccine has become available recently. It is becoming apparent that antibodies to DENVs can promote infection by Zika virus (ZIKV), a related mosquito-borne flavivirus. A drug to treat these flaviviral infections continues to be an unmet public health need.
   Methods: We screened an 'in-house' library of approximately 2,000 small molecules for inhibitors of cloned DENV-2 protease. Putative inhibitor binding to DENV-2 protease was analysed by in silico docking. Anti-DENV activity was analysed by monitoring viral antigen synthesis by ELISA, viral RNA synthesis by reverse-transcription coupled to real-time polymerase chain reaction and infectious virus production by plaque assay, in DENV-infected Vero cells.
   Results: A quinoline derivative, BT24, was identified for the first time as a potent inhibitor of the cloned DENV-2 protease (half maximal inhibitory concentration [IC50]=0.5 mu M). In silico analysis revealed that BT24 binds to an allosteric site in the vicinity of the active site of DENV-2 protease. Cell-based assays demonstrated that BT24 can inhibit all four DENVs in infected Vero cells.
   Conclusions: BT24 is a DENV-2 protease inhibitor which manifests the capacity to inhibit the replication of all four DENVs in cultured cells. It may provide a lead for a pan-DENV inhibitory drug.
C1 [Beesetti, Hemalatha; Swaminathan, Sathyamangalam] Birla Inst Technol & Sci Pilani, Dept Biol Sci, Hyderabad Campus, Hyderabad, India.
   [Beesetti, Hemalatha; Tyagi, Poornima; Khanna, Navin; Swaminathan, Sathyamangalam] Int Ctr Genet Engn & Biotechnol, Mol Med Div, Recombinant Gene Prod Grp, New Delhi, India.
   [Medapi, Brahmam; Krishna, Vagolu Siva; Sriram, Dharmarajan] Birla Inst Technol & Sci Pilani, Dept Pharm, Hyderabad Campus, Hyderabad, India.
RP Swaminathan, S (corresponding author), Birla Inst Technol & Sci Pilani, Dept Biol Sci, Hyderabad Campus, Hyderabad, India.; Swaminathan, S (corresponding author), Int Ctr Genet Engn & Biotechnol, Mol Med Div, Recombinant Gene Prod Grp, New Delhi, India.
EM swami@icgeb.res.in
OI Vagolu, Siva Krishna/0000-0003-1540-9995; Swaminathan,
   Sathyamangalam/0000-0002-4388-2248
FU BITS Pilani Hyderabad Campus; Department of Biotechnology, Government of
   IndiaDepartment of Biotechnology (DBT) India; INSPIRE fellowship from
   the Department of Science & Technology, Government of India
FX This work was supported by internal funds from BITS Pilani Hyderabad
   Campus in the form of RIG and OPERA awards (SS) and a grant from the
   Department of Biotechnology, Government of India (SS). HB was the
   recipient of an INSPIRE fellowship from the Department of Science &
   Technology, Government of India, during the course of this work. The
   funders had no role in the work, data interpretation and the decision to
   publish.
CR Barbosa-Lima G, 2017, EUR J MED CHEM, V127, P434, DOI 10.1016/j.ejmech.2017.01.007
   Beesetti H, 2016, EXPERT OPIN INV DRUG, V25, P1059, DOI 10.1080/13543784.2016.1201063
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   CHAMBERS TJ, 1993, J VIROL, V67, P6797, DOI 10.1128/JVI.67.11.6797-6807.1993
   CHAMBERS TJ, 1990, P NATL ACAD SCI USA, V87, P8898, DOI 10.1073/pnas.87.22.8898
   FALGOUT B, 1993, J VIROL, V67, P2034, DOI 10.1128/JVI.67.4.2034-2042.1993
   Ferguson NM, 2016, SCIENCE, V353, P1033, DOI 10.1126/science.aaf9590
   Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430
   Gubler DJ, 2012, AM J TROP MED HYG, V86, P743, DOI 10.4269/ajtmh.2012.12-0157
   Guy B, 2016, NAT REV MICROBIOL, V14, P45, DOI 10.1038/nrmicro.2015.2
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Halstead SB, 2016, VACCINE, V34, P1643, DOI 10.1016/j.vaccine.2016.02.004
   Khanam S, 2009, VACCINE, V27, P6011, DOI 10.1016/j.vaccine.2009.07.073
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lescar J, 2008, ANTIVIR RES, V80, P94, DOI 10.1016/j.antiviral.2008.07.001
   Li J, 2005, J BIOL CHEM, V280, P28766, DOI 10.1074/jbc.M500588200
   Lindenbach B., 2013, FIELDS VIROLOGY, V1, P712
   Low JG, 2014, LANCET INFECT DIS, V14, P706, DOI 10.1016/S1473-3099(14)70730-3
   Mukhametov A, 2014, J MOL GRAPH MODEL, V52, P103, DOI 10.1016/j.jmgm.2014.06.008
   Raut R, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0248-x
   Schwartz LM, 2015, VACCINE, V33, P3293, DOI 10.1016/j.vaccine.2015.05.010
   Swaminathan S, 2009, CURR MOL MED, V9, P152, DOI 10.2174/156652409787581592
   Thomas SJ, 2015, VACCINE, V33, pD24, DOI 10.1016/j.vaccine.2015.05.095
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   World Health Organization, 2013, WHOHTMNTD20131
NR 29
TC 3
Z9 3
U1 1
U2 4
PU INT MEDICAL PRESS LTD
PI LONDON
PA 2-4 IDOL LANE, LONDON EC3R 5DD, ENGLAND
SN 1359-6535
J9 ANTIVIR THER
JI Antivir. Ther.
PY 2018
VL 23
IS 5
BP 385
EP 394
DI 10.3851/IMP3231
PG 10
WC Infectious Diseases; Pharmacology & Pharmacy; Virology
SC Infectious Diseases; Pharmacology & Pharmacy; Virology
GA HG3RB
UT WOS:000454891000001
PM 29583121
DA 2020-07-08
ER

PT J
AU Nandi, S
   Kaur, R
   Kumar, M
   Sharma, A
   Naaz, A
   Mandal, SC
AF Nandi, Sisir
   Kaur, Ramandeep
   Kumar, Mohit
   Sharma, Ankita
   Naaz, Aaliya
   Mandal, Subhash Chandra
TI Current Breakthroughs in Structure-based Design of Synthetic and Natural
   Sourced Inhibitors Against Zika Viral Targets
SO CURRENT TOPICS IN MEDICINAL CHEMISTRY
LA English
DT Review
DE Zika Virus (ZIKV); Potential Zika targets; Synthetic and natural sourced
   ZIKV inhibitors; Structure-based design; X-ray crystallography;
   Molecular docking
ID SMALL-MOLECULE INHIBITORS; DENGUE VIRUS-REPLICATION; INFECTION IN-VITRO;
   NS2B-NS3 PROTEASE; CRYSTAL-STRUCTURE; APPROVED DRUGS; RNA-POLYMERASE;
   METHYLTRANSFERASE; HELICASE; BIOLOGY
AB Background: Zika is a worldwide pandemic dreadful viral transmission through Aedes mosquito vector. It significantly causes fever, joint pain or rash, and conjunctivitis. Pregnant mothers suffering from Zika viral infection may have fetal abnormalities due to severe neurological problems, characterized by microcephaly along with Guillain-Barre syndrome, issuing ZIKV a major public health concern as declared by the World Health Organization. There is hardly any FDA approved anti-Zika viral drugs available.
   Objective: Therefore, it is a big panic for the scientists to destroy the virus completely by generating potent inhibitors.
   Methods: For the purpose, various Zika viral targets were explored by structure-based design in the present review in connection with the discovery of various synthetic and natural sourced inhibitors against Zika virus.
   Results: The structure-based drug design tools such as x-ray crystallography and molecular docking reported various co-crystallized ligands and Zika virus inhibitors.
   Conclusion: Such inhibitors could further be modified for the design of highly active leads to combat Zika virus utilizing chemoinformatics modules.
C1 [Nandi, Sisir; Kaur, Ramandeep; Kumar, Mohit; Sharma, Ankita; Naaz, Aaliya] Uttarakhand Tech Univ, Global Inst Pharmaceut Educ & Res, Dept Pharmaceut Chem, Kashipur, India.
   [Mandal, Subhash Chandra] Jadavpur Univ, Dept Pharmaceut Technol, Div Pharmacognosy, Pharmacognosy & Phytotherapy Lab, Kolkata 700032, India.
RP Nandi, S (corresponding author), Uttarakhand Tech Univ, Global Inst Pharmaceut Educ & Res, Dept Pharmaceut Chem, Kashipur, India.
EM sisir.iicb@gmail.com
RI amsalu, ribka/G-8780-2019
CR Adcock RS, 2017, ANTIVIR RES, V138, P47, DOI 10.1016/j.antiviral.2016.11.018
   Balasubramanian A, 2017, ANTIVIR RES, V137, P141, DOI 10.1016/j.antiviral.2016.11.015
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Bhargava S., 2017, NAT PROD RES, V15, P1
   Blazquez AB, 2014, FRONT MICROBIOL, V5, DOI [10.3389/fmicb.2014.00266, 10.3389/fmicb.2014.00797]
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Bukrejewska M, 2017, ACTA CRYSTALLOGR D, V73, P767, DOI 10.1107/S2059798317010737
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Byrd CM, 2013, ANTIMICROB AGENTS CH, V57, P15, DOI 10.1128/AAC.01429-12
   Cao XC, 2016, NUCLEIC ACIDS RES, V44, P10505, DOI 10.1093/nar/gkw941
   Carneiro BM, 2016, VIROLOGY, V496, P215, DOI 10.1016/j.virol.2016.06.012
   Coloma J, 2016, CELL REP, V16, P3097, DOI 10.1016/j.celrep.2016.08.091
   Congreve M, 2005, DRUG DISCOV TODAY, V10, P895, DOI 10.1016/S1359-6446(05)03484-7
   Contreras D, 2016, JOVE-J VIS EXP, DOI 10.3791/54767
   Coutard B, 2017, J VIROL, V91, DOI 10.1128/JVI.02202-16
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   De Clercq E., 2009, V189, P53, DOI 10.1007/978-3-540-79086-0_3
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   Duan WQ, 2017, EMBO J, V36, P919, DOI 10.15252/embj.201696241
   Elfiky AA, 2016, J MED VIROL, V88, P2044, DOI 10.1002/jmv.24678
   Estoppey D, 2017, CELL REP, V19, P451, DOI 10.1016/j.celrep.2017.03.071
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Fernando S, 2016, MOL BIOTECHNOL, V58, P801, DOI 10.1007/s12033-016-9979-1
   Ferrero D.S., 2018, CRYSTAL STRUCTURE FU
   Fink SL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27224-4
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Godoy AS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14764
   Goebel S, 2016, J VIROL METHODS, V238, P13, DOI 10.1016/j.jviromet.2016.09.015
   Grenoble R, 2016, WHO DECLARES PUBLIC
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hercik K, 2017, ARCH VIROL, V162, P2091, DOI 10.1007/s00705-017-3345-x
   Jia Z., 2017, STRUCTURE ZIKA VIRUS
   Julander JG, 2017, ANTIVIR RES, V137, P14, DOI 10.1016/j.antiviral.2016.11.003
   KENDREW JC, 1958, NATURE, V181, P662, DOI 10.1038/181662a0
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Kuivanen S, 2017, ANTIVIR RES, V139, P117, DOI 10.1016/j.antiviral.2016.12.022
   Lee H, 2017, ANTIVIR RES, V139, P49, DOI 10.1016/j.antiviral.2016.12.016
   Lee JH, 2018, PHYSIOL MOL PLANT P, V101, P178, DOI 10.1016/j.pmpp.2017.03.010
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Lessler J., 2016, SCIENCE, P353
   Li CF, 2017, IMMUNITY, V46, P446, DOI 10.1016/j.immuni.2017.02.012
   Li XD, 2014, J GEN VIROL, V95, P806, DOI 10.1099/vir.0.061838-0
   Li Y., 2017, STRUCTURE ZIKA VIRUS, V18, P1242
   Lindenbach BD, 2001, FIELDS VIROLOGY, V1, P991, DOI DOI 10.1016/J.JMB.2013.11.024
   Mehrjardi MZ., 2017, VIROLOGY AUCKL, V8
   Merino-Ramos T, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00376-17, 10.1128/aac.00376-17]
   Meyer EF, 1997, PROTEIN SCI, V6, P1591, DOI 10.1002/pro.5560060724
   Mounce BC, 2017, ANTIVIR RES, V142, P148, DOI 10.1016/j.antiviral.2017.03.014
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Pascoalino Bruno S, 2016, F1000Res, V5, P2523
   Phoo WW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13410
   Pierson TC, 2012, CURR OPIN VIROL, V2, P168, DOI 10.1016/j.coviro.2012.02.011
   Ramharack P, 2018, J BIOMOL STRUCT DYN, V36, P1118, DOI 10.1080/07391102.2017.1313175
   Rausch K, 2017, CELL REP, V18, P804, DOI 10.1016/j.celrep.2016.12.068
   Roy A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180632
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
   Scaturro P, 2014, J VIROL, V88, P11540, DOI 10.1128/JVI.01745-14
   Shan C, 2016, ACS INFECT DIS, V2, P170, DOI 10.1021/acsinfecdis.6b00030
   Shang ZF, 2018, J MOL BIOL, V430, P948, DOI 10.1016/j.jmb.2018.02.006
   Sheridan M.A., 2016, P NATL ACAD SCI USA, V114, P705
   Shi PY, 2002, J VIROL, V76, P5847, DOI 10.1128/JVI.76.12.5847-5856.2002
   Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140
   Singh A, 2017, COMPUT BIOL CHEM, V71, P144, DOI 10.1016/j.compbiolchem.2017.10.007
   SLEIGH SH, 2010, PHARM MED, V24, P151
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tan CW, 2017, ANTIVIR RES, V143, P186, DOI 10.1016/j.antiviral.2017.04.017
   Tian HL, 2016, PROTEIN CELL, V7, P562, DOI 10.1007/s13238-016-0293-2
   Wang JQ, 2017, CELL, V171, P229, DOI 10.1016/j.cell.2017.09.002
   Wong G, 2017, VIROL SIN, V32, P545, DOI 10.1007/s12250-017-4057-9
   Xu HT, 2017, J ANTIMICROB CHEMOTH, V72, P727, DOI 10.1093/jac/dkw514
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yang X.Y., 2018, ZIKA VIRUS HELICASE
   Yu YF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15672
   Yuan SF, 2017, ANTIVIR RES, V145, P33, DOI 10.1016/j.antiviral.2017.07.007
   Zhang CY, 2017, BIOCHEM BIOPH RES CO, V492, P624, DOI 10.1016/j.bbrc.2016.11.098
   Zhao BY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14762
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
   Zhou H, 2017, ONCOTARGET, V8, P14830, DOI 10.18632/oncotarget.14780
   Zhou T, 2017, CELL STEM CELL, V21, P274, DOI 10.1016/j.stem.2017.06.017
   Zou G, 2011, ANTIVIR RES, V91, P11, DOI 10.1016/j.antiviral.2011.05.001
NR 82
TC 1
Z9 1
U1 1
U2 6
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1568-0266
EI 1873-5294
J9 CURR TOP MED CHEM
JI Curr. Top. Med. Chem.
PY 2018
VL 18
IS 20
BP 1792
EP 1803
DI 10.2174/1568026619666181120125525
PG 12
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA HG0AQ
UT WOS:000454604700007
PM 30465510
DA 2020-07-08
ER

PT S
AU Khurshid, Z
   Zafar, MS
   Khan, RS
   Najeeb, S
   Slowey, PD
   Rehman, IU
AF Khurshid, Zohaib
   Zafar, Muhammad S.
   Khan, Rabia S.
   Najeeb, Shariq
   Slowey, Paul D.
   Rehman, Ihtesham U.
BE Makowski, GS
TI Role of Salivary Biomarkers in Oral Cancer Detection
SO ADVANCES IN CLINICAL CHEMISTRY, VOL 86
SE Advances in Clinical Chemistry
LA English
DT Review; Book Chapter
ID SQUAMOUS-CELL CARCINOMA; EPSTEIN-BARR-VIRUS; ZIKA VIRUS; POTENTIAL
   BIOMARKERS; PROTEOMIC ANALYSIS; PROMOTER HYPERMETHYLATION;
   IMMUNOGLOBULIN-A; LICHEN-PLANUS; HEAD; PROTEIN
AB Oral cancers are the sixth most frequent cancer with a high mortality rate. Oral squamous cell carcinoma accounts for more than 90% of all oral cancers. Standard methods used to detect oral cancers remain comprehensive clinical examination, expensive biochemical investigations, and invasive biopsy. The identification of biomarkers from biological fluids (blood, urine, saliva) has the potential of early diagnosis. The use of saliva for early cancer detection in the search for new clinical markers is a promising approach because of its noninvasive sampling and easy collection methods. Human whole-mouth saliva contains proteins, peptides, electrolytes, organic, and inorganic salts secreted by salivary glands and complimentary contributions from gingival crevicular fluids and mucosal transudates. This diagnostic modality in the field of molecular biology has led to the discovery and potential of salivary biomarkers for the detection of oral cancers. Biomarkers are the molecular signatures and indicators of normal biological, pathological process, and pharmacological response to treatment hence may provide useful information for detection, diagnosis, and prognosis of the disease. Saliva's direct contact with oral cancer lesions makes it more specific and potentially sensitive screening tool, whereas more than 100 salivary biomarkers (DNA, RNA, mRNA, protein markers) have already been identified, including cytokines (IL-8, IL-1b, TNF-alpha), defensin-1, P53, Cyfra 21-1, tissue polypeptide-specific antigen, dual specificity phosphatase, spermidine/spermineN1-acetyltransferase, profilin, cofilin- 1, transferrin, and many more. However, further research is still required for the reliability and validation of salivary biomarkers for clinical applications. This chapter provides the latest up-to-date list of known and emerging potential salivary biomarkers for early diagnosis of oral premalignant and cancerous lesions and monitoring of disease activity.
C1 [Khurshid, Zohaib] King Faisal Univ, Coll Dent, Dept Prosthodont, Al Hufuf, Saudi Arabia.
   [Zafar, Muhammad S.] Taibah Univ, Coll Dent, Dept Restorat Dent, Al Madinah, Saudi Arabia.
   [Zafar, Muhammad S.] Riphah Int Univ, Dept Dent Mat, Islamic Int Dent Coll, Islamabad, Pakistan.
   [Khan, Rabia S.; Rehman, Ihtesham U.] Univ Sheffield, Kroto Res Inst, Mat Sci & Engn Dept, Sheffield, S Yorkshire, England.
   [Najeeb, Shariq] Al Farabi Coll, Restorat Dent Sci, Riyadh, Saudi Arabia.
   [Slowey, Paul D.] Oasis Diagnost Corp, Vancouver, WA USA.
RP Zafar, MS (corresponding author), Taibah Univ, Coll Dent, Dept Restorat Dent, Al Madinah, Saudi Arabia.; Zafar, MS (corresponding author), Riphah Int Univ, Dept Dent Mat, Islamic Int Dent Coll, Islamabad, Pakistan.
EM MZAFAR@taibahu.edu.sa
RI khan, rabia/AAM-1194-2020; Khurshid, Zohaib/K-9314-2015; Zafar, Muhammad
   S/N-2800-2014
OI Khurshid, Zohaib/0000-0001-7998-7335; Zafar, Muhammad
   S/0000-0002-5157-7067
CR Affoo RH, 2015, J AM GERIATR SOC, V63, P2142, DOI 10.1111/jgs.13652
   Agha-Hosseini F., 2009, J CONT DENT PRACT, V10
   Agha-Hosseini F, 2012, J ORAL PATHOL MED, V41, P736, DOI 10.1111/j.1600-0714.2012.01172.x
   AHLNER BH, 1983, ACTA OTO-LARYNGOL, V95, P173, DOI 10.3109/00016488309130932
   Al Kawas S, 2012, ARCH ORAL BIOL, V57, P1, DOI 10.1016/j.archoralbio.2011.06.013
   Almadori G, 2007, HEAD NECK-J SCI SPEC, V29, P648, DOI 10.1002/hed.20579
   Amado FML, 2013, CLIN BIOCHEM, V46, P506, DOI 10.1016/j.clinbiochem.2012.10.024
   [Anonymous], 2009, SPECIMEN SAMPLE COLL
   Baba TW, 2000, NAT MED, V6, P200
   Bahar G, 2007, CANCER, V109, P54, DOI 10.1002/cncr.22386
   Baldini C, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3523
   BANCROFT WH, 1977, J INFECT DIS, V135, P79, DOI 10.1093/infdis/135.1.79
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Basarab M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1049
   Bassim CW, 2012, J CLIN IMMUNOL, V32, P1390, DOI 10.1007/s10875-012-9738-4
   Bengmark S, 1998, GUT, V42, P2, DOI 10.1136/gut.42.1.2
   Bernabe DG, 2012, J CLIN PATHOL, V65, P934, DOI 10.1136/jclinpath-2012-200695
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bigler LR, 2009, CLIN LAB MED, V29, P71, DOI 10.1016/j.cll.2009.01.004
   Brinkmann O, 2011, ORAL ONCOL, V47, P51, DOI 10.1016/j.oraloncology.2010.10.009
   Cabras T, 2014, BIOANALYSIS, V6, P563, DOI 10.4155/bio.13.349
   Cabras T, 2010, MOL CELL PROTEOMICS, V9, P2099, DOI 10.1074/mcp.M110.001057
   Califano J, 1996, CANCER RES, V56, P2488
   Camisasca DR, 2017, J PROTEOMICS, V151, P43, DOI 10.1016/j.jprot.2016.07.029
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Caswell S. V., 2015, ADV SALIVARY DIAGNOS, P121, DOI [DOI 10.1007/978-3-662-45399-5, 10.1007/978-3-662-45399-5]
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Charrel RN, 2016, B WORLD HEALTH ORGAN, V94, P574, DOI 10.2471/BLT.16.171207
   CHEN DX, 1990, OBSTET GYNECOL, V75, P701
   Chen WQ, 2015, GENOM PROTEOM BIOINF, V13, P219, DOI 10.1016/j.gpb.2015.06.002
   Cheng YSL, 2014, CLIN ORAL INVEST, V18, P985, DOI 10.1007/s00784-013-1041-0
   Cheng YSL, 2014, CLIN TRANSL MED, V3, DOI 10.1186/2001-1326-3-3
   Chiang SH, 2015, BIOTECHNIQUES, V58, P69, DOI 10.2144/000114254
   Chiappin S, 2007, CLIN CHIM ACTA, V383, P30, DOI 10.1016/j.cca.2007.04.011
   강미선, 2009, Journal of Bacteriology and Virology, V39, P277
   Conley BA, 2004, DIS MARKERS, V20, P35, DOI 10.1155/2004/202031
   Corstjens PLAM, 2016, PERIODONTOL 2000, V70, P93, DOI 10.1111/prd.12112
   Crocker J., 2003, MOL BIOL CELLULAR PA, DOI [10.1111/j.1471-4159.2011.07232.x, DOI 10.1111/J.1471-4159.2011.07232.X]
   Cuevas-Cordoba B, 2014, OMICS, V18, P87, DOI 10.1089/omi.2013.0064
   de Jong EP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011148
   Denny P, 2008, J PROTEOME RES, V7, P1994, DOI 10.1021/pr700764j
   Devic I, 2014, BIOL BLOOD MARROW TR, V20, P1048, DOI 10.1016/j.bbmt.2014.03.031
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Division of Vector-Borne Diseases, 2014, REV DIAGN TEST ZIK C, P1, DOI [10.1007/s13398-014-0173-7.2, DOI 10.1007/S13398-014-0173-7.2]
   Dodds MWJ, 2005, J DENT, V33, P223, DOI 10.1016/j.jdent.2004.10.009
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duffy SA, 2008, CANCER-AM CANCER SOC, V113, P750, DOI 10.1002/cncr.23615
   Ebersole JL, 2013, J CLIN IMMUNOL, V33, P271, DOI 10.1007/s10875-012-9771-3
   EDGAR WM, 1992, BRIT DENT J, V172, P305, DOI 10.1038/sj.bdj.4807861
   El-Naggar AK, 2001, J MOL DIAGN, V3, P164, DOI 10.1016/S1525-1578(10)60668-X
   Elashoff D, 2012, CANCER EPIDEM BIOMAR, V21, P664, DOI 10.1158/1055-9965.EPI-11-1093
   Ellias MF, 2012, SCI WORLD J, DOI 10.1100/2012/647240
   Faccini-Martinez AA, 2016, J INFECT PUBLIC HEAL, V9, P687, DOI 10.1016/j.jiph.2016.01.001
   Falcao DP, 2013, REV BRAS REUMATOL, V53, P525, DOI [10.1016/j.rbr.2013.03.001, 10.1016/j.rbre.2013.03.001]
   Farnaud SJC, 2010, THESCIENTIFICWORLDJO, V10, P434, DOI 10.1100/tsw.2010.38
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Feller L L J, 2012, J CANC THERAPY, V3, P263, DOI DOI 10.4236/JCT.2012.34037
   Fliss MS, 2000, SCIENCE, V287, P2017, DOI 10.1126/science.287.5460.2017
   Flores IL, 2016, WORLD J CLIN CASES, V4, P356, DOI 10.12998/wjcc.v4.i11.356
   FOX RI, 1986, J IMMUNOL, V137, P3162
   Franzmann EJ, 2007, CANCER EPIDEM BIOMAR, V16, P1348, DOI 10.1158/1055-9965.EPI-06-0011
   Garde AH, 2005, SCAND J CLIN LAB INV, V65, P433, DOI 10.1080/00365510510025773
   Goncalves LD, 2010, J PROTEOMICS, V73, P1334, DOI 10.1016/j.jprot.2010.02.018
   Graamans K., 1991, DIAGNOSIS SALIVARY G, DOI [10.1007/978-94-011-3608-2, DOI 10.1007/978-94-011-3608-2]
   Groschl M, 2006, STEROIDS, V71, P1097, DOI 10.1016/j.steroids.2006.09.007
   Grover Harpreet Singh, 2013, Int J Proteomics, V2013, P850235, DOI 10.1155/2013/850235
   Gyawali N, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0132-y
   Henson BS, 2010, METHODS MOL BIOL, V666, P21, DOI 10.1007/978-1-60761-820-1_2
   Hermida M, 2002, J VIROL METHODS, V101, P29, DOI 10.1016/S0166-0934(01)00417-7
   Hodinka RL, 1998, CLIN DIAGN LAB IMMUN, V5, P419, DOI 10.1128/CDLI.5.4.419-426.1998
   Hoek GH, 2002, EUR J ORAL SCI, V110, P480, DOI 10.1034/j.1600-0722.2002.21370.x
   Hofman LF, 2001, J NUTR, V131, p1621S
   Hu S, 2008, CLIN CANCER RES, V14, P6246, DOI 10.1158/1078-0432.CCR-07-5037
   Hu Shen, 2007, Cancer Genomics & Proteomics, V4, P55
   Hu S, 2006, PROTEOMICS, V6, P6326, DOI 10.1002/pmic.200600284
   Hu ZZ, 2008, CLIN CHEM, V54, P824, DOI 10.1373/clinchem.2007.096164
   Humphrey SP, 2001, J PROSTHET DENT, V85, P162, DOI 10.1067/mpr.2001.113778
   Idle JR, 2007, CELL METAB, V6, P348, DOI 10.1016/j.cmet.2007.10.005
   Ishikawa S, 2016, SCI REP-UK, V6, DOI 10.1038/srep31520
   Jagr M, 2014, PHYSIOL RES, V63, pS141
   Jiang J, 2009, ARCH ORAL BIOL, V54, P268, DOI 10.1016/j.archoralbio.2008.10.004
   Jiang WW, 2005, CLIN CANCER RES, V11, P2486, DOI 10.1158/1078-0432.CCR-04-2147
   Jou YJ, 2011, CLIN CHIM ACTA, V412, P1357, DOI 10.1016/j.cca.2011.04.004
   Jou YJ, 2010, ANAL CHIM ACTA, V681, P41, DOI 10.1016/j.aca.2010.09.030
   Kantola S, 2000, BRIT J CANCER, V83, P614, DOI 10.1054/bjoc.2000.1323
   Katakura Akira, 2007, Bull Tokyo Dent Coll, V48, P199, DOI 10.2209/tdcpublication.48.199
   Khan RS, 2017, DIAGNOSTICS, V7, DOI 10.3390/diagnostics7030039
   Khan RS, 2016, PROTEOMES, V4, DOI 10.3390/proteomes4040041
   Khurshid S. Z. Zohaib, 2015, DENT SCI, V2, P260, DOI [10.1016/j.jobcr.2015.08.006.in, DOI 10.1016/J.JOBCR.2015.08.006.IN]
   Khurshid Z., 2016, J PAK DENT ASS, V25, P170
   Khurshid Z, 2017, SAUDI PHARM J, V25, P25, DOI 10.1016/j.jsps.2016.04.027
   Khurshid Z, 2016, SAUDI PHARM J, V24, P515, DOI 10.1016/j.jsps.2015.02.015
   Khurshid Z, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060846
   Kooren Joel A, 2011, Clin Proteomics, V8, P13, DOI 10.1186/1559-0275-8-13
   Krishna Prasad Ramnarayan Belur, 2013, Dent Res J (Isfahan), V10, P287
   Kumar M, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-014-0369-9
   KUTSCHER AH, 1967, J ORAL THER PHARMACO, V3, P391
   Kwok M. M., 2015, IJOHNS, P180
   Lee YH, 2011, CLIN CHEM, V57, P1295, DOI 10.1373/clinchem.2010.159210
   Li Y, 2004, CLIN CANCER RES, V10, P8442, DOI 10.1158/1078-0432.CCR-04-1167
   Liao PH, 2000, ORAL ONCOL, V36, P272, DOI 10.1016/S1368-8375(00)00005-1
   Liu CJ, 2012, HEAD NECK-J SCI SPEC, V34, P219, DOI 10.1002/hed.21713
   Carvalho AL, 2011, CLIN CANCER RES, V17, P4782, DOI 10.1158/1078-0432.CCR-11-0324
   Lu YC, 1997, J IMMUNOASSAY, V18, P149, DOI 10.1080/01971529708005810
   Mager DL, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-27
   Majem B, 2015, INT J MOL SCI, V16, P8676, DOI 10.3390/ijms16048676
   Malamud Daniel, 1997, American Journal of Medicine, V102, P9, DOI 10.1016/S0002-9343(97)00032-6
   Mangum JE, 2005, PROTEOMICS, V5, P2542, DOI 10.1002/pmic.200401207
   Markopoulos AK, 2010, OPEN DENT J, V4, P172, DOI 10.2174/1874210601004010172
   Martins C, 2013, J DENT, V41, P2, DOI 10.1016/j.jdent.2012.10.015
   Mussi MCM, 2016, SPEC CARE DENT, V36, P265, DOI 10.1111/scd.12175
   Meenu S., 2014, SALIVARY BIOMARKERS, V5, P1
   Messana I, 2015, J PROTEOME RES, V14, P1666, DOI 10.1021/pr501270x
   Mishra Minati, 2005, Indian J Dermatol Venereol Leprol, V71, P161
   Morris M, 2002, J IMMUNOL METHODS, V266, P111, DOI 10.1016/S0022-1759(02)00114-X
   Moulin E, 2016, New Microbes New Infect, V11, P6, DOI 10.1016/j.nmni.2016.02.003
   Mumcu G, 2012, ARCH ORAL BIOL, V57, P642, DOI 10.1016/j.archoralbio.2011.11.003
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Nagler R, 2006, CLIN CANCER RES, V12, P3979, DOI 10.1158/1078-0432.CCR-05-2412
   Nagler RM, 2009, ORAL ONCOL, V45, P1006, DOI 10.1016/j.oraloncology.2009.07.005
   Nakahara Y, 2006, INT J ORAL MAX SURG, V35, P362, DOI 10.1016/j.ijom.2005.08.005
   Nasidze I, 2009, ANAL BIOCHEM, V391, P64, DOI 10.1016/j.ab.2009.04.034
   Ng V, 2003, CLIN CHIM ACTA, V338, P131, DOI 10.1016/j.cccn.2003.08.012
   Nurkka A, 2003, CLIN DIAGN LAB IMMUN, V10, P357, DOI 10.1128/CDLI.10.3.357-361.2003
   Park N. J., SALIVARY MICRORNA DI, DOI [10.1158/1078-0432.CCR-09-0736, DOI 10.1158/1078-0432.CCR-09-0736]
   Park NJ, 2009, CLIN CANCER RES, V15, P5473, DOI 10.1158/1078-0432.CCR-09-0736
   Partridge M, 2000, CANCER RES, V60, P3893
   Pickering V, 2007, ORAL ONCOL, V43, P37, DOI 10.1016/j.oraloncology.2005.12.027
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Preza D., 2009, ACTA ODONTOL SCAND, DOI [10.1080/00016350902751545?journalcode=iode20, DOI 10.1080/00016350902751545?J0URNAL]
   Rabilloud T, 2011, J PROTEOMICS, V74, P1829, DOI 10.1016/j.jprot.2011.05.040
   Radhika T, 2016, J Oral Biol Craniofac Res, V6, pS51
   Reddy I, 2012, J ORAL SCI, V54, P279, DOI 10.2334/josnusd.54.279
   Rehan F., 2016, J PAK DENT ASS, V25, P158
   Rhodus NL, 2004, CANCER DETECT PREV, V29, P42, DOI 10.1016/j.cdp.2004.10.003
   Righini CA, 2007, CLIN CANCER RES, V13, P1179, DOI 10.1158/1078-0432.CCR-06-2027
   Roa Nelly S, 2008, Acta Odontol Latinoam, V21, P69
   Roberts Lee D, 2012, Curr Protoc Mol Biol, VChapter 30, DOI 10.1002/0471142727.mb3002s98
   Rosas SLB, 2001, CANCER RES, V61, P939
   Rosin MP, 2000, CLIN CANCER RES, V6, P357
   Rudney JD, 2009, ARCH ORAL BIOL, V54, P91, DOI 10.1016/j.archoralbio.2008.08.007
   Sahibzada HA, 2017, DIAGNOSTICS, V7, DOI 10.3390/diagnostics7020021
   Salazar MG, 2013, J CLIN PERIODONTOL, V40, P825, DOI 10.1111/jcpe.12130
   Saleh J, 2015, ARCH ORAL BIOL, V60, P242, DOI 10.1016/j.archoralbio.2014.10.004
   Sawant SS, 2008, ORAL ONCOL, V44, P722, DOI 10.1016/j.oraloncology.2007.10.008
   Schaaij-Visser TBM, 2010, J PROTEOMICS, V73, P1790, DOI 10.1016/j.jprot.2010.01.013
   Schapher M, 2009, CLIN CHEM, V55, P914, DOI 10.1373/clinchem.2008.116939
   Shah FD, 2011, INDIAN J CLIN BIOCHE, V26, P326, DOI 10.1007/s12291-011-0149-8
   Shintani S, 2010, INT J ORAL MAX SURG, V39, P68, DOI 10.1016/j.ijom.2009.10.001
   Shpitzer T, 2009, BRIT J CANCER, V101, P1194, DOI 10.1038/sj.bjc.6605290
   Shpitzer T, 2007, J CANCER RES CLIN, V133, P613, DOI 10.1007/s00432-007-0207-z
   Sidransky D, 1997, SCIENCE, V278, P1054, DOI 10.1126/science.278.5340.1054
   Siudikiene J, 2008, CARIES RES, V42, P354, DOI 10.1159/000151582
   Slavkin H C, 2011, Adv Dent Res, V23, P381, DOI 10.1177/0022034511420435
   Slots J, 2006, J PERIODONTAL RES, V41, P235, DOI 10.1111/j.1600-0765.2006.00865.x
   Slowey PD, 2015, ADV SALIVARY DIAGNOS, V7015, P33, DOI [DOI 10.1007/978-3-662-45399-5_3, 10.1007/978-3-662-45399-5_3]
   Sreebny LM, 2000, INT DENT J, V50, P140, DOI 10.1111/j.1875-595X.2000.tb00554.x
   St John MAR, 2004, ARCH OTOLARYNGOL, V130, P929, DOI 10.1001/archotol.130.8.929
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   STEPHEN KW, 1976, BRIT J CLIN PHARMACO, V3, P315, DOI 10.1111/j.1365-2125.1976.tb00609.x
   Stewart K., USE SALIVARY PROTEOM, V9, P100
   Streckfus C, 2000, CANCER INVEST, V18, P101, DOI 10.3109/07357900009038240
   Streckfus CF, 2007, EXPERT REV PROTEOMIC, V4, P329, DOI 10.1586/14789450.4.3.329
   Sugimoto M, 2010, METABOLOMICS, V6, P78, DOI 10.1007/s11306-009-0178-y
   Szabo GT, 2012, CLEFT PALATE-CRAN J, V49, P519, DOI 10.1597/10-135
   Tabak LA, 2004, J DENT RES, V83, P196, DOI 10.1177/154405910408300301
   Tang HK, 2013, MOL MED REP, V7, P761, DOI 10.3892/mmr.2012.1254
   TATEISHI K, 1994, J ORAL PATHOL MED, V23, P80, DOI 10.1111/j.1600-0714.1994.tb00261.x
   TRUELOVE EL, 1967, J DENT RES, V46, P1400, DOI 10.1177/00220345670460064301
   Vajaria BN, 2013, OR SURG OR MED OR PA, V115, P764, DOI 10.1016/j.oooo.2013.01.004
   Viet C T, 2007, J Calif Dent Assoc, V35, P844
   Viet CT, 2008, CANCER EPIDEM BIOMAR, V17, P3603, DOI 10.1158/1055-9965.EPI-08-0507
   Vitorino R, 2006, EUR J ORAL SCI, V114, P147, DOI 10.1111/j.1600-0722.2006.00328.x
   Vucicevic Boras V, 2005, Minerva Stomatol, V54, P569
   Wang L, 2017, BIOSENS BIOELECTRON, V89, P136, DOI 10.1016/j.bios.2016.06.011
   Wang QH, 2014, CLIN CHIM ACTA, V427, P79, DOI 10.1016/j.cca.2013.10.004
   Wei JE, 2011, INT J CANCER, V129, P2207, DOI 10.1002/ijc.25881
   Whembolua GLS, 2006, HORM BEHAV, V49, P478, DOI 10.1016/j.yhbeh.2005.10.005
   Wolff A, 1997, J DENT RES, V76, P1782, DOI 10.1177/00220345970760111001
   Wong DT, 2006, J AM DENT ASSOC, V137, P313, DOI 10.14219/jada.archive.2006.0180
   Wu JY, 2010, ORAL ONCOL, V46, P226, DOI 10.1016/j.oraloncology.2010.01.007
   Wu ZZ, 2009, WORLD J GASTROENTERO, V15, P865, DOI 10.3748/wjg.15.865
   Wulfkuhle JD, 2003, NAT REV CANCER, V3, P267, DOI 10.1038/nrc1043
   Yakob Maha, 2014, Curr Oral Health Rep, V1, P133
   Yang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095389
   Zhang AH, 2013, CLIN CHIM ACTA, V415, P261, DOI 10.1016/j.cca.2012.11.001
   Zhang JN, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-63
   Zhang JN, 2012, BIOCHEM BIOPH RES CO, V421, P844, DOI 10.1016/j.bbrc.2012.04.100
   Zhang L, 2001, J ORAL PATHOL MED, V30, P513, DOI 10.1034/j.1600-0714.2001.300901.x
   Zhang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015573
   Zhang Y., PROTEOMIC N GLYCOPRO, P1, DOI [10.1002/pmic.201600127.This, DOI 10.1002/PMIC.201600127.THIS]
   Zhong Lai-Ping, 2008, Shanghai Kou Qiang Yi Xue, V17, P457
   Zhong LP, 2005, INT J ORAL MAX SURG, V34, P566, DOI 10.1016/j.ijom.2004.10.007
   Zimmermann BG, 2007, ANN NY ACAD SCI, V1098, P184, DOI 10.1196/annals.1384.002
NR 194
TC 15
Z9 16
U1 5
U2 20
PU ELSEVIER ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0065-2423
BN 978-0-12-815204-1
J9 ADV CLIN CHEM
JI Advan. Clin. Chem.
PY 2018
VL 86
BP 23
EP 70
DI 10.1016/bs.acc.2018.05.002
PG 48
WC Medical Laboratory Technology
SC Medical Laboratory Technology
GA BL6ED
UT WOS:000453661400003
PM 30144841
DA 2020-07-08
ER

PT J
AU Carneiro, WA
AF Carneiro, Walber Araujo
TI FUNDAMENTAL RIGHTS OF PERIPHERAL CONSTITUTIONS: A NEW THEORETICAL
   APPROACH AND THE ZIKA VIRUS IN BRAZIL
SO BRICS LAW JOURNAL
LA English
DT Article
DE fundamental rights; constitutional law; balance; systems theory; Zika
   virus
AB This essay proposes a new theoretical model directed towards the observation of fundamental rights present in the Constitutions of peripheral States. Parting from a critical revision of classic perspectives oriented by the dogmatic affirmation of fundamental rights and the institutional tradition derived from sociological observation, these rights perform a dual function. They are responsible for the structuring of normative expectations and, at the same time, they construct internal dogmatic limits within the system. Through the contributions of phenomenology and social systems theory, this model suggests autonomous spheres of fundamentality in contrast to the classical unity of fundamental rights. Furthermore, the balancing schemes are substituted for an internal "law of collision." Conflict resolution undergoes a shift from the traditional method to the system's reflexive pragmatics, contributing to the legal security and the democratic legitimacy of judicial review. Finally, it verifies how this theory could be applied to the advent of the Zika virus which affected Brazil from 2015 to 2017. As the Zika virus crisis involves different spheres of fundamentality, entailing a range of systems of law and therefore revealing different collision patterns, this essay demonstrates how this new approach could contribute to the control of solutions.
C1 [Carneiro, Walber Araujo] Univ Fed Bahia, Law Sch, Legal Theory & Philosophy Law, Rua Paz S-N, BR-40150140 Salvador, BA, Brazil.
RP Carneiro, WA (corresponding author), Univ Fed Bahia, Law Sch, Legal Theory & Philosophy Law, Rua Paz S-N, BR-40150140 Salvador, BA, Brazil.
EM walber.carneiro@gmail.com
CR ALEINIKOFF TA, 1987, YALE LAW J, V96, P943, DOI 10.2307/796529
   ALEXY Robert, 2008, TEORIA DIREITOS FUND
   Carneiro W. A., 2011, HERMENEUTICA JURIDIC
   CLAM Jean, 2006, QUESTOES FUNDAMENTAI
   Dworkin R., 2007, O IMPERIO DO DIREITO
   Fisher-Lescano A, 2004, MICHIGAN J INT LAW, V25, P999
   Gadamer H. - G, 2000, RETROSPECTIVA DIALOG, V203
   Galindo Monteagudo J., 2007, SOC SOC
   Hanzlik E, 2017, CHILDREN-BASEL, V4, DOI 10.3390/children4060047
   Heidegger M., 2004, LOGICA PREGUNTA VERD
   Hesse K., 2009, SIGNIFICADO DIREITOS
   HESSE Konrad, 1998, ELEMENTOS DIREITO CO
   Husserl E., 1973, EXPERIENCE JUDGMENT
   Ladeur K. - H, 1992, POSTMODERNE RECHTSTH
   Ladeur K. - H., 2016, CRITICA PONDERACAO M, V97
   Luhmann N., 2007, SOC SOC
   Luhmann N., 1991, SISTEMAS SOCIALES LI
   Luhmann N., 2010, DERECHOS FUNDAMENTAL
   Muller F., 1984, STRUKTURIERENDE RECH
   Neves Marcelo, 2007, CONSTITUCIONALIZACAO
   NEVES Marcelo, 2013, ENTRE HIDRA HERCULES
   Panikkar R., 1975, MONCHANIN, V8, P12
   SANTOS Boaventura de Sousa, 2003, REV CRITICA CIENCIAS, V65, P3
   Smend R., 1928, VERFASSUNG VERFASSUN
   Soliano V., 2016, JURISDICAO CONSTITUC
   Stichweh R., 2017, WELTGESELLSCHAFT BON, V549
   Teubner G., 1989, DIREITO COMO SISTEMA
   Teubner G., 2012, VERFASSUNGSFRAGMENTE
   WALZER M, 1983, SPHERES JUSTICE DEFE
NR 29
TC 0
Z9 0
U1 0
U2 1
PU LLC V EM PUBLISHING HOUSE
PI MOSCOW
PA UL LOBACHEVSKOGO, 92, KORPUS 2, MOSCOW, 119454, RUSSIA
SN 2409-9058
EI 2412-2343
J9 BRICS LAW J
JI BRICS Law J.
PY 2018
VL 5
IS 4
BP 61
EP 89
DI 10.21684/2412-2343-2018-5-4-61-89
PG 29
WC Law
SC Government & Law
GA HE4LA
UT WOS:000453336800003
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU dos Santos, BMC
   Coelho, FC
   Armstrong, M
   Saraceni, V
   Lemos, C
AF Coimbra dos Santos, Beatriz Macedo
   Coelho, Flavio Codeco
   Armstrong, Margaret
   Saraceni, Valeria
   Lemos, Cristina
TI Zika: an ongoing threat to women and infants
SO CADERNOS DE SAUDE PUBLICA
LA English
DT Article
DE Zika Virus; Women; Child; Incidence
ID SEXUAL TRANSMISSION; VIRUS; BRAZIL
AB Recent data from the municipality of Rio de Janeiro, Brazil, shows a sharp drop in the number of reported occurrences of Zika during the summer of 2016/2017 compared to the previous summer. There is still a much higher incidence among women than men, almost certainly due to sexual transmission. An unexpected feature of the new data is that there are proportionally far more cases affecting children under 15 months than older age classes. By comparing incidence rates in 2016/2017 and 2015/2016, we were able to deduce the proportion of reported cases affecting men and women, and verify that gender disparity is still present. Women and children are still risk groups for Zika infection, even during non-epidemic seasons.
C1 [Coimbra dos Santos, Beatriz Macedo; Coelho, Flavio Codeco; Armstrong, Margaret] Fundacao Getulio Vargas, Praia Botafogo 190, BR-22250900 Rio De Janeiro, RJ, Brazil.
   [Saraceni, Valeria; Lemos, Cristina] Secretaria Municipal Saude, Rio De Janeiro, Brazil.
RP dos Santos, BMC (corresponding author), Fundacao Getulio Vargas, Praia Botafogo 190, BR-22250900 Rio De Janeiro, RJ, Brazil.
EM beatrizmcoimbra@outlook.com
CR Bastos Maria do Ceu, 2018, THESIS
   Codeco C, 2016, BIORXIV
   Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023
   Cohen J, 2017, SCIENCE, V357, P631, DOI 10.1126/science.357.6352.631
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Freour T., 2016, EURO SURVEILL, V21
   Guerra-Silveira F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062390
   Hamer DH, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0571-z
   Maxian O, 2017, EPIDEMICS-NETH, V21, P48, DOI 10.1016/j.epidem.2017.06.003
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Pacheco O, 2016, N ENGL J MED
   Possas C, 2017, MEM I OSWALDO CRUZ, V112, P319, DOI 10.1590/0074-02760160510
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
NR 14
TC 2
Z9 2
U1 0
U2 0
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PY 2018
VL 34
IS 11
AR e00038218
DI 10.1590/0102-311X00038218
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA HF0TG
UT WOS:000453875600001
PM 30427409
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU dos Santos, BMC
   Coelho, FC
   Armstrong, M
   Saraceni, V
   Lemos, C
AF Coimbra dos Santos, Beatriz Macedo
   Coelho, Flavio Codeco
   Armstrong, Margaret
   Saraceni, Valeria
   Lemos, Cristina
TI Reply to commentary on Zika: An Ongoing Threat to Women and Infants
SO CADERNOS DE SAUDE PUBLICA
LA English
DT Editorial Material
C1 [Coimbra dos Santos, Beatriz Macedo; Coelho, Flavio Codeco; Armstrong, Margaret] Fundacao Getulio Vargas, Praia Botafogo 190, BR-22250900 Rio De Janeiro, RJ, Brazil.
   [Saraceni, Valeria; Lemos, Cristina] Secretaria Municipal Saude, Rio De Janeiro, Brazil.
RP dos Santos, BMC (corresponding author), Fundacao Getulio Vargas, Praia Botafogo 190, BR-22250900 Rio De Janeiro, RJ, Brazil.
EM beatrizmcoimbra@outlook.com
CR Balmaseda A, 2010, J INFECT DIS, V201, P5, DOI 10.1086/648592
   Barros AC, 2018, 347104 BIORXIV, DOI [10.1101/347104, DOI 10.1101/347104]
   de Azevedo MB, 2018, REV SOC BRAS MED TRO, V51, P347, DOI 10.1590/0037-8682-0327-2017
NR 3
TC 0
Z9 0
U1 0
U2 0
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PY 2018
VL 34
IS 11
AR e00192318
DI 10.1590/0102-311X00192318
PG 2
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA HF0UN
UT WOS:000453879300001
PM 30427419
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Villela, DAM
AF Maciel Villela, Daniel Antunes
TI Commentary on Zika: An Ongoing Threat to Women and Infants
SO CADERNOS DE SAUDE PUBLICA
LA English
DT Editorial Material
C1 [Maciel Villela, Daniel Antunes] Fundacao Oswaldo Cruz, Programa Comp Cient, Av Brasil 4365, BR-21040360 Rio De Janeiro, Brazil.
RP Villela, DAM (corresponding author), Fundacao Oswaldo Cruz, Programa Comp Cient, Av Brasil 4365, BR-21040360 Rio De Janeiro, Brazil.
EM daniel.villela@fiocruz.br
RI Villela, Daniel/AAG-6445-2019
OI Villela, Daniel/0000-0001-8371-2959
CR Freour T., 2016, EURO SURVEILL, V21
   Guerra-Silveira F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062390
   Santos BMC, 2018, CAD SAUDE PUBLICA, V34
NR 3
TC 0
Z9 0
U1 0
U2 0
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PY 2018
VL 34
IS 11
AR e00183018
DI 10.1590/0102-311X00183018
PG 2
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA HF0UI
UT WOS:000453878800001
PM 30427418
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT S
AU Voigt, A
   Semenova, T
   Yamamoto, J
   Etienne, V
   Nguyen, CQ
AF Voigt, Alexandria
   Semenova, Touyana
   Yamamoto, Janet
   Etienne, Veronique
   Nguyen, Cuong Q.
BE Gu, J
   Wang, X
TI Therapeutic Antibody Discovery in Infectious Diseases Using Single-Cell
   Analysis
SO SINGLE CELL BIOMEDICINE
SE Advances in Experimental Medicine and Biology
LA English
DT Article; Book Chapter
DE Single cell; Monoclonal antibodies; Hybridoma; Flow cytometry;
   Infectious diseases
ID BROADLY NEUTRALIZING ANTIBODY; HUMAN MONOCLONAL-ANTIBODIES; MUCOSAL SHIV
   CHALLENGE; ZIKA VIRUS-INFECTION; HUMAN B-CELLS; PHAGE DISPLAY; PASSIVE
   TRANSFER; RAPID SELECTION; GENERATION; HIV
AB Since the discovery of mouse hybridoma technology by Kohler and Milstein in 1975, significant progress has been made in monoclonal antibody production. Advances in B cell immortalization and phage display technologies have generated a myriad of valuable monoclonal antibodies for diagnosis and treatment. Technological breakthroughs in various fields of 'omics have shed crucial insights into cellular heterogeneity of a biological system in which the functional individuality of a single cell must be considered. Based on this important concept, remarkable discoveries in single-cell analysis have made in identifying and isolating functional B cells that produce beneficial therapeutic monoclonal antibodies. In this review, we will discuss three traditional methods of antibody discovery. Recent technological platforms for single-cell antibody discovery will be reviewed. We will discuss the application of the single-cell analysis in finding therapeutic antibodies for human immunodeficiency virus and emerging Zika arbovirus.
C1 [Voigt, Alexandria; Semenova, Touyana; Yamamoto, Janet; Etienne, Veronique; Nguyen, Cuong Q.] Univ Florida, Coll Vet Med, Dept Infect Dis & Pathol, Gainesville, FL 32611 USA.
   [Nguyen, Cuong Q.] Univ Florida, Coll Dent, Dept Oral Biol, Gainesville, FL 32610 USA.
   [Nguyen, Cuong Q.] Univ Florida, Ctr Orphaned Autoimmune Dis, Gainesville, FL 32611 USA.
RP Nguyen, CQ (corresponding author), Univ Florida, Coll Vet Med, Dept Infect Dis & Pathol, Gainesville, FL 32611 USA.; Nguyen, CQ (corresponding author), Univ Florida, Coll Dent, Dept Oral Biol, Gainesville, FL 32610 USA.; Nguyen, CQ (corresponding author), Univ Florida, Ctr Orphaned Autoimmune Dis, Gainesville, FL 32611 USA.
EM nguyenc@ufl.edu
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R21 AI130561]
CR Aggarwal S, 2012, NAT BIOTECHNOL, V30, P1191, DOI 10.1038/nbt.2437
   Ahmad M, 2017, ANNU REV VIROL, DOI [10.1146/ANNUREV-VIROLOGY-101416-041929, DOI 10.1146/ANNUREV-VIR0L0GY-101416-041929]
   Andris-Widhopf J, 2000, J IMMUNOL METHODS, V242, P159, DOI 10.1016/S0022-1759(00)00221-0
   Araujo AQC, 2016, BRAIN, V139, P2122, DOI 10.1093/brain/aww158
   Ayat H, 2013, BIOLOGICALS, V41, P345, DOI 10.1016/j.biologicals.2013.05.004
   Baba TW, 2000, NAT MED, V6, P200
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Bonsignori M, 2012, J VIROL, V86, P4688, DOI 10.1128/JVI.07163-11
   Brady JM, 2017, IMMUNOL REV, V275, P324, DOI 10.1111/imr.12478
   Braunagel M, 1997, NUCLEIC ACIDS RES, V25, P4690, DOI 10.1093/nar/25.22.4690
   Brekke OH, 2003, NAT REV DRUG DISCOV, V2, P52, DOI 10.1038/nrd984
   Caskey M, 2015, NATURE, V522, P487, DOI 10.1038/nature14411
   Cheong R, 2010, EXPERT OPIN DRUG DIS, V5, P715, DOI 10.1517/17460441.2010.495116
   Chiem NH, 1998, CLIN CHEM, V44, P591
   Christensen PA, 2009, SCAND J IMMUNOL, V69, P1, DOI 10.1111/j.1365-3083.2008.02164.x
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Deal CE, 2015, CURR OPIN HIV AIDS, V10, P190, DOI 10.1097/COH.0000000000000145
   DEKRUIF J, 1995, P NATL ACAD SCI USA, V92, P3938, DOI 10.1073/pnas.92.9.3938
   Dias-Neto E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008338
   Ecker DM, 2015, MABS-AUSTIN, V7, P9, DOI 10.4161/19420862.2015.989042
   Esfandiary L, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1010-5
   Fitzgerald V, 2017, METHODS, V116, P34, DOI 10.1016/j.ymeth.2016.11.006
   Frontera JA, 2016, NEW ENGL J MED, V375, P1581, DOI 10.1056/NEJMe1611840
   Fujii R, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh147
   Fukushi S, 2012, J VIROL METHODS, V180, P68, DOI 10.1016/j.jviromet.2011.12.013
   FULWYLER MJ, 1965, SCIENCE, V150, P910, DOI 10.1126/science.150.3698.910
   Gautam R, 2016, NATURE, V533, P105, DOI 10.1038/nature17677
   GOLDSTEIN G, 1985, NEW ENGL J MED, V313, P337
   Goodman M, 2009, NAT REV DRUG DISCOV, V8, P837, DOI 10.1038/nrd3040
   Hammers CM, 2014, J INVEST DERMATOL, V134, DOI 10.1038/jid.2013.521
   Hansel TT, 2010, NAT REV DRUG DISCOV, V9, P325, DOI 10.1038/nrd3003
   Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974
   Ho IY, 2016, J IMMUNOL METHODS, V438, P67, DOI 10.1016/j.jim.2016.09.001
   Holland EG, 2013, J IMMUNOL METHODS, V394, P55, DOI 10.1016/j.jim.2013.05.003
   JONES PT, 1986, NATURE, V321, P522, DOI 10.1038/321522a0
   Klein F, 2013, SCIENCE, V341, P1199, DOI 10.1126/science.1241144
   Klein F, 2012, J EXP MED, V209, P1469, DOI 10.1084/jem.20120423
   KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0
   Kuppers R, 2003, NAT REV IMMUNOL, V3, P801, DOI 10.1038/nri1201
   Lelievre JD, 2016, J VIRUS ERAD, V2, P5
   Lim BN, 2014, BIOTECHNOL LETT, V36, P2381, DOI 10.1007/s10529-014-1635-x
   Love JC, 2006, NAT BIOTECHNOL, V24, P703, DOI 10.1038/nbt1210
   Love KR, 2013, TRENDS BIOTECHNOL, V31, P16, DOI 10.1016/j.tibtech.2013.03.001
   Low NM, 1996, J MOL BIOL, V260, P359, DOI 10.1006/jmbi.1996.0406
   Mahy M, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1291169
   Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999
   McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696
   Miersch S, 2012, METHODS, V57, P486, DOI 10.1016/j.ymeth.2012.06.012
   Moldt B, 2012, P NATL ACAD SCI USA, V109, P18921, DOI 10.1073/pnas.1214785109
   Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385
   Nemes P, 2011, ANAL CHEM, V83, P6810, DOI 10.1021/ac2015855
   Nguyen CQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058127
   Oehler E, 2014, EUROSURVEILLANCE, V19, P4
   Ogunniyi AO, 2014, VACCINE, V32, P2866, DOI 10.1016/j.vaccine.2014.02.020
   Ogunniyi AO, 2009, NAT PROTOC, V4, P767, DOI 10.1038/nprot.2009.40
   Pansri P, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-6
   Poorolajal J, 2016, PUBLIC HEALTH, V139, P3, DOI 10.1016/j.puhe.2016.05.004
   Ravn U, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq789
   Reagan-Steiner S, 2017, MMWR-MORBID MORTAL W, V66, P636, DOI 10.15585/mmwr.mm6624a3
   Reichert JM, 2005, NAT BIOTECHNOL, V23, P1073, DOI 10.1038/nbt0905-1073
   Reichert JM, 2001, NAT BIOTECHNOL, V19, P819, DOI 10.1038/nbt0901-819
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Ronan JL, 2009, J IMMUNOL METHODS, V340, P164, DOI 10.1016/j.jim.2008.10.018
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Saunders KO, 2015, J VIROL, V89, P5895, DOI 10.1128/JVI.00210-15
   Sblattero D, 2000, NAT BIOTECHNOL, V18, P75
   Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227
   Scheid JF, 2009, J IMMUNOL METHODS, V343, P65, DOI 10.1016/j.jim.2008.11.012
   Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930
   Schirrmann T, 2011, MOLECULES, V16, P412, DOI 10.3390/molecules16010412
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shingai M, 2014, J EXP MED, V211, P2061, DOI 10.1084/jem.20132494
   SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944
   Smith K, 2009, NAT PROTOC, V4, P372, DOI 10.1038/nprot.2009.3
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   SUN LK, 1987, P NATL ACAD SCI USA, V84, P214, DOI 10.1073/pnas.84.1.214
   't Hoen PAC, 2012, ANAL BIOCHEM, V421, P622, DOI 10.1016/j.ab.2011.11.005
   Thie H, 2008, CURR PHARM BIOTECHNO, V9, P439, DOI 10.2174/138920108786786349
   Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017
   Tsioris K, 2015, INTEGR BIOL-UK, V7, P1587, DOI [10.1039/c5ib00169b, 10.1039/C5IB00169B]
   Turunen L, 2009, J BIOMOL SCREEN, V14, P282, DOI 10.1177/1087057108330113
   Urban PL, 2011, MOL BIOSYST, V7, P2837, DOI 10.1039/c1mb05248a
   Vaughan TJ, 1996, NAT BIOTECHNOL, V14, P309, DOI 10.1038/nbt0396-309
   Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373
   Wang S, 2011, ANTIBODY TECHNOL J, V2011, P4, DOI [10.2147/ANTI.S20195, DOI 10.2147/ANTI.S20195]
   Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907
   Wheeler AR, 2003, ANAL CHEM, V75, P3581, DOI 10.1021/ac0340758
   Willats WGT, 1999, PLANT J, V18, P57, DOI 10.1046/j.1365-313X.1999.00427.x
   Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532
   Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659
   Yamashita M, 2007, CYTOTECHNOLOGY, V55, P55, DOI 10.1007/s10616-007-9072-5
   Yang M, 2017, VACCINE, V35, P4287, DOI 10.1016/j.vaccine.2017.04.052
   Zhang S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13679
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 94
TC 3
Z9 3
U1 3
U2 8
PU SPRINGER-VERLAG SINGAPORE PTE LTD
PI SINGAPORE
PA 152 BEACH ROAD, #21-01/04 GATEWAY EAST, SINGAPORE, 189721, SINGAPORE
SN 0065-2598
EI 2214-8019
BN 978-981-13-0502-3; 978-981-13-0501-6
J9 ADV EXP MED BIOL
JI Adv.Exp.Med.Biol.
PY 2018
VL 1068
BP 89
EP 102
DI 10.1007/978-981-13-0502-3_8
D2 10.1007/978-981-13-0502-3
PG 14
WC Biology; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; Research & Experimental
   Medicine
GA BL6HD
UT WOS:000453888200008
PM 29943298
DA 2020-07-08
ER

PT S
AU Chen, Q
AF Chen, Qiang
BE Kuntz, M
TI Recombinant Therapeutic Molecules Produced in Plants
SO TRANSGENIC PLANTS AND BEYOND
SE Advances in Botanical Research
LA English
DT Review; Book Chapter
ID VIRUS-LIKE PARTICLES; WEST NILE VIRUS; ANTIBODY-DEPENDENT ENHANCEMENT;
   ENZYME REPLACEMENT THERAPY; MONOCLONAL-ANTIBODIES; ZIKA VIRUS; IDIOTYPE
   VACCINES; IMMUNE-RESPONSES; RAPID PRODUCTION; VIRAL VECTORS
AB Research on the use of plants for production of protein-based therapeutics has increased tremendously since the initial experiments in the early 1990s. Plant-based expression systems offer several production advantages of low cost, rapidity, scalability, and a significantly lower chance of contamination with prion or mammalian viruses. In addition, the capability of plants in producing homogeneous N-glycans allows the development of novel therapeutics with superior efficacy and safety to their mammalian cell-produced counterparts. Various plant species have been used to develop and produce vaccines, antibodies, and pharmaceutical enzymes against a myriad of diseases by multiple expression technologies. While most of these plant-made therapeutics are in preclinical development, many have progressed into human clinical study phases and several have been approved by regulatory agencies. The current status and recent advancement of plant-based expression systems and key clinical products will be presented in this chapter. The remaining challenges and future directions for the field of plant-made therapeutics will be discussed.
C1 [Chen, Qiang] Arizona State Univ, Sch Life Sci, Tempe, AZ 85281 USA.
   [Chen, Qiang] Arizona State Univ, Ctr Immunotherapy Vaccines & Canc Therapy, Tempe, AZ 85281 USA.
RP Chen, Q (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85281 USA.; Chen, Q (corresponding author), Arizona State Univ, Ctr Immunotherapy Vaccines & Canc Therapy, Tempe, AZ 85281 USA.
EM qiang.chen.4@asu.edu
OI chen, qiang/0000-0003-1498-7013
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Arntzen C, 2015, PLANT BIOTECHNOL J, V13, P1013, DOI 10.1111/pbi.12460
   Attar N., 2016, NAT REV MICROBIOL, V14, P62, DOI DOI 10.1038/NRMICR0.2015.28
   Ausar SF, 2006, J BIOL CHEM, V281, P19478, DOI 10.1074/jbc.M603313200
   Bendandi M, 2010, ANN ONCOL, V21, P2420, DOI 10.1093/annonc/mdq256
   Bethell D. R., 2007, GEN RECOGNIZED SAFE
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Check Hayden E. E., 2014, NATURE, DOI DOI 10.1038/NATURE.2014.15698
   Chen BJ, 2007, J VIROL, V81, P7111, DOI 10.1128/JVI.00361-07
   Chen Q., 2014, RECOMBINANT PROTEINS, V2
   Chen Q., 2013, MOL VACCINES, P153, DOI DOI 10.1007/978-3-7091-1419-3_8
   Chen Q., 2016, US patent # US, Patent No. [9499608 B2, 9499608]
   Chen Q., 2008, BIOL ENG, V1, P291, DOI DOI 10.13031/201326854
   Chen Q., 2009, NEW GENERATION VACCI, P306
   Chen Qiang, 2016, F1000Res, V5, DOI 10.12688/f1000research.8010.1
   Chen Q, 2016, P NATL ACAD SCI USA, V113, P9404, DOI 10.1073/pnas.1610803113
   Chen Q, 2016, METHODS MOL BIOL, V1385, P55, DOI 10.1007/978-1-4939-3289-4_4
   Chen Q, 2015, BIOTECHNOL J, V10, P671, DOI 10.1002/biot.201400428
   Chen Q, 2014, CABI BIOTECH SER, P42, DOI 10.1079/9781780643434.0042
   Chen Q, 2014, BIOMED RES INT, DOI 10.1155/2014/418064
   Chen Q, 2011, TRANSGENIC HORTICULTURAL CROPS: CHALLENGES AND OPPORTUNITIES, P83
   Chen Q, 2013, HUM VACC IMMUNOTHER, V9, P26, DOI 10.4161/hv.22218
   Chen Q, 2011, HUM VACCINES, V7, P331, DOI 10.4161/hv.7.3.14262
   Chen XL, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-9
   D'Aoust MA, 2010, PLANT BIOTECHNOL J, V8, P607, DOI 10.1111/j.1467-7652.2009.00496.x
   Daniell H, 1999, TRENDS PLANT SCI, V4, P467, DOI 10.1016/S1360-1385(99)01503-4
   Daniell Henry, 2006, Biotechnology Journal, V1, P1071, DOI 10.1002/biot.200600145
   Dent M, 2016, J GEN VIROL, V97, P3280, DOI 10.1099/jgv.0.000635
   Dugdale B, 2013, PLANT CELL, V25, P2429, DOI 10.1105/tpc.113.113944
   Fox J. L., 2012, Nature Biotechnology, V30, P472, DOI 10.1038/nbt0612-472
   Fulton A, 2015, J CHROMATOGR A, V1389, P128, DOI 10.1016/j.chroma.2015.02.013
   Giritch A, 2006, P NATL ACAD SCI USA, V103, P14701, DOI 10.1073/pnas.0606631103
   Gleba YY, 2014, CURR TOP MICROBIOL, V375, P155, DOI 10.1007/82_2013_352
   He JY, 2014, BIOMED RES INT, DOI 10.1155/2014/952865
   He JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093541
   He JY, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/106783
   He Y, 2011, P NATL ACAD SCI USA, V108, P19078, DOI 10.1073/pnas.1109736108
   Henao-Restrepo AM, 2017, LANCET, V389, P505, DOI 10.1016/S0140-6736(16)32621-6
   Herbst-Kralovetz M, 2010, EXPERT REV VACCINES, V9, P299, DOI 10.1586/ERV.09.163
   Hey C, 2012, CHEM ENG TECHNOL, V35, P142, DOI 10.1002/ceat.201100259
   Hiwasa-Tanase K, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00539
   Hjelm BE, 2014, HUM VACC IMMUNOTHER, V10, P410, DOI 10.4161/hv.27147
   Huang Z, 2010, BIOTECHNOL BIOENG, V106, P9, DOI 10.1002/bit.22652
   Huang Z, 2009, BIOTECHNOL BIOENG, V103, P706, DOI 10.1002/bit.22299
   KLEE H, 1987, ANNU REV PLANT PHYS, V38, P467, DOI 10.1146/annurev.pp.38.060187.002343
   Komarova TV, 2010, EXPERT REV VACCINES, V9, P859, DOI [10.1586/erv.10.85, 10.1586/ERV.10.85]
   Kwon KC, 2015, PLANT BIOTECHNOL J, V13, P1017, DOI 10.1111/pbi.12462
   Lai HF, 2014, PLANT BIOTECHNOL J, V12, P1098, DOI 10.1111/pbi.12217
   Lai HF, 2012, PLANT CELL REP, V31, P573, DOI 10.1007/s00299-011-1196-6
   Lai HF, 2012, PLANT BIOTECHNOL J, V10, P95, DOI 10.1111/j.1467-7652.2011.00649.x
   Lai HF, 2010, P NATL ACAD SCI USA, V107, P2419, DOI 10.1073/pnas.0914503107
   Lakshmi PS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054708
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Rivera AL, 2012, PHYS LIFE REV, V9, P308, DOI 10.1016/j.plrev.2012.06.002
   Leuzinger K, 2013, JOVE-J VIS EXP, DOI 10.3791/50521
   Lico C, 2008, J CELL PHYSIOL, V216, P366, DOI 10.1002/jcp.21423
   Loos A, 2014, P NATL ACAD SCI USA, V111, P6263, DOI 10.1073/pnas.1320544111
   Lyon GM, 2014, NEW ENGL J MED, V371, P2402, DOI 10.1056/NEJMoa1409838
   Ma JKC, 2015, PLANT BIOTECHNOL J, V13, P1106, DOI 10.1111/pbi.12416
   Maruyama N, 2014, J BIOSCI BIOENG, V118, P441, DOI 10.1016/j.jbiosc.2014.04.004
   McCormick AA, 2008, P NATL ACAD SCI USA, V105, P10131, DOI 10.1073/pnas.0803636105
   Morandini F, 2011, PLANT BIOTECHNOL J, V9, P911, DOI 10.1111/j.1467-7652.2011.00605.x
   MORENS DM, 1994, CLIN INFECT DIS, V19, P500, DOI 10.1093/clinids/19.3.500
   Olinger GG, 2012, P NATL ACAD SCI USA, V109, P18030, DOI 10.1073/pnas.1213709109
   Pardi N, 2017, METHODS MOL BIOL, V1499, P109, DOI 10.1007/978-1-4939-6481-9_6
   Phoolcharoen W, 2011, P NATL ACAD SCI USA, V108, P20695, DOI 10.1073/pnas.1117715108
   Phoolcharoen W, 2011, PLANT BIOTECHNOL J, V9, P807, DOI 10.1111/j.1467-7652.2011.00593.x
   Pogue GP, 2010, PLANT BIOTECHNOL J, V8, P638, DOI 10.1111/j.1467-7652.2009.00495.x
   Pushko P, 2000, VACCINE, V19, P142, DOI 10.1016/S0264-410X(00)00113-4
   Qiu XG, 2014, NATURE, V514, P47, DOI 10.1038/nature13777
   Ramessar K, 2008, P NATL ACAD SCI USA, V105, P3727, DOI 10.1073/pnas.0708841104
   Regnault A, 1999, J EXP MED, V189, P371, DOI 10.1084/jem.189.2.371
   Richardson JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005308
   Roque ACA, 2004, BIOTECHNOL PROGR, V20, P639, DOI 10.1021/bp030070k
   Santi L, 2008, VACCINE, V26, P1846, DOI 10.1016/j.vaccine.2008.01.053
   Santi L, 2006, METHODS, V40, P66, DOI 10.1016/j.ymeth.2006.05.020
   Schulz S, 2015, P NATL ACAD SCI USA, V112, pE5454, DOI 10.1073/pnas.1513311112
   Shaaltiel Y, 2015, PLANT BIOTECHNOL J, V13, P1033, DOI 10.1111/pbi.12366
   Stoger E, 2000, PLANT MOL BIOL, V42, P583, DOI 10.1023/A:1006301519427
   Strasser R, 2008, PLANT BIOTECHNOL J, V6, P392, DOI 10.1111/j.1467-7652.2008.00330.x
   Su J, 2015, PLANT BIOTECHNOL J, V13, P1023, DOI 10.1111/pbi.12413
   Su J, 2015, BIOMATERIALS, V70, P84, DOI 10.1016/j.biomaterials.2015.08.004
   Takaiwa F, 2014, TRANSGENIC RES, V23, P573, DOI 10.1007/s11248-014-9790-3
   Takata N, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-30
   Thuenemann EC, 2013, PLANT BIOTECHNOL J, V11, P839, DOI 10.1111/pbi.12076
   Tuse D, 2014, BIOMED RES INT, DOI 10.1155/2014/256135
   Vaghchhipawala Z, 2011, METHODS MOL BIOL, V678, P65, DOI 10.1007/978-1-60761-682-5_6
   Walsh G, 2014, NAT BIOTECHNOL, V32, P992, DOI 10.1038/nbt.3040
   XI JA, 1992, J VIROL, V66, P6527, DOI 10.1128/JVI.66.11.6527-6532.1992
   Yang M, 2018, PLANT BIOTECHNOL J, V16, P572, DOI 10.1111/pbi.12796
   Yang M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08247-9
   Yang M, 2017, VACCINE, V35, P4287, DOI 10.1016/j.vaccine.2017.04.052
   Zeitlin L, 2011, P NATL ACAD SCI USA, V108, P20690, DOI 10.1073/pnas.1108360108
   Zhang XR, 2006, PLANT BIOTECHNOL J, V4, P419, DOI 10.1111/j.1467-7652.2006.00191.x
   Zimran A, 2011, BLOOD, V118, P5767, DOI 10.1182/blood-2011-07-366955
NR 95
TC 1
Z9 1
U1 1
U2 5
PU ACADEMIC PRESS LTD-ELSEVIER SCIENCE LTD
PI LONDON
PA 125 LONDON WALL, LONDON EC2Y 5AS, ENGLAND
SN 0065-2296
BN 978-0-12-809447-1
J9 ADV BOT RES
JI Adv. Bot. Res.
PY 2018
VL 86
BP 207
EP 244
DI 10.1016/bs.abr.2017.11.006
PG 38
WC Plant Sciences
SC Plant Sciences
GA BL6DY
UT WOS:000453656300008
DA 2020-07-08
ER

PT B
AU Kot, P
   Muradov, M
   Ryecroft, S
   Pedrola, MO
   Shaw, A
   Hemingway, J
   Deb, R
   Coleman, M
AF Kot, Patryk
   Muradov, Magomed
   Ryecroft, Samuel
   Pedrola, Montserrat Ortoneda
   Shaw, Andy
   Hemingway, Janet
   Deb, Rinki
   Coleman, Micheal
GP IEEE
TI Identification of Optimal Frequencies to Determine Alpha-Cypermethrin
   using Machine Learning Feature Selection Techniques
SO 2018 IEEE CONGRESS ON EVOLUTIONARY COMPUTATION (CEC)
SE IEEE Congress on Evolutionary Computation
LA English
DT Proceedings Paper
CT IEEE Congress on Evolutionary Computation (IEEE CEC) as part of the IEEE
   World Congress on Computational Intelligence (IEEE WCCI)
CY JUL 08-13, 2018
CL Rio de Janeiro, BRAZIL
SP IEEE, IEEE Computat Intelligence Soc
DE Alpha-cypermethrin; Electromagnetic waves; Malaria; Non-destructive;
   Sensor; Visceral Lieshmaniasis
ID INDUSTRIAL
AB Machine learning feature space reduction techniques allow for vast feature spaces to be reduced with little loss or even significant improvements in the reliability of predictions of models. Microwave spectroscopy with feature spaces of over 8000 are not uncommon when considering magnitude and phase. Applying Machine learning techniques to this type of feature space allows for a quicker reduction and helps to identify the most suitable predictive features. The control of insect vectors that transmit diseases including malaria, visceral leishmaniasis and zika rely on the use of insecticide. These diseases affect millions, malaria alone accounted for 214 million new cases resulting in 438,000 deaths in 2015. One method used in controlling the vectors is through indoor residual spraying, applying insecticide to the wall surface inside houses. Alphacypermethrin is one of the insecticides that is currently sprayed in several countries for vector control. Quality assurance and monitoring of the control activities is challenging relying on the use of laboratory-reared insects. This was improved with a chemical based Insecticide Quantification Kit, but these assays have been challenging to operationalise. An electromagnetic sensor is being developed to investigate the potential to detect alpha-cypermethrin. Preliminary experiments were carried out to differentiate tiles sprayed with Technical Grade alpha-cypermethrin, wettable powder containing 5% alpha-cypermethrin and wettable powder with over dose of alpha-cypermethrin using a horn antenna at a frequency range between 1 GHz to 6 GHz. The experimental results indicated the potential use of electromagnetic waves to determine alpha-cypermethrin in a non-destructive manner.
C1 [Kot, Patryk; Muradov, Magomed; Ryecroft, Samuel; Pedrola, Montserrat Ortoneda; Shaw, Andy] Liverpool John Moores Univ, BEST Res Inst, Liverpool, Merseyside, England.
   [Hemingway, Janet; Deb, Rinki; Coleman, Micheal] LSTM, Liverpool, Merseyside, England.
RP Kot, P (corresponding author), Liverpool John Moores Univ, BEST Res Inst, Liverpool, Merseyside, England.
EM p.kot@ljmu.ac.uk
OI Muradov, Magomed/0000-0002-5526-632X; Kot, Patryk/0000-0001-5526-7536;
   Shaw, Andy/0000-0001-5961-2464
FU Bill AMP; Melinda Gates Foundation grant at Liverpool School of Tropical
   Medicine
FX This work was supported by Bill & Melinda Gates Foundation grant at
   Liverpool School of Tropical Medicine.
CR Adous M, 2006, MEAS SCI TECHNOL, V17, P2241, DOI 10.1088/0957-0233/17/8/026
   Balanis Constantine A., 2005, ANTENNA THEORY ANAL
   Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324
   Breiman L., 1997, 486 U CAL BERK STAT
   Cashman S, 2017, IEEE SENS J, V17, P4092, DOI 10.1109/JSEN.2017.2705281
   CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1007/BF00994018
   Diallo MA, 2012, I CONF SENS TECHNOL, P618, DOI 10.1109/ICSensT.2012.6461754
   Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451
   Goh J. H., 2011, 2011 IEEE Symposium on Computers & Informatics (ISCI), P290, DOI 10.1109/ISCI.2011.5958929
   Huang Y., 2008, ANTENNAS THEORY PRAC
   Killeen G. F., 2017, BMJ GLOB HEALTH, V2, P1
   Korostynska O, 2014, SENSOR ACTUAT B-CHEM, V198, P49, DOI 10.1016/j.snb.2014.03.030
   Korostynska O, 2014, SENSOR REV, V34, P182, DOI 10.1108/SR-11-2012-725
   Kot P, 2017, INT J CIV ENG, V15, P355, DOI 10.1007/s40999-016-0074-6
   Kot P, 2016, CONSTR BUILD MATER, V122, P435, DOI 10.1016/j.conbuildmat.2016.06.092
   Mason A, 2013, SENSOR ACTUAT A-PHYS, V202, P170, DOI 10.1016/j.sna.2013.04.015
   Mason L, 2000, ADV NEUR IN, V12, P512
   Muradov M, 2016, SMART SENSOR MEAS IN, V16, P221, DOI 10.1007/978-3-319-21671-3_10
   Roy A., 2015, INT J ADV RES ELETRO, V4, P488
   Russell TL, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-178
   Teng K. H., 2017, INT J ELECTROMAGN AP, V7, P38
   Vijayakumar K., 2009, J APP PHY, V178, P1
   WHO, 2012, GLOB PLAN INS RES MA
   World Health Organization, 2016, TEST PROC INREMO
NR 24
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-5090-6017-7
J9 IEEE C EVOL COMPUTAT
PY 2018
BP 516
EP 522
DI 10.1109/CEC.2018.8477757
PG 7
WC Computer Science, Artificial Intelligence; Computer Science, Theory &
   Methods; Engineering, Electrical & Electronic
SC Computer Science; Engineering
GA BL5AC
UT WOS:000451175500068
OA Green Accepted
DA 2020-07-08
ER

PT S
AU Mafra-Neto, A
   Saroli, J
   da Silva, RO
   Mboera, LE
   White, GB
   Foster, W
   Spencer, KL
   Ebrahimi, B
   Sonenshine, DE
   Daniels, T
   Kemibala, EE
   Borges, R
   Dekker, T
AF Mafra-Neto, Agenor
   Saroli, Jesse
   da Silva, Rodrigo Oliveira
   Mboera, Leonard E.
   White, Graham B.
   Foster, Woodbridge
   Spencer, Kim Li
   Ebrahimi, Babak
   Sonenshine, Daniel E.
   Daniels, Thomas
   Kemibala, Elison E.
   Borges, Rafael
   Dekker, Teun
BE Norris, EJ
   Coats, JR
   Gross, AD
   Clark, JM
TI Getting Them Where They Live-Semiochemical-Based Strategies To Address
   Major Gaps in Vector Control Programs: Vectrax, SPLAT BAC, Trojan Cow,
   and SPLAT TK
SO ADVANCES IN THE BIORATIONAL CONTROL OF MEDICAL AND VETERINARY PESTS
SE ACS Symposium Series
LA English
DT Proceedings Paper
CT Biorational Control of Medical and Veterinary Pests Symposium / 254th
   ACS National Meeting
CY AUG 20-24, 2017
CL Washington, DC
SP ACS, Agrochem Div
ID MOSQUITO OVIPOSITION PHEROMONE; ANOPHELES-GAMBIAE; AEDES-AEGYPTI;
   CULEX-QUINQUEFASCIATUS; ENVIRONMENTAL-MANAGEMENT; ASSEMBLY PHEROMONE;
   CATTLE OWNERSHIP; LACTIC-ACID; MALARIA; RESISTANCE
AB For most of the company's history, ISCA Technologies' main focus for semiochemical research has been on the development of solutions using these behavior-modifying chemicals to manage agricultural insect pests. However, in recent years, ISCA scientists have expanded their research into another field: management of hematophagous vectors of disease, including mosquitoes, responsible for transmitting such widespread and devastating diseases as malaria, dengue, lymphatic filariasis, Zika, and West Nile virus; and ticks, which transmit Lyme disease, anaplasmosis, and babesiosis, among others. Discussed herein are four examples of semiochemical-based technologies utilizing the attract-and-kill approach to suppress populations of disease-carrying arthropods: Vectrax, SPLAT BAC, Trojan Cow, and SPLAT TK. Each of these formulations is being developed to achieve effective control of vector populations by a different mechanism, by manipulating a different aspect of the target vector's behavior. Vectrax is a flowable formulation comprising a blend of floral attractants and phagostimulants, intended to attract adult sugar-seeking mosquitoes of any species, sex, or physiological status. Vectrax is designed to be blended with the user's insecticide of choice just prior to application, a process comprised of tank-mixing. As a larvicide formulation, SPLAT BAC targets mosquitoes at the larval stage of their life cycle, before they mature into adults capable of breeding or transmitting disease, incorporating two bacterial control agents, Bacillus thuringiensis israelensis and Bacillus sphaericus, in ISCA's controlled release SPLAT technology (Specialized Pheromone & Lure Application Technology). If the development of this product is successful, the controlled-release matrix will enable SPLAT BAC to be applied to prospective larval habitats preemptively before a rain event, a major advantage over previously developed larvicides. Trojan Cow is designed to manipulate the host-seeking behavior of anthropophilic (human-preferring) mosquitoes, by applying a scent cue associated with humans to livestock animals treated with the deworming medication, ivermectin. This compound, which benefits the treated animal by reducing infestation by helminthic parasites, is lethal to both the malaria vector (Anopheles mosquitoes) and the parasite (Plasmodium spp.). SPLAT TK targets the deer tick, Ixodes scapularis, the vector of Lyme disease the most common vector-borne illness in the U.S. by sustaining the controlled release of arrestment pheromones along the borders of areas where contact between the tick vector and its host is most likely to occur (hiking trails, backyards, etc.). In field studies, these arrestment pheromones caused host-seeking ticks to approach and cluster around point sources of SPLAT TK, containing a tank-mixed acaricide, creating the opportunity to eliminate them before they can attach to a human or animal host. Adoption of effective semiochemical-based technologies like those whose research and development are described here could change the way arthropods vectors of disease are managed around the world, providing safer, more effective tools for their control.
C1 [Mafra-Neto, Agenor; Saroli, Jesse; da Silva, Rodrigo Oliveira; Spencer, Kim Li] ISCA Technol, 1230 West Spring St, Riverside, CA 92507 USA.
   [Mboera, Leonard E.] Southern African Ctr Infect Dis Surveillance, POB 3297, Morogoro, Tanzania.
   [White, Graham B.] Univ Florida, IFAS, Gainesville, FL 32611 USA.
   [Foster, Woodbridge; Ebrahimi, Babak] Ohio State Univ, 318 West 12th Ave, Columbus, OH 43210 USA.
   [Sonenshine, Daniel E.] Old Dominion Univ, Norfolk, VA 23529 USA.
   [Sonenshine, Daniel E.] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20852 USA.
   [Daniels, Thomas] Fordham Univ, Louis Calder Ctr, Biol Field Stn, Armonk, NY 10504 USA.
   [Kemibala, Elison E.] Vector Control Training Ctr, Minist Hlth Community Dev Gender Elderly & Childr, POB 136, Muheza, Tanga, Tanzania.
   [Borges, Rafael] ISCA Tecnol Ltd, BR 285,Km 461-N 2-951, Ijui, RS, Brazil.
   [Dekker, Teun] Swedish Univ Agr Sci, Dept Plant Protect Biol, Box 102, S-23053 Alnarp, Sweden.
RP Mafra-Neto, A (corresponding author), ISCA Technol, 1230 West Spring St, Riverside, CA 92507 USA.
EM president@iscatech.com
RI Sonenshine, Daniel/AAF-3625-2020
FU U.S. Department of DefenseUnited States Department of Defense
   [W81XWH-14-C-0039]; National Science FoundationNational Science
   Foundation (NSF) [1648402, IIP-1142630]; U.S. Deployed War Fighters
   Program (SPLAT BAC: Award) [W91QY-16-1-0008]; Bill and Melinda Gates
   FoundationGates Foundation [OPP1106745]; USDA SBIR program (SPLAT TK:
   Award) [2015-33610-23427]; National Institutes of HealthUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [2R44AI134144-02]
FX The authors would like to thank the U.S. Department of Defense (Vectrax:
   Award No. W81XWH-14-C-0039), the National Science Foundation
   (Vectrax-IGR: Award No. 1648402, SPLAT BAC Phase I: Award No.
   IIP-1142630), the National Institutes of Health (SPLAT BAC Phase II:
   2R44AI134144-02), the U.S. Deployed War Fighters Program (SPLAT BAC:
   Award No. W91QY-16-1-0008), the Bill and Melinda Gates Foundation
   (Trojan Cow: Award No. OPP1106745), and the USDA SBIR program (SPLAT TK:
   Award No. 2015-33610-23427) for generously funding the research projects
   that enabled the development of the products and technologies discussed
   in this chapter. Our thanks are also extended to our main collaborators
   on these projects: Dr. Leonard Mboera and his team at the National
   Institute for Medical Research (Dar es Salaam, Tanzania), Dr. Marta Maia
   at the Ifakara Health Institute (Dar es Salaam, Tanzania), Dr. Alongkot
   Ponlawat at the US Army Medical Directorate of the Armed Forces Research
   Institute of Medical Sciences (USAMD-AFRIMS, Bangkok, Thailand), and
   Babak Ebrahimi at Ohio State University (Columbus, OH) for their work on
   Vectrax; Dirk Louis P. Schorkopf, Christos Spanoudis, Rickard Ignell, of
   the Swedish University of Agricultural Sciences, Alnarp, Sweden, as well
   as representatives of Dynamic Aviation, for their collaboration on SPLAT
   BAC; researchers at the NIMR in Tanzania for their work on Trojan Cow;
   and Dr. Thomas Daniels and Dr. Daniel Sonenshine and their research
   teams at Fordham University, New York and Old Dominion University,
   Virginia, respectively, for their work on SPLAT TK. The effort, input,
   and ideas provided by these researchers and their respective
   institutions were vital in accomplishing our objectives and goals for
   this work. We are also grateful for the services of Katherine Villagran,
   who was responsible for the drafting and preparation of this manuscript.
CR ACREE F, 1968, SCIENCE, V161, P1346, DOI 10.1126/science.161.3848.1346
   Afify A, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-315
   AHMADI A, 1983, MOSQ NEWS, V43, P343
   Allan SA, 2002, J CHEM ECOL, V28, P15, DOI 10.1023/A:1013554517148
   [Anonymous], 2011, MECTIZAN DONATION PR
   Aschwanden C, 2001, B WORLD HEALTH ORGAN, V79, P797
   AULT SK, 1994, AM J TROP MED HYG, V50, P35, DOI 10.4269/ajtmh.1994.50.35
   Barbour AG, 1998, BRIT MED BULL, V54, P647, DOI 10.1093/oxfordjournals.bmb.a011717
   Berenbaum M, 1996, BUGS SYSTEM INSECTS
   Bockarie MJ, 1999, MED VET ENTOMOL, V13, P120, DOI 10.1046/j.1365-2915.1999.00159.x
   BOUMA M, 1995, T ROY SOC TROP MED H, V89, P351, DOI 10.1016/0035-9203(95)90004-7
   BRUCECHWATT LJ, 1985, ESSENTIAL MALARIOLOG
   Byrne R., 2017, ZIKAS COSTLY BITE CA
   Carr AL, 2016, EXP APPL ACAROL, V68, P519, DOI 10.1007/s10493-015-0009-y
   Center for Disease Control and Prevention (CDC), WORKPL SAF HLTH TOP
   Centers for Disease Control and Prevention, HIST TIM TRANSCR SUP
   Centers for Disease Control and Prevention, 2013, CDC HLTH INF INT TRA
   Centers for Disease Control. Lyme disease-United States, 1994, MMWR-MORBID MORTAL W, V44, P459
   Chaccour CJ, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-153
   Chaki PP, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-311
   Clausen PH, 1998, MED VET ENTOMOL, V12, P169, DOI 10.1046/j.1365-2915.1998.00097.x
   Cohen J., 2016, SCIENCE, DOI [10.1126/science.aaf9988, DOI 10.1126/SCIENCE.AAF9988]
   Costantini C, 1996, MED VET ENTOMOL, V10, P220, DOI 10.1111/j.1365-2915.1996.tb00734.x
   Costello A, 2009, LANCET, V373, P1693, DOI [10.1016/S0140-6736(09)60935-1, 10.1016/S0140-6736(09)60929-6]
   DAVIS EE, 1976, J INSECT PHYSIOL, V22, P1371, DOI 10.1016/0022-1910(76)90160-8
   Deen JL, 2006, LANCET, V368, P170, DOI 10.1016/S0140-6736(06)69006-5
   Dekker T, 2002, MED VET ENTOMOL, V16, P91, DOI 10.1046/j.0269-283x.2002.00345.x
   Dobson M., 2007, DIS EXTRAORDINARY ST
   Estrada-Pena A, 1999, EXP APPL ACAROL, V23, P685, DOI 10.1023/A:1006241108739
   Fallon B. A., 2017, CONQUERING LYME DIS
   Fillinger U, 2009, B WORLD HEALTH ORGAN, V87, P655, DOI 10.2471/BLT.08.055632
   Foley DH, 2000, T ROY SOC TROP MED H, V94, P625, DOI 10.1016/S0035-9203(00)90211-6
   FOSTER WA, 1995, ANNU REV ENTOMOL, V40, P443, DOI 10.1146/annurev.en.40.010195.002303
   Fritz ML, 2009, ANN TROP MED PARASIT, V103, P539, DOI 10.1179/000349809X12459740922138
   Ganesan K, 2006, AUST J ENTOMOL, V45, P75, DOI 10.1111/j.1440-6055.2006.00513.x
   Gaugler R., 2011, MED VET ENTOMOL, P1365
   Geier M, 1996, CIBA F SYMP, V200, P132
   Geissbuhler Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005107
   George JE, 2004, PARASITOLOGY, V129, pS353, DOI 10.1017/S0031182003004682
   Guedes DRD, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.59
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   HENDERSON CF, 1955, J ECON ENTOMOL, V48, P157, DOI 10.1093/jee/48.2.157
   HEWITT S, 1994, MED VET ENTOMOL, V8, P160, DOI 10.1111/j.1365-2915.1994.tb00156.x
   Iakubovich V Ia, 1989, Med Parazitol (Mosk), P60
   Impoinvil DE, 2004, MED VET ENTOMOL, V18, P108, DOI 10.1111/j.0269-283X.2004.00484.x
   JONGEJAN F, 1994, REV SCI TECH OIE, V13, P1201, DOI 10.20506/rst.13.4.818
   Killeen Gerry F, 2002, Malar J, V1, P8, DOI 10.1186/1475-2875-1-8
   Killeen GF, 2002, LANCET INFECT DIS, V2, P618, DOI 10.1016/S1473-3099(02)00397-3
   Kilpatrick AM, 2012, LANCET, V380, P1946, DOI 10.1016/S0140-6736(12)61151-9
   KLINE DL, 1994, J AM MOSQUITO CONTR, V10, P280
   Kobylinski KC, 2011, AM J TROP MED HYG, V85, P3, DOI 10.4269/ajtmh.2011.11-0160
   Kupferschmidt K, 2016, SCIENCE, V21, DOI [10.1126/science.aaf5794, DOI 10.1126/SCIENCE.AAF5794]
   Lima JBP, 2003, AM J TROP MED HYG, V68, P329, DOI 10.4269/ajtmh.2003.68.329
   Lindh JM, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0636-0
   Mafra-Neto A, 2014, ACS SYM SER, V1172, P211
   Mafra-Neto A, 2013, ACS SYM SER, V1141, P31
   Mahande AM, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-109
   Majambere S, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-76
   Manda H, 2007, MED VET ENTOMOL, V21, P103, DOI 10.1111/j.1365-2915.2007.00672.x
   Mendki MJ, 2000, CURR SCI INDIA, V78, P1295
   Michaelakis A, 2007, PEST MANAG SCI, V63, P954, DOI 10.1002/ps.1418
   Mochizuki F, 2002, APPL ENTOMOL ZOOL, V37, P299, DOI 10.1303/aez.2002.299
   Mukabana WR, 2012, J CHEM ECOL, V38, P235, DOI 10.1007/s10886-012-0088-8
   Mukabana WR, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-1
   Mulla MS, 2003, J AM MOSQUITO CONTR, V19, P39
   NAYAR JK, 1971, J INSECT PHYSIOL, V17, P2221, DOI 10.1016/0022-1910(71)90180-6
   NAYAR JK, 1971, J INSECT PHYSIOL, V17, P471, DOI 10.1016/0022-1910(71)90026-6
   Olagbemiro TO, 1999, J AGR FOOD CHEM, V47, P3411, DOI 10.1021/jf990294b
   Omura S, 2008, INT J ANTIMICROB AG, V31, P91, DOI 10.1016/j.ijantimicag.2007.08.023
   Ong SQ, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0639-2
   OTIENO DA, 1985, INSECT SCI APPL, V6, P667, DOI 10.1017/S1742758400002873
   Pascual M, 2006, P NATL ACAD SCI USA, V103, P5829, DOI 10.1073/pnas.0508929103
   Policy Cures, 2014, EST COSTS MEAS INV M
   Roberts L., 2016, SCIENCE, DOI [10.1126/science.aaf9947, DOI 10.1126/SCIENCE.AAF9947]
   Saul A, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-32
   SCHULTZ G W, 1989, Southeast Asian Journal of Tropical Medicine and Public Health, V20, P49
   Sharma KR, 2008, PARASITOL RES, V103, P1065, DOI 10.1007/s00436-008-1094-1
   SHOUSHA A. T., 1948, BULL WORLD HEALTH ORGAN, V1, P309
   Sonenshine DE, 2003, J MED ENTOMOL, V40, P849, DOI 10.1603/0022-2585-40.6.849
   Soper FL, 1943, ANOPHELES GAMBIAE BR
   Spitzen J, 2008, PHYSIOL ENTOMOL, V33, P116, DOI 10.1111/j.1365-3032.2008.00612.x
   Sylla M, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-365
   TESH RB, 1990, AM J TROP MED HYG, V43, P229, DOI 10.4269/ajtmh.1990.43.229
   Tolle Michael A, 2009, Curr Probl Pediatr Adolesc Health Care, V39, P97, DOI 10.1016/j.cppeds.2009.01.001
   University of Florida Department of Entomology & Nematology Website, 2014, FEAT CREAT BLACKL TI
   University of Minnesota Horse Extension Website, TICKS HORS WHAT DIS
   Utzinger J, 2001, TROP MED INT HEALTH, V6, P677, DOI 10.1046/j.1365-3156.2001.00769.x
   VALE GA, 1979, B ENTOMOL RES, V69, P459, DOI 10.1017/S0007485300018964
   Wang Y, 2014, PEST MANAG SCI, V70, P1299, DOI 10.1002/ps.3702
   Welter S. C., 2005, California Agriculture, V59, P16, DOI 10.3733/ca.v059n01p16
   Winstanley P, 2004, CLIN MICROBIOL REV, V17, P612, DOI 10.1128/CMR.17.3.612-637.2004
   Wirth MC, 2010, J MED ENTOMOL, V47, P814, DOI 10.1603/ME09227
   Wirth MC, 2010, ENVIRON MICROBIOL, V12, P1154, DOI 10.1111/j.1462-2920.2010.02156.x
   Wondwosen B, 2016, SCI REP-UK, V6, DOI 10.1038/srep37930
   Yuan ZM, 2000, BIOCONTROL SCI TECHN, V10, P41, DOI 10.1080/09583150029378
   2010, WORLD MALARIA REPORT, P1
NR 96
TC 2
Z9 2
U1 3
U2 4
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 SIXTEENTH ST NW, WASHINGTON, DC 20036 USA
SN 0097-6156
EI 1947-5918
BN 978-0-8412-3358-4
J9 ACS SYM SER
JI ACS Symp. Ser.
PY 2018
VL 1289
BP 101
EP 152
PG 52
WC Biotechnology & Applied Microbiology; Chemistry, Applied; Entomology
SC Biotechnology & Applied Microbiology; Chemistry; Entomology
GA BL5CH
UT WOS:000451241600007
DA 2020-07-08
ER

PT J
AU Sommariva, S
   Vamos, C
   Mantzarlis, A
   Dao, LUL
   Tyson, DM
AF Sommariva, Silvia
   Vamos, Cheryl
   Mantzarlis, Alexios
   Dao, Lillie Uyen-Loan
   Tyson, Dinorah Martinez
TI Spreading the (Fake) News: Exploring Health Messages on Social Media and
   the Implications for Health Professionals Using a Case Study
SO AMERICAN JOURNAL OF HEALTH EDUCATION
LA English
DT Article
ID ZIKA VIRUS; MISINFORMATION; EDUCATION; FACEBOOK; NETWORK
AB Background: The importance of social networking sites (SNSs) as platforms to engage in the correction of fake news has been documented widely. More evidence is needed to understand the popularity of health-related rumors and how Health Educators can optimize their use of SNSs. Purpose: The purpose of this study was to explore the spread of health rumors and verified information on SNSs using the Zika virus as a case study. Methods: A content analysis of Zika-related news stories on SNSs between February 2016 and January 2017 was conducted to verify accuracy (phase 1). Phase 1 was followed by an analysis of volume of shares (phase 2) and a thematic analysis of headlines (phase 3). Results: Rumors had three times more shares than verified stories. Popular rumors portray Zika as a conspiracy against the public and a low-risk issue and connect it to the use of pesticides. Discussion: This study identifies the value of integrating in-depth analysis of popular health-related rumors into the development of communication strategies. Translation to Health Education Practice: Misinformation on SNSs can hinder disease prevention efforts. This study shows how information circulating on SNSs can be analyzed from a quantitative and qualitative standpoint to help Health Educators maximize the use of online communication platforms.
C1 [Sommariva, Silvia; Vamos, Cheryl; Dao, Lillie Uyen-Loan; Tyson, Dinorah Martinez] Univ S Florida, Tampa, FL 33620 USA.
   [Mantzarlis, Alexios] Poynter Inst Media Studies, St Petersburg, FL USA.
RP Sommariva, S (corresponding author), Univ S Florida, Coll Publ Hlth, Dept Community & Family Hlth, 13201 Bruce B Downs Blvd, Tampa, FL 33612 USA.
EM sommarivas@health.usf.edu
RI Ahmed, Mohamed/AAG-9664-2019
CR Adamski A, 2018, J INFECTION, V76, P529, DOI 10.1016/j.jinf.2018.02.010
   Ai JW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.42
   ALLCOTT H, 2017, J ECON PERSPECT, V31, P211, DOI [DOI 10.1257/jep.31.2.211, DOI 10.1257/JEP.31.2.211]
   Aurini JD, 2016, QUALITATIVE RES STRA
   Barthel M, 2016, MANY AM BELIEVE FAKE
   BERLO DK, 1960, PROCESS COMMUNICATIO
   Bernard RH, 2010, ANAL QUALITATIVE DAT
   Bode L, 2018, HEALTH COMMUN, V33, P1131, DOI 10.1080/10410236.2017.1331312
   Boyd DM, 2007, J COMPUT-MEDIAT COMM, V13, P210, DOI 10.1111/j.1083-6101.2007.00393.x
   Brasil Ministerio da Saude, 2016, GUID HLTH SURV
   Capurro D, 2014, J MED INTERNET RES, V16, P213, DOI 10.2196/jmir.2679
   Cascione S., 2016, BRAZIL ENLISTS ARMY
   Cavallo DN, 2012, AM J PREV MED, V43, P527, DOI 10.1016/j.amepre.2012.07.019
   Centers for Disease Control and Prevention, 2015, HLTH COMM STRAT
   Centers for Disease Control and Prevention Office of the Associate Director for Communication, 2011, HLTH COMM SOC MED TO
   Chang D., 2016, MIAMI HERALD
   Bueno FTC, 2017, CIENC SAUDE COLETIVA, V22, P2305, DOI 10.1590/1413-81232017227.07012017
   De Broucker T, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0590-9
   de Oliveira WK, 2017, NEW ENGL J MED, V376, P1591, DOI 10.1056/NEJMc1608612
   European Center for Disease Prevention and Control, 2016, SOC MED STRAT DEV GU
   Feng L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126090
   Gabielkov M, 2016, ACM SIGM JUN 14 ANT
   Garrett RK, 2016, J COMPUT-MEDIAT COMM, V21, P331, DOI 10.1111/jcc4.12164
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Glynn CJ, 2012, COMPUT HUM BEHAV, V28, P113, DOI 10.1016/j.chb.2011.08.017
   Gottfried J., 2016, NEWS USE SOCIAL MEDI
   Guess A., 2018, SELECTIVE EXPOSURE M, P9
   Hanson C, 2011, AM J HEALTH EDUC, V42, P197, DOI 10.1080/19325037.2011.10599188
   Hanson C, 2008, AM J HEALTH EDUC, V39, P157, DOI 10.1080/19325037.2008.10599032
   Hennink M., 2011, QUALITATIVE RES METH
   Carod-Artal FJ, 2018, EXPERT REV ANTI-INFE, V16, P399, DOI 10.1080/14787210.2018.1466702
   Kaur Manmeet, 2016, Indian J Community Med, V41, P93, DOI 10.4103/0970-0218.173495
   Kuchler H, 2017, FINANCIAL TIMES
   La Capria K., 2016, FACT CHECK MOSQUITO
   Lazer D, 2017, COMB FAK NEWS AG RES
   Lewandowsky S, 2012, PSYCHOL SCI PUBL INT, V13, P106, DOI 10.1177/1529100612451018
   Mackert Michael, 2012, Stud Health Technol Inform, V182, P93
   Margolin DB, 2018, POLIT COMMUN, V35, P196, DOI 10.1080/10584609.2017.1334018
   McCormack K, 2008, HEALTH PROMOT PRACT, V9, P116, DOI 10.1177/1524839908315134
   Merchant RM, 2011, NEW ENGL J MED, V365, P289, DOI 10.1056/NEJMp1103591
   Mitchell A., 2016, PATHWAYS TO NEWS
   Moorhead SA, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.1933
   Mosseri Adam, 2016, NEWS FEED FYI ADDRES
   Mullin Benjamin, 2016, FACEBOOK HAS PLAN FI
   Roberts M, 2017, STUD HEALTH TECHNOL, V240, P464, DOI 10.3233/978-1-61499-790-0-464
   Sharma M, 2017, AM J INFECT CONTROL, V45, P301, DOI 10.1016/j.ajic.2016.08.022
   Shi JY, 2018, HEALTH COMMUN, V33, P49, DOI 10.1080/10410236.2016.1242035
   Shirley DAT, 2017, PEDIATR CLIN N AM, V64, P937, DOI 10.1016/j.pcl.2017.03.012
   Silverman C., 2016, THIS ANAL SHOWS VIRA
   Smith MK, 2014, J RACIAL ETHN HEALTH, V1, P194, DOI 10.1007/s40615-014-0025-3
   Swire B, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.160802
   Thackeray R, 2009, HEALTH PROMOT PRACT, V10, P171, DOI 10.1177/1524839908330729
   Toppenberg-Pejcic D, 2019, HEALTH COMMUN, V34, P437, DOI 10.1080/10410236.2017.1405488
   Turner-McGrievy GM, 2013, TRANSL BEHAV MED, V3, P287, DOI 10.1007/s13142-012-0183-y
   Valente PK, 2017, AM J PUBLIC HEALTH, V107, P1376, DOI 10.2105/AJPH.2017.303924
   Vargo CJ, 2018, NEW MEDIA SOC, V20, P2028, DOI 10.1177/1461444817712086
   Wardle C, 2017, FAKE NEWS ITS COMPLI
   WHO, 2016, ZIK VIR FACT SHEET
   World Health Organization, 2016, DISP RUM ZIK COMPL
   YATES BL, 1999, J HLTH ED, V30, P180, DOI DOI 10.1080/10556699.1999.10603399
NR 60
TC 9
Z9 9
U1 14
U2 33
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1932-5037
EI 2168-3751
J9 AM J HEALTH EDUC
JI Am. J. Health Educ.
PY 2018
VL 49
IS 4
SI SI
BP 246
EP 255
DI 10.1080/19325037.2018.1473178
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GL1JT
UT WOS:000436858200008
DA 2020-07-08
ER

PT J
AU Pachar, MR
   Arauz, D
   Gundacker, ND
   Suarez, M
   Suarez, JA
   Moreno, B
   Lopez-Verges, S
   Arauz, AB
AF Pachar, Monica R.
   Arauz, Dimelza
   Gundacker, Nathan D.
   Suarez, Marixcel
   Antonio Suarez, Jose
   Moreno, Brechla
   Lopez-Verges, Sandra
   Arauz, Ana B.
TI Zika Virus-Associated Cerebellitis with Complete Clinical Recovery
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID TRANSMISSION; INFECTIONS; DENGUE
AB Zika virus (ZIKV) was first detected in the Americas in Brazil in 2015, with a rapid spread to surrounding countries. In Panama, the outbreak began in November 2015 in an indigenous community located on the Caribbean side of the country. Zika virus is typically associated with a diffuse rash, fever, and conjunctivitis. It can rarely cause neurologic manifestations, most commonly microcephaly and Guillain-Barre 'syndrome. Encephalitis and acute encephalomyelitis are known complications, but ZIKV-associated cerebellitis has yet to be reported in the literature. Herein, we report a case of cerebellitis in a patient infected with ZIKV. This patient developed severe frontal headache and vertigo on the third day of illness, and dysarthria and ataxia on the fifth day. After 1 week of hospitalization, the patient completely recovered. The laboratory serological diagnosis was complicated because of the detection of antibodies against dengue, suggesting a secondary flavivirus infection.
C1 [Pachar, Monica R.; Suarez, Marixcel; Arauz, Ana B.] Hosp Santo Tomas, Infect Dis, Panama City, Panama.
   [Arauz, Dimelza; Moreno, Brechla; Lopez-Verges, Sandra] Gorgas Mem Inst Hlth Studies, Dept Res Virol & Biotechnol, Panama City, Panama.
   [Antonio Suarez, Jose] Gorgas Mem Inst Hlth Studies, Clin Res Unit, Panama City, Panama.
   [Gundacker, Nathan D.] Med Coll Wisconsin, Milwaukee, WI 53226 USA.
RP Lopez-Verges, S (corresponding author), Gorgas Mem Inst Hlth Studies, Calle 36 Este, Panama City, Panama.; Arauz, AB (corresponding author), Hosp Santo Tomas, Calle 37 Este, Panama City, Panama.
EM dra.pachar@hotmail.com; darauz@gorgas.gob.pa; ndgundacker@gmail.com;
   marixcel@gmail.com; jsuarez@gorgas.gob.pa; brechla@yahoo.es;
   slopez@gorgas.gob.pa; anabelenarauz@gmail.com
OI Suarez Sancho, Jose Antonio/0000-0001-9407-1624; Pachar,
   Monica/0000-0003-4400-4209; Arauz, Ana Belen/0000-0001-5880-8908
FU MEF. project [09044.051]; HST; ICGES
FX This work has been carried out with management funds of HST and ICGES,
   as well as MEF. project 09044.051 (S. L. V.).
CR [Anonymous], 2016, MMWR-MORBID MORTAL W, V65, P474, DOI 10.15585/mmwr.mm6518e1
   Arauz D, 2016, EMERG INFECT DIS, V22, P1515, DOI 10.3201/eid2208.160292
   Blacksell SD, 2011, CLIN VACCINE IMMUNOL, V18, P2095, DOI 10.1128/CVI.05285-11
   Brito CAA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005583
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Hunsperger EA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003171
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   May M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161355
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Pruitt AA, 2014, NEUROL CLIN, V32, P1117, DOI 10.1016/j.ncl.2014.07.009
   Salud Md, 2016, BOLETINES SEMENALES
   Soares CN, 2016, J CLIN VIROL, V83, P63, DOI 10.1016/j.jcv.2016.08.297
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
   Tan SK, 2017, J VIROL METHODS, V248, P66, DOI 10.1016/j.jviromet.2017.04.018
   Weeratunga Praveen N, 2014, Pract Neurol, V14, P176, DOI 10.1136/practneurol-2013-000571
   Withana Milinda, 2014, BMC Res Notes, V7, P125, DOI 10.1186/1756-0500-7-125
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 20
TC 2
Z9 2
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 5
BP 1318
EP 1320
DI 10.4269/ajtmh.18-0261
PG 3
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HD3DZ
UT WOS:000452395000041
PM 30255830
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Neri, VC
   Xavier, MF
   Barros, PO
   Bento, CM
   Marignier, R
   Alvarenga, RP
AF Neri, Vanderson Carvalho
   Xavier, Maria Filomena
   Barros, Priscila Oliveira
   Bento, Cleonice Melo
   Marignier, Romain
   Alvarenga, Regina Papais
TI Case Report: Acute Transverse Myelitis after Zika Virus Infection
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID GLYCOPROTEIN
AB We report here one case of Zika virus (ZIKV) infection associated with auto-immunity directed against the central nervous system in a Brazilian woman who developed acute transverse myelitis 9 days after recovery from an acute episode of fever with generalized erythema. Imaging of the spinal cord showed an elongated area on the T1-T10 level with gadolinium uptake. The diagnostic of the ZIKV infection was confirmed by cerebrospinal fluid and serum analysis. This patient had serum positivity for autoantibodies against myelin oligodendrocyte glycoprotein (MOG), a specific antibody against the myelin sheath. We propose that a direct central nervous system infection by ZIKV could lead to a specific auto-immunity against MOG protein.
C1 [Neri, Vanderson Carvalho; Alvarenga, Regina Papais] Univ Fed Estado Rio de Janeiro, Dept Neurol, Rio De Janeiro, Brazil.
   [Xavier, Maria Filomena; Alvarenga, Regina Papais] Hosp Fed Lagoa, Multiple Sclerosis Treatment Ctr, Rio De Janeiro, Brazil.
   [Barros, Priscila Oliveira; Bento, Cleonice Melo] Univ Fed Estado Rio de Janeiro, Dept Microbiol & Parasitol, Rio De Janeiro, Brazil.
   [Marignier, Romain] Hosp Civils Lyon, Hop Neurol PierreWertheimer, OFSEP, Serv Neurol A, Bron, France.
   [Marignier, Romain] Hosp Civils Lyon, Hop Neurol PierreWertheimer, OFSEP, Eugene Devic EDMUS Fdn Multiple Sclerosis, Bron, France.
   [Marignier, Romain] Univ Lyon, Univ Lyon 1, Lyon, France.
RP Neri, VC (corresponding author), Univ Fed Estado Rio de Janeiro, Dept Neurol, Hosp Univ Gaffree Guinle, R Mariz & Barros 775, BR-20270 Rio De Janeiro, Brazil.
EM vandersoncn@yahoo.com.br; filoxavier@yahoo.com.br;
   pri.obarros@outlook.com; cbento@unirio.br; marignierro@gmail.com;
   regina_alvarenga2004@hotmail.com
RI Barros, Priscila O./AAA-3188-2020
OI Barros, Priscila O./0000-0002-6173-0416
FU MERK SERONO; TEVA PHARMA; BIOGEN IDECBiogen; NOVARTISNovartis;
   GENZYMEGenzyme Corporation; SANOFISanofi-Aventis
FX R. M. reports grants and personal fees from: MERK SERONO, TEVA PHARMA,
   BIOGEN IDEC, NOVARTIS, GENZYME, and SANOFI. R. P. A. reports grants and
   personal fees from: TEVA PHARMA, MERK SERONO, BIOGEN IDEC, and NOVARTIS.
   V. C. N., C. M. B., and P. O. B. report personal fees from:
   CAPES/MINISTERIO DA EDUCACAO.
CR Araujo AQC, 2016, BRAIN, V139, P2122, DOI 10.1093/brain/aww158
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cobo-Calvo A, 2016, MULT SCLER J, V22, P312, DOI 10.1177/1352458515591071
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Lucchese G, 2016, AUTOIMMUN REV, V15, P801, DOI 10.1016/j.autrev.2016.03.020
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Ramanathan S, 2014, NEUROL-NEUROIMMUNOL, V1, DOI 10.1212/NXI.0000000000000040
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Von Budingen HC, 2001, J CLIN IMMUNOL, V21, P155
NR 11
TC 1
Z9 3
U1 0
U2 2
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 6
BP 1419
EP 1421
DI 10.4269/ajtmh.17-0938
PG 3
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HD3FO
UT WOS:000452400500013
PM 30277201
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Mita-Mendoza, NK
   McMahon, E
   Kenneson, A
   Barbachano-Guerrero, A
   Beltran-Ayala, E
   Cueva, C
   King, CA
   Lupone, CD
   Castro-Sesquen, YE
   Gilman, RH
   Endy, TP
   Stewart-Ibarra, AM
AF Mita-Mendoza, Neida K.
   McMahon, Elizabeth
   Kenneson, Aileen
   Barbachano-Guerrero, Arturo
   Beltran-Ayala, Efrain
   Cueva, Cinthya
   King, Christine A.
   Lupone, Christina D.
   Castro-Sesquen, Yagahira E.
   Gilman, Robert H.
   Endy, Timothy P.
   Stewart-Ibarra, Anna M.
TI Chagas Disease in Southern Coastal Ecuador: Coinfections with
   Arboviruses and a Comparison of Serological Assays for Chagas Disease
   Diagnosis
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID EXCRETED-SECRETED ANTIGENS; TRYPANOSOMA-CRUZI; DENGUE; CHIKUNGUNYA
AB Occurrence of Chagas disease and arbovirus coinfections is unknown, despite the vast co-endemic areas throughout the Americas. This study examined the proportion of individuals positive for Trypanosoma cruzi and coinfections with dengue, chikungunya, and Zika viruses in Machala, Ecuador (January 2014-December 2015). Chagas seropositivity was evaluated with five commercially available assays. Dengue infections were identified by nonstructural protein 1 rapid test and enzyme linked immunosorbent assay (ELISA), immunoglobulin M ELISA, and reverse transcription PCR (RT-PCR); chikungunya and Zika infections were identified by RT-PCR. Of 658 individuals, six were positive for T. cruzi (0.91%), including one T. cruzi/dengue coinfection and one T. cruzi/chikungunya/dengue coinfection. The clinical manifestations of coinfected individuals corresponded to severe dengue and dengue with warning signs, respectively. We observed discrepant results by using the Hemagen Chagas kit and the rapid test Chagas Detect Plus (false positives: 3.9% and 15.4%), highlighting the need to assess diagnostic assays in geographic regions with distinct taxonomic units of T. cruzi.
C1 [Mita-Mendoza, Neida K.; McMahon, Elizabeth; Kenneson, Aileen; Cueva, Cinthya; Lupone, Christina D.; Endy, Timothy P.; Stewart-Ibarra, Anna M.] SUNY Upstate Med Univ, Inst Global Hlth & Translat Sci, 750 East Adams St, Syracuse, NY 13210 USA.
   [Barbachano-Guerrero, Arturo; King, Christine A.; Endy, Timothy P.] SUNY Upstate Med Univ, Dept Microbiol & Immunol, Syracuse, NY 13210 USA.
   [Beltran-Ayala, Efrain] Univ Tecn Machala, Dept Med, Machala, El Oro Province, Ecuador.
   [Castro-Sesquen, Yagahira E.; Gilman, Robert H.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA.
   [Endy, Timothy P.; Stewart-Ibarra, Anna M.] SUNY Upstate Med Univ, Dept Med, Syracuse, NY 13210 USA.
RP Mita-Mendoza, NK (corresponding author), SUNY Upstate Med Univ, Inst Global Hlth & Translat Sci, 750 East Adams St, Syracuse, NY 13210 USA.
EM mitamenn@upstate.edu
OI Barbachano-Guerrero, Arturo/0000-0001-7483-839X; Stewart-Ibarra,
   Anna/0000-0002-3383-4672
FU Inbios International; Syracuse University
FX Y. C. S. reports grants and nonfinancial support from Inbios
   International, other from Hemagen, during the conduct of the study; and
   grants and nonfinancial support from Inbios International outside the
   submitted work. E. M. reports grants from Syracuse University, during
   the conduct of the study.
CR Abras A, 2016, J CLIN MICROBIOL, V54, P1566, DOI 10.1128/JCM.00142-16
   Aguilar HM, 1999, MEM I OSWALDO CRUZ, V94, P387, DOI 10.1590/S0074-02761999000700076
   Black CL, 2007, J PARASITOL, V93, P12, DOI 10.1645/GE-899R.1
   Breniere SF, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004792
   Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X
   Chaturvedi UC, 2000, FEMS IMMUNOL MED MIC, V28, P183, DOI 10.1111/j.1574-695X.2000.tb01474.x
   Costales JA, 2015, ACTA TROP, V151, P88, DOI 10.1016/j.actatropica.2015.07.017
   Eguez KE, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005501
   Souza VDG, 2012, PARASITOL INT, V61, P690, DOI 10.1016/j.parint.2012.07.008
   Griffiths EC, 2011, J INFECTION, V63, P200, DOI 10.1016/j.jinf.2011.06.005
   Health in the Americas, 2017, SUMM REG OUTC COUNTR
   Mangada MM, 2005, J IMMUNOL, V175, P2676, DOI 10.4049/jimmunol.175.4.2676
   Mitchell C., 2016, ZIKA CUMULATIVE CASE
   PAHO WHO, 2017, CHIK STAT DAT
   PAHO WHO, 2016, DENG ANN CAS REP DEN
   Patterson J, 2016, WEST J EMERG MED, V17, P671, DOI 10.5811/westjem.2016.9.30904
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X
   Sommerfeld J, 2015, T ROY SOC TROP MED H, V109, P85, DOI 10.1093/trstmh/tru176
   Stewart-Ibarra AM, 2018, AM J TROP MED HYG, V98, P1444, DOI 10.4269/ajtmh.17-0762
   Umezawa ES, 1996, J CLIN MICROBIOL, V34, P2143, DOI 10.1128/JCM.34.9.2143-2147.1996
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Zarate-Blades CR, 2007, DIAGN MICR INFEC DIS, V57, P229, DOI 10.1016/j.diagmicrobio.2006.08.004
NR 23
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 6
BP 1530
EP 1533
DI 10.4269/ajtmh.18-0441
PG 4
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HD3FO
UT WOS:000452400500029
PM 30350764
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Berenson, AB
   Hirth, JM
   Guo, FJ
   Fuchs, EL
   Weaver, SC
AF Berenson, Abbey B.
   Hirth, Jacqueline M.
   Guo, Fangjian
   Fuchs, Erika L.
   Weaver, Scott C.
TI Prevention Practices among United States Pregnant Women Who Travel to
   Zika Outbreak Areas
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID VIRUS OUTBREAK; TRANSMISSION; KNOWLEDGE
AB We surveyed pregnant women from the United States to assess the prevention practices they used when traveling to countries with ongoing Zika virus (ZIKV) outbreaks. Of the 749 who agreed to participate, 710 completed the survey's travel questions and 59 of those had traveled to a ZIKV outbreak area in the past 12 months. Only 43% of the women who had traveled to ZIKV outbreak areas reported frequently using mosquito repellant with 32% stating they did not use it at all. They also did not frequently use other recommended methods to prevent mosquito bites. With the established risks to babies born to women who contract the ZIKV during pregnancy, it is a great concern that a large number of women who travel to outbreak areas during pregnancy are not protecting themselves against mosquito bites. Pregnant women need to be educated on the importance of taking precautions.
C1 [Berenson, Abbey B.; Hirth, Jacqueline M.; Guo, Fangjian; Fuchs, Erika L.] Univ Texas Med Branch, Ctr Interdisciplinary Res Womens Hlth, Galveston, TX 77555 USA.
   [Berenson, Abbey B.; Hirth, Jacqueline M.; Guo, Fangjian; Fuchs, Erika L.] Univ Texas Med Branch, Dept Obstet & Gynecol, Galveston, TX 77555 USA.
   [Weaver, Scott C.] Univ Texas Med Branch, Dept Pathol, Inst Human Infect & Immunol, Galveston, TX 77555 USA.
   [Weaver, Scott C.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
RP Berenson, AB (corresponding author), Univ Texas Med Branch, 301 Univ Blvd, Galveston, TX 77555 USA.
EM abberens@utmb.edu; jmhirth@utmb.edu; faguo@utmb.edu; elfuchs@utmb.edu;
   sweaver@utmb.edu
RI Weaver, Scott C/D-6490-2011
OI Weaver, Scott C/0000-0001-8016-8556
FU Office of Research on Women's Health (ORWH)United States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   Office of Research on Women's Health (ORWH) [K12HD052023]; Eunice
   Kennedy Shriver National Institute of Child Health and Human Development
   (NICHD) at the National Institutes of Health (NIH); NIH/NICHDUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child
   Health & Human Development (NICHD) [T32HD055163]
FX Drs. Fuchs and Guo are supported by an institutional research career
   development award (K12HD052023: Building Interdisciplinary Research
   Careers in Women's Health Program-BIRCWH; Berenson, PI) from the Office
   of Research on Women's Health (ORWH) and the Eunice Kennedy Shriver
   National Institute of Child Health and Human Development (NICHD) at the
   National Institutes of Health (NIH). Dr. Fuchs also worked on the
   project as a postdoctoral fellow supported by an institutional training
   grant (National Research Service Award T32HD055163, Berenson, PI) from
   NIH/NICHD. The content is solely the responsibility of the authors and
   does not necessarily represent the official views of the NIH.
CR Berenson AB, 2017, AM J TROP MED HYG, V97, P155, DOI 10.4269/ajtmh.17-0062
   Centers for Disease Control and Prevention, 2017, CDC ISS UPD ZIK REC
   Centers for Disease Control and Prevention, 2017, INS REP US SAF
   Centers for Disease Control and Prevention, 2017, ALL COUNTR TERR ACT
   Centers for Disease Control and Prevention, 2017, PROT YOURS YOUR BAB
   Centers for Disease Control and Prevention, 2017, PREV DENG PREGN
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Mouchtouri VA, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14040367
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Whittemore K, 2017, EMERG INFECT DIS, V23, P164, DOI 10.3201/eid2301.161614
NR 11
TC 4
Z9 4
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 98
IS 1
BP 178
EP 180
DI 10.4269/ajtmh.17-0595
PG 3
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA GE1BD
UT WOS:000430950900034
PM 29141747
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Smith, DR
   Sprague, TR
   Hollidge, BS
   Valdez, SM
   Padilla, SL
   Bellanca, SA
   Golden, JW
   Coyne, SR
   Kulesh, DA
   Miller, LJ
   Haddow, AD
   Koehler, JW
   Gromowski, GD
   Jarman, RG
   Alera, MTP
   Yoon, IK
   Buathong, R
   Lowen, RG
   Kane, CD
   Minogue, TD
   Bavari, S
   Tesh, RB
   Weaver, SC
   Linthicum, KJ
   Pitt, ML
   Nasar, F
AF Smith, Darci R.
   Sprague, Thomas R.
   Hollidge, Bradley S.
   Valdez, Stephanie M.
   Padilla, Susana L.
   Bellanca, Stephanie A.
   Golden, Joseph W.
   Coyne, Susan R.
   Kulesh, David A.
   Miller, Lynn Jean
   Haddow, Andrew D.
   Koehler, Jeff W.
   Gromowski, Gregory D.
   Jarman, Richard G.
   Alera, Maria Theresa P.
   Yoon, In-Kyu
   Buathong, Rome
   Lowen, Robert G.
   Kane, Christopher D.
   Minogue, Timothy D.
   Bavari, Sina
   Tesh, Robert B.
   Weaver, Scott C.
   Linthicum, Kenneth J.
   Pitt, Margaret L.
   Nasar, Farooq
TI African and Asian Zika Virus Isolates Display Phenotypic Differences
   Both In Vitro and In Vivo
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID JAPANESE-ENCEPHALITIS-VIRUS; AEDES-AEGYPTI MOSQUITOS; ENVELOPE PROTEIN;
   YELLOW-FEVER; MOUSE NEUROVIRULENCE; GENETIC-DETERMINANTS; SEQUENCE
   ALIGNMENT; SEROLOGICAL SURVEY; TRANSMISSION; ATTENUATION
AB Zika virus (ZIKV) is a mosquito-borne member of the genus Flavivirus that has emerged since 2007 to cause outbreaks in Africa, Asia, Oceania, and most recently, in the Americas. Here, we used an isolate history as well as genetic and phylogenetic analyses to characterize three low-passage isolates representing African (ArD 41525) and Asian (CPC-0740, SV0127-14) lineages to investigate the potential phenotypic differences in vitro and in vivo. The African isolate displayed a large plaque phenotype (similar to 3-4 mm) on Vero and HEK-293 cells, whereas the Asian isolates either exhibited a small plaque phenotype (similar to 1-2 mm) or did not produce any plaques. In multistep replication kinetics in nine different vertebrate and insect cell lines, the African isolate consistently displayed faster replication kinetics and yielded similar to 10- to 10,000-fold higher peak virus titers (infectious or RNA copies) compared with the Asian isolates. Oral exposure of Aedes aegypti mosquitoes with the African isolate yielded higher infection and dissemination rates compared with the Asian isolates. Infection of Ifnar1(-/-) mice with the African isolate produced a uniformly fatal disease, whereas infection with the Asian isolates produced either a delay in time-to-death or a significantly lower mortality rate. Last, the African isolate was > 10,000-fold more virulent than the Asian isolates in an interferon type I antibody blockade mouse model. These data demonstrate substantial phenotypic differences between low-passage African and Asian isolates both in vitro and in vivo and warrant further investigation. They also highlight the need for basic characterization of ZIKV isolates, as the utilization of the uncharacterized isolates could have consequences for animal model and therapeutic/vaccine development.
C1 [Smith, Darci R.; Sprague, Thomas R.; Hollidge, Bradley S.; Valdez, Stephanie M.; Padilla, Susana L.; Bellanca, Stephanie A.; Golden, Joseph W.; Miller, Lynn Jean; Haddow, Andrew D.; Lowen, Robert G.; Bavari, Sina; Pitt, Margaret L.; Nasar, Farooq] US Army Med Res Inst Infect Dis, Virol Div, 1301 Ditto Ave, Frederick, MD 21702 USA.
   [Coyne, Susan R.; Kulesh, David A.; Koehler, Jeff W.; Minogue, Timothy D.] US Army Med Res Inst Infect Dis, Diagnost Syst Div, Frederick, MD USA.
   [Gromowski, Gregory D.; Jarman, Richard G.] Walter Reed Army Inst Res, Silver Spring, MD USA.
   [Alera, Maria Theresa P.] Armed Forces Res Inst Med Sci, Dept Virol, Bangkok, Thailand.
   [Yoon, In-Kyu] Int Vaccine Inst, Seoul, South Korea.
   [Buathong, Rome] Minist Publ Hlth, Dept Dis Control, Bur Epidemiol, Nonthaburi, Thailand.
   [Kane, Christopher D.] US Army Med Res Inst Infect Dis, Mol & Translat Sci Div, Frederick, MD USA.
   [Tesh, Robert B.; Weaver, Scott C.] Univ Texas Med Branch, Inst Human Infect & Immun, Ctr Trop Dis, Galveston, TX 77555 USA.
   [Tesh, Robert B.; Weaver, Scott C.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
   [Tesh, Robert B.; Weaver, Scott C.; Nasar, Farooq] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
   [Linthicum, Kenneth J.] ARS, Ctr Med Agr & Vet Entomol, USDA, Gainesville, FL USA.
   [Bellanca, Stephanie A.; Haddow, Andrew D.; Lowen, Robert G.] US Army Med Res Inst Infect Dis, Dept Entomol, Ft Detrick, MD USA.
   [Coyne, Susan R.; Kulesh, David A.; Koehler, Jeff W.; Minogue, Timothy D.] US Army Med Res Inst Infect Dis, Diagnost Syst Div, Ft Detrick, MD USA.
   [Gromowski, Gregory D.; Jarman, Richard G.] Walter Reed Army Inst Res, Viral Dis Branch, Silver Spring, MD USA.
   [Alera, Maria Theresa P.] Philippines Armed Forces Res Inst Med Sci, Virol Res Unit, Cebu, Philippines.
   [Yoon, In-Kyu] Int Vaccine Inst, Dept Dengue, Seoul, South Korea.
   [Kane, Christopher D.] US Army Med Res Inst Infect Dis, Mol & Translat Sci Div, Therapeut Dev Ctr, Ft Detrick, MD USA.
   [Bavari, Sina; Pitt, Margaret L.] US Army Med Res Inst Infect Dis, Ft Detrick, MD USA.
   [Linthicum, Kenneth J.] Ctr Med Agr & Vet Entomol, Gainesville, FL USA.
RP Smith, DR (corresponding author), US Army Med Res Inst Infect Dis, Virol Div, 1301 Ditto Ave, Frederick, MD 21702 USA.; Nasar, F (corresponding author), US Army Med Res Inst Infect Dis, Div Virol, 1425 Porter St, Frederick, MD 21702 USA.
EM darci.r.smith.ctr@mail.mil; thomas.r.sprague7.ctr@mail.mil;
   bradley.s.hollidge.ctr@mail.mil; stephanie.m.valdez5.ctr@mail.mil;
   susana.l.padilla.mil@mail.mil; stephanie.a.bellanca.ctr@mail.mil;
   joseph.w.golden.ctr@mail.mil; susan.r.coyne.civ@mail.mil;
   david.a.kulesh.civ@mail.mil; lynn.j.miller.mil@mail.mil;
   andrew.d.haddow.ctr@mail.mil; jeff.w.koehler.ctr@mail.mil;
   gregory.d.gromowski.civ@mail.mil; richard.g.jarman.mil@mail.mil;
   mariatheresa.alera.ca@afrims.org; inkyu.yoon@ivi.int;
   romebua@health2.moph.go.th; robert.g.lowen.mil@mail.mil;
   christopher.d.kane.ctr@mail.mil; timothy.d.minogue.civ@mail.mil;
   sina.bavari.civ@mail.mil; rtesh@utmb.edu; sweaver@utmb.edu;
   kenneth.linthicum@ars.usda.gov; margaret.l.pitt.civ@mail.mil;
   farooq.nasar.ctr@mail.mil
RI Nasar, Farooq/C-7659-2019; Kane, Christopher/C-8256-2019; Bavari,
   Sina/L-3642-2019; Haddow, Andrew D/C-5902-2008; Pitt, Margaret
   Louise/AAD-3437-2019
OI Nasar, Farooq/0000-0003-3658-9649; Kane,
   Christopher/0000-0002-0469-1668; Bavari, Sina/0000-0001-8424-5635;
   Haddow, Andrew D/0000-0002-8957-2608; Pitt, Margaret
   Louise/0000-0003-0080-3260; Golden, Joseph/0000-0002-9709-313X; ,
   Stephanie/0000-0001-8385-0462
FU Defense Advanced Research Projects AgencyUnited States Department of
   DefenseDefense Advanced Research Projects Agency (DARPA); National
   Research Council Research Associateship
FX This study was supported by a grant from the Defense Advanced Research
   Projects Agency. Dr. B. S. H. is supported by National Research Council
   Research Associateship.
CR Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227
   Arroyo J, 2004, J VIROL, V78, P12497, DOI 10.1128/JVI.78.22.12497-12507.2004
   Arroyo J, 2001, J VIROL, V75, P934, DOI 10.1128/JVI.75.2.934-942.2001
   Beasley DWC, 2005, J VIROL, V79, P8339, DOI 10.1128/JVI.79.13.8339-8347.2005
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Bray M, 1998, J VIROL, V72, P1647, DOI 10.1128/JVI.72.2.1647-1651.1998
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Chan JFW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.99
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   de Wispelaere M, 2012, J VIROL, V86, P7072, DOI 10.1128/JVI.00224-12
   Deardorff ER, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002335
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duggal NK, 2017, AM J TROP MED HYG, V97, P1410, DOI 10.4269/ajtmh.17-0263
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Ellison DW, 2016, GENOME ANNOUNC, V4
   Erb SM, 2010, VIROLOGY, V406, P328, DOI 10.1016/j.virol.2010.07.024
   FAGBAMI A, 1977, TROP GEOGR MED, V29, P187
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   FELSENSTEIN J, 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X
   Fields BN, 2013, FLAVIVIRIDAE FIELDS
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Goo L, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006178
   Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Gromowski GD, 2015, J VIROL, V89, P6328, DOI 10.1128/JVI.00219-15
   Grubaugh ND, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004874
   Gualano RC, 1998, J GEN VIROL, V79, P437, DOI 10.1099/0022-1317-79-3-437
   Haddow AD, 2017, EMERG INFECT DIS, V23, P1274, DOI 10.3201/eid2308.170036
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hurrelbrink RJ, 2001, J VIROL, V75, P7692, DOI 10.1128/JVI.75.16.7692-7702.2001
   JAN C, 1978, B SOC PATHOL EXOT, V71, P140
   Jerzak GVS, 2008, VIROLOGY, V374, P256, DOI 10.1016/j.virol.2008.02.032
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Ladner J. T, 2016, GENOME ANNOUNC, V4
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Liu WJ, 2003, J VIROL, V77, P7804, DOI 10.1128/JVI.77.14.7804-7813.2003
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Mandl CW, 2000, J VIROL, V74, P9601, DOI 10.1128/JVI.74.20.9601-9609.2000
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Monath TP, 2002, J VIROL, V76, P1932, DOI 10.1128/JVI.76.4.1932-1943.2002
   MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Muylaert IR, 1997, J VIROL, V71, P291, DOI 10.1128/JVI.71.1.291-298.1997
   Oehler E., 2014, Eurosurveillance, V19, P20720
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   PILITT DR, 1972, J MED ENTOMOL, V9, P334, DOI 10.1093/jmedent/9.4.334
   Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817
   Prestwood TR, 2008, J VIROL, V82, P8411, DOI 10.1128/JVI.00611-08
   Robin Y., 1975, Bulletin Soc Path Exot, V68, P249
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Rumyantsev AA, 2006, J VIROL, V80, P1427, DOI 10.1128/JVI.80.3.1427-1439.2006
   SALUZZO JF, 1981, B SOC PATHOL EXOT, V74, P490
   SALUZZO JF, 1982, B SOC PATHOL EXOT, V75, P262
   Setoh YX, 2017, MSPHERE, V2, DOI [10.1128/mSphereDirect.00190-17, 10.1128/mspheredirect.00190-17]
   Simonin Y, 2016, EBIOMEDICINE, V12, P161, DOI 10.1016/j.ebiom.2016.09.020
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Smith DR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005296
   Tajima S, 2010, VIROLOGY, V396, P298, DOI 10.1016/j.virol.2009.10.035
   Vasilakis N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000467
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   Widman DG, 2017, MBIO, V8, DOI [10.1128/mBio.02014-16, 10.1128/mbio.02014-16]
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhao ZJ, 2005, J GEN VIROL, V86, P2209, DOI 10.1099/vir.0.80638-0
NR 74
TC 25
Z9 25
U1 0
U2 9
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 98
IS 2
BP 432
EP 444
DI 10.4269/ajtmh.17-0685
PG 13
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA GE1BC
UT WOS:000430950800015
PM 29280428
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Oliveira, J
   Felzemburgh, R
   Costa, F
   Nery, N
   Mattos, A
   Henriques, DF
   Ko, AI
AF Oliveira-Filho, Jamary
   Felzemburgh, Ridalva
   Costa, Federico
   Nery, Nivison, Jr.
   Mattos, Adriana
   Henriques, Daniele F.
   Ko, Albert I.
CA Salvador Zika Response Team
TI Seizures as a Complication of Congenital Zika Syndrome in Early Infancy
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID VIRUS SYNDROME
AB Zika virus transmission in Brazil was linked to a large outbreak of microcephaly but less is known about longer term anthropometric and neurological outcomes. We studied a cohort of infants born between October 31, 2015, and January 9, 2016, in a state maternity hospital, followed up for 101 +/- 28 days by home visits. Microcephaly (< 2 standard deviations, Intergrowth standard) occurred in 62 of 412 (15%) births. Congenital Zika syndrome (CZS) was diagnosed in 29 patients. Among CZS patients, we observed a significant gain in anthropometric measures (P < 0.001) but no significant gain in percentile for these measures. The main neurological outcome was epilepsy, occurring in 48% of infants at a rate of 15.6 cases per 100 patient-months, frequently requiring multiple anti-seizure medications. The cumulative fatality rate was 7.4% (95% confidence interval: 2.1-23.4%). Health-care professionals should be alerted on the high risk of epilepsy and death associated with CZS in early infancy and the need to actively screen for seizures and initiate timely treatment.
C1 [Oliveira-Filho, Jamary] Univ Fed Bahia, Postgrad Program Hlth Sci, Fac Med Bahia, Salvador, BA, Brazil.
   [Felzemburgh, Ridalva; Costa, Federico] Univ Fed Bahia, Inst Saude, Escola Enfermagem, Salvador, BA, Brazil.
   [Felzemburgh, Ridalva; Costa, Federico] Univ Fed Bahia, Fac Med Bahia, Salvador, BA, Brazil.
   [Nery, Nivison, Jr.; Ko, Albert I.] Fundacao Oswaldo Cruz, Minist Saude, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.
   [Mattos, Adriana] Hosp Geral Roberto Santos, Secretaria Estadual Saude Bahia, Salvador, BA, Brazil.
   [Henriques, Daniele F.] Inst Evandro Chagas, Belem, Para, Brazil.
   [Ko, Albert I.] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Oliveira-Filho, Jamary] Univ Fed Bahia, Inst Ciencias Saude, Dept Biomorphol, Salvador, BA, Brazil.
   [Felzemburgh, Ridalva] Univ Fed Bahia, Escola Enfermagem, Salvador, BA, Brazil.
   [Costa, Federico; Nery, Nivison, Jr.] Fundacao Oswaldo Cruz, Lab Pathol & Mol Biol, Salvador, BA, Brazil.
   [Costa, Federico] Yale Univ, Yale Sch Publ Hlth, New Haven, CT USA.
   [Mattos, Adriana] Univ Fed Bahia, Postgrad Program Hlth Sci, Salvador, BA, Brazil.
   [Henriques, Daniele F.] Inst Evandro Chagas, Rio De Janeiro, Brazil.
   [Ko, Albert I.] Fundacao Oswaldo Cruz FIOCRUZ, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.
RP Oliveira, J (corresponding author), Inst Ciencias Saude, Rua Reitor Miguel Calmon,Sala 415, BR-40110100 Salvador, BA, Brazil.
EM jamary@mail.harvard.edu; ridalva@gmail.com; fcosta2001@gmail.com;
   nivisonjr@hotmail.com; dricamattos@gmail.com;
   danielehenriques@iec.gov.br; albert.ko@yale.edu
RI Costa, Federico/G-1838-2015; Oliveira-Filho, Jamary/B-6441-2016; Ko,
   Albert Icksang/P-2343-2015
OI Costa, Federico/0000-0001-6951-2336; Oliveira-Filho,
   Jamary/0000-0003-1915-0423; Ko, Albert Icksang/0000-0001-9023-2339;
   Rocha Nery Junior, Nivison Ruy/0000-0002-8164-0602
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [RO1 NS064905, R01 AI052473, U01
   AI088752, R25 TW009338]; Oswaldo Cruz Foundation
FX This study was supported by NIH Grants RO1 NS064905, NIH R01 AI052473,
   U01 AI088752, and R25 TW009338, and the Oswaldo Cruz Foundation.
CR Costa F, 2016, ANN INTERN MED, V164, P689, DOI 10.7326/M16-0332
   Carvalho MDCG, 2017, CLIN NEUROPHYSIOL, V128, P204, DOI 10.1016/j.clinph.2016.11.004
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Ito Y, 2013, PEDIATR INT, V55, P566, DOI 10.1111/ped.12122
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [DOI 10.1001/JAMA0PHTHALM0L.2016.0267, 10.1001/jamaophthalmol.2016.0267]
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Satterfield-Nash A, 2017, MMWR-MORBID MORTAL W, V66, P1347, DOI 10.15585/mmwr.mm6649a2
NR 8
TC 6
Z9 6
U1 0
U2 2
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 98
IS 6
BP 1860
EP 1862
DI 10.4269/ajtmh.17-1020
PG 3
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA GL4CN
UT WOS:000437095000050
PM 29692307
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Joob, B
   Wiwanitkit, V
AF Joob, Beuy
   Wiwanitkit, Viroj
TI Zika virus infection as a trigger of atopic dermatitis
SO ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
LA English
DT Letter
C1 [Joob, Beuy] Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Hainan, Peoples R China.
RP Joob, B (corresponding author), Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
EM beuyjoob@hotmail.com
CR Cosme-Blanco W, 2017, ANN ALLERG ASTHMA IM, V119, P459, DOI 10.1016/j.anai.2017.07.007
   Gourru-Lesimple G, 2017, J DERMATOL SCI, V86, P97, DOI 10.1016/j.jdermsci.2017.01.015
   Kim HY, 2017, J EUR ACAD DERMATOL, V31, P1505, DOI 10.1111/jdv.14428
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P499, DOI 10.1016/j.apjtm.2016.03.036
NR 4
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1081-1206
EI 1534-4436
J9 ANN ALLERG ASTHMA IM
JI Ann. Allergy Asthma Immunol.
PD JAN
PY 2018
VL 120
IS 1
BP 107
EP 107
PG 1
WC Allergy; Immunology
SC Allergy; Immunology
GA FQ6OY
UT WOS:000418485100026
PM 29273121
DA 2020-07-08
ER

PT J
AU Howells, ME
   Lynn, CD
   Weaver, LJ
   Langford-Sesepesara, M
   Tufa, J
AF Howells, Michaela E.
   Lynn, Christopher D.
   Weaver, Lesley Jo
   Langford-Sesepesara, Margaret
   Tufa, Joseph
TI Zika virus in American Samoa: challenges to prevention in the context of
   health disparities and non-communicable disease
SO ANNALS OF HUMAN BIOLOGY
LA English
DT Article
DE Zika virus; pre-natal care; sexual health; dual burden; American Samoa
ID PRENATAL-CARE UTILIZATION; PUBLIC-HEALTH; PACIFIC
AB Background: Zika virus (ZIKV) is linked to deleterious foetal and neonate outcomes. Maternal exposure to ZIKV through mosquitoes and sexual fluids creates a public health challenge for communities and policymakers, which is exacerbated by high levels of chronic non-communicable diseases in American Samoa.
   Aim: This study aimed to identify structural barriers to ZIKV prevention in American Samoa and situate them within locally relevant cultural and epidemiological contexts.
   Subjects and methods: This study assessed knowledge, attitudes and access to ZIKV prevention among 180 adults in American Samoan public health clinics. It queried knowledge about pre-natal care, protection against mosquitoes and condom use.
   Results: Women were most likely to identify pre-natal care as important. The majority of participants were able to identify how to prevent mosquito bites, but may have been unable to follow through due to socioeconomic and infrastructure limitations. Few participants identified condom use as a preventative measure against ZIKV. Prevention misconceptions were most pronounced in women of low socioeconomic status.
   Conclusions: These findings reinforce the need for a multi-pronged approach to ZIKV. This study highlights the need for information on culturally specific barriers and recognition of additional challenges associated with dual burden in marginal populations where social inequalities exacerbate health issues.
C1 [Howells, Michaela E.] Univ N Carolina, Dept Anthropol, Wilmington, NC 28401 USA.
   [Lynn, Christopher D.; Weaver, Lesley Jo] Univ Alabama, Dept Anthropol, Tuscaloosa, AL USA.
   [Langford-Sesepesara, Margaret; Tufa, Joseph] Amer Samoa Dept Hlth, Pago Pago, AS USA.
RP Howells, ME (corresponding author), Univ N Carolina, 601 South Coll Rd, Wilmington, NC 28403 USA.
EM howellsm@uncw.edu
CR Alvarado MG, 2017, ARCH PATHOL LAB MED, V141, P26, DOI 10.5858/arpa.2016-0382-RA
   American Samoa Department of Commerce, 2007, AM SSAM AT A GLANC
   [Anonymous], 2014, AM SAM PAR NEED CONV
   Black KJ., 2013, HDB SEXUALITY RELATE, P179
   Brener N.D., 2011, SCH HLTH PROFILES 20
   Brownson RC, 2017, EVIDENCE BASED PUBLI
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   CDC, 2017, ZIK VIR TEST DIANG
   CDC, 2016, ZIK VIR PROT YOURS O
   CDC, 2017, ZIK VIR CLIN EV DIS
   CDC, 2017, ZIK VIR
   Centers for Disease Control, 2011, YOUTH RISK BEH SURV
   Central Intelligence Agency, 2013, WORLD FACTBOOK
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Clark T, 2008, SOCIOLOGY, V42, P953, DOI 10.1177/0038038508094573
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   DePue JD, 2010, AM J PUBLIC HEALTH, V100, P2085, DOI 10.2105/AJPH.2009.170134
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Diniz D., 2017, ZIKA BRAZILIAN BACKL
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Hawley NL, 2014, MATERN CHILD HLTH J, V18, P2284, DOI 10.1007/s10995-013-1368-9
   Hewlett BS, 2003, EMERG INFECT DIS, V9, P1242
   Holme L, 1992, SAMOAN VILLAGE THEN
   Horwood P, 2013, WEST PAC SURVEILL RE, V4, DOI [10.5365/wpsar.2013.4.2.003, 10.5365/WPSAR.2013.4.2.003]
   Howells M, 2018, MATERNAL HLTH PREGNA
   Howells M, 2016, PAC J REPROD HLTH, V1, P102
   Howells M., 2013, MATERNAL PSYCHOSOCIA
   Kennedy J., 2009, OCEANIC LING, P55
   KOTELCHUCK M, 1994, AM J PUBLIC HEALTH, V84, P1414, DOI 10.2105/AJPH.84.9.1414
   Madon T, 2007, SCIENCE, V318, P1728, DOI 10.1126/science.1150009
   McGarvey S T, 2001, Pac Health Dialog, V8, P157
   McMillan K, 2011, CULT HEALTH SEX, V13, P313, DOI 10.1080/13691058.2010.529945
   Nunnally J. C., 1994, PSYCHOMETRIC THEORY
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Paul Benjamin D., 1955, HLTH CULTURE COMMUNI
   Pfeiffer J, 2008, MED ANTHROPOL Q, V22, P410, DOI 10.1111/j.1548-1387.2008.00041.x
   Roth Adam, 2014, Emerg Infect Dis, V20, DOI 10.3201/eid2008.130696
   Scrimshaw NS, 1992, RAD RAPID ASSESSMENT
   Tambo E, 2016, J INFECT PUBLIC HEAL, V9, P240, DOI 10.1016/j.jiph.2016.02.005
   US Department of Health & Human Services, 2017, HLTH RES SERV ADM DA
   WHO, 2014, AM SAM STEPS SURV FA
   Young Leslie Heather, 2002, Pac Health Dialog, V9, P296
NR 44
TC 4
Z9 4
U1 2
U2 2
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0301-4460
EI 1464-5033
J9 ANN HUM BIOL
JI Ann. Hum. Biol.
PY 2018
VL 45
IS 3
SI SI
BP 229
EP 238
DI 10.1080/03014460.2018.1465594
PG 10
WC Anthropology; Biology; Public, Environmental & Occupational Health
SC Anthropology; Life Sciences & Biomedicine - Other Topics; Public,
   Environmental & Occupational Health
GA GI5UW
UT WOS:000434437100007
PM 29877152
DA 2020-07-08
ER

PT S
AU Ngono, AE
   Shresta, S
AF Ngono, Annie Elong
   Shresta, Sujan
BE Littman, DR
   Yokoyama, WM
TI Immune Response to Dengue and Zika
SO ANNUAL REVIEW OF IMMUNOLOGY, VOL 36
SE Annual Review of Immunology
LA English
DT Review; Book Chapter
DE dengue; Zika; adaptive immunity; innate immunity; vaccine
ID T-CELL RESPONSES; ANTIBODY-DEPENDENT ENHANCEMENT; WEST NILE VIRUS; HUMAN
   NEUTRALIZING ANTIBODIES; HUMAN PLACENTAL TROPHOBLASTS; GLYCOPROTEIN
   PROTECT MICE; BLOOD MONONUCLEAR-CELLS; ORIGINAL ANTIGENIC SIN; MOUSE
   MODEL; RIG-I
AB Flaviviruses such as dengue (DENV), yellow fever (YFV), West Nile (WNV), and Zika (ZIKV) are human pathogens of global significance. In particular, DENV causes the most prevalent mosquito-borne viral diseases in humans, and ZIKV emerged from obscurity into the spotlight in 2016 as the etiologic agent of congenital Zika syndrome. Owing to the recent emergence of ZIKV as a global pandemic threat, the roles of the immune system during ZIKV infections are as yet unclear. In contrast, decades of DENV research implicate a dual role for the immune system in protection against and pathogenesis of DENV infection. As DENV and ZIKV are closely related, knowledge based on DENV studies has been used to prioritize investigation of ZIKV immunity and pathogenesis, and to accelerate ZIKV diagnostic, therapeutic, and vaccine design. This review discusses the following topics related to innate and adaptive immune responses to DENV and ZIKV: the interferon system as the key mechanism of host defense and viral target for immune evasion, antibody-mediated protection versus antibody- dependent enhancement, and T cell-mediated protection versus original T cell antigenic sin. Understanding the mechanisms that regulate the balance between immune-mediated protection and pathogenesis during DENV and ZIKV infections is critical toward development of safe and effective DENV and ZIKV therapeutics and vaccines.
C1 [Ngono, Annie Elong; Shresta, Sujan] La Jolla Inst Allergy & Immunol, Div Inflammat Biol, La Jolla, CA 92037 USA.
RP Shresta, S (corresponding author), La Jolla Inst Allergy & Immunol, Div Inflammat Biol, La Jolla, CA 92037 USA.
EM sujan@lji.org
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01 AI116813, R21 AI127988]; NINDS NIH
   HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Neurological
   Disorders & Stroke (NINDS) [R21 NS100477]
CR Aagaard KM, 2017, SCI REP-UK, V7, DOI 10.1038/srep41389
   Aguirre S, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.37
   Aguirre S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002934
   Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Alcendor DJ, 2017, J INFECT DIS, V216, P162, DOI 10.1093/infdis/jix171
   Ashour J, 2010, CELL HOST MICROBE, V8, P410, DOI 10.1016/j.chom.2010.10.007
   Azevedo RSS, 2016, J CLIN VIROL, V85, P56, DOI 10.1016/j.jcv.2016.10.024
   Balinsky CA, 2017, J VIROL, V91, DOI [10.1128/JVI.01606-16, 10.1128/jvi.01606-16]
   Balsitis SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000790
   Balsitis SJ, 2009, AM J TROP MED HYG, V80, P416, DOI 10.4269/ajtmh.2009.80.416
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Barouch DH, 2017, IMMUNITY, V46, P176, DOI 10.1016/j.immuni.2017.02.005
   Barzon L., 2016, EUROSURVEILLANCE, V21, P2016, DOI DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Beatty PR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3787
   Becquart P, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-356
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bhoopat L, 1996, ASIAN PAC J ALLERGY, V14, P107
   Bidet K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004242
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Blackley S, 2007, J VIROL, V81, P13325, DOI 10.1128/JVI.01568-07
   Boonnak K, 2008, J VIROL, V82, P3939, DOI 10.1128/JVI.02484-07
   Boonnak K, 2013, J IMMUNOL, V190, P5659, DOI 10.4049/jimmunol.1203052
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017
   Brault JB, 2016, EBIOMEDICINE, V10, P71, DOI 10.1016/j.ebiom.2016.07.018
   Brien JD, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002230
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carnec X, 2016, J VIROL, V90, P92, DOI 10.1128/JVI.01849-15
   Cerny D, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004548
   Chan KR, 2014, P NATL ACAD SCI USA, V111, P2722, DOI 10.1073/pnas.1317454111
   Chan KR, 2011, P NATL ACAD SCI USA, V108, P12479, DOI 10.1073/pnas.1106568108
   Chan YK, 2016, NAT IMMUNOL, V17, P523, DOI 10.1038/ni.3393
   Chang DC, 2016, VIROLOGY, V499, P259, DOI 10.1016/j.virol.2016.09.022
   Chareonsirisuthigul T, 2007, J GEN VIROL, V88, P365, DOI 10.1099/vir.0.82537-0
   Chatel-Chaix L, 2016, CELL HOST MICROBE, V20, P342, DOI 10.1016/j.chom.2016.07.008
   Chen HW, 2013, J IMMUNOL, V191, P4194, DOI 10.4049/jimmunol.1300799
   Chen JC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005053
   Chen JC, 2016, INT J INFECT DIS, V51, P139, DOI 10.1016/j.ijid.2016.07.015
   Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866
   Chu HY, 2015, J INFECT DIS, V212, P1618, DOI 10.1093/infdis/jiv258
   Cologna R, 2003, J VIROL, V77, P3929, DOI 10.1128/JVI.77.7.3929-3938.2003
   Colt S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005528
   Couvelard A, 1999, HUM PATHOL, V30, P1106, DOI 10.1016/S0046-8177(99)90230-7
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489
   Dalrymple NA, 2015, MBIO, V6, DOI 10.1128/mBio.00553-15
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   de Alwis R, 2016, J VIROL, V90, P4771, DOI 10.1128/JVI.02892-15
   de Alwis R, 2012, P NATL ACAD SCI USA, V109, P7439, DOI 10.1073/pnas.1200566109
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Decembre E, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004434
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Dejnirattisai W, 2011, J INFECT DIS, V203, P1775, DOI 10.1093/infdis/jir173
   Diamond MS, 2000, J VIROL, V74, P4957, DOI 10.1128/JVI.74.11.4957-4966.2000
   Diamond MS, 2001, VIROLOGY, V289, P297, DOI 10.1006/viro.2001.1114
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005048
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Duangchinda T, 2010, P NATL ACAD SCI USA, V107, P16922, DOI 10.1073/pnas.1010867107
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Durbin AP, 2008, VIROLOGY, V376, P429, DOI 10.1016/j.virol.2008.03.028
   Edeling MA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004072
   El Costa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35296
   Fernandez E, 2017, CURR OPIN VIROL, V23, P59, DOI 10.1016/j.coviro.2017.03.006
   Fibriansah G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7341
   Froeschl G, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2123-9
   Fu BS, 2017, J EXP MED, V214, P919, DOI 10.1084/jem.20161270
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Gack MU, 2016, CURR OPIN VIROL, V20, P119, DOI 10.1016/j.coviro.2016.09.013
   Goncalvez AP, 2007, P NATL ACAD SCI USA, V104, P9422, DOI 10.1073/pnas.0703498104
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Gubler DJ, 2012, AM J TROP MED HYG, V86, P743, DOI 10.4269/ajtmh.2012.12-0157
   Guzman MG, 2000, AM J EPIDEMIOL, V152, P804, DOI 10.1093/aje/152.9.804
   HALL WC, 1991, AM J TROP MED HYG, V45, P408, DOI 10.4269/ajtmh.1991.45.408
   HALSTEAD SB, 1973, J INFECT DIS, V128, P15, DOI 10.1093/infdis/128.1.15
   HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268
   HALSTEAD SB, 1979, J INFECT DIS, V140, P527, DOI 10.1093/infdis/140.4.527
   Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hasan SS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14722
   Hastings AK, 2017, CELL REP, V19, P558, DOI 10.1016/j.celrep.2017.03.058
   Hatch S, 2011, J INFECT DIS, V203, P1282, DOI 10.1093/infdis/jir012
   He ZJ, 2016, J VIROL, V90, P7219, DOI 10.1128/JVI.00221-16
   Helbig KJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002178
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Hou WH, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2338-4
   Huerre MR, 2001, VIRCHOWS ARCH, V438, P107
   Jessie K, 2004, J INFECT DIS, V189, P1411, DOI 10.1086/383043
   Jiang D, 2010, J VIROL, V84, P8332, DOI 10.1128/JVI.02199-09
   Johnson AJ, 1999, J VIROL, V73, P783, DOI 10.1128/JVI.73.1.783-786.1999
   Junjhon J, 2008, J VIROL, V82, P10776, DOI 10.1128/JVI.01180-08
   Jurado KA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88461
   KAUFMAN BM, 1987, AM J TROP MED HYG, V36, P427, DOI 10.4269/ajtmh.1987.36.427
   KAUFMAN BM, 1989, AM J TROP MED HYG, V41, P576, DOI 10.4269/ajtmh.1989.41.576
   KURANE I, 1993, AM J TROP MED HYG, V48, P222, DOI 10.4269/ajtmh.1993.48.222
   Kyle JL, 2008, VIROLOGY, V380, P296, DOI 10.1016/j.virol.2008.08.008
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003118
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Lin RJ, 2009, J IMMUNOL, V183, P8035, DOI 10.4049/jimmunol.0902728
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Lindow JC, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001742
   Liu H, 2017, J VIROL, V91, DOI [10.1128/JVI.02234-16, 10.1128/jvi.02234-16]
   Liu SF, 2016, CIRC RES, V119, P1183, DOI [10.1161/CIRCRESAHA.116.309866, 10.1161/circresaha.116.309866]
   Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07
   Malkki H, 2016, NAT REV NEUROL, V12, DOI [10.1038/nrneurol.2016.30, 10.1038/nrneurol.2016.139, 10.1038/nrneurol.2016.151, 10.1038/nrneurol.2016.175, 10.1038/nrneurol.2016.22, 10.1038/nrneurol.2016.117, 10.1038/nrneurol.2016.78, 10.1038/nrneurol.2016.79, 10.1038/nrneurol.2016.58, 10.1038/nrneurol.2016.52]
   Mangada MM, 2005, J IMMUNOL, V175, P2676, DOI 10.4049/jimmunol.175.4.2676
   Mangada MM, 2002, J INFECT DIS, V185, P1697, DOI 10.1086/340822
   Manokaran G, 2015, SCIENCE, V350, P217, DOI 10.1126/science.aab3369
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Messer WB, 2003, EMERG INFECT DIS, V9, P800
   Miller JL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040017
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Modhiran N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3863
   Modis Y, 2005, J VIROL, V79, P1223, DOI 10.1128/JVI.79.2.1223-1231.2005
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   MORENS DM, 1987, J MED VIROL, V22, P169, DOI 10.1002/jmv.1890220208
   Morrison J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003265
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Nasirudeen AMA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000926
   Navarro-Sanchez E, 2003, EMBO REP, V4, P723, DOI 10.1038/sj.embor.embor866
   Ng JKW, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004031
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Ngono AE, 2016, EBIOMEDICINE, V13, P284, DOI 10.1016/j.ebiom.2016.10.006
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Odendall C, 2014, NAT IMMUNOL, V15, P717, DOI 10.1038/ni.2915
   Olagnier D, 2014, J VIROL, V88, P4180, DOI 10.1128/JVI.03114-13
   Orozco S, 2012, J GEN VIROL, V93, P2152, DOI 10.1099/vir.0.045088-0
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Pagani I, 2017, SCI REP-UK, V7, DOI 10.1038/srep44286
   Pardy RD, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006184
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Perry ST, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001297
   Perry ST, 2009, J VIROL, V83, P8276, DOI 10.1128/JVI.00365-09
   Pierson TC, 2007, CELL HOST MICROBE, V1, P135, DOI 10.1016/j.chom.2007.03.002
   Pierson TC, 2016, CELL, V167, P625, DOI 10.1016/j.cell.2016.09.020
   Pierson Theodore C., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000665
   Pinto AK, 2015, MBIO, V6, DOI 10.1128/mBio.01316-15
   Prasad VM, 2017, NAT STRUCT MOL BIOL, V24, P184, DOI 10.1038/nsmb.3352
   Prestwood TR, 2008, J VIROL, V82, P8411, DOI 10.1128/JVI.00611-08
   Prestwood TR, 2012, J VIROL, V86, P12561, DOI 10.1128/JVI.06743-11
   Prestwood TR, 2012, J VIROL, V86, P12138, DOI 10.1128/JVI.00375-12
   Priyamvada L, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.42
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Ramos C, 1998, J NEUROVIROL, V4, P465, DOI 10.3109/13550289809114548
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Rivino L, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa0526
   Rivino L, 2013, J VIROL, V87, P2693, DOI 10.1128/JVI.02675-12
   Roach T, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0824-7
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Rodenhuis-Zybert IA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000718
   Rodrigo WWSI, 2006, J VIROL, V80, P10128, DOI 10.1128/JVI.00792-06
   Rosenberg AZ, 2017, ARCH PATHOL LAB MED, V141, P43, DOI 10.5858/arpa.2016-0401-OA
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014
   SABIN ALBERT B., 1952, AMER JOUR TROP MED AND HYG, V1, P30
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Savidis G, 2016, CELL REP, V15, P2323, DOI 10.1016/j.celrep.2016.05.074
   Schmid B, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005345
   Schmid MA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004541
   Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231
   Schoggins JW, 2012, P NATL ACAD SCI USA, V109, P14610, DOI 10.1073/pnas.1212379109
   Schuberth-Wagner C, 2015, IMMUNITY, V43, P41, DOI 10.1016/j.immuni.2015.06.015
   Schwartz DA, 2017, ARCH GYNECOL OBSTET, V295, P1361, DOI 10.1007/s00404-017-4361-5
   Shresta S, 2005, J IMMUNOL, V175, P3946, DOI 10.4049/jimmunol.175.6.3946
   Shresta S, 2004, J VIROL, V78, P2701, DOI 10.1128/JVI.78.6.2701-2710.2004
   Shrestha B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000823
   Simmons CP, 2007, J INFECT DIS, V195, P1097, DOI 10.1086/512162
   Singh PK, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92340
   Solomon T, 2000, LANCET, V355, P1053, DOI 10.1016/S0140-6736(00)02036-5
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Sukupolvi-Petty S, 2007, J VIROL, V81, P12816, DOI 10.1128/JVI.00432-07
   Sun PF, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002298
   Suthar MS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003541
   Suzuki Y, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005357
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tan JJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08806-0
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tang WW, 2016, CELL REP, V17, P3091, DOI 10.1016/j.celrep.2016.11.070
   Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840
   Tolfvenstam T, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-209
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Tsai WY, 2015, J VIROL, V89, P7348, DOI 10.1128/JVI.00273-15
   Tsai WY, 2013, J VIROL, V87, P12562, DOI 10.1128/JVI.00871-13
   Uraki R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602899
   van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898
   vandenBroek MF, 1995, IMMUNOL REV, V148, P5
   Wahala WMPB, 2009, VIROLOGY, V392, P103, DOI 10.1016/j.virol.2009.06.037
   Wahala WMPB, 2011, VIRUSES-BASEL, V3, P2374, DOI 10.3390/v3122374
   Wang JP, 2006, J IMMUNOL, V177, P7114, DOI 10.4049/jimmunol.177.10.7114
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Wang TT, 2017, SCIENCE, V355, P395, DOI 10.1126/science.aai8128
   Watrin L, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003257
   Weiskopf D, 2015, J INFECT DIS, V212, P1743, DOI 10.1093/infdis/jiv289
   Weiskopf D, 2015, P NATL ACAD SCI USA, V112, pE4256, DOI 10.1073/pnas.1505956112
   Weiskopf D, 2015, J VIROL, V89, P120, DOI 10.1128/JVI.02129-14
   Weiskopf D, 2014, J VIROL, V88, P11383, DOI 10.1128/JVI.01108-14
   Weiskopf D, 2013, P NATL ACAD SCI USA, V110, pE2046, DOI 10.1073/pnas.1305227110
   Weiskopf D, 2011, J IMMUNOL, V187, P4268, DOI 10.4049/jimmunol.1101970
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36
   Wies E, 2013, IMMUNITY, V38, P437, DOI 10.1016/j.immuni.2012.11.018
   Winkler CW, 2017, J IMMUNOL, V198, P3526, DOI 10.4049/jimmunol.1601949
   Wu SJL, 2000, NAT MED, V6, P816, DOI 10.1038/77553
   Xu Xiaojun, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.9aa2e1fb61b0f632f58a098773008c4b
   Yamanaka A, 2008, J VIROL, V82, P927, DOI 10.1128/JVI.00992-07
   Yauch LE, 2010, J IMMUNOL, V185, P5405, DOI 10.4049/jimmunol.1001709
   Yauch LE, 2009, J IMMUNOL, V182, P4865, DOI 10.4049/jimmunol.0801974
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   You J, 2015, J VIROL, V89, P12349, DOI 10.1128/JVI.01365-15
   Yu CY, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005350
   Yu CY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002780
   Zellweger RM, 2015, J VIROL, V89, P6494, DOI 10.1128/JVI.00036-15
   Zellweger RM, 2014, J IMMUNOL, V193, P4117, DOI 10.4049/jimmunol.1401597
   Zellweger RM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003723
   Zellweger RM, 2010, CELL HOST MICROBE, V7, P128, DOI 10.1016/j.chom.2010.01.004
   Zevini A, 2017, TRENDS IMMUNOL, V38, P194, DOI 10.1016/j.it.2016.12.004
   Zompi S, 2012, J IMMUNOL, V188, P404, DOI 10.4049/jimmunol.1102124
   Zust R, 2014, J VIROL, V88, P7276, DOI 10.1128/JVI.03827-13
   Zust R, 2011, NAT IMMUNOL, V12, P137, DOI 10.1038/ni.1979
   Zybert IA, 2008, J GEN VIROL, V89, P3047, DOI 10.1099/vir.0.2008/002535-0
NR 234
TC 40
Z9 42
U1 2
U2 20
PU ANNUAL REVIEWS
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0897 USA
SN 0732-0582
BN 978-0-8243-3036-1
J9 ANNU REV IMMUNOL
JI Annu. Rev. Immunol.
PY 2018
VL 36
BP 279
EP 308
DI 10.1146/annurev-immunol-042617-053142
PG 30
WC Immunology
SC Immunology
GA BK2QE
UT WOS:000433486000011
PM 29345964
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT S
AU Weaver, SC
   Charlier, C
   Vasilakis, N
   Lecuit, M
AF Weaver, Scott C.
   Charlier, Caroline
   Vasilakis, Nikos
   Lecuit, Marc
BE Caskey, CT
TI Zika, Chikungunya, and Other Emerging Vector-Borne Viral Diseases
SO ANNUAL REVIEW OF MEDICINE, VOL 69
SE Annual Review of Medicine
LA English
DT Review; Book Chapter
DE arbovirus; chikungunya; Zika; yellow fever; dengue; mosquito
ID DENGUE SHOCK SYNDROME; YELLOW-FEVER; VIRUS-INFECTION; MAYARO VIRUS;
   VACCINE CANDIDATE; OUTBREAK; TRANSMISSION; SCREEN; BRAZIL; PATHOGENESIS
AB Arthropod-borne viruses (arboviruses) have a long history of emerging to infect humans, but during recent decades, they have been spreading more widely and affecting larger populations. This is due to several factors, including increased air travel and uncontrolled mosquito vector populations. Emergence can involve simple spillover from enzootic (wildlife) cycles, as in the case of West Nile virus accompanying geographic expansion into the Americas; secondary amplification in domesticated animals, as seen with Japanese encephalitis, Venezuelan equine encephalitis, and Rift Valley fever viruses; and urbanization, in which humans become the amplification hosts and peridomestic mosquitoes, mainly Aedes aegypti, mediate human-to-human transmission. Dengue, yellow fever, chikungunya, and Zika viruses have undergone such urban emergence. We focus mainly on the latter two, which are recent arrivals in the Western Hemisphere. We also discuss a few other viruses with the potential to emerge through all of these mechanisms.
C1 [Weaver, Scott C.; Vasilakis, Nikos] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.
   [Weaver, Scott C.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
   [Weaver, Scott C.; Vasilakis, Nikos] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
   [Charlier, Caroline; Lecuit, Marc] Inst Pasteur, INSERM, Unite 1117, Biol Infect Unit, F-75006 Paris, France.
   [Charlier, Caroline; Lecuit, Marc] Paris Descartes Univ, Sorbonne Paris Cite, F-75006 Paris, France.
   [Charlier, Caroline; Lecuit, Marc] Necker Enfants Malades Univ Hosp, AP HP, Div Infect Dis & Trop Med, F-75015 Paris, France.
   [Charlier, Caroline; Lecuit, Marc] Inst Imagine, F-75015 Paris, France.
RP Weaver, SC (corresponding author), Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.; Weaver, SC (corresponding author), Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.; Weaver, SC (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
EM sweaver@utmb.edu; caroline.charlier@pasteur.fr; nivasila@utmb.edu;
   marc.lecuit@pasteur.fr
RI Weaver, Scott C/D-6490-2011; Lecuit, Marc/M-4126-2019; Lecuit,
   Marc/J-4073-2013; Charlier, Caroline/AAH-8547-2020
OI Weaver, Scott C/0000-0001-8016-8556; Lecuit, Marc/0000-0002-4491-1063;
   Lecuit, Marc/0000-0002-4491-1063; Charlier, Caroline/0000-0002-9375-3620
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R24 AI120942]
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004677
   Anders KL, 2011, AM J TROP MED HYG, V84, P127, DOI 10.4269/ajtmh.2011.10-0476
   Assuncao-Miranda I, 2013, BIOMED RES INT, DOI 10.1155/2013/973516
   Barrera R, 2017, J MED ENTOMOL, V54, P387, DOI 10.1093/jme/tjw187
   Barrett ADT, 2017, VACCINE, V35, P5951, DOI 10.1016/j.vaccine.2017.03.032
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Barzon L., 2016, EUROSURVEILLANCE, V21, P2016, DOI DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Borgherini G, 2007, CLIN INFECT DIS, V44, P1401, DOI 10.1086/517537
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   BRIGGS GG, 2008, DRUGS PREGNANCY LACT
   Bryant JE, 2007, PLOS PATHOG, V3, P668, DOI 10.1371/journal.ppat.0030075
   Callaway E, 2016, NATURE, V539, P17, DOI 10.1038/nature.2016.20878
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Capeding MR, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002331
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chang LJ, 2014, LANCET, V384, P2046, DOI 10.1016/S0140-6736(14)61185-5
   Coffey LL, 2013, FUTURE MICROBIOL, V8, P155, DOI [10.2217/FMB.12.139, 10.2217/fmb.12.139]
   Couderc T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040029
   Couderc T, 2009, MICROBES INFECT, V11, P1197, DOI 10.1016/j.micinf.2009.09.002
   Couderc T, 2009, J INFECT DIS, V200, P516, DOI 10.1086/600381
   Culjat M, 2016, CLIN INFECT DIS, V63, P805, DOI 10.1093/cid/ciw324
   Mota MTD, 2015, FUTURE VIROL, V10, P1109, DOI 10.2217/fvl.15.76
   de Valdez MRW, 2011, P NATL ACAD SCI USA, V108, P4772, DOI 10.1073/pnas.1019295108
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Erasmus JH, 2017, NAT MED, V23, P192, DOI 10.1038/nm.4253
   Eyer L, 2017, ANTIVIR RES, V142, P63, DOI 10.1016/j.antiviral.2017.03.012
   Forshey BM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000787
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gallian P, 2017, BLOOD, V129, P263, DOI 10.1182/blood-2016-09-737981
   Gerardin P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002996
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Gubler DJ, 2016, ARBOVIRUSES: MOLECULAR BIOLOGY, EVOLUTION AND CONTROL, P1
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Halsey ES, 2013, EMERG INFECT DIS, V19, P1839, DOI 10.3201/eid1911.130777
   Halstead SB, 2015, EMERG INFECT DIS, V21, P557, DOI 10.3201/eid2104.141723
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hochedez P, 2006, EMERG INFECT DIS, V12, P1565, DOI 10.3201/eid1210.060495
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Hung NT, 2005, AM J TROP MED HYG, V72, P370
   Jentes ES, 2011, LANCET INFECT DIS, V11, P622, DOI 10.1016/S1473-3099(11)70147-5
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Julander JG, 2017, ANTIVIR RES, V137, P14, DOI 10.1016/j.antiviral.2016.11.003
   Karlas A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11320
   Khor CC, 2011, NAT GENET, V43, P1139, DOI 10.1038/ng.960
   Lee TH, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004576
   Leroy EM, 2009, EMERG INFECT DIS, V15, P591, DOI 10.3201/eid1504.080664
   Li HD, 2016, NEURON, V92, P949, DOI 10.1016/j.neuron.2016.11.031
   Manimunda SP, 2011, EPIDEMIOL INFECT, V139, P1410, DOI 10.1017/S0950268810002542
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Mastrangelo E, 2012, J ANTIMICROB CHEMOTH, V67, P1884, DOI 10.1093/jac/dks147
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mourao MPG, 2009, EMERG INFECT DIS, V15, P2063, DOI 10.3201/eid1512.090917
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nitatpattana N, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-183
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   PINHEIRO F P, 1981, American Journal of Tropical Medicine and Hygiene, V30, P149
   PINHEIRO FP, 1981, AM J TROP MED HYG, V30, P674, DOI 10.4269/ajtmh.1981.30.674
   Powers AM, 2000, J GEN VIROL, V81, P471, DOI 10.1099/0022-1317-81-2-471
   Ramsauer K, 2015, LANCET INFECT DIS, V15, P519, DOI 10.1016/S1473-3099(15)70043-5
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Ritchie SA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003930
   Robertson SE, 1996, JAMA-J AM MED ASSOC, V276, P1157, DOI 10.1001/jama.276.14.1157
   Rodriguez-Morales AJ, 2016, ARTHRIT CARE RES, V68, P1849, DOI 10.1002/acr.22900
   Roy CJ, 2014, J INFECT DIS, V209, P1891, DOI 10.1093/infdis/jiu014
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Schilte C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002137
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Sheridan MA, 2017, P NATL ACAD SCI USA, V114, pE1587, DOI 10.1073/pnas.1616097114
   Silva LA, 2017, J CLIN INVEST, V127, P737, DOI 10.1172/JCI84417
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Simon-Loriere E, 2017, NEW ENGL J MED, V376, P1483, DOI 10.1056/NEJMc1701600
   Simoni MK, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12613
   SMITHBURN KC, 1954, AM J HYG, V59, P157, DOI 10.1093/oxfordjournals.aje.a119630
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Taubitz W, 2007, CLIN INFECT DIS, V45, pE1, DOI 10.1086/518701
   Taylor R, 2016, J INFECT PUBLIC HEAL, V9, P220, DOI 10.1016/j.jiph.2016.04.002
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   ter Meulen J, 2004, J INFECT DIS, V190, P1821, DOI 10.1086/425016
   Torres JR, 2016, INT J INFECT DIS, V51, P85, DOI 10.1016/j.ijid.2016.09.009
   Nguyen TH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1174-x
   van den Berg B, 2014, NAT REV NEUROL, V10, P469, DOI 10.1038/nrneurol.2014.121
   Vasilakis N, 2017, CURR OPIN VIROL, V22, P30, DOI 10.1016/j.coviro.2016.11.007
   Weaver SC, 2015, ANTIVIR RES, V120, P32, DOI 10.1016/j.antiviral.2015.04.016
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   Weaver SC, 2012, EXPERT REV VACCINES, V11, P1087, DOI [10.1586/erv.12.84, 10.1586/ERV.12.84]
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Wielanek AC, 2007, NEUROLOGY, V69, P2105, DOI 10.1212/01.wnl.0000277267.07220.88
   Wilder-Smith A, 2017, LANCET INFECT DIS, V17, P248, DOI 10.1016/S1473-3099(16)30588-6
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625
NR 103
TC 72
Z9 73
U1 16
U2 66
PU ANNUAL REVIEWS
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0897 USA
SN 0066-4219
BN 978-0-8243-0569-7
J9 ANNU REV MED
JI Annu. Rev. Med.
PY 2018
VL 69
BP 395
EP 408
DI 10.1146/annurev-med-050715-105122
PG 14
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA BJ3ZL
UT WOS:000424632300028
PM 28846489
OA Green Accepted
DA 2020-07-08
ER

PT S
AU Pereira, L
AF Pereira, Lenore
BE Enquist, L
TI Congenital Viral Infection: Traversing the Uterine-Placental Interface
SO ANNUAL REVIEW OF VIROLOGY, VOL 5
SE Annual Review of Virology
LA English
DT Article; Book Chapter
DE placenta; congenital infection; rubella virus; VZV; PVB19; CMV; ZIKV;
   HEV-1
ID VARICELLA-ZOSTER-VIRUS; HUMAN PARVOVIRUS B19; HUMAN
   CYTOMEGALOVIRUS-INFECTION; HEPATITIS-E VIRUS; TROPHOBLAST PROGENITOR
   CELLS; ZIKA VIRUS; RUBELLA-VIRUS; HOFBAUER CELLS; UNITED-STATES;
   MEMBRANE ASSOCIATION
AB Why certain viruses cross the physical barrier of the human placenta but others do not is incompletely understood. Over the past 20 years, we have gained deeper knowledge of intrauterine infection and routes of viral transmission. This review focuses on human viruses that replicate in the placenta, infect the fetus, and cause birth defects, including rubella virus, varicella-zoster virus, parvovirus B19, human cytomegalovirus (CMV), Zika virus (ZIKV), and hepatitis E virus type 1. Detailed discussions include (a) the architecture of the uterine-placental interface, (b) studies of placental explants ex vivo that provide insights into the infection and spread of CMV and ZIKV to the fetal compartment and how these viruses undermine early development, and (c) novel treatments and vaccines that limit viral replication and have the potential to reduce dissemination, vertical transmission and the occurrence of congenital disease.
C1 [Pereira, Lenore] Univ Calif San Francisco, Sch Dent, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA.
RP Pereira, L (corresponding author), Univ Calif San Francisco, Sch Dent, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA.
EM lenore.pereira@ucsf.edu
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01 AI046657, R21 AI129508]
CR Adler SP, 2012, CLIN INFECT DIS, V55, P504, DOI 10.1093/cid/cis425
   Aggarwal R, 2010, GLOBAL PREVALENCE HE
   Ahn KH, 2016, J OBSTET GYNAECOL, V36, P563, DOI 10.3109/01443615.2015.1127905
   Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Aldo PB, 2014, AM J REPROD IMMUNOL, V72, P270, DOI 10.1111/aji.12288
   Aliota MT, 2017, ANTIVIR RES, V144, P223, DOI 10.1016/j.antiviral.2017.06.001
   ANDERSON MJ, 1983, LANCET, V1, P1378
   Anteby EY, 2005, PLACENTA, V26, P476, DOI 10.1016/j.placenta.2004.08.008
   Arvin AM, 2004, CLIN INFECT DIS, V39, P233, DOI 10.1086/421999
   Arvin AM, 2013, VARICELLA ZOSTER VIR, P2015
   Arvin AM, 2010, CURR TOP MICROBIOL, V342, P189, DOI 10.1007/82_2010_29
   Avdic S, 2016, J VIROL, V90, P3819, DOI 10.1128/JVI.03066-15
   Avdic S, 2013, J VIROL, V87, P10273, DOI 10.1128/JVI.00912-13
   Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114
   Baltimore RS, 2018, NEW ENGL J MED, V378, P564, DOI 10.1056/NEJMcpc1706110
   Barouch DH, 2017, IMMUNITY, V46, P176, DOI 10.1016/j.immuni.2017.02.005
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   BENIRSCHKE K, 2000, PATHOLOGY HUMAN PLAC
   Berns KI, 2013, PARVOVIRIDAE, V195, P1768
   Best JM, 2005, VIROLOGY, V2, P959
   Bockle BC, 2008, PLACENTA, V29, P187, DOI 10.1016/j.placenta.2007.11.003
   Bonsch C, 2010, J VIROL, V84, P11737, DOI 10.1128/JVI.01143-10
   Bonvicini F, 2017, CURR OPIN VIROL, V27, P8, DOI 10.1016/j.coviro.2017.10.003
   Bonvicini F, 2011, J CLIN MICROBIOL, V49, P3514, DOI 10.1128/JCM.00854-11
   Boppana SB, 2011, NEW ENGL J MED, V364, P2111, DOI 10.1056/NEJMoa1006561
   Bose PD, 2014, J GEN VIROL, V95, P1266, DOI 10.1099/vir.0.063602-0
   Bose PD, 2011, J HEPATOL, V54, P1107, DOI 10.1016/j.jhep.2010.08.037
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   BROWN T, 1984, LANCET, V2, P1033
   Brown WC, 2016, NAT STRUCT MOL BIOL, V23, P865, DOI 10.1038/nsmb.3268
   Buhimschi CS, 2007, PLOS MED, V4, P84, DOI 10.1371/journal.pmed.0040018
   Buxmann H, 2012, J PERINAT MED, V40, P439, DOI 10.1515/jpm-2011-0257
   Cannon MJ, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-70
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Co EC, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.099465
   Colugnati FAB, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-71
   Cossart Y E, 1975, Dev Biol Stand, V30, P444
   Costa F, 2016, ANN INTERN MED, V164, P689, DOI 10.7326/M16-0332
   Damsky CH, 1998, CURR OPIN CELL BIOL, V10, P660, DOI 10.1016/S0955-0674(98)80043-4
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Delaney A, 2018, MMWR-MORBID MORTAL W, V67, P91, DOI 10.15585/mmwr.mm6703a2
   Dollard SC, 2011, CLIN VACCINE IMMUNOL, V18, P1895, DOI 10.1128/CVI.05228-11
   Dollard SC, 2010, J INHERIT METAB DIS, V33, pS249, DOI 10.1007/s10545-010-9125-3
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Drake PM, 2004, DEV DYNAM, V229, P877, DOI 10.1002/dvdy.10477
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   El Costa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35296
   Emerson SU, 2013, HEPATITIS E VIRUS, P2242
   ENDERS G, 1994, LANCET, V343, P1548, DOI 10.1016/S0140-6736(94)92943-2
   Enders G, 2013, J CLIN VIROL, V56, P102, DOI 10.1016/j.jcv.2012.09.015
   Enders G, 2011, J CLIN VIROL, V52, P244, DOI 10.1016/j.jcv.2011.07.005
   Enders M, 2010, J CLIN VIROL, V49, P163, DOI 10.1016/j.jcv.2010.07.014
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Fisher S, 2000, J VIROL, V74, P6808, DOI 10.1128/JVI.74.15.6808-6820.2000
   Foo SS, 2017, NAT MICROBIOL, V2, P1558, DOI 10.1038/s41564-017-0016-3
   Fouts AE, 2012, J VIROL, V86, P7444, DOI 10.1128/JVI.00467-12
   GARCIA AGP, 1989, PLACENTA, V10, P1
   Genbacev O, 2015, PLACENTA, V36, P716, DOI 10.1016/j.placenta.2015.05.002
   Genbacev O, 1997, SCIENCE, V277, P1669, DOI 10.1126/science.277.5332.1669
   Genbacev O, 2011, STEM CELLS, V29, P1427, DOI 10.1002/stem.686
   Gershon AA, 2010, CURR TOP MICROBIOL, V342, P359, DOI 10.1007/82_2010_12
   Gervasi MT, 2012, J PERINAT MED, V40, P329, DOI 10.1515/jpm-2012-0034
   Geyer H, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0475-9
   Glasner DR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006673
   Goldenberg RL, 2010, LANCET, V375, P1482, DOI 10.1016/S0140-6736(09)61712-8
   Gregg NM, 1941, T OPHTHALMOL SOC AUS, V3, P35
   Gustafsson C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002078
   Ha S, 2017, J VIROL, V91, DOI 10.1128/JVI.02033-16
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Halai UA, 2017, CLIN INFECT DIS, V65, P877, DOI 10.1093/cid/cix472
   HALLER H, 1995, J REPROD IMMUNOL, V28, P165, DOI 10.1016/0165-0378(94)00913-R
   Halwachs-Baumann G, 1998, J VIROL, V72, P7598, DOI 10.1128/JVI.72.9.7598-7602.1998
   Hannan NJ, 2011, EXPERT REV CLIN IMMU, V7, P789, DOI [10.1586/ECI.11.65, 10.1586/eci.11.65]
   Hargett D, 2010, P NATL ACAD SCI USA, V107, P20039, DOI 10.1073/pnas.1014509107
   Herrera BB, 2017, J INFECT DIS, V215, P1546, DOI 10.1093/infdis/jix182
   Hess AP, 2007, BIOL REPROD, V76, P102, DOI 10.1095/biolreprod.106.054791
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Hobman TC, 2013, RUBELLA VIRUS, V195, P687
   Houser BL, 2011, J IMMUNOL, V186, P2633, DOI 10.4049/jimmunol.1003153
   Hubner D, 2017, ACS INFECT DIS, V3, P886, DOI 10.1021/acsinfecdis.7b00103
   Ingman K, 2010, PLACENTA, V31, P535, DOI 10.1016/j.placenta.2010.03.003
   Iwasenko JM, 2011, J INFECT DIS, V203, P1526, DOI 10.1093/infdis/jir121
   Jaenisch T, 2017, B WORLD HEALTH ORGAN, V95, P191, DOI [10.2471/BLT.16.178608, 10.2471/blt.16.178608]
   Jemielity S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003232
   Jordan JA, 1999, PLACENTA, V20, P103, DOI 10.1053/plac.1998.0353
   Kam YW, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92428
   Keelan JA, 1997, BIOL REPROD, V57, P1438, DOI 10.1095/biolreprod57.6.1438
   Kenneson A, 2007, REV MED VIROL, V17, P253, DOI 10.1002/rmv.535
   Knipe D.M., 2013, FIELDS VIROLOGY
   KONDO K, 1994, P NATL ACAD SCI USA, V91, P11879, DOI 10.1073/pnas.91.25.11879
   Kuniholm MH, 2009, J INFECT DIS, V200, P48, DOI 10.1086/599319
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazar M, 2016, EBIOMEDICINE, V3, P86, DOI 10.1016/j.ebiom.2015.11.050
   Li HC, 2005, INVEST OPHTH VIS SCI, V46, P900, DOI 10.1167/iovs.04-0495
   Lilleri D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059863
   Lindenbach B.D., 2013, FIELDS VIROLOGY, P712
   Lindenburg ITM, 2014, FETAL DIAGN THER, V36, P263, DOI 10.1159/000362812
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Maidji E, 2010, AM J PATHOL, V177, P1298, DOI 10.2353/ajpath.2010.091210
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   McDonagh S, 2004, J INFECT DIS, V190, P826, DOI 10.1086/422330
   Michlmayr D, 2017, NAT MICROBIOL, V2, P1462, DOI 10.1038/s41564-017-0035-0
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mocarski E, 2013, CYTOMEGALOVIRUSES FI, P1960
   Modhiran N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3863
   Modrow S., 2013, VIRUSES SINGLE STRAN, P185
   MUHLEMANN K, 1992, HUM PATHOL, V23, P1234, DOI 10.1016/0046-8177(92)90290-J
   Munakata Y, 2005, BLOOD, V106, P3449, DOI 10.1182/blood-2005-02-0536
   Nigro G, 2005, NEW ENGL J MED, V353, P1350, DOI 10.1056/NEJMoa043337
   Nikkels AF, 2005, J INFECT DIS, V191, P540, DOI 10.1086/426942
   Noriega VM, 2014, J VIROL, V88, P9391, DOI 10.1128/JVI.00934-14
   Nozawa N, 2009, J CLIN VIROL, V46, pS58, DOI 10.1016/j.jcv.2009.10.004
   PARYANI SG, 1986, NEW ENGL J MED, V314, P1542, DOI 10.1056/NEJM198606123142403
   Pasquinelli G, 2009, J CLIN VIROL, V44, P33, DOI 10.1016/j.jcv.2008.10.008
   Pereira L, 2005, TRENDS MICROBIOL, V13, P164, DOI 10.1016/j.tim.2005.02.009
   Pereira L, 2003, J VIROL, V77, P13301, DOI 10.1128/JVI.77.24.13301-13314.2003
   Pereira L, 2014, J INFECT DIS, V209, P1573, DOI 10.1093/infdis/jiu019
   Perelygina L, 2017, ANTIVIR RES, V147, P58, DOI 10.1016/j.antiviral.2017.09.019
   Petitt M, 2017, CURR OPIN VIROL, V27, P48, DOI 10.1016/j.coviro.2017.11.008
   Pierson TC, 2013, FIELDS VIROLOGY, P747
   Poland GA, 2018, LANCET INFECT DIS, V18, pE211, DOI 10.1016/S1473-3099(18)30063-X
   Prakobphol A, 2006, DEV BIOL, V298, P107, DOI 10.1016/j.ydbio.2006.06.020
   Pringle KG, 2010, HUM REPROD UPDATE, V16, P415, DOI 10.1093/humupd/dmp046
   Puerta-Guardo H, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005738
   Qiu JM, 2017, CLIN MICROBIOL REV, V30, P43, DOI 10.1128/CMR.00040-16
   Trinh QD, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10010023
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Reagan-Steiner S, 2017, MMWR-MORBID MORTAL W, V66, P636, DOI 10.15585/mmwr.mm6624a3
   Red-Horse K, 2008, PLACENTA, V29, pS55, DOI 10.1016/j.placenta.2007.11.011
   Red-Horse K, 2005, DEVELOPMENT, V132, P4097, DOI 10.1242/dev.01971
   Red-Horse Kristy, 2004, Expert Reviews in Molecular Medicine, V6, P1, DOI 10.1017/S1462399404007720
   Red-Horse K, 2006, J CLIN INVEST, V116, P2643, DOI 10.1172/JC127306
   Revello MG, 2015, EBIOMEDICINE, V2, P1205, DOI 10.1016/j.ebiom.2015.08.003
   Revello MG, 2014, NEW ENGL J MED, V370, P1316, DOI 10.1056/NEJMoa1310214
   Revello MG, 2011, J CLIN VIROL, V50, P303, DOI 10.1016/j.jcv.2010.12.012
   Richard AS, 2015, P NATL ACAD SCI USA, V112, P14682, DOI 10.1073/pnas.1508095112
   Rosenberg AZ, 2017, ARCH PATHOL LAB MED, V141, P43, DOI 10.5858/arpa.2016-0401-OA
   Rosenthal LS, 2009, PEDIATR INFECT DIS J, V28, P515, DOI 10.1097/INF.0b013e318198c724
   Ross DS, 2008, J WOMENS HEALTH, V17, P849, DOI 10.1089/jwh.2007.0523
   Ross SA, 2014, J INFECT DIS, V210, P1415, DOI 10.1093/infdis/jiu263
   Russell K, 2017, CLIN INFECT DIS, V64, P211, DOI 10.1093/cid/ciw692
   SAITO S, 1994, IMMUNOL LETT, V40, P193, DOI 10.1016/0165-2478(93)00019-A
   Schleiss MR, 2017, CLIN VACCINE IMMUNOL, V24
   Sen N, 2014, CELL REP, V8, P633, DOI 10.1016/j.celrep.2014.06.024
   Seval Y, 2007, PLACENTA, V28, P841, DOI 10.1016/j.placenta.2007.01.010
   Seward JF, 2002, JAMA-J AM MED ASSOC, V287, P606, DOI 10.1001/jama.287.5.606
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   Sharma S, 2017, J VIRAL HEPATITIS, V24, P1067, DOI 10.1111/jvh.12730
   Silasi M, 2015, AM J REPROD IMMUNOL, V73, P199, DOI 10.1111/aji.12355
   Simister NE, 1996, EUR J IMMUNOL, V26, P1527, DOI 10.1002/eji.1830260718
   SINZGER C, 1993, VIRCHOWS ARCH A, V423, P249, DOI 10.1007/BF01606887
   Slukvin II, 1996, AM J REPROD IMMUNOL, V35, P16
   Snyder RE, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005287
   Soderberg-Naucler C, 2001, J VIROL, V75, P7543, DOI 10.1128/JVI.75.16.7543-7554.2001
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Standring S., 2005, GRAYS ANATOMY ANATOM
   STARKEY PM, 1988, IMMUNOLOGY, V65, P129
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Styczynski AR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005869
   Tabata T, 2007, PLACENTA, V28, P527, DOI 10.1016/j.placenta.2006.05.006
   Tabata T, 2017, J INFECT DIS, V27, P48
   Tabata T, 2016, AM J PATHOL, V186, P2970, DOI 10.1016/j.ajpath.2016.07.016
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tabata T, 2015, J VIROL, V89, P5134, DOI 10.1128/JVI.03674-14
   Perez-Gracia MT, 2017, REV MED VIROL, V27, DOI 10.1002/rmv.1929
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Toizumi M, 2017, SCI REP-UK, V7, DOI 10.1038/srep46483
   Underwood Mark A, 2005, J Perinatol, V25, P341, DOI 10.1038/sj.jp.7211290
   Vynnycky E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149160
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   Wang X, 2017, BIOLOGICALS, V50, P35, DOI 10.1016/j.biologicals.2017.09.004
   Watt AP, 2013, J MED MICROBIOL, V62, P86, DOI 10.1099/jmm.0.046714-0
   Weiffenbach J, 2012, J INFECT DIS, V205, P782, DOI 10.1093/infdis/jir855
   Weigel-Kelley KA, 2003, BLOOD, V102, P3927, DOI 10.1182/blood-2003-05-1522
   Weisblum Y, 2014, SEMIN IMMUNOPATHOL, V36, P615, DOI 10.1007/s00281-014-0449-1
   Weisblum Y, 2011, J VIROL, V85, P13204, DOI 10.1128/JVI.05749-11
   WHO, 2017, HEP E FACT SHEET
   Wilson E, 2008, J INFECT DIS, V197, pS178, DOI 10.1086/522136
   Wong S, 2008, J VIROL, V82, P2470, DOI 10.1128/JVI.02247-07
   Xu XY, 2016, EMBO J, V35, P2170, DOI 10.15252/embj.201695290
   Yamamoto AY, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.11.018
   Yamamoto-Tabata T, 2004, J VIROL, V78, P2831, DOI 10.1128/JVI.78.6.2831-2840.2004
   Young MK, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010586.pub2
   Young OM, 2015, AM J REPROD IMMUNOL, V73, P22, DOI 10.1111/aji.12336
   Zerboni L, 2014, NAT REV MICROBIOL, V12, P197, DOI 10.1038/nrmicro3215
   Zhou QJ, 2017, VACCINE, V35, P3076, DOI 10.1016/j.vaccine.2017.04.044
   Zhou Y, 2003, DEV BIOL, V263, P114, DOI 10.1016/S0012-1606(03)00449-4
   Zhou Y, 1997, J CLIN INVEST, V99, P2139, DOI 10.1172/JCI119387
   Zydek M, 2014, VIRUSES-BASEL, V6, P1346, DOI 10.3390/v6031346
NR 196
TC 20
Z9 20
U1 3
U2 9
PU ANNUAL REVIEWS
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0897 USA
SN 2327-056X
J9 ANNU REV VIROL
PY 2018
VL 5
BP 273
EP 299
DI 10.1146/annurev-virology-092917-043236
PG 27
WC Virology
SC Virology
GA BL1LF
UT WOS:000447826000013
PM 30048217
DA 2020-07-08
ER

PT J
AU Tong, X
   Smith, J
   Bukreyeva, N
   Koma, T
   Manning, JT
   Kalkeri, R
   Kwong, AD
   Paessler, S
AF Tong, Xiao
   Smith, Jeanon
   Bukreyeva, Natalya
   Koma, Takaaki
   Manning, John T.
   Kalkeri, Raj
   Kwong, Ann D.
   Paessler, Slobodan
TI Merimepodib, an IMPDH inhibitor, suppresses replication of Zika virus
   and other emerging viral pathogens
SO ANTIVIRAL RESEARCH
LA English
DT Article
DE Merimepodib; VX-497; Zika; Ebola; Antiviral; IMPDH
ID CHRONIC HEPATITIS-C; ANTIVIRAL ACTIVITY; HEMORRHAGIC-FEVER; MOUSE MODEL;
   LASSA VIRUS; RIBAVIRIN; DISEASE; DEHYDROGENASE; FAVIPIRAVIR; INFECTION
AB Zika virus (ZIKV), a member of the Flaviviridae family, has recently been linked to abnormal pregnancies, fetal death, microcephaly, and Guillain-Barre syndrome in humans. Merimepodib (MMPD, VX-497), a potent inhibitor of inosine-5'-monophosphate dehydrogenase (IMPDH), has shown antiviral activity against HCV and a variety of DNA and RNA viruses in vitro. In this report, we expand the antiviral spectrum of MMPD, and demonstrate that MMPD inhibits ZIKV RNA replication with an EC50 of 0.6 mu M. Furthermore, MMPD reduces the virus production of ZIKV as well as several other important emerging viral pathogens such as Ebola, Lassa, Chikungunya, and Junin viruses. The inhibition can be reversed by addition of exogenous guanosine to culture media, consistent with the mechanism of action of MMPD as an IMPDH inhibitor. We also provide evidence that MMPD can be used in combination with other antivirals such as ribavirin and T-705 (favipiravir) to enhance suppression of virus production.
C1 [Tong, Xiao; Kwong, Ann D.] Trek Therapeut, PBC, 125 Cambridge Pk Dr,Suite 301, Cambridge, MA 02140 USA.
   [Smith, Jeanon; Bukreyeva, Natalya; Koma, Takaaki; Manning, John T.; Paessler, Slobodan] Univ Texas Med Branch, Dept Pathol, 301 Univ Blvd, Galveston, TX 77555 USA.
   [Kalkeri, Raj] Southern Res, 431 Aviat Way, Frederick, MD 21701 USA.
RP Tong, X (corresponding author), Trek Therapeut, PBC, 125 Cambridge Pk Dr,Suite 301, Cambridge, MA 02140 USA.; Paessler, S (corresponding author), Univ Texas Med Branch, Dept Pathol, 301 Univ Blvd, Galveston, TX 77555 USA.
EM xiao.tong@trektx.com; slpaessl@utmb.edu
FU JSPS Postdoctoral Fellowship for Research AbroadMinistry of Education,
   Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for
   the Promotion of Science
FX TK was supported in part by a JSPS Postdoctoral Fellowship for Research
   Abroad.
CR Bai CQ, 2016, CLIN INFECT DIS, V63, P1288, DOI 10.1093/cid/ciw571
   Bausch DG, 2010, CLIN INFECT DIS, V51, P1435, DOI 10.1086/657315
   Bekerman E, 2015, SCIENCE, V348, P282, DOI 10.1126/science.aaa3778
   Bray M, 2008, ANTIVIR RES, V78, P1, DOI 10.1016/j.antiviral.2007.12.007
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Cohen J, 2016, SCIENCE, V353, P529, DOI 10.1126/science.353.6299.529
   Dash AP, 2013, J VECTOR DIS, V50, P77
   Emonet SF, 2011, J VIROL, V85, P1473, DOI 10.1128/JVI.02102-10
   Enria DA, 2008, ANTIVIR RES, V78, P132, DOI 10.1016/j.antiviral.2007.10.010
   Furuta Y, 2013, ANTIVIR RES, V100, P446, DOI 10.1016/j.antiviral.2013.09.015
   Goebel S, 2016, J VIROL METHODS, V238, P13, DOI 10.1016/j.jviromet.2016.09.015
   Haug CJ, 2016, NEW ENGL J MED, V374, P1801, DOI 10.1056/NEJMp1603734
   Hedstrom L, 2009, CHEM REV, V109, P2903, DOI 10.1021/cr900021w
   Julander JG, 2017, ANTIVIR RES, V137, P14, DOI 10.1016/j.antiviral.2016.11.003
   Khan M, 2011, ANTIVIR RES, V89, P1, DOI 10.1016/j.antiviral.2010.10.009
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Lustig Y, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.26.30269
   Marcellin P, 2007, J HEPATOL, V47, P476, DOI 10.1016/j.jhep.2007.03.028
   Markland W, 2000, ANTIMICROB AGENTS CH, V44, P859, DOI 10.1128/AAC.44.4.859-866.2000
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Morrison TE, 2011, AM J PATHOL, V178, P32, DOI 10.1016/j.ajpath.2010.11.018
   Mounce BC, 2016, J VIROL, V90, P9683, DOI 10.1128/JVI.01347-16
   Olschlager S, 2011, ANTIVIR RES, V91, P89, DOI 10.1016/j.antiviral.2011.05.006
   Pierson TC, 2016, CELL, V167, P625, DOI 10.1016/j.cell.2016.09.020
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Rustgi VK, 2009, HEPATOLOGY, V50, P1719, DOI 10.1002/hep.23204
   Sintchak MD, 2000, IMMUNOPHARMACOLOGY, V47, P163, DOI 10.1016/S0162-3109(00)00193-4
   Sissoko D, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001967
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tilak Rina, 2016, Med J Armed Forces India, V72, P157, DOI 10.1016/j.mjafi.2016.02.017
   Vela E, 2012, VIRUSES-BASEL, V4, P1802, DOI 10.3390/v4091802
   Wang J.-Z., 2016, BRAIN DEV, V39, P207
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Westover JB, 2016, ANTIVIR RES, V126, P62, DOI 10.1016/j.antiviral.2015.12.006
   Yun NE, 2013, J VIROL, V87, P10908, DOI 10.1128/JVI.01433-13
   Zanluca C, 2016, MICROBES INFECT, V18, P295, DOI 10.1016/j.micinf.2016.03.003
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 42
TC 20
Z9 21
U1 1
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD JAN
PY 2018
VL 149
BP 34
EP 40
DI 10.1016/j.antiviral.2017.11.004
PG 7
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA FU5MJ
UT WOS:000423897300005
PM 29126899
DA 2020-07-08
ER

PT J
AU Dutta, S
   Celestine, MJ
   Khanal, S
   Huddleston, A
   Simms, C
   Arca, JF
   Mitra, A
   Heller, L
   Kraj, PJ
   Ledizet, M
   Anderson, JF
   Neelakanta, G
   Holder, AA
   Sultana, H
AF Dutta, Shovan
   Celestine, Michael J.
   Khanal, Supreet
   Huddleston, Alexis
   Simms, Colin
   Arca, Jessa Faye
   Mitra, Amlan
   Heller, Loree
   Kraj, Piotr J.
   Ledizet, Michel
   Anderson, John F.
   Neelakanta, Girish
   Holder, Alvin A.
   Sultana, Hameeda
TI Coordination of different ligands to copper(II) and cobalt(III) metal
   centers enhances Zika virus and dengue virus loads in both arthropod
   cells and human keratinocytes
SO BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
LA English
DT Article
DE Zika virus; Dengue virus; Viral replication; Copper(II) and cobalt(III);
   Thiosemicarbazones; 1; 10-phenanthroline
ID REPLICATION IN-VITRO; INSECT REPELLENT N,N-DIETHYL-M-TOLUAMIDE;
   YELLOW-FEVER VIRUS; ESSENTIAL OILS; AROMATIC PLANTS; DEET; INFECTIONS;
   COMPONENTS; TOXICITY; ADULT
AB Trace elements such as copper and cobalt have been associated with virus-host interactions. However, studies to show the effect of conjugation of copper(II) or cobalt(III) metal centers to thiosemicarbazone ligand(s) derived from either food additives or mosquito repellent such as 2-acetylethiazole or citral, respectively, on Zika virus (ZIKV) or dengue virus (serotype 2; DENV2) infections have not been explored. In this study, we show that four compounds comprising of thiosemicarbazone ligand derived from 2-acetylethiazole viz., (E)-N-ethyl-2-[1-(thiazol-2-yl)ethylidene]hydrazinecarbothioamide (acetylethTSC) (compound 1), a copper(II) complex with acetylethTSC as a ligand (compound 2), a thiosemicarbazone ligand-derived from citral (compound 3) and a cobalt(III) complex with a citral-thiosemicarbazone ligand (compound 4) increased DENV2 and ZIKV replication in both mosquito C6/36 cells and human keratinocytes (HaCaT cells). Treatment of both cell lines with compounds 2 or 4 showed increased dengue viral titers at all three tested doses. Enhanced dengue viral plaque formation was also noted at the tested dose of 100 mu M, suggesting higher production of infectious viral particles. Treatment with the compounds 2 or 4 enhanced ZIKV and DENV2 RNA levels in HeLa cell line and primary cultures of mouse bone marrow derived dendritic cells. Also, pre-or post treatments with conjugated compounds 2 or 4 showed higher loads of ZIKV or DENV2 envelope (E) protein in HaCaT cells. No changes in loads of E protein were found in ZIKV-infected C6/36 cells, when compounds were treated after infection. In addition, we tested bis(1,10-phenanthroline)copper(II) chloride ([Cu(phen)(2)]Cl-2, (compound 5) and tris(1,10-phenanthro-line)cobalt(III) chloride ([Co(phen)(3)]Cl-3, (compound 6) that also showed enhanced DENV2 loads. Also, we found that copper(II) chloride dehydrate (CuCl(2 center dot)2H(2)O) or cobalt(II) chloride hexahydrate (CoCl(2 center dot)6H(2)O) alone had no effects as "free" cations. Taken together, these findings suggest that use of Cu(II) or Co(III) conjugation to organic compounds, in insect repellents and/or food additives could enhance DENV2/ZIKV loads in human cells and perhaps induce pathogenesis in infected individuals or individuals pre-exposed to such conjugated complexes.
   Importance: Mosquito-borne diseases are of great concern to the mankind. Use of chemicals/repellents against mosquito bites and transmission of microbes has been the topic of interest for many years. Here, we show that thiosemicarbazone ligand(s) derived from 2-acetylethiazole or citral or 1,10-phenanthroline upon conjugation with copper(II) or cobalt(III) metal centers enhances dengue virus (serotype 2; DENV2) and/or Zika virus (ZIKV) infections in mosquito, mouse and human cells. Enhanced ZIKV/DENV2 capsid mRNA or envelope protein loads were evident in mosquito cells and human keratinocytes, when treated with compounds before/after infections. Also, treatment with copper(II) or cobalt(III) conjugated compounds increased viral titers and number of plaque formations. These studies suggest that conjugation of compounds in repellents/essential oils/natural products/food additives with copper(II) or cobalt(III) metal centers may not be safe, especially in tropical and subtropical places, where several dengue infection cases and deaths are reported annually or in places with increased ZIKV caused microcephaly.
C1 [Dutta, Shovan; Khanal, Supreet; Simms, Colin; Kraj, Piotr J.; Neelakanta, Girish; Sultana, Hameeda] Old Dominion Univ, Dept Biol Sci, Norfolk, VA 23529 USA.
   [Celestine, Michael J.; Huddleston, Alexis; Arca, Jessa Faye; Mitra, Amlan; Holder, Alvin A.] Old Dominion Univ, Dept Chem & Biochem, Norfolk, VA 23529 USA.
   [Heller, Loree] Old Dominion Univ, Frank Reidy Res Ctr Bioelect, Norfolk, VA 23529 USA.
   [Heller, Loree] Old Dominion Univ, Sch Med Diagnost & Translat Sci, Coll Hlth Sci, Norfolk, VA 23529 USA.
   [Kraj, Piotr J.; Neelakanta, Girish; Sultana, Hameeda] Old Dominion Univ, Ctr Mol Med, Norfolk, VA 23529 USA.
   [Ledizet, Michel] L2 Diagnost LLC, New Haven, CT USA.
   [Anderson, John F.] Connecticut Agr Expt Stn, New Haven, CT USA.
   [Huddleston, Alexis; Arca, Jessa Faye; Mitra, Amlan] Univ Southern Mississippi, Dept Chem & Biochem, Hattiesburg, MS 39406 USA.
RP Sultana, H (corresponding author), Old Dominion Univ, Ctr Mol Med, Dept Biol Sci, Norfolk, VA 23529 USA.
EM hsultana@odu.edu
RI Holder, Alvin/B-6329-2016
OI Holder, Alvin/0000-0001-9618-5297; Khanal, Supreet/0000-0002-8483-9940
FU Old Dominion University; Mississippi INBRE - National Center for
   Research Resources/National Institutes of Health (NIH) [P20RR016476];
   National Science Foundation (NSF) for the NSF CAREER Award; NSFNational
   Science Foundation (NSF) [CHE-1431172, CHE - 1151832]
FX This work was supported by startup funds from Old Dominion University to
   HS. AAH work to generate compounds used in this study was supported by
   the Mississippi INBRE (P20RR016476), funded by the National Center for
   Research Resources/National Institutes of Health (NIH). AAH would like
   to thank the National Science Foundation (NSF) for the NSF CAREER Award,
   as this material is based upon work partially supported by the NSF under
   CHE-1431172 (Formerly CHE - 1151832). AAH would also like to thank Old
   Dominion University's Faculty Proposal Preparation Program (FP3) and
   also the Old Dominion University start-up package that allowed for the
   successful generation of the tested compounds. The following reagent was
   obtained through BEI Resources, NIAID, NIH: Monoclonal Anti-Flavivirus
   Group Antigen, Clone D1-4G2-4-15 (Produced in vitro), NR-50327. Authors
   declare no conflict of financial interests.
CR Aguiar M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005179
   Gomez LA, 2013, NAT PROD COMMUN, V8, P249
   Antwi FB, 2008, REGUL TOXICOL PHARM, V51, P31, DOI 10.1016/j.yrtph.2008.03.002
   Assuncao-Miranda I, 2016, J APPL MICROBIOL, V120, P790, DOI 10.1111/jam.13038
   Astani A., 2011, ALTERNAT MED, V2011
   Beck MA, 2001, J AM COLL NUTR, V20, p384S, DOI 10.1080/07315724.2001.10719172
   Briassoulis G, 2001, HUM EXP TOXICOL, V20, P8, DOI 10.1191/096032701676731093
   Brown M, 1997, J AM ACAD DERMATOL, V36, P243, DOI 10.1016/S0190-9622(97)70289-5
   Choi WS, 2002, J AM MOSQUITO CONTR, V18, P348
   Choumet V, 2015, REV SCI TECH OIE, V34, P473
   CLEM JR, 1993, ANN PHARMACOTHER, V27, P289, DOI 10.1177/106002809302700305
   Coller BAG, 2011, CURR OPIN IMMUNOL, V23, P391, DOI 10.1016/j.coi.2011.03.005
   Ocazionez RE, 2010, MEM I OSWALDO CRUZ, V105, P304, DOI 10.1590/S0074-02762010000300010
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Giatropoulos A, 2012, PARASITOL RES, V111, P2253, DOI 10.1007/s00436-012-3074-8
   Gillij YG, 2008, BIORESOURCE TECHNOL, V99, P2507, DOI 10.1016/j.biortech.2007.04.066
   Gilling DH, 2014, APPL ENVIRON MICROB, V80, P4898, DOI 10.1128/AEM.00402-14
   GRASSINISTRAZZA G, 1980, INORG CHIM A-LETT, V44, pL295, DOI 10.1016/S0020-1693(00)91040-5
   Hadinegoro S. R. S., 2012, INT CHILD HLTH, V32
   Hsu WS, 2013, J ENVIRON SCI HEAL B, V48, P1014, DOI 10.1080/03601234.2013.816613
   Isman MB, 2006, ANNU REV ENTOMOL, V51, P45, DOI 10.1146/annurev.ento.51.110104.151146
   Jelin A. C., 2016, F1000RES, V5
   KASHIWABARA K, 1976, B CHEM SOC JPN, V49, P1573, DOI 10.1246/bcsj.49.1573
   Katz TM, 2008, J AM ACAD DERMATOL, V58, P865, DOI 10.1016/j.jaad.2007.10.005
   Klase ZA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004877
   Koch C, 2008, PHYTOMEDICINE, V15, P71, DOI 10.1016/j.phymed.2007.09.003
   LEE CW, 1984, INORG CHEM, V23, P837, DOI 10.1021/ic00175a009
   Lewis NA, 2012, EUR J INORG CHEM, P664, DOI 10.1002/ejic.201100898
   Liao CL, 2001, J VIROL, V75, P7828, DOI 10.1128/JVI.75.17.7828-7839.2001
   Meneses R, 2009, ANN CLIN MICROB ANTI, V8, DOI 10.1186/1476-0711-8-8
   MILLER JD, 1982, NEW ENGL J MED, V307, P1341
   Minami M, 2003, MICROBIOL IMMUNOL, V47, P681, DOI 10.1111/j.1348-0421.2003.tb03431.x
   Murrell S, 2011, BIOTECHNOL ADV, V29, P239, DOI 10.1016/j.biotechadv.2010.11.008
   Osimitz TG, 2010, REGUL TOXICOL PHARM, V56, P93, DOI 10.1016/j.yrtph.2009.09.004
   Osimitz TG, 1997, J TOXICOL-CLIN TOXIC, V35, P435, DOI 10.3109/15563659709001224
   Pisseri F., 2008, Parassitologia (Rome), V50, P89
   Rahman MA, 2014, ECOTOX ENVIRON SAFE, V100, P53, DOI 10.1016/j.ecoenv.2013.11.024
   Reichling J, 2009, FORSCH KOMPLEMENTMED, V16, P79, DOI 10.1159/000207196
   Rodriguez SD, 2017, J INSECT SCI, V17, DOI 10.1093/jisesa/iew117
   Sandhaus S., 2015, INORG CHEM COM UNPUB, V49
   Seow YX, 2014, CRIT REV FOOD SCI, V54, P625, DOI 10.1080/10408398.2011.599504
   Singer M, 2016, GLOB PUBLIC HEALTH, P1
   SNYDER JW, 1986, J TOXICOL-CLIN TOXIC, V24, P429, DOI 10.3109/15563658608992605
   Soundravally R, 2015, REV INST MED TROP SP, V57, P315, DOI 10.1590/S0036-46652015000400007
   Sultana H, 2009, J IMMUNOL, V183, P650, DOI 10.4049/jimmunol.0900093
   World Health Organization, 2009, DENG GUID DIAGN TREA
   YE BH, 1994, POLYHEDRON, V13, P2185, DOI 10.1016/S0277-5387(00)81501-6
NR 47
TC 3
Z9 3
U1 3
U2 21
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-4165
EI 1872-8006
J9 BBA-GEN SUBJECTS
JI Biochim. Biophys. Acta-Gen. Subj.
PD JAN
PY 2018
VL 1862
IS 1
BP 40
EP 50
DI 10.1016/j.bbagen.2017.10.004
PG 11
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA FO1FE
UT WOS:000416501300004
PM 29030319
DA 2020-07-08
ER

PT J
AU Marsakatla, P
   Suneetha, S
   Lee, J
   Swaminathan, PD
   Vasudevan, L
   Supriya, R
   Suneetha, LM
AF Marsakatla, Prasanna
   Suneetha, Sujai
   Lee, Joshua
   Swaminathan, Paari Dominic
   Vasudevan, Logeshwaran
   Supriya, Rachael
   Suneetha, Lavanya Moses
TI Insights from the sequence similarity of Zika virus proteins with the
   Human nerve proteins
SO BIOINFORMATION
LA English
DT Article
DE Zika V; Nerve tissue proteins; Neuropathogenesis; Bioinformatics; BLAST;
   Neuromodulin; Nestin; Bombesin; Galanin; Calcium-binding protein
ID GALANIN; MECHANISMS; BIOLOGY; GAP-43; ZERO
AB Massive peptide sharing between the Zika virus polyprotein and host tissue proteins could elicit significant host-pathogen interactions and cross-reactions leading to autoimmune diseases. This study found similarities in the Zika V proteins and human nerve tissue proteins. 63 human nerve proteins were screened for similarities with the Zika V of which Neuromodulin, Nestin, Galanin, Bombesin, Calcium-binding protein were found to have similarities to the Zika V poly protein C at different sequence regions. These sequence similarities could be significant in regulating pathogenic interactions/autoimmunity, as Polyprotein C is known to be a virulent factor.
C1 [Marsakatla, Prasanna; Suneetha, Sujai; Supriya, Rachael; Suneetha, Lavanya Moses] CODEWEL Nireekshana ACET, Hyderabad 500029, Telangana, India.
   [Lee, Joshua] York Univ, Dept Sci, 4700 Keele St, Toronto, ON M3J 1P3, Canada.
   [Swaminathan, Paari Dominic] LSU Hlth Sci Ctr, Ctr Cardiovasc Dis & Sci Shreveport, Shreveport, LA USA.
   [Vasudevan, Logeshwaran] Presidency Coll, Dept Zool, Madras 05, Tamil Nadu, India.
RP Suneetha, LM (corresponding author), CODEWEL Nireekshana ACET, Hyderabad 500029, Telangana, India.
EM drlavanyasuneetha@gmail.com
FU Nireekshana ACET; CODEWEL
FX We acknowledge the support of Nireekshana ACET and CODEWEL for this
   project.
CR Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Asif A, 2017, VIRAL IMMUNOL, V30, P682, DOI 10.1089/vim.2017.0046
   Beckham JD, 2016, JAMA NEUROL, V73, P875, DOI 10.1001/jamaneurol.2016.0800
   BERSANI M, 1991, FEBS LETT, V283, P189, DOI 10.1016/0014-5793(91)80585-Q
   Briken V, 2008, CURR DRUG TARGETS, V9, P150, DOI 10.2174/138945008783502449
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Christel C, 2012, BBA-GEN SUBJECTS, V1820, P1243, DOI 10.1016/j.bbagen.2011.12.012
   Counts SE, 2008, CELL MOL LIFE SCI, V65, P1842, DOI 10.1007/s00018-008-8159-2
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Gilyarov A V, 2008, Neurosci Behav Physiol, V38, P165, DOI 10.1007/s11055-008-0025-z
   Gold CA, 2016, JAMA NEUROL, V73, P905, DOI 10.1001/jamaneurol.2016.1268
   Gutlapalli VR, 2015, BIOINFORMATION, V11, P517, DOI 10.6026/97320630011517
   Haeseleer F, 2000, J BIOL CHEM, V275, P1247, DOI 10.1074/jbc.275.2.1247
   Haeseleer F, 2002, BIOCHEM BIOPH RES CO, V290, P615, DOI 10.1006/bbrc.2001.6228
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   KAPLAN LM, 1988, P NATL ACAD SCI USA, V85, P1065, DOI 10.1073/pnas.85.4.1065
   KOSIK KS, 1988, NEURON, V1, P127, DOI 10.1016/0896-6273(88)90196-1
   LABATE ME, 1989, NEURON, V3, P299, DOI 10.1016/0896-6273(89)90254-7
   Lucchese G, 2017, VIRUS ADAPT TREAT, V9, P1
   Lucchese G, 2016, AUTOIMMUN REV, V15, P801, DOI 10.1016/j.autrev.2016.03.020
   Merfeld E, 2017, WILEY INTERDISCIP RE, V6
   Mladinich MC, 2017, MBIO, V8, DOI [10.1128/mBio.00952-17, 10.1128/mbio.00952-17]
   Raju R, 2011, NEUROCHEM RES, V36, P766, DOI 10.1007/s11064-010-0397-7
   Rigden DJ, 2016, NUCLEIC ACIDS RES, V44, pD1, DOI 10.1093/nar/gkv1356
   Rolfe AJ, 2016, CELL BIOSCI, V6, DOI 10.1186/s13578-016-0110-x
   Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75
   Stanfield Brent A, 2017, F1000Res, V6, P386, DOI 10.12688/f1000research.10591.1
   Styczynski AR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005869
   Su MA, 2012, J IMMUNOL, V188, P4906, DOI 10.4049/jimmunol.1200493
   Suneetha LM, 2003, NEUROCHEM RES, V28, P1393, DOI 10.1023/A:1024904717612
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   Tucci V, 2017, J GLOB INFECT DIS, V9, P151, DOI 10.4103/jgid.jgid_66_17
   Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419
   Vardhini D, 2004, INFECT GENET EVOL, V4, P21, DOI 10.1016/j.meegid.2003.11.001
   Wilson MR, 2017, J BIOL CHEM
   Yu XB, 2015, J PROTEOME RES, V14, P1920, DOI 10.1021/pr5013015
NR 36
TC 0
Z9 0
U1 0
U2 1
PU BIOMEDICAL INFORMATICS
PI TAMIL NADU
PA NO 42, 2ND MAIN RD, CHENNAI, TAMIL NADU, 600 020, INDIA
SN 0973-8894
EI 0973-2063
J9 BIOINFORMATION
JI Bioinformation
PY 2018
VL 14
IS 5
BP 194
EP 200
DI 10.6026/97320630014194
PG 7
WC Mathematical & Computational Biology
SC Mathematical & Computational Biology
GA GZ7NO
UT WOS:000449668000003
PM 30108415
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Lin, HH
   Yip, BS
   Huang, LM
   Wu, SC
AF Lin, Hsiao-Han
   Yip, Bak-Sau
   Huang, Li-Min
   Wu, Suh-Chin
TI Zika virus structural biology and progress in vaccine development
SO BIOTECHNOLOGY ADVANCES
LA English
DT Review
DE Zika virus; Structure biology; Vaccine; Cross reactivity
ID NEUTRALIZING HUMAN-ANTIBODIES; BORNE ENCEPHALITIS-VIRUS; DENGUE VIRUS;
   ENVELOPE GLYCOPROTEIN; MEMBRANE ASSOCIATION; NS2B-NS3 PROTEASE;
   CRYSTAL-STRUCTURE; CROSS-REACTIVITY; PROTECTION; OUTBREAK
AB The growing number of zika virus (ZIKV) infections plus a 20-fold increase in neonatal microcephaly in new-borns in Brazil have raised alarms in many countries regarding the threat to pregnant women. Instances of microcephaly and central nervous system malformations continue to increase in ZIKV outbreak regions. ZIKV is a small enveloped positive-strand RNA virus belonging to the Flavivirus genus of the Flaviviridae family. High-resolution ZIKV structures recently identified by cryo-electron microscopy indicate that the overall ZIKV structure is similar to those of other flaviviruses. With its compact surface, ZIKV is more thermally stable than the dengue virus (DENY). ZIKV E proteins have a characteristic "herringbone" structure with a single glycosylation site. The ZIKV E protein, the major protein involved in receptor binding and fusion, is formed as a head-to tail dimer on the surfaces of viral particles. The E monomer consists of three distinct domains: DI, DII, and DIII. The finger-like DII contains a fusion loop (FL) that is inserted into the host cell endosomal membrane during pH dependent conformational changes that drive fusion. Quaternary E:E dimer epitopes located at the interaction site of prM and E dimers can be further divided into two dimer epitopes. To date, more than 50 ZIKV vaccine candidates are now in various stages of research and development. Candidate ZIKV vaccines that are currently in phase I/II clinical trials include inactivated whole viruses, recombinant measles viral vector-based vaccines, DNA and mRNA vaccines, and a mosquito salivary peptide vaccine. Stabilized forms of ZIKV E:E dimer proteins have been successfully obtained either by introducing additional inter-subunit disulfide bond(s) in DII or via the direct assembly of E:E dimer proteins by immobilization with monomeric E proteins. The VLP-based approach is another alternative method for presenting native E:E dimer antigens among the vaccine components. Several forms of ZIKV VLPs have been reported featuring the co-expression of the prM-E, prM-E-NS1, C-prM-E, and NS2B/NS3 viral genes in human cells. To minimize the effect of the cross-reactive ADE-facilitating antibodies between ZIKV and DENY, several novel mutations have been reported either in or near the FL of DII or DIII to dampen the production of cross-reactive antibodies. Future ZIKV vaccine design efforts should be focused on eliciting improved neutralizing antibodies with a reduced level of cross-reactivity to confer sterilizing immunity.
C1 [Lin, Hsiao-Han; Wu, Suh-Chin] Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu, Taiwan.
   [Yip, Bak-Sau] Natl Taiwan Univ Hosp, Hsinchu Branch, Dept Neurol, Hsinchu, Taiwan.
   [Huang, Li-Min] Natl Taiwan Univ, Childrens Hosp, Dept Pediat, Hsinchu, Taiwan.
   [Wu, Suh-Chin] Natl Tsing Hua Univ, Dept Med Sci, Hsinchu, Taiwan.
RP Wu, SC (corresponding author), 101,Sect 2,Kuang Fu Rd, Hsinchu 30013, Taiwan.
EM scwu@mx.nthu.edu.tw
RI amsalu, ribka/G-8780-2019
OI Yip, Bak-Sau/0000-0001-7942-8293; HUANG, LI-MIN/0000-0002-9291-260X
FU Taiwan's Ministry of Science and Technology [MOST 106-2321-B-002-022]
FX This work is supported by Taiwan's Ministry of Science and Technology
   under grant numbers MOST 106-2321-B-002-022.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Beltramello M., 2010, CELL HOST MICROBE
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Boigard H, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005608
   Bordon Y, 2016, NAT REV IMMUNOL, V16, P718, DOI 10.1038/nri.2016.131
   Briant L, 2014, VIROLOGY, V464, P26, DOI 10.1016/j.virol.2014.06.023
   Brown WC, 2016, NAT STRUCT MOL BIOL, V23, P865, DOI 10.1038/nsmb.3268
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Campos JLS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01097-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Centers for Disease Control and Prevention (CDC), 2017, WORLD MAP AR RISK ZI
   Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   Coloma J, 2016, CELL REP, V16, P3097, DOI 10.1016/j.celrep.2016.08.091
   Crill WD, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00334
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   de Araujo J. S. S., 2016, B WHO, V4
   DeFrancesco L, 2016, NAT BIOTECHNOL, V34, P1084, DOI 10.1038/nbt1116-1084b
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   DYER O, 2016, BMJ-BRIT MED J, V353, DOI DOI 10.1136/BMJ.I3588
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Garg H, 2017, J VIROL, V91, DOI 10.1128/JVI.00834-17
   Griffin BD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15743
   Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4
   Harandi AM, 2009, EXPERT REV VACCINES, V8, P293, DOI 10.1586/14760584.8.3.293
   Harrison SC, 2016, NAT IMMUNOL, V17, P1010, DOI 10.1038/ni.3539
   Hasan SS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14722
   Jain R, 2016, NAT STRUCT MOL BIOL, V23, P752, DOI 10.1038/nsmb.3258
   Jarmer J, 2014, J VIROL, V88, P13845, DOI 10.1128/JVI.02086-14
   Keasey SL, 2017, CLIN VACCINE IMMUNOL, V24, DOI 10.1128/CVI.00036-17
   Kim E, 2016, EBIOMEDICINE, V13, P315, DOI 10.1016/j.ebiom.2016.09.028
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Lai CY, 2008, J VIROL, V82, P6631, DOI 10.1128/JVI.00316-08
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Lipsitch M, 2016, SCIENCE, V353, P1094, DOI 10.1126/science.aai8126
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Metz SW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04767-6
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Morrison C, 2016, NAT REV DRUG DISCOV, V15, P521, DOI 10.1038/nrd.2016.159
   Muthumani K, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.21
   NIH, 2017, NIH BEG STUD VACC PR
   Nutt C, 2017, LANCET, V389, P1595, DOI 10.1016/S0140-6736(17)31051-6
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Phoo WW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13410
   Pierson TC, 2016, CELL, V167, P625, DOI 10.1016/j.cell.2016.09.020
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Priyamvada L, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.42
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   Richner JM, 2017, CELL, V169, P176, DOI 10.1016/j.cell.2017.03.016
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   Ruwona TB, 2016, VACCINE, V34, P3059, DOI 10.1016/j.vaccine.2016.04.081
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Screaton G, 2015, NAT REV IMMUNOL, V15, P745, DOI 10.1038/nri3916
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Stiasny K, 2006, J VIROL, V80, P9557, DOI 10.1128/JVI.00080-06
   Suy A, 2016, NEW ENGL J MED, V375, P2611, DOI 10.1056/NEJMc1607580
   Tian HL, 2016, PROTEIN CELL, V7, P450, DOI 10.1007/s13238-016-0275-4
   Tripp RA, 2016, EXPERT REV VACCINES, V15, P1083, DOI 10.1080/14760584.2016.1192474
   Ulanova M, 2001, INFECT IMMUN, V69, P1151, DOI 10.1128/IAI.69.2.1151-1159.2001
   van den Berg B, 2013, NEUROLOGY, V80, P1650, DOI 10.1212/WNL.0b013e3182904fcc
   WHO, 2017, WHO VACC PIP TRACK
   WHO, 2017, ZIK VIR SIT REP
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
   Xu XY, 2016, EMBO J, V35, P2170, DOI 10.15252/embj.201695290
   Zhang C, 2016, BIOCH BIOPHYS RES CO
   Zhao BT, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14586
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 83
TC 20
Z9 23
U1 4
U2 37
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0734-9750
EI 1873-1899
J9 BIOTECHNOL ADV
JI Biotechnol. Adv.
PD JAN-FEB
PY 2018
VL 36
IS 1
BP 47
EP 53
DI 10.1016/j.biotechadv.2017.09.004
PG 7
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA FU9NN
UT WOS:000424182700004
PM 28916391
DA 2020-07-08
ER

PT J
AU Paixao, ES
   Teixeira, MG
   Rodrigues, LC
AF Paixao, Enny S.
   Teixeira, Maria Gloria
   Rodrigues, Laura C.
TI Zika, chikungunya and dengue: the causes and threats of new and
   re-emerging arboviral diseases
SO BMJ GLOBAL HEALTH
LA English
DT Article
ID SYMPTOMATIC DENGUE; VIRUS-INFECTIONS; ENDEMIC AREAS; THAILAND; VECTOR;
   TRANSMISSION; OUTBREAK; BURDEN; EPIDEMIOLOGY; PREGNANCY
AB The recent emergence and re-emergence of viral infections transmitted by vectors-Zika, chikungunya, dengue, Japanese encephalitis, West Nile, yellow fever and others-is a cause for international concern. Using as examples Zika, chikungunya and dengue, we summarise current knowledge on characteristics of the viruses and their transmission, clinical features, laboratory diagnosis, burden, history, possible causes of the spread and the expectation for future epidemics. Arboviruses are transmitted by mosquitoes, are of difficult diagnosis, can have surprising clinical complications and cause severe burden. The current situation is complex, because there is no vaccine for Zika and chikungunya and no specific treatment for the three arboviruses. Vector control is the only comprehensive solution available now and this remains a challenge because up to now this has not been very effective. Until we develop new technologies of control mosquito populations, the globalised and urbanised world we live in will remain vulnerable to the threat of successive arbovirus epidemics.
C1 [Paixao, Enny S.; Rodrigues, Laura C.] London Sch Hyg & Trop Med, Epidemiol & Populat Hlth, London, England.
   [Paixao, Enny S.; Teixeira, Maria Gloria] Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil.
RP Rodrigues, LC (corresponding author), London Sch Hyg & Trop Med, Epidemiol & Populat Hlth, London, England.
EM Laura.Rodrigues@lshtm.ac.uk
RI Teixeira, Maria Gloria/G-4808-2012
OI Teixeira, Maria Gloria/0000-0003-3318-3408
FU National Council for Scientific and Technological Development
   (CNPq-Brazil)National Council for Scientific and Technological
   Development (CNPq); European UnionEuropean Union (EU) [734584]
FX EP was funded by the National Council for Scientific and Technological
   Development (CNPq-Brazil). LCR is partially funded by the European
   Union's Horizon 2020 research and innovation program under Zika-PLAN
   grant agreement number 734584; however, the funder of this study had no
   role in writing of the report.
CR Anderson KB, 2007, LANCET, V369, P1452, DOI 10.1016/S0140-6736(07)60671-0
   Cardona-Ospina JA, 2015, INT J INFECT DIS, V38, P60, DOI 10.1016/j.ijid.2015.07.015
   Associacao Brasileira de Saude Coletiva, 2016, EP ZIK VIR DIR REPR
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Centers of Disease Control, 2016, REV DIAGN TEST ZIK C
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   Couturier E, 2012, RHEUMATOLOGY, V51, P1315, DOI 10.1093/rheumatology/kes015
   Dengue WHO, 2009, GUID DIAGN TREATM
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Garcia-Bujalance S, 2017, J CLIN VIROL, V96, P110, DOI 10.1016/j.jcv.2017.10.006
   Gerardin P, 2016, NEUROLOGY, V86, P94, DOI 10.1212/WNL.0000000000002234
   Gerardin P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002996
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0
   Halstead SB, 2015, EMERG INFECT DIS, V21, P557, DOI 10.3201/eid2104.141723
   Hirayama T, 2012, J CLIN MICROBIOL, V50, P2047, DOI 10.1128/JCM.06557-11
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   JUPP PG, 1981, T ROY SOC TROP MED H, V75, P15, DOI 10.1016/0035-9203(81)90005-5
   Kilpatrick AM, 2012, LANCET, V380, P1946, DOI 10.1016/S0140-6736(12)61151-9
   Knudsen A. B., 1995, Parassitologia (Rome), V37, P91
   Krow-Lucal ER, 2017, EMERG INFECT DIS, V23, P841, DOI 10.3201/eid2305.161715
   L'Azou M, 2016, NEW ENGL J MED, V374, P1155, DOI 10.1056/NEJMoa1503877
   Lahariya Chandrakant, 2006, Journal of Vector Borne Diseases, V43, P151
   Laoprasopwattana K, 2016, EPIDEMIOL INFECT, V144, P381, DOI 10.1017/S0950268815001065
   Lee AJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178199
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Medlock JM, 2015, LANCET INFECT DIS, V15, P721, DOI 10.1016/S1473-3099(15)70091-5
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Organization WH, DENG SEV DENG
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Pan American Health Organization, 2017, ZIK CAS CONG SYNDR A
   Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rigau-Perez JG, 1998, LANCET, V352, P971, DOI 10.1016/S0140-6736(97)12483-7
   Rodriguez-Morales AJ, 2015, RHEUMATOL INT, V35, P2091, DOI 10.1007/s00296-015-3302-5
   ROSS R. W., 1956, JOUR HYG, V54, P177
   Schaffner F, 2014, LANCET INFECT DIS, V14, P1271, DOI 10.1016/S1473-3099(14)70834-5
   Sissoko D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000389
   Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8
   Tan PC, 2008, OBSTET GYNECOL, V111, P1111, DOI 10.1097/AOG.0b013e31816a49fc
   Teixeira MG, 2016, AM J PUBLIC HEALTH, V106, P601, DOI 10.2105/AJPH.2016.303113
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Thavara U, 2009, SE ASIAN J TROP MED, V40, P951
   Wagner D, 2004, EMERG INFECT DIS, V10, P1872, DOI 10.3201/eid1010.031037
   Wanlapakorn N, 2014, EMERG INFECT DIS, V20, P1404, DOI 10.3201/eid2008.140481
   Weaver SC, 2009, INFECT GENET EVOL, V9, P523, DOI 10.1016/j.meegid.2009.02.003
   Yudhaputri FA, 2017, VIROLOGY, V510, P248, DOI 10.1016/j.virol.2017.07.026
NR 58
TC 59
Z9 60
U1 6
U2 14
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 2059-7908
J9 BMJ GLOB HEALTH
JI BMJ Glob. Health
PD JAN
PY 2018
VL 3
SU 1
AR UNSP e000530
DI 10.1136/bmjgh-2017-000530
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GC4QN
UT WOS:000429770000004
PM 29435366
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Rasool, N
   Jalal, A
   Amjad, A
   Hussain, W
AF Rasool, Nouman
   Jalal, Amir
   Amjad, Adnan
   Hussain, Waqar
TI Probing the Pharmacological Parameters, Molecular Docking and Quantum
   Computations of Plant Derived Compounds Exhibiting Strong Inhibitory
   Potential Against NS5 from Zika Virus
SO BRAZILIAN ARCHIVES OF BIOLOGY AND TECHNOLOGY
LA English
DT Article
DE ZIKV-NS5; Phytochemicals; Molecular Docking; DFT calculations
ID DENSITY-FUNCTIONAL THEORY; DEPENDENT RNA-POLYMERASE; IDENTIFICATION;
   SOLUBILITY; MECHANISM; BINDING
AB Zika virus (ZIKV) is known for microcephaly and neurological disease in humans and the nonstructural proteins of ZIKV play a fundamental role in the viral replication. Among the seven nonstructural proteins, NS5 is the most conserved and largest protein. Two major functional domains of NS5 i.e. methyltransferase (MTase) and RNA-dependent RNA polymerase (RdRp) are imperative for the virus life cycle and survival. The present study explicates the inhibitory action of phytochemicals from medicinal plants against NS5 from ZIKV, leading to the identification of potential inhibitors. The crystal structure of the protein is retrieved from RCSB protein data bank. A total of 2035 phytochemicals from 505 various medicinal plants are analysed for their pharmacological properties and pharmacokinetics. Compounds having effective drug-likeness are docked against the protein and further analysed using density functional theory approach. Among the 2035 phytochemicals, 13 are selected as potential inhibitors against MTase having high binding affinities and 17 compounds are selected for RdRp. HOMO and LUMO energies are calculated for the docked compounds within and outside binding pockets of MTase and RdRp, adapting the B3LYP hybrid exchange-correlation functional with def2-SV(P) basis set. Physicochemical properties such as ionization energy, electronic chemical potential, electronegativity, electron affinity, molecular softness, molecular hardness and electrophilicity index have also been analysed for selected phytochemicals. Based upon the results, it is concluded that the selected phytochemicals are highly competent to impede the replication of the virus by inhibiting the ZIKV-NS5.
C1 [Rasool, Nouman] Univ Management & Technol, Dept Life Sci, Lahore, Pakistan.
   [Rasool, Nouman] Univ Karachi, Int Ctr Chem & Biol Sci, Dr Panjwani Ctr Mol Med & Drug Res, Karachi 75270, Pakistan.
   [Jalal, Amir] Sahara Med Coll, Narowal, Pakistan.
   [Amjad, Adnan] Univ Management & Technol, Dept Chem, Lahore, Pakistan.
   [Hussain, Waqar] Univ Management & Technol, Dept Comp Sci, Lahore, Pakistan.
RP Rasool, N (corresponding author), Univ Management & Technol, Dept Life Sci, Lahore, Pakistan.
EM nouman.rasool@umt.edu.pk
RI Hussain, Waqar/AAC-9367-2020
OI Hussain, Waqar/0000-0001-8991-9424; Rasool, Nouman/0000-0003-0210-5845
CR Ahmed-Belkacem A, 2014, NUCLEIC ACIDS RES, V42, P9399, DOI 10.1093/nar/gku632
   Ai CZ, 2010, J COMPUT CHEM, V31, P1822, DOI 10.1002/jcc.21455
   Anusuya S, 2016, J BIOMOL STRUCT DYN, V34, P1512, DOI 10.1080/07391102.2015.1081620
   Brecher M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130062
   Briskin DP, 2000, PLANT PHYSIOL, V124, P507, DOI 10.1104/pp.124.2.507
   Byler KG, 2016, J MOL GRAPH MODEL, V69, P78, DOI 10.1016/j.jmgm.2016.08.011
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Daina A, 2017, SCI REP-UK, V7, DOI 10.1038/srep42717
   Delaney JS, 2004, J CHEM INF COMP SCI, V44, P1000, DOI 10.1021/ci034243x
   Eroglu E, 2007, J MOL GRAPH MODEL, V26, P701, DOI 10.1016/j.jmgm.2007.03.015
   Godoy AS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14764
   Gogoi D, 2017, COMPUT BIOL CHEM, V69, P28, DOI 10.1016/j.compbiolchem.2017.04.005
   Gopalakrishnan SB, 2014, J COMP METHOD PHY, V2014
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hussain Waqar, 2018, VirusDisease, V29, P147, DOI 10.1007/s13337-018-0446-4
   Kavitha R, 2015, BIOSYSTEMS, V138, P39, DOI 10.1016/j.biosystems.2015.10.005
   Kimura T, 2002, BIOL PHARM BULL, V25, P149, DOI 10.1248/bpb.25.149
   Lee S.K., 2003, EUROQSAR 2002 DESIGN, P418
   Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1
   Liu SB, 2005, J CHEM SCI, V117, P477, DOI 10.1007/BF02708352
   Millichap J., 2016, PED NEUROL BRIEFS, V30
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Neese F, 2012, WIRES COMPUT MOL SCI, V2, P73, DOI 10.1002/wcms.81
   Papageorgiou L, 2014, PEERJ, V2, DOI 10.7717/peerj.664
   Parr RG, 1999, J AM CHEM SOC, V121, P1922, DOI 10.1021/ja983494x
   Qaddir I, 2017, J VECTOR DIS, V54, P255
   Ramharack P, 2018, J BIOMOL STRUCT DYN, V36, P1118, DOI 10.1080/07391102.2017.1313175
   Rasool N, 2018, J MOL GRAPH MODEL, V80, P126, DOI 10.1016/j.jmgm.2017.12.011
   Shi PY, 2009, MOL VIROLOGY CONTROL
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tran N., 2011, ENCY CLIN NEUROPSYCH
   Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334
   Vektariene A, 2009, ARKIVOC ONLINE J ORG
   Wang BX, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14763
   Williamson EM, 2001, PHYTOMEDICINE, V8, P401, DOI 10.1078/0944-7113-00060
   Zou XW, 2014, ACTA CRYSTALLOGR D, V70, P1549, DOI 10.1107/S1399004714005239
NR 37
TC 3
Z9 3
U1 1
U2 5
PU INST TECNOLOGIA PARANA
PI CURITIBA-PARANA
PA RUA PROF ALGACYR MUNHOZ MADER 3775-CIC, 81350-010 CURITIBA-PARANA,
   BRAZIL
SN 1516-8913
EI 1678-4324
J9 BRAZ ARCH BIOL TECHN
JI Braz. Arch. Biol. Technol.
PY 2018
VL 61
AR e18180004
DI 10.1590/1678-4324-2018180004
PG 20
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA HD4ZI
UT WOS:000452536800001
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU de Moraes, FM
   Esposito, DLA
   Klein, TM
   da Fonseca, BAL
AF de Moraes, F. M.
   Esposito, D. L. A.
   Klein, T. M.
   da Fonseca, B. A. L.
TI Searching for the best real-time RT-PCRs to detect Zika virus
   infections: the importance of comparing several protocols
SO BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
LA English
DT Article
DE Zika virus; Flavivirus; real time RT-PCR; Diagnosis
AB Clinical manifestations of Zika, dengue, and chikungunya virus infections are very similar, making it difficult to reach a diagnosis based only on clinical grounds. In addition, there is an intense cross-reactivity between antibodies directed to Zika virus and other flaviviruses, and an accurate Zika diagnosis is best achieved by real-time RT-PCR. However, some real-time RT-PCR show better performance than others. To reach the best possible Zika diagnosis, the analytic sensitivity of some probe-based real-time RT-PCR amplifying Zika virus RNA was evaluated in spiked and clinical samples. We evaluated primers and probes to detect Zika virus, which had been published before, and tested sensitivity using serum spiked and patient samples by real-time RT-PCR. When tested against spiked samples, the previously described primers showed different sensitivity, with very similar results when samples from patients (serum and urine) were analyzed. Real-time RT-PCR designed to amplify Zika virus NS1 showed the best analytical sensitivity for all samples.
C1 [de Moraes, F. M.; Esposito, D. L. A.; da Fonseca, B. A. L.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Clin Med, Ribeirao Preto, SP, Brazil.
   [Klein, T. M.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Bioquim & Imunol, Ribeirao Preto, SP, Brazil.
RP Esposito, DLA (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Clin Med, Ribeirao Preto, SP, Brazil.
EM esposito@usp.br
RI Esposito, Danillo L.A./N-9261-2017
OI Esposito, Danillo L.A./0000-0002-2755-4471
FU Sao Paulo State Secretary of Health (FESIMA, Oficio CAF) [03/2016];
   CAPES/Zika Fast Track [88887.116621/2016-01]; Brazilian Ministry of
   Health [25000.161.997/2016-70]
FX This work was funded by grants from the Sao Paulo State Secretary of
   Health (FESIMA, Oficio CAF #03/2016), CAPES/Zika Fast Track
   (#88887.116621/2016-01) and the Brazilian Ministry of Health
   (#25000.161.997/2016-70).
CR Corman VM, 2016, B WORLD HEALTH ORGAN, V94, P880, DOI 10.2471/BLT.16.175950
   Cunha MS, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00032-16
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Leland DS, 2007, CLIN MICROBIOL REV, V20, P49, DOI 10.1128/CMR.00002-06
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pyke Alyssa T, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.4635a54dbffba2156fb2fd76dc49f65e
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shinohara K, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav011
   Shuaib W, 2016, AM J MED, V129, DOI 10.1016/j.amjmed.2016.02.027
   Tappe D, 2013, EURO SURVEILL, V19
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
NR 14
TC 0
Z9 0
U1 0
U2 0
PU ASSOC BRAS DIVULG CIENTIFICA
PI SAO PAULO
PA FACULDADE MEDICINA, SALA 21, 14049 RIBEIRAO PRETO, SAO PAULO, 00, BRAZIL
SN 0100-879X
EI 1678-4510
J9 BRAZ J MED BIOL RES
JI Brazilian J. Med. Biol. Res.
PY 2018
VL 51
IS 6
AR e7221
DI 10.1590/1414-431X20187221
PG 5
WC Biology; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; Research & Experimental
   Medicine
GA GG8WB
UT WOS:000432978400001
PM 29791591
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Colombo, TE
   Terzian, ACB
   Araujo, JP
   Parreira, R
   Cabrer, EMS
   dos Santos, INP
   Reis, AFN
   Costa, FR
   Cruz, LEAA
   Rombola, PL
   Nogueira, ML
AF Colombo, Tatiana Elias
   Bernardes Terzian, Ana Carolina
   Araujo Junior, Joao Pessoa
   Parreira, Ricardo
   Sotello Cabrer, Eliana Marcia
   Penha dos Santos, Izalco Nuremberg
   Negri Reis, Andreia Francesli
   Costa, Fabiana Rodrigues
   Arao Antonio Cruz, Lilian Elisa
   Rombola, Patricia Lopes
   Nogueira, Mauricio Lacerda
TI Zika detection: comparison of methodologies
SO BRAZILIAN JOURNAL OF MICROBIOLOGY
LA English
DT Article
DE Zika virus; Detection; Sensitivity; Specificity
ID VIRUS; ASSAYS; PCR
AB Many countries in the Americas have detected local transmission of multiple arboviruses that cause febrile illnesses. Therefore, laboratory testing has become an important tool for confirming the etiology of these diseases. The present study aimed to compare the sensitivity and specificity of three different Zika virus detection assays. One hundred serum samples from patients presenting with acute febrile symptoms were tested using a previously reported TaqMan (R) RT-qPCR assay. We used a SYBR (R) Green RT-qPCR and a conventional PCR methodologies to compare the results. Of the samples that were determined to be negative by the TaqMan (R) RT-qPCR assay, 100% (Kappa = 0.670) were also found to be negative by SYBR (R) Green RT-qPCR based on Tm comparison; however, 14% (Kappa = 0.035) were found to be positive by conventional PCR followed by agarose gel electrophoresis. The differences between the ZIKV strains circulating worldwide and the low viremia period can compromise diagnostic accuracy and thereby the accuracy of outbreak data. Therefore, improved assays are required to improve the diagnosis and surveillance of arbovirus. (C) 2017 Sociedade Brasileira de Microbiologia. Published by Elsevier Editora Ltda.
C1 [Colombo, Tatiana Elias; Bernardes Terzian, Ana Carolina; Sotello Cabrer, Eliana Marcia; Nogueira, Mauricio Lacerda] Fac Med Sao Jose do Rio Preto FAMERP, Sao Jose Do Rio Preto, SP, Brazil.
   [Araujo Junior, Joao Pessoa] Univ Estadual Paulista, Inst Biociencias Botucatu, Lab Virol, Botucatu, SP, Brazil.
   [Parreira, Ricardo] Univ Nova Lisboa, GHTM, Lisbon, Portugal.
   [Penha dos Santos, Izalco Nuremberg; Negri Reis, Andreia Francesli; Costa, Fabiana Rodrigues; Arao Antonio Cruz, Lilian Elisa; Rombola, Patricia Lopes] Prefeitura Sao Jose do Rio Preto, Dept Vigilancia Saude, Sao Jose Do Rio Preto, SP, Brazil.
RP Nogueira, ML (corresponding author), Fac Med Sao Jose do Rio Preto FAMERP, Sao Jose Do Rio Preto, SP, Brazil.
EM mnogueira@famerp.br
RI Nogueira, Mauricio L/B-7599-2012; Parreira, Ricardo/AAH-4559-2019;
   Araujo, JP/Q-3043-2019; Araujo, Joao Pessoa/C-2444-2012; Parreira,
   Ricardo/I-2304-2012
OI Nogueira, Mauricio L/0000-0003-1102-2419; Parreira,
   Ricardo/0000-0002-4832-9898; Araujo, JP/0000-0002-9153-1485; Araujo,
   Joao Pessoa/0000-0002-9153-1485; Parreira, Ricardo/0000-0002-4832-9898
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2013/21719-3]
FX We thank the FAPESP (grant #2013/21719-3 to MLN) for financial support.
CR Ai JW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.42
   Alberg AJ, 2004, J GEN INTERN MED, V19, P460, DOI 10.1111/j.1525-1497.2004.30091.x
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Borst A, 2004, EUR J CLIN MICROBIOL, V23, P289, DOI 10.1007/s10096-004-1100-1
   Bronzoni RVD, 2005, J CLIN MICROBIOL, V43, P696, DOI 10.1128/JCM.43.2.696-702.2005
   CDC, 2016, REV DIAGN TEST ZIK C
   Charrel RN, 2016, B WORLD HEALTH ORGAN, V94, P574, DOI 10.2471/BLT.16.171207
   Colin C, 2001, J VIRAL HEPATITIS, V8, P87, DOI 10.1046/j.1365-2893.2001.00280.x
   Dejnirattisai W, 2016, NAT IMMUNOL
   Estofolete CF, 2016, J CLIN VIROL, V81, P25, DOI 10.1016/j.jcv.2016.05.012
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Gyurech D, 2016, SWISS MED WKLY, V146, DOI 10.4414/smw.2016.14296
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   McHugh ML, 2012, BIOCHEM MEDICA, V22, P776
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Pyke Alyssa T, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.4635a54dbffba2156fb2fd76dc49f65e
   Smedley RC, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-49
   Tajadini Mohamadhasan, 2014, Adv Biomed Res, V3, P85, DOI 10.4103/2277-9175.127998
   Tappe D, 2013, EURO SURVEILL, V19
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   World Health Organization, 2016, LAB TEST ZIK VIR INF
NR 24
TC 1
Z9 2
U1 0
U2 7
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1517-8382
EI 1678-4405
J9 BRAZ J MICROBIOL
JI Braz. J. Microbiol.
PD JAN-MAR
PY 2018
VL 49
IS 1
BP 144
EP 147
DI 10.1016/j.bjm.2017.04.011
PG 4
WC Microbiology
SC Microbiology
GA FX8UF
UT WOS:000426369900023
PM 28927874
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Zheng, W
   Sun, W
   Simeonov, A
AF Zheng, Wei
   Sun, Wei
   Simeonov, Anton
TI Drug repurposing screens and synergistic drug-combinations for
   infectious diseases
SO BRITISH JOURNAL OF PHARMACOLOGY
LA English
DT Review
ID RESISTANT STAPHYLOCOCCUS; CYTOTOXIC SECRETIONS; CLAVULANIC ACID;
   ANTIBIOTIC USE; ZIKA VIRUS; IN-VITRO; AURANOFIN; IDENTIFICATION;
   PENICILLIN; TIME
AB Infectious diseases account for nearly one fifth of the worldwide death toll every year. The continuous increase of drug-resistant pathogens is a big challenge for treatment of infectious diseases. In addition, outbreaks of infections and new pathogens are potential threats to public health. Lack of effective treatments for drug-resistant bacteria and recent outbreaks of Ebola and Zika viral infections have become a global public health concern. The number of newly approved antibiotics has decreased significantly in the last two decades compared with previous decades. In parallel with this, is an increase in the number of drug-resistant bacteria. For these threats and challenges to be countered, new strategies and technology platforms are critically needed. Drug repurposing has emerged as an alternative approach for rapid identification of effective therapeutics to treat the infectious diseases. For treatment of severe infections, synergistic drug combinations using approved drugs identified from drug repurposing screens is a useful option which may overcome the problem of weak activity of individual drugs. Collaborative efforts including government, academic researchers and private drug industry can facilitate the translational research to produce more effective new therapeutic agents such as narrow spectrum antibiotics against drug-resistant bacteria for these global challenges.
   Linked ArticlesThis article is part of a themed section on Inventing New Therapies Without Reinventing the Wheel: The Power of Drug Repurposing. To view the other articles in this section visit
C1 [Zheng, Wei; Sun, Wei; Simeonov, Anton] NIH, Natl Ctr Adv Translat Sci, 9800 Med Ctr Dr, Bethesda, MD 20892 USA.
RP Zheng, W (corresponding author), NIH, Natl Ctr Adv Translat Sci, 9800 Med Ctr Dr, Bethesda, MD 20892 USA.
EM wzheng@mail.nih.gov
RI ; Zheng, Wei/J-8889-2014
OI Sun, Wei/0000-0002-1306-3946; Zheng, Wei/0000-0003-1034-0757
FU National Center for Advancing Translational Sciences at the National
   Institutes of Health in the United States
FX This work was supported by the Intramural Research Program of the
   National Center for Advancing Translational Sciences at the National
   Institutes of Health in the United States. We would like to thank Dr
   Ruili Huang for helpful discussion of anti-infective drugs. The authors
   thank Dr DeeAnn Visk for editing the manuscript.
CR Aldeyab MA, 2008, J ANTIMICROB CHEMOTH, V62, P593, DOI 10.1093/jac/dkn198
   Alexander SPH, 2015, BRIT J PHARMACOL, V172, P6024, DOI 10.1111/bph.13354
   Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876
   Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981
   Bassetti M, 2011, CRIT CARE, V15, DOI 10.1186/cc9997
   Breger J, 2007, PLOS PATHOG, V3, P168, DOI 10.1371/journal.ppat.0030018
   BROUGHTON MC, 1991, ANTIMICROB AGENTS CH, V35, P1348, DOI 10.1128/AAC.35.7.1348
   Butts A, 2014, MBIO, V5, DOI 10.1128/mBio.00765-13
   Carroll MW, 2015, NATURE, V524, P97, DOI 10.1038/nature14594
   Chaudhry M, 2016, APPL TRANSL GENOM, V9, P3, DOI 10.1016/j.atg.2016.04.001
   Chirullo B, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.473
   Coates A, 2002, NAT REV DRUG DISCOV, V1, P895, DOI 10.1038/nrd940
   Conlan S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009845
   Debnath A, 2012, NAT MED, V18, P956, DOI 10.1038/nm.2758
   Dekker JP, 2016, J CLIN MICROBIOL, V54, P2850, DOI 10.1128/JCM.01714-16
   Durand CR, 2016, AM J THER
   Ejim L, 2011, NAT CHEM BIOL, V7, P348, DOI [10.1038/NCHEMBIO.559, 10.1038/nchembio.559]
   Fan F, 2002, ANTIMICROB AGENTS CH, V46, P3343, DOI 10.1128/AAC.46.11.3343-3347.2002
   Fiskus W, 2014, CANCER RES, V74, P2520, DOI 10.1158/0008-5472.CAN-13-2033
   FLEISHER GR, 1983, ANTIMICROB AGENTS CH, V24, P679, DOI 10.1128/AAC.24.5.679
   Foerster S, 2017, J ANTIMICROB CHEMOTH, V72, P1961, DOI 10.1093/jac/dkx113
   Frail DE, 2015, NAT REV DRUG DISCOV, V14, P833, DOI 10.1038/nrd4707
   Gonzales PR, 2015, NAT CHEM BIOL, V11, P855, DOI 10.1038/nchembio.1911
   Granizo JJ, 2000, J ANTIMICROB CHEMOTH, V46, P767, DOI 10.1093/jac/46.5.767
   Harbut MB, 2015, P NATL ACAD SCI USA, V112, P4453, DOI 10.1073/pnas.1504022112
   He SS, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010286
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Highlander SK, 1997, AM J VET RES, V58, P749
   HOUANG ET, 1984, J ANTIMICROB CHEMOTH, V14, P529, DOI 10.1093/jac/14.5.529
   Huang RL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001862
   JACOBS MR, 1986, ANTIMICROB AGENTS CH, V29, P980, DOI 10.1128/AAC.29.6.980
   Jarvest RL, 2002, J MED CHEM, V45, P1959, DOI 10.1021/jm025502x
   Jorgensen JH, 2009, CLIN INFECT DIS, V49, P1749, DOI 10.1086/647952
   Kainer MA, 2012, NEW ENGL J MED, V367, P2194, DOI 10.1056/NEJMoa1212972
   Kouznetsova J, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.88
   Kreuels B, 2014, NEW ENGL J MED, V371, P2394, DOI 10.1056/NEJMoa1411677
   Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786
   Levin BR, 2002, NETH J MED, V60, P58
   Lewis K, 2013, NAT REV DRUG DISCOV, V12, P371, DOI 10.1038/nrd3975
   Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0
   Madeira JM, 2013, LIFE SCI, V92, P1072, DOI 10.1016/j.lfs.2013.04.005
   Madeira JM, 2014, J NEUROIMMUNOL, V276, P71, DOI 10.1016/j.jneuroim.2014.08.615
   Mahamat A, 2007, INT J ANTIMICROB AG, V30, P169, DOI 10.1016/j.ijantimicag.2007.04.005
   McCarthy M, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i5978
   Munck C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009940
   Nichols RJ, 2011, CELL, V144, P143, DOI 10.1016/j.cell.2010.11.052
   Nirmal Kumar Ganguly GKS, 2013, OMICS PERSONALIZED M, pXVIII
   Patterson S, 2016, ELIFE, V5, DOI 10.7554/eLife.09744
   Payne DJ, 2002, ANTIMICROB AGENTS CH, V46, P3118, DOI 10.1128/AAC.46.10.3118-3124.2002
   Petrova E, 2014, INNOVATION AND MARKE, pVI
   PLOTZ PH, 1962, SCIENCE, V135, P1067, DOI 10.1126/science.135.3508.1067
   Power E, 2006, CLIN MICROBIOL INFEC, V12, P25, DOI 10.1111/j.1469-0691.2006.01528.x
   Qin X, 2017, INT J ANTIMICROB AGE
   RETSEMA JA, 1980, ANTIMICROB AGENTS CH, V17, P615, DOI 10.1128/AAC.17.4.615
   Santos R, 2017, NAT REV DRUG DISCOV, V16, P19, DOI 10.1038/nrd.2016.230
   Schulz M, 2003, PHARMAZIE, V58, P447
   Schwab M, 2012, GENOME MED, V4, DOI 10.1186/gm394
   Smith KP, 2016, J CLIN MICROBIOL, V54, P2288, DOI 10.1128/JCM.00932-16
   Smith KP, 2016, ASSAY DRUG DEV TECHN, V14, P194, DOI 10.1089/adt.2016.701
   Snitkin ES, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004129
   Southan C, 2016, NUCLEIC ACIDS RES, V44, pD1054, DOI 10.1093/nar/gkv1037
   Stachyra T, 2009, J ANTIMICROB CHEMOTH, V64, P326, DOI 10.1093/jac/dkp197
   Sun W, 2017, ANTIVIR RES, V137, P165, DOI 10.1016/j.antiviral.2016.11.017
   Sun W, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.123
   Sun W, 2016, DRUG DISCOV TODAY, V21, P1189, DOI 10.1016/j.drudis.2016.05.015
   Takeda H, 2017, SCI REP-UK, V7, DOI 10.1038/srep45605
   van Belkum A, 2013, J CLIN MICROBIOL, V51, P2018, DOI 10.1128/JCM.00313-13
   WISE R, 1978, ANTIMICROB AGENTS CH, V13, P389, DOI 10.1128/AAC.13.3.389
   Woodford N, 2014, J ANTIMICROB CHEMOTH, V69, P287, DOI 10.1093/jac/dkt392
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Youn JH, 2016, J CLIN MICROBIOL, V54, P35, DOI 10.1128/JCM.01643-15
   Zheng W, 2013, DRUG DISCOV TODAY, V18, P1067, DOI 10.1016/j.drudis.2013.07.001
   Zilberberg MD, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0596-8
NR 73
TC 37
Z9 37
U1 5
U2 24
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0007-1188
EI 1476-5381
J9 BRIT J PHARMACOL
JI Br. J. Pharmacol.
PD JAN
PY 2018
VL 175
IS 2
SI SI
BP 181
EP 191
DI 10.1111/bph.13895
PG 11
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA FS2HR
UT WOS:000419599900003
PM 28685814
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Freire, IM
   Pone, SM
   Ribeiro, MD
   Aibe, MS
   Pone, MVD
   Moreira, MEL
   Dupret, L
AF Freire, Imara Moreira
   Pone, Sheila Moura
   Ribeiro, Milena da Cunha
   Aibe, Mitsue Senra
   da Silva Pone, Marcos Vinicius
   Lopes Moreira, Maria Elisabeth
   Dupret, Leila
TI Congenital Zika virus syndrome in infants: repercussions for the
   promotion of families' mental health
SO CADERNOS DE SAUDE PUBLICA
LA English
DT Article
DE Zika Virus; Mental Health; Infant; Family Relations
AB This article aims to discuss the impacts of the promotion of families' mental health following the diagnosis of Zika virus infection in the pregnant woman and/or congenital Zika virus syndrome (CZVS) in the infant. The study also aims to foster reflection on mother-infant bonding in this context. The study is relevant not only because there is still so much to learn about CZVS, with its enormous capacity for dispersion and many doubts as to the physical consequences and psychological impacts, but also due to the urgent need to provide families and/or caregivers with guidelines for care and alternatives for dealing with the illness. The study was conducted in an outpatient clinic specifically providing care to children with CZVS at the Unit for Infectious Diseases in Pediatrics in a tertiary hospital of the Brazilian Unified National Health System (SUS) in Rio de Janeiro, Brazil. The team is multidisciplinary, and each member conducts an assessment based on their specific field of knowledge. This qualitative study drew on participant observation, and the data analysis showed that the use of virtual social networks, which function (independently of the medicine approaches) as channels for communication and collective discussion of the different experiences, in order to share strategies to overcome the diagnosed impossibilities.
C1 [Freire, Imara Moreira; Pone, Sheila Moura; Ribeiro, Milena da Cunha; Aibe, Mitsue Senra; da Silva Pone, Marcos Vinicius; Lopes Moreira, Maria Elisabeth] Fundacao Oswaldo Cruz, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Av Rui Barbosa 716, BR-22250020 Rio De Janeiro, RJ, Brazil.
   [Dupret, Leila] Univ Fed Rural Rio de Janeiro, Nova Iguacu, Brazil.
RP Freire, IM (corresponding author), Fundacao Oswaldo Cruz, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Av Rui Barbosa 716, BR-22250020 Rio De Janeiro, RJ, Brazil.
EM imara.freire@iff.fiocruz.br
RI da Silva Pone, Marcos Vinicius/N-1285-2019
OI da Silva Pone, Marcos Vinicius/0000-0002-5152-2242; Moura Pone,
   Sheila/0000-0002-6246-8915
CR BARSAGLINI R.A, 2013, ADOECIMENTOS SOFRIME, P70
   Bezerra Junior B, 1992, CIDADANIA LOUCURA PO, P134
   Dimenstein MDB, 1998, ESTUDOS PSICOLOGIA, V3, P53, DOI DOI 10.1590/S1413-294X1998000100004
   Diniz D, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00046316
   Gonzalez Rey F. L., 2005, PESQUISA QUALITATIVA
   Haguette TMF, 1995, METODOLOGIAS QUALITA
   Ministerio da Saude, 2017, AP PSIC MULH GEST FA
NR 7
TC 2
Z9 2
U1 0
U2 3
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PY 2018
VL 34
IS 9
AR e00176217
DI 10.1590/0102-311X00176217
PG 5
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GT4KD
UT WOS:000444471900001
PM 30208181
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Guedes, GR
   Coutinho, RZ
   Marteleto, L
   Pereira, WHS
   Duarte, D
AF Guedes, Gilvan Ramalho
   Coutinho, Raquel Zanatta
   Marteleto, Leticia
   Silva Pereira, Wesley Henrique
   Duarte, Denise
TI Signifying Zika: heterogeneity in the representations of the virus by
   history of infection
SO CADERNOS DE SAUDE PUBLICA
LA English
DT Article
DE Zika Virus; Risk-Taking; Social Support
ID RISK PERCEPTIONS; HEALTH-SERVICES; BRAZIL; EXPOSURE
AB Despite having been broadly advertised by the mass media, many negative consequences of the Zika virus have been less significant than originally predicted. It is likely that after a few months from the epidemic's onset, personal experience with the virus has altered the person's way to deal with the disease. This study explores the relation between exposure to Zika virus and the social representation of the epidemic. More specifically, one analyzes if increased exposure to the risk of Zika infection changes the characteristics of the web of meanings surrounding the epidemic. Between August and November of 2016, 150 interviews were conducted in the municipality of Governador Valadares, Minas Gerais State, Brazil. Based on the Free Words Association Technique, data on evocations related to the Zika virus were modeled by social network analysis, allowing the characterization of the web of meanings by level of exposure to the risk of Zika infection. The analysis performed here suggests that those never infected by any disease transmitted by the Aedes aegypti mosquito have a lesser representation, incorporating information from the media through lay thinking. In contrast to those with low levels of exposure, the social representation of people infected by Zika is associated with meanings related to the most common symptoms, such as pain, rash, and itching. Personal experience seems to shape the social representation of the disease, increasing the focus on its proximate consequences. Public campaigns designed to foster protective behavior should take into consideration the heterogeneity in the representations of this epidemic to improve adherence to preventive behavior.
C1 [Guedes, Gilvan Ramalho; Coutinho, Raquel Zanatta] Univ Fed Minas Gerais, Ctr Desenvolvimento & Planejamento Reg Minas Gera, Av Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
   [Guedes, Gilvan Ramalho] Univ Penn, Ctr Populat Studies, Philadelphia, PA 19104 USA.
   [Marteleto, Leticia] Univ Texas Austin, Dept Sociol, Austin, TX 78712 USA.
   [Silva Pereira, Wesley Henrique; Duarte, Denise] Univ Fed Minas Gerais, Dept Estat, Belo Horizonte, MG, Brazil.
RP Guedes, GR (corresponding author), Univ Fed Minas Gerais, Ctr Desenvolvimento & Planejamento Reg Minas Gera, Av Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM grguedes@cedeplar.ufmg.br
FU Brazilian Graduate Studies Coordinating Board (Capes)CAPES; Brazilian
   National Research Council (CNPq)National Council for Scientific and
   Technological Development (CNPq) [431872/2016-3]; Minas Gerais State
   Research Foundation (FAPEMIG)Minas Gerais State Research Foundation
   (FAPEMIG) [APG-01553-16]; Rede Clima; CapesCAPES
FX We would like to thank the Center for Regional Development and Planning
   (CEDEPLAR), Federal University of Minas Gerais, the Population Research
   Center, University of Texas at Austin, and the Population Studies
   Center, University of Pennsylvania for institutional support (including
   English proofreading). We would also like to thank the Brazilian
   Graduate Studies Coordinating Board (Capes) for financial support of two
   of the authors, and a postdoctoral schoolarship for one of the authors.
   We also thank Leonardo Gomes Sousa for discussion on how to better
   communicate and represent results using the Gephi software. To Brazilian
   National Research Council (CNPq; 431872/2016-3), Minas Gerais State
   Research Foundation (FAPEMIG; APG-01553-16); Rede Clima and Capes for
   the financial support.
CR Abric JC, 1994, PRATIQUES SOCIALES R
   Associacao Brasileira de Empresas de Pesquisa, 2014, CRIT CLASS EC BRAS
   Bradley EH, 2007, HEALTH SERV RES, V42, P1758, DOI 10.1111/j.1475-6773.2006.00684.x
   Braga C, 2010, ACTA TROP, V113, P234, DOI 10.1016/j.actatropica.2009.10.021
   Centro de Operacoes de Emergencias em Saude Publica sobre Microcefalias, 2016, MON CAS MICR BRAS
   Cerbino-Neto J, 2016, EMERG INFECT DIS, V22, P1318, DOI 10.3201/eid2207.160375
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Chen F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052814
   de Wit JBF, 2008, HEALTH PSYCHOL, V27, P110, DOI 10.1037/0278-6133.27.1.110
   Federacao Brasileira das Associacoes de Ginecologia e Obstetricia, 2016, OR REC FEBRASGO INF
   Felippe M. F., 2016, REV GEOGR, P63
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Gruev-Vintila A, 2007, J RISK RES, V10, P555, DOI 10.1080/13669870701338064
   Guedes GR, 2015, CAD SAUDE PUBLICA, V31, P1257, DOI 10.1590/0102-311X00063514
   Hora A. M., 2013, THESIS
   Kelly J A, 2000, WMJ, V99, P41
   Lau JTF, 2003, J EPIDEMIOL COMMUN H, V57, P864, DOI 10.1136/jech.57.11.864
   Ventura DDL, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00033316
   Mansuy JM, 2016, Lancet Infect Dis, V16, P138
   Marteleto LJ, POPUL DEV REV
   Martin LM, 2000, AM J PREV MED, V18, P215, DOI 10.1016/S0749-3797(99)00158-0
   Ministerio da Saude, LEV RAP IND AED AEG
   Ministerio da Saude; Universidade Aberta do SUS; Fiocruz Unidade Cerrado Pantanal; Universidade Federal do Mato Grosso do Sul; Secretaria de Vigilancia em Saude; et al, ZIK AB CLIN AT BAS
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.026113
   Peters EM, 2004, RISK ANAL, V24, P1349, DOI 10.1111/j.0272-4332.2004.00531.x
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Prefeitura Municipal de Governador Valadares, DENG 1 LIRAA 2017 A
   Rouquette M.L., 1997, CHASSE IMMIGRE VIOLE
   Rubin GJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2651
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Secretaria de Vigilancia em Saude Ministerio da Saude, 2015, B EPIDEMIOLOGICO, V46
   Secretaria de Vigilancia em Saude Ministerio da Saude Brasil, 2017, B EPIDEMIOLOGICO, V48
   *US DEP HHS, 2002, MAK HLTH COMM PROGR
   WASSRMAN S, 1994, SOCIAL NETWORK ANAL
   Weinstein ND, 2003, BLACKW SER HLTH PSYC, P22
   World Health Organization, 2016, ZIK SIT REP ZIK VIR
NR 37
TC 1
Z9 1
U1 1
U2 4
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PY 2018
VL 34
IS 5
AR e00003217
DI 10.1590/0102-311X00003217
PG 14
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GJ2ZS
UT WOS:000435144300001
PM 29898004
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Linde, AR
   Siqueira, CE
AF Linde, Ana Rosa
   Siqueira, Carlos Eduardo
TI Women's lives in times of Zika: mosquito-controlled lives?
SO CADERNOS DE SAUDE PUBLICA
LA English
DT Article
DE Zika Virus Infection; Pregnancy; Women's Health; Sickness Impact Profile
ID VIRUS; EPIDEMIC
AB Zika virus infection during pregnancy is a cause of congenital brain abnormalities. Its consequences to pregnancies has made governments, national and international agencies issue advices and recommendations to women. There is a clear need to investigate how the Zika outbreak affects the decisions that women take concerning their lives and the life of their families, as well as how women are psychologically and emotionally dealing with the outbreak. We conducted a qualitative study to address the impact of the Zika epidemic on the family life of women living in Brazil, Puerto Rico, and the US, who were affected by it to shed light on the social repercussions of Zika. Women were recruited through the snowball sampling technique and data was collected through semi-structured interviews. We describe the effects in mental health and the coping strategies that women use to deal with the Zika epidemic. Zika is taking a heavy toll on women's emotional well-being. They are coping with feelings of fear, helplessness, and uncertainty by taking drastic precautions to avoid infection that affect all areas of their lives. Coping strategies pose obstacles in professional life, lead to social isolation, including from family and partner, and threaten the emotional and physical well-being of women. Our findings suggest that the impacts of the Zika epidemic on women may be universal and global. Zika infection is a silent and heavy burden on women's shoulders.
C1 [Linde, Ana Rosa; Siqueira, Carlos Eduardo] Univ Massachusetts, Boston, MA 02125 USA.
RP Linde, AR (corresponding author), 9 Lawn Court, Cambridge, MA 02138 USA.
EM anarosa.lindearias@umb.edu
OI Siqueira, Carlos/0000-0001-8993-3031
CR Abramson D., 2016, 1 NYU COLL GLOB PUBL
   Bahamondes L, 2017, HUM REPROD, V32, P88, DOI 10.1093/humrep/dew310
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Centers for Disease Control and Prevention, ZIK VIR 2017 CAS COU
   Diniz D, 2017, J FAM PLAN REPROD H, V43, P80, DOI 10.1136/jfprhc-2016-101678
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Galli B, 2016, REWIRE NEWS     0203
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Kempner M, 2016, REWIRE NEWS     0201
   Lathrop E, 2018, LANCET PUBLIC HEALTH, V3, pE91, DOI 10.1016/S2468-2667(18)30001-X
   McNeil Jr Donald G., 2016, NY TIMES
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Prue CE, 2017, MMWR-MORBID MORTAL W, V66, P909, DOI 10.15585/mmwr.mm6634a4
   Torjesen I, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i500
   Borges ALV, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190024
NR 15
TC 2
Z9 2
U1 0
U2 1
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PY 2018
VL 34
IS 5
AR UNSP e00178917
DI 10.1590/0102-311X00178917
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GF9TT
UT WOS:000432322400001
PM 29768589
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Javanian, M
   Masrour-Roudsari, J
   Ebrahimpour, S
AF Javanian, Mostafa
   Masrour-Roudsari, Jila
   Ebrahimpour, Soheil
TI Clinical diagnosis challenges in Zika virus infection
SO CASPIAN JOURNAL OF INTERNAL MEDICINE
LA English
DT Letter
DE Zika virus; Diagnosis; Flu like illness
C1 [Javanian, Mostafa; Masrour-Roudsari, Jila; Ebrahimpour, Soheil] Babol Univ Med Sci, Infect Dis & Trop Med Res Ctr, Hlth Res Inst, Babol Sar, Iran.
RP Ebrahimpour, S (corresponding author), Babol Univ Med Sci, Infect Dis & Trop Med Res Ctr, Hlth Res Inst, Babol Sar, Iran.
EM drsoheil1503@yahoo.com
CR Karkhah A, 2018, EUR J CLIN MICROBIOL, V37, P2035, DOI 10.1007/s10096-018-3354-z
   Kurani S, 2018, CTS-CLIN TRANSL SCI, V11, P103, DOI 10.1111/cts.12529
   Priyamvada L, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.42
   Sharma A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00110
   Wu YH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11568-4
NR 5
TC 1
Z9 1
U1 0
U2 0
PU BABOL UNIV MEDICAL SCIENCES
PI BABOL
PA ENGLISH JOURNAL OFFICE, GANJ AFROOZ AVE, BABOL, 00000, IRAN
SN 2008-6164
EI 2008-6172
J9 CASP J INTERN MED
JI Casp. J. Intern. Med.
PY 2018
VL 9
IS 4
BP 416
EP 417
DI 10.22088/cjim.9.4.416
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA HC7KL
UT WOS:000451980000018
PM 30510661
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Amaku, M
   Coutinho, FAB
   Armstrong, M
   Massad, E
AF Amaku, Marcos
   Bezerra Coutinho, Francisco Antonio
   Armstrong, Margaret
   Massad, Eduardo
TI A Note on the Risk of Infections Invading Unaffected Regions
SO COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE
LA English
DT Article
ID TRAVEL; STRATEGIES; EPIDEMIC; MODELS; VIRUS; ZIKA
AB We present two probabilistic models to estimate the risk of introducing infectious diseases into previously unaffected countries/regions by infective travellers. We analyse two distinct situations, one dealing with a directly transmitted infection (measles in Italy in 2017) and one dealing with a vector-borne infection (Zika virus in Rio de Janeiro, which may happen in the future). To calculate the risk in the first scenario, we used a simple, nonhomogeneous birth process. The second model proposed in this paper provides a way to calculate the probability that local mosquitoes become infected by the arrival of a single infective traveller during his/her infectiousness period. The result of the risk ofmeasles invasion of Italy was of 93% and the result of the risk of Zika virus invasion of Rio de Janeiro was of 22%.
C1 [Amaku, Marcos; Bezerra Coutinho, Francisco Antonio; Massad, Eduardo] Univ Sao Paulo, Sch Med, Sao Paulo, Brazil.
   [Armstrong, Margaret; Massad, Eduardo] Fundacao Getulio Vargas, Sch Appl Math, Rio De Janeiro, Brazil.
   [Massad, Eduardo] Univ Derby, Coll Nat & Life Sci, Derby, England.
   [Massad, Eduardo] London Sch Hyg & Trop Med, London, England.
RP Amaku, M (corresponding author), Univ Sao Paulo, Sch Med, Sao Paulo, Brazil.
EM amaku@usp.br
RI Amaku, Marcos/D-5252-2012; Massad, Eduardo/B-1169-2012
OI Amaku, Marcos/0000-0003-4752-6774; Massad, Eduardo/0000-0002-7200-2916
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [LIM01-HCFMUSP]; Brazilian Ministry of Health [777588/2012]; ZikaPLAN
   through the European Union's Horizon 2020 Research and Innovation
   Programme [734584]; Canadian Institutes of Health Research (CIHR),
   Consortium Canada-Latin/America-Caribean Zika Virus ProgramCanadian
   Institutes of Health Research (CIHR) [372512]
FX This work has been funded by LIM01-HCFMUSP, CNPq, by the Brazilian
   Ministry of Health (Grant no. 777588/2012), by ZikaPLAN through the
   European Union's Horizon 2020 Research and Innovation Programme (Grant
   no. 734584), and the Canadian Institutes of Health Research (CIHR),
   Consortium Canada-Latin/America-Caribean Zika Virus Program (Grant no.
   372512).
CR Amaku M, 2014, B MATH BIOL, V76, P697, DOI 10.1007/s11538-014-9939-5
   ANDERSON R M, 1991
   Bailey NT, 2006, ELEMENTS STOCHASTIC
   Bossak BH, 2009, MED HYPOTHESES, V72, P749, DOI 10.1016/j.mehy.2008.12.045
   Caley P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000143
   ECDC, 2018, MEASL EU EEA CURR OU
   European Asylum Support Office(EASO), LAT AS TRENDS
   Gomes MFC, 2014, PLOS CURRENTS, DOI 10.1371/currents.outbreaks
   Khan K, 2009, NEW ENGL J MED, V361, P212, DOI 10.1056/NEJMc0904559
   Leder K, 2013, EMERG INFECT DIS, V19, P1049, DOI 10.3201/eid1907.121573
   Lopez LF, 2016, B MATH BIOL, V78, P185, DOI 10.1007/s11538-015-0135-z
   Massad E, 2005, MED HYPOTHESES, V65, P17, DOI 10.1016/j.mehy.2004.09.029
   Massad E, 2017, EPIDEMIOL INFECT, V145, P2303, DOI 10.1017/S0950268817001200
   Massad E, 2004, MED HYPOTHESES, V63, P911, DOI 10.1016/j.mehy.2004.03.028
   Massad E, 2007, MED HYPOTHESES, V68, P442, DOI 10.1016/j.mehy.2006.07.041
   Massad Eduardo, 2017, Infect Dis Model, V2, P441, DOI 10.1016/j.idm.2017.12.001
   Massad E, 2010, MEM I OSWALDO CRUZ, V105, P179, DOI 10.1590/S0074-02762010000200012
   Pandey A, 2014, SCIENCE, V346, P991, DOI 10.1126/science.1260612
   Quam M, 2014, LANCET, V383, P1632, DOI 10.1016/S0140-6736(14)60537-7
   Simini F, 2012, NATURE, V484, P96, DOI 10.1038/nature10856
   Stannard David E., 1993, P35, DOI 10.1017/CHOL9780521332866.006
   Tatem AJ, 2012, PARASITOLOGY, V139, P1816, DOI 10.1017/S0031182012000352
   UNWTO. World, 2018, TOUR ORG NEWS, V9
   van den Broek J, 2007, BIOSTATISTICS, V8, P453, DOI 10.1093/biostatistics/kxl023
   Villela DAM, 2017, EPIDEMIOL INFECT, V145, P1649, DOI 10.1017/S0950268817000358
   Voice of Europe, 2018, MOR 5 MILL 3 WORLD I
   Wilder-Smith A, 2003, J TRAVEL MED, V10, P257
   Wilder-Smith Annelies, 2006, Travel Med Infect Dis, V4, P53, DOI 10.1016/j.tmaid.2005.04.004
NR 28
TC 1
Z9 1
U1 0
U2 5
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1748-670X
EI 1748-6718
J9 COMPUT MATH METHOD M
JI Comput. Math. Method Med.
PY 2018
AR 6289681
DI 10.1155/2018/6289681
PG 8
WC Mathematical & Computational Biology
SC Mathematical & Computational Biology
GA GN2XK
UT WOS:000438865600001
PM 30073032
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Bajpai, VK
   Chandra, V
   Kim, NH
   Rai, R
   Kumar, P
   Kim, K
   Aeron, A
   Kang, SC
   Maheshwari, DK
   Na, M
   Rather, IA
   Park, YH
AF Bajpai, Vivek K.
   Chandra, Vishal
   Kim, Na-Hyung
   Rai, Rajni
   Kumar, Pradeep
   Kim, Kangmin
   Aeron, Abhinav
   Kang, Sun Chul
   Maheshwari, D. K.
   Na, MinKyun
   Rather, Irfan A.
   Park, Yong-Ha
TI Ghost probiotics with a combined regimen: a novel therapeutic approach
   against the Zika virus, an emerging world threat
SO CRITICAL REVIEWS IN BIOTECHNOLOGY
LA English
DT Review
DE Zika virus; probiotics; probiotic peptides; viral infection; plants;
   phytoconstituents
ID DITERPENOID COMPOUND SUGIOL; VITRO ANTIVIRAL ACTIVITY; DENGUE VIRUS;
   IN-VITRO; LACTOBACILLUS-PLANTARUM; PREGNANT-WOMEN; UNITED-STATES; SEXUAL
   TRANSMISSION; PROTECTS MICE; INFECTION
AB The Zika virus (ZIKV) used to be an obscure flavivirus closely related to dengue virus (DENV). Transmission of this epidemic pathogen occurs mainly via mosquitoes, but it is also capable of placental and sexual transmission. Although the characteristics of these viruses are well defined, infections are unpredictable in terms of disease severity, unusual clinical manifestations, unexpected methods of transmission, long-term persistence, and the development of new strains. Recently, ZIKV has gained huge medical attention following the large-scale epidemics around the world, and reported cases of congenital abnormalities associated with Zika virus infections which have created a public health emergency of international concern. Despite continuous research on ZIKV, no specific treatment or vaccine has been developed, excepting a preventive strategy for congenital ZIKV infection. Probiotics, known as GRAS, are bacteria that confer various health beneficial effects, and have been shown to be effective at curing a number of viral diseases by modulating the immune system. Furthermore, probiotic preparations consisting of dead cells and cellular metabolites, so-called Ghost probiotics, can also act as biological response modifiers. Here, we review available information on the epidemiology, transmission, and clinical features of ZIKV, and on treatment and prevention strategies. In addition, we emphasize the use of probiotics and plant-based natural remedies and describe their action mechanisms, and the green technologies for microbial conversion, which could contribute to the development of novel therapies that may reduce the pathogenicity of ZIKV. Accordingly, we draw attention to new findings, unanswered questions, unresolved issues, and controversies regarding ZIKV.
C1 [Bajpai, Vivek K.; Rather, Irfan A.; Park, Yong-Ha] Yeungnam Univ, Sch Biotechnol, Dept Appl Microbiol & Biotechnol, Gyongsan, Gyeongbuk, South Korea.
   [Chandra, Vishal] Integral Univ, Dept Biosci, Lucknow, Uttar Pradesh, India.
   [Chandra, Vishal] Univ Oklahoma, Hlth Sci Ctr, SCC, Oklahoma City, OK USA.
   [Kim, Na-Hyung] Wonkwang Univ, Dept Oriental Pharm, Iksan, Jeonbuk, South Korea.
   [Rai, Rajni; Kumar, Pradeep] Yeungnam Univ, Sch Biotechnol, Gyongsan, Gyeongbuk, South Korea.
   [Kim, Kangmin; Aeron, Abhinav] Chonbuk Natl Univ, Div Biotechnol, Coll Environm & Bioresource Sci, Iksan Si, Jeonbuk, South Korea.
   [Kang, Sun Chul] Daegu Univ, Dept Biotechnol, Coll Engn, Gyongsan, Gyeongbuk, South Korea.
   [Maheshwari, D. K.] Gurukul Kangri Univ, Dept Bot & Microbiol, Haridwar, India.
   [Na, MinKyun] Chungnam Natl Univ, Coll Pharm, Daejeon, South Korea.
RP Park, YH (corresponding author), Yeungnam Univ, Sch Biotechnol, Dept Appl Microbiol & Biotechnol, Gyongsan, Gyeongbuk, South Korea.; Kang, SC (corresponding author), Daegu Univ, Dept Biotechnol, Coll Engn, Gyongsan, Gyeongbuk, South Korea.; Na, M (corresponding author), Chungnam Natl Univ, Coll Pharm, Daejeon, South Korea.
EM sckang@daegu.ac.kr; mkna@cnu.ac.kr; peter@ynu.ac.kr
RI Chandra, Vishal/AAN-8756-2020; Rather, Irfan A./AAH-1425-2019;
   Maheshwari, D K/AAC-3451-2020; amsalu, ribka/G-8780-2019
OI Maheshwari, D K/0000-0002-2532-7515; Na, MinKyun/0000-0002-4865-6506
CR Adams CA, 2010, NUTR RES REV, V23, P37, DOI 10.1017/S0954422410000090
   Ahmad Nisar, 2011, Asian Pacific Journal of Tropical Biomedicine, V1, P330, DOI 10.1016/S2221-1691(11)60055-5
   Alhoot MA, 2013, INT J MED SCI, V10, P719, DOI 10.7150/ijms.5037
   Amalaradjou MAR, 2013, BIOENGINEERED, V4, P379, DOI 10.4161/bioe.23574
   Ambrose PG, 2007, CLIN INFECT DIS, V44, P79, DOI 10.1086/510079
   [Anonymous], 2016, NEWSWEEK
   [Anonymous], 2014, LANCET, V383, P764
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Bajpai VK, 2016, PAK J PHARM SCI, V29, P1077
   Bajpai VK, 2014, BANGL J PHARMACOL, V9, P312, DOI 10.3329/bjp.v9i3.19026
   Bajpai VK, 2014, ASIAN PAC J TROP MED, V7, P9, DOI 10.1016/S1995-7645(13)60183-2
   Bajpai VK, 2011, FOOD CHEM TOXICOL, V49, P403, DOI 10.1016/j.fct.2010.11.015
   Bajpai Vivek K., 2006, Agricultural Chemistry and Biotechnology, V49, P131
   Bajpai VK, 2009, NEW BIOTECHNOL, V26, P122, DOI 10.1016/j.nbt.2009.07.007
   Bajpai VK, 2016, DARU, V24, pe8
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093153
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Bremel Robert D, 2010, Immunome Res, V6, P8, DOI 10.1186/1745-7580-6-8
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Center for Disease Control and Prevention (CDC), 2016, ZIK VIR FACT SHEET P
   Center for Disease Control and Prevention (CDC), 2016, AS ZIK OUTBR PERS LA
   Center for Disease Control and Prevention (CDC) Centers for Disease Control ROC (Taiwan), 2016, PEOPL RET ZIK AFF CO
   Chang JH, 2013, ANTIVIR RES, V99, P251, DOI 10.1016/j.antiviral.2013.06.011
   Chao KP, 2005, PLANTA MED, V71, P300, DOI 10.1055/s-2005-864094
   Chen HL, 2016, J CHIN MED ASSOC, V79, P174, DOI 10.1016/j.jcma.2016.03.001
   Chen LM, 2017, ANTIVIR RES, V141, P140, DOI 10.1016/j.antiviral.2017.02.009
   Chiang LC, 2003, J ANTIMICROB CHEMOTH, V52, P194, DOI 10.1093/jac/dkg291
   Clark MJ, 2016, CELL CHEM BIOL, V23, P443, DOI 10.1016/j.chembiol.2016.03.010
   Claud EC, 2001, FASEB J, V15, P1398, DOI 10.1096/fj.00-0833hyp
   Comia-Capate C, 2011, REVISED DENGUE CLIN, P1
   Costeloe K, 2016, LANCET, V387, P649, DOI 10.1016/S0140-6736(15)01027-2
   Cruz-Oliveira C, 2015, FEMS MICROBIOL REV, V39, P155, DOI 10.1093/femsre/fuu004
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dasgupta S, 2016, MMWR-MORBID MORTAL W, V65, P395, DOI 10.15585/mmwr.mm6515e1
   Dash G, 2015, FISH SHELLFISH IMMUN, V43, P167, DOI 10.1016/j.fsi.2014.12.007
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   Deshpande G, 2007, LANCET, V369, P1614, DOI 10.1016/S0140-6736(07)60748-X
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Ekins Sean, 2016, F1000Res, V5, P150, DOI 10.12688/f1000research.8013.1
   Evers DL, 2005, ANTIVIR RES, V68, P124, DOI 10.1016/j.antiviral.2005.08.002
   FAO WHO, 2001, PREVENTION, P1
   Fensterl V, 2009, BIOFACTORS, V35, P14, DOI 10.1002/biof.6
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gould EA, 2001, ADV VIRUS RES, V57, P71, DOI 10.1016/S0065-3527(01)57001-3
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Guo QL, 2007, ANTIVIR RES, V74, P16, DOI 10.1016/j.antiviral.2007.01.002
   Hamel R, 2016, MICROBES INFECT, V18, DOI 10.1016/j.micinf.2016.03.009
   Han HM, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-112
   Harata G, 2010, LETT APPL MICROBIOL, V50, P597, DOI 10.1111/j.1472-765X.2010.02844.x
   Hoyos A B, 1999, Int J Infect Dis, V3, P197, DOI 10.1016/S1201-9712(99)90024-3
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Izumo T, 2010, INT IMMUNOPHARMACOL, V10, P1101, DOI 10.1016/j.intimp.2010.06.012
   Jacob JR, 2004, J ALTERN COMPLEM MED, V10, P1019, DOI 10.1089/acm.2004.10.1019
   Janies DA, 2011, CLADISTICS, V27, P61, DOI 10.1111/j.1096-0031.2010.00314.x
   Joseph B, 2015, FRONT LIFE SCI, V8, P18, DOI 10.1080/21553769.2014.924080
   Kaddumukasa MA, 2014, J MED ENTOMOL, V51, P104, DOI 10.1603/ME12269
   Kawase M, 2010, LETT APPL MICROBIOL, V51, P6, DOI 10.1111/j.1472-765X.2010.02849.x
   Kiat TS, 2006, BIOORG MED CHEM LETT, V16, P3337, DOI 10.1016/j.bmcl.2005.12.075
   Kim MJ, 2014, BIOTECHNOL BIOTEC EQ, V28, P681, DOI 10.1080/13102818.2014.945237
   Kirkpatrick BD, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1517
   KISHIMOTO C, 1988, J AM COLL CARDIOL, V12, P1334, DOI 10.1016/0735-1097(88)92618-6
   Kitazato K, 2007, DRUG DISCOV THER, V1, P14
   Kobayashi N, 2011, INT IMMUNOPHARMACOL, V11, P199, DOI 10.1016/j.intimp.2010.11.019
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Lee DK, 2015, CLIN RES HEPATOL GAS, V39, P237, DOI 10.1016/j.clinre.2014.09.006
   Lehtoranta L, 2014, EUR J CLIN MICROBIOL, V33, P1289, DOI 10.1007/s10096-014-2086-y
   Li JD, 2016, EMERG INFECT DIS, V22, P1133, DOI 10.3201/eid2206.160273
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Liderot K, 2013, BIOMED RES INT, DOI 10.1155/2013/376219
   Lim SP, 2013, ANTIVIR RES, V100, P500, DOI 10.1016/j.antiviral.2013.09.013
   Lin LT, 2015, J HEPATOL, V62, P541, DOI 10.1016/j.jhep.2014.10.040
   Ma WQ, 2017, CELL, V168, P542, DOI 10.1016/j.cell.2017.01.009
   Maeda N, 2009, INT IMMUNOPHARMACOL, V9, P1122, DOI 10.1016/j.intimp.2009.04.015
   Majumder R, 2015, BANGL J PHARMACOL, V10, P688, DOI 10.3329/bjp.v10i3.24475
   Makhluf H, 2016, EXPERT OPIN DRUG DIS, V11, P921, DOI 10.1080/17460441.2016.1212013
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Marcos JF, 2009, EXPERT OPIN DRUG DIS, V4, P659, DOI 10.1517/17460440902992888
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Millar M, 2003, ARCH DIS CHILD-FETAL, V88, pF354, DOI 10.1136/fn.88.5.F354
   Ming GL, 2016, CELL STEM CELL, V19, P690, DOI 10.1016/j.stem.2016.11.014
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mousa HA., 2014, J PREVENT INFECT CON, V15, P1
   Mousa HAL., 2015, J INFECT DIS THER, V3, pe215
   Muhamad M, 2010, INT J BIOL SCI, V6, P294
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nah K, 2016, PEERJ, V4, DOI 10.7717/peerj.1904
   Nandy A, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050666
   NANNO M, 1986, JPN J CANCER RES, V77, P703
   O'Leary DR, 2006, PEDIATRICS, V117, pE537, DOI 10.1542/peds.2005-2024
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Olivares M, 2007, NUTRITION, V23, P254, DOI 10.1016/j.nut.2007.01.004
   Oliveira ERA, 2017, VIRUS RES, V227, P115, DOI 10.1016/j.virusres.2016.10.005
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Otsuki N, 2010, J ETHNOPHARMACOL, V127, P760, DOI 10.1016/j.jep.2009.11.024
   Pan American Health Organization (PAHO), 2016, ZIK VIR INF
   Pang T, 2007, IMMUNOL CELL BIOL, V85, P43, DOI 10.1038/sj.icb.7100008
   Park YH, 2013, USA Patent, Patent No. [W02012153885 A9, 2012153885]
   Pavela R, 2009, PARASITOL RES, V105, P1365, DOI 10.1007/s00436-009-1571-1
   Perry ST, 2013, ANTIVIR RES, V98, P35, DOI 10.1016/j.antiviral.2013.01.004
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pomin VH., 2017, INTERDISCIP PERSPECT, V2017
   POTHOULAKIS C, 1993, GASTROENTEROLOGY, V104, P1108, DOI 10.1016/0016-5085(93)90280-P
   Rahman S, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-76
   Rajendran L, 2010, NAT REV DRUG DISCOV, V9, P29, DOI 10.1038/nrd2897
   Rather IA, 2015, BANGL J PHARMACOL, V10, P475, DOI 10.3329/bjp.v10i2.23068
   Rehman S, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-220
   Rizzardini G, 2012, BRIT J NUTR, V107, P876, DOI 10.1017/S000711451100420X
   Saxena Shailendra K., 2016, VirusDisease, V27, P111, DOI 10.1007/s13337-016-0307-y
   Schmidt AG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000851
   Semmler M, 2014, PARASITOL RES, V113, P185, DOI 10.1007/s00436-013-3641-7
   Seo BJ, 2012, J APPL MICROBIOL, V113, P163, DOI 10.1111/j.1365-2672.2012.05326.x
   Seo BJ, 2010, VET RES COMMUN, V34, P323, DOI 10.1007/s11259-010-9357-6
   Shi SH, 2014, VIROLOGY, V464, P166, DOI 10.1016/j.virol.2014.07.011
   Skalickova S, 2015, VIRUSES-BASEL, V7, P5428, DOI 10.3390/v7102883
   Smit JM, 2011, VIRUSES-BASEL, V3, P160, DOI 10.3390/v3020160
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Stavale EJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121662
   Strom K, 2002, APPL ENVIRON MICROB, V68, P4322, DOI 10.1128/AEM.68.9.4322-4327.2002
   Tang LIC, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-3
   Tang WW, 2016, CELL REP, V17, P3091, DOI 10.1016/j.celrep.2016.11.070
   Taverniti V, 2011, GENES NUTR, V6, P261, DOI 10.1007/s12263-011-0218-x
   The Associated Press, 2016, NBC NEWS
   Tian Y, 2010, FITOTERAPIA, V81, P799, DOI 10.1016/j.fitote.2010.04.012
   Tong XK, 2010, ACTA PHARMACOL SIN, V31, P585, DOI 10.1038/aps.2010.29
   Triunfol M, 2016, LANCET INFECT DIS, V16, P156, DOI 10.1016/S1473-3099(15)00548-4
   Tsai SH, 2007, RENEW ENERG, V32, P904, DOI 10.1016/j.renene.2006.04.019
   Uy G, 2007, GRADE 2 DENGUE HEMOR
   Vouloumanou EK, 2009, INT J ANTIMICROB AG, V34, DOI 10.1016/j.ijantimicag.2008.11.005
   Waki N, 2014, LETT APPL MICROBIOL, V58, P87, DOI 10.1111/lam.12160
   Waltz E, 2016, NAT BIOTECHNOL, V34, P221, DOI 10.1038/nbt0316-221
   Warfield KL, 2015, VIRUSES-BASEL, V7, P2404, DOI 10.3390/v7052404
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Xu G, 2010, BIOL PHARM BULL, V33, P238, DOI 10.1248/bpb.33.238
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Youn HN, 2012, ANTIVIR RES, V93, P138, DOI 10.1016/j.antiviral.2011.11.004
   Zandi K, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-214
   Zandi K, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-560
   Zandi K, 2011, J MED PLANTS RES, V5, P5534
   Zanluca C, 2016, MICROBES INFECT, V18, P295, DOI 10.1016/j.micinf.2016.03.003
   Zuppa AA, 2016, PROBIOTICS, PREBIOTICS, AND SYNBIOTICS: BIOACTIVE FOODS IN HEALTH PROMOTION, P101, DOI 10.1016/B978-0-12-802189-7.00008-3
   Zwizwai R, 2016, LANCET INFECT DIS, V16, P157, DOI 10.1016/S1473-3099(16)00023-2
NR 158
TC 3
Z9 3
U1 3
U2 11
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0738-8551
EI 1549-7801
J9 CRIT REV BIOTECHNOL
JI Crit. Rev. Biotechnol.
PY 2018
VL 38
IS 3
BP 438
EP 454
DI 10.1080/07388551.2017.1368445
PG 17
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA FZ9NN
UT WOS:000427938800009
PM 28877637
DA 2020-07-08
ER

PT J
AU de Jong, W
   Rusli, M
   Bhoelan, S
   Rohde, S
   Rantam, FA
   Noeryoto, PA
   Hadi, U
   van Gorp, ECM
   Goeijenbier, M
AF de Jong, Wesley
   Rusli, Musofa
   Bhoelan, Soerajja
   Rohde, Sofie
   Rantam, Fedik A.
   Noeryoto, Purwati A.
   Hadi, Usman
   van Gorp, Eric C. M.
   Goeijenbier, Marco
TI Endemic and emerging acute virus infections in Indonesia: an overview of
   the past decade and implications for the future
SO CRITICAL REVIEWS IN MICROBIOLOGY
LA English
DT Review
DE Indonesia; dengue; chikungunya; rabies; viral hepatitis
ID JAPANESE ENCEPHALITIS-VIRUS; PATHOGENIC AVIAN INFLUENZA; GEOSENTINEL
   SURVEILLANCE NETWORK; DENGUE HEMORRHAGIC-FEVER; WEST KALIMANTAN BORNEO;
   ZIKA VIRUS; HANTAVIRUS INFECTIONS; CHIKUNGUNYA FEVER; SEROLOGICAL
   EVIDENCE; COST-EFFECTIVENESS
AB Being the largest archipelago country in the world, with a tropical climate and a unique flora and fauna, Indonesia habitats one of the most diverse biome in the world. These characteristics make Indonesia a popular travel destination, with tourism numbers increasing yearly. These characteristics also facilitate the transmission of zoonosis and provide ideal living and breading circumstances for arthropods, known vectors for viral diseases. A review of the past 10 years of literature, reports of the Ministry of Health, Republic of Indonesia and ProMED-mail shows a significant increase in dengue infection incidence. Furthermore, chikungunya, Japanese encephalitis and rabies are proven to be endemic in Indonesia. The combination of cohort studies, governmental data and ProMED-mail reveals an integrated overview for those working in travel medicine and public health, focusing on both endemic and emerging acute virus infections. This review summarizes the epidemiology of acute virus infections in Indonesia, including outbreak reports, as well as public health response measurements and their potential or efficacy. Knowledge about human behaviour, animal reservoirs, climate factors, environment and their role in emerging virus infection are discussed. We aim to support public health authorities and health care policy makers in a One Health approach.
C1 [de Jong, Wesley; Rohde, Sofie; van Gorp, Eric C. M.; Goeijenbier, Marco] Erasmus MC, Dept Virosci, Rotterdam, Netherlands.
   [Rusli, Musofa; Noeryoto, Purwati A.; Hadi, Usman] Airlangga Univ, Fac Med, Dept Internal Med, Div Trop & Infect Dis, Surabaya, Indonesia.
   [Bhoelan, Soerajja; Goeijenbier, Marco] Havenziekenhuis Inst Trop Med, Dept Internal Med, Rotterdam, Netherlands.
   [Rantam, Fedik A.] Airlangga Univ, Inst Trop Dis, Surabaya, Indonesia.
RP de Jong, W (corresponding author), Erasmus MC, Dept Virosci, Rotterdam, Netherlands.
EM w.dejong.2@erasmusmc.nl
OI Rusli, Musofa/0000-0002-4834-2259
CR Aditama TY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029971
   Aditama TY, 2011, CLIN INFECT DIS, V53, P1237, DOI 10.1093/cid/cir740
   Ampofo WK, 2015, VACCINE, V33, P4368, DOI 10.1016/j.vaccine.2015.06.090
   [Anonymous], 2015, Wkly Epidemiol Rec, V90, P349
   [Anonymous], 2016, WORLDBANK INDONESIA
   [Anonymous], 2012, GLOB MEASL RUB STRAT
   Azhar M, 2010, AVIAN DIS, V54, P749, DOI 10.1637/8713-031809-Reg.1
   Barzaga NG, 2000, VACCINE, V18, pS61, DOI 10.1016/S0264-410X(99)00467-3
   Bi ZQ, 2008, J INFECT DEV COUNTR, V2, P3
   Boggild AK, 2012, J TRAVEL MED, V19, P4, DOI 10.1111/j.1708-8305.2011.00579.x
   Boggild AK, 2010, VACCINE, V28, P7389, DOI 10.1016/j.vaccine.2010.09.009
   Buhl MR, 1996, SCAND J INFECT DIS, V28, P189, DOI 10.3109/00365549609049074
   Caglioti C, 2013, NEW MICROBIOL, V36, P211
   CDC, 2016, ONE HLTH
   Chancey C, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/376230
   Chen LH, 2010, CURR OPIN INFECT DIS, V23, P438, DOI 10.1097/QCO.0b013e32833c1d16
   Cleton N, 2012, J CLIN VIROL, V55, P191, DOI 10.1016/j.jcv.2012.07.004
   CORWIN A, 1995, T ROY SOC TROP MED H, V89, P262, DOI 10.1016/0035-9203(95)90529-4
   Corwin A, 1997, AM J TROP MED HYG, V57, P62, DOI 10.4269/ajtmh.1997.57.62
   Dalimunthe S, 1990, Paediatr Indones, V30, P42
   Dash AP, 2013, J VECTOR DIS, V50, P77
   de Vries RD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002885
   Dibia IN, 2015, J VET SCI, V16, P459, DOI 10.4142/jvs.2015.16.4.459
   DIRKVANPEENEN PF, 1975, T ROY SOC TROP MED H, V69, P477, DOI 10.1016/0035-9203(75)90102-9
   Durrheim DN, 2014, VACCINE, V32, P6880, DOI 10.1016/j.vaccine.2014.10.061
   Ernst T, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003442
   Fahri S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002354
   Gautret P, 2011, CLIN MICROBIOL INFEC, V17, P445, DOI 10.1111/j.1469-0691.2010.03271.x
   Goeijenbier M, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/taw078
   Goeijenbier M, 2014, EUROSURVEILLANCE, V19, P27, DOI 10.2807/1560-7917.ES2014.19.32.20878
   Goeijenbier M, 2013, CRIT REV MICROBIOL, V39, P26, DOI 10.3109/1040841X.2012.686481
   Groen J, 2002, INFECTION, V30, P326, DOI 10.1007/s15010-002-2194-y
   Halide H, 2008, INT J ENVIRON HEAL R, V18, P253, DOI 10.1080/09603120801966043
   Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362
   Ibrahim IN, 2013, J VET MED SCI, V75, P1003, DOI 10.1292/jvms.12-0442
   Ibrahim IN, 1996, JPN J MED SCI BIOL, V49, P69, DOI 10.7883/yoken1952.49.69
   Kandun IN, 2008, LANCET, V372, P744, DOI 10.1016/S0140-6736(08)61125-3
   Kari K, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-8
   Karyanti MR, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-412
   Konishi E, 2009, AM J TROP MED HYG, V80, P856, DOI 10.4269/ajtmh.2009.80.856
   Kosasih H, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004390
   Kosasih H, 2014, ACTA MED INDONES, V46, P58
   Kosasih H, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002483
   Kosasih H, 2011, VECTOR-BORNE ZOONOT, V11, P709, DOI 10.1089/vbz.2010.0093
   Kotaki T, 2014, INFECT GENET EVOL, V28, P48, DOI 10.1016/j.meegid.2014.09.002
   Kotaki T, 2014, JPN J INFECT DIS, V67, P227, DOI 10.7883/yoken.67.227
   Kucharz EJ, 2012, EUR J INTERN MED, V23, P325, DOI 10.1016/j.ejim.2012.01.009
   Kunasol Prayura, 1998, Southeast Asian Journal of Tropical Medicine and Public Health, V29, P255
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lane-DeGraaf KE, 2014, AM J PRIMATOL, V76, P159, DOI 10.1002/ajp.22218
   Laras K, 2005, T ROY SOC TROP MED H, V99, P128, DOI 10.1016/j.trstmh.2004.03.013
   Leung AKC, 2007, ADV THER, V24, P1340, DOI 10.1007/BF02877781
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Liu W, 2010, EPIDEMIOL INFECT, V138, P1292, DOI 10.1017/S0950268810000063
   Liu W, 2008, VACCINE, V26, P4456, DOI 10.1016/j.vaccine.2008.06.050
   MACDONALD WBG, 1989, MED J AUSTRALIA, V150, P334, DOI 10.5694/j.1326-5377.1989.tb136498.x
   Maha MS, 2009, INT J INFECT DIS, V13, pE389, DOI 10.1016/j.ijid.2009.01.009
   Mangold KA, 2013, PEDIATR EMERG CARE, V29, P665, DOI 10.1097/PEC.0b013e31828ed30e
   Mariner JC, 2014, ECOHEALTH, V11, P22, DOI 10.1007/s10393-014-0916-0
   Martina BEE, 2009, CLIN MICROBIOL REV, V22, P564, DOI 10.1128/CMR.00035-09
   Meltzer E, 2009, TRAVEL MED INFECT DI, V7, P278, DOI 10.1016/j.tmaid.2009.05.002
   Mina MJ, 2015, SCIENCE, V348, P694, DOI 10.1126/science.aaa3662
   MoH RI, 2009, IND HLTH PROF 2008
   MoH RI, 2014, IND HLTH PROF 2013
   MoH RI, 2015, IND HLTH PROF 2014
   Moreli Marcos L., 2014, VirusDisease, V25, P385, DOI 10.1007/s13337-014-0219-7
   Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759
   Moss WJ, 2012, LANCET, V379, P153, DOI 10.1016/S0140-6736(10)62352-5
   Mulyanto, 2013, ARCH VIROL, V158, P87, DOI 10.1007/s00705-012-1462-0
   Mulyatno KC, 2012, JPN J INFECT DIS, V65, P92
   Mulyatno KC, 2012, SE ASIAN J TROP MED, V43, P29
   Mustiana A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124092
   Myint KSA, 2014, AM J TROP MED HYG, V90, P260, DOI 10.4269/ajtmh.13-0445
   Napoli C, 2012, J TRAVEL MED, V19, P294, DOI 10.1111/j.1708-8305.2012.00640.x
   Nasronudin, 2014, 32 WORLD C INT MED W
   Nicholson KG, 2003, LANCET, V362, P1733, DOI 10.1016/S0140-6736(03)14854-4
   OLSON J G, 1985, Southeast Asian Journal of Tropical Medicine and Public Health, V16, P337
   OLSON JG, 1985, T ROY SOC TROP MED H, V79, P845, DOI 10.1016/0035-9203(85)90135-X
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Ooi EE, 2009, CAD SAUDE PUBLICA, V25, pS115, DOI 10.1590/S0102-311X2009001300011
   Perkasa A, 2016, EMERG INFECT DIS, V22, P924, DOI 10.3201/eid2205.151915
   Plyusnina A, 2004, SCAND J INFECT DIS, V36, P356, DOI 10.1080/00365540410019264
   Plyusnina A, 2009, J GEN VIROL, V90, P205, DOI 10.1099/vir.0.006155-0
   Porter Kevin R., 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P408
   Porter KR, 2005, AM J TROP MED HYG, V72, P60, DOI 10.4269/ajtmh.2005.72.60
   Putra AAG, 2013, EMERG INFECT DIS, V19, P648, DOI 10.3201/eid1904.120380
   Rasic G, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1230-6
   Rovida F, 2011, J CLIN VIROL, V50, P76, DOI 10.1016/j.jcv.2010.09.015
   Sasmono RT, 2015, INFECT GENET EVOL, V32, P165, DOI 10.1016/j.meegid.2015.03.006
   Sedyaningsih ER, 2008, ANN ACAD MED SINGAP, V37, P482
   Sedyaningsih-Mamahit ER, 2002, T ROY SOC TROP MED H, V96, P398, DOI 10.1016/S0035-9203(02)90373-1
   Serquina-Ramiro Laurie, 2001, Southeast Asian Journal of Tropical Medicine and Public Health, V32, P791
   Shepard DS, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002055
   Soepandi PZ, 2010, CHEST, V138, P665, DOI 10.1378/chest.09-2644
   Stahl HC, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1048
   Storms AD, 2015, EPIDEMIOL INFECT, V143, P3394, DOI 10.1017/S0950268815000771
   Suharti Catharina, 2009, Acta Med Indones, V41, P75
   Susilawathi NM, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-81
   Suwantika AA, 2014, HUM VACC IMMUNOTHER, V10, P2342, DOI 10.4161/hv.29353
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Thiberville SD, 2013, ANTIVIR RES, V99, P345, DOI 10.1016/j.antiviral.2013.06.009
   Tiwari S, 2012, BRAZ J INFECT DIS, V16, P564, DOI 10.1016/j.bjid.2012.10.004
   Townsend SE, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002372
   Tsai Theodore F., 2000, Vaccine, V18, P1, DOI 10.1016/S0264-410X(00)00037-2
   Undurraga EA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002056
   Unni SK, 2011, MICROBES INFECT, V13, P312, DOI 10.1016/j.micinf.2011.01.002
   Utsumi Takako, 2014, Kobe J Med Sci, V60, pE43
   Utsumi T, 2011, ARCH VIROL, V156, P689, DOI 10.1007/s00705-010-0883-x
   Vainio K, 2010, EUROSURVEILLANCE, V15, P2
   van der Meulen KM, 2005, ARCH VIROL, V150, P637, DOI 10.1007/s00705-004-0463-z
   Vannice KS, 2016, VACCINE, V34, P2934, DOI 10.1016/j.vaccine.2015.12.073
   VANPEENEN PF, 1974, J TROP MED HYG, V77, P244
   Vranckx R., 1997, International Journal of Infectious Diseases, V2, P31, DOI 10.1016/S1201-9712(97)90008-4
   WALTNERTOEWS D, 1990, PREV VET MED, V8, P295, DOI 10.1016/0167-5877(90)90087-X
   Wang LH, 2014, INT J INFECT DIS, V25, P122, DOI 10.1016/j.ijid.2014.04.016
   Ward MP, 2014, PREV VET MED, V114, P11, DOI 10.1016/j.prevetmed.2014.01.009
   Watson DC, 2014, CRIT REV MICROBIOL, V40, P261, DOI 10.3109/1040841X.2013.783555
   Watson JT, 2004, ANN INTERN MED, V141, P360, DOI 10.7326/0003-4819-141-5-200409070-00010
   Wertheim HFL, 2015, INFLUENZA OTHER RESP, V9, P315, DOI 10.1111/irv.12326
   WHO, 2015, JAPANESE ENCEPHALITI
   WHO, 2016, IMM SURV ASS MON MEA
   WHO, 2014, BRIEF GUID EM INF DI
   WHO SEARO, 2005, COMB EM INF DIS S E
   Wicaksono EO, 2014, 32 WORLD C INT MED W
   Widagdo W, 2017, ONE HEALTH-AMSTERDAM, V3, P11, DOI 10.1016/j.onehlt.2016.12.001
   Widasari DI, 2013, MICROBIOL IMMUNOL, V57, P692, DOI 10.1111/1348-0421.12083
   Widyastuti MDW, 2015, INFECT DIS POVERTY, V4, DOI 10.1186/s40249-015-0061-1
   Wijayanti SPM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004500
   WITTESJO B, 1995, LANCET, V345, P856, DOI 10.1016/S0140-6736(95)92990-8
   World Economic Forum, 2015, TRAV TOUR COMP REP
   World Health Organisation, 2016, IMM VACC BIOL DENG V
   World Health Organization, 2014, TOP 10 CAUS DEATH
   Yamanaka A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027322
   Yamanaka A, 2010, JPN J INFECT DIS, V63, P58
   Yang Y, 2007, EMERG INFECT DIS, V13, P1348, DOI 10.3201/eid1309.070111
   Yoshida Masao, 1999, Southeast Asian Journal of Tropical Medicine and Public Health, V30, P698
   Yoshikawa Minako Jen, 2013, Trop Med Health, V41, P67, DOI 10.2149/tmh.2011-05
NR 137
TC 6
Z9 6
U1 0
U2 6
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1040-841X
EI 1549-7828
J9 CRIT REV MICROBIOL
JI Crit. Rev. Microbiol.
PY 2018
VL 44
IS 4
BP 487
EP 503
DI 10.1080/1040841X.2018.1438986
PG 17
WC Microbiology
SC Microbiology
GA GJ8WI
UT WOS:000435671900007
PM 29451044
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Villar, M
   Mateos-Hernandez, L
   de la Fuente, J
AF Villar, Margarita
   Mateos-Hernandez, Lourdes
   de la Fuente, Jose
TI The Impact of Post-Genomics Approaches in Neurodegenerative
   Demyelinating Diseases: The Case of Guillain-Barre Syndrome
SO CURRENT MEDICINAL CHEMISTRY
LA English
DT Review
DE Post-genomics approaches; Guillain-Barre syndrome; transcriptomics;
   proteomics; systems biology; neurodegenerative
ID CEREBROSPINAL-FLUID; SYNDROME GBS; ZIKA VIRUS; PATHOGENESIS;
   IDENTIFICATION; EPIDEMIOLOGY; DIAGNOSIS; JEJUNI
AB Background: Why an autoimmune disease that is the main cause of the acute neuromuscular paralysis worldwide does not have a well-characterized cause or an effective treatment yet? The existence of different clinical variants for the Guillain-Barre syndrome (GBS) coupled with the fact that a high number of pathogens can cause an infection that sometimes, but not always, precedes the development of the syndrome, confers a high degree of uncertainty for both prognosis and treatment. In the post-genomic era, the development of omics technologies for the high-throughput analysis of biological molecules is allowing the characterization of biological systems in a degree of depth unimaginable before. In this context, this work summarizes the application of post-genomics technologies to the study of GBS.
   Methods: We performed a structured search of bibliographic databases for peer-reviewed research literature to outline the state of the art with regard the application of post-genomics technologies to the study of GBS. The quality of retrieved papers was assessed using standard tools and thirty-four were included in the review. To date, transcriptomics and proteomics have been the unique post-genomics approaches applied to GBS study. Most of these studies have been performed on cerebrospinal fluid samples and only a few studies have been conducted with other samples such as serum, Schwann cells and human peripheral nerve.
   Results and Conclusion: In the post-genomics era, transcriptomics and proteomics have shown the possibilities that omics technologies can offer for a better understanding of the immunological and pathological mechanisms involved in GBS and the identification of potential biomarkers, but these results have only shown the tip of the iceberg and there is still a long way to exploit the full potential that post-genomics approaches could offer to the study of the GBS. The integration of different omics datasets through a systems biology approach could allow network-based analyses to describe the complexity and functionality of the molecular mechanisms involved in the course of disease facilitating the discovery of novel biomarkers that could be used to improve the diagnosis, predict the disease progression, improve our understanding of the pathology, and serve as therapeutic targets for GBS.
C1 [Villar, Margarita; Mateos-Hernandez, Lourdes; de la Fuente, Jose] UCLM, JCCM, CSIC, SaBio Inst Invest Recursos Cineget IREC, Ronda Toledo 12, Ciudad Real 13005, Spain.
   [de la Fuente, Jose] Oklahoma State Univ, Dept Vet Pathobiol, Ctr Vet Hlth Sci, Stillwater, OK 74078 USA.
RP Villar, M (corresponding author), UCLM, JCCM, CSIC, SaBio Inst Invest Recursos Cineget IREC, Ronda Toledo 12, Ciudad Real 13005, Spain.
EM margaritam.villar@uclm.es
RI Villar-Rayo, Marga M/J-4155-2012; Mateos, Lourdes/P-6717-2019
OI Villar-Rayo, Marga M/0000-0003-4172-9079; Mateos,
   Lourdes/0000-0001-9566-7710
FU Research Plan of University of Castilla- La Mancha (UCLM, Spain); UCLM
   fellowship
FX M.V. was supported by the Research Plan of University of Castilla- La
   Mancha (UCLM, Spain). L.M-H was supported by the UCLM fellowship.
CR Anaya JM, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0601-y
   Ayllon N, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005120
   Chang KH, 2007, PROTEOM CLIN APPL, V1, P467, DOI 10.1002/prca.200600949
   Chang KH, 2012, PLOS ONE, V7, P80, DOI 10.1371/journal.pone.0029506
   Constantinescu CS, 1998, IMMUNOL RES, V17, P217, DOI 10.1007/BF02786446
   D'Aguanno S, 2010, NEUROSCI LETT, V485, P49, DOI 10.1016/j.neulet.2010.08.060
   Dimachkie MM, 2013, NEUROL CLIN, V31, P491, DOI 10.1016/j.ncl.2013.01.005
   Doncel-Perez E, 2016, J IMMUNOL, V196, P1102, DOI 10.4049/jimmunol.1502100
   Fokkink WJR, 2014, J PROTEOME RES, V13, P1722, DOI 10.1021/pr401213z
   Guillain G, 1916, B MEMOIRES SOCIETE M, V40, P1462
   Hanewinckel R, 2016, HAND CLINIC, V138, P263, DOI 10.1016/B978-0-12-802973-2.00015-X
   Huttlin EL, 2017, NATURE, V545, P505, DOI 10.1038/nature22366
   Jin T, 2007, EUR J NEUROL, V14, P563, DOI 10.1111/j.1468-1331.2007.01761.x
   Kuwabara S, 2004, DRUGS, V64, P597, DOI 10.2165/00003495-200464060-00003
   Lehmensiek V, 2007, J NEUROIMMUNOL, V185, P190, DOI 10.1016/j.jneuroim.2007.01.022
   Loshaj-Shala A, 2018, J NEUROIMMUNOL, V317, P77, DOI 10.1016/j.jneuroim.2018.01.006
   Loshaj-Shala A, 2015, J NEUROIMMUNOL, V289, P168, DOI 10.1016/j.jneuroim.2015.11.005
   Mateos-Hernandez L, 2016, ONCOTARGET, V7, P74582, DOI 10.18632/oncotarget.12789
   Nugent EK, 2017, AM J MED SCI, V353, P466, DOI 10.1016/j.amjms.2016.12.018
   Rinaldi S, 2013, J PERIPHER NERV SYST, V18, P99, DOI 10.1111/jns5.12020
   Rosinska J, 2012, NEUROL NEUROCHIR POL, V46, P263, DOI 10.5114/ninp.2012.28916
   Sawai S, 2014, NEUROLOGY, V83, P113, DOI 10.1212/WNL.0000000000000566
   Sevy A, 2018, CLIN NEUROPHYSIOL, V129, P127, DOI 10.1016/j.clinph.2017.10.035
   Shin T, 2013, HISTOL HISTOPATHOL, V28, P679, DOI 10.14670/HH-28.679
   Soliven B, 2014, ILAR J, V54, P282, DOI 10.1093/ilar/ilt054
   van den Berg B, 2014, NAT REV NEUROL, V10, P469, DOI 10.1038/nrneurol.2014.121
   Villar M, 2015, MOL CELL PROTEOMICS, V14, P3154, DOI 10.1074/mcp.M115.051938
   Walgaard C, 2011, EXPERT OPIN EMERG DR, V16, P105, DOI 10.1517/14728214.2011.531699
   Winer JB, 2014, AUTOIMMUN DIS, V2014, DOI 10.1155/2014/793024
   Xiao JT, 2014, CLIN REV ALLERG IMMU, V47, P274, DOI 10.1007/s12016-013-8388-5
   Xu J, 2016, SCI REP-UK, V6, DOI 10.1038/srep21819
   Yang YR, 2008, CELL MOL NEUROBIOL, V28, P737, DOI 10.1007/s10571-007-9257-7
   Yang YR, 2009, MOL BIOL REP, V36, P677, DOI 10.1007/s11033-008-9228-1
   Yuki N, 2001, ANN NEUROL, V49, P712, DOI 10.1002/ana.1012
   Ziganshin RH, 2016, MOL CELL PROTEOMICS, V15, P2366, DOI 10.1074/mcp.M115.056036
NR 35
TC 0
Z9 0
U1 0
U2 2
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 0929-8673
EI 1875-533X
J9 CURR MED CHEM
JI Curr. Med. Chem.
PY 2018
VL 25
IS 29
BP 3482
EP 3490
DI 10.2174/0929867325666180314121813
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Medicinal; Pharmacology &
   Pharmacy
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
GA GX0HO
UT WOS:000447391200004
PM 29542408
DA 2020-07-08
ER

PT J
AU Pasquier, C
   Joguet, G
   Mengelle, C
   Chapuy-Regaud, S
   Pavili, L
   Prisant, N
   Izopet, J
   Bujan, L
   Mansuy, JM
AF Pasquier, Christophe
   Joguet, Guillaume
   Mengelle, Catherine
   Chapuy-Regaud, Sabine
   Pavili, Lynda
   Prisant, Nadia
   Izopet, Jacques
   Bujan, Louis
   Mansuy, Jean-Michel
TI Kinetics of anti-ZIKV antibodies after Zika infection using two
   commercial enzyme-linked immunoassays
SO DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
LA English
DT Article
DE ZIKV; Zika; Diagnosis; Serology
ID MARTINIQUE
AB High performance assays are essential for the serological diagnosis of recent and past Zika virus (ZIKV) infections but few are presently available. We used two commercially available NS1 antigen-based enzyme-linked immunoassays to study the kinetics of anti-ZIKV IgM and IgG in 15 ZIKV-infected patients for up to 180 days after clinical onset. The Diapro assay detected anti-ZIKV IgM reactivity more frequently (100%) and for longer (median 53 days) than did the Euroimmun assay (60%; 13 days, P < 0.005). Both assays detected anti-ZIKV IgG reactivity 11 days after clinical onset in all subjects. ZIKV IgG reactivity decreased in 3 subjects, suggesting long-term false negative results with the Euroimmun assay. Existing anti-Dengue antibodies seem to modify the detection of ZIKV IgG but the specificity of the immunoassays was not assessed. These enzyme-linked immunoassays were user-friendly and provided results rapidly in our hands but they need further assessment before being widely used for diagnosis or public health surveys. (C) 2017 Elsevier Inc. All rights reserved.
C1 [Pasquier, Christophe; Mengelle, Catherine; Chapuy-Regaud, Sabine; Izopet, Jacques; Mansuy, Jean-Michel] CHU Toulouse, INSERM, UPS, Lab Virol,U1043, Toulouse, France.
   [Joguet, Guillaume; Pavili, Lynda; Prisant, Nadia] CHU Pointe A Pitre, CECOS CARAIBES, CCMR, Pointe a Pitre, Guadeloupe, France.
   [Bujan, Louis] Univ Paul Sabatier Toulouse 3, CHU Toulouse, Hop Paule de Viguier, Res Grp Human Fertil,CECOS,EA 3694, Toulouse, France.
RP Pasquier, C (corresponding author), CHU Toulouse, INSERM, UPS, Lab Virol,U1043, Toulouse, France.
EM pasquier.c@chu-toulouse.fr
OI Bujan, Louis/0000-0003-1540-0536; PASQUIER,
   Christophe/0000-0001-9223-0150; IZOPET, JACQUES/0000-0002-8462-3234
CR Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Charrel RN, 2016, B WORLD HEALTH ORGAN, V94, P574, DOI 10.2471/BLT.16.171207
   Daudens-Vaysse E, 2016, EUROSURVEILLANCE, V21, P11, DOI 10.2807/1560-7917.ES.2016.21.28.30285
   Froeschl G, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2123-9
   Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203
   Joguet G, 2017, LANCET INFECT DIS
   Keasey SL, 2017, CLIN VACCINE IMMUNOL, V24, DOI 10.1128/CVI.00036-17
   L'Azou M, 2015, AM J TROP MED HYG, V92, P1137, DOI 10.4269/ajtmh.14-0211
   L'Huillier AG, 2017, J CLIN MICROBIOL, V55, P2462, DOI 10.1128/JCM.00442-17
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Landry ML, 2017, ARCH PATHOL LAB MED, V141, P60, DOI 10.5858/arpa.2016-0406-SA
   Lustig Y, 2017, J CLIN MICROBIOL
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Safronetz D, 2017, EMERG INFECT DIS, V23, P1577, DOI 10.3201/eid2309.162043
   Shan C, 2017, EBIOMEDICINE, V17, P157, DOI 10.1016/j.ebiom.2017.03.006
   Steinhagen K, 2016, EURO SURVEILL, V21
   Wong SJ, 2017, EBIOMEDICINE, V16, P136, DOI 10.1016/j.ebiom.2017.01.008
   World Health Organization (WHO), 2016, ZIK VIR RES AG OCT 2
NR 19
TC 16
Z9 16
U1 0
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0732-8893
EI 1879-0070
J9 DIAGN MICR INFEC DIS
JI Diagn. Microbiol. Infect. Dis.
PD JAN
PY 2018
VL 90
IS 1
BP 26
EP 30
DI 10.1016/j.diagmicrobio.2017.09.001
PG 5
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA FR0DN
UT WOS:000418731400005
PM 29107414
DA 2020-07-08
ER

PT J
AU Avelino-Silva, VI
AF Avelino-Silva, Vivian Iida
TI Is Zika virus outbreak a solved issue in Brazil?
SO EINSTEIN-SAO PAULO
LA English
DT Editorial Material
ID SEXUAL TRANSMISSION; CONTACT; STATES
C1 [Avelino-Silva, Vivian Iida] Univ Sao Paulo, Fac Med, Sao Paulo, SP, Brazil.
   [Avelino-Silva, Vivian Iida] Hosp Sirio Libanes, Sao Paulo, Brazil.
RP Avelino-Silva, VI (corresponding author), Rua Dona Adma Jafet 74,3rd Andar Bela Vista, BR-01308050 Sao Paulo, SP, Brazil.
EM viviansilva87@gmail.com
RI Avelino-Silva, Vivian I/L-2640-2013
OI Avelino-Silva, Vivian I/0000-0002-6660-3088
CR Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude, 2017, B EPIDEMIOL, V48, P1
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Cancian N, 2017, BRASIL REGISTRA QUED
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Diaz-Quijano FA, 2017, ANN EPIDEMIOL, V27, P616, DOI 10.1016/j.annepidem.2017.08.009
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fields BN, 2007, FIELDS VIROLOGY, V1
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Frank C, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.23.30252
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Hancock W. T., 2014, EMERG INFECT DIS, V20, P1085
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanteri MC, 2016, TRANSFUSION, V56, P1907, DOI 10.1111/trf.13677
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Silveira M., 2015, NAO ENGRAVIDEM AGORA
   STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Watts AG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178211
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
NR 32
TC 2
Z9 2
U1 0
U2 2
PU INST ISRAELITA ENSINO & PESQUISA ALBERT EINSTEIN
PI SAO PAULO SP
PA AVENIDA ALBERT EINSTEIN, 627 701, SAO PAULO SP, 05651-901, BRAZIL
SN 1679-4508
EI 2317-6385
J9 EINSTEIN-SAO PAULO
JI Einstein
PD JAN-MAR
PY 2018
VL 16
IS 1
AR UNSP eED4325
DI 10.1590/S1679-45082018ED4325
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA GD6GC
UT WOS:000430606100017
PM 29694613
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Diaz-Menendez, M
   de la Calle-Prieto, F
   Montero, D
   Antolin, E
   Vazquez, A
   Arsuaga, M
   Trigo, E
   Garcia-Bujalance, S
   de la Calle, M
   Seco, PS
   de Ory, F
   Arribas, JR
AF Diaz-Menendez, Marta
   de la Calle-Prieto, Fernando
   Montero, Dolores
   Antolin, Eugenia
   Vazquez, Ana
   Arsuaga, Marta
   Trigo, Elena
   Garcia-Bujalance, Silvia
   de la Calle, Maria
   Sanchez Seco, Paz
   de Ory, Fernando
   Ramon Arribas, Jose
CA Grp Trabajo Multidisciplinar Hosp
TI Initial experience with imported Zika virus infection in Spain
SO ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
LA English
DT Article
DE Zika virus infection; Arbovirus; Epidemic; Travel medicine
ID PUBLIC-HEALTH; TRAVEL; MICRONESIA; RISK
AB Introduction: A considerable increase of imported Zika virus (ZIKV) infection has been reported in Europe in the last year. This is the result of the large outbreak of the disease in the Americas, along with the increase in the numbers of travellers and immigrants arriving from ZIKV endemic areas.
   Methods: A descriptive study was conducted in the Tropical Medicine Unit of Hospital La Paz-Carlos III in Madrid on travellers returning from an endemic area for ZIKV from January to April 2016. Demographic, clinical and microbiological data were analyzed.
   Results: A total of 185 patients were screened for ZIKV (59.9% women, median age of 37.7 +/- 10.3 years). Main purpose of the travel was tourism to Colombia, Brazil, and Mexico. Just under three-quarters (73%) were symptomatic, mostly with fever and headache. A total of 13 patients (7% of those screened) were diagnosed with ZIKV infections, of which four of them were pregnant. All of them were symptomatic patients, the majority immigrants, and mainly from Colombia. Diagnostic tests were based on positive neutralization antibodies (8 cases, 61.6%) and a positive RT-PCR in different organic fluids (7 cases, 53.8%) The four infected pregnant women underwent a neurosonography every 3 weeks, and no alterations were detected. RT-PCR in amniotic fluid was performed in three of them, with negative results. One of the children has already been born healthy.
   Conclusions: Our cases series represents the largest cohort of imported ZIKV to Spain described until now. Clinicians must increase awareness about the progression of the ZIKV outbreak and the affected areas so that they can include Zika virus infection in their differential diagnosis for travellers from those areas. (C) 2016 Elsevier Espana, S.L.U. and Sociedad Espanola de Enfermedades Infecciosas y Microbiologia Clinica. All rights reserved.
C1 [Diaz-Menendez, Marta; de la Calle-Prieto, Fernando; Arsuaga, Marta; Trigo, Elena] Hosp Univ La Paz Carlos III, Unidad Med Trop & Viajero, Madrid, Spain.
   [Montero, Dolores] Hosp Univ La Paz Carlos III, Serv Microbiol & Parasitol, Madrid, Spain.
   [Antolin, Eugenia] Hosp Univ La Paz Carlos III, Serv Obstet & Ginecol, Secc Ecog & Med Fetal, Madrid, Spain.
   [Vazquez, Ana; Sanchez Seco, Paz] Inst Salud Carlos III, Ctr Nacl Microbiol, Unidad Virol Arbovirus & Enfermedades Vir Importa, Madrid, Spain.
   [Garcia-Bujalance, Silvia] Hosp Univ La Paz Carlos III, Serv Microbiol, Madrid, Spain.
   [de la Calle, Maria] Hosp Univ La Paz Carlos III, Serv Obstet & Ginecol, Unidad Med Maternofetal, Madrid, Spain.
   [de Ory, Fernando] Inst Salud Carlos III, Lab Serol, Ctr Nacl Microbiol, Madrid, Spain.
   [Ramon Arribas, Jose] Hosp La Paz Carlos III, Serv Med Interna, Unidad Enfermedades Infecciosas, Madrid, Spain.
RP Diaz-Menendez, M (corresponding author), Hosp Univ La Paz Carlos III, Unidad Med Trop & Viajero, Madrid, Spain.
EM marta.diaz@salud.madrid.org
RI Vazquez, Ana/H-4911-2013; de+la+Calle, Maria/AAE-4900-2020
OI Vazquez, Ana/0000-0002-9872-3316; de la Calle-Prieto,
   Fernando/0000-0003-2544-3492
FU Red de Investigacion Cooperativa de Enfermedades Tropicales (RICET)
   [RD06/0021/0020]
FX The clinical research team acknowledges the support provided by Red de
   Investigacion Cooperativa de Enfermedades Tropicales (RICET;
   RD06/0021/0020).
CR Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Bachiller-Luque P, 2016, ENFERM INFEC MICR CL, V34, P243, DOI 10.1016/j.eimc.2016.02.012
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Focosi D, 2016, CLIN INFECT DIS, V63, P227, DOI 10.1093/cid/ciw210
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Leder K, 2008, J TRAVEL MED, V15, P263, DOI 10.1111/j.1708-8305.2008.00218.x
   Lopez LF, 2016, B MATH BIOL, V78, P185, DOI 10.1007/s11538-015-0135-z
   Maria AT, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.6.30131
   Massad E, 2016, GLOBAL HEALTH ACTION, V9, P1, DOI 10.3402/gha.v9.31669
   Mlakar J, 2016, NEW ENGL J MED, P374
   Oster A, 2012, MMWR-MORBID MORTAL W, V65, P1347
   Red Nacional Vigilancia Epidemiologica, 2016, PROT VIG ENF VIR ZIK, P1
   Rudolph KE, 2014, AM J TROP MED HYG, V90, P882, DOI 10.4269/ajtmh.13-0403
   Simon F, 2015, MED MALADIES INFECT, V45, P243, DOI 10.1016/j.medmal.2015.05.007
   Tappe D, 2013, EURO SURVEILL, V19
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Wieten RW, 2014, TRAVEL MED INFECT DI, V12, P511, DOI 10.1016/j.tmaid.2014.05.004
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
NR 23
TC 6
Z9 6
U1 2
U2 16
PU EDICIONES DOYMA S A
PI BARCELONA
PA TRAV DE GRACIA 17-21, 08021 BARCELONA, SPAIN
SN 0213-005X
EI 1578-1852
J9 ENFERM INFEC MICR CL
JI Enferm. Infec. Microbiol. Clin.
PD JAN
PY 2018
VL 36
IS 1
BP 4
EP 8
DI 10.1016/j.eimc.2016.08.003
PG 5
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA FT2ZT
UT WOS:000423015300002
PM 27743683
DA 2020-07-08
ER

PT J
AU Souto, IO
   Alejo-Cancho, I
   Brustenga, JG
   Mestres, AP
   Gutierrez, JM
   Yoldi, MJM
AF Oliveira Souto, Ines
   Alejo-Cancho, Izaskun
   Gascon Brustenga, Joaquim
   Peiro Mestres, Aida
   Munoz Gutierrez, Jose
   Martinez Yoldi, Miguel J.
TI Persistence of Zika virus in semen 93 days after the onset of symptoms
SO ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
LA English
DT Article
DE Zika virus; Semen; Persistence
ID MALE SEXUAL TRANSMISSION; UNITED-STATES; PREVENTION; EBOLA
AB Introduction: Zika virus is mainly transmitted through the bites of infected Aedes mosquitoes, although mother-to-child and sexual transmission have also been described. The presence of Zika virus in semen after infection seems to be not uncommon, but the duration of viral persistence has not been well determined.
   Methods: Molecular, serological and cell culture methods were used for the diagnosis and follow up of a case of Zika virus infection imported from Venezuela. Serial samples of serum, urine and semen were analyzed to investigate the persistence of the Zika virus.
   Results: Zika virus was detected in semen samples up to 93 days after the onset of symptoms.
   Conclusions: Our results confirm the persistence of Zika virus in semen samples for long periods after infection. (C) 2016 Elsevier Espana, S.L.U. and Sociedad Espanola de Enfermedades Infecciosas y Microbiologia Clinica. All rights reserved.
C1 [Oliveira Souto, Ines; Gascon Brustenga, Joaquim; Munoz Gutierrez, Jose; Martinez Yoldi, Miguel J.] Univ Barcelona, Hosp Clin, Trop Med & Int Hlth Dept, ISGlobal,Barcelona Ctr Int Hlth Res CRESIB, Barcelona, Spain.
   [Alejo-Cancho, Izaskun; Peiro Mestres, Aida; Martinez Yoldi, Miguel J.] Hosp Clin Barcelona, Dept Clin Microbiol, C Villarroel 170, E-08036 Barcelona, Spain.
RP Yoldi, MJM (corresponding author), Univ Barcelona, Hosp Clin, Trop Med & Int Hlth Dept, ISGlobal,Barcelona Ctr Int Hlth Res CRESIB, Barcelona, Spain.; Yoldi, MJM (corresponding author), Hosp Clin Barcelona, Dept Clin Microbiol, C Villarroel 170, E-08036 Barcelona, Spain.
EM myoldi@clinic.ub.es
RI Gascon, Joaquim/M-3598-2015; Gutierrez, Jose Munoz/AAH-6954-2020;
   Oliveira Souto, Ines/L-2947-2017
OI Gascon, Joaquim/0000-0002-5045-1585; Gutierrez, Jose
   Munoz/0000-0002-0945-1735; Peiro Mestres, Aida/0000-0001-5484-7758;
   Martinez, Miguel Julian/0000-0002-0682-1075; Oliveira Souto,
   Ines/0000-0001-6018-5797
CR Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Frank C, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.23.30252
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203
   Moureau G, 2007, VECTOR-BORNE ZOONOT, V7, P467, DOI 10.1089/vbz.2007.0206
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P323, DOI 10.15585/mmwr.mm6512e3
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rowe AK, 1999, J INFECT DIS, V179, pS28, DOI 10.1086/514318
   Soka MJ, 2016, LANCET GLOB HEALTH, V4, pE736, DOI 10.1016/S2214-109X(16)30175-9
   World Health Organization, 2016, PREV SEX TRANSM ZIK, P1
NR 13
TC 15
Z9 15
U1 1
U2 6
PU EDICIONES DOYMA S A
PI BARCELONA
PA TRAV DE GRACIA 17-21, 08021 BARCELONA, SPAIN
SN 0213-005X
EI 1578-1852
J9 ENFERM INFEC MICR CL
JI Enferm. Infec. Microbiol. Clin.
PD JAN
PY 2018
VL 36
IS 1
BP 21
EP 23
DI 10.1016/j.eimc.2016.10.009
PG 3
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA FT2ZT
UT WOS:000423015300005
PM 28007310
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Ribeiro, IG
   de Andrade, MR
   Silva, JD
   Silva, ZM
   Costa, MAD
   Vieira, MADES
   Batista, FMD
   Guimaraes, H
   Wada, MY
   Saad, E
AF Ribeiro, Igor Goncalves
   de Andrade, Marcia Regina
   Silva, Janaina de Moraes
   Silva, Zenira Martins
   de Oliveira Costa, Maria Amelia
   da Cunha e Silva Vieira, Marcelo Adriano
   de Araujo Batista, Francisca Miriane
   Guimaraes, Herlon
   Wada, Marcelo Yoshito
   Saad, Eduardo
TI Microcephaly in Piaui, Brazil: descriptive study during the Zika virus
   epidemic, 2015-2016
SO EPIDEMIOLOGIA E SERVICOS DE SAUDE
LA English
DT Article
DE Microcephaly; Zika Virus Infection; Epidemiology; Descriptive
ID LIVE BIRTHS SINASC; INFORMATION-SYSTEM; REGION; STATE
AB Objective: to describe the occurrence and characteristics of microcephaly cases in Piaui, Brazil, during an epidemic of Zika virus infection in 2015-2016. Methods: descriptive study using data of live births from January/2015 to January/2016, obtained from the Information System on Live Births (Sinasc), the Public Health Events Registry (RESP) and the active search for medical records; mothers and live births were tested for dengue, chikungunya, and Zika, besides syphilis, toxoplasmosis, rubella, cytomegalovirus, and herpes (STORCH). Results: of the 75 microcephaly cases, 34 were related to congenital infectious process; microcephaly prevalence was of 13.6/10 thousand live births; imaging exams confirmed that 34 live births presented calcifications, 23 had cerebral atrophies, 14 had lissencephaly, 12 had ventriculomegaly and 6 had dysgenesis; none tested positive for STORCH, dengue or chikungunya; 1 was IgM positive for Zika. Conclusion: there was an outbreak of microcephaly in Piaui, possibly related to infection during pregnancy Zika virus.
C1 [Ribeiro, Igor Goncalves; de Andrade, Marcia Regina; Wada, Marcelo Yoshito; Saad, Eduardo] Secretaria Vigilancia Saude, Minist Saude, Brasilia, DF, Brazil.
   [Silva, Janaina de Moraes; Silva, Zenira Martins; de Oliveira Costa, Maria Amelia; de Araujo Batista, Francisca Miriane; Guimaraes, Herlon] Secretaria Estado Saude Piaui, Superintendencia Atencao Integral Saude, Teresina, PL, Brazil.
   [da Cunha e Silva Vieira, Marcelo Adriano] Secretaria Estado Saude Piaui, Inst Doencas Trop Natan Portella, Teresina, PL, Brazil.
RP Ribeiro, IG (corresponding author), QRSW 6,Bloco B-8,Apto 105,Edificio Fidji, BR-70675628 Brasilia, DF, Brazil.
EM igor.ribeiro@saude.gov.br
RI Ribeiro, Igor Goncalves/AAA-1641-2020
OI Ribeiro, Igor Goncalves/0000-0002-4971-9484
CR Aragao MFV, BMJ
   Castilla EE, 2004, COMMUNITY GENET, V7, P76, DOI 10.1159/000080776
   Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-59
   Ferreira H, 2000, ACTA PEDIAT PORT, V31, P11
   Figueiredo Luiz Tadeu Moraes, 1994, Revista do Instituto de Medicina Tropical de Sao Paulo, V36, P417, DOI 10.1590/S0036-46651994000500005
   Herrero MM, 2008, PROTOCOLOS DIAGNOSTI, V1, P185
   Leal Maria do Carmo, 2015, Rev. Bras. Saude Mater. Infant., V15, P91, DOI 10.1590/S1519-38292015000100008
   Luquetti DV, 2010, CAD SAUDE PUBLICA, V26, P1756, DOI 10.1590/S0102-311X2010000900009
   Marinho F, 2016, EPIDEMIOL SERV SAUDE, V25, P701, DOI [10.5123/S1679-49742016000400004, 10.5123/s1679-49742016000400004]
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Mascarenhas MDM, 2011, CIENC SAUDE COLETIVA, V16, P1233, DOI 10.1590/S1413-81232011000700055
   Ministerio da Saude, 2015, B EPIDEMIOL, V46, P1
   Ministerio da Saude (BR), 2015, PROT VIG RESP OC MIC
   Ministerio da Saude (BR), 2015, RES LIRAA JAN FEV 20, P29
   [Ministerio da Saude do Brasil Secretaria devigilanciaem Saude], 2016, B EPIDEMIOLOGICO, V47, P1
   Miranda MM, 2012, FEMINA, V40, P13
   Nazer HJ, REV MED CHIL
   Nunes ML, 2016, J PEDIAT-BRAZIL, V92, P230, DOI 10.1016/j.jped.2016.02.009
   Oliveira WK, 2015, MORB MORTAL WKLY REP
   Henriques CMP, 2016, EPIDEMIOL SERV SAUDE, V25, P7, DOI [10.5123/S1679-49742016000100001, 10.5123/s1679-49742016000100001]
   Pessoa R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003201
   Sa LMSMP, 2013, THESIS
   Secretaria Estadual de Saude (PE). Secretaria Executiva de Vigilancia em Saude, 2015, PROT CLIN EP MICR
   Soc Maternal-Fetal Med SMFM Public, 2016, AM J OBSTET GYNECOL, V214, pB2, DOI 10.1016/j.ajog.2016.02.043
   Fantinato FFST, 2016, EPIDEMIOL SERV SAUDE, V25, P683, DOI [10.5123/S1679-49742016000400002, 10.5123/s1679-49742016000400002]
   Tomasi E, QUALIDADE ATENCAO PR
   Vargas A, 2016, EPIDEMIOL SERV SAUDE, V25, P691, DOI 10.5123/S1679-49742016000400003
   Viellas EF, 2014, CAD SAUDE PUBLICA, V30, DOI 10.1590/0102-311X00126013
   WHO/CDC/ICBDSR, 2014, BIRTH DEF SURV MAN P
NR 29
TC 10
Z9 10
U1 0
U2 2
PU MINISTERIO DA SAUDE
PI BRASILIA
PA ESPLANADA MINISTERIOS, BLOCO G, BRASILIA, DF 70058-900, BRAZIL
SN 1679-4974
EI 2237-9622
J9 EPIDEMIOL SERV SAUDE
JI Epidemiol. Serv. Saude
PY 2018
VL 27
IS 1
AR UNSP e20163692
DI 10.5123/S1679-49742018000100002
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GJ3PL
UT WOS:000435208700005
PM 29412347
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Restrepo-Jimenez, P
   Rodriguez, Y
   Gonzalez, P
   Chang, C
   Gershwin, ME
   Anaya, JM
AF Restrepo-Jimenez, Paula
   Rodriguez, Yhojan
   Gonzalez, Paulina
   Chang, Christopher
   Gershwin, M. Eric
   Anaya, Juan-Manuel
TI The immunotherapy of Guillain-Barre syndrome
SO EXPERT OPINION ON BIOLOGICAL THERAPY
LA English
DT Review
DE Polyneuropathy; Guillain-Barre syndrome; immunotherapy; complement;
   biological therapy; intravenous immunoglobulins; plasma exchange
ID EXPERIMENTAL AUTOIMMUNE NEURITIS; RANDOMIZED CONTROLLED-TRIAL;
   CERVICAL-BRACHIAL VARIANT; PLASMA-EXCHANGE; INTRAVENOUS IMMUNOGLOBULIN;
   COMPLEMENT INHIBITION; CLINICAL-FEATURES; INTERFERON-BETA;
   CSF-FILTRATION; IN-VIVO
AB Introduction: Guillain-Barre syndrome is the most common cause of acute flaccid paralysis worldwide. Microorganisms such as Campylobacter jejuni, Cytomegalovirus, Epstein-Barr virus, Mycoplasma pneumoniae, Haemophilus influenzae and Zika virus have been linked to the disease. The most common clinical variants are acute inflammatory demyelinating polyneuropathy and acute motor axonal neuropathy. Plasma exchange and intravenous immunoglobulins are the standard therapy for the disease.Areas covered: research to elucidate the pathophysiology of Guillain-Barre syndrome has led to the development of drugs directed towards new potential therapeutic targets. This review offers a comprehensive view of the current treatment based upon the physiopathology.Expert opinion: patients with Guillain-Barre syndrome need a multidisciplinary approach, limitation to walk unaided and disability score are indicators for treatment as well as the presence of autonomic dysfunction and pain. Admission to intensive care units should be considered for those patients presenting with respiratory failure, bulbar involvement and progression of the disease. Research aimed to deciphering the pathophysiology of the disease, discovering new biomarkers and establishing algorithms of prediction of both the disease and its outcomes is warranted.
C1 [Restrepo-Jimenez, Paula; Rodriguez, Yhojan; Anaya, Juan-Manuel] Univ Rosario, Sch Med & Hlth Sci, Ctr Autoimmune Dis Res CREA, Carrera 24 63-B-69, Bogota, Colombia.
   [Gonzalez, Paulina] Univ Pontificia Bolivariana, Clin Univ Bolivariana, Neurol Serv, Medellin, Colombia.
   [Chang, Christopher; Gershwin, M. Eric] Univ Calif Davis, Sch Med, Div Rheumatol Allergy & Clin Immunol, Davis, CA 95616 USA.
RP Anaya, JM (corresponding author), Univ Rosario, Sch Med & Hlth Sci, Ctr Autoimmune Dis Res CREA, Carrera 24 63-B-69, Bogota, Colombia.
EM juan.anaya@urosario.edu.co
RI ; Anaya, Juan-Manuel/J-1960-2016
OI Restrepo, Paula/0000-0003-2846-2648; Anaya,
   Juan-Manuel/0000-0002-6444-1249; Gonzalez, Paulina/0000-0002-3610-494X
FU Departamento Administrativo de Ciencia, Tecnologia e Innovacion, Bogota,
   Colombia [747-2016]
FX This work was supported by the Departamento Administrativo de Ciencia,
   Tecnologia e Innovacion, Bogota, Colombia[747-2016];
CR [Anonymous], 2012, CYCL TABL USP
   Bayry J, 2003, TRANSFUS CLIN BIOL, V10, P165, DOI 10.1016/S1246-7820(03)00035-1
   Bensa S, 2000, EUR J NEUROL, V7, P423, DOI 10.1046/j.1468-1331.2000.00096.x
   Berciano J, 2017, J NEUROL, V264, P221, DOI 10.1007/s00415-016-8204-2
   BOUGET J, 1993, CRIT CARE MED, V21, P651, DOI 10.1097/00003246-199305000-00006
   Bril V, 1996, NEUROLOGY, V46, P100, DOI 10.1212/WNL.46.1.100
   Carmona Alberto, 2006, Clin Transl Oncol, V8, P764, DOI 10.1007/s12094-006-0126-5
   Chalela JA, 2001, SEMIN NEUROL, V21, P399, DOI 10.1055/s-2001-19411
   Chevret S, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001798.pub3
   Creange A, 2000, BIODRUGS, V14, P1
   DANIELSSON C, 1994, EUR J IMMUNOL, V24, P2725, DOI 10.1002/eji.1830241123
   Davidson AI, 2017, J PERIPHER NERV SYST, V22, P4, DOI 10.1111/jns.12194
   Diener HC, 2001, EUR NEUROL, V46, P107, DOI 10.1159/000050777
   Dimachkie MM, 2013, NEUROL CLIN, V31, P491, DOI 10.1016/j.ncl.2013.01.005
   Donofrio Peter D, 2017, Continuum (Minneap Minn), V23, P1295, DOI 10.1212/CON.0000000000000513
   Durandy A, 2009, CLIN EXP IMMUNOL, V158, P2, DOI [10.1111/j.1365-2249.2009.04022.x, 10.1111/j.1365-2249.2009.04022.X]
   Farcas P, 1997, LANCET, V350, P1747, DOI 10.1016/S0140-6736(97)24050-X
   Fergusson D, 2005, TRANSFUSION, V45, P1640, DOI 10.1111/j.1537-2995.2005.00581.x
   Frith JC, 2001, ARTHRITIS RHEUM, V44, P2201, DOI 10.1002/1529-0131(200109)44:9<2201::AID-ART374>3.0.CO;2-E
   Garssen MPJ, 2007, J NEUROL NEUROSUR PS, V78, P1012, DOI 10.1136/jnnp.2006.102731
   GOODALL JAD, 1974, LANCET, V1, P524
   Goodfellow JA, 2016, NAT REV NEUROL, V12, P723, DOI 10.1038/nrneurol.2016.172
   GREENWOOD RJ, 1984, LANCET, V1, P877
   Guerra C, 2013, BIOMEDICA, V33, P513, DOI 10.7705/biomedica.v33i4.1438
   HAASS A, 1988, J NEUROIMMUNOL, V20, P305
   Halstead SK, 2005, ANN NEUROL, V58, P203, DOI 10.1002/ana.20546
   Halstead SK, 2008, J PERIPHER NERV SYST, V13, P228, DOI 10.1111/j.1529-8027.2008.00181.x
   Halstead SK, 2008, BRAIN, V131, P1197, DOI 10.1093/brain/awm316
   HARTUNG HP, 1995, MUSCLE NERVE, V18, P154, DOI 10.1002/mus.880180203
   Hepburn NJ, 2007, J BIOL CHEM, V282, P8292, DOI 10.1074/jbc.M609858200
   Horste GMZ, 2007, NAT CLIN PRACT NEURO, V3, P198, DOI 10.1038/ncpneuro0452
   Hughes R, 2001, ANN NEUROL, V50, P195, DOI 10.1002/ana.1088
   Hughes RAC, 2002, J ANAT, V200, P331, DOI 10.1046/j.1469-7580.2002.00041.x
   Hughes RAC, 1997, LANCET, V349, P225
   HUGHES RAC, 1978, LANCET, V2, P750, DOI 10.1016/s0140-6736(78)92644-2
   HUGHES RAC, 1993, LANCET, V341, P586
   Hughes RAC, 2007, BRAIN, V130, P2245, DOI 10.1093/brain/awm004
   Hughes RAC, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002063.pub5
   Ibrahim Homam, 2010, J Clin Neuromuscul Dis, V12, P91, DOI 10.1097/CND.0b013e3181ff49f3
   Jacobs BC, 2003, BRAIN, V126, P2220, DOI 10.1093/brain/awg235
   Jaso R, 2010, J NEUROL, V257, P488, DOI 10.1007/s00415-009-5400-3
   Jasti AK, 2016, EXPERT REV CLIN IMMU, V12, P1175, DOI 10.1080/1744666X.2016.1193006
   Jung S, 1995, NEUROSCI LETT, V200, P167, DOI 10.1016/0304-3940(95)12115-K
   Kaida K, 2009, EXPERT REV NEUROTHER, V9, P1307, DOI 10.1586/ERN.09.77
   Kaida K, 2009, GLYCOBIOLOGY, V19, P676, DOI 10.1093/glycob/cwp027
   Katzav A, 2013, IMMUNOL RES, V56, P334, DOI 10.1007/s12026-013-8406-y
   Kieseier BC, 2008, CURR OPIN NEUROL, V21, P555, DOI 10.1097/WCO.0b013e32830efc03
   Kieseier BC, 2012, AUTOIMMUN REV, V11, P191, DOI 10.1016/j.autrev.2011.05.011
   Kimachi T, 2017, MUSCLE NERVE, V55, P281, DOI 10.1002/mus.25242
   Korinthenberg R, 2005, PEDIATRICS, V116, P8, DOI 10.1542/peds.2004-1324
   Lehmann HC, 2011, J NEUROIMMUNOL, V231, P61, DOI 10.1016/j.jneuroim.2010.09.015
   Lehmann Helmar C, 2009, Ther Adv Neurol Disord, V2, P261, DOI 10.1177/1756285609104792
   Lu MO, 2011, J NEUROL, V258, P533, DOI 10.1007/s00415-010-5836-5
   Mahecha MP, 2017, IMMUNOL RES, V65, P72, DOI 10.1007/s12026-016-8816-8
   Mangano K, 2008, J NEUROIMMUNOL, V196, P107, DOI 10.1016/j.jneuroim.2008.03.008
   McGrogan A, 2009, NEUROEPIDEMIOLOGY, V32, P150, DOI 10.1159/000184748
   MENDELL JR, 1985, NEUROLOGY, V35, P1551, DOI 10.1212/WNL.35.11.1551
   Mori M, 2001, NEUROLOGY, V56, P1104, DOI 10.1212/WNL.56.8.1104
   Nagashima T, 2007, ARCH NEUROL-CHICAGO, V64, P1519, DOI 10.1001/archneur.64.10.1519
   Ortiz-Salas Paola, 2016, J Clin Neuromuscul Dis, V18, P1, DOI 10.1097/CND.0000000000000119
   Ostronoff F, 2008, BONE MARROW TRANSPL, V42, P71, DOI 10.1038/bmt.2008.81
   Overell JR, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004761.pub2
   Pfeiffer G, 1999, NERVENARZT, V70, P136, DOI 10.1007/s001150050414
   Phongsisay V, 2008, J NEUROIMMUNOL, V205, P101, DOI 10.1016/j.jneuroim.2008.09.016
   Pilch KS, 2017, EXPERT REV NEUROTHER, V17, P579, DOI 10.1080/14737175.2017.1282821
   Pritchard J, 2003, NEUROLOGY, V61, P1282, DOI 10.1212/01.WNL.0000092019.53628.88
   Rajabally Yusuf A., 2012, Inflammation & Allergy Drug Targets, V11, P330
   Randall DP, 2010, DM-DIS MON, V56, P279, DOI 10.1016/j.disamonth.2010.02.007
   Raphael JC, 1999, TRANSFUS SCI, V20, P53, DOI 10.1016/S0955-3886(98)00092-7
   ROSEN AD, 1976, J NEUROL SCI, V30, P179, DOI 10.1016/0022-510X(76)90265-3
   Sederholm BH, 2010, SEMIN NEUROL, V30, P365, DOI 10.1055/s-0030-1267280
   Shahrizaila N, 2011, EXPERT OPIN PHARMACO, V12, P1551, DOI 10.1517/14656566.2011.564160
   Terenghi F, 2007, J PERIPHER NERV SYST, V12, P142, DOI 10.1111/j.1529-8027.2007.00134.x
   Thivakaran T, 2011, J NEUROSCI RURAL PRA, V2, P168, DOI 10.4103/0976-3147.83585
   van den Berg B, 2014, NAT REV NEUROL, V10, P469, DOI 10.1038/nrneurol.2014.121
   van Doorn PA, 2008, LANCET NEUROL, V7, P939, DOI 10.1016/S1474-4422(08)70215-1
   van Koningsveld R, 2004, LANCET, V363, P192, DOI 10.1016/S0140-6736(03)15324-X
   VANDERMECHE FGA, 1992, NEW ENGL J MED, V326, P1123, DOI 10.1056/NEJM199204233261705
   Verboon C, 2017, J PERIPHER NERV SYST, V22, P226
   Wakerley BR, 2016, J NEUROL SCI, V369, P43, DOI 10.1016/j.jns.2016.08.002
   Wakerley Benjamin R, 2015, Pract Neurol, V15, P90, DOI 10.1136/practneurol-2014-000937
   Wakerley BR, 2014, J NEUROL NEUROSUR PS, V85, P339, DOI 10.1136/jnnp-2013-305397
   Walgaard C, 2011, EXPERT OPIN EMERG DR, V16, P105, DOI 10.1517/14728214.2011.531699
   Walgaard C, 2010, ANN NEUROL, V67, P781, DOI 10.1002/ana.21976
   Wang YZ, 2015, SCI REP-UK, V5, DOI 10.1038/srep13931
   Wijdicks EFM, 2017, MAYO CLIN PROC, V92, P467, DOI 10.1016/j.mayocp.2016.12.002
   Willison HJ, 2005, J PERIPHER NERV SYST, V10, P94, DOI 10.1111/j.1085-9489.2005.0010202.x
   Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1
   WOLLINSKY KH, 1992, MED HYPOTHESES, V38, P155, DOI 10.1016/0306-9877(92)90088-T
   WOLLINSKY KH, 1991, EUR ARCH PSY CLIN N, V241, P73, DOI 10.1007/BF02191143
   Wollinsky KH, 2001, NEUROLOGY, V57, P774, DOI 10.1212/WNL.57.5.774
   Xiao JT, 2014, CLIN REV ALLERG IMMU, V47, P274, DOI 10.1007/s12016-013-8388-5
   Yako K, 1999, J NEUROL SCI, V168, P85, DOI 10.1016/S0022-510X(99)00174-4
   Yata J, 2003, PEDIATR INT, V45, P543
   Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525
   Zhang G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133520
   Zou LP, 1999, J NEUROSCI RES, V56, P123
NR 97
TC 3
Z9 4
U1 0
U2 7
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1471-2598
EI 1744-7682
J9 EXPERT OPIN BIOL TH
JI Expert Opin. Biol. Ther.
PY 2018
VL 18
IS 6
BP 619
EP 631
DI 10.1080/14712598.2018.1468885
PG 13
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA GI5WU
UT WOS:000434442100003
PM 29681203
DA 2020-07-08
ER

PT J
AU Semenza, JC
   Suk, JE
AF Semenza, Jan C.
   Suk, Jonathan E.
TI Vector-borne diseases and climate change: a European perspective
SO FEMS MICROBIOLOGY LETTERS
LA English
DT Review
DE climate change; vector-borne diseases; Zika; dengue; chikungunya;
   Leishmaniasis
ID INFECTIOUS-DISEASES; IXODES-RICINUS; CHIKUNGUNYA VIRUS; MALARIA; RISK;
   LEISHMANIASIS; TRANSMISSION; ENCEPHALITIS; DRIVERS; SPREAD
AB Climate change has already impacted the transmission of a wide range of vector-borne diseases in Europe, and it will continue to do so in the coming decades. Climate change has been implicated in the observed shift of ticks to elevated altitudes and latitudes, notably including the Ixodes ricinus tick species that is a vector for Lyme borreliosis and tick-borne encephalitis. Climate change is also thought to have been a factor in the expansion of other important disease vectors in Europe: Aedes albopictus (the Asian tiger mosquito), which transmits diseases such as Zika, dengue and chikungunya, and Phlebotomus sandfly species, which transmits diseases including Leishmaniasis. In addition, highly elevated temperatures in the summer of 2010 have been associated with an epidemic of West Nile Fever in Southeast Europe and subsequent outbreaks have been linked to summer temperature anomalies. Future climate-sensitive health impacts are challenging to project quantitatively, in part due to the intricate interplay between non-climatic and climatic drivers, weather-sensitive pathogens and climate-change adaptation. Moreover, globalisation and international air travel contribute to pathogen and vector dispersion internationally. Nevertheless, monitoring forecasts of meteorological conditions can help detect epidemic precursors of vector-borne disease outbreaks and serve as early warning systems for risk reduction.
C1 [Semenza, Jan C.; Suk, Jonathan E.] European Ctr Dis Prevent & Control, Tomtebodavagen 11A, S-17183 Stockholm, Sweden.
RP Semenza, JC (corresponding author), European Ctr Dis Prevent & Control, Tomtebodavagen 11A, S-17183 Stockholm, Sweden.
EM Jan.Semenza@ecdc.europa.eu
CR Altizer S, 2013, SCIENCE, V341, P514, DOI 10.1126/science.1239401
   Tran A, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-26
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Boeckmann M, 2014, HEALTH PLACE, V30, P70, DOI 10.1016/j.healthplace.2014.08.004
   Caminade C, 2014, P NATL ACAD SCI USA, V111, P3286, DOI 10.1073/pnas.1302089111
   Caminade C, 2012, J R SOC INTERFACE, V9, P2708, DOI 10.1098/rsif.2012.0138
   Charrel RN, 2008, LANCET INFECT DIS, V8, P5, DOI 10.1016/S1473-3099(07)70296-7
   Daniel M, 2003, EUR J CLIN MICROBIOL, V22, P327, DOI 10.1007/s10096-003-0918-2
   Delisle E, 2015, EUROSURVEILLANCE, V20, P8, DOI 10.2807/1560-7917.ES2015.20.17.21108
   Ebi KL, 2017, ENVIRON HEALTH PERSP, V125, DOI 10.1289/EHP1509
   ECDC, 2013, DENG OUTBR MAD
   ECDC, 2012, ECDC TECHN REP STOCK
   ECDC, 2014, EM VECT BORN DIS
   ECDC, 2015, RAP RISK ASS CHIK CA
   Estrada-Pena A, 2012, VECTOR-BORNE ZOONOT, V12, P743, DOI 10.1089/vbz.2011.0767
   Estrada-Pena A, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00064
   Estrada-Pena A, 2011, APPL ENVIRON MICROB, V77, P3838, DOI 10.1128/AEM.00067-11
   Evlampidou I, 2015, EUROSURVEILLANCE, V20, DOI [10.2807/1560-7917.ES2015.20.33.21208, DOI 10.2807/1560-7917.ES2015.20.33.21208]
   Fischer D, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-51
   Fischer D, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001407
   Fischer D, 2010, GEOSPATIAL HEALTH, V5, P59, DOI 10.4081/gh.2010.187
   Florescu SA, 2011, EUROSURVEILLANCE, V16, P2
   Gething PW, 2010, NATURE, V465, P342, DOI 10.1038/nature09098
   Gjenero-Margan I, 2011, EUROSURVEILLANCE, V16, P2
   Gouriet F, 2006, EMERG INFECT DIS, V12, P521, DOI 10.3201/eid1203.050911
   Grandadam M, 2011, EMERG INFECT DIS, V17, P910, DOI 10.3201/eid1705.101873
   Heinz FX, 2015, EUROSURVEILLANCE, V20, P9, DOI 10.2807/1560-7917.es2015.20.13.21077
   *IPCC, 2000, SUMM POL EM SCEN
   Jaenson TGT, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-8
   Jaenson TGT, 2011, TICKS TICK-BORNE DIS, V2, P44, DOI 10.1016/j.ttbdis.2010.10.006
   Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536
   La Ruche G, 2010, EUROSURVEILLANCE, V15, P2
   Lindgren E, 2012, SCIENCE, V336, P418, DOI 10.1126/science.1215735
   Maltezou HC, 2010, TRAVEL MED INFECT DI, V8, P139, DOI 10.1016/j.tmaid.2010.04.008
   Marcantonio M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121158
   Maroli M, 2008, TROP MED INT HEALTH, V13, P256, DOI [10.1111/j.1365-3156.2007.01998.x, 10.1111/j.1365-3156.2007.01998]
   McIntyre KM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06948-9
   McMichael AJ, 2013, NEW ENGL J MED, V368, P1335, DOI 10.1056/NEJMra1109341
   Medlock JM, 2015, LANCET INFECT DIS, V15, P721, DOI 10.1016/S1473-3099(15)70091-5
   Medlock JM, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-1
   Negev M, 2015, INT J ENV RES PUB HE, V12, P6745, DOI 10.3390/ijerph120606745
   Nsoesie EO, 2016, EURO SURVEILL, V21
   Ostfeld RS, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0051
   Parham PE, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0551
   Paz S, 2013, INT J ENV RES PUB HE, V10, P3543, DOI 10.3390/ijerph10083543
   Paz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056398
   Petersen LR, 2013, JAMA-J AM MED ASSOC, V310, P308, DOI 10.1001/jama.2013.8042
   Porretta D, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-271
   Proestos Y., 2015, PHILOS T R SOC B, V370, P1
   Randolph SE, 2008, MICROBES INFECT, V10, P209, DOI 10.1016/j.micinf.2007.12.005
   Randolph SE, 2010, NAT REV MICROBIOL, V8, P361, DOI 10.1038/nrmicro2336
   Ready PD, 2010, EUROSURVEILLANCE, V15, P29
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Riahi K, 2011, CLIMATIC CHANGE, V109, P33, DOI 10.1007/s10584-011-0149-y
   Rodo X, 2013, CLIMATIC CHANGE, V118, P625, DOI 10.1007/s10584-013-0744-1
   Rogers DJ, 2014, ACTA TROP, V129, P1, DOI 10.1016/j.actatropica.2013.08.008
   Roiz D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014800
   Semenza JC, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.13.20757
   Semenza JC, 2016, ANN NY ACAD SCI, V1382, P73, DOI 10.1111/nyas.13132
   Semenza JC, 2016, EUR J PUBLIC HEALTH, V26, P372, DOI 10.1093/eurpub/ckw023
   Semenza JC, 2016, EMERG INFECT DIS, V22, P581, DOI [10.3201/eid2204.151073, 10.3201/eid2204]
   Semenza JC, 2015, INT J ENV RES PUB HE, V12, P6333, DOI 10.3390/ijerph120606333
   Semenza JC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003278
   Semenza JC, 2009, LANCET INFECT DIS, V9, P365, DOI 10.1016/S1473-3099(09)70104-5
   Semenza JC, 2016, ENV HLTH, V15
   Sudre B, 2013, EMERG INFECT DIS, V19, P784, DOI 10.3201/eid1905.120811
   Suess J, 2006, INT J MED MICROBIOL, V296, P63, DOI 10.1016/j.ijmm.2005.12.005
   Suk JE, 2016, WIRES CLIM CHANGE, V7, P551, DOI 10.1002/wcc.406
   Suk JE, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.25287
   Suk JE, 2014, INT J ENV RES PUB HE, V11, P2218, DOI 10.3390/ijerph110202218
   Suk JE, 2011, AM J PUBLIC HEALTH, V101, P2068, DOI 10.2105/AJPH.2011.300181
   Tatem AJ, 2006, P NATL ACAD SCI USA, V103, P6242, DOI 10.1073/pnas.0508391103
   Tjaden NB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03566-3
   Trajer AJ, 2013, APPL ECOL ENV RES, V11, P189, DOI 10.15666/aeer/1102_189208
   Van Bortel W, 2014, EUROSURVEILLANCE, V19, P17, DOI 10.2807/1560-7917.ES2014.19.13.20759
   Venturi G, 2017, EUROSURVEILLANCE, V22, P11, DOI 10.2807/1560-7917.ES.2017.22.39.17-00646
NR 76
TC 35
Z9 36
U1 8
U2 45
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0378-1097
EI 1574-6968
J9 FEMS MICROBIOL LETT
JI FEMS Microbiol. Lett.
PD JAN
PY 2018
VL 365
IS 2
AR 244
DI 10.1093/femsle/fnx244
PG 9
WC Microbiology
SC Microbiology
GA GB8FG
UT WOS:000429310300002
PM 29149298
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU de Azevedo, TS
   Bourke, BP
   Piovezan, R
   Sallum, MAM
AF de Azevedo, Thiago S.
   Bourke, Brian Patrick
   Piovezan, Rafael
   Sallum, Maria Anice M.
TI The influence of urban heat islands and socioeconomic factors on the
   spatial distribution of Aedes aegypti larval habitats
SO GEOSPATIAL HEALTH
LA English
DT Article
DE Aedes aegvpti; Urban heat island; Spatial analysis; Wavelets; Social
   Vulnerability index; Brazil
ID VECTOR-BORNE DISEASES; CLIMATE-CHANGE; ZIKA VIRUS; DENGUE TRANSMISSION;
   SPECIES RICHNESS; TEMPERATURE; BRAZIL; CHIKUNGUNYA; COMPETENCE;
   ALBOPICTUS
AB We addressed the potential associations among the temporal and spatial distribution of larval habitats of Aedes (Stegomyia) aegypti, the presence of urban heat islands and socioeconomic factors. Data on larval habitats were collected in Santa Barbara d'Oeste, Sao Paulo, Brazil. from 2004 to 2006, and spatial and temporal variations were analysed using a wavelet-based approach. We quantified urban heat islands by calculating surface temperatures using the results of wavelet analyses and grey level transformation from Thematic Mapper images (Landsat 5). Ae. aegypti larval habitats were geo-referenced corresponding to the wavelet analyses to test the potential association between geographical distribution of habitats and surface temperature. In an inhomogeneous spatial point process, we estimated the frequency of occurrence of larval habitats in relation to temperature. The Sao Paulo State Social Vulnerability Index in the municipality of Santa Barbara d'Oeste was used to test the potential association between presence of larval habitats and social vulnerability. We found abundant Ae. aegvpti larval habitats in areas of higher surface temperature and social vulnerability and fewer larval habitats in areas with lower surface temperature and social vulnerability.
C1 [de Azevedo, Thiago S.; Bourke, Brian Patrick; Sallum, Maria Anice M.] Univ Sao Paulo, Fac Publ Hlth, Dept Epidemiol, Rio Claro, SP, Brazil.
   [Piovezan, Rafael] Sao Paulo State Univ Unesp, Dept Zool, Rio Claro, SP, Brazil.
RP de Azevedo, TS (corresponding author), Univ Sao Paulo, Dept Epidemiol, Fac Publ Hlth, Ave Doutor Arnaldo 715, BR-01246904 Sao Paulo, SP, Brazil.
EM azevedots@gmail.com
RI Azevedo, Thiago Azevedo T. S./F-8343-2012; Bourke, Brian/O-7821-2019;
   Sallum, Maria Anice Mureb/B-8537-2012; Bourke, Brian/A-9985-2012
OI Bourke, Brian/0000-0002-2638-0967; Sallum, Maria Anice
   Mureb/0000-0002-7051-2891; Bourke, Brian/0000-0002-2638-0967
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2014/26229-7]; CNPqNational Council for Scientific and Technological
   Development (CNPq) [301877/2016-5, 402054/2014-8]
FX MAMS received financial support from FAPESP (Grant 2014/26229-7), and
   CNPq Grant no. 301877/2016-5; TSA was a beneficiary of a CNPq
   post-doctorate grant no. 402054/2014-8.
CR Anno S, 2015, GEOSPATIAL HEALTH, V10, P215, DOI 10.4081/gh.2015.376
   Araujo RV, 2015, BRAZ J INFECT DIS, V19, P146, DOI 10.1016/j.bjid.2014.10.004
   Azevedo TS, 2013, GEOGRAFIA SAUDE EXPE, P19
   Baddeley A., 2015, SPATIAL POINT PATTER
   Barcellos C, 2014, TROP MED INT HEALTH, V19, P159, DOI 10.1111/tmi.12227
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Braga IA, 2007, EPIDEMIOL SERV SAUDE, V16, P113
   Cardoso CW, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005334
   Cazelles B, 2007, J R SOC INTERFACE, V4, P625, DOI 10.1098/rsif.2007.0212
   CEPAGRI, 2013, CTR PESQ MET CLIM AP
   CHAN YC, 1971, B WORLD HEALTH ORGAN, V44, P617
   Chang AY, 2014, HEALTH HUM RIGHTS, V16, P93
   Chaves LF, 2014, ACTA TROP, V129, P15, DOI 10.1016/j.actatropica.2013.02.025
   Chowell G, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-164
   Costa F, 2017, TRENDS PARASITOL, V33, P660, DOI 10.1016/j.pt.2017.05.010
   DAUBECHIES I, 1988, COMMUN PUR APPL MATH, V41, P909, DOI 10.1002/cpa.3160410705
   Teixeira TRD, 2011, CAD SAUDE PUBLICA, V27, P591, DOI 10.1590/S0102-311X2011000300019
   Eastman JR, 1999, IDRISI 32 WINDOWS US, V1
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Ferreira AC, 2007, REV SAUDE PUBL, V41, P915, DOI 10.1590/S0034-89102007000600005
   FORATTINI O.P., 2002, CULICIDOLOGIA MED, V2
   Gubler DJ, 1998, EMERG INFECT DIS, V4, P442, DOI 10.3201/eid0403.980326
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Haughter G, 1994, SUSTAINABLE CITIES
   Cuong HQ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001322
   Huang GL, 2011, J ENVIRON MANAGE, V92, P1753, DOI 10.1016/j.jenvman.2011.02.006
   Jentes ES, 2011, LANCET INFECT DIS, V11, P622, DOI 10.1016/S1473-3099(11)70147-5
   Johansson MA, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000168
   Khormi HM, 2012, GEOSPATIAL HEALTH, V6, P171, DOI 10.4081/gh.2012.135
   Knapp S, 2017, J APPL ECOL, V54, P1152, DOI 10.1111/1365-2664.12826
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kuno G, 1995, EPIDEMIOL REV, V17, P321, DOI 10.1093/oxfordjournals.epirev.a036196
   Lafferty KD, 2009, ECOLOGY, V90, P888, DOI 10.1890/08-0079.1
   Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108
   LANDSBERG H, 1981, URBAN CLIMATE
   Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9
   McKinney M. L., 2008, Urban Ecosystems, V11, P161, DOI 10.1007/s11252-007-0045-4
   Meineke EK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059687
   Misslin R, 2016, ANN NY ACAD SCI, V1382, P56, DOI 10.1111/nyas.13084
   Mohajerani A, 2017, J ENVIRON MANAGE, V197, P522, DOI 10.1016/j.jenvman.2017.03.095
   Moreira EBM, 2011, REV BRAS GEOG FIS, V3, P589
   Murdock CC, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005640
   Nagao Y, 2008, P NATL ACAD SCI USA, V105, P2238, DOI 10.1073/pnas.0709029105
   Naish S, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-167
   Oke TR, 1995, WIND CLIMATE CITIES, P81, DOI [DOI 10.1007/978-94-017-3686-2_5, 10.1007/978-94-017-3686-2_5]
   Piovezan R., 2014, GEOGRAFIA, V39, P525
   Piovezan R, 2012, REV BRAS ENTOMOL, V56, P368, DOI 10.1590/S0085-56262012000300016
   Possas C, 2018, MEM I OSWALDO CRUZ, V113, P1, DOI 10.1590/0074-02760170361
   Reiter P, 2010, BEPA, V7, P4
   Freitas ARR, 2016, REV INST MED TROP SP, V58, DOI 10.1590/S1678-9946201658024
   Scott TW, 2000, J MED ENTOMOL, V37, P89, DOI 10.1603/0022-2585-37.1.89
   SEADE, 2010, FUND SIST EST AN DAD
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Souza-Santos R, 2000, Cad Saude Publica, V16, P31, DOI 10.1590/S0102-311X2000000100004
   Steinke V. A., 2010, REV BRAS CLIMATOL, V6, P37
   Thai KTD, 2011, EXP BIOL MED, V236, P944, DOI 10.1258/ebm.2011.010402
   Tipayamongkholgul M, 2011, GEOSPAT HLTH, V2, P191
   Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2
   TURELL MJ, 1990, AM J TROP MED HYG, V43, P543, DOI 10.4269/ajtmh.1990.43.543
   TYSON PD, 1972, ATMOS ENVIRON, V6, P533, DOI 10.1016/0004-6981(72)90070-4
   Vega-Rua A, 2014, J VIROL, V88, P6294, DOI 10.1128/JVI.00370-14
   WATTS DM, 1987, AM J TROP MED HYG, V36, P143, DOI 10.4269/ajtmh.1987.36.143
   WENG HY, 1994, J ATMOS SCI, V51, P2523, DOI 10.1175/1520-0469(1994)051<2523:WPDATL>2.0.CO;2
   WHO UNICEF, 2017, GLOB VECT CONTR RESP
   Xu L, 2017, P NATL ACAD SCI USA, V114, P113, DOI 10.1073/pnas.1618558114
   Yang HM, 2009, EPIDEMIOL INFECT, V137, P1188, DOI 10.1017/S0950268809002040
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 67
TC 2
Z9 3
U1 1
U2 3
PU UNIV NAPLES FEDERICO II
PI NAPLES
PA FAC VET MED, DEP PATHOLOGY & ANIMAL HEALTH, VET PARASITOLOGY, VIA DELLA
   VETERINARIA 1, NAPLES, 80137, ITALY
SN 1827-1987
EI 1970-7096
J9 GEOSPATIAL HEALTH
JI Geospatial Health
PY 2018
VL 13
IS 1
BP 179
EP 187
AR 623
DI 10.4081/gh.2018.623
PG 9
WC Health Care Sciences & Services; Public, Environmental & Occupational
   Health
SC Health Care Sciences & Services; Public, Environmental & Occupational
   Health
GA GR2AO
UT WOS:000442360600022
PM 29772891
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Bode, L
   Vraga, EK
AF Bode, Leticia
   Vraga, Emily K.
TI See Something, Say Something: Correction of Global Health Misinformation
   on Social Media
SO HEALTH COMMUNICATION
LA English
DT Article
ID CONSPIRACY THEORIES; NEWS; EXPOSURE; INTERNET; INFORMATION; BELIEF;
   ONLINE; CREDIBILITY; MESSAGES; POLITICS
AB Social media are often criticized for being a conduit for misinformation on global health issues, but may also serve as a corrective to false information. To investigate this possibility, an experiment was conducted exposing users to a simulated Facebook News Feed featuring misinformation and different correction mechanisms (one in which news stories featuring correct information were produced by an algorithm and another where the corrective news stories were posted by other Facebook users) about the Zika virus, a current global health threat. Results show that algorithmic and social corrections are equally effective in limiting misperceptions, and correction occurs for both high and low conspiracy belief individuals. Recommendations for social media campaigns to correct global health misinformation, including encouraging users to refute false or misleading health information, and providing them appropriate sources to accompany their refutation, are discussed.
C1 [Bode, Leticia] Georgetown Univ, Commun Culture & Technol Program, 3520 Prospect St NW Suite 311, Washington, DC 20057 USA.
   [Vraga, Emily K.] George Mason Univ, Dept Commun, Fairfax, VA 22030 USA.
RP Bode, L (corresponding author), Georgetown Univ, Commun Culture & Technol Program, 3520 Prospect St NW Suite 311, Washington, DC 20057 USA.
EM lb871@georgetown.edu
RI Vraga, Emily/K-9325-2019
OI Vraga, Emily/0000-0002-3016-3869
CR Al-Qahtani AA, 2016, J INFECT DEV COUNTR, V10, P201, DOI 10.3855/jidc.8350
   Annenberg Public Policy Center, 2016, HALF AM CONC ZIK WIL
   AUSTIN EW, 1994, JOURNALISM QUART, V71, P973, DOI 10.1177/107769909407100420
   Beaudoin CE, 2008, NEW MEDIA SOC, V10, P455, DOI 10.1177/1461444807085327
   Bessi A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118093
   Bode L., 2016, SOCIAL MEDIA POLITIC, P189
   Bode L, 2016, MASS COMMUN SOC, V19, P24, DOI 10.1080/15205436.2015.1045149
   Bode L, 2015, J COMMUN, V65, P619, DOI 10.1111/jcom.12166
   Briones R, 2012, HEALTH COMMUN, V27, P478, DOI 10.1080/10410236.2011.610258
   Brotherton R, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00279
   Bruder M, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00225
   Centers for Disease Control and Prevention, 2016, KEY MESS ZIK VIR DIS
   Cobb MD, 2013, POLIT PSYCHOL, V34, P307, DOI 10.1111/j.1467-9221.2012.00935.x
   De Meo P, 2014, COMMUN ACM, V57, P78, DOI 10.1145/2629438
   Del Vicario M, 2016, P NATL ACAD SCI USA, V113, P554, DOI 10.1073/pnas.1517441113
   DiFonzo N, 2012, J HEALTH COMMUN, V17, P1099, DOI 10.1080/10810730.2012.665417
   Druckman J.N., 2011, CAMBRIDGE HDB EXPT P, P41, DOI DOI 10.1017/CBO9780511921452.004
   Gesser-Edelsburg A, 2017, HEALTH COMMUN, V32, P169, DOI 10.1080/10410236.2015.1110224
   Goddard K, 2012, J AM MED INFORM ASSN, V19, P121, DOI 10.1136/amiajnl-2011-000089
   GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469
   Griffiths E., 2016, THE MIRROR
   Hayes A. F., 2013, INTRO MEDIATION MODE
   Hong T, 2014, COMMUN RES, V41, P159, DOI 10.1177/0093650212439710
   HUCKFELDT R, 1995, AM J POLIT SCI, V39, P1025, DOI 10.2307/2111668
   Jerit J, 2012, J POLIT, V74, P672, DOI 10.1017/S0022381612000187
   Johnson TJ, 2000, JOURNALISM MASS COMM, V77, P865, DOI 10.1177/107769900007700409
   Jolley D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089177
   Jolley D, 2014, BRIT J PSYCHOL, V105, P35, DOI 10.1111/bjop.12018
   Kahle K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156409
   Kata A, 2010, VACCINE, V28, P1709, DOI 10.1016/j.vaccine.2009.12.022
   Katz E., 1955, PERSONAL INFLUENCE
   Kim Y, 2013, COMPUT HUM BEHAV, V29, P2607, DOI 10.1016/j.chb.2013.06.005
   King Hope, 2016, CNN
   Lewandowsky S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075637
   Lewandowsky S, 2012, PSYCHOL SCI PUBL INT, V13, P106, DOI 10.1177/1529100612451018
   MEYER P, 1988, JOURNALISM QUART, V65, P567, DOI 10.1177/107769908806500301
   Miller JM, 2016, AM J POLIT SCI, V60, P824, DOI 10.1111/ajps.12234
   Mitchell A., 2015, MILLENNIALS POLITICA
   Mosseri A., 2016, FACEBOOK NEWSROOM
   Navarro A., 2016, TECH TIMES      0214
   Nyhan B, 2014, PEDIATRICS, V133, pE835, DOI 10.1542/peds.2013-2365
   Nyhan B, 2010, POLIT BEHAV, V32, P303, DOI 10.1007/s11109-010-9112-2
   Radzikowski Jacek, 2016, JMIR Public Health Surveill, V2, pe1, DOI 10.2196/publichealth.5059
   Schipani V., 2016, SCICHECK
   Simmons J., 2014, MTURK LAB EITHER WAY
   Solon O, 2016, GUARDIAN
   Swami V, 2011, BRIT J PSYCHOL, V102, P443, DOI 10.1111/j.2044-8295.2010.02004.x
   Tan ASL, 2015, J COMMUN, V65, P674, DOI 10.1111/jcom.12163
   Tavris Carol, 2007, MISTAKES WERE MADE B
   Thielman Sam, 2016, GUARDIAN
   Thorson E, 2016, POLIT COMMUN, V33, P460, DOI 10.1080/10584609.2015.1102187
   Van Prooijen JW, 2013, EUR J SOC PSYCHOL, V43, P109, DOI 10.1002/ejsp.1922
   Vraga E, 2016, COMMUN METHODS MEAS, V10, P149, DOI 10.1080/19312458.2016.1150443
   Vraga EK, 2018, INFORM COMMUN SOC, V21, P1337, DOI 10.1080/1369118X.2017.1313883
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
   Worth Katie, 2016, FRONTLINE
NR 56
TC 36
Z9 36
U1 21
U2 57
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1041-0236
EI 1532-7027
J9 HEALTH COMMUN
JI Health Commun.
PY 2018
VL 33
IS 9
BP 1131
EP 1140
DI 10.1080/10410236.2017.1331312
PG 10
WC Communication; Health Policy & Services
SC Communication; Health Care Sciences & Services
GA GI5WT
UT WOS:000434442000009
PM 28622038
DA 2020-07-08
ER

PT J
AU Mesci, P
   Macia, A
   LaRock, CN
   Tejwani, L
   Fernandes, IR
   Suarez, NA
   Zanotto, PMD
   Beltrao-Braga, PCB
   Nizet, V
   Muotri, AR
AF Mesci, Pinar
   Macia, Angela
   LaRock, Christopher N.
   Tejwani, Leon
   Fernandes, Isabella R.
   Suarez, Nicole A.
   Zanotto, Paolo M. de A.
   Beltrao-Braga, Patricia C. B.
   Nizet, Victor
   Muotri, Alysson R.
TI Modeling neuro-immune interactions during Zika virus infection
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID CEREBRAL ORGANOIDS; BLOOD MONOCYTES; STEM-CELLS; MICROGLIA;
   DIFFERENTIATION; ENHANCEMENT; MACROPHAGES; ACTIVATION; MORPHOLOGY;
   ZYMOSAN
AB Although Zika virus (ZIKV) infection is often asymptomatic, in some cases, it can lead to birth defects in newborns or serious neurologic complications in adults. However, little is known about the interplay between immune and neural cells that could contribute to the ZIKV pathology. To understand the mechanisms at play during infection and the antiviral immune response, we focused on neural precursor cells (NPCs)-microglia interactions. Our data indicate that human microglia infected with the current circulating Brazilian ZIKV induces a similar pro-inflammatory response found in ZIKV-infected human tissues. Importantly, using our model, we show that microglia interact with ZIKV-infected NPCs and further spread the virus. Finally, we show that Sofosbuvir, an FDA-approved drug for Hepatitis C, blocked viral infection in NPCs and therefore the transmission of the virus from microglia to NPCs. Thus, our model provides a new tool for studying neuro-immune interactions and a platform to test new therapeutic drugs.
C1 [Mesci, Pinar; Macia, Angela; Tejwani, Leon; Fernandes, Isabella R.; Suarez, Nicole A.; Muotri, Alysson R.] Univ Calif San Diego, Sch Med, Dept Pediat, Rady Childrens Hosp San Diego, La Jolla, CA 92093 USA.
   [Mesci, Pinar; Macia, Angela; Tejwani, Leon; Fernandes, Isabella R.; Suarez, Nicole A.; Muotri, Alysson R.] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, Stem Cell Program, La Jolla, CA 92093 USA.
   [LaRock, Christopher N.; Nizet, Victor] Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA.
   [LaRock, Christopher N.; Nizet, Victor] Univ Calif San Diego, Sch Med, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA.
   [Zanotto, Paolo M. de A.] Univ Sao Paulo, Inst Microbiol Sci, Dept Microbiol, Lab Mol Evolut & Bioinformat, BR-05508000 Sao Paulo, SP, Brazil.
   [Beltrao-Braga, Patricia C. B.] Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, Lab Stem Cell & Dis Modeling, BR-05508000 Sao Paulo, SP, Brazil.
   [Beltrao-Braga, Patricia C. B.] Univ Sao Paulo, Sch Arts Sci & Humanities, Dept Obstet, BR-03828000 Sao Paulo, SP, Brazil.
   [Beltrao-Braga, Patricia C. B.] Univ Sao Paulo, Sch Med, Ctr Cellular & Mol Therapy NETCEM, BR-01246903 Sao Paulo, SP, Brazil.
RP Muotri, AR (corresponding author), 2880 Torrey Pines Scen Dr, La Jolla, CA 92093 USA.
EM muotri@ucsd.edu
RI Nizet, Victor/AAF-3190-2019; de A. Zanotto, Paolo M./B-9286-2019;
   Beltrao-Braga, Patricia C B/D-6450-2013; LaRock, Christopher/E-1554-2013
OI de A. Zanotto, Paolo M./0000-0002-8167-0625; Beltrao-Braga, Patricia C
   B/0000-0003-0004-1091; LaRock, Christopher/0000-0003-3035-5331; Mesci,
   Pinar/0000-0003-3402-5671; Macia Ortega, Angela/0000-0001-8735-0916
FU California Institute for Regenerative MedicineCalifornia Institute for
   Regenerative Medicine [DISC2-09649]; National Institutes of HealthUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA [U19MH107367]; Zika Network FAPESP projects
   [2011/18703-2, 2014/17766-9]; NGO "the tooth fairy project"; A.P.
   Giannini Foundation; NARSAD Independent Investigator GrantNARSAD
FX This work was supported by grants from the California Institute for
   Regenerative Medicine (DISC2-09649), the National Institutes of Health
   through the U19MH107367, Zika Network FAPESP projects 2011/18703-2 and
   2014/17766-9, the NGO "the tooth fairy project", a fellowship from the
   A.P. Giannini Foundation to C.N.L., and an NARSAD Independent
   Investigator Grant to A.R.M. Dr. Mesci has an International Rett
   syndrome foundation (IRSF) mentored training fellowship. Dr. Macia has a
   NARSAD Young Investigator grant.
CR Aloisi F, 2001, GLIA, V36, P165, DOI 10.1002/glia.1106
   Anfasa F, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00292-17, 10.1128/msphere.00292-17]
   Appel N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000035
   Bayless NL, 2016, CELL HOST MICROBE, V20, P423, DOI 10.1016/j.chom.2016.09.006
   Beckham JD, 2016, JAMA NEUROL, V73, P875, DOI 10.1001/jamaneurol.2016.0800
   Biacchesi S, 2004, J VIROL, V78, P12877, DOI 10.1128/JVI.78.23.12877-12887.2004
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Chavali PL, 2017, SCIENCE, V357, P83, DOI 10.1126/science.aam9243
   Chen ST, 2008, NATURE, V453, P672, DOI 10.1038/nature07013
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Delatorre E, 2017, MEM I OSWALDO CRUZ, V112, P793, DOI 10.1590/0074-02760170299
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Douvaras P, 2017, STEM CELL REP, V8, P1516, DOI 10.1016/j.stemcr.2017.04.023
   Duggal NK, 2017, AM J TROP MED HYG, V97, P1410, DOI 10.4269/ajtmh.17-0263
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Foo SS, 2017, NAT MICROBIOL, V2, P1558, DOI 10.1038/s41564-017-0016-3
   Galliez RM, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw203
   Garcez PP, 2017, SCI REP-UK, V7, DOI 10.1038/srep40780
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637
   Griesi-Oliveira K, 2015, MOL PSYCHIATR, V20, P1350, DOI 10.1038/mp.2014.141
   Grozdanov V, 2014, ACTA NEUROPATHOL, V128, P651, DOI 10.1007/s00401-014-1345-4
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   LAWSON LJ, 1990, NEUROSCIENCE, V39, P151, DOI 10.1016/0306-4522(90)90229-W
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Lum FM, 2017, CLIN INFECT DIS, V64, P914, DOI 10.1093/cid/ciw878
   Manangeeswaran M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006004
   Mandrekar-Colucci S, 2010, CNS NEUROL DISORD-DR, V9, P156, DOI 10.2174/187152710791012071
   Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P1, DOI [DOI 10.15585/MMWR.MM6506E1ER, 10.15585/mmwr.mm6506e1]
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nageshappa S, 2016, MOL PSYCHIATR, V21, P178, DOI 10.1038/mp.2015.128
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Ohradanova-Repic A, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2015.39
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Ornelas AMM, 2017, ANN NEUROL, V81, P152, DOI 10.1002/ana.24839
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rezaie P, 1999, DEV BRAIN RES, V115, P71, DOI 10.1016/S0165-3806(99)00043-7
   Rosenberger CM, 2014, J GEN VIROL, V95, P350, DOI 10.1099/vir.0.058438-0
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Simonin Y, 2016, EBIOMEDICINE, V12, P161, DOI 10.1016/j.ebiom.2016.09.020
   SPEERT DP, 1985, J LEUKOCYTE BIOL, V38, P655
   Tan MC, 2007, VIROLOGY, V357, P1, DOI 10.1016/j.virol.2006.08.004
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   Underhill DM, 2003, J ENDOTOXIN RES, V9, P176, DOI 10.1179/096805103125001586
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   Yanagimachi MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059243
   Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525
NR 59
TC 20
Z9 20
U1 0
U2 7
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD JAN 1
PY 2018
VL 27
IS 1
BP 41
EP 52
DI 10.1093/hmg/ddx382
PG 12
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA FS1YV
UT WOS:000419575800004
PM 29048558
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Wong, G
   Qiu, XG
AF Wong, Gary
   Qiu, Xiangguo
TI Funding vaccines for emerging infectious diseases
SO HUMAN VACCINES & IMMUNOTHERAPEUTICS
LA English
DT Article
DE Ebola; influenza; funding; MERS; SARS; vaccine; vaccinology; Zika
ID EBOLA
AB Immunization has played a large role in substantially reducing the infected and death tolls from infectious diseases. In the case of emerging diseases, the identity of the pathogen responsible, as well as the time and location for the next outbreak, cannot be accurately predicted using current means. Coupled with disjointed efforts towards the development of vaccines and a lack of funds and desire to advance promising products against known emerging pathogens to clinical trials, there has been a shortage of approved products ready for emergency use. Recent outbreaks have exposed these weaknesses, and the Coalition for Epidemic Preparedness Innovations (CEPI) was created in 2016 to address these issues. In this commentary, we discuss the establishment of such a global vaccine fund, and provide some additional points to consider for stimulating further discussion on this comprehensive, ambitious initiative.
C1 [Wong, Gary] Shenzhen Third Peoples Hosp, Guangdong Key Lab Diag & Treatment Emerging Infe, Shenzhen Key Lab Pathogen & Immun, Shenzhen, Peoples R China.
   [Qiu, Xiangguo] Natl Microbiol Lab, Special Pathogens Program, Winnipeg, MB, Canada.
   [Qiu, Xiangguo] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada.
RP Qiu, XG (corresponding author), Publ Hlth Agcy Canada, Special Pathogens Program, 1015 Arlington St, Winnipeg, MB R3E 3R2, Canada.
EM xiangguo.qiu@phac-aspc.gc.ca
FU National Key Research and Development Program of China [2016YFE0205800];
   National Key Program for Infectious Disease of China [2016ZX10004222];
   Public Health Agency of Canada; National Institutes of HealthUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA [U19AI109762-1]; Canadian Institutes of Health
   ResearchCanadian Institutes of Health Research (CIHR) [IER-143487];
   Sanming Project of Medicine in Shenzhen [ZDSYS201504301534057]; Shenzhen
   Science and Technology Research and Development Project
   [JCYJ20160427151920801]; National Natural Science Foundation of China
   International Cooperation and Exchange Program [816110193]
FX This work is supported by the National Key Research and Development
   Program of China (2016YFE0205800), the National Key Program for
   Infectious Disease of China (2016ZX10004222), the Public Health Agency
   of Canada, partially supported by grants from the National Institutes of
   Health (U19AI109762-1) and Canadian Institutes of Health Research
   (IER-143487), the Sanming Project of Medicine in Shenzhen
   (ZDSYS201504301534057), the Shenzhen Science and Technology Research and
   Development Project (JCYJ20160427151920801), and the National Natural
   Science Foundation of China International Cooperation and Exchange
   Program (816110193). The authors declare no competing financial
   interests.
CR Bi YH, 2016, CELL HOST MICROBE, V20, P810, DOI 10.1016/j.chom.2016.10.022
   CEPI.net, 2017, CEPIS END TO END GAP
   CEPI.net, 2017, CEPI APPR
   Jones SM, 2005, NAT MED, V11, P786, DOI 10.1038/nm1258
   Ledgerwood JE, 2010, VACCINE, V29, P304, DOI 10.1016/j.vaccine.2010.10.037
   Lycett SJ, 2016, SCIENCE, V354, P213, DOI 10.1126/science.aaf8852
   Plotkin SA, 2015, NEW ENGL J MED, V373, P297, DOI 10.1056/NEJMp1506820
   Pronker ES, 2011, VACCINE, V29, P5846, DOI 10.1016/j.vaccine.2011.06.051
   Rottingen JA, 2017, NEW ENGL J MED, V376, P610, DOI 10.1056/NEJMp1613577
   Sullivan NJ, 2003, NATURE, V424, P681, DOI 10.1038/nature01876
   World Health Organization, 2017, LIST BLUEPR PRIOR DI
NR 11
TC 5
Z9 5
U1 0
U2 2
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 2164-5515
EI 2164-554X
J9 HUM VACC IMMUNOTHER
JI Human Vaccines Immunother.
PY 2018
VL 14
IS 7
BP 1760
EP 1762
DI 10.1080/21645515.2017.1412024
PG 3
WC Biotechnology & Applied Microbiology; Immunology
SC Biotechnology & Applied Microbiology; Immunology
GA HC9ZL
UT WOS:000452166800035
PM 29194012
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Vraga, EK
   Bode, L
AF Vraga, Emily K.
   Bode, Leticia
TI I do not believe you: how providing a source corrects health
   misperceptions across social media platforms
SO INFORMATION COMMUNICATION & SOCIETY
LA English
DT Article
DE Misinformation; Twitter; Facebook; social media; health
ID POLITICAL EXPRESSION; ZIKA VIRUS; MISINFORMATION; CREDIBILITY; TWITTER;
   CONSEQUENCES; INFORMATION; AFFORDANCES; PERCEPTIONS; POLITICIZATION
AB Social media are often criticized as serving as a source of misinformation, but in this study we examine how they may also function to correct misperceptions on an emerging health issue. We use an experimental design to consider social correction that occurs via peers, testing both the type of correction (i.e., whether a source is provided or not) and the platform on which the correction ocratcurs (i.e., Facebook versus Twitter). Our results suggest that a source is necessary to correct misperceptions about the causes of the Zika virus on both Facebook and Twitter, but the mechanism by which such correction occurs differs across platforms. Implications for successful social media campaigns to address health misinformation are addressed.
C1 [Vraga, Emily K.] George Mason Univ, Dept Commun, 4400 Univ Dr,MS 3D6, Fairfax, VA 22030 USA.
   [Bode, Leticia] Georgetown Univ, Commun Culture & Technol, Washington, DC USA.
RP Vraga, EK (corresponding author), George Mason Univ, Dept Commun, 4400 Univ Dr,MS 3D6, Fairfax, VA 22030 USA.
EM evraga@gmu.edu; lb871@georgetown.edu
RI Vraga, Emily/K-9325-2019
OI Vraga, Emily/0000-0002-3016-3869
CR Al-Qahtani AA, 2016, J INFECT DEV COUNTR, V10, P201, DOI 10.3855/jidc.8350
   Barbera P, 2014, WORKING PAPER
   Barbera P, 2015, PSYCHOL SCI, V26, P1531, DOI 10.1177/0956797615594620
   Berinsky AJ, 2017, BRIT J POLIT SCI, V47, P241, DOI 10.1017/S0007123415000186
   Bode L., HLTH COMMUNICATION
   Bode L, 2015, J COMMUN, V65, P619, DOI 10.1111/jcom.12166
   Bode L, 2015, ANN AM ACAD POLIT SS, V659, P149, DOI 10.1177/0002716214563923
   boyd danah, 2010, NETWORKED SELF IDENT, P39, DOI DOI 10.1162/DMAL.9780262524834.119
   Boyd DM, 2007, J COMPUT-MEDIAT COMM, V13, P210, DOI 10.1111/j.1083-6101.2007.00393.x
   Bruns A., 2014, TWITTER AND SOC, P15
   Castillo C., 2011, P 20 INT C WORLD WID, P675, DOI DOI 10.1145/1963405.1963500
   Diehl T, 2016, NEW MEDIA SOC, V18, P1875, DOI 10.1177/1461444815616224
   Dixon G, 2013, HEALTH EDUC RES, V28, P352, DOI 10.1093/her/cys110
   Dredze M, 2016, VACCINE, V34, P3441, DOI 10.1016/j.vaccine.2016.05.008
   Duggan M., 2015, DEMOGRAPHICS SOCIAL
   Eagly A. H., 1993, PSYCHOL ATTITUDES
   Ecker UKH, 2011, PSYCHON B REV, V18, P570, DOI 10.3758/s13423-011-0065-1
   Edwards C, 2014, COMPUT HUM BEHAV, V33, P372, DOI 10.1016/j.chb.2013.08.013
   Ehrenberg R, 2012, SCI NEWS, V182, P22, DOI DOI 10.1002/scin.v182.8
   Ellison NB, 2015, HBK COMMUN MEDIA, P205
   Feldman L, 2014, J COMMUN, V64, P590, DOI 10.1111/jcom.12108
   Fowler A, 2014, ELECT STUD, V34, P100, DOI 10.1016/j.electstud.2013.09.009
   Fox J, 2015, COMPUT HUM BEHAV, V45, P168, DOI 10.1016/j.chb.2014.11.083
   Garrett RK, 2011, HUM COMMUN RES, V37, P255, DOI 10.1111/j.1468-2958.2010.01401.x
   Gauchat G, 2012, AM SOCIOL REV, V77, P167, DOI 10.1177/0003122412438225
   Gibson J. J., 1986, ECOLOGICAL APPROACH
   Gottfried J., 2016, NEWS USE SOCIAL MEDI
   Griffiths E., 2016, THE MIRROR
   Gruzd A, 2011, AM BEHAV SCI, V55, P1294, DOI 10.1177/0002764211409378
   Hampton K, 2011, SOCIAL NETWORKING SI
   Hayes A. F., 2013, INTRO MEDIATION MODE
   Hmielowski JD, 2014, PUBLIC UNDERST SCI, V23, P866, DOI 10.1177/0963662513480091
   Jahng MR, 2016, J MASS COMMUN Q, V93, P38, DOI 10.1177/1077699015606680
   Jerit J, 2012, J POLIT, V74, P672, DOI 10.1017/S0022381612000187
   Kata A, 2010, VACCINE, V28, P1709, DOI 10.1016/j.vaccine.2009.12.022
   Lewandowsky S, 2012, PSYCHOL SCI PUBL INT, V13, P106, DOI 10.1177/1529100612451018
   Lyons B., J PUBLIC DELIBERATIO
   Maireder A., 2013, TWITTER AND SOC, P291
   Mao J, 2014, COMPUT HUM BEHAV, V33, P213, DOI 10.1016/j.chb.2014.01.002
   Marwick AE, 2011, NEW MEDIA SOC, V13, P114, DOI 10.1177/1461444810365313
   McCright AM, 2011, SOCIOL QUART, V52, P155, DOI 10.1111/j.1533-8525.2011.01198.x
   Messing S, 2014, COMMUN RES, V41, P1042, DOI 10.1177/0093650212466406
   Mitchell A., 2016, MODERN NEWS CONSUMER
   Nyhan B, 2013, MED CARE, V51, P127, DOI 10.1097/MLR.0b013e318279486b
   Nyhan B, 2010, POLIT BEHAV, V32, P303, DOI 10.1007/s11109-010-9112-2
   Nyhan Brendan, 2010, FORUM, V8, P1
   Oyeyemi SO, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6178
   PETTY RE, 1984, J PERS SOC PSYCHOL, V46, P69, DOI 10.1037/0022-3514.46.1.69
   Petty RE, 2008, PERSPECT PSYCHOL SCI, V3, P137, DOI 10.1111/j.1745-6916.2008.00071.x
   Pornpitakpan C, 2004, J APPL SOC PSYCHOL, V34, P243, DOI 10.1111/j.1559-1816.2004.tb02547.x
   Radzikowski Jacek, 2016, JMIR Public Health Surveill, V2, pe1, DOI 10.2196/publichealth.5059
   Reedy J, 2014, SOC SCI QUART, V95, P1399, DOI 10.1111/ssqu.12102
   Rojecki A, 2016, NEW MEDIA SOC, V18, P25, DOI 10.1177/1461444814535724
   Rosenbaum L, 2014, NEW ENGL J MED, V371, P1549, DOI 10.1056/NEJMms1409003
   Schrock AR, 2015, INT J COMMUN-US, V9, P1229
   Sharma M, 2017, AM J INFECT CONTROL, V45, P301, DOI 10.1016/j.ajic.2016.08.022
   Slater MD, 1996, JOURNALISM MASS COMM, V73, P974, DOI 10.1177/107769909607300415
   Small TA, 2011, INFORM COMMUN SOC, V14, P872, DOI 10.1080/1369118X.2011.554572
   Solon O, 2016, GUARDIAN
   Starbird K., 2013, ICONFERENCE 2014, V2014, P654, DOI DOI 10.9776/14308
   Taber CS, 2006, AM J POLIT SCI, V50, P755, DOI 10.1111/j.1540-5907.2006.00214.x
   Tafuri S, 2014, VACCINE, V32, P4860, DOI 10.1016/j.vaccine.2013.11.006
   Thorson K, 2016, COMMUN THEOR, V26, P309, DOI 10.1111/comt.12087
   Thorson K, 2014, INFORM COMMUN SOC, V17, P203, DOI 10.1080/1369118X.2013.862563
   Thorson K, 2013, INFORM COMMUN SOC, V16, P421, DOI 10.1080/1369118X.2012.756051
   Treem J., 2012, COMMUNICATION YB, V36, P143, DOI DOI 10.2139/SSRN.2129853
   Vraga EK, 2015, COMPUT HUM BEHAV, V45, P281, DOI 10.1016/j.chb.2014.12.025
   Westerman D, 2014, J COMPUT-MEDIAT COMM, V19, P171, DOI 10.1111/jcc4.12041
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
   World Health Organization, 2016, DISP RUM ZIK COMPL
   Worth Katie, 2016, FRONTLINE
NR 71
TC 27
Z9 27
U1 5
U2 33
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1369-118X
EI 1468-4462
J9 INFORM COMMUN SOC
JI Info. Commun. Soc.
PY 2018
VL 21
IS 10
BP 1337
EP 1353
DI 10.1080/1369118X.2017.1313883
PG 17
WC Communication; Sociology
SC Communication; Sociology
GA GJ8ZS
UT WOS:000435681500003
DA 2020-07-08
ER

PT J
AU Liu, J
   Li, QQ
   Li, XX
   Qiu, ZZ
   Li, A
   Liang, WH
   Chen, HY
   Cai, XS
   Chen, XL
   Duan, XY
   Li, JJ
   Wu, WS
   Xu, MY
   Mao, YY
   Chen, HY
   Li, JL
   Gu, WW
   Li, HW
AF Liu, Jun
   Li, Qingqing
   Li, Xiaoxin
   Qiu, Zhenzhen
   Li, Andrew
   Liang, Wenhan
   Chen, Huangyao
   Cai, Xiangsheng
   Chen, Xinglu
   Duan, Xinyue
   Li, Jingjing
   Wu, Wangsheng
   Xu, Mingyu
   Mao, Yingying
   Chen, Huiying
   Li, Jinlong
   Gu, Weiwang
   Li, Hongwei
TI Zika Virus Envelope Protein induces G2/M Cell Cycle Arrest and Apoptosis
   via an Intrinsic Cell Death Signaling Pathway in Neuroendocrine PC12
   Cells
SO INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES
LA English
DT Article
DE ZIKV; envelope protein; G2/M arrest; mitotic catastrophe; apoptosis
ID BREAST-CANCER CELLS; INFECTION; MICE; EXPRESSION; COLOMBIA; OUTBREAK;
   BRAZIL
AB Clinical evidence suggests that there exists a strong correlation between Zika virus (ZIKV) infection and abnormal development of the nervous system. However, the underlying mechanisms remain to be elusive. In this study, recombinant lentiviral vectors coding for ZIKV structural proteins and truncations (prM-Env, M-Env and Env) were transduced into PC12 cells. Envelope (Env) overexpression induced significant inhibition of proliferation and triggered G2/M cell cycle arrest and apoptosis in PC12 cells. Flow cytometry and western blot analysis showed that the apoptosis was associated with up-regulation of both p53 and p21(Cip1/Waf1) and down-regulation of cyclin B1. Presence of aberrant nuclei clusters were confirmed by immunofluorescence staining analysis. The data indicate that overexpression of prM-Env, M-Env or Env led to apoptosis via an intrinsic cell death signaling pathway that is dependent on the activation of caspase-9 and caspase-3 and accompanied by an increased ratio of Bax to Bcl-2 in transduced PC12 cells. In summary, our results suggest that ZIKV Env protein causes apoptosis in PC12 cells via an intrinsic cell death signaling pathway, which may contribute to ZIKV-induced abnormal development of the nervous system.
C1 [Liu, Jun; Li, Qingqing; Li, Xiaoxin; Qiu, Zhenzhen; Liang, Wenhan; Chen, Huangyao; Cai, Xiangsheng; Chen, Xinglu; Duan, Xinyue; Li, Jingjing; Wu, Wangsheng; Xu, Mingyu; Mao, Yingying; Chen, Huiying; Li, Jinlong; Li, Hongwei] Southern Med Univ, Sch Lab Med & Biotechnol, 1023 South Shatai Rd, Guangzhou 510515, Guangdong, Peoples R China.
   [Liu, Jun; Gu, Weiwang] Southern Med Univ, Inst Comparat Med, 1023 South Shatai Rd, Guangzhou 510515, Guangdong, Peoples R China.
   [Liu, Jun; Gu, Weiwang] Southern Med Univ, Ctr Lab Anim, 1023 South Shatai Rd, Guangzhou 510515, Guangdong, Peoples R China.
   [Liu, Jun] Southern Med Univ, Dermatol Hosp, Guangzhou, Guangdong, Peoples R China.
   [Li, Xiaoxin] Hong Kong Univ Sci & Technol, State Key Lab Mol Neurosci, Div Life Sci, Hong Kong, Peoples R China.
   [Qiu, Zhenzhen] Guangzhou Bioneeds Biotechnol Co Ltd, Guangzhou, Guangdong, Peoples R China.
   [Li, Andrew] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA.
   [Cai, Xiangsheng; Chen, Xinglu] Guangdong Pharmaceut Univ, Affiliated Hosp 1, Clin Lab, Guangzhou, Guangdong, Peoples R China.
   [Wu, Wangsheng] Jilin Agr Univ, Anim Sci & Technol Coll, Changchun, Jilin, Peoples R China.
   [Gu, Weiwang] Pearl Lab Anim Sci & Technol Co Ltd, Dongguang, Peoples R China.
   [Gu, Weiwang] Wuyi Univ, Sch Chem & Environm Engn, Jiangmen, Peoples R China.
   [Gu, Weiwang] Int Healthcare Innovat Inst, Jiangmen, Peoples R China.
RP Li, HW (corresponding author), Southern Med Univ, Sch Lab Med & Biotechnol, 1023 South Shatai Rd, Guangzhou 510515, Guangdong, Peoples R China.; Gu, WW (corresponding author), Southern Med Univ, Inst Comparat Med, 1023 South Shatai Rd, Guangzhou 510515, Guangdong, Peoples R China.; Gu, WW (corresponding author), Southern Med Univ, Ctr Lab Anim, 1023 South Shatai Rd, Guangzhou 510515, Guangdong, Peoples R China.
EM guww100@163.com; lihw@smu.edu.cn
OI Liu, Jun/0000-0002-5275-2656
FU National Key RD Projects [2017YFD0500600]; Industrial High-tech Fields
   of Science and Technology Plan Projects of Guangdong Province
   [2013B010404026]; Science and Technology Planning Project of Guangdong
   Province [2010A011200003, 2012B011000004, 2016A030303008,
   2012B060300003]; International SAMP;T Cooperation Program of China
   [2011DFA33290]; Medical Scientific Research Foundation of Guangdong
   Province [A2017124]; Department of Education of Guangdong
   ProvinceNational Natural Science Foundation of Guangdong Province
   [2016KCXTD005, 2017KSYS010]; Jiangmen Introduced Innovative Scientific
   Research Team Program
FX This study was financially supported by the National Key R&D Projects
   grant 2017YFD0500600, the Industrial High-tech Fields of Science and
   Technology Plan Projects of Guangdong Province grant 2013B010404026, the
   Science and Technology Planning Project of Guangdong Province, Grant
   2010A011200003, 2012B011000004, 2016A030303008, 2012B060300003, the
   International S&T Cooperation Program of China grant 2011DFA33290, the
   Medical Scientific Research Foundation of Guangdong Province, grant
   A2017124, the Department of Education of Guangdong Province grant
   2016KCXTD005, 2017KSYS010, the Jiangmen Introduced Innovative Scientific
   Research Team Program (2017).
CR Agrawal S, 2002, MOL CELL BIOL, V22, P1981, DOI 10.1128/MCB.22.7.1981-1992.2002
   Amulic B, 2017, DEV CELL, V43, P449, DOI 10.1016/j.devcel.2017.10.013
   Barreto ML, 2016, LANCET, V387, P919, DOI 10.1016/S0140-6736(16)00545-6
   Biederer T, 2007, NAT PROTOC, V2, P670, DOI 10.1038/nprot.2007.92
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Castilho A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026040
   Chen XL, 2017, ONCOTARGET, V8, P354, DOI 10.18632/oncotarget.13396
   Engeland K., 2017, CELL DEATH DIFFERENT
   Machado-Alba JE, 2016, INT J INFECT DIS, V51, P133, DOI 10.1016/j.ijid.2016.09.010
   Fernandes NCCA, 2017, EXP TOXICOL PATHOL, V69, P63, DOI 10.1016/j.etp.2016.11.004
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   HALDAR S, 1994, CANCER RES, V54, P2095
   KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li G, 2017, P NATL ACAD SCI USA, V114, pE376, DOI 10.1073/pnas.1619735114
   Li HD, 2016, NEURON, V92, P949, DOI 10.1016/j.neuron.2016.11.031
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   Lin YC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5767
   Liu J, 2017, INT J MED SCI, V14, P1072, DOI 10.7150/ijms.20417
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Pinheiro TJ, 2016, ARQ NEURO-PSIQUIAT, V74, P937, DOI [10.1590/0004-282x20160138, 10.1590/0004-282X20160138]
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje
   Souza BSF, 2016, SCI REP-UK, V6, DOI 10.1038/srep39775
   Strauss B, 2017, J CELL BIOL
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Torjesen I, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i500
   Vouga M, 2016, LANCET, V387, P843, DOI 10.1016/S0140-6736(16)00383-4
   Wang JZ, 2017, BRAIN DEV-JPN, V39, P294, DOI 10.1016/j.braindev.2016.10.012
   Wang Y, 2017, VIRUS RES, V229, P57, DOI 10.1016/j.virusres.2016.12.003
   Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625
   Zhao XQ, 2015, VIRUSES-BASEL, V7, P2965, DOI 10.3390/v7062755
NR 36
TC 8
Z9 8
U1 0
U2 10
PU IVYSPRING INT PUBL
PI LAKE HAVEN
PA PO BOX 4546, LAKE HAVEN, NSW 2263, AUSTRALIA
SN 1449-2288
J9 INT J BIOL SCI
JI Int. J. Biol. Sci.
PY 2018
VL 14
IS 9
BP 1099
EP 1108
DI 10.7150/ijbs.26400
PG 10
WC Biochemistry & Molecular Biology; Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics
GA GJ0SM
UT WOS:000434964600011
PM 29989100
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Koo, SH
AF Koo, Sumin Helen
TI Understanding consumer preferences on mosquito-bite protective clothing
SO INTERNATIONAL JOURNAL OF CLOTHING SCIENCE AND TECHNOLOGY
LA English
DT Article
DE Clothing; Preference; Consumer; Mosquito
ID ZIKA VIRUS; INSECT REPELLENTS; INFECTION; INDONESIA; SPREADS; AMERICA;
   DESIGN; STATE
AB Purpose - The purpose of this paper is to understand people's preferred design and functional features for mosquito-bite protective clothing.
   Design/methodology/approach - Total 348 participants were asked through an online survey about their perceptions and behaviors related to mosquito bite prevention, preferred design and functional features for clothing, preferred design and functional features for smart clothing, preferred types of transferred data, and their demographic backgrounds. A series of t-tests and analyses of variance were computed using IBM's SPSS 24.0.
   Findings - There were significant differences in functional and design preferences among participants (p < 0.05 similar to 0.001). The results suggest developing mosquito protective clothing as long pants for married people and outerwear for younger groups (10-40s), long-sleeved tops for all, and using thick fabrics for younger people than those over the 50s. Designers can develop smart clothing that can repel mosquitos through scents and cover the body, or as smart watches or wristbands to protect against mosquito bites. The connected software can present data about the mosquito numbers around the user, distances between the user and mosquitos, and product status. Marketers can target parents who showed more willingness to use the mosquito-bite protective clothing than individuals without children.
   Originality/value - The outcomes of the study will help designers when developing mosquito-bite protective clothing and ultimately decrease the rate of diseases transmitted by mosquitos.
C1 [Koo, Sumin Helen] Konkuk Univ, Dept Apparel Design, Seoul, South Korea.
RP Koo, SH (corresponding author), Konkuk Univ, Dept Apparel Design, Seoul, South Korea.
EM smkoo@konkuk.ac.kr
FU Konkuk University
FX This paper was supported by Konkuk University in 2017.
CR Anuar AA, 2016, FASH TEXT, V3, DOI 10.1186/s40691-016-0064-y
   Baxter K, 2015, UNDERSTANDING YOUR USERS: A PRACTICAL GUIDE TO USER RESEARCH METHODS, 2ND EDITION, P1
   Bernier UR, 2015, J CONTROL RELEASE, V220, P1, DOI 10.1016/j.jconrel.2015.09.049
   Bhatt L., 2015, INT J TEXT FASH TECH, V5, P15
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Center for Disease Control and Prevention, 2017, PREV MOSQ BIT
   Center for Disease Control and Prevention, 2017, ZIK VIR DIS CAS REP
   Centers for Disease Control and Prevention, 2017, ZIK TRAV INF
   Cool Wearables, 2014, WEAR TECH PREV MOSQ
   Crawshaw AF, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1737-8
   Debboun M, 2013, MED VET ENTOMOL, V27, P1, DOI 10.1111/j.1365-2915.2012.01020.x
   Du Y., 2005, PRACTICAL ASSESSMENT, V10, P1, DOI DOI 10.4135/9781412995627.D8
   Enayati A.A., 2007, ELECT MOSQUITO REPEL
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Ferraro V., 2011, DESIGNING WEARABLE T
   Fradin MS, 2002, NEW ENGL J MED, V347, P13, DOI 10.1056/NEJMoa011699
   Friedman EE, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003226
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Gupta D, 2011, INDIAN J FIBRE TEXT, V36, P327
   Harris Poll, 2015, WEAR TECH FAM CONS R
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hennessey M, 2016, AM J TRANSPLANT, V16, P1031, DOI 10.1111/ajt.13743
   Hinde N., 2014, THEY CANT BITE CLOTH
   Incognito, AV INS BIT
   Kelser EA, 2016, MICROBES INFECT, V18, P163, DOI 10.1016/j.micinf.2015.12.003
   Koo HS, 2016, INT J CLOTH SCI TECH, V28, P216, DOI 10.1108/IJCST-10-2015-0113
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Liao CS, 2010, INT J CLOTH SCI TECH, V22, P211, DOI 10.1108/09556221011018676
   Lindgren J., 2014, SMARTPHONE APPS CLAI
   Londono-Renteria B, 2015, AM J TROP MED HYG, V93, P869, DOI 10.4269/ajtmh.15-0130
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   May-Plumlee T, 2006, INT J CLOTH SCI TECH, V18, P53, DOI 10.1108/09556220610637512
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Nasci R.S., 2013, CDC HLTH INFORM INT, V56, P94
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Pinto S., 2016, ZIKA VIRUS HLTH MINI
   Pohlit AM, 2011, PLANTA MED, V77, P598, DOI 10.1055/s-0030-1270723
   Reid B., 2010, WHAT WOMEN WANT
   Rogers EM, 2003, DIFFUSION INNOVATION
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Rozendaal J.A., 1997, VECTOR CONTROL METHO
   Salah H., 2014, WEARABLE TECH LEVERA
   Statista, 2016, FACTS STAT WEAR TECH
   Koo HS, 2017, INT J CLOTH SCI TECH, V29, P180, DOI 10.1108/IJCST-03-2016-0021
   Sung D., 2015, 50 WEARABLE TECH GAM
   Tetro JA, 2016, MICROBES INFECT, V18, P167, DOI 10.1016/j.micinf.2015.12.010
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
NR 49
TC 0
Z9 0
U1 3
U2 16
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 0955-6222
EI 1758-5953
J9 INT J CLOTH SCI TECH
JI Int. J. Cloth. Sci. Technol.
PY 2018
VL 30
IS 2
BP 222
EP 234
DI 10.1108/IJCST-06-2017-0081
PG 13
WC Materials Science, Textiles
SC Materials Science
GA GE0TC
UT WOS:000430928100007
DA 2020-07-08
ER

PT J
AU Toledo-Ibarra, GA
   Rodriguez-Sanchez, EJ
   Ventura-Ramon, HG
   Diaz-Resendiz, KJG
   Giron-Perez, MI
AF Toledo-Ibarra, G. A.
   Rodriguez-Sanchez, E. J.
   Ventura-Ramon, H. G.
   Diaz-Resendiz, K. J. G.
   Giron-Perez, M. I.
TI Cholinergic alterations by exposure to pesticides used in control
   vector: Guppies fish (Poecilia reticulta) as biological model
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL HEALTH RESEARCH
LA English
DT Article
DE Vector control; pesticides; cholinergic agents; neurotoxicity
ID BIO-INSECTICIDE SPINOSAD; ACETYLCHOLINESTERASE INHIBITION; TOXICITY;
   ORGANOPHOSPHORUS; TEMEPHOS
AB Spinosad and temephos are two of the most used pesticides in Mexico for the control of vector causing disease such as dengue, chikungunya and Zika. The aim of this study was to compare the neurotoxic effects of these two pesticides using guppy fish (Poecilia reticulata) as a model organism. Guppies were exposed for 7 and 21days to technical grade temephos and spinosad at 1.0 and 0.07g/L, respectively, (10 and 0.5mg/L of active substance; concentrations recommended by the Ministery of Health of the State (Secretaria de Salud de Nayarit (SSN) Mexico)). Subsequently, acetylcholinesterase activity (AChE) and acetylcholine concentrations (ACh) in muscle tissue were determined. Temephos exposure decreased AChE activity and increased ACh concentration, whereas exposure to spinosad only increased ACh concentration. Though cholinergic alterations were more severe in fish exposed to temephos, both pesticides were equally lethal during the first seven days after exposure. Nonetheless, temephos was more lethal after 21days.
C1 [Toledo-Ibarra, G. A.; Rodriguez-Sanchez, E. J.; Ventura-Ramon, H. G.; Diaz-Resendiz, K. J. G.; Giron-Perez, M. I.] Univ Autonoma Nayarit Secretaria Invest Posgrad, Lab Inmunotoxicol, Tepic, Mexico.
   [Toledo-Ibarra, G. A.; Ventura-Ramon, H. G.; Giron-Perez, M. I.] Ctr Nayarita Innovac & Transferencia Tecnol AC, Unidad Especializada, Lab Nacl Invest Inocuidad Alimentaria LANIIA, Unidad Nayarit, Tepic, Mexico.
RP Giron-Perez, MI (corresponding author), Univ Autonoma Nayarit Secretaria Invest Posgrad, Lab Inmunotoxicol, Tepic, Mexico.; Giron-Perez, MI (corresponding author), Ctr Nayarita Innovac & Transferencia Tecnol AC, Unidad Especializada, Lab Nacl Invest Inocuidad Alimentaria LANIIA, Unidad Nayarit, Tepic, Mexico.
EM ivangiron@uan.edu.mx
OI GIRON, MANUEL IVAN/0000-0001-6808-6590; Ventura,
   Herminia/0000-0003-3573-965X; Diaz Resendiz, Karina Janice
   Guadalupe/0000-0002-9602-9881
FU Laboratorio Nacional para la Investigacion en Inocuidad Alimentaria
   (LANIIA)-Unidad Nayarit, part of the Proyect of Laboratorios Nacionales
   CONACyT [279975]
FX This work was performed in the Laboratorio Nacional para la
   Investigacion en Inocuidad Alimentaria (LANIIA)-Unidad Nayarit, part of
   the Proyect of Laboratorios Nacionales CONACyT 2017 [project number
   279975].
CR Aboul-Enein AM, 2012, AFR J PHARM PHARMACO, V6, P550, DOI 10.5897/AJPP11.855
   Abreu-Villaca Y, 2011, BEHAV BRAIN RES, V221, P367, DOI 10.1016/j.bbr.2009.12.049
   Ba-Omar TA, 2011, TISSUE CELL, V43, P29, DOI 10.1016/j.tice.2010.11.002
   Benitez-Trinidad AB, 2015, TOXICOL IN VITRO, V29, P779, DOI 10.1016/j.tiv.2015.02.008
   [CENAPRECE] Centro Nacional de Programas Preventivos y Control de Enfermedades, 2016, LIST ACT PROD REC CE
   Cleveland CB, 2007, S SERIES ACS, P109
   Deiana S, 2011, BEHAV BRAIN RES, V221, P389, DOI 10.1016/j.bbr.2010.11.036
   Eisen L, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001016
   El-Aw M.A.M, 2008, J APPL SCI RES, V4, P216
   ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9
   Ffrench-Constant RH, 2016, J NEUROGENET, V30, P163, DOI 10.1080/01677063.2016.1229781
   FUKUTO TR, 1990, ENVIRON HEALTH PERSP, V87, P245, DOI 10.2307/3431032
   Fulton MH, 2001, ENVIRON TOXICOL CHEM, V20, P37, DOI [10.1002/etc.5620200104, 10.1897/1551-5028(2001)020&lt;0037:AIIEFA&gt;2.0.CO;2]
   George L, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004006
   GRAS G, 1982, Toxicological European Research, V4, P301
   Infante-Rodriguez DA, 2011, J MED ENTOMOL, V48, P570, DOI 10.1603/ME10099
   Kirst HA, 2010, J ANTIBIOT, V63, P101, DOI 10.1038/ja.2010.5
   Leahy J, 2014, ACS SYM SER, V1172, P3
   Lewis KA, 2016, HUM ECOL RISK ASSESS, V22, P1050, DOI 10.1080/10807039.2015.1133242
   Mayes MA, 2003, REV ENVIRON CONTAM T, V179, P37, DOI 10.1007/0-387-21731-2_2
   Millar Neil S., 2007, Invertebrate Neuroscience, V7, P53, DOI 10.1007/s10158-006-0040-0
   Nava-Perez E, 2012, REV RA XIMHAI, V8, P17
   Nizri E, 2013, AMINO ACIDS, V45, P73, DOI 10.1007/s00726-011-1192-8
   Pereira BB, 2015, J TOXICOL ENV HEAL A, V78, P1033, DOI 10.1080/15287394.2015.1050566
   Piner P, 2013, ENVIRON TOXICOL PHAR, V36, P956, DOI 10.1016/j.etap.2013.08.009
   Piner P, 2012, ENVIRON TOXICOL PHAR, V34, P473, DOI 10.1016/j.etap.2012.06.012
   Racke K. D., 2007, ACS SYM SER, V947, P92
   [RAP AL] Red de accion en plaguicidas y alternativas de America Latina, 2009, ENLACE, V84-85, P24
   Ricardo Leyva Yanelys, 2010, Rev Cubana Med Trop, V62, P224
   [SS] Secretaria de Salud, 2015, PROGR ACC ENF TRANSM
   [SS] Secretaria de Salud, 2016, B EP SIST NAC VIG EP
   Townson H, 2005, B WORLD HEALTH ORGAN, V83, P942
   [US EPA] United States Environmental Protection Agency, 1997, PEST FACT SHEET NAM
   Velasquez ML, 2014, REV REBIOL, V33, P50
   Watson GB, 2001, PESTIC BIOCHEM PHYS, V71, P20, DOI 10.1006/pest.2001.2559
   Wessler IK, 2001, PULM PHARMACOL THER, V14, P423, DOI 10.1006/pupt.2001.0313
   WHO, 1992, WHO TECH REP SER, P818
   World Health Organization, 2016, VECT BORN DIS
NR 38
TC 1
Z9 1
U1 0
U2 3
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0960-3123
EI 1369-1619
J9 INT J ENVIRON HEAL R
JI Int. J. Environ. Health Res.
PY 2018
VL 28
IS 1
BP 79
EP 89
DI 10.1080/09603123.2018.1429577
PG 11
WC Environmental Sciences; Public, Environmental & Occupational Health
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA FX5QX
UT WOS:000426135800008
PM 29380629
DA 2020-07-08
ER

PT J
AU Viranaicken, W
   Ndebo, A
   Bos, S
   Souque, P
   Gadea, G
   El-Kalamouni, C
   Krejbich-Trotot, P
   Charneau, P
   Despres, P
   Roche, M
AF Viranaicken, Wildriss
   Ndebo, Alexia
   Bos, Sandra
   Souque, Philippe
   Gadea, Gilles
   El-Kalamouni, Chaker
   Krejbich-Trotot, Pascale
   Charneau, Pierre
   Despres, Philippe
   Roche, Marjolaine
TI Recombinant Zika NS1 Protein Secreted from Vero Cells Is Efficient for
   Inducing Production of Immune Serum Directed against NS1 Dimer
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE emerging disease; arbovirus; Zika virus; NS1 protein; lentiviral vector;
   recombinant antigen; humoral immunity; NS1 antiserum
ID MEMBRANE ASSOCIATION; VIRUS OUTBREAK; SOUTH-PACIFIC; ANTIBODY;
   EXPRESSION; BIOLOGY; SURFACE
AB Zika virus (ZIKV) is a mosquito-borne flavivirus that recently emerged in the South Pacific, Americas, and Caribbean islands, where the larger epidemics were documented. ZIKV infection in humans is responsible for neurological disorders and microcephaly. Flavivirus NS1 is a non-structural glycoprotein that is expressed on the cell surface and secreted as a hexameric lipoprotein particle. Intracellular NS1 exists as a dimer that is required for viral replication, whereas the secreted NS1 hexamer interacts with host factors, leading to pathophysiological conditions. In an effort to dispose of specific anti-ZIKV NS1 immune serum, Vero cells were transduced with a lentiviral vector containing the NS1 gene from an epidemic strain of ZIKV. We showed that stably transduced Vero/ZIKV NS1 cell clone was efficient in the secretion of recombinant NS1 oligomer. Immunization of adult rat with purified extracellular NS1 developed anti-ZIKV antibodies that specifically react with the NS1 dimer produced in human cells infected with African and Asian strains of ZIKV. The rat antibody against ZIKV NS1 dimer is a reliable biological tool that enables the immunological detection of secreted NS1 from host-cells infected with ZIKV.
C1 [Viranaicken, Wildriss; Ndebo, Alexia; Bos, Sandra; Gadea, Gilles; El-Kalamouni, Chaker; Krejbich-Trotot, Pascale; Despres, Philippe; Roche, Marjolaine] Univ La Reunion, PIMIT, INSERM UMR 1187, CNRS 9192,IRD 249,Platform CYROI, 2 Rue Maxime Riviere, F-97491 St Clotilde, La Reunion, France.
   [Ndebo, Alexia] Univ Geneva, Sect Sci Pharmaceut, Rue Michel Servet 1, CH-1211 Geneva, Switzerland.
   [Souque, Philippe; Charneau, Pierre] Inst Pasteur, Virol Mol & Vaccinol, 28 Rue Dr Roux, F-75724 Paris 15, France.
RP Despres, P; Roche, M (corresponding author), Univ La Reunion, PIMIT, INSERM UMR 1187, CNRS 9192,IRD 249,Platform CYROI, 2 Rue Maxime Riviere, F-97491 St Clotilde, La Reunion, France.
EM wildriss.viranaicken@univ-reunion.fr; Alexia.Ndebo@etu.unige.ch;
   sandrabos.lab@gmail.com; philippe.souque@pasteur.fr;
   gilles.gadea@inserm.fr; Chaker.El-Kalamouni@univ-reunion.fr;
   pascale.krejbich@univ-reunion.fr; pierre.charneau@pasteur.fr;
   philippe.despres@univ-reunion.fr; marjolaine.roche@univ-reunion.fr
RI Gilles, Gadea/M-9966-2015
OI Gilles, Gadea/0000-0001-6325-4866; El Kalamouni,
   Chaker/0000-0003-4673-6614; BOS, Sandra/0000-0001-5036-0336; Krejbich
   Trotot, Pascale/0000-0001-7329-1716
FU La Reunion Island University; INSERM-transfert from CVT Aviesan/DVS
   Innovation [15167A10]; ZIKAlliance project (European Union)European
   Union (EU) [734548]; ZIKAlert project (European POE FEDER)
   [SYNERGY:RE0001902]; Swiss-European Erasmus Mobility Movetia programme
   of Geneva University (Switzerland)
FX We gratefully knowledge Patrick Mavingui and all the members of PIMIT
   for helpful discussions. We thank Celine Frechina for assistance in
   concentration of proteins in cell culture supernatant and Eva Ogire for
   technical assistance. The study received fundings from the La Reunion
   Island University, INSERM-transfert (ZIKAVax project no 15167A10) from
   CVT Aviesan/DVS Innovation, the ZIKAlliance project (European
   Union-Horizon 2020 program under grant agreement no 734548) and the
   ZIKAlert project (European POE FEDER 2014-2020, Ile de La Reunion,
   action 1.05 under grant agreement no SYNERGY:RE0001902). The work of
   A.N. was supported by the Swiss-European Erasmus Mobility Movetia
   programme of Geneva University (Switzerland).
CR Alcon S, 2002, J CLIN MICROBIOL, V40, P376, DOI 10.1128/JCM.40.02.376-381.2002
   Beatty PR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3787
   Brault AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15039-8
   Brown WC, 2016, NAT STRUCT MOL BIOL, V23, P865, DOI 10.1038/nsmb.3268
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Chung KM, 2007, J VIROL, V81, P9551, DOI 10.1128/JVI.00879-07
   Coutant F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003973
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   de Wispelaere M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004081
   DESPRES P, 1991, J GEN VIROL, V72, P2811, DOI 10.1099/0022-1317-72-11-2811
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Edeling MA, 2014, P NATL ACAD SCI USA, V111, P4285, DOI 10.1073/pnas.1322036111
   Faizan MI, 2016, INTERVIROLOGY, V59, P152, DOI 10.1159/000452950
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fields B. N., 2013, FIELDS VIROLOGY, V2
   Frumence E, 2016, VIROLOGY, V493, P217, DOI 10.1016/j.virol.2016.03.006
   Gadea G, 2016, VIROLOGY, V497, P157, DOI 10.1016/j.virol.2016.07.015
   Gutsche I, 2011, P NATL ACAD SCI USA, V108, P8003, DOI 10.1073/pnas.1017338108
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   Huang JL, 2001, J MED VIROL, V65, P553, DOI 10.1002/jmv.2072
   Iglesias MC, 2006, J GENE MED, V8, P265, DOI 10.1002/jgm.837
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Noisakran S, 2007, J VIROL METHODS, V142, P67, DOI 10.1016/j.jviromet.2007.01.008
   Rastogi M, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0590-7
   SCHLESINGER JJ, 1993, VIROLOGY, V192, P132, DOI 10.1006/viro.1993.1015
   Sironi M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004978
   Viranaicken W, 2017, BIOCHIMIE, V142, P179, DOI 10.1016/j.biochi.2017.09.011
   Wan SW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092495
   Watterson D, 2016, ANTIVIR RES, V130, P7, DOI 10.1016/j.antiviral.2016.02.014
   Xu XY, 2016, EMBO J, V35, P2170, DOI 10.15252/embj.201695290
   Yun SI, 2017, J MICROBIOL, V55, P204, DOI 10.1007/s12275-017-7063-6
NR 36
TC 3
Z9 3
U1 0
U2 7
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD JAN
PY 2018
VL 19
IS 1
AR 38
DI 10.3390/ijms19010038
PG 13
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA FV2OI
UT WOS:000424407200036
PM 29295477
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Mittal, R
   Fifer, RC
   Liu, XZ
AF Mittal, Rahul
   Fifer, Robert C.
   Liu, Xue Zhong
TI A Possible Association Between Hearing Loss and Zika Virus Infections
SO JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY
LA English
DT Editorial Material
ID CYTOMEGALOVIRUS
C1 [Mittal, Rahul; Liu, Xue Zhong] Univ Miami, Miller Sch Med, Dept Otolaryngol, 1601 NW 12th Ave, Miami, FL 33136 USA.
   [Fifer, Robert C.; Liu, Xue Zhong] Univ Miami, Miller Sch Med, Dept Pediat, Miami, FL 33136 USA.
RP Liu, XZ (corresponding author), Univ Miami, Miller Sch Med, Dept Otolaryngol, 1601 NW 12th Ave, Miami, FL 33136 USA.
EM xliu@med.miami.edu
FU Florida Department of Health
FX This work was funded by the Florida Department of Health.
CR Albuquerque MDPM, 2016, EMERG INFECT DIS, V22, P1090, DOI [10.32032/eid2206.160062, 10.3201/eid2206.160062]
   Cohen BE, 2014, TRENDS HEAR, V18, DOI 10.1177/2331216514541361
   Duval M, 2014, CURR OPIN OTOLARYNGO, V22, P495, DOI 10.1097/MOO.0000000000000104
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Leal Mariana de Carvalho, 2016, Braz J Otorhinolaryngol, DOI 10.1016/j.bjorl.2016.06.001
   Rosenthal LS, 2009, PEDIATR INFECT DIS J, V28, P515, DOI 10.1097/INF.0b013e318198c724
   Vinhaes ES, 2017, CLIN INFECT DIS, V64, P675, DOI 10.1093/cid/ciw770
NR 7
TC 7
Z9 7
U1 0
U2 4
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6181
EI 2168-619X
J9 JAMA OTOLARYNGOL
JI JAMA Otolaryngol-Head Neck Surg.
PD JAN
PY 2018
VL 144
IS 1
BP 3
EP 4
DI 10.1001/jamaoto.2017.1798
PG 2
WC Otorhinolaryngology; Surgery
SC Otorhinolaryngology; Surgery
GA FT6DM
UT WOS:000423243300001
PM 28983567
DA 2020-07-08
ER

PT J
AU Ramharack, P
   Soliman, MES
AF Ramharack, Pritika
   Soliman, Mahmoud E. S.
TI Zika virus NS5 protein potential inhibitors: an enhanced in silico
   approach in drug discovery
SO JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
LA English
DT Article
DE Zika virus per-residue decomposition based pharmacophore; virtual
   screening; NS5 protein potential inhibitors; binding free energy;
   molecular dynamic simulations
ID MACROMOLECULAR PRODRUGS; UCSF CHIMERA; IDENTIFICATION; EFFICIENT;
   DOCKING; DESIGN; AGENTS; PERSPECTIVES; OUTBREAK; DATABASE
AB The re-emerging Zika virus (ZIKV) is an arthropod-borne virus that has been described to have explosive potential as a worldwide pandemic. The initial transmission of the virus was through a mosquito vector, however, evolving modes of transmission has allowed the spread of the disease over continents. The virus has already been linked to irreversible chronic central nervous system conditions. The concerns of the scientific and clinical community are the consequences of Zika viral mutations, thus suggesting the urgent need for viral inhibitors. There have been large strides in vaccine development against the virus but there are still no FDA approved drugs available. Rapid rational drug design and discovery research is fundamental in the production of potent inhibitors against the virus that will not just mask the virus, but destroy it completely. In silico drug design allows for this prompt screening of potential leads, thus decreasing the consumption of precious time and resources. This study demonstrates an optimized and proven screening technique in the discovery of two potential small molecule inhibitors of ZIKV Methyltransferase and RNA dependent RNA polymerase. This in silico per-residue energy decomposition pharmacophore' virtual screening approach will be critical in aiding scientists in the discovery of not only effective inhibitors of Zika viral targets, but also a wide range of anti-viral agents.
C1 [Ramharack, Pritika; Soliman, Mahmoud E. S.] Univ KwaZulu Natal, Sch Hlth Sci, Mol Modeling & Drug Design Res Grp, Westville Campus, ZA-4001 Durban, South Africa.
   [Soliman, Mahmoud E. S.] Univ KwaZulu Natal, Pharmaceut Sci, Westville Campus, ZA-4001 Durban, South Africa.
   [Soliman, Mahmoud E. S.] Zagazig Univ, Dept Organ Pharmaceut Chem, Fac Pharm, Zagazig, Egypt.
   [Soliman, Mahmoud E. S.] FAMU, Coll Pharm & Pharmaceut Sci, Tallahassee, FL 32307 USA.
RP Soliman, MES (corresponding author), Univ KwaZulu Natal, Sch Hlth Sci, Mol Modeling & Drug Design Res Grp, Westville Campus, ZA-4001 Durban, South Africa.; Soliman, MES (corresponding author), Univ KwaZulu Natal, Pharmaceut Sci, Westville Campus, ZA-4001 Durban, South Africa.; Soliman, MES (corresponding author), Zagazig Univ, Dept Organ Pharmaceut Chem, Fac Pharm, Zagazig, Egypt.; Soliman, MES (corresponding author), FAMU, Coll Pharm & Pharmaceut Sci, Tallahassee, FL 32307 USA.
EM soliman@ukzn.ac.za
RI Soliman, Mahmoud E S/M-8724-2013
OI Soliman, Mahmoud E S/0000-0002-8711-7783; Ramharack,
   Pritika/0000-0001-5850-6782
FU National Research Foundation [102103]
FX This work was supported by the National Research Foundation [grant
   number 102103]; the College of Health Sciences, UKZN and Center for High
   Performance Computing (http://www.chpc.ac.za) for their computational
   resources.
CR Anusuya S, 2016, J BIOMOL STRUCT DYN, V34, P1512, DOI 10.1080/07391102.2015.1081620
   Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451
   Brecher M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130062
   Brito C., 2016, LANCET NEUROL, V28, P679, DOI [10.1016/S1474-4422(16)00074-0, DOI 10.1016/S1474-4422(16)00074-0]
   Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381
   Bultet LA, 2016, NUCLEIC ACIDS RES, V44, pD27, DOI 10.1093/nar/gkv1310
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cele FN, 2016, DRUG DES DEV THER, V10, P1365, DOI 10.2147/DDDT.S95533
   Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073
   Chibueze E. C., 2017, B WORLD HEALTH ORGAN, V6, P1, DOI [10.2471/BLT.16.178426, DOI 10.2471/BLT.16.178426]
   Daina A, 2016, CHEMMEDCHEM, V11, P1117, DOI 10.1002/cmdc.201600182
   Daina A, 2014, J CHEM INF MODEL, V54, P3284, DOI 10.1021/ci500467k
   Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757
   Ekins S., 2016, F1000RESEARCH, V5, P1
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Forli S, 2016, NAT PROTOC, V11, P905, DOI 10.1038/nprot.2016.051
   Genheden S, 2015, EXPERT OPIN DRUG DIS, V10, P449, DOI 10.1517/17460441.2015.1032936
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hernandez M, 2009, NUCLEIC ACIDS RES, V37, pW413, DOI 10.1093/nar/gkp281
   Hinton TM, 2016, ADV HEALTHC MATER, V5, P534, DOI 10.1002/adhm.201500841
   Idrus S, 2012, BIOINFORMATION, V8, P348, DOI 10.6026/97320630008348
   Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+
   Koes DR, 2012, NUCLEIC ACIDS RES, V40, pW409, DOI 10.1093/nar/gks378
   Kroemer RT, 2007, CURR PROTEIN PEPT SC, V8, P312
   Kryger MBL, 2013, CHEM COMMUN, V49, P2643, DOI 10.1039/c3cc00315a
   Kumalo HM, 2016, CELL MOL BIOENG, V9, P175, DOI 10.1007/s12195-015-0421-8
   Kusumaningrum S., 2014, J APP SCI, V4, P47, DOI [10.7324/JAPS.2014.4119, DOI 10.7324/JAPS.2014.4119]
   Leyssen P, 2000, CLIN MICROBIOL REV, V13, P67, DOI 10.1128/CMR.13.1.67-82.2000
   Lim SP, 2013, VIRUSES-BASEL, V5, P2977, DOI 10.3390/v5122977
   Lipinski CA, 2012, ADV DRUG DELIVER REV, V64, P4, DOI 10.1016/j.addr.2012.09.019
   Lissauer D, 2016, BJOG-INT J OBSTET GY, V123, P1258, DOI 10.1111/1471-0528.14071
   Madden TL, 1996, METHOD ENZYMOL, V266, P131
   Mahfuz M., 2014, INDIAN J PHARM BIOL, V2, P44
   Millichap J Gordon, 2016, Pediatr Neurol Briefs, V30, P8, DOI 10.15844/pedneurbriefs-30-1-7
   Miner JJ, 2016, CELL STEM CELL, V18, P559, DOI 10.1016/j.stem.2016.04.009
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256
   Mumtaz N, 2016, CURR TREAT OPTIONS I, V8, P208, DOI [10.1007/s40506-016-0083-7, DOI 10.1007/S40506-016-0083-7]
   Munir S, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-296
   Nair Pramod C., 2014, In Silico Pharmacology, V2, P4, DOI 10.1186/s40203-014-0004-8
   Ostrovskii VA, 2012, RUSS CHEM B+, V61, P768, DOI 10.1007/s11172-012-0108-4
   Panchaud A, 2016, CLIN MICROBIOL REV, V29, P659, DOI 10.1128/CMR.00014-16
   Papageorgiou L, 2014, INT J SYSTEMS BIOL B, V2, P1, DOI [10.4018/ijsbbt.2013100101, DOI 10.4018/IJSBBT.2013100101]
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Ramharack P, 2016, RSC ADV, V6, P68719, DOI 10.1039/c6ra12142j
   Roa M, 2016, LANCET, V387, P843, DOI 10.1016/S0140-6736(16)00331-7
   Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.3.CO;2-8
   Shapshak P, 2016, GLOBAL VIROLOGY 1, P477, DOI [10.1007/978-1-4939-2410-3, DOI 10.1007/978-1-4939-2410-3]
   Shawan M. M. A. K., 2015, NAT SCI, V13, P37, DOI DOI 10.1017/CBO9781107415324.004
   Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75
   Singh RK, 2016, VET QUART, V36, P150, DOI 10.1080/01652176.2016.1188333
   Soliman MES, 2013, DRUG DEVELOP RES, V74, P283, DOI 10.1002/ddr.21078
   Sweeney NL, 2015, ACS INFECT DIS, V1, P140, DOI 10.1021/id5000458
   Tambunan USF, 2014, BIOINFORMATION, V10, P23, DOI 10.6026/97320630010023
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Troncoso A, 2016, ASIAN PAC J TROP BIO, V6, P520, DOI 10.1016/j.apjtb.2016.04.004
   Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334
   Turmel J. M., 2016, LANCET, V6736, P30775, DOI DOI 10.1016/S0140-6736(16)30775-9
   Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005
   Eswar Narayanan, 2006, Curr Protoc Bioinformatics, VChapter 5, pUnit, DOI [10.1002/cpps.20, 10.1002/0471140864.ps0209s50, 10.1002/cpbi.3, 10.1002/0471250953.bi0506s15]
   WHO, 2016, ZIK VIR MICR GUILL B, P1
   Yang Z, 2012, J STRUCT BIOL, V179, P269, DOI 10.1016/j.jsb.2011.09.006
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
   Zou XW, 2014, ACTA CRYSTALLOGR D, V70, P1549, DOI 10.1107/S1399004714005239
NR 65
TC 35
Z9 35
U1 1
U2 19
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0739-1102
EI 1538-0254
J9 J BIOMOL STRUCT DYN
JI J. Biomol. Struct. Dyn.
PY 2018
VL 36
IS 5
BP 1118
EP 1133
DI 10.1080/07391102.2017.1313175
PG 16
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA FZ8PQ
UT WOS:000427872600003
PM 28351337
DA 2020-07-08
ER

PT J
AU Murugan, K
   Jaganathan, A
   Rajaganesh, R
   Suresh, U
   Madhavan, J
   Senthil-Nathan, S
   Rajasekar, A
   Higuchi, A
   Kumar, SS
   Alarfaj, AA
   Nicoletti, M
   Petrelli, R
   Cappellacci, L
   Maggi, F
   Benelli, G
AF Murugan, Kadarkarai
   Jaganathan, Anitha
   Rajaganesh, Rajapandian
   Suresh, Udaiyan
   Madhavan, Jagan
   Senthil-Nathan, Sengottayan
   Rajasekar, Aruliah
   Higuchi, Akon
   Kumar, Suresh S.
   Alarfaj, Abdullah A.
   Nicoletti, Marcello
   Petrelli, Riccardo
   Cappellacci, Loredana
   Maggi, Filippo
   Benelli, Giovanni
TI Poly(Styrene Sulfonate)/Poly(Allylamine Hydrochloride) Encapsulation of
   TiO2 Nanoparticles Boosts Their Toxic and Repellent Activity Against
   Zika Virus Mosquito Vectors
SO JOURNAL OF CLUSTER SCIENCE
LA English
DT Article
DE Aedes aegypti; Argemone mexicana; Dengue fever; Encapsulation; Repellent
   activity
ID SYNTHESIZED SILVER NANOPARTICLES; TITANIUM-DIOXIDE NANOPARTICLES;
   CULEX-QUINQUEFASCIATUS SAY; AEGYPTI DIPTERA-CULICIDAE; AEDES-AEGYPTI;
   LEAF EXTRACT; ANOPHELES-STEPHENSI; INSECTICIDE RESISTANCE; VETERINARY
   IMPORTANCE; PREDATION EFFICIENCY
AB Green fabricated nanoparticles often need to be encapsulated and stabilized, to ensure uniform dispersion in the aquatic environment and relevant larvicidal activity over time. However, recent research showed that nanoencapsulation processes led to a reduction of nanoparticle larvicidal efficacy. We used an extract of Argemone mexicana to reduce TiO2 nanoparticles, which were then capped with PSS/PAH (poly(styrene sulfonate)/poly(allylamine hydrochloride)). The toxic and repellent potential of the nanoparticles were compared to elucidate their potential effects against the Zika virus vector Aedes aegypti. Nanoparticles were characterized by biophysical methods including UV-Vis, EDX and FTIR spectroscopy, SEM, TEM, XRD and DLS analyses. In larvicidal and pupicidal experiments, TiO2 nanoparticles achieved LC90 values from 41.648 (larva I), to 71.74 ppm (pupa). Nanoencapsulated TiO2 achieved LC90 values from 39.16 (I), to 69.12 ppm (pupa). In adulticidal experiments, LC90 of TiO2 nanoparticles on Ae. aegypti was 10.31 ppm, while LC90 of nanoencapsulated TiO2 was 9.54 ppm. At 10 ppm, the repellency towards Ae. aegypti was 80.43% for TiO2 nanoparticles, and 88.04% for nanoencapsulated TiO2. This research firstly highlighted the promising potential of PSS/PAH encapsulation, leading to the production of highly effective titania nanostructures, if compared to titania nanoparticles synthesized with eco-friendly routes without further stabilization.
C1 [Murugan, Kadarkarai; Jaganathan, Anitha; Rajaganesh, Rajapandian; Suresh, Udaiyan] Bharathiar Univ, Sch Life Sci, Div Entomol, Dept Zool, Coimbatore 641046, Tamil Nadu, India.
   [Murugan, Kadarkarai; Madhavan, Jagan] Thiruvalluvar Univ, Serkkadu, Vellore 632115, Tamil Nadu, India.
   [Senthil-Nathan, Sengottayan] Manonmaniam Sundaranar Univ, Div Biopesticides & Environm Toxicol, Sri Paramakalyani Ctr Excellence Environm Sci, Alwarkurichi 627412, Tamil Nadu, India.
   [Rajasekar, Aruliah] Thiruvalluvar Univ, Dept Biotechnol, Vellore 632115, Tamil Nadu, India.
   [Higuchi, Akon] Natl Cent Univ, Dept Chem & Mat Engn, 300 Jhongli, Taoyuan 32001, Taiwan.
   [Kumar, Suresh S.] Univ Putra Malaysia, Dept Med Microbiol & Parasitol, Serdang 43400, Selangor, Malaysia.
   [Alarfaj, Abdullah A.] King Saud Univ, Dept Bot & Microbiol, Coll Sci, Riyadh 11451, Saudi Arabia.
   [Nicoletti, Marcello] Sapienza Univ Rome, Dept Environm Biol, Piazzale Aldo Moro 5, I-00185 Rome, Italy.
   [Petrelli, Riccardo; Cappellacci, Loredana; Maggi, Filippo] Univ Camerino, Sch Pharm, Camerino, Italy.
   [Benelli, Giovanni] Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
   [Benelli, Giovanni] St Anna Sch Adv Studies, BioRobot Inst, Viale Rinaldo Piaggio 34, I-56025 Pontedera, Italy.
RP Murugan, K (corresponding author), Bharathiar Univ, Sch Life Sci, Div Entomol, Dept Zool, Coimbatore 641046, Tamil Nadu, India.; Murugan, K (corresponding author), Thiruvalluvar Univ, Serkkadu, Vellore 632115, Tamil Nadu, India.; Benelli, G (corresponding author), Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.; Benelli, G (corresponding author), St Anna Sch Adv Studies, BioRobot Inst, Viale Rinaldo Piaggio 34, I-56025 Pontedera, Italy.
EM kmvvkg@gmail.com; benelli.giovanni@gmail.com
RI Higuchi, Akon/AAA-9711-2019; Benelli, Giovanni/A-9100-2013; Aruliah,
   Rajasekar/E-4568-2015; Alarfaj, Abdullah/AAA-2018-2019; Murugan,
   Kadarkarai/AAP-3937-2020; Kumar S, Suresh/J-2423-2017
OI Benelli, Giovanni/0000-0001-8971-6010; Aruliah,
   Rajasekar/0000-0001-5324-3290; Kumar S, Suresh/0000-0002-0505-7554
FU International Scientific Partnership Program ISPP at King Saud
   University through ISPP [0062]; University Grant Commission (New Delhi,
   India)University Grants Commission, India [PDFSS-2014-15-SC-TAM-10125]
FX The authors extend their appreciation to the International Scientific
   Partnership Program ISPP at King Saud University for funding this
   research work through ISPP# 0062. Dr. Anitha Jaganathan is grateful to
   the University Grant Commission (New Delhi, India), Project No.
   PDFSS-2014-15-SC-TAM-10125.
CR Abbas Z, 2011, COLLOID SURFACE A, V384, P254, DOI 10.1016/j.colsurfa.2011.03.064
   Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a
   Amerasan D, 2012, PARASITOL RES, V111, P1953, DOI 10.1007/s00436-012-3042-3
   Apu AS, 2012, LEAVES PHARMACOLONLI, V3, P16
   Arokiyaraj S, 2015, ENVIRON SCI POLLUT R, V22, P9759, DOI 10.1007/s11356-015-4148-9
   Azarudeen RMST, 2017, J CLUST SCI, V28, P369, DOI 10.1007/s10876-016-1103-y
   Azarudeen RMST, 2017, J CLUST SCI, V28, P179, DOI 10.1007/s10876-016-1067-y
   Azarudeen RMST, 2016, RSC ADV, V6, P96573, DOI 10.1039/c6ra23208f
   Banumathi B, 2017, VET PARASITOL, V244, P102, DOI 10.1016/j.vetpar.2017.07.021
   Benelli G, 2018, ENVIRON SCI POLLUT R, V25, P10184, DOI 10.1007/s11356-017-9752-4
   Benelli G, 2017, ENTOMOL GEN, V36, P309, DOI 10.1127/entomologia/2017/0496
   Benelli G, 2017, TICKS TICK-BORNE DIS, V8, P821, DOI 10.1016/j.ttbdis.2017.08.004
   Benelli G, 2017, ACTA TROP, V174, P91, DOI 10.1016/j.actatropica.2017.06.028
   Benelli G, 2017, J CLUST SCI, V28, P3, DOI 10.1007/s10876-016-1131-7
   Benelli G, 2017, J CLUST SCI, V28, P1, DOI 10.1007/s10876-017-1165-5
   Benelli G, 2017, J CLUST SCI, V28, P11, DOI 10.1007/s10876-016-1143-3
   Benelli G, 2017, NAT PROD RES, V31, P369, DOI 10.1080/14786419.2016.1214834
   Benelli G, 2016, ENZYME MICROB TECH, V95, P58, DOI 10.1016/j.enzmictec.2016.08.022
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P3201, DOI 10.1007/s00436-015-4656-z
   Benelli G, 2015, PARASITOL RES, V114, P2801, DOI 10.1007/s00436-015-4586-9
   Bhattacharjee I, 2010, ASIAN PAC J TROP MED, V3, P547, DOI 10.1016/S1995-7645(10)60132-0
   CHEUNG PYK, 1985, APPL ENVIRON MICROB, V50, P984, DOI 10.1128/AEM.50.4.984-988.1985
   Ding WK, 2009, J FOOD SCI, V74, pM100, DOI 10.1111/j.1750-3841.2009.01067.x
   Dua VK, 2010, INDIAN J MED RES, V131, P434
   Edwin ES, 2016, ACTA TROP, V163, P167, DOI 10.1016/j.actatropica.2016.07.009
   Egerton TA, 2014, INT J COSMETIC SCI, V36, P195, DOI 10.1111/ics.12113
   Fatisson J, 2009, LANGMUIR, V25, P6062, DOI 10.1021/la804091h
   Finney DJ, 1971, PROBIT ANAL, P68, DOI DOI 10.1007/BF02431962
   GOODSELL DS, 2004, BIONANOTECHNOLOGY LE
   Govindarajan M, 2011, ASIAN PAC J TROP MED, V4, P941, DOI 10.1016/S1995-7645(11)60223-X
   Govindarajan M, 2010, ASIAN PAC J TROP MED, V3, P691, DOI 10.1016/S1995-7645(10)60167-8
   Guerra CA, 2006, ANN TROP MED PARASIT, V100, P189, DOI 10.1179/136485906X91512
   Hadapad AB, 2011, J PEST SCI, V84, P249, DOI 10.1007/s10340-010-0347-9
   Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371
   Hsieh WC, 2006, COLLOID SURFACE B, V53, P209, DOI 10.1016/j.colsurfb.2006.09.008
   Ji G, 2016, RES CHEM INTERMEDIAT, V42, P439, DOI 10.1007/s11164-015-2029-y
   KOVENDAN K., 2012, PARASITOL RES, V112, P1205
   Madhiyazhagan P, 2015, PARASITOL RES, V114, P4305, DOI 10.1007/s00436-015-4671-0
   Miao W, 2015, AQUAT TOXICOL, V161, P117, DOI 10.1016/j.aquatox.2015.02.002
   Mourtzinos I, 2007, J AGR FOOD CHEM, V55, P8088, DOI 10.1021/jf0709698
   Muller WEG, 2008, BIOMATERIALS, V29, P771, DOI 10.1016/j.biomaterials.2007.10.038
   Murugan K, 2017, J CLUST SCI, V28, P529, DOI 10.1007/s10876-016-1129-1
   Murugan K, 2016, PARASITOL RES, V115, P1085, DOI 10.1007/s00436-015-4838-8
   Murugan K, 2015, PARASITOL RES, V114, P2243, DOI 10.1007/s00436-015-4417-z
   Murugan K, 2015, EXP PARASITOL, V153, P129, DOI 10.1016/j.exppara.2015.03.017
   Naqqash MN, 2016, PARASITOL RES, V115, P1363, DOI 10.1007/s00436-015-4898-9
   Patel J. D., 2015, J ADV CHEM SCI, V1, P82
   Patri A, 2009, J APPL TOXICOL, V29, P662, DOI 10.1002/jat.1454
   Pavela R, 2016, EXP PARASITOL, V167, P103, DOI 10.1016/j.exppara.2016.05.010
   Pavela R, 2015, PARASITOL RES, V114, P3835, DOI 10.1007/s00436-015-4614-9
   Pavela R, 2015, IND CROP PROD, V76, P174, DOI 10.1016/j.indcrop.2015.06.050
   Pradeepa V, 2016, PESTIC BIOCHEM PHYS, V134, P84, DOI 10.1016/j.pestbp.2016.04.001
   Priya SP, 2017, ACTA TROP, V171, P213, DOI 10.1016/j.actatropica.2017.04.010
   Rajan R, 2015, IND CROP PROD, V70, P356, DOI 10.1016/j.indcrop.2015.03.015
   Reegan A., 2014, OSONG PUBLIC HLTH RE, V6, P64
   Reegan AD, 2014, J ASIA-PAC ENTOMOL, V17, P327, DOI 10.1016/j.aspen.2014.02.008
   Rubio-Pina J, 2013, CURR TOP MED CHEM, V13, P2200
   Salunkhe RB, 2011, PARASITOL RES, V109, P823, DOI 10.1007/s00436-011-2328-1
   SCRINIS G, 2007, INT J SOCIOL FOOD AG, V15, P1
   Senthil-Nathan S., 2015, ENV SUSTAINABILITY, P49, DOI 10.1007/978-81-322-2056-5_3.
   Senthil-Nathan S, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00359
   Sharon M., 2010, J PHYTOL, V2, P83
   Sivapriyajothi S., 2014, Journal of Entomological and Acarological Research, V46, P77, DOI 10.4081/jear.2014.1787
   Stuart B., 2002, POLYM ANAL
   Subramaniam J, 2016, ENVIRON SCI POLLUT R, V23, P7543, DOI 10.1007/s11356-015-6007-0
   Subramaniam J, 2015, ENVIRON SCI POLLUT R, V22, P20067, DOI 10.1007/s11356-015-5253-5
   Suganya A, 2013, PARASITOL RES, V112, P1385, DOI 10.1007/s00436-012-3269-z
   Sujitha V, 2015, PARASITOL RES, V114, P3315, DOI 10.1007/s00436-015-4556-2
   Suresh U, 2015, PARASITOL RES, V114, P1551, DOI 10.1007/s00436-015-4339-9
   TARAFDAR JC, 2013, AFR J BIOTECHNOL, V12, P219, DOI [DOI 10.5897/AJB12.2481, 10.5897/AJB12]
   Thanigaivel A, 2017, ECOTOX ENVIRON SAFE, V137, P210, DOI 10.1016/j.ecoenv.2016.11.004
   Varun S, 2015, INT J PHARM SCI REV, V32, P42
   Vidhyalakshmi R., 2009, BIO RES, V3, P96
   Vikram K, 2016, ACTA TROP, V153, P21, DOI 10.1016/j.actatropica.2015.09.025
   Vogel V., 1978, TXB PRACTICAL ORGANI, P1368
   Ward M, 2017, PARASITOL RES, V116, P839, DOI 10.1007/s00436-016-5352-3
   Weeraratne T.C., 2013, INT J TROP INSECT SC, V09, P1
   Whitehorn J, 2010, BRIT MED BULL, V95, P161, DOI 10.1093/bmb/ldq019
NR 79
TC 5
Z9 5
U1 5
U2 19
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1040-7278
EI 1572-8862
J9 J CLUST SCI
JI J. Clust. Sci.
PD JAN
PY 2018
VL 29
IS 1
BP 27
EP 39
DI 10.1007/s10876-017-1300-3
PG 13
WC Chemistry, Inorganic & Nuclear
SC Chemistry
GA FS2GX
UT WOS:000419597900005
DA 2020-07-08
ER

PT J
AU Balcom, D
   Carrico, R
   Goss, L
   Mutsch, K
   Bosson, R
AF Balcom, Dawn
   Carrico, Ruth
   Goss, Linda
   Mutsch, Karen
   Bosson, Rahel
TI The Impact of Zika Virus Education on Selection of Birth Control Methods
   Among Cuban Refugees Resettling in Louisville, Kentucky in 2016
SO JOURNAL OF DOCTORAL NURSING PRACTICE
LA English
DT Article
DE refugee resettlement; domestic health screen; Zika virus awareness;
   advanced practice nurse
AB Background: Cubans represented almost 40% of all refugees resettling in KY during 2015 and 2016. Their route to the United States included extended time in areas recognized as Zika endemic, making them vulnerable to Zika virus (ZV) exposure and infection. Early availability of birth control is one strategy stressed by the Centers for Disease Control and Prevention (CDC) to delay an unintended pregnancy after ZV exposure and prevent the catastrophic impact on a developing fetus. Objectives: The objectives were to determine: (a) awareness of ZV among Cuban refugees, and (b) the impact of education regarding ZV on their initial birth control decisions. Methods: During May-November 2016, 167 Cuban men and women aged 19-50 were seen by advanced practice nurses (APNs) in the University of Louisville Global Health Center (UL GHC). During the visit, awareness regarding ZV, current planned birth control method(s), and education about ZV was imparted using information developed by the CDC and provided by clinic personnel competent in delivery of culturally, socially, and linguistically appropriate messaging. Anticipated methods of birth control were then reassessed. Results: Condom use was the most prevalent contraceptive method used before and after ZV education (29% and 58% respectively, p<.001). The influence of education regarding ZV and ZV infection on selection of birth control methods (condom use) was significant (p<.001). Conclusions: Findings indicate education provided by APNs regarding ZV influence birth control selection among Cuban refugees.
C1 [Balcom, Dawn; Carrico, Ruth; Goss, Linda; Bosson, Rahel] Univ Louisville, Sch Med, Global Hlth Ctr, Div Infect Dis, Louisville, KY 40292 USA.
   [Mutsch, Karen] Northern Kentucky Univ, Dept Nursing, Coll Hlth Profess, Highland Hts, OH 41076 USA.
RP Balcom, D (corresponding author), Univ Louisville, Global Hlth Ctr, 501 E Broadway,Suite 140C, Louisville, KY 40202 USA.
EM dawn.balcom@louisville.edu
FU Kentucky Office for Refugees; Northern Kentucky University Department of
   Nursing Faculty
FX The authors acknowledge the ongoing support received from the Kentucky
   Office for Refugees and the resettlement agencies, as we work together
   to address the many health needs of the refugee populations resettling
   in Kentucky. We also acknowledge and appreciate the ongoing support from
   the Northern Kentucky University Department of Nursing Faculty regarding
   this work and movement of results into publication.
CR American Association of Colleges of Nursing, 2006, ESS DOCT ED ADV NURS
   Bosson R., 2017, J REFUGEE GLOBAL HLT, V1, P7, DOI [10.18297/RGH/V0L1/ISS1/3/, DOI 10.18297/RGH/V0L1/ISS1/3/]
   Centers for Disease Control and Prevention, 2017, ZIK VIR
   Centers for Disease Control and Prevention, 2014, IMM REF HLTH GUID US
   Centres for Disease Control and Prevention, 2017, WORLD MAP AR RISK ZI
   Ellis E. G., 2016, PRICE ZIKA 4 MILLION
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   Office of Refugee Resettlement, 2016, REF ARR DAT
   Vick K., 2017, TIME MAGAZINE
NR 9
TC 0
Z9 0
U1 0
U2 3
PU SPRINGER PUBLISHING CO
PI NEW YORK
PA 11 WEST 42ND STREET, NEW YORK, NY 10036 USA
SN 2380-9418
EI 2380-9426
J9 J DOCTORAL NURS PRAC
JI J. Doctoral Nurs. Prac.
PY 2018
VL 11
IS 1
BP 88
EP 92
DI 10.1891/2380-9418.11.1.88
PG 5
WC Nursing
SC Nursing
GA GR6TD
UT WOS:000442795000010
DA 2020-07-08
ER

PT J
AU Fernandez, CMM
   da Rosa, MF
   Fernandez, ACAM
   Lorenzetti, FB
   Raimundo, KF
   Cortez, DAG
   Goncalves, JE
   Simoes, MR
   Colauto, NB
   Lobo, VD
   Gazim, ZC
AF Mariano Fernandez, Carla Maria
   da Rosa, Maurfcio Ferreira
   Aparecida Mariano Fernandez, Ana Claudia
   Lorenzetti, Fabiana Brusco
   Raimundo, Keila Fernanda
   Garcia Cortez, Diogenes Aparicio
   Goncalves, Jose Eduardo
   Simoes, Marcia Regina
   Colauto, Nelson Barros
   Lobo, Viviane da Silva
   Gazim, Zilda Cristiani
TI Larvicidal activity against Aedes aegypti of essential oil of Laurus
   nobilis leaves obtained at different seasons
SO JOURNAL OF ESSENTIAL OIL RESEARCH
LA English
DT Article
DE Dengue; Laurus nobilis; linalool; 1,8-cineole; larvicide; seasonality
ID CHEMICAL-COMPOSITION; L.; LARVAE
AB Aedes aegypti is a mosquito and vector of dengue, chikungunya and Zika virus making it a serious global health problem. We aimed to evaluate the chemical composition of the essential oil (EO) of Laurus nobilis leaves obtained at different seasons and its A. aegypti larvicidal activity. The EO was obtained from fresh leaves by hydrodistillation. Larvicidal activity was determined by the larval immersion test. It was identified 37 EO chemical compounds and the major ones were 1,8-cineole and linalool. Seasonal variations affected EO larvicidal activity: spring LC50 was 0.41 mg/mL and LC(99 )0.77 mg/mL, autumn LC50 was 0.60 mg/mL and LC99 1.37 mg/mL, winter LC50 was 0.66 mg/mL and LC99 3.19 mg/mL and summer LC50 was 0.91 mg/mL and LC99 2.50 mg/mL. The EO extracted during spring showed the highest larvicidal activity on A. aegypti larvae. Our results present a new perspective of L. nobilis EO use as a larvicidal agent.
C1 [Mariano Fernandez, Carla Maria; da Rosa, Maurfcio Ferreira; Aparecida Mariano Fernandez, Ana Claudia; Simoes, Marcia Regina] State Univ Western Parana, Postgrad Program Pharmaceut Sci, Cascavel, Brazil.
   [Lorenzetti, Fabiana Brusco; Garcia Cortez, Diogenes Aparicio] Univ Estadual Maringa, Postgrad Program Pharmaceut Sci, Maringa, Parana, Brazil.
   [Raimundo, Keila Fernanda; Colauto, Nelson Barros; Gazim, Zilda Cristiani] Univ Paranaense, Postgrad Program Biotechnol Appl Agr, Umuarama, Brazil.
   [Garcia Cortez, Diogenes Aparicio] Cesumar Univ, Postgrad Programs Hlth Promot, Maringa, Parana, Brazil.
   [Goncalves, Jose Eduardo] Cesumar Univ, Postgrad Programs Clean Technol, Maringa, Parana, Brazil.
   [Goncalves, Jose Eduardo] Cesumar Inst Sci Technol & Innovat ICETI, Maringa, Parana, Brazil.
   [Lobo, Viviane da Silva] Fed Technol Univ Parana, Postgrad Program Chem Technol & Biochem Proc, Curitiba, Parana, Brazil.
RP Gazim, ZC (corresponding author), Univ Paranaense, Postgrad Program Biotechnol Appl Agr, Umuarama, Brazil.
EM cristianigazim@prof.unipar.br
RI de Andrade, Carla Maria Mariano Fernandez/AAD-9639-2020; Goncalves, Jose
   Eduardo/Y-1015-2018; Goncalves, Jose Eduardo/AAA-1428-2019; Colauto,
   Nelson/AAG-5416-2019
OI de Andrade, Carla Maria Mariano Fernandez/0000-0001-7324-5533;
   Goncalves, Jose Eduardo/0000-0002-2505-0536; Goncalves, Jose
   Eduardo/0000-0002-2505-0536; Colauto, Nelson/0000-0003-4390-8302; Gazim,
   Zilda Cristiani/0000-0003-0392-5976
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)CAPES
FX The authors thank Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES) for providing financial support.
CR Abu-Dahab R, 2014, REC NAT PROD, V8, P136
   Adams R.P., 2012, IDENTIFICATION ESSEN
   Bernuci KZ, 2016, MOLECULES, V21, DOI 10.3390/molecules21121698
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   Braga IA, 2007, EPIDEMIOL SERV SAUDE, V16, P279
   CAMARGO M. F., 1998, REV PATOLOGIA TROPIC, V27, P65
   Camilotti J., 2015, Journal of Medicinal Plants Research, V9, P1021
   Costa J.G.M., 2005, REV BRAS FARMACOGN, V15, P304, DOI DOI 10.1590/S0102-695X2005000400008
   Gois RWD, 2011, J ESSENT OIL RES, V23, P59
   da Silveira SM, 2012, CIENC RURAL, V42, P1300, DOI 10.1590/S0103-84782012000700026
   Dadalioglu I, 2004, J AGR FOOD CHEM, V52, P8255, DOI 10.1021/jf049033e
   De Morais L.A.S., 2009, HORTIC BRAS, V27, pS4050
   Derwich E., 2009, Australian Journal of Basic and Applied Sciences, V3, P3818
   Lira PD, 2009, IND CROP PROD, V30, P259, DOI 10.1016/j.indcrop.2009.04.005
   Dias CN, 2014, PARASITOL RES, V113, P565, DOI 10.1007/s00436-013-3687-6
   Drapeau J, 2009, FLAVOUR FRAG J, V24, P160, DOI 10.1002/ffj.1928
   El SN, 2014, FOOD NUTR SCI, V2014, P97, DOI DOI 10.4236/fns.2014.52013
   Evrendilek GA, 2015, INT J FOOD MICROBIOL, V202, P35, DOI 10.1016/j.ijfoodmicro.2015.02.030
   Fiorini C., 1997, Flavour and Fragrance Journal, V12, P91, DOI 10.1002/(SICI)1099-1026(199703)12:2<91::AID-FFJ623>3.0.CO;2-3
   Gumus T, 2010, FOOD SCI BIOTECHNOL, V19, P1241, DOI 10.1007/s10068-010-0177-9
   Inan O, 2012, J CLEAN PROD, V27, P151, DOI 10.1016/j.jclepro.2012.01.003
   Jorge M.H.A., 2007, SERIE PLANTAS MED CO, P1
   Julio NB, 2009, MEM I OSWALDO CRUZ, V104, P626, DOI 10.1590/S0074-02762009000400016
   Leite AM, 2009, REV BRAS FARMACOGN, V19, P842, DOI 10.1590/S0102-695X2009000600008
   Lorenzi H, 2003, ARVORES EXOTICAS BRA
   Lorenzi H., 2008, PLANTAS MED BRASIL N
   Magalhaes LAM, 2010, MOLECULES, V15, P5734, DOI 10.3390/molecules15085734
   Cavalca PAM, 2010, BRAZ ARCH BIOL TECHN, V53, P835, DOI 10.1590/S1516-89132010000400012
   Marques André M, 2015, Univ. Sci., V20, P61, DOI 10.11144/Javeriana.SC20-1.amgp
   Moghtader M., 2012, Journal of Ecology and the Natural Environment, V4, P150
   Ozcan M, 2005, J MED FOOD, V8, P408, DOI 10.1089/jmf.2005.8.408
   Pandey SK, 2013, PEST MANAG SCI, V69, P1235, DOI 10.1002/ps.3488
   Pavela R, 2009, IND CROP PROD, V30, P311, DOI 10.1016/j.indcrop.2009.06.005
   Pereira Álvaro Itaúna Schalcher, 2014, Educ. quím, V25, P446
   Sayyah M, 2003, PHYTOTHER RES, V17, P733, DOI 10.1002/ptr.1197
   Senfi Fariba, 2014, Archives of Phytopathology and Plant Protection, V47, P472, DOI 10.1080/03235408.2013.812819
   Sertkaya E, 2010, IND CROP PROD, V31, P107, DOI 10.1016/j.indcrop.2009.09.009
   Silva F.C., 2009, MANUAL ANALISES QUIM
   Simoes C. M. O., 2007, FARMACOGNOSIA PLANTA
   Tabanca N, 2013, J AGR FOOD CHEM, V61, P12283, DOI 10.1021/jf4052682
NR 41
TC 1
Z9 1
U1 0
U2 12
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1041-2905
EI 2163-8152
J9 J ESSENT OIL RES
JI J. Essent. Oil Res.
PY 2018
VL 30
IS 5
BP 379
EP 387
DI 10.1080/10412905.2018.1473294
PG 9
WC Chemistry, Applied; Food Science & Technology
SC Chemistry; Food Science & Technology
GA GR6JQ
UT WOS:000442756200010
DA 2020-07-08
ER

PT J
AU Ibrahim, NK
   Moshref, RH
   Moshref, LH
   Walid, JB
   Alsati, HS
AF Ibrahim, Nahla K.
   Moshref, Rana H.
   Moshref, Leena H.
   Walid, Jawaher B.
   Alsati, Hadeel S.
TI Knowledge and attitudes towards Zika virus among medical students in
   King Abdulaziz University, Jeddah, Saudi Arabia
SO JOURNAL OF INFECTION AND PUBLIC HEALTH
LA English
DT Article
DE Emerging diseases; Zika virus; Medical students; Knowledge; Attitude
ID HEALTH-CARE STUDENTS; WORKERS KNOWLEDGE; MASS GATHERINGS; SEXUAL
   TRANSMISSION; 2 CITIES; EPIDEMIOLOGY; INFECTION; COLOMBIA; PREPAREDNESS;
   SYMPTOMS
AB Zika Virus (ZIKV) and its associated consequences remain vital public health challenge of international concerns. The current study was done to assess knowledge and attitudes towards ZIKV and the factors associated with good knowledge among medical students in King Abdulaziz University, Jeddah. A cross-sectional study was conducted among 426 students. They were selected through multistage stratified random sample method, 2016. A validated, confidential, interviewing questionnaire contained 25 knowledge and 10 attitude items was used. Descriptive and inferential statistics were done.
   Results revealed that Facebook was the commonest source of ZIKV information. About half of the participants correctly identified mosquito bites and vertical route as ZIKV transmission modes. However, smaller percentages recognized the sexual and blood transmission modes. Calculations of knowledge score revealed that 77.5%, 15.0%, and 7.5% of the participants obtained poor, fair, and satisfactory scores, respectively. Age, educational year and attending ZIKV training were significantly associated with good knowledge (p <0.05). Concerning attitudes, about half of the participants agreed that ZIKV could add new burden on healthcare system of the affected countries. Most of participants were interested in learning more about ZIKV, emerging diseases and travel epidemiology.
   In conclusion, medical students had limited knowledge about ZIKV, and good attitudes towards learning about it. Conduction of ZIKV educational programs, and development of courses about emerging disease epidemiology are required. (C) 2017 The Authors. Published by Elsevier Limited on behalf of King Saud Bin Abdulaziz University for Health Sciences. This is an open access article under the CC BY-NC-ND license
C1 [Ibrahim, Nahla K.; Alsati, Hadeel S.] King Abdulaziz Univ, Family & Community Med Dept, Fac Med, Jeddah 21551, Saudi Arabia.
   [Ibrahim, Nahla K.] Alexandria Univ, High Inst Publ Hlth, Epidemiol Dept, Alexandria, Egypt.
   [Moshref, Rana H.; Moshref, Leena H.; Walid, Jawaher B.] King Abdulaziz Univ, Fac Med, Jeddah, Saudi Arabia.
RP Ibrahim, NK (corresponding author), King Abdulaziz Univ, Family & Community Med Dept, Fac Med, Jeddah 21551, Saudi Arabia.
EM nahlakhamis@yahoo.com; ranahatem0987@gmail.com;
   leenahatem0987@gmail.com; j-b-w@live.com; hadeel_al_s@hotmail.com
RI Ibrahim, Nahla/K-6967-2012
CR Abushouk AI, 2016, J CLIN VIROL, V84, P53, DOI 10.1016/j.jcv.2016.09.012
   Al-Tawfiq JA, 2014, INT J INFECT DIS, V27, P26, DOI 10.1016/j.ijid.2014.07.001
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Chen HL, 2016, J CHIN MED ASSOC, V79, P174, DOI 10.1016/j.jcma.2016.03.001
   Colt S, 2016, B WHO
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Dhiman RC, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00168
   Elachola H, 2016, LANCET
   Bedoya-Arias JE, 2015, J INFECT DEV COUNTR, V9, P330, DOI 10.3855/jidc.6445
   Estofolete CF, 2016, J CLIN VIROL, V81, P25, DOI 10.1016/j.jcv.2016.05.012
   Fan Y, 2016, WILEY INTERDISCIP RE
   Gupta Nidhi, 2016, Niger Postgrad Med J, V23, P33, DOI 10.4103/1117-1936.180179
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hajra A, 2016, N AM J MED SCI, V8, DOI 10.4103/1947-2714.179112
   Hart CE, 2017, EMERG INFECT DIS, P3
   Ibrahim NK, 2017, J INFECT PUBLIC HEAL, V10, P438, DOI 10.1016/j.jiph.2016.06.002
   Ibrahim NK, 2016, PAK J MED SCI, V32, P1038, DOI 10.12669/pjms.324.10038
   Ibrahim NK, 2014, AUSTIN J PUBLIC HLTH, V1, P1
   Ibrahim NK, 2009, J INFECT PUBLIC HEAL, V40, P30
   Betancourt-Trejos ML, 2016, TRAVEL MED INFECT DI, V14, P283, DOI 10.1016/j.tmaid.2016.03.017
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Memish ZA, 2013, E MEDITERR HEALTH J, V19, pS5
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Sabogal-Roman JA, 2016, TRAVEL MED INFECT DI, V14, P52, DOI 10.1016/j.tmaid.2015.12.003
   Wang WEI, 2012, CLIN EPIDEMIOLOGY BA, P101, DOI DOI 10.1111/J.1526-4610.2011.01916.X.
   WHO, 2017, ZIK SIT REP
NR 32
TC 4
Z9 4
U1 1
U2 4
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 1876-0341
EI 1876-035X
J9 J INFECT PUBLIC HEAL
JI J. Infect. Public Health
PD JAN-FEB
PY 2018
VL 11
IS 1
BP 18
EP 23
DI 10.1016/j.jiph.2017.02.015
PG 6
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA FX2HJ
UT WOS:000425880000003
PM 28697901
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Houghton, F
AF Houghton, Frank
TI Zika, the Olympics, and golden opportunities
SO JOURNAL OF INFECTION AND PUBLIC HEALTH
LA English
DT Letter
DE Zika virus; Malaria; Public Health
C1 [Houghton, Frank] Eastern Washington Univ, Dept Publ Hlth & Hlth Adm, Spokane, WA USA.
RP Houghton, F (corresponding author), Eastern Washington Univ, Dept Publ Hlth & Hlth Adm, Eastern Washington Univ Ctr, Rm 232,Phase 1 Bldg,668 N Riverpoint Blvd, Spokane, WA 99202 USA.
EM fhoughton@ewu.edu
RI Houghton, Frank/I-7223-2019
OI Houghton, Frank/0000-0002-7599-5255
CR Eubanks SY, 2013, PROLOGUE BAD ACTS RA
   GLANTZ SA, 1996, CIGARETTE PAPERS
   Kluger R., ASHES ASHES AM 100 Y
   Mackenbach JP, 2009, J EPIDEMIOL COMMUN H, V63, P181, DOI 10.1136/jech.2008.077032
   Michaels D., 2008, DOUBT IS THEIR PRODU
   Proctor RN, 2012, TOB CONTROL, V21, P87, DOI 10.1136/tobaccocontrol-2011-050338
   Santora M., 2016, NY TIMES
   Schumacher E. F., 1979, GOOD WORK
   WHO, ZIK VIR
   World Health Organization, 2015, MAL FACT SHEET WORLD
   2013, WORLD MAL REP 2013, P1
NR 11
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 1876-0341
EI 1876-035X
J9 J INFECT PUBLIC HEAL
JI J. Infect. Public Health
PD JAN-FEB
PY 2018
VL 11
IS 1
BP 138
EP 138
DI 10.1016/j.jiph.2016.09.017
PG 1
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA FX2HJ
UT WOS:000425880000028
PM 28143801
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Zheng, B
   Tang, MX
   Yu, JS
   Qiu, JX
AF Zheng, Bo
   Tang, Moxun
   Yu, Jianshe
   Qiu, Junxiong
TI Wolbachia spreading dynamics in mosquitoes with imperfect maternal
   transmission
SO JOURNAL OF MATHEMATICAL BIOLOGY
LA English
DT Article
DE Population dynamics; Wolbachia; Imperfect maternal transmission;
   Cytoplasmic incompatibility; Monomorphism, polymorphism, bistability
ID CYTOPLASMIC INCOMPATIBILITY; DROSOPHILA-SIMULANS; POPULATIONS;
   INFECTION; ESTABLISHMENT; EVOLUTION; INVASION; MODELS; DENGUE
AB Mosquitoes are primary vectors of life-threatening diseases such as dengue, malaria, and Zika. A new control method involves releasing mosquitoes carrying bacterium Wolbachia into the natural areas to infect wild mosquitoes and block disease transmission. In this work, we use differential equations to describe Wolbachia spreading dynamics, focusing on the poorly understood effect of imperfect maternal transmission. We establish two useful identities and employ them to prove that the system exhibits monomorphic, bistable, and polymorphic dynamics, and give sufficient and necessary conditions for each case. The results suggest that the largest maternal transmission leakage rate supporting Wolbachia spreading does not necessarily increase with the fitness of infected mosquitoes. The bistable dynamics is defined by the existence of two stable equilibria, whose basins of attraction are divided by the separatrix of a saddle point. By exploring the analytical property of the separatrix with some sharp estimates, we find that Wolbachia in a completely infected population could be wiped out ultimately if the initial population size is small. Surprisingly, when the infection shortens the lifespan of infected females that would impede Wolbachia spreading, such a reversion phenomenon does not occur.
C1 [Zheng, Bo; Yu, Jianshe; Qiu, Junxiong] Guangzhou Univ, Coll Math & Informat Sci, Guangzhou 510006, Guangdong, Peoples R China.
   [Zheng, Bo; Tang, Moxun] Michigan State Univ, Dept Math, E Lansing, MI 48824 USA.
RP Tang, MX (corresponding author), Michigan State Univ, Dept Math, E Lansing, MI 48824 USA.
EM tang@math.msu.edu
FU China Scholarship CouncilChina Scholarship Council [201409945004];
   National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [11301103, 11631005, 11626246]; Program for
   Changjiang Scholars and Innovative Research Team in UniversityProgram
   for Changjiang Scholars & Innovative Research Team in University
   (PCSIRT) [IRT_16R16]; Guangdong Innovative Research Team program
   [2011S009]
FX This work was supported by China Scholarship Council (No. 201409945004),
   National Natural Science Foundation of China (11301103, 11631005,
   11626246), Program for Changjiang Scholars and Innovative Research Team
   in University (IRT_16R16), and Guangdong Innovative Research Team
   program (2011S009). We thank Glenn Webb, Michael Turelli, and Zhiyong Xi
   for their suggestions and encouragements. We are also indebted to the
   two anonymous reviewers for their careful reading of the manuscript and
   constructive criticism.
CR Bian GW, 2013, SCIENCE, V340, P748, DOI 10.1126/science.1236192
   Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   CASPARI E, 1959, EVOLUTION, V13, P568, DOI 10.2307/2406138
   Dobson SL, 2002, P ROY SOC B-BIOL SCI, V269, P437, DOI 10.1098/rspb.2001.1876
   Farkas JZ, 2010, B MATH BIOL, V72, P2067, DOI 10.1007/s11538-010-9528-1
   Hamm CA, 2014, MOL ECOL, V23, P4871, DOI 10.1111/mec.12901
   Haygood R, 2009, EVOLUTION, V63, P432, DOI 10.1111/j.1558-5646.2008.00550.x
   Hirsch M. W., 2003, DIFFERENTIAL EQUATIO
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   HOFFMANN AA, 1988, GENETICS, V119, P435
   Hoffmann AA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003115
   Hu LC, 2015, THEOR POPUL BIOL, V106, P32, DOI 10.1016/j.tpb.2015.09.003
   Huang MG, 2016, SCI CHINA MATH, V59, P1249, DOI 10.1007/s11425-016-5149-y
   Huang MG, 2015, SCI CHINA MATH, V58, P77, DOI 10.1007/s11425-014-4934-8
   Keeling MJ, 2003, HEREDITY, V91, P382, DOI 10.1038/sj.hdy.6800343
   Kriesner P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003607
   McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326
   NISBET RM, 1983, THEOR POPUL BIOL, V23, P114, DOI 10.1016/0040-5809(83)90008-4
   Rasgon JL, 2003, J MED ENTOMOL, V40, P125, DOI 10.1603/0022-2585-40.2.125
   TURELLI M, 1991, NATURE, V353, P440, DOI 10.1038/353440a0
   TURELLI M, 1995, GENETICS, V140, P1319
   Turelli M, 2010, EVOLUTION, V64, P232, DOI 10.1111/j.1558-5646.2009.00822.x
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Waltz E, 2016, NATURE, V533, P450, DOI 10.1038/533450a
   Weeks AR, 2007, PLOS BIOL, V5, P997, DOI 10.1371/journal.pbio.0050114
   Xi ZY, 2005, SCIENCE, V310, P326, DOI 10.1126/science.1117607
   Zhang Z, 2006, QUALITATIVE THEORY D, V101
   Zheng B, 2014, SIAM J APPL MATH, V74, P743, DOI 10.1137/13093354X
NR 29
TC 19
Z9 19
U1 0
U2 26
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0303-6812
EI 1432-1416
J9 J MATH BIOL
JI J. Math. Biol.
PD JAN
PY 2018
VL 76
IS 1-2
BP 235
EP 263
DI 10.1007/s00285-017-1142-5
PG 29
WC Biology; Mathematical & Computational Biology
SC Life Sciences & Biomedicine - Other Topics; Mathematical & Computational
   Biology
GA FS0GP
UT WOS:000419452400007
PM 28573466
DA 2020-07-08
ER

PT J
AU Yanez-Arenas, C
   Rioja-Nieto, R
   Martin, GA
   Dzul-Manzanilla, F
   Chiappa-Carrara, X
   Buenfil-Avila, A
   Manrique-Saide, P
   Correa-Morales, F
   Diaz-Quinonez, JA
   Perez-Renteria, C
   Ordonez-Alvarez, J
   Vazquez-Prokopec, G
   Huerta, H
AF Yanez-Arenas, Carlos
   Rioja-Nieto, Rodolfo
   Martin, Gerardo A.
   Dzul-Manzanilla, Felipe
   Chiappa-Carrara, Xavier
   Buenfil-Avila, Aura
   Manrique-Saide, Pablo
   Correa-Morales, Fabian
   Alberto Diaz-Quinonez, Jose
   Perez-Renteria, Crescencio
   Ordonez-Alvarez, Jose
   Vazquez-Prokopec, Gonzalo
   Huerta, Heron
TI Characterizing environmental suitability of Aedes albopictus (Diptera:
   Culicidae) in Mexico based on regional and global niche models
SO JOURNAL OF MEDICAL ENTOMOLOGY
LA English
DT Article
DE Aedes albopictus; ecological niche modeling; Mexico; occupied niche;
   fundamental niche
ID ECOLOGICAL NICHE; 1ST RECORD; CLIMATE SURFACES; COMPLEXITY; INVASION;
   UPDATE; TIGER; SKUSE; LIMIT; AREA
AB The Asian tiger mosquito, Aedes albopictus (Skuse) (Diptera: Culicidae), is an invasive species and a vector of numerous human pathogens, including chikungunya, dengue, yellow fever, and Zika viruses. This mosquito had been reported from 36 geographic locations in Mexico by 2005, increasing to 101 locations by 2010 and 501 locations (spanning 16 states) by 2016. Here we modeled the occupied niche for Ae. albopictus in Mexico to characterize the environmental conditions related to its presence, and to generate updated environmental suitability maps. The predictors with the greatest contribution to characterizing the occupied niche for Ae. albopictus were NDVI and annual mean temperature. We also estimated the environmental suitability for Ae. albopictus in regions of the country where it has not been documented yet, by means of: 1) transferring its occupied niche model to these regions and 2) modeling its fundamental niche using global data. Our models will help vector control and public health institutions to identify areas where Ae. albopictus has not yet been recorded but where it may be present. We emphasize that most of Mexico has environmental conditions that potentially allow the survival of Ae. albopictus, which underscores the need for systematic mosquito monitoring in all states of the country.
C1 [Yanez-Arenas, Carlos; Chiappa-Carrara, Xavier; Buenfil-Avila, Aura] Univ Nacl Autonoma Mexico, Lab Biol Conservac, Grp Anal Ecol Geog Aplicada, Parque Cient & Tecnol Yucatan, Sierra Papacal 11800, Yucatan, Mexico.
   [Rioja-Nieto, Rodolfo] Univ Nacl Autonoma Mexico, Lab Anal Espacial Zonas Costeras, Parque Cient & Tecnol Yucatan, Sierra Papacal 11800, Yucatan, Mexico.
   [Dzul-Manzanilla, Felipe; Correa-Morales, Fabian] Ctr Nacl Programas Prevent & Control Enfermedades, Secretaria Salud, Benjamin Franklin 132, Delegacion Miguel Hidalg 11800, Cdmx, Mexico.
   [Martin, Gerardo A.] James Cook Univ, Coll Publ Hlth Med & Vet Sci, Wildlife Hlth Res Grp, James Cook Dr, Douglas, Qld 4811, Australia.
   [Manrique-Saide, Pablo] Univ Autonoma Yucatan, Unidad Colaborat Bioensayos Entomol, Dept Zool, Campus Ciencias Biol & Agr, Merida 97315, Yucatan, Mexico.
   [Alberto Diaz-Quinonez, Jose; Perez-Renteria, Crescencio; Ordonez-Alvarez, Jose; Huerta, Heron] Inst Diagnost & Referencia Epidemiol Dr Manuel Ma, Secretaria Salud, Francisco de P Miranda 177, Delegacion Alvaro Obrego 01480, Cdmx, Mexico.
   [Alberto Diaz-Quinonez, Jose] Univ Nacl Autonoma Mexico, Fac Med, Ciudad Univ,Ave Univ 3000, Ciudad De Mexico 04510, Cdmx, Mexico.
   [Vazquez-Prokopec, Gonzalo] Emory Univ, Dept Environm Sci, Atlanta, GA 30322 USA.
RP Yanez-Arenas, C (corresponding author), Univ Nacl Autonoma Mexico, Lab Biol Conservac, Grp Anal Ecol Geog Aplicada, Parque Cient & Tecnol Yucatan, Sierra Papacal 11800, Yucatan, Mexico.
EM lichoso@gmail.com
RI Rioja-Nieto, Rodolfo/L-5756-2019; Yanez-Arenas, Carlos/X-6091-2018
OI Rioja-Nieto, Rodolfo/0000-0003-4854-7120; Yanez-Arenas,
   Carlos/0000-0002-6299-275X; Chiappa-Carrara, Xavier/0000-0002-1708-2095;
   Correa Morales, Fabian/0000-0002-6193-1242; Diaz-Quinonez, Jose
   Alberto/0000-0002-3503-7079
CR Aranda C, 2006, MED VET ENTOMOL, V20, P150, DOI 10.1111/j.1365-2915.2006.00605.x
   Barve N, 2013, ENMGADGETS TOOLS PRE
   Barve N, 2011, ECOL MODEL, V222, P1810, DOI 10.1016/j.ecolmodel.2011.02.011
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Boria RA, 2014, ECOL MODEL, V275, P73, DOI 10.1016/j.ecolmodel.2013.12.012
   Brady OJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-338
   Brady OJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-351
   Brown HE, 2008, REMOTE SENS ENVIRON, V112, P2301, DOI [10.1016/j.rse.2007.10.005, 10.1016/j.rse.2007.10.008]
   Caminade C., 2012, J R SOC INTERFACE, P1
   Campbell LP, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0135
   Casas-Martinez M, 2003, EMERG INFECT DIS, V9, P606
   Cianci D, 2015, INT J HEALTH GEOGR, V14, DOI 10.1186/s12942-015-0001-0
   Cuervo-Robayo AP, 2014, INT J CLIMATOL, V34, P2427, DOI 10.1002/joc.3848
   Escobar LE, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1403-y
   Estallo EL, 2008, J AM MOSQUITO CONTR, V24, P368, DOI 10.2987/5705.1
   Ettinger SJ, 2009, TXB VET INTERNAL MED
   Farajollahi A, 2013, J AM MOSQUITO CONTR, V29, P203, DOI 10.2987/11-6198R.1
   Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088
   Gasperi G, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001836
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Guerra CA, 2008, PLOS MED, V5, P300, DOI 10.1371/journal.pmed.0050038
   Guillaumot L, 2012, PARASITE VECTOR, V5, P1
   Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276
   HUETE A R, 1988, Remote Sensing of Environment, V25, P295
   Ibanez-Bernal S, 1997, MED VET ENTOMOL, V11, P305, DOI 10.1111/j.1365-2915.1997.tb00413.x
   IBANEZBERNAL S, 1994, J AM MOSQUITO CONTR, V10, P231
   Kerr JT, 2003, TRENDS ECOL EVOL, V18, P299, DOI 10.1016/S0169-5347(03)00071-5
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kriticos DJ, 2012, METHODS ECOL EVOL, V3, P53, DOI 10.1111/j.2041-210X.2011.00134.x
   Lowe S, 2000, 100 WORLDS WORST INV
   Martinez-Meyer E, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.0637
   Mohammed A, 2011, ACTA TROP, V119, P38, DOI 10.1016/j.actatropica.2011.04.004
   Moore CG, 1997, EMERG INFECT DIS, V3, P329, DOI 10.3201/eid0303.970309
   Nihei N, 2014, GEOSPATIAL HEALTH, V8, P417, DOI 10.4081/gh.2014.30
   Noor AM, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-159
   Orta Pensina Hector, 2001, Journal of the American Mosquito Control Association, V17, P260
   Orta-Pesina H, 2005, SALUD PUBLICA MEXICO, V47, P163, DOI 10.1590/s0036-36342005000200010
   Ortega-Morales AI, 2016, J VECTOR ECOL, V41, P314, DOI 10.1111/jvec.12229
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x
   Pech-May A, 2016, ACTA TROP, V157, P30, DOI 10.1016/j.actatropica.2016.01.021
   Peterson A.T., 2011, ECOLOGICAL NICHES GE
   Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008
   Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026
   Qiao HJ, 2016, ECOGRAPHY, V39, P805, DOI 10.1111/ecog.01961
   Radosavljevic A, 2014, J BIOGEOGR, V41, P629, DOI 10.1111/jbi.12227
   Reyes-Villanueva F, 2013, J VECTOR DIS, V50, P202
   Salomon-Grajales J, 2012, EMERG INFECT DIS, V18, P525, DOI 10.3201/eid1803.111626
   Say J., 1823, J ACAD NAT SCI-PHILA, V3, P9
   Shcheglovitova M, 2013, ECOL MODEL, V269, P9, DOI 10.1016/j.ecolmodel.2013.08.011
   Soberon Jorge, 2005, Biodiversity Informatics, V2, P1
   The R Development Core Team, 2017, R LANG ENV STAT COMP
   Thomas SM, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-100
   Torres-Avendano JI, 2015, J AM MOSQUITO CONTR, V31, P164, DOI 10.2987/14-6461R
   Toto JC, 2003, MED VET ENTOMOL, V17, P343, DOI 10.1046/j.1365-2915.2003.00447.x
   TOVAR MLR, 1994, J AM MOSQUITO CONTR, V10, P587
   VanDerWal J, 2009, AM NAT, V174, P282, DOI 10.1086/600087
   Veloz SD, 2009, J BIOGEOGR, V36, P2290, DOI 10.1111/j.1365-2699.2009.02174.x
   Villegas-Trejo A, 2010, J AM MOSQUITO CONTR, V26, P321, DOI 10.2987/10-6014.1
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Yanez-Arenas C, 2016, CLIMATIC CHANGE, V134, P697, DOI 10.1007/s10584-015-1544-6
   Yanez-Arenas C, 2012, OIKOS, V121, P2081, DOI 10.1111/j.1600-0706.2012.20350.x
NR 62
TC 5
Z9 4
U1 1
U2 18
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-2585
EI 1938-2928
J9 J MED ENTOMOL
JI J. Med. Entomol.
PD JAN
PY 2018
VL 55
IS 1
BP 69
EP 77
DI 10.1093/jme/tjx185
PG 9
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA FT2LZ
UT WOS:000422975600009
PM 29186544
DA 2020-07-08
ER

PT J
AU Morejon, B
   Pilaquinga, F
   Domenech, F
   Ganchala, D
   Debut, A
   Neira, M
AF Morejon, Bianca
   Pilaquinga, Fernanda
   Domenech, Flavia
   Ganchala, Danny
   Debut, Alexis
   Neira, Marco
TI Larvicidal Activity of Silver Nanoparticles Synthesized Using Extracts
   of Ambrosia arborescens (Asteraceae) to Control Aedes aegypti L.
   (Diptera: Culicidae)
SO JOURNAL OF NANOTECHNOLOGY
LA English
DT Article
ID LEAF EXTRACT; SESQUITERPENE LACTONES; GREEN SYNTHESIS; FILARIASIS;
   MALARIA; VECTOR; TRANSMISSION; MECHANISM; DENGUE; PLANT
AB The mosquito species Aedes aegypti is the primary vector of dengue, chikungunya, and Zika infections worldwide. Since effective vaccines or drugs are not available for the prevention and/or treatment of these pathologies, vector control has been adopted as the main approach to reduce their transmission. To control Aedes populations, the most commonly used tool is the application of chemical insecticides and, despite their effectiveness, indiscriminate use of these chemicals has led to high operational costs, appearance of resistant populations, and adverse nontarget effects. Plant-derived insecticides may be an eco-friendly, cost-effective, and safe biocontrol alternative. The present study was carried out to evaluate the larvicidal activity of leaf extracts of Ambrosia arborescens and green-synthesized silver nanoparticles (AgNPs) using aqueous extracts obtained from this plant against third instar larvae of Ae. aegypti. To test this, larvae were exposed for 24 h to the aqueous plant extract at 1500, 3000, 4500, and 6000 ppm and the plant-synthesized AgNPs at 0.2, 0.3, 0.4, and 0.5 ppm. In laboratory assays, AgNPs were more toxic (LC50 = 0.28 ppm; LC90 = 0.43 ppm) than the plant extract (LC50 = 1844.61 ppm; LC90 = 6043.95 ppm). These results suggest that A. arborescens aqueous extract and green-synthesized silver nanoparticles produced from those extracts have the potential to be developed into suitable alternative tools useful for the control of Ae. aegypti populations.
C1 [Morejon, Bianca; Neira, Marco] Pontificia Univ Catolica Ecuador, Ctr Res Hlth Latin Amer, Exact & Nat Sci Dept, Quito, Ecuador.
   [Pilaquinga, Fernanda; Domenech, Flavia; Ganchala, Danny] Pontificia Univ Catolica Ecuador, Lab Nanotechnol, Exact & Nat Sci Dept, Quito, Ecuador.
   [Pilaquinga, Fernanda] Univ Balearic Isl, Dept Chem, Palma De Mallorca, Balearic Island, Spain.
   [Debut, Alexis] Univ Fuerzas Armadas ESPE, Sangolqui, Ecuador.
RP Neira, M (corresponding author), Pontificia Univ Catolica Ecuador, Ctr Res Hlth Latin Amer, Exact & Nat Sci Dept, Quito, Ecuador.
EM mvneira@puce.edu.ec
RI Debut, Alexis/H-8424-2019
OI Debut, Alexis/0000-0002-8269-7619; Pilaquinga,
   Fernanda/0000-0002-0841-6313
FU PUCE's Research Grants [N13409, N13438]
FX This research was supported in part by PUCE's Research Grants N13409 and
   N13438. The authors would also like to thank Mr. Ricardo Zambrano for
   his help in obtaining suitable plant samples and Dr. Svetlana Ivanova
   from the University of Sevilla for her support in the characterization
   of nanoparticles.
CR Aguilar M., 2009, THESIS
   Álvarez-Londoño Juan C., 2013, Rev. salud pública, V15, P227
   Anandalakshmi K, 2016, APPL NANOSCI, V6, P399, DOI 10.1007/s13204-015-0449-z
   Arjunan NK, 2012, VECTOR-BORNE ZOONOT, V12, P262, DOI 10.1089/vbz.2011.0661
   Benelli G, 2017, J KING SAUD UNIV SCI, V29, P424, DOI 10.1016/j.jksus.2016.08.006
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bisset J, 2006, J MED ENTOMOL, V43, P1185, DOI 10.1603/0022-2585(2006)43[1185:SOIAAA]2.0.CO;2
   Borase H., 2013, J NANOMEDICINE BIOTH, V3
   Carvalho DO, 2014, JOVE-J VIS EXP, DOI 10.3791/3579
   CHAMBERLAIN R, 1961, ANNU REV ENTOMOL, V6, P371, DOI 10.1146/annurev.en.06.010161.002103
   Cook GC, 2008, MANSONS TROPICAL DIS
   da Silva JJ, 2007, REV SOC BRAS MED TRO, V40, P612, DOI 10.1590/S0037-86822007000600002
   De la Torre L., 2008, ENCICLOPEDIA PLANTAS
   Rodriguez YCD, 2013, J MED ENTOMOL, V50, P310, DOI 10.1603/ME12056
   De Leo M, 2010, PHYTOCHEMISTRY, V71, P804, DOI 10.1016/j.phytochem.2010.02.002
   Domenech F., 2017, THESIS
   Eisa A., 2010, TOXICITY AMBROSIA MA
   Finney D.T., 1971, PROBIT ANAL
   Frierson J. Gordon, 2010, Yale Journal of Biology and Medicine, V83, P77
   Gerberg E., 1994, MANUAL MOSQUITO REAR
   Govindarajan M, 2005, Trop Biomed, V22, P1
   Govindarajan M, 2011, ASIAN PAC J TROP MED, V4, P24, DOI 10.1016/S1995-7645(11)60026-6
   Haldar KM, 2013, PARASITOL RES, V112, P1451, DOI 10.1007/s00436-013-3288-4
   HERZ W, 1969, PHYTOCHEMISTRY, V8, P877, DOI 10.1016/S0031-9422(00)85877-X
   Hurst TP, 2007, J ECON ENTOMOL, V100, P61, DOI 10.1603/0022-0493(2007)100[61:SEOMLO]2.0.CO;2
   Jagruti H, 2014, INT J MOSQ RES A, V1, P33
   Jorgensen P.M., 1999, MONOGRAPHS SYSTEMATI, V75, P1
   Li V., 2014, THESIS
   Mauseth J. D., 2003, BOT INTRO PLANT BIOL
   Muthukumaran U, 2015, PARASITOL RES, V114, P1817, DOI 10.1007/s00436-015-4368-4
   Myers NRA, 2010, NATURE, V403, P853
   Nalini M., 2017, EGYPTIAN J BASIC APP, V4, P212, DOI DOI 10.1016/j.ejbas.2017.04.005
   Ndikau M, 2017, INT J ANAL CHEM, DOI 10.1155/2017/8108504
   Neerman M. F., 2003, International Journal of Aromatherapy, V13, P114, DOI 10.1016/S0962-4562(03)00078-X
   Parkhomenko A. Y., 2006, PHARM CHEM J, V40, P627, DOI DOI 10.1007/S11094-006-0208-2
   Poopathi S, 2010, J PHYSL PATHOPHYSIOL, V1, P22
   Pradeep T, 2012, TXB NANOSCIENCE NANO
   Priyadarshini KA, 2012, PARASITOL RES, V111, P997, DOI 10.1007/s00436-012-2924-8
   R Core Team, 2013, R LANG ENV STAT COMP
   Rais M., 2012, Patent WO, Patent No. [2012074355 A1, 2012074355A1]
   Rajakumar G, 2011, ACTA TROP, V118, P196, DOI 10.1016/j.actatropica.2011.03.003
   Ramesh S, 2016, BIOMATER SCI-UK, V4, P1713, DOI 10.1039/c6bm00688d
   Rawani A, 2013, ACTA TROP, V128, P613, DOI 10.1016/j.actatropica.2013.09.007
   Ruales C., 2013, PLANTAS QUITO VEGETA
   Sardar T, 2015, COMMUN NONLINEAR SCI, V22, P511, DOI 10.1016/j.cnsns.2014.08.009
   SPRING O, 1982, Z NATURFORSCH C, V37, P1087
   Subramaniam J, 2015, ENVIRON SCI POLLUT R, V22, P20067, DOI 10.1007/s11356-015-5253-5
   Tennyson S., 2015, Asian Pacific Journal of Tropical Disease, V5, pS73
   Thiyagarajan P., 2014, ACTA BIOL INDICA, V3, P527
   Trifunschi S., 2015, INT CURR PHARM J, V4, P382
   Venables W. N., 2002, MODERN APPL STAT S
   Vera M., 2008, ESTUDIO FITOQUIMICO
   WHO-World Health Organization, 2005, GUID LAB FIELD TEST
   World Health Organization, 2009, DENG GUID DIAGN TREA
   World Health Organization (WHO), 2016, DENG DENG GRAV
NR 56
TC 4
Z9 5
U1 0
U2 2
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1687-9503
EI 1687-9511
J9 J NANOTECHNOL
JI J. Nanotechnol.
PY 2018
VL 2018
AR 6917938
DI 10.1155/2018/6917938
PG 8
WC Nanoscience & Nanotechnology
SC Science & Technology - Other Topics
GA GW5OR
UT WOS:000446985700001
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Ishwarya, R
   Vaseeharan, B
   Kalyani, S
   Banumathi, B
   Govindarajan, M
   Alharbi, NS
   Kadaikunnan, S
   Al-anbr, MN
   Khaled, JM
   Benelli, G
AF Ishwarya, Ramachandran
   Vaseeharan, Baskaralingam
   Kalyani, Subramanian
   Banumathi, Balan
   Govindarajan, Marimuthu
   Alharbi, Naiyf S.
   Kadaikunnan, Shine
   Al-anbr, Mohammed N.
   Khaled, Jamal M.
   Benelli, Giovanni
TI Facile green synthesis of zinc oxide nanoparticles using Ulva lactuca
   seaweed extract and evaluation of their photocatalytic, antibiofilm and
   insecticidal activity
SO JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY
LA English
DT Article
DE Biofilm; Dengue; Histology; Aedes aegypti; Methylene blue; Zika virus;
   Mosquito control
ID VECTOR AEDES-AEGYPTI; ZNO NANOPARTICLES; CULEX-QUINQUEFASCIATUS;
   ANTIBACTERIAL ACTIVITY; SILVER NANOPARTICLES; VETERINARY IMPORTANCE;
   PREDATION EFFICIENCY; FORMATION MECHANISM; GOLD NANOPARTICLES; BIOFILM
   FORMATION
AB The bioactivity of semiconductor nanocomplexes has been poorly studied in the field of pesticide science. In this research, the synthesis of zinc nanoparticles was accomplished through new effortless green chemistry process, using the Ulva lactuca seaweed extract as a reducing and capping agent. The production of U. lactuca-fabricated ZnO nanoparticles (Ul-ZnO Nps) was characterized by powder X-ray diffraction (XRD), UV-visible, Fourier transform infrared (FTIR) spectroscopy, selected area electron diffraction (SAED) analysis and transmission electron microscopy (TEM). The U. lactuca-fabricated ZnO NPs were tested for their photodegradative action against organic dyes, as well as for antibiofilm and larvicidal activities. The UV visible absorbance spectrum of Ul-ZnO NPs exhibited the absorbance band at 325 nm and TEM highlighted average crystallite sizes of nano particles of 10-50 nm. Methylene blue (MB) dye was efficiently corrupted under sunlight in presence of Ul-ZnO NPs. Excellent bactericidal activity was shown by the Ul-ZnO Nps on Gram positive (Bacillus licheniformis and Bacillus pumilis) and Gram negative (Escherichia coliand Proteus vulgaris) bacteria. High antibiofilm potential was noted under both dark and sunlight conditions. The impact of a single treatment with Ul-ZnO NPs on biofilm architecture was also analyzed by confocal laser scanning microscopy (CLSM) on both Gram positive and Gram negative bacteria. Moreover, Ul-ZnO NPs led to 100% mortality of Aedes aegypti fourth instar larvae at the concentration of 50 mu g/ml within 24 h. The effects of ZnO nanoparticle-based treatment on mosquito larval morphology and histology were monitored. Overall, based on our results, we believe that the synthesis of multifunctional Ul-ZnO Nps using widely available seaweed products can be promoted as a potential eco-friendly option to chemical methods currently used for nanosynthesis of antimicrobials and insecticides.
C1 [Ishwarya, Ramachandran; Vaseeharan, Baskaralingam; Kalyani, Subramanian; Banumathi, Balan] Alagappa Univ, Dept Anim Hlth & Management, Biomat & Biotechnol Anim Hlth Lab, Karaikkudi 630004, Tamil Nadu, India.
   [Govindarajan, Marimuthu] Annamalai Univ, Dept Zool, Unit Vector Control Phytochem & Nanotechnol, Annamalainagar 608002, Tamil Nadu, India.
   [Govindarajan, Marimuthu] Govt Coll Women, Dept Zool, Kumbakonam 602001, Tamil Nadu, India.
   [Alharbi, Naiyf S.; Kadaikunnan, Shine; Al-anbr, Mohammed N.; Khaled, Jamal M.] King Saud Univ, Coll Sci, Dept Bot & Microbiol, Riyadh 11451, Saudi Arabia.
   [Benelli, Giovanni] Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
   [Benelli, Giovanni] Scuola Super Sant Anna, BioRobot Inst, Viale Rinaldo Piaggio 34, I-56025 Pisa, Italy.
RP Vaseeharan, B (corresponding author), Alagappa Univ, Dept Anim Hlth & Management, Biomat & Biotechnol Anim Hlth Lab, Karaikkudi 630004, Tamil Nadu, India.; Kadaikunnan, S (corresponding author), King Saud Univ, Coll Sci, Dept Bot & Microbiol, Riyadh 11451, Saudi Arabia.
EM vaseeharanb@gmail.com; sshine@ksu.edu.sa
RI Khaled, Jamal/D-8188-2017; Alharbi, Naiyf S/B-9402-2019; Benelli,
   Giovanni/A-9100-2013; /L-2836-2013; GOVINDARAJAN, MARIMUTHU/A-8070-2019
OI Benelli, Giovanni/0000-0001-8971-6010; /0000-0001-7018-5379;
   GOVINDARAJAN, MARIMUTHU/0000-0002-4662-8931
FU Alagappa University Research Fellowship (AURF), Karaikudi, India
   [Ph.D/1075/AURF Fellowship/2015]; Department of Biotechnology (DBT), New
   Delhi, IndiaDepartment of Biotechnology (DBT) India
   [BT/PR7903/AAQ/3/638/2013]; Deanship of Scientific Research at King Saud
   UniversityDeanship of Scientific Research at King Saud University
   [RG-1438-091]
FX The authors would like to extend their grateful thanks to the Alagappa
   University Research Fellowship (AURF) [Ph.D/1075/AURF Fellowship/2015],
   Karaikudi, India and this work was partially supported by Department of
   Biotechnology (DBT), New Delhi, India, under the Project grants code:
   BT/PR7903/AAQ/3/638/2013. The authors extend their appreciation to the
   Deanship of Scientific Research at King Saud University for funding this
   work through research group No. RG-1438-091.
CR Al-Mehmadi R. M., 2010, Journal of King Saud University Science, V22, P77, DOI 10.1016/j.jksus.2010.02.004
   Alkaladi A, 2014, INT J MOL SCI, V15, P2015, DOI 10.3390/ijms15022015
   Applerot G, 2009, ADV FUNCT MATER, V19, P842, DOI 10.1002/adfm.200801081
   Aruoja V, 2009, SCI TOTAL ENVIRON, V407, P1461, DOI 10.1016/j.scitotenv.2008.10.053
   Ashajyothi C, 2016, J NANOSTRUCTURE CHEM, V6, P329, DOI 10.1007/s40097-016-0205-2
   Ashokan AP, 2017, J CLUST SCI, V28, P205, DOI 10.1007/s10876-016-1075-y
   Azizi S, 2014, MATER LETT, V116, P275, DOI 10.1016/j.matlet.2013.11.038
   Banumathi B, 2017, J CLUST SCI, V28, P2857, DOI 10.1007/s10876-017-1263-4
   Banumathi B, 2017, VET PARASITOL, V244, P102, DOI 10.1016/j.vetpar.2017.07.021
   Banumathi B, 2017, PARASITOL RES, V116, P1637, DOI 10.1007/s00436-017-5438-6
   Benelli G, 2017, ENVIRON SCI POLLUT R, P1
   Benelli G, 2018, ACTA TROP, V178, P73, DOI 10.1016/j.actatropica.2017.10.021
   Benelli G, 2017, ENTOMOL GEN, V36, P309, DOI 10.1127/entomologia/2017/0496
   Benelli G, 2017, ACTA TROP, V174, P91, DOI 10.1016/j.actatropica.2017.06.028
   Benelli G, 2017, J CLUST SCI, V28, P287, DOI 10.1007/s10876-016-1088-6
   Benelli G, 2016, ENZYME MICROB TECH, V95, P58, DOI 10.1016/j.enzmictec.2016.08.022
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   Bhatkhande DS, 2002, J CHEM TECHNOL BIOT, V77, P102, DOI 10.1002/jctb.532
   Brayner R, 2006, NANO LETT, V6, P866, DOI 10.1021/nl052326h
   Byrappa K, 2006, B MATER SCI, V29, P433, DOI 10.1007/BF02914073
   Chakrabarti S, 2004, J HAZARD MATER, V112, P269, DOI 10.1016/j.jhazmat.2004.05.013
   Darroudi M, 2013, CERAM INT, V39, P6917, DOI 10.1016/j.ceramint.2013.02.026
   Deepak P., 2016, ARTIFICIAL CELLS NAN
   Dimkpa CO, 2011, ENVIRON POLLUT, V159, P1749, DOI 10.1016/j.envpol.2011.04.020
   Dishun Zhao, 2009, Frontiers of Chemical Engineering in China, V3, P206, DOI 10.1007/s11705-009-0053-4
   Dwivedi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111289
   Fallatah S. A., 2010, J ARAB SOC MED RES, V5, P123
   Fortunato E, 2005, THIN SOLID FILMS, V487, P205, DOI 10.1016/j.tsf.2005.01.066
   Fujishima A., 2000, J PHOTOCH PHOTOBIO C, V1, P1, DOI DOI 10.1016/S1389-5567(00)00002-2
   Gajjar Priyanka, 2009, J Biol Eng, V3, P9, DOI 10.1186/1754-1611-3-9
   Harding F., 2006, BREAST CANC CAUSE PR, P83
   Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209
   Hayat K, 2010, J ENVIRON SCI HEAL A, V45, P1413, DOI 10.1080/10934529.2010.500934
   Heinlaan M, 2008, CHEMOSPHERE, V71, P1308, DOI 10.1016/j.chemosphere.2007.11.047
   Hsueh Y.H., 2015, PLOS ONE, V10
   Ishwarya R, 2017, J PHOTOCH PHOTOBIO B, V174, P133, DOI 10.1016/j.jphotobiol.2017.07.026
   Jones N, 2008, FEMS MICROBIOL LETT, V279, P71, DOI 10.1111/j.1574-6968.2007.01012.x
   Kalimuthu K, 2017, PROCESS SAF ENVIRON, V109, P82, DOI 10.1016/j.psep.2017.03.027
   Kirthi AV, 2011, PARASITOL RES, V109, P461, DOI 10.1007/s00436-011-2277-8
   Lardeux F, 2002, ANN TROP MED PARASIT, V96, pS105, DOI 10.1179/000349802125002455
   Lee JH, 2014, MICROBIOL RES, V169, P888, DOI 10.1016/j.micres.2014.05.005
   Lewis K, 2001, ANTIMICROB AGENTS CH, V45, P999, DOI 10.1128/AAC.45.4.999-1007.2001
   Madhiyazhagan P, 2017, J APPL PHYCOL, V29, P649, DOI 10.1007/s10811-016-0953-x
   Malaikozhundan B, 2017, MICROB PATHOGENESIS, V104, P268, DOI 10.1016/j.micpath.2017.01.029
   Murugan K, 2011, HYDROBIOLOGIA, V666, P331, DOI 10.1007/s10750-011-0629-0
   Murugan K, 2015, PARASITOL RES, V115, P651
   Murugan K, 2015, PARASITOL RES, V114, P2243, DOI 10.1007/s00436-015-4417-z
   Murugan K, 2015, EXP PARASITOL, V153, P129, DOI 10.1016/j.exppara.2015.03.017
   Narendhran S, 2016, B MATER SCI, V39, P1, DOI 10.1007/s12034-015-1136-0
   Nie L, 2006, SMALL, V2, P621, DOI 10.1002/smll.200500193
   Pandimurugan R, 2016, ADV POWDER TECHNOL, V27, P1062, DOI 10.1016/j.apt.2016.03.014
   Raghupathi KR, 2011, LANGMUIR, V27, P4020, DOI 10.1021/la104825u
   Ramimoghadam D, 2013, CHEM CENT J, V7, DOI 10.1186/1752-153X-7-71
   Seil JT, 2011, ACTA BIOMATER, V7, P2579, DOI 10.1016/j.actbio.2011.03.018
   Shankar PD, 2016, ENZYME MICROB TECH, V95, P28, DOI 10.1016/j.enzmictec.2016.10.015
   Sharma D, 2010, THIN SOLID FILMS, V519, P1224, DOI 10.1016/j.tsf.2010.08.073
   Sharon M., 2010, J PHYTOL, V2, P83
   Singh A. K., 2013, Journal of Nanoparticles, DOI 10.1155/2013/310809
   Sinha S., 2009, J APPL BIOSCI, V19, P113
   Sirelkhatim A, 2015, NANO-MICRO LETT, V7, P219, DOI 10.1007/s40820-015-0040-x
   Suresh D, 2015, MAT SCI SEMICON PROC, V31, P446, DOI 10.1016/j.mssp.2014.12.023
   Tayyebi A, 2016, J ALLOY COMPD, V663, P738, DOI 10.1016/j.jallcom.2015.12.169
   Thaya R, 2016, MICROB PATHOGENESIS, V100, P124, DOI 10.1016/j.micpath.2016.09.010
   Thema FT, 2015, MATER LETT, V161, P124, DOI 10.1016/j.matlet.2015.08.052
   Tiwari D. K., 2008, World Applied Sciences Journal, V3, P417
   Vanathi P, 2014, MATER LETT, V134, P13, DOI 10.1016/j.matlet.2014.07.029
   Veerakumar K, 2014, PARASITOL RES, V113, P1775, DOI 10.1007/s00436-014-3823-y
   Vijayakumar S, 2015, SPECTROCHIM ACTA A, V137, P886, DOI 10.1016/j.saa.2014.08.064
   Vijayakumar S, 2017, MICROB PATHOGENESIS, V107, P88, DOI 10.1016/j.micpath.2017.03.019
   Vijayakumar S, 2016, BIOMED PHARMACOTHER, V84, P1213, DOI 10.1016/j.biopha.2016.10.038
   World Health Organization, 1996, REP WHO INF CONS EV, V1, P69
   Xiong HM, 2013, ADV MATER, V25, P5329, DOI 10.1002/adma.201301732
   Yoon SH, 2006, ISAF IEEE, P322
NR 74
TC 58
Z9 58
U1 18
U2 102
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 1011-1344
J9 J PHOTOCH PHOTOBIO B
JI J. Photochem. Photobiol. B-Biol.
PD JAN
PY 2018
VL 178
BP 249
EP 258
DI 10.1016/j.jphotobiol.2017.11.006
PG 10
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA FV6YI
UT WOS:000424727600030
PM 29169140
DA 2020-07-08
ER

PT J
AU Abinaya, M
   Vaseeharan, B
   Divya, M
   Sharmili, A
   Govindarajan, M
   Alharbi, NS
   Kadaikunnan, S
   Khaled, JM
   Benelli, G
AF Abinaya, Muthukumar
   Vaseeharan, Baskaralingam
   Divya, Mani
   Sharmili, Aruna
   Govindarajan, Marimuthu
   Alharbi, Naiyf S.
   Kadaikunnan, Shine
   Khaled, Jamal M.
   Benelli, Giovanni
TI Bacterial exopolysaccharide (EPS)-coated ZnO nanoparticles showed high
   antibiofilm activity and larvicidal toxicity against malaria and Zika
   virus vectors
SO JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY
LA English
DT Article
DE Exopolysaccharides; Zinc oxide nanoparticles; Antibiofilm; Malaria;
   Dengue
ID ZINC-OXIDE NANOPARTICLES; BACILLUS-LICHENIFORMIS DAHB1; SILVER
   NANOPARTICLES; STRUCTURAL-CHARACTERIZATION; ANTIBACTERIAL ACTIVITY;
   CERIODAPHNIA-CORNUTA; PATHOGENIC BACTERIA; GREEN SYNTHESIS;
   AEDES-AEGYPTI; ANTIOXIDANT
AB In this study, a novel and effective approach was performed to synthesize ZnO nanoparticles (ZnO NPs) using the exopolysaccharides (EPS) from the probiotic strain Bacillus lichenifonnis Dahbl. EPS acted as reducing and stabilizing agent for the formation of EPS-ZnO NPs by co-precipitation method. Structural characterization was investigated by a surface plasma resonance centered at 375 nm in UV-vis spectrum. FIR spectrum exhibited functional groups with strong absorption peak at 3814.7-420 cm(-1). XRD showed the crystalline nature of EPS-ZnO NPs. TEM showed that the EPS-ZnO NPs were hexagonal in shape, with size within the range of 10-100 nm. The presence of Zn was confirmed by EDX analysis. Antibacterial activity of EPS-ZnO NPs was demonstrated as 100 mu g/ml significantly inhibited the effective growth control of Gram-negative (Pseudomonas aeruginosa and Proteus vulgaris) and Gram-positive (Bacillus subtilis and Bacillus pumilus) bacteria. Light microscopy and confocal laser scanning microscopy evidenced that the antibiofihn activity of EPS-ZnO NPs was higher against Gram-negative bacteria over Gram positive bacteria. EPS-ZnO NPs also inhibited the biofilm growth of Candida albicans at the concentration of 75 mu g/ml. The hemolytic test showed low cytotoxicity of EPS-ZnO NPs at 5 mg/ml. In addition, EPS-ZnO NPs achieved 100% mortality against third instars mosquito larvae of Anopheles stephensi and Aedes aegypti at very low doses. Moreover, histology studies revealed the presence of damaged cells and tissues in the mid-gut of treated mosquito larvae. The multipurpose properties of EPS-ZnO NPs revealed in the present study can be further considered for pharmaceutical, parasitological and entomological applications.
C1 [Abinaya, Muthukumar; Vaseeharan, Baskaralingam; Divya, Mani] Alagappa Univ, Dept Anim Hlth & Management, Biomat & Biotechnol Anim Hlth Lab, Sci Block 6th Floor,Burma Colony, Karaikkudi 630004, Tamil Nadu, India.
   [Sharmili, Aruna] Stella Maris Coll, Dept Biotechnol, Madras 625003, Tamil Nadu, India.
   [Govindarajan, Marimuthu] Annamalai Univ, Dept Zool, Unit Vector Control Phytochem & Nanotechnol, Annamalainagar 608002, Tamil Nadu, India.
   [Alharbi, Naiyf S.; Kadaikunnan, Shine; Khaled, Jamal M.] King Saud Univ, Coll Sci, Dept Bot & Microbiol, Riyadh 11451, Saudi Arabia.
   [Benelli, Giovanni] Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
   [Benelli, Giovanni] Scuola Super Sant Anna, BioRobot Inst, Viale Rinaldo Piaggio 34, I-56025 Pisa, Italy.
RP Vaseeharan, B (corresponding author), Alagappa Univ, Dept Anim Hlth & Management, Biomat & Biotechnol Anim Hlth Lab, Sci Block 6th Floor,Burma Colony, Karaikkudi 630004, Tamil Nadu, India.
EM vaseeharanb@gmail.com
RI GOVINDARAJAN, MARIMUTHU/A-8070-2019; Khaled, Jamal/D-8188-2017;
   /L-2836-2013; Benelli, Giovanni/A-9100-2013; Alharbi, Naiyf
   S/B-9402-2019
OI GOVINDARAJAN, MARIMUTHU/0000-0002-4662-8931; /0000-0001-7018-5379;
   Benelli, Giovanni/0000-0001-8971-6010; Muthukumar,
   Abinaya/0000-0002-9635-4852
FU Department of Biotechnology (DBT), Government of India, New Delhi,
   IndiaDepartment of Biotechnology (DBT) India [BT/PR7903/AAQ/3/638/2013];
   INSPIRE fellowship, DST, New Delhi, India; Deanship of Scientific
   Research at King Saud UniversityDeanship of Scientific Research at King
   Saud University [RG-1438-074]
FX The authors gratefully acknowledge the financial support of Department
   of Biotechnology (DBT), Government of India, New Delhi, India, under the
   Project Grant BT/PR7903/AAQ/3/638/2013. M.A. thanks the support of
   INSPIRE fellowship, DST, New Delhi, India. The authors extend their
   appreciation to the Deanship of Scientific Research at King Saud
   University for funding this work through research group No. RG-1438-074.
CR Aderibigbe BA, 2017, MOLECULES, V22, DOI 10.3390/molecules22081370
   Arena A, 2006, INT IMMUNOPHARMACOL, V6, P8, DOI 10.1016/j.intimp.2005.07.004
   Banumathi B, 2017, PARASITOL RES, V116, P1637, DOI 10.1007/s00436-017-5438-6
   Benelli G, 2017, ENV SCI POLLUT RES I
   Benelli G, 2017, TICKS TICK-BORNE DIS, V8, P821, DOI 10.1016/j.ttbdis.2017.08.004
   Benelli G, 2017, ACTA TROP, V174, P91, DOI 10.1016/j.actatropica.2017.06.028
   Benelli G, 2017, J CLUST SCI, V28, P287, DOI 10.1007/s10876-016-1088-6
   Benelli G, 2016, ENZYME MICROB TECH, V95, P58, DOI 10.1016/j.enzmictec.2016.08.022
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Chandran P, 2014, COLLOID SURFACE B, V122, P611, DOI 10.1016/j.colsurfb.2014.07.039
   Chen JC, 2007, J HAZARD MATER, V142, P88, DOI 10.1016/j.jhazmat.2006.07.061
   Chen X, 2016, FOOD HYDROCOLLOID, V53, P69, DOI 10.1016/j.foodhyd.2014.12.032
   Das D, 2013, COLLOID SURFACE B, V111, P556, DOI 10.1016/j.colsurfb.2013.06.041
   Deepali S., 2011, APPL SURF SCI, V257, P9661
   Dharumadurai Dhanasekaran, 2013, Asian Pacific Journal of Tropical Disease, V3, P174
   Elshikh M, 2016, BIOTECHNOL LETT, V38, P1015, DOI 10.1007/s10529-016-2079-2
   Eskandari M, 2011, PHYSICA B, V406, P112, DOI 10.1016/j.physb.2010.10.035
   Fang YW, 2013, CARBOHYD POLYM, V92, P1172, DOI 10.1016/j.carbpol.2012.10.016
   [房耀维 Fang Yaowei], 2010, [食品科学, Food Science], V31, P276
   Govindarajan M, 2016, PARASITOL RES, V115, P807, DOI 10.1007/s00436-015-4809-0
   Ishwarya R, 2017, J PHOTOCH PHOTOBIO B, V174, P133, DOI 10.1016/j.jphotobiol.2017.07.026
   Ismail B, 2010, ARCH MICROBIOL, V192, P1049, DOI 10.1007/s00203-010-0636-y
   Jayaseelan BD, 2013, ANN MICROBIOL, V63, P1601, DOI 10.1007/s13213-013-0623-z
   Jayaseelan C, 2012, SPECTROCHIM ACTA A, V90, P78, DOI 10.1016/j.saa.2012.01.006
   Junter GA, 2016, ACTA BIOMATER, V30, P13, DOI 10.1016/j.actbio.2015.11.010
   Kairyte K, 2013, J PHOTOCH PHOTOBIO B, V128, P78, DOI 10.1016/j.jphotobiol.2013.07.017
   Kanmani P, 2013, PROCESS BIOCHEM, V48, P1099, DOI 10.1016/j.procbio.2013.05.011
   Khan SS, 2011, WATER RES, V45, P5184, DOI 10.1016/j.watres.2011.07.024
   Khan SS, 2011, J HAZARD MATER, V192, P299, DOI 10.1016/j.jhazmat.2011.05.024
   Kim B.S., 2010, BIOCATALYSIS BIOMOLE, P447
   Liu CH, 2010, BIORESOURCE TECHNOL, V101, P5528, DOI 10.1016/j.biortech.2010.01.151
   Ma HB, 2013, ENVIRON POLLUT, V172, P76, DOI 10.1016/j.envpol.2012.08.011
   Mahendran S., 2013, INT J REC SCI RES, V4, P501
   Malaikozhundan B, 2017, MICROB PATHOGENESIS, V104, P268, DOI 10.1016/j.micpath.2017.01.029
   Malaikozhundan B, 2016, BIOCATAL AGR BIOTECH, V8, P189, DOI 10.1016/j.bcab.2016.09.007
   Nagajyothi PC, 2015, J PHOTOCH PHOTOBIO B, V146, P10, DOI 10.1016/j.jphotobiol.2015.02.008
   Patel AK, 2010, FOOD TECHNOL BIOTECH, V48, P451
   Peralta M.A., 2015, PHYTOMEDICINE, V20, P12
   Raliya R, 2014, INT J BIOL MACROMOL, V65, P362, DOI 10.1016/j.ijbiomac.2014.01.060
   Rosi NL, 2005, CHEM REV, V105, P1547, DOI 10.1021/cr030067f
   Saratale R.G., 2017, ENV SCI POLLUT RES I
   Sarker SD, 2007, METHODS, V42, P321, DOI 10.1016/j.ymeth.2007.01.006
   Selvarajan E, 2013, MATER LETT, V112, P180, DOI 10.1016/j.matlet.2013.09.020
   Serpone N, 2007, INORG CHIM ACTA, V360, P794, DOI 10.1016/j.ica.2005.12.057
   Shanmugasundaram T., 2016, ARTIF CELL NANOMED B, V30, P1
   Shanthi S, 2016, MICROB PATHOGENESIS, V93, P70, DOI 10.1016/j.micpath.2016.01.014
   Shirley, 2010, DIG J NANOMATER BIOS, V5, P447
   Sinha S., 2009, J APPL BIOSCI, V19, P1113
   Sivalingam Manju, 2014, Journal of the Fisheries Society of Taiwan, V41, P123
   Stiefel P, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0376-x
   Suganya P, 2017, J PHOTOCH PHOTOBIO B, V173, P404, DOI 10.1016/j.jphotobiol.2017.06.004
   Sundararajan B, 2017, J TRACE ELEM MED BIO, V43, P187, DOI 10.1016/j.jtemb.2017.03.008
   Surendra TV, 2016, J PHOTOCH PHOTOBIO B, V162, P550, DOI 10.1016/j.jphotobiol.2016.07.032
   Thaya R, 2016, MICROB PATHOGENESIS, V100, P124, DOI 10.1016/j.micpath.2016.09.010
   Vaseeharan B, 2010, LETT APPL MICROBIOL, V50, P352, DOI 10.1111/j.1472-765X.2010.02799.x
   Velusamy P, 2015, IND CROP PROD, V66, P103, DOI 10.1016/j.indcrop.2014.12.042
   Vigneshwaran N, 2006, NANOTECHNOLOGY, V17, P5087, DOI 10.1088/0957-4484/17/20/008
   Vijayakumar S, 2015, SPECTROCHIM ACTA A, V137, P886, DOI 10.1016/j.saa.2014.08.064
   Vijayakumar S, 2016, LIMNOLOGICA, V61, P44, DOI 10.1016/j.limno.2016.09.007
   Vijayakumar S, 2016, BIOMED PHARMACOTHER, V84, P1213, DOI 10.1016/j.biopha.2016.10.038
   Vijayakumar S, 2016, J ENVIRON CHEM ENG, V4, P2076, DOI 10.1016/j.jece.2016.03.036
   Wang CL, 2011, NEW BIOTECHNOL, V28, P559, DOI 10.1016/j.nbt.2011.03.003
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Xu HW, 2014, FRONT PLANT SCI, V10, P1, DOI DOI 10.1016/J.ENVP0L.2014.10.031
   Yadav A, 2006, B MATER SCI, V29, P641, DOI 10.1007/s12034-006-0017-y
   Yoksan R, 2010, MAT SCI ENG C-MATER, V30, P891, DOI 10.1016/j.msec.2010.04.004
   Yu K. X., 2015, ASIAN PAC J TROP DIS, V8
   Yuranova T, 2007, CATAL TODAY, V122, P109, DOI 10.1016/j.cattod.2007.01.040
NR 68
TC 39
Z9 39
U1 7
U2 45
PU ELSEVIER GMBH
PI MUNICH
PA HACKERBRUCKE 6, 80335 MUNICH, GERMANY
SN 0946-672X
J9 J TRACE ELEM MED BIO
JI J. Trace Elem. Med. Biol.
PY 2018
VL 45
BP 93
EP 103
DI 10.1016/j.jtemb.2017.10.002
PG 11
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA FS5DC
UT WOS:000419812800014
PM 29173489
DA 2020-07-08
ER

PT J
AU Devakumar, D
   Bamford, A
   Ferreira, MU
   Broad, J
   Rosch, RE
   Groce, N
   Breuer, J
   Cardoso, MA
   Copp, AJ
   Alexandre, P
   Rodrigues, LC
   Abubakar, I
AF Devakumar, Delan
   Bamford, Alasdair
   Ferreira, Marcelo U.
   Broad, Jonathan
   Rosch, Richard E.
   Groce, Nora
   Breuer, Judith
   Cardoso, Marly A.
   Copp, Andrew J.
   Alexandre, Paula
   Rodrigues, Laura C.
   Abubakar, Ibrahim
TI Infectious causes of microcephaly: epidemiology, pathogenesis,
   diagnosis, and management
SO LANCET INFECTIOUS DISEASES
LA English
DT Review
ID HERPES-SIMPLEX-VIRUS; HUMAN CYTOMEGALOVIRUS-INFECTION;
   CONGENITAL-RUBELLA SYNDROME; VARICELLA-ZOSTER-VIRUS; ZIKA VIRUS;
   TOXOPLASMA-GONDII; CEREBRAL ORGANOIDS; VIRAL-INFECTIONS; PARVOVIRUS B19;
   BIRTH-DEFECTS
AB Microcephaly is an important sign of neurological malformation and a predictor of future disability. The 2015-16 outbreak of Zika virus and congenital Zika infection brought the world's attention to links between Zika infection and microcephaly. However, Zika virus is only one of the infectious causes of microcephaly and, although the contexts in which they occur vary greatly, all are of concern. In this Review, we summarise important aspects of major congenital infections that can cause microcephaly, and describe the epidemiology, transmission, clinical features, pathogenesis, management, and long-term consequences of these infections. We include infections that cause substantial impairment: cytomegalovirus, herpes simplex virus, rubella virus, Toxoplasma gondii, and Zika virus. We highlight potential issues with classification of microcephaly and show how some infants affected by congenital infection might be missed or incorrectly diagnosed. Although Zika virus has brought the attention of the world to the problem of microcephaly, prevention of all infectious causes of microcephaly and appropriately managing its consequences remain important global public health priorities.
C1 [Devakumar, Delan; Abubakar, Ibrahim] UCL, Inst Global Hlth, London WC1N 1EH, England.
   [Bamford, Alasdair] Great Ormond St Hosp Sick Children, Infect Dis Dept, London, England.
   [Ferreira, Marcelo U.] Univ Sao Paulo, Dept Parasitol, Inst Biomed Sci, Sao Paulo, Brazil.
   [Cardoso, Marly A.] Univ Sao Paulo, Dept Nutr, Sch Publ Hlth, Sao Paulo, Brazil.
   [Bamford, Alasdair; Rosch, Richard E.; Copp, Andrew J.; Alexandre, Paula] UCL, Great Ormond St Inst Child Hlth, London, England.
   [Broad, Jonathan] Univ Oxford, Dept Paediat, Oxford, England.
   [Groce, Nora] UCL, Leonard Cheshire Disabil & Inclus Dev Ctr, London, England.
   [Breuer, Judith] UCL, Div Infect & Immun, London, England.
   [Rodrigues, Laura C.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.
RP Devakumar, D (corresponding author), UCL, Inst Global Hlth, London WC1N 1EH, England.
EM d.devakumar@ucl.ac.uk
RI Cardoso, Marly A/B-8010-2013; Zebrafish, UCL/A-3125-2009; Rosch, Richard
   Ewald/H-8409-2019; Ferreira, Marcelo U/G-8289-2011
OI Cardoso, Marly A/0000-0003-0973-3908; Rosch, Richard
   Ewald/0000-0002-0316-5818; Ferreira, Marcelo U/0000-0002-5293-9090;
   Alexandre, Ana/0000-0002-6333-6199; Breuer, Judith/0000-0001-8246-0534;
   Groce, Nora/0000-0002-7885-7042
FU UK National Institute for Health Research (NIHR)National Institute for
   Health Research (NIHR); Royal Society, Dorothy Hodgkin FellowshipRoyal
   Society of London; NIHRNational Institute for Health Research (NIHR)
   [SRF-2011-04-001, NF-SI-0616-10037]; NIHR UCL/UCLH Biomedical Research
   Centre; European Union's Horizon research and innovation programme under
   Zika-PLAN [734584]
FX We thank Fabien Lafaille (St Giles Laboratory of Human Genetics of
   Infectious Diseases, The Rockefeller University, New York, NY, USA) who
   advised on herpes simplex virus and brain development; and the Joint
   Medical Research Council/Wellcome Trust (099175/Z/12/Z) Human
   Developmental Biology Resource for providing the human brain section
   shown in figure 2. DD receives salary support from the UK National
   Institute for Health Research (NIHR), and PA receives salary support
   from the Royal Society, Dorothy Hodgkin Fellowship. IA is supported by
   the NIHR (SRF-2011-04-001; NF-SI-0616-10037). JuB receives funding from
   the NIHR UCL/UCLH Biomedical Research Centre. LCR is partially funded by
   the European Union's Horizon 2020 research and innovation programme
   under Zika-PLAN grant agreement no 734584.
CR Alanen A, 2005, BJOG-INT J OBSTET GY, V112, P50, DOI 10.1111/j.1471-0528.2004.00320.x
   Alanen A, 2000, CLIN INFECT DIS, V30, P363, DOI 10.1086/313666
   [Anonymous], 2013, CHILDREN DISABILITIE
   Ashwal S, 2009, NEUROLOGY, V73, P887, DOI 10.1212/WNL.0b013e3181b783f7
   Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   Barefoot Katharine H, 2002, J Perinatol, V22, P86, DOI 10.1038/sj.jp.7210584
   Barkovich AJ, 2005, NEUROLOGY, V65, P1873, DOI 10.1212/01.wnl.0000183747.05269.2d
   Best JM, 2007, SEMIN FETAL NEONAT M, V12, P182, DOI 10.1016/j.siny.2007.01.017
   Bharucha T, 2016, NEUROPATH APPL NEURO, V42, P317, DOI 10.1111/nan.12326
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Braun E, 2006, J GEN VIROL
   Britt W, 2015, MED MICROBIOL IMMUN, V204, P263, DOI 10.1007/s00430-015-0399-9
   Britto PR, 2017, LANCET, V389, P91, DOI 10.1016/S0140-6736(16)31390-3
   Buchman JJ, 2010, NEURON, V66, P386, DOI 10.1016/j.neuron.2010.03.036
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cannon MJ, 2010, REV MED VIROL, V20, P202, DOI 10.1002/rmv.655
   Capobiango JD, 2014, BRAZ J INFECT DIS, V18, P364, DOI 10.1016/j.bjid.2013.11.009
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Centers for Disease Control, 2016, FACTS MICR
   Centers for Disease Control and Prevention, 2015, DPDX LAB ID PAR DIS
   Cheeran MCJ, 2009, CLIN MICROBIOL REV, V22, P99, DOI 10.1128/CMR.00023-08
   Chen JF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4885
   Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192
   Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023
   COOPER LZ, 1969, AM J DIS CHILD, V118, P18, DOI 10.1001/archpedi.1969.02100040020004
   Cortina-Borja M, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000351
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Aiuto L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049700
   DAFFOS F, 1988, NEW ENGL J MED, V318, P271, DOI 10.1056/NEJM198802043180502
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Dard C, 2016, TRENDS PARASITOL, V32, P492, DOI 10.1016/j.pt.2016.04.001
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   DOLK H, 1991, DEV MED CHILD NEUROL, V33, P974
   Dollard SC, 2007, REV MED VIROL, V17, P355, DOI 10.1002/rmv.544
   Dreher AM, 2014, J PEDIATR-US, V164, P855, DOI 10.1016/j.jpeds.2013.12.007
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Feldman B, 2011, AM J OBSTET GYNECOL, V4, pe1
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   GIVENS KT, 1993, BRIT J OPHTHALMOL, V77, P358, DOI 10.1136/bjo.77.6.358
   Graham KA, 2017, MMWR-MORBID MORTAL W, V66, P125, DOI 10.15585/mmwr.mm6605a1
   Groce N, 2014, SOCIAL INJUSTICE PUB
   Hamel R, 2016, MICROBES INFECT, V18, DOI 10.1016/j.micinf.2016.03.009
   Health Protection Agency, 2011, GUID VIR RASH PREGN
   Heinonen K, 2008, PEDIATRICS, V121, pE1325, DOI 10.1542/peds.2007-1172
   Holt RL, 2011, PEDIATR NEUROL, V44, P239, DOI 10.1016/j.pediatrneurol.2010.11.009
   Hu SX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105219
   Hughes BL, 2016, AM J OBSTET GYNECOL
   HUTTO C, 1987, J PEDIATR-US, V110, P97, DOI 10.1016/S0022-3476(87)80298-6
   Johansson AB, 2004, CLIN INFECT DIS, V38, pE57, DOI 10.1086/382673
   Johnson KE, 2015, OVERVIEW TORCH INFEC
   Jones JL, 2001, AM J EPIDEMIOL, V154, P357, DOI 10.1093/aje/154.4.357
   Kenneson A, 2007, REV MED VIROL, V17, P253, DOI 10.1002/rmv.535
   Khamduang W, 2011, JAIDS-J ACQ IMM DEF, V58, P188, DOI [10.1097/QAI.0B013E31822D0433, 10.1097/QAI.0b013e31822d0433]
   Kimberlin DW, 2015, NEW ENGL J MED, V372, P933, DOI 10.1056/NEJMoa1404599
   Kimberlin DW, 2013, PEDIATRICS, V131, pE635, DOI 10.1542/peds.2012-3216
   Kimberlin DW, 2004, CLIN MICROBIOL REV, V17, P1, DOI 10.1128/CMR.17.1.1-13.2004
   Kimberlin DW, 2003, J PEDIATR-US, V143, P16, DOI 10.1016/S0022-3476(03)00192-6
   Kimberlin DW, 2001, PEDIATRICS, V108, P230, DOI 10.1542/peds.108.2.230
   Krauss MJ, 2003, AM J OBSTET GYNECOL, V188, P1484, DOI 10.1067/mob.2003.452
   Lafaille FG, 2012, NATURE, V491, P769, DOI 10.1038/nature11583
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Lazar M, 2016, EBIOMEDICINE, V3, P86, DOI 10.1016/j.ebiom.2015.11.050
   Lazzarotto T, 2008, J CLIN VIROL, V41, P192, DOI 10.1016/j.jcv.2007.10.015
   Lee JY, 2000, CLIN MICROBIOL REV, V13, P571, DOI 10.1128/CMR.13.4.571-587.2000
   Leruez-Ville M, 2016, EXPERT REV ANTI-INFE, V14, P479, DOI 10.1586/14787210.2016.1173540
   Leviton A, 2002, EARLY HUM DEV, V69, P91, DOI 10.1016/S0378-3782(02)00065-8
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li XJ, 2015, J VIROL, V89, P6792, DOI 10.1128/JVI.00351-15
   Lipitz S, 2013, ULTRASOUND OBST GYN, V41, P508, DOI 10.1002/uog.12377
   Looker KJ, 2008, B WORLD HEALTH ORGAN, V86, P805, DOI 10.2471/BLT.07.046128
   Looker KJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114989
   Luo MH, 2010, J VIROL, V84, P3528, DOI 10.1128/JVI.02161-09
   Manicklal S, 2013, CLIN MICROBIOL REV, V26, P86, DOI 10.1128/CMR.00062-12
   Marquez L, 2011, PEDIATR INFECT DIS J, V30, P153, DOI 10.1097/INF.0b013e3181f55a5c
   Marthiens V, 2013, NAT CELL BIOL, V15, P731, DOI 10.1038/ncb2746
   McAuley JB, 2014, J PEDIAT INF DIS SOC, V3, pS30, DOI 10.1093/jpids/piu077
   McLeod R, 2009, MEM I OSWALDO CRUZ, V104, P320, DOI 10.1590/S0074-02762009000200029
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mendelson E, 2006, REPROD TOXICOL, V21, P350, DOI 10.1016/j.reprotox.2006.02.001
   MILLER E, 1982, LANCET, V2, P781
   Mitra S, 2013, WORLD DEV, V41, P1, DOI 10.1016/j.worlddev.2012.05.024
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Morris JK, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4721
   Nguyen T. V., 2014, EBIOMEDICINE, V2, P59
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Noyola DE, 2001, J PEDIATR-US, V138, P325, DOI 10.1067/mpd.2001.112061
   O'Rahilly R., 1987, DEV STAGES HUMAN EMB, V637
   Odeberg J, 2006, J VIROL, V80, P8929, DOI 10.1128/JVI.00676-06
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Ornoy A, 2006, REPROD TOXICOL
   Palmer M, 2011, J DISABIL POLICY STU, V21, P210, DOI 10.1177/1044207310389333
   Pandolfi E, 2017, EUR J PUBLIC HEALTH, V27, P530, DOI 10.1093/eurpub/ckw259
   Pass RF, 1999, VIRAL INFECT OBSTET
   Passemard S, 2013, HAND CLINIC, V111, P129, DOI 10.1016/B978-0-444-52891-9.00013-0
   Petersen E, 2007, SEMIN FETAL NEONAT M, V12, P214, DOI 10.1016/j.siny.2007.01.011
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Picone O, 2013, PRENATAL DIAG, V33, P751, DOI 10.1002/pd.4118
   Pillai S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10072
   Pinninti SG, 2013, PEDIATR CLIN N AM, V60, P351, DOI 10.1016/j.pcl.2012.12.005
   Plotkin SARS, 2011, INFECT DIS FETUS NEW, P861
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Razek AAKA, 2009, AM J NEURORADIOL, V30, P4, DOI 10.3174/ajnr.A1223
   Reef SE, 2000, CLIN INFECT DIS, V31, P85, DOI 10.1086/313928
   Remington J, 1995, INFECT DIS FETUS NEW, P1
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Rolland M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005547
   RORKE LB, 1968, LANCET, V2, P153
   Rorman E, 2006, REPROD TOXICOL, V21, P458, DOI 10.1016/j.reprotox.2005.10.006
   Sabin AB, 1942, ADV PEDIATR, V1, P1
   Sahara S, 2009, NEURON, V63, P48, DOI 10.1016/j.neuron.2009.06.006
   Schoenfisch AL, 2011, J MED MICROBIOL, V60, P768, DOI 10.1099/jmm.0.027771-0
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Seo S, 2009, KOREAN J LAB MED, V29, P557, DOI 10.3343/kjlm.2009.29.6.557
   Shah T, 2016, ARCH DIS CHILDHOOD-E, V101, P232, DOI 10.1136/archdischild-2015-309656
   Sheevani, 2005, Indian J Med Microbiol, V23, P34
   Silasi M, 2015, AM J REPROD IMMUNOL, V73, P199, DOI 10.1111/aji.12355
   Szabo N, 2010, ACTA PAEDIATR, V99, P690, DOI 10.1111/j.1651-2227.2009.01666.x
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7
   The United Nations Children's Fund, 2005, VIOL DIS CHILDR
   Thiebaut R, 2007, LANCET, V369, P115
   Tondury G, 1966, J PEDIAT
   Torgerson PR, 2013, B WORLD HEALTH ORGAN, V91, P501, DOI 10.2471/BLT.12.111732
   UN, 2006, UN CONV RIGHTS PERS
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   Von der Hagen M, 2014, DEV MED CHILD NEUROL, V56, P732, DOI 10.1111/dmcn.12425
   Vynnycky E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149160
   Waddell LA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156376
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Wang ZD, 2017, LANCET HIV, V4, pE177, DOI 10.1016/S2352-3018(17)30005-X
   Webster WS, 1998, TERATOLOGY, V58, P13
   Wells MF, 2016, CELL STEM CELL
   WHO, 2011, WORLD REPORT ON DISABILITY, P1
   WHO, 2016, RUB
   WHO, 2017, ZIK SIT REP
   WHO, 2016, ZIK VIR FACT SHEET
   WHO, 2016, RAP ADV GUID
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Woods CG, 2013, ARCH DIS CHILD, V98, P707, DOI 10.1136/archdischild-2012-302882
   Woods CG, 2004, CURR OPIN NEUROBIOL, V14, P112, DOI 10.1016/j.conb.2004.01.003
   World Health Organization, 2017, IMM COV FACT SHEET
   World Health Organization, 2016, PSYCH SUPP PREGN WOM
   World Health Organization, WHO CHILD GROWTH STA
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Yamin A.E., 2016, HLTH HUMAN RIGHTS ZI
NR 151
TC 21
Z9 23
U1 2
U2 25
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD JAN
PY 2018
VL 18
IS 1
BP E1
EP E13
DI 10.1016/S1473-3099(17)30398-5
PG 13
WC Infectious Diseases
SC Infectious Diseases
GA FQ8VG
UT WOS:000418640700001
PM 28844634
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Fernandez, E
   Kose, N
   Edeling, MA
   Adhikari, J
   Sapparapu, G
   Lazarte, SM
   Nelson, CA
   Govero, J
   Gross, ML
   Fremont, DH
   Crowe, JE
   Diamond, MS
AF Fernandez, Estefania
   Kose, Nurgun
   Edeling, Melissa A.
   Adhikari, Jagat
   Sapparapu, Gopal
   Lazarte, Susana M.
   Nelson, Christopher A.
   Govero, Jennifer
   Gross, Michael L.
   Fremont, Daved H.
   Crowe, James E., Jr.
   Diamond, Michael S.
TI Mouse and Human Monoclonal Antibodies Protect against Infection by
   Multiple Genotypes of Japanese Encephalitis Virus
SO MBIO
LA English
DT Article
DE antibody; flavivirus; immunotherapy; pathogenesis; virology
ID WEST-NILE-VIRUS; ENVELOPE PROTEIN; DENGUE-VIRUS; DOMAIN-III;
   NEUTRALIZING ANTIBODIES; CRYSTAL-STRUCTURE; STRUCTURAL BASIS;
   MEMBRANE-FUSION; 5TH GENOTYPE; ZIKA VIRUS
AB Japanese encephalitis virus (JEV) remains a leading cause of viral encephalitis worldwide. Although JEV-specific antibodies have been described, an assessment of their ability to neutralize multiple genotypes of JEV has been limited. Here, we describe the development of a panel of mouse and human neutralizing monoclonal antibodies (MAbs) that inhibit infection in cell culture of four different JEV genotypes tested. Mechanism-of-action studies showed that many of these MAbs inhibited infection at a postattachment step, including blockade of virus fusion. Mapping studies using site-directed mutagenesis and hydrogen-deuterium exchange with mass spectrometry revealed that the lateral ridge on domain III of the envelope protein was a primary recognition epitope for our panel of strongly neutralizing MAbs. Therapeutic studies in mice demonstrated protection against lethality caused by genotype I and III strains when MAbs were administered as a single dose even 5 days after infection. This information may inform the development of vaccines and therapeutic antibodies as emerging strains and genotypic shifts become more prevalent.
   IMPORTANCE Although Japanese encephalitis virus (JEV) is a vaccine-preventable cause of viral encephalitis, the inactivated and live attenuated platforms available are derived from strains belonging to a single genotype (GIII) due to its historical prevalence in areas of JEV epidemics. Related to this, studies with vaccines and antibodies have focused on assessing the in vitro and in vivo protective responses to homologous or heterologous GIII strains. An epidemiological shift in JEV genotype distribution warrants the induction of broadly neutralizing antibody responses that inhibit infection of multiple JEV genotypes. Here, we generated a panel of mouse and human neutralizing monoclonal antibodies and evaluated their inhibitory activity, epitope location, and capacity for protection against multiple JEV genotypes in mice.
C1 [Fernandez, Estefania; Edeling, Melissa A.; Nelson, Christopher A.; Govero, Jennifer; Fremont, Daved H.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.
   [Kose, Nurgun; Sapparapu, Gopal; Crowe, James E., Jr.] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA.
   [Kose, Nurgun; Sapparapu, Gopal; Crowe, James E., Jr.] Vanderbilt Univ, Med Ctr, Vanderbilt Vaccine Ctr, Nashville, TN USA.
   [Adhikari, Jagat; Gross, Michael L.] Washington Univ, Dept Chem, St Louis, MO 63130 USA.
   [Lazarte, Susana M.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.
   [Lazarte, Susana M.] Univ Texas Southwestern Med Sch Dallas, Dept Med, Dallas, TX USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol, St Louis, MO 63130 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Immunotherapy Programs, St Louis, MO 63130 USA.
   [Fremont, Daved H.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.
   [Fremont, Daved H.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA.
RP Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol, St Louis, MO 63130 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Immunotherapy Programs, St Louis, MO 63130 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.
EM diamond@wusm.wustl.edu
RI Crowe, James E./B-5549-2009; Diamond, Michael/AAH-1733-2019
OI Crowe, James E./0000-0002-0049-1079; Diamond,
   Michael/0000-0002-8791-3165
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [HHSN272201400018C, T32 AI007163,
   P41GM103422]
FX This work was supported by a contract from the NIH (HHSN272201400018C to
   D.H.F., M.S.D., and J.E.C.) and T32 AI007163 to E.F. The mass
   spectrometry resource was supported by NIH (P41GM103422).
CR [Anonymous], 2015, Wkly Epidemiol Rec, V90, P69
   Austin SK, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002930
   Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   Borah J, 2011, J CLIN VIROL, V52, P45, DOI 10.1016/j.jcv.2011.06.001
   Brien James D, 2013, Curr Protoc Microbiol, V31, DOI 10.1002/9780471729259.mc15d03s31
   Brien JD, 2010, J VIROL, V84, P10630, DOI 10.1128/JVI.01190-10
   BURKE D S, 1985, Southeast Asian Journal of Tropical Medicine and Public Health, V16, P199
   Busby SA, 2007, INT J MASS SPECTROM, V259, P130, DOI 10.1016/j.ijms.2006.08.006
   Campbell GL, 2011, B WORLD HEALTH ORGAN, V89, P766, DOI 10.2471/BLT.10.085233
   Chen E, 2016, P NATL ACAD SCI USA, V113, P6277, DOI 10.1073/pnas.1600488113
   Chen KM, 2009, J MICROBIOL IMMUNOL, V42, P296
   CHEN WR, 1992, AM J TROP MED HYG, V47, P61, DOI 10.4269/ajtmh.1992.47.61
   CHEN WR, 1990, J GEN VIROL, V71, P2915, DOI 10.1099/0022-1317-71-12-2915
   Cockburn JJB, 2012, EMBO J, V31, P767, DOI 10.1038/emboj.2011.439
   Davidson E, 2014, IMMUNOLOGY, V143, P13, DOI 10.1111/imm.12323
   Edeling MA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004072
   Goncalvez AP, 2008, J VIROL, V82, P7009, DOI 10.1128/JVI.00291-08
   Goo L, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006178
   Halstead SB, 2010, VACCINES: A BIOGRAPHY, P317, DOI 10.1007/978-1-4419-1108-7_18
   HAMMON WM, 1949, AM J HYG, V50, P51, DOI 10.1093/oxfordjournals.aje.a119344
   Jarmer J, 2014, J VIROL, V88, P13845, DOI 10.1128/JVI.02086-14
   KIMURAKURODA J, 1988, J IMMUNOL, V141, P3606
   KIMURAKURODA J, 1983, J VIROL, V45, P124, DOI 10.1128/JVI.45.1.124-132.1983
   KIMURAKURODA J, 1986, J GEN VIROL, V67, P2663, DOI 10.1099/0022-1317-67-12-2663
   Liao MF, 2005, J CELL BIOL, V171, P111, DOI 10.1083/jcb.200507075
   Lin CW, 2003, J VIROL, V77, P2600, DOI 10.1128/JVI.77.4.2600-2606.2003
   Luca VC, 2012, J VIROL, V86, P2337, DOI 10.1128/JVI.06072-11
   Ma SP, 2003, AM J TROP MED HYG, V69, P151, DOI 10.4269/ajtmh.2003.69.151
   Mancia F, 2004, STRUCTURE, V12, P1355, DOI 10.1016/j.str.2004.06.012
   MASON PW, 1989, J GEN VIROL, V70, P2037, DOI 10.1099/0022-1317-70-8-2037
   Mohammed MAF, 2011, INFECT GENET EVOL, V11, P855, DOI 10.1016/j.meegid.2011.01.020
   Nybakken GE, 2005, NATURE, V437, P764, DOI 10.1038/nature03956
   Nybakken GE, 2006, J VIROL, V80, P11467, DOI 10.1128/JVI.01125-06
   Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240
   Oliphant T, 2006, J VIROL, V80, P12149, DOI 10.1128/JVI.01732-06
   Pal P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003312
   Pascal BD, 2012, J AM SOC MASS SPECTR, V23, P1512, DOI 10.1007/s13361-012-0419-6
   Pierson Theodore C., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000665
   Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   ROEHRIG JT, 1990, VIROLOGY, V177, P668, DOI 10.1016/0042-6822(90)90532-V
   Schuh AJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002411
   Schuh AJ, 2010, J GEN VIROL, V91, P95, DOI 10.1099/vir.0.013631-0
   Shimoda H, 2013, J VET MED SCI, V75, P1077, DOI 10.1292/jvms.12-0558
   Shrestha B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000823
   Smith DP, 2013, MBIO, V4, DOI 10.1128/mBio.00133-12
   Solomon T, 2000, J NEUROL NEUROSUR PS, V68, P405, DOI 10.1136/jnnp.68.4.405
   Solomon T, 1998, LANCET, V351, P1094, DOI 10.1016/S0140-6736(97)07509-0
   Stiasny K, 2007, J VIROL, V81, P11526, DOI 10.1128/JVI.01041-07
   Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016
   Sukupolvi-Petty S, 2007, J VIROL, V81, P12816, DOI 10.1128/JVI.00432-07
   Takhampunya R, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-449
   Thompson BS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000453
   Throsby M, 2006, J VIROL, V80, P6982, DOI 10.1128/JVI.00551-06
   Uchil PD, 2001, AM J TROP MED HYG, V65, P242, DOI 10.4269/ajtmh.2001.65.242
   VAUGHN DW, 1992, EPIDEMIOL REV, V14, P197, DOI 10.1093/oxfordjournals.epirev.a036087
   Vratskikh O, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003458
   Wahala WMPB, 2009, VIROLOGY, V392, P103, DOI 10.1016/j.virol.2009.06.037
   Wahala WMPB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000821
   Wang HY, 2007, J GEN VIROL, V88, P885, DOI 10.1099/vir.0.82185-0
   Wang HY, 2015, THER CLIN RISK MANAG, V11, P435, DOI 10.2147/TCRM.S51168
   Xu H, 2009, PROTEOMICS, V9, P1548, DOI 10.1002/pmic.200700322
   Yan YT, 2015, BIOCHEMISTRY-US, V54, P5322, DOI 10.1021/acs.biochem.5b00761
   ZHANG MJ, 1989, J MED VIROL, V29, P133, DOI 10.1002/jmv.1890290211
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 66
TC 11
Z9 11
U1 1
U2 5
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2150-7511
J9 MBIO
JI mBio
PD JAN-FEB
PY 2018
VL 9
IS 1
AR e00008-18
DI 10.1128/mBio.00008-18
PG 17
WC Microbiology
SC Microbiology
GA FY6XN
UT WOS:000427006300092
PM 29487230
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Wen, D
   Li, SH
   Dong, FF
   Zhang, YA
   Lin, YF
   Wang, JM
   Zou, Z
   Zheng, AH
AF Wen, Dan
   Li, Suhua
   Dong, Fangfang
   Zhang, Yanan
   Lin, Yongfang
   Wang, Jumei
   Zou, Zhen
   Zheng, Aihua
TI N-glycosylation of Viral E Protein Is the Determinant for Vector Midgut
   Invasion by Flaviviruses
SO MBIO
LA English
DT Article
DE flavivirus; glycosylation; mosquito; transmission; Zika
ID VIRUS ENVELOPE PROTEIN; WEST-NILE-VIRUS; AEDES-AEGYPTI MOSQUITOS; ZIKA
   VIRUS; DENGUE VIRUS; DC-SIGN; STRUCTURAL BASIS; IN-VITRO; INFECTION;
   GLYCOPROTEIN
AB Transmission of flaviviruses by hematophagous insects such as mosquitoes requires acquisition of the virus during blood feeding on the host, with midgut as the primary infection site. Here, we report that N-glycosylation of the E protein, which is conserved among most flaviviruses, is critical for the Zika virus (ZIKV) to invade the vector midgut by inhibiting the reactive oxygen species (ROS) pathway of the mosquito immune system. Our data further show that removal of the ZIKV E glycosylation site prevents mosquito infection by flaviviruses via the oral route, whereas there is no effect on infection by intrathoracic microinjection, which bypasses the midgut. Interestingly, the defect in infection of the mosquito midgut by the mutant virus through blood feeding is rescued by reduction of the ROS level by application of vitamin C, a well-known antioxidant. Therefore, our data demonstrate that ZIKV utilizes the glycosylation on the envelope to antagonize the vector immune defense during infection.
   IMPORTANCE Most flaviviruses, including Zika virus (ZIKV), are transmitted between hosts by arthropod vectors, such as mosquitoes, which acquire the virus during a blood meal. Here, by mutagenesis, we found a major role of the N-glycosylation of flavivirus E protein in its transmission circle, facilitating its survival against the vector immune system during invasion of the mosquito midgut while blood feeding on the host. In spite of the extensive studies of the involvement of N-glycan modification of flavivirus E protein in virus-host interactions, we discovered its critical role in virus-vector interaction and the evolution of flavivirus. Given the deleterious effects of ZIKV on human health, this study might have a significant impact on development of novel transmission-blocking strategies.
C1 [Wen, Dan; Li, Suhua; Dong, Fangfang; Zhang, Yanan; Lin, Yongfang; Wang, Jumei; Zou, Zhen; Zheng, Aihua] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China.
   [Wen, Dan; Li, Suhua; Dong, Fangfang; Zhang, Yanan; Lin, Yongfang; Wang, Jumei; Zou, Zhen; Zheng, Aihua] Univ Chinese Acad Sci, Beijing, Peoples R China.
RP Zou, Z; Zheng, AH (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China.; Zou, Z; Zheng, AH (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.
EM zouzhen@ioz.ac.cn; zhengaihua@ioz.ac.cn
FU Strategic Priority Research Program of the Chinese Academy of
   SciencesChinese Academy of Sciences [XDB11030800, XDB11030600]; National
   Key Plan for Scientific Research and Development of China
   [2016YFD0500300, 2014CB138405, 2017YFC1201004]; Natural Science
   Foundation of ChinaNational Natural Science Foundation of China
   [L1524009]; Open Research Fund Program of the State Key Laboratory of
   Integrated Pest Management [IPM1511, IPM1603]
FX This project was funded by the Strategic Priority Research Program of
   the Chinese Academy of Sciences (XDB11030800, XDB11030600), National Key
   Plan for Scientific Research and Development of China (2016YFD0500300,
   2014CB138405), National Key Plan for Scientific Research and Development
   of China (2017YFC1201004), the Natural Science Foundation of China
   (L1524009), and the Open Research Fund Program of the State Key
   Laboratory of Integrated Pest Management (IPM1511 and IPM1603).
CR Annamalai AS, 2017, J VIROL, V91, DOI [10.1128/JVI.01348-17, 10.1128/jvi.01348-17]
   Ansarah-Sobrinho C, 2008, VIROLOGY, V381, P67, DOI 10.1016/j.virol.2008.08.021
   Attardo GM, 2005, INSECT BIOCHEM MOLEC, V35, P661, DOI 10.1016/j.ibmb.2005.02.013
   Bae YS, 2010, TRENDS IMMUNOL, V31, P278, DOI 10.1016/j.it.2010.05.003
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Bryant JE, 2007, VIROLOGY, V366, P415, DOI 10.1016/j.virol.2007.05.007
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Cirimotich CM, 2011, SCIENCE, V332, P855, DOI 10.1126/science.1201618
   Crill WD, 2004, J VIROL, V78, P13975, DOI 10.1128/JVI.78.24.13975-13986.2004
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Feinberg H, 2001, SCIENCE, V294, P2163, DOI 10.1126/science.1066371
   Fontes-Garfias CR, 2017, CELL REP, V21, P1180, DOI 10.1016/j.celrep.2017.10.016
   Goo L, 2018, VIROLOGY, V515, P191, DOI 10.1016/j.virol.2017.12.032
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Gubler DJ, 2017, J INFECT DIS, V216, pS860, DOI 10.1093/infdis/jix451
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hasan SS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14722
   HAYS AR, 1990, ROUX ARCH DEV BIOL, V199, P114, DOI 10.1007/BF02029559
   Higgs S, 2016, VECTOR-BORNE ZOONOT, V16, P75, DOI 10.1089/vbz.2016.29001.hig
   Huang JH, 2015, INSECT BIOCHEM MOLEC, V67, P15, DOI 10.1016/j.ibmb.2015.05.004
   Imperato PJ, 2016, J COMMUN HEALTH, V41, P674, DOI 10.1007/s10900-016-0177-7
   Kanzaki H, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00351
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lee E, 1997, VIROLOGY, V232, P281, DOI 10.1006/viro.1997.8570
   Lee E, 2010, J VIROL, V84, P5171, DOI 10.1128/JVI.01900-09
   Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615
   Liu JW, 2016, ADV COMPUT SCI TECH, P1
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Liu Y, 2015, MOLECULES, V20, P2272, DOI 10.3390/molecules20022272
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Martin CSS, 2009, TRENDS MICROBIOL, V17, P514, DOI 10.1016/j.tim.2009.08.002
   Miller JL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040017
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100
   Mondotte JA, 2007, J VIROL, V81, P7136, DOI 10.1128/JVI.00116-07
   Mossenta M, 2017, BIOCHEM BIOPH RES CO, V492, P579, DOI 10.1016/j.bbrc.2017.01.022
   Moudy RM, 2011, AM J TROP MED HYG, V85, P374, DOI 10.4269/ajtmh.2011.10-0697
   Moudy RM, 2009, VIROLOGY, V387, P222, DOI 10.1016/j.virol.2009.01.038
   Murata R, 2010, AM J TROP MED HYG, V82, P696, DOI 10.4269/ajtmh.2010.09-0262
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Pan XL, 2012, P NATL ACAD SCI USA, V109, pE23, DOI 10.1073/pnas.1116932108
   Pierson TC, 2013, CURR OPIN VIROL, V3, P3, DOI 10.1016/j.coviro.2012.12.001
   Pokidysheva E, 2006, CELL, V124, P485, DOI 10.1016/j.cell.2005.11.042
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Schwarz MC, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00246-16
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Shi PY, 2002, J VIROL, V76, P5847, DOI 10.1128/JVI.76.12.5847-5856.2002
   Shirato K, 2004, J GEN VIROL, V85, P3637, DOI 10.1099/vir.0.80247-0
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Stiasny K, 2006, J VIROL, V80, P9557, DOI 10.1128/JVI.00080-06
   Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840
   Vigerust DJ, 2007, TRENDS MICROBIOL, V15, P211, DOI 10.1016/j.tim.2007.03.003
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Wang XL, 2017, P NATL ACAD SCI USA, V114, pE2709, DOI 10.1073/pnas.1619326114
   Widman DG, 2017, MBIO, V8, DOI [10.1128/mBio.02014-16, 10.1128/mbio.02014-16]
   Xiao XP, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004848
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463
   Zhang Y, 2004, STRUCTURE, V12, P1607, DOI 10.1016/j.str.2004.06.019
   Zheng AH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4877
NR 68
TC 17
Z9 17
U1 0
U2 3
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2150-7511
J9 MBIO
JI mBio
PD JAN-FEB
PY 2018
VL 9
IS 1
AR e00046-18
DI 10.1128/mBio.00046-18
PG 14
WC Microbiology
SC Microbiology
GA FY6XN
UT WOS:000427006300077
PM 29463651
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Nading, A
   Lowe, L
AF Nading, Alex
   Lowe, Lucy
TI Social Justice as Epidemic Control: Two Latin American Case Studies
SO MEDICAL ANTHROPOLOGY
LA English
DT Article
DE Latin America; Zika; epidemiology; health communication; race and
   gender; social movements
ID ZIKA VIRUS; REPRODUCTIVE RIGHTS; ILLEGAL ABORTION; ITINERARIES
AB In this article, we draw on two casesone of the reproductive justice movements in the wake of the Latin American Zika epidemic, and one of an environmental justice movements spurred by an epidemic of chronic kidney disease among sugarcane workersto argue for social justice as an elastic technology of epidemic control. In its compressed form, social justice simply refers to the fair distribution of medical goods. In its expanded form, it emphasizes the recognition and representation not just of medical problems, but of entangled histories of racial, gendered, and economic inequity.
C1 [Nading, Alex] Brown Univ, Inst Int & Publ Affairs, Providence, RI 02912 USA.
   [Lowe, Lucy] Univ Edinburgh, Sch Social & Polit Sci, Edinburgh, Midlothian, Scotland.
RP Nading, A (corresponding author), 1109 Thayer St,Box 1970, Providence, RI 02912 USA.
EM alex_nading@brown.edu
OI Nading, Alex/0000-0002-1731-321X
FU Wenner-Gren Foundation for Anthropological Research
FX Portions of this research were funded by a Wenner-Gren Foundation for
   Anthropological Research Post-PhD grant.
CR Adams Vincanne, 2016, METRICS WHAT COUNTS
   Aiken ARA, 2016, NEW ENGL J MED, V375, P396, DOI 10.1056/NEJMc1605389
   Ali M, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0282-9
   Baer H. A., 2003, MED ANTHR WORLD SYST
   Biehl J., 2013, PEOPLE COME 1 CRITIC
   Briggs C. L., 2003, STORIES TIME CHOLERA
   Briggs Charles L., 2016, TELL ME WHY MY CHILD
   Brooks D., 2012, SUMMARY REPORT BOSTO
   Bullard Robert D., 2000, DUMPING DIXIE RACE C
   CAO (Compliance Advisor Ombudsman), 2008, 25331 INT FIN CORP C
   Chatterjee R., 2016, SCI ONLINE      0331, DOI [10.1126/science.aaf9999, DOI 10.1126/SCIENCE.AAF9999]
   Checker Melissa, 2005, POLLUTED PROMISES EN
   COLLUCCI C, 2016, BMJ-BRIT MED J, V354, DOI DOI 10.1136/bmj.i4657
   Daryani P., 2018, HOPKINS BLOOMBERG PU
   Davis C., 2017, LAST RESORT WOMEN AR
   De Zordo S, 2016, HIST CIENC SAUDE-MAN, V23, P19, DOI 10.1590/S0104-59702016000100003
   Diniz D., 2017, ZIKA BRAZILIAN BACKL
   Diniz D, 2017, DEV WORLD BIOETH, V17, P142, DOI 10.1111/dewb.12175
   Diniz D, 2016, DEV WORLD BIOETH, V16, P62, DOI 10.1111/dewb.12119
   Diniz D, 2012, CIENC SAUDE COLETIVA, V17, P1671, DOI 10.1590/S1413-81232012000700002
   Diniz SG, 2017, REPROD HEALTH MATTER, V25, P21, DOI 10.1080/09688080.2017.1397442
   Farmer P, 1999, INFECT INEQUALITIES
   Fassin Didier, 2012, MED ANTHR INTERSECTI, P95
   Fortun K., 2001, ADVOCACY BHOPAL ENV
   Fraser N., 2013, FORTUNES FEMINISM ST
   Fraser N, 2010, SCALES JUSTICE REIMA
   Glum J., 2016, INT BUSINESS TIMES
   Gomperts R, 2014, CONTRACEPTION, V89, P129, DOI 10.1016/j.contraception.2013.11.005
   Velez ACG, 2016, REPROD HEALTH MATTER, V24, P57, DOI 10.1016/j.rhm.2016.11.008
   Gregg Mitman, 2004, LANDSCAPES EXPOSURE
   Harris LH, 2016, AM J BIOETHICS, V16, P1, DOI 10.1080/15265161.2016.1177367
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Hoebink P., 2014, SUGAR NICARAGUA REPO
   Human Rights Watch, 2017, NEGL UNPR IMP ZIK OU
   Human Rights Watch, 2017, BRAZ REJ AB BAN
   Johnson C, 2017, J INT POLIT THEORY, V13, P233, DOI 10.1177/1755088217702671
   Lock Margaret M., 2010, ANTHR BIOMEDICINE
   Luna Z, 2013, ANNU REV LAW SOC SCI, V9, P327, DOI 10.1146/annurev-lawsocsci-102612-134037
   McNeil Jr Donald G., 2016, NY TIMES
   Morgan LM, 2012, ANTHROPOL MED, V19, P241, DOI 10.1080/13648470.2012.675046
   Murphy M., 2012, SEIZING MEANS REPROD
   Murphy M, 2015, SOC STUD SCI, V45, P717, DOI 10.1177/0306312715589136
   Nguyen VK, 2010, REPUBLIC THERAPY TRI
   Nixon Rob, 2011, SLOW VIOLENCE ENV PO
   Ottinger G, 2013, REFINING EXPERTISE R
   Petryna A., 2002, LIFE EXPOSED BIOL CI
   Petryna Adriana, 2009, EXPT TRAVEL CLIN TRI
   Pigg SL, 2013, SOC SCI MED, V99, P127, DOI 10.1016/j.socscimed.2013.07.018
   Ramirez GA, 2017, FEMINIST STUD, V43, P423
   Rasanathan JJK, 2017, AM J PUBLIC HEALTH, V107, P525, DOI 10.2105/AJPH.2017.303658
   Redfield P, 2013, LIFE CRISIS ETHICAL
   Rodrigues LC, 2017, AM J PUBLIC HEALTH, V107, P831, DOI 10.2105/AJPH.2017.303792
   Roncal-Jimenez C, 2016, AM J KIDNEY DIS, V67, P20, DOI 10.1053/j.ajkd.2015.08.021
   Schroeder R, 2008, SOC NATUR RESOUR, V21, P547, DOI 10.1080/08941920802100721
   Silliman J., 2016, UNDIVIDED RIGHTS WOM
   Singh S, 2006, INT FAM PLAN PERSPEC, V32, P136, DOI 10.1363/3213606
   Stern AM, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00081516
   Valente PK, 2017, AM J PUBLIC HEALTH, V107, P1376, DOI 10.2105/AJPH.2017.303924
   Wei C, 2015, SILENT EPIDEMIC NICA
   Wei C., 2017, CLIMATE CHANGE IS AL
   Whiteford Linda, 2000, GLOBAL HLTH POLICY L
   Yates-Doerr Emily, 2015, WEIGHT OBESITY HUNGE
NR 62
TC 0
Z9 0
U1 1
U2 2
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0145-9740
EI 1545-5882
J9 MED ANTHROPOL
JI Med. Anthropol.
PY 2018
VL 37
IS 6
SI SI
BP 458
EP 471
DI 10.1080/01459740.2018.1485021
PG 14
WC Anthropology; Reproductive Biology; Social Sciences, Biomedical
SC Anthropology; Reproductive Biology; Biomedical Social Sciences
GA HC8IU
UT WOS:000452046900003
PM 30004260
DA 2020-07-08
ER

PT J
AU Vieira, MADES
   Costa, CHN
   Linhares, AD
   Borba, AD
   Henriques, DF
   da Silva, EVP
   Tavares, FN
   Batista, FMD
   Guimaraes, HCL
   Martins, LC
   Monteiro, TAF
   Cruz, ACR
   Azevedo, RDD
   Vasconcelos, PFD
AF da Cunha e Silva Vieira, Marcelo Adriano
   Nery Costa, Carlos Henrique
   Linhares, Alexandre da Costa
   Borba, Amariles de Sousa
   Henriques, Daniele Freitas
   Pinto da Silva, Eliana Vieira
   Tavares, Fernando Neto
   de Araujo Batista, Francisca Miriane
   Lima Guimaraes, Herlon Clistenes
   Martins, Livia Caricio
   Furtado Monteiro, Talita Antonia
   Ribeiro Cruz, Ana Cecilia
   da Silva Azevedo, Raimunda do Socorro
   da Costa Vasconcelos, Pedro Fernando
TI Potential role of dengue virus, chikungunya virus and Zika virus in
   neurological diseases
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE chikungunya virus; dengue virus; encephalitis; Guillain-Barre syndrome;
   transverse myelitis; Zika virus
ID COMPLICATIONS; ENCEPHALITIS; EPIDEMIC; ROUTINE
AB This study showed that laboratory markers of recent infection by dengue, Zika or chikungunya arboviruses were detected in the biological samples of approximately one-third of patients with encephalitis, myelitis, encephalomyelitis or Guillain-Barr syndrome, in a surveillance programme in Piaui state, Brazil, between 2015-2016. Fever and myalgia had been associated with these cases. Since in non-tropical countries most infections or parainfectious diseases associated with the nervous system are attributed to herpesviruses, enteroviruses, and Campylobacter jejuni, the present findings indicate that in tropical countries, arboviruses may now play a more important role and reinforce the need for their surveillance and systematic investigation in the tropics.
C1 [da Cunha e Silva Vieira, Marcelo Adriano] Secretaria Estado Saude Piaui, Inst Doencas Tropicais Natan Portella, Dept Neurol, Teresina, PI, Brazil.
   [da Cunha e Silva Vieira, Marcelo Adriano; Borba, Amariles de Sousa] Fundacao Municipal Saude Teresina, Diretoria Vigilancia Saude, Teresina, PI, Brazil.
   [da Cunha e Silva Vieira, Marcelo Adriano; Furtado Monteiro, Talita Antonia] Ist Evandro Chagas, Programa Posgrad Virol, Ananindeua, PA, Brazil.
   [Nery Costa, Carlos Henrique] Secretaria Estado Saude Piaui, Inst Doencas Tropicais Natan Portella, Dept Infectol, Teresina, PI, Brazil.
   [Linhares, Alexandre da Costa; Tavares, Fernando Neto; Furtado Monteiro, Talita Antonia] Inst Evandro Chagas, Seca Virol Geral, Ananindeua, PA, Brazil.
   [Henriques, Daniele Freitas; Pinto da Silva, Eliana Vieira; Martins, Livia Caricio; Ribeiro Cruz, Ana Cecilia; da Silva Azevedo, Raimunda do Socorro; da Costa Vasconcelos, Pedro Fernando] Inst Evandro Chagas, Secao Arbovirol & Febres Hemorrag, Ananindeua, PA, Brazil.
   [de Araujo Batista, Francisca Miriane; Lima Guimaraes, Herlon Clistenes] Secretaria Estado Saude Piaui, Diretoria Unidade Vigilancia & Assistencia Saude, Teresina, PI, Brazil.
RP Vieira, MADES (corresponding author), Secretaria Estado Saude Piaui, Inst Doencas Tropicais Natan Portella, Dept Neurol, Teresina, PI, Brazil.; Vieira, MADES (corresponding author), Fundacao Municipal Saude Teresina, Diretoria Vigilancia Saude, Teresina, PI, Brazil.; Vieira, MADES (corresponding author), Ist Evandro Chagas, Programa Posgrad Virol, Ananindeua, PA, Brazil.
EM macsvieira@superig.com.br
RI Cruz, Ana Cecilia Ribeiro/V-9276-2019; Azevedo, Raimunda/T-4656-2019;
   Vasconcelos, Pedro/AAH-3142-2019
OI Azevedo, Raimunda/0000-0003-1932-9976; 
FU Instituto Evandro Chagas; CNPqNational Council for Scientific and
   Technological Development (CNPq); FAPEPI;  [301641/2010-2]; 
   [303999/2016-0]
FX Instituto Evandro Chagas, CNPq, FAPEPI.; PFCV is a fellow of the CNPq
   and supported by grants 301641/2010-2 and 303999/2016-0.
CR Azevedo RSS, 2016, J CLIN VIROL, V85, P56, DOI 10.1016/j.jcv.2016.10.024
   Bastos MS, 2014, J MED VIROL, V86, P1522, DOI 10.1002/jmv.23953
   Bookstaver PB, 2017, J CENT NERV SYST DIS, V9, DOI 10.1177/1179573517703342
   Centers for Disease Control, 2015, ARB DIS NEUR NONN 20
   Cerny T, 2017, NEUROCRIT CARE, V27, P447, DOI 10.1007/s12028-017-0413-8
   CLARKE DH, 1958, AM J TROP MED HYG, V7, P561, DOI 10.4269/ajtmh.1958.7.561
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   da Silva IRF, 2017, JAMA NEUROL, V74, P1190, DOI 10.1001/jamaneurol.2017.1703
   Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   Markoulatos P, 2001, J CLIN MICROBIOL, V39, P4426, DOI 10.1128/JCM.39.12.4426-4432.2001
   Martin DA, 2000, J CLIN MICROBIOL, V38, P1823, DOI 10.1128/JCM.38.5.1823-1826.2000
   McGrogan A, 2009, NEUROEPIDEMIOLOGY, V32, P150, DOI 10.1159/000184748
   MS/SVS - Ministerio da Saude/Secretaria de Vigilancia em Saude, 2015, PROT VIG CAS MAN NEU
   Munoz LS, 2016, SEMIN REPROD MED, V34, P273, DOI 10.1055/s-0036-1592066
   OPAS-Organizacion Panamericana de la Salud, 2016, INSTR DIAGN AT PAC C
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Santiago GA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002311
   SESAPI - Secretaria de Estado da Saude do Piaui, 2016, B EP ARB SINDR NEUR
   Soares CN, 2011, J NEUROL SCI, V303, P75, DOI 10.1016/j.jns.2011.01.012
   Solomon T, 2012, J INFECTION, V64, P347, DOI 10.1016/j.jinf.2011.11.014
   Styczynski AR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005869
   Tournebize P, 2009, REV NEUROL-FRANCE, V165, P48, DOI 10.1016/j.neurol.2008.06.009
   Tunkel AR, 2008, CLIN INFECT DIS, V47, P303, DOI 10.1086/589747
   Vieira MACS, 2015, AM J TROP MED HYG, V93, P377, DOI 10.4269/ajtmh.15-0170
   Vinhaes ES, 2017, CLIN INFECT DIS, V64, P675, DOI 10.1093/cid/ciw770
   Wilder-Smith Annelies, 2017, Lancet Infect Dis, V17, pe101, DOI 10.1016/S1473-3099(16)30518-7
   ZOLL GJ, 1992, J CLIN MICROBIOL, V30, P160, DOI 10.1128/JCM.30.1.160-165.1992
NR 30
TC 1
Z9 1
U1 0
U2 5
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PY 2018
VL 113
IS 11
AR UNSP e170538
DI 10.1590/0074-02760170538
PG 6
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA GY8KH
UT WOS:000448874800001
PM 30379197
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Freire, CCD
   Palmisano, G
   Braconi, CT
   Cugola, FR
   Russo, FB
   Beltrao-Brages, PCB
   Lamarino, A
   Neto, DFD
   Sall, AA
   Rosa-Fernandes, L
   Larsen, MR
   Zanotto, PMD
AF de Melo Freire, Caio Cesar
   Palmisano, Giuseppe
   Braconi, Carla T.
   Cugola, Fernanda R.
   Russo, Fabiele B.
   Beltrao-Brages, Patricia C. B.
   Lamarino, Atila
   de Lima Neto, Daniel Ferreira
   Sall, Amadou Alpha
   Rosa-Fernandes, Livia
   Larsen, Martin R.
   de Andrade Zanotto, Paolo Marinho
TI NS1 codon usage adaptation to humans in pandemic Zika virus
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE Zika virus; codon usage biases; proteomics; NS1 protein
ID INTERNAL INITIATION; MOLECULAR-BIOLOGY; TRANSLATION; BIAS; STRATEGY;
   KUNJIN; DENGUE
AB BACKGROUND Zika virus (ZIKV) was recognised as a zoonotic pathogen in Africa and southeastern Asia. Human infections were infrequently reported until 2007, when the first known epidemic occurred in Micronesia. After 2013, the Asian lineage of ZIKV spread along the Pacific Islands and Americas, causing severe outbreaks with millions of human infections. The recent human infections of ZIKV were also associated with severe complications, such as an increase in cases of Guillain-Barre syndrome and the emergence of congenital Zika syndrome.
   OBJECTIVES To better understand the recent and rapid expansion of ZIKV, as well as the presentation of novel complications, we compared the genetic differences between the African sylvatic lineage and the Asian epidemic lineage that caused the recent massive outbreaks.
   FINDINGS The epidemic lineages have significant codon adaptation in NS1 gene to translate these proteins in human and Aedes aegypti mosquito cells compared to the African zoonotic lineage. Accordingly, a Brazilian epidemic isolate (Z(RR)) produced more NS1 protein than the MR766 African lineage (Z(AF)) did, as indicated by proteomic data from infections of neuron progenitor cellsderived neurospheres. Although Z(BR) replicated more efficiently in these cells, the differences observed in the stoichiometry of ZIKV proteins were not exclusively explained by the differences in viral replication between the lineages.
   MAIN CONCLUSIONS Our findings suggest that natural, silent translational selection in the second half of 20th century could have improved the fitness of Asian ZIKV lineage in human and mosquito cells.
C1 [de Melo Freire, Caio Cesar] Univ Fed Sao Carlos, Dept Genet & Evolucao, Sao Carlos, SP, Brazil.
   [Palmisano, Giuseppe] Univ Sao Paulo, Inst Ciencias Biomed, Dept Parasitol, Sao Paulo, SP, Brazil.
   [Braconi, Carla T.; Lamarino, Atila; de Lima Neto, Daniel Ferreira; de Andrade Zanotto, Paolo Marinho] Univ Sao Paulo, Inst Ciencias Biomed, Dept Microbiol, Lab Evolucao Mol & Bioinforrnat, Sao Paulo, SP, Brazil.
   [Cugola, Fernanda R.; Russo, Fabiele B.; Beltrao-Brages, Patricia C. B.] Univ Sao Paulo, Lab Celulas Tronco, Dept Cirurgia, Sao Paulo, SP, Brazil.
   [Beltrao-Brages, Patricia C. B.] Univ Sao Paulo, Dept Obstet, Escola Artes Ciencias & Humanidades, Sao Paulo, SP, Brazil.
   [Sall, Amadou Alpha] Inst Pasteur, Dakar, Senegal.
   [Rosa-Fernandes, Livia; Larsen, Martin R.] Univ Southern Denmark, Dept Biochem & Mol Biol, Odense, Denmark.
RP Zanotto, PMD (corresponding author), Univ Sao Paulo, Inst Ciencias Biomed, Dept Microbiol, Lab Evolucao Mol & Bioinforrnat, Sao Paulo, SP, Brazil.
EM pzanotto@usp.br
RI Rosa-Fernandes, Livia/AAH-3734-2019; de A. Zanotto, Paolo
   M./B-9286-2019; Beltrao-Braga, Patricia C B/D-6450-2013; Palmisano,
   Giuseppe/N-3602-2013; Braconi, Carla T./B-3320-2014; Fernandes, Livia
   Rosa/K-6818-2014; Larsen, Martin Rossel/F-1411-2015
OI Rosa-Fernandes, Livia/0000-0003-1612-1950; de A. Zanotto, Paolo
   M./0000-0002-8167-0625; Beltrao-Braga, Patricia C B/0000-0003-0004-1091;
   Palmisano, Giuseppe/0000-0003-1336-6151; Braconi, Carla
   T./0000-0002-5370-8980; Fernandes, Livia Rosa/0000-0003-1612-1950;
   Larsen, Martin Rossel/0000-0001-6203-0123
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2014/17766-9, 2014/06090-4, 2012/04818-5, 2014/03911-7, 2016/03605-9,
   2014/06863]; CNPqNational Council for Scientific and Technological
   Development (CNPq) [421160/2016-0]; CNPq scholarshipNational Council for
   Scientific and Technological Development (CNPq)
FX FAPESP (project #2014/17766-9), CNPq (project 421160/2016-0).; CCMF, AI,
   CTB and DFLN are supported by FAPESP (#2014/06090-4, #2012/04818-5,
   #2014/03911-7 and #2016/03605-9); GP is supported by FAPESP (grant
   #2014/06863); PMAZ held a CNPq scholarship.
CR Bahir I, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.71
   Barzon L., 2016, EUROSURVEILLANCE, V21, P2016, DOI DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Brandis G, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005926
   Brinton MA, 2014, VIRUSES-BASEL, V6, P13, DOI 10.3390/v6010013
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511
   Cristina J, 2016, VIRUS RES, V223, P147, DOI 10.1016/j.virusres.2016.06.022
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Edgil D, 2006, J VIROL, V80, P2976, DOI 10.1128/JVI.80.6.2976-2986.2006
   Eisenberg E, 2013, TRENDS GENET, V29, P569, DOI 10.1016/j.tig.2013.05.010
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Freire C. C. d, 2015, BIORXIV, DOI [10.1101/032839, DOI 10.1101/032839]
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Jenkins GM, 2001, J MOL EVOL, V52, P383, DOI 10.1007/s002390010168
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Longdon B, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004395
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Palmisano G, 2010, NAT PROTOC, V5, P1974, DOI 10.1038/nprot.2010.167
   Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079
   Possas C, 2017, MEM I OSWALDO CRUZ, V112, P319, DOI 10.1590/0074-02760160510
   SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281
   WESTAWAY EG, 1977, VIROLOGY, V80, P320, DOI 10.1016/S0042-6822(77)80008-1
   WESTAWAY EG, 1984, VIRUS RES, V1, P333, DOI 10.1016/0168-1702(84)90022-4
   WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9
NR 29
TC 3
Z9 4
U1 2
U2 4
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PY 2018
VL 113
IS 5
AR UNSP e170385
DI 10.1590/0074-02760170385
PG 8
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA GF9VH
UT WOS:000432326600001
PM 29768530
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Epelboin, Y
   Chaney, SC
   Guidez, A
   Habchi-Hanriot, N
   Talaga, S
   Wang, LJ
   Dusfour, I
AF Epelboin, Yanouk
   Chaney, Sarah C.
   Guidez, Amandine
   Habchi-Hanriot, Nausicaa
   Talaga, Stanislas
   Wang, Lanjiao
   Dusfour, Isabelle
TI Successes and failures of sixty years of vector control in French
   Guiana: what is the next step?
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Review
DE French Guiana; vector control; insecticide resistance; Anopheles
   darlingi; Aedes aegypti
ID AEDES-AEGYPTI; ANOPHELES-DARLINGI; INSECTICIDE RESISTANCE;
   DIPTERA-CULICIDAE; BRAZILIAN AMAZON; MALARIA CONTROL; RAIN-FOREST;
   DENGUE; GUYANA; TRANSMISSION
AB Since the 1940s, French Guiana has implemented vector control to contain or eliminate malaria, yellow fever, and, recently, dengue, chikungunya, and Zika. Over time, strategies have evolved depending on the location, efficacy of the methods, development of insecticide resistance, and advances in vector control techniques. This review summarises the history of vector control in French Guiana by reporting the records found in the private archives of the Institute Pasteur in French Guiana and those accessible in libraries worldwide. This publication highlights successes and failures in vector control and identifies the constraints and expectations for vector control in this French overseas territory in the Americas.
C1 [Epelboin, Yanouk; Guidez, Amandine; Habchi-Hanriot, Nausicaa; Talaga, Stanislas; Wang, Lanjiao; Dusfour, Isabelle] Inst Pasteur, Unit Vector Adaptat & Control, Vectopole Amazonien Emile Abonnenc, Cayenne, French Guiana.
RP Dusfour, I (corresponding author), Inst Pasteur, Unit Vector Adaptat & Control, Vectopole Amazonien Emile Abonnenc, Cayenne, French Guiana.
EM isabelle.dusfour@pasteur.fr
CR Angella AF, 2007, MEM I OSWALDO CRUZ, V102, P953, DOI 10.1590/S0074-02762007000800010
   ARS-Agence Regionale de Sante Guyane, 2015, PLAN LUTT PAL GUY CO
   Bartlett-Healy K, 2011, INT J ENV RES PUB HE, V8, P1358, DOI 10.3390/ijerph8051358
   Brown A W, 1957, Bull World Health Organ, V16, P201
   Cebret A, 1996, B SOC PATHOL EXOT, V89, P148
   Chaud P, 2006, SURVEILLANCE EPIDEMI
   Claustre J, 2001, B SOC PATHOL EXOT, V94, P353
   DDAS/Etat DSP/IPG-Direction Departementale des Affaires Sanitaires et Sociales/Etat Direction de la Securite Publique/Institut Pasteur de la Guyane, 2001, CONV 257 DDASS DIR C
   DDAS/Etat DSP/IPG-Direction Departementale des Affaires Sanitaires et Sociales/Etat Direction de la Securite Publique/Institut Pasteur de la Guyane, 1994, CONV 257 DDASS DIR C
   DDAS/Etat DSP/IPG-Direction Departementale des Affaires Sanitaires et Sociales/Etat Direction de la Securite Publique/Institut Pasteur de la Guyane, 1993, CONV 257 DDASS DIR C
   DDAS/Etat DSP/IPG-Direction Departementale des Affaires Sanitaires et Sociales/Etat Direction de la Securite Publique/Institut Pasteur de la Guyane, 1995, CONV 257 DDASS DIR C
   DE BEZERRA A., 1936, Folha Medica, V17, P125
   de Santi VP, 2017, MED SANTE TROP, V27, P111, DOI 10.1684/mst.2017.0659
   de Thoisy B, 2004, T ROY SOC TROP MED H, V98, P409, DOI 10.1016/j.trstmh.2003.12.003
   Duchemin JB, 1996, RAPPORT ANNUEL ASPEC
   Dusfour I, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004226
   Dusfour I, 2011, MEM I OSWALDO CRUZ, V106, P346, DOI 10.1590/S0074-02762011000300015
   Epelboin L, 2016, Bull Soc Pathol Exot, V109, P114, DOI 10.1007/s13149-016-0490-5
   Faucon F, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005526
   Faucon F, 2015, GENOME RES, V25, P1347, DOI 10.1101/gr.189225.115
   Fischer M, 2014, MMWR-MORBID MORTAL W, V63, P500
   FLOCH H., 1955, REV BRASIL MALARIOI E DOENCAS TROP, V7, P195
   FLOCH H, 1955, Riv Malariol, V34, P77
   Floch H, 1966, Bull Soc Pathol Exot Filiales, V59, P874
   FLOCH H, 1956, Publ Inst Pasteur Guyane Fr Inini, V17, P1
   FLOCH H, 1955, Publ Inst Pasteur Guyane Fr Inini, V16, P1
   FLOCH H, 1954, Bull World Health Organ, V11, P579
   FLOCH H, 1958, Bull World Health Organ, V18, P667
   Floch H., 1950, LUTTE ANTIAMARILE LU
   Floch H, 1943, I PASTEUR GUYANE TER, V72, P8
   Floch H, 1943, I PASTEUR GUYANE TER, V71, P10
   Floch H, 1943, PUBL I PASTEUR GUYAN, V68
   Floch H., 1954, ARCH I PASTEUR GUYAN, V349
   Floch H., 1951, ARCH I PASTEUR GUYAN, V234
   Floch H., 1955, ARCH I PASTEUR GUYAN, V369
   Floch H., 1952, ARCH I PASTEUR GUYAN, V266
   Floch H., 1954, ARCH I PASTEUR GUYAN, V317
   Floch H., 1953, ARCH I PASTEUR GUYAN, V282
   Floch H., 1964, ARCH I PASTEUR GUYAN, V484
   Floch H., 1965, ARCH I PASTEUR GUYAN, V493
   Floch H., 1952, ARCH I PASTEUR GUYAN, V257, P8
   Floch H., 1965, ARCH I PASTEUR GUYAN, V495
   Floch H, 1951, ARCH I PASTEUR GUYAN, V223, P4
   Floch H., 1952, ARCH I PASTEUR GUYAN, V251
   Floch HA, 1945, I PASTEUR GUYANE TER, V109, P17
   FLOCH HERVE, 1954, BULL SOC PATHOL EXOT, V47, P549
   FLOCH HERVE, 1954, BULL SOC PATHOL EXOT, V47, P555
   Fonseca-Gonzalez I, 2009, MEM I OSWALDO CRUZ, V104, P18, DOI 10.1590/S0074-02762009000100003
   FONTAN R, 1959, Publ Inst Pasteur Guyane Fr Inini, V20, P1
   Fouque F, 1996, B SOC PATHOL EXOT, V89, P115
   Fouque F, 1999, RAPPORT ANNUEL UNITE
   Fouque F, 1998, RAPPORT ANNUEL UNITE
   Fouque F., 1998, OVERVIEW ARBOVIROLOG, P272
   Fouque F, 1997, RAPPORT ANNUEL UNITE
   Fouque F, 1995, REPORT SCI COUNCIL 2
   Fritzell C, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005081
   Gabaldon A., 1939, PUBI DIV MALARIOL, V4
   Giglioli G., 1939, AGR J BR GUIANA, V10
   Girod R, 2008, BASAG, V5, P3
   Haziza P-S, 1973, EPIDEMIOLOGIE PALUDI
   Hiwat H, 2010, T ROY SOC TROP MED H, V104, P207, DOI 10.1016/j.trstmh.2009.07.007
   Hiwat H, 2012, AM J TROP MED HYG, V86, P649, DOI 10.4269/ajtmh.2012.11-0414
   Hiwat H, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-177
   IARC-International Agency for Research on Cancer, 2015, EV 5 ORG INS HERB
   Juminer B., 1981, Medecine Tropicale, V41, P135
   L'Azou M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003235
   Le Tyrant M., 2013, POLITIQUES RISQUE LI
   Liu NN, 2015, ANNU REV ENTOMOL, V60, P537, DOI 10.1146/annurev-ento-010814-020828
   Mansotte F, 2010, Med Trop (Mars), V70, P249
   Mansotte F, 2010, SANTE PUBLIQUE, V22, P181, DOI 10.3917/spub.102.0181
   Mieulet E, 2014, HEALTH RISK SOC, V16, P581, DOI 10.1080/13698575.2014.949224
   MOUCHET J, 1989, B SOC PATHOL EXOT, V82, P393
   Musset L, 2014, MEM I OSWALDO CRUZ, V109, P525, DOI 10.1590/0074-0276140031
   Neveu-lemaire G., 1902, Archives de Parasitologie, Vvi, P5
   PAJOT F-X, 1978, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V16, P105
   PAJOT F-X, 1977, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V15, P15
   Pajot F-X, 1985, CAH ORSTOM EMP, V23, P209
   Petit-Sinturel M, 2016, B VEILLE SANIT, V2, P7
   Pocquet N, 2014, EVALUATION SENSIBILI
   Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395
   Quenel P, 2011, B EPIDEMIOL HEBD, V33-34, P358
   Raccurt C P, 1997, Med Trop (Mars), V57, P401
   Ranson H, 2010, TROPIKA NET J, V1, P1
   Ranson H, 2016, TRENDS PARASITOL, V32, P187, DOI 10.1016/j.pt.2015.11.010
   Reynes JM, 1996, B SOC PATHOL EXOT, V89, P98
   Reynes JM, 1995, RAPPORT ANNUEL ASPEC
   Galardo AKR, 2015, REV SOC BRAS MED TRO, V48, P765, DOI 10.1590/0037-8682-0082-2015
   Rodriguez MM, 2005, J AM MOSQUITO CONTR, V21, P437, DOI 10.2987/8756-971X(2006)21[437:PISOAA]2.0.CO;2
   ROZENDAAL JA, 1989, J AM MOSQUITO CONTR, V5, P339
   Varon LS, 2010, REV PANAM SALUD PUBL, V27, P66, DOI 10.1590/S1020-49892010000100010
   Silvain J-F, 1979, ETUDE ECOLOGIE ANOPH
   SOPER FL, 1967, B WORLD HEALTH ORGAN, V36, P536
   Talaga S, 2015, J MED ENTOMOL, V52, P770, DOI 10.1093/jme/tjv109
   TOWNSEND CHARLES H. T., 1934, REVISTA ENT [RIO DE JANEIRO], V4, P486
   UNEP/FAO-United Nations Environment Programme/Food and Agriculture Organization of the United Nations, 1991, JOINT FAOUN PROGR OP
   Vezenegho SB, 2016, MEM I OSWALDO CRUZ, V111, P561, DOI 10.1590/0074-02760160150
   WHO, 2004, GLOB STRAT FRAM INT
   WHO, 1960, INS RES VECT CONTR 1
   WHO-World Health Organization, 1999, GLOB PARTN ROLL BACK
   World Health Organization, 2016, TEST PROC INREMO
   World Health Organization, 2012, HDB INT VECT MAN
NR 101
TC 6
Z9 6
U1 0
U2 5
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PY 2018
VL 113
IS 5
AR UNSP e170398
DI 10.1590/0074-02760170398
PG 10
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA GA9WT
UT WOS:000428693000004
PM 29538490
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Fukutani, E
   Rodrigues, M
   Kasprzykowski, JI
   de Araujo, CF
   Paschoal, AR
   Ramos, PIP
   Fukutani, KF
   de Queiroz, ATL
AF Fukutani, Eduardo
   Rodrigues, Moreno
   Kasprzykowski, Jose Irahe
   de Araujo, Cintia Figueiredo
   Paschoal, Alexandre Rossi
   Pereira Ramos, Pablo Ivan
   Fukutani, Kiyoshi Ferreira
   Lopo de Queiroz, Artur Trancoso
TI Follow up of a robust meta-signature to identify Zika virus infection in
   Aedes aegypti: another brick in the wall
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE RNA-seq; signature; transcriptome; Zika virus
ID YELLOW-FEVER; EXPRESSION; AMERICA
AB The mosquito Aedes aegypti is the main vector of several arthropod-borne diseases that have global impacts. In a previous meta-analysis, our group identified a vector gene set containing 110 genes strongly associated with infections of dengue, West Nile and yellow fever viruses. Of these 110 genes, four genes allowed a highly accurate classification of infected status. More recently, a new study of Ae. aegypti infected with Zika virus (ZIKV) was published, providing new data to investigate whether this "infection" gene set is also altered during a ZIKV infection. Our hypothesis is that the infection-associated signature may also serve as a proxy to classify the ZIKV infection in the vector. Raw data associated with the NCBI/BioProject were downloaded and re-analysed. A total of 18 paired-end replicates corresponding to three ZIKV-infected samples and three controls were included in this study. The nMDS technique with a logistic regression was used to obtain the probabilities of belonging to a given class. Thus, to compare both gene sets, we used the area under the curve and performed a comparison using the bootstrap method. Our meta-signature was able to separate the infected mosquitoes from the controls with good predictive power to classify the Zika-infected mosquitoes.
C1 [Fukutani, Eduardo; Rodrigues, Moreno; Kasprzykowski, Jose Irahe; Pereira Ramos, Pablo Ivan; Lopo de Queiroz, Artur Trancoso] Fundacao Oswaldo Cruz Fiocruz, Inst Goncalo Moniz, Salvador, BA, Brazil.
   [Kasprzykowski, Jose Irahe; Lopo de Queiroz, Artur Trancoso] Fundacao Oswaldo Cruz Fiocruz, Programa Posgrad Biotecnol Saude Invest, Salvador, BA, Brazil.
   [de Araujo, Cintia Figueiredo] Univ Fed Bahia, Serv Imunol, Salvador, BA, Brazil.
   [Paschoal, Alexandre Rossi] Univ Tecnol Fed Parana, Cornelio Procopio, PR, Brazil.
   [Fukutani, Kiyoshi Ferreira] Univ Sao Paulo, Fac Med Ribeirao Preto, Ribeirao Preto, Brazil.
   [Fukutani, Kiyoshi Ferreira] Univ Salvador, Salvador, BA, Brazil.
RP Fukutani, KF (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Ribeirao Preto, Brazil.; Fukutani, KF (corresponding author), Univ Salvador, Salvador, BA, Brazil.
EM ferreirafk@gmail.com
RI Fukutani, Kiyoshi/T-1630-2019; Paschoal, Alexandre Rossi
   Rossi/I-4074-2013; Fukutani, Kiyoshi/N-7905-2016; Ramos, Pablo I.
   Pereira/H-6276-2019
OI Paschoal, Alexandre Rossi Rossi/0000-0002-8887-0582; Fukutani,
   Kiyoshi/0000-0003-2223-0918; Ramos, Pablo I.
   Pereira/0000-0002-9075-7861; Rodrigues, Moreno/0000-0002-1594-2311; de
   Queiroz, Artur Trancoso Lopo/0000-0003-4908-9993
FU FAPESB [JCB0004/2013]; FAPESPFundacao de Amparo a Pesquisa do Estado de
   Sao Paulo (FAPESP) [2017/03491-6]; CNPq Universal MCTI/CNPQ/Universal
   14/2014 [454505/2014-0]
FX FAPESB (process no. JCB0004/2013), FAPESP (no. 2017/03491-6), CNPq
   Universal MCTI/CNPQ/Universal 14/2014 (no. 454505/2014-0).
CR Anglero-Rodriguez YI, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02050
   Bae HG, 2005, J CLIN VIROL, V33, P274, DOI 10.1016/j.jcv.2004.12.001
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Cauchemez S, 2014, EUROSURVEILLANCE, V19, P15, DOI 10.2807/1560-7917.ES2014.19.28.20854
   Etebari K, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00456-17
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fukutani KF, 2018, FRONT BIOENG BIOTECH, V5, DOI 10.3389/fbioe.2017.00084
   Lorenzo MG, 2014, J BRAZIL CHEM SOC, V25, P1799, DOI 10.5935/0103-5053.20140202
   Mosso C, 2008, VIROLOGY, V378, P193, DOI 10.1016/j.virol.2008.05.012
   NCBI - National Center for Biotechnology Information, SRA KNOWL BAS
   Oksanen J, 2017, VEGAN COMMUNITY ECOL, V1, P1
   Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197
   Paules CI, 2017, NEW ENGL J MED, V376, P1397, DOI 10.1056/NEJMp1702172
   Pradier S, 2012, REV SCI TECH OIE, V31, P829
   Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77
   Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616
   Slavov SN, 2016, BRAZ J MED BIOL RES, V49, DOI 10.1590/1414-431X20165420
   Soneson Charlotte, 2015, F1000Res, V4, P1521, DOI 10.12688/f1000research.7563.2
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   WANG H, 1991, NATURE, V352, P729, DOI 10.1038/352729a0
   WHO - World Health Organization, 2016, WHI DIR GEN SUMM OUT
   World Helth Organization, GLOB STRAT DENG PREV
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 23
TC 0
Z9 0
U1 0
U2 7
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PY 2018
VL 113
IS 6
AR UNSP e180053
DI 10.1590/0074-02760180053
PG 3
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA GH5VV
UT WOS:000433506500001
PM 29846381
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU de Mendonca, MCL
   Mares-Guia, MA
   Rodrigues, CDD
   dos Santos, CC
   Chalhoub, FLL
   Araujo, ESM
   Chieppe, AO
   Nogueira, RMR
   de Filippis, AMB
AF Lima de Mendonca, Marcos Cesar
   Mares-Guia, Maria Angelica
   dos Santos Rodrigues, Cintia Damasceno
   dos Santos, Carolina Cardoso
   Levy Chalhoub, Flavia Lowen
   Machado Araujo, Eliane Saraiva
   Chieppe, Alexandre Otavio
   Ribeiro Nogueira, Rita Maria
   Bispo de Filippis, Ana Maria
TI Imported case of Dengue virus 3 genotype I in Rio de Janeiro state,
   Brazil
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE dengue; sequencing; genotyping
ID EPIDEMIOLOGY; COLOMBIA
AB The dengue virus (DENV), of the genus Flavivirus (Flaviviridae), has four antigenically distinct serotypes, of which DENV-3 is classified into five genotypes. Here, we describe the detection of DENV-3 genotype I in sera of a Brazilian patient travelling from Singapore to Rio de Janeiro, Brazil, by using multiplex real-time RT-PCR, DNA sequencing of the whole envelope protein gene, and phylogenetic analysis. The virus shares ancestry with those identified in Bali, Indonesia, in 2015. It is possible that arboviruses such as Chikungunya ECSA genotype, DENV-4 genotype I, and Zika were introduced in Brazil from other continents during the multiple international events hosted by the country over the last four years, including World Youth Day, the Soccer World Cup, and the Summer Olympics.
C1 [Lima de Mendonca, Marcos Cesar; Mares-Guia, Maria Angelica; dos Santos Rodrigues, Cintia Damasceno; dos Santos, Carolina Cardoso; Levy Chalhoub, Flavia Lowen; Machado Araujo, Eliane Saraiva; Ribeiro Nogueira, Rita Maria; Bispo de Filippis, Ana Maria] Inst Oswaldo Cruz, Lab Flavivirus, Fundacao Oswald Cruz Fiocruz, Rio De Janeiro, RJ, Brazil.
   [Chieppe, Alexandre Otavio] Secretaria Estado Saude Rio de Janeiro, Rio De Janeiro, RJ, Brazil.
RP de Mendonca, MCL (corresponding author), Inst Oswaldo Cruz, Lab Flavivirus, Fundacao Oswald Cruz Fiocruz, Rio De Janeiro, RJ, Brazil.
EM marcosclm@ioc.fiorcuz.br
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); FAPERJCarlos Chagas Filho Foundation for Research Support of the
   State of Rio de Janeiro (FAPERJ)
FX CNPq, FAPERJ.
CR Aquino VH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007299
   Araujo JMG, 2009, INFECT GENET EVOL, V9, P716, DOI 10.1016/j.meegid.2008.10.005
   Guo CC, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00317
   LANCIOTTI RS, 1994, J GEN VIROL, V75, P65, DOI 10.1099/0022-1317-75-1-65
   Megawati D, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005483
   Miagostovich MP, 2002, BRAZ J MED BIOL RES, V35, P869, DOI 10.1590/S0100-879X2002000800002
   Santiago GA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002311
   Usme-Ciro JA, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-101
   WHITEHEAD RH, 1971, T ROY SOC TROP MED H, V65, P661, DOI 10.1016/0035-9203(71)90051-4
NR 9
TC 1
Z9 1
U1 0
U2 4
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PY 2018
VL 113
IS 8
AR UNSP e180036
DI 10.1590/0074-02760180036
PG 3
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA GK3QN
UT WOS:000436060300001
PM 29947712
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Naveca, FG
   Pontes, GS
   Chang, AYH
   da Silva, GAV
   do Nascimento, VA
   Monteiro, DCD
   da Silva, MS
   Abdalla, LF
   Santos, JHA
   de Almeida, TAP
   Mejia, MDC
   de Mesquita, TGR
   Encarnacao, HVD
   Gomes, MD
   Amaral, LR
   Campi-Azevedo, AC
   Coelho-dos-Reis, JG
   Antonelli, LRD
   Teixeira-Carvalho, A
   Martins, OA
   Ramasawmy, R
AF Naveca, Felipe Gomes
   Pontes, Gemilson Soares
   Chang, Aileen Yu-hen
   Villarouco da Silva, George Allan
   do Nascimento, Valdinete Alves
   da Silva Monteiro, Dana Cristina
   da Silva, Marineide Souza
   Abdalla, Ligia Fernandes
   Abdalla Santos, Joao Hugo
   Pires de Almeida, Tatiana Amaral
   Contreras Mejia, Matilde del Carmen
   Ramos de Mesquita, Tirza Gabrielle
   de Souza Encarnacao, Helia Valeria
   Gomes, Matheus de Souza
   Amaral, Laurence Rodrigues
   Campi-Azevedo, Ana Carolina
   Coelho-dos-Reis, Jordana Graziela
   do Vale Antonelli, Lis Ribeiro
   Teixeira-Carvalho, Andrea
   Martins-Filho, Olindo Assis
   Ramasawmy, Rajendranath
TI Analysis of the Immunological biomarker profile during acute Zika virus
   Infection reveals the overexpression of CXCL10, a chemokine linked to
   neuronal damage
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE Zika virus; CXCL10; biomarkers; chemokines; cytokines
ID VIRAL-INFECTIONS; YELLOW-FEVER; ENCEPHALITIS; INFLAMMATION; ACTIVATION;
   CHILDREN; DISEASES
AB BACKGROUND Infection with Zika virus (ZIKV) manifests in a broad spectrum of disease ranging from mild illness to severe neurological complications and little is known about Zika immunopathogenesis.
   OBJECTIVES To define the immunologic biomarkers that correlate with acute ZIKV infection.
   METHODS We characterized the levels of circulating cytokines, chemokines, and grow th factors in 54 infected patients of both genders at five different time points after symptom onset using microbeads multiplex immunoassay; comparison to 100 agematched controls was performed for statistical analysis and data mining.
   FINDINGS ZIKV-infected patients present a striking systemic inflammatory response with high levels of pro-inflammatory mediators. Despite the strong inflammatory pattern, IL-1Ra and IL-4 are also induced during the acute infection. Interestingly, the inflammatory cytokines IL-1 beta, IL-13, IL,-17, TNF-alpha, and IFN-gamma; chemokines CXCL8, CCL2. CCL5; and the growth factor G-CSF, displaced a bimodal distribution accompanying viremia. While this is the first manuscript to document bimodal distributions of viremia in ZIKV infection, this has been documented in other viral infections, with a primary viremia peak during mild systemic disease and a secondary peak associated with distribution of the virus to organs and tissues.
   MAIN CONCLUSIONS Biomarker network analysis demonstrated distinct dynamics in concurrence with the bimodal viremia profiles at different time points during ZIKV infection. Such a robust cytokine and chemokine response has been associated with blood-brain barrier permeability and neuroinvasiveness in other flaviviral infections. High-dimensional data analysis further identified CXCL10, a chemokine involved in foetal neuron apoptosis and Guillain-Barre syndrome, as the most promising biomarker of acute ZIKV infection for potential clinical application.
C1 [Naveca, Felipe Gomes; do Nascimento, Valdinete Alves; Pires de Almeida, Tatiana Amaral; Contreras Mejia, Matilde del Carmen] Fundacao Oswaldo Cruz, FIOCRUZ, Inst Leonidas & Maria Deane, Programa Posgrad Biol Interacao Patogenohospedeir, Manaus, Amazonas, Brazil.
   [Naveca, Felipe Gomes; Villarouco da Silva, George Allan; da Silva Monteiro, Dana Cristina; da Silva, Marineide Souza; Abdalla, Ligia Fernandes] Univ Fed Amazonas, Programa Posgrad Imunol Basica & Aplicada, Manaus, Amazonas, Brazil.
   [Pontes, Gemilson Soares] Inst Nacl de Pesquisas da Amazonia, Manaus, Amazonas, Brazil.
   [Chang, Aileen Yu-hen] George Washington Univ, Washington, DC USA.
   [Abdalla, Ligia Fernandes] Univ Estado Amazonas, Manaus, Amazonas, Brazil.
   [Abdalla Santos, Joao Hugo] Hosp Adventista Manaus, Manaus, Amazonas, Brazil.
   [Villarouco da Silva, George Allan; Ramos de Mesquita, Tirza Gabrielle; de Souza Encarnacao, Helia Valeria; Ramasawmy, Rajendranath] Fundacao Med Trop Dr Heitor Vieira Dourado, Manaus, Amazonas, Brazil.
   [Gomes, Matheus de Souza; Amaral, Laurence Rodrigues] Univ Fed Uberlandia, Patos De Minas, MG, Brazil.
   [Campi-Azevedo, Ana Carolina; Coelho-dos-Reis, Jordana Graziela; do Vale Antonelli, Lis Ribeiro; Teixeira-Carvalho, Andrea; Martins-Filho, Olindo Assis] Fundacao Oswald Cruz, FIOCRUZ, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil.
   [Ramasawmy, Rajendranath] Univ Nilton Lins, Manaus, Amazonas, Brazil.
RP Naveca, FG (corresponding author), Fundacao Oswaldo Cruz, FIOCRUZ, Inst Leonidas & Maria Deane, Programa Posgrad Biol Interacao Patogenohospedeir, Manaus, Amazonas, Brazil.; Naveca, FG (corresponding author), Univ Fed Amazonas, Programa Posgrad Imunol Basica & Aplicada, Manaus, Amazonas, Brazil.
EM felipe.naveca@fiocruz.br
RI Ramasawmy, Rajendranath/V-4926-2019; Amaral, Laurence Rodrigues
   do/R-2209-2019; Antonelli, Lis/R-4910-2019; Pontes,
   Gemilson/B-6103-2016; Naveca, Felipe/H-1130-2012
OI Amaral, Laurence Rodrigues do/0000-0003-4681-5451; Antonelli,
   Lis/0000-0002-4969-8812; Pontes, Gemilson/0000-0001-9001-7954; Naveca,
   Felipe/0000-0002-2888-1060; Campi-Azevedo, Ana
   Carolina/0000-0001-6306-3605; Martins-Filho, Olindo
   Assis/0000-0002-5494-4889; Nascimento, Valdinete/0000-0002-7786-4718
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); CAPESCAPES; FINEPCiencia Tecnologia e Inovacao (FINEP);
   CNPqNational Council for Scientific and Technological Development (CNPq)
   [440856/2016-7, 440682/2016-9]; CAPESCAPES [88881.130825/2016-00,
   88887.130823/2016-00, 88881.130829/2016-01]; FINEPCiencia Tecnologia e
   Inovacao (FINEP) [TED264/16]
FX CNPq, CAPES, FINEP.; FGN and OAMF were supported by CNPq (Grants
   440856/2016-7, 440682/2016-9) and CAPES (Grants 88881.130825/2016-00,
   88887.130823/2016-00, 88881.130829/2016-01); OAMF is also funded by
   FINEP (Grant TED264/16).
CR Campi-Azevedo AC, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-391
   Chaudhary V, 2017, J VIROL, V91, DOI 10.1128/JVI.00163-17
   Chiang S, 2013, MUSCLE NERVE, V48, P320, DOI 10.1002/mus.23829
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   Edwards MR, 2017, J ALLERGY CLIN IMMUN, V140, P909, DOI 10.1016/j.jaci.2017.07.025
   FENNER F, 1948, LANCET, V252, P915, DOI 10.1016/S0140-6736(48)91599-2
   Galliez RM, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw203
   Gotsch F, 2007, J MATERN-FETAL NEO M, V20, P777, DOI 10.1080/14767050701483298
   Grip O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005263
   Gurukumar KR, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-10
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Kam YW, 2017, J INFECT DIS, V216, P172, DOI 10.1093/infdis/jix261
   Klein RS, 2005, J VIROL, V79, P11457, DOI 10.1128/JVI.79.17.11457-11466.2005
   Klein SL, 2012, BIOESSAYS, V34, P1050, DOI 10.1002/bies.201200099
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   Liu ML, 2011, CYTOKINE GROWTH F R, V22, P121, DOI 10.1016/j.cytogfr.2011.06.001
   Luiza-Silva M, 2011, J INFECT DIS, V204, P873, DOI 10.1093/infdis/jir439
   Melchjorsen J, 2003, J LEUKOCYTE BIOL, V74, P331, DOI 10.1189/jlb.1102577
   Mellor PS, 2004, VET RES, V35, P445, DOI 10.1051/vetres:2004021
   Naveca FG, 2017, MEM I OSWALDO CRUZ, V112, P510, DOI 10.1590/0074-02760160062
   Nie CQ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000369
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Ornelas AMM, 2017, ANN NEUROL, V81, P152, DOI 10.1002/ana.24839
   de Figueiredo RMP, 2008, EMERG INFECT DIS, V14, P667, DOI 10.3201/eid1404.071185
   Sathupan P, 2007, ANN TROP PAEDIATR, V27, P179, DOI 10.1179/146532807X220280
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   ter Meulen J, 2004, J INFECT DIS, V190, P1821, DOI 10.1086/425016
   Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140
   Zlotnik A, 2012, IMMUNITY, V36, P705, DOI 10.1016/j.immuni.2012.05.008
NR 30
TC 13
Z9 14
U1 0
U2 6
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PY 2018
VL 113
IS 6
AR UNSP e170542
DI 10.1590/0074-02760170542
PG 13
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA GF9VE
UT WOS:000432326300001
PM 29768624
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Nunes, ARD
   Alves, BEB
   Pereira, HWB
   Nascimento, YM
   Morais, IC
   Fernandes, JV
   Araujo, JMG
   Lanza, DCF
AF Nunes, Allan R. D.
   Alves, Brenda Elen B.
   Pereira, Hannaly W. B.
   Nascimento, Yasmin M.
   Morais, Ingryd C.
   Fernandes, Jose Verissimo
   Araujo, Joselio M. G.
   Lanza, Daniel C. F.
TI Improved reverse transcription-polymerase chain reaction assay for the
   detection of flaviviruses with semi-nested primers for discrimination
   between dengue virus serotypes and Zika virus
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE arbovirus; Flaviviridae; West Nile virus; yellow fever virus
ID RIO-DE-JANEIRO; RAPID IDENTIFICATION; UNIVERSAL PRIMERS; SEQUENCES;
   BRAZIL; PCR; TRANSMISSION; COINFECTION
AB BACKGROUND The genus Flavivirus includes a variety of medically important viruses, including dengue virus (DENV) and Zika virus (ZIKV), which are most prevalent in Brazil. Because the clinical profile of patients affected by different DENV serotypes or ZIKV may be similar, the development of new methods that facilitate a rapid and accurate diagnosis is crucial.
   OBJECTIVES The current study aimed to develop an improved reverse transcription-polymerase chain reaction (RT-PCR) protocol for universal detection of flaviviruses by using semi-nested primers that discriminate between DENV serotypes and ZIKV.
   METHODS The bioinformatics workflow adopted for primer design included: (1) alignment of 1,442 flavivirus genome sequences, (2) characterisation of 27 conserved regions, (3) generation of a primer set comprising 77 universal primers, and (4) selection of primer pairs with greatest coverage and specificity. Following primer design, the reaction was validated in vitro. The same approach was applied to the design of primers specific for DENV and ZIKV, using a species-specific sequence database.
   FINDINGS The new assay amplified an 800-806 nt variable region of the NS5 gene and allowed discrimination of virtually all flavivirus species using reference-sequence comparison. The 800-806 nt fragment was validated as a template for a semi-nested multiplex PCR using five additional primers for the detection of DENV and ZIKV. These primers were designed to generate amplicons of different sizes, allowing differentiation of the four serotypes of DENV, and ZIKV using agarose gel electrophoresis.
   MAIN CONCLUSIONS The bioinformatics pipeline allowed efficient primer design, making it possible to identify the best targets within the coding region of the NS5 protein. The multiplex system proved effective in differentiation of DENV1-4 and ZIKV on a 2% agarose gel. The possibility of discriminating DENV serotypes and ZIKV in the same reaction provided a faster result consuming less sample. In addition, this simplified approach ensured the reduction of the cost per analysis.
C1 [Nunes, Allan R. D.; Lanza, Daniel C. F.] Univ Fed Rio Grande do Norte, Dept Bioquim, Lab Biol Mol Aplicada, Natal, RN, Brazil.
   [Alves, Brenda Elen B.; Pereira, Hannaly W. B.; Nascimento, Yasmin M.; Morais, Ingryd C.; Fernandes, Jose Verissimo; Araujo, Joselio M. G.] Univ Fed Rio Grande do Norte, Dept Microbiol & Parasitol, Lab Biol Mol Doencas Infecciosas & Canc, Natal, RN, Brazil.
   [Nunes, Allan R. D.; Morais, Ingryd C.; Lanza, Daniel C. F.] Univ Fed Rio Grande do Norte, Programa Posgrad Bioquim, Natal, RN, Brazil.
   [Alves, Brenda Elen B.; Pereira, Hannaly W. B.; Fernandes, Jose Verissimo; Araujo, Joselio M. G.] Univ Fed Rio Grande do Norte, Programa Posgrad Biol Parasitaria, Natal, RN, Brazil.
   [Alves, Brenda Elen B.; Pereira, Hannaly W. B.; Nascimento, Yasmin M.; Morais, Ingryd C.; Araujo, Joselio M. G.] Univ Fed Rio Grande do Norte, Inst Med Trop, Lab Virol, Natal, RN, Brazil.
RP Lanza, DCF (corresponding author), Univ Fed Rio Grande do Norte, Dept Bioquim, Lab Biol Mol Aplicada, Natal, RN, Brazil.; Lanza, DCF (corresponding author), Univ Fed Rio Grande do Norte, Programa Posgrad Bioquim, Natal, RN, Brazil.
EM danielclanza@gmail.com
RI Araujo, Joselio M G/B-5502-2013
OI Araujo, Joselio M G/0000-0003-3548-2786; Fernandes, Jose
   Verissimo/0000-0002-5169-6496
FU CAPESCAPES; CNPqNational Council for Scientific and Technological
   Development (CNPq)
FX CAPES, CNPq.
CR Calvet GA, 2016, J CLIN VIROL, V74, P1, DOI 10.1016/j.jcv.2015.11.014
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Chao DY, 2007, J CLIN MICROBIOL, V45, P584, DOI 10.1128/JCM.00842-06
   CHOW VTK, 1993, ARCH VIROL, V133, P157, DOI 10.1007/BF01309751
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Dyer J, 2007, J VIROL METHODS, V145, P9, DOI 10.1016/j.jviromet.2007.05.001
   ELDADAH ZA, 1991, J MED VIROL, V33, P260, DOI 10.1002/jmv.1890330410
   Figueiredo LTM, 1998, AM J TROP MED HYG, V59, P357, DOI 10.4269/ajtmh.1998.59.357
   FULOP L, 1993, J VIROL METHODS, V44, P179, DOI 10.1016/0166-0934(93)90053-T
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msv279, 10.1093/molbev/msw054]
   Kuno G, 1998, J VIROL METHODS, V72, P27, DOI 10.1016/S0166-0934(98)00003-2
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144
   Maher-Sturgess SL, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-16
   Nogueira RMR, 2011, MEM I OSWALDO CRUZ, V106, P255, DOI 10.1590/S0074-02762011000300001
   PIERRE V, 1994, RES VIROLOGY, V145, P93, DOI 10.1016/S0923-2516(07)80011-2
   PURI B, 1994, ARCH VIROL, V134, P29, DOI 10.1007/BF01379104
   Nogueira RMR, 2007, REV PANAM SALUD PUBL, V22, P358, DOI 10.1590/S1020-49892007001000009
   SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454
   Sanchez-Seco MP, 2005, J VIROL METHODS, V126, P101, DOI 10.1016/j.jviromet.2005.01.025
   Scaramozzino N, 2001, J CLIN MICROBIOL, V39, P1922, DOI 10.1128/JCM.39.5.1922-1927.2001
   SCHATZMAYR H G, 1986, Memorias do Instituto Oswaldo Cruz, V81, P245, DOI 10.1590/S0074-02761986000200019
   Simmonds P, 2017, J GEN VIROL, V98, P2, DOI 10.1099/jgv.0.000672
   TAJIMA F, 1984, MOL BIOL EVOL, V1, P269
   TANAKA M, 1993, J VIROL METHODS, V41, P311, DOI 10.1016/0166-0934(93)90020-R
   Villamil-Gomez WE, 2016, INT J INFECT DIS, V51, P135, DOI 10.1016/j.ijid.2016.07.017
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 28
TC 2
Z9 2
U1 0
U2 2
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PY 2018
VL 113
IS 5
AR UNSP e170393
DI 10.1590/0074-02760170393
PG 9
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA GA9WT
UT WOS:000428693000003
PM 29513820
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Padilha, KP
   Resck, MEB
   da Cunha, OAT
   Teles-de-Freitas, R
   Campos, SS
   Sorgine, MHF
   Lourenco-de-Oliveira, R
   Farnesi, LC
   Bruno, RV
AF Padilha, Karine Pedreira
   Barreto Resck, Maria Eduarda
   Talyuli da Cunha, Octavio Augusto
   Teles-de-Freitas, Rayane
   Campos, Stephanie Silva
   Ferreira Sorgine, Marcos Henrique
   Lourenco-de-Oliveira, Ricardo
   Farnesi, Luana Cristina
   Bruno, Rafaela Vieira
TI Zika infection decreases Aedes aegypti locomotor activity but does not
   influence egg production or viability
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
ID SURVIVAL RATE; VIRUS; CULICIDAE; DIPTERA; ALBOPICTUS; BRAZIL
AB BACKGROUND Zika has emerged as a new public health threat after the explosive epidemic in Brazil in 2015. It is an arbovirus transmitted mainly by Aedes aegypti mosquitoes. The knowledge of physiological, behavioural and biological features in virus-infected vectors may help the understanding of arbovirus transmission dynamics and elucidate their influence in vector capacity.
   OBJECTIVES We aimed to investigate the effects of Zika virus (ZIKV) infection in the behaviour of Ae. aegypti females by analysing the locomotor activity, egg production and viability.
   METHODOLOGY Ae. aegypti females were orally infected with ZIKV through an artificial feeder to access egg production, egg viability and locomotor activity. For egg production and viability assays, females were kept in cages containing an artificial site for oviposition and eggs were counted. Locomotor activity assays were performed in activity monitors and an average of 5th, 6th and 7th days after infective feeding was calculated.
   FINDINGS No significant difference in the number of eggs laid per females neither in their viability were found between ZIKV infected and non-infected females, regardless the tested pair of mosquito population and virus strain and the gonotrophic cycles. Locomotor activity assays were performed regardless of the locomotor activity in ZIKV infected females was observed, in both LD and DD conditions.
   MAIN CONCLUSIONS The lower locomotor activity may reduce the mobility of the mosquitoes and may explain case clustering within households reported during Zika outbreaks such as in Rio de Janeiro 2015. Nevertheless, the mosquitoes infected with ZIKV are still able to disseminate and to transmit the disease, especially in places where there are many oviposition sites.
C1 [Padilha, Karine Pedreira; Barreto Resck, Maria Eduarda; Teles-de-Freitas, Rayane; Farnesi, Luana Cristina; Bruno, Rafaela Vieira] Fundacao Oswaldo Cruz Fiocruz, Inst Oswaldo Cruz, Lab Biol Mol Insetos, Rio De Janeiro, RJ, Brazil.
   [Padilha, Karine Pedreira; Talyuli da Cunha, Octavio Augusto; Ferreira Sorgine, Marcos Henrique] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo Meis, Lab Bioquim Insetos Hematofagos, Rio De Janeiro, RJ, Brazil.
   [Campos, Stephanie Silva; Lourenco-de-Oliveira, Ricardo] Fundacao Oswaldo Cruz Fiocruz, Inst Oswaldo Cruz, Lab Mosquitos Transmissores Hematozoarios, Rio De Janeiro, RJ, Brazil.
   [Ferreira Sorgine, Marcos Henrique; Lourenco-de-Oliveira, Ricardo; Bruno, Rafaela Vieira] Conselho Nacl Desenvolvimento Cient & Tecnol, Inst Nacl Ciencia & Tecnol Entomol Med, Rio De Janeiro, RJ, Brazil.
RP Bruno, RV (corresponding author), Fundacao Oswaldo Cruz Fiocruz, Inst Oswaldo Cruz, Lab Biol Mol Insetos, Rio De Janeiro, RJ, Brazil.; Bruno, RV (corresponding author), Conselho Nacl Desenvolvimento Cient & Tecnol, Inst Nacl Ciencia & Tecnol Entomol Med, Rio De Janeiro, RJ, Brazil.
EM rafaelav@ioc.fiocruz.br
RI Bruno, Rafaela/AAQ-7611-2020
FU Instituto Nacional de Ciencia e Tecnologia em Entomologia Medica
   (INCT-EM); CNPqNational Council for Scientific and Technological
   Development (CNPq); IOC-FIOCRUZ; FAPERJCarlos Chagas Filho Foundation
   for Research Support of the State of Rio de Janeiro (FAPERJ)
FX Instituto Nacional de Ciencia e Tecnologia em Entomologia Medica
   (INCT-EM), CNPq, IOC-FIOCRUZ, FAPERJ.
CR Anglero-Rodriguez YI, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02050
   Coelho SVA, 2017, J VIROL METHODS, V246, P65, DOI 10.1016/j.jviromet.2017.04.011
   Araripe LO, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2635-9
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Buckner EA, 2013, J MED ENTOMOL, V50, P1291, DOI 10.1603/ME13047
   Chapman RF, 1998, INSECTS STRUCTURE FU
   Clements A.N, 1999, BIOL MOSQUITOES SENS, V2
   Consoli R.A.G.B., 1994, PRINCIPAIS MOSQUITOS
   Couto-Lima D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05186-3
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   dos Santos TP, 2017, ACTA TROP, V176, P140, DOI 10.1016/j.actatropica.2017.07.014
   Farnesi LC, 2009, MEM I OSWALDO CRUZ, V104, P124, DOI 10.1590/S0074-02762009000100020
   Fernandes RS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004993
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Fuller TL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188002
   Gaburro J, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0069-2
   Gentile C, 2009, J BIOL RHYTHM, V24, P444, DOI 10.1177/0748730409349169
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Leming MT, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1128
   Lima-Camara TN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017690
   Lima-Camara TN, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-304
   Maciel-de-Freitas R, 2011, T ROY SOC TROP MED H, V105, P452, DOI 10.1016/j.trstmh.2011.05.006
   Maciel-De-Freitas R, 2008, CAD SAUDE PUBLICA, V24, P2747, DOI 10.1590/S0102-311X2008001200003
   Oliveira JHM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005525
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Possas C, 2017, MEM I OSWALDO CRUZ, V112, P319, DOI 10.1590/0074-02760160510
   Rund SSC, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-218
   Ryckebusch F, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112384
   Vega-Rua A, 2014, J VIROL, V88, P6294, DOI 10.1128/JVI.00370-14
NR 30
TC 3
Z9 3
U1 0
U2 1
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PY 2018
VL 113
IS 10
AR UNSP e180290
DI 10.1590/0074-02760180290
PG 6
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA GR9EQ
UT WOS:000443050000001
PM 30156598
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Moser, LA
   Oldfield, LM
   Fedorova, N
   Puri, V
   Shrivastava, S
   Amedeo, P
   Isom, R
   Hu, LH
   Durbin, A
   Rocchi, I
   Williams, T
   Tan, GS
   Shabman, RS
   Bernard, KA
   Pickett, BE
AF Moser, Lindsey A.
   Oldfield, Lauren M.
   Fedorova, Nadia
   Puri, Vinita
   Shrivastava, Susmita
   Amedeo, Paolo
   Isom, Richard
   Hu, Lihui
   Durbin, Alan
   Rocchi, Iara
   Williams, Torrey
   Tan, Gene S.
   Shabman, Reed S.
   Bernard, Kristen A.
   Pickett, Brett E.
TI Whole-Genome Sequences of Zika Virus FLR Strains after Passage in Vero
   or C6/36 Cells
SO MICROBIOLOGY RESOURCE ANNOUNCEMENTS
LA English
DT Article
AB We report 26 complete genomes of Zika virus (ZIKV) isolated after passaging the Zika virus strain FLR in mosquito (C6/36) and mammalian (Vero) cell lines. The consensus ZIKV genomes we recovered show greater than 99% nucleotide identify with each other and with the FLR strain used as input.
C1 [Moser, Lindsey A.; Bernard, Kristen A.] Univ Wisconsin, Madison, WI USA.
   [Oldfield, Lauren M.; Fedorova, Nadia; Puri, Vinita; Shrivastava, Susmita; Amedeo, Paolo; Isom, Richard; Hu, Lihui; Shabman, Reed S.] J Craig Venter Inst, Rockville, MD USA.
   [Durbin, Alan; Rocchi, Iara; Williams, Torrey; Tan, Gene S.; Pickett, Brett E.] J Craig Venter Inst, La Jolla, CA 92037 USA.
   [Puri, Vinita] GlaxoSmithKline, Rockville, MD USA.
   [Shabman, Reed S.] Amer Type Culture Collect, Gaithersburg, MD USA.
RP Pickett, BE (corresponding author), J Craig Venter Inst, La Jolla, CA 92037 USA.
EM bpickett@jcvi.org
RI Pickett, Brett/AAE-3582-2020
OI Pickett, Brett/0000-0001-7930-8160
FU National Institute of Allergy and Infectious Diseases, National
   Institutes of Health, Department of Health and Human ServicesUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [U19AI110819]
FX This project has been funded in whole or part with federal funds from
   the National Institute of Allergy and Infectious Diseases, National
   Institutes of Health, Department of Health and Human Services, under
   award number U19AI110819.
CR ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   Basile K, 2017, PATHOLOGY, V49, P698, DOI 10.1016/j.pathol.2017.08.002
   Djikeng A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-5
   Lahon A, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005019
   Moser LA, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00039-15
   Wang SL, 2012, NUCLEIC ACIDS RES, V40, pW186, DOI 10.1093/nar/gks528
NR 6
TC 1
Z9 1
U1 0
U2 0
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2576-098X
J9 MICROBIOL RESOUR ANN
JI Microbiol. Resour. Ann.
PD JAN
PY 2018
VL 6
IS 4
AR e01528-17
DI 10.1128/genomeA.01528-17
PG 2
WC Microbiology
SC Microbiology
GA HD1ZN
UT WOS:000452311000017
PM 29371358
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Gladwyn-Ng, I
   Cordon-Barris, L
   Alfano, C
   Creppe, C
   Couderc, T
   Morelli, G
   Thelen, N
   America, M
   Bessieres, B
   Encha-Razavi, F
   Bonniere, M
   Suzuki, IK
   Flamand, M
   Vanderhaeghen, P
   Thiry, M
   Lecuit, M
   Nguyen, L
AF Gladwyn-Ng, Ivan
   Cordon-Barris, Lluis
   Alfano, Christian
   Creppe, Catherine
   Couderc, Therese
   Morelli, Giovanni
   Thelen, Nicolas
   America, Michelle
   Bessieres, Bettina
   Encha-Razavi, Ferechte
   Bonniere, Maryse
   Suzuki, Ikuo K.
   Flamand, Marie
   Vanderhaeghen, Pierre
   Thiry, Marc
   Lecuit, Marc
   Nguyen, Laurent
TI Stress-induced unfolded protein response contributes to Zika
   virus-associated microcephaly
SO NATURE NEUROSCIENCE
LA English
DT Article
ID RESISTANCE; INFECTION; MIGRATION; DEATH; CELLS
AB Accumulating evidence support a causal link between Zika virus (ZIKV) infection during gestation and congenital microcephaly. However, the mechanism of ZIKV-associated microcephaly remains unclear. We combined analyses of ZIKV-infected human fetuses, cultured human neural stem cells and mouse embryos to understand how ZIKV induces microcephaly. We show that ZIKV triggers endoplasmic reticulum stress and unfolded protein response in the cerebral cortex of infected postmortem human fetuses as well as in cultured human neural stem cells. After intracerebral and intraplacental inoculation of ZIKV in mouse embryos, we show that it triggers endoplasmic reticulum stress in embryonic brains in vivo. This perturbs a physiological unfolded protein response within cortical progenitors that controls neurogenesis. Thus, ZIKV-infected progenitors generate fewer projection neurons that eventually settle in the cerebral cortex, whereupon sustained endoplasmic reticulum stress leads to apoptosis. Furthermore, we demonstrate that administration of pharmacological inhibitors of unfolded protein response counteracts these pathophysiological mechanisms and prevents microcephaly in ZIKV-infected mouse embryos. Such defects are specific to ZIKV, as they are not observed upon intraplacental injection of other related flaviviruses in mice.
C1 [Gladwyn-Ng, Ivan; Cordon-Barris, Lluis; Alfano, Christian; Creppe, Catherine; Morelli, Giovanni; Thelen, Nicolas; America, Michelle; Thiry, Marc; Nguyen, Laurent] Univ Liege, GIGA Neurosci, Interdisciplinary Cluster Appl Genoprote GIGA R, CHU Sart Tilman, Liege, Belgium.
   [Couderc, Therese; Lecuit, Marc] Inst Pasteur, Biol Infect Unit, Paris, France.
   [Couderc, Therese; Lecuit, Marc] INSERM, U1117, Paris, France.
   [Morelli, Giovanni] Hasselt Univ, BIOMED, Hasselt, Belgium.
   [Bessieres, Bettina; Encha-Razavi, Ferechte; Bonniere, Maryse] Hop Necker Enfant Malades, Dept Histol Embryol Cytogenet, Paris, France.
   [Bessieres, Bettina] Inst Imagine, INSERM, U1163, Paris, France.
   [Suzuki, Ikuo K.; Vanderhaeghen, Pierre] ULB, Inst Interdisciplinary Res Human Biol IRIBHM, Brussels, Belgium.
   [Suzuki, Ikuo K.; Vanderhaeghen, Pierre] ULB Inst Neurosci UNI, Brussels, Belgium.
   [Flamand, Marie] Inst Pasteur, Struct Virol Unit, Paris, France.
   [Vanderhaeghen, Pierre] Univ Libre Bruxelles, WELBIO, Brussels, Belgium.
   [Lecuit, Marc] Paris Descartes Univ, Necker Enfants Malades Univ Hosp, Sorbonne Paris Cite, Div Infect Dis & Trop Med,Inst Imagine, Paris, France.
RP Nguyen, L (corresponding author), Univ Liege, GIGA Neurosci, Interdisciplinary Cluster Appl Genoprote GIGA R, CHU Sart Tilman, Liege, Belgium.; Lecuit, M (corresponding author), Inst Pasteur, Biol Infect Unit, Paris, France.; Lecuit, M (corresponding author), INSERM, U1117, Paris, France.; Lecuit, M (corresponding author), Paris Descartes Univ, Necker Enfants Malades Univ Hosp, Sorbonne Paris Cite, Div Infect Dis & Trop Med,Inst Imagine, Paris, France.
EM marc.lecuit@pasteur.fr; lnguyen@ulg.ac.be
RI Lecuit, Marc/M-4126-2019; Suzuki, Ikuo/N-7399-2018; Lecuit,
   Marc/J-4073-2013
OI Lecuit, Marc/0000-0002-4491-1063; Suzuki, Ikuo/0000-0003-2896-0292;
   Lecuit, Marc/0000-0002-4491-1063; Thelen, Nicolas/0000-0001-8042-1275;
   MORELLI, Giovanni/0000-0002-4002-9049; Vanderhaeghen,
   Pierre/0000-0001-7899-5720; Nguyen, Laurent/0000-0002-8560-3008
FU F.R.S.-F.N.R.SFonds de la Recherche Scientifique - FNRS; European
   Union's Horizon 2020 Research and Innovation Programme under ZIKAlliance
   Grant [734548]; European Virus Archives goes Global (EVAg) project
   [653316]; Institut Pasteur; InsermInstitut National de la Sante et de la
   Recherche Medicale (Inserm); LabEx IBEID; Fonds Leon Fredericq;
   Fondation Medicale Reine Elisabeth; Fondation Simone et Pierre Clerdent;
   Belgian Science Policy (IAP-VII network) [P7/20]; ARCFondation ARC pour
   la Recherche sur le CancerAustralian Research Council [ARC11/16-01];
   ERANET Neuron STEM-MCD; WELBIO Program of the Walloon Region; AXA
   Research Fund; Fondation ULB; ERANET Neuron Microkin; ERANET E-rare
   Euromicro;  [ERC-2013 ERC-2013-AG-340020]
FX The authors are thankful for technical help from the GIGA-Imaging
   Platform of ULg; M. Leruez-Ville for human sample collection; P.V.
   Drion, E.D. Valentin and C. Grignet for the flaviviral facility; C.
   d'Alessandro, M. Sambon and M. Lavina for technical assistance; E.
   Simon-Loriere for sharing ZIKV quantification protocol; and E. Peyre for
   graphical assistance. L.N., I.G.-N. and C. C. receive financial support
   from F.R.S.-F.N.R.S. This work was supported by the European Union's
   Horizon 2020 Research and Innovation Programme under ZIKAlliance Grant
   Agreement No 734548 (to L.N. and M.L.) and by the European Virus
   Archives goes Global (EVAg) project under grant agreement No 653316.
   M.L. is also funded by Institut Pasteur, Inserm and LabEx IBEID. L.N.
   and P.V. are funded by F.R.S.-F.N.R.S., the Fonds Leon Fredericq, the
   Fondation Medicale Reine Elisabeth, the Fondation Simone et Pierre
   Clerdent and the Belgian Science Policy (IAP-VII network P7/20). L.N. is
   funded by ARC (ARC11/16-01) and the ERANET Neuron STEM-MCD; P.V. is
   funded by the WELBIO Program of the Walloon Region, the AXA Research
   Fund, the Fondation ULB, ERANET Neuron Microkin, ERANET E-rare Euromicro
   and ERC-2013 ERC-2013-AG-340020.
CR Axten JM, 2013, ACS MED CHEM LETT, V4, P964, DOI 10.1021/ml400228e
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Bernard-Marissal N, 2012, J NEUROSCI, V32, P4901, DOI 10.1523/JNEUROSCI.5431-11.2012
   Bonnin A, 2011, NATURE, V472, P347, DOI 10.1038/nature09972
   Borgs L, 2016, SCI REP-UK, V6, DOI 10.1038/srep33377
   Brault JB, 2016, EBIOMEDICINE, V10, P71, DOI 10.1016/j.ebiom.2016.07.018
   Cau E, 1997, DEVELOPMENT, V124, P1611
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chavali PL, 2017, SCIENCE, V357, P83, DOI 10.1126/science.aam9243
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   El Ghouzzi V, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.266
   Gladwyn-Ng I, 2016, NEURAL DEV, V11, DOI 10.1186/s13064-016-0062-1
   Gladwyn-Ng IE, 2015, NEURAL DEV, V10, DOI 10.1186/s13064-015-0032-z
   Gupta A, 2002, NAT REV GENET, V3, P342, DOI 10.1038/nrg799
   Gupta A, 2016, ONCOGENE, V35, P5860, DOI 10.1038/onc.2016.121
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Laguesse S, 2015, DEV CELL, V35, P553, DOI 10.1016/j.devcel.2015.11.005
   Laguesse S, 2015, CELL TISSUE RES, V359, P17, DOI 10.1007/s00441-014-1979-5
   Lambert N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017753
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Monel B, 2017, EMBO J, V36, P1653, DOI 10.15252/embj.201695597
   Olgar Y., 2017, MOL CELL BIOCH
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Paul D, 2015, ANNU REV VIROL, V2, P289, DOI 10.1146/annurev-virology-100114-055007
   Pillai PS, 2016, SCIENCE, V352, P463, DOI 10.1126/science.aaf3926
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Rash BG, 2006, CURR OPIN NEUROBIOL, V16, P25, DOI 10.1016/j.conb.2006.01.004
   Sarnat H B, 2001, Eur J Paediatr Neurol, V5, P57, DOI 10.1053/ejpn.2001.0466
   Sarnat HB, 2013, HAND CLINIC, V111, P117, DOI 10.1016/B978-0-444-52891-9.00012-9
   Sessa A, 2010, GENE DEV, V24, P1816, DOI 10.1101/gad.575410
   STAEHELI P, 1986, CELL, V44, P147, DOI 10.1016/0092-8674(86)90493-9
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tielens S, 2016, CELL RES, V26, P1131, DOI 10.1038/cr.2016.112
   Tsuru A, 2016, SCI REP-UK, V6, DOI 10.1038/srep24217
   Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038
   Woods CG, 2013, ARCH DIS CHILD, V98, P707, DOI 10.1136/archdischild-2012-302882
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Yoon KJ, 2017, CELL STEM CELL, V21, P349, DOI 10.1016/j.stem.2017.07.014
NR 42
TC 33
Z9 33
U1 3
U2 26
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1097-6256
EI 1546-1726
J9 NAT NEUROSCI
JI Nat. Neurosci.
PD JAN
PY 2018
VL 21
IS 1
BP 63
EP +
DI 10.1038/s41593-017-0038-4
PG 11
WC Neurosciences
SC Neurosciences & Neurology
GA FT4WL
UT WOS:000423155800014
PM 29230053
DA 2020-07-08
ER

PT J
AU Gardy, JL
   Loman, NJ
AF Gardy, Jennifer L.
   Loman, Nicholas J.
TI APPLICATIONS OF NEXT-GENERATION SEQUENCING Towards a genomics-informed,
   real-time, global pathogen surveillance system
SO NATURE REVIEWS GENETICS
LA English
DT Review
ID DIGITAL DISEASE DETECTION; ZIKA VIRUS; SYNDROMIC SURVEILLANCE;
   INFECTIOUS-DISEASE; OUTBREAK DETECTION; ZOONOTIC VIRUSES; PUBLIC-HEALTH;
   EBOLA; TRANSMISSION; EPIDEMIOLOGY
AB The recent Ebola and Zika epidemics demonstrate the need for the continuous surveillance, rapid diagnosis and real-time tracking of emerging infectious diseases. Fast, affordable sequencing of pathogen genomes - now a staple of the public health microbiology laboratory in well-resourced settings - can affect each of these areas. Coupling genomic diagnostics and epidemiology to innovative digital disease detection platforms raises the possibility of an open, global, digital pathogen surveillance system. When informed by a One Health approach, in which human, animal and environmental health are considered together, such a genomics-based system has profound potential to improve public health in settings lacking robust laboratory capacity.
C1 [Gardy, Jennifer L.] British Columbia Ctr Dis Control, Vancouver, BC V5Z 4R4, Canada.
   [Gardy, Jennifer L.] Univ British Columbia, Schl Populat & Publ Hlth, Vancouver, BC V6T 1Z3, Canada.
   [Loman, Nicholas J.] Univ Birmingham, Inst Microbiol & Infect, Birmingham B15 2TT, W Midlands, England.
RP Gardy, JL (corresponding author), British Columbia Ctr Dis Control, Vancouver, BC V5Z 4R4, Canada.; Gardy, JL (corresponding author), Univ British Columbia, Schl Populat & Publ Hlth, Vancouver, BC V6T 1Z3, Canada.
EM jennifer.gardy@bccdc.ca
RI Loman, Nicholas/Z-1573-2019
OI Gardy, Jennifer/0000-0001-7255-7631
FU Canada Research Chairs programCanada Research Chairs; Michael Smith
   Foundation for Health Research program
FX J.L.G. is funded by the Canada Research Chairs and Michael Smith
   Foundation for Health Research programmes.
CR Abat C, 2016, INT J INFECT DIS, V48, P22, DOI 10.1016/j.ijid.2016.04.021
   [Anonymous], 2004, SEEK SEC PATH OP ACC
   Anthony SJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9147
   Anthony SJ, 2013, MBIO, V4, DOI 10.1128/mBio.00598-13
   Aslam AA, 2014, J MED INTERNET RES, V16, DOI 10.2196/jmir.3532
   Baele G, 2017, SYST BIOL, V66, pE47, DOI 10.1093/sysbio/syw054
   Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505
   Birko S., PLOS ONE, V10
   Blackley DJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600378
   Bogich TL, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001354
   Braden CR, 2013, EMERG INFECT DIS, V19, P864, DOI 10.3201/eid1906.130192
   Brownstein J., 2007, EUROSURVEILLANCE, V12, P3322
   Brownstein JS, 2009, NEW ENGL J MED, V360, P2153, DOI 10.1056/NEJMp0904012
   Budowle B, 2008, APPL ENVIRON MICROB, V74, P5599, DOI 10.1128/AEM.00966-08
   Budowle Bruce, 2014, Investig Genet, V5, P9, DOI 10.1186/2041-2223-5-9
   Bull S, 2015, J EMPIR RES HUM RES, V10, P302, DOI 10.1177/1556264615594606
   Calain P., 2016, J MED ETHICS
   Carneiro HA, 2009, CLIN INFECT DIS, V49, P1557, DOI 10.1086/630200
   Castro-Wallace Sarah L., 2016, BIORXIV
   Chretien JP, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002109
   Commission on a Global Health Risk Framework for the Future, 2016, NEGL DIM GLOB SEC FR
   Cook R., 2004, C SUMMARY ONE WORLD
   Cook S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023610
   Daszak P, 2009, ECOHEALTH, V6, P1, DOI 10.1007/s10393-009-0253-x
   Deurenberg RH, 2017, J BIOTECHNOL, V243, P16, DOI 10.1016/j.jbiotec.2016.12.022
   Didelot X, 2017, MOL BIOL EVOL, V34, P997, DOI 10.1093/molbev/msw275
   Drummond AJ, 2003, TRENDS ECOL EVOL, V18, P481, DOI 10.1016/S0169-5347(03)00216-7
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Duchene S, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000094
   Dudas G, 2017, NATURE, V544, P309, DOI 10.1038/nature22040
   Edwards A., 2017, BIORXIV
   Edwards Arwyn, 2016, BIORXIV, V78
   Evans DK, 2015, LANCET, V385, P945, DOI 10.1016/S0140-6736(15)60179-9
   Evans TS, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003813
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0356-2
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Filejski C, 2016, Can Commun Dis Rep, V42, P118
   Flahault A, 2017, SWISS MED WKLY, V147, DOI 10.4414/smw.2017.14423
   Fournier A, 2015, ZOONOSES PUBLIC HLTH, V62, P417, DOI 10.1111/zph.12179
   Furtak V, 2016, EUROSURVEILLANCE, V21, P40, DOI 10.2807/1560-7917.ES.2016.21.15.30193
   Geller G, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0106-2
   Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657
   Godfroid J, 2017, ARCH PUBLIC HEALTH, V75, DOI 10.1186/s13690-017-0207-7
   Gostin LO, 2017, MED LAW REV, V25, P185, DOI 10.1093/medlaw/fwx016
   Gostin LO, 2009, BRIT MED BULL, V90, P7, DOI 10.1093/bmb/ldp014
   Graham RMA, 2014, EPIDEMIOL INFECT, V142, P2347, DOI 10.1017/S0950268814000375
   Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Grumaz S, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0326-8
   Guthrie JL, 2017, ANN NY ACAD SCI, V1388, P59, DOI 10.1111/nyas.13273
   Hall MD, 2016, REV SCI TECH OIE, V35, P287, DOI 10.20506/rst.35.1.2433
   Hartley DM, 2013, CLIN MICROBIOL INFEC, V19, P1006, DOI 10.1111/1469-0691.12273
   Henning Kelly J, 2004, MMWR Suppl, V53, P5
   Hoenen T, 2016, EMERG INFECT DIS, V22, P331, DOI 10.3201/eid2202.151796
   HOLMES EC, 1995, J INFECT DIS, V171, P45, DOI 10.1093/infdis/171.1.45
   Holmes EC, 2016, NATURE, V538, P193, DOI 10.1038/nature19790
   Houldcroft CJ, 2017, NAT REV MICROBIOL, V15, P183, DOI 10.1038/nrmicro.2016.182
   Howard HC, 2013, PUBLIC HEALTH GENOM, V16, P100, DOI 10.1159/000346474
   Hulth A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004378
   Inns T, 2015, EUROSURVEILLANCE, V20, P15, DOI 10.2807/1560-7917.ES2015.20.16.21098
   International Association of Public Health Institutes, PUBL HLTH SURV CALL
   Ishii T, 2015, TRENDS MOL MED, V21, P473, DOI 10.1016/j.molmed.2015.05.006
   Jackson BR, 2016, CLIN INFECT DIS, V63, P380, DOI 10.1093/cid/ciw242
   Jain M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1103-0
   Joensen KG, 2014, J CLIN MICROBIOL, V52, P1501, DOI 10.1128/JCM.03617-13
   Johnson Sarah S, 2017, J Biomol Tech, V28, P2, DOI 10.7171/jbt.17-2801-009
   Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536
   Kallas EG, 2016, JAMA PEDIATR, V170, P633, DOI 10.1001/jamapediatrics.2016.0857
   Kamath PL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11448
   Kelly TR, 2017, PREV VET MED, V137, P112, DOI 10.1016/j.prevetmed.2016.11.023
   Khoury MJ, 2016, AM J PREV MED, V50, P398, DOI 10.1016/j.amepre.2015.08.031
   Knoppers Bartha Maria, 2014, Hugo J, V8, P3, DOI 10.1186/s11568-014-0003-1
   Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198
   Majumder Maimuna S, 2016, JMIR Public Health Surveill, V2, pe30, DOI 10.2196/publichealth.5814
   Mandl KD, 2004, J AM MED INFORM ASSN, V11, P141, DOI 10.1197/jamia.M1356
   Mate SE, 2015, NEW ENGL J MED, V373, P2448, DOI 10.1056/NEJMoa1509773
   McIntyre ABR, 2016, NPJ MICROGRAVITY, V2, DOI 10.1038/npjmgrav.2016.35
   Moon S, 2015, LANCET, V386, P2204, DOI 10.1016/S0140-6736(15)00946-0
   Morse SS, 2012, LANCET, V380, P1956, DOI 10.1016/S0140-6736(12)61684-5
   Murray KA, 2015, P NATL ACAD SCI USA, V112, P12746, DOI 10.1073/pnas.1507442112
   National Research Council (US), 2009, SUST GLOB SURV RESP
   Neher RA, 2015, BIOINFORMATICS, V31, P3546, DOI 10.1093/bioinformatics/btv381
   Newson AJ, 2016, BMC MED GENOMICS, V9, DOI 10.1186/s12920-016-0219-0
   NICHOL ST, 1993, SCIENCE, V262, P914, DOI 10.1126/science.8235615
   Norstrom MM, 2012, NEW MICROBIOL, V35, P101
   O'Shea J, 2017, INT J MED INFORM, V101, P15, DOI 10.1016/j.ijmedinf.2017.01.019
   Olson SH, 2015, EMERG INFECT DIS, V21, P1285, DOI 10.3201/eid2108.141156
   Pal C, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0199-5
   Paul MJ, 2014, PLOS CURR
   Pendleton KM, 2017, AM J RESP CRIT CARE, V196, P1610, DOI 10.1164/rccm.201703-0537LE
   Perkel J, 2016, NATURE, V538, P127, DOI 10.1038/538127a
   Phan MVT, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew027
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Popinga A, 2015, GENETICS, V199, P595, DOI 10.1534/genetics.114.172791
   Popovich KJ, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0570-0
   Pybus OG, 2001, SCIENCE, V292, P2323, DOI 10.1126/science.1058321
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996
   Quick J, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0677-2
   Raza S., MICROB GENOMICS
   Rosenberg R, 2015, CELL MOL LIFE SCI, V72, P1115, DOI 10.1007/s00018-014-1785-y
   Rosenberg R, 2013, P NATL ACAD SCI USA, V110, P13961, DOI 10.1073/pnas.1307243110
   Ross E., 2014, PERSPECTIVES DATA SH
   Sane J., OVERCOMING BARRIERS
   Schlaberg R, 2017, ARCH PATHOL LAB MED, V141, P776, DOI 10.5858/arpa.2016-0539-RA
   Schmedes SE, 2016, J CLIN MICROBIOL, V54, P1964, DOI 10.1128/JCM.00046-16
   Schmidt K, 2017, J ANTIMICROB CHEMOTH, V72, P104, DOI 10.1093/jac/dkw397
   Schwind JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110236
   Seytre B, 2016, Bull Soc Pathol Exot, V109, P314, DOI 10.1007/s13149-016-0524-z
   Shi M, 2016, NATURE, V540, P539, DOI 10.1038/nature20167
   Smolinski MS, 2015, AM J PUBLIC HEALTH, V105, P2124, DOI 10.2105/AJPH.2015.302696
   Temmam S, 2014, INT J MOL SCI, V15, P10377, DOI 10.3390/ijms150610377
   Doan T, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0344-6
   Trewby H, 2017, EMERG INFECT DIS, V23, P1454, DOI 10.3201/eid2309.170325
   Wilson MR, 2015, ANN NEUROL, V78, P722, DOI 10.1002/ana.24499
   Wilson MR, 2014, NEW ENGL J MED, V370, P2408, DOI 10.1056/NEJMoa1401268
   Woolhouse M, 2007, CRIT REV MICROBIOL, V33, P231, DOI 10.1080/10408410701647560
   Worobey M, 2017, NATURE, V546, P355, DOI 10.1038/nature22495
   Yozwiak NL, 2015, NATURE, V518, P477, DOI 10.1038/518477a
   Zinszer K., PLOS CURR
NR 121
TC 98
Z9 100
U1 14
U2 77
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-0056
EI 1471-0064
J9 NAT REV GENET
JI Nat. Rev. Genet.
PD JAN
PY 2018
VL 19
IS 1
BP 9
EP 20
DI 10.1038/nrg.2017.88
PG 12
WC Genetics & Heredity
SC Genetics & Heredity
GA FS5NY
UT WOS:000419846000008
PM 29129921
OA Green Published
DA 2020-07-08
ER

PT J
AU Hasan, SS
   Sevvana, M
   Kuhn, RJ
   Rossmann, MG
AF Hasan, S. Saif
   Sevvana, Madhumati
   Kuhn, Richard J.
   Rossmann, Michael G.
TI Structural biology of Zika virus and other flaviviruses
SO NATURE STRUCTURAL & MOLECULAR BIOLOGY
LA English
DT Review
ID WEST-NILE-VIRUS; BORNE ENCEPHALITIS-VIRUS; ENVELOPE PROTEIN-E;
   DENGUE-VIRUS; MEMBRANE-FUSION; DC-SIGN; NEUTRALIZATION MECHANISM;
   MONOCLONAL-ANTIBODY; CRYSTAL-STRUCTURE; IN-VITRO
AB Zika virus (ZIKV) is an enveloped, icosahedral flavivirus that has structural and functional similarities to other human flavivirus pathogens such as dengue (DENV), West Nile (WNV) and Japanese encephalitis (JEV) viruses. ZIKV infections have been linked to fetal microcephaly and the paralytic Guillain-Barre syndrome. This review provides a comparative structural analysis of the assembly, maturation and host-cell entry of ZIKV with other flaviviruses, especially DENV. We also discuss the mechanisms of neutralization by antibodies.
C1 [Hasan, S. Saif; Sevvana, Madhumati; Kuhn, Richard J.; Rossmann, Michael G.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.
RP Rossmann, MG (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.
EM mr@purdue.edu
RI Sevvana, Madhumati/S-3297-2019
OI Sevvana, Madhumati/0000-0003-4992-6296
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [AI076331, AI073755]
FX Much of the work described here was supported by NIH grant AI076331 to
   M.G.R. and R.J.K. We are also grateful for NIH grant AI073755 awarded to
   M.S. Diamond (PI) with a subaward to M.G.R. and R.J.K. We thank the
   Purdue Cryo-EM facility for their help and support. We are also grateful
   to the Purdue Rosen Center for Advanced Computing for research computing
   support over many decades. We have greatly benefitted from discussions
   and help from numerous postdocs over the years (in particular, B.
   Kaufmann and T. Klose) as well as graduate students in both the Kuhn and
   Rossmann faculty research labs at Purdue. We thank S. Kelly for help in
   preparing this manuscript.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   ALLISON SL, 1995, J VIROL, V69, P695, DOI 10.1128/JVI.69.2.695-700.1995
   Allison SL, 1999, J VIROL, V73, P5605, DOI 10.1128/JVI.73.7.5605-5612.1999
   Allison SL, 2001, J VIROL, V75, P4268, DOI 10.1128/JVI.75.9.4268-4275.2001
   Aoki C, 2006, J BIOCHEM, V139, P607, DOI 10.1093/jb/mvj067
   Barba-Spaeth G, 2005, J EXP MED, V202, P1179, DOI 10.1084/jem.20051352
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Beasley DWC, 2005, J VIROL, V79, P8339, DOI 10.1128/JVI.79.13.8339-8347.2005
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bielefeldt-Ohmann H, 1998, VIRUS RES, V57, P63, DOI 10.1016/S0168-1702(98)00087-2
   Boigard H, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005608
   Bressanelli S, 2004, EMBO J, V23, P728, DOI 10.1038/sj.emboj.7600064
   Bryant JE, 2007, VIROLOGY, V366, P415, DOI 10.1016/j.virol.2007.05.007
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Ceccaldi PE, 2004, FEMS MICROBIOL LETT, V233, P1, DOI 10.1016/j.femsle.2004.01.035
   Chahal JS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00193-w
   Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866
   CHENG RH, 1995, CELL, V80, P621
   Cherrier MV, 2009, EMBO J, V28, P3269, DOI 10.1038/emboj.2009.245
   Cockburn JJB, 2012, STRUCTURE, V20, P303, DOI 10.1016/j.str.2012.01.001
   Cockburn JJB, 2012, EMBO J, V31, P767, DOI 10.1038/emboj.2011.439
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Davidson AD, 2009, ADV VIRUS RES, V74, P41, DOI 10.1016/S0065-3527(09)74002-3
   Davis CW, 2006, J BIOL CHEM, V281, P37183, DOI 10.1074/jbc.M605429200
   Davis CW, 2006, J VIROL, V80, P1290, DOI 10.1128/JVI.80.3.1290-1301.2006
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dokland T, 2004, STRUCTURE, V12, P1157, DOI 10.1016/j.str.2004.04.024
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Fibriansah G, 2013, J VIROL, V87, P7585, DOI 10.1128/JVI.00757-13
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   GUIRAKHOO F, 1992, VIROLOGY, V191, P921, DOI 10.1016/0042-6822(92)90267-S
   Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456
   Hasan SS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14722
   Heinz FX, 2012, VACCINE, V30, P4301, DOI 10.1016/j.vaccine.2011.09.114
   HEINZ FX, 1994, VIROLOGY, V198, P109, DOI 10.1006/viro.1994.1013
   Johnston LJ, 1996, J VIROL, V70, P4761, DOI 10.1128/JVI.70.7.4761-4766.1996
   Kanai R, 2006, J VIROL, V80, P11000, DOI 10.1128/JVI.01735-06
   Kaufmann B, 2011, MICROBES INFECT, V13, P1, DOI 10.1016/j.micinf.2010.09.005
   Kaufmann B, 2010, P NATL ACAD SCI USA, V107, P18950, DOI 10.1073/pnas.1011036107
   Kaufmann B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000672
   Kaufmann B, 2006, P NATL ACAD SCI USA, V103, P12400, DOI 10.1073/pnas.0603488103
   Kielian M, 2006, NAT REV MICROBIOL, V4, P67, DOI 10.1038/nrmicro1326
   Kim E, 2016, EBIOMEDICINE, V13, P315, DOI 10.1016/j.ebiom.2016.09.028
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kostyuchenko VA, 2013, J VIROL, V87, P7700, DOI 10.1128/JVI.00197-13
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Lagunas-Rangel FA, 2017, J VIRUS ERAD, V3, P124
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lee H, 2017, ANTIVIR RES, V139, P49, DOI 10.1016/j.antiviral.2016.12.016
   Lee JWM, 2006, J BIOL CHEM, V281, P1352, DOI 10.1074/jbc.M506614200
   Lescar J, 2001, CELL, V105, P137, DOI 10.1016/S0092-8674(01)00303-8
   Li L, 2008, SCIENCE, V319, P1830, DOI 10.1126/science.1153263
   Lindenbach Brett D., 2007, FIELDS VIROLOGY, P1101
   Lok SM, 2008, NAT STRUCT MOL BIOL, V15, P312, DOI 10.1038/nsmb.1382
   Lorenz IC, 2002, J VIROL, V76, P5480, DOI 10.1128/JVI.76.11.5480-5491.2002
   Lozach PY, 2005, J BIOL CHEM, V280, P23698, DOI 10.1074/jbc.M504337200
   Ma LX, 2004, P NATL ACAD SCI USA, V101, P3414, DOI 10.1073/pnas.0305892101
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mentor NA, 1997, ACTA VIROL, V41, P175
   Miller JL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040017
   Mirza MU, 2016, SCI REP-UK, V6, DOI 10.1038/srep37313
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100
   Modis Y, 2005, J VIROL, V79, P1223, DOI 10.1128/JVI.79.2.1223-1231.2005
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Morrison C, 2016, NAT REV DRUG DISCOV, V15, P521, DOI 10.1038/nrd.2016.159
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Mukhopadhyay S, 2003, SCIENCE, V302, P248, DOI 10.1126/science.1089316
   Murata R, 2010, AM J TROP MED HYG, V82, P696, DOI 10.4269/ajtmh.2010.09-0262
   Murray CL, 2008, NAT REV MICROBIOL, V6, P699, DOI 10.1038/nrmicro1928
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nelson S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000060
   Nybakken GE, 2006, J VIROL, V80, P11467, DOI 10.1128/JVI.01125-06
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Plevka P, 2011, EMBO REP, V12, P602, DOI 10.1038/embor.2011.75
   Pokidysheva E, 2006, CELL, V124, P485, DOI 10.1016/j.cell.2005.11.042
   Prasad VM, 2017, NAT STRUCT MOL BIOL, V24, P184, DOI 10.1038/nsmb.3352
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   RANDOLPH VB, 1990, VIROLOGY, V174, P450, DOI 10.1016/0042-6822(90)90099-D
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   Richard AS, 2017, P NATL ACAD SCI USA, V114, P2024, DOI 10.1073/pnas.1620558114
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Rios M, 2006, TRANSFUSION, V46, P659, DOI 10.1111/j.1537-2995.2006.00769.x
   Rossmann MG, 2001, J STRUCT BIOL, V136, P190, DOI 10.1006/jsbi.2002.4435
   Ryan J.R, 2016, BIOSECUR BIOTERROR
   Saiz JC, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00411-17, 10.1128/aac.00411-17]
   Sakoonwatanyoo P, 2006, INTERVIROLOGY, V49, P161, DOI 10.1159/000089377
   Salas-Benito J, 2007, AM J TROP MED HYG, V77, P283, DOI 10.4269/ajtmh.2007.77.283
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Stadler K, 1997, J VIROL, V71, P8475, DOI 10.1128/JVI.71.11.8475-8481.1997
   Stephen P, 2016, J AM CHEM SOC, V138, P16212, DOI 10.1021/jacs.6b10399
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Stiasny K, 1996, J VIROL, V70, P8142, DOI 10.1128/JVI.70.11.8142-8147.1996
   Stiasny K, 2006, J GEN VIROL, V87, P2755, DOI 10.1099/vir.0.82210-0
   Strauss J.H., 2002, VIRUSES HUMAN DIS, V371
   Suksanpaisan L, 2007, J MED VIROL, V79, P300, DOI 10.1002/jmv.20798
   Sumathy K, 2017, SCI REP-UK, V7, DOI 10.1038/srep46375
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840
   Theiler M, 1937, J EXP MED, V65, P767, DOI 10.1084/jem.65.6.767
   Thul PJ, 2017, SCIENCE, V356, DOI 10.1126/science.aal3321
   Thullier P, 2001, J GEN VIROL, V82, P1885, DOI 10.1099/0022-1317-82-8-1885
   Tio PH, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-25
   Uhlen M, 2017, SCIENCE, V357, P660, DOI 10.1126/science.aan2507
   Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419
   Valle JRD, 2005, J VIROL, V79, P4557, DOI 10.1128/JVI.79.8.4557-4567.2005
   Wang CY, 2013, JPN J INFECT DIS, V66, P341, DOI 10.7883/yoken.66.341
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Wang ZQ, 2013, J VIROL, V87, P8909, DOI 10.1128/JVI.00472-13
   Wei HY, 2003, J GEN VIROL, V84, P3095, DOI 10.1099/vir.0.19308-0
   Wu SJL, 2000, NAT MED, V6, P816, DOI 10.1038/77553
   Xie XP, 2017, MBIO, V8, DOI [10.1128/mBio.02134-16, 10.1128/mbio.02134-16]
   Yu IM, 2009, J VIROL, V83, P12101, DOI 10.1128/JVI.01637-09
   Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264
   Zhang S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13679
   Zhang W, 2003, NAT STRUCT BIOL, V10, P907, DOI 10.1038/nsb990
   Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463
   Zhang XZ, 2015, J VIROL, V89, P743, DOI 10.1128/JVI.02411-14
   Zhang XZ, 2013, P NATL ACAD SCI USA, V110, P6795, DOI 10.1073/pnas.1304300110
   Zhang Y, 2004, STRUCTURE, V12, P1607, DOI 10.1016/j.str.2004.06.019
   Zhang Y, 2003, EMBO J, V22, P2604, DOI 10.1093/emboj/cdg270
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
   Zmurko J, 2015, REV MED VIROL, V25, P205, DOI 10.1002/rmv.1835
NR 130
TC 40
Z9 41
U1 2
U2 51
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1545-9993
EI 1545-9985
J9 NAT STRUCT MOL BIOL
JI Nat. Struct. Mol. Biol.
PD JAN
PY 2018
VL 25
IS 1
BP 13
EP 20
DI 10.1038/s41594-017-0010-8
PG 8
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA FU0NN
UT WOS:000423547700004
PM 29323278
DA 2020-07-08
ER

PT J
AU Zandi, S
   Bodaghi, B
   Garweg, JG
AF Zandi, Souska
   Bodaghi, Bahram
   Garweg, Justus G.
TI Review for Disease of the Year: Treatment of Viral Anterior Uveitis: A
   Perspective
SO OCULAR IMMUNOLOGY AND INFLAMMATION
LA English
DT Review
DE Acyclovir; antivirals; treatment; valacyclovir; viral anterior uveitis
ID POLYMERASE-CHAIN-REACTION; RUBELLA-VIRUS; CLINICAL-FEATURES;
   CYTOMEGALOVIRUS; DIAGNOSIS; IRIDOCYCLITIS; MANAGEMENT; SECONDARY; DNA
AB Purpose: To define a clinically tailored therapeutic strategy for the treatment of viral anterior uveitis (VAU).
   Methods: A PubMed search spanning the past 5 years was conducted using the MesH-terms "viral anterior uveitis" and "therapy."
   Results: The herpes simplex virus (HSV), the varicella zoster virus (VZV), and the cytomegalovirus (CMV) are the predominant pathogens in VAU. Other viruses, including rubella, chikungunya, and zika, have been linked with distinct forms of the disease. Depending on the causative agent and the host immunocompetence, the mainstay treatment for suspected VAU is a combination of topical or systemic antivirals and topical corticosteroids, supplemented with cycloplegics and intraocular-pressure-lowering medication.
   Conclusions: Oral acyclovir, valacyclovir, and famciclovir are the mainstay of treatment for HSV- and VZV-induced infections. Brivudin serves as an alternative in insufficiently responsive cases. CMV-induced infections respond well to valganciclovir. A 3- to 12-month course of prophylactic treatment against recurrences is worth considering.
C1 [Zandi, Souska; Garweg, Justus G.] Swiss Eye Inst, Clin Vitreoretinal Dis, Bern, Switzerland.
   [Zandi, Souska; Garweg, Justus G.] Berner Augenklin Lindenhofspital, Bern, Switzerland.
   [Bodaghi, Bahram] Sorbonne Univ, DHU ViewRestore, UPMC, APHP, Paris, France.
   [Garweg, Justus G.] Univ Bern, Bern, Switzerland.
RP Garweg, JG (corresponding author), Berner Augenklin Lindenhofspital, Swiss Eye Inst, Bremgartenstr 119, CH-3012 Bern, Switzerland.
EM justus.garweg@augenklinik-bern.ch
OI Zandi, Souska/0000-0001-9351-4278
CR Accorinti M, 2014, GRAEF ARCH CLIN EXP, V252, P1817, DOI 10.1007/s00417-014-2782-4
   Agrawal RV, 2010, INDIAN J OPHTHALMOL, V58, P11, DOI 10.4103/0301-4738.58468
   Chan NSW, 2018, OCUL IMMUNOL INFLAMM, V26, P107, DOI 10.1080/09273948.2017.1394471
   Chee SP, 2010, BRIT J OPHTHALMOL, V94, P1648, DOI 10.1136/bjo.2009.167767
   Chee SP, 2008, AM J OPHTHALMOL, V145, P834, DOI 10.1016/j.ajo.2007.12.015
   Chee SP, 2008, AM J OPHTHALMOL, V146, P883, DOI 10.1016/j.ajo.2008.09.001
   Choi JA, 2016, J OPHTHALMIC INFLAMM, V6, DOI 10.1186/s12348-016-0100-5
   Chronopoulos A, 2016, BMC OPHTHALMOL, V16, DOI 10.1186/s12886-016-0369-z
   Daas L, 2017, OPHTHALMOLOGE, V114, P481, DOI 10.1007/s00347-017-0494-y
   de Groot-Mijnes JDF, 2006, AM J OPHTHALMOL, V141, P212, DOI 10.1016/j.ajo.2005.07.078
   de Groot-Mijnes JDF, 2010, AM J OPHTHALMOL, V150, P628, DOI 10.1016/j.ajo.2010.05.015
   Gaynor BD, 2000, INT OPHTHALMOL CLIN, V40, P85, DOI 10.1097/00004397-200004000-00008
   Goldstein DA, 2009, CAN J OPHTHALMOL, V44, P314, DOI 10.3129/i09-018
   Jap A, 2011, CURR OPIN OPHTHALMOL, V22, P483, DOI 10.1097/ICU.0b013e32834be021
   Kongyai N, 2012, EYE, V26, P529, DOI 10.1038/eye.2011.363
   Laaks D, 2015, AFR HEALTH SCI, V15, P748, DOI 10.4314/ahs.v15i3.7
   Mahendradas P, 2010, INDIAN J OPHTHALMOL, V58, P545, DOI 10.4103/0301-4738.71707
   Markomichelakis NN, 2002, OPHTHALMOLOGY, V109, P879, DOI 10.1016/S0161-6420(02)00961-2
   Merayo-Lloves J, 1999, OPHTHALMOLOGICA, V213, P300, DOI 10.1159/000027443
   Pogorzalek N, 2011, J FR OPHTALMOL, V34, P157, DOI 10.1016/j.jfo.2010.11.005
   Quentin CD, 2004, AM J OPHTHALMOL, V138, P46, DOI 10.1016/j.ajo.2004.02.055
   Schacher S, 1998, KLIN MONATSBL AUGENH, V212, P359, DOI 10.1055/s-2008-1034906
   Shoughy SS, 2015, CLIN OPHTHALMOL, V9, P2325, DOI 10.2147/OPTH.S93655
   Sungur Gulten Karatas, 2010, International Ophthalmology, V30, P191, DOI 10.1007/s10792-009-9305-z
   Suzuki J, 2010, GRAEF ARCH CLIN EXP, V248, P1487, DOI 10.1007/s00417-010-1434-6
   Takahashi H, 2008, JPN J OPHTHALMOL, V52, P136, DOI 10.1007/s10384-007-0508-4
   Van der Lelij A, 2000, OPHTHALMOLOGY, V107, P1164, DOI 10.1016/S0161-6420(00)00115-9
   Wensing B, 2011, OPHTHALMOLOGY, V118, P1905, DOI 10.1016/j.ophtha.2011.03.033
   Westeneng AC, 2007, AM J OPHTHALMOL, V144, P781, DOI 10.1016/j.ajo.2007.06.034
   Yamamoto S, 1996, BRIT J OPHTHALMOL, V80, P465, DOI 10.1136/bjo.80.5.465
NR 30
TC 4
Z9 4
U1 1
U2 1
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0927-3948
EI 1744-5078
J9 OCUL IMMUNOL INFLAMM
JI Ocul. Immunol. Inflamm.
PY 2018
VL 26
IS 7
BP 1135
EP 1142
DI 10.1080/09273948.2018.1498109
PG 8
WC Ophthalmology
SC Ophthalmology
GA HD3QL
UT WOS:000452433400022
PM 30096015
DA 2020-07-08
ER

PT J
AU Vivekanandhan, P
   Karthi, S
   Shivakumar, MS
   Benelli, G
AF Vivekanandhan, Perumal
   Karthi, Sengodan
   Shivakumar, Muthugounder S.
   Benelli, Giovanni
TI Synergistic effect of entomopathogenic fungus Fusarium oxysporum extract
   in combination with temephos against three major mosquito vectors
SO PATHOGENS AND GLOBAL HEALTH
LA English
DT Article
DE Fusariurn oxysporum; temephos; Zika virus; FT-IR; GC-MS; histopathology
ID CULEX-QUINQUEFASCIATUS SAY; ESSENTIAL OILS; ANOPHELES-STEPHENSI;
   AEDES-AEGYPTI; LARVAE; TOXICITY; INSECTICIDES; CHALLENGES; COLEOPTERA;
   RESISTANCE
AB Mosquito control using chemical insecticides is facing a major challenge due to development of insecticide resistance. Improving the efficiency of existing insecticides using synergistic secondary metabolites of biological origin is increasingly being researched. Herein, we evaluated the toxicity of Fusarium oxysporum extract alone and in binary combinations with temephos, on larvae and pupae of Anopheles stephensi, Aedes aegypti and Culex quinquefaciatus. F. oxysporum extract was characterized using TLC, FT-IR and GC-MS. After 24 h of exposure, the binary combination of temephos + F. oxysporum extract (1:1 ratio) was highly toxic to larvae of An. stephensi (LC50 : 35.927 mu g/ml), Ae. aegypti (LC50 : 20.763 mu g/ml) and Cx. quinquefasciatus, (LC50 : 51.199 mu g/ml). For pupae LC50 values were 38.668, 26.394, and 72.086 mu g/ml, respectively. Histology studies of mosquitoes exposed to F. oxysporum extract showed vacuolation in epithelium, as well as in adipose, and muscle tissues of larval midgut. Overall, our results show that the synergistic combination of temephos and F oxysporum extract is highly effective to control mosquito young instars.
C1 [Vivekanandhan, Perumal; Karthi, Sengodan; Shivakumar, Muthugounder S.] Periyar Univ, Dept Biotechnol, Mol Entomol Lab, Salem, India.
   [Benelli, Giovanni] Univ Pisa, Dept Agr Food & Environm, Pisa, Italy.
   [Benelli, Giovanni] Scuola Super Sant Anna, BioRobot Inst, Pisa, Italy.
RP Shivakumar, MS (corresponding author), Periyar Univ, Dept Biotechnol, Mol Entomol Lab, Salem, India.
EM skentomology@gmail.com
RI Shivakumar, Muthugounder S./AAD-6241-2019; Benelli,
   Giovanni/A-9100-2013; Perumal, Vivekanandhan/H-2783-2017; Karthi,
   Sengodan/D-5371-2015
OI Benelli, Giovanni/0000-0001-8971-6010; Perumal,
   Vivekanandhan/0000-0002-3283-1306; Shivakumar, Muthugounder
   S/0000-0002-1910-5510
FU Periyar University [PU/AD3/URF/16169/2016]
FX The authors are grateful to Periyar University for providing financial
   support under University Research Fellowship Scheme (Ref No.
   PU/AD3/URF/16169/2016). We also thank the Institute of Vector Control
   and Zoonoses (IVCZ) Hosur for supplying eggs as well as the Vellore
   Institute of Technology (VIT) for FT-IR and GC-MS analysis.
CR Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a
   Abdel-Baky NF, 2003, J APPL ENTOMOL, V127, P228, DOI 10.1046/j.1439-0418.2003.00662.x
   Amerasan D, 2016, J PEST SCI, V89, P249, DOI 10.1007/s10340-015-0675-x
   ANDERSON TE, 1989, J ECON ENTOMOL, V82, P83, DOI 10.1093/jee/82.1.83
   Benelli G, 2017, ENTOMOL GEN, V36, P309, DOI 10.1127/entomologia/2017/0496
   Benelli G, 2017, ACTA TROP, V174, P91, DOI 10.1016/j.actatropica.2017.06.028
   Benelli G, 2017, IND CROP PROD, V96, P186, DOI 10.1016/j.indcrop.2016.11.059
   Benelli G, 2017, PARASITOL INT, V66, P166, DOI 10.1016/j.parint.2017.01.012
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   BHAN S, 2015, INT J MOSQ RES A, V2, P34
   Chirchir D. K., 2013, African Journal of Biotechnology, V12, P6302
   Cuthbertson AGS, 2005, MYCOPATHOLOGIA, V160, P35, DOI 10.1007/s11046-005-6835-4
   Deepika TL, 2012, PARASITOL RES, V111, P1151, DOI 10.1007/s00436-011-2493-2
   Dhanasekaran D, 2010, INT J APPL BIOL PHAR, V1, P374
   Farenhorst M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012081
   Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371
   Hiromori H, 1998, APPL ENTOMOL ZOOL, V33, P77, DOI 10.1303/aez.33.77
   Hiromori H, 2001, APPL ENTOMOL ZOOL, V36, P231, DOI 10.1303/aez.2001.231
   Kaakeh W, 1997, J ECON ENTOMOL, V90, P473, DOI 10.1093/jee/90.2.473
   KELLER S, 1991, Sydowia, V43, P39
   Maurya P, 2011, ENTOMOL RES, V41, P211, DOI 10.1111/j.1748-5967.2011.00347.x
   Melnikov, 1971, CHEM PEST, P177
   Muthusamy R, 2015, J VECTOR DIS, V52, P159
   Pavela R, 2016, TRENDS PLANT SCI, V21, P1000, DOI 10.1016/j.tplants.2016.10.005
   Pavela R, 2015, PARASITOL RES, V114, P3835, DOI 10.1007/s00436-015-4614-9
   Priyanka, 2001, J AM MOSQUITO CONTR, V17, P127
   Quintela ED, 1998, J ECON ENTOMOL, V91, P110, DOI 10.1093/jee/91.1.110
   Ramkumar G, 2015, PARASITOL RES, V114, P2553, DOI 10.1007/s00436-015-4459-2
   Samson R. A., 1988, ATLAS ENTOMOPATHOGEN, DOI [10.1007/978-3-662-05890-9, DOI 10.1007/978-3-662-05890-9, 10.1007/978-3-662-05890-9.]
   Santos AV, 2007, MYCOPATHOLOGIA, V163, P233, DOI 10.1007/s11046-007-9009-8
   Saurav K, 2013, PARASITOL RES, V112, P215, DOI 10.1007/s00436-011-2682-z
   Senthilkumar G., 2011, Asian Journal of Pharmaceutical Research, V1, P19
   Senthilkumar N, 2014, J AGR LIFE SCI, V1, P108
   Seye F, 2012, MALAR CHEMO CONTR EL, V1, P6, DOI [10.4303/mcce/235494, DOI 10.4303/MCCE/235494]
   Silva RO, 2008, REV PATOLOGIA TROPIC, V33, P207, DOI DOI 10.5216/RPT.V33I2.3446
   Singh G, 2012, PARASITOL RES, V110, P267, DOI 10.1007/s00436-011-2482-5
   Soni N, 2010, PARASITOL RES, V107, P1329, DOI 10.1007/s00436-010-2003-y
   Srivastava C. N., 2011, Journal of Entomological Research, V35, P255
   Vivekanandhan P, 2018, PHYSIOL MOL PLANT P, V101, P156, DOI 10.1016/j.pmpp.2017.05.005
   Vyas N, 2007, PARASITOL RES, V101, P385, DOI 10.1007/s00436-007-0496-9
   Weiser J., 1992, Cytobios, V69, P179
   *WHO, 2005, WHOCDSWHOPESGCDPP200
   World Health Organization, 2016, WEEKLY EPIDEMIOLOGIC, V85, P365
   World Health Organization, WORLD MAL REP 2015
NR 45
TC 9
Z9 9
U1 3
U2 8
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 2047-7724
EI 2047-7732
J9 PATHOG GLOB HEALTH
JI Pathog. Glob. Health
PY 2018
VL 112
IS 1
BP 37
EP 46
DI 10.1080/20477724.2018.1438228
PG 10
WC Public, Environmental & Occupational Health; Parasitology; Tropical
   Medicine
SC Public, Environmental & Occupational Health; Parasitology; Tropical
   Medicine
GA GF8IZ
UT WOS:000432215500005
PM 29457957
OA Green Published
DA 2020-07-08
ER

PT J
AU Bora, K
   Das, D
   Barman, B
   Borah, P
AF Bora, Kaustubh
   Das, Dulmoni
   Barman, Bhupen
   Borah, Probodh
TI Are Internet videos useful sources of information during global public
   health emergencies ? A case study of YouTube videos during the 2015-16
   Zika virus pandemic
SO PATHOGENS AND GLOBAL HEALTH
LA English
DT Article
DE Public health; internet; social media; health communication; health
   information; pandemic
ID GUILLAIN-BARRE-SYNDROME; SOCIAL MEDIA; BIRTH-DEFECTS; INFECTION; EBOLA;
   MISINFORMATION; STATES; SITES; WOMEN; WEB
AB Background: Internet-videos, though popular sources of public health information, are often unverified and anecdotal. We critically evaluated YouTube videos about Zika virus available during the recent Zika pandemic.
   Methods: Hundred-and-one videos were retrieved from YouTube (search term: zika virus). Based upon content, they were classified as: informative, misleading or personal experience videos. Quality and reliability of these videos were evaluated using standardized tools. The viewer interaction metrics (e.g. no. of views, shares, etc.), video characteristics (video length, etc.) and the sources of upload were also assessed; and their relationship with the type, quality and reliability of the videos analyzed.
   Results: Overall, 70.3% videos were informative, while 23.8% and 5.9% videos were misleading and related to personal experiences, respectively. Although with shorter lengths (P < 0.01) and superior quality (P < 0.01), yet informative videos were viewed (P = 0.054), liked (P < 0.01) and shared (P < 0.05) less often than their misleading counterparts. Videos from independent users were more likely to be misleading (adjusted OR = 6.48, 95% CI: 1.69 - 24.83), of poorer (P < 0.05) quality and reliability than government/news agency videos.
   Conclusion: A considerable chunk of the videos were misleading. They were more popular (than informative videos) and could potentially spread misinformation. Videos from trust-worthy sources like university/health organizations were scarce. Curation/authentication of health information in online video platforms (like YouTube) is necessary. We discuss means to harness them as useful source of information and highlight measures to curb dissemination of misinformation during public health emergencies.
C1 [Bora, Kaustubh] ICMR Reg Med Res Ctr, Dibrugarh 786010, Assam, India.
   [Das, Dulmoni] Indira Gandhi Natl Open Univ, Reg Study Ctr, Dept Psychol, Shillong, Meghalaya, India.
   [Das, Dulmoni] Army Inst Nursing, Dept Mental Hlth Nursing, Gauhati, Assam, India.
   [Barman, Bhupen] NEIGRIHMS, Dept Gen Med, Shillong, Meghalaya, India.
   [Borah, Probodh] Coll Vet Sci, BIF, Gauhati, Assam, India.
   [Borah, Probodh] Coll Vet Sci, Adv State Biotech Hub, Gauhati, Assam, India.
   [Borah, Probodh] Coll Vet Sci, Dept Anim Biotechnol, Gauhati, Assam, India.
RP Bora, K (corresponding author), ICMR Reg Med Res Ctr, Dibrugarh 786010, Assam, India.
EM kaustubhbora1@gmail.com
CR Ali S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005135
   Athanasopoulou C, 2016, INFORM HEALTH SOC CA, V41, P307, DOI 10.3109/17538157.2015.1008485
   Attaran A, 2016, LANCET INFECT DIS, V16, P1001, DOI 10.1016/S1473-3099(16)30230-4
   Banas JA, 2010, COMMUN MONOGR, V77, P281, DOI 10.1080/03637751003758193
   Basch Corey H, 2017, J Prev Med Public Health, V50, P133, DOI 10.3961/jpmph.16.107
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Beck F, 2014, J MED INTERNET RES, V16, P193, DOI 10.2196/jmir.2934
   Bernard A, 2007, AM J GASTROENTEROL, V102, P2070, DOI 10.1111/j.1572-0241.2007.01325.x
   Bujnowska-Fedak MM, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1473-3
   Charnock D, 1999, J EPIDEMIOL COMMUN H, V53, P105, DOI 10.1136/jech.53.2.105
   Chen XY, 2015, INT J REFRACT MET H, V52, P1, DOI 10.1016/j.ijrmhm.2015.04.004
   Chua AYK, 2017, INT J MED INFORM, V108, P36, DOI 10.1016/j.ijmedinf.2017.08.010
   Cook J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175799
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Delli K, 2016, ORAL DIS, V22, P196, DOI 10.1111/odi.12404
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dubey D, 2014, CLIN MED RES, V12, P129, DOI 10.3121/cmr.2013.1194
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dzieciolowska S, 2017, SCI REP-UK, V7, DOI 10.1038/srep40067
   Esquivel A, 2006, BMJ-BRIT MED J, V332, P939, DOI 10.1136/bmj.38753.524201.7C
   Garrett RK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184733
   Gonsalves G, 2014, NEW ENGL J MED, V371, P2348, DOI 10.1056/NEJMp1413425
   Hofer BK, 1997, REV EDUC RES, V67, P88, DOI 10.3102/00346543067001088
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Kumar N, 2014, J AM SOC HYPERTENS, V8, P481, DOI 10.1016/j.jash.2014.05.001
   Lewandowsky S, 2012, PSYCHOL SCI PUBL INT, V13, P106, DOI 10.1177/1529100612451018
   Madathil KC, 2015, HEALTH INFORM J, V21, P173, DOI 10.1177/1460458213512220
   Merino JG, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6712
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Morahan-Martin JM, 2004, CYBERPSYCHOL BEHAV, V7, P497, DOI 10.1089/cpb.2004.7.497
   Nagpal SJS, 2015, TRAVEL MED INFECT DI, V13, P338, DOI 10.1016/j.tmaid.2015.05.002
   Oduyebo T, 2017, MMWR-MORBID MORTAL W, V66, P781, DOI 10.15585/mmwr.mm6629e1
   Pandey Ambarish, 2010, Am J Prev Med, V38, pe1, DOI 10.1016/j.amepre.2009.11.007
   Paploski IAD, 2016, EMERG INFECT DIS, V22, P1438, DOI 10.3201/eid2208.160496
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Ribeiro GS, 2016, REV SOC BRAS MED TRO, V49, P1, DOI 10.1590/0037-8682-0036-2016
   Rodriguez-Morales AJ, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0128-2
   Russo S, 2016, LARVICIDE AFFAIR RIP
   Sharma M, 2017, AM J INFECT CONTROL, V45, P301, DOI 10.1016/j.ajic.2016.08.022
   Singh AG, 2012, J RHEUMATOL, V39, P899, DOI 10.3899/jrheum.111114
   Sood A, 2011, UROLOGY, V77, P558, DOI 10.1016/j.urology.2010.07.536
   Stellefson M, 2014, CHRON RESP DIS, V11, P61, DOI 10.1177/1479972314525058
   Teng Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0165085
   Van de Belt TH, 2013, J MED INTERNET RES, V15, P152, DOI 10.2196/jmir.2607
   Vance K, 2009, DERMATOL CLIN, V27, P133, DOI 10.1016/j.det.2008.11.010
   Weatherhead JE, 2016, CURRENT TROPICAL MED, V3, P120
   World Health Organization. Fifth meeting of the Emergency Committee under the International Health Regulations, 2005, 5 M EM COMM INT HLTH
NR 48
TC 5
Z9 5
U1 21
U2 30
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 2047-7724
EI 2047-7732
J9 PATHOG GLOB HEALTH
JI Pathog. Glob. Health
PY 2018
VL 112
IS 6
BP 320
EP 328
DI 10.1080/20477724.2018.1507784
PG 9
WC Public, Environmental & Occupational Health; Parasitology; Tropical
   Medicine
SC Public, Environmental & Occupational Health; Parasitology; Tropical
   Medicine
GA HA7GF
UT WOS:000450448500004
PM 30156974
OA Green Published
DA 2020-07-08
ER

PT J
AU Ferreira, AO
   Vasconcelos, BG
   Favaron, PO
   Santos, AC
   Leandro, RM
   Pereira, FTV
   Maria, DA
   Miglino, MA
AF Ferreira, Amanda O.
   Vasconcelos, Bruno G.
   Favaron, Phelipe O.
   Santos, Amilton C.
   Leandro, Rafael M.
   Pereira, Flavia T. V.
   Maria, Durvanei A.
   Miglino, Maria Angelica
TI Bovine central nervous system development
SO PESQUISA VETERINARIA BRASILEIRA
LA English
DT Article
DE Bovine central nervous system; encephalon; encephalic vesicles; CNS;
   ontogeny; spinal cord
AB Central nervous system (CNS) development researches are extremely important to the most common congenital disorders and organogenesis comprehension. However, few studies show the entire developmental process during the critical period. Present research can provide data to new researches related to normal development and abnormalities and changes that occur along the CNS organogenesis, especially nowadays with the need for preliminary studies in animal models, which could be used for experimental research on the influence of viruses, such as the influence of Zika virus on the development of the neural system and its correlation with microcephaly in human newborns. Then, present study describes CNS organogenesis in cattle according to microscopic and macroscopic aspects, identifying structures and correlating to gestational period. Fourteen embryos and nine bovine fetuses at different ages were collected and analyzed. All individuals were measured in order to detect the gestational period. Bovine embryo at 17 days age has its neural tube, cranial neuropore, caudal neuropore and somites developed. After 24 days of development, were observed in cranial part of neural tube five encephalic vesicles denominated: telencephalon, diencephalon, mesencephalon, metencephalon and myelencephalon. In addition, the caudal part of neural tube was identified with the primitive spinal cord. The primordial CNS differentiation occurred from 90 to 110 days. The five encephalic vesicles, primordial spinal cord and the cavities: third ventricule, mesencephalic aqueduct, fourth ventricle and central canal in spinal cord were observed. With 90 days, the main structures were identified: (1) cerebral hemispheres, corpus callosum and fornix, of the telencephalon; (2) interthalamic adhesion, thalamus, hypothalamus and epythalamus (glandula pinealis), of the diencephalon; (3) cerebral peduncles and quadruplets bodies, of the mesencephalon; (4) pons and cerebellum, of the metencephalon; (5) medulla oblongata or bulb, of the myelencephalon; and (6) spinal cord, of the primitive spinal cord. After 110 days of gestation, the five encephalic vesicles and its structures were completely developed. It was noted the presence of the spinal cord with the cervicothoracic and lumbossacral intumescences. In summary, the results describes the formation of the neural tube from the neural plate of the ectoderm, the encephalic vesicles derived from the neural tube and subsequent structural and cavities subdivisions, thus representing the complete embryology of the central nervous system.
C1 [Ferreira, Amanda O.; Favaron, Phelipe O.; Santos, Amilton C.; Leandro, Rafael M.; Maria, Durvanei A.; Miglino, Maria Angelica] Univ Sao Paulo, Fac Med Vet & Zootecnia, Av Prof Dr Orlando Marques de Paiva 87, BR-05508270 Sao Paulo, SP, Brazil.
   [Vasconcelos, Bruno G.] Univ Fed Vales Jequitinhonha & Mucuri, Inst Ciencias Agr, Av Vereador Joao Narciso 1380, BR-38610000 Unai, MG, Brazil.
   [Pereira, Flavia T. V.] Univ Estadual Paulista Julio de Mesquita Filho Un, Campus Dracena, BR-17900000 Dracena, SP, Brazil.
RP Ferreira, AO (corresponding author), Univ Sao Paulo, Fac Med Vet & Zootecnia, Av Prof Dr Orlando Marques de Paiva 87, BR-05508270 Sao Paulo, SP, Brazil.
EM olivotti@usp.br; vasconcelosufvjm@gmail.com;
   phelipe.favaron@yahoo.com.br; amiltonsantoss@usp.br;
   rafael.magdanelo@gmail.com; fverechia@dracena.unesp.br; durvanei@usp.br;
   miglino@usp.br
FU CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)CAPES
FX Thanks are due to CAPES (Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior) for funding the project.
CR Arthur G.H., 1979, REPRODUCAO OBSTETRIC
   Cagnoto DG, 2009, CIENC RURAL, V39, P2154, DOI 10.1590/S0103-84782009005000155
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Silva FMD, 2016, PESQUI VET BRASIL, V36, P753, DOI 10.1590/S0100-736X2016000800013
   EVANS H E, 1973, Zentralblatt fuer Veterinaermedizin Reihe C, V2, P11
   Greene NDE, 2009, PRENATAL DIAG, V29, P303, DOI 10.1002/pd.2206
   HILDEBRAND M., 2006, ANALISE ESTRUTURA VE
   Maddox-Hyttel P., 2007, ACTA SCI VET, V35, P823
   Melz Laércio Juarez, 2014, Rev. Econ. Sociol. Rural, V52, P743, DOI 10.1590/S0103-20032014000400007
   Moore K.L., 2004, EMBRIOLOGIA CLIN
   Morini A.C., 2009, THESIS
   Noden D.M., 1990, EMBRIOLOGIA ANIMALES
   PRADA I, 2014, NEUROANATOMIA FUNCIO
   REXROAD CE, 1974, J DAIRY SCI, V57, P346, DOI 10.3168/jds.S0022-0302(74)84891-5
   Franciolli ALR, 2011, PESQUI VET BRASIL, V31, P441, DOI 10.1590/S0100-736X2011000500012
   Rissi DR, 2010, PESQUI VET BRASIL, V30, P958, DOI 10.1590/S0100-736X2010001100010
   Sinowatz F., 2010, ESSENTIAL DOMESTIC A
   Winters LM, 1942, TECH B U MINN AGR RE, V50, P1
NR 18
TC 0
Z9 0
U1 2
U2 6
PU REVISTA PESQUISA VETERINARIA BRASILEIRA
PI RIO JANEIRO
PA EMBRAPA-SAUDE ANIMAL, KM47 SEROPEDICA, 23851-970 RIO JANEIRO, BRAZIL
SN 0100-736X
EI 1678-5150
J9 PESQUI VET BRASIL
JI Pesqui. Vet. Bras.
PD JAN
PY 2018
VL 38
IS 1
BP 147
EP 153
DI 10.1590/1678-5150-pvb-5020
PG 7
WC Veterinary Sciences
SC Veterinary Sciences
GA GD3QG
UT WOS:000430418000024
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Lee, JH
   Velmurugan, P
   Park, JH
   Murugan, K
   Lovanh, N
   Park, YJ
   Oh, BT
   Venkatachalam, P
   Benelli, G
AF Lee, Jeong-Ho
   Velmurugan, Palanivel
   Park, Jung-Hee
   Murugan, Kadarkarai
   Lovanh, Nanh
   Park, Yool-Jin
   Oh, Byung-Taek
   Venkatachalam, Perumal
   Benelli, Giovanni
TI A novel photo-biological engineering method for Salvia
   miltiorrhiza-mediated fabrication of silver nanoparticles using LED
   lights sources and its effectiveness against Aedes aegypti mosquito
   larvae and microbial pathogens
SO PHYSIOLOGICAL AND MOLECULAR PLANT PATHOLOGY
LA English
DT Article
DE Salvia miltiorrhiza; LED; Nanoparticles; Characterization;
   Antibacterial; Zika virus
ID LEAF EXTRACT; CULEX-QUINQUEFASCIATUS; ANTIOXIDANT ACTIVITIES; VETERINARY
   IMPORTANCE; ANTITUMOR ACTIVITIES; GREEN SYNTHESIS; ANTIBACTERIAL;
   DENGUE; BUNGE; POLYSACCHARIDE
AB In this study, Salvia miltiorrhiza-synthesized Ag nanoparticles (AgNPs) fabricated using sunlight or various LED lights were studied for their biophysical features and evaluated as larvicides against Aedes aegypti mosquitoes and growth inhibitors on different species of microbial pathogens. AgNPs production post-exposure to sunlight or different LED light conditions (i.e. blue, red, green, and white) was confirmed by characteristic surface Plasmon resonance (SPR) at maximum lambda of 430, 420, 460, 450, and 460 nm, respectively. Optimization of pH, reducing extract concentration, metal ion concentration and time elapsed from the nano-biosynthesis was achieved. High-resolution transmission electron microscopy (HR-TEM) showed that most AgNPs was spherical, triangular and oval, with average size of 18.5, 28.02, 50.22, 16.26 and 10.12 nm for white, green, red, blue and sunlight, respectively. XRD confirmed the all the obtained AgNPs showed face centered cubic (fcc) crystal lattice. FT-IR analysis of all synthesized AgNPs indicated the involvement of phenol, amine, hydroxyl and amino groups in the reduction of nano-Ag. All tested AgNPs inhibited the growth of Brevibacterium linens (KACC-14346), Propionibacterium acnes (KACC 11946), Staphylococcus aureus (KACC-10768) and Staphylococcus epidermidis. As a general trend, larvicidal assays conducted on dengue and Zika virus vector Aedes aegypti showed that, after 48 h of exposure, the toxicity achieved by sunlight-fabricated AgNPs was slightly higher if compared to AgNPs fabricated using various LED lights. Overall, our research highlighted the importance of abiotic parameters, with special reference to light condition, during green nanosynthesis of antimicrobials and larvicides. (c) 2017 Elsevier Ltd. All rights reserved.
C1 [Lee, Jeong-Ho] Sunchang Res Inst Hlth & Longev, Sunchang 56015, Jeonbuk, South Korea.
   [Velmurugan, Palanivel; Park, Jung-Hee; Oh, Byung-Taek] Chonbuk Natl Univ, Coll Environm & Bioresource Sci, Adv Inst Environm & Biosci, Div Biotechnol, Iksan 54596, Jeonbuk, South Korea.
   [Murugan, Kadarkarai] Thiruvalluvar Univ, Dept Zool, Vellore 632115, Tamil Nadu, India.
   [Lovanh, Nanh] USDA ARS, AWMRU, 230 Bennett Lane, Bowling Green, KY 42104 USA.
   [Park, Yool-Jin] Chonbuk Natl Univ, Coll Environm & Bioresource Sci, Dept Ecol Landscape Architecture Design, Iksan 54596, Jeonbuk, South Korea.
   [Oh, Byung-Taek] Chonbuk Natl Univ, Coll Agr & Life Sci, Plant Med Res Ctr, Jenoju 54896, Jeonbuk, South Korea.
   [Venkatachalam, Perumal] Periyar Univ, Dept Biotechnol, Salem 636011, Tamil Nadu, India.
   [Benelli, Giovanni] Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
RP Oh, BT (corresponding author), Chonbuk Natl Univ, Coll Environm & Bioresource Sci, Adv Inst Environm & Biosci, Div Biotechnol, Iksan 54596, Jeonbuk, South Korea.
EM btoh@jbnu.ac.kr
RI P, Venkatachalam/AAC-2222-2019; Velmurugan, Palanivel/C-9503-2009;
   Murugan, Kadarkarai/AAP-3937-2020
OI Velmurugan, Palanivel/0000-0001-6506-1953
FU BK21 plus program through the National Research Foundation (NRF) -
   Ministry of Education of Korea
FX This research was supported by the BK21 plus program through the
   National Research Foundation (NRF) funded by the Ministry of Education
   of Korea.
CR Ahmed S, 2016, J ADV RES, V7, P17, DOI 10.1016/j.jare.2015.02.007
   Amaladhas T.P., 2013, ADV MAT LETT, V4, P779, DOI DOI 10.5185/AMLETT.2013.2427
   Banu AN, 2014, PARASITOL RES, V113, P3843, DOI 10.1007/s00436-014-4052-0
   Benelli G., 2017, J CLUST SCI
   Benelli G, 2016, ENZYME MICROB TECH, V95, P58, DOI 10.1016/j.enzmictec.2016.08.022
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   Chandramohan B, 2016, PARASITOL RES, V115, P1015, DOI 10.1007/s00436-015-4829-9
   Chaudhuri RG, 2012, CHEM REV, V112, P2373, DOI 10.1021/cr100449n
   Chitra G, 2015, PARASITOL RES, V114, P1407, DOI 10.1007/s00436-015-4320-7
   Deng Jing, 2006, Shanghai Kou Qiang Yi Xue, V15, P210
   Dinesh D, 2015, PARASITOL RES, V114, P1519, DOI 10.1007/s00436-015-4336-z
   Gong Y, 2011, INT J CANCER, V129, P1042, DOI 10.1002/ijc.25678
   Haider A, 2015, ADV MATER SCI ENG, V2015, DOI 10.1155/2015/165257
   Jiang YY, 2014, INT J BIOL MACROMOL, V70, P92, DOI 10.1016/j.ijbiomac.2014.06.036
   John TJ, 2011, LANCET, V377, P252, DOI 10.1016/S0140-6736(10)61265-2
   Koodalingam A, 2009, PARASITOL RES, V105, P1425, DOI 10.1007/s00436-009-1574-y
   Kumar KR, 2015, PARASITOL RES, V114, P411, DOI 10.1007/s00436-014-4198-9
   Kumar V, 2016, J PHOTOCH PHOTOBIO B, V155, P39, DOI 10.1016/j.jphotobiol.2015.12.011
   Lee JH, 2016, J PHOTOCH PHOTOBIO B, V162, P93, DOI 10.1016/j.jphotobiol.2016.06.029
   Li YG, 2009, J CHROMATOGR A, V1216, P1941, DOI 10.1016/j.chroma.2008.12.032
   Liu L, 2013, CARBOHYD POLYM, V92, P479, DOI 10.1016/j.carbpol.2012.09.061
   Matkowski A, 2008, BIORESOURCE TECHNOL, V99, P7892, DOI 10.1016/j.biortech.2008.02.013
   Okafor F, 2013, INT J ENV RES PUB HE, V10, P5221, DOI 10.3390/ijerph10105221
   Raja S, 2015, J IND ENG CHEM, V29, P257, DOI 10.1016/j.jiec.2015.03.033
   Santhosh SB, 2015, PARASITOL RES, V114, P3087, DOI 10.1007/s00436-015-4511-2
   Shetty V, 2013, PEST MANAG SCI, V69, P257, DOI 10.1002/ps.3383
   Suganya G, 2014, PARASITOL RES, V113, P875, DOI 10.1007/s00436-013-3718-3
   Suresh G, 2014, SPECTROCHIM ACTA A, V127, P61, DOI 10.1016/j.saa.2014.02.030
   Suresh U, 2015, PARASITOL RES, V114, P1551, DOI 10.1007/s00436-015-4339-9
   Velmurugan P, 2016, MATER LETT, V174, P61, DOI 10.1016/j.matlet.2016.03.069
   Velmurugan P, 2013, APPL MICROBIOL BIOT, V97, P361, DOI 10.1007/s00253-012-3892-8
   Wang N, 2014, CARBOHYD POLYM, V111, P47, DOI 10.1016/j.carbpol.2014.04.061
   Zhang YA, 2010, FOOD CHEM TOXICOL, V48, P2656, DOI 10.1016/j.fct.2010.06.036
   Zhao GR, 2006, FOOD CHEM, V99, P767, DOI 10.1016/j.foodchem.2005.09.002
NR 35
TC 4
Z9 4
U1 1
U2 9
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0885-5765
J9 PHYSIOL MOL PLANT P
JI Physiol. Mol. Plant Pathol.
PD JAN
PY 2018
VL 101
BP 178
EP 186
DI 10.1016/j.pmpp.2017.03.010
PG 9
WC Plant Sciences
SC Plant Sciences
GA FX9ND
UT WOS:000426426800019
DA 2020-07-08
ER

PT J
AU Paquin-Proulx, D
   Avelino-Silva, VI
   Santos, BAN
   Barsotti, NS
   Siroma, F
   Ramos, JF
   Tonacio, AC
   Song, A
   Maestri, A
   Cerqueira, NB
   Felix, AC
   Levi, JE
   Greenspun, BC
   Rougvie, MD
   Rosenberg, MG
   Nixon, DF
   Kallas, EG
AF Paquin-Proulx, Dominic
   Avelino-Silva, Vivian I.
   Santos, Bianca A. N.
   Barsotti, Nathalia Silveira
   Siroma, Fabiana
   Ramos, Jessica Fernandes
   Tonacio, Adriana Coracini
   Song, Alice
   Maestri, Alvino
   Cerqueira, Natalia Barros
   Felix, Alvina Clara
   Levi, Jose Eduardo
   Greenspun, Benjamin C.
   Rougvie, Miguel de Mulder
   Rosenberg, Michael G.
   Nixon, Douglas F.
   Kallas, Esper G.
TI MAIT cells are activated in acute Dengue virus infection and after in
   vitro Zika virus infection
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID INVARIANT T-CELLS; TRANSMISSION; POPULATION; IMMUNITY
AB Dengue virus (DENV) and Zika virus (ZIKV) are members of the Flaviviridae and are pre-dominantly transmitted via mosquito bites. Both viruses are responsible for a growing number of infections in tropical and subtropical regions. DENV infection can cause lethargy with severe morbidity and dengue shock syndrome leading to death in some cases. ZIKV is now linked with Guillain-Barre A syndrome and fetal malformations including microcephaly and developmental disorders (congenital Zika syndrome). The protective and pathogenic roles played by the immune response in these infections is unknown. Mucosal-associated invariant T (MAIT) cells are a population of innate T cells with potent anti-bacterial activity. MAIT cells have also been postulated to play a role in the immune response to viral infections. In this study, we evaluated MAIT cell frequency, phenotype, and function in samples from subjects with acute and convalescent DENV infection. We found that in acute DENV infection, MAIT cells had elevated co-expression of the activation markers CD38 and HLA-DR and had a poor IFN gamma response following bacterial stimulation. Furthermore, we found that MAIT cells can produce IFN gamma in response to in vitro infection with ZIKV. This MAIT cell response was independent of MR1, but dependent on IL-12 and IL-18. Our results suggest that MAIT cells may play an important role in the immune response to Flavivirus infections.
C1 [Paquin-Proulx, Dominic; Greenspun, Benjamin C.; Rougvie, Miguel de Mulder; Nixon, Douglas F.] George Washington Univ, Dept Microbiol Immunol & Trop Med, Washington, DC 20052 USA.
   [Avelino-Silva, Vivian I.; Santos, Bianca A. N.; Barsotti, Nathalia Silveira; Ramos, Jessica Fernandes; Tonacio, Adriana Coracini; Song, Alice; Maestri, Alvino; Cerqueira, Natalia Barros; Kallas, Esper G.] Univ Sao Paulo, Sch Med, Sao Paulo, Brazil.
   [Avelino-Silva, Vivian I.; Siroma, Fabiana; Ramos, Jessica Fernandes; Tonacio, Adriana Coracini; Song, Alice] Hosp Sirio Libanes, Sao Paulo, Brazil.
   [Felix, Alvina Clara; Levi, Jose Eduardo] Univ Sao Paulo, Inst Med Trop Sao Paulo, Dept Molestias Infecciosas & Parasitarias LIM 52, Sao Paulo, Brazil.
   [Felix, Alvina Clara; Levi, Jose Eduardo] Univ Sao Paulo, Fac Med, Sao Paulo, Brazil.
   [Rosenberg, Michael G.] Jacobi Med Ctr, Pediat Infect Dis Dept, Bronx, NY USA.
RP Paquin-Proulx, D (corresponding author), George Washington Univ, Dept Microbiol Immunol & Trop Med, Washington, DC 20052 USA.
EM dpaquin_proulx@gwu.edu
RI de Mulder Rougvie, Miguel/AAG-6224-2020; Song, Alice Tung
   Wan/F-2494-2014; Avelino-Silva, Vivian I/L-2640-2013
OI de Mulder Rougvie, Miguel/0000-0002-8026-7076; Song, Alice Tung
   Wan/0000-0001-6992-9326; Avelino-Silva, Vivian I/0000-0002-6660-3088;
   Silveira Barsotti, Nathalia/0000-0003-3513-5258; Kallas,
   Esper/0000-0003-2026-6925; Paquin Proulx, Dominic/0000-0003-1407-3414
FU District of Columbia Center for AIDS Research, an NIH [AI117970]; GWU
   SMHS Office of International Medicine Programs
FX This research was funded in part by a pilot award, and facilities and
   services, from the District of Columbia Center for AIDS Research, an NIH
   funded program (AI117970), and from the GWU SMHS Office of International
   Medicine Programs. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Calvet GA, 2016, J CLIN VIROL, V74, P1, DOI 10.1016/j.jcv.2015.11.014
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cosgrove C, 2013, BLOOD, V121, P951, DOI 10.1182/blood-2012-06-436436
   de Matos AM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003520
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   Dias J, 2017, P NATL ACAD SCI US
   Dias J, 2016, J LEUKOCYTE BIOL, V100, P233, DOI 10.1189/jlb.4TA0815-391RR
   Fagundes CT, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001449
   Gold MC, 2014, J EXP MED, V211, P1601, DOI 10.1084/jem.20140507
   Hengst J, 2016, EUR J IMMUNOL, V46, P2204, DOI 10.1002/eji.201646447
   Joao Esau Custodio, 2017, Pediatr Infect Dis J, V36, P500, DOI 10.1097/INF.0000000000001482
   Kjer-Nielsen L, 2012, NATURE, V491, P717, DOI 10.1038/nature11605
   Le Bourhis L, 2010, NAT IMMUNOL, V11, P701, DOI 10.1038/ni.1890
   Leeansyah E, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005072
   Leeansyah E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4143
   Leeansyah E, 2013, BLOOD, V121, P1124, DOI 10.1182/blood-2012-07-445429
   Leeansyah E, 2013, CURR OPIN HIV AIDS, V8, P117, DOI 10.1097/COH.0b013e32835c7134
   Li J, 2016, AUSTRALAS J DERMATOL
   Loh L, 2016, P NATL ACAD SCI USA, V113, P10133, DOI 10.1073/pnas.1610750113
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Mustafa AS, 2001, FEMS IMMUNOL MED MIC, V30, P229, DOI 10.1111/j.1574-695X.2001.tb01575.x
   Pacsa AS, 2000, FEMS IMMUNOL MED MIC, V28, P151, DOI 10.1111/j.1574-695X.2000.tb01470.x
   Pal T, 2014, J CLIN VIROL, V61, P365, DOI 10.1016/j.jcv.2014.09.003
   Pang JX, 2015, AM J TROP MED HYG, V92, P1156, DOI 10.4269/ajtmh.15-0031
   Paquin-Proulx D, 2017, IMMUNOHORIZON, V1, P141
   Paquin-Proulx D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175345
   Penot P, 2017, EURO SURVEILL, V22
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reantragoon R, 2013, J EXP MED, V210, P2305, DOI 10.1084/jem.20130958
   Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014
   Salou M, 2017, CURR OPIN IMMUNOL, V48, P7, DOI 10.1016/j.coi.2017.07.009
   Tang XZ, 2013, J IMMUNOL, V190, P3142, DOI 10.4049/jimmunol.1203218
   Teunissen MBM, 2014, J INVEST DERMATOL, V134, P2898, DOI 10.1038/jid.2014.261
   Treiner E, 2003, NATURE, V422, P164, DOI 10.1038/nature01433
   Ussher JE, 2014, EUR J IMMUNOL, V44, P195, DOI 10.1002/eji.201343509
   van de Weg CAM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002236
   van de Weg CAM, 2012, J CLIN VIROL, V53, P38, DOI 10.1016/j.jcv.2011.09.028
   van Wilgenburg B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11653
   Yauch LE, 2009, J IMMUNOL, V182, P4865, DOI 10.4049/jimmunol.0801974
NR 40
TC 11
Z9 11
U1 0
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JAN
PY 2018
VL 12
IS 1
AR e0006154
DI 10.1371/journal.pntd.0006154
PG 15
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA FU7HJ
UT WOS:000424022700027
PM 29357366
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ant, TH
   Herd, CS
   Geoghegan, V
   Hoffmann, AA
   Sinkins, SP
AF Ant, Thomas H.
   Herd, Christie S.
   Geoghegan, Vincent
   Hoffmann, Ary A.
   Sinkins, Steven P.
TI The Wolbachia strain wAu provides highly efficient virus transmission
   blocking in Aedes aegypti
SO PLOS PATHOGENS
LA English
DT Article
ID LIFE-SHORTENING WOLBACHIA; CYTOPLASMIC INCOMPATIBILITY; DENGUE
   TRANSMISSION; INFECTION; DROSOPHILA; ESTABLISHMENT; POPULATIONS;
   ALBOPICTUS; AUSTRALIA; MOSQUITOS
AB Introduced transinfections of the inherited bacteria Wolbachia can inhibit transmission of viruses by Aedes mosquitoes, and in Ae. aegypti are now being deployed for dengue control in a number of countries. Only three Wolbachia strains from the large number that exist in nature have to date been introduced and characterized in this species. Here novel Ae. aegypti transinfections were generated using the wAlbA and wAu strains. In its native Ae. albopictus, wAlbA is maintained at lower density than the co-infecting wAlbB, but following transfer to Ae. aegypti the relative strain density was reversed, illustrating the strain-specific nature of Wolbachia-host co-adaptation in determining density. The wAu strain also reached high densities in Ae. aegypti, and provided highly efficient transmission blocking of dengue and Zika viruses. Both wAu and wAlbA were less susceptible than wMel to density reduction/ incomplete maternal transmission resulting from elevated larval rearing temperatures. Although wAu does not induce cytoplasmic incompatibility (CI), it was stably combined with a CI-inducing strain as a superinfection, and this would facilitate its spread into wild populations. Wolbachia wAu provides a very promising new option for arbovirus control, particularly for deployment in hot tropical climates.
C1 [Ant, Thomas H.; Herd, Christie S.; Geoghegan, Vincent; Sinkins, Steven P.] Univ Glasgow, Ctr Virus Res, Glasgow, Lanark, Scotland.
   [Ant, Thomas H.; Herd, Christie S.; Geoghegan, Vincent; Sinkins, Steven P.] Univ Lancaster, Biomed & Life Sci, Lancaster, England.
   [Hoffmann, Ary A.] Univ Melbourne, Inst Bio21, Pest & Environm Adaptat Res Grp, Parkville, Vic, Australia.
   [Hoffmann, Ary A.] Univ Melbourne, Sch BioSci, Parkville, Vic, Australia.
RP Sinkins, SP (corresponding author), Univ Glasgow, Ctr Virus Res, Glasgow, Lanark, Scotland.; Sinkins, SP (corresponding author), Univ Lancaster, Biomed & Life Sci, Lancaster, England.
EM steven.sinkins@glasgow.ac.uk
RI Hoffmann, Ary/R-2972-2019
OI Hoffmann, Ary/0000-0001-9497-7645; Herd, Christie/0000-0002-3539-1908
FU Wellcome TrustWellcome Trust [202888, 108508]; Medical Research
   CouncilMedical Research Council UK (MRC) [ZK/16-021]; Biotechnology and
   Biological sciences Research CouncilBiotechnology and Biological
   Sciences Research Council (BBSRC) [BB/K004506]
FX The study was supported by Wellcome Trust wellcome.ac.uk (202888,
   108508), Medical Research Council mrc.ac.uk (ZK/16-021), Biotechnology
   and Biological sciences Research Council bbsrc.ac.uk (BB/K004506. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Axford JK, 2016, AM J TROP MED HYG, V94, P507, DOI 10.4269/ajtmh.15-0608
   Beckmann JF, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.7
   Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833
   Blagrove MSC, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002152
   Blagrove MSC, 2012, P NATL ACAD SCI USA, V109, P255, DOI 10.1073/pnas.1112021108
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   CASPARI E, 1959, EVOLUTION, V13, P568, DOI 10.2307/2406138
   Chrostek E, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006540
   Chrostek E, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002065
   Chrostek E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099025
   Dutton TJ, 2004, INSECT MOL BIOL, V13, P317, DOI 10.1111/j.0962-1075.2004.00490.x
   Ferguson NM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010370
   Frentiu FD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002688
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Hoffmann AA, 1996, HEREDITY, V76, P1, DOI 10.1038/hdy.1996.1
   Hoffmann AA, 2015, EVOL APPL, V8, P751, DOI 10.1111/eva.12286
   Hoffmann AA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003115
   Joubert DA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005434
   Kambris Z, 2009, SCIENCE, V326, P134, DOI 10.1126/science.1177531
   Kriesner P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003607
   LePage DP, 2017, NATURE, V543, P243, DOI 10.1038/nature21391
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   LIVAK KJ, 1984, GENETICS, V107, P611
   Lu P, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001754
   Martinez J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004369
   McGraw EA, 2002, P NATL ACAD SCI USA, V99, P2918, DOI 10.1073/pnas.052466499
   McMeniman CJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000748
   McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Osborne SE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000656
   Richardson K, 2011, J MED ENTOMOL, V48, P914, DOI 10.1603/ME10204
   Rohrscheib CE, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006521
   Rohrscheib CE, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005888
   Ross P, 2016, WOLBACHIA INFECT AED
   Sutton ER, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-928
   Nguyen TH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1174-x
   TURELLI M, 1991, NATURE, V353, P440, DOI 10.1038/353440a0
   Ulrich JN, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004873
   van den Hurk AF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001892
   Vasconcelos PFC, 2016, VECTOR-BORNE ZOONOT, V16, P566, DOI 10.1089/vbz.2016.2031
   Veneti Z, 2003, GENETICS, V164, P545
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   WILLIAMS EH, 1993, J INVERTEBR PATHOL, V61, P206, DOI 10.1006/jipa.1993.1037
   Woolfit M, 2013, GENOME BIOL EVOL, V5, P2189, DOI 10.1093/gbe/evt169
   Xi ZY, 2005, SCIENCE, V310, P326, DOI 10.1126/science.1117607
   Ye YXH, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003894
   Yeap HL, 2011, GENETICS, V187, P583, DOI 10.1534/genetics.110.122390
NR 47
TC 39
Z9 39
U1 2
U2 25
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD JAN
PY 2018
VL 14
IS 1
AR e1006815
DI 10.1371/journal.ppat.1006815
PG 19
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA FU7AB
UT WOS:000424003200034
PM 29370307
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Sriwijitalai, W
   Wiwanitkit, V
AF Sriwijitalai, Won
   Wiwanitkit, Viroj
TI Zika Virus Infection, Pregnancy and Microcephaly
SO REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA
LA English
DT Article
C1 [Sriwijitalai, Won] RVT Med Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Joseph Ayobabalola Univ, Lagos, Nigeria.
RP Sriwijitalai, W (corresponding author), RVT Med Ctr, Bangkok, Thailand.
EM wonsriwi@gmail.com
CR Aragao MFVV, 2017, AM J NEURORADIOL, V38, P1427, DOI 10.3174/ajnr.A5216
   Duarte G, 2017, REV BRAS GINECOL OBS, V39, P235, DOI 10.1055/s-0037-1603450
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P499, DOI 10.1016/j.apjtm.2016.03.036
   Wiwanitkit V, 2010, EXPERT REV ANTI-INFE, V8, P841, DOI [10.1586/eri.10.53, 10.1586/ERI.10.53]
NR 4
TC 0
Z9 0
U1 0
U2 3
PU FEDERACAO BRASILEIRA SOC GINECOLOGIA & OBSTETRICIA-FEBRASGO
PI RIO DE JANEIRO RJ
PA AV DAS AMERICAS, 8445, SALA 711-BARRA DA TIJUCA, RIO DE JANEIRO RJ,
   22793-081, BRAZIL
SN 0100-7203
EI 1806-9339
J9 REV BRAS GINECOL OBS
JI Rev. Bras. Ginecol. Obstet.
PD JAN
PY 2018
VL 40
IS 1
BP 53
EP 53
DI 10.1055/s-0037-1605375
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA FS8WA
UT WOS:000422694200009
PM 29341036
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Duarte, G
AF Duarte, Geraldo
TI Reply to: Zika Virus Infection, Pregnancy and Microcephaly
SO REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA
LA English
DT Article
C1 [Duarte, Geraldo] Univ Sao Paulo, Ave Bandeirantes 3900, BR-14049900 Ribeirao Preto, SP, Brazil.
RP Duarte, G (corresponding author), Univ Sao Paulo, Ave Bandeirantes 3900, BR-14049900 Ribeirao Preto, SP, Brazil.
EM gduarte@fmrp.usp.br
CR Centers for Disease Control and Prevention, 2016, ZIK VIR SYMPT DIAGN
   Dogan AC, 2017, J MATERN-FETAL NEO M, V30, P386, DOI 10.3109/14767058.2016.1174210
   Duarte G, 2017, REV BRAS GINECOL OBS, V39, P235, DOI 10.1055/s-0037-1603450
   Hamel R, 2016, MICROBES INFECT, V18, DOI 10.1016/j.micinf.2016.03.009
   Musso D, 2016, LANCET, V387, P1812, DOI 10.1016/S0140-6736(16)30317-8
   Picone O, 2016, J GYNECOL OBST BIO R, V45, P415, DOI 10.1016/j.jgyn.2016.03.005
   Shastry Siri, 2016, Emerg Med Clin North Am, V34, pe25, DOI 10.1016/j.emc.2016.04.001
   Simoes R, 2016, REV ASSOC MED BRAS, V62, P108, DOI [10.1590/1806-9282.62.02.106, 10.1590/1806-9282.62.02.108]
NR 8
TC 0
Z9 0
U1 0
U2 0
PU FEDERACAO BRASILEIRA SOC GINECOLOGIA & OBSTETRICIA-FEBRASGO
PI RIO DE JANEIRO RJ
PA AV DAS AMERICAS, 8445, SALA 711-BARRA DA TIJUCA, RIO DE JANEIRO RJ,
   22793-081, BRAZIL
SN 0100-7203
EI 1806-9339
J9 REV BRAS GINECOL OBS
JI Rev. Bras. Ginecol. Obstet.
PD JAN
PY 2018
VL 40
IS 1
BP 54
EP 55
DI 10.1055/s-0037-1617425
PG 2
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA FS8WA
UT WOS:000422694200010
PM 29341037
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Joob, B
   Wiwanitkit, V
AF Joob, Beuy
   Wiwanitkit, Viroj
TI Zika virus infection and psychosis
SO REVISTA BRASILEIRA DE PSIQUIATRIA
LA English
DT Letter
ID MENINGOENCEPHALITIS
C1 [Joob, Beuy] Med Acad Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Joseph Ayo Babalola Univ, Ilara Mokin, Nigeria.
RP Joob, B (corresponding author), Med Acad Ctr, Bangkok, Thailand.
CR Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Correa-Oliveira GE, 2017, REV BRAS PSIQUIATR, V39, P381, DOI 10.1590/1516-4446-2017-2308
   Joob B, 2017, CASE STUDY CASE REP, V7, P29
   Pinheiro TJ, 2016, ARQ NEURO-PSIQUIAT, V74, P937, DOI [10.1590/0004-282x20160138, 10.1590/0004-282X20160138]
   Schwartzmann PV, 2017, MAYO CLIN PROC, V92, P460, DOI 10.1016/j.mayocp.2016.12.019
NR 5
TC 0
Z9 0
U1 0
U2 0
PU ASSOC BRASILEIRA PSIQUIATRIA
PI SAO PAULO
PA SUBSCRIPTION DEPARTMENT, RUA PEDRO DE TOLEDO, 967 - CASA 01, SAO PAULO,
   SP 04039-032  A, BRAZIL
SN 1516-4446
EI 1809-452X
J9 REV BRAS PSIQUIATR
JI Rev. Bras. Psiquiatr.
PD JAN-MAR
PY 2018
VL 40
IS 1
DI 10.1590/1516-4446-2017-2561
PG 1
WC Psychiatry
SC Psychiatry
GA FZ9IG
UT WOS:000427922900020
PM 29590269
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Regadas, VC
   Silva, MDE
   Abud, LG
   Labadessa, LMPL
   de Oliveira, RGG
   Miyake, CH
   Queiroz, RM
AF Regadas, Vanessa Couras
   de Castro e Silva, Marcio
   Abud, Lucas Giansante
   Pereira Lopes Labadessa, Luiz Mario
   Gomes de Oliveira, Rafael Gouvea
   Miyake, Cecilia Hissae
   Queiroz, Rodolfo Mendes
TI Microcephaly caused by congenital Zika virus infection and viral
   detection in maternal urine during pregnancy
SO REVISTA DA ASSOCIACAO MEDICA BRASILEIRA
LA English
DT Editorial Material
DE Zika; Virus; Pregnancy; Urine; Microcephaly
AB Currently Latin America is undergoing a major epidemic of Zika virus, which is transmitted by Aedes mosquitoes. Concern for Zika virus infection has been increasing as it is suspected of causing brain defects in newborns such as microcephaly and, more recently, potential neurological and autoimmune complications including Guillian-Barre syndrome and acute disseminated encephalomyelitis. We describe a case of virus infection in a 25-year-old woman during the first trimester of her pregnancy, confirmed by laboratory tests only for the detection of viral particles in maternal urine, with imaging studies demonstrating the progression of cranial and encephalic changes in the fetus and later in the newborn, such as head circumference reduction, cerebral calcifications and ventriculomegaly.
C1 [Regadas, Vanessa Couras; de Castro e Silva, Marcio; Pereira Lopes Labadessa, Luiz Mario; Gomes de Oliveira, Rafael Gouvea; Queiroz, Rodolfo Mendes] Documenta Hosp Materno Infantil Sinha Junqueira, Dept Radiol & Med Imaging, Ribeirao Preto, SP, Brazil.
   [Regadas, Vanessa Couras; de Castro e Silva, Marcio; Abud, Lucas Giansante; Pereira Lopes Labadessa, Luiz Mario; Gomes de Oliveira, Rafael Gouvea; Miyake, Cecilia Hissae; Queiroz, Rodolfo Mendes] Documenta Hosp Sao Francisco, Dept Radiol & Med Imaging, Ribeirao Preto, SP, Brazil.
RP Queiroz, RM (corresponding author), Rua Bernardino Campos 980, BR-14015130 Ribeirao Preto, SP, Brazil.
EM rod_queiroz@hotmail.com
OI Mendes Queiroz, Rodolfo/0000-0002-4893-4422
CR Cavalheiro S, 2016, CHILD NERV SYST, V32, P1057, DOI 10.1007/s00381-016-3074-6
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   de Souza AS, 2016, CLIN INFECT DIS, V63, P1622, DOI 10.1093/cid/ciw613
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Lamb LE, 2016, INT UROL NEPHROL, V48, P1961, DOI 10.1007/s11255-016-1406-9
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Sarno M, 2017, ULTRASOUND OBST GYN, V50, P717, DOI 10.1002/uog.17303
   St George K, 2017, J CLIN MICROBIOL, V55, P535, DOI 10.1128/JCM.01232-16
NR 9
TC 4
Z9 4
U1 0
U2 8
PU ASSOC MEDICA BRASILEIRA
PI SAO PAULO
PA RUA SAO CARLOS DO PINHAL 324, CAIXA POSTAL 8904, SAO PAULO, SP, BRAZIL
SN 0104-4230
J9 REV ASSOC MED BRAS
JI Rev. Assoc. Med. Bras.
PD JAN
PY 2018
VL 64
IS 1
BP 11
EP 14
DI 10.1590/1806-9282.64.01.11
PG 4
WC Medicine, General & Internal
SC General & Internal Medicine
GA FZ4QF
UT WOS:000427576100005
PM 29561936
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Ferreira, AC
   Neto, FC
   Mondini, A
AF Ferreira, Aline Chimello
   Neto, Francisco Chiaravalloti
   Mondini, Adriano
TI Dengue in Araraquara, state of Sao Paulo: epidemiology, climate and
   Aedes aegypti infestation
SO REVISTA DE SAUDE PUBLICA
LA English
DT Article
DE Dengue, epidemiology; Disease Outbreaks; Risk Factors; Communicable
   Diseases; Epidemiological Surveillance
ID BRAZIL; FEVER; TRANSMISSION; AUSTRALIA; VIRUS
AB OBJECTIVE: To describe the epidemiology of dengue in a medium-sized city in the state of Sao Paulo.
   METHODS: Data, such as circulating serotypes, severe cases and deaths, age group, sex, among others, were obtained on reported and confirmed dengue cases in Araraquara, state of Sao Paulo, between 1991 and 2015. Climatic and infestation data were also analyzed. These variables were evaluated descriptively, using statistical measures such as frequencies, averages, minimum and maximum. Dengue incidence rates were calculated according to month, year, age and sex, and time series of dengue cases, infestation, and climatic variables.
   RESULTS: Approximately 16,500 cases of dengue fever were reported between 1991 and 2015. The highest number of reports was recorded in 2015 (7,811 cases). In general, the age group with the highest number of reports is between 20 and 59 years old. The highest incidences, generally between March and May, occurred after the increase in rainfall and infestation in January.
   CONCLUSIONS: Increased levels of infestation due to rainfall are reflected in incidence rates of the disease. It is fundamental to know the epidemiology of dengue in medium-sized cities. Such information can be extended to diseases such as Zika and Chikungunya, which are transmitted by the same vector and were reported in the city. The intensification of surveillance efforts in periods before epidemics could be a strategy to be considered to control the viral spread.
C1 [Ferreira, Aline Chimello] Univ Estadual Paulista, Fac Ciencias Farmaceut, Programa Posgrad Biociencias & Biotecnol Aplicada, Araraquara, SP, Brazil.
   [Neto, Francisco Chiaravalloti] Univ Sao Paulo, Fac Saude Publ, Dept Epidemiol, Sao Paulo, SP, Brazil.
   [Mondini, Adriano] Univ Estadual Paulista, Fac Ciencias Farmaceut, Dept Ciencias Biol, Araraquara, SP, Brazil.
RP Ferreira, AC (corresponding author), Rua Portugal,1285 Apto 32 Bom Jardim, BR-15084070 Sao Jose Do Rio Preto, SP, Brazil.
EM alinechf@gmail.com
RI Mondini, Adriano/F-7446-2012; Neto, Francisco Chiaravalloti/F-8006-2012;
   Mondini, Adriano/AAB-4358-2020
OI Mondini, Adriano/0000-0002-5557-9721; Neto, Francisco
   Chiaravalloti/0000-0003-2686-8740; Mondini, Adriano/0000-0002-5557-9721
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2013/02338-9]
FX Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP - Process
   2013/02338-9).
CR Azevedo TS, 2011, HYGIEA, V7, P19
   Back Anne Tuiskunen, 2013, Infect Ecol Epidemiol, V3, DOI 10.3402/iee.v3i0.19839
   Barbazan P, 2010, MED VET ENTOMOL, V24, P66, DOI 10.1111/j.1365-2915.2009.00848.x
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brasil. Ministerio da Sande, 2005, GUIA VIGILANCIA EPID
   Casagrande EE, 2014, ARARAQUARA ANOS 2000
   Cavalcante WD, 2011, REV BRAS FARM, V92, P287
   Centro de Vigilancia Epidemiologica, 2015, DAD EST
   Augusto LGD, 2016, LANCET, V387, P1052, DOI 10.1016/S0140-6736(16)00626-7
   Dibo MR, 2008, MEM I OSWALDO CRUZ, V103, P554, DOI 10.1590/S0074-02762008000600008
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Ferreira GLC, 2012, REV INST MED TROP SP, V54, pS5, DOI 10.1590/S0036-46652012000700003
   Governo do Estado de Sao Paulo, 2016, POT CHAM SAO PAUL
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Higa Yukiko, 2011, Tropical Medicine and Health, V39, P17, DOI 10.2149/tmh.2011-S04
   Hino P, 2010, CIENC SAUDE COLETIVA, V15, P233, DOI 10.1590/S1413-81232010000100028
   Honorio NA, 2015, CAD SAUDE PUBLICA, V31, P906, DOI 10.1590/0102-311XPE020515
   Horta MA, 2014, INT J ENVIRON HEAL R, V24, P471, DOI 10.1080/09603123.2013.865713
   Idrees Sobia, 2012, Genet Vaccines Ther, V10, P6, DOI 10.1186/1479-0556-10-6
   Instituto Brasileiro de Geografia e Estatistica, EST POP MUN UN FED B
   Johansson MA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000382
   Kularatne SAM, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4661
   Mondini A, 2005, REV SAUDE PUBL, V39, P444, DOI [10.1590/S0034-89102005000300016, 10.1590/s0034-89102005000300016]
   Nogueira RMR, 2005, EMERG INFECT DIS, V11, P1376
   Paixao ES, 2015, REV SOC BRAS MED TRO, V48, P399, DOI 10.1590/0037-8682-0145-2015
   Pinto RC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161884
   Porta M, 2008, DICT EPIDEMIOLOGY
   Ramadona AL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152688
   Richardson K, 2011, J MED ENTOMOL, V48, P914, DOI 10.1603/ME10204
   Roseghini WFF, 2011, REV BRAS CLIMATOL, P94
   Scandar SAS, 2010, B EPIDEMIOL PAUL, V7, P4
   Souza LJ, 2016, DENGUE ZIKA CHIKUNGU
   Viana Dione Viero, 2013, Rev. bras. epidemiol., V16, P240, DOI 10.1590/S1415-790X2013000200002
   Viennet E, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-379
   Villabona-Arenas CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063496
   Wilder-Smith A, 2016, LANCET INFECT DIS, V16, P629, DOI 10.1016/S1473-3099(16)00076-1
   World Health Organization, 2009, DENG GUID DIAGN TREA
NR 37
TC 6
Z9 6
U1 0
U2 2
PU REVISTA DE SAUDE PUBLICA
PI SAO PAULO
PA FACULDADE SAUDE PUBL DA USP, AV DR ARNALDO 715, 01246-904SP SAO PAULO,
   BRAZIL
SN 0034-8910
EI 1518-8787
J9 REV SAUDE PUBL
JI Rev. Saude Publica
PY 2018
VL 52
AR 18
DI 10.11606/S1518-8787.2018052000414
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FX5LV
UT WOS:000426121500005
PM 29489994
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Avelino-Silva, VL
   Alvarenga, C
   Abreu, C
   Tozetto-Mendoza, TR
   do Canto, CLM
   Manuli, ER
   Mendes-Correa, MC
   Sabino, EC
   Figueiredo, WM
   Segurado, AC
   Mayaud, P
AF Avelino-Silva, Vivian Lida
   Alvarenga, Conrado
   Abreu, Carolina
   Tozetto-Mendoza, Tania Regina
   Motta do Canto, Cynthia Liliane
   Manuli, Erika Regina
   Mendes-Correa, Maria Cassia
   Sabino, Ester Cerdeira
   Figueiredo, Walter Manso
   Segurado, Aluisio Cotrim
   Mayaud, Philippe
TI Potential effect of Zika virus infection on human male fertility?
SO REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO
LA English
DT Article
DE Zika virus; exual transmission; Shedding; Semen; Spermogram; Fertility;
   Brazil
ID SEXUAL TRANSMISSION; MICRONESIA; SEMEN
AB Background: Zika virus (ZIKV) sexual transmission and prolonged viral shedding in semen have been previously reported, suggesting a strong viral affinity for genital tissues. A transient impact of ZIKV on male fertility was shown in animal and human studies. Methods: Adult male patients with confirmed ZIKV infection diagnosed in the city of Araraquara, Brazil during the epidemic season of 2016 were invited one year after the acute infection to respond to a questionnaire of genital symptoms and to provide a semen sample for molecular ZIKV testing and spermogram analysis, as well as a serum sample for hormonal testing. Results: 101 of 187 tested patients had positive ZIKV RT-PCR in plasma and/or urine samples (54%. 72 women and 29 men). Of 15 adult male participants for whom telephone contact was successful, 14 responded to the questionnaire of genital symptoms and six consented to provide a semen sample at a median of 12 months after the acute infection. We report abnormal spermogram results from patients one year after confirmed ZIKV infection. Conclusions: Our findings suggest a possible long-term detrimental effect of ZIKV infection on human male fertility that has to be further explored in well-characterized samples from cohort studies conducted in ZIKV-endemic areas.
C1 [Avelino-Silva, Vivian Lida; Segurado, Aluisio Cotrim] Univ Sao Paulo, Fac Med, Dept Molestias Infecciosas & Parasitarias, Av Dr Eneas Carvalho Aguiar 470, BR-05403000 Sao Paulo, SP, Brazil.
   [Alvarenga, Conrado; Abreu, Carolina] Lab Med Masculina, Sao Paulo, SP, Brazil.
   [Tozetto-Mendoza, Tania Regina; Motta do Canto, Cynthia Liliane; Manuli, Erika Regina; Mendes-Correa, Maria Cassia; Sabino, Ester Cerdeira] Univ Sao Paulo, Inst Med Trop Sao Paulo, Sao Paulo, SP, Brazil.
   [Figueiredo, Walter Manso] Serv Especial Saude Araraquara, Sao Paulo, Brazil.
   [Mayaud, Philippe] London Sch Hyg & Trop Med, London, England.
RP Avelino-Silva, VL (corresponding author), Univ Sao Paulo, Fac Med, Dept Molestias Infecciosas & Parasitarias, Av Dr Eneas Carvalho Aguiar 470, BR-05403000 Sao Paulo, SP, Brazil.
EM viviansilva87@gmail.com
RI Avelino-Silva, Vivian I/L-2640-2013; Sabino, Ester Cerdeira/F-7750-2010;
   Segurado, Aluisio C/K-2229-2012
OI Avelino-Silva, Vivian I/0000-0002-6660-3088; Sabino, Ester
   Cerdeira/0000-0003-2623-5126; Segurado, Aluisio C/0000-0002-6311-8036
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPESCAPES
   [CSF-PVE-S-88887.122640/2016-00]; Ministry of Education, Brazil;
   European Union's Horizon 2020 Research and Innovation Program under the
   ZIKAlliance Grant [734548]
FX This work was partially supported by Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior - CAPES, process
   CSF-PVE-S-88887.122640/2016-00, Ministry of Education, Brazil; and the
   European Union's Horizon 2020 Research and Innovation Program under the
   ZIKAlliance Grant Agreement No 734548.
CR Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6
   Brasil. Ministerio da Saude, 2015, PROT VIG RESP OC MIC
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Joguet G, 2017, LANCET INFECT DIS, V17, P1200, DOI 10.1016/S1473-3099(17)30444-9
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Matheron S, 2016, CLIN INFECT DIS, V63, DOI 10.1093/cid/ciw509
   Ministerio da Saude, 2018, B EPIDEMIOL, V49, P1
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Sherley M, 2018, SEX HEALTH, V15, P183, DOI 10.1071/SH17046
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Uraki R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602899
   World Health Organization, 2010, WHO LAB MAN EX PROC
NR 16
TC 7
Z9 7
U1 0
U2 3
PU INST MEDICINA TROPICAL SAO PAULO
PI SAO PAULO
PA AV DR ENEAS CARVALHO DE AGUIAR, 470, C CESAR, SAO PAULO, 05403-000,
   BRAZIL
SN 0036-4665
EI 1678-9946
J9 REV INST MED TROP SP
JI Rev. Inst. Med. Trop. Sao Paulo
PY 2018
VL 60
AR UNSP e64
DI 10.1590/S1678-9946201860064
PG 4
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA GY8FT
UT WOS:000448858700004
PM 30379231
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Costa, SDB
   Branco, MDFC
   Aquino, J
   Rodrigues, ZMR
   Queiroz, RCD
   Araujo, AS
   Camara, APB
   dos Santos, PS
   Pereira, EDA
   da Silva, MD
   da Costa, FRV
   dos Santos, AVD
   Medeiros, MNL
   Alcantara, JO
   Vasconcelos, VV
   dos Santos, AM
   da Silva, AAM
AF Brito Costa, Silmery da Silva
   Freitas Carvalho Branco, Maria dos Remedios
   Aquino Junior, Jose
   Ribeiro Rodrigues, Zulimar Marita
   de Sousa Queiroz, Rejane Christine
   Araujo, Adriana Soraya
   Barros Camara, Ana Patricia
   dos Santos, Polyana Sousa
   Amorim Pereira, Emile Danielly
   da Silva, Maria do Socorro
   Vieira da Costa, Flavia Regina
   Damasceno dos Santos, Amanda Valeria
   Lima Medeiros, Maria Nilza
   Alcantara Junior, Jose Odval
   Vasconcelos, Vitor Vieira
   dos Santos, Alcione Miranda
   Moura da Silva, Antonio Augusto
TI Spatial analysis of probable cases of dengue fever, chikungunya fever
   and zika virus infections in Maranhao State, Brazil
SO REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO
LA English
DT Article
DE Dengue fever; Chikungunya fever; Zika virus infection; Spatial analysis;
   Socioeconomic factors; Socio-demographic factors
ID RIO-DE-JANEIRO; AEDES-AEGYPTI; INFORMATION; MORTALITY
AB Dengue fever, chikungunya fever, and zika virus infections are increasing public health problems in the world, the last two diseases having recently emerged in Brazil. This ecological study employed spatial analysis of probable cases of dengue fever, chikungunya fever, and zika virus infections reported to the National Mandatory Reporting System (SINAN) in Maranhao State from 2015 to 2016. The software GeoDa version 1.10 was used for calculating global and local Moran indices. The global Moran index identified a significant autocorrelation of incidence rates of dengue (I=0.10; p=0.1009) and zika (I=0.07; p=0.03). The study found a positive spatial correlation between dengue and the population density (I=0.31; p<0.001) and a negative correlation with the Performance Index of Unified Health System (PIUHS) by basic care coverage (I=-0.08; p=0.01). Regarding chikungunya fever, there were positive spatial correlations with the population density (I=0.06; p=0.03) and the Municipal Human Development Index (MHDI) (I=0.10; p=0.002), and a negative correlation with the Gini index (I=-0.01; p<0.001) and the PIUHS by basic care coverage (I=-0.18; p<0.001). Lastly, we found positive spatial correlations between Zika virus infections and the population density (I=0.13; p=0.005) and the MHDI (I=0.12; p<0.001), as well as a negative correlation with the Gini index (I=-0.11; p<0.001) and the PIUHS by basic care coverage (I=-0.05; p=0.03). Our results suggest that several socio-demographic factors influenced the occurrence of dengue fever. chikungunya fever, and zika virus infections in Maranhao State.
C1 [Brito Costa, Silmery da Silva; Freitas Carvalho Branco, Maria dos Remedios; de Sousa Queiroz, Rejane Christine; Barros Camara, Ana Patricia; dos Santos, Alcione Miranda; Moura da Silva, Antonio Augusto] Univ Fed Maranhao, Programa Posgrad Saude Colet Sao Luis, Maranhao, Brazil.
   [Aquino Junior, Jose; Ribeiro Rodrigues, Zulimar Marita; Araujo, Adriana Soraya; Vieira da Costa, Flavia Regina] Univ Fed Maranhao, Programa Posgrad Saude & Ambiente, Sao Luis, Maranhao, Brazil.
   [dos Santos, Polyana Sousa] Kroton Educ, Sao Luis, Maranhao, Brazil.
   [Amorim Pereira, Emile Danielly] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ Sergio Arouca, Rio De Janeiro, RJ, Brazil.
   [da Silva, Maria do Socorro] Secretaria Municipal Saude, Sao Luis, Maranhao, Brazil.
   [Damasceno dos Santos, Amanda Valeria] Univ Fed Maranhao, Curso Geog, Sao Luis, Maranhao, Brazil.
   [Lima Medeiros, Maria Nilza] Univ CEUMA, Programa Posgrad Gestao Programas & Serv Saude, Sao Luis, Maranhao, Brazil.
   [Alcantara Junior, Jose Odval] Univ Fed Maranhao, Programa Posgrad Ciencias Sociais, Sao Luis, Maranhao, Brazil.
   [Vasconcelos, Vitor Vieira] Univ Fed ABC, Programa Posgrad Ciencia & Tecnol Ambiental, Sao Bernardo Do Campo, SP, Brazil.
RP Costa, SDB (corresponding author), Univ Fed Maranhao, Programa Posgrad Saude Colet, Rua Barao de Itapary 155, BR-65020070 Sao Luis, MA, Brazil.
EM silmery_ce@hotmail.com
RI Vasconcelos, Vitor V Vieira/N-8823-2015; Santos, Alcione/V-3743-2019;
   Silva, Antonio A M/B-5410-2009
OI Vasconcelos, Vitor V Vieira/0000-0002-3063-2776; Silva, Antonio A
   M/0000-0003-4968-5138; Queiroz, Rejane/0000-0003-4019-2011; Freitas
   Carvalho Branco, Maria dos Remedios/0000-0002-3537-0840
FU National Council for Scientific and Technological DevelopmentNational
   Council for Scientific and Technological Development (CNPq)
FX The National Council for Scientific and Technological Development funded
   this research.
CR Albuquerque Ceres, 2017, Saúde debate, V41, P118, DOI 10.1590/0103-11042017s10
   Avelino-Silva VI, 2017, REV CIEN SAUDE, V7, P1, DOI DOI 10.21876/rcsfmit.v7i3.675
   Barbosa IR, 2015, REV CIENC PLURAL, V1, P62
   Bisanzio D, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006298
   Bogaz C., 2017, LEVANTAMENTO INFESTA
   Bohm AW, 2016, EPIDEMIOL SERV SAUDE, V25, P725, DOI 10.5123/S1679-49742016000400006
   Braga IA, 2007, EPIDEMIOL SERV SAUDE, V16, P113
   Brasil. Ministerio da Saude. Departamento de Atencao Basica, IND DES SIST UN SAUD
   Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude. Departamento de Vigilancia das Doencas Transmissiveis, 2012, LEV RAP IND AED AEG
   Coelho GE, 2015, ARBOVIROSES IMPORTAN, P15
   de Almeida AS, 2009, REV SAUDE PUBL, V43, P666, DOI 10.1590/s0034-89102009000400013
   Teixeira TRD, 2008, CAD SAUDE PUBLICA, V24, P2160, DOI 10.1590/S0102-311X2008000900022
   Donalisio MR, 2017, REV SAUDE PUBL, V51, DOI [10.1590/S1518-8787.2017051006889, 10.1590/s1518-8787.2017051006889]
   Druck S, ANALISE ESPACIAL DAD
   Honorato Taizi, 2014, Rev. bras. epidemiol., V17, P150, DOI 10.1590/1809-4503201400060013
   Honorio NA, 2009, J MED ENTOMOL, V46, P1001, DOI 10.1603/033.046.0505
   Instituto Brasileiro de Geografia e Estatistica, CONH CID EST BRAS
   Khormi HM, 2011, GEOSPATIAL HEALTH, V6, P77, DOI 10.4081/gh.2011.159
   Lucena L, 2011, REV PAN AMAZ SAUDE, V2, P19
   Machado Juliana Pires, 2009, Cad. Saúde Pública, V25, P1025, DOI 10.1590/S0102-311X2009000500009
   MARSHALL RJ, 1991, J R STAT SOC C-APPL, V40, P283
   Medronho RA, 2009, EPIDEMIOLOGIA, P493
   Ministerio da Saude, 2018, B EPIDEMIOL, V49, P1
   [Ministerio da Saude do Brasil Secretaria devigilanciaem Saude], 2016, B EPIDEMIOLOGICO, V47, P1
   Mondini Adriano, 2007, Rev. Saúde Pública, V41, P923, DOI 10.1590/S0034-89102007000600006
   Oliveira FL, 2016, REV HUMANO SER, V1, P64
   Programa das Nacoes Unidas para o Desenvolvimento, ATL DES HUM BRAS
   Reyes-Castro PA, 2017, ACTA TROP, V167, P174, DOI 10.1016/j.actatropica.2017.01.001
   Rivas AV, 2018, REV SOC BRAS MED TRO, V51, P71, DOI 10.1590/0037-8682-0228-2017
   Rizzi CB, 2017, HYGIEA, V13, P24
   Rodrigues M, 2014, CIENC SAUDE COLETIVA, V19, P2047, DOI 10.1590/1413-81232014197.18012013
   Roque ACM, 2015, REV CIENC PLURAL, V1, P51
   Scandar SAS, 2010, B EPIDEMIOL PAUL, V7, P4
   Teixeira MG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002520
   Trevino JA, 2016, TRIMEST ECON, V83, P679, DOI 10.20430/ete.v83i332.236
   Uchimura Liza Yurie Teruya, 2017, Rev. Bras. Saude Mater. Infant., V17, pS259, DOI 10.1590/1806-9304201700s100012
NR 36
TC 1
Z9 1
U1 0
U2 0
PU INST MEDICINA TROPICAL SAO PAULO
PI SAO PAULO
PA AV DR ENEAS CARVALHO DE AGUIAR, 470, C CESAR, SAO PAULO, 05403-000,
   BRAZIL
SN 0036-4665
EI 1678-9946
J9 REV INST MED TROP SP
JI Rev. Inst. Med. Trop. Sao Paulo
PY 2018
VL 60
AR UNSP e62
DI 10.1590/S1678-9946201860062
PG 10
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA GY8FT
UT WOS:000448858700002
PM 30379229
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU de Oliveira, MI
   Namiyama, GM
   Cabral, GB
   Ferreira, JL
   Taniwaki, N
   Afonso, AMS
   Lima, IR
   de Brigido, LFM
AF de Oliveira, Maria Isabel
   Namiyama, Gislene Mitsue
   Cabral, Gabriela Bastos
   Ferreira, Joao Leandro
   Taniwaki, Noemi
   Sardinha Afonso, Ana Maria
   Lima, Isabella Rillo
   Macedo de Brigido, Luis Fernando
TI Isolation of infectious Zika virus from a urine sample cultured in SIRC
   cells from a patient suspected of having rubella virus
SO REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO
LA English
DT Article
DE Zika virus; Rubella virus; Isolation; Genotype
ID MEASLES
AB A great, variety of viruses which cause exanthema share other clinical manifestations, making the etiologic identification a very difficult task, relying exclusively on the clinical examination. Rubella virus (RV) infection during the early stages of pregnancy can lead to serious birth defects, known as congenital rubella syndrome (CRS). In the present report, we described the presence of Zika virus (ZIKV) particles in urine samples and also ZIKV isolation in SIRC cells from the urine of a patient in acute phase of suspected rubella disease. The 50-year-old unvaccinated woman living in Sao Paulo, Brazil, was admitted to the emergency room with fever, headache, rash, arthralgia and prostration. Urine samples were collected for virus isolation and RT-qPCR. SIRC and Vero cells were inoculated with urine samples during 7 days. RT-qPCR was performed using measles virus (MV) and RV primers and both were found to be negative. After this result, RT-qPCR was performed for parvovirus B19, herpes virus 6 and ZIKV. The urine sample and the isolate were positive by Real Time PCR for ZIKV and negative for all other viruses tested. The sequences isolated are from the Asiatic lineage.
C1 [de Oliveira, Maria Isabel; Sardinha Afonso, Ana Maria; Lima, Isabella Rillo] Adolfo Lutz Inst, Ctr Virol, Nucleo Doencas Resp, Av Dr Arnaldo 355, BR-01246902 Sao Paulo, SP, Brazil.
   [Namiyama, Gislene Mitsue; Taniwaki, Noemi] Adolfo Lutz Inst, Nucleo Microscopia Eletron, Sao Paulo, SP, Brazil.
   [Cabral, Gabriela Bastos; Ferreira, Joao Leandro; Macedo de Brigido, Luis Fernando] Adolfo Lutz Inst, Ctr Virol, Nucleo Doencas Vinculacao Sexual & Sanguinea, Sao Paulo, SP, Brazil.
RP de Oliveira, MI (corresponding author), Adolfo Lutz Inst, Ctr Virol, Nucleo Doencas Resp, Av Dr Arnaldo 355, BR-01246902 Sao Paulo, SP, Brazil.
EM olive40@uol.com.br
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2016/14813-1]
FX Partially funded by FAPESP, grant No 2016/14813-1.
CR Auger N, 2017, ARCH DIS IN PRESS
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Calvert AE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185340
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   de Moraes JC, 2011, J INFECT DIS, V204, pS627, DOI 10.1093/infdis/jir490
   de Oliveira MI, 2014, REV INST MED TROP SP, V56, P366, DOI 10.1590/S0036-46652014000400018
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Figueiredo CA, 2000, REV SAUDE PUBL, V34, P353, DOI 10.1590/S0034-89102000000400007
   Figueiredo CA, 2012, REV ASSOC MED BRAS, V58, P527, DOI 10.1590/S0104-42302012000500007
   Hobman T., 2007, FIELDS VIROLOGY, P1069
   Hubschen JM, 2017, CLIN MICROBIOL INFEC, V23, P511, DOI 10.1016/j.cmi.2017.04.009
   Musso D, 2017, J MED VIROL, V89, P1505, DOI 10.1002/jmv.24735
   REED L. J., 1938, AMER JOUR HYG, V27, P493
NR 13
TC 2
Z9 2
U1 0
U2 5
PU INST MEDICINA TROPICAL SAO PAULO
PI SAO PAULO
PA AV DR ENEAS CARVALHO DE AGUIAR, 470, C CESAR, SAO PAULO, 05403-000,
   BRAZIL
SN 0036-4665
EI 1678-9946
J9 REV INST MED TROP SP
JI Rev. Inst. Med. Trop. Sao Paulo
PY 2018
VL 60
DI 10.1590/S1678-9946201860015
PG 5
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA FY9KL
UT WOS:000427184400006
PM 29557985
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Garcia-Rejon, JE
   Ulloa-Garcia, A
   Cigarroa-Toledo, N
   Pech-May, A
   Machain-Williams, C
   Cetina-Trejo, RC
   Talavera-Aguilar, LG
   Torres-Chable, OM
   Navarro, JC
   Baak-Baak, CM
AF Garcia-Rejon, Julian E.
   Ulloa-Garcia, Armando
   Cigarroa-Toledo, Nohemi
   Pech-May, Angelica
   Machain-Williams, Carlos
   Carmina Cetina-Trejo, Rosa
   Gabriela Talavera-Aguilar, Lourdes
   Margarito Torres-Chable, Oswaldo
   Carlos Navarro, Juan
   Marcial Baak-Baak, Carlos
TI Study of Aedes aegypti population with emphasis on the gonotrophic cycle
   length and identification of arboviruses: implications for vector
   management in cemeteries
SO REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO
LA English
DT Article
DE Arbovirus; Dengue; Mexico; Daily survival; Zika virus
ID DENGUE VIRUS; DIPTERA-CULICIDAE; CULEX-QUINQUEFASCIATUS; MERIDA CITY;
   MEXICO; MOSQUITOS; ALBOPICTUS; YUCATAN; PARAMETERS; SEQUENCES
AB Aedes aegypti is the vector of the arboviruses causing dengue. chikungunya and zika infections in Mexico. However, its presence in public places has not been fully evaluated. In a cemetery from Merida, Yucatan, Mexico. the productivity of Ae. aegypti, the gonotrophic cycle, and the presence of Ae. aegypti females infected with arboviruses were evaluated. Immature and adult mosquitoes were inspected every two months between April 2016 to June 2017. For the gonotrophic cycle length, the daily pattern of total and parous female ratio was registered and was analyzed using time series analysis. Ae. aegypti females were sorted into pools and assayed for flavivirus RNA by RT-PCR and Sanger sequencing. Aedes aegypti immatures represented 82.86% (8,627/10,411) of the collection. In total, 1,648 Ae. aegypti females were sorted into 166 pools. Two pools were positive; one for dengue virus (DENV-1) and the other for zika virus (ZIKV). The phylogenetic analysis revealed that the DENV-1 is more closely related to isolates from Brazil. While ZIKV is more closely related to the Asian lineage, which were isolates from Guatemala and Mexico. We report some evidence of vertical transmission of DENV-1 in nulliparous females of Ae. aegypti. The gonotrophic cycle was four and three days in the rainy and dry season, respectively. The cemetery of Merida is an important focus of Ae. aegypti proliferation, and these environments may play a role in arboviruses transmission; probably limiting the efficacy of attempts to suppress the presence of mosquitoes in domestic environments.
C1 [Garcia-Rejon, Julian E.; Cigarroa-Toledo, Nohemi; Machain-Williams, Carlos; Carmina Cetina-Trejo, Rosa; Gabriela Talavera-Aguilar, Lourdes; Marcial Baak-Baak, Carlos] Univ Autonoma Yucatan, Ctr Invest Reg Dr Hideyo Noguchi, Lab Arbovirol, Calle 96 S-N X Ave Jacinto Canek & 47 Franccionam, Merida 97225, Yucatan, Mexico.
   [Ulloa-Garcia, Armando] Ctr Reg Invest Salud Publ, Inst Nacl Salud Publ, Tapachula, Chiapas, Mexico.
   [Pech-May, Angelica] Inst Nacl Med Trop, Puerto Iguazu, Misiones, Argentina.
   [Margarito Torres-Chable, Oswaldo] Univ Juarez Autonoma Tabasco, Lab Enfermedades Trop & Transmitidas Vector, Villahermosa, Tabasco, Mexico.
   [Carlos Navarro, Juan] Univ Int SEK, Fac Ciencias Nat & Ambientales, Lab Biodiversidad & Salud Ambiental, Quito, Ecuador.
RP Baak-Baak, CM (corresponding author), Univ Autonoma Yucatan, Ctr Invest Reg Dr Hideyo Noguchi, Lab Arbovirol, Calle 96 S-N X Ave Jacinto Canek & 47 Franccionam, Merida 97225, Yucatan, Mexico.
EM carlos.baak@correo.uady.mx
RI Cigarroa, Nohemi/F-4460-2019; Garcia-Rejon, Julian Everardo/E-4285-2017
OI Cigarroa, Nohemi/0000-0002-0363-0222; chable,
   torres/0000-0001-7482-6663; Baak-Baak, Carlos M./0000-0002-3772-6740;
   Garcia-Rejon, Julian Everardo/0000-0002-6681-1581; Pech-May,
   Angelica/0000-0003-4942-7788
FU Consejo Nacional de Ciencia y Tecnologia de Mexico, Grant Problemas
   Nacionales [PDCPN 2014-247005]
FX The study was supported by the Consejo Nacional de Ciencia y Tecnologia
   de Mexico, Grant Problemas Nacionales PDCPN 2014-247005.
CR Abe M, 2005, TROP MED INT HEALTH, V10, P597, DOI 10.1111/j.1365-3156.2005.01428.x
   Arana-Guardia R, 2014, ACTA TROP, V134, P33, DOI 10.1016/j.actatropica.2014.01.011
   Baak-Baak CM, 2017, NEOTROP ENTOMOL, V46, P622, DOI 10.1007/s13744-017-0499-x
   Baak-Baak CM, 2014, J MED ENTOMOL, V51, P475, DOI 10.1603/ME13209
   BIRLEY MH, 1981, J MED ENTOMOL, V18, P181, DOI 10.1093/jmedent/18.3.181
   BOCKARIE MJ, 1995, TROP MED PARASITOL, V46, P164
   Campanella JJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-29
   CARPENTER SJ, 1955, MOSQUITOES N AM N ME
   Cigarroa-Toledo N, 2016, EMERG INFECT DIS, V22, P1804, DOI 10.3201/eid2210.152087
   CONWAY GR, 1974, J ANIM ECOL, V43, P289, DOI 10.2307/3366
   Darsie Jr R. F., 2005, IDENTIFICATION GEOGR
   DAVIDSON G, 1954, NATURE, V174, P792, DOI 10.1038/174792a0
   DETINOVA TS, 1962, AGE GROUPING METHODS
   Eisen L, 2014, J MED ENTOMOL, V51, P885, DOI 10.1603/ME14008
   Ferreira-de-Lima VH, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2643-9
   Fryxell RTT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122895
   Garcia-Rejon J, 2008, AM J TROP MED HYG, V79, P940, DOI 10.4269/ajtmh.2008.79.940
   Garcia-Rejon JE, 2011, J MED ENTOMOL, V48, P644, DOI 10.1603/ME10253
   Garcia-Rejon JE, 2011, AM J TROP MED HYG, V84, P489, DOI 10.4269/ajtmh.2011.10-0654
   Goindin D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135489
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Hall T., 2011, GERF B BIOSCI, V2, P60, DOI DOI 10.1017/S0317167100012865
   HOLMES PR, 1987, J ANIM ECOL, V56, P427, DOI 10.2307/5058
   Huerta H, 2017, T ROY SOC TROP MED H, V111, P328, DOI 10.1093/trstmh/trx056
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msv279, 10.1093/molbev/msw054]
   Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187
   MCCLELLAND GA, 1971, NATURE, V232, P485, DOI 10.1038/232485a0
   Nyamah MA, 2011, TROP BIOMED, V28, P312
   PANT CP, 1973, J MED ENTOMOL, V10, P219, DOI 10.1093/jmedent/10.2.219
   Rebollar-Tellez EA, 1995, REV BIOMED, V6, P135
   Salomon-Grajales J, 2012, EMERG INFECT DIS, V18, P525, DOI 10.3201/eid1803.111626
   Scaramozzino N, 2001, J CLIN MICROBIOL, V39, P1922, DOI 10.1128/JCM.39.5.1922-1927.2001
   SCHULTZ GW, 1989, J AM MOSQUITO CONTR, V5, P508
   SHEPPARD PM, 1969, J ANIM ECOL, V38, P661, DOI 10.2307/3042
   Soares-Pinheiro VC, 2017, BRAZ J BIOL, V77, P396, DOI 10.1590/1519-6984.19815
   TRPIS M, 1986, AM J TROP MED HYG, V35, P1263, DOI 10.4269/ajtmh.1986.35.1263
   Vezzani D, 2009, MED VET ENTOMOL, V23, P78, DOI 10.1111/j.1365-2915.2008.00783.x
   Vezzani D, 2004, REV SAUDE PUBL, V38, P738, DOI [10.1590/S0034-89102004000500020, 10.1590/s0034-89102004000500020]
   Vezzani D, 2007, TROP MED INT HEALTH, V12, P299, DOI [10.1111/j.1365-3165.2006.01781.x, 10.1111/j.1365-3156.2006.01781.x]
   Wong J, 2011, J MED ENTOMOL, V48, P45, DOI 10.1603/ME10149
NR 40
TC 1
Z9 1
U1 0
U2 2
PU INST MEDICINA TROPICAL SAO PAULO
PI SAO PAULO
PA AV DR ENEAS CARVALHO DE AGUIAR, 470, C CESAR, SAO PAULO, 05403-000,
   BRAZIL
SN 0036-4665
EI 1678-9946
J9 REV INST MED TROP SP
JI Rev. Inst. Med. Trop. Sao Paulo
PY 2018
VL 60
AR UNSP e44
DI 10.1590/S1678-9946201860044
PG 14
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA GQ9JX
UT WOS:000442092500005
PM 30133604
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Menchaca-Armenta, I
   Ocampo-Torres, M
   Hernandez-Gomez, A
   Zamora-Cerritos, K
AF Menchaca-Armenta, Imelda
   Ocampo-Torres, Moises
   Hernandez-Gomez, Arnulfo
   Zamora-Cerritos, Karen
TI Risk perception and level of knowledge of diseases transmitted by Aedes
   aegypti
SO REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO
LA English
DT Article
DE A. aegypti; Dengue; Chikungunya; Zika; Risk perception; KAP
ID CHIKUNGUNYA VIRUS; DENGUE; ATTITUDES; PREVENTION; FEVER; ZIKA
AB Diseases caused by viruses such as dengue, chikungunya and zika are mosquito-borne diseases transmitted by Aedes aegypti. We performed a cross-sectional study of healthcare personnel and the general population using questionnaires to identify the level of knowledge, attitudes and practices, and risk perception for dengue, chikungunya and zika. A total of 248 questionnaires were applied, 63.3% to healthcare personnel and 36.7% to the general population. Of the healthcare personnel, 53% were men, and in the general population 74% were women. Nahuatl and Spanish were spoken by both, healthcare personnel (28%) and the general population (23%). The level of knowledge, attitudes and practices and risk perception of the population and personnel showed significant differences (p<0.05). Among healthcare personnel, nurses and vector operating staff had the lowest level of knowledge. On the other hand, the questions with the lowest scores were 1) symptoms of Zika in both groups, 2) circulating dengue serotypes in healthcare personnel and 3) symptoms of chikungunya in the general population. The results of this work allow us to identify information gaps in which knowledge, attitudes and practices, and risk perception need to be increased.
C1 [Menchaca-Armenta, Imelda; Ocampo-Torres, Moises; Hernandez-Gomez, Arnulfo; Zamora-Cerritos, Karen] Coordinac Invest Salud, Serv Salud Hidalgo, Av Mexico,300,Colonia Aquiles Serdan, Pachuca 42039, Hidalgo, Mexico.
RP Menchaca-Armenta, I (corresponding author), Coordinac Invest Salud, Serv Salud Hidalgo, Av Mexico,300,Colonia Aquiles Serdan, Pachuca 42039, Hidalgo, Mexico.
EM imeldamenchacaa@gmail.com
FU Servicios de Salud de Hidalgo
FX This study was funded by Servicios de Salud de Hidalgo.
CR Arenas-Monreal L, 2015, SALUD PUBLICA MEXICO, V57, P66
   Boonchutima S, 2017, J INFECT PUBLIC HEAL, V10, P836, DOI 10.1016/j.jiph.2017.01.016
   Castro M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081875
   Castro Peraza Marta, 2010, Rev Cubana Med Trop, V62, P245
   Cifuentes E, 2007, SALUD PUBLICA MEXICO, V49, pE114
   Dhimal M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102028
   Diagne CT, 2014, AM J TROP MED HYG, V91, P635, DOI 10.4269/ajtmh.13-0627
   Eidex RB, 2004, LANCET, V364, P936, DOI 10.1016/S0140-6736(04)17017-7
   Guzman MG, 2006, REV PANAM SALUD PUBL, V19, P204, DOI 10.1590/S1020-49892006000300015
   Gyawali N, 2016, ASIAN PAC J TROP BIO, V6, P360, DOI 10.1016/j.apjtb.2016.01.002
   Handel Andrew S, 2016, Trop Dis Travel Med Vaccines, V2, P8, DOI 10.1186/s40794-016-0024-y
   Harapan H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159139
   Ho TS, 2013, J FORMOS MED ASSOC, V112, P18, DOI 10.1016/j.jfma.2012.11.004
   Ibrahim Nahla Khamis Ragab, 2009, J Infect Public Health, V2, P30, DOI 10.1016/j.jiph.2009.01.004
   Iffat W, 2016, J HLTH ED RES DEV, V4
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kumar VA, 2010, TROP BIOMED, V27, P330
   Mejia R, 2016, OCCUP DIS ENV MED, V4, P83
   Mexico. Sistema Nacional de Vigilancia Epidemiologica, 2015, B EPIDEMIOL, V40, P38
   Mexico. Sistema Nacional de Vigilancia Epidemiologica, 2016, B EPIDEMIOL, V33, P35
   Moro ML, 2010, INT HEALTH, V2, P223, DOI 10.1016/j.inhe.2010.07.003
   Organizacion Panamericana de la Salud, FIEBR CHIK DENG AM A
   Pan American Health Organization, WHO ANN PUBL HTLH EM
   Parks W., 2004, PLANNING SOCIAL MOBI
   Pasteur Sanofi, PRIMERA VACUNA DENGU
   Patel AB, 2011, NATL J MED RES, V1, P45
   Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230
   ROSENBAUM J, 1995, AM J TROP MED HYG, V53, P111, DOI 10.4269/ajtmh.1995.53.111
   Shuaib F, 2010, W INDIAN MED J, V59, P139
   Valantine B, 2017, INT J COMMUNITY MED, V4, P623
   van Benthem BHB, 2002, TROP MED INT HEALTH, V7, P993, DOI 10.1046/j.1365-3156.2002.00950.x
   Weaver SC, 2012, EXPERT REV VACCINES, V11, P1087, DOI [10.1586/erv.12.84, 10.1586/ERV.12.84]
   Wong LP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122890
NR 33
TC 1
Z9 1
U1 1
U2 4
PU INST MEDICINA TROPICAL SAO PAULO
PI SAO PAULO
PA AV DR ENEAS CARVALHO DE AGUIAR, 470, C CESAR, SAO PAULO, 05403-000,
   BRAZIL
SN 0036-4665
EI 1678-9946
J9 REV INST MED TROP SP
JI Rev. Inst. Med. Trop. Sao Paulo
PY 2018
VL 60
DI 10.1590/S1678-9946201860010
PG 9
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA FY9KL
UT WOS:000427184400001
PM 29538507
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Lopes, TRR
   Silva, CS
   Pastor, AF
   Silva, JV
AF Rocha Lopes, Thaisa Regina
   Silva, Caroline Simoes
   Pastor, Andre Filipe
   Joaquim Silva Junior, Jose Valter
TI Dengue in Brazil in 2017: what happened?
SO REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO
LA English
DT Letter
ID ZIKA VIRUS; TRANSMISSION; INFECTION
C1 [Rocha Lopes, Thaisa Regina] Univ Fed Pernambuco, Setor Virol, Lab Imunopatol Keizo Asami, Recife, PE, Brazil.
   [Silva, Caroline Simoes; Joaquim Silva Junior, Jose Valter] Fundacao Oswaldo Cruz, Inst Aggeu Magalhaes, Dept Virol & Terapia Expt, Recife, PE, Brazil.
   [Pastor, Andre Filipe] Inst Fed Educ Ciencia & Tecnol Sertao Pernambucan, Floresta, PE, Brazil.
RP Silva, JV (corresponding author), Fundacao Oswaldo Cruz, Inst Aggeu Magalhaes, Dept Virol & Terapia Expt, Recife, PE, Brazil.
EM josevalterjsilvajr@gmail.com
CR Fares RCG, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/321873
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   George J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10901-1
   Goertz GP, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005654
   Silva JVJ, 2017, REV INST MED TROP SP, V59, DOI [10.1590/S1678-9946201759021, 10.1590/s1678-9946201759021]
   Le Coupanec A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081708
   Ministerio da Saude, 2018, B EPIDEMIOL, V49, P1
   [Ministerio da Saude do Brasil Secretaria devigilanciaem Saude], 2016, B EPIDEMIOLOGICO, V47, P1
   Ministerio da Saude Secretaria de Vigilancia em Saude, 2017, B EPIDEMIOL, V48, P1, DOI DOI 10.5588/IJTLD.11.0170
   Mohan Alladi, 2010, Indian J Dermatol, V55, P54, DOI 10.4103/0019-5154.60355
   Netto EM, 2017, MBIO, V8, DOI [10.1128/mBio.01390-17, 10.1128/mbio.01390-17]
   Ribeiro GS, 2018, LANCET GLOB HEALTH, V6, pE140, DOI 10.1016/S2214-109X(17)30496-5
   Ruckert C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15412
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Torres JR, 2017, J TROP MED-US, V2017, DOI 10.1155/2017/8045435
   VENKATACHALAM R, 2014, ASIAN PACIFIC J T S2, V4, pS573
   Viana Dione Viero, 2013, Rev. bras. epidemiol., V16, P240, DOI 10.1590/S1415-790X2013000200002
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 18
TC 4
Z9 4
U1 0
U2 0
PU INST MEDICINA TROPICAL SAO PAULO
PI SAO PAULO
PA AV DR ENEAS CARVALHO DE AGUIAR, 470, C CESAR, SAO PAULO, 05403-000,
   BRAZIL
SN 0036-4665
EI 1678-9946
J9 REV INST MED TROP SP
JI Rev. Inst. Med. Trop. Sao Paulo
PY 2018
VL 60
AR UNSP e43
DI 10.1590/S1678-9946201860043
PG 3
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA GQ9JX
UT WOS:000442092500004
PM 30133603
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Fors, M
   Silva, E
   Gonzalez, P
AF Fors, Martha
   Silva, Eduardo
   Gonzalez, Paloma
TI Epidemiological characteristics of a Zika outbreak in Portoviejo,
   Ecuador, 2016
SO REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC
   HEALTH
LA English
DT Article
DE Zika virus infection; epidemics; Zika virus; Ecuador
ID VIRUS; TRANSMISSION; WOMEN
AB Objective. To estimate the number and percentage of cases with Zika diagnosis at a hospital in Portoviejo, Manabi, Ecuador.
   Methods. This was a hospital-based, retrospective, observational, descriptive, cross-sectional study conducted at the Dr. Verdi Cevallos Balda Hospital from January - August 2016. A secondary analysis of a database was performed to estimate the number and percentage of patients positive for Zika virus, by sex, age group, ethnicity, and type of medical care. Prevalence and odds ratios with 95% Confidence Intervals were calculated using the Mantel and Haenszel method. Laboratory diagnostics included assays for the detection of Zika, chikungunya, dengue, and others.
   Results. In all, 467 suspected cases of Zika were identified based on clinical criteria. Of these, 148 cases (31.7%) were confirmed by detection of ZIKV RNA. The peak of the outbreak was documented in May - July 2016 during the rainy season, following the earthquake of April 2016. The adjusted odds ratios indicated that Zika virus was less likely in men and in subjects < 20 years of age. Most of the infected pregnant women (61%) were in the second trimester of pregnancy. No cases of microcephaly were reported.
   Conclusions. Because Zika was more likely to occur among women and >= those 20 years of age, surveillance of these groups is imperative to avoid transmission to newborns. Future studies that address the research gap and inform the country's Zika control efforts are recommended.
C1 [Fors, Martha] Univ Amer, Escuela Med, Quito, Pichincha, Ecuador.
   [Silva, Eduardo] Hosp Dr Verdi Cevallos Balda, Manabi, Portoviejo, Ecuador.
   [Gonzalez, Paloma] Biblioteca Univ Amer, Quito, Pichincha, Ecuador.
RP Fors, M (corresponding author), Univ Amer, Escuela Med, Quito, Pichincha, Ecuador.
EM marthafors@udlanet.ec
RI amsalu, ribka/G-8780-2019; Fors, Martha/M-8612-2018
OI Fors, Martha/0000-0002-0844-199X
FU Ministry of Health of Ecuador
FX The Ministry of Health of Ecuador provided funding for this study, but
   had no role in the study design, data collection or analysis, decision
   to publish, or preparation of the manuscript.
CR Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hernandez PE, 2016, SALUS, V20, P2
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Karwowski MP, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2016-0621
   Ministry of Health of Ecuador, RESP FRENT ENF VIR Z
   Ministry of Health of Ecuador, ZIKA SEMANA EPIDEMIO
   Perret C, 2016, REV CHIL INFECTOL, V33, P187, DOI 10.4067/S0716-10182016000200008
   Vasquez D, 2017, AM J PUBLIC HEALTH, V107, P1137, DOI 10.2105/AJPH.2017.303769
   von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.1016/j.jclinepi.2007.11.008
   Zambrano H, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12630
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 15
TC 0
Z9 0
U1 1
U2 6
PU PAN AMER HEALTH ORGANIZATION
PI WASHINGTON
PA 525 23RD ST NW, WASHINGTON, DC 20037 USA
SN 1020-4989
J9 REV PANAM SALUD PUBL
JI Rev. Panam. Salud Publica
PY 2018
VL 42
AR UNSP e68
DI 10.26633/RPSP.2018.68
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GP8GD
UT WOS:000441147400048
PM 31093096
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Casazza, RL
   Lazear, HM
AF Casazza, Rebecca L.
   Lazear, Helen M.
TI Antiviral immunity backfires: Pathogenic effects of type I interferon
   signaling in fetal development
SO SCIENCE IMMUNOLOGY
LA English
DT Editorial Material
ID ZIKA VIRUS
AB Interferon-alpha/beta signaling is pathogenic in a mouse model of congenital Zika virus infection.
C1 [Casazza, Rebecca L.; Lazear, Helen M.] Univ North Carolina Chapel Hill, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.
RP Lazear, HM (corresponding author), Univ North Carolina Chapel Hill, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.
EM helen.lazear@med.unc.edu
OI Casazza, Rebecca/0000-0002-8271-6947; Lazear, Helen/0000-0002-8649-4579
CR Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Crow YJ, 2015, NAT REV IMMUNOL, V15, P429, DOI 10.1038/nri3850
   Jagger BW, 2017, CELL HOST MICROBE, V22, P366, DOI 10.1016/j.chom.2017.08.012
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mor G, 2017, NAT REV IMMUNOL, V17, P469, DOI 10.1038/nri.2017.64
   Paixao ES, 2016, LANCET INFECT DIS, V16, P857, DOI 10.1016/S1473-3099(16)00088-8
   Yockey LJ, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao1680
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
NR 10
TC 8
Z9 8
U1 0
U2 4
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 2470-9468
J9 SCI IMMUNOL
JI Sci. Immunol.
PD JAN
PY 2018
VL 3
IS 19
AR eaar3446
DI 10.1126/sciimmunol.aar3446
PG 3
WC Immunology
SC Immunology
GA GI4GX
UT WOS:000434330300005
PM 29305463
DA 2020-07-08
ER

PT J
AU Yockey, LJ
   Jurado, KA
   Arora, N
   Millet, A
   Rakib, T
   Milano, KM
   Hastings, AK
   Fikrig, E
   Kong, Y
   Horvath, TL
   Weatherbee, S
   Kliman, HJ
   Coyne, CB
   Iwasaki, A
AF Yockey, Laura J.
   Jurado, Kellie A.
   Arora, Nitin
   Millet, Alon
   Rakib, Tasfia
   Milano, Kristin M.
   Hastings, Andrew K.
   Fikrig, Erol
   Kong, Yong
   Horvath, Tamas L.
   Weatherbee, Scott
   Kliman, Harvey J.
   Coyne, Carolyn B.
   Iwasaki, Akiko
TI Type I interferons instigate fetal demise after Zika virus infection
SO SCIENCE IMMUNOLOGY
LA English
DT Article
ID SYNCYTIAL KNOTS; SEXUAL TRANSMISSION; GROWTH RESTRICTION; STIMULATED
   GENES; III INTERFERONS; HYPOXIA LEADS; RECOGNITION; PLACENTA; BRAIN;
   PROTECTION
AB Zika virus (ZIKV) infection during pregnancy is associated with adverse fetal outcomes, including microcephaly, growth restriction, and fetal demise. Type I interferons (IFNs) are essential for host resistance against ZIKV, and IFN-alpha/beta receptor (IFNAR)-deficient mice are highly susceptible to ZIKV infection. Severe fetal growth restriction with placental damage and fetal resorption is observed after ZIKV infection of type I IFN receptor knockout (Ifnar1(-/-))dams mated with wild-type sires, resulting in fetuses with functional type I IFN signaling. The role of type I IFNs in limiting or mediating ZIKV disease within this congenital infection model remains unknown. In this study, we challenged Ifnar1(-/-) dams mated with Ifnar1(+/-) sires with ZIKV. This breeding scheme enabled us to examine pregnant dams that carry a mixture of fetuses that express (Ifnar1(+/-)) or do not express IFNAR (Ifnar1(-/-)) within the same uterus. Virus replicated to a higher titer in the placenta of Ifnar1(-/-) than within the Ifnar1(+/-) concepti. Yet, rather unexpectedly, we found that only Ifnar1(+/-) fetuses were resorbed after ZIKV infection during early pregnancy, whereas their Ifnar1(-/-) littermates continue to develop. Analyses of the fetus and placenta revealed that, after ZIKV infection, IFNAR signaling in the conceptus inhibits development of the placental labyrinth, resulting in abnormal architecture of the maternal-fetal barrier. Exposure of midgestation human chorionic villous explants to type I IFN, but not type III IFNs, altered placental morphology and induced cytoskeletal rearrangements within the villous core. Our results implicate type I IFNs as a possible mediator of pregnancy complications, including spontaneous abortions and growth restriction, in the context of congenital viral infections.
C1 [Yockey, Laura J.; Jurado, Kellie A.; Millet, Alon; Rakib, Tasfia; Iwasaki, Akiko] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA.
   [Arora, Nitin; Coyne, Carolyn B.] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15224 USA.
   [Milano, Kristin M.; Kliman, Harvey J.] Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06520 USA.
   [Hastings, Andrew K.; Fikrig, Erol] Yale Univ, Sch Med, Dept Internal Med, Sect Infect Dis, New Haven, CT 06520 USA.
   [Fikrig, Erol; Iwasaki, Akiko] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.
   [Kong, Yong] Yale Sch Publ Hlth, New Haven, CT 06520 USA.
   [Horvath, Tamas L.] Comparat Med Sect, Program Integrat Cell Signaling & Neurobiol Metab, New Haven, CT 06520 USA.
   [Weatherbee, Scott] Yale Univ, Dept Genet, Sch Med, New Haven, CT 06520 USA.
   [Coyne, Carolyn B.] UPMC, Childrens Hosp Pittsburgh, Ctr Microbial Pathogenesis, Pittsburgh, PA 15224 USA.
RP Iwasaki, A (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA.; Iwasaki, A (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.
EM akiko.iwasaki@yale.edu
RI Iwasaki, Akiko/Z-1591-2019; Kong, Yong/B-5105-2014
OI Iwasaki, Akiko/0000-0002-7824-9856; Kong, Yong/0000-0002-2881-5274;
   Arora, Nitin/0000-0001-6840-4333
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [1R21AI131284, T32GM007205, F30
   HD094717-01, 4T32AI007019-41, R01HD075665]; Burroughs Wellcome
   Investigators in the Pathogenesis of Infectious Disease AwardBurroughs
   Wellcome Fund; Burroughs Wellcome Fund Postdoctoral Enrichment
   ProgramBurroughs Wellcome Fund
FX This study was supported in part by the NIH (1R21AI131284 to A. I.,
   T32GM007205 and F30 HD094717-01 to L.J.Y., 4T32AI007019-41 to K.A.J, and
   R01HD075665 to C.B.C) and a Burroughs Wellcome Investigators in the
   Pathogenesis of Infectious Disease Award to C.B.C. K.A.J. is a recipient
   of the Burroughs Wellcome Fund Postdoctoral Enrichment Program. A.I. and
   E.F. are investigators of the Howard Hughes Medical Institute.
CR Andrade D, 2015, ARTHRITIS RHEUMATOL, V67, P977, DOI 10.1002/art.39029
   Barzon L., 2016, EUROSURVEILLANCE, V21, P2016, DOI DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Burton GJ, 2009, TAIWAN J OBSTET GYNE, V48, P28, DOI 10.1016/S1028-4559(09)60032-2
   Cappelletti M, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.91288
   Chawla-Sarkar M, 2003, APOPTOSIS, V8, P237, DOI 10.1023/A:1023668705040
   Coan PM, 2005, J ANAT, V207, P783, DOI 10.1111/j.1469-7580.2005.00488.x
   Corry J, 2017, P NATL ACAD SCI USA, V114, P9433, DOI 10.1073/pnas.1707513114
   Cotechini T, 2015, PLACENTA, V36, P960, DOI 10.1016/j.placenta.2015.05.016
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Crouse J, 2015, NAT REV IMMUNOL, V15, P231, DOI 10.1038/nri3806
   Crow YJ, 2011, ANN NY ACAD SCI, V1238, P91, DOI 10.1111/j.1749-6632.2011.06220.x
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dupressoir A, 2009, P NATL ACAD SCI USA, V106, P12127, DOI 10.1073/pnas.0902925106
   EZEKOWITZ RAB, 1992, NEW ENGL J MED, V326, P1456, DOI 10.1056/NEJM199205283262203
   Fogarty NME, 2013, AM J PATHOL, V183, P144, DOI 10.1016/j.ajpath.2013.03.016
   Foxman EF, 2015, P NATL ACAD SCI USA, V112, P827, DOI 10.1073/pnas.1411030112
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900
   Ibn-Salem J, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0423-1
   Jagger BW, 2017, CELL HOST MICROBE, V22, P366, DOI 10.1016/j.chom.2017.08.012
   Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36
   Kong Y, 2011, GENOMICS, V98, P152, DOI 10.1016/j.ygeno.2011.05.009
   Larsen EC, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-154
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Loukeris K, 2010, PEDIATR DEVEL PATHOL, V13, P305, DOI 10.2350/09-08-0692-OA.1
   Mameli G, 2007, VIROLOGY, V362, P120, DOI 10.1016/j.virol.2006.12.019
   Matsumoto M, 2008, ADV DRUG DELIVER REV, V60, P805, DOI 10.1016/j.addr.2007.11.005
   McConkey CA, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501462
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180
   Mor G, 2016, AM J REPROD IMMUNOL, V75, P421, DOI 10.1111/aji.12505
   Mori M, 2016, SEMIN IMMUNOPATHOL, V38, P635, DOI 10.1007/s00281-016-0574-0
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   Odendall C, 2015, CURR OPIN VIROL, V12, P47, DOI 10.1016/j.coviro.2015.02.003
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Pan American Health Organization, 2016, ZIK SUSP CONF CAS RE
   Papaioannou VE, 2012, VET PATHOL, V49, P64, DOI 10.1177/0300985810395725
   PrabhuDas M, 2015, NAT IMMUNOL, V16, P328, DOI 10.1038/ni.3131
   Racicot K, 2017, J IMMUNOL, V198, P3029, DOI 10.4049/jimmunol.1601824
   Ream M, 2008, AM J PHYSIOL-REG I, V295, pR583, DOI 10.1152/ajpregu.00771.2007
   Robbins JR, 2012, CURR OPIN MICROBIOL, V15, P36, DOI 10.1016/j.mib.2011.11.006
   Roberts RM, 2007, CYTOKINE GROWTH F R, V18, P403, DOI 10.1016/j.cytogfr.2007.06.010
   Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570
   Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314
   Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008
   Sones JL, 2016, PHYSIOL GENOMICS, V48, P565, DOI 10.1152/physiolgenomics.00125.2015
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Takeuchi O, 2007, IMMUNOL REV, V220, P214, DOI 10.1111/j.1600-065X.2007.00562.x
   Teklenburg G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010258
   Thaxton JE, 2013, J IMMUNOL, V190, P3639, DOI 10.4049/jimmunol.1203488
   Thompson VC, 2012, INT J CANCER, V131, P662, DOI 10.1002/ijc.26414
   Trollmann R, 2010, AM J PHYSIOL-REG I, V299, pR1489, DOI 10.1152/ajpregu.00697.2009
   Uraki R, 2017, J INFECT DIS, V215, P1720, DOI 10.1093/infdis/jix204
   Winkler CW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07099-7
   Wu YX, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.6
   Xavier-Neto J, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005363
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
NR 61
TC 65
Z9 65
U1 3
U2 16
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 2470-9468
J9 SCI IMMUNOL
JI Sci. Immunol.
PD JAN
PY 2018
VL 3
IS 19
AR eaao1680
DI 10.1126/sciimmunol.aao1680
PG 12
WC Immunology
SC Immunology
GA GI4GX
UT WOS:000434330300003
PM 29305462
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Xie, BP
   Qiu, GH
   Hu, PP
   Liang, Z
   Liang, YM
   Sun, B
   Bai, LP
   Jiang, ZH
   Chen, JX
AF Xie, Bao-Ping
   Qiu, Gui-Hua
   Hu, Pei-Pei
   Liang, Zhen
   Liang, Ye-Mei
   Sun, Bin
   Bai, Li-Ping
   Jiang, Zhi-Hong
   Chen, Jin-Xiang
TI Simultaneous detection of Dengue and Zika virus RNA sequences with a
   three-dimensional Cu-based zwitterionic metal-organic framework,
   comparison of single and synchronous fluorescence analysis
SO SENSORS AND ACTUATORS B-CHEMICAL
LA English
DT Article
DE Fluorescent RNA biosensor; Metal-organic framework; Dengue and Zika
   virus; Simultaneous detection; Single and synchronous analysis
ID FLAVIVIRUS DRUG DISCOVERY; MULTIPLEXED DNA DETECTION; SENSING PLATFORM;
   MOLECULAR BEACONS; GLOBAL THREAT; BIOSENSOR; BIOMOLECULES; INFECTION;
   DIAGNOSIS; POLYMERS
AB A water soluble and stable metal-organic framework (MOF) [Cu(Dcbcp)(bpe)](n) (1, Dcbcp = N-(3,5-dicarboxylbenzyl)-(3-carboxyl) pyridinium, bpe = 1,2-bis(4-pyridyl) ethylene) was synthesized. MOF 1 possesses a three-dimensional open framework with large pores and has a high affinity toward carboxyfluorescein (FAM) or 5(6)-carboxyrhodamine, triethylammonium salt (ROX)-tagged single-stranded probe DNA (P-DNA) through pi stacking, electrostatic interactions, thus quenching the fluorescence of tag. The two formed P-DNA@1 systems can be applied for simultaneous detection of Dengue virus (DENV) and Zika virus (ZIKV) RNA sequences, which is attributed to the different affinities of MOF 1 with P-DNA and the double-stranded DNA/RNA formed upon recognition. With the same detection time of 36 min and 2 min, the detection limits are 332 and 192 pM with the single detection method, 184 and 121 pM with synchronous fluorescence detection method. Both assays are highly specific and not interfered by other mismatched RNA sequences, even down to single-base mismatched RNA sequences. There was no cross-reaction between the two probes for synchronous detection. Comparing these two methods, synchronous fluorescence analysis improves the detection efficiency by saving the time and increasing the detection limits, which may attribute to its avoiding the interference of Raleigh light scattering signal to the fluorescence signal. (C) 2017 Published by Elsevier B.V.
C1 [Xie, Bao-Ping; Qiu, Gui-Hua; Hu, Pei-Pei; Liang, Zhen; Liang, Ye-Mei; Sun, Bin; Chen, Jin-Xiang] Southern Med Univ, Sch Pharmaceut Sci, Guangdong Prov Key Lab New Drug Screening, Guangzhou 510515, Guangdong, Peoples R China.
   [Xie, Bao-Ping; Qiu, Gui-Hua; Hu, Pei-Pei; Liang, Zhen; Liang, Ye-Mei; Sun, Bin; Chen, Jin-Xiang] Southern Med Univ, Sch Pharmaceut Sci, Guangzhou Key Lab Drug Res & Treatment, Guangzhou 510515, Guangdong, Peoples R China.
   [Bai, Li-Ping; Jiang, Zhi-Hong] Macau Univ Sci & Technol, Macau Inst Appl Res Med & Hlth, Taipa, Macau, Peoples R China.
RP Chen, JX (corresponding author), Southern Med Univ, Sch Pharmaceut Sci, Guangdong Prov Key Lab New Drug Screening, Guangzhou 510515, Guangdong, Peoples R China.; Chen, JX (corresponding author), Southern Med Univ, Sch Pharmaceut Sci, Guangzhou Key Lab Drug Res & Treatment, Guangzhou 510515, Guangdong, Peoples R China.
EM jxchen@smu.edu.cn
RI BAI, Li-Ping/O-5691-2016
OI BAI, Li-Ping/0000-0002-2806-6883
FU Guangdong Provincial Department of Science and Technology of China
   [2015A010105016]; Natural Science Foundation of GuangdongNational
   Natural Science Foundation of Guangdong Province [2015A030313284];
   Natural Science Foundation of ChinaNational Natural Science Foundation
   of China [21401098]; open project of State Key Laboratory of Quality
   Research in Chinese Medicine (Macau University of Science and
   Technology) [MUST-SKL-2016-04]; Macao Science and Technology Development
   Fund, Macau Special Administrative Region; Tertiary Education Services
   Office, Macau Special Administrative Region
FX We are grateful for the financial support from the Guangdong Provincial
   Department of Science and Technology of China (2015A010105016), the
   Natural Science Foundation of Guangdong (2015A030313284), the Natural
   Science Foundation of China (21401098), the open project of State Key
   Laboratory of Quality Research in Chinese Medicine (Macau University of
   Science and Technology, MUST-SKL-2016-04) funded by the Macao Science
   and Technology Development Fund, Macau Special Administrative Region.
   The authors also would like to thank the Tertiary Education Services
   Office, Macau Special Administrative Region for the financial support.
CR Bentsi-Enchill AD, 2013, VACCINE, V31, P2603, DOI 10.1016/j.vaccine.2013.03.038
   Boeuf P, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0660-0
   Botting C, 2012, EXPERT OPIN DRUG DIS, V7, P417, DOI 10.1517/17460441.2012.673579
   Chen LF, 2013, ANALYST, V138, P3490, DOI 10.1039/c3an00426k
   Chen M, 2015, DALTON T, V44, P13369, DOI 10.1039/c5dt01648g
   Chen Q, 2014, J CLIN MICROBIOL, V52, P234, DOI 10.1128/JCM.02820-13
   De Regge N, 2012, TRANSBOUND EMERG DIS, V59, P471, DOI 10.1111/tbed.12000
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dubertret B, 2001, NAT BIOTECHNOL, V19, P365, DOI 10.1038/86762
   Fang JM, 2014, ANALYST, V139, P801, DOI 10.1039/c3an01975f
   Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0
   Guo JF, 2014, RSC ADV, V4, P9379, DOI 10.1039/c3ra47389a
   Hajra A, 2016, N AM J MED SCI, V8, DOI 10.4103/1947-2714.179112
   Kanoo P, 2013, INORG CHEM, V52, P10735, DOI 10.1021/ic401924d
   Kok WM, 2016, EXPERT OPIN DRUG DIS, V11, P433, DOI 10.1517/17460441.2016.1160887
   Kumar P, 2015, TRAC-TREND ANAL CHEM, V73, P39, DOI 10.1016/j.trac.2015.04.009
   Lescar J, 2012, MOLECULAR VIROLOGY AND CONTROL OF FLAVIVIRUSES, P101
   Li HL, 2011, CHEM COMMUN, V47, P961, DOI 10.1039/c0cc04326e
   Liu R, 2016, INT J NANOMED, V11, DOI 10.2147/IJN.S100877
   Lu CH, 2009, ANGEW CHEM INT EDIT, V48, P4785, DOI 10.1002/anie.200901479
   Maxwell DJ, 2002, J AM CHEM SOC, V124, P9606, DOI 10.1021/ja025814p
   Morris W, 2014, J AM CHEM SOC, V136, P7261, DOI 10.1021/ja503215w
   Moulin E, 2016, New Microbes New Infect, V11, P6, DOI 10.1016/j.nmni.2016.02.003
   Nakayama-Ratchford N, 2007, J AM CHEM SOC, V129, P2448, DOI 10.1021/ja068684j
   Parkash O, 2015, VIRUSES-BASEL, V7, P5410, DOI 10.3390/v7102877
   Perez EM, 2015, CHEM SOC REV, V44, P6425, DOI 10.1039/c5cs00578g
   Pettitt J, 2016, J INFECT DIS, V213, P1237, DOI 10.1093/infdis/jiv454
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Qin L, 2016, CHEM COMMUN, V52, P132, DOI 10.1039/c5cc06697b
   SHELDRICK GM, 1997, SHELX 97 SHELXL 97 P
   Shen YZ, 2014, SENSOR ACTUAT B-CHEM, V199, P389, DOI 10.1016/j.snb.2014.04.014
   Singh D, 2015, CRYST GROWTH DES, V15, P3356, DOI 10.1021/acs.cgd.5b00450
   Skorepova E, 2013, CRYST GROWTH DES, V13, P5193, DOI 10.1021/cg4007394
   Spek AL, 2015, ACTA CRYSTALLOGR C, V71, P9, DOI 10.1107/S2053229614024929
   Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8
   Swathi RS, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2956498
   Tian JQ, 2015, BIOSENS BIOELECTRON, V71, P1, DOI 10.1016/j.bios.2015.04.009
   Wang CH, 2016, CHEM SOC REV, V45, P5107, DOI 10.1039/c6cs00362a
   Wang GY, 2014, J MATER CHEM A, V2, P2213, DOI 10.1039/c3ta14199c
   Wang ST, 2015, ANALYST, V140, P434, DOI 10.1039/c4an01738b
   Wang YH, 2011, ANAL CHEM, V83, P8130, DOI 10.1021/ac201631b
   Wei XF, 2013, J MATER CHEM B, V1, P1812, DOI 10.1039/c3tb00501a
   Orellano PW, 2016, VACCINE, V34, P616, DOI 10.1016/j.vaccine.2015.12.040
   Wu YF, 2015, NANOSCALE, V7, P1753, DOI 10.1039/c4nr05447d
   Xiang DS, 2013, SCI CHINA CHEM, V56, P380, DOI 10.1007/s11426-012-4767-7
   Yang RH, 2008, J AM CHEM SOC, V130, P8351, DOI 10.1021/ja800604z
   Yang SP, 2015, ANAL CHEM, V87, P12206, DOI 10.1021/acs.analchem.5b03084
   Ye T, 2014, ANALYST, V139, P1721, DOI 10.1039/c3an02077k
   Zhang HT, 2014, CHEM COMMUN, V50, P12069, DOI 10.1039/c4cc05571c
   Zhao HQ, 2016, ANAL CHIM ACTA, V922, P55, DOI 10.1016/j.aca.2016.03.054
   Zhao HQ, 2016, DALTON T, V45, P5092, DOI 10.1039/c5dt04410c
   Zhu CF, 2013, J AM CHEM SOC, V135, P5998, DOI 10.1021/ja4019572
   Zhu X, 2013, CHEM COMMUN, V49, P1276, DOI 10.1039/c2cc36661d
NR 53
TC 21
Z9 23
U1 12
U2 139
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-4005
J9 SENSOR ACTUAT B-CHEM
JI Sens. Actuator B-Chem.
PD JAN
PY 2018
VL 254
BP 1133
EP 1140
DI 10.1016/j.snb.2017.06.085
PG 8
WC Chemistry, Analytical; Electrochemistry; Instruments & Instrumentation
SC Chemistry; Electrochemistry; Instruments & Instrumentation
GA FK2JH
UT WOS:000413308000138
DA 2020-07-08
ER

PT J
AU Hashim, NA
   Ahmad, A
   Talib, A
   Athaillah, F
   Krishnan, KT
AF Hashim, Nur Aida
   Ahmad, Abu Hassan
   Talib, Anita
   Athaillah, Farida
   Krishnan, Kumara Thevan
TI Co-breeding Association of Aedes albopictus (Skuse) and Aedes aegypti
   (Linnaeus) (Diptera: Culicidae) in Relation to Location and Container
   Size
SO TROPICAL LIFE SCIENCES RESEARCH
LA English
DT Article
DE Aedes albopictus; Aedes aeypti; Co-Breeding Association; Shared Breeding
   Habitat
ID LARVAL COMPETITION; WESTERN HIMALAYAS; HEMATOPHAGOUS ARTHROPODS;
   ECOLOGICAL NOTES; HILL DISTRICTS; DENGUE VECTORS; MOSQUITOS; HABITATS;
   MALAYSIA; REGION
AB The occurrence of major outbreaks of dengue, and other vector borne diseases such as chikungunya and zika in tropical and subtropical regions has rendered control of the diseases a top-priority for many affected countries including Malaysia. Control of the mosquito vectors Aedes aegypti and Aedes albopictus through the reduction of breeding sites and the application of insecticidesto kill immature forms and adults are the main control efforts to combat these diseases. The present study describes the association between Ae. albopictus and Ae. aegypti in shared breeding sites. This study is important given that any measure taken against one species may affect the other. A yearlong larval survey was conducted in four dengue endemic areas of Penang Island. Sorenson's coefficient index indicated that no association between number of the immatures of the two species regardless of container size and study location. Therefore, the mean number Ae. albopictus immature was not decreased in the presence of Ae. aegypti in shared breeding container. However Ae. aegypti appeared to prefer breeding in habitats not occupied by Ae. albopictus, the two species sharing breeding sites only where available containers were limited. In control efforts, eliminating the preferred breeding containers for one species might not affect or reduce the population of the other species.
C1 [Hashim, Nur Aida] Univ Malaysia Terengganu, Sch Food Sci & Technol, Kuala Nerus 21030, Terengganu, Malaysia.
   [Ahmad, Abu Hassan] Univ Sains Malaysia, Sch Biol Sci, Usm Pulau Pinang 11800, Malaysia.
   [Talib, Anita] Univ Sains Malaysia, Sch Distance Educ, Usm Pulau Pinang 11800, Malaysia.
   [Athaillah, Farida] Syiah Kuala Univ, Fac Vet Med, Banda Aceh, Indonesia.
   [Krishnan, Kumara Thevan] Univ Malaysia Kelantan, Fac Agro Based Ind, Jeli Campus, Jeli 17600, Kelantan, Malaysia.
RP Hashim, NA (corresponding author), Univ Malaysia Terengganu, Sch Food Sci & Technol, Kuala Nerus 21030, Terengganu, Malaysia.
EM aida.hashim@umt.edu.my
FU Postgraduate Research Grant Scheme (PRGS) Universiti Sains Malaysia
   [1001/PBIOLOGY/841011]
FX The authors are highly indebted to Miss Rosmawati Hussein for her
   technical assistance. This work was supported by Postgraduate Research
   Grant Scheme (PRGS) Universiti Sains Malaysia, Grant no
   1001/PBIOLOGY/841011.
CR Almiron WR, 1996, MEM I OSWALDO CRUZ, V91, P1, DOI 10.1590/S0074-02761996000100001
   Alto BW, 2008, P ROY SOC B-BIOL SCI, V275, P463, DOI 10.1098/rspb.2007.1497
   Alto BW, 2005, ECOLOGY, V86, P3279, DOI 10.1890/05-0209
   Bara J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126703
   Barrera R, 1996, ECOL ENTOMOL, V21, P117, DOI 10.1111/j.1365-2311.1996.tb01178.x
   Basari N, 2016, TROP BIOMED, V33, P420
   BHAT HR, 1975, INDIAN J MED RES, V63, P1583
   BHAT HR, 1975, INDIAN J MED RES, V63, P232
   BHATT R M, 1990, Indian Journal of Malariology, V27, P167
   BLACK WC, 1989, J MED ENTOMOL, V26, P260, DOI 10.1093/jmedent/26.4.260
   Blaustein L, 2005, J VECTOR ECOL, V30, P299
   CHAN KL, 1971, B WORLD HEALTH ORGAN, V44, P643
   Chen CD, 2006, TROP BIOMED, V23, P224
   Chen CD, 2006, MALAYSIA DENGUE B, V30, P197
   COLE LC, 1949, ECOLOGY, V30, P411, DOI 10.2307/1932444
   Devi NP, 2007, J INSECT SCI, V7
   Dieng Hamady, 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P228, DOI 10.1016/S2221-1691(12)60047-1
   FAGER EW, 1957, ECOLOGY, V38, P586, DOI 10.2307/1943124
   GILOTRA SK, 1967, B WORLD HEALTH ORGAN, V37, P437
   HARDY JL, 1988, ARBOVIRUSES EPIDEMIO, V1, P87
   Hawley W.A., 1988, Journal of the American Mosquito Control Association, V4, P1
   HURLBERT SH, 1969, ECOLOGY, V50, P1, DOI 10.2307/1934657
   Hwang Ji-Sen, 1994, Chinese Journal of Entomology, V14, P233
   Juliano SA, 2004, OECOLOGIA, V139, P583, DOI 10.1007/s00442-004-1532-4
   Juliano SA, 1998, ECOLOGY, V79, P255, DOI 10.1890/0012-9658(1998)079[0255:SIARAM]2.0.CO;2
   Kalra N. L., 1997, Dengue Bulletin, V21, P84
   KLOWDEN MJ, 1993, J AM MOSQUITO CONTR, V9, P169
   Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646
   LEE H L, 1987, Tropical Biomedicine, V4, P111
   Lian CW, 2006, TROP BIOMED, V23, P85
   Lounibos LP, 2002, J VECTOR ECOL, V27, P86
   Lounibos LP, 2002, ANNU REV ENTOMOL, V47, P233, DOI 10.1146/annurev.ento.47.091201.145206
   MALHOTRA P R, 1987, Indian Journal of Malariology, V24, P151
   May R.M., 1975, P81
   MOORE CG, 1969, ANN ENTOMOL SOC AM, V62, P1325, DOI 10.1093/aesa/62.6.1325
   Mousson L, 2005, GENET RES, V86, P1, DOI 10.1017/S0016672305007627
   Nazni WA, 2009, SE ASIAN J TROP MED, V40, P40
   O'Meara G. F., 1993, American Entomologist, V39, P163
   Pant C P, 1973, MOSQUITO SYSTEMATIC, V15, P41
   PARKER AG, 1983, MOSQ NEWS, V43, P79
   Phon C K., 2007, THESIS
   Pielou E.C., 1977, MATH ECOL, P385
   Preisser EL, 2005, ECOLOGY, V86, P501, DOI 10.1890/04-0719
   Rajnikant K, 1998, J MALARIOLOGY, V35, P22
   REISEN WK, 1981, PAKISTAN J SCI RES, V3, P1
   RUDNICK ALBERT, 1960, MOSQUITO NEWS, V20, P247
   Rueda LM, 2004, ZOOTAXA, P1, DOI 10.11646/zootaxa.589.1.1
   Saifur RGM, 2013, J AM MOSQUITO CONTR, V29, P33, DOI 10.2987/12-6228R.1
   Service M. W., 1992, Southeast Asian Journal of Tropical Medicine and Public Health, V23, P681
   Singh R. K., 2008, Journal of Vector Borne Diseases, V45, P170
   SMITH C E G, 1956, J Trop Med Hyg, V59, P243
   Southwood T.R.E., 1978, ECOLOGICAL METHODS P
   SPRENGER D, 1986, J AM MOSQUITO CONTR, V2, P217
   SUCHARIT S, 1978, Southeast Asian Journal of Tropical Medicine and Public Health, V9, P93
   SULAIMAN S, 1991, Mosquito Borne Diseases Bulletin, V8, P35
   Surendran Sinnathamby N., 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P276
   Tun-Lin W., 1999, Dengue Bulletin, V23, P73
   Wan-Norafikah O, 2010, TROP BIOMED, V27, P662
   YAP H H, 1975, Southeast Asian Journal of Tropical Medicine and Public Health, V6, P519
NR 59
TC 0
Z9 0
U1 0
U2 3
PU UNIV SAINS MALAYSIA
PI PULAU PINANG
PA SCH BIOL SCI, PULAU PINANG, 00000, MALAYSIA
SN 1985-3718
EI 2180-4249
J9 TROP LIFE SCI RES
JI Trop. Life Sci. Res.
PY 2018
VL 29
IS 1
BP 213
EP 227
DI 10.21315/tlsr2018.29.1.14
PG 15
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA GT3QW
UT WOS:000444419200014
PM 29644025
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Sanchez-Montalva, A
   Pou, D
   Sulleiro, E
   Salvador, F
   Bocanegra, C
   Trevino, B
   Rando, A
   Serre, N
   Pumarola, T
   Almirante, B
   Molina, I
AF Sanchez-Montalva, Adrian
   Pou, Diana
   Sulleiro, Elena
   Salvador, Fernando
   Bocanegra, Cristina
   Trevino, Begona
   Rando, Ariadna
   Serre, Nuria
   Pumarola, Tomas
   Almirante, Benito
   Molina, Israel
TI Zika virus dynamics in body fluids and risk of sexual transmission in a
   non-endemic area
SO TROPICAL MEDICINE & INTERNATIONAL HEALTH
LA English
DT Article
DE Zika virus dynamics; Zika sexual transmission; Zika persistence; Zika in
   genital tract fluids; dynamique du virus Zika; transmission sexuelle du
   virus Zika; persistance du virus Zika; Zika dans les fluides genitaux
ID FEMALE GENITAL-TRACT; EPIDEMIC AREA; JANUARY 2016; SEMEN; INFECTION;
   DISEASE; STATES; TRANSFUSION; PREVENTION; TRAVELER
AB ObjectiveTo understand Zika virus (ZIKV) dynamics in fluids of infected individuals and the risk of sexual transmission.
   MethodsProspective study at two centres in Spain. Patients with probable or confirmed diagnosis of ZIKV infection were clinically followed up, and fluid samples were collected from saliva, serum, urine and semen or vaginal secretion following the study protocol. Non-traveller-sexual partners were offered to participate.
   ResultsFrom January 2016 to December 2016, we included a total of 11 traveller patients and six sexual contacts. Six patients were male, with a median age of 38 years (IQR 30-45). We performed 61 RT-PCR determinations, seven of which were positive. Positive results were retrieved from serum, urine, semen and vaginal tract. One of four women tested positive for ZIKV RNA in vaginal swabs collected during the first 45 days after symptoms onset. Clearance occurred between day 37 and day 69 after symptoms onset. One of five men tested positive for ZIKV RNA in semen collected during the first 45 days after symptoms onset. Clearance occurred between day 23 and 107 after symptoms onset. Six patients had sexual relations during the defined period. All tested patients were negative for ZIKV infection by serological testing.
   ConclusionZIKV shedding persistence in genital fluids occurs in a significant number of symptomatic patients after visiting an endemic area. We did not find any ZIKV seroconversion among the three male contacts who were investigated. Diagnostic algorithms may be updated to include genital tract fluid specimens in the diagnostic process.
   ObjectifComprendre la dynamique du virus Zika (ZIKV) dans les fluides d'individus infectes et le risque de transmission sexuelle.
   MethodesEtude prospective dans deux centres en Espagne. Les patients avec un diagnostic probable ou confirme d'infection au ZIKV ont ete cliniquement suivis et des echantillons de fluides ont ete preleves dans la salive, le serum, l'urine, le sperme ou la secretion vaginale selon le protocole de l'etude. Des partenaires sexuels non-voyageurs ont ete invites a participer.
   ResultatsDe janvier a decembre 2016, nous avons inclus un total de 11 patients voyageurs et 6 contacts sexuels. 6 patients etaient des hommes, avec un age median de 38 ans (IQR 30-45). Nous avons effectue 61 analyses par RT-PCR, dont 7 etaient positives. Des resultats positifs ont ete obtenus a partir du serum, de l'urine, du sperme et des voies vaginales. Une des 5 femmes a ete testee positive pour l'ARN du ZIKV dans les ecouvillons vaginaux recueillis au cours des 45 premiers jours apres l'apparition des symptomes. La clairance s'est produite entre les jours 37 et 69 apres l'apparition des symptomes. Un des 6 hommes a ete teste positif pour l'ARN du ZIKV dans le sperme preleve au cours des 45 premiers jours apres l'apparition des symptomes. La clairance s'est produite entre les jours 23 et 107 apres l'apparition des symptomes. Six patients ont eu des relations sexuelles au cours de la periode definie. Tous les patients testes etaient negatifs par les tests serologiques pour l'infection par le ZIKV.
   ConclusionLa persistance du ZIKV dans les liquides genitaux se manifeste chez un nombre significatif de patients symptomatiques apres une visite dans une zone endemique. Nous n'avons trouve aucune seroconversion au ZIKV parmi les 3 contacts masculins qui ont ete investigues. Les algorithmes de diagnostic devraient etre mis a jour pour inclure des echantillons de fluides du tractus genital dans le processus de diagnostic.
C1 [Sanchez-Montalva, Adrian; Pou, Diana; Salvador, Fernando; Bocanegra, Cristina; Trevino, Begona; Serre, Nuria; Almirante, Benito; Molina, Israel] Univ Autonoma Barcelona, Catalan Hlth Inst, Hosp Univ Vall dHebron, PROSICS Int Hlth Program,Trop Med Unit,Infect Dis, Barcelona, Spain.
   [Sulleiro, Elena; Rando, Ariadna; Pumarola, Tomas] Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Dept Microbiol, Barcelona, Spain.
RP Sanchez-Montalva, A (corresponding author), Hosp Univ Vall dHebron, Dept Enfermedades Infecciosas, Passeig Vall dHebron 119-129,Edificio Gen, Barcelona 08035, Spain.
EM adsanche@vhebron.net
RI Pumarola, Tomas/AAB-5532-2019
OI Pumarola, Tomas/0000-0002-5171-7461; Salvador,
   Fernando/0000-0002-0546-1354; Serre Delcor, Nuria/0000-0001-5984-4185;
   Rando Segura, Ariadna/0000-0003-4555-7286; Molina Romero,
   Israel/0000-0001-6642-7515; Almirante, Benito/0000-0002-1189-2361;
   Sulleiro, Elena/0000-0002-9783-6060
CR Althaus CL, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002157
   Anderson KB, 2016, ANN INTERN MED, V165, P175, DOI 10.7326/M16-0617
   Atkinson B, 2017, EMERG INFECT DIS, V23, P611, DOI 10.3201/eid2304.161692
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brooks JT, 2016, MMWR-MORBID MORTAL W, V65, P745, DOI 10.15585/mmwr.mm6529e2
   Brooks RB, 2016, MMWR-MORBID MORTAL W, V65, P915, DOI 10.15585/mmwr.mm6534e2
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Frank C, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.23.30252
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P894, DOI 10.1016/S1473-3099(16)30153-0
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   de Salazar PM, 2016, ENFERM INFEC MICR CL, V34, P247, DOI 10.1016/j.eimc.2016.02.016
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Nicastri E, 2016, EMERG INFECT DIS, V22, P2228, DOI 10.3201/eid2212.161280
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Paz-Bailey G, 2017, NEW ENGL J MED, DOI [10.1056/NEJMoa1613108, DOI 10.1056/NEJM0A1613108]
   Reusken C, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.23.30251
   Silveira FP, 2016, J HEART LUNG TRANSPL, V35, P560, DOI 10.1016/j.healun.2016.03.010
   Solomon T, 2016, LANCET INFECT DIS, V16, P402, DOI 10.1016/S1473-3099(16)00125-0
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Visseaux B, 2016, LANCET INFECT DIS, V16, P1220, DOI 10.1016/S1473-3099(16)30387-5
   Walker WL, 2016, MMWR-MORBID MORTAL W, V65, P983, DOI 10.15585/mmwr.mm6536e5
   WHO, PREV SEX TRANSM ZIK
   World Health Organization, 2016, 5 M EM COMM INT HLTH
   World Health Organization (WHO), ZIK SIT REP
NR 38
TC 15
Z9 15
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1360-2276
EI 1365-3156
J9 TROP MED INT HEALTH
JI Trop. Med. Int. Health
PD JAN
PY 2018
VL 23
IS 1
BP 92
EP 100
DI 10.1111/tmi.13019
PG 9
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FR5XM
UT WOS:000419139900010
PM 29194880
OA Bronze
DA 2020-07-08
ER

PT J
AU Boskova, V
   Stadler, T
   Magnus, C
AF Boskova, Veronika
   Stadler, Tanja
   Magnus, Carsten
TI The influence of phylodynamic model specifications on parameter
   estimates of the Zika virus epidemic
SO VIRUS EVOLUTION
LA English
DT Article
DE tree height; substitution rate; tree prior; molecular epidemiology;
   start of epidemic
ID R-PACKAGE; EVOLUTION; SPREAD; TIME; PERFORMANCE; DYNAMICS; BRAZIL
AB Each new virus introduced into the human population could potentially spread and cause a worldwide epidemic. Thus, early quantification of epidemic spread is crucial. Real-time sequencing followed by Bayesian phylodynamic analysis has proven to be extremely informative in this respect. Bayesian phylodynamic analyses require a model to be chosen and prior distributions on model parameters to be specified. We study here how choices regarding the tree prior influence quantification of epidemic spread in an emerging epidemic by focusing on estimates of the parameters clock rate, tree height, and reproductive number in the currently ongoing Zika virus epidemic in the Americas. While parameter estimates are quite robust to reasonable variations in the model settings when studying the complete data set, it is impossible to obtain unequivocal estimates when reducing the data to local Zika epidemics in Brazil and Florida, USA. Beyond the empirical insights, this study highlights the conceptual differences between the so-called birth-death and coalescent tree priors: while sequence sampling times alone can strongly inform the tree height and reproductive number under a birth-death model, the coalescent tree height prior is typically only slightly influenced by this information. Such conceptual differences together with non-trivial interactions of different priors complicate proper interpretation of empirical results. Overall, our findings indicate that phylodynamic analyses of early viral spread data must be carried out with care as data sets may not necessarily be informative enough yet to provide estimates robust to prior settings. It is necessary to do a robustness check of these data sets by scanning several models and prior distributions. Only if the posterior distributions are robust to reasonable changes of the prior distribution, the parameter estimates can be trusted. Such robustness tests will help making real-time phylodynamic analyses of spreading epidemic more reliable in the future.
C1 [Boskova, Veronika; Stadler, Tanja; Magnus, Carsten] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Mattenstr, CH-4058 Basel, Switzerland.
   [Boskova, Veronika; Stadler, Tanja; Magnus, Carsten] SIB, Basel, Switzerland.
RP Boskova, V; Stadler, T (corresponding author), Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Mattenstr, CH-4058 Basel, Switzerland.; Boskova, V; Stadler, T (corresponding author), SIB, Basel, Switzerland.
EM veronika.boskova@bsse.ethz.ch; tanja.stadler@bsse.ethz.ch
RI Stadler, Tanja/J-4742-2013
OI Stadler, Tanja/0000-0001-6431-535X; Magnus, Carsten/0000-0003-1125-2783
FU ETH ZurichETH Zurich; European Research Council under the Seventh
   Framework Programme of the European Commission [335529]
FX The authors express their gratitude to Louis du Plessis for helpful
   discussions and for making his skyline plotting scripts and TreeSlicer
   class from unreleased BEAST2 package smoothingpriors
   (https://github.com/laduplessis/smoothingpriors) available. V.B., T.S.,
   and C.M. thank ETH Zurich for funding. T.S. and V.B. were supported by
   the European Research Council under the Seventh Framework Programme of
   the European Commission (PhyPD: grant agreement number 335529).
CR ANDERSON R M, 1991
   Boskova V, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003913
   Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537
   Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/msi103
   Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214
   Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088
   du Plessis L, 2015, TRENDS MICROBIOL, V23, P383, DOI 10.1016/j.tim.2015.04.007
   Duchene S, 2015, MOL BIOL EVOL, V32, P1895, DOI 10.1093/molbev/msv056
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Heled J, 2015, SYST BIOL, V64, P369, DOI 10.1093/sysbio/syu089
   Kampstra P, 2008, J STAT SOFTW, V28, P1, DOI DOI 10.18637/JSS.V028.C01
   Kingman J, 1982, J APPL PROB A, V19, P27, DOI DOI 10.2307/3213548
   Korber B, 2000, SCIENCE, V288, P1789, DOI 10.1126/science.288.5472.1789
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Moller S., 2016, IMPACT TREE PRIOR PU
   Murray GGR, 2016, METHODS ECOL EVOL, V7, P80, DOI 10.1111/2041-210X.12466
   Nee S, 2006, ANNU REV ECOL EVOL S, V37, P1, DOI 10.1146/annurev.ecolsys.37.091305.110035
   Neuwirth E., 2014, RCOLORBREWER COLORBR
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Pan American Health Organization and World Health Organization Regional Office for the Americas, 2015, TECHNICAL REPORT
   Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412
   R Core Team, 2013, R LANG ENV STAT COMP
   Rambaut A., 2012, FIGTREE V1 4 MOLECUL
   Rambaut A., 2015, TREEANNOTATOR V2 3 0
   Rambaut A., 2014, TRACER V1 6 MOL EVOL
   Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007
   Ramsden C, 2008, MOL BIOL EVOL, V25, P1488, DOI 10.1093/molbev/msn093
   Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x
   SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454
   Smith BJ, 2007, J STAT SOFTW, V21, P1
   Stadler T, 2013, P NATL ACAD SCI USA, V110, P228, DOI 10.1073/pnas.1207965110
   Stadler T, 2011, SYST BIOL, V60, P676, DOI 10.1093/sysbio/syr029
   Stadler T, 2010, J THEOR BIOL, V267, P396, DOI 10.1016/j.jtbi.2010.09.010
   To TH, 2016, SYST BIOL, V65, P82, DOI 10.1093/sysbio/syv068
   Vaughan TG, 2013, MOL BIOL EVOL, V30, P1480, DOI 10.1093/molbev/mst057
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   World Health Organization (WHO), 2016, ZIKA SIT REP NEUR SY
NR 43
TC 9
Z9 9
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
EI 2057-1577
J9 VIRUS EVOL
JI Virus Evol.
PD JAN
PY 2018
VL 4
IS 1
AR UNSP vex044
DI 10.1093/ve/vex044
PG 14
WC Virology
SC Virology
GA GL3GM
UT WOS:000437019000006
PM 29403651
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Shean, RC
   Greninger, AL
AF Shean, Ryan C.
   Greninger, Alexander L.
TI Private collection: high correlation of sample collection and patient
   admission date in clinical microbiological testing complicates sharing
   of phylodynamic metadata
SO VIRUS EVOLUTION
LA English
DT Article
DE collection date; admission date; Safe Harbor; privacy; protected health
   information; HIPAA
ID EBOLA-VIRUS; REAL-TIME; METAGENOMIC IDENTIFICATION; UNITED-STATES; ZIKA
   VIRUS; GENOME; OUTBREAK; SURVEILLANCE; EPIDEMIOLOGY; TRANSMISSION
AB Infectious pathogens are known for their rapid evolutionary rates with new mutations arising over days to weeks. The ability to rapidly recover whole genome sequences and analyze the spread and evolution of pathogens using genetic information and pathogen collection dates has lead to interest in real-time tracking of infectious transmission and outbreaks. However, the level of temporal resolution afforded by these analyses may conflict with definitions of what constitutes protected health information (PHI) and privacy requirements for de-identification for publication and public sharing of research data and metadata. In the United States, dates and locations associated with patient care that provide greater resolution than year or the first three digits of the zip code are generally considered patient identifiers. Admission and discharge dates are specifically named as identifiers in Department of Health and Human Services guidance. To understand the degree to which one can impute admission dates from specimen collection dates, we examined sample collection dates and patient admission dates associated with more than 270,000 unique microbiological results from the University of Washington Laboratory Medicine Department between 2010 and 2017. Across all positive microbiological tests, the sample collection date exactly matched the patient admission date in 68.8% of tests. Collection dates and admission dates were identical from emergency department and outpatient testing 86.7% and 96.5% of the time, respectively, with >99% of tests collected within 1 day from the patient admission date. Samples from female patients were significantly more likely to be collected closer to admission date that those from male patients. We show that PHI-associated dates such as admission date can confidently be imputed from deposited collection date. We suggest that publicly depositing microbiological collection dates at greater resolution than the year may not meet routine Safe Harbor-based requirements for patient de-identification. We recommend the use of Expert Determination to determine PHI for a given study and/or direct patient consent if clinical laboratories or phylodynamic practitioners desire to make these data available.
C1 [Shean, Ryan C.; Greninger, Alexander L.] Univ Washington, Dept Lab Med, 1616 Eastlake Ave East,Suite 320, Seattle, WA 98102 USA.
   [Shean, Ryan C.; Greninger, Alexander L.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1100 Eastlake Ave East, Seattle, WA 98102 USA.
RP Greninger, AL (corresponding author), Univ Washington, Dept Lab Med, 1616 Eastlake Ave East,Suite 320, Seattle, WA 98102 USA.; Greninger, AL (corresponding author), Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1100 Eastlake Ave East, Seattle, WA 98102 USA.
EM agrening@uw.edu
OI Greninger, Alexander/0000-0002-7443-0527
FU Department of Laboratory Medicine at the University of Washington; Mary
   Gates Research Scholarship
FX The authors are supported by the Department of Laboratory Medicine at
   the University of Washington and the Mary Gates Research Scholarship.
CR Allard MW, 2016, J CLIN MICROBIOL, V54, P1975, DOI 10.1128/JCM.00081-16
   Benitez K, 2010, J AM MED INFORM ASSN, V17, P169, DOI 10.1136/jamia.2009.000026
   Brissette MD, 2017, ARCH PATHOL LAB MED, V141, P1394, DOI 10.5858/arpa.2016-0477-CP
   Capobianchi MR, 2013, CLIN MICROBIOL INFEC, V19, P15, DOI 10.1111/1469-0691.12056
   Carroll MW, 2015, NATURE, V524, P97, DOI 10.1038/nature14594
   Crane Genevieve M, 2016, AMA J Ethics, V18, P817, DOI 10.1001/journalofethics.2016.18.8.stas1-1608
   Dudas G, 2017, NATURE, V544, P309, DOI 10.1038/nature22040
   El Emam K, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1139
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Federhen S, 2014, STAND GENOMIC SCI, V9, DOI 10.4056/sigs.4851102
   Gardy J, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0726-x
   Gardy JL, 2011, NEW ENGL J MED, V364, P730, DOI 10.1056/NEJMoa1003176
   Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657
   Golle P., 2006, P 5 ACM WORKSH PRIV, P77, DOI DOI 10.1145/1179601.1179615
   Greninger A., 2017, BIORXIV, DOI [10.1101/181248, DOI 10.1101/181248]
   Greninger AL, 2017, NPJ GENOM MED, V2, DOI 10.1038/s41525-017-0033-4
   Greninger AL, 2017, J PEDIAT INF DIS SOC, V6, P168, DOI 10.1093/jpids/pix019
   Greninger AL, 2017, J CLIN MICROBIOL, V55, P177, DOI 10.1128/JCM.01881-16
   Greninger AL, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0235-2
   Greninger AL, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0220-9
   Greninger AL, 2015, LANCET INFECT DIS, V15, P671, DOI 10.1016/S1473-3099(15)70093-9
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Isom J, 2017, ADV ANAT PATHOL, V24, P294, DOI 10.1097/PAP.0000000000000159
   Jackson BR, 2016, CLIN INFECT DIS, V63, P380, DOI 10.1093/cid/ciw242
   Kozyreva VK, 2017, J CLIN MICROBIOL, V55, P2502, DOI 10.1128/JCM.00361-17
   Kozyreva VK, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00344-16
   Lippert C, 2017, P NATL ACAD SCI USA, V114, P10166, DOI 10.1073/pnas.1711125114
   Liu V, 2015, JAMA-J AM MED ASSOC, V313, P1471, DOI 10.1001/jama.2015.2252
   Meyers L., 2017, BIORXIV, DOI [10.1101/157156, DOI 10.1101/157156]
   Naccache SN, 2016, EMERG INFECT DIS, V22, P1788, DOI 10.3201/eid2210.160663
   Naccache SN, 2014, GENOME RES, V24, P1180, DOI 10.1101/gr.171934.113
   OCR) O. for C. R, 2008, PUBL HLTH
   Ogimi C, 2017, J INFECT DIS, V216, P203, DOI 10.1093/infdis/jix264
   Pace Wilson D, 2005, Ann Fam Med, V3 Suppl 1, pS38, DOI 10.1370/afm.301
   Park DJ, 2015, CELL, V161, P1516, DOI 10.1016/j.cell.2015.06.007
   Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996
   Roach DJ, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005413
   Sarpatwari A, 2014, NEW ENGL J MED, V371, P1644, DOI 10.1056/NEJMsb1405487
   Simon-Loriere E, 2015, NATURE, V524, P102, DOI 10.1038/nature14612
   Snitkin ES, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004129
   Sweeney L., 2013, ARXIV13071370CS
   Thomson E, 2016, J CLIN MICROBIOL, V54, P2470, DOI 10.1128/JCM.00330-16
   Wartenberg D, 2010, AM J PUBLIC HEALTH, V100, P407, DOI 10.2105/AJPH.2009.166249
   Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1
NR 44
TC 3
Z9 3
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 2057-1577
J9 VIRUS EVOL
JI Virus Evol.
PD JAN
PY 2018
VL 4
IS 1
AR UNSP vey005
DI 10.1093/ve/vey005
PG 9
WC Virology
SC Virology
GA GL3GM
UT WOS:000437019000011
PM 29511571
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Li, SX
   Armstrong, N
   Zhao, H
   Hou, WH
   Liu, J
   Chen, CY
   Wan, JK
   Wang, W
   Zhong, CL
   Liu, C
   Zhu, H
   Xia, NS
   Cheng, T
   Tang, QY
AF Li, Shuxuan
   Armstrong, Najealicka
   Zhao, Huan
   Hou, Wangheng
   Liu, Jian
   Chen, Chunye
   Wan, Junkai
   Wang, Wei
   Zhong, Chunlian
   Liu, Che
   Zhu, Hua
   Xia, Ningshao
   Cheng, Tong
   Tang, Qiyi
TI Zika Virus Fatally Infects Wild Type Neonatal Mice and Replicates in
   Central Nervous System
SO VIRUSES-BASEL
LA English
DT Article
DE Zika virus (ZIKV); neonatal mouse; pathogenesis; microcephaly;
   Flavivirus
ID MURINE MODEL; BRAIN; BRAZIL; EMERGENCE; EFFICACY; DEFECTS; HISTORY;
   STRAIN; LEADS
AB Zika virus (ZIKV) has been defined as a teratogenic pathogen behind the increased number of cases of microcephaly in French Polynesia, Brazil, Puerto Rico, and other South American countries. Experimental studies using animal models have achieved tremendous insight into understanding the viral pathogenesis, transmission, teratogenic mechanisms, and virus-host interactions. However, the animals used in published investigations are mostly interferon (IFN)-compromised, either genetically or via antibody treatment. Herein, we studied ZIKV infection in IFN-competent mice using African (MR766) and Asian strains (PRVABC59 and SZ-WIV01). After testing four different species of mice, we found that BALB/c neonatal mice were resistant to ZIKV infection, that Kunming, ICR and C57BL/6 neonatal mice were fatally susceptible to ZIKV infection, and that the fatality of C57BL/6 neonates from 1 to 3 days old were in a viral dose-dependent manner. The size and weight of the brain were significantly reduced, and the ZIKV-infected mice showed neuronal symptoms such as hind-limb paralysis, tremor, and poor balance during walking. Pathologic and immunofluorescent experiments revealed that ZIKV infected different areas of the central nervous system (CNS) including gray matter, hippocampus, cerebral cortex, and spinal cord, but not olfactory bulb. Interestingly, ZIKV replicated in multiple organs and resulted in pathogenesis in liver and testis, implying that ZIKV infection may engender a high health risk in neonates by postnatal infection. In summary, we investigated ZIKV pathogenesis using an animal model that is not IFN-compromised.
C1 [Li, Shuxuan; Zhao, Huan; Hou, Wangheng; Chen, Chunye; Wan, Junkai; Wang, Wei; Liu, Che; Xia, Ningshao; Cheng, Tong] Xiamen Univ, Sch Life Sci, Natl Inst Diagnost & Vaccine Dev Infect Dis, State Key Lab Mol Vaccinol & Mol Diagnost, Xiamen 361102, Peoples R China.
   [Armstrong, Najealicka; Tang, Qiyi] Howard Univ, Coll Med, Dept Microbiol, Washington, DC 20059 USA.
   [Liu, Jian; Zhu, Hua] Rutgers State Univ, New Jersey Med Sch, Dept Microbiol & Mol Genet, 225 Warren St, Newark, NJ USA.
   [Zhong, Chunlian] Xiamen Univ, Coll Med, Dept Basic Med Sci, Xiamen 361102, Peoples R China.
RP Cheng, T (corresponding author), Xiamen Univ, Sch Life Sci, Natl Inst Diagnost & Vaccine Dev Infect Dis, State Key Lab Mol Vaccinol & Mol Diagnost, Xiamen 361102, Peoples R China.; Tang, QY (corresponding author), Howard Univ, Coll Med, Dept Microbiol, Washington, DC 20059 USA.
EM lishuxuan37@163.com; narmstrong@Howard.edu; zh373183889@163.com;
   houwangheng@xmu.edu.cn; jl2147@njms.rutgers.edu; m13113141373@163.com;
   wjk927@163.com; lukewang@xmu.edu.cn; zhongchunlian0117@126.com;
   liuche@xmu.edu.cn; zhuhu@njms.rutgers.edu; nsxia@xmu.edu.cn;
   tcheng@xmu.edu.cn; qiyi.tang@howard.edu
RI Li, Shuxuan/AAG-5831-2019
OI Tang, Qiyi/0000-0002-6487-2356; Xia, Ningshao/0000-0003-0179-5266;
   Cheng, Tong/0000-0002-1638-6214
FU National Science and Technology Major Projects for Major New Drugs
   Innovation and Development [2017ZX09101005-005-003]; National Science
   and Technology Major Project of Infectious Diseases [2017ZX10304402];
   NIH/NIAIDUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [SC1AI112785]
FX This work was supported by the National Science and Technology Major
   Projects for Major New Drugs Innovation and Development (No.
   2017ZX09101005-005-003) (T.C.), the National Science and Technology
   Major Project of Infectious Diseases (No. 2017ZX10304402) (T.C.), the
   NIH/NIAID SC1AI112785 (Q.T.).
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Bollati M, 2010, ANTIVIR RES, V87, P125, DOI 10.1016/j.antiviral.2009.11.009
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Costa F, 2016, ANN INTERN MED, V164, P689, DOI 10.7326/M16-0332
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   da Silva SR, 2016, J MED VIROL, V88, P1291, DOI 10.1002/jmv.24563
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   Deng CL, 2016, VIROL SIN, V31, P176, DOI 10.1007/s12250-016-3778-5
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fernandes NCCA, 2017, EXP TOXICOL PATHOL, V69, P63, DOI 10.1016/j.etp.2016.11.004
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Hickman HD, 2016, TRENDS MOL MED, V22, P639, DOI 10.1016/j.molmed.2016.06.004
   HUTCHINGS PR, 1986, IMMUNOLOGY, V59, P445
   Jagger BW, 2017, CELL HOST MICROBE, V22, P366, DOI 10.1016/j.chom.2017.08.012
   Julander JG, 2017, ANTIVIR RES, V137, P14, DOI 10.1016/j.antiviral.2016.11.003
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Manangeeswaran M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006004
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Ming GL, 2016, CELL STEM CELL, V19, P690, DOI 10.1016/j.stem.2016.11.014
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Olagnier D, 2016, DNA CELL BIOL, V35, P367, DOI 10.1089/dna.2016.3404
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Roduit C, 2002, INFECT IMMUN, V70, P3521, DOI 10.1128/IAI.70.7.3521-3528.2002
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   SABIN ALBERT B., 1952, AMER JOUR TROP MED AND HYG, V1, P30
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   Smith DR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005296
   Stratton SJ, 2016, PREHOSP DISASTER MED, V31, P119, DOI 10.1017/S1049023X16000170
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Teixeira MG, 2016, AM J PUBLIC HEALTH, V106, P601, DOI 10.2105/AJPH.2016.303113
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Weger-Lucarelli J., 2017, J VIROL, V91, DOI [10. 1128/JVI. 01765-16 27795432, DOI 10.1128/JVI.01765-1627795432]
   Werner H, 2016, ULTRASOUND OBST GYN, V47, P657, DOI 10.1002/uog.15901
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Wise J, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1242
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zhang FR, 2016, NUCLEIC ACIDS RES, V44, P8610, DOI [10.1093/nar/gkw765, 10]
   Zhang F, 2017, EBIOMEDICINE, V25, P95, DOI 10.1016/j.ebiom.2017.10.019
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 61
TC 18
Z9 21
U1 0
U2 5
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD JAN
PY 2018
VL 10
IS 1
AR 49
DI 10.3390/v10010049
PG 16
WC Virology
SC Virology
GA FV2RE
UT WOS:000424414900048
PM 29361773
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Okoli, A
   Okeke, MI
   Tryland, M
   Moens, U
AF Okoli, Arinze
   Okeke, Malachy I.
   Tryland, Morten
   Moens, Ugo
TI CRISPR/Cas9Advancing Orthopoxvirus Genome Editing for Vaccine and Vector
   Development
SO VIRUSES-BASEL
LA English
DT Review
DE CRISPR; Cas9; genome editing; modified Vaccinia virus Ankara;
   orthopoxvirus; recombination; risk assessment; site-specific; Vaccinia
   virus; vaccine; vector
ID HEPATITIS-B-VIRUS; EPSTEIN-BARR-VIRUS; RNA-GUIDED ENDONUCLEASE;
   ZINC-FINGER NUCLEASES; HOST-RANGE SELECTION; CRISPR-CAS NUCLEASES;
   RANDOMIZED PHASE-II; OFF-TARGET; ANKARA MVA; ZIKA VIRUS
AB The clustered regularly interspaced short palindromic repeat (CRISPR)/associated protein 9 (Cas9) technology is revolutionizing genome editing approaches. Its high efficiency, specificity, versatility, flexibility, simplicity and low cost have made the CRISPR/Cas9 system preferable to other guided site-specific nuclease-based systems such as TALENs (Transcription Activator-like Effector Nucleases) and ZFNs (Zinc Finger Nucleases) in genome editing of viruses. CRISPR/Cas9 is presently being applied in constructing viral mutants, preventing virus infections, eradicating proviral DNA, and inhibiting viral replication in infected cells. The successful adaptation of CRISPR/Cas9 to editing the genome of Vaccinia virus paves the way for its application in editing other vaccine/vector-relevant orthopoxvirus (OPXV) strains. Thus, CRISPR/Cas9 can be used to resolve some of the major hindrances to the development of OPXV-based recombinant vaccines and vectors, including sub-optimal immunogenicity; transgene and genome instability; reversion of attenuation; potential of spread of transgenes to wildtype strains and close contacts, which are important biosafety and risk assessment considerations. In this article, we review the published literature on the application of CRISPR/Cas9 in virus genome editing and discuss the potentials of CRISPR/Cas9 in advancing OPXV-based recombinant vaccines and vectors. We also discuss the application of CRISPR/Cas9 in combating viruses of clinical relevance, the limitations of CRISPR/Cas9 and the current strategies to overcome them.
C1 [Okoli, Arinze; Okeke, Malachy I.; Tryland, Morten] Siva Innovat Ctr, GenOk Ctr Biosafety, Biosafety Genome Editing Res Grp, N-9294 Tromso, Norway.
   [Tryland, Morten] Artic Univ Norway, Dept Artic & Marine Biol, Artic Infect Biol, N-9037 Tromso, Norway.
   [Moens, Ugo] Arctic Univ Norway, Inst Med Biol, Mol Inflammat Res Grp, N-9037 Tromso, Norway.
RP Okoli, A (corresponding author), Siva Innovat Ctr, GenOk Ctr Biosafety, Biosafety Genome Editing Res Grp, N-9294 Tromso, Norway.
EM arinze.okoli@genok.no; malachy.okeke@uit.no; morten.tryland@uit.no;
   ugo.moens@uit.no
RI Okoli, Arinze/G-8310-2019
OI Tryland, Morten/0000-0001-5394-5196; Okoli, Arinze/0000-0003-0256-0856
FU GenOk-Centre for Biosafety, Tromso, Norway; Uit-The Arctic University of
   Norway, Tromso; SANCOOP grant from Forskningsradet, Norway [234196]
FX The supports of GenOk-Centre for Biosafety, Tromso, Norway; and Uit-The
   Arctic University of Norway, Tromso are acknowledged. The authors thank
   Thomas Bohn for his valuable comments on the manuscript. Arinze Okoli
   acknowledges the SANCOOP grant (Grant number 234196) from
   Forskningsradet, Norway.
CR Sanz M, 2017, SCI REP-UK, V7, DOI 10.1038/srep43876
   Antoine G, 1998, VIROLOGY, V244, P365, DOI 10.1006/viro.1998.9123
   Arlen PM, 2006, CLIN CANCER RES, V12, P1260, DOI 10.1158/1078-0432.CCR-05-2059
   Baldo A, 2013, CURR GENE THER, V13, P385
   BALL LA, 1987, J VIROL, V61, P1788, DOI 10.1128/JVI.61.6.1788-1795.1987
   Besenbacher S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6969
   Bi YW, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004090
   Bikard D, 2014, NAT BIOTECHNOL, V32, P1146, DOI 10.1038/nbt.3043
   Blanchard TJ, 1998, J GEN VIROL, V79, P1159, DOI 10.1099/0022-1317-79-5-1159
   BLASCO R, 1995, GENE, V158, P157, DOI 10.1016/0378-1119(95)00149-Z
   Bloom K, 2017, METHODS MOL BIOL, V1540, P85, DOI 10.1007/978-1-4939-6700-1_8
   Boch J, 2010, ANNU REV PHYTOPATHOL, V48, P419, DOI 10.1146/annurev-phyto-080508-081936
   Bonifati S, 2016, VIROLOGY, V495, P92, DOI 10.1016/j.virol.2016.05.002
   Braggin JE, 2016, VIROLOGY, V489, P75, DOI 10.1016/j.virol.2015.11.032
   Bulli L, 2016, J VIROL, V90, P7469, DOI 10.1128/JVI.00458-16
   Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218
   Chandrasekharan JA, 2016, J VIROL, V90, P11020, DOI 10.1128/JVI.01491-16
   Cheung MB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163709
   Chou YY, 2016, SCI REP-UK, V6, DOI 10.1038/srep36921
   Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143
   Cottingham Matthew G, 2012, Methods Mol Biol, V890, P37, DOI 10.1007/978-1-61779-876-4_3
   Dai PH, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003989
   Dang Y, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0846-3
   DeWitt MA, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf9336
   Di Pilato M, 2015, J GEN VIROL, V96, P2360, DOI 10.1099/vir.0.000183
   Domi A, 2002, P NATL ACAD SCI USA, V99, P12415, DOI 10.1073/pnas.192420599
   Dong CS, 2015, ANTIVIR RES, V118, P110, DOI 10.1016/j.antiviral.2015.03.015
   Dorningues P, 2015, J GEN VIROL, V96, P3236, DOI 10.1099/jgv.0.000283
   Draper SJ, 2010, NAT REV MICROBIOL, V8, P62, DOI 10.1038/nrmicro2240
   Drexler I, 1998, J GEN VIROL, V79, P347, DOI 10.1099/0022-1317-79-2-347
   Dreyer T, 2016, BIOCHEM BIOPH RES CO, V478, P1563, DOI 10.1016/j.bbrc.2016.08.152
   Dufrasne FE, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8100285
   Ebina H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02510
   Edvardsen RB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108622
   Estoppey D, 2017, CELL REP, V19, P451, DOI 10.1016/j.celrep.2017.03.071
   Fehlner-Gardiner C, 2012, J WILDLIFE DIS, V48, P157, DOI 10.7589/0090-3558-48.1.157
   FRANKE CA, 1985, MOL CELL BIOL, V5, P1918, DOI 10.1128/MCB.5.8.1918
   Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808
   Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623
   Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004
   Garber DA, 2012, J VIROL, V86, P12605, DOI 10.1128/JVI.00246-12
   Garcia-Arriaza J, 2014, HUM VACC IMMUNOTHER, V10, P2235, DOI 10.4161/hv.28974
   Garcia-Arriaza J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066894
   Gill SS, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.28545
   Goossens M, 2013, CURR GENE THER, V13, P413
   Gudmundsdotter L, 2009, VACCINE, V27, P4468, DOI 10.1016/j.vaccine.2009.05.018
   Guha TK, 2017, COMPUT STRUCT BIOTEC, V15, P146, DOI 10.1016/j.csbj.2016.12.006
   Guilinger JP, 2014, NAT BIOTECHNOL, V32, P577, DOI 10.1038/nbt.2909
   Gulley JL, 2014, CANCER IMMUNOL RES, V2, P133, DOI 10.1158/2326-6066.CIR-13-0108
   Guo XY, 2016, SCI REP-UK, V6, DOI 10.1038/srep25552
   Haeussler M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1012-2
   Hansen H, 2004, VACCINE, V23, P499, DOI 10.1016/j.vaccine.2004.06.032
   He M, 2016, ONCOTARGET, V7, P75698, DOI 10.18632/oncotarget.12359
   Heler R, 2015, NATURE, V519, P199, DOI 10.1038/nature14245
   Hou PP, 2015, SCI REP-UK, V5, DOI 10.1038/srep15577
   Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010
   Hu WH, 2014, P NATL ACAD SCI USA, V111, P11461, DOI 10.1073/pnas.1405186111
   Hurwitz SN, 2017, J VIROL, V91, DOI 10.1128/JVI.02251-16
   Jansen Rund, 2002, OMICS A Journal of Integrative Biology, V6, P23, DOI 10.1089/15362310252780816
   Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508
   Jiang X, 2017, EXP THER MED, V13, P3305, DOI 10.3892/etm.2017.4407
   Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829
   Kaminski R, 2016, GENE THER, V23, P690, DOI 10.1038/gt.2016.41
   Kaminski R, 2016, SCI REP-UK, V6, DOI 10.1038/srep31527
   Kaminski R, 2016, SCI REP-UK, V6, DOI 10.1038/srep22555
   Kanda T, 2016, J VIROL, V90, P4383, DOI 10.1128/JVI.00060-16
   Kang H, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.42
   Karimova M, 2015, SCI REP-UK, V5, DOI 10.1038/srep13734
   Katz E, 2002, J VIROL, V76, P11637, DOI 10.1128/JVI.76.22.11637-11644.2002
   Kaufman HL, 2005, J CLIN INVEST, V115, P1903, DOI 10.1172/JCI24624
   Kim HS, 2017, J BIOL CHEM, V292, P10664, DOI 10.1074/jbc.M117.782425
   Kim K, 2017, NAT BIOTECHNOL, V35, P435, DOI 10.1038/nbt.3816
   Lebbink RJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep41968
   Li C, 2015, J GEN VIROL, V96, P2381, DOI 10.1099/vir.0.000139
   Li H, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00091
   Liang C, 2016, RETROVIROLOGY, V13, DOI 10.1186/s12977-016-0270-0
   Liang X, 2016, SCI REP-UK, V6, DOI 10.1038/srep19176
   Liao HK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7413
   Limsirichai P, 2016, MOL THER, V24, P499, DOI 10.1038/mt.2015.213
   Lin CL, 2016, SCI REP-UK, V6, DOI 10.1038/srep34531
   Lin SR, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.38
   Liu L, 2017, BIOTECHNIQUES, V62, P183, DOI 10.2144/000114537
   Liu X, 2015, J GEN VIROL, V96, P2252, DOI 10.1099/vir.0.000159
   Liu YZ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03070-8
   Long CZ, 2014, SCIENCE, V345, P1184, DOI 10.1126/science.1254445
   Lorenzo Maria M, 2004, Methods Mol Biol, V269, P15
   Ma HM, 2015, CELL REP, V12, P673, DOI 10.1016/j.celrep.2015.06.049
   Ma YJ, 2017, CELL HOST MICROBE, V21, P580, DOI 10.1016/j.chom.2017.04.005
   Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033
   Marceau CD, 2016, NATURE, V535, P159, DOI 10.1038/nature18631
   Masud H., 2017, J VIROL, V91, DOI [10. 1128/JVI. 00975-17 28904200, DOI 10.1128/JVI.00975-1728904200]
   MCLEOD M, 1986, MOL CELL BIOL, V6, P3357, DOI 10.1128/MCB.6.10.3357
   McNeel DG, 2015, HUM VACC IMMUNOTHER, V11, P2469, DOI 10.1080/21645515.2015.1062190
   Meisinger-Henschel C, 2010, J VIROL, V84, P9907, DOI 10.1128/JVI.00756-10
   Men K, 2017, SCI CHINA LIFE SCI, V60, P447, DOI 10.1007/s11427-017-9032-4
   Meng B, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0197-x
   MERCHLINSKY M, 1992, VIROLOGY, V190, P522, DOI 10.1016/0042-6822(92)91246-Q
   Morbitzer R, 2011, NUCLEIC ACIDS RES, V39, P5790, DOI 10.1093/nar/gkr151
   Moss B, 1996, Adv Exp Med Biol, V397, P7
   MOYER RW, 1980, CELL, V22, P545, DOI 10.1016/0092-8674(80)90364-5
   Okeke MI, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9110318
   Okeke Malachy Ifeanyi, 2009, Virol J, V6, P55, DOI 10.1186/1743-422X-6-55
   Okoli A.S., 2016, KNOWLEDGE BASE ASSES
   Orubu T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040167
   PAEZ E, 1985, P NATL ACAD SCI USA, V82, P3365, DOI 10.1073/pnas.82.10.3365
   Paquet D, 2016, NATURE, V533, P125, DOI 10.1038/nature17664
   Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059
   Paszkowski P, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005824
   Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673
   Pavot V, 2017, METHODS MOL BIOL, V1581, P97, DOI 10.1007/978-1-4939-6869-5_6
   Peng RX, 2016, FEBS J, V283, P1218, DOI 10.1111/febs.13586
   Holgado MP, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8050139
   Qi YH, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005893
   Ramanan V, 2015, SCI REP-UK, V5, DOI 10.1038/srep10833
   Ramirez JC, 2000, J VIROL, V74, P923, DOI 10.1128/JVI.74.2.923-933.2000
   Ran FA, 2017, ANAL BIOCHEM, V532, P90, DOI 10.1016/j.ab.2016.10.018
   Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021
   Rehm KE, 2011, VACCINE, V29, P3276, DOI 10.1016/j.vaccine.2011.02.023
   Ren QP, 2015, SCI REP-UK, V5, DOI 10.1038/srep08865
   RODRIGUEZ JF, 1989, J VIROL, V63, P997, DOI 10.1128/JVI.63.2.997-1001.1989
   Roehm PC, 2016, SCI REP-UK, V6, DOI 10.1038/srep23146
   Russell TA, 2015, J VIROL METHODS, V213, P18, DOI 10.1016/j.jviromet.2014.11.009
   Sali TM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005324
   Salsman J., 2017, CURR GENE THER, DOI [10. 2174/1566523217666171122094629 29173169, DOI 10.2174/156652321766617112209462929173169]
   SAM CK, 1981, ANN INST PASTEUR VIR, V132, P135, DOI 10.1016/S0769-2617(81)80016-0
   Sandvik T, 1998, J CLIN MICROBIOL, V36, P2542, DOI 10.1128/JCM.36.9.2542-2547.1998
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002
   Seeger C, 2016, MOL THER, V24, P1258, DOI 10.1038/mt.2016.94
   Seeger C, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.68
   Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/NMETH.2857, 10.1038/nmeth.2857]
   Sivan G, 2015, MBIO, V6, DOI 10.1128/mBio.01122-15
   SMITH GL, 1983, NATURE, V302, P490, DOI 10.1038/302490a0
   SMITH GL, 1983, GENE, V25, P21, DOI 10.1016/0378-1119(83)90163-4
   Song J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10548
   Staib C, 2000, BIOTECHNIQUES, V28, P1137, DOI 10.2144/00286st04
   Staib C, 2005, J GEN VIROL, V86, P1997, DOI 10.1099/vir.0.80646-0
   Staib Caroline, 2004, Methods Mol Biol, V269, P77
   STERNBERG N, 1981, J MOL BIOL, V150, P467, DOI 10.1016/0022-2836(81)90375-2
   Stovicek V., 2017, FEMS YEAST RES, V17, DOI [10. 1093/femsyr/fox030 28505256, DOI 10.1093/FEMSYR/F0X03028505256]
   Terns RM, 2014, TRENDS GENET, V30, P111, DOI 10.1016/j.tig.2014.01.003
   Timm A, 2006, VACCINE, V24, P4618, DOI 10.1016/j.vaccine.2005.08.037
   Tischer BK, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/472537
   Tischer BK, 2010, METHODS MOL BIOL, V634, P421, DOI 10.1007/978-1-60761-652-8_30
   Tryland M, 2011, EMERG INFECT DIS, V17, P626, DOI 10.3201/eid1704.091899
   Tsai SQ, 2016, NAT REV GENET, V17, P300, DOI 10.1038/nrg.2016.28
   Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908
   Turner EM, 2015, J VIROL, V89, P8444, DOI 10.1128/JVI.01143-15
   Ueda S, 2016, MICROBIOL IMMUNOL, V60, P483, DOI 10.1111/1348-0421.12395
   Ura T, 2014, VACCINES, V2, P624, DOI 10.3390/vaccines2030624
   van Diemen FR, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005701
   van Pijkeren JP, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-S1-S10
   Wang B, 2017, J BIOL CHEM, V292, P5860, DOI [10.1074/jbc.M116.768168, 10.1074/jbc.m116.768168]
   Wang G, 2016, CELL REP, V17, P2819, DOI 10.1016/j.celrep.2016.11.057
   Wang JB, 2014, P NATL ACAD SCI USA, V111, P13157, DOI 10.1073/pnas.1410785111
   Wang J, 2015, WORLD J GASTROENTERO, V21, P9554, DOI 10.3748/wjg.v21.i32.9554
   Wang WJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083908
   Wang Z, 2016, CELL REP, V15, P481, DOI 10.1016/j.celrep.2016.03.042
   Wang ZD, 2010, VACCINE, V28, P1547, DOI 10.1016/j.vaccine.2009.11.056
   Wayengera M, 2012, THEOR BIOL MED MODEL, V9, DOI 10.1186/1742-4682-9-30
   Wayengera M, 2011, THEOR BIOL MED MODEL, V8, DOI 10.1186/1742-4682-8-26
   Wayengera M, 2011, THEOR BIOL MED MODEL, V8, DOI 10.1186/1742-4682-8-23
   Wei YZ, 2015, GENE DEV, V29, P356, DOI 10.1101/gad.257550.114
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   Werden SJ, 2008, ADV VIRUS RES, V71, P135, DOI 10.1016/S0065-3527(08)00003-1
   White MK, 2015, DISCOV MED, V19, P255
   Wollebo HS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136046
   Wu Xuebing, 2014, Quant Biol, V2, P59
   Wu YX, 2013, CELL STEM CELL, V13, P659, DOI 10.1016/j.stem.2013.10.016
   Wyatt L.S., 2017, CURR PROTOC MOL BIOL, V117
   Wyatt LS, 2008, VIROLOGY, V372, P260, DOI 10.1016/j.virol.2007.10.033
   Wyatt LS, 2017, MBIO, V8, DOI 10.1128/mBio.00790-17
   Wyvekens N, 2015, HUM GENE THER, V26, P425, DOI 10.1089/hum.2015.084
   Xu L, 2017, MOL THER, V25, P1782, DOI 10.1016/j.ymthe.2017.04.027
   Xu Y., 2017, INT J MOL SCI, V18, DOI [10. 3390/ijms18030586 28282856, DOI 10.3390/IJMS1803058628282856]
   Yamauchi S, 2016, SCI REP-UK, V6, DOI 10.1038/srep38336
   Yang DK, 2013, CLIN EXP VACCINE RES, V2, P19, DOI 10.7774/cevr.2013.2.1.19
   Yao XD, 2003, J VIROL, V77, P7281, DOI 10.1128/JVI.77.13.7281-7290.2003
   Ye L, 2014, P NATL ACAD SCI USA, V111, P9591, DOI 10.1073/pnas.1407473111
   Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884
   Yoder KE, 2016, SCI REP-UK, V6, DOI 10.1038/srep29530
   Yuan M, 2016, JOVE-J VIS EXP, DOI 10.3791/54171
   Yuan M, 2015, MOL THER-METH CLIN D, V2, DOI 10.1038/mtm.2015.35
   Yuan M, 2015, J VIROL, V89, P5176, DOI 10.1128/JVI.00339-15
   Yuen K.-S., 2017, VIRUS RES, DOI [10. 1016/j. virusres. 2017. 04. 019 28456574, DOI 10.1016/J.VIRUSRES.2017.04.01928456574]
   Yuen KS, 2017, METHODS MOL BIOL, V1498, P23, DOI 10.1007/978-1-4939-6472-7_2
   Yuen KS, 2015, J GEN VIROL, V96, P626, DOI 10.1099/jgv.0.000012
   Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038
   Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625
   Zhang XH, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.37
   Zhang YH, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00175-6
   Zhen S, 2015, GENE THER, V22, P404, DOI 10.1038/gt.2015.2
   Zhen S, 2014, BIOCHEM BIOPH RES CO, V450, P1422, DOI 10.1016/j.bbrc.2014.07.014
   Zheng T, 2017, SCI REP-UK, V7, DOI 10.1038/srep40638
   Zhou SJ, 2017, CELL DEATH DIFFER, V24, P1577, DOI 10.1038/cdd.2017.87
   Zhou T, 2015, J BIOL CHEM, V290, P22184, DOI 10.1074/jbc.M115.675207
   Zhou T, 2014, J VIROL, V88, P3474, DOI 10.1128/JVI.03286-13
   Zhu W, 2016, VIRUS RES, V217, P125, DOI 10.1016/j.virusres.2016.04.003
   Zhu WJ, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0150-z
   Zou Z, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01554-1
NR 200
TC 7
Z9 8
U1 0
U2 9
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD JAN
PY 2018
VL 10
IS 1
AR 50
DI 10.3390/v10010050
PG 27
WC Virology
SC Virology
GA FV2RE
UT WOS:000424414900049
PM 29361752
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Espinosa, M
   Di Fino, EMA
   Abril, M
   Lanfri, M
   Periago, MV
   Scavuzzo, CM
AF Espinosa, Manuel
   Alvarez Di Fino, Eliana Marina
   Abril, Marcelo
   Lanfri, Mario
   Victoria Periago, Maria
   Marcelo Scavuzzo, Carlos
TI Operational satellite-based temporal modelling of Aedes population in
   Argentina
SO GEOSPATIAL HEALTH
LA English
DT Article
DE Aedes aegspti; Dengue; Modelling; Remote sensing; Argentina
ID GEOGRAPHICAL INFORMATION-SYSTEM; LAND-SURFACE TEMPERATURE; DIFFERENCE
   WATER INDEX; LIFE TABLE MODEL; AEGYPTI DIPTERA; DENGUE-FEVER;
   ENVIRONMENTAL-DISTANCE; TRANSMISSION; CLIMATE; IMPACT
AB Aedes aegypti is a vector for Chikungunya, Dengue and Zika viruses in Latin America and is therefore a large public health problem for the region. For this reason, several inter-institutional and multidisciplinary efforts have been made to support vector control actions through the use of geospatial technologies. This study presents the development of an operational system for the application of free access to remotely sensed products capable of assessing the oviposition activity of Ae. aegypti in all of Argentina's northern region with the specific aim to improve the current Argentine National Dengue risk system. Temporal modelling implemented includes remotely sensed variables like the normalized difference vegetation index, the normalized difference water index, day and night land surface temperature and precipitation data available from NASA's tropical rainfall measuring mission and global precipitation measurement. As a training data set, four years of weekly mosquito oviposition data from four different cities in Argentina were used. A series of satellite-generated variables was built, downloading and resampling the these products both spatially and temporally. From an initial set of 41 variables chosen based on the correlation between these products and the oviposition series, a subset of 11 variables were preserved to develop temporal forecasting models of oviposition using a lineal multivariate method in the four cities. Subsequently, a general model was generated using data from the cities. Finally, in order to obtain a model that could be broadly used, an extrapolation method using the concept of environmental distance was developed. Although the system was oriented towards the surveillance of dengue fever, the methodology could also be applied to other relevant vector-borne diseases as well as other geographical regions in Latin America.
C1 [Espinosa, Manuel; Alvarez Di Fino, Eliana Marina; Abril, Marcelo; Victoria Periago, Maria] Mundo Sano Fdn, Paraguay 1535,C1061ABC, Buenos Aires, DF, Argentina.
   [Lanfri, Mario; Marcelo Scavuzzo, Carlos] Teofilo Tabanera Space Ctr, Mario Gulich Inst Higher Space Studies, Cordoba, Argentina.
   [Alvarez Di Fino, Eliana Marina] Natl Univ Cordoba, Fac Med Sci, Sch Nutr, Cordoba, Argentina.
RP Espinosa, M (corresponding author), Mundo Sano Fdn, Paraguay 1535,C1061ABC, Buenos Aires, DF, Argentina.
EM mespinosa@mundosano.org
RI Periago, Maria Victoria/AAO-7914-2020
OI Periago, Maria Victoria/0000-0002-1470-5146
FU Fundacion Mundo Sano
FX Fundacion Mundo Sano.
CR Andreo V, 2009, AUSTRAL ECOL, V34, P132, DOI 10.1111/j.1442-9993.2008.01889.x
   Arboleda S, 2009, INT J ENV RES PUB HE, V6, P3040, DOI 10.3390/ijerph6123040
   Beck LR, 2000, EMERG INFECT DIS, V6, P217, DOI 10.3201/eid0603.000301
   Butt B, 2011, REMOTE SENS ENVIRON, V115, P3367, DOI 10.1016/j.rse.2011.08.001
   Christophers S., 1960, AEDES AEGYPTI L YELL
   Villanueva VD, 2018, ECOL RES, V33, P225, DOI 10.1007/s11284-017-1539-z
   Eisen L, 2014, J MED ENTOMOL, V51, P496, DOI 10.1603/ME13214
   Espinosa M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004621
   Espinosa MO, 2016, GEOSPATIAL HEALTH, V11, P307, DOI 10.4081/gh.2016.471
   Estallo EL, 2008, J AM MOSQUITO CONTR, V24, P368, DOI 10.2987/5705.1
   Estallo EL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127820
   Estallo EL, 2011, VECTOR-BORNE ZOONOT, V11, P543, DOI 10.1089/vbz.2009.0165
   Fernández Eduardo M, 2012, Rev. Mus. Argent. Cienc. Nat., V14, P1
   FOCKS DA, 1993, J MED ENTOMOL, V30, P1003, DOI 10.1093/jmedent/30.6.1003
   FOCKS DA, 1993, J MED ENTOMOL, V30, P1018, DOI 10.1093/jmedent/30.6.1018
   Gao BC, 1996, REMOTE SENS ENVIRON, V58, P257, DOI 10.1016/S0034-4257(96)00067-3
   German A., 2018, Remote Sensing Applications: Society and Environment, V11, P231, DOI 10.1016/j.rsase.2018.07.006
   GOMES AC, 1998, INF EPIDEMIOL SUS, V7, P49
   Gomez-Bravo A, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2296-0
   Gorla David E, 2002, Ecol. austral, V12, P117
   Gu YX, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL029127
   Hay SI, 1997, INT J REMOTE SENS, V18, P2899, DOI 10.1080/014311697217125
   Hay SI, 2000, ADV PARASIT, V47, P1, DOI 10.1016/S0065-308X(00)47005-3
   Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276
   Hirzel AH, 2003, ENVIRON MANAGE, V32, P614, DOI 10.1007/s00267-003-0040-3
   Hopp MJ, 2001, CLIMATIC CHANGE, V48, P441, DOI 10.1023/A:1010717502442
   Justice CO, 2002, REMOTE SENS ENVIRON, V83, P3, DOI 10.1016/S0034-4257(02)00084-6
   Kalluri S, 2007, PLOS PATHOG, V3, P1361, DOI 10.1371/journal.ppat.0030116
   Khormi HM, 2011, GEOSPATIAL HEALTH, V6, P77, DOI 10.4081/gh.2011.159
   Kummerow C, 1998, J ATMOS OCEAN TECH, V15, P809, DOI 10.1175/1520-0426(1998)015<0809:TTRMMT>2.0.CO;2
   Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108
   Leisler B., 1985, CURRENT ORNITHOLOGY
   Liang GD, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.18
   Estallo EL, 2016, IEEE J-STARS, V9, P5461, DOI 10.1109/JSTARS.2016.2604577
   Estallo EL, 2012, INT J REMOTE SENS, V33, P4254, DOI 10.1080/01431161.2011.640962
   Mordecai EA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005568
   Morin CW, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004002
   Morin CW, 2013, ENVIRON HEALTH PERSP, V121, P1264, DOI 10.1289/ehp.1306556
   Ostfeld RS, 2005, TRENDS ECOL EVOL, V20, P328, DOI 10.1016/j.tree.2005.03.009
   Peres LF, 2004, REMOTE SENS ENVIRON, V91, P377, DOI 10.1016/j.rse.2004.03.011
   Polop F, 2008, ECOL RES, V23, P217, DOI 10.1007/s11284-007-0371-2
   Porcasi X, 2006, J MED ENTOMOL, V43, P1060, DOI 10.1603/0022-2585(2006)43[1060:IORHBT]2.0.CO;2
   Porcasi Ximena, 2005, Mastozool. neotrop., V12, P199
   Porcasi X, 2012, GEOSPATIAL HEALTH, V6, pS31
   R Core Team, 2014, R LANG ENV STAT COMP
   Rai PK, 2012, HLTH SCI J
   RITCHIE SA, 1984, MOSQ NEWS, V44, P77
   Rocchini D, 2015, PROG PHYS GEOG, V39, P283, DOI 10.1177/0309133315574659
   ROGERS DJ, 1991, PREV VET MED, V11, P201, DOI 10.1016/S0167-5877(05)80005-4
   Rotela C, 2007, ACTA TROP, V103, P1, DOI 10.1016/j.actatropica.2007.05.003
   Rotela C, 2017, GEOSPATIAL HEALTH, V12, P226, DOI 10.4081/gh.2017.564
   Rotela CH, 2010, REV SELPER, V30
   RUEDA LM, 1990, J MED ENTOMOL, V27, P892, DOI 10.1093/jmedent/27.5.892
   Salomon OD, 2006, MEM I OSWALDO CRUZ, V101, P295, DOI 10.1590/S0074-02762006000300013
   Sarfraz MS, 2014, GEOSPATIAL HEALTH, V8, pS685, DOI 10.4081/gh.2014.297
   Scavuzzo JM, 2018, ACTA TROP, V185, P167, DOI 10.1016/j.actatropica.2018.05.003
   Tatem Andrew J, 2004, Int J Appl Earth Obs Geoinf, V6, P33, DOI 10.1016/j.jag.2004.07.001
   Tran A, 2004, EMERG INFECT DIS, V10, P615, DOI 10.3201/eid1004.030186
   Vasconcelos PFC, 2016, VECTOR-BORNE ZOONOT, V16, P295, DOI 10.1089/vbz.2016.1952
   Waide R. B., 2013, ECOL B, V54, P21
   WAINWRIGHT PC, 1994, ECOLOGICAL MORPHOLOG
   Wan Z, 2004, INT J REMOTE SENS, V25, P261, DOI 10.1080/0143116031000116417
   WAN Z, 1999, MODIS LAND SURFACE T
   Wong J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001015
   Yang K, 2012, GEOSPATIAL HEALTH, V6, P195, DOI 10.4081/gh.2012.137
NR 65
TC 0
Z9 0
U1 0
U2 0
PU UNIV NAPLES FEDERICO II
PI NAPLES
PA FAC VET MED, DEP PATHOLOGY & ANIMAL HEALTH, VET PARASITOLOGY, VIA DELLA
   VETERINARIA 1, NAPLES, 80137, ITALY
SN 1827-1987
EI 1970-7096
J9 GEOSPATIAL HEALTH
JI Geospatial Health
PY 2018
VL 13
IS 2
BP 247
EP 258
AR 734
DI 10.4081/gh.2018.734
PG 12
WC Health Care Sciences & Services; Public, Environmental & Occupational
   Health
SC Health Care Sciences & Services; Public, Environmental & Occupational
   Health
GA HA1VM
UT WOS:000450015700008
PM 30451465
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT S
AU Dowd, KA
   Pierson, TC
AF Dowd, Kimberly A.
   Pierson, Theodore C.
BE Enquist, L
TI The Many Faces of a Dynamic Virion: Implications of Viral Breathing on
   Flavivirus Biology and Immunogenicity
SO ANNUAL REVIEW OF VIROLOGY, VOL 5
SE Annual Review of Virology
LA English
DT Article; Book Chapter
DE flavivirus; antibody; neutralization; humoral immunity; virus breathing;
   conformational dynamics; vaccine development
ID TICK-BORNE ENCEPHALITIS; WEST-NILE-VIRUS; ANTIBODY-DEPENDENT
   ENHANCEMENT; ENVELOPE PROTEIN-E; RECOMBINANT SUBVIRAL PARTICLES; HUMAN
   DENDRITIC CELLS; LETHAL JEV INFECTION; COMMON COLD VIRUS; DENGUE-VIRUS;
   ZIKA VIRUS
AB Flaviviruses are arthropod-borne RNA viruses that are a significant threat to global health due to their widespread distribution, ability to cause severe disease in humans, and capacity for explosive spread following introduction into new regions. Members of this genus include dengue, tick-borne encephalitis, yellow fever, and Zika viruses. Vaccination has been a highly successful means to control flaviviruses, and neutralizing antibodies are an important component of a protective immune response. High-resolution structures of flavivirus structural proteins and virions, alone and in complex with antibodies, provide a detailed understanding of viral fusion mechanisms and virus-antibody interactions. However, mounting evidence suggests these structures provide only a snapshot of an otherwise structurally dynamic virus particle. The contribution of the structural ensemble arising from viral breathing to the biology, antigenicity, and immunity of flaviviruses is discussed, including implications for the development and evaluation of flavivirus vaccines.
C1 [Dowd, Kimberly A.; Pierson, Theodore C.] NIAID, Viral Pathogenesis Sect, Viral Dis Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
RP Dowd, KA (corresponding author), NIAID, Viral Pathogenesis Sect, Viral Dis Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
EM dowdka@mail.nih.gov; piersontc@mail.nih.gov
CR Aberle JH, 1999, J IMMUNOL, V163, P6756
   Abzug MJ, 2016, J PEDIAT INF DIS SOC, V5, P53, DOI 10.1093/jpids/piv015
   Allison SL, 2003, J VIROL, V77, P11357, DOI 10.1128/JVI.77.21.11357-11366.2003
   Allison SL, 1999, J VIROL, V73, P5605, DOI 10.1128/JVI.73.7.5605-5612.1999
   Allison SL, 2001, J VIROL, V75, P4268, DOI 10.1128/JVI.75.9.4268-4275.2001
   Ansarah-Sobrinho C, 2008, VIROLOGY, V381, P67, DOI 10.1016/j.virol.2008.08.021
   Apte-Sengupta S, 2014, CURR OPIN VIROL, V9, P134, DOI 10.1016/j.coviro.2014.09.020
   Austin SK, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002930
   Balsitis SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000790
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Barrett ADT, 2017, VACCINE, V35, P5951, DOI 10.1016/j.vaccine.2017.03.032
   BASAVAPPA R, 1994, PROTEIN SCI, V3, P1651, DOI 10.1002/pro.5560031005
   Belnap DM, 2000, J VIROL, V74, P1342, DOI 10.1128/JVI.74.3.1342-1354.2000
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Boehr DD, 2008, SCIENCE, V320, P1429, DOI 10.1126/science.1158818
   Bothner B, 1998, J BIOL CHEM, V273, P673, DOI 10.1074/jbc.273.2.673
   Bressanelli S, 2004, EMBO J, V23, P728, DOI 10.1038/sj.emboj.7600064
   Brien JD, 2010, J VIROL, V84, P10630, DOI 10.1128/JVI.01190-10
   Bubeck D, 2005, J VIROL, V79, P7745, DOI 10.1128/JVI.79.12.7745-7755.2005
   Butan C, 2014, J VIROL, V88, P1758, DOI 10.1128/JVI.01949-13
   CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37
   Carnec X, 2016, J VIROL, V90, P92, DOI 10.1128/JVI.01849-15
   Carson SD, 2014, J VIROL, V88, P11568, DOI 10.1128/JVI.01790-14
   Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866
   Cherrier MV, 2009, EMBO J, V28, P3269, DOI 10.1038/emboj.2009.245
   Colpitts TM, 2011, J GEN VIROL, V92, P2281, DOI 10.1099/vir.0.031427-0
   Crill WD, 2001, J VIROL, V75, P7769, DOI 10.1128/JVI.75.16.7769-7773.2001
   Curry S, 1996, J VIROL, V70, P7125, DOI 10.1128/JVI.70.10.7125-7131.1996
   Davis CW, 2006, J VIROL, V80, P1290, DOI 10.1128/JVI.80.3.1290-1301.2006
   de Alwis R, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004386
   de Alwis R, 2012, P NATL ACAD SCI USA, V109, P7439, DOI 10.1073/pnas.1200566109
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   DELLAPORTA AJ, 1978, J GEN VIROL, V38, P1, DOI 10.1099/0022-1317-38-1-1
   DIANA GD, 1985, PHARMACOL THERAPEUT, V29, P287, DOI 10.1016/0163-7258(85)90005-1
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Dowd KA, 2015, MBIO, V6, DOI 10.1128/mBio.01559-15
   Dowd KA, 2014, J VIROL, V88, P11726, DOI 10.1128/JVI.01140-14
   Dowd KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002111
   Dowd KA, 2011, VIROLOGY, V411, P306, DOI 10.1016/j.virol.2010.12.020
   Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105
   Elshuber S, 2003, J GEN VIROL, V84, P183, DOI 10.1099/vir.0.18723-0
   Ferlenghi I, 2001, MOL CELL, V7, P593, DOI 10.1016/S1097-2765(01)00206-4
   Fibriansah G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7341
   Fibriansah G, 2014, EMBO MOL MED, V6, P358, DOI 10.1002/emmm.201303404
   Fibriansah G, 2013, J VIROL, V87, P7585, DOI 10.1128/JVI.00757-13
   FONSECA BAL, 1994, VACCINE, V12, P279, DOI 10.1016/0264-410X(94)90206-2
   FRICKS CE, 1990, J VIROL, V64, P1934, DOI 10.1128/JVI.64.5.1934-1945.1990
   Gallichotte EN, 2015, MBIO, V6, DOI 10.1128/mBio.01461-15
   Gaudinski MR, 2018, LANCET, V391, P552, DOI 10.1016/S0140-6736(17)33105-7
   GOLLINS SW, 1986, NATURE, V321, P244, DOI 10.1038/321244a0
   Goo L, 2018, VIROLOGY, V515, P191, DOI 10.1016/j.virol.2017.12.032
   Goo L, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006178
   Goo L, 2016, MBIO, V7, DOI [10.1128/mBio.01396-16, 10.1128/mbio.01396-16]
   Griffin BD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15743
   GUIRAKHOO F, 1992, VIROLOGY, V191, P921, DOI 10.1016/0042-6822(92)90267-S
   Guttman M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7144
   Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hasan SS, 2018, NAT STRUCT MOL BIOL, V25, P13, DOI 10.1038/s41594-017-0010-8
   Hasan SS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14722
   Hastings AK, 2017, CELL REP, V19, P558, DOI 10.1016/j.celrep.2017.03.058
   Hayden FG, 2003, CLIN INFECT DIS, V36, P1523, DOI 10.1086/375069
   HE RT, 1995, J MED VIROL, V45, P451, DOI 10.1002/jmv.1890450417
   Heinz FX, 2007, VACCINE, V25, P7559, DOI 10.1016/j.vaccine.2007.08.024
   Heinz FX, 1995, VACCINE, V13, P1636, DOI 10.1016/0264-410X(95)00133-L
   Hogle JM, 2002, ANNU REV MICROBIOL, V56, P677, DOI 10.1146/annurev.micro.56.012302.160757
   HOGLE JM, 1985, SCIENCE, V229, P1358, DOI 10.1126/science.2994218
   Holmes EC, 2003, INFECT GENET EVOL, V3, P19, DOI 10.1016/S1567-1348(03)00004-2
   Jarmer J, 2014, J VIROL, V88, P13845, DOI 10.1128/JVI.02086-14
   Jemielity S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003232
   Jimenez-Clavero MA, 2000, VIROLOGY, V270, P76, DOI 10.1006/viro.2000.0256
   Junjhon J, 2010, J VIROL, V84, P8353, DOI 10.1128/JVI.00696-10
   Karplus M, 2005, P NATL ACAD SCI USA, V102, P6679, DOI 10.1073/pnas.0408930102
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Katzelnick LC, 2015, SCIENCE, V349, P1338, DOI 10.1126/science.aac5017
   Kaufmann B, 2010, P NATL ACAD SCI USA, V107, P18950, DOI 10.1073/pnas.1011036107
   Kielian M, 2006, NAT REV MICROBIOL, V4, P67, DOI 10.1038/nrmicro1326
   Kiermayr S, 2009, J VIROL, V83, P8482, DOI 10.1128/JVI.00660-09
   Konishi E, 2002, VACCINE, V20, P1058, DOI 10.1016/S0264-410X(01)00446-7
   KONISHI E, 1992, VIROLOGY, V188, P714, DOI 10.1016/0042-6822(92)90526-U
   Kostyuchenko VA, 2014, J VIROL, V88, P477, DOI 10.1128/JVI.02641-13
   Kroeger MA, 2002, ARCH VIROL, V147, P1155, DOI 10.1007/s00705-002-0809-3
   Kroschewski H, 2003, VIROLOGY, V308, P92, DOI 10.1016/S0042-6822(02)00097-1
   Kuhn RJ, 2015, VIROLOGY, V479, P508, DOI 10.1016/j.virol.2015.03.025
   Lee E, 2000, J VIROL, V74, P8867, DOI 10.1128/JVI.74.19.8867-8875.2000
   Lewis JK, 1998, P NATL ACAD SCI USA, V95, P6774, DOI 10.1073/pnas.95.12.6774
   Li L, 2008, SCIENCE, V319, P1830, DOI 10.1126/science.1153263
   LI QH, 1994, J VIROL, V68, P3965, DOI 10.1128/JVI.68.6.3965-3970.1994
   Lim XX, 2017, STRUCTURE, V25, P1391, DOI 10.1016/j.str.2017.07.007
   Lok SM, 2008, NAT STRUCT MOL BIOL, V15, P312, DOI 10.1038/nsmb.1382
   Lozach PY, 2005, J BIOL CHEM, V280, P23698, DOI 10.1074/jbc.M504337200
   Lu LL, 2018, NAT REV IMMUNOL, V18, P46, DOI 10.1038/nri.2017.106
   Luca VC, 2012, J VIROL, V86, P2337, DOI 10.1128/JVI.06072-11
   Markoff L, 2000, VACCINE, V18, P26, DOI 10.1016/S0264-410X(00)00038-4
   MASON PW, 1991, VIROLOGY, V180, P294, DOI 10.1016/0042-6822(91)90034-9
   Mead PS, 2018, CURR OPIN INFECT DIS, V31, P39, DOI 10.1097/QCO.0000000000000414
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Mehlhop E, 2009, CELL HOST MICROBE, V6, P381, DOI 10.1016/j.chom.2009.09.003
   Metz SW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04767-6
   Miller JL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040017
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Moesker B, 2010, J GEN VIROL, V91, P389, DOI 10.1099/vir.0.015255-0
   Moller-Tank S, 2014, VIROLOGY, V468, P565, DOI 10.1016/j.virol.2014.09.009
   Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030
   Monath TP, 2002, AM J TROP MED HYG, V66, P533, DOI 10.4269/ajtmh.2002.66.533
   Montoya M, 2018, J INFECT DIS, V218, P536, DOI 10.1093/infdis/jiy164
   Mukherjee S, 2014, J VIROL, V88, P7210, DOI 10.1128/JVI.03690-13
   Munro JB, 2014, SCIENCE, V346, P759, DOI 10.1126/science.1254426
   MURRAY JM, 1993, J GEN VIROL, V74, P175, DOI 10.1099/0022-1317-74-2-175
   Navarro-Sanchez E, 2003, EMBO REP, V4, P723, DOI 10.1038/sj.embor.embor866
   Nelson S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000060
   Noble CG, 2012, ANTIVIR RES, V96, P115, DOI 10.1016/j.antiviral.2012.09.007
   Nybakken GE, 2005, NATURE, V437, P764, DOI 10.1038/nature03956
   Nybakken GE, 2006, J VIROL, V80, P11467, DOI 10.1128/JVI.01125-06
   Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240
   Oliphant T, 2006, J VIROL, V80, P12149, DOI 10.1128/JVI.01732-06
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Patel B, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005554
   Paul David, 2013, World J Virol, V2, P32, DOI 10.5501/wjv.v2.i2.32
   Perera R, 2008, CURR OPIN MICROBIOL, V11, P369, DOI 10.1016/j.mib.2008.06.004
   Pierson TC, 2007, CELL HOST MICROBE, V1, P135, DOI 10.1016/j.chom.2007.03.002
   Pierson TC, 2013, CURR OPIN VIROL, V3, P3, DOI 10.1016/j.coviro.2012.12.001
   Pierson TC, 2012, CURR OPIN VIROL, V2, P168, DOI 10.1016/j.coviro.2012.02.011
   PINCUS S, 1992, VIROLOGY, V187, P290, DOI 10.1016/0042-6822(92)90317-I
   Plevka P, 2014, J STRUCT BIOL, V185, P27, DOI 10.1016/j.jsb.2013.11.001
   Plevka P, 2011, EMBO REP, V12, P602, DOI 10.1038/embor.2011.75
   Prasad VM, 2017, NAT STRUCT MOL BIOL, V24, P184, DOI 10.1038/nsmb.3352
   Reisdorph N, 2003, VIROLOGY, V314, P34, DOI 10.1016/S0042-6822(03)00452-5
   Rey FA, 2018, EMBO REP, V19, P206, DOI 10.15252/embr.201745302
   Rey FA, 2017, CURR OPIN VIROL, V24, P132, DOI 10.1016/j.coviro.2017.06.009
   Richard AS, 2015, P NATL ACAD SCI USA, V112, P14682, DOI 10.1073/pnas.1508095112
   Richner JM, 2017, CELL, V169, P176, DOI 10.1016/j.cell.2017.03.016
   Rodenhuis-Zybert IA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000718
   Rodrigo WWSI, 2009, VIROLOGY, V394, P175, DOI 10.1016/j.virol.2009.09.024
   Roehrig JT, 1998, VIROLOGY, V246, P317, DOI 10.1006/viro.1998.9200
   ROIVAINEN M, 1993, VIROLOGY, V195, P762, DOI 10.1006/viro.1993.1427
   ROSSMANN MG, 1985, NATURE, V317, P145, DOI 10.1038/317145a0
   Rouvinski A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15411
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   Sauter P, 2008, J MED VIROL, V80, P866, DOI 10.1002/jmv.21171
   Schalich J, 1996, J VIROL, V70, P4549, DOI 10.1128/JVI.70.7.4549-4557.1996
   Scherwitzl I, 2017, CURR OPIN VIROL, V23, P95, DOI 10.1016/j.coviro.2017.04.002
   Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09
   Shi X, 2016, MABS-AUSTIN, V8, P574, DOI 10.1080/19420862.2016.1148850
   Shrestha B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000823
   Stadler K, 1997, J VIROL, V71, P8475, DOI 10.1128/JVI.71.11.8475-8481.1997
   Stiasny K, 2006, J VIROL, V80, P9557, DOI 10.1128/JVI.00080-06
   Sukupolvi-Petty S, 2013, J VIROL, V87, P8826, DOI 10.1128/JVI.01314-13
   Sukupolvi-Petty S, 2010, J VIROL, V84, P9227, DOI 10.1128/JVI.01087-10
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840
   Tebas Pablo, 2017, N Engl J Med, DOI 10.1056/NEJMoa1708120
   Teoh EP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003888
   Thompson BS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000453
   Tomori O, 1999, ADV VIRUS RES, V53, P5, DOI 10.1016/S0065-3527(08)60341-3
   van der Schaar HM, 2007, J VIROL, V81, P12019, DOI 10.1128/JVI.00300-07
   VanBlargan LA, 2016, MICROBIOL MOL BIOL R, V80, DOI 10.1128/MMBR.00024-15
   Vaney MC, 2011, CELL MICROBIOL, V13, P1451, DOI 10.1111/j.1462-5822.2011.01653.x
   Vogt MR, 2011, J VIROL, V85, P11567, DOI 10.1128/JVI.05859-11
   Vogt MR, 2009, J VIROL, V83, P6494, DOI 10.1128/JVI.00286-09
   Wahala WMPB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000821
   Wang XX, 2017, NAT COMMUN, V8, DOI [10.1038/s41467-017-00024-6, 10.1038/s41467-017-01822-8]
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Weaver SC, 2013, TRENDS MICROBIOL, V21, P360, DOI 10.1016/j.tim.2013.03.003
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   World Hlth Org, 2017, VACCINE, V35, P1200, DOI 10.1016/j.vaccine.2016.10.070
   Xie XP, 2017, MBIO, V8, DOI [10.1128/mBio.02134-16, 10.1128/mbio.02134-16]
   Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264
   Zaitseva E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001131
   Zellweger RM, 2010, CELL HOST MICROBE, V7, P128, DOI 10.1016/j.chom.2010.01.004
   Zhang W, 2003, NAT STRUCT BIOL, V10, P907, DOI 10.1038/nsb990
   Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463
   Zhang XZ, 2013, P NATL ACAD SCI USA, V110, P6795, DOI 10.1073/pnas.1304300110
   Zhang Y, 2004, STRUCTURE, V12, P1607, DOI 10.1016/j.str.2004.06.019
   Zhang Y, 2003, EMBO J, V22, P2604, DOI 10.1093/emboj/cdg270
NR 178
TC 7
Z9 7
U1 1
U2 9
PU ANNUAL REVIEWS
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0897 USA
SN 2327-056X
J9 ANNU REV VIROL
PY 2018
VL 5
BP 185
EP 207
DI 10.1146/annurev-virology-092917-043300
PG 23
WC Virology
SC Virology
GA BL1LF
UT WOS:000447826000009
PM 30265634
DA 2020-07-08
ER

PT S
AU Glasner, DR
   Puerta-Guardo, H
   Beatty, PR
   Harris, E
AF Glasner, Dustin R.
   Puerta-Guardo, Henry
   Beatty, P. Robert
   Harris, Eva
BE Enquist, L
TI The Good, the Bad, and the Shocking: The Multiple Roles of Dengue Virus
   Nonstructural Protein 1 in Protection and Pathogenesis
SO ANNUAL REVIEW OF VIROLOGY, VOL 5
SE Annual Review of Virology
LA English
DT Article; Book Chapter
DE dengue; NS1; endothelial permeability; vascular leak; immune evasion;
   vaccines
ID HEPATITIS-C VIRUS; T-CELL RESPONSES; LINKED-IMMUNOSORBENT-ASSAY;
   HEMORRHAGIC-FEVER; NS1 PROTEIN; ZIKA VIRUS; EBOLA-VIRUS; ENDOTHELIAL
   GLYCOCALYX; MONOCLONAL-ANTIBODIES; GLYCOPROTEIN NS1
AB Dengue virus (DENV) is the most prevalent medically important mosquito-borne virus in the world. Upon DENV infection of a host cell, DENV nonstructural protein 1 (NS1) can be found intracellularly as a monomer, associated with the cell surface as a dimer, and secreted as a hexamer into the bloodstream. NS1 plays a variety of roles in the viral life cycle, particularly in RNA replication and immune evasion of the complement pathway. Over the past several years, key roles for NS1 in the pathogenesis of severe dengue disease have emerged, including direct action of the protein on the vascular endothelium and triggering release of vasoactive cytokines from immune cells, both of which result in endothelial hyperpermeability and vascular leak. Importantly, the adaptive immune response generates a robust response against NS1, and its potential contribution to dengue vaccines is also discussed.
C1 [Glasner, Dustin R.; Puerta-Guardo, Henry; Beatty, P. Robert; Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
RP Glasner, DR (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
EM drglasner@berkeley.edu; hpuertaguardo@gmail.com; prbeatty@berkeley.edu;
   eharris@berkeley.edu
OI Glasner, Dustin/0000-0001-9821-6683
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01 AI124493]
CR Adikari TN, 2016, CLIN EXP IMMUNOL, V184, P90, DOI 10.1111/cei.12747
   Akey DL, 2014, SCIENCE, V343, P881, DOI 10.1126/science.1247749
   Alayli F, 2016, VIROLOGY, V496, P227, DOI 10.1016/j.virol.2016.06.008
   Alcon S, 2002, J CLIN MICROBIOL, V40, P376, DOI 10.1128/JCM.40.02.376-381.2002
   Amorim JH, 2012, VACCINE, V30, P837, DOI 10.1016/j.vaccine.2011.12.034
   Angelo MA, 2017, J VIROL, V91, DOI 10.1128/JVI.02147-16
   [Anonymous], 2012, GLOB STRAT DENG PREV
   Atoom AM, 2014, VIROLOGY, V462, P377, DOI 10.1016/j.virol.2014.04.018
   Avirutnan P, 2006, J INFECT DIS, V193, P1078, DOI 10.1086/500949
   Avirutnan P, 2007, PLOS PATHOG, V3, P1798, DOI 10.1371/journal.ppat.0030183
   Avirutnan P, 2011, J IMMUNOL, V187, P424, DOI 10.4049/jimmunol.1100750
   Avirutnan P, 2010, J EXP MED, V207, P793, DOI 10.1084/jem.20092545
   Aye KS, 2014, HUM PATHOL, V45, P1221, DOI 10.1016/j.humpath.2014.01.022
   Azeredo EL, 2001, IMMUNOBIOLOGY, V204, P494, DOI 10.1078/0171-2985-00058
   Balmaseda A, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.01785-17, 10.1128/jcm.01785-17]
   Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114
   Balsitis SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000790
   Beatty PR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3787
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bosch I, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan1589
   Bozza FA, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-86
   BRANDT WE, 1970, J IMMUNOL, V105, P1565
   Chakravarti A, 2006, INDIAN J MED RES, V123, P25
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chandele A, 2016, J VIROL, V90, P11259, DOI 10.1128/JVI.01424-16
   Chen CY, 2013, AMB EXPRESS, V3, DOI 10.1186/2191-0855-3-49
   Chen HR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004828
   Chen JC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005053
   Chen LC, 2006, AM J TROP MED HYG, V74, P142, DOI 10.4269/ajtmh.2006.74.142
   Chen M., 2009, J WATER RES PROT, V1, P1
   Chen Y, 2010, VIROLOGY, V398, P290, DOI 10.1016/j.virol.2009.12.010
   Cheng HJ, 2009, MOL IMMUNOL, V47, P398, DOI 10.1016/j.molimm.2009.08.033
   Chisenhall DM, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-252
   Chu YT, 2017, LAB INVEST, V97, P602, DOI 10.1038/labinvest.2017.10
   Chuang YC, 2011, J IMMUNOL, V187, P6483, DOI 10.4049/jimmunol.1102218
   CHURDBOONCHART V, 1991, AM J TROP MED HYG, V44, P481, DOI 10.4269/ajtmh.1991.44.481
   Clarke D, 2006, J BIOL CHEM, V281, P37057, DOI 10.1074/jbc.M602434200
   Conde JN, 2016, J VIROL, V90, P9570, DOI 10.1128/JVI.00912-16
   Conway MJ, 2014, J VIROL, V88, P164, DOI 10.1128/JVI.02235-13
   Crabtree MB, 2005, ARCH VIROL, V150, P771, DOI 10.1007/s00705-004-0430-8
   Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357
   Didsbury A, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-551
   Dolnik O, 2004, EMBO J, V23, P2175, DOI 10.1038/sj.emboj.7600219
   Dredge K, 2011, BRIT J CANCER, V104, P635, DOI 10.1038/bjc.2011.11
   Dudek SM, 2001, J APPL PHYSIOL, V91, P1487
   Durbin AP, 2008, VIROLOGY, V376, P429, DOI 10.1016/j.virol.2008.03.028
   Dussart P, 2006, CLIN VACCINE IMMUNOL, V13, P1185, DOI 10.1128/CVI.00229-06
   Duyen HTL, 2011, J INFECT DIS, V203, P1292, DOI 10.1093/infdis/jir014
   Edeling MA, 2014, P NATL ACAD SCI USA, V111, P4285, DOI 10.1073/pnas.1322036111
   Escudero-Perez B, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004509
   Falconar AKI, 1997, ARCH VIROL, V142, P897, DOI 10.1007/s007050050127
   FALCONAR AKI, 1994, ARCH VIROL, V137, P315, DOI 10.1007/BF01309478
   Falconar AKI, 1999, ARCH VIROL, V144, P2313, DOI 10.1007/s007050050646
   Falconar AKI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021024
   FALGOUT B, 1990, J VIROL, V64, P4356, DOI 10.1128/JVI.64.9.4356-4363.1990
   FALKLER WA, 1973, J IMMUNOL, V111, P1804
   Falzarano D, 2006, CHEMBIOCHEM, V7, P1605, DOI 10.1002/cbic.200600223
   Flamand M, 1999, J VIROL, V73, P6104, DOI 10.1128/JVI.73.7.6104-6110.1999
   Fry SR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001199
   Ge Y, 2013, J VIROL, V87, P11160, DOI 10.1128/JVI.03099-12
   Glasner DR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006673
   Goncalves AJS, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004277
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Gutsche I, 2011, P NATL ACAD SCI USA, V108, P8003, DOI 10.1073/pnas.1017338108
   Guy B, 2011, VACCINE, V29, P7229, DOI 10.1016/j.vaccine.2011.06.094
   Guzmán María G., 2002, Rev Panam Salud Publica, V11, P223, DOI 10.1590/S1020-49892002000400003
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Hafirassou ML, 2017, CELL REP, V21, P3900, DOI 10.1016/j.celrep.2017.11.094
   HALSTEAD SB, 1979, J INFECT DIS, V140, P527, DOI 10.1093/infdis/140.4.527
   HALSTEAD SB, 1977, J EXP MED, V146, P201, DOI 10.1084/jem.146.1.201
   Halstead SB, 2016, AM J TROP MED HYG, V95, P741, DOI 10.4269/ajtmh.16-0222
   Hatch S, 2011, J INFECT DIS, V203, P1282, DOI 10.1093/infdis/jir012
   Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006
   HENCHAL EA, 1988, J GEN VIROL, V69, P2101, DOI 10.1099/0022-1317-69-8-2101
   Hertz T, 2017, J IMMUNOL, V198, P4025, DOI 10.4049/jimmunol.1700029
   Huang JH, 1999, J MED VIROL, V57, P1, DOI 10.1002/(SICI)1096-9071(199901)57:1&lt;1::AID-JMV1&gt;3.0.CO;2-T
   Hunsperger EA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003171
   Iyngkaran N., 1995, Singapore Medical Journal, V36, P218
   Jeewandara C, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003459
   Jeffers SA, 2002, J VIROL, V76, P12463, DOI 10.1128/JVI.76.24.12463-12472.2002
   Jiang L, 2010, VIRUS RES, V150, P49, DOI 10.1016/j.virusres.2010.02.012
   Nguyen-Pouplin J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001282
   Flores-Mendoza LK, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/5197592
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Kawai N, 2009, CLIN INFECT DIS, V48, P996, DOI 10.1086/597360
   King CA, 2002, J VIROL, V76, P8408, DOI 10.1128/JVI.76.16.8408-8419.2002
   KLIKS SC, 1989, AM J TROP MED HYG, V40, P444, DOI 10.4269/ajtmh.1989.40.444
   KUNO G, 1990, J MED VIROL, V32, P102, DOI 10.1002/jmv.1890320207
   KURANE I, 1994, ARCH VIROL, P59
   Kurane I, 1994, Curr Top Microbiol Immunol, V189, P93
   Kyle JL, 2007, J INFECT DIS, V195, P1808, DOI 10.1086/518007
   La Braga E, 2001, MEM I OSWALDO CRUZ, V96, P229, DOI 10.1590/S0074-02762001000200015
   Lai YC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07308-3
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Libraty DH, 2002, J INFECT DIS, V186, P1165, DOI 10.1086/343813
   Lin CF, 2005, J IMMUNOL, V174, P395, DOI 10.4049/jimmunol.174.1.395
   Lin CF, 2003, J MED VIROL, V69, P82, DOI 10.1002/jmv.10261
   Lin CF, 2002, J IMMUNOL, V169, P657, DOI 10.4049/jimmunol.169.2.657
   Lin CF, 2008, LAB INVEST, V88, P1079, DOI 10.1038/labinvest.2008.70
   Lin YS, 2011, EXP BIOL MED, V236, P515, DOI 10.1258/ebm.2011.010339
   Lindenbach BD, 1999, J VIROL, V73, P4611, DOI 10.1128/JVI.73.6.4611-4621.1999
   Lindenbach BD, 1997, J VIROL, V71, P9608, DOI 10.1128/JVI.71.12.9608-9617.1997
   Liu IJ, 2011, J BIOL CHEM, V286, P9726, DOI 10.1074/jbc.M110.170993
   Liu JY, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.87, 10.1038/nmicrobiol.2016.87]
   Lu H, 2013, MOL IMMUNOL, V54, P109, DOI 10.1016/j.molimm.2012.11.007
   Luik P, 2009, P NATL ACAD SCI USA, V106, P12712, DOI 10.1073/pnas.0905966106
   Mackenzie JM, 1996, VIROLOGY, V220, P232, DOI 10.1006/viro.1996.0307
   Madan V, 2015, VIRUSES-BASEL, V7, P4461, DOI 10.3390/v7082826
   Malavige GN, 2013, J CLIN VIROL, V58, P605, DOI 10.1016/j.jcv.2013.10.023
   Malavige GN, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-341
   MANDL CW, 1989, VIROLOGY, V173, P291, DOI 10.1016/0042-6822(89)90246-8
   MASON PW, 1989, VIROLOGY, V169, P354, DOI 10.1016/0042-6822(89)90161-X
   Masrinoul P, 2011, JPN J INFECT DIS, V64, P109
   MCCLOUD T G, 1970, Virology, V41, P569
   Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Modhiran N, 2017, IMMUNOL CELL BIOL, V95, P491, DOI 10.1038/icb.2017.5
   Modhiran N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3863
   Montserret R, 2010, J BIOL CHEM, V285, P31446, DOI 10.1074/jbc.M110.122895
   Muller DA, 2012, J GEN VIROL, V93, P771, DOI 10.1099/vir.0.039321-0
   Muylaert IR, 1996, VIROLOGY, V222, P159, DOI 10.1006/viro.1996.0406
   Nascimento EJM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006782
   Noisakran S, 2008, J GEN VIROL, V89, P2492, DOI 10.1099/vir.0.83620-0
   Ojha A, 2017, SCI REP-UK, V7, DOI 10.1038/srep41697
   Ousingsawat J, 2011, PFLUG ARCH EUR J PHY, V461, P579, DOI 10.1007/s00424-011-0947-0
   Pang T, 2007, IMMUNOL CELL BIOL, V85, P43, DOI 10.1038/sj.icb.7100008
   Paranavitane SA, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0570-8
   Paules CI, 2017, NEW ENGL J MED, V376, P1397, DOI 10.1056/NEJMp1702172
   Perera R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002584
   Pierson TC, 2013, FIELDS VIROLOGY, P747
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   PRYOR MJ, 1994, J GEN VIROL, V75, P1183, DOI 10.1099/0022-1317-75-5-1183
   Puerta-Guardo H, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005738
   Reitsma S, 2007, PFLUG ARCH EUR J PHY, V454, P345, DOI 10.1007/s00424-007-0212-8
   Ritchie JP, 2011, CLIN CANCER RES, V17, P1382, DOI 10.1158/1078-0432.CCR-10-2476
   Saez-Llorens X, 2017, LANCET INFECT DIS, V17, P615, DOI 10.1016/S1473-3099(17)30166-4
   SAHAPHONG S, 1980, Southeast Asian Journal of Tropical Medicine and Public Health, V11, P194
   SANGKAWIBHA N, 1984, AM J EPIDEMIOL, V120, P653, DOI 10.1093/oxfordjournals.aje.a113932
   Scaturro P, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005277
   SCHLESINGER JJ, 1987, J GEN VIROL, V68, P853, DOI 10.1099/0022-1317-68-3-853
   Schmid MA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005676
   Schneider BS, 2008, T ROY SOC TROP MED H, V102, P400, DOI 10.1016/j.trstmh.2008.01.024
   Selck FW, 2014, VECTOR-BORNE ZOONOT, V14, P824, DOI 10.1089/vbz.2013.1528
   Shepard DS, 2016, LANCET INFECT DIS, V16, P935, DOI 10.1016/S1473-3099(16)00146-8
   Shu PY, 2000, J MED VIROL, V62, P224, DOI 10.1002/1096-9071(200010)62:2&lt;224::AID-JMV14&gt;3.0.CO;2-C
   Shu PY, 2002, J CLIN MICROBIOL, V40, P1840, DOI 10.1128/JCM.40.5.1840-1844.2002
   Simon AY, 2015, BLOOD, V126, P378, DOI 10.1182/blood-2014-09-598029
   Somnuke P, 2011, VIROLOGY, V413, P253, DOI 10.1016/j.virol.2011.02.022
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   St John AL, 2013, ELIFE, V2, DOI 10.7554/eLife.00481
   Steidel M, 2012, J MED VIROL, V84, P490, DOI 10.1002/jmv.23204
   Suharti C, 2003, EUR CYTOKINE NETW, V14, P172
   Sun DS, 2007, J THROMB HAEMOST, V5, P2291, DOI 10.1111/j.1538-7836.2007.02754.x
   Suwarto S, 2017, J INFECT DIS, V215, P992, DOI 10.1093/infdis/jix041
   Syenina A, 2015, ELIFE, V4, DOI 10.7554/eLife.05291
   Tang THC, 2017, SCI REP-UK, V7, DOI 10.1038/srep46191
   Tang YL, 2017, AM J TROP MED HYG, V97, P1049, DOI 10.4269/ajtmh.17-0003
   Thiemmeca S, 2016, J IMMUNOL, V197, P4053, DOI 10.4049/jimmunol.1600323
   Tricou V, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001309
   Trung DT, 2010, CURR TOP MICROBIOL, V338, P57, DOI 10.1007/978-3-642-02215-9_5
   Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088
   TUCHINDA M, 1977, Southeast Asian Journal of Tropical Medicine and Public Health, V8, P80
   Valdes K, 2000, CLIN DIAGN LAB IMMUN, V7, P856, DOI 10.1128/CDLI.7.5.856-857.2000
   Volchkov VE, 1999, CURR TOP MICROBIOL, V235, P35
   Wan SB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089545
   Wan SW, 2017, J IMMUNOL, V199, P2834, DOI 10.4049/jimmunol.1601523
   Wan SW, 2008, AM J INFECT DIS, V4, P85, DOI 10.3844/ajidsp.2008.85.91
   Weinbaum S, 2007, ANNU REV BIOMED ENG, V9, P121, DOI 10.1146/annurev.bioeng.9.060906.151959
   Weiskopf D, 2015, J VIROL, V89, P120, DOI 10.1128/JVI.02129-14
   Weiskopf D, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00093
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   Wills BA, 2004, J INFECT DIS, V190, P810, DOI 10.1086/422754
   World Health Organization, 1997, DENG HAEM FEV DIAGN
   World Health Organization, 2017, UPD QUEST ANSW REL D
   World Health Organization and the Special Programme for Research and Training in Tropical Diseases (TDR), 2009, DENG GUID DIAGN TREA
   Ferreira RAX, 2015, ACTA TROP, V149, P138, DOI 10.1016/j.actatropica.2015.04.023
   Xu HY, 2006, ICAT 2006: 16TH INTERNATIONAL CONFERENCE ON ARTIFICIAL REALITY AND TELEXISTENCE - WORSHOPS, PROCEEDINGS, P1, DOI 10.1109/GLOCOM.2006.749
   Xu XY, 2016, EMBO J, V35, P2170, DOI 10.15252/embj.201695290
   Youn S, 2012, J VIROL, V86, P7360, DOI 10.1128/JVI.00157-12
   Young PR, 2000, J CLIN MICROBIOL, V38, P1053, DOI 10.1128/JCM.38.3.1053-1057.2000
   Yuan SY, 2010, REGULATION ENDOTHELI
   Zellweger RM, 2010, CELL HOST MICROBE, V7, P128, DOI 10.1016/j.chom.2010.01.004
NR 182
TC 20
Z9 20
U1 1
U2 6
PU ANNUAL REVIEWS
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0897 USA
SN 2327-056X
J9 ANNU REV VIROL
PY 2018
VL 5
BP 227
EP 253
DI 10.1146/annurev-virology-101416-041848
PG 27
WC Virology
SC Virology
GA BL1LF
UT WOS:000447826000011
PM 30044715
OA Green Accepted
DA 2020-07-08
ER

PT S
AU Maximova, OA
   Pletnev, AG
AF Maximova, Olga A.
   Pletnev, Alexander G.
BE Enquist, L
TI Flaviviruses and the Central Nervous System: Revisiting
   Neuropathological Concepts
SO ANNUAL REVIEW OF VIROLOGY, VOL 5
SE Annual Review of Virology
LA English
DT Article; Book Chapter
DE flaviviruses; CNS; neurotropism; viremia; CNS barriers; neuroinvasion;
   neuropathogenesis; immune response
ID WEST-NILE-VIRUS; TICK-BORNE ENCEPHALITIS; I INTERFERON RESPONSE;
   IMMUNE-RESPONSES; JAPANESE ENCEPHALITIS; VIRAL-INFECTIONS;
   OLFACTORY-BULB; BALANCED VIEW; SPINAL-CORD; BRAIN
AB Flaviviruses are major emerging human pathogens on a global scale. Some flaviviruses can infect the central nervous system of the host and therefore are regarded as neurotropic. The most clinically relevant classical neurotropic flaviviruses include Japanese encephalitis virus, West Nile virus, and tick-borne encephalitis virus. In this review, we focus on these flaviviruses and revisit the concepts of flaviviral neurotropism, neuropathogenicity, neuroinvasion, and resultant neuropathogenesis. We attempt to synthesize the current knowledge about interactions between the central nervous system and flaviviruses from the neuroanatomical and neuropathological perspectives and address some misconceptions and controversies. We hope that revisiting these neuropathological concepts will improve the understanding of flaviviral neuroinfections. This, in turn, may provide further guiding foundations for relevant studies of other emerging or geographically expanding flaviviruses with neuropathogenic potential, such as Zika virus and dengue virus, and pave the way for intelligent therapeutic strategies harnessing potentially beneficial, protective host responses to interfere with disease progression and outcome.
C1 [Maximova, Olga A.; Pletnev, Alexander G.] NIAID, Infect Dis Lab, NIH, Bethesda, MD 20892 USA.
RP Maximova, OA (corresponding author), NIAID, Infect Dis Lab, NIH, Bethesda, MD 20892 USA.
EM maximovao@niaid.nih.gov; apletnev@niaid.nih.gov
CR Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030
   Abbott NJ, 2002, J ANAT, V200, P629, DOI 10.1046/j.1469-7580.2002.00064.x
   Aguzzi A, 2013, SCIENCE, V339, P156, DOI 10.1126/science.1227901
   Albrecht P, 1968, Curr Top Microbiol Immunol, V43, P44
   Armah HB, 2007, BRAIN PATHOL, V17, P354, DOI 10.1111/j.1750-3639.2007.00080.x
   Bai FW, 2010, J INFECT DIS, V202, P1804, DOI 10.1086/657416
   Bardina SV, 2012, IMMUNOL RES, V54, P121, DOI 10.1007/s12026-012-8333-3
   Bechmann I, 2007, TRENDS IMMUNOL, V28, P5, DOI 10.1016/j.it.2006.11.007
   Biber K, 2014, GLIA, V62, P841, DOI 10.1002/glia.22654
   Binder GK, 2001, SCIENCE, V293, P303, DOI 10.1126/science.1059742
   Blakely PK, 2009, J NEUROPATH EXP NEUR, V68, P1061, DOI 10.1097/NEN.0b013e3181b8ba14
   BROADWELL RD, 1993, EXP NEUROL, V120, P245, DOI 10.1006/exnr.1993.1059
   Brown AN, 2007, VIROLOGY, V368, P422, DOI 10.1016/j.virol.2007.06.033
   Carrithers MD, 2014, HAND CLINIC, V123, P215, DOI 10.1016/B978-0-444-53488-0.00009-2
   Carty M, 2014, TRENDS IMMUNOL, V35, P79, DOI 10.1016/j.it.2013.10.012
   Chambers TJ, 2003, ADV VIRUS RES, V60, P273, DOI 10.1016/S0065-3527(03)60008-4
   Cheng ZQ, 2016, JOURNAL PRACT, V10, P744, DOI [10.1111/jnc.13062, 10.1080/17512786.2015.1063079]
   Cho H, 2012, VIRUSES-BASEL, V4, P3812, DOI 10.3390/v4123812
   Choi I, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006445
   Colonna M, 2017, ANNU REV IMMUNOL, V35, P441, DOI 10.1146/annurev-immunol-051116-052358
   CSERR HF, 1992, BRAIN PATHOL, V2, P269, DOI 10.1111/j.1750-3639.1992.tb00703.x
   Dai JF, 2008, J VIROL, V82, P4164, DOI 10.1128/JVI.02621-07
   Daniels BP, 2017, J CLIN INVEST, V127, P843, DOI 10.1172/JCI88720
   Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472
   Davis LE, 2006, ANN NEUROL, V60, P286, DOI 10.1002/ana.20959
   Diamond MS, 2012, TRENDS IMMUNOL, V33, P522, DOI 10.1016/j.it.2012.05.008
   Diamond MS, 2009, FRONT BIOSCI-LANDMRK, V14, P3024, DOI 10.2741/3432
   Diamond MS, 2003, VIRAL IMMUNOL, V16, P259, DOI 10.1089/088282403322396082
   Diniz JAP, 2006, AM J TROP MED HYG, V75, P691, DOI 10.4269/ajtmh.2006.75.691
   Dorrbecker B, 2010, TRAVEL MED INFECT DI, V8, P213, DOI 10.1016/j.tmaid.2010.05.010
   Dorries R, 2001, CURR TOP MICROBIOL, V253, P219
   Durrant DM, 2016, ACS CHEM NEUROSCI, V7, P464, DOI 10.1021/acschemneuro.6b00043
   Duvernoy HM, 2007, BRAIN RES REV, V56, P119, DOI 10.1016/j.brainresrev.2007.06.002
   Dyrna F, 2013, J NEUROIMMUNE PHARM, V8, P763, DOI 10.1007/s11481-013-9473-5
   Engelhardt B, 2005, TRENDS IMMUNOL, V26, P485, DOI 10.1016/j.it.2005.07.004
   Engelhardt B, 2016, ACTA NEUROPATHOL, V132, P317, DOI 10.1007/s00401-016-1606-5
   Engelhardt B, 2012, TRENDS IMMUNOL, V33, P579, DOI 10.1016/j.it.2012.07.004
   Faber HK, 1933, J EXP MED, V57, P933, DOI 10.1084/jem.57.6.933
   Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005
   Fernandez-Garcia MD, 2009, CELL HOST MICROBE, V5, P318, DOI 10.1016/j.chom.2009.04.001
   Fredericksen BL, 2014, J NEUROVIROL, V20, P113, DOI 10.1007/s13365-013-0180-z
   Galea I, 2007, TRENDS IMMUNOL, V28, P12, DOI 10.1016/j.it.2006.11.004
   Garcia M, 2017, EUR CYTOKINE NETW, V28, P41, DOI 10.1684/ecn.2017.0394
   Gelpi E, 2005, J NEUROPATH EXP NEUR, V64, P506, DOI 10.1093/jnen/64.6.506
   Gelpi E, 2006, J NEUROVIROL, V12, P322, DOI 10.1080/13550280600848746
   Gosztonyi G, 2001, CURR TOP MICROBIOL, V253, P1
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Graeber MB, 2010, SCIENCE, V330, P783, DOI 10.1126/science.1190929
   Griffin DE, 2003, NAT REV IMMUNOL, V3, P493, DOI 10.1038/nri1105
   Griffiths MJ, 2014, HAND CLINIC, V123, P561, DOI 10.1016/B978-0-444-53488-0.00026-2
   Guarner J, 2004, HUM PATHOL, V35, P983, DOI 10.1016/j.humpath.2004.04.008
   Gyure KA, 2009, J NEUROPATH EXP NEUR, V68, P1053, DOI 10.1097/NEN.0b013e3181b88114
   Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997
   Harling-Berg CJ, 1999, J NEUROIMMUNOL, V101, P111, DOI 10.1016/S0165-5728(99)00130-7
   HARRISON AK, 1982, EXP MOL PATHOL, V37, P292, DOI 10.1016/0014-4800(82)90043-0
   Hurrelbrink RJ, 2003, ADV VIRUS RES, V60, P1, DOI 10.1016/S0065-3527(03)60001-1
   Hussmann KL, 2013, J VIROL, V87, P2814, DOI 10.1128/JVI.02577-12
   Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9
   JOHNSON RT, 1985, ANN NEUROL, V18, P567, DOI 10.1002/ana.410180510
   Johnston LJ, 2000, J INVEST DERMATOL, V114, P560, DOI 10.1046/j.1523-1747.2000.00904.x
   Kalinke U, 2011, VIRULENCE, V2, P367, DOI 10.4161/viru.2.4.16138
   Kettenmann H, 2013, NEURON, V77, P10, DOI 10.1016/j.neuron.2012.12.023
   Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010
   Kimelberg HK, 2010, NEUROSCIENTIST, V16, P79, DOI 10.1177/1073858409342593
   Klein RS, 2008, TRENDS MOL MED, V14, P286, DOI 10.1016/j.molmed.2008.05.004
   Koyuncu OO, 2013, CELL HOST MICROBE, V13, P379, DOI 10.1016/j.chom.2013.03.010
   Kristensson K, 2011, NAT REV NEUROSCI, V12, P345, DOI 10.1038/nrn3029
   Krueger M, 2010, GLIA, V58, P1, DOI 10.1002/glia.20898
   Kurhade C, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0487-9
   Labuda M, 1996, VIROLOGY, V219, P357, DOI 10.1006/viro.1996.0261
   LaSala PR, 2010, CLIN LAB MED, V30, P221, DOI 10.1016/j.cll.2010.01.002
   Li F, 2015, J VIROL, V89, P5602, DOI 10.1128/JVI.00143-15
   Libbey JE, 2014, HAND CLINIC, V123, P225, DOI 10.1016/B978-0-444-53488-0.00010-9
   Lim PY, 2011, J VIROL, V85, P5197, DOI 10.1128/JVI.02692-10
   Lindenbach BD, 2013, FIELDS VIROLOGY, P712
   Lindqvist R, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0748-7
   Liou ML, 1998, CELL TISSUE RES, V293, P389, DOI 10.1007/s004410051130
   Louyeau A, 2015, TRENDS IMMUNOL, V36, P569, DOI 10.1016/j.it.2015.08.006
   Maximova OA, 2008, J VIROL, V82, P5255, DOI 10.1128/JVI.00172-08
   Maximova OA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004980
   Maximova OA, 2014, VACCINE, V32, P3187, DOI 10.1016/j.vaccine.2014.04.002
   Maximova OA, 2009, J HISTOCHEM CYTOCHEM, V57, P973, DOI 10.1369/jhc.2009.954180
   McMinn PC, 1996, VIROLOGY, V220, P414, DOI 10.1006/viro.1996.0329
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Mishra MK, 2007, NEUROCHEM INT, V50, P764, DOI 10.1016/j.neuint.2007.01.014
   MONATH TP, 1983, LAB INVEST, V48, P399
   MONATH TP, 1986, TOGAVIRIDAE FLAVIVIR, P375
   Morrey JD, 2008, J GEN VIROL, V89, P467, DOI 10.1099/vir.0.83345-0
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   Nagata N, 2015, J NEUROPATH EXP NEUR, V74, P250, DOI 10.1097/NEN.0000000000000166
   Nair S, 2015, CURR OPIN IMMUNOL, V36, P47, DOI 10.1016/j.coi.2015.06.011
   Nathanson N, 2014, HAND CLINIC, V123, P175, DOI 10.1016/B978-0-444-53488-0.00007-9
   Netland J, 2013, VIRUSES-BASEL, V5, P2573, DOI 10.3390/v5102573
   Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647
   NIR Y, 1965, BRIT J EXP PATHOL, V46, P443
   Omalu BI, 2003, BRAIN PATHOL, V13, P465, DOI 10.1111/j.1750-3639.2003.tb00477.x
   Owens T, 2008, J NEUROPATH EXP NEUR, V67, P1113, DOI 10.1097/NEN.0b013e31818f9ca8
   Palus M, 2017, VIROLOGY, V507, P110, DOI 10.1016/j.virol.2017.04.012
   Palus M, 2014, J GEN VIROL, V95, P2411, DOI 10.1099/vir.0.068411-0
   Pedrosa PBS, 2011, INT J INFECT DIS, V15, pE366, DOI 10.1016/j.ijid.2011.03.005
   Pierson TC, 2013, FIELDS VIROLOGY, P747
   Puccioni-Sohler M, 2015, ARQ NEURO-PSIQUIAT, V73, P698, DOI 10.1590/0004-282X20150074
   Quick ED, 2014, J VIROL, V88, P13005, DOI 10.1128/JVI.01994-14
   Quicke KM, 2013, VIRUSES-BASEL, V5, P2643, DOI 10.3390/v5112643
   Ransohoff RM, 2012, NAT REV IMMUNOL, V12, P623, DOI 10.1038/nri3265
   Ransohoff RM, 2012, J CLIN INVEST, V122, P1164, DOI 10.1172/JCI58644
   Ransohoff RM, 2003, NAT REV IMMUNOL, V3, P569, DOI 10.1038/nri1130
   Raper D, 2016, TRENDS NEUROSCI, V39, P581, DOI 10.1016/j.tins.2016.07.001
   Rock RB, 2004, CLIN MICROBIOL REV, V17, P942, DOI 10.1128/CMR.17.4.942-964.2004
   Ruzek D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020472
   Salinas S, 2010, NAT REV MICROBIOL, V8, P645, DOI 10.1038/nrmicro2395
   Samuel MA, 2007, P NATL ACAD SCI USA, V104, P17140, DOI 10.1073/pnas.0705837104
   Schwerk C, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00080
   Sejvar J. J., 2016, Emerging infections 10, P175
   Sejvar JJ, 2007, CLIN INFECT DIS, V44, P1617, DOI 10.1086/518281
   Sejvar JJ, 2014, VIRUSES-BASEL, V6, P606, DOI 10.3390/v6020606
   Sips GJ, 2012, REV MED VIROL, V22, P69, DOI 10.1002/rmv.712
   Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8
   Spector R, 2015, EXP NEUROL, V273, P57, DOI 10.1016/j.expneurol.2015.07.027
   Spector R, 2015, EXP NEUROL, V267, P78, DOI 10.1016/j.expneurol.2015.02.032
   Suen WW, 2014, VIRUSES-BASEL, V6, P2796, DOI 10.3390/v6072796
   Suthar MS, 2013, NAT REV MICROBIOL, V11, P115, DOI 10.1038/nrmicro2950
   Szretter KJ, 2009, J VIROL, V83, P9329, DOI 10.1128/JVI.00836-09
   Thongtan T, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/890586
   Trapp BD, 2007, GLIA, V55, P360, DOI 10.1002/glia.20462
   Tremblay ME, 2011, J NEUROSCI, V31, P16064, DOI 10.1523/JNEUROSCI.4158-11.2011
   Tremblay ME, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000527
   Tschen SI, 2006, EUR J IMMUNOL, V36, P603, DOI 10.1002/eji.200535123
   Turtle L, 2012, QJM-INT J MED, V105, P219, DOI 10.1093/qjmed/hcs013
   van Marle G, 2007, J VIROL, V81, P10933, DOI 10.1128/JVI.02422-06
   Vasek MJ, 2016, NATURE, V534, P538, DOI 10.1038/nature18283
   Verma S, 2010, VIROLOGY, V397, P130, DOI 10.1016/j.virol.2009.10.036
   Wake H, 2009, J NEUROSCI, V29, P3974, DOI 10.1523/JNEUROSCI.4363-08.2009
   Wang H, 2009, J NEUROVIROL, V15, P293, DOI 10.1080/13550280902973978
   Wang PH, 2008, J VIROL, V82, P8978, DOI 10.1128/JVI.00314-08
   Wang SH, 2008, J IMMUNOL, V181, P2084, DOI 10.4049/jimmunol.181.3.2084
   Wolburg H, 2010, ACTA NEUROPATHOL, V119, P75, DOI 10.1007/s00401-009-0627-8
   Yamada M, 2009, J COMP PATHOL, V141, P156, DOI 10.1016/j.jcpa.2009.04.006
NR 138
TC 12
Z9 12
U1 3
U2 8
PU ANNUAL REVIEWS
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0897 USA
SN 2327-056X
EI 2327-0578
J9 ANNU REV VIROL
PY 2018
VL 5
BP 255
EP 272
DI 10.1146/annurev-virology-092917-043439
PG 18
WC Virology
SC Virology
GA BL1LF
UT WOS:000447826000012
PM 30265628
DA 2020-07-08
ER

PT J
AU David, MR
   Garcia, GA
   Valle, D
   Maciel-de-Freitas, R
AF David, Mariana Rocha
   Garcia, Gabriela Azambuja
   Valle, Denise
   Maciel-de-Freitas, Rafael
TI Insecticide Resistance and Fitness: The Case of Four Aedes aegypti
   Populations from Different Brazilian Regions
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Article
ID ZIKA VIRUS; COSTS; EVOLUTION; GENETICS; HISTORY; GENES; COMPETITION;
   MUTATIONS; SURVIVAL; KDR
AB Background. Chemical control is still a major strategy to constrain vector density and mitigate pathogen transmission. However, insecticide overuse poses a high selective pressure, favouring the spread of resistance alleles in natural populations. In an insecticide-free environment, a fitness cost is expected in resistant insects when compared to susceptible counterparts. This study investigates whether insecticide resistance to an organophosphate (temephos) and a pyrethroid (deltamethrin) is associated with fitness traits in four Aedes aegypti wild populations sampled every three months over one year. Findings. We measured development time from larvae to adult, female survival, wing length, fecundity, and adult resistance to starvation in field insecticide resistant Ae. aegypti populations four times over a year. 'these results were confronted with resistance levels to temephos and deltamethrin and with potentially related mechanisms, including a kdr mutation in the pyrethroid target site. No differences in fitness cost were found after contrasting mosquitoes from the same population collected throughout a year, irrespective of differences in insecticide resistance levels. Additionally, significant differences were not observed among field populations. However, compared to the reference strain Rockefeller, field females survived significantly less. Moreover, larval development was equal or slower in three out of four field populations. In no case differences were evidenced in starvation tolerance, wing length, and fecundity. Conclusions. Overall, field resistant mosquitoes seemed to have a slight fitness disadvantage when compared with the Rockefeller susceptible strain which might represent a potential fitness cost of insecticide resistance. However, after comparing Ae. aegypti from the same population but sampled at different moments, or from different field populations, mosquito life-history traits varied independently of resistance ratios. 'the metabolic deviations necessary to overcome the adverse effects of insecticides may cause an energy trade-off that affects energy allocation and ultimately basic demands of insect biology. The extent of fitness cost due to insecticide resistance is critical information to delay the evolution of resistance in wild vector populations.
C1 [David, Mariana Rocha; Garcia, Gabriela Azambuja; Maciel-de-Freitas, Rafael] Fiocruz MS, Inst Oswaldo Cruz, Lab Mosquitos Transmissores Hematozoarios, Rio De Janeiro, Brazil.
   [Valle, Denise] Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Mol Flavivirus, Rio De Janeiro, Brazil.
   [Valle, Denise; Maciel-de-Freitas, Rafael] Inst Nacl Ciencia & Tecnol Entomol Mol, Rio De Janeiro, Brazil.
RP David, MR (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Mosquitos Transmissores Hematozoarios, Rio De Janeiro, Brazil.
EM maridavid@ioc.fiocruz.br
OI Rocha David, Mariana/0000-0003-1241-3585
FU Programa Nacional de Controle da Dengue/Ministerio da Saude (PNCD/MS);
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq),National Council for Scientific and Technological Development
   (CNPq); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do
   Rio de Janeiro (FAPERJ)Carlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ); Instituto Nacional de
   Ciencia e Tecnologia-Entomologia Molecular (INCT-EM)
FX This work was funded by Programa Nacional de Controle da
   Dengue/Ministerio da Saude (PNCD/MS), Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao Carlos Chagas
   Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), and
   Instituto Nacional de Ciencia e Tecnologia-Entomologia Molecular
   (INCT-EM). We would like to acknowledge the teams of the Health
   Secretaries from each one of the municipalities and states involved in
   the study: Santarem/PA, Parnamirim/RN, Duque de Caxias/RJ, and Campo
   Grande/MS; all the public health personnel that worked with us in each
   municipality; the technical assistance of professionals fromthe
   Laboratorio de Mosquitos Transmissores de Hematozoarios and Laboratorio
   de Fisiologia e Controle de Artropodes Vetores, in particular, Valdice
   Paula, Rafael Guedes, and Gilberto Couto Alcantara; and Claudia Codeco
   and Claudio Struchiner for statistical analysis support. English
   revision was made by Mitchell Raymond Lishon, Native of Chicago,
   Illinois, USA, UCLA, 1969.
CR Agnew P, 2002, ECOL ENTOMOL, V27, P396, DOI 10.1046/j.1365-2311.2002.00430.x
   Alvarez-Gonzalez LC, 2017, PEST MANAG SCI, V73, P2287, DOI 10.1002/ps.4609
   Diniz DFA, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1276-5
   Belinato TA, 2012, MEM I OSWALDO CRUZ, V107, P916, DOI 10.1590/S0074-02762012000700013
   Bellinato DF, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/8603263
   Berticat C, 2002, GENET RES, V79, P41, DOI 10.1017/S001667230100547X
   Berticat C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-104
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Linss JGB, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-25
   Bourguet D, 2004, EVOLUTION, V58, P128, DOI 10.1111/j.0014-3820.2004.tb01579.x
   Braga I. A., 2007, EPIDEMIOLOGIA SERVIC, V16
   Brito LP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060878
   BUSVINE JR, 1951, NATURE, V168, P193, DOI 10.1038/168193a0
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   CARRIERE Y, 1994, P ROY SOC B-BIOL SCI, V258, P35, DOI 10.1098/rspb.1994.0138
   Charlwood JD, 2003, WAG UR FRON, V2, P47
   Chediak M, 2016, MEM I OSWALDO CRUZ, V111, P311, DOI 10.1590/0074-02760150409
   Chevillon C, 1999, BIOL J LINN SOC, V68, P147, DOI 10.1111/j.1095-8312.1999.tb01163.x
   Chevillon C, 1997, GENET RES, V70, P195, DOI 10.1017/S0016672397003029
   Codeco CT, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003475
   Consoli R.A.G.B., 1994, PRINCIPAIS MOSQUITOS
   Coustau C, 2000, TRENDS ECOL EVOL, V15, P378, DOI 10.1016/S0169-5347(00)01929-7
   CROW JF, 1957, ANNU REV ENTOMOL, V2, P227, DOI 10.1146/annurev.en.02.010157.001303
   Djogbenou L, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-12
   FAY R. W., 1966, MOSQUITO NEWS, V26, P531
   Fernandes RS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004993
   Focks D. A., REV ENTOMOLOGICAL SA, V2003
   Garcia GD, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006227
   Grossman MK, 2018, BIOL LETTERS, V14, DOI 10.1098/rsbl.2018.0022
   Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018
   HOFFMANN F, 1992, J MOL BIOL, V223, P17, DOI 10.1016/0022-2836(92)90710-2
   Jaramillo-O N., 2014, PLOS ONE, V9
   Kliot A, 2012, PEST MANAG SCI, V68, P1431, DOI 10.1002/ps.3395
   Kuno G, 2010, J MED ENTOMOL, V47, P957, DOI 10.1603/ME10152
   Leisnham PT, 2008, J MED ENTOMOL, V45, P210, DOI 10.1603/0022-2585(2008)45[210:GVIASA]2.0.CO;2
   Lenormand T, 1999, NATURE, V400, P861, DOI 10.1038/23685
   Lima JBP, 2003, AM J TROP MED HYG, V68, P329, DOI 10.4269/ajtmh.2003.68.329
   Maciel-de-Freitas R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092424
   MALLET J, 1989, TRENDS ECOL EVOL, V4, P336, DOI 10.1016/0169-5347(89)90088-8
   Marcombe S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-494
   Martinez-Torres D, 1998, INSECT MOL BIOL, V7, P179, DOI 10.1046/j.1365-2583.1998.72062.x
   Martins Ademir Jesus, 2013, Evolution Medicine and Public Health, P148, DOI 10.1093/emph/eot012
   Martins AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031889
   Melo-Santos MAV, 2010, ACTA TROP, V113, P180, DOI 10.1016/j.actatropica.2009.10.015
   Ministerio da Saude, SIST INF AGR NOT SIN
   Ministerio da Saude Secretaria de Vigilancia em Saude, 2017, B EPIDEMIOL, V48, P1, DOI DOI 10.5588/IJTLD.11.0170
   Miyo T, 2000, GENES GENET SYST, V75, P97, DOI 10.1266/ggs.75.97
   Montella IR, 2007, AM J TROP MED HYG, V77, P467, DOI 10.4269/ajtmh.2007.77.467
   Montella IR, 2012, MEM I OSWALDO CRUZ, V107, P437, DOI 10.1590/S0074-02762012000400001
   Moyes C. L., 2017, DISEASES, V11
   NASCI RS, 1986, J AM MOSQUITO CONTR, V2, P61
   Oehler E, 2014, EUROSURVEILLANCE, V19, P4
   Pan American Health Organization, 2016, NUMB REP CAS CHIK FE
   Garcia GP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000531
   R R Development Core Team, 2011, R LANG ENV STAT COMP
   Rivero A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001000
   ROUSH RT, 1987, ANNU REV ENTOMOL, V32, P361, DOI 10.1146/annurev.en.32.010187.002045
   Schechtman H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123961
   Severson DW, 1997, J HERED, V88, P520, DOI 10.1093/oxfordjournals.jhered.a023148
   Suman DS, 2011, MED VET ENTOMOL, V25, P276, DOI 10.1111/j.1365-2915.2010.00939.x
   Tun-Lin W, 2000, MED VET ENTOMOL, V14, P31, DOI 10.1046/j.1365-2915.2000.00207.x
   Vega-Rua A, 2014, J VIROL, V88, P6294, DOI 10.1128/JVI.00370-14
   WHO, 1998, TEST PROC INS RES MO
   World Health Organization, 1981, DIV VECT BIOL CONTR
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 66
TC 3
Z9 3
U1 0
U2 2
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2018
VL 2018
AR 6257860
DI 10.1155/2018/6257860
PG 12
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA GX6SV
UT WOS:000447894000001
PM 30402487
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Kim, K
AF Kim, Kenneth
TI Seroconversion does not a reservoir host make: No scientific proof to
   date that dogs are a reservoir for Zika virus
SO CANADIAN VETERINARY JOURNAL-REVUE VETERINAIRE CANADIENNE
LA English
DT Editorial Material
C1 [Kim, Kenneth] SDx Histopathol, Carlsbad, CA 92013 USA.
RP Kim, K (corresponding author), SDx Histopathol, Carlsbad, CA 92013 USA.
EM sdxpath@gmail.com
CR ASPCA, 2017, PET STAT
   Blanning TC, 2016, FREDERICK GREAT KING
   Byron GG, 1808, EPITAPH TO A DOG
   CDC, 2016, ZIK AN
   Darwin C., 1909, ORIGIN SPECIES
   Go YY, 2014, CLIN EXP VACCINE RES, V3, P58, DOI 10.7774/cevr.2014.3.1.58
   Haydon DT, 2002, EMERG INFECT DIS, V8, P1468
   Joob B, 2017, ASIAN PAC J TROP MED, V10, P199, DOI 10.1016/j.apjtm.2017.01.011
   Narayan P., 2012, TIMES INDIA
   ONeill E., 1988, BLEMIES WILL LAST WI
   Scott W., 2005, THE TALISMAN
   Vest GG, 1870, C REC, V101, pS4823
NR 12
TC 1
Z9 1
U1 0
U2 0
PU CANADIAN VET MED ASSOC
PI OTTAWA
PA 339 BOOTH ST, OTTAWA, ONTARIO K1R 7K1, CANADA
SN 0008-5286
EI 1928-9022
J9 CAN VET J
JI Can. Vet. J.-Rev. Vet. Can.
PD JAN
PY 2018
VL 59
IS 1
BP 93
EP 93
PG 1
WC Veterinary Sciences
SC Veterinary Sciences
GA GX6AX
UT WOS:000447839900015
PM 29302110
DA 2020-07-08
ER

PT J
AU Campos, TD
   Duraes-Carvalho, R
   Rezende, AM
   de Carvalho, OV
   Kohl, A
   Wallau, GL
   Pena, LJ
AF Campos, Tulio De Lima
   Duraes-Carvalho, Ricardo
   Rezende, Antonio Mauro
   de Carvalho, Otavio Valerio
   Kohl, Alain
   Wallau, Gabriel Luz
   Pena, Lindomar Jose
TI Revisiting Key Entry Routes of Human Epidemic Arboviruses into the
   Mainland Americas through Large-Scale Phylogenomics
SO INTERNATIONAL JOURNAL OF GENOMICS
LA English
DT Article
ID ZIKA VIRUS; MOLECULAR EVOLUTION; DENGUE VIRUSES; PHYLOGEOGRAPHY;
   TRANSMISSION; ACCURATE; TYPE-2; HAITI
AB The rapid worldwide spread of chikungunya (CHIKV), dengue (DENV), and Zika (ZIKV) viruses have raised great international concern. Knowledge about the entry routes and geographic expansion of these arboviruses to the mainland Americas remain incomplete and controversial. Epidemics caused by arboviruses continue to cause socioeconomic burden globally, particularly in countries where vector control is difficult due to climatic or infrastructure factors. Understanding how the virus circulates and moves from one country to another is of paramount importance to assist government and health officials in anticipating future epidemics, as well as to take steps to help control or mitigate the spread of the virus. Through the analyses of the sequences of arbovirus genomes collected at different locations over time, we identified patterns of accumulated mutations, being able to trace routes of dispersion of these viruses. Here, we applied robust phylogenomic methods to trace the evolutionary dynamics of these arboviruses with special focus on Brazil, the epicenter of these triple epidemics. Our results show that CHIKV, DENV-1-4, and ZIKV followed a similar path prior to their first introductions into the mainland Americas, underscoring the need for systematic arboviral surveillance at major entry points of human population movement between countries such as airports and seaports.
C1 [Campos, Tulio De Lima] Oswaldo Cruz Fdn FIOCRUZ, Aggeu Magalhaes Inst IAM, Bioinformat Core Facil, Recife, PE, Brazil.
   [Duraes-Carvalho, Ricardo; de Carvalho, Otavio Valerio; Pena, Lindomar Jose] Oswaldo Cruz Fdn FIOCRUZ, Aggeu Magalhaes Inst IAM, Dept Virol, Recife, PE, Brazil.
   [Rezende, Antonio Mauro] Oswaldo Cruz Fdn FIOCRUZ, Aggeu Magalhaes Inst IAM, Dept Microbiol, Recife, PE, Brazil.
   [Kohl, Alain] Univ Glasgow, MRC, Ctr Virus Res, Glasgow G61 1QH, Lanark, Scotland.
   [Kohl, Alain] Univ Glasgow, MRC, Ctr Virus Res, Glasgow, Lanark, Scotland.
   [Wallau, Gabriel Luz] Oswaldo Cruz Fdn FIOCRUZ, Aggeu Magalhaes Inst IAM, Dept Entomol, Recife, PE, Brazil.
RP Pena, LJ (corresponding author), Oswaldo Cruz Fdn FIOCRUZ, Aggeu Magalhaes Inst IAM, Dept Virol, Recife, PE, Brazil.; Wallau, GL (corresponding author), Oswaldo Cruz Fdn FIOCRUZ, Aggeu Magalhaes Inst IAM, Dept Entomol, Recife, PE, Brazil.
EM gabriel.wallau@cpqam.fiocruz.br; lindomarvet10@gmail.com
RI Wallau, Gabriel Luz/B-5911-2008; de Lima Campos, Tulio/N-5204-2018;
   Rezende, Antonio Mauro/S-2126-2018
OI Wallau, Gabriel Luz/0000-0002-1419-5713; de Lima Campos,
   Tulio/0000-0003-0446-848X; Rezende, Antonio Mauro/0000-0003-4775-1779
FU Pernambuco State Research Foundation (FACEPE) [APQ-0154-2.12/16,
   APQ-1776-2.12/15, APQ-0078-2.02/16, DCR-0026-2.12/16]; National Counsel
   of Technological and Scientific Development (CNPq)National Council for
   Scientific and Technological Development (CNPq) [300700/2016-4]; UK
   Medical Research CouncilMedical Research Council UK (MRC) [MC_UU_12014,
   MR/N017552/1]
FX This work was supported by the following Brazilian agencies: the
   Pernambuco State Research Foundation (FACEPE, Grant nos.
   APQ-0154-2.12/16; APQ-1776-2.12/15, APQ-0078-2.02/16, and
   DCR-0026-2.12/16), the National Counsel of Technological and Scientific
   Development (CNPq, Process no. 300700/2016-4), and by the UK Medical
   Research Council (MC_UU_12014 and MR/N017552/1).
CR Allicock OM, 2012, MOL BIOL EVOL, V29, P1533, DOI 10.1093/molbev/msr320
   Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453
   Araujo JMG, 2009, INFECT GENET EVOL, V9, P716, DOI 10.1016/j.meegid.2008.10.005
   Baele G, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-85
   Baele G, 2013, MOL BIOL EVOL, V30, P239, DOI 10.1093/molbev/mss243
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Beltran-Silva S. L., 2018, REV MED HOSP GEN MEX, V81, P146, DOI [10.1016/j.hgmx.2016.09.011, DOI 10.1016/J.HGMX.2016.09.011]
   Best SM, 2016, CURR BIOL, V26, pR1258, DOI 10.1016/j.cub.2016.09.029
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bouckaert R. R., 2014, DENSITREE 2 SEEING T
   Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   CAREY D E, 1971, Journal of the History of Medicine and Allied Sciences, V26, P243
   Carrington CVF, 2005, J VIROL, V79, P14680, DOI 10.1128/JVI.79.23.14680-14687.2005
   Centers for Disease Control and Prevention, 2016, ALL COUNTR TERR ACT
   Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109
   de Bruycker-Nogueira F, 2016, INFECT GENET EVOL, V45, P454, DOI 10.1016/j.meegid.2016.09.025
   de Melo FL, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000390
   Dick OB, 2012, AM J TROP MED HYG, V87, P584, DOI 10.4269/ajtmh.2012.11-0770
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Ernst T, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003442
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Foster JE, 2004, VIROLOGY, V324, P48, DOI 10.1016/j.virol.2004.03.020
   Francisco AP, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-152
   de Araujo JMG, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001784
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Gong Z, 2016, TRENDS MICROBIOL, V24, P521, DOI 10.1016/j.tim.2016.05.002
   Guzman MG, 2003, J CLIN VIROL, V27, P1, DOI 10.1016/S1386-6532(03)00010-6
   Halstead SB, 2006, REV PANAM SALUD PUBL, V20, P407, DOI 10.1590/S1020-49892006001100007
   Huerta-Cepas J, 2016, MOL BIOL EVOL, V33, P1635, DOI 10.1093/molbev/msw046
   Iovine NM, 2017, CLIN INFECT DIS, V64, P72, DOI 10.1093/cid/ciw667
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Lednicky J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004687
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Mir D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098519
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Nascimento M, 2017, BIOINFORMATICS, V33, P128, DOI 10.1093/bioinformatics/btw582
   Patterson J, 2016, WEST J EMERG MED, V17, P671, DOI 10.5811/westjem.2016.9.30904
   Pickett BE, 2012, NUCLEIC ACIDS RES, V40, pD593, DOI 10.1093/nar/gkr859
   Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490
   Rawlinson T, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002685
   RICOHESSE R, 1990, VIROLOGY, V174, P479, DOI 10.1016/0042-6822(90)90102-W
   Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180
   Rupp JC, 2015, J GEN VIROL, V96, P2483, DOI 10.1099/jgv.0.000249
   Salvador FS, 2016, TRAVEL MED INFECT DI, V14, P49, DOI 10.1016/j.tmaid.2015.10.004
   Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502
   Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Wilder-Smith A, 2017, LANCET INFECT DIS, V17, P1109, DOI 10.1016/S1473-3099(17)30494-2
   YOSHIHARA T, 1995, EUR ARCH OTO-RHINO-L, V252, P106
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 56
TC 6
Z9 6
U1 0
U2 0
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2314-436X
EI 2314-4378
J9 INT J GENOMICS
JI Int. J. Genomics
PY 2018
AR 6941735
DI 10.1155/2018/6941735
PG 9
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Genetics & Heredity
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Genetics & Heredity
GA GX6WF
UT WOS:000447903500001
PM 30402454
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Rocha, AMD
   de Mello, MJG
   Torres, JRD
   Valenca, ND
   Maia, ACD
   Cavalcanti, NV
AF de Oliveira Rocha, Aline Maria
   Goncalves de Mello, Maria Julia
   Dias Torres, Juliane Roberta
   Valenca, Natalia de Oliveira
   de Azevedo Maia, Alessandra Costa
   Cavalcanti, Nara Vasconcelos
TI Palliative Care in Congenital Syndrome of the Zika Virus Associated with
   Hospitalization and Emergency Consultation: Palliative Care and
   Congenital Syndrome of Zika
SO JOURNAL OF TROPICAL MEDICINE
LA English
DT Article
ID BRAZIL
AB Background. Congenital syndrome of Zika virus (CSZV) is associated with neuromotor and cognitive developmental disorders, limiting the independence and autonomy of affected children and high susceptibility to complications, so palliative care needs to be discussed and applied. Aim. To identify factors associated with emergency visits and hospitalizations of patients with CSZV and clinical interventions performed from the perspective of palliative care. Design. This is a cross-sectional study with bidirectional longitudinal component. Data were collected between May and October 2017 through the review of medical records and interviews with relatives of patients hospitalized. Setting/Participants. The study was developed in a tertiary care hospital involving patients with confirmed CSZV born as of August 2015 and followed up until October 2017. Patients under investigation were excluded. Results. 145 patients were followed up at the specialized outpatient clinic, 92 (63.5%) were consulted at least once in the emergency room, and 49% had already been hospitalized, with the main reason being neurological causes, while 24.1% had never required any emergency visit or hospitalization. No risk factors were associated with the occurrence of consultations or hospitalizations. Such events happened at an early age and were accompanied by a high number of invasive procedures and interventions. An approach in palliative care was only identified in two hospitalized patients. Conclusions. For the patient with known severe malformations caused by congenital infection by the Zika virus with indication of palliative care, this approach could be used in order to allow life without suffering and disproportionate invasive method.
C1 [de Oliveira Rocha, Aline Maria; Goncalves de Mello, Maria Julia; Dias Torres, Juliane Roberta; Valenca, Natalia de Oliveira; de Azevedo Maia, Alessandra Costa] Inst Integral Med Prof Fernando Figueira, Recife, PE, Brazil.
   [Cavalcanti, Nara Vasconcelos] Univ Pernambuco, Inst Integral Med Prof Fernando Figueira, Recife, PE, Brazil.
RP Rocha, AMD (corresponding author), Inst Integral Med Prof Fernando Figueira, Recife, PE, Brazil.
EM line_rocha90@hotmail.com
CR Alves Lucas Victor, 2016, Rev. Bras. Saude Mater. Infant., V16, pS27, DOI 10.1590/1806-9304201600s100003
   Alvino Ana Catarina Matos Ishigami, 2016, Rev. Bras. Saude Mater. Infant., V16, pS83, DOI 10.1590/1806-9304201600s100007
   [Anonymous], 2017, CONGENITAL SYNDROME
   [Anonymous], 2017, FORG UNPR IMP ZIK VI
   Aragao MFVV, 2017, AM J NEURORADIOL, V38, P1427, DOI 10.3174/ajnr.A5216
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Botelho Ana Carla Gomes, 2016, Rev. Bras. Saude Mater. Infant., V16, P39, DOI 10.1590/1806-9304201600s100004
   Brazil: Ministry of Health, 2017, INT GUID SURV HLTH C
   Carvalho R.T., 2012, MANUAL PALLIATIVE CA
   Chambers L., 2003, GUIDE DEV CHILDRENS
   Chanes I.R., 2016, CADERNOS IBEROAMERIC, V5, P56
   del Campo M, 2017, AM J MED GENET A, V173, P841, DOI 10.1002/ajmg.a.38170
   Di Cavalcanti D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175065
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Iglesias S., 2016, RESIDENCIA PEDIAT, V6, P46
   Lopez-Camelo J. S., 2015, DOCUMENT ECLAMC FINA
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Ministry of Health Secretariat of Health Surveillance Department of Surveillance of Communicable Diseases, 2015, SURV PROT RESP OCC M
   Neta T.J.C., 2016, REV BRASILEIRA SAUDE, V16, P17
   Pan American Health Organization, 2015, EP AL NEUR SYNDR CON
   Pernambuco State Secretariat of Health of Pernambuco Executive Secretariat of Health Surveillance, 2015, CLIN EP PROT INV CAS
   Pernambuco State Secretariat of Health of Pernambuco Executive Secretariat of Health Surveillance, 2015, CLIN EP PROT INV MIC
   Petribu N.C., 2017, BMJ-BRIT MED J, V359, P1
   Possas C, 2017, MEM I OSWALDO CRUZ, V112, P319, DOI 10.1590/0074-02760160510
   Schaub B, 2017, LANCET INFECT DIS, V17, P520, DOI [10.1016/S1473-3099(17)30102-0, 10.1016/s1473-3099(17)30102-0]
   Souza A.S.R., 2016, REV BRASILEIRA SAUDE, V16, P475
   Teixeira MG, 2016, AM J PUBLIC HEALTH, V106, P601, DOI 10.2105/AJPH.2016.303113
   WHO, 2014, US BIRTH DEF SURV MA
NR 28
TC 0
Z9 0
U1 0
U2 0
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1687-9686
EI 1687-9694
J9 J TROP MED-US
JI J. Trop. Med.
PY 2018
VL 2018
AR 1025193
DI 10.1155/2018/1025193
PG 8
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA GX7BF
UT WOS:000447918400001
PM 30405727
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Jakubiec-Krzesniak, K
   Rajnisz-Mateusiak, A
   Guspiel, A
   Ziemska, J
   Solecka, J
AF Jakubiec-Krzesniak, Katarzyna
   Rajnisz-Mateusiak, Aleksandra
   Guspiel, Adam
   Ziemska, Joanna
   Solecka, Jolanta
TI Secondary Metabolites of Actinomycetes and their Antibacterial,
   Antifungal and Antiviral Properties
SO POLISH JOURNAL OF MICROBIOLOGY
LA English
DT Review
DE bioactive; secondary metabolites; actinomycetes; antibacterial activity;
   Streptomyces sp.
ID MARINE-DERIVED ACTINOMYCETE; ATACAMA DESERT SOIL; STREPTOMYCES SP; A-C;
   NATURAL-PRODUCTS; SPIROTETRONATE ANTIBIOTICS; STAPHYLOCOCCUS-AUREUS;
   EMENDED DESCRIPTION; RARE ACTINOMYCETE; ZIKA VIRUS
AB The growing resistance of microorganisms towards antibiotics has become a serious global problem. Therapeutics with novel chemical scaffolds and/or mechanisms of action are urgently needed to combat infections caused by multidrug resistant pathogens, including bacteria, fungi and viruses. Development of novel antimicrobial agents is still highly dependent on the discovery of new natural products. At present, most antimicrobial drugs used in medicine are of natural origin. Among the natural producers of bioactive substances, Actinobacteria continue to be an important source of novel secondary metabolites for drug application. In this review, the authors report on the bioactive antimicrobial secondary metabolites of Actinobacteria that were described between 2011 and April 2018. Special attention is paid to the chemical scaffolds, biological activities and origin of these novel antibacterial, antifungal and antiviral compounds. Arenimycin C, chromopeptide lactone RSP 01, kocurin, macrolactins A1 and B1, chaxamycin D as well as anthracimycin are regarded as the most effective compounds with antibacterial activity. In turn, the highest potency among selected antifungal compounds is exhibited by enduspeptide B, neomaclafungins A-I and kribelloside D, while ahmpatinin Bu-i, antimycin A1a, and pentapeptide 4862F are recognized as the strongest antiviral agents.
C1 [Jakubiec-Krzesniak, Katarzyna; Rajnisz-Mateusiak, Aleksandra; Guspiel, Adam; Ziemska, Joanna; Solecka, Jolanta] Natl Inst Hyg, Natl Inst Publ Hlth, Dept Environm Hlth & Safety, Warsaw, Poland.
RP Solecka, J (corresponding author), Natl Inst Hyg, Natl Inst Publ Hlth, Dept Environm Hlth & Safety, Warsaw, Poland.
EM jsolecka@pzh.gov.pl
RI Guspiel, Adam/N-7978-2017
OI Guspiel, Adam/0000-0003-1960-7497; Solecka, Jolanta/0000-0002-6052-3423
FU National Institute of Public Health - National Institute of Hygiene
   [17/ZS]
FX This work was supported by the National Institute of Public Health -
   National Institute of Hygiene in the frame of project No 17/ZS.
CR Abdelfattah MS, 2016, CHEM PHARM BULL, V64, P668, DOI 10.1248/cpb.c16-00038
   Abdelkader MSA, 2018, J ANTIBIOT, V71, P425, DOI 10.1038/s41429-017-0012-0
   Bae M, 2015, ORG LETT, V17, P712, DOI 10.1021/ol5037248
   Baltz RH, 2011, J IND MICROBIOL BIOT, V38, P657, DOI 10.1007/s10295-010-0934-z
   Barka EA, 2016, MICROBIOL MOL BIOL R, V80, P1, DOI 10.1128/MMBR.00019-15
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Blazquez Ana-Belen, 2016, World J Virol, V5, P135
   Bruntner C, 2005, J ANTIBIOT, V58, P346, DOI 10.1038/ja.2005.43
   Butler MS, 2017, J ANTIBIOT, V70, P3, DOI 10.1038/ja.2016.72
   Carlson S, 2015, J NAT PROD, V78, P381, DOI 10.1021/np500767u
   Chater Keith F, 2016, F1000Res, V5, P2795
   Chen CX, 2013, APPL MICROBIOL BIOT, V97, P3885, DOI 10.1007/s00253-012-4681-0
   Chen MH, 2018, RSC ADV, V8, P5138, DOI 10.1039/c7ra13241g
   Chen Y, 2017, TETRAHEDRON, V73, P527, DOI 10.1016/j.tet.2016.12.033
   Cheng C, 2016, TETRAHEDRON LETT, V57, P2786, DOI 10.1016/j.tetlet.2016.05.042
   Cruz JCS, 2017, J ANTIBIOT, V70, P73, DOI 10.1038/ja.2016.62
   Cumsille A, 2017, MAR DRUGS, V15, DOI 10.3390/md15090286
   Dalisay DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077078
   Fabricio M., 2016, METALLOMICS, V8, P469
   Goodfellow M, 2017, ANTON LEEUW INT J G, V110, P1133, DOI 10.1007/s10482-017-0886-7
   Guo X, 2015, APPL ENVIRON MICROB, V81, P3086, DOI 10.1128/AEM.03859-14
   Hashizume H, 2017, J ANTIBIOT, V70, P699, DOI 10.1038/ja.2017.34
   Hassan HM, 2015, J ANTIBIOT, V68, P206, DOI 10.1038/ja.2014.122
   Hensler ME, 2014, J ANTIBIOT, V67, P549, DOI 10.1038/ja.2014.36
   Hou JB, 2012, J ANTIBIOT, V65, P523, DOI 10.1038/ja.2012.61
   Idris H, 2017, ANTON LEEUW INT J G, V110, P705, DOI 10.1007/s10482-017-0838-2
   Igarashi M, 2017, J ANTIBIOT, V70, P582, DOI 10.1038/ja.2016.161
   Igarashi Y, 2012, J ANTIBIOT, V65, P355, DOI 10.1038/ja.2012.30
   Igarashi Y, 2011, J NAT PROD, V74, P670, DOI 10.1021/np100727h
   Jang KH, 2013, ANGEW CHEM INT EDIT, V52, P7822, DOI 10.1002/anie.201302749
   Jiang ZK, 2015, J ANTIBIOT, V68, P771, DOI 10.1038/ja.2015.70
   Kang HS, 2014, J AM CHEM SOC, V136, P18111, DOI 10.1021/ja510606j
   Khalil ZG, 2017, J ANTIBIOT, V70, P1097, DOI 10.1038/ja.2017.119
   Kim SH, 2016, J NAT PROD, V79, P51, DOI 10.1021/acs.jnatprod.5b00634
   Komaki Hisayuki, 2015, BMC Res Notes, V8, P548, DOI 10.1186/s13104-015-1526-9
   Lacret R, 2015, MAR DRUGS, V13, P128, DOI 10.3390/md13010128
   Latha S, 2017, CRIT REV MICROBIOL, V43, P567, DOI 10.1080/1040841X.2016.1271308
   Lee LH, 2012, WORLD J MICROB BIOT, V28, P2125, DOI 10.1007/s11274-012-1018-1
   Li SM, 2011, MAR DRUGS, V9, P1428, DOI 10.3390/md9081428
   Lin ZJ, 2014, J ANTIBIOT, V67, P121, DOI 10.1038/ja.2013.115
   Liu LL, 2012, MAR DRUGS, V10, P2571, DOI 10.3390/md10112571
   Liu X, 2013, MOLECULES, V18, P236, DOI 10.3390/molecules18010236
   Lu C, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0359-5
   Lu YH, 2017, MOLECULES, V22, DOI 10.3390/molecules22020251
   Mahajan G, 2013, ANTIMICROB AGENTS CH, V57, P5315, DOI 10.1128/AAC.01059-13
   Manivasagan P, 2014, MICROBIOL RES, V169, P262, DOI 10.1016/j.micres.2013.07.014
   Maxwell A, 2003, CURR TOP MED CHEM, V3, P283, DOI 10.2174/1568026033452500
   Medema MH, 2015, NAT CHEM BIOL, V11, P639, DOI [10.1038/NCHEMBIO.1884, 10.1038/nchembio.1884]
   Medema MH, 2011, NUCLEIC ACIDS RES, V39, pW339, DOI 10.1093/nar/gkr466
   Mondol MAM, 2014, MAR DRUGS, V12, P2913, DOI 10.3390/md12052913
   Moon K, 2015, J NAT PROD, V78, P524, DOI 10.1021/np500736b
   Newman DJ, 2016, J NAT PROD, V79, P629, DOI 10.1021/acs.jnatprod.5b01055
   Niu SW, 2011, J ANTIBIOT, V64, P711, DOI 10.1038/ja.2011.78
   Oh D, 2011, ORG LETT, V13, P15
   Onaka H, 2017, J ANTIBIOT, V70, P865, DOI 10.1038/ja.2017.51
   ONeill J., 2016, TACKLING DRUG RESIST
   Pan HQ, 2013, MAR DRUGS, V11, P3891, DOI 10.3390/md11103891
   Pascoalino Bruno S, 2016, F1000Res, V5, P2523
   Paulus C, 2017, SCI REP-UK, V7, DOI 10.1038/srep42382
   Phillips JW, 2011, CHEM BIOL, V18, P955, DOI 10.1016/j.chembiol.2011.06.011
   Qin ZW, 2017, CHEM SCI, V8, P3218, DOI 10.1039/c6sc04265a
   Rajnisz A, 2016, POL J MICROBIOL, V65, P51, DOI 10.5604/17331331.1197275
   Rao M, 2013, NAT PROD RES, V27, P2190, DOI 10.1080/14786419.2013.811661
   Rateb ME, 2011, J NAT PROD, V74, P1965, DOI 10.1021/np200470u
   Rateb ME, 2011, J NAT PROD, V74, P1491, DOI 10.1021/np200320u
   Rathod BB, 2018, APPL MICROBIOL BIOT, V102, P1241, DOI 10.1007/s00253-017-8696-4
   Rathore SS, 2016, RSC ADV, V6, P96250, DOI 10.1039/c6ra15952d
   Rausch K, 2017, CELL REP, V18, P804, DOI 10.1016/j.celrep.2016.12.068
   Raveh A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082318
   Riquelme C, 2017, APPL MICROBIOL BIOT, V101, P843, DOI 10.1007/s00253-016-7932-7
   Saiz JC, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00411-17, 10.1128/aac.00411-17]
   Sato S, 2012, J NAT PROD, V75, P1974, DOI 10.1021/np300719g
   Sawa R, 2018, J ANTIBIOT, V71, P91, DOI 10.1038/ja.2017.140
   Shin B, 2016, J NAT PROD, V79, P1886, DOI 10.1021/acs.jnatprod.6b00268
   Singh BP, 2018, NEW FUTURE DEV MICRO
   Singh SB, 2015, ANTIMICROB AGENTS CH, V59, P3474, DOI 10.1128/AAC.00382-15
   Solecka J, 2013, POSTEP MIKROBIOL, V52, P83
   Solecka J, 2012, CENT EUR J BIOL, V7, P373, DOI 10.2478/s11535-012-0036-1
   Song YX, 2013, J NAT PROD, V76, P2263, DOI 10.1021/np4006025
   Sun P, 2011, BIOORGAN MED CHEM, V19, P6557, DOI 10.1016/j.bmc.2011.06.053
   Thong WL, 2016, J NAT PROD, V79, P857, DOI 10.1021/acs.jnatprod.5b00922
   Um S, 2013, J ORG CHEM, V78, P12321, DOI 10.1021/jo401974g
   WHO, 2017, GLOB PRIOR LIST ANT
   Wink J., 2017, BIOL BIOTECHNOLOGY A
   World Health Organization, 2014, ANT RES GLOB REP SUR
   Wu ZC, 2013, MAR DRUGS, V11, P2113, DOI 10.3390/md11062113
   Xin WX, 2012, MAR DRUGS, V10, P2388, DOI 10.3390/md10112388
   Xu JH, 2017, J ANTIBIOT, V70, P733, DOI 10.1038/ja.2017.37
   Yang JY, 2016, J ANTIBIOT, V69, P62, DOI 10.1038/ja.2015.76
   Yu LK, 2014, J NAT PROD, V77, P976, DOI 10.1021/np401071x
   Zhang HY, 2012, FEMS MICROBIOL LETT, V332, P105, DOI 10.1111/j.1574-6968.2012.02582.x
   Ziemska J, 2013, CENT EUR J BIOL, V8, P943, DOI 10.2478/s11535-013-0209-6
   Zotchev SB, 2012, J BIOTECHNOL, V158, P168, DOI 10.1016/j.jbiotec.2011.06.002
NR 93
TC 6
Z9 6
U1 6
U2 18
PU POLSKIE TOWARZYSTWO MIKROBIOLOGOW-POLISH SOCIETY OF MICROBIOLOGISTS
PI WARSAW
PA CHELMSKA STR 30-34, WARSAW, 00-725, POLAND
SN 1733-1331
J9 POL J MICROBIOL
JI Pol. J. Microbiol.
PY 2018
VL 67
IS 3
BP 259
EP 272
DI 10.21307/pjm-2018-048
PG 14
WC Microbiology
SC Microbiology
GA GW3LZ
UT WOS:000446808100002
PM 30451442
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Sultan, N
   Bukhari, SA
   Ali, I
   Asif, M
   Umar, Z
   Akash, MSH
AF Sultan, Neelam
   Bukhari, Shazia Anwer
   Ali, Irfan
   Asif, Muhammad
   Umar, Zunaira
   Akash, Muhammad Sajid Hamid
TI Zika Virus: A Critical Analysis and Pharmaceutical Perspectives
SO CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION
LA English
DT Article
DE Zika virus; transmission of Zika virus; pathogenesis of Zika virus;
   epidemiology of Zika virus
ID SEXUAL TRANSMISSION; INFECTION; BRAZIL; EPIDEMIOLOGY; CHIKUNGUNYA;
   EMERGENCE; HISTORY; BIOLOGY; VIREMIA; UPDATE
AB Zika virus belongs to family of viruses 'Flaviviridae' and spreads mostly by daytime-active Aedes mosquitoes. The resulting infection is known as Zika fever. It is usually asymptomatic or often causes mild symptoms, which are very similar to dengue fever. The Aedes aegypti mosquito is also responsible for dengue and chikungunya viruses. Zika virus can spread by crossing the placental barrier from a pregnant mother to a fetus, which can result in microcephaly, severe brain malformations including Guillain-Barre syndrome (GBS), and other birth defects. Until now, there is no specific treatment of Zika fever disease, and Zika virus illness cannot be prevented by medications or vaccines. According to WHO, no vaccine is likely to be available until 2020. The only way of preventing this disease is to prevent the mosquito bites. This article presents the history of Zika virus, its reported cases including microcephaly and GBS, and a comparison of its symptoms with those of dengue and chikungunya diseases, as well as preventive measures. With advances in research and technology, knowledge about the Zika virus has grown, yet some questions remain unanswered regarding Zika virus's genetic diversity, pathophysiology, transmission vectors and reservoirs, potential synergetic of coinfection with other related arboviruses, and treatment. These problems highlight the need for further research to achieve adequate the surveillance, infection management, optimized treatment, and public health mediations in Zika virus outbreaks. This article contributes to our understanding of the disease mechanism, genome structure, diagnosis, transmission, and preventive strategies to combat Zika virus infection.
C1 [Sultan, Neelam; Bukhari, Shazia Anwer; Umar, Zunaira] Govt Coll Univ Faisalabad, Dept Biochem, Faisalabad, Pakistan.
   [Ali, Irfan] Akhuwat Univ, Faisalabad Inst Res Sci & Technol, Faisalabad, Pakistan.
   [Asif, Muhammad] Baluchistan Univ Informat Technol Engn & Manageme, Dept Biotechnol, Quetta, Pakistan.
   [Akash, Muhammad Sajid Hamid] Govt Coll Univ Faisalabad, Dept Pharmaceut Chem, Faisalabad, Pakistan.
RP Akash, MSH (corresponding author), Govt Coll Univ Faisalabad, Dept Pharmaceut Chem, Faisalabad, Pakistan.
EM sajidakash@gmail.com
RI amsalu, ribka/G-8780-2019; Akash, Muhammad Sajid Hamid/C-3477-2018
OI Akash, Muhammad Sajid Hamid/0000-0002-9446-5233
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P1249, DOI 10.1001/jama.2016.12760
   Abushouk AI, 2016, J CLIN VIROL, V84, P53, DOI 10.1016/j.jcv.2016.09.012
   Allwinn R, 2002, MED MICROBIOL IMMUN, V190, P199, DOI 10.1007/s00430-001-0107-9
   Atif M, 2016, INFECTION, V44, P695, DOI 10.1007/s15010-016-0935-6
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Bastos CM, 2016, REV BRASILEIRA MED F, V11, P1
   Bollati M, 2010, ANTIVIR RES, V87, P125, DOI 10.1016/j.antiviral.2009.11.009
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chen LH, 2016, ANN INTERN MED, V164, P613, DOI 10.7326/M16-0150
   Cousins S., 2017, 3 ZIKA CASES ARE FOU
   Daniel KL, 2016, MMWR-MORBID MORTAL W, V65, P352, DOI 10.15585/mmwr.mm6513e1
   de Silva N., 2015, COMMUNICATION, P38
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dyer O, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i3588
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Galan-Huerta K, 2016, MED U, V18, P115, DOI DOI 10.1016/J.RMU.2016.05.003
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Gulland A, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i6500
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hennessey M., 2015, CTR DIS CONTROL PREV, V65, P55, DOI DOI 10.15585/MMWR.MM6503E1
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Kumar A, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00403
   Landry ML, 2017, ARCH PATHOL LAB MED, V141, P60, DOI 10.5858/arpa.2016-0406-SA
   Lim SK, 2017, INFECT CHEMOTHER, V49, P91, DOI 10.3947/ic.2017.49.2.91
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Maharajan MK, 2016, CLIN REV ALLERG IMMU, V51, P383, DOI 10.1007/s12016-016-8554-7
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Marston HD, 2016, NEW ENGL J MED, V375, P1209, DOI 10.1056/NEJMp1607762
   MCCARTHY M, 2016, BMJ CLIN RES, V352, DOI DOI 10.1136/BMJ.I855
   McNeil D, 2016, THE NEW YORK TIMES
   Menezes D, 2016, ANTHROPOL MED, V23, P225, DOI 10.1080/13648470.2016.1171578
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moghadam SRJ, 2016, ASIAN PAC J TROP BIO, V6, P989, DOI 10.1016/j.apjtb.2016.09.007
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P323, DOI 10.15585/mmwr.mm6512e3
   Pabbaraju K, 2016, J CLIN VIROL, V83, P66, DOI 10.1016/j.jcv.2016.09.001
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Petersen E, 2017, INFECT DIS GEOGRAPHI, P55
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rathore Mobeen H, 2017, Adv Pediatr, V64, P27, DOI 10.1016/j.yapd.2017.04.002
   Saiz JC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00496
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sharma A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00110
   Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Smith AE, 2004, SCIENCE, V304, P237, DOI 10.1126/science.1094823
   Taraporewala ZF, 2004, VIRUS RES, V101, P57, DOI 10.1016/j.virusres.2003.12.006
   Teixeira MG, 2016, AM J PUBLIC HEALTH, V106, P601, DOI 10.2105/AJPH.2016.303113
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
NR 68
TC 0
Z9 0
U1 0
U2 1
PU BEGELL HOUSE INC
PI DANBURY
PA 50 NORTH ST, DANBURY, CT 06810 USA
SN 1045-4403
EI 2162-6502
J9 CRIT REV EUKAR GENE
JI Crit. Rev. Eukaryot. Gene Expr.
PY 2018
VL 28
IS 4
BP 357
EP 371
DI 10.1615/CritRevEukaryotGeneExpr.2018025061
PG 15
WC Biotechnology & Applied Microbiology; Genetics & Heredity
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA GV8TZ
UT WOS:000446422200008
PM 30311585
DA 2020-07-08
ER

PT J
AU Hotez, PJ
AF Hotez, Peter J.
TI The global fight to develop antipoverty vaccines in the anti-vaccine era
SO HUMAN VACCINES & IMMUNOTHERAPEUTICS
LA English
DT Article
DE hookworm; schistosomiasis; dengue; yellow fever; Zika; Ebola; trials for
   developing countries; tropical medicine; vaccinology
ID NEGLECTED TROPICAL DISEASES; BILLION; PEOPLE; HEALTH; IMPACT
AB Antipoverty vaccines are the vaccines targeting a group of approximately 20 neglected tropical diseases (NTDs), as currently defined by the World Health Organization (WHO). The antipoverty moniker refers to the fact that NTDs trap populations in poverty due to their chronic and deleterious effects on child intellect and worker productivity. Therefore, NTD vaccines can be expected to promote both global health and economic advancement. Unfortunately, antipoverty vaccine development has lagged behind vaccines for major childhood infections and pandemic threats, despite evidence for their cost-effectiveness and cost-savings. Currently, the only licensed vaccines for NTDs include those for yellow fever, dengue, and rabies, although several other NTD vaccines for hookworm disease, schistosomiasis, leishmaniasis, and Zika and Ebola virus infections are in different stages of clinical development, while others are at the preclinical development stage. With the exception of the viral NTD vaccines there so far has been minimal industry interest in the antipoverty vaccines, leaving their development to a handful of non-profit product development partnerships. The major scientific and geopolitical hurdles to antipoverty vaccine development are discussed, including a rising antivaccine (antivax) movement now entering highly populated low- and middle-income countries.
C1 [Hotez, Peter J.] Texas Childrens Hosp, Baylor Coll Med, Dept Pediat, Ctr Vaccine Dev,Natl Sch Trop Med, Houston, TX 77030 USA.
   [Hotez, Peter J.] Texas Childrens Hosp, Baylor Coll Med, Dept Mol Virol & Microbiol, Ctr Vaccine Dev,Natl Sch Trop Med, Houston, TX 77030 USA.
   [Hotez, Peter J.] Baylor Univ, Dept Biol, Waco, TX 76798 USA.
   [Hotez, Peter J.] Rice Univ, James Baker III Inst Publ Policy, Houston, TX USA.
   [Hotez, Peter J.] Texas A&M Univ, Bush Sch Govt & Publ Policy, Scowcroft Inst Int Affairs, College Stn, TX USA.
RP Hotez, PJ (corresponding author), 1 Baylor Plaza, Houston, TX 77030 USA.
EM hotez@bcm.edu
CR Bacon KM, 2013, VACCINE, V31, P480, DOI 10.1016/j.vaccine.2012.11.032
   Bartsch SM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004922
   Bartsch SM, 2016, VACCINE, V34, P2197, DOI 10.1016/j.vaccine.2016.03.018
   Hotez P, 2006, ADV EXP MED BIOL, V582, P23
   Hotez P, 2011, HEALTH AFFAIR, V30, P1080, DOI 10.1377/hlthaff.2011.0317
   Hotez PJ, 2007, NEW ENGL J MED, V357, P1018, DOI 10.1056/NEJMra064142
   Hotez PJ, 2006, VACCINE, V24, P5787, DOI 10.1016/j.vaccine.2006.05.008
   Hotez PJ, 2006, PLOS MED, V3, P576, DOI 10.1371/journal.pmed.0030102
   Hotez PJ, 2018, MICROBES INFECT, V20, P63, DOI 10.1016/j.micinf.2017.10.004
   Hotez PJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005896
   Hotez PJ, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2004186
   Hotez PJ, 2017, VACCINE, V35, P5403, DOI 10.1016/j.vaccine.2017.02.002
   Hotez PJ, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002153
   Hotez PJ, 2016, VACCINE, V34, P3549, DOI 10.1016/j.vaccine.2016.03.112
   Hotez PJ, 2016, ANNU REV MED, V67, P405, DOI 10.1146/annurev-med-051214-024241
   Hotez PJ, 2009, LANCET, V373, P1570, DOI 10.1016/S0140-6736(09)60233-6
   Hotez PJ, NEGLECTED TROPICAL D
   Hotez PJ, SCI AM
   Lee BY, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005531
   Lee BY, 2013, LANCET INFECT DIS, V13, P342, DOI 10.1016/S1473-3099(13)70002-1
   Lee BY, 2012, HUM VACC IMMUNOTHER, V8, P1293, DOI 10.4161/hv.20966
   Lo NC, 2017, JAMA PEDIATR, V171, P887, DOI 10.1001/jamapediatrics.2017.1695
   Molyneux DH, 2005, PLOS MED, V2, P1064, DOI 10.1371/journal.pmed.0020336
   Policy Cures, 2015, G FINDER REP 2015
   Vos T, 2017, LANCET, V390, P1211, DOI 10.1016/S0140-6736(17)32154-2
   Webster JP, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0434
   WHO, NEGL DIS
NR 27
TC 12
Z9 12
U1 0
U2 9
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 2164-5515
EI 2164-554X
J9 HUM VACC IMMUNOTHER
JI Human Vaccines Immunother.
PY 2018
VL 14
IS 9
BP 2128
EP 2131
DI 10.1080/21645515.2018.1430542
PG 4
WC Biotechnology & Applied Microbiology; Immunology
SC Biotechnology & Applied Microbiology; Immunology
GA GV7YM
UT WOS:000446351100007
PM 29393710
OA Green Published, Bronze
DA 2020-07-08
ER

PT S
AU Zevika, M
   Soewono, E
AF Zevika, Mona
   Soewono, Edy
BE VanHeijster, P
   Quam, M
   Handayani, D
TI Deterministic and Stochastic CTMC Models from Zika Disease Transmission
SO SYMPOSIUM ON BIOMATHEMATICS (SYMOMATH) 2017
SE AIP Conference Proceedings
LA English
DT Proceedings Paper
CT Symposium on BioMathematics (SYMOMATH)
CY AUG 27-29, 2017
CL Inst Teknologi Bandung, Bandung, INDONESIA
SP Inst Teknologi Bandung, Ctr Math Modeling & Simulat, Indonesian BioMathemat Soc, Inst Teknologi Bandung, Inst Res & Community Serv
HO Inst Teknologi Bandung
ID EXTINCTION; THRESHOLDS
AB Zika infection is one of the most important mosquito-borne diseases in the world. Zika virus (ZIKV) is transmitted by many Aedes-type mosquitoes including Aedes aegypti. Pregnant women with the Zika virus are at risk of having a fetus or infant with a congenital defect and suffering from microcephaly. Here, we formulate a Zika disease transmission model using two approaches, a deterministic model and a continuous-time Markov chain stochastic model. The basic reproduction ratio is constructed from a deterministic model. Meanwhile, the CTMC stochastic model yields an estimate of the probability of extinction and outbreaks of Zika disease. Dynamical simulations and analysis of the disease transmission are shown for the deterministic and stochastic models.
C1 [Zevika, Mona; Soewono, Edy] Inst Teknol Bandung, Dept Math, Bandung 40132, Indonesia.
RP Zevika, M (corresponding author), Inst Teknol Bandung, Dept Math, Bandung 40132, Indonesia.
EM monazevika@s.itb.ac.id; esoewono@math.itb.ac.id
CR Agusto FB, 2017, ECOL COMPLEX, V29, P61, DOI 10.1016/j.ecocom.2016.12.007
   Agusto F.B., 2017, INFECT DIS MODELLING, P1
   Ali Amjad, 2017, ASIAN PACIC J TROPIC, V10
   Allen LJS, 2013, MATH BIOSCI, V243, P99, DOI 10.1016/j.mbs.2013.02.006
   Allen LJS, 2012, J BIOL DYNAM, V6, P590, DOI 10.1080/17513758.2012.665502
   Allen LJS, 2010, INTRO STOCHASTIC PRO
   ATHREYA KB, 1972, BRANCHING PROCESSES
   Diekmann O., 2000, MATH EPIDEMIOLOGY IN
   Dorman KS, 2004, SIAM REV, V46, P202, DOI 10.1137/S0036144502417843
   Esteva L, 1998, MATH BIOSCI, V150, P131, DOI 10.1016/S0025-5564(98)10003-2
   Gebre Y, 2016, ASIAN PAC J TROP BIO, V6, P815, DOI 10.1016/j.apjtb.2016.08.008
   Harris T. E., 1963, THEORY BRANCHING PRO
   Kalimuthu Kandasamy, 2017, PROCESS SAF ENVIRON, V109, P8296
   Kindhauser MK, 2016, B WHO
   Lahodny Jr Glenn E., 2013, B MATH BIOL, V75
   OlynkWidmar Nicole J., 2017, PREVENTIVE MED REPOR, V6, P162
   Pennison S, 2010, THESIS
   Riou J, 2017, EPIDEMICS-NETH, V19, P43, DOI 10.1016/j.epidem.2017.01.001
   Soewono Edy, 2017, EFFECT POSPTONING PR
   Zambrano LI, 2016, J INFECT PUBLIC HLTH
NR 20
TC 0
Z9 0
U1 0
U2 1
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 978-0-7354-1629-1
J9 AIP CONF PROC
PY 2018
VL 1937
AR UNSP 020023
DI 10.1063/1.5026095
PG 9
WC Mathematical & Computational Biology; Mathematics, Applied
SC Mathematical & Computational Biology; Mathematics
GA BL0QS
UT WOS:000446376700023
DA 2020-07-08
ER

PT J
AU Barbe, D
   Pennington-Gray, LP
AF Barbe, Danielle
   Pennington-Gray, Lori
TI Using situational crisis communication theory to understand Orlando
   hotels' Twitter response to three crises in the summer of 2016
SO JOURNAL OF HOSPITALITY AND TOURISM INSIGHTS
LA English
DT Article
DE Social media; Tourism; Lodging; Crisis communication; Hotel
ID SOCIAL MEDIA; HURRICANE EVACUATION; PLANNING LESSONS; ADOPTION;
   MANAGEMENT; DETERMINANTS; HOSPITALITY; INTENTION; INSIGHTS; TOURISTS
AB Purpose - The purpose of this paper is to assess the crisis communication strategies implemented by hotel and lodging organizations via social media. Specifically, this study analyzed Twitter content by hotels in Orlando, Florida during the summer of 2016 when several crises occurred that made global media coverage, including the alligator snatching on Disney property, the mass shooting at Pulse nightclub and growing concerns of Zika virus.
   Design/methodology/approach - To understand crisis communication in the hotel industry, this study was guided by the technology-environment-organization framework and situational crisis communication theory (SCCT). Twitter content between June 1 and August 31, 2016 from Orlando hotels was collected and content analyzed to determine: was the message related to the crisis event, the SCCT strategy used and the influence of hotel organizational factors (ownership, size, classification) on the use of social media for crisis communication.
   Findings - Results indicate that most hotels are not currently using Twitter as a form of crisis communication. Only the shooting at Pulse Nightclub was communicated and the SCCT bolster strategy was used throughout each of the crisis-related message, reminding stakeholders that they too are a victim.
   Originality/value - This study provides insight into the ways hotels are using social media for crisis communication. Each crisis explored was different, and while the hotels were not responsible for creating the crises, they are responsible for the safety of guests. These results inform hoteliers that there is a responsibility to communicate during a crisis, particularly for informative purposes.
C1 [Barbe, Danielle; Pennington-Gray, Lori] Univ Florida, Dept Tourism Recreat & Sport Management, Gainesville, FL 32611 USA.
RP Barbe, D (corresponding author), Univ Florida, Dept Tourism Recreat & Sport Management, Gainesville, FL 32611 USA.
EM dbarbe@ufl.edu
OI , Danielle/0000-0003-1708-7184
CR Aluri A, 2015, INT J CONTEMP HOSP M, V27, P670, DOI 10.1108/IJCHM-09-2013-0415
   American Red Cross, 2013, SOC MED DIS BEST PRA
   ANDERSON C, 2012, CORNELL HOSP Q, V12, P6
   Avsic Zupanc Tatjana, 2016, Zdr Varst, V55, P228
   Awa HO, 2017, J ENTERP INF MANAG, V30, P893, DOI 10.1108/JEIM-03-2016-0079
   Burby RJ, 1996, DISASTERS, V20, P49, DOI 10.1111/j.1467-7717.1996.tb00514.x
   Cahyanto I, 2016, TOURISM MANAGE, V52, P264, DOI 10.1016/j.tourman.2015.06.014
   Cahyanto I, 2015, J TRAVEL RES, V54, P329, DOI 10.1177/0047287513517418
   Cahyanto I, 2014, J DESTIN MARK MANAGE, V2, P253, DOI 10.1016/j.jdmm.2013.10.003
   Caplan D., 2016, ABC NEWS
   Chaffey D., 2016, SMART INSIGHTS SOCIA
   Chang H. C., 2010, P AM SOC INFORM SCI, V47, P1, DOI DOI 10.1002/MEET.14504701295
   Chau PYK, 1997, MIS QUART, V21, P1, DOI 10.2307/249740
   Coombs Timothy W., 2002, MANAGEMENT COMMUNICA, V16, P165, DOI DOI 10.1177/089331802237233
   Coombs WT, 2007, CORP REPUT REV, V10, P163, DOI 10.1057/palgrave.crr.1550049
   Coombs W. T., 2014, ONGOING CRISIS COMMU
   Coombs W. T., 1999, J PUBLIC RELAT RES, V11, P125, DOI DOI 10.1207/S1532754XJPRR1102_02
   Coombs WT, 2018, SOCIAL MEDIA AND CRISIS COMMUNICATION, P21
   Coombs WT, 2015, BUS HORIZONS, V58, P141, DOI 10.1016/j.bushor.2014.10.003
   Cordeiro M., 2016, ORLANDO WEEKLY
   Deng S. L., 1992, International Journal of Hospitality Management, V11, P225, DOI 10.1016/0278-4319(92)90020-V
   Fall L. T., 2006, J TRAVEL TOUR MARK, V19, P77
   Faulkner B, 2001, TOURISM MANAGE, V22, P135, DOI 10.1016/S0261-5177(00)00048-0
   Fuchs M, 2010, J TRAVEL RES, V49, P165, DOI 10.1177/0047287509336469
   Gangwar H, 2014, J ENTERP INF MANAG, V27, P488, DOI 10.1108/JEIM-08-2012-0047
   Gilgoff D., 2013, NATL GEOGRAPHIC DAIL
   Hossain MA, 2011, INFORM TECHNOL PEOPL, V24, P236, DOI 10.1108/09593841111158365
   Hughes AL, 2009, INT J EMERG MANAG, V6, P248, DOI 10.1504/IJEM.2009.031564
   Kirk D., 1998, International Journal of Hospitality Management, V17, P33, DOI 10.1016/S0278-4319(98)00005-X
   Lacy S, 1996, JOURNALISM MASS COMM, V73, P963, DOI 10.1177/107769909607300414
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Le Y, 2006, ANN TOURISM RES, V33, P545, DOI 10.1016/j.annals.2006.01.002
   Leung D, 2015, TOUR RECREAT RES, V40, P391, DOI 10.1080/02508281.2015.1090152
   Levy SE, 2013, CORNELL HOSP Q, V54, P49, DOI 10.1177/1938965512464513
   Liu BJ, 2015, INT J HOSP MANAG, V47, P76, DOI 10.1016/j.ijhm.2015.03.005
   MacKay K, 2017, INT J CONTEMP HOSP M, V29, P669, DOI [10.1108/ijchm-10-2015-0618, 10.1108/IJCHM-10-2015-0618]
   Malhotra R, 2009, WORLDW HOSP TOUR THE, V1, P66, DOI 10.1108/17554210910949896
   Matyas C, 2011, NAT HAZARDS, V59, P871, DOI 10.1007/s11069-011-9801-0
   Mensah I., 2006, INT J HOSP MANAG, V25, P414, DOI DOI 10.1016/J.IJHM.2005.02.003
   Miller M, 2016, WASHINGTON POST
   Miller N, 2016, ORLANDO SENTINEL
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Neuman WL, 2012, BASICS SOCIAL RES QU
   Oliveira T., 2011, ELECT J INF SYST EVA, V14, P110
   Oxford Economics, 2018, EC IMP OUT OF STAT V
   Paraskevas A., 2006, Management Decision, V44, P892, DOI 10.1108/00251740610680587
   Pariona A, 2017, WORLD ATLAS
   Pedicini S, 2017, ORLANDO SENTINEL
   Pennington-Gray L., 2016, HOMELAND SECURITY NE, P1
   Pforr C., 2006, SCH MANAGEMENT WORKI
   Ramdani B, 2013, J SMALL BUS ENTERP D, V20, P735, DOI 10.1108/JSBED-12-2011-0035
   Ritchie B. W., 2004, J TRAVEL TOUR MARK, V15, P199, DOI DOI 10.1300/J073V15N02_11
   Ritchie BW, 2014, J TRAVEL RES, V53, P12, DOI 10.1177/0047287513482775
   Ritchie BW, 2011, SCAND J HOSP TOUR, V11, P367, DOI 10.1080/15022250.2011.600591
   Ritchie BW, 2004, TOURISM MANAGE, V25, P669, DOI 10.1016/j.tourman.2003.09.004
   Rogers E. M., 1995, DIFFUSION INNOVATION
   Rousaki B, 2006, TOUR HOSP RES, V7, P27, DOI 10.1057/palgrave.thr.6050030
   Santora M., 2016, NY TIMES
   Schroeder A, 2013, J TRAVEL TOUR MARK, V30, P126, DOI 10.1080/10548408.2013.751271
   Schwarz A, 2016, HDB INT CRISIS COMMU
   Seeger MW, 2006, J APPL COMMUN RES, V34, P232, DOI 10.1080/00909880600769944
   Seeger MW, 2001, J BUS ETHICS, V31, P369, DOI 10.1023/A:1010759319845
   Sigala M., 2011, Information Technology and Tourism, V13, P269, DOI 10.3727/109830512X13364362859812
   Smerecnik KR, 2011, J SUSTAIN TOUR, V19, P171, DOI 10.1080/09669582.2010.517316
   Stafford G., 2002, Cornell Hotel and Restaurant Administration Quarterly, V43, P27, DOI 10.1177/0010880402435003
   Stake R., 2000, HDB QUALITATIVE RES, P435, DOI DOI 10.1258/096214400320575624
   Statista, 2017, NUMB SOC NETW US US
   Stobbe M., 2017, ORLANDO SENTINEL
   Tarlow P., 2014, INT J RELIG TOURISM, V2, P10
   Tornatzky LG, 1990, PROCESSES TECHNOLOGI
   Trusov M, 2009, J MARKETING, V73, P90, DOI 10.1509/jmkg.73.5.90
   Tzschentke NA, 2008, INT J HOSP MANAG, V27, P126, DOI 10.1016/j.ijhm.2007.07.010
   Ulmer RR, 2002, PUBLIC RELAT REV, V28, P361, DOI 10.1016/S0363-8111(02)00165-0
   Visit Florida, 2017, RESEARCH
   Visit Orlando, 2017, YEAR REV 2016 REP
   Visit Orlando, 2017, BOARD HIGHL 3 QUART
   Visser S, 2016, CNN
   Wachinger G, 2013, RISK ANAL, V33, P1049, DOI 10.1111/j.1539-6924.2012.01942.x
   Wang J, 2012, TOURISM MANAGE, V33, P1057, DOI 10.1016/j.tourman.2011.12.006
   Wang YM, 2010, TECHNOL FORECAST SOC, V77, P803, DOI 10.1016/j.techfore.2010.03.006
   World Tourism Organisation, 1998, HDB NAT DIS RED TOUR
   World Travel & Tourism Council, 2017, TRAV TOUR EC IMP 201
   Yin R., 2003, CASE STUDY RES DESIG, V5
NR 83
TC 2
Z9 2
U1 13
U2 17
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 2514-9792
EI 2514-9806
J9 J HOSP TOUR INSIGHTS
JI J. Hosp. Tour. Insights
PY 2018
VL 1
IS 3
SI SI
BP 258
EP 275
DI 10.1108/JHTI-02-2018-0009
PG 18
WC Hospitality, Leisure, Sport & Tourism
SC Social Sciences - Other Topics
GA GU7HG
UT WOS:000445490700006
DA 2020-07-08
ER

PT J
AU Willcox, AC
   Collins, MH
   Jadi, R
   Keeler, C
   Parr, JB
   Mumba, D
   Kashamuka, M
   Tshefu, A
   de Silva, AM
   Meshnick, SR
AF Willcox, Alexandra C.
   Collins, Matthew H.
   Jadi, Ramesh
   Keeler, Corinna
   Parr, Jonathan B.
   Mumba, Dieudonne
   Kashamuka, Melchior
   Tshefu, Antoinette
   de Silva, Aravinda M.
   Meshnick, Steven R.
TI Seroepidemiology of Dengue, Zika, and Yellow Fever Viruses among
   Children in the Democratic Republic of the Congo
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID NEUTRALIZING ANTIBODIES; IMMUNE-RESPONSE; INFANTS; MEASLES; VACCINE;
   SEROPREVALENCE; INTERFERENCE; IMMUNIZATION; INFECTIONS; OUTBREAK
AB Flaviviruses such as Zika, dengue, and yellow fever cause epidemics throughout the tropics and account for substantial global morbidity and mortality. Although malaria and other vector-borne diseases have long been appreciated in Africa, flavivirus epidemiology is incompletely understood. Despite the existence of an effective vaccine, yellow fever continues to cause outbreaks and deaths, including at least 42 fatalities in the Democratic Republic of the Congo (DRC) in 2016. Here, we leveraged biospecimens collected as part of the nationally representative 2013-2014 Demographic and Health Survey in the DRC to examine serological evidence of flavivirus infection or vaccination in children aged 6 months to 5 years. Even in this young stratum of the Congolese population, we find evidence of infection by dengue and Zika viruses based on results from enzyme-linked immunosorbent assay and neutralization assay. Surprisingly, there was remarkable discordance between reported yellow fever vaccination status and results of serological assays. The estimated seroprevalences of neutralizing antibodies against each virus are yellow fever, 6.0% (95% confidence interval [CI] = 4.6-7.5%); dengue, 0.4% (0.1-0.9%); and Zika, 0.1% (0.0-0.5%). These results merit targeted, prospective studies to assess effectiveness of yellow fever vaccination programs, determine flavivirus seroprevalence across a broader age range, and investigate how these emerging diseases contribute to the burden of acute febrile illness in the DRC.
C1 [Willcox, Alexandra C.; Meshnick, Steven R.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27515 USA.
   [Collins, Matthew H.] Emory Sch Med, Emory Vaccine Ctr, Hope Clin, Dept Med,Div Infect Dis, Decatur, GA USA.
   [Jadi, Ramesh; de Silva, Aravinda M.] Univ N Carolina, Sch Med, Dept Microbiol & Immunol, Chapel Hill, NC 27515 USA.
   [Keeler, Corinna] Univ N Carolina, Dept Geog, Chapel Hill, NC 27515 USA.
   [Parr, Jonathan B.] Univ N Carolina, Sch Med, Dept Med, Div Infect Dis, Chapel Hill, NC 27515 USA.
   [Mumba, Dieudonne] Inst Natl Rech Biomed, Kinshasa, DEM REP CONGO.
   [Kashamuka, Melchior; Tshefu, Antoinette] Univ Kinshasa, Fac Med, Ecole Sante Publ, Kinshasa, DEM REP CONGO.
   [Willcox, Alexandra C.] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD USA.
RP Collins, MH (corresponding author), Emory Univ, Hope Clin, 500 Irvin Court,Suite 200, Decatur, GA 30030 USA.; Meshnick, SR (corresponding author), 3301 Michael Hooker Res Ctr,CB 7435, Chapel Hill, NC 27599 USA.
EM alexandra.c.willcox@gmail.com; mcoll28@emory.edu;
   ramesh_jadi@med.unc.edu; cykeeler@live.unc.edu;
   jonathan_parr@med.unc.edu; mumbadieudonne@yahoo.fr;
   mwandaga@email.unc.edu; antotshe@yahoo.com;
   aravinda_desilva@med.unc.edu; meshnick@email.unc.edu
OI Keeler, Corinna/0000-0002-3445-6589; Willcox,
   Alexandra/0000-0001-6037-6841
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01AI107949]; Bill & Melinda Gates
   FoundationGates Foundation
FX This project was funded by NIH grant R01AI107949. Sample collection was
   supported in part by a grant from the Bill & Melinda Gates Foundation to
   Anne Rimoin.
CR Amanna IJ, 2016, EXPERT REV VACCINES, V15, P1519, DOI 10.1080/14760584.2016.1198259
   Amarasinghe A, 2011, EMERG INFECT DIS, V17, P1349, DOI 10.3201/eid1708.101515
   Amaya-Larios IY, 2014, AM J TROP MED HYG, V91, P1057, DOI 10.4269/ajtmh.14-0145
   [Anonymous], 2013, Wkly Epidemiol Rec, V88, P201
   [Anonymous], 1967, Nutr Rev, V25, P108
   Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   Belmusto-Worn VE, 2005, AM J TROP MED HYG, V72, P189, DOI 10.4269/ajtmh.2005.72.189
   Braack L, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-017-2559-9
   Braga C, 2010, ACTA TROP, V113, P234, DOI 10.1016/j.actatropica.2009.10.021
   BRES PLJ, 1986, B WORLD HEALTH ORGAN, V64, P775
   BROWN RE, 1966, TROP GEOGR MED, V18, P125
   Caldas IR, 2014, VACCINE, V32, P4977, DOI 10.1016/j.vaccine.2014.07.021
   Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   Corbett KS, 2015, J INFECT DIS, V211, P590, DOI 10.1093/infdis/jiu481
   Doctor SM, 2016, DIAGN MICR INFEC DIS, V85, P16, DOI 10.1016/j.diagmicrobio.2016.01.004
   Gardner CL, 2010, CLIN LAB MED, V30, P237, DOI 10.1016/j.cll.2010.01.001
   Gotuzzo E, 2013, AM J TROP MED HYG, V89, P434, DOI 10.4269/ajtmh.13-0264
   Grobusch MP, 2013, CLIN MICROBIOL INFEC, V19, P885, DOI 10.1111/1469-0691.12332
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Halstead SB, 2002, EMERG INFECT DIS, V8, P1474, DOI 10.3201/eid0812.020170
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488
   ICF International, 2012, MEAS DHS BIOM FIELD
   Kading RC, 2013, J WILDLIFE DIS, V49, P587, DOI 10.7589/2012-08-212
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Leder K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185689
   Lee PX, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004805
   LHUILLIER M, 1989, J BIOL STAND, V17, P9, DOI 10.1016/0092-1157(89)90023-1
   Mbanzulu KM, 2017, INT J INFECT DIS, V57, P32, DOI 10.1016/j.ijid.2017.01.016
   Micallef L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101717
   Michel R, 2015, VACCINE, V33, P2301, DOI 10.1016/j.vaccine.2015.03.069
   Ministere du Plan et Suivi de laMise en oeuvre de la Revolution de la Modernite (MPSMRM) Ministere de la Sante Publique (MSP) ICF International, 2014, ENQ DEM SANT REP DEM
   Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Silva JRN, 2011, VACCINE, V29, P6327, DOI 10.1016/j.vaccine.2011.05.019
   Nur YA, 1999, AM J TROP MED HYG, V61, P885, DOI 10.4269/ajtmh.1999.61.885
   Osei-Kwasi M, 2001, B WORLD HEALTH ORGAN, V79, P1056
   Otshudiema JO, 2017, MMWR-MORBID MORTAL W, V66, P335, DOI 10.15585/mmwr.mm6612a5
   Patel D, 2013, TRAVEL MED INFECT DI, V11, P266, DOI 10.1016/j.tmaid.2013.08.007
   Pengsaa K, 2006, J INFECT DIS, V194, P1570, DOI 10.1086/508492
   Prasad N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127962
   Prayitno A, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005621
   Robertson SE, 1996, JAMA-J AM MED ASSOC, V276, P1157, DOI 10.1001/jama.276.14.1157
   Roehrig JT, 2008, VIRAL IMMUNOL, V21, P123, DOI 10.1089/vim.2008.0007
   Rothman KJ, 2015, EPISHEET SPREADSHEET
   Rytter MJH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105017
   Schwarz NG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176708
   Staples JE, 2015, MMWR-MORBID MORTAL W, V64, P647
   Stefano I, 1999, VACCINE, V17, P1042, DOI 10.1016/S0264-410X(98)00320-X
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Tissera H, 2014, AM J TROP MED HYG, V91, P132, DOI 10.4269/ajtmh.13-0540
   Van Esbroeck M, 2016, EUROSURVEILLANCE, V21, P32, DOI 10.2807/1560-7917.ES.2016.21.21.30237
   van Panhuis WG, 2011, AM J TROP MED HYG, V85, P355, DOI 10.4269/ajtmh.2011.11-0125
   Villarroel PMS, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006239
   Watanaveeradej V, 2003, AM J TROP MED HYG, V69, P123, DOI 10.4269/ajtmh.2003.69.123
   WHO, 2010, YELL FEV DEM REP CON
   World Health Organisation, 2016, YELL FEV SIT REP
   World Health Organization, 2014, DIS OUTBR NEWS ARCH
   World Health Organization, 2014, DISEASE OUTBREAK NEW
   World Health Organization, 2017, WHO VACC REV DIS MON
   2015, MEM I O CRUZ, V110, P771
NR 61
TC 6
Z9 6
U1 1
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 3
BP 756
EP 763
DI 10.4269/ajtmh.18-0156
PG 8
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA GS5GF
UT WOS:000443684800034
PM 29988000
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Ward, MJ
   Alger, J
   Berrueta, M
   Bock, H
   Buekens, P
   Cafferata, ML
   Ciganda, A
   Garcia, J
   Garcia, K
   Lopez, W
   Lorenzana, I
   Parham, L
   Wesson, DM
AF Ward, Matthew J.
   Alger, Jackeline
   Berrueta, Mabel
   Bock, Harry
   Buekens, Pierre
   Luisa Cafferata, Maria
   Ciganda, Alvaro
   Garcia, Jorge
   Garcia, Kimberly
   Lopez, Wendy
   Lorenzana, Ivette
   Parham, Leda
   Wesson, Dawn M.
TI Zika Virus and the World Health Organization Criteria for Determining
   Recent Infection Using Plaque Reduction Neutralization Testing
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID INTERIM GUIDANCE; DENGUE
AB The recent Zika virus (ZIKV) epidemic swept across Latin America and the Caribbean, where dengue virus (DENV) is endemic. The antigenic similarities of these closely related flaviviruses left researchers and clinicians with challenges to interpret serological tests. Thirty-six women attending a prenatal clinic in Honduras and with positive DENV IgM enzyme-linked immunoabsorbent assays (ELISAs) were screened with a ZIKV immunoglobulin M ELISA, reverse transcription polymerase chain reaction for ZIKV and DENV 1-4, and plaque reduction neutralization tests (PRNTs) for ZIKV and DENV-2. Plaque reduction neutralization test results were interpreted using the World Health Organization (WHO) and Centers for Disease Control and Prevention (CDC) criteria. Using the WHO criteria of a PRNT90 titer >= 20 and a 4-fold difference between ZIKV and DENV titers, we determined that 69.4% of samples had a recent ZIKV infection, compared with 5.6% using CDC criteria. The interpretation of ZIKV PRNTs in a DENV-endemic region is highly dependent on the choice of interpretation criteria.
C1 [Ward, Matthew J.; Buekens, Pierre; Wesson, Dawn M.] Tulane Univ, Sch Publ Hlth & Trop Med, New Orleans, LA USA.
   [Alger, Jackeline; Garcia, Jorge; Lopez, Wendy] Hosp Escuela Univ, Dept Lab Clin, Tegucigalpa, Honduras.
   [Alger, Jackeline; Garcia, Jorge] Inst Enfermedades Infecciosas & Parasitol Antonio, Tegucigalpa, Honduras.
   [Berrueta, Mabel; Luisa Cafferata, Maria; Ciganda, Alvaro] IECS, Buenos Aires, DF, Argentina.
   [Bock, Harry] Secretaria Salud Honduras, Reg Sanitaria Metropolitana Dist Cent, Tegucigalpa, Honduras.
   [Garcia, Kimberly; Lorenzana, Ivette; Parham, Leda] Univ Nacl Autonoma Honduras, Escuela Microbiol, CIG, Inst Invest Microbiol, Tegucigalpa, Honduras.
   [Ward, Matthew J.; Buekens, Pierre; Wesson, Dawn M.] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Trop Med, Suite 2300,1440 Canal St 8317, New Orleans, LA 70112 USA.
RP Ward, MJ (corresponding author), Tulane Univ, Sch Publ Hlth & Trop Med, Dept Trop Med, Suite 2300,1440 Canal St 8317, New Orleans, LA 70112 USA.
EM mward11@tulane.edu; jackelinealger@gmail.com; mberrueta@iecs.org.ar;
   hbockme@hotmail.com; pbuekens@tulane.edu;
   marialuisa.cafferata@gmail.com; aciganda@gmail.com;
   jalgar62_84@yahoo.com.ar; kimfa_2010@hotmail.com; wlopez36@hotmail.com;
   ivettelorenzana@yahoo.com; lparham29@hotmail.com; wesson@tulane.edu
OI Alger, Jackeline/0000-0001-9244-0668; Ward, Matthew/0000-0001-8373-8438
CR Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1
   [Anonymous], 2016, Wkly Epidemiol Rec, V91, P73
   Buekens P, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0200-6
   Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   Epelboin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005933
   Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lee WT, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01591-17
   Lieberman MM, 2009, CLIN VACCINE IMMUNOL, V16, P1332, DOI 10.1128/CVI.00119-09
   Lindsey NP, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01115-17
   San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346
   de Vasconcelos ZFM, 2018, CHILD NERV SYST, V34, P79, DOI 10.1007/s00381-017-3641-5
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Pridjian G, 2016, BIRTH DEFECTS RES A, V106, P716, DOI 10.1002/bdra.23523
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Safronetz D, 2017, EMERG INFECT DIS, V23, P1577, DOI 10.3201/eid2309.162043
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
NR 17
TC 6
Z9 6
U1 0
U2 2
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 3
BP 780
EP 782
DI 10.4269/ajtmh.18-0237
PG 3
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA GS5GF
UT WOS:000443684800037
PM 29943723
OA Bronze, Green Published
DA 2020-07-08
ER

PT S
AU Young, PR
AF Young, Paul R.
BE Hilgenfeld, R
   Vasudevan, SG
TI Arboviruses: A Family on the Move
SO DENGUE AND ZIKA: CONTROL AND ANTIVIRAL TREATMENT STRATEGIES
SE Advances in Experimental Medicine and Biology
LA English
DT Article; Proceedings Paper
CT 2nd Tofo Advanced Study Week on Emerging Viruses - Dengue and Zika -
   Control and Antiviral Treatment Strategies
CY AUG 28-SEP 01, 2016
CL Inhambane, MOZAMBIQUE
DE Arthropod-borne viruses; Zoonotic infections; Virosphere; Arbovirus
   transmission; Climate change impacts
ID CLIMATE-CHANGE; VECTOR-BORNE; DISEASES
AB Arboviruses are a diverse group of vectorborne viruses, many of whose members are the cause of significant human morbidity and mortality. Over the last 30 years, the emergence and/or resurgence of arboviruses have posed a considerable global health threat. The ongoing geographical expansion of the dengue viruses (DENY), along with the explosive outbreaks of West Nile virus (WNV), Chikungunya virus (CHIKV) and more recently, Zika virus (ZIKV) have all served as reminders that new epidemics may emerge at any time from this diversity. A clearer understanding of what mechanisms drive these dramatic changes in vector-host transmission cycles that result in the human population becoming significantly more exposed, will help to prepare us for the next emerging epidemic/pandemic. This Chapter seeks to provide a brief overview of the arboviruses, their mode of transmission and some of the known factors that drive their expansion.
C1 [Young, Paul R.] Univ Queensland, Sch Chem & Mol Biosci, Australian Infect Dis Res Ctr, Brisbane, Qld, Australia.
RP Young, PR (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, Australian Infect Dis Res Ctr, Brisbane, Qld, Australia.
EM p.young@uq.edu.au
FU Australian National Health and Medical Research CouncilNational Health
   and Medical Research Council of Australia
FX This brief overview has been adapted, in part from [21]. The author
   wishes to express his thanks for ongoing funding support from the
   Australian National Health and Medical Research Council and to
   ViralZone, SIB Swiss Institute of Bioinformatics for granting their
   permission to use the virus schematics in Fig. 1.1.
CR [Anonymous], 1985, WHO TECH REP SER, P1
   CALISHER CH, 1988, ARBOVIRUSES EPIDEMIO, V1, P19
   Calisher Charles H., 1995, P1
   Claflin SB, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005070
   Dunn FL, 1988, ARBOVIRUSES EPIDEMIO, VI, P281
   Githeko AK, 2000, B WORLD HEALTH ORGAN, V78, P1136
   Gonzalez JP, 1997, FACTORS IN THE EMERGENCE OF ARBOVIRUS DISEASES, P117
   Gould EA, 2009, T ROY SOC TROP MED H, V103, P109, DOI 10.1016/j.trstmh.2008.07.025
   Gould E, 2017, ONE HEALTH-AMSTERDAM, V4, P1, DOI 10.1016/j.onehlt.2017.06.001
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Her Z, 2009, MICROBES INFECT, V11, P1165, DOI 10.1016/j.micinf.2009.09.004
   Mayer SV, 2017, ACTA TROP, V166, P155, DOI 10.1016/j.actatropica.2016.11.020
   McMichael AJ, 2006, LANCET, V367, P859, DOI 10.1016/S0140-6736(06)68079-3
   Mills JN, 2010, ENVIRON HEALTH PERSP, V118, P1507, DOI 10.1289/ehp.0901389
   Morin CW, 2013, P NATL ACAD SCI USA, V110, P15620, DOI 10.1073/pnas.1307135110
   Pfeffer M, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-35
   Porterfield JS, 1986, TOGAVIRIDAE FLAVIVIR, P1
   Sharma A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00110
   Shi M, 2016, J VIROL, V90, P659, DOI 10.1128/JVI.02036-15
   SIMPSON DIH, 1972, BRIT MED BULL, V28, P10, DOI 10.1093/oxfordjournals.bmb.a070876
   Young PR, 2014, MANSONS TROPICAL DIS, P129
NR 21
TC 5
Z9 5
U1 0
U2 5
PU SPRINGER-VERLAG SINGAPORE PTE LTD
PI SINGAPORE
PA 152 BEACH ROAD, #21-01/04 GATEWAY EAST, SINGAPORE, 189721, SINGAPORE
SN 0065-2598
EI 2214-8019
BN 978-981-10-8727-1; 978-981-10-8726-4
J9 ADV EXP MED BIOL
JI Adv.Exp.Med.Biol.
PY 2018
VL 1062
BP 1
EP 10
DI 10.1007/978-981-10-8727-1_1
PG 10
WC Infectious Diseases; Medicine, Research & Experimental; Tropical
   Medicine; Virology
SC Infectious Diseases; Research & Experimental Medicine; Tropical
   Medicine; Virology
GA BK8XO
UT WOS:000443965000002
PM 29845521
DA 2020-07-08
ER

PT S
AU Hilgenfeld, R
   Vasudevan, SG
AF Hilgenfeld, Rolf
   Vasudevan, Subhash G.
BE Hilgenfeld, R
   Vasudevan, SG
TI Dengue and Zika: Control and Antiviral Treatment Strategies Preface
SO DENGUE AND ZIKA: CONTROL AND ANTIVIRAL TREATMENT STRATEGIES
SE Advances in Experimental Medicine and Biology
LA English
DT Editorial Material
CT 2nd Tofo Advanced Study Week on Emerging Viruses - Dengue and Zika -
   Control and Antiviral Treatment Strategies
CY AUG 28-SEP 01, 2016
CL Inhambane, MOZAMBIQUE
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER-VERLAG SINGAPORE PTE LTD
PI SINGAPORE
PA 152 BEACH ROAD, #21-01/04 GATEWAY EAST, SINGAPORE, 189721, SINGAPORE
SN 0065-2598
EI 2214-8019
BN 978-981-10-8727-1; 978-981-10-8726-4
J9 ADV EXP MED BIOL
JI Adv.Exp.Med.Biol.
PY 2018
VL 1062
BP V
EP VI
PG 2
WC Infectious Diseases; Medicine, Research & Experimental; Tropical
   Medicine; Virology
SC Infectious Diseases; Research & Experimental Medicine; Tropical
   Medicine; Virology
GA BK8XO
UT WOS:000443965000001
DA 2020-07-08
ER

PT S
AU Gudo, ES
   Falk, K
   Cliff, J
AF Gudo, Eduardo Samo
   Falk, Kerstin
   Cliff, Julie
BE Hilgenfeld, R
   Vasudevan, SG
TI Historical Perspective of Arboviruses in Mozambique and Its Implication
   for Current and Future Epidemics
SO DENGUE AND ZIKA: CONTROL AND ANTIVIRAL TREATMENT STRATEGIES
SE Advances in Experimental Medicine and Biology
LA English
DT Article; Proceedings Paper
CT 2nd Tofo Advanced Study Week on Emerging Viruses - Dengue and Zika -
   Control and Antiviral Treatment Strategies
CY AUG 28-SEP 01, 2016
CL Inhambane, MOZAMBIQUE
DE Arboviruses; Dengue; Chikungunya; Zika virus; Malaria seroepidemiology
ID ZIKA VIRUS; OUTBREAK; CHIKUNGUNYA
AB Mozambique is a tropical country situated in the Southern part of Africa, a region where data on the burden and epidemiology of arbovirus is presently quite scarce although the frequency of outbreaks caused by arboviruses is rapidly increasing. Outbreaks of dengue fever have been reported in Mozambique, Angola and Tanzania and a recent unprecedented outbreak of Yellow fever has been recorded in Angola. These new outbreaks collectively suggest that arboviruses, and specifically flavivirus infections, are endemic in Mozambique.
   Although recent data on arbovirus activity is scarce, the work of Kokernot et al. [R.H. Kokernot, K.C. Smithburn, A.F. Gandara, B.M. Mc'Intosh and C.S. Heymann Anais Inst Med Trop (1960),17:201-230] describes sero-epidemiological and entomological studies carried out in several parts of Mozambique during the 1950s. Complementary sero-epidemiological investigations on arboviruses that were conducted in the early 1980s also found serological evidence of several arboviruses which included Dengue, Chikungunya, Zika, Rift Valey Fever, Sinbdis virus, Wesselsbron, Bunyamwera, Pongola and Bawamba Fever and Yellow Fever.
   Notably the first description of Chikungunya virus in 1952-1953 in Tanzania also included reported cases in northern Mozambique. Furthermore, DENV serotype 3 was for the first time described in northern Mozambique in 1984 and 1985. Since several arboviral infections result in acute self limiting fever they have remained unsuspected for several decades. However, it is well known that during the 1980's intensive malaria control initiatives which included massive distribution of bed nets, community education and indoor and outdoor spraying campaigns were implemented. It is possible that these measures may have influenced the epidemiology of arboviruses. However, the impact of these interventions in controlling the spread of arboviruses is not known.
   In conclusion, the old literature on arboviruses in Mozambique is relevant for assessing the gaps and current risk of occurrence of these pathogens at the region, particularly in a time in which they are spreading worldwide.
C1 [Gudo, Eduardo Samo] Natl Inst Hlth, Maputo, Mozambique.
   [Falk, Kerstin] Publ Hlth Agcy Sweden, Solna, Sweden.
   [Falk, Kerstin] Karolinska Inst, Solna, Sweden.
   [Cliff, Julie] Eduardo Mondlane Univ, Fac Med, Maputo, Mozambique.
RP Gudo, ES (corresponding author), Natl Inst Hlth, Maputo, Mozambique.
CR Aly Mussa Manuel, 2017, BMC Res Notes, V10, P88, DOI [10.1186/s13104-017-2394-2, 10.1186/s13104-017-2417-z]
   Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   GUBLER DJ, 1986, AM J TROP MED HYG, V35, P1280, DOI 10.4269/ajtmh.1986.35.1280
   Gudo ES, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005001
   Gudo ES, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005052
   Gyawali N, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0132-y
   Higa Yukiko, 2015, Tropical Medicine and Health, V43, P107, DOI 10.2149/tmh.2014-29
   KOKERNOT R. H., 1960, AN INST MED TROP, V17, P201
   Larrieu S, 2012, MED TROP MARS, V72
   Massangaie M, 2016, AM J TROP MED HYG, V94, P413, DOI 10.4269/ajtmh.15-0543
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Wahid B, 2017, INT J INFECT DIS, V58, P69, DOI 10.1016/j.ijid.2017.03.006
   WHO, 2016, GEN SUMM OUTC EM COM
   World Health Organization ROfA, 2016, ZIK VIR RISK ASS WHO
   WORTH C. BROOKE, 1960, AN INST MED TROP, V17, P231
NR 17
TC 0
Z9 0
U1 0
U2 1
PU SPRINGER-VERLAG SINGAPORE PTE LTD
PI SINGAPORE
PA 152 BEACH ROAD, #21-01/04 GATEWAY EAST, SINGAPORE, 189721, SINGAPORE
SN 0065-2598
EI 2214-8019
BN 978-981-10-8727-1; 978-981-10-8726-4
J9 ADV EXP MED BIOL
JI Adv.Exp.Med.Biol.
PY 2018
VL 1062
BP 11
EP 18
DI 10.1007/978-981-10-8727-1_2
PG 8
WC Infectious Diseases; Medicine, Research & Experimental; Tropical
   Medicine; Virology
SC Infectious Diseases; Research & Experimental Medicine; Tropical
   Medicine; Virology
GA BK8XO
UT WOS:000443965000003
PM 29845522
DA 2020-07-08
ER

PT S
AU Ohst, C
   Saschenbrecker, S
   Stiba, K
   Steinhagen, K
   Probst, C
   Radzimski, C
   Lattwein, E
   Komorowski, L
   Stocker, W
   Schlumberger, W
AF Ohst, Claudia
   Saschenbrecker, Sandra
   Stiba, Konstanze
   Steinhagen, Katja
   Probst, Christian
   Radzimski, Christiane
   Lattwein, Erik
   Komorowski, Lars
   Stoecker, Winfried
   Schlumberger, Wolfgang
BE Hilgenfeld, R
   Vasudevan, SG
TI Reliable Serological Testing for the Diagnosis of Emerging Infectious
   Diseases
SO DENGUE AND ZIKA: CONTROL AND ANTIVIRAL TREATMENT STRATEGIES
SE Advances in Experimental Medicine and Biology
LA English
DT Article; Proceedings Paper
CT 2nd Tofo Advanced Study Week on Emerging Viruses - Dengue and Zika -
   Control and Antiviral Treatment Strategies
CY AUG 28-SEP 01, 2016
CL Inhambane, MOZAMBIQUE
DE Antibody detection; Serological tests; Indirect immunofluorescence test;
   ELISA; NS1 antigen specific test for Dengue and Zika
ID LINKED-IMMUNOSORBENT-ASSAY; DENGUE VIRUS-INFECTIONS; RT-PCR ASSAY; ZIKA
   VIRUS; CHIKUNGUNYA-VIRUS; IMMUNOGLOBULIN-M; ANTIBODY-RESPONSES; PROTEIN
   NS1; CAPTURE-ELISA; SECONDARY INFECTIONS
AB Climate change, increased urbanization and international travel have facilitated the spread of mosquito vectors and the viral species they carry. Zika virus (ZIKV) is currently spreading in the Americas, while dengue virus (DENV) and chikungunya virus (CHIKV) have already become firmly established in most tropical and also many non-tropical regions. ZIKV, DENV and CHIKV overlap in their endemic areas and cause similar clinical symptoms, especially in the initial stages of infection. Infections with each of these viruses can lead to severe complications, and coinfections have been reported. Therefore, laboratory analyses play an important role in differential diagnostics. A timely and accurate diagnosis is crucial for patient management, prevention of unnecessary therapies, rapid adoption of vector control measures, and collection of epidemiological data.
   There are two pillars to diagnosis: direct pathogen detection and the determination of specific antibodies. Serological tests provide a longer diagnostic window than direct methods, and are suitable for diagnosing acute and past infections, for disease surveillance and for vaccination monitoring. ELISA and indirect immunofluorescence test (IIFT) systems based on optimized antigens enable sensitive and specific detection of antibodies against ZIKV, DENV and CHIKV in patient serum or plasma. In recent years, Euroimmun (Lubeck, Germany) has developed numerous test systems for the serological diagnosis of (re-) emerging diseases, including a very sensitive and specific anti-ZIKV ELISA.
C1 [Ohst, Claudia; Saschenbrecker, Sandra; Stiba, Konstanze; Steinhagen, Katja; Probst, Christian; Radzimski, Christiane; Lattwein, Erik; Komorowski, Lars; Stoecker, Winfried; Schlumberger, Wolfgang] Euroimmun AG, Inst Expt Immunol, Lubeck, Germany.
RP Saschenbrecker, S (corresponding author), Euroimmun AG, Inst Expt Immunol, Lubeck, Germany.
EM s.saschenbrecker@euroimmun.de
CR Alcon S, 2002, J CLIN MICROBIOL, V40, P376, DOI 10.1128/JCM.40.02.376-381.2002
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Bessoff K, 2008, CLIN VACCINE IMMUNOL, V15, P1513, DOI 10.1128/CVI.00140-08
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Blacksell SD, 2006, CLIN INFECT DIS, V42, P1127, DOI 10.1086/501358
   Blacksell SD, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/151967
   Blacksell SD, 2012, CLIN VACCINE IMMUNOL, V19, P804, DOI 10.1128/CVI.05717-11
   Blacksell SD, 2011, CLIN VACCINE IMMUNOL, V18, P2095, DOI 10.1128/CVI.05285-11
   Blacksell SD, 2011, CLIN VACCINE IMMUNOL, V18, P1773, DOI 10.1128/CVI.05288-11
   BRAVO JR, 1987, T ROY SOC TROP MED H, V81, P816, DOI 10.1016/0035-9203(87)90041-1
   Burdino E, 2016, EMERG INFECT DIS, V22, P1837, DOI 10.3201/eid2210.151784
   Caglayik DY, 2012, MIKROBIYOL BUL, V46, P122
   Caglioti C, 2013, NEW MICROBIOL, V36, P211
   CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37
   Calleri G, 2016, TRAVEL MED INFECT DI, V14, P506, DOI 10.1016/j.tmaid.2016.07.001
   Calvo EP, 2016, ACTA TROP, V163, P32, DOI 10.1016/j.actatropica.2016.07.021
   Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009
   CDC, 2016, GUID US LAB TEST ZIK
   Chanama S, 2004, J CLIN VIROL, V31, P185, DOI 10.1016/j.jcv.2004.03.005
   Chien LJ, 2006, J CLIN MICROBIOL, V44, P1295, DOI 10.1128/JCM.44.4.1295-1304.2006
   Cleton NB, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003580
   Corbett KS, 2015, J INFECT DIS, V211, P590, DOI 10.1093/infdis/jiu481
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   Cuzzubbo AJ, 2000, J CLIN VIROL, V16, P135, DOI 10.1016/S1386-6532(99)00076-1
   De Decker S, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003596
   De Paula Sérgio Oliveira, 2004, Braz J Infect Dis, V8, P390, DOI 10.1590/S1413-86702004000600002
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Dussart P, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000280
   Dussart P, 2006, CLIN VACCINE IMMUNOL, V13, P1185, DOI 10.1128/CVI.00229-06
   Falconar AKI, 2006, CLIN VACCINE IMMUNOL, V13, P1044, DOI 10.1128/CVI.00105-06
   FDA, 2016, EM US AUTH
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Fourcade C, 2016, J CLIN VIROL, V82, P1, DOI 10.1016/j.jcv.2016.06.011
   Frank C, 2016, EURO SURVEILL, V21
   Fry SR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001199
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Granger D, 2016, 32 CLIN VIR S MAY 19
   Guzman MG, 2004, INT J INFECT DIS, V8, P69, DOI 10.1016/j.ijid.2003.03.003
   Hunsperger EA, 2009, EMERG INFECT DIS, V15, P436, DOI 10.3201/eid1503.080923
   Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203
   INSTAND, 2016, REP EXT AU ASS SCHEM
   Johnson BW, 2016, AM J TROP MED HYG, V95, P182, DOI 10.4269/ajtmh.16-0013
   Kosasih H, 2012, SE ASIAN J TROP MED, V43, P55
   KUNO G, 1985, B WORLD HEALTH ORGAN, V63, P279
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Landry ML, 2017, ARCH PATHOL LAB MED, V141, P60, DOI 10.5858/arpa.2016-0406-SA
   Latz A, 2015, 25 EUR C CLIN MICR I
   Laurent P, 2007, CLIN CHEM, V53, P1408, DOI 10.1373/clinchem.2007.086595
   Lewthwaite P, 2010, TROP MED INT HEALTH, V15, P811, DOI 10.1111/j.1365-3156.2010.02537.x
   Libraty DH, 2002, J INFECT DIS, V186, P1165, DOI 10.1086/343813
   Litzba N, 2008, J VIROL METHODS, V149, P175, DOI 10.1016/j.jviromet.2008.01.004
   Matheus S, 2016, EMERG INFECT DIS, V22, P1691, DOI 10.3201/eid2209.160725
   Meltzer E, 2016, EMERG INFECT DIS, V22, P1521, DOI 10.3201/eid2208.160480
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nawa M, 2005, CLIN DIAGN LAB IMMUN, V12, P1235, DOI 10.1128/CDLI.12.10.1235-1237.2005
   Niedrig M, 2009, CLIN MICROBIOL INFEC, V15, P880, DOI 10.1111/j.1469-0691.2009.02851.x
   Nunes MRT, 2011, J VIROL METHODS, V171, P13, DOI 10.1016/j.jviromet.2010.09.021
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Osorio L, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-361
   Pabbaraju K, 2016, J CLIN VIROL, V83, P66, DOI 10.1016/j.jcv.2016.09.001
   PAHO, 2016, DENG GUID PAT CAR RE
   PAHO/WHO, 2015, ZIK VIR ZIKV SURV AM
   Pal S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113411
   Peeling RW, 2010, NAT REV MICROBIOL, pS30, DOI 10.1038/nrmicro2459
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Prat CM, 2014, EMERG INFECT DIS, V20, P2129, DOI 10.3201/eid2012.141269
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Puschnik A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002274
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Reusken C, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.23.30251
   Rivetz B, 2009, CLIN BIOCHEM, V42, P180, DOI 10.1016/j.clinbiochem.2008.10.017
   Rodrigues LC, 2016, LANCET INFECT DIS
   ROSEN L, 1981, AM J TROP MED HYG, V30, P177, DOI 10.4269/ajtmh.1981.30.177
   Sa-Ngasang A, 2006, EPIDEMIOL INFECT, V134, P820, DOI 10.1017/S0950268805005753
   Sang CT, 1998, CLIN DIAGN LAB IMMUN, V5, P7, DOI 10.1128/CDLI.5.1.7-10.1998
   Schilling S, 2004, J CLIN VIROL, V31, P179, DOI 10.1016/j.jcv.2004.03.020
   Shu PY, 2003, CLIN DIAGN LAB IMMUN, V10, P622, DOI 10.1128/CDLI.10.4.622-630.2003
   Sierra B, 2012, AM J TROP MED HYG, V87, P538, DOI 10.4269/ajtmh.2012.11-0531
   Smith MD, 2015, J ADV BIOL BIOTECHNO, V2, P79
   Steinhagen K, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Suk-Yin Chan, 1994, Southeast Asian Journal of Tropical Medicine and Public Health, V25, P258
   Tang KF, 2012, EXPERT REV ANTI-INFE, V10, P895, DOI [10.1586/eri.12.76, 10.1586/ERI.12.76]
   TDR/PDVI/WHO, 2009, DIAGN EV SER, V3
   TDR/WHO, 2009, DENG GUD DIAGN TRATM
   Tricou V, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-142
   Van Esbroeck M, 2016, EUROSURVEILLANCE, V21, P32, DOI 10.2807/1560-7917.ES.2016.21.21.30237
   Vaughn DW, 1997, J INFECT DIS, V176, P322, DOI 10.1086/514048
   Vaughn DW, 1999, AM J TROP MED HYG, V60, P693, DOI 10.4269/ajtmh.1999.60.693
   Vazquez S, 2007, J CLIN VIROL, V39, P194, DOI 10.1016/j.jcv.2007.04.003
   Vickers IE, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0164-9
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Wang SM, 2016, METHODS MOL BIOL, V1426, P105, DOI 10.1007/978-1-4939-3618-2_10
   Wang SM, 2010, AM J TROP MED HYG, V83, P690, DOI 10.4269/ajtmh.2010.10-0117
   Welch RJ, 2014, J VIROL METHODS, V195, P247, DOI 10.1016/j.jviromet.2013.10.019
   World Health Organization, 2016, CURR ZIK PROD PIP
   Yap G, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000753
   Young PR, 2000, J CLIN MICROBIOL, V38, P1053, DOI 10.1128/JCM.38.3.1053-1057.2000
   Zavattoni M, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.31.30308
NR 99
TC 3
Z9 3
U1 2
U2 6
PU SPRINGER-VERLAG SINGAPORE PTE LTD
PI SINGAPORE
PA 152 BEACH ROAD, #21-01/04 GATEWAY EAST, SINGAPORE, 189721, SINGAPORE
SN 0065-2598
EI 2214-8019
BN 978-981-10-8727-1; 978-981-10-8726-4
J9 ADV EXP MED BIOL
JI Adv.Exp.Med.Biol.
PY 2018
VL 1062
BP 19
EP 43
DI 10.1007/978-981-10-8727-1_3
PG 25
WC Infectious Diseases; Medicine, Research & Experimental; Tropical
   Medicine; Virology
SC Infectious Diseases; Research & Experimental Medicine; Tropical
   Medicine; Virology
GA BK8XO
UT WOS:000443965000004
PM 29845523
DA 2020-07-08
ER

PT S
AU Gallichotte, EN
   Baric, RS
   de Silva, AM
AF Gallichotte, Emily N.
   Baric, Ralph S.
   de Silva, Aravinda M.
BE Hilgenfeld, R
   Vasudevan, SG
TI The Molecular Specificity of the Human Antibody Response to Dengue Virus
   Infections
SO DENGUE AND ZIKA: CONTROL AND ANTIVIRAL TREATMENT STRATEGIES
SE Advances in Experimental Medicine and Biology
LA English
DT Article; Proceedings Paper
CT 2nd Tofo Advanced Study Week on Emerging Viruses - Dengue and Zika -
   Control and Antiviral Treatment Strategies
CY AUG 28-SEP 01, 2016
CL Inhambane, MOZAMBIQUE
DE Dengue virus; Neutralizing antibodies; Human antibodies; Dengue
   epitopes; Dengue vaccines
ID HUMAN MONOCLONAL-ANTIBODIES; ORIGINAL ANTIGENIC SIN; MEMORY B-CELLS;
   NEUTRALIZING ANTIBODIES; CROSS-REACTIVITY; SURFACE-PROTEINS; HIGHLY
   POTENT; ZIKA VIRUS; DOMAIN-III; SEROTYPE 3
AB Dengue viruses (DENV) are mosquito-borne positive sense RNA viruses in the family Flaviviridae. The four serotypes of DENV (DENV1, DENV2, DENV3, DENV4) are widely distributed and it is estimated over a third of the world's population is at risk of infection [4]. While the majority of infections are asymptomatic, DENV infection can cause a spectrum of disease, from mild flu-like symptoms, to the more severe DENV hemorrhagic fever and shock syndrome [24]. Over the past 20 years, there have been intense efforts to develop a tetravalent live-attenuated DENV vaccine [36]. The process of vaccine development has been largely empirical, because effective live attenuated vaccines have been developed for other flaviviruses like yellow fever and Japanese encephalitis viruses. However, recent results from phase III live attenuated DENV vaccine efficacy trials are mixed with evidence for efficacy in some populations but not others [20]. In light of unexpected results from DENV vaccine trials, in this chapter we will review recent discoveries about the human antibody response to natural DENV infection and discuss the relevance of this work to understanding vaccine performance.
C1 [Gallichotte, Emily N.; Baric, Ralph S.; de Silva, Aravinda M.] Univ N Carolina, Sch Med, Dept Microbiol & Immunol, Chapel Hill, NC 27515 USA.
   [Baric, Ralph S.] Univ N Carolina, Sch Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27515 USA.
RP de Silva, AM (corresponding author), Univ N Carolina, Sch Med, Dept Microbiol & Immunol, Chapel Hill, NC 27515 USA.
EM desilva@med.unc.edu
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [P01 AI106695]
CR Amorim JH, 2014, VIRUS RES, V181, P53, DOI 10.1016/j.virusres.2014.01.001
   Avirutnan P, 2006, J INFECT DIS, V193, P1078, DOI 10.1086/500949
   Beatty PR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3787
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   Coloma J, 2015, NAT IMMUNOL, V16, P135, DOI 10.1038/ni.3081
   Corbett KS, 2015, J INFECT DIS, V211, P590, DOI 10.1093/infdis/jiu481
   de Alwis R, 2012, P NATL ACAD SCI USA, V109, P7439, DOI 10.1073/pnas.1200566109
   de Alwis R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001188
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Dowd KA, 2015, MBIO, V6, DOI 10.1128/mBio.01559-15
   Dowd KA, 2014, J VIROL, V88, P11726, DOI 10.1128/JVI.01140-14
   Fibriansah G, 2015, SCIENCE, V349, P88, DOI 10.1126/science.aaa8651
   Fibriansah G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7341
   Fibriansah G, 2014, EMBO MOL MED, V6, P358, DOI 10.1002/emmm.201303404
   Gallichotte EN, 2015, MBIO, V6, DOI 10.1128/mBio.01461-15
   Goo L, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006178
   Gromowski GD, 2007, VIROLOGY, V366, P349, DOI 10.1016/j.virol.2007.05.042
   Guy B, 2016, NAT REV MICROBIOL, V14, P45, DOI 10.1038/nrmicro.2015.2
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Hadjilaou A, 2015, J IMMUNOL, V195, P3490, DOI 10.4049/jimmunol.1500918
   Halstead S. B., 2015, F1000RES, V4
   HALSTEAD SB, 1983, AM J TROP MED HYG, V32, P154, DOI 10.4269/ajtmh.1983.32.154
   Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4
   Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0
   Halstead SB, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.AID-0022-2014
   Hasan SS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14722
   HE RT, 1995, J MED VIROL, V45, P451, DOI 10.1002/jmv.1890450417
   Henein S, 2017, J INFECT DIS, V215, P351, DOI 10.1093/infdis/jiw576
   Kaufmann B, 2010, P NATL ACAD SCI USA, V107, P18950, DOI 10.1073/pnas.1011036107
   Kuhn RJ, 2015, VIROLOGY, V479, P508, DOI 10.1016/j.virol.2015.03.025
   Kurosaki T, 2015, NAT REV IMMUNOL, V15, P149, DOI 10.1038/nri3802
   Kwakkenbos MJ, 2010, NAT MED, V16, P123, DOI 10.1038/nm.2071
   Libraty DH, 2002, J INFECT DIS, V186, P1165, DOI 10.1086/343813
   Liu Y, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.74
   Matheus S, 2005, J CLIN MICROBIOL, V43, P2793, DOI 10.1128/JCM.43.6.2793-2797.2005
   Messer WB, 2016, J VIROL, V90, P5090, DOI 10.1128/JVI.00155-16
   Mukherjee S, 2016, VIROLOGY, V497, P33, DOI 10.1016/j.virol.2016.06.022
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Nivarthi UK, 2017, J VIROL, V91, DOI 10.1128/JVI.02041-16
   Olkowski S, 2013, J INFECT DIS, V208, P1026, DOI 10.1093/infdis/jit273
   Patel B, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005554
   Robinson WH, 2015, NAT REV RHEUMATOL, V11, P171, DOI 10.1038/nrrheum.2014.220
   Roehrig JT, 2003, ADV VIRUS RES, V59, P141, DOI 10.1016/S0065-3527(03)59005-4
   Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   Smith DP, 2013, MBIO, V4, DOI 10.1128/mBio.00133-12
   Smith K, 2009, NAT PROTOC, V4, P372, DOI 10.1038/nprot.2009.3
   Smith SA, 2016, J VIROL, V90, P780, DOI 10.1128/JVI.01805-15
   Smith SA, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.AID-0027-2014
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Sukupolvi-Petty S, 2007, J VIROL, V81, P12816, DOI 10.1128/JVI.00432-07
   Teoh EP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003888
   Tsai WY, 2015, J VIROL, V89, P7348, DOI 10.1128/JVI.00273-15
   Tsai WY, 2013, J VIROL, V87, P12562, DOI 10.1128/JVI.00871-13
   de Souza VAUF, 2007, J CLIN VIROL, V39, P230, DOI 10.1016/j.jcv.2007.04.005
   Wahala WMPB, 2009, VIROLOGY, V392, P103, DOI 10.1016/j.virol.2009.06.037
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Yu IM, 2009, J VIROL, V83, P12101, DOI 10.1128/JVI.01637-09
   Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264
   Zompi S, 2013, P NATL ACAD SCI USA, V110, P8761, DOI 10.1073/pnas.1306333110
   Zompi S, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001568
   Zybert IA, 2008, J GEN VIROL, V89, P3047, DOI 10.1099/vir.0.2008/002535-0
NR 63
TC 3
Z9 3
U1 0
U2 1
PU SPRINGER-VERLAG SINGAPORE PTE LTD
PI SINGAPORE
PA 152 BEACH ROAD, #21-01/04 GATEWAY EAST, SINGAPORE, 189721, SINGAPORE
SN 0065-2598
EI 2214-8019
BN 978-981-10-8727-1; 978-981-10-8726-4
J9 ADV EXP MED BIOL
JI Adv.Exp.Med.Biol.
PY 2018
VL 1062
BP 63
EP 76
DI 10.1007/978-981-10-8727-1_5
PG 14
WC Infectious Diseases; Medicine, Research & Experimental; Tropical
   Medicine; Virology
SC Infectious Diseases; Research & Experimental Medicine; Tropical
   Medicine; Virology
GA BK8XO
UT WOS:000443965000006
PM 29845525
DA 2020-07-08
ER

PT S
AU Shi, Y
   Dai, LP
   Song, H
   Gao, GF
AF Shi, Yi
   Dai, Lianpan
   Song, Hao
   Gao, George F.
BE Hilgenfeld, R
   Vasudevan, SG
TI Structures of Zika Virus E & NS1: Relations with Virus Infection and
   Host Immune Responses
SO DENGUE AND ZIKA: CONTROL AND ANTIVIRAL TREATMENT STRATEGIES
SE Advances in Experimental Medicine and Biology
LA English
DT Article; Proceedings Paper
CT 2nd Tofo Advanced Study Week on Emerging Viruses - Dengue and Zika -
   Control and Antiviral Treatment Strategies
CY AUG 28-SEP 01, 2016
CL Inhambane, MOZAMBIQUE
DE Crystal structure; Zika virus; Neutralizing antibodies; NS1; E protein
ID WEST-NILE-VIRUS; NEUTRALIZING HUMAN-ANTIBODIES; CROSS-REACTIVE
   ANTIBODIES; BORNE ENCEPHALITIS-VIRUS; MALE SEXUAL TRANSMISSION;
   FC-GAMMA-RECEPTOR; DENGUE VIRUS; PROTEIN NS1; MEMBRANE ASSOCIATION;
   ENVELOPE PROTEIN
AB Zika virus (ZIKV), first discovered in the Zika forest in Uganda in 1947 was understudied until the recent explosive epidemic in several South American countries where it has become strongly associated with congenital birth defects leading to severe cranial malformations and neurological conditions. The increase in number of case of microcephaly in newborn children associated with ZIKV infection triggered the World Health Organization to declare the epidemic as a Public Health Emergency of International Concern in February of 2016. ZIKV is a member of the flavivirus genus and is transmitted by Aedes aegypti mosquitoes, however in the current epidemic clear evidence is emerging to suggest the virus can be sexually transmitted from human to human. The differences in epidemiology and manifestations of ZIKV infection during these outbreaks have prompted researchers to investigate mechanisms of dissemination, pathogenesis, and host immune response which contributes significantly to the control of the virus infection. The E and NS1 proteins of ZIKV are the major targets for neutralizing and protective antibodies. In this chapter, we mainly focus on recent research on the crystal structures of the ZIKV E and NS1 proteins, and their relations with virus infection and immune responses. These studies will be helpful to develop novel therapeutics and vaccines for protection and control of ZIKV infection.
C1 [Shi, Yi; Gao, George F.] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China.
   [Dai, Lianpan; Song, Hao; Gao, George F.] Chinese Acad Sci, Beijing Inst Life Sci, RNIH, Beijing, Peoples R China.
RP Shi, Y; Gao, GF (corresponding author), Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China.; Gao, GF (corresponding author), Chinese Acad Sci, Beijing Inst Life Sci, RNIH, Beijing, Peoples R China.
EM shiyi@im.ac.cn; gaof@im.ac.cn
CR Akey DL, 2014, SCIENCE, V343, P881, DOI 10.1126/science.1247749
   Alcon S, 2002, J CLIN MICROBIOL, V40, P376, DOI 10.1128/JCM.40.02.376-381.2002
   ALLISON SL, 1995, J VIROL, V69, P695, DOI 10.1128/JVI.69.2.695-700.1995
   Amorim JH, 2014, VIRUS RES, V181, P53, DOI 10.1016/j.virusres.2014.01.001
   Avirutnan P, 2007, PLOS PATHOG, V3, P1798, DOI 10.1371/journal.ppat.0030183
   Avirutnan P, 2010, J EXP MED, V207, P793, DOI 10.1084/jem.20092545
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Beatty PR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3787
   Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brown WC, 2016, NAT STRUCT MOL BIOL, V23, P865, DOI 10.1038/nsmb.3268
   Calvet GA, 2016, CURR OPIN INFECT DIS, V29, P459, DOI 10.1097/QCO.0000000000000301
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Chen JC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005053
   Cheng HJ, 2009, EXP BIOL MED, V234, P63, DOI 10.3181/0805-RM-147
   Cherrier MV, 2009, EMBO J, V28, P3269, DOI 10.1038/emboj.2009.245
   Chuang YC, 2014, J VIROL, V88, P13759, DOI 10.1128/JVI.02166-14
   Chuang YC, 2011, J IMMUNOL, V187, P6483, DOI 10.4049/jimmunol.1102218
   Chung KM, 2006, J VIROL, V80, P1340, DOI 10.1128/JVI.80.3.1340-1351.2006
   Chung KM, 2006, P NATL ACAD SCI USA, V103, P19111, DOI 10.1073/pnas.0605668103
   Dai LP, 2016, IUBMB LIFE, V68, P783, DOI 10.1002/iub.1556
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Deng Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018605
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Edeling MA, 2014, P NATL ACAD SCI USA, V111, P4285, DOI 10.1073/pnas.1322036111
   Fibriansah G, 2013, J VIROL, V87, P7585, DOI 10.1128/JVI.00757-13
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Hilgenfeld R, 2016, EMBO J, V35, P2631, DOI 10.15252/embj.201695871
   Kaufmann B, 2010, P NATL ACAD SCI USA, V107, P18950, DOI 10.1073/pnas.1011036107
   Kaufmann B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000672
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Liu IJ, 2011, J BIOL CHEM, V286, P9726, DOI 10.1074/jbc.M110.170993
   Lok SM, 2008, NAT STRUCT MOL BIOL, V15, P312, DOI 10.1038/nsmb.1382
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Modhiran N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3863
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   SCHLESINGER JJ, 1987, J GEN VIROL, V68, P853, DOI 10.1099/0022-1317-68-3-853
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Stiasny K, 2004, J VIROL, V78, P3178, DOI 10.1128/JVI.78.6.3178-3183.2004
   Stiasny K, 1996, J VIROL, V70, P8142, DOI 10.1128/JVI.70.11.8142-8147.1996
   Sun DS, 2007, J THROMB HAEMOST, V5, P2291, DOI 10.1111/j.1538-7836.2007.02754.x
   Sun DS, 2015, J IMMUNOL, V195, P2743, DOI 10.4049/jimmunol.1500136
   Vogt MR, 2011, J VIROL, V85, P11567, DOI 10.1128/JVI.05859-11
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Xu XY, 2016, EMBO J, V35, P2170, DOI 10.15252/embj.201695290
   Yin Y, 2013, VIRAL IMMUNOL, V26, P185, DOI 10.1089/vim.2012.0063
   Young PR, 2000, J CLIN MICROBIOL, V38, P1053, DOI 10.1128/JCM.38.3.1053-1057.2000
   Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264
   Zhang YJ, 2016, PROTEIN CELL, V7, P461, DOI 10.1007/s13238-016-0274-5
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 63
TC 4
Z9 4
U1 3
U2 11
PU SPRINGER-VERLAG SINGAPORE PTE LTD
PI SINGAPORE
PA 152 BEACH ROAD, #21-01/04 GATEWAY EAST, SINGAPORE, 189721, SINGAPORE
SN 0065-2598
EI 2214-8019
BN 978-981-10-8727-1; 978-981-10-8726-4
J9 ADV EXP MED BIOL
JI Adv.Exp.Med.Biol.
PY 2018
VL 1062
BP 77
EP 87
DI 10.1007/978-981-10-8727-1_6
PG 11
WC Infectious Diseases; Medicine, Research & Experimental; Tropical
   Medicine; Virology
SC Infectious Diseases; Research & Experimental Medicine; Tropical
   Medicine; Virology
GA BK8XO
UT WOS:000443965000007
PM 29845526
DA 2020-07-08
ER

PT S
AU de Silva, AM
   Rey, FA
   Young, PR
   Hilgenfeld, R
   Vasudevan, SG
AF de Silva, Aravinda M.
   Rey, Felix A.
   Young, Paul R.
   Hilgenfeld, Rolf
   Vasudevan, Subhash G.
BE Hilgenfeld, R
   Vasudevan, SG
TI Viral Entry and NS1 as Potential Antiviral Drug Targets
SO DENGUE AND ZIKA: CONTROL AND ANTIVIRAL TREATMENT STRATEGIES
SE Advances in Experimental Medicine and Biology
LA English
DT Editorial Material
CT 2nd Tofo Advanced Study Week on Emerging Viruses - Dengue and Zika -
   Control and Antiviral Treatment Strategies
CY AUG 28-SEP 01, 2016
CL Inhambane, MOZAMBIQUE
DE Flavivirus entry mechanism; Therapeutic antibodies; Entry inhibitors;
   NS1 pathogenicity; NS1 delipidation
AB A general discussion on viral entry and NS1 as potential drug targets was held at the Tofo Advanced Study Week (TASW) on Emerging Viral Diseases in September 2016. The opportunities and gaps for developing therapeutic countermeasures, to take advantage of the high-resolution cryo-electron microscopy structures of dengue and Zika viruses as well as the novel features of NS1 revealed by the 3D structures, were deliberated.
C1 [de Silva, Aravinda M.] Univ N Carolina, Sch Med, Dept Microbiol & Immunol, Chapel Hill, NC 27515 USA.
   [Rey, Felix A.] Inst Pasteur, Struct Virol Unit, CNRS UMR3569, 25-28 Rue Dr Roux, F-75015 Paris, France.
   [Young, Paul R.] Univ Queensland, Australian Infect Dis Res Ctr, Sch Chem & Mol Biosci, Brisbane, Qld, Australia.
   [Hilgenfeld, Rolf] Univ Lubeck, Inst Biochem, Lubeck, Germany.
   [Vasudevan, Subhash G.] Duke NUS Med Sch Singapore, Emerging Infect Dis Program, Singapore, Singapore.
RP Hilgenfeld, R (corresponding author), Univ Lubeck, Inst Biochem, Lubeck, Germany.; Vasudevan, SG (corresponding author), Duke NUS Med Sch Singapore, Emerging Infect Dis Program, Singapore, Singapore.
EM desilva@med.unc.edu; felix.rey@pasteur.fr; p.young@uq.edu.au;
   hilgenfeld@biochem.uni-luebeck.de; subhash.vasudevan@duke-nus.edu.sg
NR 0
TC 1
Z9 1
U1 0
U2 1
PU SPRINGER-VERLAG SINGAPORE PTE LTD
PI SINGAPORE
PA 152 BEACH ROAD, #21-01/04 GATEWAY EAST, SINGAPORE, 189721, SINGAPORE
SN 0065-2598
EI 2214-8019
BN 978-981-10-8727-1; 978-981-10-8726-4
J9 ADV EXP MED BIOL
JI Adv.Exp.Med.Biol.
PY 2018
VL 1062
BP 107
EP 113
DI 10.1007/978-981-10-8727-1_8
PG 7
WC Infectious Diseases; Medicine, Research & Experimental; Tropical
   Medicine; Virology
SC Infectious Diseases; Research & Experimental Medicine; Tropical
   Medicine; Virology
GA BK8XO
UT WOS:000443965000009
PM 29845528
DA 2020-07-08
ER

PT S
AU Lescar, J
   Soh, S
   Lee, LT
   Vasudevan, SG
   Kang, CB
   Lim, SP
AF Lescar, Julien
   Soh, Sherryl
   Lee, Le Tian
   Vasudevan, Subhash G.
   Kang, Congbao
   Lim, Siew Pheng
BE Hilgenfeld, R
   Vasudevan, SG
TI The Dengue Virus Replication Complex: From RNA Replication to
   Protein-Protein Interactions to Evasion of Innate Immunity
SO DENGUE AND ZIKA: CONTROL AND ANTIVIRAL TREATMENT STRATEGIES
SE Advances in Experimental Medicine and Biology
LA English
DT Article; Proceedings Paper
CT 2nd Tofo Advanced Study Week on Emerging Viruses - Dengue and Zika -
   Control and Antiviral Treatment Strategies
CY AUG 28-SEP 01, 2016
CL Inhambane, MOZAMBIQUE
DE Flavivirus; Replication complex; Protein-protein interactions; Innate
   immunity evasion; Antiviral drug discovery
ID WEST-NILE-VIRUS; AMINO-ACID-RESIDUES; NS4B PROTEIN; MEMBRANE TOPOLOGY;
   NS3 PROTEIN; VIRAL REPLICATION; CRYSTAL-STRUCTURE; DRUG DISCOVERY;
   3-DIMENSIONAL ARCHITECTURE; SECONDARY STRUCTURE
AB Viruses from the Flavivirus family are the causative agents of dengue fever, Zika, Japanese encephalitis, West Nile encephalitis or Yellow fever and constitute major or emerging public health problems. A better understanding of the flavivirus replication cycle is likely to offer new opportunities for the design of antiviral therapies to treat severe conditions provoked by these viruses, but it should also help reveal fundamental biological mechanisms of the host cell. During virus replication, RNA synthesis is mediated by a dynamic and membrane-bound multi-protein assembly, named the replication complex (RC). The RC is composed of both viral and host-cell proteins that assemble within vesicles composed of the endoplasmic reticulum membrane, near the nucleus. At the heart of the flavivirus RC lies NS4B, a viral integral membrane protein that plays a role in virulence and in down-regulating the innate immune response. NS4B binds to the NS2B-NS3 protease-helicase, which itself interacts with the NS5 methyltransferase polymerase. We present an overview of recent structural and functional data that augment our understanding of how viral RNA is replicated by dengue virus. We focus on structural data that illuminate the various roles played by proteins NS2B-NS3, NS4B and NS5. By participating in viral RNA cap methylation, the NS5 methyltransferase enables the virus to escape the host cell innate immune response. We present the molecular basis for this activity. We summarize what we know about the network of interactions established by NS2B-NS3, NS4B and NS5 ("their interactome"). This leads to a working model that is captured in the form of a rather naive "cartoon", which we hope will be refined towards an atomic model in the near future.
C1 [Lescar, Julien; Soh, Sherryl; Lee, Le Tian] Nanyang Inst Struct Biol, Singapore, Singapore.
   [Lescar, Julien] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore.
   [Soh, Sherryl] Novartis Inst Trop Dis, Singapore, Singapore.
   [Vasudevan, Subhash G.] Duke NUS Med Sch Singapore, Emerging Infect Dis Program, Singapore, Singapore.
   [Kang, Congbao] Expt Therapeut Ctr, Singapore, Singapore.
   [Lim, Siew Pheng] Denka Life Innovat Pte Ltd, Singapore, Singapore.
   [Lim, Siew Pheng] Novartis Inst Trop Dis, Singapore, Singapore.
RP Lescar, J (corresponding author), Nanyang Inst Struct Biol, Singapore, Singapore.; Lescar, J (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore.
EM julien@ntu.edu.sg; siewpheng-lim@denka.com.sg
RI Kang, Congbao/AAP-7572-2020
OI Kang, Congbao/0000-0002-9886-9374; Lim, Siew Pheng/0000-0002-7377-5662
FU  [NRF2016NRF-CRP001-063]
FX This work was supported by grant NRF2016NRF-CRP001-063 to the laboratory
   of JL. We acknowledge the contributions of many coworkers (some now PIs
   active in the field) whose names are listed in the references. We also
   apologize for omitting some relevant primary litterature due to space
   limitations.
CR Akey DL, 2014, SCIENCE, V343, P881, DOI 10.1126/science.1247749
   Ashour J, 2009, J VIROL, V83, P5408, DOI 10.1128/JVI.02188-08
   Belov GA, 2012, CURR OPIN VIROL, V2, P740, DOI 10.1016/j.coviro.2012.09.006
   Bressanelli S, 2004, EMBO J, V23, P728, DOI 10.1038/sj.emboj.7600064
   Bussetta C, 2012, BIOCHEMISTRY-US, V51, P5921, DOI 10.1021/bi300406n
   Chatel-Chaix L, 2015, J VIROL, V89, P7170, DOI 10.1128/JVI.00867-15
   Choi KH, 2016, METHOD MOL BIOL, V1138, P241
   Choksupmanee O, 2012, BIOCHEMISTRY-US, V51, P2840, DOI 10.1021/bi2018267
   Chung KY, 2010, VIROLOGY, V402, P52, DOI 10.1016/j.virol.2010.03.011
   Cyrklaff M, 2013, PNAS, V102, P2772
   Dalrymple NA, 2015, MBIO, V6, DOI 10.1128/mBio.00553-15
   Decroly E, 2012, NAT REV MICROBIOL, V10, P51, DOI 10.1038/nrmicro2675
   den Boon JA, 2010, ANNU REV MICROBIOL, V64, P241, DOI 10.1146/annurev.micro.112408.134012
   Ferguson NM, 2016, SCIENCE, V353, P1033, DOI 10.1126/science.aaf9590
   Fernandez-Garcia MD, 2009, CELL HOST MICROBE, V5, P318, DOI 10.1016/j.chom.2009.04.001
   Fischl W, 2011, CURR OPIN MICROBIOL, V14, P470, DOI 10.1016/j.mib.2011.07.012
   Grant D, 2011, J VIROL, V85, P7775, DOI 10.1128/JVI.00665-11
   Guo F, 2016, J VIROL, V90, P10774, DOI 10.1128/JVI.01253-16
   Heaton NS, 2010, P NATL ACAD SCI USA, V107, P17345, DOI 10.1073/pnas.1010811107
   Hino T, 2013, CURR OPIN STRUC BIOL, V23, P563, DOI 10.1016/j.sbi.2013.04.007
   Huang QW, 2013, PROTEIN EXPRES PURIF, V92, P156, DOI 10.1016/j.pep.2013.09.015
   Kelley JF, 2011, VIROLOGY, V418, P27, DOI 10.1016/j.virol.2011.07.006
   Khadka S, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M111.012187-1, 10.1074/mcp.M111.012187]
   Kim AR, 2005, ACTA CRYSTALLOGR D, V61, P1306, DOI 10.1107/S0907444905018822
   Klema VJ, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005451
   Kong GH, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005139
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Kummerer BM, 2002, J VIROL, V76, P4773, DOI 10.1128/JVI.76.10.4773-4784.2002
   Lescar J, 2008, ANTIVIR RES, V80, P94, DOI 10.1016/j.antiviral.2008.07.001
   Lescar J, 2009, CURR OPIN STRUC BIOL, V19, P759, DOI 10.1016/j.sbi.2009.10.011
   Leung JY, 2008, J VIROL, V82, P4731, DOI 10.1128/JVI.00002-08
   Li XD, 2016, J VIROL, V90, P5735, DOI 10.1128/JVI.00340-16
   Li Y, 2016, ANGEW CHEM INT EDIT, V55, P12068, DOI 10.1002/anie.201606609
   Li Y, 2015, BBA-BIOMEMBRANES, V1848, P3150, DOI 10.1016/j.bbamem.2015.09.016
   Li Y, 2015, BBA-BIOMEMBRANES, V1848, P2244, DOI 10.1016/j.bbamem.2015.06.010
   Lim SP, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005737
   Lim SP, 2013, ANTIVIR RES, V100, P500, DOI 10.1016/j.antiviral.2013.09.013
   Lim SP, 2013, J BIOL CHEM, V288, P31105, DOI 10.1074/jbc.M113.508606
   Lim SP, 2008, ANTIVIR RES, V80, P360, DOI 10.1016/j.antiviral.2008.08.005
   Lu GL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003549
   Luo D, 2008, J VIROL, V82, P173, DOI 10.1128/JVI.01788-07
   Luo DH, 2010, J BIOL CHEM, V285, P18817, DOI 10.1074/jbc.M109.090936
   Luo DH, 2008, EMBO J, V27, P3209, DOI 10.1038/emboj.2008.232
   Malet H, 2008, ANTIVIR RES, V80, P23, DOI 10.1016/j.antiviral.2008.06.007
   Miller S, 2006, J BIOL CHEM, V281, P8854, DOI 10.1074/jbc.M512697200
   Miller S, 2008, NAT REV MICROBIOL, V6, P363, DOI 10.1038/nrmicro1890
   Miorin L, 2013, J VIROL, V87, P6469, DOI 10.1128/JVI.03456-12
   Munoz-Jordan JL, 2005, J VIROL, V79, P8004, DOI 10.1128/JVI.79.13.8004-8013.2005
   Noble CG, 2013, J VIROL, V87, P5291, DOI 10.1128/JVI.00045-13
   Paul David, 2013, World J Virol, V2, P32, DOI 10.5501/wjv.v2.i2.32
   Perera R, 2008, CURR OPIN MICROBIOL, V11, P369, DOI 10.1016/j.mib.2008.06.004
   Phoo WW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13410
   Puig-Basagoiti F, 2007, VIROLOGY, V361, P229, DOI 10.1016/j.virol.2006.11.012
   Quinkert D, 2005, J VIROL, V79, P13594, DOI 10.1128/JVI.79.21.13594-13605.2005
   Ritchie TK, 2009, METHOD ENZYMOL, V464, P211, DOI 10.1016/S0076-6879(09)64011-8
   Robinson LN, 2015, CELL, V162, P493, DOI 10.1016/j.cell.2015.06.057
   Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7
   Saw WG, 2015, ACTA CRYSTALLOGR D, V71, P2309, DOI 10.1107/S1399004715017721
   Sessions OM, 2009, NATURE, V458, P1047, DOI 10.1038/nature07967
   Sofia MJ, 2016, CELL, V167, P25, DOI 10.1016/j.cell.2016.08.044
   Stern O, 2013, J VIROL, V87, P4080, DOI 10.1128/JVI.01900-12
   Tay MYF, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005886
   Tay MYF, 2015, J BIOL CHEM, V290, P2379, DOI 10.1074/jbc.M114.607341
   Theiler M, 1937, J EXP MED, V65, P787, DOI 10.1084/jem.65.6.787
   Uchil PD, 2003, J BIOL CHEM, V278, P24388, DOI 10.1074/jbc.M301717200
   Umareddy I, 2006, J GEN VIROL, V87, P2605, DOI 10.1099/vir.0.81844-0
   Walzthoeni T, 2013, CURR OPIN STRUC BIOL, V23, P252, DOI 10.1016/j.sbi.2013.02.008
   Wang QY, 2015, J VIROL, V89, P8233, DOI 10.1128/JVI.00855-15
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   Wicker JA, 2006, VIROLOGY, V349, P245, DOI 10.1016/j.virol.2006.03.007
   Wicker JA, 2012, VIROLOGY, V426, P22, DOI 10.1016/j.virol.2011.11.022
   Xia Y, 2004, ANNU REV BIOCHEM, V73, P1051, DOI 10.1146/annurev.biochem.73.011303.073950
   Xie XP, 2015, ANTIVIR RES, V118, P39, DOI 10.1016/j.antiviral.2015.03.007
   Xie XP, 2014, VIROLOGY, V450, P250, DOI 10.1016/j.virol.2013.12.025
   Xie XP, 2013, J VIROL, V87, P4609, DOI 10.1128/JVI.02424-12
   Xie XP, 2011, J VIROL, V85, P11183, DOI 10.1128/JVI.05468-11
   Yap TL, 2007, J VIROL, V81, P4753, DOI 10.1128/JVI.02283-06
   Youn S, 2012, J VIROL, V86, P7360, DOI 10.1128/JVI.00157-12
   Zhao YQ, 2015, P NATL ACAD SCI USA, V112, P14834, DOI 10.1073/pnas.1514978112
   Zou G, 2011, J BIOL CHEM, V286, P14362, DOI 10.1074/jbc.M110.214189
   Zou J, 2015, J VIROL, V89, P3471, DOI 10.1128/JVI.03454-14
   Zou J, 2014, J VIROL, V88, P3379, DOI 10.1128/JVI.02782-13
NR 82
TC 6
Z9 6
U1 2
U2 7
PU SPRINGER-VERLAG SINGAPORE PTE LTD
PI SINGAPORE
PA 152 BEACH ROAD, #21-01/04 GATEWAY EAST, SINGAPORE, 189721, SINGAPORE
SN 0065-2598
EI 2214-8019
BN 978-981-10-8727-1; 978-981-10-8726-4
J9 ADV EXP MED BIOL
JI Adv.Exp.Med.Biol.
PY 2018
VL 1062
BP 115
EP 129
DI 10.1007/978-981-10-8727-1_9
PG 15
WC Infectious Diseases; Medicine, Research & Experimental; Tropical
   Medicine; Virology
SC Infectious Diseases; Research & Experimental Medicine; Tropical
   Medicine; Virology
GA BK8XO
UT WOS:000443965000010
PM 29845529
DA 2020-07-08
ER

PT S
AU Hilgenfeld, R
   Lei, J
   Zhang, LL
AF Hilgenfeld, Rolf
   Lei, Jian
   Zhang, Linlin
BE Hilgenfeld, R
   Vasudevan, SG
TI The Structure of the Zika Virus Protease, NS2B/NS3(Pro)
SO DENGUE AND ZIKA: CONTROL AND ANTIVIRAL TREATMENT STRATEGIES
SE Advances in Experimental Medicine and Biology
LA English
DT Article; Proceedings Paper
CT 2nd Tofo Advanced Study Week on Emerging Viruses - Dengue and Zika -
   Control and Antiviral Treatment Strategies
CY AUG 28-SEP 01, 2016
CL Inhambane, MOZAMBIQUE
DE Zika virus history; Zika virus disease; congenital Zika syndrome; Zika
   virus protease; boronic-acid inhibitor; Zika virus protease
   dimerization; X-ray crystallography; NMR spectroscopy; anti-Zika virus
   drug discovery
ID NS2B-NS3 PROTEASE; CRYSTAL-STRUCTURE; NS3 PROTEIN; IN-VITRO; INHIBITORS;
   INFECTIONS; OUTBREAK; NIGERIA; IDENTIFICATION; TRANSMISSION
AB In this chapter, we first briefly review the history of Zika virus (ZIKV) over the past 70 years since its discovery. We then focus on the ZIKV NS2B/NS3 protease, a major potential target for anti-ZIKV therapeutics. We describe the structure of the complex between Zika virus NS2B-NS3 protease and a peptide boronic-acid inhibitor that we determined in early 2016. We then review other structural studies on the Zika virus protease, which have been published in the past few months. Three different types of construct for the protease have been investigated by X-ray crystallography and NMR spectroscopy: the traditional "linked" construct comprising the NS2B cofactor, a Gly(4)SerGly(4) linker, and the NS3(Pro) chain; a construct where the linker has been replaced by LysThr-Gly-Lys-Arg, which leads to autocleavage; and the bimolecular "unlinked" protease consisting of the NS2B cofactor segment and NS3(pro). In complex with an inhibitor, the protease adopts a closed, "active" conformation with the NS2B chain wrapped around the NS3(Pro) and contributing to the S2 pocket. In the ligand-free state, the Gly(4)SerGly(4)-linked enzyme adopts an open or relaxed conformation, with the C-terminal half of the NS2B cofactor highly flexible and disordered. Very surprisingly, however, the "unlinked", bimolecular protease has been reported to adopt the closed conformation in the crystal, even though, apparently, no peptide was bound to the substrate-binding site. The Gly(4)SerGly(4)-linked enzyme has been used successfully in drug discovery efforts.
C1 [Hilgenfeld, Rolf; Lei, Jian; Zhang, Linlin] Univ Lubeck, Inst Biochem, Ctr Struct & Cell Biol Med, Ratzeburger Allee 160, D-23562 Lubeck, Germany.
   [Hilgenfeld, Rolf; Zhang, Linlin] Univ Lubeck, German Ctr Infect Res DZIF, Hamburg Lubeck Borstel Riems Site, Lubeck, Germany.
RP Hilgenfeld, R (corresponding author), Univ Lubeck, Inst Biochem, Ctr Struct & Cell Biol Med, Ratzeburger Allee 160, D-23562 Lubeck, Germany.; Hilgenfeld, R (corresponding author), Univ Lubeck, German Ctr Infect Res DZIF, Hamburg Lubeck Borstel Riems Site, Lubeck, Germany.
EM hilgenfeld@biochem.uni-luebeck.de
CR Aliota MT, 2017, ANTIVIR RES, V144, P223, DOI 10.1016/j.antiviral.2017.06.001
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Brecher M, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006411
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chan JFW, 2017, ANTIVIR RES, V141, P29, DOI 10.1016/j.antiviral.2017.02.002
   Chen X, 2016, CELL RES, V26, P1260, DOI 10.1038/cr.2016.116
   Clum S, 1997, J BIOL CHEM, V272, P30715, DOI 10.1074/jbc.272.49.30715
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   FAGBAMI A, 1977, TROP GEOGR MED, V29, P187
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Gruba N, 2016, FEBS LETT, V590, P3459, DOI 10.1002/1873-3468.12443
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Hammamy MZ, 2013, CHEMMEDCHEM, V8, P231, DOI 10.1002/cmdc.201200497
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Ho ZJM, 2017, LANCET INFECT DIS, V17, P813, DOI 10.1016/S1473-3099(17)30249-9
   KOKERNOT R. H., 1960, AN INST MED TROP, V17, P201
   Kuiper BD, 2017, BIOCHEM BIOPH RES CO, V492, P668, DOI 10.1016/j.bbrc.2017.03.108
   Lee H, 2017, ANTIVIR RES, V139, P49, DOI 10.1016/j.antiviral.2016.12.016
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Leung D, 2001, J BIOL CHEM, V276, P45762, DOI 10.1074/jbc.M107360200
   Li J, 2005, J BIOL CHEM, V280, P28766, DOI 10.1074/jbc.M500588200
   Li Y, 2017, FEBS LETT, V591, P2338, DOI 10.1002/1873-3468.12741
   Li Y, 2017, STRUCTURE, V25, P1242, DOI 10.1016/j.str.2017.06.006
   Li Z, 2017, CELL RES, V27, P1046, DOI 10.1038/cr.2017.88
   Lim HJ, 2017, BIOTECHNOL LETT, V39, P415, DOI 10.1007/s10529-016-2261-6
   Luo DH, 2010, J BIOL CHEM, V285, P18817, DOI 10.1074/jbc.M109.090936
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Mahawaththa MC, 2017, ANTIVIR RES, V142, P141, DOI 10.1016/j.antiviral.2017.03.011
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nitsche C, 2017, J MED CHEM, V60, P511, DOI 10.1021/acs.jmedchem.6b01021
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Phoo WW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13410
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   RICE CM, 1985, SCIENCE, V229, P726, DOI 10.1126/science.4023707
   Roth A, 2014, EURO SURVEILL, V19
   Roy A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180632
   Rut W, 2017, ANTIVIR RES, V139, P88, DOI 10.1016/j.antiviral.2016.12.018
   Sahoo Maheswata, 2016, Genomics & Informatics, V14, P104, DOI 10.5808/GI.2016.14.3.104
   Shiryaev SA, 2017, ANTIVIR RES, V143, P218, DOI 10.1016/j.antiviral.2017.04.015
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   SMITHBURN KC, 1954, AM J HYG, V59, P157, DOI 10.1093/oxfordjournals.aje.a119630
   Tian HL, 2016, PROTEIN CELL, V7, P450, DOI 10.1007/s13238-016-0275-4
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Weinert T, 2015, NAT METHODS, V12, P131, DOI 10.1038/nmeth.3211
   WENGLER G, 1991, J GEN VIROL, V72, P851, DOI 10.1099/0022-1317-72-4-851
   Yuan SF, 2017, ANTIVIR RES, V145, P33, DOI 10.1016/j.antiviral.2017.07.007
   Zhang ZZ, 2016, SCIENCE, V354, P1597, DOI 10.1126/science.aai9309
NR 57
TC 2
Z9 2
U1 2
U2 6
PU SPRINGER-VERLAG SINGAPORE PTE LTD
PI SINGAPORE
PA 152 BEACH ROAD, #21-01/04 GATEWAY EAST, SINGAPORE, 189721, SINGAPORE
SN 0065-2598
EI 2214-8019
BN 978-981-10-8727-1; 978-981-10-8726-4
J9 ADV EXP MED BIOL
JI Adv.Exp.Med.Biol.
PY 2018
VL 1062
BP 131
EP 145
DI 10.1007/978-981-10-8727-1_10
PG 15
WC Infectious Diseases; Medicine, Research & Experimental; Tropical
   Medicine; Virology
SC Infectious Diseases; Research & Experimental Medicine; Tropical
   Medicine; Virology
GA BK8XO
UT WOS:000443965000011
PM 29845530
DA 2020-07-08
ER

PT S
AU Tay, MYF
   Vasudevan, SG
AF Tay, Moon Y. F.
   Vasudevan, Subhash G.
BE Hilgenfeld, R
   Vasudevan, SG
TI The Transactions of NS3 and NS5 in Flaviviral RNA Replication
SO DENGUE AND ZIKA: CONTROL AND ANTIVIRAL TREATMENT STRATEGIES
SE Advances in Experimental Medicine and Biology
LA English
DT Article; Proceedings Paper
CT 2nd Tofo Advanced Study Week on Emerging Viruses - Dengue and Zika -
   Control and Antiviral Treatment Strategies
CY AUG 28-SEP 01, 2016
CL Inhambane, MOZAMBIQUE
DE NS5 RNA-dependent RNA-dependent RNA polymerase; Dengue virus infectious
   clone; NS3 helicase; Site-directed mutagenesis; NS3 and NS5 antibodies
ID DENGUE VIRUS TYPE-2; NONSTRUCTURAL PROTEIN 5; NUCLEAR-LOCALIZATION
   SIGNAL; WEST-NILE-VIRUS; CRYSTAL-STRUCTURE; IN-VITRO; METHYLTRANSFERASE
   DOMAIN; POLYMERASE NS5; CATALYTIC DOMAIN; STRUCTURAL BASIS
AB Dengue virus (DENV) replication occurs in virus-induced vesicles that contain the replication complex (RC) where viral RNA, viral proteins and host proteins participate in RNA-RNA, RNA-protein and protein-protein interactions to ensure viral genome synthesis. However, the details of the multitude of interactions involved in the biogenesis of the infectious virion are not fully understood. In this review, we will focus on the interaction between non-structural (NS) proteins NS3 and NS5, as well as their interactions with viral RNA and briefly also the interaction of NS5 with the host nuclear transport receptor protein importin-alpha. The multifunctional NS3 protease/helicase and NS5 methyltransferase (MTase)/RNA-dependent RNA polymerase (RdRp) contain all the enzymatic activities required to synthesize the viral RNA genome. The success stories of drug discovery and development with Hepatitis C virus (HCV), a member of the Flaviviridae family, has led to the view that DENV NS3 and NS5 may be attractive antiviral drug targets. However, more than 10 years of intensive research effort by Novatis has revealed that they are not "low hanging fruits" and therefore, the search for potent directly acting antivirals (DAAs) remains a pipeline goal for several medium to large drug discovery enterprises. The effort to discover DAAs for DENV has been boosted by the epidemic outbreak of the closely related flavivirus member - Zika virus (ZIKV). Because the viral RNA replication occurs within a molecular machine that is composed several viral and host proteins, much interest has turned to characterising functionally essential protein-protein interactions in order to identify potential allosteric inhibitor binding sites within the RC.
C1 [Tay, Moon Y. F.] Nanyang Technol Univ, Nanyang Technol Univ Food Technol Ctr NAFTEC, Singapore, Singapore.
   [Vasudevan, Subhash G.] Duke NUS Med Sch Singapore, Emerging Infect Dis Program, Singapore, Singapore.
RP Vasudevan, SG (corresponding author), Duke NUS Med Sch Singapore, Emerging Infect Dis Program, Singapore, Singapore.
EM subhash.vasudevan@duke-nus.edu.sg
OI Vasudevan, Subhash/0000-0002-5083-3831
FU National Medical Research CouncilMedical Research Council UK (MRC)
   [NMRC/CBRG/0103/2016]; National Research Foundation in
   SingaporeSingapore National Research Foundation [NRF-CRP17-2017-04]
FX We thank our past and present collaborators David A. Jans, Jade K.
   Forwood, Andrew Brooks, Magnus Johansson, Andrew Davidson, Julien
   Lescar, Dahai Luo, Yap T.L., Siew Pheng Lim, Nicole J. Moreland, Indira
   Umareddy, Aruna Sampath, Yongqian Zhao, Ivan H.W. Ng, Kitti W.K. Chan,
   Wuan Geok Saw, Gerhard Gruber, Crystall Swarbrick, Shu Ann Chan, Kate
   Smith, Gottfried Otting, Zheng Yin, Li Shang and Rolf Hilgenfeld for
   their important contributions to understanding of flavivirus NS
   proteins. The research on NS3 and NS5 interactions of flaviviruses in
   the Vasudevan lab is supported by National Medical Research Council
   (NMRC/CBRG/0103/2016) and National Research Foundation
   (NRF-CRP17-2017-04) in Singapore.
CR Akey DL, 2014, SCIENCE, V343, P881, DOI 10.1126/science.1247749
   Aleshin AE, 2007, PROTEIN SCI, V16, P795, DOI 10.1110/ps.072753207
   AMBERG SM, 1994, J VIROL, V68, P3794, DOI 10.1128/JVI.68.6.3794-3802.1994
   Amberg SM, 1999, J VIROL, V73, P8083, DOI 10.1128/JVI.73.10.8083-8094.1999
   ARIAS CF, 1993, VIROLOGY, V193, P888, DOI 10.1006/viro.1993.1198
   Ashour J, 2009, J VIROL, V83, P5408, DOI 10.1128/JVI.02188-08
   Bartelma G, 2002, VIROLOGY, V299, P122, DOI 10.1006/viro.2002.1504
   Benarroch D, 2004, VIROLOGY, V328, P208, DOI 10.1016/j.virol.2004.07.004
   Brooks AJ, 2002, J BIOL CHEM, V277, P36399, DOI 10.1074/jbc.M204977200
   CAHOUR A, 1992, J VIROL, V66, P1535, DOI 10.1128/JVI.66.3.1535-1542.1992
   CHAMBERS TJ, 1991, J VIROL, V65, P6042, DOI 10.1128/JVI.65.11.6042-6050.1991
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chen CJ, 1997, J VIROL, V71, P3466, DOI 10.1128/JVI.71.5.3466-3473.1997
   Collins TJ, 2007, BIOTECHNIQUES, V43, P25
   Cui TA, 1998, VIROLOGY, V246, P409, DOI 10.1006/viro.1998.9213
   Donnelly M, 2007, J VIROL, V81, P2283, DOI 10.1128/JVI.01677-06
   Egloff MP, 2007, J MOL BIOL, V372, P723, DOI 10.1016/j.jmb.2007.07.005
   Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757
   Elster C, 1997, J GEN VIROL, V78, P1589, DOI 10.1099/0022-1317-78-7-1589
   Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073
   Forwood JK, 1999, BIOCHEM BIOPH RES CO, V257, P731, DOI 10.1006/bbrc.1999.0370
   GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P3889, DOI 10.1093/nar/17.10.3889
   Gutsche I, 2011, P NATL ACAD SCI USA, V108, P8003, DOI 10.1073/pnas.1017338108
   Heaton NS, 2010, P NATL ACAD SCI USA, V107, P17345, DOI 10.1073/pnas.1010811107
   Hodge K, 2016, J BIOL CHEM, V291, P17437, DOI 10.1074/jbc.M116.724013
   Iglesias NG, 2011, J VIROL, V85, P5745, DOI 10.1128/JVI.02343-10
   Issur M, 2009, RNA, V15, P2340, DOI 10.1261/rna.1609709
   Johansson M, 2001, J GEN VIROL, V82, P735, DOI 10.1099/0022-1317-82-4-735
   KAPOOR M, 1995, J BIOL CHEM, V270, P19100, DOI 10.1074/jbc.270.32.19100
   Kelley JF, 2011, VIROLOGY, V418, P27, DOI 10.1016/j.virol.2011.07.006
   Klema VJ, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005451
   Kong GH, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005139
   Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106
   Kroschewski H, 2008, J BIOL CHEM, V283, P19410, DOI 10.1074/jbc.M800613200
   Kumar A, 2013, J VIROL, V87, P4545, DOI 10.1128/JVI.03083-12
   Leung D, 2001, J BIOL CHEM, V276, P45762, DOI 10.1074/jbc.M107360200
   Li HT, 1999, J VIROL, V73, P3108, DOI 10.1128/JVI.73.4.3108-3116.1999
   Li J, 2005, J BIOL CHEM, V280, P28766, DOI 10.1074/jbc.M500588200
   Lim SP, 2013, J BIOL CHEM, V288, P31105, DOI 10.1074/jbc.M113.508606
   Lindenbach BD, 1999, J VIROL, V73, P4611, DOI 10.1128/JVI.73.6.4611-4621.1999
   Lindenbach Brett D., 2007, FIELDS VIROLOGY, P1101
   LOBIGS M, 1993, P NATL ACAD SCI USA, V90, P6218, DOI 10.1073/pnas.90.13.6218
   Lu GL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003549
   Luo D, 2008, J VIROL, V82, P173, DOI 10.1128/JVI.01788-07
   Luo DH, 2010, J BIOL CHEM, V285, P18817, DOI 10.1074/jbc.M109.090936
   Mackenzie JM, 1998, VIROLOGY, V245, P203, DOI 10.1006/viro.1998.9156
   Mairiang D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053535
   Malet H, 2007, J BIOL CHEM, V282, P10678, DOI 10.1074/jbc.M607273200
   Marfori M, 2012, TRAFFIC, V13, P532, DOI 10.1111/j.1600-0854.2012.01329.x
   Mazzon M, 2009, J INFECT DIS, V200, P1261, DOI 10.1086/605847
   Medin CL, 2005, J VIROL, V79, P11053, DOI 10.1128/JVI.79.17.11053-11061.2005
   Moreland NJ, 2012, J VIROL METHODS, V179, P97, DOI 10.1016/j.jviromet.2011.10.006
   Morrison J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003265
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Muller DA, 2012, J GEN VIROL, V93, P771, DOI 10.1099/vir.0.039321-0
   Noble CG, 2012, J VIROL, V86, P438, DOI 10.1128/JVI.06225-11
   Noble CG, 2010, ANTIVIR RES, V85, P450, DOI 10.1016/j.antiviral.2009.12.011
   Phong WY, 2011, BIOSCIENCE REP, V31, P399, DOI 10.1042/BSR20100142
   Potisopon S, 2014, NUCLEIC ACIDS RES, V42, P11642, DOI 10.1093/nar/gku666
   PREUGSCHAT F, 1991, VIROLOGY, V185, P689, DOI 10.1016/0042-6822(91)90540-R
   PREUGSCHAT F, 1990, J VIROL, V64, P4364, DOI 10.1128/JVI.64.9.4364-4374.1990
   Pryor MJ, 2007, TRAFFIC, V8, P795, DOI 10.1111/j.1600-0854.2007.00579.x
   Rawlinson SM, 2009, J BIOL CHEM, V284, P15589, DOI 10.1074/jbc.M808271200
   Selisko B, 2010, J GEN VIROL, V91, P112, DOI 10.1099/vir.0.015511-0
   Shi PY, 2014, SCIENCE, V343, P849, DOI 10.1126/science.1251249
   Shiryaev SA, 2009, J GEN VIROL, V90, P2081, DOI 10.1099/vir.0.012864-0
   Su XC, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000561
   Tajima S, 2011, ARCH VIROL, V156, P63, DOI 10.1007/s00705-010-0816-8
   Takahashi H, 2012, ANTIVIR RES, V96, P305, DOI 10.1016/j.antiviral.2012.09.023
   Tay MYF, 2013, ANTIVIR RES, V99, P301, DOI 10.1016/j.antiviral.2013.06.002
   Tay MYF, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005886
   Tay MYF, 2015, J BIOL CHEM, V290, P2379, DOI 10.1074/jbc.M114.607341
   Tomassini JE, 2003, VIROLOGY, V313, P274, DOI 10.1016/S0042-6822(03)00314-3
   Uchil PD, 2003, J BIOL CHEM, V278, P24388, DOI 10.1074/jbc.M301717200
   Umareddy I, 2006, J GEN VIROL, V87, P2605, DOI 10.1099/vir.0.81844-0
   Vasudevan SG, 2001, FARMACO, V56, P33, DOI 10.1016/S0014-827X(01)01014-X
   Verdine GL, 2012, METHOD ENZYMOL, V503, P3, DOI 10.1016/B978-0-12-396962-0.00001-X
   Wang CC, 2009, FEBS LETT, V583, P691, DOI 10.1016/j.febslet.2009.01.008
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   WENGLER G, 1993, VIROLOGY, V197, P265, DOI 10.1006/viro.1993.1587
   Xu T, 2005, J VIROL, V79, P10278, DOI 10.1128/JVI.79.16.10278-10288.2005
   Yap TL, 2007, J VIROL, V81, P4753, DOI 10.1128/JVI.02283-06
   Yik JHN, 2004, MOL CELL BIOL, V24, P5094, DOI 10.1128/MCB.24.12.5094-5105.2004
   Yon C, 2005, J BIOL CHEM, V280, P27412, DOI 10.1074/jbc.M501393200
   Yu L, 2013, VIROLOGY, V446, P365, DOI 10.1016/j.virol.2013.08.006
   Yusof R, 2000, J BIOL CHEM, V275, P9963, DOI 10.1074/jbc.275.14.9963
   ZHANG LW, 1992, J VIROL, V66, P7549, DOI 10.1128/JVI.66.12.7549-7554.1992
   Zhang ZZ, 2016, SCIENCE, V354, P1597, DOI 10.1126/science.aai9309
   Zhao YQ, 2015, P NATL ACAD SCI USA, V112, P14834, DOI 10.1073/pnas.1514978112
   Zhao YQ, 2014, VIRUS RES, V179, P225, DOI 10.1016/j.virusres.2013.11.010
   Zhou YS, 2007, J VIROL, V81, P3891, DOI 10.1128/JVI.02704-06
   Zou G, 2011, J BIOL CHEM, V286, P14362, DOI 10.1074/jbc.M110.214189
   Zou J, 2015, J VIROL, V89, P3471, DOI 10.1128/JVI.03454-14
   Zou J, 2015, J VIROL, V89, P3455, DOI 10.1128/JVI.03453-14
   Zou J, 2014, J VIROL, V88, P3379, DOI 10.1128/JVI.02782-13
   Zust R, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003521
NR 96
TC 3
Z9 4
U1 4
U2 8
PU SPRINGER-VERLAG SINGAPORE PTE LTD
PI SINGAPORE
PA 152 BEACH ROAD, #21-01/04 GATEWAY EAST, SINGAPORE, 189721, SINGAPORE
SN 0065-2598
EI 2214-8019
BN 978-981-10-8727-1; 978-981-10-8726-4
J9 ADV EXP MED BIOL
JI Adv.Exp.Med.Biol.
PY 2018
VL 1062
BP 147
EP 163
DI 10.1007/978-981-10-8727-1_11
PG 17
WC Infectious Diseases; Medicine, Research & Experimental; Tropical
   Medicine; Virology
SC Infectious Diseases; Research & Experimental Medicine; Tropical
   Medicine; Virology
GA BK8XO
UT WOS:000443965000012
PM 29845531
DA 2020-07-08
ER

PT S
AU Kummerer, BM
AF Kuemmerer, Beate M.
BE Hilgenfeld, R
   Vasudevan, SG
TI Establishment and Application of Flavivirus Replicons
SO DENGUE AND ZIKA: CONTROL AND ANTIVIRAL TREATMENT STRATEGIES
SE Advances in Experimental Medicine and Biology
LA English
DT Article; Proceedings Paper
CT 2nd Tofo Advanced Study Week on Emerging Viruses - Dengue and Zika -
   Control and Antiviral Treatment Strategies
CY AUG 28-SEP 01, 2016
CL Inhambane, MOZAMBIQUE
DE Flavivirus reverse genetics technology; Non-infectious replicons;
   Selectable marker proteins; Yellow fever virus NS2A protein; Nienokoue
   virus
ID WEST-NILE-VIRUS; ANTIBODY-MEDIATED NEUTRALIZATION; BORNE
   ENCEPHALITIS-VIRUS; PACKAGING CELL-LINE; FULL-LENGTH CDNA; DENGUE VIRUS;
   KUNJIN VIRUS; SUBGENOMIC REPLICONS; DRUG DISCOVERY; ZIKA VIRUS
AB Dengue virus (DENV) and Zika virus (ZIKV) are enveloped, positive-strand RNA viruses belonging to the genus Flavivirus in the family Flaviviridae. The genome of similar to 11 kb length encodes one long open reading frame flanked by a 5' and a 3' untranslated region (UTR). The 5' end is capped and the 3' end lacks a poly(A) tail. The encoded single polyprotein is cleaved co-and posttranslationally by cellular and viral proteases. The first one-third of the genome encodes the structural proteins (C-prM-E), whereas the nonstructural (NS) proteins NS1-NS2A-NS3-NS4A-2K-NS4B-NS5 are encoded by the remaining two-thirds of the genome.
   Research on flaviviruses was driven forward by the ability to produce recombinant viruses using reverse genetics technology. It is known that the purified RNA of flaviviruses is per se infectious, which allows initiation of a complete viral life cycle by transfecting the genomic RNA into susceptible cells. In 1989, the first infectious flavivirus RNA was transcribed from full-length cDNA templates of yellow fever virus (YFV) facilitating molecular genetic analyses of this virus. In addition to the production of infectious recombinant viruses, reverse genetics can also be used to establish non-infectious replicons. Replicons contain an in-frame deletion in the structural protein genes but still encode all nonstructural proteins and contain the UTRs necessary to mediate efficient replication, a factor that enables their analyses under Biosafety Level (BSL) 1 conditions. This is particularly important since many flaviviruses are BSL3 agents.
   The review will cover strategies for generating flavivirus replicons, including the establishment of bacteriophage (T7 or SP6) promoter-driven constructs as well as cytomegalovirus (CMV) promoter-driven constructs. Furthermore, different reporter replicons or replicons expressing selectable marker proteins will be outlined using examples of their application to answer basic questions of the flavivirus replication cycle, to select and test antiviral compounds or to produce virus replicon particles. The establishment and application of flavivirus replicons will further be exemplified by my own data using an established YFV reporter replicon to study the role of YFV NS2A in the viral life cycle. In addition, we established a reporter replicon of a novel insect-specific flavivirus, namely Nienokoue virus (NIEV), to define the barrier(s) involved in host range restriction.
C1 [Kuemmerer, Beate M.] Univ Bonn, Inst Virol, Med Ctr, Bonn, Germany.
   [Kuemmerer, Beate M.] German Ctr Infect Res DZIF, Partner Site Bonn Cologne, Bonn, Germany.
RP Kummerer, BM (corresponding author), Univ Bonn, Inst Virol, Med Ctr, Bonn, Germany.; Kummerer, BM (corresponding author), German Ctr Infect Res DZIF, Partner Site Bonn Cologne, Bonn, Germany.
EM kuemmerer@virology-bonn.de
CR Alvarez DE, 2005, VIROLOGY, V339, P200, DOI 10.1016/j.virol.2005.06.009
   Anraku I, 2002, J VIROL, V76, P3791, DOI 10.1128/JVI.76.8.3791-3799.2002
   Cao F, 2011, J VIROL METHODS, V178, P87, DOI 10.1016/j.jviromet.2011.08.018
   Corver J, 2003, J VIROL, V77, P2265, DOI 10.1128/JVI.77.3.2265-2270.2003
   Gehrke R, 2003, J VIROL, V77, P8924, DOI 10.1128/JVI.77.16.8924-8933.2003
   Harvey TJ, 2004, J VIROL, V78, P531, DOI 10.1128/JVI.78.22.12225-12235.2004
   Harvey TJ, 2003, J VIROL, V77, P7796, DOI 10.1128/JVI.77.14.7796-7803.2003
   Huang YT, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0181-8
   Huang Y, 2012, J VIROL METHODS, V179, P217, DOI 10.1016/j.jviromet.2011.11.002
   Jones CT, 2005, VIROLOGY, V331, P247, DOI 10.1016/j.virol.2004.10.034
   Junglen S, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00375-16, 10.1128/msphere.00375-16]
   Khromykh AA, 1997, J VIROL, V71, P1497, DOI 10.1128/JVI.71.2.1497-1505.1997
   Khromykh AA, 2001, J VIROL, V75, P4633, DOI 10.1128/JVI.75.10.4633-4640.2001
   LAI CJ, 1991, P NATL ACAD SCI USA, V88, P5139, DOI 10.1073/pnas.88.12.5139
   Leardkamolkarn V, 2012, J BIOMOL SCREEN, V17, P283, DOI 10.1177/1087057111426903
   Li SH, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-64
   Lindenbach B., 2013, FIELDS VIROLOGY, V1, P712
   Lo MK, 2003, J VIROL, V77, P12901, DOI 10.1128/JVI.77.23.12901-12906.2003
   Lu CY, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9040076
   Mukherjee S, 2014, METHODS MOL BIOL, V1138, P75, DOI 10.1007/978-1-4939-0348-1_6
   Pang X, 2001, BMC Microbiol, V1, P18, DOI 10.1186/1471-2180-1-18
   Pierson TC, 2006, VIROLOGY, V346, P53, DOI 10.1016/j.virol.2005.10.030
   Puig-Basagoiti F, 2005, ANTIMICROB AGENTS CH, V49, P4980, DOI 10.1128/AAC.49.12.4980-4988.2005
   Pyankov OV, 2015, J INFECT DIS, V212, pS368, DOI 10.1093/infdis/jiv019
   Qing M, 2010, ANTIVIR RES, V86, P163, DOI 10.1016/j.antiviral.2010.02.313
   Reynard O, 2011, J INFECT DIS, V204, pS1060, DOI 10.1093/infdis/jir347
   Scaturro P, 2014, J VIROL, V88, P11540, DOI 10.1128/JVI.01745-14
   Scholle F, 2004, J VIROL, V78, P11605, DOI 10.1128/JVI.78.21.11605-11614.2004
   Shi PY, 2002, VIROLOGY, V296, P219, DOI 10.1006/viro.2002.1453
   SUMIYOSHI H, 1995, J INFECT DIS, V171, P1144, DOI 10.1093/infdis/171.5.1144
   Suzuki R, 2007, VIROLOGY, V362, P374, DOI 10.1016/j.virol.2006.11.026
   Suzuki R, 2014, J GEN VIROL, V95, P60, DOI 10.1099/vir.0.058008-0
   Varnavski AN, 1999, VIROLOGY, V255, P366, DOI 10.1006/viro.1998.9564
   Vossmann S, 2015, J VIROL, V89, P4951, DOI 10.1128/JVI.03351-14
   Xie XP, 2016, EBIOMEDICINE, V12, P156, DOI 10.1016/j.ebiom.2016.09.013
   Yamanaka A, 2017, J VIROL METHODS, V243, P164, DOI 10.1016/j.jviromet.2017.02.011
   Yang CC, 2014, ANTIMICROB AGENTS CH, V58, P110, DOI 10.1128/AAC.01281-13
   Yoshii K, 2009, J VIROL METHODS, V161, P173, DOI 10.1016/j.jviromet.2009.05.016
NR 38
TC 4
Z9 4
U1 1
U2 5
PU SPRINGER-VERLAG SINGAPORE PTE LTD
PI SINGAPORE
PA 152 BEACH ROAD, #21-01/04 GATEWAY EAST, SINGAPORE, 189721, SINGAPORE
SN 0065-2598
EI 2214-8019
BN 978-981-10-8727-1; 978-981-10-8726-4
J9 ADV EXP MED BIOL
JI Adv.Exp.Med.Biol.
PY 2018
VL 1062
BP 165
EP 173
DI 10.1007/978-981-10-8727-1_12
PG 9
WC Infectious Diseases; Medicine, Research & Experimental; Tropical
   Medicine; Virology
SC Infectious Diseases; Research & Experimental Medicine; Tropical
   Medicine; Virology
GA BK8XO
UT WOS:000443965000013
PM 29845532
DA 2020-07-08
ER

PT S
AU Nitsche, C
AF Nitsche, Christoph
BE Hilgenfeld, R
   Vasudevan, SG
TI Strategies Towards Protease Inhibitors for Emerging Flaviviruses
SO DENGUE AND ZIKA: CONTROL AND ANTIVIRAL TREATMENT STRATEGIES
SE Advances in Experimental Medicine and Biology
LA English
DT Article; Proceedings Paper
CT 2nd Tofo Advanced Study Week on Emerging Viruses - Dengue and Zika -
   Control and Antiviral Treatment Strategies
CY AUG 28-SEP 01, 2016
CL Inhambane, MOZAMBIQUE
DE Protease; Inhibitor; Peptides; Small-molecular; Flavivirus; Dengue; West
   Nile; Zika
ID WEST-NILE-VIRUS; SMALL-MOLECULE INHIBITORS; TETRAPEPTIDE ALDEHYDE
   INHIBITORS; DENGUE VIRUS; NS2B-NS3 PROTEASE; ZIKA VIRUS; NS2B/NS3
   PROTEASE; ANTIVIRAL ACTIVITY; PEPTIDE INHIBITORS; MEDICINAL CHEMISTRY
AB Infections with flaviviruses are a continuing public health threat. In addition to vaccine development and vector control, the search for antiviral agents that alleviate symptoms in patients are of considerable interest. Among others, the flaviviral protease NS2B-NS3 is a promising drug target to inhibit viral replication. Flaviviral proteases share a high degree of structural similarity and substrate-recognition profile, which may facilitate a strategy towards development of pan-flaviviral protease inhibitors. However, the success of various drug discovery attempts during the last decade has been limited by the nature of the viral enzyme as well as a lack of robust structural templates. Small-molecular, structurally diverse protease inhibitors have been reported to reach affinities in the lower micromolar range. Peptide-based, substrate-derived compounds are often nanomolar inhibitors, however, with highly compromised drug-likeness. With some exceptions, the antiviral cellular activity of most of the reported compounds have been patchy and insufficient for further development. Recent progress has been made in the elucidation of inhibitor binding using different structural methods. This will hopefully lead to more rational attempts for the identification of various lead compounds that may be successful in cellular assays, animal models and ultimately translated to patients.
C1 [Nitsche, Christoph] Australian Natl Univ, Res Sch Chem, Canberra, ACT, Australia.
RP Nitsche, C (corresponding author), Australian Natl Univ, Res Sch Chem, Canberra, ACT, Australia.
EM christoph.nitsche@anu.edu.au
FU Alexander von Humboldt FoundationAlexander von Humboldt Foundation
FX Funding by the Alexander von Humboldt Foundation is gratefully
   acknowledged.
CR Balasubramanian A, 2016, ANTIVIR RES, V134, P6, DOI 10.1016/j.antiviral.2016.08.014
   Behnam MAM, 2016, J MED CHEM, V59, P5622, DOI 10.1021/acs.jmedchem.5b01653
   Behnam MAM, 2015, J MED CHEM, V58, P9354, DOI 10.1021/acs.jmedchem.5b01441
   Behnam MAM, 2014, ACS MED CHEM LETT, V5, P1037, DOI 10.1021/ml500245v
   Bodenreider C, 2009, ANAL BIOCHEM, V395, P195, DOI 10.1016/j.ab.2009.08.013
   Castanha PMS, 2017, J INFECT DIS, V215, P781, DOI 10.1093/infdis/jiw638
   Chan JFW, 2017, ANTIVIR RES, V141, P29, DOI 10.1016/j.antiviral.2017.02.002
   Chappell KJ, 2008, CURR MED CHEM, V15, P2771, DOI 10.2174/092986708786242804
   Chen WN, 2016, J AM CHEM SOC, V138, P4539, DOI 10.1021/jacs.6b00416
   Chen X, 2016, CELL RES, V26, P1260, DOI 10.1038/cr.2016.116
   de la Cruz L, 2014, FEBS J, V281, P1517, DOI 10.1111/febs.12729
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073
   Ezgimen M, 2012, ANTIVIR RES, V94, P18, DOI [10.1016/j.antiviral.2012.02.003, 10.1016/j.antivira1.2012.02.003]
   Gupta G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134823
   Hammamy MZ, 2013, CHEMMEDCHEM, V8, P231, DOI 10.1002/cmdc.201200497
   Johnston PA, 2007, ASSAY DRUG DEV TECHN, V5, P737, DOI 10.1089/adt.2007.101
   Kato F, 2016, ANTIVIR RES, V131, P141, DOI 10.1016/j.antiviral.2016.04.014
   Knehans T, 2011, J COMPUT AID MOL DES, V25, P263, DOI 10.1007/s10822-011-9418-0
   Knox JE, 2006, J MED CHEM, V49, P6585, DOI 10.1021/jm0607606
   Koh-Stenta X, 2015, DRUG DES DEV THER, V9, P6389, DOI 10.2147/DDDT.S94207
   Kuiper BD, 2017, BIOCHEM BIOPH RES CO, V492, P668, DOI 10.1016/j.bbrc.2017.03.108
   Lee H, 2017, ANTIVIR RES, V139, P49, DOI 10.1016/j.antiviral.2016.12.016
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Lescar J, 2008, ANTIVIR RES, V80, P94, DOI 10.1016/j.antiviral.2008.07.001
   Lim SP, 2013, VIRUSES-BASEL, V5, P2977, DOI 10.3390/v5122977
   Lim SP, 2013, ANTIVIR RES, V100, P500, DOI 10.1016/j.antiviral.2013.09.013
   Lima AB, 2015, BIOORGAN MED CHEM, V23, P5748, DOI 10.1016/j.bmc.2015.07.012
   Liu HL, 2014, BIOORGAN MED CHEM, V22, P6344, DOI 10.1016/j.bmc.2014.09.057
   Mahawaththa MC, 2017, ANTIVIR RES, V142, P141, DOI 10.1016/j.antiviral.2017.03.011
   Mueller NH, 2008, ANTIMICROB AGENTS CH, V52, P3385, DOI 10.1128/AAC.01508-07
   Nitsche C, 2017, PROG NUCL MAG RES SP, V98-99, P20, DOI 10.1016/j.pnmrs.2016.11.001
   Nitsche C, 2017, J MED CHEM, V60, P511, DOI 10.1021/acs.jmedchem.6b01021
   Nitsche C, 2014, CHEM REV, V114, P11348, DOI 10.1021/cr500233q
   Nitsche C, 2013, J MED CHEM, V56, P8389, DOI 10.1021/jm400828u
   Nitsche C, 2012, ANTIVIR RES, V94, P72, DOI 10.1016/j.antiviral.2012.02.008
   Noble CG, 2012, J VIROL, V86, P438, DOI 10.1128/JVI.06225-11
   Phoo WW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13410
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Prusis P, 2013, BIOCHEM BIOPH RES CO, V434, P767, DOI 10.1016/j.bbrc.2013.03.139
   Schuller A, 2011, ANTIVIR RES, V92, P96, DOI 10.1016/j.antiviral.2011.07.002
   Shiryaev SA, 2006, BIOCHEM J, V393, P503, DOI 10.1042/BJ20051374
   Shiryaev SA, 2017, ANTIVIR RES, V143, P218, DOI 10.1016/j.antiviral.2017.04.015
   Shiryaev SA, 2011, ASSAY DRUG DEV TECHN, V9, P69, DOI 10.1089/adt.2010.0309
   Sidique S, 2009, BIOORG MED CHEM LETT, V19, P5773, DOI 10.1016/j.bmcl.2009.07.150
   Stoermer MJ, 2008, J MED CHEM, V51, P5714, DOI 10.1021/jm800503y
   Su XC, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000561
   Takagi Y, 2017, BIOORG MED CHEM LETT, V27, P3586, DOI 10.1016/j.bmcl.2017.05.027
   Weigel LF, 2015, J MED CHEM, V58, P7719, DOI 10.1021/acs.jmedchem.5b00612
   Weng ZB, 2017, EUR J MED CHEM, V125, P751, DOI 10.1016/j.ejmech.2016.09.063
   Wu HM, 2015, ANTIMICROB AGENTS CH, V59, P1100, DOI 10.1128/AAC.03543-14
   Yang CC, 2014, ANTIMICROB AGENTS CH, V58, P110, DOI 10.1128/AAC.01281-13
   Yang CC, 2011, ANTIMICROB AGENTS CH, V55, P229, DOI 10.1128/AAC.00855-10
   Yin Z, 2006, BIOORG MED CHEM LETT, V16, P36, DOI 10.1016/j.bmcl.2005.09.062
   Yin Z, 2006, BIOORG MED CHEM LETT, V16, P40, DOI 10.1016/j.bmcl.2005.09.049
   Zhang ZZ, 2016, SCIENCE, V354, P1597, DOI 10.1126/science.aai9309
   Zhou GC, 2013, BIOORG MED CHEM LETT, V23, P6549, DOI 10.1016/j.bmcl.2013.10.071
NR 57
TC 10
Z9 10
U1 0
U2 9
PU SPRINGER-VERLAG SINGAPORE PTE LTD
PI SINGAPORE
PA 152 BEACH ROAD, #21-01/04 GATEWAY EAST, SINGAPORE, 189721, SINGAPORE
SN 0065-2598
EI 2214-8019
BN 978-981-10-8727-1; 978-981-10-8726-4
J9 ADV EXP MED BIOL
JI Adv.Exp.Med.Biol.
PY 2018
VL 1062
BP 175
EP 186
DI 10.1007/978-981-10-8727-1_13
PG 12
WC Infectious Diseases; Medicine, Research & Experimental; Tropical
   Medicine; Virology
SC Infectious Diseases; Research & Experimental Medicine; Tropical
   Medicine; Virology
GA BK8XO
UT WOS:000443965000014
PM 29845533
OA Green Published
DA 2020-07-08
ER

PT S
AU Jans, DA
   Martin, AJ
AF Jans, David A.
   Martin, Alexander J.
BE Hilgenfeld, R
   Vasudevan, SG
TI Nucleocytoplasmic Trafficking of Dengue Non-structural Protein 5 as a
   Target for Antivirals
SO DENGUE AND ZIKA: CONTROL AND ANTIVIRAL TREATMENT STRATEGIES
SE Advances in Experimental Medicine and Biology
LA English
DT Article; Proceedings Paper
CT 2nd Tofo Advanced Study Week on Emerging Viruses - Dengue and Zika -
   Control and Antiviral Treatment Strategies
CY AUG 28-SEP 01, 2016
CL Inhambane, MOZAMBIQUE
DE Dengue virus; DENV; Nucleus; Nuclear trafficking; Nucleocytoplasmic
   trafficking; Antiviral; 4-HPR
ID PHASE-I TRIAL; NUCLEAR-LOCALIZATION SIGNALS; CHILDRENS ONCOLOGY GROUP;
   RNA POLYMERASE NS5; VIRUS-REPLICATION; DOUBLE-BLIND; IMPORTIN BETA-1;
   VIRAL HELICASE; INFECTED-CELLS; HOST FACTORS
AB Signal-dependent movement of proteins into and out of the nucleus through the importin superfamily of transporters is central to the replication of many viruses in infected cells, including RNA viruses such as the flavivirus Dengue virus (DENV). DENV non-structural protein 5 (NS5) traffics into and out of the host cell nucleus/nucleolus, being observed in the nucleus, although to differing extents, very early in infection in the case of all 4 DENV serotypes; with results from both reverse genetics and inhibitor studies indicating that this trafficking is critical to DENV infection. Knowledge of the transporters and targeting signals responsible for nuclear trafficking of NS5 has enabled inhibitors of DENV NS5 nuclear import to be identified using a novel screening/counterscreen approach. N-(4-hydroxyphenyl) retinamide (4-HPR) is of particular interest as a specific, non-toxic inhibitor able to protect against infection by all four serotypes of DENV, as well as the severe, antibody-enhanced form of DENV infection, in a lethal mouse model. Since 4-HPR can also inhibit DENV-related flaviviruses of medical significance such as West Nile Virus and Zika virus, it is of great interest for future commercialisation. Targeting nucleocytoplasmic trafficking of flavivirus proteins promises to be a powerful strategy to counter flaviviruses, for which the development of protective vaccines has thus far proven problematic.
C1 [Jans, David A.; Martin, Alexander J.] Monash Univ, Dept Biochem & Mol Biol, Nucl Signalling Lab, Melbourne, Vic, Australia.
RP Jans, DA (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Nucl Signalling Lab, Melbourne, Vic, Australia.
EM david.jans@monash.edu
OI Jans, David/0000-0001-5115-4745
FU National Health and Medical Research Council, AustraliaNational Health
   and Medical Research Council of Australia [APP1059137, APP1103050]
FX The authors acknowledge the many collaborators over a number of years,
   with special thanks to Prof. S. G. Vasudevan (Duke NUS) and Prof. J.
   Forwood (Charles Sturt University) for very important contributions
   spanning almost 18 years of research. We also acknowledge the support of
   the National Health and Medical Research Council, Australia for research
   funding (APP1059137) and senior principal research fellowship (to DAJ;
   APP1103050).
CR Anwar A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023246
   Bartenschlager R, 2008, FUTURE MICROBIOL, V3, P155, DOI 10.2217/17460913.3.2.155
   Bartholomeus A, 1999, J VIRAL HEPATITIS, V6, P261, DOI 10.1046/j.1365-2893.1999.00173.x
   Brooks AJ, 2002, J BIOL CHEM, V277, P36399, DOI 10.1074/jbc.M204977200
   BUCKLEY A, 1992, J GEN VIROL, V73, P1125, DOI 10.1099/0022-1317-73-5-1125
   Caly L, 2016, METHODS MOL BIOL, V1442, P93, DOI 10.1007/978-1-4939-3687-8_8
   Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   COSTA A, 1989, EUR J CANCER CLIN ON, V25, P805, DOI 10.1016/0277-5379(89)90124-7
   Coudeville L, 2016, VACCINE, V34, P6417, DOI 10.1016/j.vaccine.2015.11.023
   den Boon JA, 2010, CELL HOST MICROBE, V8, P77, DOI 10.1016/j.chom.2010.06.010
   Dow G, 2012, ANTIVIR RES, V96, P203, DOI 10.1016/j.antiviral.2012.08.011
   EDWARD Z, 1993, MICROBIOL IMMUNOL, V37, P239, DOI 10.1111/j.1348-0421.1993.tb03206.x
   Forwood JK, 1999, BIOCHEM BIOPH RES CO, V257, P731, DOI 10.1006/bbrc.1999.0370
   Fraser JE, 2016, J VIROL, V90, P5797, DOI 10.1128/JVI.02727-15
   Fraser JE, 2014, J INFECT DIS, V210, P1780, DOI 10.1093/infdis/jiu319
   Fulcher AJ, 2016, BBA-MOL CELL RES, V1863, P254, DOI 10.1016/j.bbamcr.2015.11.019
   Fulcher AJ, 2011, BBA-MOL CELL RES, V1813, P2176, DOI 10.1016/j.bbamcr.2011.03.019
   Fulcher AJ, 2010, FASEB J, V24, P1454, DOI 10.1096/fj.09-136564
   Garaventa A, 2003, CLIN CANCER RES, V9, P2032
   Gotz V, 2016, SCI REP-UK, V6, DOI 10.1038/srep25428
   Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Hanley KA, 2002, J VIROL, V76, P525, DOI 10.1128/JVI.76.2.525-531.2002
   Hannemann H, 2013, J BIOL CHEM, V288, P22621, DOI 10.1074/jbc.M113.481382
   Helt AM, 2005, J VIROL, V79, P13218, DOI 10.1128/JVI.79.21.13218-13230.2005
   Hu MJ, 2017, BIOCHEM BIOPH RES CO, V489, P460, DOI 10.1016/j.bbrc.2017.05.171
   Jans DA, 2000, BIOESSAYS, V22, P532, DOI 10.1002/(SICI)1521-1878(200006)22:6<532::AID-BIES6>3.0.CO;2-O
   Johansson M, 2001, J GEN VIROL, V82, P735, DOI 10.1099/0022-1317-82-4-735
   Kannan RP, 2011, J VIROL, V85, P7989, DOI 10.1128/JVI.00280-11
   KAPOOR M, 1995, J BIOL CHEM, V270, P19100, DOI 10.1074/jbc.270.32.19100
   Klema VJ, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005451
   Kong GH, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005139
   Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207
   Kumar A, 2013, J VIROL, V87, P4545, DOI 10.1128/JVI.03083-12
   Kuusisto HV, 2015, BBA-MOL CELL RES, V1853, P1870, DOI 10.1016/j.bbamcr.2015.05.002
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Lindenbach BD, 2001, FIELDS VIROLOGY, V1, P991, DOI DOI 10.1016/J.JMB.2013.11.024
   Low JG, 2014, LANCET INFECT DIS, V14, P706, DOI 10.1016/S1473-3099(14)70730-3
   Lundberg L, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005122
   Lundberg L, 2013, ANTIVIR RES, V100, P662, DOI 10.1016/j.antiviral.2013.10.004
   Mackenzie JM, 1999, J VIROL, V73, P9555, DOI 10.1128/JVI.73.11.9555-9567.1999
   Marceau CD, 2016, NATURE, V535, P159, DOI 10.1038/nature18631
   Maurer BJ, 2013, PEDIATR BLOOD CANCER, V60, P1801, DOI 10.1002/pbc.24643
   Medin CL, 2005, J VIROL, V79, P11053, DOI 10.1128/JVI.79.17.11053-11061.2005
   Mendonca J, 2014, ONCOTARGET, V5, P6102, DOI 10.18632/oncotarget.2174
   Miura K, 2006, BIOCHEM BIOPH RES CO, V341, P132, DOI 10.1016/j.bbrc.2005.12.151
   Murray CL, 2008, NAT REV MICROBIOL, V6, P699, DOI 10.1038/nrmicro1928
   Nigg EA, 1997, NATURE, V386, P779, DOI 10.1038/386779a0
   Noppakunmongkolchai W, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0494-6
   Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x
   Poon IKH, 2005, TRAFFIC, V6, P173, DOI 10.1111/j.1600-0854.2005.00268.x
   Pryor Melinda J, 2006, Novartis Found Symp, V277, P149, DOI 10.1002/0470058005.ch11
   Pryor MJ, 2007, TRAFFIC, V8, P795, DOI 10.1111/j.1600-0854.2007.00579.x
   Rao RD, 2011, MED ONCOL, V28, pS39, DOI 10.1007/s12032-010-9682-1
   Rawlinson SM, 2009, J BIOL CHEM, V284, P15589, DOI 10.1074/jbc.M808271200
   Rawlinson SM, 2006, CURR DRUG TARGETS, V7, P1623, DOI 10.2174/138945006779025383
   Tay MYF, 2013, ANTIVIR RES, V99, P301, DOI 10.1016/j.antiviral.2013.06.002
   Tay MYF, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005886
   Uchil PD, 2003, J BIOL CHEM, V278, P24388, DOI 10.1074/jbc.M301717200
   Villablanca JG, 2006, J CLIN ONCOL, V24, P3423, DOI 10.1200/JCO.2005.03.9271
   Villablanca JG, 2011, CLIN CANCER RES, V17, P6858, DOI 10.1158/1078-0432.CCR-11-0995
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   Wagstaff KM, 2006, ANAL BIOCHEM, V348, P49, DOI 10.1016/j.ab.2005.10.029
   Wagstaff KM, 2012, BIOCHEM J, V443, P851, DOI 10.1042/BJ20120150
   Wagstaff KM, 2011, J BIOMOL SCREEN, V16, P192, DOI 10.1177/1087057110390360
   Wagstaff KM, 2009, TRAFFIC, V10, P1188, DOI 10.1111/j.1600-0854.2009.00937.x
   Whitehorn J, 2016, CLIN INFECT DIS, V62, P468, DOI 10.1093/cid/civ949
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625
   Zou G, 2011, J BIOL CHEM, V286, P14362, DOI 10.1074/jbc.M110.214189
NR 70
TC 5
Z9 5
U1 3
U2 4
PU SPRINGER-VERLAG SINGAPORE PTE LTD
PI SINGAPORE
PA 152 BEACH ROAD, #21-01/04 GATEWAY EAST, SINGAPORE, 189721, SINGAPORE
SN 0065-2598
EI 2214-8019
BN 978-981-10-8727-1; 978-981-10-8726-4
J9 ADV EXP MED BIOL
JI Adv.Exp.Med.Biol.
PY 2018
VL 1062
BP 199
EP 213
DI 10.1007/978-981-10-8727-1_15
PG 15
WC Infectious Diseases; Medicine, Research & Experimental; Tropical
   Medicine; Virology
SC Infectious Diseases; Research & Experimental Medicine; Tropical
   Medicine; Virology
GA BK8XO
UT WOS:000443965000016
PM 29845535
DA 2020-07-08
ER

PT S
AU dos Santos, EA
   Fink, K
AF dos Santos, Eduardo Alves
   Fink, Katja
BE Hilgenfeld, R
   Vasudevan, SG
TI Animal Models for Dengue and Zika Vaccine Development
SO DENGUE AND ZIKA: CONTROL AND ANTIVIRAL TREATMENT STRATEGIES
SE Advances in Experimental Medicine and Biology
LA English
DT Article; Proceedings Paper
CT 2nd Tofo Advanced Study Week on Emerging Viruses - Dengue and Zika -
   Control and Antiviral Treatment Strategies
CY AUG 28-SEP 01, 2016
CL Inhambane, MOZAMBIQUE
DE Dengue animal models; Zika non-human primate model; Conditional knockout
   IFNAR mouse model; Non-IFN-receptor-based immuno-compromised mouse
   models; Humanized mice for dengue and Zika vaccine testing
ID RECOMBINANT FUSION PROTEIN; TOLL-LIKE RECEPTORS; VIRUS-INFECTION; DNA
   VACCINE; MOUSE MODEL; RHESUS-MONKEYS; TYPE-2 VIRUS; DOMAIN-III;
   PROTECTIVE EFFICACY; ANTIBODY-RESPONSES
AB The current status of animal models in the study of dengue and Zika are covered in this review. Mouse models deficient in IFN signaling are used to overcome the natural resistance of mice to non-encephalitic flaviviruses. Conditional IFNAR mice and non-human primates (NHP) are useful immuno-competent models. Sterile immunity after dengue vaccination is not observed in NHPs. Placental and fetal development in NHPs is similar to humans, facilitating studies on infection-mediated fetal impairment.
C1 [dos Santos, Eduardo Alves; Fink, Katja] ASTAR, Agcy Sci, Singapore Immunol Network, Singapore, Singapore.
RP Fink, K (corresponding author), ASTAR, Agcy Sci, Singapore Immunol Network, Singapore, Singapore.
EM katja_fink@immunol.a-star.edu.sg
CR Aguirre S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002934
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   Amanna IJ, 2014, EXPERT REV VACCINES, V13, P589, DOI 10.1586/14760584.2014.906309
   An J, 1999, VIROLOGY, V263, P70, DOI 10.1006/viro.1999.9887
   Angsubhakorn Subhkij, 1994, Southeast Asian Journal of Tropical Medicine and Public Health, V25, P554
   Ashour J, 2010, CELL HOST MICROBE, V8, P410, DOI 10.1016/j.chom.2010.10.007
   Atrasheuskaya A, 2003, FEMS IMMUNOL MED MIC, V35, P33, DOI 10.1111/j.1574-695X.2003.tb00646.x
   Balsitis SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000790
   Becker R, 2016, NAT MED, V22, P225, DOI 10.1038/nm0316-225
   Bente DA, 2005, J VIROL, V79, P13797, DOI 10.1128/JVI.79.21.13797-13799.2005
   Bernard L, 2008, ANTIVIR RES, V80, P194, DOI 10.1016/j.antiviral.2008.06.005
   Bernardo L, 2008, CLIN VACCINE IMMUNOL, V15, P439, DOI 10.1128/CVI.00208-07
   Bernardo L, 2008, ARCH VIROL, V153, P849, DOI 10.1007/s00705-008-0050-9
   Bernardo L, 2009, CLIN VACCINE IMMUNOL, V16, P1829, DOI 10.1128/CVI.00191-09
   Blaney JE, 2004, AM J TROP MED HYG, V71, P811, DOI 10.4269/ajtmh.2004.71.811
   Blaney JE, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-39
   Bournazos S, 2015, J EXP MED, V212, P1361, DOI 10.1084/jem.20151267
   Bowie AG, 2008, NAT REV IMMUNOL, V8, P911, DOI 10.1038/nri2436
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Bray M, 1996, J VIROL, V70, P4162, DOI 10.1128/JVI.70.6.4162-4166.1996
   Brewoo JN, 2012, VACCINE, V30, P1513, DOI 10.1016/j.vaccine.2011.11.072
   Butrapet Siritorn, 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P589
   Calvert AE, 2006, J GEN VIROL, V87, P339, DOI 10.1099/vir.0.81256-0
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chan KWK, 2015, ANTIVIR RES, V123, P5, DOI 10.1016/j.antiviral.2015.08.013
   Chen HC, 2004, J MED VIROL, V73, P419, DOI 10.1002/jmv.20108
   Chen HC, 2007, J VIROL, V81, P5518, DOI 10.1128/JVI.02575-06
   Chen L, 2007, J VIROL, V81, P11634, DOI 10.1128/JVI.00996-07
   Chen ST, 2008, NATURE, V453, P672, DOI 10.1038/nature07013
   Clements DE, 2010, VACCINE, V28, P2705, DOI 10.1016/j.vaccine.2010.01.022
   Cox J, 2012, J VIROL, V86, P7637, DOI 10.1128/JVI.00534-12
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Domnich A, 2014, HUM VACC IMMUNOTHER, V10, P2819, DOI 10.4161/hv.29984
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   ECKELS KH, 1994, AM J TROP MED HYG, V50, P472, DOI 10.4269/ajtmh.1994.50.472
   Eckels KH, 2003, AM J TROP MED HYG, V69, P12, DOI 10.4269/ajtmh.2003.69.12
   Engelmann F, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003295
   Fernandez S, 2015, AM J TROP MED HYG, V92, P698, DOI 10.4269/ajtmh.14-0268
   Frias-Staheli N, 2014, J VIROL, V88, P2205, DOI 10.1128/JVI.03085-13
   Fuchs J, 2014, VACCINE, V32, P6537, DOI 10.1016/j.vaccine.2014.08.087
   Galler R, 2005, BRAZ J MED BIOL RES, V38, P1835, DOI 10.1590/S0100-879X2005001200012
   Girschick HJ, 2001, J IMMUNOL, V166, P377, DOI 10.4049/jimmunol.166.1.377
   Govindarajan D, 2015, VACCINE, V33, P4105, DOI 10.1016/j.vaccine.2015.06.067
   Guirakhoo F, 2000, J VIROL, V74, P5477, DOI 10.1128/JVI.74.12.5477-5485.2000
   Guirakhoo F, 2004, J VIROL, V78, P9998, DOI 10.1128/JVI.78.18.9998-10008.2004
   Guirakhoo F, 2004, J VIROL, V78, P4761, DOI 10.1128/JVI.78.9.4761-4775.2004
   Guirakhoo F, 2002, VIROLOGY, V298, P146, DOI 10.1006/viro.2002.1462
   Guy B, 2009, AM J TROP MED HYG, V80, P302, DOI 10.4269/ajtmh.2009.80.302
   Guzman MG, 2003, AM J TROP MED HYG, V69, P129, DOI 10.4269/ajtmh.2003.69.129
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Hanley KA, 2004, VACCINE, V22, P3440, DOI 10.1016/j.vaccine.2004.02.031
   Hermida L, 2006, VACCINE, V24, P3165, DOI 10.1016/j.vaccine.2006.01.036
   Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900
   Huang CYH, 2003, J VIROL, V77, P11436, DOI 10.1128/JVI.77.21.11436-11447.2003
   Huang KJ, 2000, J GEN VIROL, V81, P2177, DOI 10.1099/0022-1317-81-9-2177
   Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581
   Izquierdo A, 2008, VIRUS RES, V138, P135, DOI 10.1016/j.virusres.2008.08.008
   Jaiswal S, 2012, IMMUNOLOGY, V136, P334, DOI 10.1111/j.1365-2567.2012.03585.x
   Jaiswal S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007251
   Johnson AJ, 1999, J VIROL, V73, P783, DOI 10.1128/JVI.73.1.783-786.1999
   Kariko K, 2005, IMMUNITY, V23, P165, DOI 10.1016/j.immuni.2005.06.008
   Kim E, 2016, EBIOMEDICINE, V13, P315, DOI 10.1016/j.ebiom.2016.09.028
   Koraka P, 2007, VACCINE, V25, P5409, DOI 10.1016/j.vaccine.2007.04.079
   Kuruvilla JG, 2007, VIROLOGY, V369, P143, DOI 10.1016/j.virol.2007.06.005
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lee YR, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-65
   Lee YR, 2005, INTERVIROLOGY, V48, P161, DOI 10.1159/000081744
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   Li XF, 2013, J VIROL, V87, P13694, DOI 10.1128/JVI.00931-13
   Li XX, 1996, J BIOL CHEM, V271, P5790, DOI 10.1074/jbc.271.10.5790
   Lin YL, 1998, J VIROL, V72, P9729, DOI 10.1128/JVI.72.12.9729-9737.1998
   Lum LCS, 1996, AM J TROP MED HYG, V54, P256, DOI 10.4269/ajtmh.1996.54.256
   MARCHETTE NJ, 1990, AM J TROP MED HYG, V43, P212, DOI 10.4269/ajtmh.1990.43.212
   Marcos E, 2013, ARCH VIROL, V158, P225, DOI 10.1007/s00705-012-1471-z
   Markoff L, 2002, J VIROL, V76, P3318, DOI 10.1128/JVI.76.7.3318-3328.2002
   McBurney SP, 2016, VACCINE, V34, P3500, DOI 10.1016/j.vaccine.2016.03.108
   Men R, 2000, VACCINE, V18, P3113, DOI 10.1016/S0264-410X(00)00121-3
   Men RH, 1996, J VIROL, V70, P3930, DOI 10.1128/JVI.70.6.3930-3937.1996
   Milligan GN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125476
   Mladinich KM, 2012, IMMUNOGENETICS, V64, P111, DOI 10.1007/s00251-011-0566-0
   Mota J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020762
   Mota J, 2009, J VIROL, V83, P8638, DOI 10.1128/JVI.00581-09
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Omatsu T, 2011, J GEN VIROL, V92, P2272, DOI 10.1099/vir.0.031229-0
   Orozco S, 2012, J GEN VIROL, V93, P2152, DOI 10.1099/vir.0.045088-0
   Osorio JE, 2011, AM J TROP MED HYG, V84, P978, DOI 10.4269/ajtmh.2011.10-0592
   Paes MV, 2005, VIROLOGY, V338, P236, DOI 10.1016/j.virol.2005.04.042
   PATEY O, 1993, AM J TROP MED HYG, V48, P793, DOI 10.4269/ajtmh.1993.48.793
   Pentsuk N, 2009, BIRTH DEFECTS RES B, V86, P328, DOI 10.1002/bdrb.20201
   Perry ST, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001297
   Perry ST, 2009, J VIROL, V83, P8276, DOI 10.1128/JVI.00365-09
   Pinto AK, 2015, MBIO, V6, DOI 10.1128/mBio.01316-15
   Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604
   Porter KR, 2012, VACCINE, V30, P336, DOI 10.1016/j.vaccine.2011.10.085
   Prestwood TR, 2012, J VIROL, V86, P12561, DOI 10.1128/JVI.06743-11
   Putnak JR, 2005, VACCINE, V23, P4442, DOI 10.1016/j.vaccine.2005.03.042
   Putnak R, 1996, J INFECT DIS, V174, P1176, DOI 10.1093/infdis/174.6.1176
   Putnak R, 2003, AM J TROP MED HYG, V68, P469, DOI 10.4269/ajtmh.2003.68.469
   Raviprakash K, 2000, J GEN VIROL, V81, P1659, DOI 10.1099/0022-1317-81-7-1659
   Raviprakash K, 2008, J VIROL, V82, P6927, DOI 10.1128/JVI.02724-07
   Raviprakash K, 2006, VIROLOGY, V353, P166, DOI 10.1016/j.virol.2006.05.005
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Sarathy VV, 2015, J GEN VIROL, V96, P3035, DOI 10.1099/jgv.0.000246
   Sarathy VV, 2015, J VIROL, V89, P1254, DOI 10.1128/JVI.01320-14
   Sariol CA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00452
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schul W, 2007, J INFECT DIS, V195, P665, DOI 10.1086/511310
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Shi P-Y, 2012, MOL VIROLOGY CONTR F
   Shresta S, 2005, J IMMUNOL, V175, P3946, DOI 10.4049/jimmunol.175.6.3946
   Shresta S, 2004, VIROLOGY, V319, P262, DOI 10.1016/j.virol.2003.09.048
   Shresta S, 2004, J VIROL, V78, P2701, DOI 10.1128/JVI.78.6.2701-2710.2004
   Shresta S, 2006, J VIROL, V80, P10208, DOI 10.1128/JVI.00062-06
   Simmons M, 2006, J VIROL, V80, P9577, DOI 10.1128/JVI.00284-06
   Simmons M, 2010, VIROLOGY, V396, P280, DOI 10.1016/j.virol.2009.10.023
   Sridharan A, 2013, J VIROL, V87, P11648, DOI 10.1128/JVI.01156-13
   St John AL, 2013, ELIFE, V2, DOI 10.7554/eLife.00481
   Strouts FR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004731
   Sumathy K, 2017, SCI REP-UK, V7, DOI 10.1038/srep46375
   Sun W, 2006, J INFECT DIS, V193, P1658, DOI 10.1086/503372
   Suphatrakul A, 2015, VACCINE, V33, P5613, DOI 10.1016/j.vaccine.2015.08.090
   Tan GK, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000672
   Valdes I, 2009, VIROLOGY, V394, P249, DOI 10.1016/j.virol.2009.08.029
   Vasconcelos PFC, 2016, VECTOR-BORNE ZOONOT, V16, P566, DOI 10.1089/vbz.2016.2031
   Vaughan K, 2010, VIRAL IMMUNOL, V23, P259, DOI 10.1089/vim.2010.0006
   Velzing J, 1999, VACCINE, V17, P1312, DOI 10.1016/S0264-410X(98)00393-4
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Waddell LA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156376
   Wang SY, 2015, HUM VACC IMMUNOTHER, V11, P1418, DOI 10.1080/21645515.2015.1011996
   Whitehead SS, 2003, VACCINE, V21, P4307, DOI 10.1016/S0264-410X(03)00488-2
   Whitehead SS, 2003, J VIROL, V77, P1653, DOI 10.1128/JVI.77.2.1653-1657.2003
   WHO Strategic Advisory Group of Experts, 2016, WKLY EPIDEMIOL REC, V91, P282
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Yauch LE, 2009, J IMMUNOL, V182, P4865, DOI 10.4049/jimmunol.0801974
   Yin Z, 2009, P NATL ACAD SCI USA, V106, P20435, DOI 10.1073/pnas.0907010106
   Yoneyama M, 2007, J BIOL CHEM, V282, P15315, DOI 10.1074/jbc.R700007200
   Yu CY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002780
   Zellweger RM, 2014, J IMMUNOL, V193, P4117, DOI 10.4049/jimmunol.1401597
   Zellweger RM, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00151
   Zellweger RM, 2010, CELL HOST MICROBE, V7, P128, DOI 10.1016/j.chom.2010.01.004
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
   Zust R, 2014, J VIROL, V88, P7276, DOI 10.1128/JVI.03827-13
   Zust R, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003521
NR 149
TC 5
Z9 5
U1 1
U2 2
PU SPRINGER-VERLAG SINGAPORE PTE LTD
PI SINGAPORE
PA 152 BEACH ROAD, #21-01/04 GATEWAY EAST, SINGAPORE, 189721, SINGAPORE
SN 0065-2598
EI 2214-8019
BN 978-981-10-8727-1; 978-981-10-8726-4
J9 ADV EXP MED BIOL
JI Adv.Exp.Med.Biol.
PY 2018
VL 1062
BP 215
EP 239
DI 10.1007/978-981-10-8727-1_16
PG 25
WC Infectious Diseases; Medicine, Research & Experimental; Tropical
   Medicine; Virology
SC Infectious Diseases; Research & Experimental Medicine; Tropical
   Medicine; Virology
GA BK8XO
UT WOS:000443965000017
PM 29845536
DA 2020-07-08
ER

PT S
AU Lowen, RG
   Bocan, TM
   Kane, CD
   Cazares, LH
   Kota, KP
   Ladner, JT
   Nasar, F
   Pitt, L
   Smith, DR
   Soloveva, V
   Sun, MG
   Zeng, XK
   Bavari, S
AF Lowen, Robert G.
   Bocan, Thomas M.
   Kane, Christopher D.
   Cazares, Lisa H.
   Kota, Krishna P.
   Ladner, Jason T.
   Nasar, Farooq
   Pitt, Louise
   Smith, Darci R.
   Soloveva, Veronica
   Sun, Mei G.
   Zeng, Xiankun
   Bavari, Sina
BE Hilgenfeld, R
   Vasudevan, SG
TI Countering Zika Virus: The USAMRIID Response
SO DENGUE AND ZIKA: CONTROL AND ANTIVIRAL TREATMENT STRATEGIES
SE Advances in Experimental Medicine and Biology
LA English
DT Article; Proceedings Paper
CT 2nd Tofo Advanced Study Week on Emerging Viruses - Dengue and Zika -
   Control and Antiviral Treatment Strategies
CY AUG 28-SEP 01, 2016
CL Inhambane, MOZAMBIQUE
DE Animal models of infection; Next-generation sequencing; High content
   imaging; PET imaging; Rapid medical countermeasure to emerging viruses
ID ELECTRON-MICROSCOPY; VIRAL REPLICATION; 18 KDA; DISEASE; LIGHT; PET;
   VISUALIZATION; METABOLITES; DISCOVERY; MODEL
AB The United States Army Medical Research Institute of Infectious Diseases (USAMRIID) possesses an array of expertise in diverse capabilities for the characterization of emerging infectious diseases from the pathogen itself to human or animal infection models. The recent Zika virus (ZIKV) outbreak was a challenge and an opportunity to put these capabilities to work as a cohesive unit to quickly respond to a rapidly developing threat. Next-generation sequencing was used to characterize virus stocks and to understand the introduction and spread of ZIKV in the United States. High Content Imaging was used to establish a High Content Screening process to evaluate antiviral therapies. Functional genotnics was used to identify critical host factors for ZIKV infection. An animal model using the temporal blockade of IFN-I in immunocompetent laboratory mice was investigated in conjunction with Positron Emission Tomography to study ZIKV. Correlative light and electron microscopy was used to examine ZIKV interaction with host cells in culture and infected animals. A quantitative mass spectrometry approach was used to examine the protein and metabolite type or concentration changes that occur during ZIKV infection in blood, cells, and tissues. Multiplex fluorescence in situ hybridization was used to confirm ZIKV replication in mouse and NHP tissues. The integrated rapid response approach developed at USAMRIID presented in this review was successfully applied and provides a new template pathway to follow if a new biological threat emerges. This streamlined approach will increase the likelihood that novel medical countermeasures could be rapidly developed, evaluated, and translated into the clinic.
C1 [Lowen, Robert G.; Bocan, Thomas M.; Kane, Christopher D.; Cazares, Lisa H.; Kota, Krishna P.; Nasar, Farooq; Pitt, Louise; Smith, Darci R.; Soloveva, Veronica; Sun, Mei G.; Zeng, Xiankun; Bavari, Sina] US Army, Med Res Inst Infect Dis, Ft Detrick, MD 21702 USA.
   [Ladner, Jason T.] No Arizona Univ, Pathogen & Microbiome Inst, Flagstaff, AZ USA.
RP Lowen, RG (corresponding author), US Army, Med Res Inst Infect Dis, Ft Detrick, MD 21702 USA.
EM robert.g.lowen.mil@mail.mil
RI Cazares, Lisa/H-1166-2019; Bavari, Sina/L-3642-2019; Nasar,
   Farooq/C-7659-2019; Kane, Christopher/C-8256-2019
OI Cazares, Lisa/0000-0001-5754-6192; Bavari, Sina/0000-0001-8424-5635;
   Nasar, Farooq/0000-0003-3658-9649; Kane,
   Christopher/0000-0002-0469-1668; Zeng, Xiankun
   (Kevin)/0000-0003-3526-8755; Pitt, Margaret Louise/0000-0003-0080-3260
FU DARPAUnited States Department of DefenseDefense Advanced Research
   Projects Agency (DARPA)
FX Funding for ZIKV research was provided by DARPA. The authors would like
   to thank Dr. Michael Wiley, Ms. Karla Prieto, Mr. Daniel Reyes, Ms.
   Elyse Nagle, Dr. Mariano Sanchez-Lockhart and Dr. Gustavo Palacios for
   their contributions toward the genomic characterization. The authors
   would like to acknowledge Mr. Kyle Kuszpit and Robert Stafford for their
   assistance in performing the imaging studies and Drs. Xiang Zhang,
   Falguni Basuli, and Rolf Swenson from the Imaging Probe Development
   Center at NIH for providing the PET radiotracers. The authors would also
   like to thank Mr. Brandon Kline and Ms. Kathy Kuehl for EM support and
   Ms. Tara Kenny, Ms. Xiaoli Chi, Mr. Rouzbeh Zamani, Mr. Glenn Gomba, Mr.
   Collin Dube for their support of HCI screening work.
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Atieh T, 2016, SCI REP-UK, V6, DOI 10.1038/srep39384
   Bernards N, 2015, MOL IMAGING BIOL, V17, P67, DOI 10.1007/s11307-014-0765-9
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Bocan TM, 2015, MOL IMAGING BIOL, V17, P4, DOI 10.1007/s11307-014-0759-7
   Boigard H, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005608
   Cazares LH, 2011, ANAL BIOANAL CHEM, V401, P17, DOI 10.1007/s00216-011-5003-6
   Chan JFW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.99
   Cortese M, 2017, CELL REP, V18, P2113, DOI 10.1016/j.celrep.2017.02.014
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Ellison DW, 2016, GENOME ANNOUNC, V4
   Fujimura Y, 2014, METABOLITES, V4, P319, DOI 10.3390/metabo4020319
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Harhausen D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069529
   Hellstrom K, 2015, METHODS, V90, P49, DOI 10.1016/j.ymeth.2015.04.019
   Herderschee J, 2015, J LEUKOCYTE BIOL, V98, P23, DOI 10.1189/jlb.6RU0115-020R
   Herholz K, 2003, ANN NUCL MED, V17, P79, DOI 10.1007/BF02988444
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kruger DH, 2000, LANCET, V355, P1713, DOI 10.1016/S0140-6736(00)02250-9
   Ladner J. T, 2016, GENOME ANNOUNC, V4
   Larson DR, 2005, P NATL ACAD SCI USA, V102, P15453, DOI 10.1073/pnas.0504812102
   Lavisse S, 2015, EUR J NUCL MED MOL I, V42, P478, DOI 10.1007/s00259-014-2962-9
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Leguia M, 2015, PATHOGENS, V4, P816, DOI 10.3390/pathogens4040816
   Li SF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169256
   Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0
   Ly A, 2016, NAT PROTOC, V11, P1428, DOI 10.1038/nprot.2016.081
   Martinez MG, 2014, J VIROL, V88, P6922, DOI 10.1128/JVI.00592-14
   Mielke R, 1998, J NEURAL TRANSM, V105, P821, DOI 10.1007/s007020050097
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   MORGAN C, 1960, J EXP MED, V112, P373, DOI 10.1084/jem.112.2.373
   Mudhasani R, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005437
   Mudhasani R, 2015, J BIOMOL SCREEN, V20, P141, DOI 10.1177/1087057114556253
   NAZERIAN K, 1970, J VIROL, V5, P79, DOI 10.1128/JVI.5.1.79-90.1970
   Noda T, 2011, J INFECT DIS, V204, pS878, DOI 10.1093/infdis/jir310
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Panchal RG, 2010, J BIOMOL SCREEN, V15, P755, DOI 10.1177/1087057110374357
   Perreira JM, 2016, ADV VIRUS RES, V94, P1, DOI 10.1016/bs.aivir.2015.11.001
   Pottier G, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4508
   Radoshitzky SR, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005466
   Reid S, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.61
   Rella CE, 2014, PATHOG DIS, V72, P167, DOI 10.1111/2049-632X.12199
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Sheehan KCF, 2006, J INTERF CYTOK RES, V26, P804, DOI 10.1089/jir.2006.26.804
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Smith DR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005296
   Spuul P, 2011, J VIROL, V85, P4739, DOI 10.1128/JVI.00085-11
   Sridhar S, 2015, J MOL DIAGN, V17, P230, DOI 10.1016/j.jmoldx.2014.12.002
   Thompson A, 2003, ANAL CHEM, V75, P1895, DOI 10.1021/ac0262560
   van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898
   Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 57
TC 2
Z9 2
U1 0
U2 0
PU SPRINGER-VERLAG SINGAPORE PTE LTD
PI SINGAPORE
PA 152 BEACH ROAD, #21-01/04 GATEWAY EAST, SINGAPORE, 189721, SINGAPORE
SN 0065-2598
EI 2214-8019
BN 978-981-10-8727-1; 978-981-10-8726-4
J9 ADV EXP MED BIOL
JI Adv.Exp.Med.Biol.
PY 2018
VL 1062
BP 303
EP 318
DI 10.1007/978-981-10-8727-1_21
PG 16
WC Infectious Diseases; Medicine, Research & Experimental; Tropical
   Medicine; Virology
SC Infectious Diseases; Research & Experimental Medicine; Tropical
   Medicine; Virology
GA BK8XO
UT WOS:000443965000022
PM 29845541
DA 2020-07-08
ER

PT S
AU Low, JG
   Gatsinga, R
   Vasudevan, SG
   Sampath, A
AF Low, Jenny G.
   Gatsinga, Rene
   Vasudevan, Subhash G.
   Sampath, Aruna
BE Hilgenfeld, R
   Vasudevan, SG
TI Dengue Antiviral Development: A Continuing Journey
SO DENGUE AND ZIKA: CONTROL AND ANTIVIRAL TREATMENT STRATEGIES
SE Advances in Experimental Medicine and Biology
LA English
DT Article; Proceedings Paper
CT 2nd Tofo Advanced Study Week on Emerging Viruses - Dengue and Zika -
   Control and Antiviral Treatment Strategies
CY AUG 28-SEP 01, 2016
CL Inhambane, MOZAMBIQUE
DE Drug repurposing; Alpha glucosidase inhibitors; Host targets; FDG
   imaging; Dengue biomarker
ID PLACEBO-CONTROLLED TRIAL; RESEARCH-AND-DEVELOPMENT; ZIKA
   VIRUS-INFECTION; VIRAL NS4B PROTEIN; DRUG DISCOVERY; DOUBLE-BLIND;
   IN-VIVO; MOUSE MODELS; INHIBITOR; REPLICATION
AB Dengue lever is a leading cause of illness and mortality in the tropics and subtropics. There are no therapeutics currently available and a recently approved vaccine is not very efficacious demanding an urgent need to develop an effective antiviral. The path to successful dengue drug development depends on availability of relevant preclinical testing models and better understanding of dengue pathogenesis. In recent years, efforts to develop dengue therapeutics have focused on both repurposing approved drugs as well as discovery of new chemical entities that act via virus or host targeted mechanisms. Here, we discuss the various innovative approaches, their outcome, and the lessons gleaned from the development efforts.
C1 [Low, Jenny G.] Singapore Gen Hosp, Dept Infect Dis, Singapore, Singapore.
   [Low, Jenny G.] Duke NUS Med Sch, Programme Emerging Infect Dis, Singapore, Singapore.
   [Gatsinga, Rene; Vasudevan, Subhash G.] Duke NUS Med Sch Singapore, Emerging Infect Dis Program, Singapore, Singapore.
   [Sampath, Aruna] Emergent BioSolut Inc, Gaithersburg, MD 20879 USA.
RP Sampath, A (corresponding author), Emergent BioSolut Inc, Gaithersburg, MD 20879 USA.
EM sampatha1@ebsi.com
OI Vasudevan, Subhash/0000-0002-5083-3831
FU National Institute of Allergy and Infectious DiseasesUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [HHSN272201100030C]; National Medical Research Council of
   SingaporeNational Medical Research Council, Singapore
   [NMRC/CTGCoD/0001/2015, NMRC/CBRG/0103/2016]
FX UV-4B development was supported by a contract award from the National
   Institute of Allergy and Infectious Diseases, HHSN272201100030C. The
   National Medical Research Council of Singapore is gratefully
   acknowledged for the support of dengue translational research grants
   (NMRC/CTGCoD/0001/2015 (JGL) and NMRC/CBRG/0103/2016 (SGV)).
CR [Anonymous], 2012, GLOB STRAT DENG PREV
   Avirutnam P, 2016, EUR C CLIN MICROBIOL
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Beatty PR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3787
   Bente DA, 2005, J VIROL, V79, P13797, DOI 10.1128/JVI.79.21.13797-13799.2005
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Byrd CM, 2013, ANTIMICROB AGENTS CH, V57, P15, DOI 10.1128/AAC.01429-12
   Caputo AT, 2016, P NATL ACAD SCI USA, V113, pE4630, DOI 10.1073/pnas.1604463113
   Chacko AM, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93474
   Chan KWK, 2015, ANTIVIR RES, V123, P5, DOI 10.1016/j.antiviral.2015.08.013
   Chen HC, 2004, J MED VIROL, V73, P419, DOI 10.1002/jmv.20108
   Chen HC, 2007, J VIROL, V81, P5518, DOI 10.1128/JVI.02575-06
   Chen L, 2007, J VIROL, V81, P11634, DOI 10.1128/JVI.00996-07
   Chen LC, 2006, AM J TROP MED HYG, V74, P142, DOI 10.4269/ajtmh.2006.74.142
   Chen YL, 2014, J VIROL, V88, P1740, DOI 10.1128/JVI.02841-13
   Choy MM, 2013, AM J TROP MED HYG, V89, P1001, DOI 10.4269/ajtmh.13-0100
   Dawicki W, 2007, CURR OPIN IMMUNOL, V19, P31, DOI 10.1016/j.coi.2006.11.006
   Duyen HTL, 2011, J INFECT DIS, V203, P1292, DOI 10.1093/infdis/jir014
   Endy TP, 2014, J INFECT DIS, V209, P556, DOI 10.1093/infdis/jiu112
   Eriksson S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003174
   Furuta T, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001505
   Goncalvez AP, 2007, P NATL ACAD SCI USA, V104, P9422, DOI 10.1073/pnas.0703498104
   Guirakhoo F, 2002, VIROLOGY, V298, P146, DOI 10.1006/viro.2002.1462
   Gunther VJ, 2011, VACCINE, V29, P3895, DOI 10.1016/j.vaccine.2011.03.038
   Halstead SB, 2016, VACCINE, V34, P1643, DOI 10.1016/j.vaccine.2016.02.004
   Hayden FG, 1999, NEW ENGL J MED, V341, P1336, DOI 10.1056/NEJM199910283411802
   John DV, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0191-6
   Keller Thomas H, 2006, Novartis Found Symp, V277, P102, DOI 10.1002/0470058005.ch8
   Kirkpatrick BD, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1517
   Kuruvilla JG, 2007, VIROLOGY, V369, P143, DOI 10.1016/j.virol.2007.06.005
   Lescar J, 2008, ANTIVIR RES, V80, P94, DOI 10.1016/j.antiviral.2008.07.001
   Lim SP, 2015, ANTIVIR RES, V119, P57, DOI 10.1016/j.antiviral.2015.04.010
   Lim SP, 2013, ANTIVIR RES, V100, P500, DOI 10.1016/j.antiviral.2013.09.013
   Low JG, 2014, LANCET INFECT DIS, V14, P706, DOI 10.1016/S1473-3099(14)70730-3
   Low JGH, 2017, J INFECT DIS, V215, pS96, DOI 10.1093/infdis/jiw423
   Malavige GN, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-341
   Modhiran N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3863
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Tuan NM, 2017, CLIN INFECT DIS, V64, P656, DOI 10.1093/cid/ciw863
   Nguyen NM, 2013, J INFECT DIS, V207, P1442, DOI 10.1093/infdis/jis470
   Perry ST, 2013, ANTIVIR RES, V98, P35, DOI 10.1016/j.antiviral.2013.01.004
   Plummer E, 2015, J VIROL, V89, P5592, DOI 10.1128/JVI.00028-15
   Potts JA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000769
   Rajapakse S, 2014, INFECT DRUG RESIST, V7, P137, DOI 10.2147/IDR.S55380
   Robinson LN, 2015, CELL, V162, P493, DOI 10.1016/j.cell.2015.06.057
   SABIN AB, 1945, SCIENCE, V101, P640, DOI 10.1126/science.101.2634.640
   SABIN ALBERT B., 1952, AMER JOUR TROP MED AND HYG, V1, P30
   Farias KJS, 2015, VIRAL IMMUNOL, V28, P161, DOI 10.1089/vim.2014.0090
   St John AL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003783
   St John AL, 2013, ELIFE, V2, DOI 10.7554/eLife.00481
   Statler J, 2008, J CLIN ULTRASOUND, V36, P413, DOI 10.1002/jcu.20476
   Sung C, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004851
   Sung C, 2014, DENGUE AND DENGUE HEMORRHAGIC FEVER, 2ND EDITION, P293, DOI 10.1079/9781845939649.0293
   Takhampunya R, 2006, J GEN VIROL, V87, P1947, DOI 10.1099/vir.0.81655-0
   Tam DTH, 2012, CLIN INFECT DIS, V55, P1216, DOI 10.1093/cid/cis655
   Tan GK, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000672
   Tay MYF, 2013, ANTIVIR RES, V99, P301, DOI 10.1016/j.antiviral.2013.06.002
   Teoh EP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003888
   Tricou Vianney, 2010, PLoS Negl Trop Dis, V4, pe785, DOI 10.1371/journal.pntd.0000785
   van Cleef KWR, 2013, ANTIVIR RES, V99, P165, DOI 10.1016/j.antiviral.2013.05.011
   Vannice KS, 2016, VACCINE, V34, P2934, DOI 10.1016/j.vaccine.2015.12.073
   Wagstaff KM, 2012, BIOCHEM J, V443, P851, DOI 10.1042/BJ20120150
   Wang QY, 2015, J VIROL, V89, P8233, DOI 10.1128/JVI.00855-15
   Warfield KL, 2016, ANTIVIR RES, V129, P93, DOI 10.1016/j.antiviral.2016.03.001
   WARFIELD KL, 2016, VIRUSES-BASEL, V8, DOI DOI 10.3390/V8030071
   Watanabe S, 2016, ANTIVIR RES, V127, P10, DOI 10.1016/j.antiviral.2015.12.008
   Watanabe S, 2012, ANTIVIR RES, V96, P32, DOI 10.1016/j.antiviral.2012.07.008
   Watanabe S, 2012, J VIROL, V86, P5508, DOI 10.1128/JVI.07081-11
   Whitehorn J, 2016, CLIN INFECT DIS, V62, P468, DOI 10.1093/cid/civ949
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Xie XP, 2015, ANTIVIR RES, V118, P39, DOI 10.1016/j.antiviral.2015.03.007
   Xie XP, 2011, J VIROL, V85, P11183, DOI 10.1128/JVI.05468-11
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yauch LE, 2008, ANTIVIR RES, V80, P87, DOI 10.1016/j.antiviral.2008.06.010
   Yin Z, 2009, P NATL ACAD SCI USA, V106, P20435, DOI 10.1073/pnas.0907010106
NR 75
TC 4
Z9 4
U1 0
U2 0
PU SPRINGER-VERLAG SINGAPORE PTE LTD
PI SINGAPORE
PA 152 BEACH ROAD, #21-01/04 GATEWAY EAST, SINGAPORE, 189721, SINGAPORE
SN 0065-2598
EI 2214-8019
BN 978-981-10-8727-1; 978-981-10-8726-4
J9 ADV EXP MED BIOL
JI Adv.Exp.Med.Biol.
PY 2018
VL 1062
BP 319
EP 332
DI 10.1007/978-981-10-8727-1_22
PG 14
WC Infectious Diseases; Medicine, Research & Experimental; Tropical
   Medicine; Virology
SC Infectious Diseases; Research & Experimental Medicine; Tropical
   Medicine; Virology
GA BK8XO
UT WOS:000443965000023
PM 29845542
DA 2020-07-08
ER

PT S
AU O'Neill, SL
AF O'Neill, Scott L.
BE Hilgenfeld, R
   Vasudevan, SG
TI The Use of Wolbachia by the World Mosquito Program to Interrupt
   Transmission of Aedes aegypti Transmitted Viruses
SO DENGUE AND ZIKA: CONTROL AND ANTIVIRAL TREATMENT STRATEGIES
SE Advances in Experimental Medicine and Biology
LA English
DT Article; Proceedings Paper
CT 2nd Tofo Advanced Study Week on Emerging Viruses - Dengue and Zika -
   Control and Antiviral Treatment Strategies
CY AUG 28-SEP 01, 2016
CL Inhambane, MOZAMBIQUE
DE World Mosquito Program; Biological mosquito control; Cytoplasmic
   Incompatibility; wMel Wolbachia strain; Randomised control cluster trial
ID ZIKA VIRUS; POPULATIONS; DENGUE; INFECTION; STRAIN
AB The biological control of mosquito transmission by the use of the naturally occurring insect-specific bacterial endosymbiont Wolbachia has been successfully tested in small field trials. The approach has been translated successfully to larger field sites in Townsville, Australia and expanded to more than 10 countries through the Eliminate Dengue Program. The broader application of the program beyond limiting the transmission of dengue and including other Aedes aegypti borne mosquitoes has seen the program growing into a global not-for-profit initiative to be known as the World Mosquito Program.
C1 [O'Neill, Scott L.] Monash Univ, Inst Vector Borne Dis, Clayton, Vic, Australia.
RP O'Neill, SL (corresponding author), Monash Univ, Inst Vector Borne Dis, Clayton, Vic, Australia.
EM scott.oneill@monash.edu
RI O'Neill, Scott L/B-3568-2009
OI O'Neill, Scott L/0000-0002-4131-3615
CR Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004677
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Ferguson NM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010370
   Frentiu FD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002688
   Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Hoffmann M, 2014, ENVIRON ENTOMOL, V43, P1215, DOI 10.1603/EN14193
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Murray JV, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00043
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Werren JH, 2008, NAT REV MICROBIOL, V6, P741, DOI 10.1038/nrmicro1969
   WHO [World Health Organization], 2016, MOSQ VECT CONTR EM R
   Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544
NR 14
TC 19
Z9 19
U1 0
U2 9
PU SPRINGER-VERLAG SINGAPORE PTE LTD
PI SINGAPORE
PA 152 BEACH ROAD, #21-01/04 GATEWAY EAST, SINGAPORE, 189721, SINGAPORE
SN 0065-2598
EI 2214-8019
BN 978-981-10-8727-1; 978-981-10-8726-4
J9 ADV EXP MED BIOL
JI Adv.Exp.Med.Biol.
PY 2018
VL 1062
BP 355
EP 360
DI 10.1007/978-981-10-8727-1_24
PG 6
WC Infectious Diseases; Medicine, Research & Experimental; Tropical
   Medicine; Virology
SC Infectious Diseases; Research & Experimental Medicine; Tropical
   Medicine; Virology
GA BK8XO
UT WOS:000443965000025
PM 29845544
DA 2020-07-08
ER

PT S
AU Gudo, ES
   Ali, S
   Antonio, VS
   Chelene, IR
   Chongo, I
   Demanou, M
   Falk, K
   Guiliche, OC
   Heinrich, N
   Monteiro, V
   Muianga, AF
   Oludele, J
   Mula, F
   Mutuku, F
   Amade, N
   Alho, P
   Betsem, E
   Chimbuinhe, Z
   Cristovam, AJ
   Galano, G
   Gessain, A
   Harris, E
   Heise, M
   Inalda, F
   Jala, I
   Jaszi, E
   King, C
   Kitron, U
   Kummerer, BM
   LaBeaud, AD
   Lagerqvist, N
   Malai, G
   Mazelier, M
   Mendes, S
   Mukoko, D
   Ndenga, B
   Njouom, R
   Pinto, G
   Tivane, A
   Vu, DM
   Vulule, J
AF Gudo, Eduardo Samo
   Ali, S.
   Antonio, V. S.
   Chelene, I. R.
   Chongo, I.
   Demanou, M.
   Falk, K.
   Guiliche, O. C.
   Heinrich, N.
   Monteiro, V.
   Muianga, A. F.
   Oludele, J.
   Mula, F.
   Mutuku, F.
   Amade, N.
   Alho, P.
   Betsem, E.
   Chimbuinhe, Z.
   Cristovam, A. J.
   Galano, G.
   Gessain, A.
   Harris, E.
   Heise, M.
   Inalda, F.
   Jala, I.
   Jaszi, E.
   King, C.
   Kitron, U.
   Kuemmerer, B. M.
   LaBeaud, A. D.
   Lagerqvist, N.
   Malai, G.
   Mazelier, M.
   Mendes, S.
   Mukoko, D.
   Ndenga, B.
   Njouom, R.
   Pinto, G.
   Tivane, A.
   Vu, D. M.
   Vulule, J.
BE Hilgenfeld, R
   Vasudevan, SG
TI Seroepidemiological Studies of Arboviruses in Africa
SO DENGUE AND ZIKA: CONTROL AND ANTIVIRAL TREATMENT STRATEGIES
SE Advances in Experimental Medicine and Biology
LA English
DT Article; Proceedings Paper
CT 2nd Tofo Advanced Study Week on Emerging Viruses - Dengue and Zika -
   Control and Antiviral Treatment Strategies
CY AUG 28-SEP 01, 2016
CL Inhambane, MOZAMBIQUE
DE Differential diagnosis; Virology in Africa; Molecular surveillance of
   emerging viruses in Africa; Seroprevalence of emerging viruses in
   Africa; Prospective studies of emerging virus transmission in Africa
AB The literature on sero-epidemiological studies of flaviviral infections in the African continent is quite scarce. Much of the viral epidemiology studies have been focussing on diseases such as HIV/AIDS because of their sheer magnitude and impact on the lives of people in the various affected countries. Increasingly disease outbreaks caused by arboviruses such as the recent cases of chikungunya virus, dengue virus and yellow fever virus have prompted renewed interest in studying these viruses. International agencies from the US, several EU nations and China are starting to build collaborations to build capacity in many African countries together with established institutions to conduct these studies. The Tofo Advanced Study Week (TASW) was established to bring the best scientists from the world to the tiny seaside town of Praia do Tofo to rub shoulders with African virologists and discuss cutting-edge science and listen to the work of researchers in the field. In 2015 the 1st TASW focussed on Ebola virus. The collections of abstracts from participants at the 2nd TASW which focused on Dengue and Zika virus as well as presentations on other arboviruses are collated in this chapter.
C1 [Gudo, Eduardo Samo; Ali, S.; Antonio, V. S.; Chelene, I. R.; Chongo, I.; Guiliche, O. C.; Monteiro, V.; Muianga, A. F.; Oludele, J.; Mula, F.; Amade, N.; Alho, P.; Inalda, F.; Pinto, G.; Tivane, A.] Natl Inst Hlth, Maputo, Mozambique.
   [Demanou, M.; Mazelier, M.; Njouom, R.] CPC, Lab Arbovirus & Virus Fievres Hemorrag, Yaounde, Cameroon.
   [Falk, K.; Lagerqvist, N.] Publ Hlth Agcy Sweden, Solna, Sweden.
   [Falk, K.; Lagerqvist, N.] Karolinska Inst, Solna, Sweden.
   [Heinrich, N.] Univ Munich LMU, Med Ctr, Infect Dis & Trop Med, Munich, Germany.
   [Mutuku, F.] Tech Univ Mombasa, Mombasa, Kenya.
   [Betsem, E.] Univ Yaounde I, Fac Med & Sci Biomed, Yaounde, Cameroon.
   [Betsem, E.; Gessain, A.] Inst Pasteur, Unite Epidemiol & Physiopathol Virus Oncogenes, Paris, France.
   [Chimbuinhe, Z.; Galano, G.] Pemba Prov Hosp, Pemba, Mozambique.
   [Cristovam, A. J.] Direccao Prov Maputo, Maputo, Mozambique.
RP Gudo, ES (corresponding author), Natl Inst Hlth, Maputo, Mozambique.; Demanou, M (corresponding author), CPC, Lab Arbovirus & Virus Fievres Hemorrag, Yaounde, Cameroon.; Falk, K (corresponding author), Publ Hlth Agcy Sweden, Solna, Sweden.; Falk, K (corresponding author), Karolinska Inst, Solna, Sweden.; Heinrich, N (corresponding author), Univ Munich LMU, Med Ctr, Infect Dis & Trop Med, Munich, Germany.; Mutuku, F (corresponding author), Tech Univ Mombasa, Mombasa, Kenya.
EM kerstin.falk@folkhalsomyndigheten.se; heinrich@lrz.uni-muenchen.de
RI Vu, David/AAI-4197-2020; Mutuku, Francis/AAO-3761-2020
OI Vu, David/0000-0002-0930-4524; King, Charles/0000-0001-8349-9270
CR Boche R, 1974, Bull Soc Pathol Exot Filiales, V67, P126
   Demanou M, 2015, VIROL SIN, V30, P470
NR 2
TC 1
Z9 1
U1 0
U2 2
PU SPRINGER-VERLAG SINGAPORE PTE LTD
PI SINGAPORE
PA 152 BEACH ROAD, #21-01/04 GATEWAY EAST, SINGAPORE, 189721, SINGAPORE
SN 0065-2598
EI 2214-8019
BN 978-981-10-8727-1; 978-981-10-8726-4
J9 ADV EXP MED BIOL
JI Adv.Exp.Med.Biol.
PY 2018
VL 1062
BP 361
EP 371
DI 10.1007/978-981-10-8727-1_25
PG 11
WC Infectious Diseases; Medicine, Research & Experimental; Tropical
   Medicine; Virology
SC Infectious Diseases; Research & Experimental Medicine; Tropical
   Medicine; Virology
GA BK8XO
UT WOS:000443965000026
PM 29845545
DA 2020-07-08
ER

PT J
AU Trus, I
   Darbellay, J
   Huang, Y
   Gilmour, M
   Safronetz, D
   Gerdts, V
   Karniychuk, U
AF Trus, Ivan
   Darbellay, Joseph
   Huang, Yanyun
   Gilmour, Matthew
   Safronetz, David
   Gerdts, Volker
   Karniychuk, Uladzimir
TI Persistent Zika virus infection in porcine conceptuses is associated
   with elevated in utero cortisol levels
SO VIRULENCE
LA English
DT Letter
DE Zika virus; cortisol; pig; fetus; placenta; 11-HSD; HPA axis
ID PLACENTAL 11-BETA-HYDROXYSTEROID DEHYDROGENASE; AMNIOTIC-FLUID; NEONATAL
   PIGS; BIRTH; RESPONSES; STRESS; ALTERS; BRAIN; AXIS
C1 [Trus, Ivan; Darbellay, Joseph; Gerdts, Volker; Karniychuk, Uladzimir] Univ Saskatchewan, Vaccine & Infect Dis Org Int Vaccine Ctr VIDO Int, Saskatoon, SK, Canada.
   [Huang, Yanyun] Prairie Diagnost Serv, Saskatoon, SK, Canada.
   [Gilmour, Matthew; Safronetz, David] Publ Hlth Agcy Canada, Canada Natl Microbiol Lab, Winnipeg, MB, Canada.
   [Gerdts, Volker; Karniychuk, Uladzimir] Univ Saskatchewan, Western Coll Vet Med, Dept Vet Microbiol, Saskatoon, SK, Canada.
   [Karniychuk, Uladzimir] Univ Saskatchewan, Sch Publ Hlth, Saskatoon, SK, Canada.
RP Karniychuk, U (corresponding author), Univ Saskatchewan, Vaccine & Infect Dis Org Int Vaccine Ctr VIDO Int, Saskatoon, SK, Canada.
EM u.karniychuk@usask.ca
OI Karniychuk, Uladzimir/0000-0001-7802-9223; Trus,
   Ivan/0000-0003-2849-5140
FU Genome CanadaGenome Canada [418402]; Public Health Agency of Canada;
   Government of Saskatchewan (Innovation Saskatchewan grant) [418836]
FX Financial support was provided by Genome Canada (Emerging Issue Program
   grant #418402), the Public Health Agency of Canada and the Government of
   Saskatchewan (Innovation Saskatchewan grant #418836). This paper was
   published with the permission of the Director of VIDO-InterVac,
   manuscript #829.
CR Alonso-Spilsbury M, 2005, ANIM REPROD SCI, V90, P1, DOI 10.1016/j.anireprosci.2005.01.007
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Corry J, 2017, P NATL ACAD SCI USA, V114, P9433, DOI 10.1073/pnas.1707513114
   Daniel JA, 1999, J ANIM SCI, V77, P742
   Darbellay J, 2017, EBIOMEDICINE, V25, P73, DOI 10.1016/j.ebiom.2017.09.021
   Darbellay J, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2016.133
   Enwonwu CO, 1996, EUR J ORAL SCI, V104, P322, DOI 10.1111/j.1600-0722.1996.tb00085.x
   Fan Xiao-peng, 2008, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V22, P330
   FENCL MDM, 1975, NEW ENGL J MED, V292, P133, DOI 10.1056/NEJM197501162920304
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   French NP, 1999, AM J OBSTET GYNECOL, V180, P114, DOI 10.1016/S0002-9378(99)70160-2
   FUJIKURA T, 1975, AM J OBSTET GYNECOL, V121, P45, DOI 10.1016/0002-9378(75)90973-4
   Haussmann MF, 2000, J ANIM SCI, V78, P2399
   Kanitz E, 2006, J ENDOCRINOL, V191, P207, DOI 10.1677/joe.1.06868
   Klemcke HG, 2003, BIOL REPROD, V69, P1945, DOI 10.1095/biolreprod.103.018150
   Klemcke HG, 2000, LIFE SCI, V66, P1045, DOI 10.1016/S0024-3205(99)00669-4
   Klemcke HG, 1996, BIOL REPROD, V55, P217, DOI 10.1095/biolreprod55.1.217
   Kossintseva I, 2006, AM J PHYSIOL-ENDOC M, V290, pE282, DOI 10.1152/ajpendo.00328.2005
   Lind NM, 2007, NEUROSCI BIOBEHAV R, V31, P728, DOI 10.1016/j.neubiorev.2007.02.003
   Miller NM, 2005, BJOG-INT J OBSTET GY, V112, P921, DOI 10.1111/j.1471-0528.2005.00620.x
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Otten W, 2010, DOMEST ANIM ENDOCRIN, V38, P146, DOI 10.1016/j.domaniend.2009.09.002
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rault JL, 2015, ANIMALS, V5, P545, DOI 10.3390/ani5030371
   Reynolds RM, 2013, PSYCHONEUROENDOCRINO, V38, P1, DOI 10.1016/j.psyneuen.2012.08.012
   Sarkar P, 2008, J NEUROENDOCRINOL, V20, P489, DOI 10.1111/j.1365-2826.2008.01659.x
   Schreur PJW, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0044-y
   Tabata T, 2018, J INFECT DIS, V217, P1202, DOI 10.1093/infdis/jix552
   Trevisan M, 2009, J CELL PHYSIOL, V221, P629, DOI 10.1002/jcp.21896
   Turpin DL, 2016, ANIMALS, V6, DOI 10.3390/ani6110066
   Turpin DL, 2016, ANIMALS, V6, DOI 10.3390/ani6030024
   Wood CE, 2016, F1000RESEARCH, V5
   Zupan M, 2017, REV BRAS ZOOTECN, V46, P33, DOI [10.1590/s1806-92902017000100006, 10.1590/S1806-92902017000100006]
NR 33
TC 5
Z9 5
U1 0
U2 1
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 2150-5594
EI 2150-5608
J9 VIRULENCE
JI Virulence
PY 2018
VL 9
IS 1
BP 1338
EP 1343
DI 10.1080/21505594.2018.1504558
PG 6
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA GS7YD
UT WOS:000443920200002
PM 30058440
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Sinigaglia, A
   Riccetti, S
   Trevisan, M
   Barzon, L
AF Sinigaglia, Alessandro
   Riccetti, Silvia
   Trevisan, Marta
   Barzon, Luisa
TI In silico approaches to Zika virus drug discovery
SO EXPERT OPINION ON DRUG DISCOVERY
LA English
DT Review
DE Antiviral drugs; drug design; hit discovery; NS2B-NS3 protease; NS3
   helicase; NS5 MTase/RdRp; virtual screening; Zika virus
ID DEPENDENT RNA-POLYMERASES; SMALL-MOLECULE INHIBITORS; DENGUE VIRUS;
   NS2B-NS3 PROTEASE; CRYSTAL-STRUCTURE; ANTIVIRAL DRUG; NS5
   METHYLTRANSFERASE; SEXUAL TRANSMISSION; ENVELOPE PROTEIN; APPROVED DRUGS
AB Introduction: After the WHO declared Zika virus (ZIKV) as a public health emergency of international concern, intense research for the development of vaccines and drugs has been undertaken, leading to the development of several candidates.
   Areas covered: This review discusses the developments achieved so far by computational methods in the discovery of candidate compounds targeting ZIKV proteins, i.e. the envelope and capsid structural proteins, the NS3 helicase/protease, and the NS5 methyltransferase/RNA-dependent RNA polymerase.
   Expert opinion: Research for effective drugs against ZIKV is still in a very early discovery phase. Notwithstanding the intense efforts for the development of new drugs and the identification of several promising candidates by using different approaches, including computational methods, so far only a few candidates have been experimentally tested. An important caveat of anti-flavivirus drug development is represented by the difficult of reproducing the in vivo microenvironment of the replication complex, which may lead to discrepancies between in vitro results and experimental evaluation in vivo. Moreover, anti-ZIKV drugs have the additional requirement of an excellent safety profile in pregnancy and ability to diffuse to different tissues, including the central nervous system, the testis, and the placenta.
C1 [Sinigaglia, Alessandro; Riccetti, Silvia; Trevisan, Marta; Barzon, Luisa] Univ Padua, Dept Mol Med, Via A Gabelli 63, I-35121 Padua, Italy.
RP Barzon, L (corresponding author), Univ Padua, Dept Mol Med, Via A Gabelli 63, I-35121 Padua, Italy.
EM luisa.barzon@unipd.it
RI Barzon, Luisa/K-7961-2016; TREVISAN, MARTA/K-6591-2016
OI Barzon, Luisa/0000-0003-0720-8456; TREVISAN, MARTA/0000-0002-3148-7240
CR Allison SL, 2001, J VIROL, V75, P4268, DOI 10.1128/JVI.75.9.4268-4275.2001
   Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Barzon L., 2016, EUROSURVEILLANCE, V21, P2016, DOI DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Barzon L, 2018, CLIN INFECT DIS, V66, P1173, DOI 10.1093/cid/cix967
   Barzon L, 2017, EXPERT OPIN BIOL TH, V17, P1185, DOI 10.1080/14712598.2017.1346081
   Barzon L, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw202
   Basak SC, 2016, CURR COMPUT-AID DRUG, V12, P2, DOI 10.2174/1573409912999160315115502
   Benmansour F, 2017, EUR J MED CHEM, V125, P865, DOI 10.1016/j.ejmech.2016.10.007
   Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Boldescu V, 2017, NAT REV DRUG DISCOV, V16, P565, DOI 10.1038/nrd.2017.33
   Brecher M, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006411
   Brecher M, 2015, ACS INFECT DIS, V1, P340, DOI 10.1021/acsinfecdis.5b00070
   Brecher M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130062
   Brown WC, 2016, NAT STRUCT MOL BIOL, V23, P865, DOI 10.1038/nsmb.3268
   Byler KG, 2016, J MOL GRAPH MODEL, V69, P78, DOI 10.1016/j.jmgm.2016.08.011
   Byrd CM, 2013, ANTIMICROB AGENTS CH, V57, P15, DOI 10.1128/AAC.01429-12
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Ceron-Carrasco JP, 2016, DRUG DES, V5, P2
   Chan JFW, 2017, ANTIVIR RES, V141, P29, DOI 10.1016/j.antiviral.2017.02.002
   Choi KH, 2009, CURR OPIN STRUC BIOL, V19, P746, DOI 10.1016/j.sbi.2009.10.015
   Clyde K, 2008, VIROLOGY, V379, P314, DOI 10.1016/j.virol.2008.06.034
   Coloma J, 2016, CELL REP, V16, P3097, DOI 10.1016/j.celrep.2016.08.091
   Cortese M, 2017, CELL REP, V18, P2113, DOI 10.1016/j.celrep.2017.02.014
   Coutard B, 2017, J VIROL, V91, DOI 10.1128/JVI.02202-16
   Coutard B, 2014, ANTIVIR RES, V106, P61, DOI 10.1016/j.antiviral.2014.03.013
   Cox Bryan D., 2015, Antiviral Chemistry & Chemotherapy, V24, P118, DOI 10.1177/2040206616653873
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489
   Devnarain N, 2018, CHEM BIOL DRUG DES, V92, P1838, DOI 10.1111/cbdd.13353
   Devnarain N, 2017, RSC ADV, V7, P47416, DOI 10.1039/c7ra05918c
   Dokland T, 2004, STRUCTURE, V12, P1157, DOI 10.1016/j.str.2004.04.024
   Dong HP, 2008, ANTIVIR RES, V80, P1, DOI 10.1016/j.antiviral.2008.05.003
   Duan WQ, 2017, EMBO J, V36, P919, DOI 10.15252/embj.201696241
   Egloff MP, 2007, J MOL BIOL, V372, P723, DOI 10.1016/j.jmb.2007.07.005
   Ekins S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005023
   Ekins Sean, 2016, F1000Res, V5, P275
   Ekins Sean, 2016, F1000Res, V5, P150, DOI 10.12688/f1000research.8013.1
   Elfiky AA, 2018, SAR QSAR ENVIRON RES, V29, P409, DOI 10.1080/1062936X.2018.1454981
   Elfiky AA, 2018, J MED VIROL, V90, P13, DOI 10.1002/jmv.24934
   Elfiky AA, 2016, J MED VIROL, V88, P2044, DOI 10.1002/jmv.24678
   Elfiky AA, 2013, PROTEIN J, V32, P75, DOI 10.1007/s10930-013-9462-9
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Fajardo-Sanchez E, 2017, J BIOMOL STRUCT DYN, V35, P1283, DOI 10.1080/07391102.2016.1179595
   Fernando S, 2016, MOL BIOTECHNOL, V58, P801, DOI 10.1007/s12033-016-9979-1
   da Silva IRF, 2017, JAMA NEUROL, V74, P1190, DOI 10.1001/jamaneurol.2017.1703
   Ferrer-Orta C, 2006, CURR OPIN STRUC BIOL, V16, P27, DOI 10.1016/j.sbi.2005.12.002
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Freire JM, 2015, FEBS J, V282, P2267, DOI 10.1111/febs.13274
   Freire JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081450
   Ganesan A, 2017, EXPERT OPIN DRUG DIS, V12, P407, DOI 10.1080/17460441.2017.1291628
   Gaudinski MR, 2018, LANCET, V391, P552, DOI 10.1016/S0140-6736(17)33105-7
   Godoy AS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14764
   Gorbalenya AE, 2002, J MOL BIOL, V324, P47, DOI 10.1016/S0022-2836(02)01033-1
   Gupta AK, 2016, SCI REP-UK, V6, DOI 10.1038/srep32713
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Huang KY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S16-S10
   Hughes TB, 2015, ACS CENTRAL SCI, V1, P168, DOI 10.1021/acscentsci.5b00131
   Idrus S, 2012, BIOINFORMATION, V8, P348, DOI 10.6026/97320630008348
   Jain R, 2016, NAT STRUCT MOL BIOL, V23, P752, DOI 10.1038/nsmb.3258
   Carod-Artal FJ, 2018, EXPERT REV ANTI-INFE, V16, P399, DOI 10.1080/14787210.2018.1466702
   Jun SR, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1894-3
   Kampmann T, 2009, ANTIVIR RES, V84, P234, DOI 10.1016/j.antiviral.2009.09.007
   Kanai R, 2006, J VIROL, V80, P11000, DOI 10.1128/JVI.01735-06
   Kang CB, 2017, TRENDS MICROBIOL, V25, P797, DOI 10.1016/j.tim.2017.07.001
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kozakov D, 2015, NAT PROTOC, V10, P733, DOI 10.1038/nprot.2015.043
   Lee H, 2017, ANTIVIR RES, V139, P49, DOI 10.1016/j.antiviral.2016.12.016
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Li Z, 2018, ANTIVIR RES, V150, P217, DOI 10.1016/j.antiviral.2017.12.018
   Lim SP, 2011, J BIOL CHEM, V286, P6233, DOI 10.1074/jbc.M110.179184
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Luo DH, 2015, ANTIVIR RES, V118, P148, DOI 10.1016/j.antiviral.2015.03.014
   Ma J, 2016, J CHEM INF MODEL, V56, P2353
   Ma LX, 2004, P NATL ACAD SCI USA, V101, P3414, DOI 10.1073/pnas.0305892101
   Malet H, 2008, ANTIVIR RES, V80, P23, DOI 10.1016/j.antiviral.2008.06.007
   Mier-y-Teran-Romero L, 2018, BMC MED, V16, DOI [10.1186/S12916-018-1052-4, 10.1186/s12916-018-1052-4]
   Milani M, 2009, ANTIVIR RES, V83, P28, DOI 10.1016/j.antiviral.2009.03.001
   Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Modjarrad K, 2018, LANCET, V391, P563, DOI 10.1016/S0140-6736(17)33106-9
   Mottin M, 2018, DRUG DISCOV TODAY
   Mottin M, 2017, BIOCHEM BIOPH RES CO, V492, P643, DOI 10.1016/j.bbrc.2017.03.070
   Munjal A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01469
   PAHO, ZIK CUM CAS
   Pattnaik A, 2018, ANTIVIR RES, V151, P78, DOI 10.1016/j.antiviral.2017.12.016
   Phoo WW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13410
   POCH O, 1989, EMBO J, V8, P3867, DOI 10.1002/j.1460-2075.1989.tb08565.x
   Prasad VM, 2017, NAT STRUCT MOL BIOL, V24, P184, DOI 10.1038/nsmb.3352
   Ramharack P, 2018, DRUG DISCOV TODAY, P30072
   Ramharack P, 2018, J BIOMOL STRUCT DYN, V36, P1118, DOI 10.1080/07391102.2017.1313175
   Ramharack P, 2016, RSC ADV, V6, P68719, DOI 10.1039/c6ra12142j
   Ray D, 2006, J VIROL, V80, P8362, DOI 10.1128/JVI.00814-06
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
   Sahoo Maheswata, 2016, Genomics & Informatics, V14, P104, DOI 10.5808/GI.2016.14.3.104
   Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632
   Satterfield-Nash A, 2017, MMWR-MORBID MORTAL W, V66, P1347, DOI 10.15585/mmwr.mm6649a2
   Scaturro P, 2014, J VIROL, V88, P11540, DOI 10.1128/JVI.01745-14
   Shan C, 2018, CELL HOST MICROBE, V24, P12, DOI 10.1016/j.chom.2018.05.021
   Shang ZF, 2018, J MOL BIOL, V430, P948, DOI 10.1016/j.jmb.2018.02.006
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   Shiryaev SA, 2017, ANTIVIR RES, V143, P218, DOI 10.1016/j.antiviral.2017.04.015
   Singh A, 2017, COMPUT BIOL CHEM, V71, P144, DOI 10.1016/j.compbiolchem.2017.10.007
   Sirohi D, 2017, J INFECT DIS, V216, pS935, DOI 10.1093/infdis/jix515
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Smit JM, 2011, VIRUSES-BASEL, V3, P160, DOI 10.3390/v3020160
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Stephen P, 2016, J AM CHEM SOC, V138, P16212, DOI 10.1021/jacs.6b10399
   Tan CW, 2017, ANTIVIR RES, V143, P186, DOI 10.1016/j.antiviral.2017.04.017
   Tebas Pablo, 2017, N Engl J Med, DOI 10.1056/NEJMoa1708120
   Tian HL, 2016, PROTEIN CELL, V7, P562, DOI 10.1007/s13238-016-0293-2
   Tian HL, 2016, PROTEIN CELL, V7, P450, DOI 10.1007/s13238-016-0275-4
   Tsai CH, 2006, CURR PHARM DESIGN, V12, P1339, DOI 10.2174/138161206776361156
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Wang BX, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14763
   Wang QY, 2009, ANTIMICROB AGENTS CH, V53, P1823, DOI 10.1128/AAC.01148-08
   Wilder-Smith A, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1067-x
   Wolber G, 2008, DRUG DISCOV TODAY, V13, P23, DOI 10.1016/j.drudis.2007.09.007
   World Health Organization, 2016, WHO STAT 1 M INT HLT
   World Health Organization. Fifth meeting of the Emergency Committee under the International Health Regulations, 2005, 5 M EM COMM INT HLTH
   Wu JQ, 2015, INT J MOL SCI, V16, P12943, DOI 10.3390/ijms160612943
   Xie XP, 2017, J INFECT DIS, V216, pS945, DOI 10.1093/infdis/jix406
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yu YF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15672
   Yuan SF, 2017, ANTIVIR RES, V145, P33, DOI 10.1016/j.antiviral.2017.07.007
   Zhang CY, 2017, BIOCHEM BIOPH RES CO, V492, P624, DOI 10.1016/j.bbrc.2016.11.098
   Zhang ZZ, 2016, SCIENCE, V354, P1597, DOI 10.1126/science.aai9309
   Zhao BY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14762
NR 129
TC 4
Z9 5
U1 0
U2 6
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1746-0441
EI 1746-045X
J9 EXPERT OPIN DRUG DIS
JI Expert. Opin. Drug Discov.
PY 2018
VL 13
IS 9
BP 825
EP 835
DI 10.1080/17460441.2018.1515909
PG 11
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA GS7GO
UT WOS:000443869200005
PM 30160181
DA 2020-07-08
ER

PT J
AU Devillers, J
   Larghi, A
   Lagneau, C
AF Devillers, J.
   Larghi, A.
   Lagneau, C.
TI QSAR modelling of synergists to increase the efficacy of deltamethrin
   against pyrethroid-resistant Aedes aegypti mosquitoes($)
SO SAR AND QSAR IN ENVIRONMENTAL RESEARCH
LA English
DT Article
DE Aedes aegypti; resistance; pyrethroids; synergist; three-layer
   perceptron; nonlinear QSAR
ID PIPERONYL BUTOXIDE; DIPTERA-CULICIDAE; INSECTICIDE SYNERGISTS; METABOLIC
   RESISTANCE; PIPERACEAE AMIDES; ZIKA VIRUS; TOXICITY; PESTICIDES; NIGRUM;
   SUSCEPTIBILITY
AB Space spraying of deltamethrin allows the control of adult Aedes (Stegomyia) aegypti mosquitoes. Unfortunately, many vector control programs are threatened by the development of resistances that decrease the efficacy of this adulticide. Faced with this situation, we can either try to use another insecticide presenting a different mechanism of action or find a strategy that brings back the efficacy of the insecticide at a satisfying level to pursue its use in vector control. Restoration of the efficacy of an insecticide can be obtained by means of a synergist. In this context, QSAR modelling was used to find synergists to combine with deltamethrin for increasing its efficacy against resistant strains of Ae. aegypti. Seventy-four structurally diverse chemicals with their 24-hour LD50 values, obtained under the same experimental conditions on Ae. aegypti females, were used. Molecules were described by means of autocorrelation vectors encoding lipophilicity, molar refractivity, H-bonding acceptor and donor ability. A three-layer perceptron (TLP) was employed as statistical tool. The performances of the models were evaluated through the analysis of the prediction results obtained on the different training and test sets (80%/20%) as well as from an out-sample test set. A 6/4/1 TLP computed with the Broyden-Fletcher-Goldfarb-Shanno second-order training algorithm led to the best prediction results. The convergence was obtained in 132 cycles. The sum of squares was used as error function. The hidden and output activation functions were tanh and exponential, respectively. Various chemical structures were identified as potential synergists and searched for their commercial availability. Molecules of interest were tested in vivo on Ae. aegypti by using the susceptible reference Bora Bora strain and two resistant strains from Martinique island. This led to the identification of the PSM-05 molecule that shows interesting synergistic activity.
C1 [Devillers, J.] CTIS, Rillieux La Pape, France.
   [Larghi, A.; Lagneau, C.] EID Mediterranee, Montpellier, France.
RP Devillers, J (corresponding author), CTIS, Rillieux La Pape, France.
EM j.devillers@ctis.fr
FU French Biodiversity Agency on "Resistance and Pesticides" [2101587412]
FX This action is led by the Ministries for Agriculture and Ecological
   Transition, with the financial support of the French Biodiversity Agency
   on "Resistance and Pesticides" research call, by appropriations from the
   fee for diffuse pollution for funding the Ecophyto (contract DeltaSyn,
   #2101587412).
CR Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a
   Aizoun N, 2014, J PARASITOL VECTOR B, V6, P1
   Al Nazawi AM, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2096-6
   Alvarez LC, 2013, J MED ENTOMOL, V50, P1031, DOI 10.1603/ME12254
   BBERNARD C, 1993, J TOXICOL ENV HEALTH, V38, P199, DOI 10.1080/15287399309531712
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bingham G, 2011, TROP MED INT HEALTH, V16, P492, DOI 10.1111/j.1365-3156.2010.02717.x
   BROOKS GT, 1964, BIOCHEM PHARMACOL, V13, P827, DOI 10.1016/0006-2952(64)90025-5
   BROTO P, 1990, EURO CH ENV, V1, P105
   Chadwick E.R., 1963, PYRETH POST, V7, P11
   Chouaibou M, 2014, ACTA TROP, V130, P108, DOI 10.1016/j.actatropica.2013.10.020
   Dadzie SK, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1960-3
   Dekeyser MA, 2005, PEST MANAG SCI, V61, P103, DOI 10.1002/ps.994
   Devillers J, 2000, SAR QSAR ENVIRON RES, V11, P25, DOI 10.1080/10629360008033227
   Devillers J, 1999, ANALUSIS, V27, P23, DOI 10.1051/analusis:1999270023
   Devillers J, 2004, SAR QSAR ENVIRON RES, V15, P501, DOI 10.1080/10629360412331297443
   Devillers J, 2015, SAR QSAR ENVIRON RES, V26, P263, DOI 10.1080/1062936X.2015.1026571
   Devillers J, 2014, SAR QSAR ENVIRON RES, V25, P805, DOI 10.1080/1062936X.2014.958291
   Devillers J, 1995, SAR QSAR Environ Res, V4, P29, DOI 10.1080/10629369508234012
   DeVillers J, 2000, TOXICOL METHOD, V10, P69, DOI 10.1080/105172300242562
   Devillers J, 2003, SAR QSAR ENVIRON RES, V14, P1, DOI 10.1080/1062936021000058737
   Devillers J, 2002, SAR QSAR ENVIRON RES, V13, P555, DOI 10.1080/10629360290023377
   DEVILLERS J, 1999, TOPOLOGICAL INDICES, P595
   DEVILLERS J, 1995, SAR QSAR ENVIRON RES, V3, P301
   DEVILLERS J, 1996, GENETIC ALGORITHMS M
   Devillers J., 2018, COMPUTATIONAL DESIGN, P297
   Devillers J., 2013, MODELING BIOL EFFECT, P341
   Devillers J., 1991, APPL MULTIVARIATE AN
   DEVILLERS J, 2002, HONEY BEES ESTIMATIN
   Devillers J., 2018, COMPUTATIONAL DESIGN
   Devillers J, 1999, TOPOLOGICAL INDICES
   Devillers J, 1996, NEURAL NETWORKS QSAR
   Devillers James, 2003, Bulletin of Insectology, V56, P103
   Devillers J, 2009, QSAR ENVIRON HEALTH, P1
   Doucet JP, 2017, SAR QSAR ENVIRON RES, V28, P451, DOI [10.1080/1062936X.2017.1328855, 10.1080/1062936x.2017.1328855]
   Drgan V, 2016, SAR QSAR ENVIRON RES, V27, P501, DOI 10.1080/1062936X.2016.1196388
   Du YZ, 2016, INSECTS, V7, DOI 10.3390/insects7040060
   EAGLESON C, 1940, Patent No. 2202145
   Fakoorziba MR, 2009, ENVIRON TOXICOL, V24, P19, DOI 10.1002/tox.20386
   FALES J. H., 1957, Soap & Chemical Specialties, V33, P79
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Gallian P, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005254
   Gomes E.O., 2016, VECTOR BIOL J, V1, P3
   Gyawali N, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0132-y
   Haller HL, 1942, J ORG CHEM, V7, P183, DOI 10.1021/jo01196a011
   HANSCH C, 1979, SUBSTITUENT CONSTANT
   Hedenburg O.F., 1948, U. S. Patent, Patent No. [2,452,188, 2452188]
   Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371
   HEWLETT PS, 1961, NATURE, V192, P1273, DOI 10.1038/1921273a0
   Hopkins L.O., 1965, TROPITAL A NEW SYNER, V8, P3
   Hou X, 2016, SAR QSAR ENVIRON RES, V27, P101, DOI 10.1080/1062936X.2015.1134652
   JACOBSON M, 1953, J AM CHEM SOC, V75, P2584, DOI 10.1021/ja01107a011
   Karcher W., 1990, ENV CHEM TOXICOLOGY
   Katritzky A. R., 2005, CODESSA PRO USERS MA
   Khan K, 2017, SAR QSAR ENVIRON RES, V28, P567, DOI 10.1080/1062936X.2017.1352621
   Kotsakiozi P, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005653
   Lacey LA, 2007, J AM MOSQUITO CONTR, V23, P133, DOI 10.2987/8756-971X(2007)23[133:BTSIAB]2.0.CO;2
   LaForge FB, 1942, J ORG CHEM, V7, P416, DOI 10.1021/jo01196a012
   Marcombe S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-494
   Marcombe S, 2009, AM J TROP MED HYG, V80, P745, DOI 10.4269/ajtmh.2009.80.745
   METCALF RL, 1967, ANNU REV ENTOMOL, V12, P229, DOI 10.1146/annurev.en.12.010167.001305
   Miranda JE, 2003, APIDOLOGIE, V34, P409, DOI 10.1051/apido:2003036
   MIYAKADO M, 1985, J PESTIC SCI, V10, P11
   MIYAKADO M, 1980, AGR BIOL CHEM TOKYO, V44, P1701, DOI 10.1080/00021369.1980.10864200
   Moores GD, 2009, PEST MANAG SCI, V65, P150, DOI 10.1002/ps.1661
   Paris M, 2011, ECOTOXICOLOGY, V20, P1184, DOI 10.1007/s10646-011-0663-8
   Park IK, 2002, J AGR FOOD CHEM, V50, P1866, DOI 10.1021/jf011457a
   Park IK, 2012, NAT PROD RES, V26, P2129, DOI 10.1080/14786419.2011.628178
   Paterno A, 2016, SAR QSAR ENVIRON RES, V27, P221, DOI 10.1080/1062936X.2016.1156571
   Perumalsamy H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080226
   Posen HJ, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2016-000087
   Pridgeon JW, 2008, J MED ENTOMOL, V45, P82, DOI 10.1603/0022-2585(2008)45[82:SOAACQ]2.0.CO;2
   Pridgeon JW, 2007, J MED ENTOMOL, V44, P263, DOI 10.1603/0022-2585(2007)44[263:SROPAT]2.0.CO;2
   Pridgeon JW, 2010, J MED ENTOMOL, V47, P172, DOI 10.1603/ME08265
   Pridgeon JW, 2009, J AM MOSQUITO CONTR, V25, P168, DOI 10.2987/08-5837.1
   REKKER RF, 1992, CALCULATION DRUG LIP
   Ruckert C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15412
   Smith LB, 2016, PESTIC BIOCHEM PHYS, V133, P1, DOI 10.1016/j.pestbp.2016.03.005
   Synerholm Martin E., 1947, CONTR BOYCE THOMPSON INST, V15, P35
   Van Nieuwenhuyse P, 2012, PESTIC BIOCHEM PHYS, V104, P88, DOI 10.1016/j.pestbp.2012.05.013
   Vijayan V. A., 2007, Journal of Communicable Diseases, V39, P159
   WACHS H, 1947, SCIENCE, V105, P530, DOI 10.1126/science.105.2733.530-a
   Wang P, 2017, SAR QSAR ENVIRON RES, V28, P341, DOI 10.1080/1062936X.2017.1320585
   Wang Z, 2015, DRUG DEV IND PHARM, V41, P613, DOI 10.3109/03639045.2014.886697
   WHO, 2009, WHOHTMNTDWHOPES20092
   Yaicharoen R, 2005, J VECTOR ECOL, V30, P144
   Yap CW, 2011, J COMPUT CHEM, V32, P1466, DOI 10.1002/jcc.21707
   Zeller H, 2016, J INFECT DIS, V214, pS436, DOI 10.1093/infdis/jiw391
NR 88
TC 2
Z9 2
U1 0
U2 2
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1062-936X
EI 1029-046X
J9 SAR QSAR ENVIRON RES
JI SAR QSAR Environ. Res.
PY 2018
VL 29
IS 8
SI SI
BP 613
EP 629
DI 10.1080/1062936X.2018.1503846
PG 17
WC Chemistry, Multidisciplinary; Computer Science, Interdisciplinary
   Applications; Environmental Sciences; Mathematical & Computational
   Biology; Toxicology
SC Chemistry; Computer Science; Environmental Sciences & Ecology;
   Mathematical & Computational Biology; Toxicology
GA GR5QI
UT WOS:000442692500004
PM 30141356
DA 2020-07-08
ER

PT S
AU Carvalho, MT
   de Santana, GS
   de Andrade, AN
   Cabral, A
   Rosa-Leao, ND
   de Melo-Santos, MAV
   Gomes, ASL
AF Carvalho, Mariana T.
   de Santana, Gisele S.
   de Andrade, Audrey N.
   Cabral, Amanda
   Rosa-Leao, Nairane da Silva
   de Melo-Santos, Maria Alice V.
   Gomes, Anderson S. L.
BE Osinski, M
   Parak, WJ
   Liang, XJ
TI Exploiting silver nanoparticles with PMAA against Aedes aegypti larvae
   development: potential larvicidal activity
SO COLLOIDAL NANOPARTICLES FOR BIOMEDICAL APPLICATIONS XIII
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Colloidal Nanoparticles for Biomedical Applications XIII
CY JAN 27-29, 2018
CL San Francisco, CA
SP SPIE, Ocean Opt Inc
DE Silver nanoparticles; Green synthesis; Aedes aegypti; Larvicidal control
ID OPTICAL COHERENCE TOMOGRAPHY; MOSQUITOS; DENGUE
AB Aedes aegypti is one of the mosquito species with major epidemiological importance in Brazil, involved with the transmission of the arboviruses such as Dengue, Chikungunya and Zika. Since the mosquito is well adapted to the urban environments, where there are large amounts of breeding sites for larvae and pupae, its control has become increasingly difficult. Since 1996, the usual control is made by using chemical larvicides, but the continued use of some of these compounds has led to the selection of A. aegypti resistant populations. Therefore, the search for new insecticidal substances is necessary to guarantee the control of this specie. Our goal is to establish a new larvicide with high toxicity without the drawback of resistance. For this, we developed a low-cost green synthesized silver nanoparticles with a poly(methacrylic acid) outer layer, catalyzed with ultra violet light. We tested nanoparticles samples produced from different batches in laboratory bioassays against fourth-instar larvae. The results showed a desired toxic activity, presenting 10% to 100% of mortalities in concentrations ranging from 0.01 to 1.1 ppm, and from the bioassay we have obtained LC50 = 0.027 ppm and LC90 = 0.044 ppm, after 24 hours of exposure. Imaging the threated larvae by optical microscopy and optical coherence tomography helped to clarify the potential larvae death mechanism. These results associated with the simplicity and low cost of production of these silver nanoparticles, reveal their great potential for the development of products to control of A. aegypti larvae.
C1 [Carvalho, Mariana T.; de Santana, Gisele S.; de Andrade, Audrey N.; Gomes, Anderson S. L.] Univ Fed Pernambuco, Dept Fis, Av Prof Luiz Freire, BR-50670901 Recife, PE, Brazil.
   [de Santana, Gisele S.; de Andrade, Audrey N.] Univ Fed Pernambuco, Dept Quim Fundamental, Av Jorn Anibal Fernandes, BR-50740560 Recife, PE, Brazil.
   [Cabral, Amanda; Rosa-Leao, Nairane da Silva; de Melo-Santos, Maria Alice V.] Fiocruz MS, Dept Entomol, Inst Aggeu Magalhaes, Av Prof Moraes Rego, BR-50670420 Recife, PE, Brazil.
RP Carvalho, MT (corresponding author), Univ Fed Pernambuco, Dept Fis, Av Prof Luiz Freire, BR-50670901 Recife, PE, Brazil.
EM carvalho.mariana.t@gmail.com
RI Carvalho, M. T./J-7610-2012
OI Carvalho, M. T./0000-0002-4281-5799
FU FACEPE; INL
FX The authors would like to thank FACEPE for the financial support. Also,
   we would like to thank Prof. Denise Zezell from IPEN - USP - SP, for the
   support on getting the TEM images of the nanoparticles, and Prof.
   Christiano de Matos, from Mackenzie Presbyterian University - SP, for
   the support on getting the SEM and the sample size measurements of the
   nanoparticles. Mariana T. Carvalho is currently at INL - International
   Iberian Nanotechnology Laboratory, Portugal, and she would like to thank
   INL for supporting the completion of this work, as well its presentation
   at SPIE Bios 2018.
CR Araujo AP, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-297
   Bellinato DF, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/8603263
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Braga IA, 2007, EPIDEMIOL SERV SAUDE, V16, P113
   Brown K, 2014, FORENSIC SCI INT, V242, P157, DOI 10.1016/j.forsciint.2014.07.001
   DEBARJAC H, 1984, WHOVBC84892
   Dubas ST, 2008, TALANTA, V76, P29, DOI 10.1016/j.talanta.2008.01.062
   Dubas ST, 2006, COLLOID SURFACE A, V289, P105, DOI 10.1016/j.colsurfa.2006.04.012
   Govindarajan M, 2017, ARTIF CELL NANOMED B, V45, P1317, DOI 10.1080/21691401.2016.1228664
   Grisales N, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002438
   Jirakanjanakit N, 2007, ENVIRON ENTOMOL, V36, P506, DOI 10.1603/0046-225X(2007)36[506:TOTRIA]2.0.CO;2
   Kalimuthu K, 2017, PROCESS SAF ENVIRON, V109, P82, DOI 10.1016/j.psep.2017.03.027
   Kanayairam Velayutham, 2016, Journal of Basic and Applied Zoology, V74, P16, DOI 10.1016/j.jobaz.2016.02.002
   Kong H, 2008, LANGMUIR, V24, P2051, DOI 10.1021/la703085e
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Melo-Santos MAV, 2010, ACTA TROP, V113, P180, DOI 10.1016/j.actatropica.2009.10.015
   Podoleanu AG, 2012, J MICROSC-OXFORD, V247, P209, DOI 10.1111/j.1365-2818.2012.03619.x
   Ravichandran NK, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17081897
   Rocha HDR, 2015, ACTA TROP, V152, P66, DOI 10.1016/j.actatropica.2015.08.013
   Saade J, 2014, MATER CHEM PHYS, V148, P1184, DOI 10.1016/j.matchemphys.2014.09.045
   Sap-lam N, 2010, Journal of Applied Sciences, V10, P3132
   Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012
   Spadaro D, 2010, APPL SURF SCI, V256, P3812, DOI 10.1016/j.apsusc.2010.01.031
   Spadaro D, 2009, APPL SURF SCI, V255, P8403, DOI 10.1016/j.apsusc.2009.05.108
   Srinivasan VJ, 2006, OPHTHALMOLOGY, V113, P2054, DOI 10.1016/j.ophtha.2006.05.046
   Torres SM, 2014, REV SAUDE PUBL, V48, P445, DOI 10.1590/S0034-8910.2014048005022
   World Health Organization, 1981, WHOVBC81807
NR 28
TC 1
Z9 1
U1 2
U2 4
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
EI 1996-756X
BN 978-1-5106-1500-7; 978-1-5106-1499-4
J9 PROC SPIE
PY 2018
VL 10507
AR UNSP 105070O
DI 10.1117/12.2291573
PG 7
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Optics
SC Engineering; Science & Technology - Other Topics; Optics
GA BK7WP
UT WOS:000442253500010
DA 2020-07-08
ER

PT J
AU Auteri, M
   La Russa, F
   Blanda, V
   Torina, A
AF Auteri, Michelangelo
   La Russa, Francesco
   Blanda, Valeria
   Torina, Alessandra
TI Insecticide Resistance Associated with kdr Mutations in Aedes
   albopictus: An Update on Worldwide Evidences
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Review
ID SODIUM-CHANNEL GENE; ZIKA VIRUS; PYRETHROID INSECTICIDES; 1ST DETECTION;
   ANOPHELES-SINENSIS; DIPTERA-CULICIDAE; AEGYPTI DIPTERA; DENGUE VECTORS;
   BINDING-SITES; IDENTIFICATION
AB Insecticide resistance is an increasing problem worldwide that limits the efficacy of control methods against several pests of health interest. Among them, Aedes albopictus mosquitoes are efficient vectors of relevant pathogens causing animal and human diseases worldwide, including yellow fever, chikungunya, dengue, and Zika. Different mechanisms are associated in conferring resistance to chemical insecticides. One of the most widespread and analysed mechanisms is the knockdown resistance (kdr) causing resistance to DDT and pyrethroids. The mechanism is associated with mutations in the voltage sensitive sodium channel, which is involved in beginning and propagation of action potentials in nervous cells. The mechanism was originally discovered in the housefly and then it was found in a large number of arthropods. In 2011, a kdr associated mutation was evidenced for the first time in A. albopictus and afterward several evidences were reported in the different areas of the world, including China, USA, Brazil, India, and Mediterranean Countries. This review aims to update and summarize current evidences on kdr in A. albopictus, in order to stimulate further researches to analyse in depth A. albopictus resistance status across the world, especially in countries where the presence of this vector is still an emerging issue. Such information is currently needed given the wellknown vector role of A. albopictus in the transmission of severe infectious diseases. Furthermore, the widespread use of chemical insecticides for control strategies against A. albopictus progressively lead to pressure selection inducing the rise of insecticide resistance-related mutations in the species. Such event is especially evident in some countries as China, often related to a history of uncontrolled use of chemical insecticides. Thus, a careful picture on the diffusion of kdr mutations worldwide represents a milestone for the implementation of control plans and the triggering of novel research on alternative strategies for mosquito-borne infections.
C1 [Auteri, Michelangelo; La Russa, Francesco; Blanda, Valeria; Torina, Alessandra] Ist Zooprofilatt Sperimentale Sicilia, Lab Entomol & Control Environm Vectors, Via Gino Marinuzzi 3, I-90129 Palermo, Italy.
RP Blanda, V (corresponding author), Ist Zooprofilatt Sperimentale Sicilia, Lab Entomol & Control Environm Vectors, Via Gino Marinuzzi 3, I-90129 Palermo, Italy.
EM valeria.blanda@gmail.com
RI Torina, Alessandra/I-3029-2016; Blanda, Valeria/J-5772-2016; La Russa,
   Francesco/K-8730-2016
OI Torina, Alessandra/0000-0003-1555-8309; Blanda,
   Valeria/0000-0003-4657-407X; La Russa, Francesco/0000-0003-0947-853X
FU Italian Ministry of HealthMinistry of Health, Italy [RC IZS SI 16/16]
FX The study was funded by Italian Ministry of Health (Project RC IZS SI
   16/16).
CR Aguirre-Obando OA, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2089-5
   Angelini P., 2008, Parassitologia (Rome), V50, P97
   Bengoa M, 2017, J AM MOSQUITO CONTR, V33, P246, DOI 10.2987/17-6636R.1
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brady OJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-338
   Brady OJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-351
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   BROWN GB, 1988, MOL PHARMACOL, V34, P54
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Caputo B, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001793
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chatterjee M, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006192
   Chen HY, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0125-x
   COATS JR, 1990, ENVIRON HEALTH PERSP, V87, P255, DOI 10.2307/3431033
   Corbel V, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2224-3
   Dalla Bona AC, 2012, ZOOLOGIA-CURITIBA, V29, P540, DOI 10.1590/S1984-46702012000600005
   Delatte H., PLOS NEGLECTED TROPI, V7
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dong K., 2010, INSECT PHARM CHANNEL, P25
   dos Santos R. L. C., REV SAUDE PUBLICA, V37
   Du YZ, 2013, P NATL ACAD SCI USA, V110, P11785, DOI 10.1073/pnas.1305118110
   European Centre for Disease Prevention and Control, 2017, CLUST AUT CHIK CAS I
   Chaves LF, 2015, B INSECTOL, V68, P61
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   GAMMON DW, 1981, PESTIC BIOCHEM PHYS, V15, P181, DOI 10.1016/0048-3575(81)90084-5
   Goldin AL, 2002, J EXP BIOL, V205, P575
   Harris AF, 2010, AM J TROP MED HYG, V83, P277, DOI 10.4269/ajtmh.2010.09-0623
   Hawley W.A., 1988, Journal of the American Mosquito Control Association, V4, P1
   Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018
   Higa Yukiko, 2011, Tropical Medicine and Health, V39, P17, DOI 10.2149/tmh.2011-S04
   Insecticide Resistance Action Committee (IRAC), 2006, PREV MAN INS RES VEC, P14
   Ishak IH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0797-2
   Jupille H, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004901
   Kamgang B, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-79
   Kasai S, 2011, JPN J INFECT DIS, V64, P217
   Kim H, 2007, PESTIC BIOCHEM PHYS, V87, P54, DOI 10.1016/j.pestbp.2006.06.009
   Kliot A, 2012, PEST MANAG SCI, V68, P1431, DOI 10.1002/ps.3395
   Knox TB, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-76
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kushwah RBS, 2015, J VECTOR DIS, V52, P95
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li Y., 2018, PARASITES VECTORS, V11
   Liu H, 2004, J MED ENTOMOL, V41, P946, DOI 10.1603/0022-2585-41.5.946
   Liu NN, 2015, ANNU REV ENTOMOL, V60, P537, DOI 10.1146/annurev-ento-010814-020828
   Liu ZZ, 2017, EMERG INFECT DIS, V23, P1085, DOI 10.3201/eid2307.161528
   LOMBET A, 1988, BRAIN RES, V459, P44, DOI 10.1016/0006-8993(88)90284-3
   LOUGHNEY K, 1989, CELL, V58, P1143, DOI 10.1016/0092-8674(89)90512-6
   Marcombe S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101992
   Martens WJM, 1998, ENVIRON HEALTH PERSP, V106, P241, DOI 10.2307/3433924
   Martinez-Torres D, 1998, INSECT MOL BIOL, V7, P179, DOI 10.1046/j.1365-2583.1998.72062.x
   Medeiros AS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194108
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Moyes CL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005625
   Narahashi T, 1996, PHARMACOL TOXICOL, V79, P1, DOI 10.1111/j.1600-0773.1996.tb00234.x
   NASCI RS, 1986, J AM MOSQUITO CONTR, V2, P61
   Ngoagouni C., 2016, PARASITE VECTOR, V9, P1
   O'Reilly AO, 2006, BIOCHEM J, V396, P255, DOI 10.1042/BJ20051925
   Oliveira EE, 2013, NEUROTOXICOLOGY, V38, P42, DOI 10.1016/j.neuro.2013.06.001
   Patterson J, 2016, WEST J EMERG MED, V17, P671, DOI 10.5811/westjem.2016.9.30904
   Pichler V, 2018, PEST MANAG SCI, V74, P1319, DOI 10.1002/ps.4840
   Ranson H, 2000, INSECT MOL BIOL, V9, P491, DOI 10.1046/j.1365-2583.2000.00209.x
   Rath A, 2018, PEST MANAG SCI, V74, P1431, DOI 10.1002/ps.4827
   REITER P, 1987, J AM MOSQUITO CONTR, V3, P494
   Rinkevich FD, 2013, PESTIC BIOCHEM PHYS, V106, P93, DOI 10.1016/j.pestbp.2013.02.007
   Santos J, 2017, ACTA TROP, V168, P80, DOI 10.1016/j.actatropica.2017.01.015
   Scholte Ernst-Jan, 2007, European Mosquito Bulletin, V22, P5
   Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263
   SCOTT JG, 1983, PESTIC BIOCHEM PHYS, V19, P141, DOI 10.1016/0048-3575(83)90133-5
   Simard F, 2005, J MED ENTOMOL, V42, P726, DOI 10.1603/0022-2585(2005)042[0726:GDABSP]2.0.CO;2
   Smartt CT, 2017, J MED ENTOMOL, V54, P1085, DOI 10.1093/jme/tjx058
   Smith LB, 2016, PESTIC BIOCHEM PHYS, V133, P1, DOI 10.1016/j.pestbp.2016.03.005
   Soderlund DM, 1990, PESTICIDE RESISTANCE
   Tan WL, 2012, J MED ENTOMOL, V49, P1012, DOI 10.1603/ME11266
   Usherwood PNR, 2007, FEBS LETT, V581, P5485, DOI 10.1016/j.febslet.2007.10.057
   Vais H, 2001, PEST MANAG SCI, V57, P877, DOI 10.1002/ps.392
   Vontas J, 2012, PESTIC BIOCHEM PHYS, V104, P126, DOI 10.1016/j.pestbp.2012.05.008
   Williamson MS, 1996, MOL GEN GENET, V252, P51, DOI 10.1007/BF02173204
   Xu JB, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004696
   Zhang YQ, 2016, J BIOL CHEM, V291, P20113, DOI 10.1074/jbc.M116.742056
NR 79
TC 8
Z9 8
U1 0
U2 8
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2018
VL 2018
AR 3098575
DI 10.1155/2018/3098575
PG 10
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA GQ8VY
UT WOS:000442039600001
PM 30175124
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Moreira, MCN
   Nascimento, M
   Mendes, CHF
   Pinto, M
   Valongueiro, S
   Moreira, MEL
   Lyra, TM
   Kuper, H
AF Nunes Moreira, Martha Cristina
   Nascimento, Marcos
   Figueira Mendes, Corina Helena
   Pinto, Marcia
   Valongueiro, Sandra
   Lopes Moreira, Maria Elisabeth
   Lyra, Tereza Maciel
   Kuper, Hannah
CA SEIZ Res Grp
TI Emergency and permanence of the Zika virus epidemic: an agenda
   connecting research and policy
SO CADERNOS DE SAUDE PUBLICA
LA English
DT Editorial Material
C1 [Nunes Moreira, Martha Cristina; Nascimento, Marcos; Figueira Mendes, Corina Helena; Pinto, Marcia; Lopes Moreira, Maria Elisabeth] Fundacao Oswaldo Cruz, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Av Rui Barbosa 716,2o Andar, BR-22250020 Rio De Janeiro, RJ, Brazil.
   [Valongueiro, Sandra] Univ Fed Pernambuco, Recife, PE, Brazil.
   [Lyra, Tereza Maciel] Fundacao Oswaldo Cruz, Inst Aggeu Magalhaes, Recife, PE, Brazil.
   [Kuper, Hannah] London Sch Hyg & Trop Med, London, England.
RP Moreira, MCN (corresponding author), Fundacao Oswaldo Cruz, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Av Rui Barbosa 716,2o Andar, BR-22250020 Rio De Janeiro, RJ, Brazil.
EM moreira@iff.fiocruz.br
RI Moreira, Martha Cristina Nunes/AAQ-5567-2020
OI Nascimento, Marcos/0000-0002-3363-4232
FU Horizon 2020, the European Union's Framework Programme for Research and
   Innovation, under the Zika Preparedness Latin American Network
   (ZikaPLAN) of the United Kingdom's Department for International
   Development (DFID) [734584]; Wellcome TrustWellcome Trust
   [206016/Z/16/A]; Brazilian National Research Council (CNPq)National
   Council for Scientific and Technological Development (CNPq); Rio de
   Janeiro State Research Foundation (FAPERJ)Carlos Chagas Filho Foundation
   for Research Support of the State of Rio de Janeiro (FAPERJ)
FX Our funding was provided by the Horizon 2020, the European Union's
   Framework Programme for Research and Innovation, under the Zika
   Preparedness Latin American Network (ZikaPLAN) grant agreement n. 734584
   of the United Kingdom's Department for International Development (DFID)
   and Wellcome Trust (206016/Z/16/A). We thank the Brazilian National
   Research Council (CNPq) and the Rio de Janeiro State Research Foundation
   (FAPERJ) for the funding of research productivity for the students M. C.
   N. Moreira and M. E. L. Moreira.
CR Aquino EML, 2014, CAD SAUDE PUBLICA, V30, P2005, DOI 10.1590/0102-311X00009214
   Vignola RCB, 2014, J AFFECT DISORDERS, V155, P104, DOI 10.1016/j.jad.2013.10.031
   Diniz D, 2016, RECIIS ONLINE, V10, P1
   do Brasil Governo, GOV AC AC EM DIANT A
   FLEISCHER S., 2017, CADERNOS GENERO DIVE, V3, P93
   Governo do Brasil, MIN SAUD DECL FIM EM
   Latour B., 2012, REAGREGANDO SOCIAL I
   Ventura DDL, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00033316
   Mauss Marcel, 2003, SOCIOLOGIA ANTROPOLO, P183
   Nacoes Unidas no Brasil, OMS DECL VIR ZIK MIC
   Moreira MCN, 2017, CAD SAUDE PUBLICA, V33, DOI [10.1590/0102-311X00189516, 10.1590/0102-311x00189516]
   Organizacao Pan-Americana da Saude; Orga-nizacao Mundial da Saude, OMS DECL FIM EM SAUD
   Scarpelli AC, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-35
   Scott RP, 2017, CADERNOS GENERO DIVE, V3, P73
   Secretaria de Atencao a Saude Ministerio da Saude, 2016, PROT AT SAUD RESP OC
   SHERBOURNE CD, 1991, SOC SCI MED, V32, P705, DOI 10.1016/0277-9536(91)90150-B
   Silva ACR, 2017, REV ANTHR, V28, P223
NR 17
TC 3
Z9 3
U1 0
U2 0
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PY 2018
VL 34
IS 8
AR e00075718
DI 10.1590/0102-311X00075718
PG 4
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GR2PF
UT WOS:000442418000001
PM 30133655
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU de Franca, GVA
   Pedi, VD
   Garcia, MHD
   do Carmo, GMI
   Leal, MB
   Garcia, LP
AF Araujo de Franca, Giovanny Vinicius
   Pedi, Vaneide Daciane
   de Oliveira Garcia, Marcio Henrique
   Ikeda do Carmo, Greice Madeleine
   Leal, Mariana Bertol
   Garcia, Leila Posenato
TI Congenital syndrome associated with Zika virus infection among live
   births in Brazil: a description of the distribution of reported and
   confirmed cases in 2015-2016
SO EPIDEMIOLOGIA E SERVICOS DE SAUDE
LA English
DT Article
DE Zika Virus Infection; Zika Virus; Microcephaly; Epidemics; Epidemiology,
   Descriptive
ID SURVEILLANCE; OUTBREAK
AB Objective: to describe the temporal and spatial distribution of reported and confirmed cases of congenital Zika virus syndrome (CZS) in live births in Brazil during 2015-2016. Methods: we conducted a descriptive study with data from the Public Health Events Registry, including cases born in 2015 or 2016, and registered between epidemiological week 45/2015 and 2/2017. Results: we analyzed 9.953 reported cases, of which 2.018 (20.3%) were confirmed and 2.819 (28.3%) were still under investigation at the epidemiological week 2/2017; 404 (4.1%) out of the 9.953 cases had laboratory confirmation for Zika virus; the prevalence of confirmed cases of CZS was 3.8/10 thousand livebirths in 2015 and 3.1/10 thousand live births in 2016. Conclusion: one fifth of the cases reported in 2015-16 were confirmed the CZS, reinforcing their relevance as a public health problem; efforts aimed at the diagnostic confirmation of the syndrome should be prioritized.
C1 [Araujo de Franca, Giovanny Vinicius; Pedi, Vaneide Daciane; de Oliveira Garcia, Marcio Henrique; Ikeda do Carmo, Greice Madeleine] Minist Saude, Secretaria Vigilancia Saude, Brasilia, DF, Brazil.
   [Leal, Mariana Bertol] Minist Saude, Secretaria Atencao Saude, Brasilia, DF, Brazil.
   [Garcia, Leila Posenato] Inst Pesquisa Econ Aplicada, Diretoria Estudos & Polit Sociais, Brasilia, DF, Brazil.
RP de Franca, GVA (corresponding author), Setor Radio & Televisao Norte 701,Via W5 Norte, BR-70719040 Brasilia, DF, Brazil.
EM giovanny.franca@saude.gov.br
CR Brasil Ministerio da Saude Secretaria de Vigilancia em Saude, 2017, VIR ZIK BRAS RESP SU
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   del Campo M, 2017, AM J MED GENET A, V173, P841, DOI 10.1002/ajmg.a.38170
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Eickmann SH, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00047716
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-59
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Garcia LP, 2016, EPIDEMIOL SERV SAUDE, V25, P679, DOI [10.5123/S1679-49742016000400001, 10.5123/s1679-49742016000400001]
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Marinho F, 2016, EPIDEMIOL SERV SAUDE, V25, P701, DOI [10.5123/S1679-49742016000400004, 10.5123/s1679-49742016000400004]
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Ministerio da Saude, 2015, PROT VIG RESP OC MIC
   Ministerio da Saude, 2015, B EPIDEMIOL, V46, P1
   Ministerio da Saude (BR), 2015, REG EV SAUD PUBL RES
   Ministerio da Saude (BR). Departamento de informatica do SUS, 2016, SIST INF NASC VIV EV
   Ministerio da Saude (BR). Secretaria de Vigilancia em Saude, 2017, BOL EP, V48, P1
   Ministerio da Saude. Secretaria de Vigilancia em Saude. Secretaria de Atencao a Saude, 2017, OR INT VIG AT SAUD A
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Stegmann Barbara J, 2002, Curr Womens Health Rep, V2, P253
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   WHO, 2007, WHO CHILD GROWTH STA
   WHO (World Health Organization), 2016, INT HLTH REG
   World Health Organization, 2016, WHO STAT 1 M INT HLT
NR 29
TC 1
Z9 1
U1 0
U2 0
PU MINISTERIO DA SAUDE
PI BRASILIA
PA ESPLANADA MINISTERIOS, BLOCO G, BRASILIA, DF 70058-900, BRAZIL
SN 1679-4974
EI 2237-9622
J9 EPIDEMIOL SERV SAUDE
JI Epidemiol. Serv. Saude
PY 2018
VL 27
IS 2
AR UNSP e2017473
DI 10.5123/S1679-497420180002000014
PG 12
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GQ6EE
UT WOS:000441795700021
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU da Nobrega, MEB
   Araujo, ELD
   Wada, MY
   Leite, PLE
   Dimech, GS
   Percio, J
AF Brasil da Nobrega, Martha Elizabeth
   de Lima Araujo, Emerson Luiz
   Wada, Marcelo Yoshito
   Leal e Leite, Priscila
   Dimech, George Santiago
   Percio, Jadher
TI Outbreak of Guillain-Barre syndrome possibly related to prior Zika virus
   infection, Metropolitan Region of Recife, Pernambuco, Brazil, 2015
SO EPIDEMIOLOGIA E SERVICOS DE SAUDE
LA English
DT Article
DE Epidemiology, Descriptive; Disease Outbreaks; Guillain-Barre Syndrome;
   Zika virus; Brazil
ID METAANALYSIS; VACCINATION; GUIDELINES; DIAGNOSIS
AB Objetivo: to investigate the occurrence of GBS in the Metropolitan Region of Recife, PE, Brazil, 2015. Methods: this was a descriptive study using data from the Hospital Information System, National Pharmaceutical Services Management System and interviews; GBS cases were classified according to Brighton criteria and prior infection according to laboratory and clinical criteria. Results: in 2015, the number of GBS hospitalizations had a threefold increase in comparison to 2014. We investigated 44 confirmed or probable GBS cases, of which 18 had symptoms of Zika infection up to 35 days before the occurrence of GBS, mainly rash; one case was laboratory-confirmed for Zika virus infection and one death was registered. Conclusion: the findings reinforce a possible relationship between GBS and Zika infection, given the absence of increased GBS occurrence in previous dengue epidemic years, absence of chikungunya transmission records, presence of clinical manifestations compatible with infection and a laboratory confirmation.
C1 [Brasil da Nobrega, Martha Elizabeth; de Lima Araujo, Emerson Luiz; Wada, Marcelo Yoshito; Percio, Jadher] Minist Saude, Secretaria Vigilancia Saude, Programa Treinamento Epidemiol Campo Aplicada, Serv Sistema Unico Saude, Brasilia, DF, Brazil.
   [Leal e Leite, Priscila] Minist Saude, Secretaria Vigilancia Saude, Coordenacao Geral Programas Controle Malaria & Do, Brasilia, DF, Brazil.
   [Dimech, George Santiago] Secretaria Estadual Saude Pernambuco, Vigilancia Saude, Recife, PE, Brazil.
   [Dimech, George Santiago] Secretaria Estadual Saude Pernambuco, Controle Doencas & Agravos, Recife, PE, Brazil.
RP da Nobrega, MEB (corresponding author), Ctr Informacoes Estrateg & Resposta Vigilancia Sa, Secretaria Estado Saude Publ Para, Tv Padre Eutiquio 1-300, BR-66013090 Belem, Para, Brazil.
EM nobrega.mb@gmail.com
CR Malta JMAS, 2017, EPIDEMIOL SERV SAUDE, V26, P9, DOI [10.5123/S1679-49742017000100002, 10.5123/s1679-49742017000100002]
   Benamer HTS, 2014, J NEUROL SCI, V343, P221, DOI 10.1016/j.jns.2014.05.065
   Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude. Coordenacao-Geral de Desenvolvimento da Epidemiologia em Servicos, 2016, COORD GER DES EP SER
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chaudhary S. C., 2011, BMJ CASE REP, V2011
   Dimachkie MM, 2013, NEUROL CLIN, V31, P491, DOI 10.1016/j.ncl.2013.01.005
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P910, DOI 10.15585/mmwr.mm6534e1
   Eldar AH, 2014, AUTOIMMUN REV, V13, P525, DOI 10.1016/j.autrev.2014.01.033
   Goncalves E, 2011, REV INST MED TROP SP, V53, P223, DOI 10.1590/S0036-46652011000400009
   Goodfellow JA, 2016, NAT REV NEUROL, V12, P723, DOI 10.1038/nrneurol.2016.172
   Hardy TA, 2011, CURR ALLERGY ASTHM R, V11, P197, DOI 10.1007/s11882-011-0190-y
   Huang WC, 2015, NEUROEPIDEMIOLOGY, V44, P249, DOI 10.1159/000430917
   Israeli E, 2012, CLIN REV ALLERG IMMU, V42, P121, DOI 10.1007/s12016-010-8213-3
   Jacobs BC, 1998, NEUROLOGY, V51, P1110, DOI 10.1212/WNL.51.4.1110
   Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9
   LIM JY, 2016, MEDICINE, V95, DOI DOI 10.1097/MD.0000000000005580
   Ministerio da Saude, 2015, PROT VIG CAS MAN NEU
   Ministerio da Saude (BR). Departamento de Informatica do Sistema Unico de Saude-Datasus, 2012, INF SAUD TABNET PROJ
   Mohammad QD, NEUROLOGY
   Oehler E, 2015, EUROSURVEILLANCE, V20, P13, DOI 10.2807/1560-7917.ES.2015.20.48.30079
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Rocha MSG, 2004, ARQ NEURO-PSIQUIAT, V62, P33, DOI 10.1590/S0004-282X2004000100006
   Sejvar JJ, 2011, NEUROEPIDEMIOLOGY, V36, P123, DOI 10.1159/000324710
   Sejvar JJ, 2011, VACCINE, V29, P599, DOI 10.1016/j.vaccine.2010.06.003
   van den Berg B, 2014, NAT REV NEUROL, V10, P469, DOI 10.1038/nrneurol.2014.121
   Vellozzi C, 2014, CLIN INFECT DIS, V58, P1149, DOI 10.1093/cid/ciu005
   Vucic S, 2009, J CLIN NEUROSCI, V16, P733, DOI 10.1016/j.jocn.2008.08.033
   Webb AJS, 2015, J NEUROL NEUROSUR PS, V86, P1196, DOI 10.1136/jnnp-2014-309056
   Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1
NR 29
TC 2
Z9 2
U1 0
U2 1
PU MINISTERIO DA SAUDE
PI BRASILIA
PA ESPLANADA MINISTERIOS, BLOCO G, BRASILIA, DF 70058-900, BRAZIL
SN 1679-4974
EI 2237-9622
J9 EPIDEMIOL SERV SAUDE
JI Epidemiol. Serv. Saude
PY 2018
VL 27
IS 2
AR UNSP e2017039
DI 10.5123/S1679-49742018000200016
PG 11
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GQ6EE
UT WOS:000441795700005
PM 29995102
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Franca, GVA
   Garcia, LP
AF Franca, G. V. A.
   Garcia, L. P.
TI Congenital syndrome associated with Zika virus infection among live
   births in Brazil: a description of the distribution of reported and
   confirmed cases in 2015-2016 (vol 27, pg 1, 2018)
SO EPIDEMIOLOGIA E SERVICOS DE SAUDE
LA English
DT Correction
CR [Anonymous], 2018, EPIDEMIOLOGY HLTH SE
NR 1
TC 9
Z9 9
U1 0
U2 0
PU MINISTERIO DA SAUDE
PI BRASILIA
PA ESPLANADA MINISTERIOS, BLOCO G, BRASILIA, DF 70058-900, BRAZIL
SN 1679-4974
EI 2237-9622
J9 EPIDEMIOL SERV SAUDE
JI Epidemiol. Serv. Saude
PY 2018
VL 27
IS 2
PG 1
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GQ6EE
UT WOS:000441795700022
OA DOAJ Gold
DA 2020-07-08
ER

PT S
AU Spurny, L
AF Spurny, Lubomir
BE Weiss, J
TI Work and Performance: A few Comments on the Czech Modern Music
SO NOVA GLASBA V 'NOVI' EVROPI MED OBEMA SVETOVNIMA VOJNAMA
SE Studia Musicologica Labacensia
LA English
DT Proceedings Paper
CT International Musicological Symposium on New Music in the New Europe
   between the Two World Wars
CY MAR 18-21, 2017
CL Knight's Hall Theater, Ljubljana, SLOVENIA
SP SAVA, DELO
HO Knight's Hall Theater
DE Czech music; musicology; performance; score; interpretation research;
   analysis of recorded music
AB The study describes development of performance in the Czech music. For example, composer and pianist Erwin Schulhoff, Karel Reiner, Alois Haba, E. F. Burian, cellist Vasa Cerny and clarinetist Milan Kostohryz expressed their opinions on the topic of interpretation. Area that appears most suitable for processing is chamber music and particularly one specific part, so called "Czech quartet school." It is one of few artistic activities in the field of Czech musical culture where we can observe the continual development with all eventual divides and deviations. The founding significance belongs to the Bohemian Quartet. In the beginning of the loth century it was primarily the Sevak-Lhotsky Quartet, Zika's (Czechoslovak) and Prague Quartets. Interpretation of the Bohemian Quartet especially began to change with the inventions of the phonograph and a gramophone record. The fact that music can be written not only in the sheet but also as a sound, not only its progression but also qualities elusive in the notation, redirects the attention to topical and currently ongoing flow of music. Here we can also find the impulse (which is often overlooked) of the development of new tradition of performance.
C1 [Spurny, Lubomir] Masaryk Univ, Brno, Czech Republic.
RP Spurny, L (corresponding author), Masaryk Univ, Brno, Czech Republic.
CR Bowen JA, 1996, J MUSICOL RES, V16, P111, DOI 10.1080/01411899608574728
   Cook N., 1999, RETHINKING MUSIC, P239
   Cook Nicholas, 1995, PRACTICE PERFORMANCE, P105
   Cook Nicholas, 2013, SCORE MUSIC PERFORMA
   Danuser Hermann, 1992, MUSIK 20 JAHRHUNDERT
   FRIBERG A, 1991, COMPUT MUSIC J, V15, P56, DOI 10.2307/3680917
   Kuna Milan, 1982, CAS HUDBA K DRAMATUR
   Schenker Heinrich, 1923, FLUGBLATTER ZUM ZEUG
   STRAVINSKY I, 1942, POETIQUE MUSICALE
   Zich Otakar, 1986, ESTETIKA DRAMATICKEH
NR 10
TC 0
Z9 0
U1 0
U2 0
PU ZALOZBA UNIV PRIMORSKEM/ UNIV PRIMORSKA PRESS
PI KOPER
PA TITOV TRG 4, KOPER, SI-6000, SLOVENIA
SN 2536-2445
BN 978-961-7023-74-9
J9 STUD MUSICOLOG LABA
PY 2018
VL 2
BP 107
EP +
PG 10
WC Music
SC Music
GA BK6RB
UT WOS:000440768900009
DA 2020-07-08
ER

PT J
AU D'Agostino, M
   Samuel, NO
   Sarol, MJ
   de Cosio, FG
   Marti, M
   Luo, TY
   Brooks, I
   Espinal, M
AF D'Agostino, Marcelo
   Samuel, Noah O.
   Sarol, Maria Janina
   de Cosio, Federico G.
   Marti, Myrna
   Luo, Tianyu
   Brooks, Ian
   Espinal, Marcos
TI Open data and public health
SO REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC
   HEALTH
LA English
DT Review
DE Information systems; data sources; public health; health systems;
   confidentiality
ID LEGAL; STATE
AB This article provides an overview of the intersection of open data and public health by first defining open government data, public health data, and other key concepts and relevant terminologies. There are differing perceptions on the urgency and importance of the openness of public health data. It has been established that disease outbreaks such as happened during the Ebola and Zika virus epidemics are indicative of the need for countries to develop a framework that will provide guidance for the management of public health data. Such a framework should ensure that data collected during public health emergencies are accessible to the appropriate authorities and in a form that can help with timely decision-making during such public health crises. In this article, we highlight available open data policies across many countries, including in the Americas. Our analysis shows that there are currently no articulated policy guidelines for the collection and management of public health data across many countries, especially in Latin America. We propose that any national data governance strategy must address potential benefits, possible risks, examples of data that could be shared, and the attributes of such data. Finally, we stress that the key concern in the Americas should be the development of regional frameworks for open data in public health that can be adopted or adapted by each country through appropriate national or subnational policies and strategies.
C1 [D'Agostino, Marcelo; de Cosio, Federico G.; Marti, Myrna; Espinal, Marcos] Pan Amer Hlth Org, Washington, DC 20037 USA.
   [Samuel, Noah O.; Sarol, Maria Janina; Brooks, Ian] Univ Illinois, Sch Informat Sci, Champaign, IL USA.
   [Luo, Tianyu] Syracuse Univ, Sch Informat Studies, Syracuse, NY USA.
RP D'Agostino, M (corresponding author), Pan Amer Hlth Org, Washington, DC 20037 USA.
EM dagostim@paho.org
RI Samuel, Noah/M-4850-2019
CR [Anonymous], WHAT IS PUBL HLTH
   Batagan Lorena, 2014, Informatica Economica, V18, P80
   Berners-Lee T., LINKED DATA
   Carney TJ, 2015, AM J PUBLIC HEALTH, V105, P1740, DOI 10.2105/AJPH.2015.302771
   CDC Foundation, WHAT IS PUBL HLTH
   Crouch EAC, RISK BENEFIT ANAL
   Fiorenza P, BRIEF HIST OPEN DATA
   Gasner MR, 2014, AM J PUBLIC HEALTH, V104, P993, DOI 10.2105/AJPH.2013.301775
   Global Open Data Index, OP DAT IND 2015 CIV
   Greenberg CJ, 2016, EPIDEMIOL BIOSTAT PU, V13, DOI 10.2427/11950
   Hendler J, 2012, IEEE INTELL SYST, V27, P25, DOI 10.1109/MIS.2012.27
   Homan Tobias, 2015, BMC Res Notes, V8, P397, DOI 10.1186/s13104-015-1373-8
   Jaakola Ari, 2015, Statistical Journal of the IAOS, V31, P117, DOI 10.3233/SJI-150873
   Martin Erika G, 2017, J Public Health Manag Pract, V23, pe5, DOI 10.1097/PHH.0000000000000388
   Nguyen LH, 2014, AM J PUBLIC HEALTH, V104, P2043, DOI 10.2105/AJPH.2014.302143
   Open Knowledge International, WHY OP DAT
   Open Knowledge International, 2015, GLOB OP DAT IND, DOI https://index.okfn.org
   Richardson V, 2015, J LAW MED ETHICS, V43, P83, DOI 10.1111/jlme.12224
   Rinciog O, 2015, 2015 E HLTH BIOENG C
   Samuel NO, 2016, AFR J LIBR ARCH INFO, V26, P17
   Sheehan J, INCREASING ACCESS RE
   Stebbins M., EXPANDING PUBLIC ACC
   Tilahun B, 2014, JMIR MED INF, V2, P196, DOI 10.2196/medinform.3531
   United Nations Educational Scientific and Cultural Organization, LAT AM CAR
   Vest JR, 2014, HEALTH SERV RES, V49, P373, DOI 10.1111/1475-6773.12138
NR 25
TC 2
Z9 2
U1 2
U2 10
PU PAN AMER HEALTH ORGANIZATION
PI WASHINGTON
PA 525 23RD ST NW, WASHINGTON, DC 20037 USA
SN 1020-4989
J9 REV PANAM SALUD PUBL
JI Rev. Panam. Salud Publica
PY 2018
VL 42
AR UNSP e66
DI 10.26633/RPSP.2018.66
PG 8
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GP8GD
UT WOS:000441147400046
PM 31093094
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Guerra-Reyes, L
   Fu, TCJ
   Williams, D
   Herbenick, D
   Dodge, B
   Reece, M
   Fortenberry, JD
AF Guerra-Reyes, Lucia
   Fu, Tsung-chieh Jane
   Williams, Deana
   Herbenick, Debby
   Dodge, Brian
   Reece, Michael
   Fortenberry, J. Dennis
TI Knowledge of Zika and perception o f risk among sexually-active adults
   in the United States of America: results from a nationally
   representative sample
SO REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC
   HEALTH
LA English
DT Article
DE Zika virus infection; prevention & control; sexual health; United States
ID HETEROSEXUAL MEN; MIAMI-DADE; VIRUS; HEALTH; TRANSMISSION; OUTBREAK;
   INTERNET; STUDENTS; FLORIDA; RATES
AB Objective. To examine knowledge of Zika transmission and risk perception and to assess variability by condom use in a probability sample of sexually-active adults in the United States.
   Methods. Data for this study came from the 2016 wave of the National Survey of Sexual Health and Behavior, a nationally representative probability sample of adults in the United States. Data were collected in November 2016 via a cross-sectional Internet-based survey administered to members of a Knowledge Panel, an address-based random sample service managed by GfK. A weighted subsample (n = 1713) of sexually active adults, 18 - 50 years of age, was included in analyses.
   Results. More than 90% of men and women reported low or no perceived risk of Zika. Most participants identified mosquito bite as a route of transmission, while significantly fewer identified sexual intercourse (approximate to 40%) and vertical (29% men, 41% women) transmission routes.
   Conclusion. Sexually-active adults in the United States, especially young men, lack awareness of sexual and vertical transmission of Zika Virus. Given the likely endemic nature of Zika, this low-risk perception is an important prevention challenge. Zika prevention messaging should address lesser known transmission routes, emphasize male education, and promote correct and consistent condom use.
C1 [Guerra-Reyes, Lucia; Fu, Tsung-chieh Jane; Herbenick, Debby; Dodge, Brian; Reece, Michael] Indiana Univ, Sch Publ Hlth, Ctr Sexual Hlth Promot, Bloomington, IN 47405 USA.
   [Williams, Deana] Indiana Univ, Dept Appl Hlth Sci, Bloomington, IN 47405 USA.
   [Fortenberry, J. Dennis] Indiana Univ Sch Med, Sect Adolescent Med, Bloomington, IN USA.
RP Guerra-Reyes, L (corresponding author), Indiana Univ, Sch Publ Hlth, Ctr Sexual Hlth Promot, Bloomington, IN 47405 USA.
EM luguerra@indiana.edu
RI Guerra-Reyes, Lucia/P-5474-2016; Fu, Tsung-chieh/E-6136-2019; Dodge,
   Brian/H-3123-2013
OI Guerra-Reyes, Lucia/0000-0003-3300-0720; Fu,
   Tsung-chieh/0000-0003-2118-7225; Dodge, Brian/0000-0003-4491-6603
FU Church and Dwight Incorporated (Cincinnati, Ohio, United States)
FX This study was funded by Church and Dwight Incorporated (Cincinnati,
   Ohio, United States), maker of Trojan (R) condoms.
CR Abramson D, 2016, US PUBLICS PERCEPTIO, P1
   Adler NE, 2002, HEALTH AFFAIR, V21, P60, DOI 10.1377/hlthaff.21.2.60
   Boulet SL, 2016, MMWR-MORBID MORTAL W, V65, P780, DOI 10.15585/mmwr.mm6530e2
   Brooks JT, 2016, MMWR-MORBID MORTAL W, V65, P745, DOI 10.15585/mmwr.mm6529e2
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Chang L, 2009, PUBLIC OPIN QUART, V73, P641, DOI 10.1093/poq/nfp075
   D'Ortenzio E, NEW ENGL J MED, DOI [10.1056/NEJMc, DOI 10.1056/NEJMC]
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P451, DOI 10.15585/mmwr.mm6517e2
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Gutmann M., 2007, FIXING MEN SEX BIRTH
   Hajra A, 2016, N AM J MED SCI, V8, DOI 10.4103/1947-2714.179112
   Harris KM, 2009, VACCINE, V27, P815, DOI 10.1016/j.vaccine.2008.11.052
   Herbenick D, 2010, J SEX MED, V7, P346, DOI 10.1111/j.1743-6109.2010.02020.x
   Kaiser Family Foundation, SURV AM US ROL GLOB
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Lucey DR, 2016, JAMA-J AM MED ASSOC, V315, P865, DOI 10.1001/jama.2016.0904
   March of Dimes Foundation National Opinion Research Center Chicago, ZIK VIR GAPS AM KNOW
   Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3
   Moore KJ, 2017, J OCCUP ENVIRON MED, V59, pE17, DOI 10.1097/JOM.0000000000000960
   Osamor PE, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005127
   Oussayef NL, 2017, MMWR-MORBID MORTAL W, V65, P1482, DOI 10.15585/mmwr.mm6552e1
   Painter JE, 2017, VACCINE, V35, P960, DOI 10.1016/j.vaccine.2016.12.050
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rhodes SD, 2012, AIDS EDUC PREV, V24, P514, DOI 10.1521/aeap.2012.24.6.514
   Rodriguez-Morales AJ, 2016, ANN CLIN MICROB ANTI, P15
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P5, DOI 10.1016/j.tmaid.2016.01.011
   Rothman EF, 2008, PEDIATRICS, V122, pE298, DOI 10.1542/peds.2007-3412
   Sauermann H, 2013, RES POLICY, V42, P273, DOI 10.1016/j.respol.2012.05.003
   Shacham E, 2017, AM J PUBLIC HEALTH, V107, P724, DOI 10.2105/AJPH.2017.303670
   Shartzer A, 2016, WOMEN REPROD AGE LAC
   Tepper NK, 2016, MMWR-MORBID MORTAL W, V65, P311, DOI 10.15585/mmwr.mm6512e1
   Torjesen I, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i500
   United States Census Bureau, GEOGR TERMS CONC CEN
   United States Census Bureau and Bureau of Labor Statistics, CURR POP SURV
   United States Centers for Disease Control and Prevention, 2017, ZIK CAS US
   United States Centers for Disease Control and Prevention, ZIK CDC 2016 CAS COU
   WHO, 2016, ZIK VIR INF US AM PU
   Wilson TE, 2014, AIDS EDUC PREV, V26, P383, DOI 10.1521/aeap.2014.26.5.383
   Wise J, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1242
   World Health Organization, 2016, KNOWL ATT PRACT SURV
   World Health Organization, 2016, 5 7 EM COMM INT HLTH
   World Health Organization, 2016, ZIK VIR FACTSH
NR 43
TC 2
Z9 2
U1 0
U2 2
PU PAN AMER HEALTH ORGANIZATION
PI WASHINGTON
PA 525 23RD ST NW, WASHINGTON, DC 20037 USA
SN 1020-4989
J9 REV PANAM SALUD PUBL
JI Rev. Panam. Salud Publica
PY 2018
VL 42
AR UNSP e43
DI 10.26633/RPSP.2018.43
PG 9
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GP8GD
UT WOS:000441147400023
PM 31093071
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Shen, ZH
   Sun, ZH
   Becnel, JJ
   Estep, A
   Wedge, DE
   Tan, CX
   Weng, JQ
   Han, L
   Liu, XH
AF Shen, Zhong-Hua
   Sun, Zhao-Hui
   Becnel, James J.
   Estep, Alden
   Wedge, David E.
   Tan, Cheng-Xia
   Weng, Jian-Quan
   Han, Liang
   Liu, Xing-Hai
TI Synthesis and Mosquiticidal Activity of Novel Hydrazone Containing
   Pyrimidine Derivatives against Aedes aegypti
SO LETTERS IN DRUG DESIGN & DISCOVERY
LA English
DT Article
DE Mosquito activity; pyrimidine derivatives; synthesis; structure-activity
   relationship; hydrazone; Aedes aegypti
ID ANTIFUNGAL ACTIVITY; SULFONYLUREA DERIVATIVES; NEMATOCIDAL ACTIVITY;
   HERBICIDAL ACTIVITY; BIOLOGICAL-ACTIVITY; SUSCEPTIBILITY; PESTICIDES;
   DESIGN
AB Background: Aedes aegypti is the main mosquito vector for the transmission of several serious diseases, including Japanese encephalitis, yellow fever, Zika, and dengue virus. Increasing resistance to the limited number of public health chemicals requires the evaluation of new chemicals as potential control products.
   Methods: Pyrimidine-based compounds have shown some efficacy for agricultural uses and as mosquitocidal products. In this paper, a series of novel pyrimidine acyl-hydrazone derivatives were synthesized. Their structures were elucidated by H-1 NMR and HRMS.
   Results: Mosquitocidal activity was assessed against immature and adult Ae. aegypti to determine efficacy and to guide further synthetic efforts. Bioassay using 1st instar Ae. aegypti produced about 33% mortality for compounds 4b and 4l but determined that most of the compounds exhibited minimal larvicidal activity at 1ug/ul after 24 hours of exposure.
   Conclusion: Compound 4m (N'-(4-bromobenzylidene)-2-((2-(diethylamino)-6-methylpyrimidin-4-yl) oxy)acetohydrazide) was the most effective adulticide in this synthetic group and exhibited 40% mortality at a concentration of 3.125 mu g/mosq.
C1 [Shen, Zhong-Hua; Sun, Zhao-Hui; Tan, Cheng-Xia; Weng, Jian-Quan; Han, Liang; Liu, Xing-Hai] Zhejiang Univ Technol, Coll Chem Engn, Hangzhou 310014, Zhejiang, Peoples R China.
   [Wedge, David E.; Liu, Xing-Hai] USDA ARS, Nat Prod Utilizat Res Unit, University, MS 38677 USA.
   [Becnel, James J.] ARS, USDA, Ctr Med Agr & Vet Entomol, Gainesville, FL 32608 USA.
   [Estep, Alden] CMAVE Detachment, Navy Entomol Ctr Excellence, Gainesville, FL 32608 USA.
RP Liu, XH (corresponding author), Zhejiang Univ Technol, Chaowang Rd 18, Hangzhou, Zhejiang, Peoples R China.; Wedge, DE (corresponding author), USDA ARS, Nat Prod Utilizat Res Unit, Oxford, MS 38655 USA.
EM dwedge@olemiss.edu; xhliu@zjut.edu.cn
OI Estep, Alden/0000-0002-8281-3229
FU Zhejiang Provincial Science Foundation of China [LY16C140007]
FX This work was funded by Zhejiang Provincial Science Foundation of China
   (No. LY16C140007).
CR Chang F, 2014, J AGR FOOD CHEM, V62, P476, DOI 10.1021/jf4045843
   Chen W, 2015, CHEM J CHINESE U, V36, P672, DOI 10.7503/cjcu20140955
   Dia I, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-238
   Hirata K, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003085
   Huang SQ, 2005, PESTICIDES, V44, P81
   Karunaratne SHPP, 2013, PESTIC BIOCHEM PHYS, V107, P98, DOI 10.1016/j.pestbp.2013.05.011
   Kasai S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002948
   Liu XH, 2017, PEST MANAG SCI, V73, P1900, DOI 10.1002/ps.4556
   Liu XH, 2017, EUR J MED CHEM, V125, P881, DOI 10.1016/j.ejmech.2016.10.017
   Liu XH, 2017, PEST MANAG SCI, V73, P953, DOI 10.1002/ps.4370
   Liu XH, 2016, BIOORG MED CHEM LETT, V26, P3626, DOI 10.1016/j.bmcl.2016.06.004
   Liu XH, 2015, BIOORG MED CHEM LETT, V25, P5524, DOI 10.1016/j.bmcl.2015.10.064
   Liu XH, 2011, PHOSPHORUS SULFUR, V186, P552, DOI 10.1080/10426507.2010.508059
   Lopez B, 2014, J MED ENTOMOL, V51, P644, DOI 10.1603/ME13185
   Meepagala K. M., 2015, Agricultural Sciences, V6, P1195, DOI 10.4236/as.2015.610114
   Mehlhorn H, 2005, PARASITOL RES, V95, P363, DOI 10.1007/s00436-004-1297-z
   Mehlhorn H, 2012, PARASITOL RES, V110, P259, DOI 10.1007/s00436-011-2480-7
   Pan L, 2013, CHEM J CHINESE U, V34, P1416
   Pan L, 2012, EUR J MED CHEM, V50, P18, DOI 10.1016/j.ejmech.2012.01.011
   Pridgeon JW, 2008, J MED ENTOMOL, V45, P82, DOI 10.1603/0022-2585(2008)45[82:SOAACQ]2.0.CO;2
   Pridgeon JW, 2009, J MED ENTOMOL, V46, P335, DOI 10.1603/033.046.0219
   Vasilakis N, 2007, VIROLOGY, V358, P402, DOI 10.1016/j.virol.2006.08.049
   Wang BL, 2010, J AGR FOOD CHEM, V58, P5515, DOI 10.1021/jf100300a
   Yan SL, 2014, LETT DRUG DES DISCOV, V11, P940, DOI 10.2174/1570180811666140423222141
   Yang YZ, 2015, CHINESE J ORG CHEM, V35, P100, DOI 10.6023/cjoc201408004
   Zhai ZW, 2016, LETT DRUG DES DISCOV, V13, P521, DOI 10.2174/157018081306160618181757
   Zhang LJ, 2014, LETT DRUG DES DISCOV, V11, P1107, DOI 10.2174/1570180811666140610212731
   Zhao W, 2017, LETT DRUG DES DISCOV, V14, P323, DOI 10.2174/1570180813666160930164327
NR 28
TC 24
Z9 24
U1 5
U2 15
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1570-1808
EI 1875-628X
J9 LETT DRUG DES DISCOV
JI Lett. Drug Des. Discov.
PY 2018
VL 15
IS 9
BP 951
EP 956
DI 10.2174/1570180815666180102141640
PG 6
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA GN3II
UT WOS:000438897300005
DA 2020-07-08
ER

PT J
AU Tsuyuki, K
   Gipson, JD
   Barbosa, RM
   Urada, LA
   Morisky, DE
AF Tsuyuki, Kiyomi
   Gipson, Jessica D.
   Barbosa, Regina Maria
   Urada, Lianne A.
   Morisky, Donald E.
TI Preventing syndemic Zika virus, HIV/STIs and unintended pregnancy: dual
   method use and consistent condom use among Brazilian women in marital
   and civil unions
SO CULTURE HEALTH & SEXUALITY
LA English
DT Article
DE Condom use; HIV prevention; dual method use; reproductive health;
   relationship context; Brazil
ID HIV-POSITIVE WOMEN; CONTRACEPTIVE USE; SEXUAL RELATIONSHIPS;
   REPRODUCTIVE HEALTH; ECONOMIC ASYMMETRIES; RELATIONSHIP CONTEXT;
   UNPLANNED PREGNANCY; ADOLESCENT FEMALES; 1ST INTERCOURSE; AGE DIFFERENCE
AB Syndemic Zika virus, HIV and unintended pregnancy call for an urgent understanding of dual method (condoms with another modern nonbarrier contraceptive) and consistent condom use. Multinomial and logistic regression analysis using data from the Pesquisa Nacional de Demografia e Saude da Crianca e da Mulher (PNDS), a nationally representative household survey of reproductive-aged women in Brazil, identified the socio-demographic, fertility and relationship context correlates of exclusive non-barrier contraception, dual method use and condom use consistency. Among women in marital and civil unions, half reported dual protection (30% condoms, 20% dual methods). In adjusted models, condom use was associated with older age and living in the northern region of Brazil or in urban areas, whereas dual method use (versus condom use) was associated with younger age, living in the southern region of Brazil, living in nonurban areas and relationship age homogamy. Among condom users, consistent condom use was associated with reporting Afro-religion or other religion, not wanting (more) children and using condoms only (versus dual methods). Findings highlight that integrated STI prevention and family planning services should target young married/in union women, couples not wanting (more) children and heterogamous relationships to increase dual method use and consistent condom use.
C1 [Tsuyuki, Kiyomi; Gipson, Jessica D.; Morisky, Donald E.] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Community Hlth Sci, Los Angeles, CA 90095 USA.
   [Barbosa, Regina Maria] Univ Estadual Campinas, Nucleo Estudos Populacao Elza Berquo, Sao Paulo, Brazil.
   [Urada, Lianne A.] San Diego State Univ, Sch Social Work, San Diego, CA 92182 USA.
RP Tsuyuki, K (corresponding author), Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Community Hlth Sci, Los Angeles, CA 90095 USA.
EM ktsuyuki@ucsd.edu
FU UCLA Graduate Division; UCLA Latin American Institute; UCLA Bixby Center
   of Population and Reproductive Health; National Institute of Drug Abuse
   (NIDA)United States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute on Drug Abuse
   (NIDA) [T32DA023356, K01DA036439]; National Institute of Alcohol Abuse
   and Alcoholism (NIAAA)United States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   on Alcohol Abuse & Alcoholism (NIAAA) [K01AA025009]; UCLA Center for
   AIDS Research (CFAR); National Institute of Minority Health and Health
   Disparities (NIMHD) [L60MD011184]
FX This study was supported by the UCLA Graduate Division, the UCLA Center
   for AIDS Research (CFAR), the UCLA Latin American Institute, the UCLA
   Bixby Center of Population and Reproductive Health, the National
   Institute of Drug Abuse (NIDA; T32DA023356, K01DA036439), the National
   Institute of Alcohol Abuse and Alcoholism (NIAAA; K01AA025009) and the
   National Institute of Minority Health and Health Disparities (NIMHD;
   L60MD011184).
CR Abma J, 1998, FAM PLANN PERSPECT, V30, P12, DOI 10.2307/2991518
   [Anonymous], 2008, PESQ NAC DEM SAUD CR
   Antelman G, 2015, J FAM PLAN REPROD H, V41, DOI 10.1136/jfprhc-2013-100784
   ATKINSON MP, 1985, J MARRIAGE FAM, V47, P685, DOI 10.2307/352269
   Bajos N, 1997, AIDS CARE, V9, P227, DOI 10.1080/09540129750125244
   Barbosa R. M., 1995, REPROD HEALTH MATTER, V3, P37
   Bastos F I, 2000, Cad Saude Publica, V16, P65, DOI 10.1590/S0102-311X2000000700006
   Beltrão Kaizô Iwakami, 2009, Cad. Pesqui., V39, P125, DOI 10.1590/S0100-15742009000100007
   Berer M, 2006, REPROD HEALTH MATTER, V14, P162, DOI 10.1016/S0968-8080(06)28262-4
   Blavatsky I., 2008, PESQUISA NACL DEMOGR, P36
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Britto Marcelo, 2008, PLAN FAM BRAS 50 AN
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Bruns B., 2011, ACHIEVING WORLD CLAS
   Calazans G, 2005, AIDS, V19, pS42, DOI 10.1097/01.aids.0000191490.59112.c5
   Coelho EDC, 2012, ACTA PAUL ENFERM, V25, P415, DOI 10.1590/S0103-21002012000300015
   Cates W, 2002, SEX TRANSM DIS, V29, P168, DOI 10.1097/00007435-200203000-00007
   CEBRAP, 2000, COMP SEX POP BRAS PE
   Chibwesha C. J., 2011, INFECT DIS OBSTET GY, V2011, P8
   Chimbiri AM, 2007, SOC SCI MED, V64, P1102, DOI 10.1016/j.socscimed.2006.10.012
   Clark LF, 1996, CLAR SYMP, P80
   Connell Raewyn W., 1987, GENDER POWER
   Corbett AM, 2009, PERSPECT SEX REPRO H, V41, P218, DOI 10.1363/4121809
   Darroch JE, 1999, FAM PLANN PERSPECT, V31, P160, DOI 10.2307/2991588
   Departamento de DST Aids e Hepatites Virais, 2015, B EP AIDS DST
   DiClemente RJ, 2002, SEX TRANSM DIS, V29, P20, DOI 10.1097/00007435-200201000-00004
   Drefahl S, 2010, DEMOGRAPHY, V47, P313
   Ferreira ALCG, 2010, REPROD HEALTH, V7, DOI 10.1186/1742-4755-7-5
   Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292
   Flood M, 2003, CULT HEALTH SEX, V5, P353, DOI 10.1080/1369105011000028273
   Ford K, 2001, FAM PLANN PERSPECT, V33, P100, DOI 10.2307/2673765
   Ford K, 2002, SEX TRANSM DIS, V29, P13, DOI 10.1097/00007435-200201000-00003
   Fusco CLB, 2012, CAD SAUDE PUBLICA, V28, P709, DOI 10.1590/S0102-311X2012000400010
   Hebling Eliana Maria, 2004, Cad. Saúde Pública, V20, P1211, DOI 10.1590/S0102-311X2004000500014
   Higgins JA, 2007, PERSPECT SEX REPRO H, V39, P240, DOI 10.1363/3924007
   Higgins JA, 2014, CONTRACEPTION, V90, P4, DOI 10.1016/j.contraception.2014.02.029
   Hopkins K, 2005, SOC SCI MED, V61, P541, DOI 10.1016/j.socscimed.2004.12.011
   IBGE, 2007, PESQ NAC AM DOM 2006
   Ickovics JR, 2001, HANDBOOK OF HEALTH PSYCHOLOGY, P817
   Kaestle CE, 2002, PERSPECT SEX REPRO H, V34, P304, DOI 10.2307/3097749
   Kalmijn M, 2010, AM J SOCIOL, V115, P1252, DOI 10.1086/649050
   Karney BR, 2010, AIDS BEHAV, V14, pS189, DOI 10.1007/s10461-010-9802-0
   Kusunoki Y, 2011, DEMOGRAPHY, V48, P1451, DOI 10.1007/s13524-011-0061-0
   Luke N, 2005, INT FAM PLAN PERSPEC, V31, P6, DOI 10.1363/3100605
   Luke N, 2003, STUD FAMILY PLANN, V34, P67, DOI 10.1111/j.1728-4465.2003.00067.x
   Lundberg S, 1996, J ECON PERSPECT, V10, P139, DOI 10.1257/jep.10.4.139
   Prietsch SOM, 2011, CAD SAUDE PUBLICA, V27, P1906, DOI 10.1590/S0102-311X2011001000004
   MacPhail C, 2007, CONTRACEPTION, V75, P383, DOI 10.1016/j.contraception.2006.12.020
   Malarcher S, 2010, EQUITY, SOCIAL DETERMINANTS AND PUBLIC HEALTH PROGRAMMES, P177
   Malta M, 2010, PATIENT EDUC COUNS, V81, P476, DOI 10.1016/j.pec.2010.09.013
   Manlove BL, 2004, PERSPECT SEX REPRO H, V36, P265, DOI 10.1363/3626504
   Manlove J, 2003, PERSPECT SEX REPRO H, V35, P246, DOI 10.1111/j.1931-2393.2003.tb00177.x
   Manning WD, 2000, FAM PLANN PERSPECT, V32, P104, DOI 10.2307/2648158
   Manning WD, 2009, PERSPECT SEX REPRO H, V41, P181, DOI 10.1363/4118109
   Marin BV, 2000, J ADOLESCENT HEALTH, V27, P409
   Mason K O, 1994, Health Transit Rev, V4 Suppl, P217
   McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Ministerio da Saude, 2009, PESQ NAC DEM SAUD CR
   MOS, 2014, B EP AIDS DST
   PAIVA V, 2003, CONDOM USE NATL SURV
   Paiva Vera, 2008, Rev Saude Publica, V42 Suppl 1, P45, DOI 10.1590/S0034-89102008000800007
   Paiva V, 2006, REV SAUDE PUBL, V40, P109, DOI 10.1590/S0034-89102006000800015
   Pazol K, 2010, PUBLIC HEALTH REP, V125, P208, DOI 10.1177/003335491012500209
   Peipert JF, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2008.01.038
   PIMENTA MC, 2000, SAFE PASSAGE ADULT L
   PINHO M. D., 2002, REV BRASILEIRA ESTUD, V19, P277
   Quisumbing AR, 2003, OXFORD B ECON STAT, V65, P283, DOI 10.1111/1468-0084.t01-1-00052
   Roa M, 2016, LANCET, V387, P843, DOI 10.1016/S0140-6736(16)00331-7
   Rosenthal D, 1998, AIDS CARE, V10, P35, DOI 10.1080/09540129850124569
   Shafii T, 2004, SEX TRANSM DIS, V31, P366, DOI 10.1097/00007435-200406000-00010
   SHEHAN CL, 1991, J FAM ISSUES, V12, P291, DOI 10.1177/019251391012003003
   StataCorp L. P., 2014, STATA VERS 13 1
   Stein CR, 2008, SEX TRANSM DIS, V35, P447, DOI 10.1097/OLQ.0b013e3181659236
   Teixeira Ana Maria Ferreira Borges, 2006, Cad. Saúde Pública, V22, P1385, DOI 10.1590/S0102-311X2006000700004
   Tsuyuki Kiyomi, 2013, J Sex Transm Dis, V2013, P540789, DOI 10.1155/2013/540789
   Tsuyuki K, 2016, J FAM PLAN REPROD H, V42, P271, DOI 10.1136/jfprhc-2015-101175
   Upadhyaya UD, 2016, CONTRACEPTION, V94, P68, DOI 10.1016/j.contraception.2016.02.025
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Viellas EF, 2014, CAD SAUDE PUBLICA, V30, DOI 10.1590/0102-311X00126013
   Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029
   Westhaver Russell, 2005, SEXUALITIES, V8, P347, DOI DOI 10.1177/1363460705053338
NR 82
TC 1
Z9 1
U1 0
U2 2
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1369-1058
EI 1464-5351
J9 CULT HEALTH SEX
JI Cult. Health Sex
PY 2018
VL 20
IS 9
BP 1006
EP 1022
DI 10.1080/13691058.2017.1406535
PG 17
WC Family Studies; Social Sciences, Biomedical
SC Family Studies; Biomedical Social Sciences
GA GP2YH
UT WOS:000440703400004
PM 29231077
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Guidry, JPD
   Carlyle, KE
   LaRose, JG
   Perrin, P
   Ryan, M
   Messner, M
   Adams, J
AF Guidry, Jeanine P. D.
   Carlyle, Kellie E.
   LaRose, Jessica G.
   Perrin, Paul
   Ryan, Mark
   Messner, Marcus
   Adams, Jay
TI Framing and visual type: Effect on future Zika vaccine uptake intent
SO JOURNAL OF PUBLIC HEALTH RESEARCH
LA English
DT Article
DE Zika; Zika vaccine; framing; visuals
ID LOSS-FRAMED MESSAGES; HEALTH BELIEF MODEL; HUMAN-PAPILLOMAVIRUS; 2009
   H1N1; BEHAVIOR; COMMUNICATION; PREDICTORS; VIRUS; RISK; ACCEPTABILITY
AB Introduction: The Zika virus is associated with the birth defect microcephaly, and while a vaccine was not available in early-2017, several were under development. This study's purpose was to identify effective communication strategies to promote uptake of a new vaccine, particularly among women of reproductive age.
   Design and methods: In order to study the effects of Zika message framing (gain vs. loss) and visual type (photo vs. infographic) on future Zika vaccine uptake intent, a 2x2 between-subjects experiment was performed via an online survey in 2017 among 339 U.S. women of reproductive age (18-49 years). Participants were exposed to one of four messages, all resembling Instagram posts: gain-framed vs. loss-framed infographic, and gain-framed vs. loss-framed photo. These messages were followed by questions about Zika vaccine uptake intent as well as intermediate psychosocial variables that could lead to intent.
   Results: There was no interaction between framing and visual type (P=0.116), and there was no effect for framing (P=0.185) or visual type (P=0.724) on future Zika vaccine uptake intent, which is likely indicative of insufficient dosage of the intervention. However, when focusing on intermediate psychosocial constructs that are known to influence behavior and intent, gain-framed messages were more effective in increasing subjective norms (P=0.005) as related to a future Zika vaccine, as well as perceived benefits (P=0.016) and self-efficacy (P=0.032).
   Conclusions: Gain-framed messages seem to be more effective than loss-framed messages to increase several constructs that could, in turn, affect future Zika vaccine uptake intent. This is a novel finding since, traditionally, loss-framed messages are considered more beneficial in promoting vaccine-related health behaviors.
C1 [Guidry, Jeanine P. D.; Messner, Marcus; Adams, Jay] Virginia Commonwealth Univ, Robertson Sch Media & Culture, 901 W Broad St Suite 2216, Richmond, VA 23284 USA.
   [Carlyle, Kellie E.; LaRose, Jessica G.] Virginia Commonwealth Univ, Dept Hlth Behav & Policy, Richmond, VA USA.
   [Perrin, Paul] Virginia Commonwealth Univ, Dept Psychol, Box 2018, Richmond, VA 23284 USA.
   [Ryan, Mark] Virginia Commonwealth Univ, Dept Family Med, Richmond, VA USA.
RP Guidry, JPD (corresponding author), Virginia Commonwealth Univ, Robertson Sch Media & Culture, 901 W Broad St Suite 2216, Richmond, VA 23284 USA.
EM guidryjd@vcu.edu
OI Guidry, Jeanine/0000-0002-6903-7464
CR Abhyankar Purva, 2008, Psychol Health Med, V13, P1, DOI 10.1080/13548500701235732
   Ajzen I, 2011, PSYCHOL HEALTH, V26, P1113, DOI 10.1080/08870446.2011.613995
   Ancker JS, 2006, J AM MED INFORM ASSN, V13, P608, DOI 10.1197/jamia.M2115
   Bennett KK, 2012, J SOC PSYCHOL, V152, P480, DOI 10.1080/00224545.2011.639408
   Borzsei LK, 2013, NEW MEDIA STUDIES MA
   Brewer NT, 2007, PREV MED, V45, P107, DOI 10.1016/j.ypmed.2007.05.013
   Briones R, 2012, HEALTH COMMUN, V27, P478, DOI 10.1080/10410236.2011.610258
   Chen MF, 2011, J COMMUN HEALTH NURS, V28, P29, DOI 10.1080/07370016.2011.539087
   Chew C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014118
   Cohen J., 2003, APPL MULTIPLE REGRES, P390
   Constine J., 2017, INSTAGRAMS GROWTH SP
   Dredze M, 2016, VACCINE, V34, P3441, DOI 10.1016/j.vaccine.2016.05.008
   Farrelly MC, 2005, AM J PUBLIC HEALTH, V95, P425, DOI 10.2105/AJPH.2004.049692
   Fu KW, 2016, AM J INFECT CONTROL, V44, P1700, DOI 10.1016/j.ajic.2016.04.253
   Gallagher KM, 2012, ANN BEHAV MED, V43, P101, DOI 10.1007/s12160-011-9308-7
   Garcia-Retamero R, 2011, J EXP PSYCHOL-APPL, V17, P270, DOI 10.1037/a0023677
   Gargano LM, 2011, HUM VACCINES, V7, P89, DOI 10.4161/hv.7.1.13460
   Gerend MA, 2008, ANN BEHAV MED, V35, P221, DOI 10.1007/s12160-008-9024-0
   Gerend MA, 2007, HEALTH PSYCHOL, V26, P745, DOI 10.1037/0278-6133.26.6.745
   Gerend MA, 2012, ANN BEHAV MED, V44, P171, DOI 10.1007/s12160-012-9366-5
   Guidry JPD, 2015, VACCINE, V33, P5051, DOI 10.1016/j.vaccine.2015.08.064
   Houts PS, 2006, PATIENT EDUC COUNS, V61, P173, DOI 10.1016/j.pec.2005.05.004
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Lazard A, 2015, SCI COMMUN, V37, P6, DOI 10.1177/1075547014555997
   Lee ST, 2013, HEALTH COMMUN, V28, P119, DOI 10.1080/10410236.2012.658550
   Lipkus IM, 2007, MED DECIS MAKING, V27, P696, DOI 10.1177/0272989x07307271
   Love B, 2013, AM J INFECT CONTROL, V41, P568, DOI 10.1016/j.ajic.2012.10.016
   McWhirter JE, 2014, J HEALTH COMMUN, V19, P738, DOI 10.1080/10810730.2013.837562
   Mo PKH, 2015, HEALTH EDUC RES, V30, P706, DOI 10.1093/her/cyv038
   Myers LB, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-15
   Nan XL, 2012, HEALTH COMMUN, V27, P559, DOI 10.1080/10410236.2011.617243
   Nielsen, 2017, 2016 NIELS SOC MED R
   O'Keefe DJ, 2012, HEALTH COMMUN, V27, P776, DOI 10.1080/10410236.2011.640974
   Occa A, 2016, J HEALTH COMMUN, V21, P1, DOI 10.1080/10810730.2015.1018611
   PAIVIO A, 1991, CAN J PSYCHOL, V45, P255, DOI 10.1037/h0084295
   Rosenstock I. M., 1974, HLTH ED MONOGRAPHS, V2, P324
   Rothman AJ, 2006, J COMMUN, V56, pS202, DOI 10.1111/j.1460-2466.2006.00290.x
   Seltzer EK, 2017, PUBLIC HEALTH, V150, P170, DOI 10.1016/j.puhe.2017.07.015
   Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632
   Southwell BG, 2005, COMMUN RES, V32, P112, DOI 10.1177/0093650204271401
   Southwell BG, 2016, EMERG INFECT DIS, V22, P1320, DOI 10.3201/eid2207.160415
   World Health Organization, 2017, SIT REP ZIK VIR MICR
NR 42
TC 1
Z9 1
U1 0
U2 0
PU PAGEPRESS PUBL
PI PAVIA
PA MEDITGROUP, VIA G BELLI, 4, PAVIA, 27100, ITALY
SN 2279-9028
EI 2279-9036
J9 J PUBLIC HEALTH RES
JI J. Public Health Res.
PY 2018
VL 7
IS 1
BP 35
EP 42
AR 1162
DI 10.4081/jphr.2018.1162
PG 8
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GP3FO
UT WOS:000440728100006
PM 29780762
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Frutos, MGL
   Ochoa, JH
   Barbas, MG
   Lucchini, HD
   Moya, M
   Malinger, G
AF Frutos, Maria Guadalupe Lovagnini
   Ochoa, Jose Hector
   Barbas, Maria Gabriela
   Lucchini, Hector Dante
   Moya, Martin
   Malinger, Gustavo
TI New Insights into the Natural History of Congenital Zika Virus Syndrome
SO FETAL DIAGNOSIS AND THERAPY
LA English
DT Article
DE Zika virus; Brain malformations; Congenital Zika virus syndrome;
   Prenatal diagnosis; Fetal ultrasound; Fetal MRI
ID INFECTION
AB We describe the prenatal evolution of the brain findings in a patient with proved Zika virus infection at 8 weeks of gestation showing the very early appearance at 17 weeks of ventriculomegaly and signs of brain parenchymal involvement without microcephaly. The involvement of the brain becomes more evident at 22 and 27 weeks with the apparition of calcifications and microcephaly. Interestingly, the postnatal findings failed to show significant worsening when compared to these prenatal findings. (C) 2017 S. Karger AG, Basel
C1 [Frutos, Maria Guadalupe Lovagnini; Ochoa, Jose Hector; Lucchini, Hector Dante; Moya, Martin] Cordoba Natl Univ, Univ Matern Hosp HUMN, Cordoba, Argentina.
   [Frutos, Maria Guadalupe Lovagnini; Ochoa, Jose Hector] Diagnus SA, Prenatal Diag Ctr, Cordoba, Argentina.
   [Barbas, Maria Gabriela] Minist Hlth, Cent Lab Dept, Cordoba, Argentina.
   [Malinger, Gustavo] Tel Aviv Sourasky Med Ctr, Lis Matern Hosp, Div Ultrasound Obstet & Gynecol, 6 Weitzman St, IL-6423906 Tel Aviv, Israel.
   [Malinger, Gustavo] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel.
RP Malinger, G (corresponding author), Tel Aviv Sourasky Med Ctr, Lis Matern Hosp, Div Ultrasound Obstet & Gynecol, 6 Weitzman St, IL-6423906 Tel Aviv, Israel.
EM gmalinger@gmail.com
CR Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Pomar L, 2017, ULTRASOUND OBST GYN, V49, P729, DOI 10.1002/uog.17404
NR 6
TC 1
Z9 1
U1 0
U2 1
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1015-3837
EI 1421-9964
J9 FETAL DIAGN THER
JI Fetal Diagn. Ther.
PY 2018
VL 44
IS 1
BP 72
EP 76
DI 10.1159/000479866
PG 5
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA GO5VJ
UT WOS:000440096900010
PM 28898891
DA 2020-07-08
ER

PT J
AU Rabbani, SA
   Mustafa, F
   Shouqair, T
   Mohamed, I
   Tahsin, N
AF Rabbani, Syed Arman
   Mustafa, Farhan
   Shouqair, Tasneem
   Mohamed, Itaf
   Tahsin, Nada
TI Zika virus disease knowledge among the future health-care providers of
   the United Arab Emirates
SO JOURNAL OF ADVANCED PHARMACEUTICAL TECHNOLOGY & RESEARCH
LA English
DT Article
DE Health-care providers; knowledge; United Arab Emirates; Zika virus
   disease
ID WOMEN
AB Zika virus (ZIKV) disease has become a major public health concern. Although there are no reported cases of ZIKV disease in the United Arab Emirates (UAE), there is a potential risk of transmission due to large expatriate population and high influx of international travelers. This cross-sectional study was conducted to assess the knowledge of ZIKV disease among the students of a medical and health sciences university in the UAE. Their knowledge of ZIKV disease was assessed using a specially designed, pretested, and validated questionnaire. Of the 500 respondents included in the final analysis, 314 (62.8%) respondents presented with poor knowledge of ZIKV disease. The mean knowledge score of the study population was 10.48 +/- 2.48 out of a maximum of 17. Gender, college and year of study, nationality and attendance in lecture/conference/workshop on Zika were significantly associated with the level of knowledge. The males possessed significantly (P = 0.046) better knowledge as compared to the females. Students of medical college had significantly (P = 0.005) better knowledge as compared to students of other colleges. The level of knowledge improved significantly (P = 0.026) as the year of study progressed. There is a need for medical and paramedical students to update their knowledge of ZIKV disease as they are the future health-care providers who will be responsible for creating awareness about such outbreaks and their preventive measures.
C1 [Rabbani, Syed Arman] RAK Med & Hlth Sci Univ, Dept Clin Pharm & Pharmacol, Ras Al Khaymah, U Arab Emirates.
   [Mustafa, Farhan; Shouqair, Tasneem; Mohamed, Itaf; Tahsin, Nada] RAK Med & Hlth Sci Univ, RAK Coll Pharmaceut Sci, Ras Al Khaymah, U Arab Emirates.
RP Rabbani, SA (corresponding author), RAK Med & Hlth Sci Univ, RAK Coll Pharmaceut Sci, Dept Clin Pharm & Pharmacol, Ras Al Khaymah, U Arab Emirates.
EM arman@rakmhsu.ac.ae
OI Rabbani, Syed Arman/0000-0002-8454-8158
FU RAK Medical and Health Sciences University
FX The authors would like to thank students of RAK Medical and Health
   Sciences University for participating in the study. The authors also
   thank Dr. S. Gurumadhva Rao, Vice Chancellor; Dr. B. G. Nagavi, Dean;
   Dr. Padma G. M. Rao, Associate Dean, RAK Medical and Health Sciences
   University for their support and encouragement.
CR Aidoo-Frimpong G, 2017, ANN GLOB HEALTH, V83, P59
   [Anonymous], ZIK VIR
   Arief M, 2017, JPPCM, V3, P81, DOI DOI 10.5530/jppcm.2017.2.20
   Cheema S, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2603-6
   Gupta Nidhi, 2016, Niger Postgrad Med J, V23, P33, DOI 10.4103/1117-1936.180179
   Harapan H, 2017, ASIAN PAC J TROP MED, V10, P182, DOI 10.1016/j.apjtm.2017.01.018
   Michael GC, 2017, S AFR FAM PRACT, V59, P148, DOI 10.1080/20786190.2017.1313484
   Shereef EA, 2017, INT J SCI RES, V6, P1429
   Singh M, 2017, DENTISTRY, V7, P420, DOI [10.4172/2161-1122.1000420, DOI 10.4172/2161-1122.1000420]
   Situation report Zika virus microcephaly Guillain Barre syndrome, SIT REP ZIK VIR MICR
   Whittemore K, 2017, EMERG INFECT DIS, V23, P164, DOI 10.3201/eid2301.161614
   WHO, ZIK VIR
   World Health Organization, 2016, 5 M EM COMM INT HLTH
NR 13
TC 1
Z9 2
U1 0
U2 1
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 2231-4040
EI 0976-2094
J9 J ADV PHARM TECHNOL
JI J. Adv. Pharm. Technol. Res.
PD JAN-MAR
PY 2018
VL 9
IS 1
BP 20
EP 25
DI 10.4103/japtr.JAPTR_239_17
PG 6
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA GO5FL
UT WOS:000440043900005
PM 29441320
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Brissett, DI
   Tuholske, C
   Allen, IE
   Larios, NS
   Mendoza, DJ
   Murillo, AG
   Bloch, EM
AF Brissett, Daniela I.
   Tuholske, Cascade
   Allen, Isabel E.
   Larios, Noely S.
   Mendoza, Diego J.
   Murillo, Ana G.
   Bloch, Evan M.
TI Zika Virus: Knowledge Assessment of Residents and Health-Care Providers
   in Roatan, Honduras, following an Outbreak
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID DISEASE; PREVENTION
AB Few studies have evaluated the effectiveness of Zika virus (ZIKV) public health educational campaigns. Following a ZIKV educational campaign in Roatan, Honduras (October 2016), a survey was administered (March-May 2017) to residents (N = 348) and health-care professionals ([HCPs]; N = 44) to evaluate ZIKV knowledge, attitudes, and preventive practices, with attention to sexual health. Knowledge scores were calculated and mapped using participants' home locations. The knowledge scores between HCPs and residents were significantly different (mean 17 versus 11; P < 0.001). Only 6% of residents and 14% of HCPs knew that ZIKV was sexually transmissible. Few reported abstinence (2.6% residents; 9.4% HCPs) or condom use (1.6% residents; 12.5% HCPs) to prevent ZIKV infection. Of all subjects, 15.6% were pregnant or had a pregnant partner in the past year; 57.6% expressed concern over ZIKV. Mapping demonstrated spatial heterogeneity in knowledge. The findings suggest a need for improved public health messaging in ZIKV-affected areas.
C1 [Brissett, Daniela I.] Univ Calif San Francisco, Sch Med, 513 Parnassus Ave,S-245, San Francisco, CA 94143 USA.
   [Tuholske, Cascade] Univ Calif Santa Barbara, Dept Geog, Santa Barbara, CA 93106 USA.
   [Allen, Isabel E.] Univ Calif San Francisco, Dept Epidemiol, San Francisco, CA 94143 USA.
   [Larios, Noely S.] Univ Nacl Autonoma Honduras, Sch Med, Fac Ciencias Sociales, Tegucigalpa, Honduras.
   [Mendoza, Diego J.; Murillo, Ana G.] Univ Catolica Honduras, Sch Med, Tegucigalpa, Honduras.
   [Bloch, Evan M.] Johns Hopkins Med, Dept Pathol, Baltimore, MD USA.
   [Brissett, Daniela I.] Univ Calif San Francisco, Sch Med, Med Ctr, San Francisco, CA USA.
   [Allen, Isabel E.] Univ Calif San Francisco, Med Ctr, Dept Epidemiol, San Francisco, CA USA.
RP Brissett, DI (corresponding author), Univ Calif San Francisco, Sch Med, 513 Parnassus Ave,S-245, San Francisco, CA 94143 USA.
EM daniela.brissett@ucsf.edu; cascade@umail.ucsb.edu;
   isabel.allen@ucsf.edu; noelylariosa@gmail.com; diegomv_1691@hotmail.com;
   anagaby_1119@hotmail.com; ebloch2@jhmi.edu
FU Universidad Catolica de Honduras (UN ICAH) Committee Review; UCSF
   Resource Allocation Program for Trainees (Rapt'r) Grants
FX We thank Martha Medina, Shantaye Godfrey, Cherry Kay Safrey, and staff
   at the Public Hospital Roatan for their support; Jaime Gustavo Nunez
   Cruz and the Universidad Catolica de Honduras (UN ICAH) Committee Review
   for approving and supporting the study; and the U.S. Geological Survey
   for providing Landsat imagery. This study was supported by Sklar-Gilbert
   and the UCSF Resource Allocation Program for Trainees (Rapt'r) Grants.
CR Berenson AB, 2017, AM J TROP MED HYG, V97, P155, DOI 10.4269/ajtmh.17-0062
   Brooks T, 2017, EMERG INFECT DIS, V23, P1360, DOI 10.3201/eid2308.161944
   CDC Foundation, 2016, ZIK RISK COMM COMM E
   CDC Foundation, 2016, CLIN GUID HEALTHC PR
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   KULLDORFF M, 1995, STAT MED, V14, P799, DOI 10.1002/sim.4780140809
   Mead PS, 2018, CURR OPIN INFECT DIS, V31, P39, DOI 10.1097/QCO.0000000000000414
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Paz-Bailey G, 2017, ASTMH 66 ANN M NOV 6
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Prue CE, 2017, MMWR-MORBID MORTAL W, V66, P909, DOI 10.15585/mmwr.mm6634a4
   Sabogal-Roman JA, 2016, TRAVEL MED INFECT DI, V14, P52, DOI 10.1016/j.tmaid.2015.12.003
   Stycos Mayone J, 1964, PUBLIC OPIN QUART, V28, P367
   WHO, 2017, ZIK SIT REP
   WHO, 2016, PREV SEX TRANSM ZIK
   World Health Organization, 2016, ZIK SIT REP
   World Health Organization, 2016, KNOWL ATT PRACT SURV
   World Health Organization, 2015, ZIK CAS US
NR 20
TC 5
Z9 5
U1 0
U2 2
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 1
BP 211
EP 215
DI 10.4269/ajtmh.18-0014
PG 5
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA GM4EY
UT WOS:000438069400039
PM 29761757
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Masmejan, S
   Baud, D
   Musso, D
   Panchaud, A
AF Masmejan, Sophie
   Baud, David
   Musso, Didier
   Panchaud, Alice
TI Zika virus, vaccines, and antiviral strategies
SO EXPERT REVIEW OF ANTI-INFECTIVE THERAPY
LA English
DT Review
DE Antiviral; arbovirus; flavivirus; drugs; emerging diseases; vaccine;
   zika virus; ZIKV; pregnancy; microcephaly; fetus
ID ANTIBODY-DEPENDENT ENHANCEMENT; INFECTION IN-VITRO; FDA-APPROVED DRUG;
   INHIBITS ZIKA; NS2B-NS3 PROTEASE; DNA VACCINE; PROTECTIVE EFFICACY;
   CHIKUNGUNYA VIRUS; DENGUE VIRUS; REPLICATION
AB Introduction: Zika virus (ZIKV) recently emerged as a global public health emergency of international concern. ZIKV is responsible for severe neurological complications in adults and infection during pregnancy and can lead to congenital Zika syndrome. There is no licensed vaccine or drug to prevent or treat ZIKV infection.Areas covered: The aim of this article is to provide an overview and update of the progress of research on anti-ZIKV vaccine and medications until the end of 2017, with a special emphasis on drugs that can be used during pregnancy.Expert commentary: Development of new vaccines and drugs is challenging and several points particular to ZIKV infections augment this difficulty: (1) Cross-reactions between ZIKV and other flaviviruses, the impact of ZIKV vaccination on subsequent flavivirus infections, and vice-versa, is unknown, (2) Drugs against ZIKV should be safe in pregnant women, and (3) Evaluation of the efficacy of vaccine and drugs against ZIKV in clinical trials phase II-IV will be complicated due to the decline of ZIKV circulation.
C1 [Masmejan, Sophie; Baud, David] Lausanne Univ Hosp, Mother Child Dept, Obstet Unit, Lausanne, Switzerland.
   [Musso, Didier] Inst Louis Malarde, Unit Emerging Infect Dis, Tahiti, French Polynesi, France.
   [Musso, Didier] Aix Marseille Univ, IRD, AP HM, SSA,VITROME,IHU Mediterranee Infect, Marseille, France.
   [Panchaud, Alice] Univ Geneva & Lausanne, Sch Pharmaceut Sci, Geneva, Switzerland.
   [Panchaud, Alice] Univ Hosp, STIS, Lausanne, Switzerland.
   [Panchaud, Alice] Univ Hosp, Div Clin Pharmacol, Dept Lab, Lausanne, Switzerland.
   [Panchaud, Alice] Univ Hosp Lausanne, Serv Pharm, Dept Lab, Lausanne, Switzerland.
RP Baud, D (corresponding author), CHU Vaudois, Serv Obstet, Dept Mere Enfant, Obstet Unit,Mother Child Dept,Univ Hosp Lausanne, Lausanne, Switzerland.
EM David.baud@chuv.ch
RI amsalu, ribka/G-8780-2019; Musso, Didier/P-7809-2016; Panchaud,
   Alice/S-6535-2019; Musso, Didier/AAO-8178-2020
OI Musso, Didier/0000-0002-9226-0971; Panchaud, Alice/0000-0001-6086-2401;
   Musso, Didier/0000-0002-9226-0971; Baud, David/0000-0001-9914-6496
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Adcock RS, 2017, ANTIVIR RES, V138, P47, DOI 10.1016/j.antiviral.2016.11.018
   Albulescu IC, 2017, ANTIVIR RES, V143, P230, DOI 10.1016/j.antiviral.2017.04.016
   Andrade DV, 2017, VIRUS RES
   [Anonymous], 2016, Nature, V537, P7, DOI 10.1038/537007a
   [Anonymous], 2017, ZIK VIR SAF SUBST HU
   Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   Balasubramanian A, 2017, ANTIVIR RES, V137, P141, DOI 10.1016/j.antiviral.2016.11.015
   Barbosa-Lima G, 2017, EUR J MED CHEM, V127, P434, DOI 10.1016/j.ejmech.2017.01.007
   Barbosa-Limaa G, 2017, EUR J MED CHEM, V127, P334, DOI 10.1016/j.ejmech.2016.12.058
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Behrendt P, 2017, ANTIVIR RES, V147, P19, DOI 10.1016/j.antiviral.2017.09.006
   Terzian ACB, 2017, CLIN INFECT DIS, V65, P1260, DOI 10.1093/cid/cix558
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Blohm GM, 2018, CLIN INFECT DIS, V66, P1120, DOI 10.1093/cid/cix968
   Blom K, 2017, J INTERN MED, V282, P206, DOI 10.1111/joim.12638
   Boigard H, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005608
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Briggs GG, 2017, DRUGS PREGNANCY LACT
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Cai L., 2017, ARCH VIROL
   Cairns DM, 2018, BIOL OPEN, V7, DOI 10.1242/bio.031807
   Cairns DM, 2016, STEM CELL REP, V7, P557, DOI 10.1016/j.stemcr.2016.07.017
   Cao B, 2017, J EXP MED, V214, P2303, DOI 10.1084/jem.20170957
   Cao RY, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx009
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Capone S, 2013, EXPERT REV VACCINES, V12, P379, DOI [10.1586/erv.13.15, 10.1586/ERV.13.15]
   Carneiro BM, 2016, VIROLOGY, V496, P215, DOI 10.1016/j.virol.2016.06.012
   Chan JFW, 2017, ANTIVIR RES, V141, P29, DOI 10.1016/j.antiviral.2017.02.002
   Chan JFW, 2016, EBIOMEDICINE, V14, P112, DOI 10.1016/j.ebiom.2016.11.017
   Chen JL, 2017, CELL REP, V21, P1588, DOI 10.1016/j.celrep.2017.10.059
   Chen LM, 2017, ANTIVIR RES, V141, P140, DOI 10.1016/j.antiviral.2017.02.009
   Cohen J, 2017, SCIENCE, V357, P631, DOI 10.1126/science.357.6352.631
   Contreras D, 2016, JOVE-J VIS EXP, DOI 10.3791/54767
   Costa VV, 2017, MBIO, V8, DOI [10.1128/mBio.00350-17, 10.1128/mbio.00350-17]
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   de Carvalho OV, 2017, INT J ANTIMICROB AG, V50, P718, DOI 10.1016/j.ijantimicag.2017.08.016
   del Campo M, 2017, AM J MED GENET A, V173, P841, DOI 10.1002/ajmg.a.38170
   Delvecchio R, 2016, VIRUSES, V8, P1
   Deng YQ, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw175
   Devillers J, 2018, SAR QSAR ENVIRON RES, V29, P103, DOI 10.1080/1062936X.2017.1411642
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Estoppey D, 2017, CELL REP, V19, P451, DOI 10.1016/j.celrep.2017.03.071
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Fernando S, 2016, MOL BIOTECHNOL, V58, P801, DOI 10.1007/s12033-016-9979-1
   Ferreira AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09797-8
   Garg H, 2017, J VIROL, V91, DOI 10.1128/JVI.00834-17
   Gaudinski MR, 2018, LANCET, V391, P552, DOI 10.1016/S0140-6736(17)33105-7
   Ghezzi S, 2017, ANTIVIR RES, V140, P13, DOI 10.1016/j.antiviral.2016.12.023
   Goebel S, 2016, J VIROL METHODS, V238, P13, DOI 10.1016/j.jviromet.2016.09.015
   Griffin BD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15743
   Gubler DJ, 2017, J INFECT DIS, V216, pS860, DOI 10.1093/infdis/jix451
   Han JF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10595-5
   Han YS, 2018, J MED VIROL, V90, P796, DOI 10.1002/jmv.25031
   Heinz FX, 2012, VACCINE, V30, P4301, DOI 10.1016/j.vaccine.2011.09.114
   Julander JG, 2017, ANTIVIR RES, V137, P14, DOI 10.1016/j.antiviral.2016.11.003
   Kamiyama N, 2017, ANTIVIR RES, V146, P1, DOI 10.1016/j.antiviral.2017.08.007
   Keller-Stanislawski B, 2014, VACCINE, V32, P7057, DOI 10.1016/j.vaccine.2014.09.052
   Kim E, 2016, EBIOMEDICINE, V13, P315, DOI 10.1016/j.ebiom.2016.09.028
   Kuivanen S, 2017, ANTIVIR RES, V139, P117, DOI 10.1016/j.antiviral.2016.12.022
   Lagunas-Rangel FA, 2017, J VIRUS ERAD, V3, P124
   Lanko K, 2017, ANTIVIR RES, V145, P82, DOI 10.1016/j.antiviral.2017.07.010
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Li CF, 2017, EBIOMEDICINE, V24, P189, DOI 10.1016/j.ebiom.2017.09.034
   Li CF, 2017, IMMUNITY, V46, P446, DOI 10.1016/j.immuni.2017.02.012
   Makhluf H, 2018, VACCINES-BASEL, V6, DOI 10.3390/vaccines6010007
   Merino-Ramos T, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00376-17, 10.1128/aac.00376-17]
   Mesci P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19526-4
   Mitchell C., 2016, ZIKA CUMULATIVE CASE
   Modjarrad K, 2018, LANCET, V391, P563, DOI 10.1016/S0140-6736(17)33106-9
   MORENS DM, 1994, CLIN INFECT DIS, V19, P500, DOI 10.1093/clinids/19.3.500
   Mounce BC, 2017, ANTIVIR RES, V142, P148, DOI 10.1016/j.antiviral.2017.03.014
   Mumtaz N, 2017, ANTIVIR RES, V146, P161, DOI 10.1016/j.antiviral.2017.09.004
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2018, LANCET INFECT DIS, V18, pE172, DOI 10.1016/S1473-3099(17)30446-2
   Musso D, 2016, LANCET, V387, P1993, DOI 10.1016/S0140-6736(16)30428-7
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Muthumani K, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.21
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Pascoalino Bruno S, 2016, F1000Res, V5, P2523
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Pires de Mello C. P., 2017, ANTIMICROB AGENTS CH
   Pitts JD, 2017, ANTIVIR RES, V147, P124, DOI 10.1016/j.antiviral.2017.10.014
   Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10
   Priyamvada L, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.42
   Pryke KM, 2017, MBIO, V8, DOI [10.1128/mBio.00452-17, 10.1128/mbio.00452-17]
   Raekiansyah M, 2017, TROP MED HEALTH, V45, DOI 10.1186/s41182-017-0072-7
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rausch K, 2017, CELL REP, V18, P804, DOI 10.1016/j.celrep.2016.12.068
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Royle J, 1997, VET J LOND ENGL, V19, P2017
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
   Sahoo Maheswata, 2016, Genomics & Informatics, V14, P104, DOI 10.5808/GI.2016.14.3.104
   Savidis G, 2016, CELL REP, V15, P2323, DOI 10.1016/j.celrep.2016.05.074
   Schaefer C, 2014, DRUGS PREGNANCY LACT
   Schandock F., 2017, ADV HEALTHC MATER, V6
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Schwartz DA, 2017, ARCH PATHOL LAB MED, V141, P18, DOI [10.5858/arpa.2016-04, 10.5858/arpa.2016-0429-ED]
   Shan C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00737-8
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Shirbaghaee Z, 2016, BIOPOLYMERS, V105, P113, DOI 10.1002/bip.22759
   Shiryaev SA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15467-6
   Shiryaev SA, 2017, ANTIVIR RES, V143, P218, DOI 10.1016/j.antiviral.2017.04.015
   Skipetrova A, 2018, VACCINE, V36, P3345, DOI 10.1016/j.vaccine.2018.04.050
   Snyder B, 2018, J MED VIROL, V90, P8, DOI 10.1002/jmv.24932
   Stein DR, 2017, ANTIVIR RES, V146, P164, DOI 10.1016/j.antiviral.2017.09.005
   Sumathy K, 2017, SCI REP-UK, V7, DOI 10.1038/srep46375
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
   Sze A, 2017, VIRUSES, V9, P10
   Tan CW, 2017, ANTIVIR RES, V143, P186, DOI 10.1016/j.antiviral.2017.04.017
   Tebas P, 2017, N ENGL J MED
   Tong X, 2018, ANTIVIR RES, V149, P34, DOI 10.1016/j.antiviral.2017.11.004
   Valentine G, 2016, EXPERT REV ANTI-INFE, V14, P1127, DOI 10.1080/14787210.2016.1245614
   Van der Hoek KH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04138-1
   Vazquez-Calvo A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01314
   Vemula SV, 2010, EXPERT OPIN BIOL TH, V10, P1469, DOI 10.1517/14712598.2010.519332
   Wang CX, 2017, BIOCHEM BIOPH RES CO, V493, P1555, DOI 10.1016/j.bbrc.2017.10.016
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   WHO, WHO DIR GEN SUMM OUT
   WHO, PREV SEX TRANSM ZIK
   WHO, MOSQ VECT CONTR EM R
   Wong G, 2017, VIROL SIN, V32, P545, DOI 10.1007/s12250-017-4057-9
   Xie X, 2017, MBIO, V8, P1
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE365, DOI 10.1016/S2214-109X(16)00086-3
   Yang M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08247-9
   Yang M, 2017, VACCINE, V35, P4287, DOI 10.1016/j.vaccine.2017.04.052
   Yi GH, 2017, EBIOMEDICINE, V25, P87, DOI 10.1016/j.ebiom.2017.10.006
   Yu YF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15672
   Yuan SF, 2017, ANTIVIR RES, V145, P33, DOI 10.1016/j.antiviral.2017.07.007
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
   Zorrilla CD, 2017, J INFECT DIS, V216, pS891, DOI 10.1093/infdis/jix448
NR 141
TC 5
Z9 5
U1 0
U2 4
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1478-7210
EI 1744-8336
J9 EXPERT REV ANTI-INFE
JI Expert Rev. Anti-Infect. Ther.
PY 2018
VL 16
IS 6
BP 471
EP 483
DI 10.1080/14787210.2018.1483239
PG 13
WC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
SC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
GA GM4TX
UT WOS:000438118000004
PM 29897831
DA 2020-07-08
ER

PT J
AU Al-Obaidi, MMJ
   Bahadoran, A
   Wang, SM
   Manikam, R
   Raju, CS
   Sekaran, SD
AF Al-Obaidi, M. M. Jamil
   Bahadoran, A.
   Wang, S. M.
   Manikam, R.
   Raju, Ch. S.
   Sekaran, S. D.
TI Disruption of the blood brain barrier is vital property of neurotropic
   viral infection of the central nervous system
SO ACTA VIROLOGICA
LA English
DT Review
DE adhesion molecules; blood-brain barrier; central nervous system;
   neuroviruses; tight junction
ID WEST-NILE-VIRUS; MESSENGER-RNA EXPRESSION; CELL-ADHESION MOLECULES;
   HERPES-SIMPLEX ENCEPHALITIS; TIGHT JUNCTION PROTEINS; TOLL-LIKE
   RECEPTOR-3; NIPAH VIRUS; RABIES VIRUS; JAPANESE ENCEPHALITIS;
   ENDOTHELIAL-CELLS
AB The blood brain barrier consisting of astrocytes, pericytes and brain microvascular endothelial cells plays a vital role in the pathogenesis of neurotropic viruses by controlling the access of circulating molecules, immune cells or viruses into the central nervous system (CNS). However, this barrier is not impenetrable and neuroviruses have evolved to disrupt and evade it. This review aims to describe the underlying entry mechanisms of several neuroviruses such as (Japanese encephalitis virus (JEV), West Nile virus (WNV), Zika virus (ZIKV), Nipah virus (NiV), Rabies virus (RABV), Herpes simplex virus (HSV) and Human immunodeficiency virus (HIV)) into the CNS through BBB disruption. The mechanisms, through which neurotropic viruses enter the BBB, are being studied and are becoming clearer, however, some aspects still remain unknown. Some of these viruses are able to invade the brain parenchyma by a 'Trojan horse' mechanism, through diapedesis of infected immune cells that either cross the BBB paracellularly or transcellularly. Important mechanisms of BBB disruption associated with paracellular entry of viruses include alterations in expression or phosphorylation of tight junction proteins, disruption of the basal lamina and disruption of the actin cytoskeleton. In the absence of such mechanisms, indirect effects of viruses on the immune system are likely causes of barrier disruption.
C1 [Al-Obaidi, M. M. Jamil; Bahadoran, A.; Raju, Ch. S.] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia.
   [Wang, S. M.] Univ Teknol MARA, Fac Med, Inst Med Mol Biotechnol, Selangor, Malaysia.
   [Manikam, R.] Univ Malaya, Med Ctr, Dept Trauma & Emergency Med, Kuala Lumpur, Malaysia.
   [Sekaran, S. D.] MAHSA Univ, Fac Med, Dept Microbiol, Bandar Saujana Putra, Selangor, Malaysia.
RP Sekaran, SD (corresponding author), MAHSA Univ, Fac Med, Dept Microbiol, Bandar Saujana Putra, Selangor, Malaysia.
EM shamaladevi@mahsa.edu.my
RI Sekaran, Shamala Devi/B-8482-2008; Devi, Shamala Devi/B-9735-2010;
   Samudi, Chandramathi/G-5937-2012; Al-Obaidi, Mazen/N-6078-2019
OI Sekaran, Shamala Devi/0000-0002-0478-0425; Devi, Shamala
   Devi/0000-0002-0478-0425; Al-Obaidi, Mazen/0000-0001-5950-4498
FU University of MalayaUniversiti Malaya [UMRG-PR021C-13HTM]
FX This study was supported by the University of Malaya under Grant
   UMRG-PR021C-13HTM.
CR Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030
   Abbott NJ, 2000, CELL MOL NEUROBIOL, V20, P131, DOI 10.1023/A:1007074420772
   Afonso PV, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000205
   Agrawal T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069465
   An SF, 1999, J NEUROPATH EXP NEUR, V58, P1156, DOI 10.1097/00005072-199911000-00005
   Andras IE, 2005, J CEREBR BLOOD F MET, V25, P1159, DOI 10.1038/sj.jcbfm.9600115
   Argyris EG, 2007, VIROLOGY, V367, P440, DOI 10.1016/j.virol.2007.06.010
   Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522
   ARSENIONUNES ML, 1975, ACTA NEUROPATHOL, V33, P245, DOI 10.1007/BF00688397
   Bailey SL, 2006, CRIT REV IMMUNOL, V26, P149, DOI 10.1615/CritRevImmunol.v26.i2.40
   BANATI RB, 1993, GLIA, V7, P111, DOI 10.1002/glia.440070117
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Beuche W, 2000, NEUROREPORT, V11, P3419, DOI 10.1097/00001756-200011090-00003
   Bonaparte MI, 2005, P NATL ACAD SCI USA, V102, P10652, DOI 10.1073/pnas.0504887102
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Casrouge A, 2006, SCIENCE, V314, P308, DOI 10.1126/science.1128346
   CECCALDI PE, 1989, J NEUROPATH EXP NEUR, V48, P620, DOI 10.1097/00005072-198911000-00004
   Chai QQ, 2015, J VIROL, V89, P870, DOI 10.1128/JVI.02154-14
   Chai QQ, 2014, J VIROL, V88, P4698, DOI 10.1128/JVI.03149-13
   Charlton K.M., 1988, P101
   Chen ST, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002655
   Chua KB, 2000, SCIENCE, V288, P1432, DOI 10.1126/science.288.5470.1432
   CITI S, 1989, J CELL SCI, V93, P107
   CITI S, 1988, NATURE, V333, P272, DOI 10.1038/333272a0
   Daffis S, 2008, J VIROL, V82, P10349, DOI 10.1128/JVI.00935-08
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   de Wit E, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001432
   deVries HE, 1996, J NEUROIMMUNOL, V64, P37, DOI 10.1016/0165-5728(95)00148-4
   Diagana M, 2007, J NEUROL SCI, V262, P165, DOI 10.1016/j.jns.2007.06.041
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dietrich JB, 2002, J NEUROIMMUNOL, V128, P58, DOI 10.1016/S0165-5728(02)00114-5
   Dore DP, 2008, CURR PHARM DESIGN, V14, P1581, DOI [10.2174/138161208784705469, DOI 10.2174/138161208784705469]
   Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1
   Eugenin EA, 2006, J NEUROSCI, V26, P1098, DOI 10.1523/JNEUROSCI.3863-05.2006
   Farkas BE, 1975, ACTA NEUROPATHOL, V33, P51, DOI [10.1007/BF00685964, DOI 10.1007/BF00685964]
   Faul EJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001016
   Fields B. N., 2007, FIELDS VIROLOGY
   Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921
   Fletcher NF, 2011, VET J, V188, P260, DOI 10.1016/j.tvjl.2010.03.022
   Fontana JM, 2008, IMMUNOL REV, V225, P46, DOI 10.1111/j.1600-065X.2008.00669.x
   Fredericksen BL, 2008, J VIROL, V82, P609, DOI 10.1128/JVI.01305-07
   FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777
   Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539
   Gartner S, 2000, SCIENCE, V287, P602, DOI 10.1126/science.287.5453.602
   GAUDIN Y, 1992, VIROLOGY, V187, P627, DOI 10.1016/0042-6822(92)90465-2
   German AC, 2006, T ROY SOC TROP MED H, V100, P1135, DOI 10.1016/j.trstmh.2006.02.008
   Ghoshal A, 2007, GLIA, V55, P483, DOI 10.1002/glia.20474
   Gonzalez-Scarano F, 2005, NAT REV IMMUNOL, V5, P69, DOI 10.1038/nri1527
   Goodbourn S, 2009, J INTERF CYTOK RES, V29, P539, DOI 10.1089/jir.2009.0071
   Gralinski LE, 2009, J VIROL, V83, P9398, DOI 10.1128/JVI.00954-09
   GUMBINER B, 1991, P NATL ACAD SCI USA, V88, P3460, DOI 10.1073/pnas.88.8.3460
   Gupta N, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-92
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hauwel M, 2005, BRAIN RES REV, V48, P220, DOI 10.1016/j.brainresrev.2004.12.012
   HEIDENREICH F, 1994, J NEUROIMMUNOL, V52, P117, DOI 10.1016/0165-5728(94)90105-8
   HUDSON SJ, 1991, J INFECT DIS, V163, P720, DOI 10.1093/infdis/163.4.720
   Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476
   Ivey NS, 2009, J NEUROVIROL, V15, P111, DOI 10.1080/13550280902769764
   Jackson AC, 2008, J NEUROVIROL, V14, P368, DOI 10.1080/13550280802216502
   JAMIESON GA, 1991, J MED VIROL, V33, P224, DOI 10.1002/jmv.1890330403
   JOHNSON RT, 1968, ARCH NEUROL-CHICAGO, V18, P260, DOI 10.1001/archneur.1968.00470330050004
   Kacem K, 1998, GLIA, V23, P1
   Kanmogne GD, 2005, J NEUROPATH EXP NEUR, V64, P498, DOI 10.1093/jnen/64.6.498
   Kim YC, 2000, J DERMATOL SCI, V24, P38, DOI 10.1016/S0923-1811(00)00080-3
   Kobayashi H, 2007, CURR MED CHEM, V14, P377, DOI 10.2174/092986707779941032
   Kolb SA, 1998, J NEUROIMMUNOL, V84, P143, DOI 10.1016/S0165-5728(97)00247-6
   Koyuncu OO, 2013, CELL HOST MICROBE, V13, P379, DOI 10.1016/j.chom.2013.03.010
   Kuang Y, 2009, VIRUS RES, V144, P18, DOI 10.1016/j.virusres.2009.03.014
   Kumar M, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-73
   Lai CY, 2012, J NEUROCHEM, V123, P250, DOI 10.1111/j.1471-4159.2012.07889.x
   Lander HM, 2014, AM J TROP MED HYG, V90, P993, DOI 10.4269/ajtmh.13-0382
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2011, J VIROL, V85, P7186, DOI 10.1128/JVI.00396-11
   Lee B, 2007, ANN NY ACAD SCI, V1102, P51, DOI 10.1196/annals.1408.004
   Lehner C, 2011, ANTIOXID REDOX SIGN, V15, P1305, DOI 10.1089/ars.2011.3923
   LENTZ TL, 1982, SCIENCE, V215, P182, DOI 10.1126/science.7053569
   Li F, 2015, J VIROL, V89, P5602, DOI 10.1128/JVI.00143-15
   Li XD, 2013, SCIENCE, V341, P1390, DOI 10.1126/science.1244040
   Lim PY, 2011, J VIROL, V85, P5197, DOI 10.1128/JVI.02692-10
   Liu YL, 2000, J NEUROVIROL, V6, pS70
   Lo EH, 2002, J NEUROSCI RES, V69, P1, DOI 10.1002/jnr.10270
   Lopez RMA, 2012, J IMMUNOL, V189, P3130, DOI [10.4049/jimmunol.1103460, DOI 10.4049/JIMMUNOL.1103460]
   Luby SP, 2012, EPIDEMIOLOGY HENIPAV, P25
   Luissint AC, 2012, FLUIDS BARRIERS CNS, V9, DOI 10.1186/2045-8118-9-23
   Maisner A, 2009, THROMB HAEMOSTASIS, V102, P1014, DOI 10.1160/TH09-05-0310
   MARCOVISTZ R, 1987, J INTERFERON RES, V7, P17, DOI 10.1089/jir.1987.7.17
   Mariano C, 2011, EUR J CELL BIOL, V90, P787, DOI 10.1016/j.ejcb.2011.06.005
   Martines RB, 2016, MORBIDITY MORTALITY, V65
   Martinez-Torres FJ, 2004, NEUROSCI LETT, V368, P274, DOI 10.1016/j.neulet.2004.06.064
   Mathieu C, 2011, J VIROL, V85, P7863, DOI 10.1128/JVI.00549-11
   McGavern DB, 2011, NAT REV IMMUNOL, V11, P318, DOI 10.1038/nri2971
   Meaney-Delman D, 2016, MORBIDITY MORTALITY, V65
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mishra MK, 2009, NEUROCHEM INT, V55, P717, DOI 10.1016/j.neuint.2009.07.006
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Morita K, 1999, J CELL BIOL, V147, P185, DOI 10.1083/jcb.147.1.185
   Munster VJ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00736
   Nair S, 2015, CURR OPIN IMMUNOL, V36, P47, DOI 10.1016/j.coi.2015.06.011
   Nakamuta S, 2008, J NEUROVIROL, V14, P186, DOI 10.1080/13550280801993630
   Nayak S, 2016, SEMIN REPROD MED, V34, P266, DOI 10.1055/s-0036-1592071
   Negrete OA, 2005, NATURE, V436, P401, DOI 10.1038/nature03838
   Negrete Oscar A, 2006, PLoS Pathog, V2, pe7
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Ohnishi H, 2004, J BIOL CHEM, V279, P46014, DOI 10.1074/jbc.M402616200
   Ohtsuki S, 2008, J NEUROCHEM, V104, P147, DOI 10.1111/j.1471-4159.2007.05008.x
   Pekny M, 1998, GLIA, V22, P390, DOI 10.1002/(SICI)1098-1136(199804)22:4<390::AID-GLIA8>3.3.CO;2-E
   Persidsky Y, 1997, J NEUROVIROL, V3, P401, DOI 10.3109/13550289709031186
   Phares TW, 2006, J IMMUNOL, V176, P7666, DOI 10.4049/jimmunol.176.12.7666
   POLI G, 1989, SCIENCE, V244, P575, DOI 10.1126/science.2470148
   Poliakov A, 2004, DEV CELL, V7, P465, DOI 10.1016/j.devcel.2004.09.006
   Raschilas F, 2002, CLIN INFECT DIS, V35, P254, DOI 10.1086/341405
   Retallack H, 2016, BIORXIV
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Savarin C, 2008, CURR OPIN PHARMACOL, V8, P472, DOI 10.1016/j.coph.2008.05.002
   SCHLITT M, 1986, J INFECT DIS, V153, P732, DOI 10.1093/infdis/153.4.732
   Schnell MJ, 2010, NAT REV MICROBIOL, V8, P51, DOI 10.1038/nrmicro2260
   Sejvar JJ, 2007, ANN NEUROL, V62, P235, DOI 10.1002/ana.21178
   Sellner J, 2005, NEUROSCI LETT, V374, P197, DOI 10.1016/j.neulet.2004.10.054
   Sellner J, 2006, BRAIN RES, V1125, P155, DOI 10.1016/j.brainres.2006.09.093
   SHIMA DT, 1995, MOL MED, V1, P182, DOI 10.1007/BF03401566
   Shirato K, 2004, J GEN VIROL, V85, P3637, DOI 10.1099/vir.0.80247-0
   Sorensen LN, 2008, J IMMUNOL, V181, P8604, DOI 10.4049/jimmunol.181.12.8604
   Sorgeloos F, 2013, VIRUSES-BASEL, V5, P834, DOI 10.3390/v5030834
   Stanimirovic D, 2000, BRAIN PATHOL, V10, P113
   STEVENSON BR, 1986, J CELL BIOL, V103, P755, DOI 10.1083/jcb.103.3.755
   Strazza M, 2011, BRAIN RES, V1399, P96, DOI 10.1016/j.brainres.2011.05.015
   Suthar MS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003168
   Szretter KJ, 2010, J VIROL, V84, P12125, DOI 10.1128/JVI.01026-10
   Thoulouze MI, 1998, J VIROL, V72, P7181, DOI 10.1128/JVI.72.9.7181-7190.1998
   Town T, 2009, IMMUNITY, V30, P242, DOI 10.1016/j.immuni.2008.11.012
   Tuffereau C, 1998, EMBO J, V17, P7250, DOI 10.1093/emboj/17.24.7250
   Tyler KL, 2009, ARCH NEUROL-CHICAGO, V66, P939, DOI 10.1001/archneurol.2009.153
   Ubogu EE, 2006, J NEUROIMMUNOL, V179, P132, DOI 10.1016/j.jneuroim.2006.06.004
   Verma S, 2009, VIROLOGY, V385, P425, DOI 10.1016/j.virol.2008.11.047
   Verma S, 2010, VIROLOGY, V397, P130, DOI 10.1016/j.virol.2009.10.036
   Wang LZ, 2011, BRAIN RES, V1381, P202, DOI 10.1016/j.brainres.2011.01.007
   Wang PH, 2008, J VIROL, V82, P8978, DOI 10.1128/JVI.00314-08
   Wang SH, 2008, J IMMUNOL, V181, P2084, DOI 10.4049/jimmunol.181.3.2084
   Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140
   Weingartl H, 2005, J VIROL, V79, P7528, DOI 10.1128/JVI.79.12.7528-7534.2005
   Welte T, 2009, J GEN VIROL, V90, P2660, DOI 10.1099/vir.0.011783-0
   WIKTOR TJ, 1973, J IMMUNOL, V110, P269
   Wilhelm I, 2011, ACTA NEUROBIOL EXP, V71, P113
   Wong KT, 2002, AM J PATHOL, V161, P2153, DOI 10.1016/S0002-9440(10)64493-8
   Wu DT, 2000, J NEUROVIROL, V6, pS82
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Xu ZK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037886
   Yang Y, 2011, VIROL J, V8, P1, DOI [10.1186/1743-422X-8-1, DOI 10.1186/1743-422X-8-1]
   ZHANG RL, 1995, BRAIN RES, V682, P182, DOI 10.1016/0006-8993(95)00346-R
   Zhao L, 2009, J VIROL, V83, P11808, DOI 10.1128/JVI.01346-09
NR 151
TC 9
Z9 11
U1 2
U2 12
PU AEPRESS SRO
PI BRATISLAVA
PA BAJZOVA 7, BRATISLAVA, 821 08, SLOVAKIA
SN 0001-723X
EI 1336-2305
J9 ACTA VIROL
JI Acta Virol.
PY 2018
VL 62
IS 1
BP 16
EP 27
DI 10.4149/av_2018_102
PG 12
WC Virology
SC Virology
GA GM2XV
UT WOS:000437959400002
PM 29521099
OA Bronze
DA 2020-07-08
ER

PT J
AU Cunningham, ET
   Khairallah, M
   Rathinam, SR
   Belfort, R
   Zierhut, M
AF Cunningham, Emmett T., Jr.
   Khairallah, Moncef
   Rathinam, Sivakumar R.
   Belfort, Rubens, Jr.
   Zierhut, Manfred
TI Mosquito-Borne Uveitis
SO OCULAR IMMUNOLOGY AND INFLAMMATION
LA English
DT Editorial Material
ID VIRUS-INFECTION; ZIKA VIRUS; MANIFESTATIONS
C1 [Cunningham, Emmett T., Jr.] Calif Pacific Med Ctr, Dept Ophthalmol, San Francisco, CA USA.
   [Cunningham, Emmett T., Jr.] Stanford Univ, Dept Ophthalmol, Sch Med, Stanford, CA 94305 USA.
   [Cunningham, Emmett T., Jr.] UCSF Sch Med, Francis I Proctor Fdn, San Francisco, CA USA.
   [Khairallah, Moncef] Univ Monastir, Fattouma Bourguiba Univ Hosp, Dept Ophthalmol, Fac Med, Monastir, Tunisia.
   [Rathinam, Sivakumar R.] Aravind Eye Hosp, Uvea Dept, Madurai, Tamil Nadu, India.
   [Belfort, Rubens, Jr.] Univ Fed Sao Paulo, Dept Ophthalmol, Sao Paulo, Brazil.
   [Zierhut, Manfred] Univ Tubingen, Ctr Ophthalmol, Tubingen, Germany.
RP Cunningham, ET (corresponding author), West Coast Retina Med Grp, 1445 Bush St, San Francisco, CA 94109 USA.
EM emmett_cunningham@yahoo.com
FU Pacific Vision Foundation; San Francisco Retina Foundation
FX Supported in part by The Pacific Vision Foundation (ETC) and The San
   Francisco Retina Foundation (ETC).
CR Agrawal R, 2018, OCUL IMMUNOL INFLAMM, V26, P654, DOI 10.1080/09273948.2017.1294184
   Akanda M, 2018, OCUL IMMUNOL INFLAMM, V26, P671, DOI 10.1080/09273948.2017.1351571
   Al-Hazmi A, 2005, OPHTHALMOLOGY, V112, P313, DOI 10.1016/j.ophtha.2004.09.018
   Bakri Sophie J, 2004, Curr Opin Ophthalmol, V15, P537, DOI 10.1097/01.icu.0000143687.45232.f1
   Cunningham ET, 2017, OCUL IMMUNOL INFLAMM, V25, P737, DOI 10.1080/09273948.2017.1415077
   de Andrade Gabriel Costa, 2017, Int J Retina Vitreous, V3, P4, DOI 10.1186/s40942-016-0057-4
   Rocha VFD, 2018, OCUL IMMUNOL INFLAMM, V26, P677, DOI 10.1080/09273948.2017.1358378
   Freitas BD, 2017, CURR OPIN OPHTHALMOL, V28, P595, DOI 10.1097/ICU.0000000000000420
   Garg S, 2005, SURV OPHTHALMOL, V50, P3, DOI 10.1016/j.survophthal.2004.10.001
   Guo CC, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00317
   Joob B, 2018, OCUL IMMUNOL INFLAMM, V26, P683, DOI 10.1080/09273948.2017.1311927
   Khairallah M, 2013, CURR OPIN OPHTHALMOL, V24, P574, DOI 10.1097/ICU.0b013e3283654e09
   Khairallah M, 2013, OPHTHALMIC RES, V49, P66, DOI 10.1159/000344009
   Khairallah Moncef, 2010, International Ophthalmology, V30, P465, DOI 10.1007/s10792-009-9319-6
   Lima LH, 2018, OCUL IMMUNOL INFLAMM, V26, P660, DOI 10.1080/09273948.2017.1285036
   Lin J, 2018, OCUL IMMUNOL INFLAMM, V26, P680, DOI 10.1080/09273948.2016.1263340
   Marquezan MC, 2018, SURV OPHTHALMOL, V63, P166, DOI 10.1016/j.survophthal.2017.06.001
   Martinez-Pulgarin DF, 2016, TRAVEL MED INFECT DI, V14, P451, DOI 10.1016/j.tmaid.2016.05.008
   Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030
   Ng AW, 2015, SURV OPHTHALMOL, V60, P106, DOI 10.1016/j.survophthal.2014.07.003
   Ng CWK, 2018, OCUL IMMUNOL INFLAMM, V26, P666, DOI 10.1080/09273948.2016.1254804
   Oo HH, 2018, OCUL IMMUNOL INFLAMM, V26, P684, DOI 10.1080/09273948.2017.1328246
   Padhi TR, 2017, SURV OPHTHALMOL, V62, P161, DOI 10.1016/j.survophthal.2016.09.005
   Singh Mandeep S, 2018, Am J Ophthalmol Case Rep, V10, P6, DOI 10.1016/j.ajoc.2018.01.023
   Ventura CV, 2018, PROG RETIN EYE RES
   White NJ, 2014, LANCET, V383, P723, DOI 10.1016/S0140-6736(13)60024-0
   Yip VCH, 2012, OPHTHALMOL THER, V1, DOI 10.1007/s40123-012-0002-z
NR 27
TC 0
Z9 0
U1 0
U2 0
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0927-3948
EI 1744-5078
J9 OCUL IMMUNOL INFLAMM
JI Ocul. Immunol. Inflamm.
PY 2018
VL 26
IS 5
BP 651
EP 653
DI 10.1080/09273948.2018.1485402
PG 3
WC Ophthalmology
SC Ophthalmology
GA GL7DG
UT WOS:000437355500001
PM 29969369
OA Bronze
DA 2020-07-08
ER

PT J
AU Agrawal, R
   Oo, HH
   Balne, PK
   Ng, L
   Tong, L
   Leo, YS
AF Agrawal, Rupesh
   Oo, Hnin Hnin
   Balne, Praveen Kumar
   Ng, Lisa
   Tong, Louis
   Leo, Yee Sin
TI Zika Virus and the Eye
SO OCULAR IMMUNOLOGY AND INFLAMMATION
LA English
DT Review
DE Ocular surface; tears; Zika virus
ID TRANSMISSION; DENGUE
AB Zika virus (ZIKV), a mosquito-borne flavivirus, is the latest global health concern. Transmission is mainly via Aedes mosquitoes and the infection can be diagnosed on molecular or serologic testings. It typically causes a mild self-remitting illness of low-grade fever, maculopapular rash, and myalgia, but when severe, it is associated with neurological deficits and congenital structural defects. Ocular manifestations are usually mild like nonpurulent conjunctivitis in adults, though it may be linked to uveitis, maculopathy, and hypertensive iridocyclitis. Ocular signs seem to be more significant in congenital ZIKVmacular pigment mottling, neuroretinal atrophy with macular involvement, iris coloboma, and changes in retinal vasculature are noted in infants with infected mothers. Risk factors include ZIKV infection in first trimester and smaller cephalic diameter at birth. Hence, ophthalmic examination in newborns is now recommended. Currently, prevention and active surveillance are integral as there is no known vaccine, and treatment is only symptomatic.
C1 [Agrawal, Rupesh] Tan Tock Seng Hosp, Natl Healthcare Grp, Inst Eye, Singapore 308433, Singapore.
   [Agrawal, Rupesh; Oo, Hnin Hnin; Tong, Louis] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore.
   [Agrawal, Rupesh; Balne, Praveen Kumar; Tong, Louis] Singapore Eye Res Inst, Dept Preclin Res, Singapore, Singapore.
   [Ng, Lisa] ASTAR, Singapore Immunol Network SigN, Singapore, Singapore.
   [Tong, Louis] Singapore Natl Eye Ctr, Dept Ocular Surface Inflammat, Singapore, Singapore.
   [Leo, Yee Sin] Tan Tock Seng Hosp, IIDE, Singapore, Singapore.
RP Agrawal, R (corresponding author), Tan Tock Seng Hosp, Natl Healthcare Grp, Inst Eye, Singapore 308433, Singapore.
EM rupesh_agrawal@ttsh.com.sg
RI Balne, Praveen Kumar/X-7075-2019
OI Balne, Praveen Kumar/0000-0001-8365-9991; Ng, Lisa/0000-0003-4071-5222
CR [Anonymous], 2016, LANCET, V387, P96, DOI 10.1016/S0140-6736(16)00014-3
   Beckham JD, 2016, JAMA NEUROL, V73, P875, DOI 10.1001/jamaneurol.2016.0800
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Contreras D, 2016, JOVE-J VIS EXP, DOI 10.3791/54767
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   Demir T, 2016, FOLIA MICROBIOL, V61, P523, DOI 10.1007/s12223-016-0467-6
   desPaula Freitas B, 2016, JAMA OPHTHALMOL
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Fontes BM, 2016, ARQ BRAS OFTALMOL, V79, P63, DOI 10.5935/0004-2749.20160020
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grossi-Soyster ELaBeaud A., 2016, CURR OPIN PEDIATR, V28, P1
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Jamil Z, 2016, ASIAN PAC J TROP MED, V9, P606, DOI 10.1016/j.apjtm.2016.05.020
   Jampol LM, 2016, JAMA OPHTHALMOL
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Mawson AR, 2016, BIORESEARCH OPEN ACC, V5, P171, DOI 10.1089/biores.2016.0004
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i855
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Miner JJ, 2016, CELL REP, V22111247, P31175
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Organization  P. A. H., 2015, PAN AM HLTH ORG EP A
   Parke DW, 2016, OPHTHALMOLOGY, V123, P2432, DOI 10.1016/j.ophtha.2016.06.039
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Russell K, 2016, MMWR-MORBID MORTAL W, V65
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Slenczka W, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.EI10-0019-2016
   Song JZ, 2016, ANAL CHEM, V88, P7289, DOI 10.1021/acs.analchem.6b01632
   Sun JF, 2016, JAMA OPHTHALMOL, V134, P1330, DOI 10.1001/jamaophthalmol.2016.3417
   Valentine G, 2016, J PEDIAT INF DIS SOC, V5, P323, DOI 10.1093/jpids/piw037
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
NR 41
TC 10
Z9 10
U1 1
U2 5
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0927-3948
EI 1744-5078
J9 OCUL IMMUNOL INFLAMM
JI Ocul. Immunol. Inflamm.
PY 2018
VL 26
IS 5
BP 654
EP 659
DI 10.1080/09273948.2017.1294184
PG 6
WC Ophthalmology
SC Ophthalmology
GA GL7DG
UT WOS:000437355500002
PM 28318359
DA 2020-07-08
ER

PT J
AU Joob, B
   Wiwanitkit, V
AF Joob, Beuy
   Wiwanitkit, Viroj
TI In Response to: "Agrawal R, Oo HH, Balne PK, et al. Zika Virus and the
   Eye"
SO OCULAR IMMUNOLOGY AND INFLAMMATION
LA English
DT Letter
C1 [Joob, Beuy] Sanitat 1 Med Acad Ctr, Bangkok 10330, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Dept Trop Med, Haikou, Hainan, Peoples R China.
RP Joob, B (corresponding author), Sanitat 1 Med Acad Ctr, Bangkok 10330, Thailand.
EM beuyjoob@hotmail.com
CR Agrawal R, 2018, OCUL IMMUNOL INFLAMM, V26, P654, DOI 10.1080/09273948.2017.1294184
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P499, DOI 10.1016/j.apjtm.2016.03.036
NR 2
TC 1
Z9 1
U1 0
U2 0
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0927-3948
EI 1744-5078
J9 OCUL IMMUNOL INFLAMM
JI Ocul. Immunol. Inflamm.
PY 2018
VL 26
IS 5
BP 683
EP 683
DI 10.1080/09273948.2017.1311927
PG 1
WC Ophthalmology
SC Ophthalmology
GA GL7DG
UT WOS:000437355500008
PM 28448734
DA 2020-07-08
ER

PT J
AU Oo, HH
   Balne, PK
   Agrawal, R
AF Oo, Hnin Hnin
   Balne, Praveen Kumar
   Agrawal, Rupesh
TI Author's Reply: Zika Virus Infection and Ophthalmic Examination in
   Newborn
SO OCULAR IMMUNOLOGY AND INFLAMMATION
LA English
DT Letter
ID INFANTS
C1 [Oo, Hnin Hnin; Agrawal, Rupesh] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore.
   [Balne, Praveen Kumar; Agrawal, Rupesh] Singapore Eye Res Inst, Translat Preclin Model Platform, Singapore, Singapore.
   [Agrawal, Rupesh] Tan Tock Seng Hosp, Natl Healthcare Grp, Inst Eye, Singapore 308433, Singapore.
RP Agrawal, R (corresponding author), Tan Tock Seng Hosp, Natl Healthcare Grp, Inst Eye, Singapore 308433, Singapore.
EM rupesh_agrawal@ttsh.com.sg
RI Balne, Praveen Kumar/X-7075-2019
OI Balne, Praveen Kumar/0000-0001-8365-9991
CR Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P1420, DOI 10.1001/jamaophthalmol.2016.4283
NR 4
TC 1
Z9 1
U1 0
U2 0
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0927-3948
EI 1744-5078
J9 OCUL IMMUNOL INFLAMM
JI Ocul. Immunol. Inflamm.
PY 2018
VL 26
IS 5
BP 684
EP 684
DI 10.1080/09273948.2017.1328246
PG 1
WC Ophthalmology
SC Ophthalmology
GA GL7DG
UT WOS:000437355500009
PM 28622059
DA 2020-07-08
ER

PT J
AU Zanluca, C
   de Noronha, L
   dos Santos, CND
AF Zanluca, Camila
   de Noronha, Lucia
   Duarte dos Santos, Claudia Nunes
TI Maternal-fetal transmission of the zika virus: An intriguing interplay
SO TISSUE BARRIERS
LA English
DT Review
DE ex vivo models; Hofbauer cells; maternal-fetal transmission; natural
   infections; placental barriers; Zika virus
ID HUMAN PLACENTAL TROPHOBLASTS; SEXUAL TRANSMISSION; VIRAL-INFECTION;
   MOUSE MODEL; PATHOLOGY; BRAZIL; STATES; BRAIN; PROLIFERATION;
   COMPLICATIONS
AB In this review, we give an overview of aspects related to the congenital transmission of the Zika virus (ZIKV). Although we acknowledge that important advances in research on ZIKV pathogenesis have come from studies using animal models, particularly non-human primates, this review emphasizes studies using ex-vivo human cells and tissues as well as natural infections in pregnant women. The possible routes used by ZIKV to cross or breach the placental barrier and infect the fetal central nervous system are presented. Understanding the viral infection biology and ZIKV pathogenesis during pregnancy may guide the design of affordable antiviral strategies to benefit pregnant women in areas at risk.
C1 [Zanluca, Camila; Duarte dos Santos, Claudia Nunes] Inst Carlos Chagas Fiocruz PR, Lab Virol Mol, Curitiba, Parana, Brazil.
   [de Noronha, Lucia] Pontificia Univ Catolica Parana, Lab Patol Expt, Curitiba, Parana, Brazil.
RP dos Santos, CND (corresponding author), ICC Fiocruz, Rua Prof Algacyr Munhoz Mader,3775 Cidade Ind Cur, BR-81350070 Curitiba, Parana, Brazil.
EM clsantos@fiocruz.br
RI Santos, Claudia Duarte dos/P-4868-2019; noronha, lucia/F-6339-2015
OI Santos, Claudia Duarte dos/0000-0001-8707-6638; noronha,
   lucia/0000-0003-0310-7164; Zanluca, Camila/0000-0001-7350-9105
FU CNDS; CNPqNational Council for Scientific and Technological Development
   (CNPq)
FX CNDS and LN have a CNPq fellowship.
CR Aagaard KM, 2017, SCI REP-UK, V7, DOI 10.1038/srep41389
   Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   [Anonymous], 2017, B EPIDEMIOLOGICO MON
   Arora N, 2017, CELL HOST MICROBE, V21, P561, DOI 10.1016/j.chom.2017.04.007
   Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6
   Baurakiades E, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-101
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Beckham JD, 2016, JAMA NEUROL, V73, P875, DOI 10.1001/jamaneurol.2016.0800
   Benirschke K., 2012, PATHOLOGY HUMAN PLAC, P41
   Bernischkee K, 2012, PATHOLOGY HUMAN PLAC, P55
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao B, 2017, J EXP MED, V214, P2303, DOI 10.1084/jem.20170957
   Cao B, 2017, J INTERF CYTOK RES, V37, P287, DOI 10.1089/jir.2017.0011
   Carroll T, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006537
   Corry J, 2017, P NATL ACAD SCI USA, V114, P9433, DOI 10.1073/pnas.1707513114
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   de Laval F, 2017, NEW ENGL J MED, V377, P697, DOI 10.1056/NEJMc1612600
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   de Souza AS, 2016, CLIN INFECT DIS, V63, P1622, DOI 10.1093/cid/ciw613
   Delorme-Axford E, 2013, P NATL ACAD SCI USA, V110, P12048, DOI 10.1073/pnas.1304718110
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   da Silva IRF, 2017, JAMA NEUROL, V74, P1190, DOI 10.1001/jamaneurol.2017.1703
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   HALSTEAD SB, 1977, J EXP MED, V146, P201, DOI 10.1084/jem.146.1.201
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Joguet G, 2017, LANCET INFECT DIS, V17, P1200, DOI 10.1016/S1473-3099(17)30444-9
   Jurado KA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88461
   Khan S, 2016, J EXP MED, V213, P2913, DOI 10.1084/jem.20161289
   Kim CJ, 2015, AM J OBSTET GYNECOL, V213, pS53, DOI 10.1016/j.ajog.2015.08.041
   Kim K, 2016, TRENDS MICROBIOL, V24, P622, DOI 10.1016/j.tim.2016.06.002
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P1, DOI [DOI 10.15585/MMWR.MM6506E1ER, 10.15585/mmwr.mm6506e1]
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mor G, 2016, AM J REPROD IMMUNOL, V75, P421, DOI 10.1111/aji.12505
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P7
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   PAHO, 2017, REG ZIK EP UPD AM
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Reagan-Steiner S, 2017, MMWR-MORBID MORTAL W, V66, P636, DOI 10.15585/mmwr.mm6624a3
   Ritter JM, 2017, ARCH PATHOL LAB MED, V141, P49, DOI 10.5858/arpa.2016-0397-SA
   Rodriguez-Martinez H, 2011, AM J REPROD IMMUNOL, V66, P11, DOI 10.1111/j.1600-0897.2011.01033.x
   Rosenberg AZ, 2017, ARCH PATHOL LAB MED, V141, P43, DOI 10.5858/arpa.2016-0401-OA
   Russell K, 2017, CLIN INFECT DIS, V64, P211, DOI 10.1093/cid/ciw692
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Satosar A, 2004, HUM PATHOL, V35, P536, DOI 10.1016/j.humpath.2004.01.015
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Schwartz DA, 2017, ARCH GYNECOL OBSTET, V295, P1361, DOI 10.1007/s00404-017-4361-5
   Sheridan MA, 2017, P NATL ACAD SCI USA, V114, pE1587, DOI 10.1073/pnas.1616097114
   Simoni MK, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12613
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tang WW, 2016, CELL REP, V17, P3091, DOI 10.1016/j.celrep.2016.11.070
   Sebastian UU, 2017, J CRIT CARE, V42, P275, DOI 10.1016/j.jcrc.2017.07.038
   Visseaux B, 2016, LANCET INFECT DIS, V16, P1220, DOI 10.1016/S1473-3099(16)30387-5
   Waldorf KMA, 2011, BJOG-INT J OBSTET GY, V118, P136, DOI 10.1111/j.1471-0528.2010.02728.x
   Weisblum Y, 2017, J VIROL, V91, DOI DOI 10.1128/JVI.01905-16
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zambrano H, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12630
   Zanluca C, 2016, MICROBES INFECT, V18, P295, DOI 10.1016/j.micinf.2016.03.003
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhang ZW, 2017, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00206
NR 76
TC 6
Z9 6
U1 0
U2 3
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 2168-8370
J9 TISSUE BARRIERS
JI Tissue Barriers
PY 2018
VL 6
IS 1
AR e1402143
DI 10.1080/21688370.2017.1402143
PG 11
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA GL6DL
UT WOS:000437269200005
PM 29370577
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Powell, JR
AF Powell, Jeffrey R.
TI Mosquito-Borne Human Viral Diseases: Why Aedes aegypti?
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID YELLOW-FEVER VIRUS; CHIKUNGUNYA VIRUS; ZIKA VIRUS; DENGUE VIRUS; AFRICA;
   EPIDEMIOLOGY; EMERGENCE; EVOLUTION; AMERICA; SPREAD
AB Although numerous viruses are transmitted by mosquitoes, four have caused the most human suffering over the centuries and continuing today. These are the viruses causing yellow fever, dengue, chikungunya, and Zika fevers. Africa is clearly the ancestral home of yellow fever, chikungunya, and Zika viruses and likely the dengue virus. Several species of mosquitoes, primarily in the genus Aedes, have been transmitting these viruses and their direct ancestors among African primates for millennia allowing for coadaptation among viruses, mosquitoes, and primates. One African primate (humans) and one African Aedes mosquito (Aedes aegypti) have escaped Africa and spread around the world. Thus it is not surprising that this native African mosquito is the most efficient vector of these native African viruses to this native African primate. This makes it likely that when the next disease-causing virus comes out of Africa, Ae. aegypti will be the major vector to humans.
C1 [Powell, Jeffrey R.] Yale Univ, 21 Sachem St, New Haven, CT 05620 USA.
RP Powell, JR (corresponding author), Yale Univ, 21 Sachem St, New Haven, CT 05620 USA.
EM jeffrey.powell@yale.edu
FU National Institute of Allergy and Infectious Diseases of the US National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID)
FX I receive financial support from the National Institute of Allergy and
   Infectious Diseases of the US National Institutes of Health.
CR Armitage SJ, 2011, SCIENCE, V331, P453, DOI 10.1126/science.1199113
   Barrett ADT, 2007, ANNU REV ENTOMOL, V52, P209, DOI 10.1146/annurev.ento.52.110405.091454
   Brown JE, 2014, EVOLUTION, V68, P514, DOI 10.1111/evo.12281
   Bryant JE, 2007, PLOS PATHOG, V3, P668, DOI 10.1371/journal.ppat.0030075
   CACCONE A, 1989, EVOLUTION, V43, P925, DOI 10.1111/j.1558-5646.1989.tb02540.x
   Crawford JE, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0351-0
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Eltis D, 2010, ATLAS TRANSATLATIC S
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Gaunt MW, 2001, J GEN VIROL, V82, P1867, DOI 10.1099/0022-1317-82-8-1867
   Gloria-Soria A, 2016, MOL ECOL, V25, P5377, DOI 10.1111/mec.13866
   Gubler DJ, 2004, COMP IMMUNOL MICROB, V27, P319, DOI 10.1016/j.cimid.2004.03.013
   Gubler DJ, 2014, DENGUE AND DENGUE HEMORRHAGIC FEVER, 2ND EDITION, P1, DOI 10.1079/9781845939649.0001
   Hanley KA, 2013, INFECT GENET EVOL, V19, P292, DOI 10.1016/j.meegid.2013.03.008
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hublin JJ, 2017, NATURE, V546, P289, DOI 10.1038/nature22336
   JUPP PG, 1990, J AM MOSQUITO CONTR, V6, P415
   JUPP PG, 1981, T ROY SOC TROP MED H, V75, P15, DOI 10.1016/0035-9203(81)90005-5
   Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646
   Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9
   LOUNIBOS LP, 1981, ECOL ENTOMOL, V6, P129, DOI 10.1111/j.1365-2311.1981.tb00601.x
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Mayer SV, 2017, ACTA TROP, V166, P155, DOI 10.1016/j.actatropica.2016.11.020
   McBride CS, 2014, NATURE, V515, P222, DOI 10.1038/nature13964
   McDougall I, 2005, NATURE, V433, P733, DOI 10.1038/nature03258
   McNeill William H., 1976, PLAGUES PEOPLES
   McSherry James, 1993, P660, DOI 10.1017/CHOL9780521332866.095
   Murphy FA, 2004, EMERG INFECT DIS, V10, P762
   Patch RW, 1996, HISTORIAN, V58, P731, DOI 10.1111/j.1540-6563.1996.tb00971.x
   Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X
   Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395
   Ritchie SA, 2014, DENGUE AND DENGUE HEMORRHAGIC FEVER, 2ND EDITION, P455, DOI 10.1079/9781845939649.0455
   ROSS R. W., 1956, JOUR HYG, V54, P177
   RUDNICK A, 1986, I MED RES MALAYS B, V23, P51
   RUDNICK ALBERT, 1965, J MED ENTOMOL, V2, P203, DOI 10.1093/jmedent/2.2.203
   SMITH C E G, 1956, J Trop Med Hyg, V59, P243
   Tattersall I, 2009, P NATL ACAD SCI USA, V106, P16018, DOI 10.1073/pnas.0903207106
   Vasilakis N, 2011, NAT REV MICROBIOL, V9, P532, DOI 10.1038/nrmicro2595
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   White TD, 2009, SCIENCE, V326, P75, DOI 10.1126/science.1175802
NR 40
TC 16
Z9 16
U1 0
U2 4
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 98
IS 6
BP 1563
EP 1565
DI 10.4269/ajtmh.17-0866
PG 3
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA GL4CN
UT WOS:000437095000005
PM 29557341
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Squiers, L
   Herrington, J
   Kelly, B
   Bann, C
   Becker-Dreps, S
   Stamm, L
   Johnson, M
   McCormack, L
AF Squiers, Linda
   Herrington, James
   Kelly, Bridget
   Bann, Carla
   Becker-Dreps, Sylvia
   Stamm, Lola
   Johnson, Mihaela
   McCormack, Lauren
TI Zika Virus Prevention: US Travelers' Knowledge, Risk Perceptions, and
   Behavioral Intentions-A National Survey
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID UNITED-STATES; BIRTH-DEFECTS; PUERTO-RICO; PREGNANCY; OUTBREAK;
   CONTRACEPTION; TRANSMISSION; ALBOPICTUS; INFECTION; INTERNET
AB Limited data exist about U.S. travelers' knowledge, risk perceptions, and behaviors related to the Zika virus (ZIKV). Using an internet research panel, in March 2017, we surveyed 1,202 Americans in the continental United States and PuertoRicowho planned to travel to a ZIKV-affected country, state, or U.S. territory in 2017. We compared levels of knowledge and perceived risk of ZIKV, and intentions to practice ZIKV prevention behaviors across respondents from three regions: Puerto Rico, at-risk states, and other states. More than 80% of respondents correctly understood that a person could acquire ZIKV through a bite from an infected mosquito, and over 64% of respondents knew that a pregnant woman could pass the virus to her fetus. Less than half of the respondents from at-risk states and other states knew that ZIKV could be transmitted sexually, as compared with three-quarters of respondents from Puerto Rico. Compared with respondents from at-risk and other states, respondents from Puerto Rico were the most knowledgeable for almost all types of knowledge assessed. Knowledge about post-travel precautions was low across all three regions. Differences in perceived risk and intentions to practice specific prevention behaviors also varied among regions. Significant gaps exist in U.S. travelers' knowledge about how to prevent ZIKV transmission both during and after travel. Input and collaboration from the travel industry, health care providers, and the media are needed to help educate travelers about how to prevent ZIKV infection and transmission.
C1 [Squiers, Linda; Kelly, Bridget; Bann, Carla; Johnson, Mihaela; McCormack, Lauren] RTI Int, 6110 Execut Blvd,Suite 902, Res Triangle Pk, NC 20852 USA.
   [Herrington, James; Becker-Dreps, Sylvia; Stamm, Lola] Univ N Carolina, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27515 USA.
   [Becker-Dreps, Sylvia] Univ N Carolina, Sch Med, Chapel Hill, NC 27515 USA.
   [Squiers, Linda; Kelly, Bridget; Johnson, Mihaela; McCormack, Lauren] RTI Int, Publ Hlth Res Div, Social Policy Hlth & Econ Res, Res Triangle Pk, NC USA.
   [Herrington, James] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Hlth Behav, Chapel Hill, NC 27515 USA.
   [Bann, Carla] RTI Int, Div Stat & Data Sci, Dept Survey Comp & Stat Sci, Res Triangle Pk, NC USA.
   [Becker-Dreps, Sylvia] Univ N Carolina, Sch Med, Chapel Hill, NC 27515 USA.
   [Stamm, Lola] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27515 USA.
RP Squiers, L (corresponding author), RTI Int, 6110 Execut Blvd,Suite 902, Res Triangle Pk, NC 20852 USA.
EM lsquiers@rti.org; jim.herrington@unc.edu; bkelly@rti.org; cmb@rti.org;
   sbd@email.unc.edu; lstamm@email.unc.edu; mjohnson@rti.org; lmac@rti.org
OI Bann, Carla/0000-0001-9305-8305
FU University of North Carolina Gillings School of Global Public Health;
   RTI International; Bill & Melinda Gates FoundationGates Foundation
FX This study was co-funded by the University of North Carolina Gillings
   School of Global Public Health and RTI International. Funding for this
   work was provided by the Bill & Melinda Gates Foundation to the CDC
   Foundation, which issued a grant to RTI International to develop and
   implement the campaign.
CR Callegaro M, 2008, PUBLIC OPIN QUART, V72, P1008, DOI 10.1093/poq/nfn065
   Center for Diseases Control and Prevention (CDC), 2018, ESTIMATED POT RANG A
   Centers for Disease Control and Prevention, 2017, TRANSMISSION
   Centers for Disease Control and Prevention, 2017, ZIK VIR SEX TRANSM P
   Centers for Disease Control and Prevention, 2017, 2016 CAS COUNTS US
   DILLMAN DA, 2001, DIMENSIONS INTERNET, P159
   Granato C, 2016, INT J GYNECOL OBSTET, V133, P137, DOI 10.1016/j.ijgo.2016.03.006
   Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8
   Hahn MB, 2016, J MED ENTOMOL, V53, P1169, DOI 10.1093/jme/tjw072
   Hayes EB, 2005, EMERG INFECT DIS, V11, P1167, DOI 10.3201/eid1108.050289a
   Hennessey M., 2015, CTR DIS CONTROL PREV, V65, P55, DOI DOI 10.15585/MMWR.MM6503E1
   Herrington JE, 2003, VECTOR-BORNE ZOONOT, V3, P157, DOI 10.1089/153036603322662156
   Hesse BW, 2005, ARCH INTERN MED, V165, P2618, DOI 10.1001/archinte.165.22.2618
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Lathrop E, 2018, LANCET PUBLIC HEALTH, V3, pE91, DOI 10.1016/S2468-2667(18)30001-X
   Liu ZZ, 2017, EMERG INFECT DIS, V23, P1085, DOI 10.3201/eid2307.161528
   Manfreda KL, 2008, INT J MARKET RES, V50, P79
   MarketWatch, 2016, COMPR ZIK PREV CAMP
   Monaghan Andrew J, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.50dfc7f46798675fc63e7d7da563da76
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   National Governor's Association, 2017, ZIK STAT WHAT YOU NE
   NORC at the University of Chicago, 2016, NEW SURV AM ATT ZIK
   Pan American Health Organization, 2017, REG ZIK EP UPD AM
   Petchenik J, 2011, HUM DIMENS WILDL, V16, P216, DOI DOI 10.1080/10871209.2011.563434
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   RTI International, 2017, PROC EV REP DET ZIK
   Salazar D, 2016, NACDS FDN LAUNCHES Z
   Samy AM, 2016, MEM I OSWALDO CRUZ, V111, P559, DOI 10.1590/0074-02760160149
   Semega JL, 2017, INCOME POVERTY US 20
   Shacham E, 2017, AM J PUBLIC HEALTH, V107, P724, DOI 10.2105/AJPH.2017.303670
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   Smith D, 2011, J COMMUN HEALTHC, V4, P200, DOI DOI 10.1179/1753807611Y.0000000010
   Southwell BG, 2016, EMERG INFECT DIS, V22, P1320, DOI 10.3201/eid2207.160415
   Splitlog L, 2016, CAMPAIGN EMPOWERS PU
   Tepper NK, 2016, MMWR-MORBID MORTAL W, V65, P311, DOI 10.15585/mmwr.mm6512e1
   TexaxZika. org, MATERIALS
   The Associated Press- NORC Center for Public Affairs Research, 2016, ZIK VIR AM AW OP US
   Transportation. gov, 2013, NEW FHWA REP REV STA
   U. S. Census Bureau, 2016, EMPL STAT
   U. S. Department of Commerce International Trade Administra- tion National Travel and Tourism Office, 2017, US CIT TRAFF OV REG
   United States Census Bureau, 2016, QUICKFACTS
   Widmar Nicole J Olynk, 2017, Prev Med Rep, V6, P162, DOI 10.1016/j.pmedr.2017.02.023
NR 42
TC 9
Z9 9
U1 0
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 98
IS 6
BP 1837
EP 1847
DI 10.4269/ajtmh.17-0898
PG 11
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA GL4CN
UT WOS:000437095000047
PM 29737272
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Vielot, NA
   Stamm, L
   Herrington, J
   Squiers, L
   Kelly, B
   McCormack, L
   Becker-Dreps, S
AF Vielot, Nadja A.
   Stamm, Lola
   Herrington, James
   Squiers, Linda
   Kelly, Bridget
   McCormack, Lauren
   Becker-Dreps, Sylvia
TI United States Travelers' Concern about Zika Infection and Willingness to
   Receive a Hypothetical Zika Vaccine
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID VIRUS OUTBREAK; CASE SERIES; PROTECTION; REGRET; HEALTH; BRAZIL; WORRY
AB The ongoing Zika pandemic has affected many countries that are common travel destinations. We assessed the willingness to receive a prophylactic Zika virus (ZIKV) vaccine, currently under development, among travelers to areas with reported autochthonous ZIKV transmission. We surveyed United States (U.S.) residents aged 18-44 years who had ever heard of ZIKV and planned to travel to Florida and/or Texas (N=420) or a U.S. territory or foreign country (N = 415) in 2017, using a nationally representative internet panel. Travelers to Florida and/or Texas reported less concern about ZIKV infection than travelers to other destinations (27% versus 36%, P = 0.01). Female sex, Hispanic ethnicity, discussing ZIKV with medical professionals, ZIKV risk perception, and self-efficacy for ZIKV prevention predicted concern about ZIKV infection in both groups. Travelers to Florida and/or Texas (43%) and other destinations (44%) were equally willing to receive a ZIKV vaccine. Hispanic ethnicity, discussing ZIKV with medical professionals, and concern about ZIKV infection predicted vaccine willingness in both groups. Likelihood of using existing ZIKV prevention methods, confidence in the U.S. government to prevent ZIKV spread, self-efficacy for ZIKV prevention, and knowledge about ZIKV symptoms further predicted vaccine willingness in travelers to other destinations. In multivariable analyses, only concern about ZIKV infection was associated with vaccine willingness in both groups (prevalence ratio [95% confidence interval]: Florida and/or Texas: 1.34 [1.06, 1.69]; other: 1.82 [1.44, 2.29]). Targeted communications can educate travelers, particularly travelers who are pregnant or may become pregnant, about ZIKV risk to generate ZIKV vaccine demand.
C1 [Vielot, Nadja A.; Becker-Dreps, Sylvia] Univ N Carolina, Sch Med, Dept Family Med, 590 Manning Dr, Chapel Hill, NC 27599 USA.
   [Stamm, Lola; Becker-Dreps, Sylvia] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27515 USA.
   [Herrington, James] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Hlth Behav, Chapel Hill, NC 27515 USA.
   [Squiers, Linda; Kelly, Bridget; McCormack, Lauren] RTI Int, Res Triangle Pk, NC USA.
   [Squiers, Linda; Kelly, Bridget; McCormack, Lauren] RTI Int, Publ Hlth Res Div, Res Triangle Pk, NC USA.
RP Vielot, NA (corresponding author), Univ N Carolina, Sch Med, Dept Family Med, 590 Manning Dr, Chapel Hill, NC 27599 USA.
EM nadjavielot@unc.edu; lstamm@email.unc.edu; jimhsph@email.unc.edu;
   lsquiers@rti.org; bkelly@rti.org; lmac@rti.org; sbd@email.unc.edu
RI Vielot, Nadja/AAI-3632-2020; Vielot, Nadja/AAK-7532-2020
OI Vielot, Nadja/0000-0002-9004-0609
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Angelidou A, 2018, NEONATOLOGY, V113, P177, DOI 10.1159/000484656
   Bacaner N, 2004, JAMA-J AM MED ASSOC, V291, P2856, DOI 10.1001/jama.291.23.2856
   Barouch DH, 2017, IMMUNITY, V46, P176, DOI 10.1016/j.immuni.2017.02.005
   Blakey SM, 2017, J CLIN PSYCHOL MED S, V24, P270, DOI 10.1007/s10880-017-9514-y
   Boer H, 1996, PREDICTING HLTH BEHA, P95
   Centers for Disease Control and Prevention, 2017, ZIK TRAV INF
   Centers for Disease Control and Prevention, 2016, CAS COUNTS US
   Centres for Disease Control and Prevention, 2017, WORLD MAP AR RISK ZI
   Chapman GB, 2006, HEALTH PSYCHOL, V25, P82, DOI 10.1037/0278-6133.25.1.82
   Collins MH, 2017, CLIN THER, V39, P1519, DOI 10.1016/j.clinthera.2017.07.001
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Ellingson MK, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1516-0
   Finer LB, 2016, NEW ENGL J MED, V374, P843, DOI 10.1056/NEJMsa1506575
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   GfK, 2017, GFK KNOWL PAN
   International Trade Administration, 2015, US CIT TRAFF OV REG
   Kapogiannis BG, 2017, JAMA PEDIATR, V171, P478, DOI 10.1001/jamapediatrics.2017.0002
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Liao Q, 2013, VACCINE, V31, P4084, DOI 10.1016/j.vaccine.2013.07.009
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Neave PE, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-287
   Paules CI, 2017, JAMA-J AM MED ASSOC, V317, P691, DOI 10.1001/jama.2016.21079
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   Satterfield-Nash A, 2017, MMWR-MORBID MORTAL W, V66, P1347, DOI 10.15585/mmwr.mm6649a2
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Squiers L, 2018, AM J TROP MED HYG, V98, P1837, DOI 10.4269/ajtmh.17-0898
   Taha SA, 2013, J HEALTH COMMUN, V18, P278, DOI 10.1080/10810730.2012.727960
   Wong LP, 2017, VACCINE, V35, P5912, DOI 10.1016/j.vaccine.2017.08.074
   Wong LP, 2017, J COMMUN HEALTH, V42, P854, DOI 10.1007/s10900-017-0326-7
NR 32
TC 2
Z9 2
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 98
IS 6
BP 1848
EP 1856
DI 10.4269/ajtmh.17-0907
PG 9
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA GL4CN
UT WOS:000437095000048
PM 29692314
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Ryan, SJ
   Lippi, CA
   Carlson, CJ
   Stewart-Ibarra, AM
   Borbor-Cordova, MJ
   Romero, M
   Cox, SA
   Mahon, R
   Trotman, A
   Rollock, L
   Gittens-St Hilaire, M
   King, D
   Daniel, S
AF Ryan, Sadie J.
   Lippi, Catherine A.
   Carlson, Colin J.
   Stewart-Ibarra, Anna M.
   Borbor-Cordova, Mercy J.
   Romero, Moory
   Cox, Shelly-Ann
   Mahon, Roche
   Trotman, Adrian
   Rollock, Leslie
   Gittens-St Hilaire, Marquita
   King, Desmond
   Daniel, Steven
TI Zika Virus Outbreak, Barbados, 2015-2016
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
AB Barbados is a Caribbean island country of approximately 285,000 people, with a thriving tourism industry. In 2015, Zika spread rapidly throughout the Americas, and its proliferation through the Caribbean islands followed suit. Barbados reported its first confirmed autochthonous Zika transmission to the Pan American Health Organization in January 2016, a month before the global public health emergency was declared. After detection of suspected Zika cases on Barbados in 2015, 926 individuals were described as suspected cases, and 147 laboratory-confirmed cases were reported through December 2016, the end of the most recent epidemiological year. In this short report, we describe the epidemiological characteristics of 926 clinical case records that were originally suspected as cases of Zika, and which were subsequently sent for testing and confirmation; 147 were found positive for Zika, using reverse transcription-polymerase chain reaction methods, another 276 tested negative, and the remaining 503 were either pending results or still in the suspected category. Women were represented at about twice the rate of men in case records where gender was reported (71.9%), and confirmed cases (78.2%), and 19 of the confirmed positive cases were children under the age of 10.
C1 [Ryan, Sadie J.; Lippi, Catherine A.] Univ Florida, Dept Geog, Quantitat Dis Ecol & Conservat Lab, Gainesville, FL 32611 USA.
   [Ryan, Sadie J.; Lippi, Catherine A.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA.
   [Ryan, Sadie J.] Univ KwaZulu Natal, Sch Life Sci, Durban, South Africa.
   [Carlson, Colin J.] Univ Maryland, Natl Socioenvironm Synth Ctr, Annapolis, MD USA.
   [Carlson, Colin J.] Georgetown Univ, Dept Biol, Washington, DC 20057 USA.
   [Stewart-Ibarra, Anna M.; Romero, Moory] SUNY Upstate Med Univ, Ctr Global Hlth & Translat Sci, Syracuse, NY 13210 USA.
   [Borbor-Cordova, Mercy J.] Escuela Super Politecn Litoral ESPOL, Fac Ingn Maritima Ciencias Ocean & Recursos Nat F, Guayaquil, Ecuador.
   [Cox, Shelly-Ann; Mahon, Roche; Trotman, Adrian; King, Desmond] Caribbean Inst Meteorol & Hydrol, Bridgetown, Barbados.
   [Rollock, Leslie; Daniel, Steven] Minist Hlth, St Michael, Barbados.
   [Gittens-St Hilaire, Marquita] Univ West Indies Cave Hill, Fac Med Sci, Bridgetown, St Michael, Barbados.
   [Gittens-St Hilaire, Marquita] Minist Hlth, Barbados Leptospira Lab, St Michael, Barbados.
   [Ryan, Sadie J.; Lippi, Catherine A.] Univ Florida, Dept Geog, 3128 Turlington Hall, Gainesville, FL 32611 USA.
RP Ryan, SJ (corresponding author), Univ Florida, Dept Geog, 3128 Turlington Hall, Gainesville, FL 32611 USA.
EM sjryan@ufl.edu; clippi@ufl.edu; ccarlson@sesync.org;
   stewarta@upstate.edu; meborbor@espol.edu.ec; romero.moory@gmail.com;
   scox@cimh.edu.bb; rmahon@cimh.edu.bb; atrotman@cimh.edu.bb;
   leslie.rollock@health.gov.bb; marquita.gittens@cavehill.uwi.edu;
   desmond.king@health.gov; steve.daniel@health.gov.bb
RI Ryan, Sadie Jane/H-7488-2019
OI Ryan, Sadie Jane/0000-0002-4308-6321; Borbor, Mercy/0000-0002-7418-141X;
   Stewart-Ibarra, Anna/0000-0002-3383-4672; Lippi,
   Catherine/0000-0002-7988-0324; Mahon, Roche/0000-0001-9621-7033
FU Caribbean Institute for Meteorology and Hydrology (CIMH) through the
   United States Agency for International Development's (USAID) Programme
   for Building Regional Climate Capacity in the Caribbean (BRCCC
   Programme)United States Agency for International Development (USAID)
FX This study was solicited by the Caribbean Institute for Meteorology and
   Hydrology (CIMH) through the United States Agency for International
   Development's (USAID) Programme for Building Regional Climate Capacity
   in the Caribbean (BRCCC Programme) with funding made possible by the
   generous support of the American people.
CR Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Kumar A, 2015, W INDIAN MED J, V64, P37, DOI 10.7727/wimj.2015.110
   Pacheco Oscar, 2016, N Engl J Med, DOI 10.1056/NEJMoa1604037
   PAHO [Pan American Health Organization], 2017, ZIK EP REP PUERT RIC
   Pan American Health Organization, 2016, ZIK RES CAS DEF
   Rodrigues LC, 2016, LANCET, V387, P2070, DOI 10.1016/S0140-6736(16)00742-X
   Ryan SJ, 2017, EMERG INFECT DIS, V23, P1926, DOI 10.3201/eid2311.171140
NR 7
TC 1
Z9 1
U1 1
U2 4
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 98
IS 6
BP 1857
EP 1859
DI 10.4269/ajtmh.17-0978
PG 3
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA GL4CN
UT WOS:000437095000049
PM 29637883
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Lorono-Pino, MA
   Uitz-Mena, A
   Carrillo-Solis, C
   Zapata-Gil, RJ
   Camas-Tec, DM
   Talavera-Aguilar, LG
   Cetina-Trejo, RC
   Flores-Flores, LF
   Puc-Tinal, MC
   Caamal-Jimenez, C
   Reyes-Solis, G
   Garcia-Rejon, JE
   Saavedra-Rodriguez, K
   Eisen, L
   Keefe, TJ
   Black, WC
   Beaty, BJ
AF Lorono-Pino, Maria A.
   Uitz-Mena, Ana
   Carrillo-Solis, ClaudiaM.
   Zapata-Gil, Rocio J.
   Camas-Tec, Dora M.
   Talavera-Aguilar, Lourdes G.
   Cetina-Trejo, Rosa C.
   Flores-Flores, Luis F.
   Puc-Tinal, Maria C.
   Caamal-Jimenez, Clara
   Reyes-Solis, Guadalupe
   Garcia-Rejon, Julian E.
   Saavedra-Rodriguez, Karla
   Eisen, Lars
   Keefe, Thomas J.
   Black, William C.
   Beaty, Barry J.
TI The Use of Insecticide-Treated Curtains for Control of Aedes aegypti and
   Dengue Virus Transmission in "Fraccionamiento" Style Houses in Mexico
SO JOURNAL OF TROPICAL MEDICINE
LA English
DT Article
ID WATER CONTAINER COVERS; BG-SENTINEL TRAPS; VECTOR CONTROL; RESISTANCE;
   STRATEGIES; ABUNDANCE; SCREENS; MERIDA
AB Dengue, chikungunya, yellow fever, and Zika viruses transmitted by Aedes aegypti mosquitoes are major public health threats in the tropical and subtropical world. In Mexico, construction of large tracts of "fraccionamientos" high density housing to accommodate population growth and urbanization has provided fertile ground for Ae. aegypti-transmitted viruses. We investigated the utility of pyrethroid-treated window curtains to reduce both the abundance of Ae. aegypti and to prevent dengue virus (DENV) transmission in fraccionamiento housing. Windows and doors of fraccionamiento homes in urban/suburban areas, where Ae. aegypti pyrethroid resistance associated with the Ile1016 knock down resistance (kdr) mutation in the voltage gated sodium channel gene was high, and in rural areas, where kdr resistance was low, were fitted with either insecticide-treated curtains (ITCs) or non-treated curtains (NTCs). The homes were monitored for mosquito abundance and DENV infection. ITCs reduced the indoor abundance of Ae. aegypti and the number of DENV-infected mosquitoes in homes in rural but not in urban/suburban study sites. The presence of non-treated screens also was associated with reduced numbers of mosquitoes in homes. "Super-infested" homes, yielding more than 50 mosquitoes, including DENV-infected mosquitoes, provide a significant public health risk to occupants, visitors, and people in neighboring homes.
C1 [Lorono-Pino, Maria A.; Uitz-Mena, Ana; Carrillo-Solis, ClaudiaM.; Zapata-Gil, Rocio J.; Camas-Tec, Dora M.; Talavera-Aguilar, Lourdes G.; Cetina-Trejo, Rosa C.; Flores-Flores, Luis F.; Puc-Tinal, Maria C.; Caamal-Jimenez, Clara; Reyes-Solis, Guadalupe; Garcia-Rejon, Julian E.] Univ Autonoma Yucatan, Ctr Invest Reg Dr Hideyo Noguchi, Merida 97000, Yuc, Mexico.
   [Saavedra-Rodriguez, Karla; Eisen, Lars; Black, William C.; Beaty, Barry J.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Arthropod Borne & Infect Dis Lab, Ft Collins, CO 80521 USA.
   [Keefe, Thomas J.] Colorado State Univ, Dept Environm Hlth & Radiol Hlth Sci, Ft Collins, CO 80523 USA.
RP Lorono-Pino, MA (corresponding author), Univ Autonoma Yucatan, Ctr Invest Reg Dr Hideyo Noguchi, Merida 97000, Yuc, Mexico.
EM maria.lorono@gmail.com
RI ; Garcia-Rejon, Julian Everardo/E-4285-2017
OI Cetina Trejo, Rosa/0000-0003-3489-9520; Camas Tec,
   Dora/0000-0003-3254-2712; Garcia-Rejon, Julian
   Everardo/0000-0002-6681-1581; Talavera Aguilar,
   Lourdes/0000-0002-8673-3808
FU United States National Institutes of HealthUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA [AI
   088647, AI121211]; Sumitomo Chemical Corporation
FX The authors thank the study participants in Merida, Maxcanu, Motul, and
   Uman for their participation and assistance in these studies. The
   authors also acknowledge the substantial contributions of members of the
   Laboratorio de Arbovirologia, Universidad Autonoma de Yucatan, for their
   contributions to the study, including Moises Novelo-Canto, Victor
   Rivero-Osorno, Damian Lavalle-Kantun, Carlos Coba-Tun, Carlos Baak-Baak,
   Roger Arana-Guardia, Yamili Chan-Dzul, Miguel Castro-Gutierrez, Vanessa
   Castro-Gutierrez, Jacobo Canul, Mildred P. Lopez-Uribe, and Genny
   Lopez-Uribe. The authors also thank Dr. Steven M. Fry for supporting the
   project with planning, data analysis, editing, and laboratory equipment
   maintenance. Finally, they thank Dr. John Lucas of Sumitomo Chemical
   Corporation for helpful discussions and suggestions during the studies,
   and Noriko Yamada and Sarah Goretta of Sumitomo Chemical Corporation for
   the analyses of permethrin and PBO concentrations in the curtains. This
   research was supported by the United States National Institutes of
   Health [Grant AI 088647 and in part by Grant AI121211] and by the
   Sumitomo Chemical Corporation, which graciously provided the Olyset Plus
   bednets that were repurposed as window curtains for the homes.
CR Lorono-Pino MA, 2013, AM J TROP MED HYG, V89, P385, DOI 10.4269/ajtmh.12-0772
   Andriessen R, 2015, P NATL ACAD SCI USA, V112, P12081, DOI 10.1073/pnas.1510801112
   [Anonymous], 2014, LIST MAT INS APR 201
   [Anonymous], 2008, LIST MAT INS APR 200
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Beaty B. J., 2016, GLOBAL HLTH IMPACTS
   Buhagiar TS, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2219-0
   Che-Mendoza A, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006283
   Che-Mendoza A, 2015, T ROY SOC TROP MED H, V109, P106, DOI 10.1093/trstmh/tru189
   Darsie Jr R. F., 2005, IDENTIFICATION GEOGR
   Denham S, 2015, J AM MOSQUITO CONTR, V31, P52, DOI 10.2987/14-6445R.1
   Diaz FJ, 2006, ARCH MED RES, V37, P760, DOI 10.1016/j.arcmed.2006.02.004
   Dick OB, 2012, AM J TROP MED HYG, V87, P584, DOI 10.4269/ajtmh.2012.11-0770
   Dzul-Manzanilla F, 2017, J MED ENTOMOL, V54, P501, DOI 10.1093/jme/tjw203
   Eisen L., 2008, VECTOR BORNE DIS UND, P150
   Eisen L, 2014, J MED ENTOMOL, V51, P885, DOI 10.1603/ME14008
   Eisen L, 2009, J MED ENTOMOL, V46, P1245, DOI 10.1603/033.046.0601
   Toledo ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119373
   Flores AE, 2006, J AM MOSQUITO CONTR, V22, P672, DOI 10.2987/8756-971X(2006)22[672:MOIRIF]2.0.CO;2
   Garcia-Rejon J, 2008, AM J TROP MED HYG, V79, P940, DOI 10.4269/ajtmh.2008.79.940
   Garcia-Rejon JE, 2011, AM J TROP MED HYG, V84, P489, DOI 10.4269/ajtmh.2011.10-0654
   Dantes HG, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003158
   Gratz NG, 1999, ANNU REV ENTOMOL, V44, P51, DOI 10.1146/annurev.ento.44.1.51
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209
   Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010
   Hemingway J, 2006, TRENDS PARASITOL, V22, P308, DOI 10.1016/j.pt.2006.05.003
   Johnson PH, 2012, J MED ENTOMOL, V49, P29, DOI 10.1603/ME11116
   Jones CH, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-846
   Kroeger A, 2006, BMJ-BRIT MED J, V332, P1247, DOI 10.1136/bmj.332.7552.1247
   KUNO G, 1991, J VIROL METHODS, V33, P101, DOI 10.1016/0166-0934(91)90011-N
   Lunn D, 2009, STAT MED, V28, P3049, DOI 10.1002/sim.3680
   Manrique-Saide P, 2015, EMERG INFECT DIS, V21, P308, DOI 10.3201/eid2102.140533
   McCarthy MA, 2007, BAYESIAN METHODS FOR ECOLOGY, P1, DOI 10.1017/CBO9780511802454
   Mercer DR, 2012, J MED ENTOMOL, V49, P51, DOI 10.1603/ME11087
   Moyes CL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005625
   Paz-Soldan VA, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3191-x
   Garcia GP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000531
   Quintero J, 2015, T ROY SOC TROP MED H, V109, P116, DOI 10.1093/trstmh/tru208
   Saavedra-Rodriguez K, 2007, INSECT MOL BIOL, V16, P785, DOI 10.1111/j.1365-2583.2007.00774.x
   Saavedra-Rodriguez K, 2015, AM J TROP MED HYG, V92, P201, DOI 10.4269/ajtmh.14-0277
   Scott TW, 2012, TRENDS PARASITOL, V28, P114, DOI 10.1016/j.pt.2012.01.001
   Sokal R. R., 1969, BIOMETRY PRINCIPLES
   Vanlerberghe V, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000994
   Vazquez-Prokopec GM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005656
   Vazquez-Prokopec GM, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602024
   Vera-Maloof FZ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004263
   White MR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101364
   Wilson AL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003228
NR 49
TC 0
Z9 1
U1 1
U2 5
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1687-9686
EI 1687-9694
J9 J TROP MED-US
JI J. Trop. Med.
PY 2018
VL 2018
AR 4054501
DI 10.1155/2018/4054501
PG 22
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA GL5CN
UT WOS:000437180600001
PM 30018645
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Kim, DTH
   Bao, DT
   Park, H
   Ngoc, NM
   Yeo, SJ
AF Do Thi Hoang Kim
   Duong Tuan Bao
   Park, Hyun
   Nguyen Minh Ngoc
   Yeo, Seon-Ju
TI Development of a novel peptide aptamer-based immunoassay to detect Zika
   virus in serum and urine
SO THERANOSTICS
LA English
DT Article
DE Zika virus; peptide aptamer; immunoassay; serum; urine
ID HUMAN-ANTIBODY RESPONSES; B-CELL EPITOPES; HORSERADISH-PEROXIDASE;
   DENGUE; INFECTION; STABILIZATION; PREDICTION; DIAGNOSIS; SELECTION;
   LIGAND
AB Zika virus (ZIKV) has been identified as a cause of adverse outcomes of pregnancy, including microcephaly and other congenital diseases. Most people infected with ZIKV do not show any symptoms. Development of a method to discriminate dengue virus (DENY) and ZIKV infections has been challenging, and efficient assays for patient management are limited, attributable to high levels of cross-reactivity among co-circulating Flaviviruses. Thus, there is an urgent need for a specific high-throughput diagnostic assay to discriminate ZIKV infections from other Flavivirus infections.
   Methods: A novel epitope peptide of the ZIKV envelope protein was predicted using three immune epitope database analysis tools and then further modified. A molecular docking study was conducted using three-dimensional structures of the ZIKV envelope and peptide. Experimentally, interactions between the selected peptides and virus were assessed via a fluorescence-linked sandwich immunosorbent assay (FLISA), and performance of peptide-linked sandwich FLISA was evaluated in virus-spiked human serum and urine.
   Results: The Z _10.8 peptide (KRAVVSCAEA) was predicted to be a suitable detector, with a higher binding affinity than other candidates based on four criteria (binding affinity, root mean square deviation, position of amine residue of lysine at the N-terminus, and interactive site) in a docking study. Z _10.8 was significantly more efficient at detecting ZIKV than the other two peptides, as shown in the direct FLISA (P < 0.001). Further, the equilibrium dissociation constant (K-d) for the Z_10.8 peptide was 706.0 +/- 177.9 (mean +/- SD, nM), with specificity to discriminate ZIKV from DENY. The limit of detection for the sandwich FLISA was calculated as 1x10(4) tissue culture infective dose (TCID)(50)/mL. The presence of serum or urine did not interfere with the performance of the Z_10.8-linked sandwich FLISA.
   Conclusion: Four criteria are suggested for the development of an in silico modeled peptide aptamer; this computerized peptide aptamer discriminated ZIKV from DENY via immunoassay.
C1 [Do Thi Hoang Kim; Duong Tuan Bao; Park, Hyun; Nguyen Minh Ngoc; Yeo, Seon-Ju] Wonkwang Univ, Sch Med, Dept Infect Biol, Zoonosis Res Ctr, 460 Iksan Daero, Iksan 54538, South Korea.
RP Yeo, SJ (corresponding author), Wonkwang Univ, Sch Med, Dept Infect Biol, Zoonosis Res Ctr, 460 Iksan Daero, Iksan 54538, South Korea.
EM yeosj@wku.ac.kr
FU Priority Research Centers Program through National Research Foundation
   of Korea (NRF); Ministry of Education [NRF-2015R1A6A1A03032236]
FX This research was supported by the Priority Research Centers Program
   through the National Research Foundation of Korea (NRF), funded by the
   Ministry of Education (NRF-2015R1A6A1A03032236).
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Alcendor DJ, 2017, J INFECT DIS, V216, P162, DOI 10.1093/infdis/jix171
   [Anonymous], 2018, AM RED CROSS INFECT
   Armbruster David A, 2008, Clin Biochem Rev, V29 Suppl 1, pS49
   ARTIGAS JMG, 1981, POSTGRAD MED J, V57, P219, DOI 10.1136/pgmj.57.666.219
   Bottger R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178943
   CDC, UPD GUID US LAB TEST
   Chames P, 2009, BRIT J PHARMACOL, V157, P220, DOI 10.1111/j.1476-5381.2009.00190.x
   Chen J, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.67
   Chigurupati Pragati, 2015, Asian J Transfus Sci, V9, P9, DOI 10.4103/0973-6247.150938
   Dallakyan S, 2010, COMP VIRTUAL SCREENI
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Bao DT, 2017, THERANOSTICS, V7, P1835, DOI 10.7150/thno.18857
   El-Manzalawy Y, 2008, J MOL RECOGNIT, V21, P243, DOI 10.1002/jmr.893
   Avila-Bonilla RG, 2017, VIRUS RES, V232, P139, DOI 10.1016/j.virusres.2017.03.005
   Goncalves A, 2018, J INFECT DIS, V217, P1060, DOI 10.1093/infdis/jix678
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hnasko RM, 2015, METHODS MOL BIOL, V1318, P43, DOI 10.1007/978-1-4939-2742-5_4
   Hulme EC, 2010, BRIT J PHARMACOL, V161, P1219, DOI 10.1111/j.1476-5381.2009.00604.x
   Jenssen Havard, 2008, V494, P177, DOI 10.1007/978-1-59745-419-3_10
   Jespersen MC, 2017, NUCLEIC ACIDS RES, V45, pW24, DOI 10.1093/nar/gkx346
   Karen L, 2004, IMMUNOASSAY METHODS
   Kaur P, 2016, METHODS MOL BIOL, V1426, P93, DOI 10.1007/978-1-4939-3618-2_9
   Kong HY, 2013, BIOMOL THER, V21, P423, DOI 10.4062/biomolther.2013.085
   LAMAN JD, 1991, J IMMUNOL METHODS, V145, P1, DOI 10.1016/0022-1759(91)90304-X
   Latha MS, 2017, BIOINFORMATION, V13, P388, DOI 10.6026/97320630013388
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lee KH, 2017, ANAL CHEM, V89, P12743, DOI 10.1021/acs.analchem.7b02862
   Li YY, 2014, LANGMUIR, V30, P8500, DOI 10.1021/la5017438
   Martina BEE, 2009, CLIN MICROBIOL REV, V22, P564, DOI 10.1128/CMR.00035-09
   Metz SW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04767-6
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Musso D, 2017, CLIN MICROBIOL INFEC, V23, DOI 10.1016/j.cmi.2017.07.006
   Musso D, 2017, J MED VIROL, V89, P1505, DOI 10.1002/jmv.24735
   Paixao ES, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000530
   Pan KY, 2011, J MOL EVOL, V72, P90, DOI 10.1007/s00239-010-9405-4
   Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059
   Pollard TD, 2010, MOL BIOL CELL, V21, P4061, DOI 10.1091/mbc.E10-08-0683
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Rather IA, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00305
   Reverdatto S, 2015, CURR TOP MED CHEM, V15, P1082, DOI 10.2174/1568026615666150413153143
   Rey FA, 2018, EMBO REP, V19, P206, DOI 10.15252/embr.201745302
   Ruscito A, 2016, FRONT CHEM, V4, DOI 10.3389/fchem.2016.00014
   Saha S, 2006, PROTEINS, V65, P40, DOI 10.1002/prot.21078
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   SHATERNKOV V. A., 1966, VOP MED KHIM, V12, P496
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Tate Jill, 2004, Clin Biochem Rev, V25, P105
   Thrailkill KM, 2005, CLIN CHEM LAB MED, V43, P1392, DOI 10.1515/CCLM.2005.238
   Vicenti I, 2018, VIRUS RES, V244, P64, DOI 10.1016/j.virusres.2017.11.003
   Wang JQ, 2017, CELL, V171, P229, DOI 10.1016/j.cell.2017.09.002
   Yang JY, 2015, NUCLEIC ACIDS RES, V43, pW174, DOI 10.1093/nar/gkv342
   Yang M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08247-9
   Yeh JTH, 2013, SCI REP-UK, V3, DOI 10.1038/srep01156
   Zhang B, 2017, NAT MED, V23, P548, DOI 10.1038/nm.4302
   Zhou WZ, 2014, ANALYST, V139, P2627, DOI 10.1039/c4an00132j
NR 57
TC 8
Z9 8
U1 1
U2 16
PU IVYSPRING INT PUBL
PI LAKE HAVEN
PA PO BOX 4546, LAKE HAVEN, NSW 2263, AUSTRALIA
SN 1838-7640
J9 THERANOSTICS
JI Theranostics
PY 2018
VL 8
IS 13
BP 3629
EP 3642
DI 10.7150/thno.25955
PG 14
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA GJ6HQ
UT WOS:000435485300014
PM 30026871
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ahmad, F
   Siddiqui, A
   Kamal, MA
   Sohrab, SS
AF Ahmad, Fahim
   Siddiqui, Amna
   Kamal, Mohammad A.
   Sohrab, Sayed Sartaj
TI Inhibition of Neurogenesis by Zika Virus Infection
SO CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS
LA English
DT Review
DE Zika virus; neurodegeneration; microcephaly; neuroprogenitor cells;
   mosquitoes; infection
ID RADIAL GLIAL-CELLS; WEST-NILE-VIRUS; FRENCH-POLYNESIA; VERTICAL
   TRANSMISSION; CEREBRAL-CORTEX; DECEMBER 2013; BREAST-MILK; OUTBREAK;
   FEVER; ORGANOIDS
AB Background & Objective: The link between Zika Virus (ZIKV) epidemic and neurological disorder has raised an urgent global alarm. The current epidemic of ZIKV has triggered quick responses in the scientific world. The first case of ZIKV was reported in 2015 from Brazil and now has spread over 30 countries. Nearly four hundred cases of traveler associated ZIKV infection have also been reported in the United States. ZIKV is primarily transmitted by mosquito belonging to the genus Aedes that are widely distributed throughout the world. Additionally, the virus can also be transmitted from male to female by sexual contact. The epidemiological investigations during the current outbreak found a causal link between infection in pregnant women and the development of microcephaly (MCPH) in their unborn babies. This finding is a cause of grave concern since MCPH is a serious neural developmental disorder that can lead to significant post-natal developmental abnormalities and disabilities. Recently, published data indicates that ZIKV infection severely affects the growth of fetal neural progenitor cells and cerebral neurons resulting in malformation of cerebral cortex leading to MCPH. Recently, it has been reported that ZIKV infection deregulates the signaling pathway of neuronal cell and inhibits the neurogenesis.
   Conclusion: In this review, we discussed the information about cellular and molecular mechanisms of neurodegeneration of human neuronal cells and inhibition of neurogenesis. The provided information in this review will be very useful further not only in neuro-scientific research but also in the desig and development of management strategies for MCPH and other mosquito-borne diseases.
C1 [Ahmad, Fahim] Southern Res, Drug Discovery Div, Dept Infect Dis, 2000 Ninth Ave South, Birmingham, AL 35205 USA.
   [Siddiqui, Amna] Univ Alabama Birmingham, Dept Biochem & Mol Genet, 845 19th St South, Birmingham, AL 35205 USA.
   [Sohrab, Sayed Sartaj] King Abdulaziz Univ, Special Infect Agents Unit, King Fahd Med Res Ctr, POB 21589, Jeddah, Saudi Arabia.
   [Kamal, Mohammad A.] King Abdulaziz Univ, King Fahd Med Res Ctr, POB 21589, Jeddah, Saudi Arabia.
   [Kamal, Mohammad A.] Novel Global Community Educ Fdn, Sydney, NSW, Australia.
   [Kamal, Mohammad A.] Enzymoics, 7 Peterlee Pl, Hebersham, NSW 2770, Australia.
RP Sohrab, SS (corresponding author), King Abdulaziz Univ, Special Infect Agents Unit, King Fahd Med Res Ctr, Post Box 80216, Jeddah 21589, Saudi Arabia.
EM ssohrab@kau.edu.sa
RI amsalu, ribka/G-8780-2019; Sohrab, Syed/H-9613-2012; Kamal, Mohammad
   Amjad/J-2918-2014; SOHRAB, SAYED SARTAJ/J-7271-2019
OI Kamal, Mohammad Amjad/0000-0003-0088-0565; 
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Abuelo Dianne, 2007, Semin Pediatr Neurol, V14, P118, DOI 10.1016/j.spen.2007.07.003
   Ahmad F., 2016, EC MICROBIOLOGY ECO, V4, P12
   Ahmad SSY, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1062
   Ashwal S, 2009, NEUROLOGY, V73, P887, DOI 10.1212/WNL.0b013e3181b783f7
   Atif M, 2016, INFECTION, V44, P695, DOI 10.1007/s15010-016-0935-6
   Barthel A, 2013, CLIN INFECT DIS, V57, P415, DOI 10.1093/cid/cit227
   Basarab M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1049
   Bennett JE, 2014, PRINCIPLES PRACTICE, P1
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Borrell V, 2014, CURR OPIN NEUROBIOL, V27, P39, DOI 10.1016/j.conb.2014.02.007
   BUCKLEY A, 1988, J GEN VIROL, V69, P1913, DOI 10.1099/0022-1317-69-8-1913
   Bystron I, 2008, NAT REV NEUROSCI, V9, P110, DOI 10.1038/nrn2252
   Caio C, 2015, BIORXIV, V25
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Campos-Gomez J, 2016, VIROLOGY, V496, P77, DOI 10.1016/j.virol.2016.05.012
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Centers for Disease Control and Prevention, 2016, ZIK VIR DIS US 2015
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Chen LH, 2004, CLIN INFECT DIS, V39, pE56, DOI 10.1086/423807
   Chen LH, 2016, ANN INTERN MED, V164, P613, DOI 10.7326/M16-0150
   Corno C, 2016, CURR MED CHEM, V23, P1496, DOI 10.2174/0929867323666160405112954
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   De Carvalho NS, 2016, BRAZ J INFECT DIS, V20, P282, DOI 10.1016/j.bjid.2016.02.006
   Derraik JG, 2015, AUST NZ J PUBL HEAL, V39, P5, DOI 10.1111/1753-6405.12302
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dowall SD, 2016, PLOS NEGLECT TROP D, V5
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duijster JW, 2016, INFECTION, P1
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Faheem M, 2015, BMC MED GENOMICS, V8, DOI 10.1186/1755-8794-8-S1-S4
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hennessey M, 2016, AM J TRANSPLANT, V16, P1031, DOI 10.1111/ajt.13743
   Hinckley AF, 2007, PEDIATRICS, V119, pE666, DOI 10.1542/peds.2006-2107
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Karim S, 2014, CNS NEUROL DISORD-DR, V13, P1213, DOI 10.2174/187152731307141015122638
   Karimi O, 2016, LANCET, V387, P939, DOI [10.1016/S0140-6736(16)00502-X, 10.1016/s0140-6736(16)00502-X]
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li F, 2015, J VIROL, V89, P5602, DOI 10.1128/JVI.00143-15
   Majumder MS, 2016, B WORLD HEALTH ORGAN, V10, P1, DOI DOI 10.2471/BLT.16.171009)
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Microbe Wiki, 2016, REPR CYCL ZIK VIR HO
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Molnar Z, 2012, PROG BRAIN RES, V195, P45, DOI 10.1016/B978-0-444-53860-4.00003-9
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Olagnier D, 2016, DNA CELL BIOL, V35, P367, DOI 10.1089/dna.2016.3404
   Pan American Health Organization, 2015, EP AL NEUR SYNDR CON
   Paz S, 2016, LANCET, V387, P745, DOI 10.1016/S0140-6736(16)00256-7
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Qiming L, 2016, CELL STEM CELLS, V19, P120
   Rakic P, 2007, BRAIN RES REV, V55, P204, DOI 10.1016/j.brainresrev.2007.02.010
   Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7
   Secretaria Estadual de Saude de Pernambuco, 2015, PROT CLIN EP INV AO
   Sexton DJ, 2016, ZIKA VIRUS INFECT
   Siddiqui A, 2017, ECON MICROBIOL, V12, P250
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Tang BL, 2016, ARCH MICROBIOL, V198, P595, DOI 10.1007/s00203-016-1268-7
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140
   WHO, 2016, ZIK SIT REP NEUR SYN
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310, DOI 10.4269/ajtmh.2001.64.310
   Woods CG, 2013, ARCH DIS CHILD, V98, P707, DOI 10.1136/archdischild-2012-302882
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 90
TC 2
Z9 2
U1 1
U2 7
PU BENTHAM SCIENCE PUBL
PI BUSUM
PA PO BOX 294, BUSUM, 1400 AG, NETHERLANDS
SN 1871-5273
EI 1996-3181
J9 CNS NEUROL DISORD-DR
JI CNS Neurol. Disord.-Drug Targets
PY 2018
VL 17
IS 2
BP 78
EP 86
DI 10.2174/1871527317666180202115114
PG 9
WC Neurosciences; Pharmacology & Pharmacy
SC Neurosciences & Neurology; Pharmacology & Pharmacy
GA GK1UD
UT WOS:000435906600002
PM 29422006
DA 2020-07-08
ER

PT J
AU Colavita, F
   Bordoni, V
   Caglioti, C
   Biava, M
   Castilletti, C
   Bordi, L
   Quartu, S
   Iannetta, M
   Ippolito, G
   Agrati, C
   Capobianchi, MR
   Lalle, E
AF Colavita, Francesca
   Bordoni, Veronica
   Caglioti, Claudia
   Biava, Mirella
   Castilletti, Concetta
   Bordi, Licia
   Quartu, Serena
   Iannetta, Marco
   Ippolito, Giuseppe
   Agrati, Chiara
   Capobianchi, Maria Rosaria
   Lalle, Eleonora
TI ZIKV Infection Induces an Inflammatory Response but Fails to Activate
   Types I, II, and III IFN Response in Human PBMC
SO MEDIATORS OF INFLAMMATION
LA English
DT Article
ID INTERFERON-ALPHA; COORDINATE INDUCTION; VIRUS; GAMMA
AB The recent epidemic in the Americas caused by Zika virus (ZIKV), Asian lineage, spurred the research towards a better understanding of how ZIKV infection affects the host immune response. The aim of this study was to evaluate the effects of Asian and East African ZIKV strain infection on the induction of IFN and proinflammatory and Th2 cytokines in human PBMC. We reported a slight modulation of type II IFN in PBMC exposed to Asian strain, but not to African strain, and a complete lack of type I and III IFN induction by both strains, suggesting the ability of ZIKV to evade the IFN system not only inhibiting the antiviral IFN response but also IFN production. Moreover, we highlighted a polyfunctional immune activation only in PBMC exposed to Asian strain, due to the induction of an inflammatory profile (IL-6, IL-8) and of a Th9 (IL-9) response. Overall, our data show a different ability of the ZIKV Asian strain, with respect to the African strain, to activate host immune response that may have pathogenetic implications for virus spread in vivo, including mother-to-child transmission and induction of severe fetal complications, as birth defects and neurological disorders.
C1 [Colavita, Francesca; Caglioti, Claudia; Biava, Mirella; Castilletti, Concetta; Bordi, Licia; Quartu, Serena; Capobianchi, Maria Rosaria; Lalle, Eleonora] Natl Inst Infect Dis L Spallanzani IRCCS, Lab Virol, Via Portuense 292, I-00149 Rome, Italy.
   [Bordoni, Veronica; Agrati, Chiara] Natl Inst Infect Dis L Spallanzani IRCCS, Cellular Immunol Lab, Via Portuense 292, I-00149 Rome, Italy.
   [Iannetta, Marco] Natl Inst Infect Dis L Spallanzani IRCCS, Clin Dept, Via Portuense 292, I-00149 Rome, Italy.
   [Ippolito, Giuseppe] Natl Inst Infect Dis L Spallanzani IRCCS, Dept Epidemiol, Via Portuense 292, I-00149 Rome, Italy.
RP Castilletti, C (corresponding author), Natl Inst Infect Dis L Spallanzani IRCCS, Lab Virol, Via Portuense 292, I-00149 Rome, Italy.
EM concetta.castilletti@inmi.it
RI Iannetta, Marco/M-4619-2019; Iannetta, Marco/B-5596-2017; Castilletti,
   Concetta/B-6545-2016; Colavita, Francesca/I-8848-2018; Castilletti,
   Concetta/AAA-8408-2019; Agrati, Chiara/K-8806-2016
OI Iannetta, Marco/0000-0002-6938-8627; Iannetta,
   Marco/0000-0002-6938-8627; Castilletti, Concetta/0000-0001-9819-236X;
   Colavita, Francesca/0000-0003-0640-8667; Castilletti,
   Concetta/0000-0001-9819-236X; lalle, eleonora/0000-0002-7063-9905;
   Quartu, Serena/0000-0003-3866-3021; Agrati, Chiara/0000-0002-5252-0927;
   PERNO, CARLO FEDERICO/0000-0002-0825-5388; Ippolito,
   Giuseppe/0000-0002-1076-2979
FU Italian Ministry of HealthMinistry of Health, Italy
   [2016-RF-2016-02364155]; European UnionEuropean Union (EU) [653316]
FX The contribution of the Laboratory of Microbiology and Infectious
   Disease Biorepository from the National Institute for Infectious
   Diseases "L. Spallanzani," Rome, Italy, is warmly acknowledged. This
   study was partly supported by the Italian Ministry of Health (Ricerca
   Corrente and Ricerca Finalizzata 2016-RF-2016-02364155) and by the
   European Union's Horizon 2020 Research and Innovation Programme under
   Grant agreement no. 653316.
CR Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   CAPOBIANCHI MR, 1988, ARCH VIROL, V103, P219, DOI 10.1007/BF01311094
   CAPOBIANCHI MR, 1993, AIDS RES HUM RETROV, V9, P957, DOI 10.1089/aid.1993.9.957
   CAPOBIANCHI MR, 1985, P SOC EXP BIOL MED, V178, P551
   Castilletti C, 2005, VIROLOGY, V341, P163, DOI 10.1016/j.virol.2005.07.015
   Chaudhary V, 2017, J VIROL, V91, DOI 10.1128/JVI.00163-17
   Iani FCD, 2016, AM J TROP MED HYG, V95, P193, DOI 10.4269/ajtmh.15-0537
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Guzman-Fulgencio M, 2012, J ANTIMICROB CHEMOTH, V67, P1238, DOI 10.1093/jac/dkr595
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Kaplan MH, 2015, NAT REV IMMUNOL, V15, P295, DOI 10.1038/nri3824
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   McNamara PS, 2004, LANCET, V363, P1031, DOI 10.1016/S0140-6736(04)15838-8
   Mehta VK, 2017, J POSTGRAD MED, V63, P11, DOI 10.4103/0022-3859.188545
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Rodrigues LC, 2016, LANCET, V387, P2070, DOI 10.1016/S0140-6736(16)00742-X
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   Versteeg GA, 2010, CURR OPIN MICROBIOL, V13, P508, DOI 10.1016/j.mib.2010.05.009
   Yu M, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00409
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 27
TC 5
Z9 5
U1 1
U2 2
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 0962-9351
EI 1466-1861
J9 MEDIAT INFLAMM
JI Mediat. Inflamm.
PY 2018
VL 2018
AR 2450540
DI 10.1155/2018/2450540
PG 6
WC Cell Biology; Immunology
SC Cell Biology; Immunology
GA GK0MB
UT WOS:000435803100001
PM 29967565
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT S
AU Goswami, NK
   Srivastav, AK
   Ghosh, M
   Shanmukha, B
AF Goswami, Naba Kumar
   Srivastav, Akhil Kumar
   Ghosh, Mini
   Shanmukha, B.
BE Govindarajan, A
   Siva, EP
   Suja, K
TI Mathematical modeling of zika virus disease with nonlinear incidence and
   optimal control
SO PROCEEDINGS OF THE 10TH NATIONAL CONFERENCE ON MATHEMATICAL TECHNIQUES
   AND ITS APPLICATIONS (NCMTA 18)
SE Journal of Physics Conference Series
LA English
DT Proceedings Paper
CT 10th National Conference on Mathematical Techniques and its Applications
   (NCMTA)
CY JAN 04-06, 2018
CL SRM Inst Sci & Technol, Kattankulathur, INDIA
SP SRM Inst Sci & Technol, Fac Engn & Technol, Dept Math
HO SRM Inst Sci & Technol
AB The Zika virus was first discovered in a rhesus monkey in the Zika Forest of Uganda in 1947, and it was isolated from humans in Nigeria in 1952. Zika virus disease is primarily a mosquito-borne disease, which is transmitted to human primarily through the bite of an infected Aedes species mosquito. However, there is documented evidence of sexual transmission of this disease too. In this paper, a nonlinear mathematical model for Zika virus by considering nonlinear incidence is formulated and analyzed. The equilibria and the basic reproduction number (R-0) of the model are found. The stability of the different equilibria of the model is discussed in detail. When the basic reproduction number R-0 < 1, the disease-free equilibrium is locally and globally stable i.e. in this case disease dies out. For R-0 > 1, we have endemic equilibrium which is locally stable under some restriction on parameters. Further this model is extended to optimal control model and is analyzed by using Pontryagin's Maximum Principle. It has been observed that optimal control plays a significant role in reducing the number of zika infectives. Finally, numerical simulation is performed to illustrate the analytical findings.
C1 [Goswami, Naba Kumar] Univ Mysore, PET Res Ctr, Dept Math, Mysore, Karnataka, India.
   [Srivastav, Akhil Kumar; Ghosh, Mini] Vellore Inst Technol, Sch Adv Sci, Div Math, Madras, Tamil Nadu, India.
   [Shanmukha, B.] PES Coll Engn, Dept Math, Mandya, Karnataka, India.
RP Goswami, NK (corresponding author), Univ Mysore, PET Res Ctr, Dept Math, Mysore, Karnataka, India.
EM nabakrgoswami@gmail.com
CR Adam J K, 2016, PLOS NEGLECT TROP D, DOI [10.1371/journal.pntd.0004726, DOI 10.1371/JOURNAL.PNTD.0004726]
   Agusto F B, 2017, Infect Dis Model, V2, P244, DOI 10.1016/j.idm.2017.05.003
   Bonyah E., 2016, Asian Pacific Journal of Tropical Disease, V6, P673, DOI 10.1016/S2222-1808(16)61108-8
   Buonomo B, 2011, NONLINEAR ANAL-MODEL, V16, P30, DOI 10.15388/NA.16.1.14113
   Castillo-Chavez C, 2002, IMA VOL MATH APPL, V125, P229
   CDC, 2016, CDC EM OP CTR MOV HI
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Lenhart S, 2007, OPTIMAL CONTROL APPL
   Li MY, 1996, SIAM J MATH ANAL, V27, P1070, DOI 10.1137/S0036141094266449
   Pan American Health Organization (PAHO), ZIK VIR INF
   Pontryagin L. S., 1962, MATH THEORY OPTIMAL
   Ruan SG, 2003, J DIFFER EQUATIONS, V188, P135, DOI 10.1016/S0022-0396(02)00089-X
   Shapshak P, 2015, GLOBAL VIROLOGY 1 ID
   Srivastav AK, 2016, MODEL EARTH SYST ENV, V2, DOI 10.1007/s40808-016-0222-7
   van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6
   Victor M M, 2016, INFECT DIS MODELLING, V2, P1
   World Health Organization (WHO), 2005, WHO STAT 1 M INT HLT
   Xiao DM, 2007, MATH BIOSCI, V208, P419, DOI 10.1016/j.mbs.2006.09.025
NR 18
TC 2
Z9 2
U1 0
U2 3
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 1742-6588
EI 1742-6596
J9 J PHYS CONF SER
PY 2018
VL 1000
AR UNSP 012114
DI 10.1088/1742-6596/1000/1/012114
PG 16
WC Mathematics, Applied; Physics, Applied
SC Mathematics; Physics
GA BK3HH
UT WOS:000435018300114
OA Other Gold
DA 2020-07-08
ER

PT J
AU Sherley, M
   Ong, CW
AF Sherley, Miranda
   Ong, Chong-Wei
TI Sexual transmission of Zika virus: a literature review
SO SEXUAL HEALTH
LA English
DT Review
DE microcephaly; prevention; STI
ID UNITED-STATES; VIRAL LOAD; INFECTION; DISEASE; SEMEN; TRAVELER; SALIVA;
   WOMEN; RNA; PERSISTENCE
AB Zika virus is an emerging health threat worldwide. A member of the yellow fever virus family, it is primarily spread by mosquitoes of the Aedes (Stegomyia) genus. Unusually for a mosquito-borne virus, sexual spread has also been reported; with cases of male-to-female, female-to-male and male-to-male sexual transmission all now published in the scientific literature, in both symptomatic and asymptomatic infection. Female-to-female sexual transmission has not yet been reported, but is biologically plausible. The extent of the effect of sexual transmission on the spread of Zika virus around the world is not well-characterised, but has particular relevance to travellers to and from non-endemic regions, and assisted reproduction services.
C1 [Sherley, Miranda] Canberra Hosp, Canberra Sexual Hlth Ctr, Bldg 5,Level 1,POB 11, Woden, ACT 2606, Australia.
   [Ong, Chong-Wei] Canberra Hosp, Infect Dis Unit, Bldg 10,Level 4,POB 11, Woden, ACT 2606, Australia.
   [Ong, Chong-Wei] Canberra Hosp, Microbiol Unit, Bldg 10,Level 4,POB 11, Woden, ACT 2606, Australia.
   [Sherley, Miranda] Australian Natl Univ, ANU Coll Hlth & Med, Med Sch, Acton, ACT 0200, Australia.
RP Sherley, M (corresponding author), Canberra Hosp, Canberra Sexual Hlth Ctr, Bldg 5,Level 1,POB 11, Woden, ACT 2606, Australia.; Sherley, M (corresponding author), Australian Natl Univ, ANU Coll Hlth & Med, Med Sch, Acton, ACT 0200, Australia.
EM Miranda.Sherley@act.gov.au
CR Abushouk AI, 2016, J CLIN VIROL, V84, P53, DOI 10.1016/j.jcv.2016.09.012
   Allard A, 2017, P NATL ACAD SCI USA, V114, P8969, DOI 10.1073/pnas.1703073114
   Althaus CL, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002157
   Armstrong P, 2016, MMWR-MORBID MORTAL W, V65, P286, DOI 10.15585/mmwr.mm6511e1
   Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6
   Atkinson B, 2017, EMERG INFECT DIS, V23, P611, DOI 10.3201/eid2304.161692
   Atkinson B, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.01116-16
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Baca-Carrasco D, 2016, B MATH BIOL, V78, P2228, DOI 10.1007/s11538-016-0219-4
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Basu R, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0623-2
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Boggild AK, 2017, CAN MED ASSOC J, V189, pE334, DOI 10.1503/cmaj.161241
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Brooks RB, 2016, MMWR-MORBID MORTAL W, V65, P915, DOI 10.15585/mmwr.mm6534e2
   Carroll T, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006537
   Chan JFW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.99
   Chen JC, 2016, INT J INFECT DIS, V51, P139, DOI 10.1016/j.ijid.2016.07.015
   Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   de Laval F, 2017, NEW ENGL J MED, V377, P697, DOI 10.1056/NEJMc1612600
   de Laval F, 2016, LANCET, V388, P868, DOI 10.1016/S0140-6736(16)31429-5
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   European Centre for Disease Prevention and Control (ECDC), 2016, ZIK VIR INF FACTSH H
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Fourcade C, 2016, J CLIN VIROL, V82, P1, DOI 10.1016/j.jcv.2016.06.011
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Frank C, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.23.30252
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Froeschl G, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2123-9
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Gaskell KM, 2017, EMERG INFECT DIS, V23, P137, DOI 10.3201/eid2301.161300
   Gulland A, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i6500
   Haddow AD, 2017, EMERG INFECT DIS, V23, P1274, DOI 10.3201/eid2308.170036
   Hamer DH, 2017, ANN INTERN MED, V166, P99, DOI 10.7326/M16-1842
   Harrower J, 2016, EMERG INFECT DIS, V22, P1855, DOI 10.3201/eid2210.160951
   Hashimoto T, 2017, EMERG INFECT DIS, V23, P1222, DOI 10.3201/eid2307.170519
   Hearn P, 2014, AM J TROP MED HYG S1, V91, P62
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Huits RMHG, 2016, B WORLD HEALTH ORGAN, DOI [10.2471/BLT.16.181370, DOI 10.2471/BLT.16.181370, 10.2471/blt.16.181370]
   Jang HC, 2016, J KOREAN MED SCI, V31, P1173, DOI 10.3346/jkms.2016.31.7.1173
   Joguet G, 2017, LANCET INFECT DIS, V17, P1200, DOI 10.1016/S1473-3099(17)30444-9
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P894, DOI 10.1016/S1473-3099(16)30153-0
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Matheron S, 2016, CLIN INFECT DIS, V63, DOI 10.1093/cid/ciw509
   Maxian O, 2017, EPIDEMICS-NETH, V21, P48, DOI 10.1016/j.epidem.2017.06.003
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Ministerio de Salud (MINSAL), 2016, MINSAL CONF PRIM CAS
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Musso D, 2017, CLIN MICROBIOL INFEC, V23, DOI 10.1016/j.cmi.2017.07.006
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nayak S, 2016, SEMIN REPROD MED, V34, P266, DOI 10.1055/s-0036-1592071
   Newman CM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00246-8
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Nicastri E, 2016, EMERG INFECT DIS, V22, P2228, DOI 10.3201/eid2212.161280
   Souto IO, 2018, ENFERM INFEC MICR CL, V36, P21, DOI 10.1016/j.eimc.2016.10.009
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Penot P, 2017, REV MED INTERNE, V38, P547, DOI 10.1016/j.revmed.2016.12.011
   Penot P, 2017, EUROSURVEILLANCE, V22, P8, DOI 10.2807/1560-7917.ES.2017.22.3.30444
   Percivalle E, 2017, NEW MICROBIOL, V40, P197
   Prisant N, 2017, CLIN INFECT DIS, V64, P107, DOI 10.1093/cid/ciw669
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Rafiei N, 2016, MED J AUSTRALIA, V204, P186, DOI 10.5694/mja15.01275
   Report S, 2017, ZIK VIR MICR GUILL B
   Reusken C, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.23.30251
   Russell K, 2017, CLIN INFECT DIS, V64, P211, DOI 10.1093/cid/ciw692
   Sun JF, 2017, J INFECTION, V75, P356, DOI 10.1016/j.jinf.2017.07.001
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Visseaux B, 2016, LANCET INFECT DIS, V16, P1220, DOI 10.1016/S1473-3099(16)30387-5
   WHO, 2016, DIS OUTBREAK NE 0208
   Wikan N, 2017, LANCET INFECT DIS, V17, P15, DOI 10.1016/S1473-3099(16)30525-4
   Wu D, 2016, J INFECTION, V73, P300, DOI 10.1016/j.jinf.2016.06.008
   Yakob L, 2016, LANCET INFECT DIS, V16, P1100, DOI 10.1016/S1473-3099(16)30324-3
   Yin YX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.100
   Zambrano H, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12630
NR 84
TC 4
Z9 4
U1 1
U2 5
PU CSIRO PUBLISHING
PI CLAYTON
PA UNIPARK, BLDG 1, LEVEL 1, 195 WELLINGTON RD, LOCKED BAG 10, CLAYTON, VIC
   3168, AUSTRALIA
SN 1448-5028
EI 1449-8987
J9 SEX HEALTH
JI Sex Health
PY 2018
VL 15
IS 3
BP 183
EP 199
DI 10.1071/SH17046
PG 17
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA GH9DY
UT WOS:000433970500001
PM 29268073
DA 2020-07-08
ER

PT J
AU Meghani, Z
   Kuzma, J
AF Meghani, Zahra
   Kuzma, Jennifer
TI Regulating animals with gene drive systems: lessons from the regulatory
   assessment of a genetically engineered mosquito
SO JOURNAL OF RESPONSIBLE INNOVATION
LA English
DT Article
DE Gene drive; genetically engineered (GE) mosquito; risk assessment; FDA:
   Oxitec; Zika
ID NEOLIBERALISM; POPULATION; FRAMEWORK; RISK; FOOD
AB For the purposes of conservation or suppression of species, gene drive technology has significant potential. Theoretically speaking, with the release of even relatively few animals with gene drive systems in an ecosystem, beneficial or harmful genes could be introduced into the entire wild-type population of that species. Given the profound impact that gene drives could have on species and ecosystems, their use is a highly contentious issue. Communities and groups have differing beliefs about nature and its conservation or preservation, as well as concerns about the ecological safety of the eradication, replacement or enhancement of particular species of animals by means of genetic engineering. For all those reasons, the rigorous regulation of insects and other animals with gene drive systems is crucial. In this paper, we consider the question of whether the United States Food and Drug Administration is prepared to effectively regulate insects and other animals with gene drives.
C1 [Meghani, Zahra] Univ Rhode Isl, Dept Philosophy, Kingston, RI 02881 USA.
   [Kuzma, Jennifer] North Carolina State Univ, Raleigh, NC USA.
RP Meghani, Z (corresponding author), Univ Rhode Isl, Dept Philosophy, Kingston, RI 02881 USA.
EM meghaniz@uri.edu
RI Bell, E/M-9188-2018
OI Bell, E/0000-0003-4896-3327; Kuzma, Jennifer/0000-0003-4456-9613
FU National Science Foundation - SES and Science in Society Program
   [1533990]; Genetic Engineering and Society Center (GES) at North
   Carolina State University (NCSU); Center for Nanotechnology in Society
   at Arizona State University
FX The workshop was funded by the National Science Foundation - SES and
   Science in Society Program [grant number 1533990] with additional
   co-funding by the Genetic Engineering and Society Center (GES) at North
   Carolina State University (NCSU) and the Center for Nanotechnology in
   Society at Arizona State University. The views, however, are those of
   the authors and not these institutions.
CR [Anonymous], 1984, FED REG, V49, P50
   Barben D, 2007, HANDBOOK OF SCIENCE AND TECHNOLOGY STUDIES, THIRD EDITION, P979
   Barley SR, 2007, J MANAGE INQUIRY, V16, P201, DOI 10.1177/1056492607305891
   Boete C, 2016, LANCET GLOB HEALTH, V4, pE363, DOI 10.1016/S2214-109X(16)00084-X
   Burt A, 2003, P ROY SOC B-BIOL SCI, V270, P921, DOI 10.1098/rspb.2002.2319
   Carvalho DO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003864
   Cowan T, 2012, DEREGULATING GENETIC
   Daghrir R, 2013, ENVIRON CHEM LETT, V11, P209, DOI 10.1007/s10311-013-0404-8
   Esvelt KM, 2014, ELIFE, V3, DOI 10.7554/eLife.03401
   FDA, 2017, CLAR FDA EPA JUR MOS
   FDA (United States Food and Drug Administration), 1992, FED REGISTER, V57, P22984
   FDA-CVM, 2009, GUID IND REG INT ALT
   FDA-CVM, 2008, FDAS RESP PUBL COMM
   FDA-CVM, 2016, PREL FIND NO SIGN IM
   Gantz VM, 2015, P NATL ACAD SCI USA, V112, pE6736, DOI 10.1073/pnas.1521077112
   Gloria-Soria A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003029
   Hammond A, 2016, NAT BIOTECHNOL, V34, P78, DOI 10.1038/nbt.3439
   Harris AF, 2012, NAT BIOTECHNOL, V30, P828, DOI 10.1038/nbt.2350
   Harris AF, 2011, NAT BIOTECHNOL, V29, P1034, DOI 10.1038/nbt.2019
   Harvey D, 2005, BRIEF HIST NEOLIBERA
   Hilts Philip J., 2003, PROTECTING AM HLTH F
   JASANOFF Sheila, 2005, DESIGNS NATURE SCI D
   Kuzma J, 2018, J RESPONSIBLE INNOV, V5, pS13, DOI 10.1080/23299460.2017.1410344
   Kuzma J., 2008, NANOETHICS, V2, P149, DOI DOI 10.1007/S11569-008-0035-X
   Kuzma J, 2016, SCIENCE, V353, P1211, DOI 10.1126/science.aai7854
   Levidow L, 2007, SCI TECHNOL HUM VAL, V32, P26, DOI 10.1177/0162243906293885
   Markel H, 2005, JAMA-J AM MED ASSOC, V294, P2489, DOI 10.1001/jama.294.19.2489
   Meghani Z., 2009, Bulletin of Science, Technology and Society, V29, P9, DOI 10.1177/0270467608329950
   Meghani Z, 2017, CONSUMER PERCEPTION, P495
   Meghani Z, 2017, J AGR ENVIRON ETHIC, V30, P715, DOI 10.1007/s10806-017-9696-1
   Meghani Z, 2014, J AGR ENVIRON ETHIC, V27, P967, DOI 10.1007/s10806-014-9511-1
   Meghani Z, 2011, J AGR ENVIRON ETHIC, V24, P575, DOI 10.1007/s10806-010-9287-x
   Murphy B.D., 2010, RISK ANAL AUSTR RELE
   National Academies of Sciences Engineering and Medicine [NASEM], 2016, GEN DRIV HOR ADV SCI
   National Academies of Sciences Engineering and Medicine [NASEM], 2017, PREP FUT PROD BIOT
   National Research Council (NRC), 1996, UNDERSTANDING RISK I
   Nimmo D. D., 2016, OUTLOOKS PEST MANAGE, V26, P207
   Otts SS, 2014, BIOL INVASIONS, V16, P1289, DOI 10.1007/s10530-012-0327-5
   Oxitec, 2016, DRAFT ENV ASS INV US
   Oye KA, 2014, SCIENCE, V345, P626, DOI 10.1126/science.1254287
   Parthasarathy S, 2012, BUILDING GENETIC MED
   Reagan R, 1981, FED REGISTER, V46, P13193
   Reagan Ronald, 1982, COMMUNICATION
   Reeves RG, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001502
   Thompson P. B., 1997, Agriculture and Human Values, V14, P11, DOI 10.1023/A:1007397315714
   Unlu M., 2009, MICHIGAN TELECOMMUNI, V16, P511
   White House, 2015, MOD REG SYST BIOT PR
   Wickson F, 2007, NEW GENET SOC, V26, P325, DOI 10.1080/14636770701701832
NR 48
TC 11
Z9 11
U1 2
U2 14
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 2329-9460
EI 2329-9037
J9 J RESPONSIBLE INNOV
JI J. Responsible Innov.
PY 2018
VL 5
SU 1
SI SI
BP S203
EP S222
DI 10.1080/23299460.2017.1407912
PG 20
WC Ethics; History & Philosophy Of Science; Management; Social Issues
SC Social Sciences - Other Topics; History & Philosophy of Science;
   Business & Economics; Social Issues
GA GI6DF
UT WOS:000434459000012
OA Other Gold
DA 2020-07-08
ER

PT B
AU Hsu, CL
   Sun, A
   Zhao, YT
   Aronoff-Spencer, E
   Hall, DA
AF Hsu, Chung-Lun
   Sun, Alexander
   Zhao, Yunting
   Aronoff-Spencer, Eliah
   Hall, Drew A.
GP IEEE
TI A 16x20 Electrochemical CMOS Biosensor Array with In-Pixel Averaging
   Using Polar Modulation
SO 2018 IEEE CUSTOM INTEGRATED CIRCUITS CONFERENCE (CICC)
SE IEEE Custom Integrated Circuits Conference
LA English
DT Proceedings Paper
CT IEEE Custom Integrated Circuits Conference (CICC)
CY APR 08-11, 2018
CL San Diego, CA
SP IEEE, Silicon Labs, Analog Devices, Cadence Design Syst, Cirrus Log, Huawei, IMEC, Intel, Samsung, Catalyst Fdn, IBM, Mentor Graph
DE point-of-care (POC); electrochemical impedance spectroscopy (EIS);
   biosensor array; phase-to-digital converter
ID TO-DIGITAL CONVERTER
AB Biosensors based on electrochemical impedance spectroscopy (EIS), an ultra-sensitive, label-free sensing technique, are a promising technology for precise and rapid disease diagnosis at the point-of-care (POC). However, EIS usually requires mixers and lock-in detection to measure both the magnitude and phase of the complex impedance. To address this issue, we report a 16x20 electrochemical biosensor array with on chip sensors that implements a polar-mode measurement method that allows the readout circuitry to be mostly digital and small enough to fit within a 140x140 mu m(2) pixel. The architecture enables in-pixel digitization and accumulation, which increases the SNR by 10 dB for each 10x increase in readout time. Implemented in a 0.18 mu m process, the 3x4 mm(2) chip achieves state-of-the-art performance with an rms phase error of 0.04% at 50 kHz and was used to measure hybridization of Zika virus oligonucleotides.
C1 [Hsu, Chung-Lun; Sun, Alexander; Zhao, Yunting; Hall, Drew A.] Univ Calif San Diego, Dept Elect & Comp Engn, La Jolla, CA 92093 USA.
   [Aronoff-Spencer, Eliah] Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA.
RP Hall, DA (corresponding author), Univ Calif San Diego, Dept Elect & Comp Engn, La Jolla, CA 92093 USA.
EM drewhall@ucsd.edu
RI Hall, Drew A/C-6068-2012
OI Hall, Drew A/0000-0003-0674-074X
CR Augustyniak, 2006, IEEE ISSCC, P59
   Chen TA, 2017, IEEE T BIOMED CIRC S, V11, P370, DOI 10.1109/TBCAS.2016.2592511
   Elshazly A, 2014, IEEE J SOLID-ST CIRC, V49, P1184, DOI 10.1109/JSSC.2014.2305651
   Herne TM, 1997, J AM CHEM SOC, V119, P8916, DOI 10.1021/ja9719586
   Manickam Arun, 2010, 2010 IEEE International Solid-State Circuits Conference (ISSCC), P130, DOI 10.1109/ISSCC.2010.5434019
   Mazhab-Jafari H, 2012, IEEE T BIOMED CIRC S, V6, P468, DOI 10.1109/TBCAS.2012.2226334
   Yang C, 2009, IEEE J SOLID-ST CIRC, V44, P2844, DOI 10.1109/JSSC.2009.2028054
NR 7
TC 0
Z9 0
U1 1
U2 3
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-5386-2483-8
J9 IEEE CUST INTEGR CIR
PY 2018
PG 4
WC Engineering, Electrical & Electronic
SC Engineering
GA BK2XQ
UT WOS:000434207400039
DA 2020-07-08
ER

PT J
AU Rajesh, R
   Koshy, SL
   Renuka, R
   Abraham, E
AF Rajesh, Reza
   Koshy, Sharon Liza
   Renuka, R.
   Abraham, Elessy
TI A REVIEW ON ZIKA VIRUS ASSOCIATED MICROCEPHALY
SO INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES
LA English
DT Review
DE zikavirus (ZIKV); microcephaly; zikavaccine; flavivirus; Aedesaegypti
ID DNA VACCINE; NEUTRALIZING ANTIBODY; HEALTHY-ADULTS; CLINICAL-TRIAL;
   DENGUE VIRUS; INFECTION; EPIDEMIOLOGY; TRANSMISSION; PROTECTION;
   DIAGNOSIS
AB Microcephaly is a condition where a babys head is much smaller than expected. During pregnancy, a babys head grows as brain is enlarging. Microcephaly can occur because a babys brain has not developed properly during pregnancy or has stopped growing after birth, which results in a smaller head size. Zika virus is a mosquito-borne flavivirus transmitted primarily by Aedesaegypti mosquitoes. These vectors also transmit dengue and chikungunya virus and are found throughout much of the Americas, including parts of the United States. Zika virus infections have been confirmed in infants with microcephaly. In the current outbreak in Brazil, a marked increase in the number of infants born with microcephaly has been reported. Studies are under way to investigate the association of Zika virus infection and microcephaly.There are currently no drugs approved for the treatment of ZIKVinfection.Clinical trials are going on for the development of Zika vaccine. The aim of drug development is primarily to reduce viral load, reduce symptoms, and protect the unborn fetus from neurological sequelae. In order to develop effective anti-ZIKV vaccines and therapeutics, improved animal models and a better understanding of immunological correlates of protection against ZIKV are required. This review will summarize what is currently known about ZIKV, the clinical manifestations and epidemiology of Zika as well as, host immune responses against ZIKV, and the current state of development of vaccines and therapeutics against ZIKV.
C1 [Rajesh, Reza; Koshy, Sharon Liza; Renuka, R.; Abraham, Elessy] Nazareth Coll Pharm, Othera PO, Thiruvalla, Kerala, India.
RP Rajesh, R (corresponding author), Nazareth Coll Pharm, Othera PO, Thiruvalla, Kerala, India.
EM rezarajesh2015@gmail.com; vikrant.nawale71@gmail.com
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Adcock RS, 2017, ANTIVIR RES, V138, P47, DOI 10.1016/j.antiviral.2016.11.018
   Azevedo RSS, 2016, J CLIN VIROL, V85, P56, DOI 10.1016/j.jcv.2016.10.024
   Balasubramanian A, 2017, ANTIVIR RES, V137, P141, DOI 10.1016/j.antiviral.2016.11.015
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Boeuf P, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0660-0
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Calvet GA, 2016, CURR OPIN INFECT DIS, V29, P459, DOI 10.1097/QCO.0000000000000301
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Carteaux G, N ENGL J MED, V201, P1595
   Carvalho MDCG, 2017, CLIN NEUROPHYSIOL, V128, P204, DOI 10.1016/j.clinph.2016.11.004
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Frank C, 2016, EURO SURVEILL, V21
   Frank C, 2016, EMBO MOL MED, V8, P305, DOI 10.15252/emmm.201506058
   Freour T., 2016, EURO SURVEILL, V21
   Grossi-Soyster E. N, 2016, CURR OPIN PEDIAT
   Halstead SB, 2009, ANN NY ACAD SCI, V1171, pE48, DOI 10.1111/j.1749-6632.2009.05052.x
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875
   Kramps T, 2017, METHODS MOL BIOL, V1499, P1, DOI 10.1007/978-1-4939-6481-9_1
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Landry ML, 2017, ARCH PATHOL LAB MED, V141, P60, DOI 10.5858/arpa.2016-0406-SA
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Ledgerwood JE, 2011, J INFECT DIS, V203, P1396, DOI 10.1093/infdis/jir054
   Lehrer Axel T, 2011, J Bioterror Biodef, V2011, P3
   Martin JE, 2007, J INFECT DIS, V196, P1732, DOI 10.1086/523650
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Ramaiah A, 2017, INFECT GENET EVOL, V51, P74, DOI 10.1016/j.meegid.2017.03.012
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Salam A. P, 2017, ANN INTERN MED
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231
   Sharma A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00110
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Soares CN, 2016, J CLIN VIROL, V83, P63, DOI 10.1016/j.jcv.2016.08.297
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   US Food and Drug Administration, EM US AUTH
   Versteeg GA, 2010, CURR OPIN MICROBIOL, V13, P508, DOI 10.1016/j.mib.2010.05.009
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   WHO, 2017, SIT REP
   WHO, VACC PIP TRACK ZIK
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 50
TC 0
Z9 0
U1 0
U2 1
PU SSJ COLL PHARMACY-SSJCP
PI NAGPUR
PA 125B-125 SANTRANJIPURA, TLIPHONE EXCHANGE RD, NAGPUR, 440001, INDIA
SN 2349-7750
J9 INDO AM J PHARM SCI
JI Indo Am. J. Pharm. Sci.
PD JAN
PY 2018
VL 5
IS 1
BP 420
EP 428
DI 10.5281/zenodo.1160874
PG 9
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA GI4YZ
UT WOS:000434378600058
DA 2020-07-08
ER

PT J
AU Ga'al, H
   Fouad, H
   Mao, GF
   Tian, JX
   Mo, JC
AF Ga'al, Hassan
   Fouad, Hatem
   Mao, Guofeng
   Tian, Jiaxin
   Mo Jianchu
TI Larvicidal and pupicidal evaluation of silver nanoparticles synthesized
   using Aquilaria sinensis and Pogostemon cablin essential oils against
   dengue and zika viruses vector Aedes albopictus mosquito and its
   histopathological analysis
SO ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY
LA English
DT Article
DE Aedes albopictus; essential oil; Aquilaria sinensis; pogostemon cablin;
   Zika virus; histological analysis
ID GREEN SYNTHESIS; LEAF EXTRACTS; BIOSYNTHESIS; AEGYPTI; COMPONENTS;
   MALARIA; ANTIBACTERIAL; NANOCRYSTALS; INHIBITION; SATIVA
AB Mosquitoes pose a threat to humans and animals, causing millions of deaths every year. Vector control by effective eco-friendly pesticides of natural origin is a serious issue that requires urgent attention. The employment of green-reducing extracts for nanoparticles biosynthesis in a rapid and single-step process represents a promising strategy. In this study, silver nanoparticles (AgNPs) were biofabricated using an essential oil of Aquilaria sinensis (AsEO) and Pogostemonis Herba essential oil of Pogostemon cablin (PcEO) in one step and cost-effective manner. UV-vis spectrophotometry, Fourier transform infrared spectroscopy, scanning electron microscopy, transmission electron microscopy, X-ray diffraction analysis and energy-dispersive X-ray spectroscopy were used to confirm the AgNPs formation and their biophysical characterization. The larvicidal and pupicidal toxicity of AsEO, PcEO and biosynthesized AgNPs were evaluated against larvae and pupae of the dengue and Zika virus vector Aedes albopictus. Compared to the tested essential oils, the biofabricated AgNPs showed the highest toxicity against larvae and pupae of Ae.albopictus. In particular, the LC50 values of AsEO ranged from 44.23 (I) to 166 (pupae), LC50 values of PcEO ranged from 32.49 (I) to 90.05 (IV), LC50 values of AsEO-AgNPs from 0.81 (I) to 1.12 (IV) and LC50 values of PcEO-AgPNs from 0.85 (I) to 1.19 (IV). Furthermore, histological analysis of the midgut cells of the control and treated larvae exhibited that the epithelial cells and brush border were highly affected by the fabricated AgNPs compared to the essential oils (AsEO and PcEO). Overall, the A. sinensis and P. cablin essential oils fabricated AgNPs have a potential of application as a biopesticide for mosquito control through safer and cost-effective approach.
C1 [Ga'al, Hassan; Fouad, Hatem; Mao, Guofeng; Tian, Jiaxin; Mo Jianchu] Zhejiang Univ, Inst Insect Sci, Minist Agr, Key Lab Agr Entomol, Hangzhou, Zhejiang, Peoples R China.
   [Ga'al, Hassan] Somali Natl Univ, Fac Vet & Anim Husb, Dept Entomol, Mogadishu, Somalia.
   [Fouad, Hatem] Agr Res Ctr, Plant Protect Res Inst, Dept Field Crop Pests, Cairo, Egypt.
RP Mo, JC (corresponding author), Zhejiang Univ, Coll Agr & Biotechnol, Inst Insect Sci, Minist Agr,Key Lab Agr Entomol, Yuhangtang Rd 866, Hangzhou 310058, Zhejiang, Peoples R China.
EM mojianchu@zju.edu.cn
RI Fouad, Hatem/N-3071-2015
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81271873]
FX This work was financially supported by the National Natural Science
   Foundation of China [81271873].
CR Al-Mekhlafi FA, 2018, SAUDI J BIOL SCI, V25, P52, DOI 10.1016/j.sjbs.2017.02.010
   Albuquerque ELD, 2013, ACTA TROP, V127, P181, DOI 10.1016/j.actatropica.2013.04.011
   Azarudeen RMST, 2017, J ASIA-PAC ENTOMOL, V20, P359, DOI 10.1016/j.aspen.2017.02.007
   Basu S, 2016, APPL NANOSCI, V6, P1, DOI 10.1007/s13204-015-0407-9
   Bedini S, 2016, IND CROP PROD, V85, P318, DOI 10.1016/j.indcrop.2016.03.008
   Benelli G, 2017, IND CROP PROD, V96, P186, DOI 10.1016/j.indcrop.2016.11.059
   Benelli G, 2017, PARASITOL RES, V116, P1175, DOI 10.1007/s00436-017-5395-0
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Bharathi VP, 2017, ARTIF CELL NANOMED B, V45, P1568, DOI 10.1080/21691401.2016.1261873
   Bhuvaneswari R, 2016, J KING SAUD UNIV SCI, V28, P318, DOI 10.1016/j.jksus.2015.10.006
   de Castro DSB, 2016, EXP PARASITOL, V171, P84, DOI 10.1016/j.exppara.2016.10.008
   Buhagiar Joseph A., 2009, European Mosquito Bulletin, V27, P65
   Chen HM, 2015, FITOTERAPIA, V100, P110, DOI 10.1016/j.fitote.2014.11.017
   Chen HQ, 2011, MOLECULES, V16, P4884, DOI 10.3390/molecules16064884
   Cunze S, 2016, PARASITE VECTOR, V9, P1
   Dahham SS, 2016, BMC COMPLEM ALTERN M, V16, P11
   Deepak P, 2017, ARTIF CELL NANOMED B, V45, P990, DOI 10.1080/21691401.2016.1198365
   Elemike EE, 2017, MAT SCI ENG C-MATER, V75, P980, DOI 10.1016/j.msec.2017.02.161
   Finney DJ, 1971, PROBIT ANAL, P68, DOI DOI 10.1007/BF02431962
   Fouad H, 2018, ARTIF CELL NANOMED B, V46, P558, DOI 10.1080/21691401.2017.1329739
   Fouad H, 2017, ARTIF CELL NANOMED B, V45, P1369, DOI 10.1080/21691401.2016.1241793
   Gopinath K, 2017, J CLUST SCI, V28, P1541, DOI 10.1007/s10876-017-1164-6
   Govindarajan M., 2016, ARTIF CELL NANOMED B, P1
   Govindarajan M, 2018, PHYSIOL MOL PLANT P, V101, P219, DOI 10.1016/j.pmpp.2017.01.003
   Govindarajan M, 2016, J PHOTOCH PHOTOBIO B, V161, P482, DOI 10.1016/j.jphotobiol.2016.06.016
   Govindarajan M, 2016, EXP PARASITOL, V161, P40, DOI 10.1016/j.exppara.2015.12.011
   Jinu U, 2018, PHYSIOL MOL PLANT P, V101, P163, DOI 10.1016/j.pmpp.2017.05.003
   Kalimuthu K, 2017, PROCESS SAF ENVIRON, V109, P82, DOI 10.1016/j.psep.2017.03.027
   Kjanijou M., 2012, Asian Journal of Biological Sciences, V5, P201
   Krishna IM, 2016, APPL NANOSCI, V6, P681, DOI 10.1007/s13204-015-0479-6
   Kumar PM, 2016, PARASITOL RES, V115, P751, DOI 10.1007/s00436-015-4799-y
   Manjamadha VP, 2016, BIOPROC BIOSYST ENG, V39, P401, DOI 10.1007/s00449-015-1523-3
   Manju S, 2016, MICROB PATHOGENESIS, V91, P129, DOI 10.1016/j.micpath.2015.11.021
   Ngoagouni C, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2101-0
   Nunes FC, 2015, PARASITOL RES, V114, P543, DOI 10.1007/s00436-014-4216-y
   Park HM, 2012, J ASIA-PAC ENTOMOL, V15, P631, DOI 10.1016/j.aspen.2012.07.006
   Rajaganesh R, 2016, RES VET SCI, V109, P40, DOI 10.1016/j.rvsc.2016.09.012
   Ramanibai R, 2016, J ASIA-PAC ENTOMOL, V19, P603, DOI 10.1016/j.aspen.2016.06.007
   Rokade AA, 2017, J CLUST SCI, V28, P2017, DOI 10.1007/s10876-017-1196-y
   Suman TY, 2013, IND CROP PROD, V47, P239, DOI 10.1016/j.indcrop.2013.03.010
   Sundararajan B, 2017, J TRACE ELEM MED BIO, V43, P187, DOI 10.1016/j.jtemb.2017.03.008
   Suresh U, 2018, PHYSIOL MOL PLANT P, V101, P225, DOI 10.1016/j.pmpp.2017.01.002
   Vilas V, 2016, J MOL LIQ, V221, P179, DOI 10.1016/j.molliq.2016.05.066
   Vilas V, 2016, MAT SCI ENG C-MATER, V61, P429, DOI 10.1016/j.msec.2015.12.083
   WHO, 1996, REP WHO INF CONS EV
   Yuan CG, 2017, J CLUST SCI, V28, P1319, DOI 10.1007/s10876-016-1147-z
   Zahran HEM, 2017, J ASIA-PAC ENTOMOL, V20, P133, DOI 10.1016/j.aspen.2016.12.006
   Zhang RQ, 2016, EUR J DRUG METAB PH, V41, P441, DOI 10.1007/s13318-015-0272-7
   Zhang Z, 2014, J BRAZIL CHEM SOC, V25, P20, DOI 10.5935/0103-5053.20130263
NR 49
TC 6
Z9 6
U1 0
U2 16
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 2169-1401
EI 2169-141X
J9 ARTIF CELL NANOMED B
JI Artif. Cell. Nanomed. Biotechnol.
PY 2018
VL 46
IS 6
BP 1171
EP 1179
DI 10.1080/21691401.2017.1365723
PG 9
WC Biotechnology & Applied Microbiology; Engineering, Biomedical; Materials
   Science, Biomaterials
SC Biotechnology & Applied Microbiology; Engineering; Materials Science
GA GI5GE
UT WOS:000434398200009
PM 28859534
OA Bronze
DA 2020-07-08
ER

PT J
AU Stewart-Ibarra, AM
   Ryan, SJ
   Kenneson, A
   King, CA
   Abbott, M
   Barbachano-Guerrero, A
   Beltran-Ayala, E
   Borbor-Cordova, MJ
   Cardenas, WB
   Cueva, C
   Finkelstein, JL
   Lupone, CD
   Jarman, RG
   Berry, IM
   Mehta, S
   Polhemus, M
   Silva, M
   Endy, TP
AF Stewart-Ibarra, Anna M.
   Ryan, Sadie J.
   Kenneson, Aileen
   King, Christine A.
   Abbott, Mark
   Barbachano-Guerrero, Arturo
   Beltran-Ayala, Efrain
   Borbor-Cordova, Mercy J.
   Cardenas, Washington B.
   Cueva, Cinthya
   Finkelstein, Julia L.
   Lupone, Christina D.
   Jarman, Richard G.
   Berry, Irina Maljkovic
   Mehta, Saurabh
   Polhemus, Mark
   Silva, Mercy
   Endy, Timothy P.
TI The Burden of Dengue Fever and Chikungunya in Southern Coastal Ecuador:
   Epidemiology, Clinical Presentation, and Phylogenetics from the First
   Two Years of a Prospective Study
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID PRIMARY-SCHOOL CHILDREN; ZIKA VIRUS; KAMPHAENG PHET; AEDES-AEGYPTI;
   AUTOCHTHONOUS TRANSMISSION; MAXIMUM-LIKELIHOOD; THAI VILLAGES;
   INFECTION; AMERICA; SURVEILLANCE
AB Here, we report the findings from the first 2 years (2014-2015) of an arbovirus surveillance study conducted in Machala, Ecuador, a dengue-endemic region. Patients with suspected dengue virus (DENV) infections (index cases, N= 324) were referred from five Ministry of Health clinical sites. A subset of DENV-positive index cases (N= 44) were selected, and individuals from the index household and four neighboring homes within 200 m were recruited (N = 400). Individuals who entered the study, other than the index cases, are referred to as associates. In 2014, 70.9% of index cases and 35.6% of associates had acute or recent DENV infections. In 2015, 28.3% of index cases and 12.8% of associates had acute or recentDENV infections. For every DENV infection captured by passive surveillance, we detected an additional three acute or recent DENV infections in associates. Of associates with acuteDENV infections, 68% reported dengue-like symptoms, with the highest prevalence of symptomatic acute infections in children aged less than 10 years. The first chikungunya virus (CHIKV) infections were detected on epidemiological week 12 in 2015; 43.1% of index cases and 3.5% of associates had acute CHIKV infections. No Zika virus infections were detected. Phylogenetic analyses of isolates of DENV from 2014 revealed genetic relatedness and shared ancestry of DENV1, DENV2, and DENV4 genomes from Ecuador with those from Venezuela and Colombia, indicating the presence of viral flow between Ecuador and surrounding countries. Enhanced surveillance studies, such as this, provide high-resolution data on symptomatic and inapparent infections across the population.
C1 [Stewart-Ibarra, Anna M.; Ryan, Sadie J.; Kenneson, Aileen; King, Christine A.; Abbott, Mark; Cueva, Cinthya; Lupone, Christina D.; Polhemus, Mark; Endy, Timothy P.] SUNY Upstate Med Univ, Ctr Global Hlth & Translat Sci, 505 Irving Ave, Syracuse, NY 13210 USA.
   [Stewart-Ibarra, Anna M.; Polhemus, Mark; Endy, Timothy P.] SUNY Upstate Med Univ, Dept Med, Syracuse, NY 13210 USA.
   [Ryan, Sadie J.] Univ Florida, Dept Geog, Gainesville, FL 32611 USA.
   [Ryan, Sadie J.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA.
   [Ryan, Sadie J.] Univ Kwazulu Natal, Coll Life Sci, Durban, South Africa.
   [King, Christine A.; Abbott, Mark; Barbachano-Guerrero, Arturo; Endy, Timothy P.] SUNY Upstate Med Univ, Dept Microbiol & Immunol, Syracuse, NY 13210 USA.
   [Beltran-Ayala, Efrain] Univ Tecn Machala, Dept Med, Machala, El Oro, Ecuador.
   [Borbor-Cordova, Mercy J.; Cardenas, Washington B.] Escuela Super Politecn Litoral, Fac Ciencias Vida, Lab Invest Biomed, Guayaquil, Guayas Province, Ecuador.
   [Finkelstein, Julia L.; Mehta, Saurabh] Cornell Univ, Div Nutr Sci, Ithaca, NY USA.
   [Lupone, Christina D.] SUNY Upstate Med Univ, Dept Publ Hlth & Preventat Med, Syracuse, NY 13210 USA.
   [Jarman, Richard G.; Berry, Irina Maljkovic] Walter Reed Army Inst Res, Viral Dis Branch, Silver Spring, MD USA.
   [Silva, Mercy] Minist Hlth, Machala, El Oro, Ecuador.
   [Kenneson, Aileen] US Ctr Dis Control, Atlanta, GA USA.
   [Barbachano-Guerrero, Arturo; Cardenas, Washington B.] Escuela Super Politecn Litoral ESPOL, Dept Marine Engn Ocean & Biol Sci & Nat Resources, Guayaquil, Ecuador.
RP Stewart-Ibarra, AM (corresponding author), SUNY Upstate Med Univ, Ctr Global Hlth & Translat Sci, 505 Irving Ave, Syracuse, NY 13210 USA.
EM stewarta@upstate.edu; sjryan@ufl.edu; aileen.kenneson@yahoo.com;
   kingch@upstate.edu; abbottm@upstate.edu; barbacha@upstate.edu;
   felixbeltran57@hotmail.com; meborbor@espol.edu.ec;
   wbcarden@espol.edu.ec; cinthya.cueva10@gmail.com;
   jfinkelstein@cornell.edu; luponec@upstate.edu;
   richard.g.jarman.mil@mail.mil; irina.maljkovicberry.ctr@mail.mil;
   smehta@cornell.edu; polhemum@upstate.edu; mercysilvab@hotmail.com;
   endyt@upstate.edu
RI Mehta, Saurabh/L-8490-2017; Ryan, Sadie Jane/H-7488-2019
OI Mehta, Saurabh/0000-0003-3788-0665; Ryan, Sadie
   Jane/0000-0002-4308-6321; Borbor, Mercy/0000-0002-7418-141X; Maljkovic
   Berry, Irina/0000-0001-8555-5352; Barbachano-Guerrero,
   Arturo/0000-0001-7483-839X
FU Department of Defense Global Emerging Infection Surveillance (GEIS)
   [P0220_13_OT]; Department of Medicine of SUNY Upstate Medical
   University; NSFNational Science Foundation (NSF) [DEB EEID 1518681, DEB
   RAPID 1641145]; Prometeo program of the National Secretary of Higher
   Education, Science, Technology, and Innovation (SENESCYT) of Ecuador
FX This study was supported, in part, by the Department of Defense Global
   Emerging Infection Surveillance (GEIS) grant (P0220_13_OT) and the
   Department of Medicine of SUNY Upstate Medical University. A. M. S.-I.
   and S. J. R. were additionally supported by NSF DEB EEID 1518681 and NSF
   DEB RAPID 1641145. Additional support was provided to A. M. S.-I.
   through the Prometeo program of the National Secretary of Higher
   Education, Science, Technology, and Innovation (SENESCYT) of Ecuador.
CR Alava A., 2005, REV ECUAT HIG MED TR, V42, P11
   Ali A, 2013, INT J INFECT DIS, V17, pE518, DOI 10.1016/j.ijid.2013.01.007
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   Anders KL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003528
   Balmaseda A, 2010, J INFECT DIS, V201, P5, DOI 10.1086/648592
   Beckett CG, 2005, AM J TROP MED HYG, V72, P777, DOI 10.4269/ajtmh.2005.72.777
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Borbor-Cordova M, 2016, CLIMATE SERVICES HLT
   CAMARGO S, 1967, B WORLD HEALTH ORGAN, V36, P602
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Dick OB, 2012, AM J TROP MED HYG, V87, P584, DOI 10.4269/ajtmh.2012.11-0770
   Endy TP, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000975
   Endy TP, 2002, AM J EPIDEMIOL, V156, P40, DOI 10.1093/aje/kwf005
   Espino C, 2010, ACTIVE SURVEILLANCE
   Fernandez E, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-2024-y
   Fry SR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001199
   Gonzalez V, 2007, GUAYAQUIL AEDES AEGY, P1740
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Handel Andrew S, 2016, Trop Dis Travel Med Vaccines, V2, P8, DOI 10.1186/s40794-016-0024-y
   Heydari N, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14020196
   Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55
   Kenneson A, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006150
   Krisher LK, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1630-x
   Kuan G, 2009, AM J EPIDEMIOL, V170, P120, DOI 10.1093/aje/kwp092
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Le Gonidec E, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004755
   LI H, 2013, 13033997 ARXIV, V1303, P3997, DOI DOI 10.1093/BI0INF0RMATICS/BTP352
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Lowe R, 2017, LANCET PLANET HEALTH, V1, pE142, DOI 10.1016/S2542-5196(17)30064-5
   San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346
   Lustig Y, 2016, EURO SURVEILL
   Mammen MP, 2008, PLOS MED, V5, P1605, DOI 10.1371/journal.pmed.0050205
   Ministerio de Salud Publica, 2010, CAS DENG REP EP LOC
   Murray KO, 2013, VECTOR-BORNE ZOONOT, V13, P835, DOI 10.1089/vbz.2013.1413
   Olkowski S, 2016, 040220 BIORXIV, DOI [10.1101/040220, DOI 10.1101/040220]
   PAHO, 2017, ZIK CAS CONG SYNDR A
   PAHO/WHO, 2017, ANN CAS REP DENG
   PAHO/WHO, 2017, NUMB REP CAS CHIK FE
   Pal S, 2015, J CLIN MICROBIOL, V53, P1092, DOI 10.1128/JCM.03042-14
   Pan-ngum W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050765
   Pang JX, 2015, EXPERT REV ANTI-INFE, V13, P731, DOI 10.1586/14787210.2015.1028364
   Parreira R, 2014, J INFECT DEV COUNTR, V8, P1210, DOI 10.3855/jidc.4910
   Ponce P, 2018, J MED ENTOMOL, V55, P248, DOI 10.1093/jme/tjx165
   Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083
   Pyke AT, 2016, SCI REP-UK, V6, DOI 10.1038/srep22356
   Quintero J, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-38
   Ramos MM, 2008, AM J TROP MED HYG, V79, P123, DOI 10.4269/ajtmh.2008.79.123
   Reiner RC, 2014, P NATL ACAD SCI USA, V111, pE2694, DOI 10.1073/pnas.1314933111
   Restrepo BN, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/120496
   Rico-Hesse R, 2010, CURR TOP MICROBIOL, V338, P45, DOI 10.1007/978-3-642-02215-9_4
   Rocha C, 2009, AM J TROP MED HYG, V80, P656, DOI 10.4269/ajtmh.2009.80.656
   Santiago GA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002311
   Shepard DS, 2011, AM J TROP MED HYG, V84, P200, DOI 10.4269/ajtmh.2011.10-0503
   Sommerfeld J, 2012, PATHOG GLOB HEALTH, V106, P428, DOI 10.1179/2047773212Y.0000000055
   Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8
   Standish K, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000633
   Ibarra AMS, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1135
   Stewart-Ibarra AM, 2013, PLOS ONE, V8
   Stewart-Ibarra AM, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0610-4
   Stewart-Ibarra AM, 2013, AM J TROP MED HYG, V88, P971, DOI 10.4269/ajtmh.12-0478
   Stoddard ST, 2013, P NATL ACAD SCI USA, V110, P994, DOI 10.1073/pnas.1213349110
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   Thai KTD, 2010, J INFECTION, V60, P229, DOI 10.1016/j.jinf.2010.01.003
   Thomas L, 2008, AM J TROP MED HYG, V78, P990
   Thomas SJ, 2015, AM J TROP MED HYG, V93, P24, DOI 10.4269/ajtmh.14-0242
   United States Centers for Disease Control and Prevention, 2013, DENV 1 4 REAL TIM RT
   United States Centers for Disease Control (CDC), 1989, MMWR-MORBID MORTAL W, V38, P419
   Viennet E, 2017, LANCET PLANET HEALTH, V1, pE126, DOI 10.1016/S2542-5196(17)30065-7
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   WHO, 2017, DENG SEV DENG
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Yoon IK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001730
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zim MAM, 2013, J CLIN VIROL, V56, P141, DOI 10.1016/j.jcv.2012.10.019
NR 77
TC 13
Z9 13
U1 0
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 98
IS 5
BP 1444
EP 1459
DI 10.4269/ajtmh.17-0762
PG 16
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA GG9RD
UT WOS:000433037800038
PM 29512482
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Biava, M
   Caglioti, C
   Castilletti, C
   Bordi, L
   Carletti, F
   Colavita, F
   Quartu, S
   Nicastri, E
   Iannetta, M
   Vairo, F
   Liuzzi, G
   Taglietti, F
   Ippolito, G
   Capobianchi, MR
   Lalle, E
AF Biava, Mirella
   Caglioti, Claudia
   Castilletti, Concetta
   Bordi, Licia
   Carletti, Fabrizio
   Colavita, Francesca
   Quartu, Serena
   Nicastri, Emanuele
   Iannetta, Marco
   Vairo, Francesco
   Liuzzi, Giuseppina
   Taglietti, Fabrizio
   Ippolito, Giuseppe
   Capobianchi, Maria Rosaria
   Lalle, Eleonora
TI Persistence of ZIKV-RNA in the cellular fraction of semen is accompanied
   by a surrogate-marker of viral replication. Diagnostic implications for
   sexual transmission
SO NEW MICROBIOLOGICA
LA English
DT Article
DE Zika virus; Semen; Replication markers; Cell-associated ZIKV-RNA; Sexual
   transmission
ID VIRUS
AB As asymptomatic infections represent 80% of ZIKV-infected individuals, sexual transmission is a rising concern. Recent studies highlighted a preferential association of ZIKV with the cellular fraction (CF) of different specimen types. Our aim was to evaluate the presence of ZIKV-RNA in different body fluids, focusing on semen specimens to assess the ZIKV-RNA content in either the unfractionated sample, its CF or seminal plasma (SP). In addition, to establish if the presence of ZIKV genome was associated with active virus replication, we measured the levels of negative-strand ZIKV-RNA. ZIKV total-RNA was detected in blood, urine and unfractionated semen, and neg-RNA in semen CF and SP samples longitudinally collected from two ZIKV-positive men followed at the National Institute for Infectious Diseases "L. Spallanzani", Italy. In both patients, ZIKV total-RNA was detected in CF with ct values always lower than in the corresponding unfractionated samples, and was observed even in the CF from negative unfractionated semen samples. In Patient 2, neg-RNA was also detected in CF, suggesting ongoing viral replication. Our results demonstrate higher clinical sensitivity of CF as compared to whole semen testing, emphasizing the need to extend ZIKV-RNA testing to CF, to rule out virus presence and the possible risk of sexual transmission.
C1 [Biava, Mirella; Caglioti, Claudia; Castilletti, Concetta; Bordi, Licia; Carletti, Fabrizio; Colavita, Francesca; Quartu, Serena; Capobianchi, Maria Rosaria; Lalle, Eleonora] IRCCS, Natl Inst Infect Dis L Spallanzani, Lab Virol, Rome, Italy.
   [Nicastri, Emanuele; Iannetta, Marco; Liuzzi, Giuseppina; Taglietti, Fabrizio] IRCCS, Natl Inst Infect Dis Lazzaro Spallanzani, Clin Dept, Rome, Italy.
   [Vairo, Francesco; Ippolito, Giuseppe] IRCCS, Natl Inst Infect Dis L Spallanzani, Dept Epidemiol Preclin Res & Adv Diagnost, Rome, Italy.
RP Castilletti, C (corresponding author), IRCCS, Natl Inst Infect Dis L Spallanzani, Lab Virol, Rome, Italy.
EM concetta.castilletti@inmi.it
RI Castilletti, Concetta/B-6545-2016; Colavita, Francesca/I-8848-2018;
   Iannetta, Marco/M-4619-2019; Iannetta, Marco/B-5596-2017; nicastri,
   emanuele/K-7780-2016; Castilletti, Concetta/AAA-8408-2019
OI Castilletti, Concetta/0000-0001-9819-236X; Colavita,
   Francesca/0000-0003-0640-8667; Iannetta, Marco/0000-0002-6938-8627;
   Iannetta, Marco/0000-0002-6938-8627; nicastri,
   emanuele/0000-0002-5606-8712; Castilletti, Concetta/0000-0001-9819-236X;
   Quartu, Serena/0000-0003-3866-3021; PERNO, CARLO
   FEDERICO/0000-0002-0825-5388; Ippolito, Giuseppe/0000-0002-1076-2979;
   lalle, eleonora/0000-0002-7063-9905
FU Italian Ministry of HealthMinistry of Health, Italy; European Seventh
   Framework ProgrammeEuropean Union (EU) [278433-PREDEMICS]; European
   Union Horizon Programme [653316-EVAg]
FX This work was supported by grants of Italian Ministry of Health, for
   "Ricerca Corrente" and "Ricerca Finalizzata", by European Seventh
   Framework Programme [Grant n. 278433-PREDEMICS]; European Union Horizon
   2020 Programme [Grant n. 653316-EVAg].
CR Barzon L., 2016, EUROSURVEILLANCE, V21, P2016, DOI DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Biava M, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006065
   CDC Centers for Disease Control and Prevention, 2017, AR ZIK
   Coffey LL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171148
   Crozier I, 2016, J INFECT DIS, V214, P1467, DOI 10.1093/infdis/jiw079
   European Centre for Disease Prevention and Control, 2016, ZIK VIR DIS EP POT A
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Musso D., 2014, EURO SURVEILL, V19
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Paz-Bailey G, 2017, N ENGL J MED
   Petersen LR, 2016, NEW ENGL J MED, V375, P294, DOI 10.1056/NEJMc1606769
   Uraki R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602899
NR 15
TC 5
Z9 5
U1 0
U2 2
PU EDIZIONI INT SRL
PI PAVIA
PA DIV EDIMES, EDIZIONI MEDICO SCIENTIFICHE PAVIA, VIA RIVIERA, PAVIA,
   39-27100, ITALY
SN 1121-7138
J9 NEW MICROBIOL
JI New Microbiol.
PD JAN
PY 2018
VL 41
IS 1
BP 30
EP 33
PG 4
WC Microbiology
SC Microbiology
GA GG7JQ
UT WOS:000432874700003
PM 29112766
DA 2020-07-08
ER

PT J
AU Grossi, PA
   Percivalle, E
   Campanini, G
   Sarasini, A
   Premoli, M
   Zavattoni, M
   Girello, A
   Gasperina, DD
   Balsamo, ML
   Baldanti, F
   Rovida, F
AF Grossi, Paolo Antonio
   Percivalle, Elena
   Campanini, Giulia
   Sarasini, Antonella
   Premoli, Marta
   Zavattoni, Maurizio
   Girello, Alessia
   Gasperina, Daniela Dalla
   Balsamo, Maria Luisa
   Baldanti, Fausto
   Rovida, Francesca
TI An autochthonous sexually transmitted Zika virus infection in Italy 2016
SO NEW MICROBIOLOGICA
LA English
DT Article
DE Zika virus; Sexual transmission; Non-vector-borne transmission
ID MICRONESIA; OUTBREAK
AB We describe two cases of Zika virus infection involving an Italian patient returning from the Dominican Republic and his wife, who remained in Italy and had not travelled to Zika virus endemic areas in the previous months. The infection was transmitted through unprotected sexual intercourse after the man's return to Italy.
C1 [Grossi, Paolo Antonio; Gasperina, Daniela Dalla; Balsamo, Maria Luisa] Univ Insubria, Dept Surg & Morphol Sci Clin Med, Varese, Italy.
   [Percivalle, Elena; Campanini, Giulia; Sarasini, Antonella; Premoli, Marta; Zavattoni, Maurizio; Girello, Alessia; Baldanti, Fausto; Rovida, Francesca] Fdn IRCCS Policlin San Matteo, Microbiol & Virol Dept, Pavia, Italy.
   [Baldanti, Fausto] Univ Pavia, Dept Clin Surg Diagnost & Pediat Sci, Pavia, Italy.
RP Baldanti, F (corresponding author), Fdn IRCCS Policlin San Matteo, Microbiol & Virol Dept, Pavia, Italy.; Baldanti, F (corresponding author), Univ Pavia, Dept Clin Surg Diagnost & Pediat Sci, Pavia, Italy.
EM f.baldanti@smatteo.pv.it
RI Rovida, Francesca/K-7984-2016; percivalle, elena/K-7994-2016; Campanini,
   Giulia/J-4889-2018; Girello, Alessia/J-5350-2018; Baldanti,
   Fausto/J-4924-2018; DALLA GASPERINA, DANIELA/K-9580-2016; GROSSI,
   PAOLO/A-6158-2013
OI Rovida, Francesca/0000-0003-2345-2790; percivalle,
   elena/0000-0002-3355-1410; Campanini, Giulia/0000-0002-3536-2437;
   Girello, Alessia/0000-0002-9498-157X; Baldanti,
   Fausto/0000-0002-3358-8969; DALLA GASPERINA,
   DANIELA/0000-0002-1187-6222; GROSSI, PAOLO/0000-0003-2883-5061
FU Ministero della Salute, Fondazione IRCCS Policlinico San Matteo, Ricerca
   CorrenteMinistry of Health, Italy [80206]
FX We thank all the technical staff for handling the specimens and
   performing the assays. We thank Mrs Daniela Sartori for manuscript
   editing and Mrs Sheila McVeigh for English revision. This work was
   funded by Ministero della Salute, Fondazione IRCCS Policlinico San
   Matteo, Ricerca Corrente (grant no. 80206).
CR Barzon L., 2016, EUROSURVEILLANCE, V21, P2016, DOI DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Pan American Health Organization/ World Health Organization, ZIK EP
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Scaramozzino N, 2001, J CLIN MICROBIOL, V39, P1922, DOI 10.1128/JCM.39.5.1922-1927.2001
   Timiryasova TM, 2013, AM J TROP MED HYG, V88, P962, DOI 10.4269/ajtmh.12-0461
NR 13
TC 3
Z9 3
U1 0
U2 0
PU EDIZIONI INT SRL
PI PAVIA
PA DIV EDIMES, EDIZIONI MEDICO SCIENTIFICHE PAVIA, VIA RIVIERA, PAVIA,
   39-27100, ITALY
SN 1121-7138
J9 NEW MICROBIOL
JI New Microbiol.
PD JAN
PY 2018
VL 41
IS 1
BP 80
EP 82
PG 3
WC Microbiology
SC Microbiology
GA GG7JQ
UT WOS:000432874700013
PM 29112768
DA 2020-07-08
ER

PT J
AU Carod-Artal, FJ
AF Javier Carod-Artal, Francisco
TI Neurological complications of Zika virus infection
SO EXPERT REVIEW OF ANTI-INFECTIVE THERAPY
LA English
DT Review
DE Congenital Zika virus syndrome; encephalitis; flavivirus; Guillain-Barre
   syndrome; microcephaly; myelitis; Zika virus
ID GUILLAIN-BARRE-SYNDROME; AUTONOMIC DYSFUNCTION; IMAGING FINDINGS;
   COLOMBIA; PREGNANCY; OUTBREAK; AMERICA; BRAZIL; EPIDEMIOLOGY;
   MENINGOENCEPHALITIS
AB Introduction: Zika virus (ZIKV) disease is a vector-borne infectious disease transmitted by Aedes mosquitoes. Recently, ZIKV has caused outbreaks in most American countries.Areas covered: Publications about neurological complications of ZIKV infection retrieved from pubmed searchers were reviewed, and reference lists and relevant articles from review articles were also examined. Vertical/intrauterine transmission leads to congenital infection and causes microcephaly and congenital ZIKV syndrome. ZIKV preferentially infects human neural progenitor cells and triggers cell apoptosis. ZIKV RNA has been identified in foetal brain tissue and brains of microcephalic infants who died; amniotic fluid and placentas of pregnant mothers; and umbilical cord, cerebro-spinal fluid and meninges of newborns. The increase in the number of Guillain-Barre syndrome (GBS) cases during the ZIKV outbreak in the Americas provides epidemiological evidence for the link between ZIKV infection and GBS. Less frequently reported ZIKV neurological complications include encephalitis/meningoencephalitis, acute disseminated encephalomyelitis, myelitis, cerebrovascular complications (ischemic infarction; vasculopathy), seizures and encephalopathy, sensory polyneuropathy and sensory neuronopathy. Analysis of GBS incidence could serve as an epidemiological marker' or sentinel for ZIKV disease and other neurological complications associated to ZIKV.Expert commentary: An expanding spectrum of neurological complications associated with ZIKV infection is being recognised.
C1 [Javier Carod-Artal, Francisco] Raigmore Hosp, Dept Neurol, Inverness, Scotland.
   [Javier Carod-Artal, Francisco] Univ Int Catalunya, Trop Neurol, Barcelona, Spain.
RP Carod-Artal, FJ (corresponding author), Raigmore Hosp, Dept Neurol, Inverness, Scotland.; Carod-Artal, FJ (corresponding author), Univ Int Catalunya, Trop Neurol, Barcelona, Spain.
EM fjcarod-artal@hotmail.com
CR Abrams RPM, 2017, NEUROTHERAPEUTICS, V14, P1027, DOI 10.1007/s13311-017-0575-2
   Anaya JM, 2017, J AUTOIMMUN, V77, P123, DOI 10.1016/j.jaut.2016.12.007
   [Anonymous], ZIK VIR
   Aragao MFVV, 2017, AM J NEURORADIOL, V38, P1045, DOI 10.3174/ajnr.A5125
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Ferreira MLB, 2017, AM J TROP MED HYG, V97, P1405, DOI 10.4269/ajtmh.17-0106
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Artal FJC, 2016, EXPERT REV NEUROTHER, V16, P205, DOI 10.1586/14737175.2015.1134321
   Carod-Artal FJ, 2016, REV NEUROLOGIA, V62, P317, DOI 10.33588/rn.6207.2016152
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chibueze EC, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0285-6
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   de Magalhaes-Barbosa MC, 2016, TRAVEL MED INFECT DI, V14, P458, DOI 10.1016/j.tmaid.2016.09.006
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   de Souza AS, 2018, CHILD NERV SYST, V34, P85, DOI 10.1007/s00381-017-3637-1
   Deseda CC, 2017, CURR OPIN PEDIATR, V29, P97, DOI 10.1097/MOP.0000000000000442
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P910, DOI 10.15585/mmwr.mm6534e1
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Machado-Alba JE, 2016, INT J INFECT DIS, V51, P133, DOI 10.1016/j.ijid.2016.09.010
   Eppes C, 2017, AM J OBSTET GYNECOL, V216, P209, DOI 10.1016/j.ajog.2017.01.020
   Fabrizius RG, 2016, AM J TROP MED HYG, V95, P1161, DOI 10.4269/ajtmh.16-0397
   FAGBAMI A, 1977, TROP GEOGR MED, V29, P187
   da Silva IRF, 2017, JAMA NEUROL, V74, P1190, DOI 10.1001/jamaneurol.2017.1703
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Galliez RM, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw203
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Gaudinski MR, 2018, LANCET, V391, P552, DOI 10.1016/S0140-6736(17)33105-7
   Gold CA, 2016, JAMA NEUROL, V73, P905, DOI 10.1001/jamaneurol.2016.1268
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Huang WC, 2016, SCI REP-UK, V6, DOI 10.1038/srep34793
   Jampol LM, 2016, JAMA OPHTHALMOL, V134, P535, DOI 10.1001/jamaophthalmol.2016.0284
   Carod-Artal FJ, 2018, CLIN AUTON RES, V28, P161, DOI 10.1007/s10286-018-0516-0
   Carod-Artal FJ, 2018, CLIN AUTON RES, V28, P67, DOI 10.1007/s10286-017-0452-4
   Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9
   Jouannic JM, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00625-5
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Landais A, 2017, J NEUROL SCI, V383, P211, DOI 10.1016/j.jns.2017.10.045
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Leis AA, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00170
   Lira Cleto T, 2016, PEDIAT NEUROLOGY, V65
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   McArthur MA, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9060143
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Medina MT, 2016, J NEUROL SCI, V369, P271, DOI 10.1016/j.jns.2016.08.044
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mendez N, 2017, ARCH PUBLIC HEALTH, V75, DOI 10.1186/s13690-017-0233-5
   Miller E, 2017, J NEUROL SCI, V375, P367, DOI 10.1016/j.jns.2017.02.029
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Mulkey SB, 2018, PEDIATR NEUROL, V81, P55, DOI 10.1016/j.pediatrneurol.2018.01.006
   Martinez ARM, 2018, MUSCLE NERVE, V57, pE100, DOI 10.1002/mus.25958
   Nascimento OJM, 2017, NEUROLOGY, V88, P2330, DOI 10.1212/WNL.0000000000004026
   Niemeyer B, 2017, EUR NEUROL, V77, P45, DOI 10.1159/000453396
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Palacios E, 2019, NEUROLOGIA, V34, P204, DOI 10.1016/j.nrl.2016.08.006
   Pan American Health Organization/ World Health Organization, 2016, GUID SURV ZIK VIR DI
   Parke DW, 2016, OPHTHALMOLOGY, DOI [10.1016/j.optha.2016.06.039., DOI 10.1016/J.OPTHA.2016.06.039, 10.1016/j.optha.2016.06.039]
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Pradhan F, 2017, AM J TROP MED HYG, V97, P340, DOI 10.4269/ajtmh.16-0921
   Resiere D, 2018, J CLIN VIROL, V98, P8, DOI 10.1016/j.jcv.2017.11.002
   Reyna-Villasmil E, 2016, MED CLIN-BARCELONA, V146, P331, DOI 10.1016/j.medcli.2016.02.002
   Rodriguez Y, 2018, CLIN AUTON RES, V28, P211, DOI 10.1007/s10286-018-0515-1
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Roze B, 2016, EUROSURVEILLANCE, P21, DOI DOI 10.28707/1560-7917.ES.2016.21.9.30154
   Saad T, 2018, CHILD NERV SYST, V34, P73, DOI 10.1007/s00381-017-3634-4
   Salinas JL, 2017, J NEUROL SCI, V381, P272, DOI 10.1016/j.jns.2017.09.001
   Sarmiento-Ospina A, 2016, LANCET INFECT DIS, V16, P523, DOI 10.1016/S1473-3099(16)30006-8
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Satterfield-Nash A, 2017, MMWR-MORBID MORTAL W, V66, P1347, DOI 10.15585/mmwr.mm6649a2
   Schaub B, 2017, LANCET CHILD ADOLESC, V1, P45, DOI 10.1016/S2352-4642(17)30001-9
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Schwartz DA, 2017, ARCH GYNECOL OBSTET, V295, P1361, DOI 10.1007/s00404-017-4361-5
   Sejvar JJ, 2011, VACCINE, V29, P599, DOI 10.1016/j.vaccine.2010.06.003
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Soares CN, 2016, J CLIN VIROL, V83, P63, DOI 10.1016/j.jcv.2016.08.297
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tebas Pablo, 2017, N Engl J Med, DOI 10.1056/NEJMoa1708120
   Sebastian UU, 2017, J CRIT CARE, V42, P275, DOI 10.1016/j.jcrc.2017.07.038
   Uncini A, 2017, J NEUROL NEUROSUR PS, V88, P266, DOI 10.1136/jnnp-2016-314310
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Villamil-Gomez WE, 2017, TRAVEL MED INFECT DI, V16, P62, DOI 10.1016/j.tmaid.2017.03.012
   Watrin L, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003257
   WHO, 2017, ZIK VIR SIT REP
   World Health Organization, ZIK VIR RES AG
   Zacharias N, 2017, AJP REP, V7, P68, DOI 10.1055/s-0037-1601890
NR 97
TC 16
Z9 16
U1 2
U2 8
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1478-7210
EI 1744-8336
J9 EXPERT REV ANTI-INFE
JI Expert Rev. Anti-Infect. Ther.
PY 2018
VL 16
IS 5
BP 399
EP 410
DI 10.1080/14787210.2018.1466702
PG 12
WC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
SC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
GA GG2RI
UT WOS:000432539700007
PM 29668332
DA 2020-07-08
ER

PT J
AU Mohydin, M
   Tahir, H
   Rasheed, MHU
   Bashir, F
AF Mohydin, Mahnoor
   Tahir, Hamza
   Rasheed, Mohammad Haroon Ur
   Bashir, Faiza
TI Zika Virus: An Emerging Infection
SO PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES
LA English
DT Article
DE Arboviruses; Aedes aegypti; Aedes aegypti; Zika Virus
ID MANAGEMENT
AB Zika Virus (ZIKV) having its name originated from Zika forest belongs to the family of Flaviviradae, which is a clinical classifying group of Arboviruses. In 1952 the first human case was being reported and since then, more cases have been reported specifically in the African-Asian equatorial belt. Zika virus spread around the globe makes it an alarming concern, thus it has been declared by WHO as a state of 'international emergency'. The Infected Aedes aegypti species mosquito is a vector of transmission in the African region, while Aedes albopictus is a vector of transmission in the Asian region. Zika Virus is transmitted through blood and lymphatics, saliva, semen, and more importantly transmitted from an infected mother to an infant, during anytime of pregnancy. No anti-viral treatment exists for ZIKV so as no vaccination is present for ZIKV. The best preventive measure is to create a barrier for viral transmission. Moreover, public awareness carries great importance in preventing infection of Zika Virus.
C1 [Mohydin, Mahnoor; Tahir, Hamza; Rasheed, Mohammad Haroon Ur] Lahore Med & Dent Coll, Lahore, Pakistan.
   [Bashir, Faiza] SIMS, Pathol Dept, Lahore, Pakistan.
RP Mohydin, M (corresponding author), Lahore Med & Dent Coll, Lahore, Pakistan.
EM mahnoormohydin@gmail.com
CR Ahmad SSY, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1062
   Basile K, 2017, PATHOLOGY, V49, P698, DOI 10.1016/j.pathol.2017.08.002
   Baud D, 2016, LANCET INFECT DIS, V16, P523, DOI 10.1016/S1473-3099(16)30008-1
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Dogan AC, 2017, J MATERN-FETAL NEO M, V30, P386, DOI 10.3109/14767058.2016.1174210
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Huang ASE, 2016, J FORMOS MED ASSOC, V115, P223, DOI 10.1016/j.jfma.2016.03.002
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Panchaud A, 2016, CLIN MICROBIOL REV, V29, P659, DOI 10.1128/CMR.00014-16
   SAIZ JC, 2016, FRONT MICROBIOL, V7
   Sharma A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00110
   Shuaib W, 2016, AM J MED, V129, DOI 10.1016/j.amjmed.2016.02.027
   Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140
NR 16
TC 0
Z9 0
U1 0
U2 0
PU LAHORE MEDICAL & DENTAL COLL
PI LAHORE
PA CANAL BANK N, TULSPURA, LAHORE, 00000, PAKISTAN
SN 1996-7195
J9 PAK J MED HEALTH SCI
JI Pak. J. Med. Health Sci.
PD JAN-MAR
PY 2018
VL 12
IS 1
BP 418
EP 420
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA GF8UK
UT WOS:000432248900121
DA 2020-07-08
ER

PT J
AU Carvalho, HL
   de Amorim, AL
   Araujo, IF
   Marino, BLB
   Jimenez, DEQ
   Ferreira, RMA
   Hage-Melim, LIS
   Souto, RNP
   Porto, ALM
   Ferreira, IM
AF Carvalho, Harlyson L.
   de Amorim, Andreia L.
   Araujo, Inana F.
   Marino, Bianca L. B.
   Jimenez, David E. Q.
   Ferreira, Ricardo M. A.
   Hage-Melim, Lorane I. S.
   Souto, Raimundo N. P.
   Porto, Andre L. M.
   Ferreira, Irlon M.
TI A Simple and Efficient Protocol for the Knoevenagel Reaction of
   Benzylidenemalononitriles and the Evaluation of the Larvicidal Activity
   on Aedes Aegypti
SO REVISTA VIRTUAL DE QUIMICA
LA English
DT Article
DE Aedes aegypti; Green chemistry; Larvicidal activity; Molecular docking
ID MOLECULAR DOCKING; HYDROGEN-PEROXIDE; IODINE; ACETYLCHOLINESTERASE;
   CONDENSATION; RESISTANCE; VECTORS
AB Mosquitoes of the genus Aedes are responsible for dengue, yellow fever, chikungunya and Zika. Although important advances have emerged in the development of alternative methods for mosquito control, chemical insecticides remain a vital part of integrated control programs. In this paper were synthetized benzylidenemalononitrile derivatives in good yields (71-99%) using only water and glycerol at room temperature. A study of the larvicidal activity between benzylidenemalononitriles showed that the compound 2e (R= 4-Cl) possesses excellent larvicidal activity (LC50 and LC90 of 9.42 and 15.02, respectively at 24 h). A study of molecular docking was applied to identify the type of interaction of compound 2e with binding sites at the enzyme acetylcholinesterase. The profile of the interaction showed a score 48.9795 with five bonds at three different amino acids.
C1 [Carvalho, Harlyson L.; de Amorim, Andreia L.; Araujo, Inana F.; Ferreira, Irlon M.] Univ Fed Amapa, Grp Biocatalise & Biotransformacao Quim Organ, Colegiado Quim, Rod JK,KM 02, BR-68902280 Macapa, Amapa, Brazil.
   [Araujo, Inana F.; Ferreira, Ricardo M. A.; Souto, Raimundo N. P.] Univ Fed Amapa, Lab Artropodes, Colegiado Biol, Rod JK,KM 02, BR-68902280 Macapa, Amapa, Brazil.
   [Marino, Bianca L. B.; Hage-Melim, Lorane I. S.] Univ Fed Amapa, Lab Quim Farmaceut & Med, Rod JK,KM 02, BR-68902280 Macapa, Amapa, Brazil.
   [Jimenez, David E. Q.; Porto, Andre L. M.] Univ Sao Paulo, Lab Quim Organ & Biocatalise, Inst Quim Sao Carlos, Av Joao Dagnone,1100,Ed Quimica Ambiental, BR-13563120 Sao Carlos, SP, Brazil.
RP Ferreira, IM (corresponding author), Univ Fed Amapa, Grp Biocatalise & Biotransformacao Quim Organ, Colegiado Quim, Rod JK,KM 02, BR-68902280 Macapa, Amapa, Brazil.
EM irlon.ferreira@gmail.com
RI Ferreira, Irlon M./K-3300-2014; Hage-Melim, Lorane I S/N-4214-2015;
   Jimenez, David Esteban Quintero/AAG-3488-2019; FILHO, IRAMI
   ARAUJO/C-2258-2014; Meleiro Porto, Andre Luiz/H-2584-2012
OI Hage-Melim, Lorane I S/0000-0002-7851-7363; FILHO, IRAMI
   ARAUJO/0000-0003-2471-7447; Souto, Raimundo/0000-0002-8795-1217; Meleiro
   Porto, Andre Luiz/0000-0002-0857-2340; Fauro de Araujo,
   Inana/0000-0002-3168-3137
FU Foundation of the State of Amapa [015/2015]
FX The authors thank the Foundation of the State of Amapa for financial
   support PAPESQ/UNIFAP EDITAL No 015/2015.
CR Arora S, 2017, TOXICOL LETT, V268, P8, DOI 10.1016/j.toxlet.2016.12.009
   Bharathi A., 2014, BIOMEDICAL RES INT, V2014, P2
   CRAMPTON JM, 1994, ANN TROP MED PARASIT, V88, P3, DOI 10.1080/00034983.1994.11812828
   da Silva JBP, 2015, EUR J MED CHEM, V100, P162, DOI 10.1016/j.ejmech.2015.04.061
   de Resende JBM, 2017, CATAL LETT, V147, P167, DOI 10.1007/s10562-016-1916-1
   Dubrulle M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005895
   Erickson JA, 2004, J MED CHEM, V47, P45, DOI 10.1021/jm030209y
   Ferreira IM, 2014, SYNTHETIC COMMUN, V44, P2094, DOI 10.1080/00397911.2013.879900
   Gallo RDC, 2012, TETRAHEDRON LETT, V53, P5372, DOI 10.1016/j.tetlet.2012.07.102
   Gupta S., 2014, BIOMED RES INT, V2014, P1, DOI DOI 10.1155/2014/93201725050379
   Harel M, 2000, PROTEIN SCI, V9, P1063, DOI 10.1110/ps.9.6.1063
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Huang JJ, 2015, TETRAHEDRON, V71, P8628, DOI 10.1016/j.tet.2015.09.018
   Jimenez D. E. Q., 2017, CURRENT MICROWAVE CH, V4, P1
   Kushwah R., 2015, PLOS NEGLECT TROP D, V9, P1
   Li GW, 2012, GREEN CHEM, V14, P2234, DOI 10.1039/c2gc35483g
   Lima EP, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-5
   Lo Presti A, 2016, INFECT GENET EVOL, V41, P270, DOI 10.1016/j.meegid.2016.04.006
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Nkya TE, 2013, INSECT BIOCHEM MOLEC, V43, P407, DOI 10.1016/j.ibmb.2012.10.006
   Oliveira AEMFM, 2017, J NANOBIOTECHNOL, V15, DOI 10.1186/s12951-016-0234-5
   Oliveira AEMFM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145835
   Reegan AD, 2016, MED CHEM RES, V25, P1411, DOI 10.1007/s00044-016-1579-x
   Sharghi H, 2013, TETRAHEDRON, V69, P4708, DOI 10.1016/j.tet.2013.03.073
   Shehab WS, 2016, ARAB J CHEM, V9, pS966, DOI 10.1016/j.arabjc.2011.10.008
   Smith LB, 2016, PESTIC BIOCHEM PHYS, V133, P1, DOI 10.1016/j.pestbp.2016.03.005
   Sonawane J. P., 2015, INT J PHYS SCI, V4, P60
   SWARINGEN RA, 1979, J ORG CHEM, V44, P4825, DOI 10.1021/jo00394a017
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Turpaev K, 2011, BIOCHEM PHARMACOL, V82, P535, DOI 10.1016/j.bcp.2011.05.028
   Vontas J, 2012, PESTIC BIOCHEM PHYS, V104, P126, DOI 10.1016/j.pestbp.2012.05.008
   Wang HF, 2017, CATAL SCI TECHNOL, V7, P405, DOI 10.1039/c6cy01669c
   Wells G, 2000, J MED CHEM, V43, P1550, DOI 10.1021/jm990947f
   WHO-World Health Organization, 2005, GUID LAB FIELD TEST
   Xu DZ, 2013, RSC ADV, V3, P23075, DOI 10.1039/c3ra43921f
NR 35
TC 0
Z9 0
U1 0
U2 3
PU BRAZILIAN CHEMICAL SOC
PI NITEROI
PA SECRETERIA REGIONAL RIO DO JANEIRO, UNIV FED FLUMINENSE, NITEROI, RJ
   24020-141, BRAZIL
SN 1984-6835
J9 REV VIRTUAL QUIM
JI Rev. Virtual Quim.
PY 2018
VL 10
IS 2
BP 362
EP 374
DI 10.21577/1984-6835.20180028
PG 13
WC Chemistry, Multidisciplinary
SC Chemistry
GA GF6FD
UT WOS:000432061600012
DA 2020-07-08
ER

PT J
AU Mourya, DT
   Gokhale, MD
   Majumdar, TD
   Yadav, PD
   Kumar, V
   Mavale, MS
AF Mourya, Devendra T.
   Gokhale, Mangesh D.
   Majumdar, Triparna D.
   Yadav, Pragya D.
   Kumar, Vimal
   Mavale, Mangala S.
TI Experimental Zika virus infection in Aedes aegypti: Susceptibility,
   transmission & co-infection with dengue & chikungunya viruses
SO INDIAN JOURNAL OF MEDICAL RESEARCH
LA English
DT Article
DE Aedes aegypti; chikungunya; co-infection; dengue; transmission; Zika
ID MOSQUITOS; BRAZIL; EPIDEMIC; INDIA; STATE; PCR
AB Background & objectives: There are reports about the susceptibility of Aedes mosquitoes to ZIKV from various countries, however, no such information is available from Indian sub-continent, although, high level of group cross-reactivity of ZIKV with other flaviviruses has been reported. During outbreak situations, many cases of Dengue (DEN) and Chikungunya (CHIK) are reported. In such scenario, vector mosquitoes are likely to get co-infection/secondary-infection with one or other virus. The present study was carried out to determine the susceptibility of Indian strain of Aedes aegypti to Zika virus (ZIKV) strain (MR-766) and the effect of co-infection/super-infection with either dengue virus (serotype-2) (DENV) or chikungunya virus (CHIKV) on ZIKV replication.
   Methods: Ae. aegypti mosquitoes used in this study were reared for many generations since 1980 at laboratory colony maintained at the ICMR-National Institute of Virology, Pune, India. Transmissibility of ZIKV from infected mosquitoes to suckling mice was also studied. Mosquitoes were experimentally infected with ZIKV and super-infected with either DENV or CHIKV via membrane-feeding route and incubated for 14 days at 28 +/- 2 degrees C and humidity of 85 +/- 5 per cent. Replication of these viruses in mosquitoes was confirmed using real-time reverse transcription-polymerase chain reaction and immunofluorescence assay. Twenty infected mosquitoes were allowed to feed upon four suckling CD1 mice for about 30 min. Transmission of the ZIKV by infected mosquitoes to suckling mice was confirmed by the appearance of clinical signs and the presence of viral RNA in different organs.
   Results: Concomitant infection of mosquitoes with all the three viruses showed simultaneous propagation of all three viruses, confirmed by real time RT-PCR and IFA. Infection of mosquitoes with CHIKV followed by ZIKV showed positivity in individual head squashes (7%) for both viruses using IFA; only 8.3 per cent showed dual positivity with primary infection of ZIKV followed by DENV; 8.3 per cent dual infection positivity was observed when infected with DENV followed by ZIKV; 5 per cent showed dual infection was observed when infected with ZIKV followed by CHIKV. Ae. aegypti was found to be susceptible to ZIKV strain as ZIKV could be detected from the second post-infection day (PID) in infected mosquitoes. Transmission of ZIKV to mice by the bite of infected Ae. aegypti establishes this species as a potential vector.
   Interpretation & conclusions: From super-infection experiments, it was concluded that ZIKV might have a relative advantage in replication dynamics over DENV. Vertical transmission was not observed for ZIKV in experimentally infected mosquitoes (n= 920 larvae). Further studies are required to understand the possibility of silently circulating ZIKV in India, which remain non-detected because of lack of surveillance.
C1 [Gokhale, Mangesh D.; Mavale, Mangala S.] Med Entomol Grp, Pune, Maharashtra, India.
   [Majumdar, Triparna D.; Yadav, Pragya D.; Kumar, Vimal] Maximum Containment Lab, Pune, Maharashtra, India.
   [Mourya, Devendra T.; Gokhale, Mangesh D.; Majumdar, Triparna D.; Yadav, Pragya D.; Kumar, Vimal; Mavale, Mangala S.] ICMR Natl Inst Virol, Sus Rd, Pune 411021, Maharashtra, India.
   [Kumar, Vimal] ICMR Natl JALMA Inst Leprosy & Other Mycobacteria, Agra, Uttar Pradesh, India.
RP Mourya, DT (corresponding author), Med Entomol Grp, Pune, Maharashtra, India.; Mourya, DT (corresponding author), ICMR Natl Inst Virol, Sus Rd, Pune 411021, Maharashtra, India.
EM dtmourya@gmail.com
FU Indian Council of Medical Research, New Delhi, IndiaIndian Council of
   Medical Research (ICMR)
FX We received a grant from the Indian Council of Medical Research, New
   Delhi, India for conducting this study. The funders had no role in study
   design, data collection and interpretation, or the decision to submit
   the work for publication.
CR Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cecilia Dayaraj, 2014, WHO South East Asia J Public Health, V3, P22, DOI 10.4103/2224-3151.206879
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   Laue T, 1999, J CLIN MICROBIOL, V37, P2543, DOI 10.1128/JCM.37.8.2543-2547.1999
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Mourya D. T., 2001, Indian Journal of Malariology, V38, P43
   Mourya D. T., 2007, Journal of Vector Borne Diseases, V44, P233
   Mourya DT, 2000, T ROY SOC TROP MED H, V94, P460, DOI 10.1016/S0035-9203(00)90141-X
   Mourya DT, 2001, ACTA VIROL, V45, P305
   MOURYA DT, 1987, INDIAN J MED RES, V85, P593
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Platt KB, 1997, AM J TROP MED HYG, V57, P119, DOI 10.4269/ajtmh.1997.57.119
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Teixeira MG, 2016, AM J PUBLIC HEALTH, V106, P601, DOI 10.2105/AJPH.2016.303113
   Thangamani S, 2016, AM J TROP MED HYG, V95, P1169, DOI 10.4269/ajtmh.16-0448
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   Waggoner JJ, 2016, EMERG INFECT DIS, V22, P1295, DOI 10.3201/eid2207.160326
   World Health Organization, DIS OUTBREAK NE 0208
NR 25
TC 4
Z9 4
U1 0
U2 3
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 0971-5916
J9 INDIAN J MED RES
JI Indian J. Med. Res.
PD JAN
PY 2018
VL 147
BP 88
EP 96
DI 10.4103/ijmr.IJMR_1142_17
PG 9
WC Immunology; Medicine, General & Internal; Medicine, Research &
   Experimental
SC Immunology; General & Internal Medicine; Research & Experimental
   Medicine
GA GF5PE
UT WOS:000432019200015
PM 29749366
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Hummel, P
   Saxena, A
   Klingler, C
AF Hummel, Patrik
   Saxena, Abha
   Klingler, Corinna
TI Rapid qualitative review of ethical issues surrounding healthcare for
   pregnant women or women of reproductive age in epidemic outbreaks
SO EPIDEMIOLOGY AND HEALTH
LA English
DT Review
DE Ethics; Pregnancy; Epidemics; Reproductive health; Review
ID PUBLIC-HEALTH; FULL SPECTRUM; ZIKA; VACCINATION; CHALLENGES; AIDS
AB This article describes, categorizes, and discusses the results of a rapid literature review aiming to provide an overview of the ethical issues and corresponding solutions surrounding pregnancies in epidemic outbreaks. The review was commissioned by the World Health Organization to inform responses to the Zika outbreak that began in 2015. Due to the urgency of the response efforts that needed to be informed by the literature search, a rapid qualitative review of the literature published in PubMed was conducted. The search and analysis were based on the operationalization of 3 key concepts: ethics, pregnancy, and epidemic outbreak. Ethical issues and solutions were interpreted within a principlist framework. The data were analyzed using qualitative content analysis. The search identified 259 publications, of which the full text of 23 papers was read. Of those, 20 papers contained a substantive part devoted to the topic of interest and were therefore analyzed further. We clustered the ethical issues and solutions around 4 themes: uncertainty, harms, autonomy/liberty, and effectiveness. Recognition of the identified ethical issues and corresponding solutions can inform and improve response efforts, public health planning, policies, and decision-making, as well as the activities of medical staff and counselors who practice before, during, or after an epidemic outbreak that affects pregnant women or those of reproductive age. The rapid review format proved to be useful despite its limited data basis and expedited review process.
C1 [Hummel, Patrik] Univ St Andrews, Dept Philosophy, 17-19 Coll St, St Andrews KY16 9AL, Fife, Scotland.
   [Saxena, Abha] WHO, Eth & Knowledge, Geneva, Switzerland.
   [Klingler, Corinna] Ludwig Maximilians Univ Munchen, Inst Eth Hist & Theory Med, Munich, Germany.
RP Hummel, P (corresponding author), Univ St Andrews, Dept Philosophy, 17-19 Coll St, St Andrews KY16 9AL, Fife, Scotland.
EM pah20@st-andrews.ac.uk
FU German Academic Exchange Service (DAAD)Deutscher Akademischer Austausch
   Dienst (DAAD); WHO Global Health Ethics Unit
FX Patrik Hummel is grateful for a Carlo Schmid Fellowship from the German
   Academic Exchange Service (DAAD) in 2015-2016 in support of his
   internship with the WHO Global Health Ethics Unit.
CR Ali M, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0283-8
   BAYER R, 1988, AIDS, V2, pS217, DOI 10.1097/00002030-198800001-00033
   BAYER R, 1990, MILBANK Q, V68, P179, DOI 10.2307/3350050
   Beauchamp TL, 2013, PRINCIPLES BIOMEDICA, P1
   Beigi RH, 2010, CRIT CARE, V14, DOI 10.1186/cc8928
   Benagiano G, 2011, REPROD BIOMED ONLINE, V22, P701, DOI 10.1016/j.rbmo.2011.02.007
   Black BO, 2015, BJOG-INT J OBSTET GY, V122, P284, DOI 10.1111/1471-0528.13232
   Burke D, 2016, POPE SUGGESTS CONTRA
   Byron K, 2017, J MED ETHICS, V43, P334, DOI 10.1136/medethics-2016-103862
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Centers for Disease Control and Prevention, 2017, ZIK VIR
   Committee on Ethics, 2013, Obstet Gynecol, V121, P1138, DOI 10.1097/01.AOG.0000429660.31589.6a
   Farrell RM, 2009, AM J PUBLIC HEALTH, V99, pS231, DOI 10.2105/AJPH.2008.140780
   Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD
   Ibanez Ximena Andion, 2008, HIV AIDS Policy Law Rev, V13, P82
   Klingler C, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4200-4
   Lee LM, 2012, J LAW MED ETHICS, V40, P85, DOI 10.1111/j.1748-720X.2012.00648.x
   Marckmann G, 2015, FRONT PUBLIC HEALTH, V3, DOI 10.3389/fpubh.2015.00023
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mertz M, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0688-1
   Moher D, 2010, INT J SURG, V8, P336, DOI 10.1016/j.ijsu.2010.02.007
   Moukarram H, 2012, J OBSTET GYNAECOL, V32, P537, DOI 10.3109/01443615.2012.692738
   Nokleby H, 2010, EUROSURVEILLANCE, V15, P23
   Nuffield Council on Bioethics, 2016, ZIK ETH CONS
   Pan American Health Organization, 2016, ZIK ETH CONS ETH GUI
   Pan American Health Organization, 2016, PAHO WHO REG RES AG
   Porta M, 2014, DICT EPIDEMIOLOGY, P93
   Saenz C, 2016, LANCET GLOB HEALTH, V4, pE686, DOI 10.1016/S2214-109X(16)30222-4
   Schreier M, 2012, QUALITATIVE CONTENT, P107
   Seitzer F, 2016, J NEUROL, V263, P201, DOI 10.1007/s00415-015-7867-4
   Strech D, 2013, BRIT J PSYCHIAT, V202, P400, DOI 10.1192/bjp.bp.112.116335
   Whicher DM, 2015, J PATIENT SAF, V11, P174, DOI 10.1097/PTS.0000000000000064
   WHO, 2017, ZIK SIT REP
   WHO, 2016, PREV SEX TRANSM ZIK
   World Health Organization, 2016, WHO DIR GEN BRIEFS E
NR 35
TC 1
Z9 1
U1 0
U2 2
PU KOREAN SOC EPIDEMIOLOGY
PI SUWON
PA DEPT SOCIAL & PREVENTIVE MEDICINE, SUNGKYUNKWAN UNIV SCH MEDICINE,
   SUWON, 16419, SOUTH KOREA
SN 2092-7193
J9 EPIDEMIOL HEALTH
JI Epidemiol. Health
PY 2018
VL 40
AR e2018003
DI 10.4178/epih.e2018003
PG 8
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GF0LF
UT WOS:000431621400006
PM 29370682
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Qu, ZL
   Xue, L
   Hyman, JM
AF Qu, Zhuolin
   Xue, Ling
   Hyman, James M.
TI MODELING THE TRANSMISSION OF WOLBACHIA IN MOSQUITOES FOR CONTROLLING
   MOSQUITO-BORNE DISEASES
SO SIAM JOURNAL ON APPLIED MATHEMATICS
LA English
DT Article
DE mosquito-borne diseases; maternal transmission; backward bifurcation;
   integrated mosquito management
ID AEDES-AEGYPTI DIPTERA; DENGUE VECTOR; CULICIDAE; INSECTICIDES;
   RESISTANCE; AUSTRALIA; INFECTION; DYNAMICS; OVITRAP; SPREAD
AB We develop and analyze an ordinary differential equation model to quantify the effectiveness of different approaches in creating a sustained infection of Wolbachia bacteria in wild mosquitoes. Wolbachia is a natural parasitic microbe that can reduce the ability of mosquitoes to spread mosquito-borne viral diseases such as dengue fever, chikungunya, and Zika. It is difficult to sustain an infection of the maternal transmitted Wolbachia in a wild mosquito population because of the reduced fitness of the Wolbachia-infected mosquitoes and cytoplasmic incompatibility limiting maternal transmission. The infection will only persist if the fraction of the infected mosquitoes exceeds a minimum threshold. Our two-sex mosquito model captures the complex transmission cycle by accounting for heterosexual transmission, multiple pregnant states for female mosquitoes, and the aquatic-life stage. We identify important dimensionless numbers and analyze the critical threshold condition for obtaining a sustained Wolbachia infection in the natural population. This threshold effect is characterized by a backward bifurcation with three coexisting equilibria of the system of differential equations: a stable disease-free equilibrium, an unstable intermediate-infection endemic equilibrium, and a stable high-infection endemic equilibrium. We perform sensitivity analysis on epidemiological and environmental parameters to determine their relative importance to Wolbachia transmission and prevalence. We also compare the effectiveness of different integrated mitigation strategies and observe that the most efficient approach to establish the Wolbachia infection is to first reduce the natural mosquitoes and then release both infected males and pregnant females. The initial reduction of natural population could be accomplished by either residual spraying or ovitraps.
C1 [Qu, Zhuolin; Hyman, James M.] Tulane Univ, Dept Math, New Orleans, LA 70118 USA.
   [Xue, Ling] Harbin Engn Univ, Dept Math, Harbin 150001, Heilongjiang, Peoples R China.
   [Xue, Ling] Univ Manitoba, Dept Math, Winnipeg, MB R3T 2N2, Canada.
RP Qu, ZL (corresponding author), Tulane Univ, Dept Math, New Orleans, LA 70118 USA.
EM zqu1@tulane.edu; Ling.Xue@umanitoba.ca; mhyman@tulane.edu
RI Hyman, James M/AAF-7389-2020; amsalu, ribka/G-8780-2019
OI Hyman, James M/0000-0001-5247-5794; 
FU NSF-MPS/NIH-NIGMS award [NSF-1563531]; NIH-NIGMS Models of Infectious
   Disease Agent Study (MIDAS) award [U01GM097661]; National Natural
   Science Foundation of ChinaNational Natural Science Foundation of China
   [KY11100150025]; Fundamental Research Funds for the Central Universities
   of ChinaFundamental Research Funds for the Central Universities
   [GK2110260150]
FX This work was partially supported by the NSF-MPS/NIH-NIGMS award
   NSF-1563531 and the NIH-NIGMS Models of Infectious Disease Agent Study
   (MIDAS) award U01GM097661. The second author's work was supported by
   National Natural Science Foundation of China KY11100150025, and the
   Fundamental Research Funds for the Central Universities of China
   GK2110260150.
CR Achee NL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003655
   Alphey L, 2010, VECTOR-BORNE ZOONOT, V10, P295, DOI 10.1089/vbz.2009.0014
   AMERICAN MOSQUITO CONTROL ASSOCIATION, 2017, CONTROL
   Barrera R, 2014, J MED ENTOMOL, V51, P145, DOI 10.1603/ME13096
   BELTON P, 1994, J AM MOSQUITO CONTR, V10, P297
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   CENTERS FOR DISEASE CONTROL AND PREVENTION, 2017, CHIK PREV
   CENTERS FOR DISEASE CONTROL AND PREVENTION, 2017, DENG PREV
   CENTERS FOR DISEASE CONTROL AND PREVENTION, 2017, ZIK VIR TREATM
   Chitnis N, 2008, B MATH BIOL, V70, P1272, DOI 10.1007/s11538-008-9299-0
   Farkas JZ, 2010, B MATH BIOL, V72, P2067, DOI 10.1007/s11538-010-9528-1
   Foster Woodbridge A., 2002, P203, DOI 10.1016/B978-012510451-7/50014-1
   Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x
   Hoffmann AA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003115
   Hughes H, 2013, B MATH BIOL, V75, P796, DOI 10.1007/s11538-013-9835-4
   Kamgang JC, 2008, MATH BIOSCI, V213, P1, DOI 10.1016/j.mbs.2008.02.005
   Keeling MJ, 2003, HEREDITY, V91, P382, DOI 10.1038/sj.hdy.6800343
   KOILLER J., 2014, RES REPORT
   LAVEN H, 1956, NATURE, V177, P141, DOI 10.1038/177141a0
   Lumjuan N, 2005, INSECT BIOCHEM MOLEC, V35, P861, DOI 10.1016/j.ibmb.2005.03.008
   Martinez-Torres D, 1999, INSECT MOL BIOL, V8, P339, DOI 10.1046/j.1365-2583.1999.83121.x
   McGraw EA, 2013, NAT REV MICROBIOL, V11, P181, DOI 10.1038/nrmicro2968
   McMeniman CJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000748
   McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Ndii MZ, 2015, MATH BIOSCI, V262, P157, DOI 10.1016/j.mbs.2014.12.011
   Ndii MZ, 2012, ANZIAM J, V53, P213, DOI 10.1017/S1446181112000132
   Nguyen HT, 2009, J AM MOSQUITO CONTR, V25, P74, DOI 10.2987/08-5752.1
   O'Connor L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001797
   Promsiri Suwannee, 2006, Insect Science, V13, P179, DOI 10.1111/j.1744-7917.2006.00080.x
   Ritchie S. A., 2002, Dengue Bulletin, V26, P7
   Ritchie SA, 2009, MED VET ENTOMOL, V23, P295, DOI 10.1111/j.1365-2915.2009.00833.x
   Segoli M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003294
   Styer LM, 2007, VECTOR-BORNE ZOONOT, V7, P86, DOI 10.1089/vbz.2007.0216
   Tun-Lin W, 2000, MED VET ENTOMOL, V14, P31, DOI 10.1046/j.1365-2915.2000.00207.x
   TURELLI M, 1991, NATURE, V353, P440, DOI 10.1038/353440a0
   van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   WORLD MOSQUITO PROGRAM, 2017, OUR RES WOLB
   Xue L, 2017, J BIOL DYNAM, V11, P216, DOI 10.1080/17513758.2016.1229051
NR 40
TC 4
Z9 4
U1 0
U2 8
PU SIAM PUBLICATIONS
PI PHILADELPHIA
PA 3600 UNIV CITY SCIENCE CENTER, PHILADELPHIA, PA 19104-2688 USA
SN 0036-1399
EI 1095-712X
J9 SIAM J APPL MATH
JI SIAM J. Appl. Math.
PY 2018
VL 78
IS 2
BP 826
EP 852
DI 10.1137/17M1130800
PG 27
WC Mathematics, Applied
SC Mathematics
GA GE4QM
UT WOS:000431201200009
DA 2020-07-08
ER

PT J
AU Farrell, DF
   Lupone, CD
   Kenneson, A
   Cueva, C
   Heydari, N
   Aguilera, JHB
   Polhemus, M
   Endy, TP
   Stewart-Ibarra, AM
AF Farrell, Daniel F.
   Lupone, Christina D.
   Kenneson, Aileen
   Cueva, Cinthya
   Heydari, Naveed
   Barzallo Aguilera, Julio H.
   Polhemus, Mark
   Endy, Timothy P.
   Stewart-Ibarra, Anna M.
TI Case Report: An Acute Chikungunya Infection and a Recent Secondary
   Dengue Infection in a Peripartum Case in Ecuador
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID COINFECTION; VIRUS; ZIKA; PATIENT
AB Dengue virus (DENV) and chikungunya virus (CHIKV) are transmitted by the same mosquito vectors and now co-circulate in many parts of the world; however, coinfections and serial infections are not often diagnosed or reported. A 38 week pregnant woman was admitted to the hospital with a diagnosis of suspected DENV and CHIKV in southern coastal Ecuador. The pregnancy was complicated by mild polyhydramnios and fetal tachycardia, and a healthy newborn was born. The patient was positive for a recent secondary DENV infection (Immunoglobulin M and Immunoglobulin G positive) and an acute CHIKV infection (real-time reverse transcriptase polymerase chain reaction positive) (Asian genotype). The newborn was not tested for either virus. This case resulted in a benign clinical course with a favorable pregnancy outcome.
C1 [Farrell, Daniel F.; Lupone, Christina D.; Kenneson, Aileen; Cueva, Cinthya; Heydari, Naveed; Polhemus, Mark; Endy, Timothy P.; Stewart-Ibarra, Anna M.] SUNY Upstate Med Univ, Ctr Global Hlth & Translat Sci, 505 Irving Ave, Syracuse, NY 13210 USA.
   [Lupone, Christina D.; Stewart-Ibarra, Anna M.] SUNY Upstate Med Univ, Dept Publ Hlth & Prevent Med, Syracuse, NY 13210 USA.
   [Polhemus, Mark; Endy, Timothy P.; Stewart-Ibarra, Anna M.] SUNY Upstate Med Univ, Dept Med, Syracuse, NY 13210 USA.
   [Barzallo Aguilera, Julio H.] Teofilo Davila Hosp, Minist Hlth, Machala, Ecuador.
   [Endy, Timothy P.] SUNY Upstate Med Univ, Dept Microbiol & Immunol, Syracuse, NY 13210 USA.
   [Stewart-Ibarra, Anna M.] SUNY Upstate Med Univ, Publ Hlth & Preventat Med, Syracuse, NY 13210 USA.
RP Stewart-Ibarra, AM (corresponding author), SUNY Upstate Med Univ, Ctr Global Hlth & Translat Sci, 505 Irving Ave, Syracuse, NY 13210 USA.
EM farrelda@upstate.edu; luponec@upstate.edu; aileen.kenneson@yahoo.com;
   cinthya.cueva10@gmail.com; heydarin@upstate.edu;
   juliobarzallo@hotmail.com; polhemum@upstate.edu; endyt@upstate.edu;
   stewarta@upstate.edu
RI amsalu, ribka/G-8780-2019
OI Stewart-Ibarra, Anna/0000-0002-3383-4672
CR Abele H, 2012, FETAL DIAGN THER, V32, P251, DOI 10.1159/000338659
   Acevedo Nathalie, 2017, Front Microbiol, V8, P42, DOI 10.3389/fmicb.2017.00042
   Bhat Vivek G, 2015, Open Microbiol J, V9, P33, DOI 10.2174/1874285801509010033
   Brooks JBB, 2017, J INFECT PUBLIC HEAL, V10, P359, DOI 10.1016/j.jiph.2016.08.010
   Caron M, 2012, CLIN INFECT DIS, V55, pE45, DOI 10.1093/cid/cis530
   Chahar HS, 2009, EMERG INFECT DIS, V15, P1077, DOI 10.3201/eid1507.080638
   Costantine MM, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00065
   Furuya-Kanamori L, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1417-2
   Gerardin P, 2008, PLOS MED, V5, P413, DOI 10.1371/journal.pmed.0050060
   Hamza A, 2013, GEBURTSH FRAUENHEILK, V73, P1241, DOI 10.1055/s-0033-1360163
   Mercado M, 2016, EURO SURVEILL, P21
   Omarjee R, 2014, EUROSURVEILLANCE, V19, P10, DOI 10.2807/1560-7917.ES2014.19.13.20753
   Phi Hung Le, 2015, F1000Res, V4, P1483, DOI 10.12688/f1000research.7589.1
   Rosso F, 2016, REV CHIL INFECTOL, V33, P464, DOI 10.4067/S0716-10182016000400013
   Stewart-Ibarra AM, 2018, AM J TROP M IN PRESS
   Thiberville SD, 2013, ANTIVIR RES, V99, P345, DOI 10.1016/j.antiviral.2013.06.009
   Tilak Rina, 2016, Med J Armed Forces India, V72, P157, DOI 10.1016/j.mjafi.2016.02.017
   Vazeille M, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000706
   Villamil-Gomez WE, 2017, J INFECT PUBLIC HEAL, V10, P133, DOI 10.1016/j.jiph.2016.02.003
   Villamil-Gomez WE, 2016, INT J INFECT DIS, V51, P135, DOI 10.1016/j.ijid.2016.07.017
   Villamil-Gomez WE, 2016, J INFECT PUBLIC HEAL, V9, P684, DOI 10.1016/j.jiph.2015.12.002
   World Health Organization, 2009, DENG GUID DIAGN TREA
NR 22
TC 2
Z9 2
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 98
IS 3
BP 838
EP 840
DI 10.4269/ajtmh.17-0781
PG 3
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA GE1BW
UT WOS:000430952800036
PM 29363451
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Feldstein, LR
   Rowhani-Rahbar, A
   Staples, JE
   Halloran, ME
   Ellis, EM
AF Feldstein, Leora R.
   Rowhani-Rahbar, Ali
   Staples, J. Erin
   Halloran, M. Elizabeth
   Ellis, Esther M.
TI An Assessment of Household and Individual-Level Mosquito Prevention
   Methods during the Chikungunya Virus Outbreak in the United States
   Virgin Islands, 2014-2015
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID AEDES; DISEASE
AB Recent large-scale chikungunya virus (CHIKV) and Zika virus epidemics in the Americas pose a growing public health threat. Given that mosquito bite prevention and vector control are the main prevention methods available to reduce transmission of these viruses, we assessed adherence to these methods in the United States Virgin Islands (USVI). We interviewed 334 USVI residents between December 2014 and February 2015 to measure differences in mosquito prevention practices by gender, income, presence of CHIKV symptoms, and age. Only 27% (91/334) of participants reported having an air conditioner, and of the 91 with air-conditioners, 18 (20%) reported never using it. Annual household income >$50,000 was associated with owning and using an air conditioner (41%; 95% confidence interval [CI]: 28-53% compared with annual household income <=$50,000: 17%; 95% CI: 12-22%). The majority of participants reported the presence of vegetation in their yard or near their home (79%; 265) and a cistern on their property (78%; 259). Only 52 (16%) participants reported wearing mosquito repellent more than once per week. Although the majority (80%; 268) of participants reported having screens on all of their windows and doors, most (82%; 273) of those interviewed still reported seeing mosquitoes in their homes. Given the uniformly low adherence to individual-and household-level mosquito bite prevention measures in the USVI, these findings emphasize the need for improved public health messaging and investment in therapeutic and vaccine research to mitigate vector-borne disease outbreaks.
C1 [Feldstein, Leora R.; Rowhani-Rahbar, Ali] Univ Washington, Sch Publ Hlth, Dept Epidemiol, 1959 Northeast Pacific St, Seattle, WA 98195 USA.
   [Feldstein, Leora R.; Halloran, M. Elizabeth] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA.
   [Staples, J. Erin] Ctr Dis Control & Prevent, Div Vector Borne Dis, Natl Ctr Emerging & Zoonot Infect Dis, Ft Collins, CO USA.
   [Halloran, M. Elizabeth] Fred Hutchinson Canc Res Ctr, Ctr Inference & Dynam Infect Dis, 1124 Columbia St, Seattle, WA 98104 USA.
   [Halloran, M. Elizabeth] Univ Washington, Sch Publ Hlth, Dept Biostat, Seattle, WA 98195 USA.
   [Ellis, Esther M.] US Virgin Isl Dept Hlth, St Croix, VI USA.
   [Staples, J. Erin] Ctr Dis Control, Arboviral Dis Branch, Ft Collins, CO USA.
   [Ellis, Esther M.] US Virgin Isl Dept Hlth, Dept Hlth, Christiansted, VI USA.
RP Feldstein, LR (corresponding author), Univ Washington, Sch Publ Hlth, Dept Epidemiol, 1959 Northeast Pacific St, Seattle, WA 98195 USA.
EM lrfeldst@uw.edu; rowhani@uw.edu; auv1@cdc.gov; betz@fhcrc.org;
   esther.ellis@doh.vi.gov
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA; National Institute of
   Allergy and Infectious DiseaseUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R37-AI032042]; National
   Institute of General Medical SciencesUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of General Medical Sciences (NIGMS) [U54 GM111274]; United
   States Virgin Islands Department of Health
FX This work was supported by the National Institutes of Health, National
   Institute of Allergy and Infectious Disease (R37-AI032042), National
   Institute of General Medical Sciences (U54 GM111274), and the United
   States Virgin Islands Department of Health.
CR Boyer S, 2013, J AM MOSQUITO CONTR, V29, P74, DOI 10.2987/12-6259R.1
   Caprara A, 2009, CAD SAUDE PUBLICA, V25, pS125, DOI 10.1590/S0102-311X2009001300012
   CDC C for DC and P, 2016, SURV CONTR AED AEG A, P1, DOI [10.1371/journal.pntd.0004043, DOI 10.1371/JOURNAL.PNTD.0004043]
   Central Intelligence Agency, 2014, CIA WORLD FACTB
   Ellis E, 2015, CHIKUNGUNYA SURVEILL
   Hennessey M, 2016, AM J TRANSPLANT, V16, P1031, DOI 10.1111/ajt.13743
   Lardeux F, 2002, J MED ENTOMOL, V39, P493, DOI 10.1603/0022-2585-39.3.493
   Pan American Health Organization, 2015, NUMB REP CAS CHIK FE
   Rougeron V, 2015, J CLIN VIROL, V64, P144, DOI 10.1016/j.jcv.2014.08.032
   Russell RC, 2005, MED VET ENTOMOL, V19, P451, DOI 10.1111/j.1365-2915.2005.00589.x
   Southeast Regional Climate Center, 2007, HIST CLIM SUMM PUERT
   The World Bank, 2016, AV PREC DEPTH MM PER
   U.S. Census Bureau, 2012, AM COMMUNITY SURVEY
   United Nations Environment Programme, 1997, RAINW HARV ROOFT CAT
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
NR 15
TC 3
Z9 3
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 98
IS 3
BP 845
EP 848
DI 10.4269/ajtmh.17-0799
PG 4
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA GE1BW
UT WOS:000430952800038
PM 29405105
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Miller, LJ
   Nasar, F
   Schellhase, CW
   Norris, SL
   Kimmel, AE
   Valdez, SM
   Wollen-Roberts, SE
   Shamblin, JD
   Sprague, TR
   Lugo-Roman, LA
   Jarman, RG
   Yoon, IK
   Alera, MT
   Bavari, S
   Pitt, MLM
   Haddow, AD
AF Miller, Lynn J.
   Nasar, Farooq
   Schellhase, Christopher W.
   Norris, Sarah L.
   Kimmel, Adrienne E.
   Valdez, Stephanie M.
   Wollen-Roberts, Suzanne E.
   Shamblin, Joshua D.
   Sprague, Thomas R.
   Lugo-Roman, Luis A.
   Jarman, Richard G.
   Yoon, In-Kyu
   Alera, Maria T.
   Bavari, Sina
   Pitt, M. Louise M.
   Haddow, Andrew D.
TI Zika Virus Infection in Syrian Golden Hamsters and Strain 13 Guinea Pigs
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID ANIMAL-MODELS; PATHOLOGICAL ASSESSMENT; MOUSE MODEL; TRANSMISSION
AB To evaluate potential immunocompetent small animal models of Zika virus (ZIKV) infection, we inoculated Syrian golden hamsters (subcutaneously or intraperitoneally) and strain 13 guinea pigs (intraperitoneally) with Senegalese ZIKV strain ArD 41525 or Philippines ZIKV strain CPC-0740. We did not detect viremia in hamsters inoculated subcutaneously with either virus strain, although some hamsters developed virus neutralizing antibodies. However, we detected statistically significant higher viremias (P = 0.0285) and a higher median neutralization titer (P = 0.0163) in hamsters inoculated intraperitoneally with strain ArD 41525 compared with strain CPC-0740. Furthermore, some hamsters inoculated with strain ArD 41525 displayed mild signs of disease. By contrast, strain 13 guinea pigs inoculated intraperitoneally with either strain did not have detectable viremias and less than half developed virus neutralizing antibodies. Our results support the use of the Syrian golden hamster intraperitoneal model to explore phenotypic variation between ZIKV strains.
C1 [Miller, Lynn J.; Lugo-Roman, Luis A.] US Army, Med Res Inst Infect Dis, Vet Med Div, 1425 Porter St, Ft Detrick, MD 21702 USA.
   [Nasar, Farooq; Kimmel, Adrienne E.; Valdez, Stephanie M.; Wollen-Roberts, Suzanne E.; Shamblin, Joshua D.; Sprague, Thomas R.; Bavari, Sina; Pitt, M. Louise M.; Haddow, Andrew D.] US Army, Med Res Inst Infect Dis, Div Virol, Ft Detrick, MD 21702 USA.
   [Schellhase, Christopher W.] US Army, Med Res Inst Infect Dis, Div Pathol, Ft Detrick, MD 21702 USA.
   [Norris, Sarah L.] US Army, Med Res Inst Infect Dis, Div Biostat, Ft Detrick, MD 21702 USA.
   [Jarman, Richard G.] Walter Reed Army Inst Res, Div Virol, Silver Spring, MD USA.
   [Yoon, In-Kyu] Int Vaccine Inst, Seoul, South Korea.
   [Alera, Maria T.] Philippines AFRIMS Virol Res Unit PARVU, Cebu, Philippines.
RP Miller, LJ (corresponding author), US Army, Med Res Inst Infect Dis, Vet Med Div, 1425 Porter St, Ft Detrick, MD 21702 USA.
EM lynn.j.miller.mil@mail.mil; farooq.nasar.ctr@mail.mil;
   christopher.w.schellhase.mil@mail.mil; sarah.l.norris2.civ@mail.mil;
   adrienne.e.kimmel.ctr@mail.mil; stephanie.m.valdez5.ctr@mail.mil;
   suzanne.e.wollen.ctr@mail.mil; joshua.d.shamblin1.civ@mail.mil;
   thomas.r.sprague7.ctr@mail.mil; luis.a.lugoroman.mil@mail.mil;
   richard.g.jarman.mil@mail.mil; InKyu.Yoon@IVI.INT;
   MariaTheresa.Alera.ca@afrims.org; sina.bavari.civ@mail.mil;
   margaret.l.pitt.civ@mail.mil; andrew.d.haddow.ctr@mail.mil
RI Pitt, Margaret Louise/AAD-3437-2019; Nasar, Farooq/C-7659-2019; Bavari,
   Sina/L-3642-2019; Haddow, Andrew D/C-5902-2008
OI Pitt, Margaret Louise/0000-0003-0080-3260; Nasar,
   Farooq/0000-0003-3658-9649; Bavari, Sina/0000-0001-8424-5635; Haddow,
   Andrew D/0000-0002-8957-2608; Wollen-Roberts,
   Suzanne/0000-0002-9409-2756; Kimmel, Adrienne/0000-0003-2977-1434;
   Norris, Sarah/0000-0002-5393-6430
FU Defense Advanced Research Projects Agency (DARPA)United States
   Department of DefenseDefense Advanced Research Projects Agency (DARPA)
FX This work was supported by a grant from The Defense Advanced Research
   Projects Agency (DARPA). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript. The views expressed in this article are those of the authors
   and do not reflect the official policy or position of the U.S.
   Department of Defense or the Department of the Army.
CR ADLER S, 1948, NATURE, V162, P256, DOI 10.1038/162256b0
   Aliota MT, 2017, ANTIVIR RES, V144, P223, DOI 10.1016/j.antiviral.2017.06.001
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Brault AC, 2016, AM J TROP MED HYG, V94, P1187, DOI 10.4269/ajtmh.16-0277
   Clark DC, 2012, ARCH VIROL, V157, P1423, DOI 10.1007/s00705-012-1337-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duggal NK, 2017, AM J TROP MED HYG, V97, P1410, DOI 10.4269/ajtmh.17-0263
   Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   Ellison DW, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00359-16
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   GECZY AF, 1975, J IMMUNOL, V115, P1704
   Gowen BB, 2008, ANTIVIR RES, V78, P79, DOI 10.1016/j.antiviral.2007.10.002
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Haddow AD, 2016, THESIS, V10
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Haddow AD, 2017, EMERG INFECT DIS, V23, P1274, DOI 10.3201/eid2308.170036
   Haddow AD, 2016, B WORLD HEALTH ORGAN, V94, P711, DOI 10.2471/BLT.16.181503
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Kumar M, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0750-4
   Ladner JT, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00377-16
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   PROPHET EB, 1992, LAB METHODS HISTOTEC
   Ragan IK, 2017, VECTOR-BORNE ZOONOT, V17, P161, DOI 10.1089/vbz.2016.2099
   Roundy CM, 2017, EMERG INFECT DIS, V23, P625, DOI 10.3201/eid2304.161484
   Safronetz D, 2013, CURR OPIN VIROL, V3, P205, DOI 10.1016/j.coviro.2013.01.001
   Shek WR, 2015, LAB ANIMAL MED, P463
   Weger-Lucarelli J, 2016, THESIS, V10
   Wright S, 1922, B US DEP AGR, V1090, P37
NR 30
TC 5
Z9 5
U1 0
U2 2
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 98
IS 3
BP 864
EP 867
DI 10.4269/ajtmh.17-0686
PG 4
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA GE1BW
UT WOS:000430952800041
PM 29405107
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Tun, MMN
   Kyaw, AK
   Hmone, SW
   Inoue, S
   Buerano, CC
   Soe, AM
   Moi, ML
   Hayasaka, D
   Thu, HM
   Hasebe, F
   Thant, KZ
   Morita, K
AF Tun, Mya Myat Ngwe
   Kyaw, Aung Kyaw
   Hmone, Saw Wut
   Inoue, Shingo
   Buerano, Corazon C.
   Soe, Aung Min
   Moi, Meng Ling
   Hayasaka, Daisuke
   Thu, Hlaing Myat
   Hasebe, Futoshi
   Thant, Kyaw Zin
   Morita, Kouichi
TI Detection of Zika Virus Infection in Myanmar
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID LINKED-IMMUNOSORBENT-ASSAY; DENGUE VIRUSES; ENCEPHALITIS; OUTBREAK;
   MICRONESIA; DIAGNOSIS; STATES
AB Zika virus (ZIKV), an emerging mosquito-borne flavivirus, causes a dengue-like infection that has recently caught global attention. The infection, which also includes some birth defects, has been documented in the Americas, Pacific Islands, and some parts of Africa and Asia. There are no published reports on local ZIKV transmission in Myanmar. In this study, a total of 462 serum samples from patients and asymptomatic persons were collected in Myanmar from 2004 to 2017. They were analyzed for ZIKV infection by immunoglobulin M capture enzyme-linked immunosorbent assay (ELISA), immunoglobulin G indirect ELISA, neutralization test, real-time polymerase chain reaction (PCR), and conventional PCR. Our study confirmed ZIKV infection in 4.9% of patients with clinical dengue symptoms and in 8.6% of persons who were asymptomatic. This is the first report on ZIKV infection in Myanmar and it suggests the occurrence of ZIKV infection in two geographically distinct sites in this country since at least 2006.
C1 [Tun, Mya Myat Ngwe; Kyaw, Aung Kyaw; Inoue, Shingo; Buerano, Corazon C.; Soe, Aung Min; Moi, Meng Ling; Hayasaka, Daisuke; Hasebe, Futoshi; Morita, Kouichi] Nagasaki Univ, Inst Trop Med, Dept Virol, 1-12-4 Sakamoto, Nagasaki 8528523, Japan.
   [Kyaw, Aung Kyaw; Soe, Aung Min; Thu, Hlaing Myat; Thant, Kyaw Zin] Dept Med Res, Virol Res Div, Pyin Oo Lwin, Myanmar.
   [Hmone, Saw Wut] Univ Med 1, Dept Pathol, Yangon, Myanmar.
   [Buerano, Corazon C.] St Lukes Med Ctr, Res & Biotechnol Div, Quezon City, Philippines.
RP Tun, MMN (corresponding author), Nagasaki Univ, Inst Trop Med, Dept Virol, 1-12-4 Sakamoto, Nagasaki 8528523, Japan.
EM myamyat@tm.nagasaki-u.ac.jp; akkyawdmr@gmail.com; sawwuthmone@gmail.com;
   pampanga@nagasaki-u.ac.jp; ccbuerano@hotmail.com;
   dr.aungminnsoe@gmail.com; sherry@nagasaki-u.ac.jp;
   hayasaka@nagasaki-u.ac.jp; hmyatthu28@gmail.com;
   rainbow@nagasaki-u.ac.jp; drkz.thant@googlemail.com;
   moritak@nagasaki-u.ac.jp
RI KYAW, Aung KYAW/R-7376-2017
OI KYAW, Aung KYAW/0000-0002-1384-8030
FU Japan Initiative for Global Research Network on Infectious
   DiseasesMinistry of Education, Culture, Sports, Science and Technology,
   Japan (MEXT); Japan-United States Cooperative Medical Science Program
   from Japan Agency for Medical Research and Development (AMED)Japan
   Agency for Medical Research and Development (AMED); Joint Usage/Research
   Center on Tropical Disease, Institute of Tropical Medicine, Nagasaki
   University
FX This work was supported by the Japan Initiative for Global Research
   Network on Infectious Diseases; Japan-United States Cooperative Medical
   Science Program from Japan Agency for Medical Research and Development
   (AMED); and Joint Usage/Research Center on Tropical Disease, Institute
   of Tropical Medicine, Nagasaki University.
CR Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Inoue S, 2010, VECTOR-BORNE ZOONOT, V10, P143, DOI 10.1089/vbz.2008.0153
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Martelli CMT, 2016, INT J INFECT DIS, V53, P15, DOI 10.1016/j.ijid.2016.11.043
   Moi ML, 2017, LANCET INFECT DIS, V17, P805, DOI 10.1016/S1473-3099(17)30412-7
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   MONATH TP, 1984, J CLIN MICROBIOL, V20, P784, DOI 10.1128/JCM.20.4.784-790.1984
   Tun MMN, 2017, JPN J INFECT DIS, V70, P357, DOI 10.7883/yoken.JJID.2016.246
   Tun MMN, 2013, J MED VIROL, V85, P1258, DOI 10.1002/jmv.23577
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Ruckert C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15412
   Thu HM, 2004, EMERG INFECT DIS, V10, P593, DOI 10.3201/eid1004.030216
   WHO, 2008, MYANM JOINT PLAN ACT
   WHO, 2016, ZIK DEF
   WHO, 2016, 1 CAS ZIK VIR INF DE
   Wilson HL, 2017, J CLIN MICROBIOL, V55, P3104, DOI [10.1128/JCM.00673-17, 10.1128/jcm.00673-17]
NR 20
TC 7
Z9 8
U1 0
U2 2
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 98
IS 3
BP 868
EP 871
DI 10.4269/ajtmh.17-0708
PG 4
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA GE1BW
UT WOS:000430952800042
PM 29363460
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Ding, ZY
   Wu, C
   Wu, HC
   Lu, QB
   Lin, JF
AF Ding, Zheyuan
   Wu, Chen
   Wu, Haocheng
   Lu, Qinbao
   Lin, Junfen
TI The Epidemiology of Imported Acute Infectious Diseases in Zhejiang
   Province, China, 2011-2016: Analysis of Surveillance Data
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID RETURNED TRAVELERS; MALARIA; FEVER; DENGUE
AB To explore epidemiological characteristics of imported acute infectious diseases between 2011 and 2016 in Zhejiang province, China. Data of imported infectious diseases from 2011 to 2016 was collected from the China Information System for Disease Control and Prevention in Zhejiang province, and subsequently analyzed for epidemiological characteristics. A survey was conducted to investigate clinicians' abilities to diagnose these diseases in Zhejiang province. From 2011 to 2016, 1,241 cases of imported acute infectious disease were reported in Zhejiang province, including 1,078 malaria cases, 156 dengue cases, three chikungunya fever cases and four Zika cases. Between 2011 and 2016, incidences of these diseases increased (P < 0.001). For malaria, male adults for labor export were the most affected group. Seasonal fluctuation was not obvious. Plasmodium falciparum was the main malaria type (822 cases) and most cases were acquired from African Region (791/822, 96.1%). Plasmodium vivax cases (194 cases) were mainly from African Region (78/194, 40.2%) and South-East Asia Region (51/194, 26.3%). Meanwhile, for dengue, adults and tourists were the most affected groups. The incidence of dengue was particularly high in August and October. The percent of correct clinician responses in the survey of diagnosis knowledge was 54.6% (standard deviation = 21.0%); this percentage was particularly low in general practitioners and clinicians from township hospitals. The capabilities of clinicians to diagnose these diseases were low and should be improved. Efforts should be made in improving and disseminating proper preventive measures of high-risk populations, surveillance of imported cases, and prevention and control of local epidemics.
C1 [Ding, Zheyuan; Wu, Chen; Wu, Haocheng; Lu, Qinbao; Lin, Junfen] Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou 310051, Zhejiang, Peoples R China.
RP Lin, JF (corresponding author), Zhejiang Prov Ctr Dis Control & Prevent, Dept Publ Hlth Surveillance & Advisory, 3399 Bin Sheng Rd, Hangzhou 310051, Zhejiang, Peoples R China.
EM zhyding@cdc.zj.cn; chenwu@cdc.zj.cn; hchwu@cdc.zj.cn; qblu@cdc.zj.cn;
   jflin@cdc.zj.cn
FU Medical Research Program of Zhejiang province [2015RCB008, 2015ZHA003,
   2017RC018]
FX This work was supported by the Medical Research Program of Zhejiang
   province (Grant Number: 2015RCB008, 2015ZHA003, 2017RC018).
CR Chen HL, 2015, AM J TROP MED HYG, V93, P305, DOI 10.4269/ajtmh.15-0080
   Chen ZH, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.89
   [丰俊 Feng Jun], 2014, [中国病原生物学杂志, Journal of Pathogen Biology], V9, P442
   Field V, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-330
   [郭青 Guo Qing], 2015, [中华疾病控制杂志, Chinese Journal of Disease Control & Prevention], V19, P683
   Jin LiZhu, 2016, Disease Surveillance, V31, P883
   Li JD, 2016, EMERG INFECT DIS, V22, P1133, DOI 10.3201/eid2206.160273
   Li ZJ, 2015, EMERG INFECT DIS, V21, P864, DOI [10.3201/eid2105.141712, 10.3201/2105.141712]
   Lin M, 2008, CHINESE J FRONT HLTH, V31, P221
   Liu W, 2016, LANCET INFECT DIS, V16, P1226, DOI 10.1016/S1473-3099(16)30401-7
   Liu YB, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-29
   Mace KE, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6612a1
   Ministry of Health of the People's Republic of China, 2016, DIAGN TREATM ZIK VIR
   Ministry of Health of the People's Republic of China, 2008, DIAGN TREATM CHIK FE
   Ministry of Health of the People's Republic of China, 2006, DIAGN CRIT MAL WS 25
   Ministry of Health of the People's Republic of China, 2008, DIAGN CRIT DENG FEV
   Ministry of Health of the People's Republic ofChina, 2015, DIAGN MAL WS 259 201
   Mizuno Y, 2012, TRAVEL MED INFECT DI, V10, P86, DOI 10.1016/j.tmaid.2012.02.005
   National Bureau of Statistics of China, 2016, CHIN STAT YB 2016
   Public Health England, 2016, MAL IMP UK 2015 IMPL
   Schwartz E, 2008, EMERG INFECT DIS, V14, P1081, DOI 10.3201/eid1407.071412
   Statistics Bureau of Zhejiang Province, 2016, STAT YB ZHEJ PROV
   Su S, 2015, LANCET, V385, P2349, DOI 10.1016/S0140-6736(15)60859-5
   Wang LD, 2012, CHINA INFORM SYSTEM
   Wang T, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003677
   Wang Y, 2016, REPORT INFECT DIS SU, V178, P282
   WHO, 2016, WORLD MAL REP 2016
   Wu YuYan, 2015, Disease Surveillance, V30, P497
   Xiao D, 2012, AM J TROP MED HYG, V87, P646, DOI 10.4269/ajtmh.2012.12-0164
   Yin JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074228
   Zhang M, 2010, CHINESE FRONTIER HLT, V33, P90
   Zhang M, 2011, J TRAVEL MED, V18, P173, DOI 10.1111/j.1708-8305.2011.00512.x
   Zhang QL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042830
NR 33
TC 2
Z9 3
U1 1
U2 2
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 98
IS 3
BP 913
EP 919
DI 10.4269/ajtmh.17-0284
PG 7
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA GE1BW
UT WOS:000430952800049
PM 29260651
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Chang, KS
   Kim, GH
   Ha, YR
   Jeong, EK
   Kim, HC
   Klein, TA
   Shin, SH
   Kim, EJ
   Jegal, S
   Chung, SJ
   Ju, YR
   Jee, YM
AF Chang, Kyu-Sik
   Kim, Gi-Hun
   Ha, Young-Ran
   Jeong, Eun Kyeong
   Kim, Heung-Chul
   Klein, Terry A.
   Shin, Seung Hwan
   Kim, Eun Jeung
   Jegal, Seung
   Chung, Se Jin
   Ju, Young-Ran
   Jee, Young Mee
TI Monitoring and Control of Aedes albopictus, a Vector of Zika Virus, Near
   Residences of Imported Zika Virus Patients during 2016 in South Korea
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID SINGAPORE-CITY; AEGYPTI L.; SKUSE; TRANSMISSION; DENGUE
AB Zika virus (ZIKV) is an arthropod-borne virus mainly transmitted by Aedes species. A total of nine of the 16 imported ZIKV reported cases during the mosquito season in the Republic of Korea (ROK), following the return of local nationals from foreign ZIKV endemic countries, were surveyed for Aedes albopictus. Surveillance and vector control of Ae. albopictus, a potential vector of ZIKV, and related species are critical for reducing the potential for autochthonous transmission in the ROK. Surveillance and vector control were coordinated by Korean Centers for Disease Control & Prevention (KCDC) and conducted by local health authorities within 200 m of imported ZIKV patients' residences. After diagnosis, thermal fogging (3 x week x 3 weeks), residual spray for homes and nearby structures (1 x week x 3 weeks), and larval control (3 x week x 3 weeks) were conducted in accordance with national guidelines developed by KCDC in early 2016. Of the nine residences surveyed using BG Sentinel traps, Ae. albopictus trap indices (TIs) for the three (3) patients' residences located near/in forested areas were significantly higher than the six patients' residences located inside villages/urban areas or low-lying farmland without trees. Overall, Ae. albopictus TIs in forested areas decreased by 90.4% after adult and larval control, whereas TIs decreased by 75.8% for residences in nonforested areas. A total of 3,216 Aedes and Ochlerotatus spp. were assayed by real-time polymerase chain reaction for ZIKV, dengue, and chikungunya virus. Both species collected before and after vector control were negative for all viruses. Vector control within 200 m of residences of imported ZIKV patients, conducted in accordance with established guidelines, may have effectively reduced human-mosquito-human transmission cycle by competent vectors in South Korea.
C1 [Chang, Kyu-Sik; Kim, Gi-Hun; Ha, Young-Ran; Jeong, Eun Kyeong; Shin, Seung Hwan; Ju, Young-Ran; Jee, Young Mee] Korea Ctr Dis Control & Prevent, Osongsaengmyeong 2 Ro, Osong, Chungbuk, South Korea.
   [Kim, Heung-Chul] USAG Yongsan, Med Detachment 5, Multifunct Med Battal 168, Med Brigade 65,Unit 15247, Seoul, South Korea.
   [Klein, Terry A.] USAG Yongsan, Med Dept Act Korea, Med Brigade 65, Unit 15281, Seoul, South Korea.
   [Kim, Eun Jeung] Seoul Metropolitan Govt Res Inst Publ Hlth & Envi, Seoul, South Korea.
   [Jegal, Seung] Gangwon Inst Hlth & Environm, Shinbuk, Gangwon, South Korea.
   [Chung, Se Jin] Incheon Inst Hlth & Environm, Incheon, South Korea.
RP Jee, YM (corresponding author), Korea Ctr Dis Control & Prevent, Osongsaengmyeong 2 Ro, Osong, Chungbuk, South Korea.
EM cks10910@icloud.com; kgh7895@korea.kr; hungchol.kim2.ln@mail.mil;
   terry.a.klein2.civ@mail.mil; ejvet@daum.net; jgseung@korea.kr;
   sejin47@korea.kr; juran@korea.kr; jeey62@korea.kr
RI Chang, Kyu-Sik/R-6752-2019
FU Korea National Vector Control Monitoring System, Korea Centers for
   Disease Control and Prevention [4834-303-210-13]; Armed Forces Health
   Surveillance Branch-Global Emerging Infections Surveillance and Response
   System (AFHSB-GEIS), Silver Spring, MD; 65th Medical Brigade, Seoul,
   Korea
FX This research was funded through grant from the Korea National Vector
   Control Monitoring System (4834-303-210-13), Korea Centers for Disease
   Control and Prevention. Partial funding was provided by the Armed Forces
   Health Surveillance Branch-Global Emerging Infections Surveillance and
   Response System (AFHSB-GEIS), Silver Spring, MD, and the 65th Medical
   Brigade, Seoul, Korea.
CR Aliota MT, 2016, EMERG INFECT DIS, V22, P1857, DOI 10.3201/eid2210.161082
   Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   Arima Y, 2014, WEST PAC SURVEILL RE, V5, P27, DOI [10.5365/WPSAR.2014.5.3.007, 10.5365/wpsar.2014.5.3.007]
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   BONNET DD, 1946, AM J TROP MED, V26, P465, DOI 10.4269/ajtmh.1946.s1-26.465
   Bureau of Social Welfare and Public Health Tokyo Metropolitan Government, 2014, DENGUE
   Caminade C, 2017, P NATL ACAD SCI USA, V114, P119, DOI 10.1073/pnas.1614303114
   CDC, 2016, DENG AED ALB MOSQ
   CHAN KL, 1971, B WORLD HEALTH ORGAN, V44, P629
   CHAN KL, 1971, B WORLD HEALTH ORGAN, V44, P643
   Chan KL, 1967, SINGAPORE PUBLIC HLT, V1, P52
   CHAN KL, 1985, SINGAPORES DENGUE HA
   CHAN YC, 1971, B WORLD HEALTH ORGAN, V44, P651
   CHAN YC, 1971, B WORLD HEALTH ORGAN, V44, P617
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   HO BC, 1971, B WORLD HEALTH ORGAN, V44, P635
   KCDC, 2016, DIS INF
   KCDC, 2016, INF DIS STAT SYST
   KCDC, 2016, DIS WEB STAT SYST
   Kutsuna S, 2015, EMERG INFECT DIS, V21, P517, DOI [10.3201/eid2103.141662, 10.3201/eid2103/141662]
   Marini F, 2010, MED VET ENTOMOL, V24, P361, DOI 10.1111/j.1365-2915.2010.00898.x
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Ooi EE, 2006, EMERG INFECT DIS, V12, P887, DOI 10.3201/10.3201/eid1206.051210
   SAS, 2010, ON DOC VERS 9 03
   Tanikawa T., 2015, Medical Entomology and Zoology, V66, P31
   WHO, 2005, 1 M INT HLTH REG IHR
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   World Health Organization, 2016, ZIK SIT REP
NR 29
TC 5
Z9 5
U1 0
U2 2
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 98
IS 1
BP 166
EP 172
DI 10.4269/ajtmh.17-0587
PG 7
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA GE1BD
UT WOS:000430950900032
PM 29141746
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Vanchiere, JA
   Ruiz, JC
   Brady, AG
   Kuehl, TJ
   Williams, LE
   Baze, WB
   Wilkerson, GK
   Nehete, PN
   McClure, GB
   Rogers, DL
   Rossi, SL
   Azar, SR
   Roundy, CM
   Weaver, SC
   Vasilakis, N
   Simmons, JH
   Abee, CR
AF Vanchiere, John A.
   Ruiz, Julio C.
   Brady, Alan G.
   Kuehl, Thomas J.
   Williams, Lawrence E.
   Baze, Wallace B.
   Wilkerson, Gregory K.
   Nehete, Pramod N.
   McClure, Gloria B.
   Rogers, Donna L.
   Rossi, Shannan L.
   Azar, Sasha R.
   Roundy, Christopher M.
   Weaver, Scott C.
   Vasilakis, Nikos
   Simmons, Joe H.
   Abee, Christian R.
TI Experimental Zika Virus Infection of Neotropical Primates
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID MICE; RHESUS; MODEL
AB The establishment of a sylvatic reservoir of Zika virus (ZIKV) in the Americas is dependent on the susceptibility of primates of sufficient population density, the duration and magnitude of viremia, and their exposure to the human mosquito-borne transmission cycle. To assess the susceptibility of squirrel (Saimiri sp.) and owl monkeys (Aotus sp.) to infection, we inoculated four animals of each species with ZIKV from the current epidemic. Viremia in the absence of detectible disease was observed in both species and seroconversion occurred by day 28. ZIKV was detected in the spleen of three owl monkeys: one at 7 days postinoculation (dpi) and two at 14 dpi. This study confirms the susceptibility to ZIKV infection of two Neotropical primate species that live in close proximity to humans in South America, suggesting that they could support awidespread sylvatic ZIKV cycle there. Collectively, establishment of a ZIKV sylvatic transmission cycle in South America would imperil eradication efforts and could provide a mechanism for continued exposure of humans to ZIKV infection and disease.
C1 [Vanchiere, John A.; Ruiz, Julio C.; Brady, Alan G.; Williams, Lawrence E.; Baze, Wallace B.; Wilkerson, Gregory K.; Nehete, Pramod N.; Simmons, Joe H.; Abee, Christian R.] Univ Texas MD Anderson Canc Ctr, Dept Vet Sci, Bastrop, TX USA.
   [Vanchiere, John A.; McClure, Gloria B.; Rogers, Donna L.] Louisiana State Univ, Dept Pediat, Hlth Sci Ctr, Shreveport, LA 71105 USA.
   [Kuehl, Thomas J.] Baylor Scott & White Clin, Dept Obstet & Gynecol, Temple, TX USA.
   [Rossi, Shannan L.; Azar, Sasha R.; Roundy, Christopher M.; Vasilakis, Nikos] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
   [Rossi, Shannan L.; Azar, Sasha R.; Roundy, Christopher M.; Vasilakis, Nikos] Univ Texas Med Branch, Ctr Biodef & Emerging Infect Dis, Galveston, TX 77555 USA.
   [Weaver, Scott C.; Vasilakis, Nikos] Univ Texas Med Branch, Dept Microbiol & Immunol, Inst Human Infect & Immun, Galveston, TX 77555 USA.
RP Vanchiere, JA (corresponding author), LSU, Hlth Sci Ctr Shreveport, Dept Pediat, 1501 Kings Hwy,5-303, Shreveport, LA 71130 USA.
EM jvanch@lsuhsc.edu; jcruiz@mdanderson.org; agbrady@mdanderson.org;
   thomas.kuehl@bswhealth.org; welawrence@mdanderson.org;
   wbaze@mdanderson.org; gkwilkerson@mdanderson.org;
   pnehete@mdanderson.org; gmcclu@lsuhsc.edu; droge1@lsuhsc.edu;
   slrossi@utmb.edu; srazar@utmb.edu; cmroundy@utmb.edu; sweaver@utmb.edu;
   nivasila@utmb.edu; jhsimmons1@mdanderson.org; cabee@mdanderson.org
RI Williams, Lawrence/AAD-6685-2020; Vanchiere, John/AAD-8979-2019
OI Williams, Lawrence/0000-0003-2267-9918; 
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [P40OD010938, R24AI120942,
   1U01AI115577]
FX NIH grants P40OD010938 (C.R.A.), R24AI120942 (S.C.W.) and 1U01AI115577
   (N.V.).
CR Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005168
   Althouse BM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005055
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Bryant JE, 2007, PLOS PATHOG, V3, P668, DOI 10.1371/journal.ppat.0030075
   Carroll T, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006537
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Ellington SR, 2016, JAMA PEDIATR, V170, P940, DOI 10.1001/jamapediatrics.2016.2974
   Favoretto S, 2016, BIORXIV, DOI [10.1101/049395, DOI 10.1101/049395]
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Hanley KA, 2013, INFECT GENET EVOL, V19, P292, DOI 10.1016/j.meegid.2013.03.008
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Ministerio da Saude B, 2005, MAN VIG EP PRIM NAO
   Nehete PN, 2017, COMPARATIVE MED, V67, P67
   Nehete PN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079836
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Roundy CM, 2017, EMERG INFECT DIS, V23, P625, DOI 10.3201/eid2304.161484
   Rylands Anthony B., 2009, P23, DOI 10.1007/978-0-387-78705-3_2
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Vasconcelos Pedro Fernando da Costa, 2003, Rev. Soc. Bras. Med. Trop., V36, P275, DOI 10.1590/S0037-86822003000200012
   Vasilakis N, 2008, AM J TROP MED HYG, V79, P128, DOI 10.4269/ajtmh.2008.79.128
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
NR 27
TC 15
Z9 15
U1 0
U2 2
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 98
IS 1
BP 173
EP 177
DI 10.4269/ajtmh.17-0322
PG 5
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA GE1BD
UT WOS:000430950900033
PM 29182145
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU de Matos, APA
   Ze-Ze, L
   Amaro, F
   Alves, MJ
AF Alves de Matos, A. P.
   Ze-Ze, Libia
   Amaro, Fatima
   Alves, Maria Joao
TI Infection of mice tissues with the Zika virus
SO ANNALS OF MEDICINE
LA English
DT Meeting Abstract
CT 2nd International Congress of CiiEM - Translational Research and
   Innovation in Human and Health Sciences
CY JUN 11-13, 2017
CL Almada, PORTUGAL
SP CiiEM
C1 [Alves de Matos, A. P.] Egas Moniz Cooperat Ensino Super CRL, Ctr Invest Interdisciplinar Egas Moniz, Quinta Da Granja, Monte Da Capari, Portugal.
   [Ze-Ze, Libia; Amaro, Fatima; Alves, Maria Joao] Inst Nacl Saude Dr Ricardo Jorge, Ctr Estudos Vectores & Doencas Infecciosas, Aguas De Moura, Portugal.
EM apamatos@gmail.com
RI Matos, Antonio P. A./A-4539-2013
OI Matos, Antonio P. A./0000-0001-9386-0349
CR Amaro F, 2015, MICROSC MICROANAL S6, V21, P48
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Saiz JC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00496
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
NR 4
TC 0
Z9 0
U1 0
U2 0
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0785-3890
EI 1365-2060
J9 ANN MED
JI Ann. Med.
PY 2018
VL 50
SU 1
BP S44
EP S45
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA GD4UK
UT WOS:000430497900053
DA 2020-07-08
ER

PT J
AU Gloria-Soria, A
   Lima, A
   Lovin, DD
   Cunningham, JM
   Severson, DW
   Powell, JR
AF Gloria-Soria, Andrea
   Lima, Andrew
   Lovin, Diane D.
   Cunningham, Joanne M.
   Severson, David W.
   Powell, Jeffrey R.
TI Origin of a High-Latitude Population of Aedes aegypti in Washington, DC
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID DIPTERA-CULICIDAE; SEPTIC TANKS; R-PACKAGE; VECTOR; DENGUE; ALBOPICTUS;
   GENETICS; PROGRAM; VIRUS; DIVERSITY
AB An overwintering population of Aedes aegypti has been documented in the Capitol Hill neighborhood of Washington, DC, since 2011. Mitochondrial cytochrome oxidase I (mtCOI) sequence data presented in a previous study traced the origin to the New World. Here, we use microsatellite and 14,071 single nucleotide polymorphisms along with mitochondrial DNA (mtDNA) sequences on Washington Ae. aegypti samples and samples from potential sources to further narrow the origin of this population. Genetically, Washington Ae. aegypti are closest to populations in Florida, meaning this is the most likely source. Florida experienced the first mosquito-borne transmission of dengue in the United States after decades of absence of this disease, as well as local transmission of chikungunya and Zika in recent years. This suggests that the Capitol Hill, Washington, DC population of Ae. aegypti is capable of transmitting viruses such as dengue, chikungunya, and Zika in modern US city environments.
C1 [Gloria-Soria, Andrea; Powell, Jeffrey R.] Yale Univ, 21 Sachem St, New Haven, CT 06520 USA.
   [Lima, Andrew] Fairfax Cty Hlth Dept, Dis Carrying Insects Program, Fairfax, VA USA.
   [Lovin, Diane D.; Cunningham, Joanne M.; Severson, David W.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.
   [Lovin, Diane D.; Cunningham, Joanne M.; Severson, David W.] Univ Notre Dame, Eck Inst Global Hlth, Notre Dame, IN 46556 USA.
RP Gloria-Soria, A (corresponding author), Yale Univ, 21 Sachem St, New Haven, CT 06520 USA.
EM andrea.gloria-soria@yale.edu; andrew.lima@fairfaxcounty.gov;
   dlovin@nd.edu; joanne.m.cunningham.55@nd.edu; dseverso@nd.edu;
   jeffrey.powell@yale.edu
RI Gloria-Soria, Andrea/AAJ-3304-2020
OI Gloria-Soria, Andrea/0000-0002-5401-3988
FU NIH NIAID grant [RO1 AI101112, R56 AI079125-A1]
FX Genetic analyses at Yale were supported by NIH NIAID grant RO1 AI101112
   and at the University of Notre Dame by NIH NIAID grant R56 AI079125-A1.
   Kirk Smith provided the documentation of subterranean Aedes aegypti in
   Arizona.
CR Alexander DH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-246
   [Anonymous], 2015, DIS MAPS DYN MAP VIE
   Barrera R, 2008, MED VET ENTOMOL, V22, P62, DOI 10.1111/j.1365-2915.2008.00720.x
   Bennett KE, 2002, AM J TROP MED HYG, V67, P85, DOI 10.4269/ajtmh.2002.67.85
   Linss JGB, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-25
   Brown JE, 2011, EMERG INFECT DIS, V17, P2335, DOI 10.3201/eid1712.110992
   Brown JE, 2011, P ROY SOC B-BIOL SCI, V278, P2446, DOI 10.1098/rspb.2010.2469
   Chadee DD, 2016, ACTA TROP, V156, P137, DOI 10.1016/j.actatropica.2015.12.022
   Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Christophers S., 1960, AEDES AEGYPTI L YELL
   Deming R, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1346-3
   Paploski IAD, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1705-0
   Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7
   Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x
   Evans BR, 2015, G3-GENES GENOM GENET, V5, P711, DOI 10.1534/g3.114.016196
   Failloux AB, 2002, J MOL EVOL, V55, P653, DOI 10.1007/s00239-002-2360-y
   Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294
   Frichot E, 2015, METHODS ECOL EVOL, V6, P925, DOI 10.1111/2041-210X.12382
   Giraldo-Calderon GI, 2015, NUCLEIC ACIDS RES, V43, pD707, DOI 10.1093/nar/gku1117
   Gloria-Soria A, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.1506
   Gloria-Soria A, 2016, MED VET ENTOMOL, V30, P235, DOI 10.1111/mve.12153
   Gloria-Soria A, 2016, MOL ECOL, V25, P5377, DOI 10.1111/mec.13866
   Gloria-Soria A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003029
   Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129
   Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x
   Kotsakiozi P, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005653
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msv279, 10.1093/molbev/msw054]
   Lima A, 2016, AM J TROP MED HYG, V94, P231, DOI 10.4269/ajtmh.15-0351
   Mackay AJ, 2009, J AM MOSQUITO CONTR, V25, P409, DOI 10.2987/09-5888.1
   Manrique-Saide P, 2012, J AM MOSQUITO CONTR, V28, P255, DOI 10.2987/12-6244R.1
   Martins AJ, 2009, TROP MED INT HEALTH, V14, P1351, DOI 10.1111/j.1365-3156.2009.02378.x
   Metzger ME, 2017, J MED ENTOMOL, V54, P533, DOI 10.1093/jme/tjw237
   Nazareno AG, 2017, MOL ECOL RESOUR, V17, P1136, DOI 10.1111/1755-0998.12654
   NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321
   PATTERSON KD, 1992, SOC SCI MED, V34, P855, DOI 10.1016/0277-9536(92)90255-O
   Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x
   Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074
   Pless E, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005718
   POWELL JR, 1980, SCIENCE, V208, P1385
   Pritchard JK, 2000, GENETICS, V155, P945
   Puechmaille SJ, 2016, MOL ECOL RESOUR, V16, P608, DOI 10.1111/1755-0998.12512
   R Core Team, 2017, R LANG ENV STAT COMP
   Radke EG, 2012, EMERG INFECT DIS, V18, P135, DOI 10.3201/eid1801.110130
   Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197
   Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x
   Saarman NP, 2017, EVOL APPL, V10, P1031, DOI 10.1111/eva.12508
   Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75
   Somers G, 2011, J MED ENTOMOL, V48, P1095, DOI 10.1603/ME11129
   Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033
   TABACHNICK WJ, 1985, AM J TROP MED HYG, V34, P1219, DOI 10.4269/ajtmh.1985.34.1219
   TESH RB, 1976, AM J TROP MED HYG, V25, P326, DOI 10.4269/ajtmh.1976.25.326
   Wang JL, 2017, MOL ECOL RESOUR, V17, P981, DOI 10.1111/1755-0998.12650
   Willing EM, 2010, MOL ECOL, V19, P968, DOI 10.1111/j.1365-294X.2010.04528.x
   Zouache K, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1078
NR 57
TC 8
Z9 8
U1 0
U2 5
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 98
IS 2
BP 445
EP 452
DI 10.4269/ajtmh.17-0676
PG 8
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA GE1BC
UT WOS:000430950800016
PM 29260658
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Altintop, MD
   Tabanca, N
   Becnel, JJ
   Bloomquist, JR
   Kaplancikli, ZA
   Ozdemir, A
AF Altintop, Mehlika Dilek
   Tabanca, Nurhayat
   Becnel, James J.
   Bloomquist, Jeffrey R.
   Kaplancikli, Zafer Asim
   Ozdemir, Ahmet
TI Synthesis and Mosquitocidal Activity of a Series of Hydrazone
   Derivatives against Aedes aegypti
SO LETTERS IN DRUG DESIGN & DISCOVERY
LA English
DT Article
DE Hydrazone; mosquito control; insecticidal activity; dengue fever; Zika
   virus; larvicidal effects
ID ACTIVITY-RELATIONSHIP QSAR; INSECTICIDAL ACTIVITY; BIOLOGICAL
   EVALUATION; ANTICANCER AGENTS; ALBOPICTUS; DESIGN; ADULT; FEVER
AB Background: Aedes aegypti is an important mosquito vector for the transmission of several infectious diseases. Current insecticides play a vital role in controlling mosquitoes; however, the frequent use of insecticides has led to the development of insecticide resistance. In order to control mosquito populations, new and effective bioactive molecules are urgently needed.
   Methods: In the current work, N-(benzylidene)-3-cyclopentylpropionic acid hydrazide derivatives (2a-p) were synthesized and evaluated for their larvicidal and adulticidal effects on Ae. aegypti.
   Results: N-(Benzylidene)-3-cyclopentylpropionic acid hydrazide (2a) and N-(4-isopropyl-benzylidene)-3-cyclopentylpropionic acid hydrazide (2i) were identified as the most potent larvicides in this series with LC50 values of 0.0097 (0.005-0.017, 95% CI) mu g/mu L and 0.2729 (0.223-0.336, 95% CI) mu g/mu L, respectively against 1st instar A. aegypti. On the other hand, compounds 2a-p showed weak adulticidal activity against adult female A. aegypti.
   Conclusion: Due to their notable larvicidal activity, compounds 2a and 2i stand out as promising candidates for further studies.
C1 [Altintop, Mehlika Dilek; Kaplancikli, Zafer Asim; Ozdemir, Ahmet] Anadolu Univ, Fac Pharm, Dept Pharmaceut Chem, TR-26470 Eskisehir, Turkey.
   [Tabanca, Nurhayat; Bloomquist, Jeffrey R.] Univ Florida, Emerging Pathogens Inst, Dept Entomol & Nematol, Gainesville, FL 32610 USA.
   [Tabanca, Nurhayat] ARS, USDA, Subtrop Hort Res Stn, Miami, FL 33158 USA.
   [Becnel, James J.] ARS, USDA, Ctr Med Agr & Vet Entomol, Gainesville, FL 32608 USA.
RP Altintop, MD (corresponding author), Anadolu Univ, Fac Pharm, Dept Pharmaceut Chem, TR-26470 Eskisehir, Turkey.
EM mdaltintop@anadolu.edu.tr
RI KAPLANCIKLI, ZAFER ASIM/L-5288-2017
OI KAPLANCIKLI, ZAFER ASIM/0000-0003-2252-0923
FU Deployed War-Fighter Protection Research Program via grants from the
   U.S. Department of Defense through the Armed Forces Pest Management
   Board
FX This study was partly funded by the Deployed War-Fighter Protection
   Research Program via grants from the U.S. Department of Defense through
   the Armed Forces Pest Management Board. We thank Miss Jessica Louton and
   Dr. Alden S. Estep (USDA-ARS, CMAVE, Gainesville, FL) for the mosquito
   bioassays.
CR Aggarwal N, 2010, J AGR FOOD CHEM, V58, P3056, DOI 10.1021/jf904144e
   Akdag K, 2014, MARMARA PHARM J, V18, P120, DOI 10.12991/mpj.2014187238
   Altintop MD, 2012, EUR J MED CHEM, V58, P299, DOI 10.1016/j.ejmech.2012.10.011
   Che ZP, 2013, J AGR FOOD CHEM, V61, P5696, DOI 10.1021/jf400536q
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Estep AS, 2016, NAT PROD COMMUN, V11, P1675
   GUBLER DJ, 1995, EMERG INFECT DIS, V1, P55
   Kaplancikli ZA, 2012, LETT DRUG DES DISCOV, V9, P310
   Kumar P, 2013, MINI-REV MED CHEM, V13, P971, DOI 10.2174/1389557511313070003
   Masi M, 2017, OPEN CHEM, V15, P156, DOI 10.1515/chem-2017-0019
   Masi M, 2017, FITOTERAPIA, V116, P34, DOI 10.1016/j.fitote.2016.11.007
   Moore CG, 1997, EMERG INFECT DIS, V3, P329, DOI 10.3201/eid0303.970309
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Narang R, 2012, CURR MED CHEM, V19, P569, DOI 10.2174/092986712798918789
   Popiolek L, 2017, MED CHEM RES, V26, P287, DOI 10.1007/s00044-016-1756-y
   Pridgeon JW, 2007, J MED ENTOMOL, V44, P263, DOI 10.1603/0022-2585(2007)44[263:SROPAT]2.0.CO;2
   Pridgeon JW, 2009, J MED ENTOMOL, V46, P335, DOI 10.1603/033.046.0219
   Reiter P, 2001, ENVIRON HEALTH PERSP, V109, P141, DOI 10.2307/3434853
   Rollas S, 2007, MOLECULES, V12, P1910, DOI 10.3390/12081910
   Sun JL, 2015, MOLECULES, V20, P5625, DOI 10.3390/molecules20045625
   Tabanca N, 2013, MED CHEM RES, V22, P2602, DOI 10.1007/s00044-012-0250-4
   Tabanca N, 2013, PEST MANAG SCI, V69, P703, DOI 10.1002/ps.3424
   Unlu I, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2034-7
   Villela DAM, 2017, EPIDEMIOL INFECT, V145, P1649, DOI 10.1017/S0950268817000358
   Wang Y, 2014, BIOORG MED CHEM LETT, V24, P2621, DOI 10.1016/j.bmcl.2014.04.074
   Yang C, 2013, BIOORG MED CHEM LETT, V23, P4806, DOI 10.1016/j.bmcl.2013.06.099
   Yang ZB, 2016, BIOORG MED CHEM LETT, V26, P1161, DOI 10.1016/j.bmcl.2016.01.047
   Zaim M, 2002, TRENDS PARASITOL, V18, P161, DOI 10.1016/S1471-4922(01)02220-6
NR 28
TC 0
Z9 0
U1 0
U2 9
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1570-1808
EI 1875-628X
J9 LETT DRUG DES DISCOV
JI Lett. Drug Des. Discov.
PY 2018
VL 15
IS 6
BP 671
EP 677
DI 10.2174/1570180814666171002155548
PG 7
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA GD6SF
UT WOS:000430638000011
DA 2020-07-08
ER

PT J
AU Elfiky, AA
   Ismail, AM
AF Elfiky, A. A.
   Ismail, A. M.
TI Molecular docking revealed the binding of nucleotide/side inhibitors to
   Zika viral polymerase solved structures
SO SAR AND QSAR IN ENVIRONMENTAL RESEARCH
LA English
DT Article
DE Zika virus; RNA-dependent RNA polymerase; molecular docking; drug
   protein interaction; NS5 solved structure
ID CRYSTAL-STRUCTURE; VIRUS NS5; SOFOSBUVIR; MECHANISM; DISCOVERY;
   CONFORMATION; RESISTANCE; DRUGS
AB A new Zika virus (ZIKV) outbreak started in 2015. According to the World Health Organization, 84 countries confirmed ZIKV infection. RNA-dependent RNA polymerase (RdRp) was an appealing target for drug designers during the last two decades. Through molecular docking, we screened 16 nucleotide/side inhibitors against ZIKV RdRp. While the mode of interaction with ZIKV is different from that in the hepatitis C virus (HCV), nucleotide/side inhibitors in this study (mostly anti-HCV) showed promising binding affinities (-6.2 to -9.7 kcal/mol calculated by AutoDock Vina) to ZIKV RdRp. Setrobuvir, YAK and, to a lesser extent, IDX-184 reveal promising results compared to other inhibitors in terms of binding ZIKV RdRp. These candidates would be powerful anti-ZIKV drugs.
C1 [Elfiky, A. A.; Ismail, A. M.] Cairo Univ, Dept Biophys, Fac Sci, Giza, Egypt.
   [Elfiky, A. A.] Abdus Salam Int Ctr Theoret Phys, Quantitat Life Sci Dept, Str Costiera, Trieste, Italy.
   [Elfiky, A. A.] Univ Alberta, Fac Pharm & Pharmaceut Sci, Edmonton, AB, Canada.
   [Ismail, A. M.] Univ Alberta, Fac Med & Dent, Biochem Dept, Edmonton, AB, Canada.
RP Elfiky, AA (corresponding author), Cairo Univ, Dept Biophys, Fac Sci, Giza, Egypt.; Elfiky, AA (corresponding author), Abdus Salam Int Ctr Theoret Phys, Quantitat Life Sci Dept, Str Costiera, Trieste, Italy.; Elfiky, AA (corresponding author), Univ Alberta, Fac Pharm & Pharmaceut Sci, Edmonton, AB, Canada.
EM abdo@sci.cu.edu.eg
RI Mohamed, Abdo/H-3595-2019
OI Mohamed, Abdo/0000-0003-4600-6240
CR [Anonymous], PYMOL MOL GRAPH SYST
   [Anonymous], MAESTR SCHROD
   [Anonymous], 2018, STRUCT AN VER SERV
   Asselah T, 2014, J HEPATOL, V61, P435, DOI 10.1016/j.jhep.2014.04.042
   BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913
   Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Doublie S, 1998, CURR OPIN STRUC BIOL, V8, P704, DOI 10.1016/S0959-440X(98)80089-4
   Duan WQ, 2017, EMBO J, V36, P919, DOI 10.15252/embj.201696241
   Elfiky A.A., 2016, SOFTWARE TECHNIQUES, P197
   Elfiky AA, 2017, FUTURE VIROL, V12, P720, DOI 10.2217/fvl-2017-0081
   Elfiky AA, 2018, J MED VIROL, V90, P13, DOI 10.1002/jmv.24934
   Elfiky AA, 2017, J MED VIROL, V89, P1040, DOI 10.1002/jmv.24736
   Elfiky AA, 2016, J MED VIROL, V88, P2044, DOI 10.1002/jmv.24678
   Elfiky AA, 2016, MED CHEM RES, V25, P1005, DOI 10.1007/s00044-016-1533-y
   Elfiky AA, 2015, J COMPUT THEOR NANOS, V12, P376, DOI 10.1166/jctn.2015.3739
   Elfiky AA, 2013, PROTEIN J, V32, P75, DOI 10.1007/s10930-013-9462-9
   Elshemey WM, 2010, PROTEIN J, V29, P545, DOI 10.1007/s10930-010-9291-z
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Ferrer-Orta C, 2015, VIRUSES-BASEL, V7, P4438, DOI 10.3390/v7082829
   Ganesan A, 2017, EXPERT OPIN DRUG DIS, V12, P407, DOI 10.1080/17460441.2017.1291628
   GELFAND MICHAEL, 1964, TRANS ROY SOC TROP MED HYG, V58, P339, DOI 10.1016/0035-9203(64)90202-0
   Godoy AS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14764
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Hercik K, 2017, ANTIVIR RES, V137, P131, DOI 10.1016/j.antiviral.2016.11.020
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   Jacome R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139001
   Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Leach A. R., 2001, MOL MODELLING PRINCI
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mallalieu NL, 2014, CLIN THER, V36, P2047, DOI 10.1016/j.clinthera.2014.10.002
   Mayhoub AS, 2012, BIOORGAN MED CHEM, V20, P3150, DOI 10.1016/j.bmc.2012.03.049
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256
   Murakami E, 2010, J BIOL CHEM, V285, P34337, DOI 10.1074/jbc.M110.161802
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2017, J MED VIROL, V89, P1505, DOI 10.1002/jmv.24735
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Pattnaik A, 2018, ANTIVIR RES, V151, P78, DOI 10.1016/j.antiviral.2017.12.016
   Powdrill MH, 2010, VIRUSES-BASEL, V2, P2169, DOI 10.3390/v2102169
   Ramharack P, 2016, RSC ADV, V6, P68719, DOI 10.1039/c6ra12142j
   Singh A, 2017, COMPUT BIOL CHEM, V71, P144, DOI 10.1016/j.compbiolchem.2017.10.007
   Tauro LB, 2017, J MED VIROL, V89, P1, DOI 10.1002/jmv.24696
   Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334
   Upadhyay AK, 2017, ACTA CRYSTALLOGR F, V73, P116, DOI 10.1107/S2053230X17001601
   Wang BX, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14763
   World Health Organization (WHO), 2016, ZIK STRAT RESP FRAM
   Xue WW, 2014, ANTIVIR RES, V104, P40, DOI 10.1016/j.antiviral.2014.01.006
   Zumla A, 2016, INT J INFECT DIS, V45, P92, DOI 10.1016/j.ijid.2016.02.1007
NR 53
TC 12
Z9 12
U1 1
U2 7
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1062-936X
EI 1029-046X
J9 SAR QSAR ENVIRON RES
JI SAR QSAR Environ. Res.
PY 2018
VL 29
IS 5
BP 409
EP 418
DI 10.1080/1062936X.2018.1454981
PG 10
WC Chemistry, Multidisciplinary; Computer Science, Interdisciplinary
   Applications; Environmental Sciences; Mathematical & Computational
   Biology; Toxicology
SC Chemistry; Computer Science; Environmental Sciences & Ecology;
   Mathematical & Computational Biology; Toxicology
GA GC9DX
UT WOS:000430098800004
PM 29652194
DA 2020-07-08
ER

PT J
AU Kluge, H
   Martin-Moreno, JM
   Emiroglu, N
   Rodier, G
   Kelley, E
   Vujnovic, M
   Permanand, G
AF Kluge, Hans
   Martin-Moreno, Jose Maria
   Emiroglu, Nedret
   Rodier, Guenael
   Kelley, Edward
   Vujnovic, Melitta
   Permanand, Govin
TI Strengthening global health security by embedding the International
   Health Regulations requirements into national health systems
SO BMJ GLOBAL HEALTH
LA English
DT Article
ID EBOLA; FRAMEWORK; COVERAGE
AB The International Health Regulations (IHR) 2005, as the overarching instrument for global health security, are designed to prevent and cope with major international public health threats. But poor implementation in countries hampers their effectiveness. In the wake of a number of major international health crises, such as the 2014 Ebola and 2016 Zika outbreaks, and the findings of a number of high-level assessments of the global response to these crises, it has become clear that there is a need for more joined-up thinking between health system strengthening activities and health security efforts for prevention, alert and response. WHO is working directly with its Member States to promote this approach, more specifically around how to better embed the IHR (2005) core capacities into the main health system functions. This paper looks at how and where the intersections between the IHR and the health system can be best leveraged towards developing greater health system resilience. This merging of approaches is a key component in pursuit of Universal Health Coverage and strengthened global health security as two mutually reinforcing agendas.
C1 [Kluge, Hans; Permanand, Govin] WHO, Reg Off Europe, Hlth Syst & Publ Hlth, Copenhagen, Denmark.
   [Martin-Moreno, Jose Maria] Univ Valencia, Prevent Med & Publ Hlth, Valencia, Spain.
   [Martin-Moreno, Jose Maria] Univ Valencia, Univ Clin Hosp INCLIVA, Valencia, Spain.
   [Emiroglu, Nedret] WHO, Reg Off Europe, Communicable Dis & Hlth Secur, Copenhagen, Denmark.
   [Rodier, Guenael] WHO, Country Hlth Emergency Preparedness & IHR, Geneva, Switzerland.
   [Kelley, Edward] WHO, Serv Delivery & Safety, Geneva, Switzerland.
   [Vujnovic, Melitta] WHO, Moscow, Russia.
RP Permanand, G (corresponding author), WHO, Reg Off Europe, Hlth Syst & Publ Hlth, Copenhagen, Denmark.
EM permanandg@who.int
OI Permanand, Govin/0000-0002-5624-4421
FU World Health OrganizationWorld Health Organization [001]
CR Africa Governance Initiative, 2015, STAT EM GOV FOUGHT E
   [Anonymous], 2005, INT HLTH REGULATIONS
   [Anonymous], 2015, REPORT HARVARD LSHTM, DOI [10.1016/S0140-6736(15)00946-0, DOI 10.1016/S0140-6736(15)00946-0]
   CDC, GLOB HLTH SEC AG
   Chamberlin Margaret, 2015, INTRAACTION REPORT D
   Cohen O, 2015, GLOBAL HEALTH ACTION, V8, DOI 10.3402/gha.v8.28871
   Commission on a Global Health Risk Framework for the Future, 2016, NEGL DIM GLOB SEC FR
   Frenk J, 2013, NEW ENGL J MED, V368, P936, DOI 10.1056/NEJMra1109339
   Ghebreyesus TA, 2017, LANCET GLOB HEALTH, V5, pE839, DOI 10.1016/S2214-109X(17)30295-4
   Gostin L., 2015, REFORMING WHO EBOLA
   Gostin LO, 2016, JAMA-J AM MED ASSOC, V315, P1451, DOI 10.1001/jama.2016.1964
   Gostin LO, 2015, LANCET, V386, P2222, DOI 10.1016/S0140-6736(15)00948-4
   Heymann DL, 2015, LANCET, V385, P1884, DOI 10.1016/S0140-6736(15)60858-3
   Hoffman JJ, 2014, ROUTLEDGE HDB GLOBAL, P239
   International Organization for Migration, 2014, INV GLOB HLTH SYST S
   Kamradt-Scott A, 2015, LANCET, V385, P111, DOI 10.1016/S0140-6736(15)60012-5
   Katz R, 2010, REVISED INT HLTH REG
   Katz R, 2015, LANCET GLOB HEALTH, V3, pE352, DOI 10.1016/S2214-109X(15)00025-X
   Kutzin J, 2016, B WORLD HEALTH ORGAN, V94, P2, DOI 10.2471/BLT.15.165050
   Martin-Moreno JM, 2016, ANNU REV PUBL HEALTH, V37, P335, DOI 10.1146/annurev-publhealth-032315-021429
   Medecins Sans Frontieres, 2015, PUSH LIM YEAR LARG E
   Murray K, 2015, CROSS BORDER HLTH TH
   Oxfam, 2015, 203 OXF
   Shoman H, 2017, GLOBALIZATION HEALTH, V13, DOI 10.1186/s12992-016-0224-2
   Smith F., 2015, STATEMENT NO MORE EP
   WHO, 2015, REP EB INT ASS PAN
   World Bank, 2014, EC IMP 2014 EB EP SH
   World Health IMA, 2015, STOPP EB ITS TRACKS
   World Health Organisation, 2015, TRAD HLTH BUILD NAT
   World Health Organization, 2011, REP REV COMM FUNCT I
   World Health Organization, 2007, EV BUS STRENGTH HLTH
NR 31
TC 17
Z9 17
U1 2
U2 5
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 2059-7908
J9 BMJ GLOB HEALTH
JI BMJ Glob. Health
PD JAN
PY 2018
VL 3
SU 1
AR UNSP e000656
DI 10.1136/bmjgh-2017-000656
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GC4QN
UT WOS:000429770000009
PM 29379650
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Paixao, ES
   Teixeira, MG
   Rodrigues, LC
AF Paixao, E. S.
   Teixeira, M. G.
   Rodrigues, L. C.
TI Zika, chikungunya and dengue: the causes and threats of new and
   re-emerging arboviral diseases (vol 3, e000530, 2017)
SO BMJ GLOBAL HEALTH
LA English
DT Correction
CR Paixao ES, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000530
NR 1
TC 0
Z9 0
U1 0
U2 2
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 2059-7908
J9 BMJ GLOB HEALTH
JI BMJ Glob. Health
PD JAN
PY 2018
VL 3
IS 1
AR UNSP e000530corr1
DI 10.1136/bmjgh-2017-000530corr1
PG 1
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GC4QL
UT WOS:000429769800015
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Paixao, ES
   Teixeira, MG
   Rodrigues, LC
AF Paixao, E. S.
   Teixeira, M. G.
   Rodrigues, L. C.
TI Zika, chikungunya and dengue: the causes and threats of new and
   re-emerging arboviral diseases (vol 3, e000530, 2017)
SO BMJ GLOBAL HEALTH
LA English
DT Correction
CR Paixao ES, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000530
NR 1
TC 0
Z9 0
U1 0
U2 1
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 2059-7908
J9 BMJ GLOB HEALTH
JI BMJ Glob. Health
PD JAN
PY 2018
VL 3
SU 1
AR UNSP e000530corr1
DI 10.1136/bmjgh-2017-000530corr1
PG 1
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GC4QN
UT WOS:000429770000005
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Alshammari, SA
   Alamri, YS
   Rabhan, FS
   Alabdullah, AA
   Alsanie, NA
   Almarshad, FA
   Alhaqbani, AN
AF Alshammari, Sulaiman A.
   Alamri, Yousif S.
   Rabhan, Fatimah S.
   Alabdullah, Aljoharah A.
   Alsanie, Noura A.
   Almarshad, Fatma A.
   Alhaqbani, Amal N.
TI Overview of dengue and Zika virus similarity, what can we learn from the
   Saudi experience with dengue fever?
SO INTERNATIONAL JOURNAL OF HEALTH SCIENCES-IJHS
LA English
DT Review
DE Aedes; Dengue; Zika; Saudi Arabia
ID CLINICAL PRESENTATION; HEMORRHAGIC-FEVER; ARABIA; EMERGENCE; MOSQUITOS
AB There is high public health alert in the Kingdom of Saudi Arabia concerning Zika virus infection. So far, there is no reported outbreak. So are we at risk of this disease? Reviewing the literature of recent outbreaks of other infectious diseases in Saudi Arabia may clarify the situation. It is evident that there is some similarity between Zika and dengue regarding vector (Aedes aegypti) which is available in the Kingdom of Saudi Arabia. Furthermore, they have similar transmission process and the required environment for infection. It seems that the Kingdom has learned from previous outbreaks, so they are well prepared to face such challenges. The Saudi Ministry of Health built the command and control center to deal with the pandemic flues. Furthermore, they are trying to create a center for disease control, and they are recruiting local and international experts in monitoring the emerging infections.
C1 [Alshammari, Sulaiman A.] King Saud Univ, Coll Med, Res Chair Hlth Educ & Hlth Promot, Dept Family & Community Med, Riyadh, Saudi Arabia.
   [Alamri, Yousif S.] Saudi Food & Drug Author, Dept Natl Drug & Poison, Informat Ctr, Riyadh, Saudi Arabia.
   [Rabhan, Fatimah S.; Alabdullah, Aljoharah A.; Alsanie, Noura A.; Almarshad, Fatma A.; Alhaqbani, Amal N.] PrincessNourah Bint Abdulrahman Univ, Dept Epidemiol, Riyadh, Saudi Arabia.
RP Alshammari, SA (corresponding author), King Saud Univ, Dept Family & Community Med, Coll Med, POB 2925, Riyadh 11461, Saudi Arabia.
EM sulaiman@ksu.edu.sa
CR AHMED AM, 2011, J INSECT SCI, V11
   Al-Azraqi TA, 2013, T R SOC TROP MED HYG, V41, P1
   Al-Ghamdi Khalid, 2009, Current World Environment, V4, P307
   Alhaeli A, 2016, J INFECT PUBLIC HEAL, V9, P117, DOI 10.1016/j.jiph.2015.05.006
   Alharthy A., 2007, ROLE GIS DENGUE CONT
   Alikhan M, 2014, J INSECT SCI, V14, DOI 10.1093/jis/14.1.69
   Alzahrani AG, 2013, T ROY SOC TROP MED H, V107, P23, DOI 10.1093/trstmh/trs011
   [Anonymous], 2016, ZIK VIR MICR GUILL B
   Ashshi AM, 2015, BLOOD TRANSFUS-ITALY, V13, P135, DOI 10.2450/2014.0134-14
   Ayyub Muhammad, 2006, J Ayub Med Coll Abbottabad, V18, P9
   Aziz A, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0487-5
   Aziz Al Thabiany, 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P849, DOI 10.1016/S2221-1691(12)60242-1
   Centers for Disease Control and Prevention, 2015, SURV CONTR AED AEG A
   Centers for Disease Control and Prevention, 2010, DENG HOM CDC
   Centers for Disease Control and Prevention, 2013, MOSQ LIF CYCL
   Central Department of Statistics and Information, 2015, AL HAJJ STAT 2015
   Dye C, 2016, B WORLD HEALTH ORGAN, V94, P158, DOI 10.2471/BLT.16.170860
   El-Bahnasawy Mamdouh M, 2014, J Egypt Soc Parasitol, V44, P405
   El-Gilany AH, 2010, ASIAN PAC J TROP MED, V3, P220, DOI 10.1016/S1995-7645(10)60013-2
   Fakeeh M, 2001, AM J TROP MED HYG, V65, P764, DOI 10.4269/ajtmh.2001.65.764
   Ghaznawi H. I., 1997, Eastern Mediterranean Health Journal, V3, P567
   GUBLER DJ, 1995, EMERG INFECT DIS, V1, P55
   Gubler Duane J, 2006, Novartis Found Symp, V277, P3, DOI 10.1002/0470058005.ch2
   Ibrahim Nahla Khamis Ragab, 2009, J Infect Public Health, V2, P30, DOI 10.1016/j.jiph.2009.01.004
   Iovine NM, 2017, CLIN INFECT DIS, V64, P72, DOI 10.1093/cid/ciw667
   Kamran S., 2013, HLTH J, V4, P60
   Khater EI, 2013, TROP BIOMED, V30, P409
   Kheir S. M., 2010, JOURNAL OF THE EGYPTIAN SOCIETY OF PARASITOLOGY, V40, P215
   Kholedi A. A. N., 2012, Eastern Mediterranean Health Journal, V18, P15
   Khormi HM, 2012, GEOSPATIAL HEALTH, V6, P171, DOI 10.4081/gh.2012.135
   Khormi LM, 2012, SCI TOTAL ENVIRON, V430, P144, DOI 10.1016/j.scitotenv.2012.05.001
   Koenig KL, 2016, WEST J EMERG MED, V17, P238, DOI 10.5811/westjem.2016.3.30188
   Mamdouh KH, 2013, J GLOB INFECT DIS, V5, P183, DOI 10.4103/0974-777X.122021
   Memish ZA, 2005, BRIT J BIOMED SCI, V62, P37
   Memish ZA, 2011, EMERG INFECT DIS, V17, P2316, DOI 10.3201/eid1712.110658
   Naeem Z., 2016, INT J HLTH SCI, V10, P5
   Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8
   WHO, 2017, ZIK SIT REP
   WHO [World Health Organization], 2016, MOSQ VECT CONTR EM R
   World Health Organization, 2006, MOSQ OTH BIT DIPT
   World Health Organization, 2015, DENG SEV DENG WHO
   World Health Organization, NEUR SYNDR CONG AN
   World Health Organization, LAB TEST ZIK VIR INF
   World Health Organization, 2016, ZIK VIR WHO
   Zanluca C, 2016, MICROBES INFECT, V18, P295, DOI 10.1016/j.micinf.2016.03.003
NR 47
TC 3
Z9 3
U1 0
U2 0
PU ACAD PUBLISHING & TRANSLATION
PI BURAIDAH
PA COLL MEDICINE, QASSIM UNIV, PO BOX 6655, BURAIDAH, 51432, SAUDI ARABIA
SN 1658-3639
J9 INT J HEALTH SCI-IJH
JI Int. J. Health Sci.-IJHS
PD JAN-FEB
PY 2018
VL 12
IS 1
BP 77
EP 82
PG 6
WC Medicine, General & Internal
SC General & Internal Medicine
GA GC1IL
UT WOS:000429534700012
PM 29623022
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Joob, B
   Wiwanitkit, V
AF Joob, Beuy
   Wiwanitkit, Viroj
TI Zika Virus Outbreak, assisted reproduction patients and pregnancy
SO JORNAL BRASILEIRO DE REPRODUCAO ASSISTIDA
LA English
DT Letter
C1 [Joob, Beuy] Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Hainan, Peoples R China.
RP Joob, B (corresponding author), Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
EM beuyjoob@hotmail.com
CR Borges E, 2017, J BRAS REPROD ASSIST, V21, P208, DOI 10.5935/1518-0557.20170040
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P499, DOI 10.1016/j.apjtm.2016.03.036
NR 2
TC 0
Z9 0
U1 0
U2 0
PU SOC BRASILEIRA REPRODUCAO ASSISTIDA-SBRA
PI RIBEIRAO
PA SOC BRASILEIRA REPRODUCAO ASSISTIDA-SBRA, RIBEIRAO, 00000, BRAZIL
SN 1517-5693
EI 1518-0557
J9 J BRAS REPROD ASSIST
JI J. Bras. Reprod. Assist.
PD JAN-MAR
PY 2018
VL 22
IS 1
BP 75
EP 75
DI 10.5935/1518-0557.20180007
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA GC6LL
UT WOS:000429902900015
PM 29516714
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Casapulla, SL
   Aidoo-Frimpong, G
   Basta, TB
   Grijalva, MJ
AF Casapulla, Sharon L.
   Aidoo-Frimpong, Gloria
   Basta, Tania B.
   Grijalva, Mario J.
TI Zika virus knowledge and attitudes in Ecuador
SO AIMS PUBLIC HEALTH
LA English
DT Article
DE ZIKV; Zika virus; Ecuador; Health Belief Model; health promotion;
   ZIKV-related knowledge and attitudes
ID TRANSMISSION; EPIDEMIOLOGY; WOMEN
AB Since its discovery in 1947 in Uganda, ZIKV has spread to 61 countries with a total of 229,238 cZIKV combined with low perceived barriers in this community set the stage for effective educational interventions or health promotion campaigns that can ameliorate the knowledge deficits surrounding transmission and prevention.onfirmed human cases worldwide. Specifically, Ecuador has recorded 3,058 confirmed cases and 7 confirmed cases of congenital syndrome associated with ZIKV. Using the Health Belief Model (HBM), this pilot study was conducted to assess Zika virus-related knowledge and attitudes among adults in Ecuador. The survey data were collected in public places in rural and urban areas of Ecuador in May 2016. Seven items measured ZIKV knowledge and 23 items measured attitudes toward ZIKV. A total of 181 Ecuadorians participated in this study. The average age of the sample was 33.4. With respect to ZIKV knowledge, the majority of the participants had heard of ZIKV (n = 162, 89.5%). More males reported first hearing of ZIKV on the internet (p = 0.02), more rural individuals reported knowing someone diagnosed with ZIKV (p = 0.02), more primary school educated individuals reported hearing about ZIKV first from their doctor/nurse (p = 0.03), and more high school graduates correctly identified that ZIKV could be transmitted from mother to child (p = 0.03). As for the HBM constructs, there was a statistically significant difference between gender and cues to action (p = 0.04), with males having a statistically significant lower mean on the cues to action items compared to females. There were also statistically significant differences between those categorized as having "adequate" knowledge compared to "low" knowledge on the benefits construct (p = 0.04) and the perceived severity construct (p = 0.03). There is a clear need for education about the transmission and prevention of ZIKV. High levels of self-efficacy for prevention behaviors for
C1 [Casapulla, Sharon L.] Ohio Univ, Heritage Coll Osteopath Med, Off Rural & Underserved Programs, Athens, OH 45701 USA.
   [Casapulla, Sharon L.; Basta, Tania B.] Heritage Coll Osteopath Med, Dept Biomed Sci, Infect & Trop Dis Inst, Athens, OH USA.
   [Aidoo-Frimpong, Gloria; Basta, Tania B.; Grijalva, Mario J.] Ohio Univ, Coll Hlth Sci & Profess, Dept Social & Publ Hlth, Athens, OH 45701 USA.
   [Grijalva, Mario J.] Pontifical Catholic Univ Ecuador, Sch Biol Sci, Ctr Res Hlth Latin Amer, Quito, Ecuador.
RP Casapulla, SL (corresponding author), Ohio Univ, Heritage Coll Osteopath Med, Off Rural & Underserved Programs, Athens, OH 45701 USA.; Casapulla, SL (corresponding author), Heritage Coll Osteopath Med, Dept Biomed Sci, Infect & Trop Dis Inst, Athens, OH USA.
EM casapull@ohio.edu
RI Grijalva, Mario J/U-8356-2018
OI Grijalva, Mario J/0000-0003-1964-1425
CR Cheema S, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2603-6
   Clarke VA, 2000, J BEHAV MED, V23, P367, DOI 10.1023/A:1005500917875
   Correspondent HSR, 2016, GUARDIAN
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   European Centre for Disease Prevention and Control (ECDC), 2016, ZIK VIR INF FACTSH H
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Glanz K, 1997, HLTH BEHAV HLTH ED T, P460
   Gupta Nidhi, 2016, Niger Postgrad Med J, V23, P33, DOI 10.4103/1117-1936.180179
   IBM Corp, IBM SPSS STAT WINDOW
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Marrs C, 2016, AM J PERINAT, V33, P625, DOI 10.1055/s-0036-1580089
   Michael GC, 2017, S AFR FAM PRACT, V59, P148, DOI 10.1080/20786190.2017.1313484
   NORC, 2016, ZIK VIR GAPS AM KNOW, P1
   Office of Management and Budget, 2010, 2010 OMB METR STAND
   PAHO, 2017, REG ZIK EP UPD AM
   PAHO/ WHO, 2017, ZIK CAS CONG SYNDR A
   Pan American Health Organization, 2017, ZIKA EP REP EC
   Priddy FH, 2006, INT J STD AIDS, V17, P99, DOI 10.1258/095646206775455667
   Rather IA, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00305
   Roberts Kathleen Johnston, 2005, J Natl Med Assoc, V97, P1662
   ROSENSTOCK IM, 1988, HEALTH EDUC QUART, V15, P175, DOI 10.1177/109019818801500203
   Sabogal-Roman JA, 2016, TRAVEL MED INFECT DI, V14, P52, DOI 10.1016/j.tmaid.2015.12.003
   Osorio-De-Castro CGS, 2017, AM J PUBLIC HEALTH, V107, P960, DOI 10.2105/AJPH.2017.303705
   Sotelo JR, 2017, EMERG INFECT DIS, V23, P854, DOI 10.3201/eid2305.161538
   Stretcher V., 1997, HLTH BEHAV HLTH ED T
   Whittemore K, 2017, EMERG INFECT DIS, V23, P164, DOI 10.3201/eid2301.161614
   WHO, 2016, ZIK VIR FACT SHEET
   WHO, 2016, ZIK CAUS STAT
   World Health Organization, 2017, SIT REP ZIK VIR MICR
   World Health Organization, KNOWL ATT PRACT SURV
NR 31
TC 3
Z9 3
U1 0
U2 2
PU AMER INST MATHEMATICAL SCIENCES-AIMS
PI SPRINGFIELD
PA PO BOX 2604, SPRINGFIELD, MO 65801-2604 USA
SN 2327-8994
J9 AIMS PUBLIC HEALTH
JI AIMS Public Health
PY 2018
VL 5
IS 1
BP 49
EP 63
DI 10.3934/publichealth.2018.1.49
PG 15
WC Health Care Sciences & Services
SC Health Care Sciences & Services
GA GB8GM
UT WOS:000429314300004
PM 30083569
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Joob, B
   Wiwanitkit, V
AF Joob, Beuy
   Wiwanitkit, Viroj
TI Congenital Toxoplasmosis, Cytomegalovirus, and Zika Virus Infections
SO JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA
LA English
DT Letter
C1 [Joob, Beuy] Med Acad Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Hainan, Peoples R China.
RP Joob, B (corresponding author), Med Acad Ctr, Bangkok, Thailand.
CR ODONOHOE JM, 1991, PEDIATR INFECT DIS J, V10, P627, DOI 10.1097/00006454-199108000-00019
   Werner H, 2017, J OBSTET GYNAECOL CA, V39, P1150, DOI 10.1016/j.jogc.2017.05.013
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P499, DOI 10.1016/j.apjtm.2016.03.036
NR 3
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER INC
PI SAN DIEGO
PA 525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1701-2163
J9 J OBSTET GYNAECOL CA
JI J. Obstet. Gynaecol. Can.
PD JAN
PY 2018
VL 40
IS 1
BP 12
EP 12
DI 10.1016/j.jogc.2017.08.024
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA GB5EZ
UT WOS:000429087400006
PM 29037967
DA 2020-07-08
ER

PT J
AU Werner, H
   Mehrjardi, MZ
   Araujo, E
AF Werner, Heron
   Mehrjardi, Mohammad Zare
   Araujo Junior, Edward
TI Author Response: Congenital Toxoplasmosis, Cytomegalovirus, and Zika
   Virus Infections: Emphasis on the Role of Neuroimaging in Screening,
   Prognostication, and Follow-Up
SO JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA
LA English
DT Letter
C1 [Werner, Heron] Clin Diagnost Imagem CDPI, Dept Radiol, Rio De Janeiro, Brazil.
   [Mehrjardi, Mohammad Zare] Shahid Beheshti Univ Med Sci, Shohada Tajrish Hosp, Sch Med, Dept Radiol, Tehran, Iran.
   [Mehrjardi, Mohammad Zare] Climax Radiol Educ Fdn, Div Clin Res, Sect Neuroimaging, Tehran, Iran.
   [Araujo Junior, Edward] Univ Fed Sao Paulo, UNIFESP, EPM, Paulista Sch Med,Dept Obstet, Sao Paulo, Brazil.
RP Werner, H (corresponding author), Clin Diagnost Imagem CDPI, Dept Radiol, Rio De Janeiro, Brazil.
RI Werner, Heron/W-1578-2019; Junior, Edward Araujo/E-1228-2012; Zare
   Mehrjardi, Mohammad/G-8980-2017
OI Junior, Edward Araujo/0000-0002-6145-2532; Zare Mehrjardi,
   Mohammad/0000-0001-5793-5323
CR Mehrjardi MZ, 2017, JPN J RADIOL, V35, P89, DOI 10.1007/s11604-016-0609-4
   Mehrjardi MZ, 2017, JPN J RADIOL, V35, P87, DOI 10.1007/s11604-016-0605-8
   Mehrjardi MZ, 2017, JPN J RADIOL, V35, P41, DOI 10.1007/s11604-016-0599-2
   Mehrjardi MZ, 2016, JPN J RADIOL, V34, P765, DOI 10.1007/s11604-016-0588-5
   Mehrjardi MZ., 2017, VIROLOGY AUCKL, V8
   Werner H, 2017, J OBSTET GYNAECOL CA, V39, P1150, DOI 10.1016/j.jogc.2017.05.013
NR 6
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER INC
PI SAN DIEGO
PA 525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1701-2163
J9 J OBSTET GYNAECOL CA
JI J. Obstet. Gynaecol. Can.
PD JAN
PY 2018
VL 40
IS 1
BP 13
EP 14
DI 10.1016/j.jogc.2017.08.032
PG 2
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA GB5EZ
UT WOS:000429087400007
PM 29037966
DA 2020-07-08
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Zika vaccine candidate fast-tracked by FDA
SO HUMAN VACCINES & IMMUNOTHERAPEUTICS
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 0
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 2164-5515
EI 2164-554X
J9 HUM VACC IMMUNOTHER
JI Human Vaccines Immunother.
PY 2018
VL 14
IS 3
SI SI
BP 503
EP 503
PG 1
WC Biotechnology & Applied Microbiology; Immunology
SC Biotechnology & Applied Microbiology; Immunology
GA GA1CU
UT WOS:000428053800010
DA 2020-07-08
ER

PT J
AU Anderson, J
   Gitter, A
   Lacey, R
   Karthikeyan, R
AF Anderson, Jenise
   Gitter, Anna
   Lacey, Ronald
   Karthikeyan, Raghupathy
TI Transport, fate, and toxicity of selected public health insecticides in
   waterways
SO TOXICOLOGICAL AND ENVIRONMENTAL CHEMISTRY
LA English
DT Review
DE Aquatic health; mosquito control; water pollution
ID 3 LIFE STAGES; SEDIMENT-ASSOCIATED PESTICIDES; ECOLOGICAL
   RISK-ASSESSMENT; GRASS SHRIMP; PYRETHROID INSECTICIDES; CALIFORNIA;
   DEGRADATION; URBAN; ORGANOPHOSPHORUS; ADULT
AB Application of public health insecticides for mosquito control has increased dramatically with the recent outbreaks in the continental United States of dengue, chikungunya, and Zika. Mosquito control is often controversial because of the potential impacts on health and the environment due to the chemicals used. The emphasis in this review is to examine the transport, fate, and potential effects of the active ingredients in selected public health insecticides used for mosquito control. Due to the many potential entry points for insecticides, especially in urban areas where use is less monitored and application may be in greater amounts per unit area, this review suggests that a potential focus might be on the prevalence and quantification of the cumulative concentrations of these insecticides in natural systems. Often concentrations resulting from a single application are unlikely to cause mortality, but multiple applications may result in concentrations of environmental concern. Minimizing entrance to waterways and public water supply sources can be achieved by applying insecticides during prime meteorological conditions where drift and volatilization are minimized, using vegetated buffer zones in agricultural areas to prevent runoff, and avoiding application to impervious surfaces in urban areas.
C1 [Anderson, Jenise; Gitter, Anna; Lacey, Ronald; Karthikeyan, Raghupathy] Texas A&M Univ, Dept Biol & Agr Engn, College Stn, TX 77843 USA.
RP Karthikeyan, R (corresponding author), Texas A&M Univ, Dept Biol & Agr Engn, College Stn, TX 77843 USA.
EM karthi@tamu.edu
RI Lacey, Ronald E/O-3956-2017
OI Lacey, Ronald E/0000-0002-4920-259X
CR Allan I. J., 2005, ENVIRON SCI TECHNOL, V39, P532
   Amweg EL, 2006, ENVIRON SCI TECHNOL, V40, P1700, DOI 10.1021/es051407c
   Bennett ER, 2005, ENVIRON TOXICOL CHEM, V24, P2121, DOI 10.1897/04-357R.1
   Budd R, 2007, J ENVIRON QUAL, V36, P1006, DOI 10.2134/jeq2006.0249
   Carpenter KD, 2016, ENVIRON MONIT ASSESS, V188, DOI 10.1007/s10661-016-5215-5
   Davis RS, 2007, INTEGR ENVIRON ASSES, V3, P373, DOI 10.1002/ieam.5630030308
   DeLorenzo ME, 2006, ECOTOX ENVIRON SAFE, V64, P122, DOI 10.1016/j.ecoenv.2006.02.001
   DeLorenzo ME, 2010, ARCH ENVIRON CON TOX, V58, P985, DOI 10.1007/s00244-010-9496-3
   Ding YP, 2010, ENVIRON TOXICOL CHEM, V29, P149, DOI 10.1002/etc.13
   Domagalski JL, 2010, ENVIRON TOXICOL CHEM, V29, P813, DOI 10.1002/etc.106
   Druzina B, 2007, INT J ENVIRON AN CH, V87, P1079, DOI 10.1080/03067310701485341
   FRANK R, 1991, ENVIRON MONIT ASSESS, V16, P137, DOI 10.1007/BF00418101
   Gan J, 2005, J ENVIRON QUAL, V34, P836, DOI 10.2134/jeq2004.0240
   Getenga Z. M., 2000, TOXICOLOGICAL ENV CH, V77, P229
   Gilliom RJ, 2001, HYDROL PROCESS, V15, P3197, DOI 10.1002/hyp.501
   Hewitt AJ, 2000, CROP PROT, V19, P623, DOI 10.1016/S0261-2194(00)00082-X
   HILL IR, 1989, PESTIC SCI, V27, P429, DOI 10.1002/ps.2780270408
   Hintzen EP, 2009, ENVIRON POLLUT, V157, P110, DOI 10.1016/j.envpol.2008.07.023
   Holmes RW, 2008, ENVIRON SCI TECHNOL, V42, P7003, DOI 10.1021/es801346g
   House WA, 2000, PEST MANAG SCI, V56, P597, DOI 10.1002/1526-4998(200007)56:7<597::AID-PS181>3.0.CO;2-C
   Janeczko AK, 2014, WATER RES, V57, P127, DOI 10.1016/j.watres.2014.03.031
   Jiang WY, 2011, ENVIRON SCI TECHNOL, V45, P602, DOI 10.1021/es1030323
   Jorgenson BC, 2012, J AGR FOOD CHEM, V60, P7333, DOI 10.1021/jf301241n
   Karthikeyan R, 2004, CRIT REV PLANT SCI, V23, P91, DOI 10.1080/07352680490273518
   Key P, 2005, J ENVIRON SCI HEAL B, V40, P585, DOI 10.1081/PFC-200061552
   Key PB, 1998, AQUAT TOXICOL, V40, P311, DOI 10.1016/S0166-445X(97)00068-4
   Key PB, 2011, J ENVIRON SCI HEAL B, V46, P426, DOI [10.1080/03601234.2011.572519, 10.1080/10934529.2011.549409]
   LARTIGES SB, 1995, ENVIRON SCI TECHNOL, V29, P1246, DOI 10.1021/es00005a016
   LeBlanc LA, 2008, HYDROBIOLOGIA, V604, P151, DOI 10.1007/s10750-008-9316-1
   Li HZ, 2017, J HAZARD MATER, V324, P258, DOI 10.1016/j.jhazmat.2016.10.056
   Medina D, 1999, B ENVIRON CONTAM TOX, V63, P39, DOI 10.1007/s001289900945
   MILES CJ, 1991, ARCH ENVIRON CON TOX, V20, P325, DOI 10.1007/BF01064397
   Palmquist Katherine, 2011, Integrated Environmental Assessment and Management, V7, P325, DOI 10.1002/ieam.162
   PAYNE NJ, 1988, PESTIC SCI, V24, P147, DOI 10.1002/ps.2780240206
   Pehkonen SO, 2002, CRIT REV ENV SCI TEC, V32, P17, DOI 10.1080/10643380290813444
   Peterson RKD, 2006, ENVIRON HEALTH PERSP, V114, P366, DOI 10.1289/ehp.8667
   Phillips PJ, 2004, PEST MANAG SCI, V60, P531, DOI 10.1002/ps.879
   Rand GM, 2002, ECOTOXICOLOGY, V11, P101, DOI 10.1023/A:1014468811664
   Remucal CK, 2014, ENVIRON SCI-PROC IMP, V16, P628, DOI 10.1039/c3em00549f
   Schleier JJ, 2008, ENVIRON TOXICOL CHEM, V27, P1063, DOI 10.1897/07-532.1
   Schleier JJ, 2013, ENVIRON TOXICOL CHEM, V32, P948, DOI 10.1002/etc.2126
   Sengupta A, 2014, ENVIRON TOXICOL CHEM, V33, P350, DOI 10.1002/etc.2457
   SHAROM MS, 1981, J AGR FOOD CHEM, V29, P1122, DOI 10.1021/jf00108a005
   Siebers J, 2003, CHEMOSPHERE, V51, P397, DOI 10.1016/S0045-6535(02)00820-2
   Vasquez M, 2011, J AGR FOOD CHEM, V59, P7874, DOI 10.1021/jf2022572
   Vasquez ME, 2011, J AGR FOOD CHEM, V59, P2486, DOI 10.1021/jf1037773
   Vasquez ME, 2010, PEST MANAG SCI, V66, P28, DOI 10.1002/ps.1826
   Weston DP, 2005, ENVIRON SCI TECHNOL, V39, P9778, DOI 10.1021/es0506354
   Weston DP, 2004, ENVIRON SCI TECHNOL, V38, P2752, DOI 10.1021/es0352193
NR 49
TC 0
Z9 0
U1 1
U2 24
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0277-2248
EI 1029-0486
J9 TOXICOL ENVIRON CHEM
JI Toxicol Environ. Chem.
PY 2018
VL 100
IS 1
BP 32
EP 46
DI 10.1080/02772248.2018.1428324
PG 15
WC Environmental Sciences; Toxicology
SC Environmental Sciences & Ecology; Toxicology
GA GA1ES
UT WOS:000428058900004
DA 2020-07-08
ER

PT J
AU Rinkenberger, N
   Schoggins, JW
AF Rinkenberger, Nicholas
   Schoggins, John W.
TI Mucolipin-2 Cation Channel Increases Trafficking Efficiency of
   Endocytosed Viruses
SO MBIO
LA English
DT Article
DE endocytosis; flavivirus; influenza; ion channels; vesicular trafficking;
   virus entry; virus-host interactions
ID INFLUENZA-VIRUS; LYSOSOMAL EXOCYTOSIS; ENDOSOMAL PATHWAY;
   MEMBRANE-PROTEIN; RELEASE CHANNEL; TRP CHANNELS; IV; GENE; AUTOPHAGY;
   CALCIUM
AB Receptor-mediated endocytosis is a cellular process commonly hijacked by viruses to enter cells. The stages of entry are well described for certain viruses, but the host factors that mediate each step are less well characterized. We previously identified endosomal cation channel mucolipin-2 (MCOLN2) as a host factor that promotes viral infection. Here, we assign a role for MCOLN2 in modulating viral entry. We show that MCOLN2 specifically promotes viral vesicular trafficking and subsequent escape from endosomal compartments. This mechanism requires channel activity, occurs independently of antiviral signaling, and broadly applies to enveloped RNA viruses that require transport to late endosomes for infection, including influenza A virus, yellow fever virus, and Zika virus. We further identify a rare allelic variant of human MCOLN2 that has a loss-of-function phenotype with respect to viral enhancement. These findings establish a mechanistic link between an endosomal cation channel and late stages of viral entry.
   IMPORTANCE Viruses must co-opt cellular processes to complete their life cycle. To enter cells, viruses frequently take advantage of cellular receptor-mediated endocytosis pathways. A growing number of host proteins are implicated in these viral uptake pathways. Here, we describe a new role for the gated cation channel MCOLN2 in viral entry. This endosomal protein modulates viral entry by enhancing the efficiency of viral trafficking through the endosomal system. Thus, MCOLN2-mediated enhancement of infection may represent a key vulnerability in the viral life cycle that could be targeted for therapeutic intervention.
C1 [Rinkenberger, Nicholas; Schoggins, John W.] Univ Texas Southwestern Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA.
RP Schoggins, JW (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA.
EM john.schoggins@utsouthwestern.edu
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [DK095031, AI117922]; UT Southwestern
   Endowed Scholars program; NIH T32 training grantUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USA
   [AI007520]; NCI Cancer Center support grantUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Cancer Institute (NCI) [CA142543]
FX This work was supported in part by NIH grants DK095031 and AI117922
   (J.W.S.) and by the UT Southwestern Endowed Scholars program (J.W.S.).
   Additional support for N.R. was obtained from NIH T32 training grant
   AI007520. The UT Southwestern Live Cell Imaging Center is supported in
   part by NCI Cancer Center support grant CA142543.
CR Abe K, 2011, PHYSIOLOGY, V26, P14, DOI 10.1152/physiol.00048.2010
   Altarescu G, 2002, NEUROLOGY, V59, P306, DOI 10.1212/WNL.59.3.306
   Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393
   AMIR N, 1987, PEDIATRICS, V79, P953
   Balish Amanda L, 2013, Curr Protoc Microbiol, VChapter 15, DOI 10.1002/9780471729259.mc15g01s29
   Bargal R, 2000, NAT GENET, V26, P118, DOI 10.1038/79095
   Bassi MT, 2000, AM J HUM GENET, V67, P1110, DOI 10.1016/S0002-9297(07)62941-3
   Cao Q, 2017, J BIOL CHEM, V292, P8424, DOI 10.1074/jbc.M116.772160
   Chu VC, 2004, P NATL ACAD SCI USA, V101, P18153, DOI 10.1073/pnas.0405172102
   de Vries E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001329
   Di Palma F, 2002, P NATL ACAD SCI USA, V99, P14994, DOI 10.1073/pnas.222425399
   Dong XP, 2008, NATURE, V455, P992, DOI 10.1038/nature07311
   Gray MA, 2016, CURR BIOL, V26, P1955, DOI 10.1016/j.cub.2016.05.070
   Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0
   Jones CT, 2005, VIROLOGY, V331, P247, DOI 10.1016/j.virol.2004.10.034
   Karacsonyi C, 2007, TRAFFIC, V8, P1404, DOI 10.1111/j.1600-0854.2007.00619.x
   Karczewski KJ, 2017, NUCLEIC ACIDS RES, V45, pD840, DOI 10.1093/nar/gkw971
   Kim HJ, 2008, EMBO J, V27, P1197, DOI 10.1038/emboj.2008.56
   Kim HJ, 2009, TRAFFIC, V10, P1157, DOI 10.1111/j.1600-0854.2009.00924.x
   Lanford RE, 2006, HEPATOLOGY, V43, P961, DOI 10.1002/hep.21167
   LaPlante JM, 2006, MOL GENET METAB, V89, P339, DOI 10.1016/j.ymgme.2006.05.016
   Lelouvier B, 2011, J BIOL CHEM, V286, P9826, DOI 10.1074/jbc.M110.169185
   Lev S, 2010, J BIOL CHEM, V285, P2771, DOI 10.1074/jbc.M109.046508
   Li X, 2015, INT IMMUNOL, V27, P83, DOI 10.1093/intimm/dxu086
   Marcus JH, 2017, BIOINFORMATICS, V33, P594, DOI 10.1093/bioinformatics/btw643
   Martina JA, 2009, TRAFFIC, V10, P1143, DOI 10.1111/j.1600-0854.2009.00935.x
   Medina DL, 2015, NAT CELL BIOL, V17, P288, DOI 10.1038/ncb3114
   Medina DL, 2011, DEV CELL, V21, P421, DOI 10.1016/j.devcel.2011.07.016
   Mercer J, 2010, ANNU REV BIOCHEM, V79, P803, DOI 10.1146/annurev-biochem-060208-104626
   Miao YX, 2015, CELL, V161, P1306, DOI 10.1016/j.cell.2015.05.009
   Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3
   Nour AM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003585
   Pryor PR, 2006, TRAFFIC, V7, P1388, DOI 10.1111/j.1600-0854.2006.00475.x
   Sakai T, 2006, J VIROL, V80, P2013, DOI 10.1128/JVI.80.4.2013-2018.2006
   Samie MA, 2009, PFLUG ARCH EUR J PHY, V459, P79, DOI 10.1007/s00424-009-0716-5
   Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047
   Schoggins JW, 2014, NATURE, V505, P691, DOI 10.1038/nature12862
   Schoggins JW, 2012, P NATL ACAD SCI USA, V109, P14610, DOI 10.1073/pnas.1212379109
   Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907
   Sieczkarski SB, 2003, TRAFFIC, V4, P333, DOI 10.1034/j.1600-0854.2003.00090.x
   Soyombo AA, 2006, J BIOL CHEM, V281, P7294, DOI 10.1074/jbc.M508211200
   STEGMANN T, 1987, BIOCHIM BIOPHYS ACTA, V904, P165, DOI 10.1016/0005-2736(87)90100-3
   Sun L, 2015, J IMMUNOL, V195, P4922, DOI 10.4049/jimmunol.1500163
   Thompson EG, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-54
   Valadez JA, 2015, GENE, V555, P194, DOI 10.1016/j.gene.2014.11.003
   van der Schaar HM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000244
   Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819
   Venkatachalam K, 2015, CELL CALCIUM, V58, P48, DOI 10.1016/j.ceca.2014.10.008
   Vergarajauregui S, 2006, TRAFFIC, V7, P337, DOI 10.1111/j.1600-0854.2006.00387.x
   Yamauchi Y, 2016, TRAFFIC, V17, P569, DOI 10.1111/tra.12387
   Zhang XL, 2016, AUTOPHAGY, V12, P1954, DOI 10.1080/15548627.2016.1212787
   Zhang XZ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10938
NR 52
TC 8
Z9 8
U1 2
U2 3
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2150-7511
J9 MBIO
JI mBio
PD JAN-FEB
PY 2018
VL 9
IS 1
AR e02314-17
DI 10.1128/mBio.02314-17
PG 16
WC Microbiology
SC Microbiology
GA FY6XN
UT WOS:000427006300052
PM 29382735
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Young, R
   Tully, M
   Dalrymple, KE
AF Young, Rachel
   Tully, Melissa
   Dalrymple, Kajsa E.
TI Engagement: use of Twitter chats to construct nominal participatory
   spaces during health crises
SO INFORMATION COMMUNICATION & SOCIETY
LA English
DT Article
DE Social media engagement; Twitter; content analysis; Ebola; Zika; health
ID SOCIAL MEDIA; PUBLIC ENGAGEMENT; COMMUNICATION
AB Although Twitter chats and other forms of social media engagement events are idealized in the literature as opportunities for dialogic communication between organizations and individuals, less is known about how engagement is operationalized within these spaces. Using textual and content analysis, we conducted two studies to explore how health organizations engage with the public via Twitter chats during the Ebola and Zika outbreaks. In official records of Ebola chats, the organization addressed both hostile and neutral public questions that pressed for specification of disease characteristics and protocol. However, in a content analysis of all public tweets sent during a later Zika chat, we found that questions were privileged, and other tweet forms and themes were excluded from the participatory space. Specifically, public comments demonstrating expertise or extending the topic of the chat were not addressed by the organization. Our analysis provides insight into the implicit rules governing how organizations engage with the public online during a rapidly evolving health crisis. We argue that the question-response dyad is a form of ideal communication that suggests engagement but maintains organizational expertise.
C1 [Young, Rachel; Tully, Melissa; Dalrymple, Kajsa E.] Univ Iowa, Sch Journalism & Mass Commun, 100 Adler Journalism Bldg, Iowa City, IA 52242 USA.
RP Young, R (corresponding author), Univ Iowa, Sch Journalism & Mass Commun, 100 Adler Journalism Bldg, Iowa City, IA 52242 USA.
EM rachel-young@uiowa.edu; melissa-tully@uiowa.edu;
   kajsa-dalrymple@uiowa.edu
RI Dalrymple, Kajsa/AAB-7920-2019
OI Dalrymple, Kajsa/0000-0002-9824-3590; Tully, Melissa/0000-0003-1850-3477
CR Adams A, 2013, PUBLIC RELAT REV, V39, P357, DOI 10.1016/j.pubrev.2013.07.016
   Agresti A., 2007, INTRO CATEGORICAL DA
   Avidar R, 2015, PUBLIC RELAT REV, V41, P214, DOI 10.1016/j.pubrev.2014.11.019
   Besley JC, 2015, SCI PUBL POLICY, V42, P201, DOI 10.1093/scipol/scu042
   Bodmer W., 1985, PUBL UND SCI
   Boulianne S, 2015, INFORM COMMUN SOC, V18, P524, DOI 10.1080/1369118X.2015.1008542
   Boulos MNK, 2007, HEALTH INFO LIBR J, V24, P2, DOI 10.1111/j.1471-1842.2007.00701.x
   Chen YRR, 2016, INFORM COMMUN SOC, V19, P978, DOI 10.1080/1369118X.2015.1086013
   Coleman S, 2014, MEDIA CULT SOC, V36, P826, DOI 10.1177/0163443714536074
   Cooper S., 2013, FORBES
   Crawford G, 2014, INFORM COMMUN SOC, V17, P1072, DOI 10.1080/1369118X.2013.877953
   Cruz S., 2014, ORANGE COUNTY REGIST
   Dalrymple KE, 2016, SCI COMMUN, V38, P442, DOI 10.1177/1075547016655546
   Drake F, 2006, PUBLIC UNDERST SCI, V15, P387, DOI 10.1177/0963662506057246
   Dredze M, 2016, VACCINE, V34, P3441, DOI 10.1016/j.vaccine.2016.05.008
   Dudo A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148867
   Durant J., 1999, SCI PUBL POLICY, V26, P313, DOI [10.3152/147154399781782329, DOI 10.3152/147154399781782329]
   Firmstone J, 2015, INFORM COMMUN SOC, V18, P680, DOI 10.1080/1369118X.2014.986180
   GLASER BG, 1965, SOC PROBL, V12, P436, DOI 10.1525/sp.1965.12.4.03a00070
   Jenkins H., 2016, PARTICIPATORY CULTUR
   Jones Jeffrey M., 2014, AM RATINGS CDC EBOLA
   Kent ML, 1998, PUBLIC RELAT REV, V24, P321, DOI 10.1016/S0363-8111(99)80143-X
   Kent ML, 2002, PUBLIC RELAT REV, V28, P21, DOI 10.1016/S0363-8111(02)00108-X
   Lazard AJ, 2015, AM J INFECT CONTROL, V43, P1109, DOI 10.1016/j.ajic.2015.05.025
   Lee T. M., 2014, CDC EBOLA TWEET CHAT
   MEGELE C, 2014, J PERSPECTIVES APPL, V2, P46, DOI DOI 10.14297/JPAAP.V2I2.106
   Meraz S, 2013, INT J PRESS/POLIT, V18, P138, DOI 10.1177/1940161212474472
   Miller JD, 2001, BIOMEDICAL COMMUNICA
   MILLER JD, 1997, PUBLIC PERCEPTIONS S
   Paek HJ, 2013, PUBLIC RELAT REV, V39, P526, DOI 10.1016/j.pubrev.2013.09.013
   Reynolds B, 2005, J HEALTH COMMUN, V10, P43, DOI 10.1080/10810730590904571
   Riffe D, 2014, ANAL MEDIA MESSAGES
   Sandman P., 1987, EPA J, V13, P21, DOI DOI 10.1177/0893318988002002006
   Seeger M. W., 2009, HDB RISK CRISIS COMM, P302
   Sharpe D, 2015, RES EVALUAT, V20, P8, DOI DOI 10.1158/1557-3265.PMS14-A34
   Smith BG, 2015, COMPUT HUM BEHAV, V53, P82, DOI 10.1016/j.chb.2015.05.060
   Taylor M, 2014, J PUBLIC RELAT RES, V26, P384, DOI 10.1080/1062726X.2014.956106
   Waters RD, 2011, J PUBLIC AFF, V11, P353, DOI 10.1002/pa.385
   Wigley S, 2012, PUBLIC RELAT REV, V38, P165, DOI 10.1016/j.pubrev.2011.08.020
NR 39
TC 4
Z9 4
U1 7
U2 14
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1369-118X
EI 1468-4462
J9 INFORM COMMUN SOC
JI Info. Commun. Soc.
PY 2018
VL 21
IS 4
BP 499
EP 515
DI 10.1080/1369118X.2017.1301518
PG 17
WC Communication; Sociology
SC Communication; Sociology
GA FY9SO
UT WOS:000427207200002
DA 2020-07-08
ER

PT J
AU Jinu, U
   Rajakumaran, S
   Senthil-Nathan, S
   Geetha, N
   Venkatachalam, P
AF Jinu, Udayabhanu
   Rajakumaran, Sankar
   Senthil-Nathan, Sengottayan
   Geetha, Natesan
   Venkatachalam, Perumal
TI Potential larvicidal activity of silver nanohybrids synthesized using
   leaf extracts of Cleistanthus collinus (Roxb.) Benth. ex Hook. f. and
   Strychnos nux-vomica L. nux-vomica against dengue, Chikungunya and Zika
   vectors
SO PHYSIOLOGICAL AND MOLECULAR PLANT PATHOLOGY
LA English
DT Article
DE Biosynthesis; Silver nanoparticles; Anopheles; Aedes; Mortality;
   Microwave irradiation; Antibacterial
ID STEPHENSI LISTON DIPTERA; AEDES-AEGYPTI DIPTERA; ANOPHELES-STEPHENSI;
   CULEX-QUINQUEFASCIATUS; ANTIBACTERIAL ACTIVITY; ENHANCED ANTIBACTERIAL;
   MEDIATED BIOSYNTHESIS; DYSOXYLUM-MALABARICUM; GOLD NANOPARTICLES; GREEN
   SYNTHESIS
AB This study focused on green engineering of stable metallic silver nanohybrids (AgNPs) using Cleistanthus collinus (Cc) and Strychnos nux-vomica (Sn) plant leaf extracts via microwave irradiation and its bioinsecticidal activity against the mosquito vectors and antimicrobial efficacy against clinically isolated human pathogens. Engineered silver nanohybrids (CcAgNPs and SnAgNPs) were characterized by UV-vis spectroscopy, Fourier Transform Infra-red spectroscopy (FTIR), X-ray diffraction spectroscopy (XRD), Field Emission Scanning Electron Microscopy (FESEM) and Energy-dispersive X-ray spectroscopy (EDX) analysis. FTIR results showed the role of alcohols, amines, alkanes, and amides in the bioreduction, capping and stabilization of synthesized silver nanoparticles. The XRD analysis confirmed the crystalline structure of the synthesized silver nanohybrids. FESEM results displayed the shape as well as size of the engineered CcAgNPs and SnAgNPs. Interestingly, the synthesized CcAgNPs was found to be triangular and pentagonal shape with 66.27-75.09 nm size and the synthesized SnAgNPs showed irregular, spherical and round shape with 54.45-60.84 nm size. The existence of silver ion signals on engineered nanohybrids at 2.8 to 4 KeV was established by EDX analysis. Further, both C. collinus and S. nux-vomica leaf extracts and engineered CcAgNPs and SnAgNPs showed highest larvicidal activity against Anopheles stephensi and Aedes aegypti fourth instar larvae. The maximum mortality rate (100%) for CcAgNPs was observed at 20 mg/l and 25 mg/l for A. aegypti and A. stephensi vectors respectively, while highest percent of mortality for SnAgNPs was noticed in both A. aegypti and A. stephensi at 25 mg/l. The LC50 dose for CcAgNPs towards A. stephensi and A. aegypti mosquito vectors noticed were 11.05 and 11.38 mg/l, respectively, whereas the LC50 data for SnAgNPs obtained was 8.82 and 7.75 mg/l for A. stephensiand A. aegypti, respectively. The larvicidal activity was positively correlated with the engineered AgNPs exposure. Both CcAgNPs and SnAgNPs found to be effective antimicrobial agent against six human microbial pathogens and these nanohybrids may be considered as effective antibacterial nanodrug. The results strongly suggest that C. collinus and S. nux-vomica plant extracts derived silver nanohybrids can be applied as a natural biolarvicidal compound to vector-control strategy as non-toxic and eco-friendly approach to prohibit Zika, Chikungunya and dengue fever in the future. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Jinu, Udayabhanu; Rajakumaran, Sankar; Venkatachalam, Perumal] Periyar Univ, Dept Biotechnol, Plant Genet Engn & Mol Biol Lab, Salem 636011, Tamil Nadu, India.
   [Senthil-Nathan, Sengottayan] Manonmaniam Sundaranar Univ, Sri Paramakalyani Ctr Excellence Environm Sci, Div Biopesticide & Environm Toxicol, Alwarkurichi 627412, Tamil Nadu, India.
   [Geetha, Natesan] Bharathiar Univ, Dept Bot, Coimbatore 641046, Tamil Nadu, India.
RP Venkatachalam, P (corresponding author), Periyar Univ, Dept Biotechnol, Plant Genet Engn & Mol Biol Lab, Salem 636011, Tamil Nadu, India.
EM pvenkat67@yahoo.com
RI P, Venkatachalam/AAC-2222-2019
CR Ambasta S. S. P., 1986, USEFUL PLANTS INDIA, P604
   Benelli G, 2016, ENZYME MICROB TECH, V95, P58, DOI 10.1016/j.enzmictec.2016.08.022
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P391, DOI 10.1007/s00436-014-4286-x
   Bhat R, 2013, J CLUST SCI, V24, P107, DOI 10.1007/s10876-012-0519-2
   Bhuvaneswari T, 2014, ACTA TROP, V135, P55, DOI 10.1016/j.actatropica.2014.03.009
   Devi HS, 2014, ADV ELECT ELECT ENG, V4, P83, DOI DOI 10.2174/0929867054637617
   Dinesh D, 2015, PARASITOL RES, V114, P1519, DOI 10.1007/s00436-015-4336-z
   Dubey M, 2009, DIG J NANOMATER BIOS, V4, P537
   Edwin ES, 2016, ACTA TROP, V163, P167, DOI 10.1016/j.actatropica.2016.07.009
   FINNEY D J, 1971, P333
   Gardea-Torresdey JL, 2002, MICROCHEM J, V71, P193, DOI 10.1016/S0026-265X(02)00011-5
   GOVINDAC.TR, 1969, TETRAHEDRON, V25, P2815, DOI 10.1016/0040-4020(69)80025-6
   Govindarajan M., 2017, PHYSIOL MOL PLANT P, V101, P218
   Govindarajan M, 2016, RES VET SCI, V104, P77, DOI 10.1016/j.rvsc.2015.11.011
   Jang Young-Su, 2002, Agricultural Chemistry and Biotechnology, V45, P131
   Jeeva K, 2014, IND CROP PROD, V52, P714, DOI 10.1016/j.indcrop.2013.11.037
   Jinu U, 2017, J CLUST SCI, V28, P489, DOI 10.1007/s10876-016-1125-5
   Jinu U, 2017, MICROB PATHOGENESIS, V105, P86, DOI 10.1016/j.micpath.2017.02.019
   Kalaiarasi K, 2015, TURK J BIOL, V39, P223, DOI 10.3906/biy-1406-10
   Kayalvizhi T, 2016, J ENVIRON ENG, V142, DOI 10.1061/(ASCE)EE.1943-7870.0001098
   Krasovskii V I, 2008, Optical Memory & Neural Networks (Information Optics), V17, P8, DOI 10.1007/s12005-008-1002-x
   Kumar PS, 2015, APPL NANOSCI, V5, P169, DOI 10.1007/s13204-014-0304-7
   Lallawmawma H, 2015, ENVIRON SCI POLLUT R, V22, P17753, DOI 10.1007/s11356-015-5001-x
   Lees RS, 2014, ACTA TROP, V132, pS2, DOI 10.1016/j.actatropica.2013.11.005
   Lija-Escaline J, 2015, PARASITOL RES, V114, P4239, DOI 10.1007/s00436-015-4662-1
   Matsumura F., 2012, TOXICOLOGY INSECTICI
   Mishra A, 2011, J NANOSCI NANOTECHNO, V11, P243, DOI 10.1166/jnn.2011.3265
   MubarakAli D, 2011, COLLOID SURFACE B, V85, P360, DOI 10.1016/j.colsurfb.2011.03.009
   Mulvaney P, 1996, LANGMUIR, V12, P788, DOI 10.1021/la9502711
   Murugan K, 2012, PARASITOL RES, V111, P1757, DOI 10.1007/s00436-012-3021-8
   Nathan SS, 2008, FITOTERAPIA, V79, P106, DOI 10.1016/j.fitote.2007.07.013
   Nathan SS, 2007, BIORESOURCE TECHNOL, V98, P1856, DOI 10.1016/j.biortech.2006.07.044
   Nathan SS, 2006, BIORESOURCE TECHNOL, V97, P1316, DOI 10.1016/j.biortech.2005.05.019
   Noginov M.A., 2006, APPL PHYS B, V86, P458
   Peng ZK, 2004, J ALLERGY CLIN IMMUN, V114, P1189, DOI 10.1016/j.jaci.2004.08.014
   Pradeepa V, 2016, PESTIC BIOCHEM PHYS, V134, P84, DOI 10.1016/j.pestbp.2016.04.001
   Prasannaraj G, 2017, J CLUST SCI, V28, P645, DOI 10.1007/s10876-017-1160-x
   Prasannaraj G, 2017, J PHOTOCH PHOTOBIO B, V167, P309, DOI 10.1016/j.jphotobiol.2017.01.009
   Priyadarshini KA, 2012, PARASITOL RES, V111, P997, DOI 10.1007/s00436-012-2924-8
   Promsiri Suwannee, 2006, Insect Science, V13, P179, DOI 10.1111/j.1744-7917.2006.00080.x
   Raghunandan D., 2009, NANOBIOTECHNOL, V5, P34, DOI DOI 10.1007/S12030-009-9030-8
   Raghunandan D, 2011, J NANOPART RES, V13, P2021, DOI 10.1007/s11051-010-9956-8
   Rajakumar G, 2011, ACTA TROP, V118, P196, DOI 10.1016/j.actatropica.2011.03.003
   Roni M, 2013, PARASITOL RES, V112, P981, DOI 10.1007/s00436-012-3220-3
   Santhosh SB, 2015, J PHOTOCH PHOTOBIO B, V153, P184, DOI 10.1016/j.jphotobiol.2015.09.018
   Satyavani K, 2011, DIG J NANOMATER BIOS, V6, P1019
   Nathan SS, 2006, BIORESOURCE TECHNOL, V97, P2077, DOI 10.1016/j.biortech.2005.09.034
   Senthil-Nathan S., 2015, ENV SUSTAINABILITY, P49, DOI 10.1007/978-81-322-2056-5_3.
   Senthil-Nathan S, 2005, ACTA TROP, V96, P47, DOI DOI 10.1016/J.ACTATROPICA.2005.07.002
   Senthil-Nathan S, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00359
   Shaalan EAS, 2005, ENVIRON INT, V31, P1149, DOI 10.1016/j.envint.2005.03.003
   Shankar SS, 2004, J COLLOID INTERF SCI, V275, P496, DOI 10.1016/j.jcis.2004.03.003
   Shekshavali T., 2012, Indian Journal of Natural Products and Resources, V3, P128
   Singh A, 2010, DIG J NANOMATER BIOS, V5, P483
   Sundaravadivelan C, 2013, PARASITOL RES, V112, P303, DOI [10.1007/s00436-012-3138-9, 10.100]
   Suresh U, 2015, PARASITOL RES, V114, P1551, DOI 10.1007/s00436-015-4339-9
   Vanaja M, 2013, APPL NANOSCI, V3, P217, DOI 10.1007/s13204-012-0121-9
   Veerakumar K, 2014, PARASITOL RES, V113, P1775, DOI 10.1007/s00436-014-3823-y
   Venkatachalam P, 2017, J CLUST SCI, V28, P607, DOI 10.1007/s10876-016-1141-5
   Venkatachalam P, 2015, J NANOMATER, V2015, DOI 10.1155/2015/753193
   Yasin Sohail, 2013, J FIBRE BIOENGINEERI, V6, P77, DOI DOI 10.3993/JFBI03201307
NR 62
TC 7
Z9 7
U1 0
U2 6
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0885-5765
J9 PHYSIOL MOL PLANT P
JI Physiol. Mol. Plant Pathol.
PD JAN
PY 2018
VL 101
BP 163
EP 171
DI 10.1016/j.pmpp.2017.05.003
PG 9
WC Plant Sciences
SC Plant Sciences
GA FX9ND
UT WOS:000426426800017
DA 2020-07-08
ER

PT J
AU Govindarajan, M
   Rajeswary, M
   Senthilmurugan, S
   Vijayan, P
   Alharbi, NS
   Kadaikunnan, S
   Khaled, JM
   Benelli, G
AF Govindarajan, Marimuthu
   Rajeswary, Mohan
   Senthilmurugan, Sengamalai
   Vijayan, Periasamy
   Alharbi, Naiyf S.
   Kadaikunnan, Shine
   Khaled, Jamal M.
   Benelli, Giovanni
TI Larvicidal activity of the essential oil from Amomum subulatum Roxb.
   (Zingiberaceae) against Anopheles subpictus, Aedes albopictus and Culex
   tritaeniorhynchus (Diptera: Culicidae), and non-target impact on four
   mosquito natural enemies
SO PHYSIOLOGICAL AND MOLECULAR PLANT PATHOLOGY
LA English
DT Article
DE Biosafety; Gambusia affinis; GC-MS; Malaria; Japanese encephalitis; West
   Nile virus; Zika virus
ID ECO-FRIENDLY LARVICIDES; CHEMICAL-COMPOSITION; VETERINARY IMPORTANCE;
   CURCUMA-AROMATICA; VOLATILE OIL; REPELLENT; MALARIA; DENGUE; VECTORS;
   STEPHENSI
AB Mosquitoes (Diptera: Culicidae) are the primary vectors of several serious diseases that affect both animals and humans. Most of these diseases, especially the ones that are caused by arboviruses such as Zika, dengue and Japanese encephalitis, cannot be effectively prevented or treated, thereby rendering the discovery of alternative measures for the control of mosquito-borne diseases an absolute necessity. The current study evaluates the acute toxicity of Amomum subulatum-derived essential oil against Anopheles subpictus, Aedes albopictus, and Culex tritaeniorhynchus. We used gas chromatographye-mass spectros-copy to analyze the chemical composition of A. subulatum EO. Analysis revealed thirty-three components. Primary constituents were 1,8- cineole (39.8%) and alpha-terpineol (11.5%). The essential oil from A. subulatum demonstrated a significant toxic effect against An. subpictus, Ae. albopictus and Cx. tritaeniorhynchus third instar larvae, with LC50 values of 41.25, 44.11 and 48.12 mu g/ml and LC90 values of 80.29, 85.6 and 89.30 mu g/ml, respectively. Concerning non-target effects in the aquatic environment, we evaluated the acute toxicity of A. subulatum oil on 4 mosquito biocontrol agents, Anisops bouvieri, Diplonychus indicus, Poecilia reticulata and Gambusia affinis. We observed that the toxicity of this oil was extremely low, with LC50 ranging between 3123 and 9104 mu g/ml. In conclusion, the A. subulatum essential oil is an interesting bioresource to develop environmental friendly mosquito larvicides. Indeed, it is effective against different Culicidae species with LC50 always lower than 50 mu g/ml, while LC50 calculated for nontarget organisms are about 100-fold higher. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Govindarajan, Marimuthu; Rajeswary, Mohan; Senthilmurugan, Sengamalai; Vijayan, Periasamy] Annamalai Univ, Dept Zool, Unit Vector Control Phytochem & Nanotechnol, Annamalainagar 608002, Tamil Nadu, India.
   [Alharbi, Naiyf S.; Kadaikunnan, Shine; Khaled, Jamal M.] King Saud Univ, Dept Bot & Microbiol, Coll Sci, Riyadh 11451, Saudi Arabia.
   [Benelli, Giovanni] Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
RP Govindarajan, M (corresponding author), Annamalai Univ, Dept Zool, Unit Vector Control Phytochem & Nanotechnol, Annamalainagar 608002, Tamil Nadu, India.; Benelli, G (corresponding author), Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
EM drgovind1979@gmail.com; benelli.giovanni@gmail.com
RI P, Vijayan/X-3918-2019; /L-2836-2013; Khaled, Jamal/D-8188-2017;
   Alharbi, Naiyf S/B-9402-2019; GOVINDARAJAN, MARIMUTHU/A-8070-2019; S,
   Senthilmurugan/AAB-4374-2019
OI /0000-0001-7018-5379; GOVINDARAJAN, MARIMUTHU/0000-0002-4662-8931; 
FU Deanship of Scientific Research at King Saud UniversityDeanship of
   Scientific Research at King Saud University [PRG-1437-36]
FX The authors extend their sincere appreciations to the Deanship of
   Scientific Research at King Saud University for its funding this
   Prolific Research Group (PRG-1437-36). The authors would like to thank
   Professor and Head, Department of Zoology, Annamalai University for the
   laboratory facilities provided.
CR Adams R.P., 2007, IDENTIFICATION ESSEN
   Amer A, 2006, PARASITOL RES, V99, P466, DOI [10.1007/s00436-006-0182-3, 10.1007/s00436-006-0184-1]
   Bailer J, 2001, IND CROP PROD, V14, P229, DOI 10.1016/S0926-6690(01)00088-7
   Bandara KANP, 2005, J ECON ENTOMOL, V98, P1163, DOI 10.1603/0022-0493-98.4.1163
   Benelli G., 2017, J CLUST SCI
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   Cheng SS, 2009, BIORESOURCE TECHNOL, V100, P452, DOI 10.1016/j.biortech.2008.02.038
   Choochote W, 2005, J VECTOR ECOL, V30, P302
   Chopra R. N., 2007, GLOSSARY INDIAN MED, V11, P57
   Conti B, 2014, PARASITOL RES, V113, P251, DOI 10.1007/s00436-013-3651-5
   De Omena MC, 2006, VECTOR-BORNE ZOONOT, V6, P216, DOI 10.1089/vbz.2006.6.216
   DEO P G, 1988, International Pest Control, V30, P118
   Govindarajan M, 2013, EXP PARASITOL, V134, P7, DOI 10.1016/j.exppara.2013.01.018
   Govindarajan M, 2012, PARASITOL RES, V110, P2023, DOI 10.1007/s00436-011-2731-7
   Govindarajan M., 2016, PARASITOL RES, P1
   Govindarajan M, 2016, ENVIRON SCI POLLUT R, V23, P23228, DOI 10.1007/s11356-016-7568-2
   Govindarajan M, 2016, ECOTOX ENVIRON SAFE, V133, P395, DOI 10.1016/j.ecoenv.2016.07.035
   Govindarajan M, 2016, COMB CHEM HIGH T SCR, V19, P565, DOI 10.2174/1386207319666160506123520
   Govindarajan M, 2016, ECOTOX ENVIRON SAFE, V129, P85, DOI 10.1016/j.ecoenv.2016.03.007
   Govindarajan M, 2016, RES VET SCI, V104, P77, DOI 10.1016/j.rvsc.2015.11.011
   Govindarajan M, 2016, PARASITOL RES, V115, P807, DOI 10.1007/s00436-015-4809-0
   Govindarajan M, 2014, PARASITOL RES, V113, P777, DOI 10.1007/s00436-013-3709-4
   Govindarajan M, 2013, PARASITOL RES, V112, P3713, DOI 10.1007/s00436-013-3557-2
   Govindarajan M, 2011, ASIAN PAC J TROP MED, V4, P106, DOI 10.1016/S1995-7645(11)60047-3
   Govindarajan M, 2010, ASIAN PAC J TROP MED, V3, P874, DOI 10.1016/S1995-7645(10)60210-6
   HUSSAIN A, 1988, MAJOR ESSENTIAL OIL
   Isman MB, 2006, ANNU REV ENTOMOL, V51, P45, DOI 10.1146/annurev.ento.51.110104.151146
   Kamsuk K, 2007, PARASITOL RES, V100, P339, DOI 10.1007/s00436-006-0256-2
   Kapoor IPS, 2012, IJEOT, V1, P1
   Kikuzaki H, 2001, J NUTR SCI VITAMINOL, V47, P167, DOI 10.3177/jnsv.47.167
   KLOCKE JA, 1987, J CHEM ECOL, V13, P2131, DOI 10.1007/BF01012562
   Mehlhorn H, 2012, PARASITOL RES, V110, P259, DOI 10.1007/s00436-011-2480-7
   Naqqash MN, 2016, PARASITOL RES, V115, P1363, DOI 10.1007/s00436-015-4898-9
   Park IK, 2005, J AGR FOOD CHEM, V53, P969, DOI 10.1021/jf048208h
   Park IK, 2002, J AGR FOOD CHEM, V50, P1866, DOI 10.1021/jf011457a
   Pavela R., 2016, PLANT SCI
   Pavela R., 2016, J PEST SCI
   Pavela R, 2016, EXP PARASITOL, V167, P103, DOI 10.1016/j.exppara.2016.05.010
   Pavela R, 2015, IND CROP PROD, V76, P174, DOI 10.1016/j.indcrop.2015.06.050
   Phukerd U., 2013, SE ASIAN J TROP MED, V44, P5
   Pitasawat B, 2003, J VECTOR ECOL, V28, P234
   Prajapati V, 2005, BIORESOURCE TECHNOL, V96, P1749, DOI 10.1016/j.biortech.2005.01.007
   Siddiqui BS, 2004, CHEM PHARM BULL, V52, P1349, DOI 10.1248/cpb.52.1349
   Silva Heloísa Helena Garcia da, 2004, Rev. Soc. Bras. Med. Trop., V37, P396, DOI 10.1590/S0037-86822004000500005
   Sivagnaname N, 2004, MEM I OSWALDO CRUZ, V99, P115, DOI 10.1590/S0074-02762004000100021
   SOMANABANDHU AO, 1992, J SCI SOC THAILAND, V18, P181
   Subramaniam J, 2016, ENVIRON SCI POLLUT R, V23, P7543, DOI 10.1007/s11356-015-6007-0
   SUKUMAR K, 1991, J AM MOSQUITO CONTR, V7, P210
   Tiwary Mohini, 2007, Journal of Vector Borne Diseases, V44, P198
   Traboulsi AF, 2002, PEST MANAG SCI, V58, P491, DOI 10.1002/ps.486
   Warrier P. K., 1995, INDIAN MED PLANTS, V5
   WHO-World Health Organization, 2005, GUID LAB FIELD TEST
NR 53
TC 4
Z9 4
U1 1
U2 15
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0885-5765
J9 PHYSIOL MOL PLANT P
JI Physiol. Mol. Plant Pathol.
PD JAN
PY 2018
VL 101
BP 219
EP 224
DI 10.1016/j.pmpp.2017.01.003
PG 6
WC Plant Sciences
SC Plant Sciences
GA FX9ND
UT WOS:000426426800024
DA 2020-07-08
ER

PT J
AU Jia, HM
   Zhang, M
   Chen, MY
   Yang, ZW
   Li, JS
   Huang, G
   Guan, DW
   Cen, XL
   Zhang, LJ
   Feng, QW
   Yi, JR
   Wu, D
   Zhong, HJ
   Ma, HL
   Song, T
AF Jia, Haimei
   Zhang, Meng
   Chen, Maoyu
   Yang, Zhiwen
   Li, Jiansen
   Huang, Guo
   Guan, Dawei
   Cen, Xiaoli
   Zhang, Lijie
   Feng, Qiwen
   Yi, Jianron
   Wu, De
   Zhong, Haojie
   Ma, Huilai
   Song, Tie
TI Zika virus infection in travelers returning from countries with local
   transmission, Guangdong, China, 2016
SO TRAVEL MEDICINE AND INFECTIOUS DISEASE
LA English
DT Article
DE Zika virus; Local transmission; Urine; Saliva
ID EPIDEMIC; URINE; RNA
AB Background: Zika virus (ZIKV) is a mosquito-borne virus spreading rapidly in the Americas, Africa, and Asia. No indigenous ZIKV infection had been seen in China. We monitored ZIKV infection among travelers returning to Enping county from ZIKV transmitting countries from 1 March to 10 April 2016.
   Methods: We analyzed data including interviews; conducted laboratory test on blood, urine, saliva, conjunctival swab or semen specimens for evidence of ZIKV infection; evaluated household for presence of Aedes mosquitoes or larvae.
   Results: A total of 925 individuals were screened, 507 (54.8%) were interviewed, 400 (43.2%) provided samples, of which 13 (3.3%) tested positive for ZIKV including 3 asymptomatic. Rash, conjunctivitis, sore throat, fever were the common symptoms; rash was more pronounced in adults than in children. ZIKV RNA was detected for 1-4 days in blood, but longer in urine and saliva (3-32 days and 2-10 days). Among interviewed, 57.0% had good knowledge about ZIKV, 45.8% were worried about ZIKV, 99.2% would go to hospital if they had infection. Aedes mosquitoes or larvae were detected in townships of infected returners.
   Conclusions: ZIKV was imported to China. Screening by symptoms alone is inadequate for detecting ZIKV infection. ZIKV surveillance, health-education, and vector control are necessary to decrease risk of ZIKV transmission.
C1 [Jia, Haimei] Fuzhou Ctr Dis Control & Prevent, Fujian 350004, Fuzhou, Peoples R China.
   [Zhang, Meng; Li, Jiansen; Guan, Dawei; Yi, Jianron; Wu, De; Zhong, Haojie; Song, Tie] Guangdong Prov Ctr Dis Control & Prevent, Guangzhou 511430, Guangdong, Peoples R China.
   [Chen, Maoyu; Huang, Guo; Feng, Qiwen] Jiangmen Ctr Dis Control & Prevent, Jiangmen 529000, Guangdong, Peoples R China.
   [Yang, Zhiwen; Cen, Xiaoli] Enping Ctr Dis Control & Prevent, Jiangmen 529400, Guangdong, Peoples R China.
   [Jia, Haimei; Zhang, Lijie; Ma, Huilai] Chinese Ctr Dis Control & Prevent, CFETP, Beijing 100050, Peoples R China.
RP Song, T (corresponding author), 160 Quanxian Rd, Guangzhou 511430, Guangdong, Peoples R China.; Jia, HM (corresponding author), 95 Quanzhong Rd, Fuzhou 350004, Fujian, Peoples R China.
EM haimei1103@126.com; 409782078@qq.com; 359774390@qq.com; 51040754@qq.com;
   16890389@qq.com; 13902883459@163.com; 89407992@qq.com;
   13632073883@163.com; cfetpzlj@126.com; 114599470@qq.com;
   89407992@qq.com; 445831343@qq.com; 1151514908@qq.com; mahl@chinacdc.cn;
   tsong@cdcp.org.cn
FU Major Public Health Program [2100409]; Jiangmen municipal Science and
   Technology Bureau [2016020400950004041]
FX This work was supported by a grant from the Major Public Health Program
   in 2015 grant number 2100409, and Jiangmen municipal Science and
   Technology Bureaugrant number 2016020400950004041.
CR [Anonymous], EM ZIK SIT REP
   Barzon L., 2016, EUROSURVEILLANCE, V21, P2016, DOI DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009
   Charrel Remi N, B WHO, P1
   Dirlikov Emilio, 2015, UPDATE ONGOING ZIKA, V65, P451
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Foy Brian D, 2011, EMERG INFECT DIS MAY, P1
   Ginier M, 2016, TRAVEL MED INFECT DI, V14, P16, DOI 10.1016/j.tmaid.2016.01.012
   Hamer DH, 2014, ANN INTERN MED, V161, P827, DOI 10.7326/M14-1958
   LaCon G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003038
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Long D, 2016, J EMERGENCY MED, V3
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Ralph MHGHuits, 2016, B WHO
   Soghaier MA, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1913-0
   Stoddard ST, 2013, P NATL ACAD SCI USA, V110, P994, DOI 10.1073/pnas.1213349110
   Thomas Dana L., 2015, LOCAL TRANSMISSION Z
   WHO, 2016, ZIK VIR MICR GUILL B, P1
NR 22
TC 8
Z9 11
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1477-8939
EI 1873-0442
J9 TRAVEL MED INFECT DI
JI Travel Med. Infect. Dis.
PD JAN-FEB
PY 2018
VL 21
BP 56
EP 61
DI 10.1016/j.tmaid.2017.11.012
PG 6
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA FY1ZV
UT WOS:000426614600008
PM 29183824
OA Bronze
DA 2020-07-08
ER

PT J
AU Aschwanden, A
   Demir, C
   Hinselmann, R
   Kasser, S
   Rohrer, A
AF Aschwanden, Andrin
   Demir, Can
   Hinselmann, Rosa
   Kasser, Sabrina
   Rohrer, Andreas
TI Zika and travel: Public health implications and communications for blood
   donors, sperm donors and pregnant women
SO TRAVEL MEDICINE AND INFECTIOUS DISEASE
LA English
DT Letter
ID VIRUS
C1 [Aschwanden, Andrin; Demir, Can; Hinselmann, Rosa; Kasser, Sabrina; Rohrer, Andreas] Univ Zurich, Med Fac, Zurich, Switzerland.
RP Hinselmann, R (corresponding author), Univ Zurich, Med Fac, Zurich, Switzerland.
EM rosa.hinselmann@uzh.ch
CR Eppes C, 2017, AM J OBSTET GYNECOL, V216, P209, DOI 10.1016/j.ajog.2017.01.020
   Grischott F, 2016, TRAVEL MED INFECT DI, V14, P313, DOI 10.1016/j.tmaid.2016.07.002
   Stefanidis Anthony, 2017, JMIR Public Health Surveill, V3, pe22, DOI 10.2196/publichealth.6925
   Washington CI, 2016, SEMIN REPROD MED, V34, P293, DOI 10.1055/s-0036-1592067
NR 4
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1477-8939
EI 1873-0442
J9 TRAVEL MED INFECT DI
JI Travel Med. Infect. Dis.
PD JAN-FEB
PY 2018
VL 21
BP 77
EP 77
DI 10.1016/j.tmaid.2017.12.003
PG 1
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA FY1ZV
UT WOS:000426614600012
PM 29233716
OA Bronze
DA 2020-07-08
ER

PT J
AU Ruiz, EF
   Vasquez-Galindo, CM
   Aquije-Pariona, XM
   Torres-Roman, JS
AF Ruiz, Eloy F.
   Vasquez-Galindo, Claudia M.
   Aquije-Pariona, Ximena M.
   Smith Torres-Roman, J.
TI Outbreaks caused by Aedes aegyptis due to El Nino in a coastal area of
   Peru
SO TRAVEL MEDICINE AND INFECTIOUS DISEASE
LA English
DT Letter
DE Disease outbreaks; Aedes; Dengue; Zika virus; Peru (Source: MeSH NLM)
C1 [Ruiz, Eloy F.] Univ Peruana Cayetano Heredia, Sch Med, Lima, Peru.
   [Ruiz, Eloy F.; Vasquez-Galindo, Claudia M.; Aquije-Pariona, Ximena M.; Smith Torres-Roman, J.] CIME, Ica, Peru.
   [Vasquez-Galindo, Claudia M.] Univ Nacl San Luis Gonzaga, Fac Nursing, Ica, Peru.
   [Aquije-Pariona, Ximena M.] Univ Privada San Juan Bautista, Fac Nursing, Ica, Peru.
   [Smith Torres-Roman, J.] Univ Nacl San Luis Gonzaga, Fac Med, Ica, Peru.
RP Torres-Roman, JS (corresponding author), CIME, Ica, Peru.; Torres-Roman, JS (corresponding author), Univ Nacl San Luis Gonzaga, Fac Med, Ica, Peru.
EM jstorresroman@gmail.com
RI ; Ruiz, Eloy/M-4339-2014
OI Torres-Roman, J. Smith/0000-0001-5310-6077; Ruiz,
   Eloy/0000-0002-4644-0074
CR Fraser B, 2017, NATURE, V544, P405, DOI 10.1038/544405a
   Miranda-Soberón Ubaldo, 2015, Rev. perú. med. exp. salud publica, V32, P607
   Riepl M., 2017, BBC MUNDO
   Roja C., 2017, B INFORM
   Ruiz EF, 2016, MEDWAVE, V16, DOI 10.5867/medwave.2016.07.6518
   Wood R, 2011, SHALE GAS PROVISIONA
   World Health Organization, 1999, SUST DEV HLTH ENV
NR 7
TC 1
Z9 1
U1 0
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1477-8939
EI 1873-0442
J9 TRAVEL MED INFECT DI
JI Travel Med. Infect. Dis.
PD JAN-FEB
PY 2018
VL 21
BP 78
EP 79
DI 10.1016/j.tmaid.2017.11.003
PG 2
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA FY1ZV
UT WOS:000426614600013
PM 29129817
DA 2020-07-08
ER

PT J
AU Kong, WL
   Li, HT
   Zhu, J
AF Kong, Weili
   Li, Hengtao
   Zhu, Jian
TI Zika virus: The transboundary pathogen from mosquito and updates
SO MICROBIAL PATHOGENESIS
LA English
DT Article
DE Zika virus; Epidemiology; Genetic mutation; Microcephaly; Molecular
   pathogenesis; Prevention
ID SMALL-MOLECULE INHIBITORS; AEDES-AEGYPTI MOSQUITOS; SEXUAL TRANSMISSION;
   SOUTH-PACIFIC; ANTIVIRAL ACTIVITY; FRENCH-POLYNESIA; RNA METHYLATION;
   DENGUE VIRUS; MOUSE MODEL; STEM-CELLS
AB Zika virus (ZIKV) is a mosquito-borne flavivirus that was relatively obscure until outbreaks started in 2013. ZIKV is associated with neurological manifestations such as Guillan-Barre Syndrome in adult and microcephaly in the newborn population. Although the majority of disease mechanisms of ZIKV is unclear, some information was updated with new scientific evidence. Currently, there are no approved drugs or vaccine that can be used for therapy during ZIKV infection. Based on the transmission mechanism of ZIKV, vector control and safe sex seem to be the most effective available preventive measures against ZIKV spread. This study summarized the current ZIKV epidemiology, the status of the existing pathogenic mechanism of ZIKV, the development of potential compounds and vaccines against ZIKV, and the control efforts against ZIKV.
C1 [Kong, Weili; Zhu, Jian] Univ Rochester, Dept Microbiol & Immunol, Med Ctr, Rochester, NY 14642 USA.
   [Zhu, Jian] Univ Rochester, Dept Biochem & Biophys, Med Ctr, Rochester, NY 14642 USA.
   [Li, Hengtao] Univ Rochester, Edmund A Hajim Sch Engn & Appl Sci, Rochester, NY USA.
RP Kong, WL (corresponding author), Univ Rochester, Dept Microbiol & Immunol, Med Ctr, Rochester, NY 14642 USA.
EM weili_kong@urmc.rochester.edu
RI kong, weili/H-8487-2019
FU NIDCR NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Dental &
   Craniofacial Research (NIDCR) [R01 DE025447]; NIGMS NIH HHSUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of General Medical Sciences (NIGMS) [R01
   GM117838]
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   Annamalai AS, 2017, J VIROL, V91, DOI [10.1128/JVI.01348-17, 10.1128/jvi.01348-17]
   Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Baronti C, 2014, GENOME ANNOUNC, V2
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Betancourt D, 2017, J IMMUNOL, V198, P3023, DOI 10.4049/jimmunol.1602180
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Bollati M, 2010, ANTIVIR RES, V87, P125, DOI 10.1016/j.antiviral.2009.11.009
   Cao B, 2017, J EXP MED, V214, P2303, DOI 10.1084/jem.20170957
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Carvalho DO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003864
   Cavalheiro S, 2016, CHILD NERV SYST, V32, P1057, DOI 10.1007/s00381-016-3074-6
   Chen LM, 2017, ANTIVIR RES, V141, P140, DOI 10.1016/j.antiviral.2017.02.009
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   de Andrade PP, 2016, B WORLD HEALTH ORGAN, V94, P766, DOI 10.2471/BLT.16.173377
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Diamond MS, 2015, CELL, V162, P488, DOI 10.1016/j.cell.2015.07.005
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   El Ghouzzi V, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.266
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Frank C, 2016, EUROPEAN COMMUNICABL, V2016, P21, DOI DOI 10.2807/1560-7917
   Frumence E, 2016, VIROLOGY, V493, P217, DOI 10.1016/j.virol.2016.03.006
   Fu Y, 2014, NAT REV GENET, V15, P293, DOI 10.1038/nrg3724
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hancock WT, 2014, EMERG INFECT DIS, V20, P1960, DOI [10.3201/eid2011.141253, 10.3201/eid2011.141380]
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Hou SM, 2017, J VIROL, V91, DOI 10.1128/JVI.00474-17
   Huits R, 2017, B WORLD HEALTH ORGAN, V95, P802, DOI [10.2471/BLT.17.181370, 10.2471/blt.17.181370]
   Jouannic JM, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00625-5
   Kim E, 2016, EBIOMEDICINE, V13, P315, DOI 10.1016/j.ebiom.2016.09.028
   Kodati S, 2017, LANCET, V389, P125, DOI 10.1016/S0140-6736(16)32518-1
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Krittanawong C, 2016, INT J CARDIOL, V221, P859, DOI 10.1016/j.ijcard.2016.06.293
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lee H, 2017, ANTIVIR RES, V139, P49, DOI 10.1016/j.antiviral.2016.12.016
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li G, 2017, P NATL ACAD SCI USA, V114, pE376, DOI 10.1073/pnas.1619735114
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Lichinchi G, 2016, CELL HOST MICROBE, V20, P666, DOI 10.1016/j.chom.2016.10.002
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Liu Z, 2017, EMERG INFECT DIS, V23
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moesker FM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002203
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Pascoalino Bruno S, 2016, F1000Res, V5, P2523
   Pierson TC, 2013, CURR OPIN VIROL, V3, P3, DOI 10.1016/j.coviro.2012.12.001
   Pitts JD, 2017, ANTIVIR RES, V147, P124, DOI 10.1016/j.antiviral.2017.10.014
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   Shan C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00737-8
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Shao Q, 2016, DEVELOPMENT, V143, P4127, DOI 10.1242/dev.143768
   Shiryaev SA, 2017, ANTIVIR RES, V143, P218, DOI 10.1016/j.antiviral.2017.04.015
   Siddharthan V, 2017, VIROLOGY, V507, P89, DOI 10.1016/j.virol.2017.04.013
   Siemann DN, 2017, J VIROL, V91, DOI 10.1128/JVI.00623-17
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Singh PK, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92340
   Spencer J. L., 2017, J INFECT DIS
   Stephen P, 2016, J AM CHEM SOC, V138, P16212, DOI 10.1021/jacs.6b10399
   Taylor TJ, 2016, VIROLOGY, V496, P186, DOI 10.1016/j.virol.2016.06.006
   Teng Y, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00327
   Tirumuru N, 2016, ELIFE, V5, DOI 10.7554/eLife.15528
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Tsetsarkin KA, 2016, MBIO, V7, DOI 10.1128/mBio.01114-16
   Uraki R, 2017, J INFECT DIS, V215, P1720, DOI 10.1093/infdis/jix204
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Wang BX, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14763
   Wang CX, 2017, BIOCHEM BIOPH RES CO, V493, P1555, DOI 10.1016/j.bbrc.2017.10.016
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Weger-Lucarelli J, 2017, J VIROL, V91, DOI 10.1128/JVI.01765-16
   Wu YH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11568-4
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
   Yoon KJ, 2017, CELL STEM CELL, V21, P349, DOI 10.1016/j.stem.2017.07.014
   Yu YF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15672
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhu Z, 2017, J EXP MED, V214, P2843, DOI 10.1084/jem.20171093
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
   Zika virus outbreaks in the Americas, 2015, REL EP HEBD SECT HYG, V90, P609
NR 107
TC 4
Z9 4
U1 0
U2 8
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0882-4010
J9 MICROB PATHOGENESIS
JI Microb. Pathog.
PD JAN
PY 2018
VL 114
BP 476
EP 482
DI 10.1016/j.micpath.2017.12.031
PG 7
WC Immunology; Microbiology
SC Immunology; Microbiology
GA FX6VZ
UT WOS:000426226700074
PM 29241768
DA 2020-07-08
ER

PT J
AU Ga'al, H
   Fouad, H
   Tian, JX
   Hu, Y
   Abbas, G
   Mo, JC
AF Ga'al, Hassan
   Fouad, Hatem
   Tian, Jiaxin
   Hu, Yin
   Abbas, Ghulam
   Mo, Jianchu
TI Synthesis, characterization and efficacy of silver nanoparticles against
   Aedes albopictus larvae and pupae
SO PESTICIDE BIOCHEMISTRY AND PHYSIOLOGY
LA English
DT Article
DE Aedes albopictus; Salicylic acid; Dinitrosalicylic acid; SAAgNPs;
   DNSAgNPs; Systemic effect
ID AEGYPTI DIPTERA-CULICIDAE; MOSQUITO LARVICIDAL ACTIVITY; SALICYLIC-ACID;
   ZIKA VIRUS; ANTIMICROBIAL ACTIVITY; DENGUE; TOXICITY; RESISTANCE;
   VECTORS; MALARIA
AB Silver nanoparticles have been studied in a wide range of medical and entomological research works due to their eco-friendly aspects. In our study salicylic acid (SA) and its derivative, 3,5-dinitrosalicylic acid (DNS), were used in a one-step synthesis of silver nanoparticles (AgNPs). First, UV-vis absorption spectroscopy was used to detect the formation of AgNPs. Second, the synthesized nanoparticles were characterized using scanning electron microscope, transmission electron microscope; energy-dispersive spectroscopy, X-ray diffraction analysis and Fourier transform infrared spectroscopy. I, II, III and IV Instar larvae and pupae of Ae. Albopictus were exposed to various concentrations of SA, DNS and synthesized AgNPs for 24 h to evaluate the larvicidal and pupicidal effect. In larvicidal bioassay of SA, moderate mortality was observed at 180 ppm against Ae. Albopictus with LC50 values of 86, 108, 135 and 141 ppm for instar larvae I, II, III and IV, respectively. Synthesized AgNPs showed highest mortality rate at 12 ppm and the LC50 values of SAAgNP5 were 1.2 ppm (I), 1.4 ppm (II), 1.8 ppm (III), 2.0 ppm (IV) and 1.4 ppm (pupae). Whereas LC50 values of DNSAgNPs were 1.2 ppm (I), 1.5 ppm (II), 1.8 ppm (III) 2.3 ppm (IV) and 1.4 ppm (pupae). Moreover, the investigations toward the systemic effect of the tested substances on the fourth instar larvae of Ae. albopictus was evaluated and the levels of total proteins, esterases, acetylcholine esterase, and phosphatase enzymes were found to be significantly decreased as compared with the control. These results highlight that SA-AgNPs and DNS-AgNPs are potential tools to control larval populations of mosquito.
C1 [Ga'al, Hassan; Fouad, Hatem; Tian, Jiaxin; Mo, Jianchu] Zhejiang Univ, Minist Agr, Inst Insect Sci, Key Lab Agr Entomol, Hangzhou 310058, Zhejiang, Peoples R China.
   [Ga'al, Hassan] Somali Natl Univ, Fac Vet & Anim Husb, Dept Entomol, Mogadishu, Somalia.
   [Fouad, Hatem] Agr Res Ctr, Plant Protect Res Inst, Dept Field Crop Pests, Cairo, Egypt.
   [Hu, Yin] Natl Termite Control Ctr, Hangzhou 310011, Zhejiang, Peoples R China.
   [Abbas, Ghulam] Univ Gujrat, Dept Chem Engn, Gujrat, Pakistan.
RP Mo, JC (corresponding author), Zhejiang Univ, Coll Agr & Biotechnol, Inst Insect Sci, Minist Agr Key Lab Agr Entomol, Yuhangtang Rd 866, Hangzhou 310058, Zhejiang, Peoples R China.
EM mojianchu@zju.edu.cn
RI Fouad, Hatem/N-3071-2015
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81271873]
FX This work was financially supported by the National Natural Science
   Foundation of China [81271873].
CR Abd-alla H., 2013, AM J RES COMMUN, V1, P273
   Agra-Neto AC, 2014, PARASITOL RES, V113, P175, DOI 10.1007/s00436-013-3640-8
   AlQahtani FS, 2017, J ASIA-PAC ENTOMOL, V20, P157, DOI 10.1016/j.aspen.2016.12.004
   ASAKURA K, 1978, J EXP MAR BIOL ECOL, V31, P325, DOI 10.1016/0022-0981(78)90067-9
   Bedini S, 2016, IND CROP PROD, V85, P318, DOI 10.1016/j.indcrop.2016.03.008
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Benelli G, 2016, PARASITOL RES MG, V8, P155, DOI 10.1007/978-3-319-25292-6_8
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   Neto ACD, 2016, INT J FOOD MICROBIOL, V221, P54, DOI 10.1016/j.ijfoodmicro.2016.01.007
   Dar MA, 2013, NANOMED-NANOTECHNOL, V9, P105, DOI 10.1016/j.nano.2012.04.007
   Devine GJ, 2007, AGR HUM VALUES, V24, P281, DOI 10.1007/s10460-007-9067-z
   Edwin ES, 2016, ACTA TROP, V163, P167, DOI 10.1016/j.actatropica.2016.07.009
   Finney D.T., 1971, PROBIT ANAL
   Fouad H., 2017, ARTIF CELL NANOMED B, P1
   Fouad H, 2017, ARTIF CELL NANOMED B, V45, P1369, DOI 10.1080/21691401.2016.1241793
   Govindarajan M, 2017, J CLUST SCI, V28, P15, DOI 10.1007/s10876-016-1035-6
   Govindarajan M, 2016, J PHOTOCH PHOTOBIO B, V161, P482, DOI 10.1016/j.jphotobiol.2016.06.016
   Govindarajan M, 2016, J ASIA-PAC ENTOMOL, V19, P51, DOI 10.1016/j.aspen.2015.11.009
   Govindarajan M, 2016, EXP PARASITOL, V161, P40, DOI 10.1016/j.exppara.2015.12.011
   Guo DW, 2015, COLLOID SURFACE B, V134, P229, DOI 10.1016/j.colsurfb.2015.06.070
   Gupta SC, 2013, TRENDS PHARMACOL SCI, V34, P508, DOI 10.1016/j.tips.2013.06.005
   Hagag ESF, 2016, EGYPT J BIOL PEST CO, V26, P269
   Huang JL, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/10/105104
   Ikezawa H., 1981, METHODS ENZYMOLOGY C, V71, P731, DOI DOI 10.1016/0076-6879(81)71086-3
   Kanayairam Velayutham, 2016, Journal of Basic and Applied Zoology, V74, P16, DOI 10.1016/j.jobaz.2016.02.002
   Koodalingam A, 2012, PESTIC BIOCHEM PHYS, V104, P267, DOI 10.1016/j.pestbp.2012.09.008
   Koodalingam A, 2011, ACTA TROP, V118, P27, DOI 10.1016/j.actatropica.2011.01.003
   Kovendan K, 2016, J ASIA-PAC ENTOMOL, V19, P1001, DOI 10.1016/j.aspen.2016.09.001
   Kumar D, 2014, PLANT SCI, V228, P127, DOI 10.1016/j.plantsci.2014.04.014
   Li XC, 2002, NATURE, V419, P712, DOI 10.1038/nature01003
   Liu ZL, 2012, PARASITOL RES, V111, P991, DOI 10.1007/s00436-012-2923-9
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Mahyoub JA, 2017, J CLUST SCI, V28, P565, DOI 10.1007/s10876-016-1127-3
   Mondal R. P., 2014, J MOSQ RES, V4
   Mueller RS, 2012, VET DERMATOL, V23, P330, DOI 10.1111/j.1365-3164.2012.01057.x
   Murugan K, 2016, PARASITOL RES, V115, P651, DOI 10.1007/s00436-015-4783-6
   Naqqash MN, 2016, PARASITOL RES, V115, P1363, DOI 10.1007/s00436-015-4898-9
   Nathan SS, 2007, PESTIC BIOCHEM PHYS, V88, P260, DOI 10.1016/j.pestbp.2006.12.004
   Pavela R, 2016, EXP PARASITOL, V165, P51, DOI 10.1016/j.exppara.2016.03.016
   Pradeepa V, 2016, PESTIC BIOCHEM PHYS, V134, P84, DOI 10.1016/j.pestbp.2016.04.001
   Qin XJ, 2015, POSTHARVEST BIOL TEC, V100, P160, DOI 10.1016/j.postharvbio.2014.09.010
   Ruuhola T, 2001, J CHEM ECOL, V27, P1595, DOI 10.1023/A:1010458208335
   Selin-Rani S, 2016, PESTIC BIOCHEM PHYS, V126, P92, DOI 10.1016/j.pestbp.2015.08.003
   Simoes M, 2009, NAT PROD REP, V26, P746, DOI 10.1039/b821648g
   Singh DP, 2004, MOL PLANT PATHOL, V5, P57, DOI 10.1111/j.1364-3703.2004.00203.x
   Solairaj D, 2017, J POLYM ENVIRON, V25, P435, DOI 10.1007/s10924-016-0822-3
   SUBHASHINI MH, 1980, ARCH INT PHYSIOL BIO, V88, P47, DOI 10.3109/13813458009080857
   Suman TY, 2013, COLLOID SURFACE B, V106, P74, DOI 10.1016/j.colsurfb.2013.01.037
   Suresh U., 2017, PHYSIOL MOL PLANT P, V97, P1
   Suresh U, 2015, PARASITOL RES, V114, P1551, DOI 10.1007/s00436-015-4339-9
   Tayeh C, 2013, J PLANT PHYSIOL, V170, P1620, DOI 10.1016/j.jplph.2013.06.015
   Thakkar KN, 2010, NANOMED-NANOTECHNOL, V6, P257, DOI 10.1016/j.nano.2009.07.002
   VANASPEREN K, 1962, J INSECT PHYSIOL, V8, P401, DOI 10.1016/0022-1910(62)90074-4
   Vimala RTV, 2015, SPECTROCHIM ACTA A, V135, P110, DOI 10.1016/j.saa.2014.06.009
   WALTER K, 1974, METHODS ENZYMIC ANAL, V2, P856
   WHO, 1996, REP WHO INF CONS EV
   WHO, 2016, WORK HLTH GROWTH INV, P13
   Zahran HEM, 2017, J ASIA-PAC ENTOMOL, V20, P133, DOI 10.1016/j.aspen.2016.12.006
NR 59
TC 3
Z9 3
U1 1
U2 18
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0048-3575
EI 1095-9939
J9 PESTIC BIOCHEM PHYS
JI Pest. Biochem. Physiol.
PD JAN
PY 2018
VL 144
BP 49
EP 56
DI 10.1016/j.pestbp.2017.11.004
PG 8
WC Biochemistry & Molecular Biology; Entomology; Physiology
SC Biochemistry & Molecular Biology; Entomology; Physiology
GA FY0YA
UT WOS:000426537400007
PM 29463408
DA 2020-07-08
ER

PT J
AU Landazabal, MAB
   Otero, ALC
   Kouznetsov, VV
   Luna, JED
   Mendez-Sanchez, SC
AF Borrero Landazabal, Mayra A.
   Carreno Otero, Aurora L.
   Kouznetsov, Vladimir V.
   Duque Luna, Jonny E.
   Mendez-Sanchez, Stelia C.
TI Alterations of mitochondrial electron transport chain and oxidative
   stress induced by alkaloid-like alpha-aminonitriles on Aedes aegypti
   larvae
SO PESTICIDE BIOCHEMISTRY AND PHYSIOLOGY
LA English
DT Article
DE Aedes aegypti; Mitochondrial bioenergetics; Girgensohnine analogues;
   alpha-aminonitriles; Oxidative stress
ID INSECTICIDE RESISTANCE; RESPIRATORY-CHAIN; GENERATION; INHIBITORS
AB Aedes aegypti mosquitoes are responsible for dengue, chikungunya, and Zika virus transmission in tropical and subtropical areas around the world. Due to the absence of vaccines or antiviral drugs for human treatment, the majority of control strategies are targeted at Ae. aegypti elimination. Our research on mosquito control insecticidal agents has previously shown that the alkaloid girgensohnine and its analogues (alpha-aminonitriles) present in vitro acetylcholinesterase inhibition and in vivo insecticidal activity against Ae. aegypti. However, acetylcholinesterase inhibition may not be the only mechanism of action behind these effects. On this basis, the principal aim of this study was to elucidate the possible action mode of four alpha-aminonitriles on Ae. aegypti by studying other important enzymatic targets, such as mitochondrial electron transport chain complexes, catalase, and superoxide dismutase, key oxidative stress enzymes. Mitochondria were isolated from Ae. aegypti larvae by differential centrifugation, stored at -70 degrees C, and fragmented using ultrasound for 10 min. The effects of alpha-aminonitriles (1 to 4) over enzymatic activities were evaluated using concentrations of 8 nM, 2 mu M, 8 mu M, and 40 mu M. Results indicated that a-aminonitriles caused significant NADH dehydrogenase and succinate oxidase inhibition (similar to 44% at the highest concentration tested). Succinate dehydrogenase and cytochrome c oxidase activities were found to increase (162% and 106% at 40 mu M, respectively). It was also observed that these compounds produced catalase inhibition and thus prevented H2O2 reduction, which induced the formation of reactive oxygen species (ROS). Moreover, NBT assay showed that compounds 3 and 4 (with 2-(pyrrolidin-1-yl) acetonitrile as substituent) increased by approximately 50% the O-2(center dot-). concentration in the mitochondrial respiratory chain. It was concluded that the tested compounds act as complex I inhibitors by blocking electron transport and causing electron leak, possibly between complex I and III. Furthermore, a-aminonitriles inhibited catalase activity; compounds 1 and 2 (with piperidine fragment) inhibited glutathione reductase activity and further promoted the accumulation of ROS, which probably induced oxidative stress.
C1 [Borrero Landazabal, Mayra A.; Mendez-Sanchez, Stelia C.] Univ Ind Santander, Escuela Quim, Grp Invest Bioquim Microbiol GIBIM, Bucaramanga 678, Colombia.
   [Carreno Otero, Aurora L.; Kouznetsov, Vladimir V.] Univ Ind Santander, Escuela Quim LQOBio, Lab Quim Organ & Biomol, Bucaramanga 678, Colombia.
   [Borrero Landazabal, Mayra A.; Duque Luna, Jonny E.] Univ Ind Santander, Fac Salud, Ctr Invest Enfermedades Trop CINTROP, Escuela Med,Dept Ciencias Basicas, Bucaramanga 678, Colombia.
RP Mendez-Sanchez, SC (corresponding author), Univ Ind Santander, Escuela Quim, Grp Invest Bioquim Microbiol GIBIM, Bucaramanga 678, Colombia.
EM scmendez@uis.edu.co
OI Duque, Jonny Edward/0000-0003-2245-0558; Borrero,
   Mayra/0000-0003-3464-4042
FU "Patrimonio Autonomo, Fondo Nacional de Financiamiento para la Ciencia
   Francisco Jose de Caldas" (Colciencias) [110265740528, 624-2014];
   Vicerrectoria de Investigacion y Extension de la Universidad Industrial
   de Santander [1389]; program of Colciencias; program of Colciencias
   [567/2012]
FX This research was supported by "Patrimonio Autonomo, Fondo Nacional de
   Financiamiento para la Ciencia Francisco Jose de Caldas" (Colciencias)
   contracts code 110265740528 (grant 624-2014), and "Vicerrectoria de
   Investigacion y Extension de la Universidad Industrial de Santander"
   grant number 1389. The authors would like to express their gratitude to
   the program of Colciencias for Young Researcher Fellowship for their
   support to Mayra Borrero and the doctoral Fellowship No. 567/2012
   granted to Aurora Carreno.
CR Aguirre-Obando OA, 2015, ZOOLOGIA-CURITIBA, V32, P14, DOI 10.1590/S1984-46702015000100003
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Otero ALC, 2014, EUR J MED CHEM, V78, P392, DOI 10.1016/j.ejmech.2014.03.067
   Ciccia G, 2000, J ETHNOPHARMACOL, V72, P185, DOI 10.1016/S0378-8741(00)00241-5
   Elston DM, 2004, J AM ACAD DERMATOL, V51, P947, DOI 10.1016/j.jaad.2004.06.011
   Fato R., 2010, BIOCHIM BIOPHYS ACTA, V1787, P384
   FLOHE L, 1984, METHOD ENZYMOL, V105, P114
   Grisales N, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002438
   Guizzetti M, 2005, TOXICOLOGY, V215, P182, DOI 10.1016/j.tox.2005.07.004
   Hill BG, 2013, CIRC RES, V113, pE107, DOI 10.1161/CIRCRESAHA.113.302987
   Lambert AJ, 2004, J BIOL CHEM, V279, P39414, DOI 10.1074/jbc.M406576200
   Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200
   Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x
   Lu SC, 2009, MOL ASPECTS MED, V30, P42, DOI 10.1016/j.mam.2008.05.005
   MARKLUND S, 1974, EUR J BIOCHEM, V47, P469
   Martin M, 2000, J PINEAL RES, V28, P242, DOI 10.1034/j.1600-079X.2000.280407.x
   MASON TL, 1973, J BIOL CHEM, V248, P1346
   Moncada S, 2010, BRIT J PHARMACOL, V160, P217, DOI 10.1111/j.1476-5381.2010.00706.x
   Nakano M, 2015, J PESTIC SCI, V40, P19, DOI 10.1584/jpestics.D14-086
   NISHIKIMI M, 1972, BIOCHEM BIOPH RES CO, V46, P849, DOI 10.1016/S0006-291X(72)80218-3
   Ocampo CB, 2011, ACTA TROP, V118, P37, DOI 10.1016/j.actatropica.2011.01.007
   Pal S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102460
   Picard M, 2011, J PHYSIOL-LONDON, V589, P4413, DOI 10.1113/jphysiol.2011.212712
   Prinz M, 2013, EUR J PHARM SCI, V49, P603, DOI 10.1016/j.ejps.2013.04.024
   Rigoulet M, 2011, ANTIOXID REDOX SIGN, V14, P459, DOI 10.1089/ars.2010.3363
   Scaini G, 2011, ACTA NEUROPSYCHIATR, V23, P112, DOI 10.1111/j.1601-5215.2011.00548.x
   SIES H, 1979, FEBS LETT, V103, P287, DOI 10.1016/0014-5793(79)81346-0
   Singer T P, 1974, Methods Biochem Anal, V22, P123, DOI 10.1002/9780470110423.ch3
   SOMLO M, 1965, BIOCHIM BIOPHYS ACTA, V97, P183, DOI 10.1016/0304-4165(65)90083-8
   Sukhorukov A. P., 2007, Edinburgh Journal of Botany, V64, P317, DOI 10.1017/S0960428607004751
   Vargas L. Y., 2013, CURR ORG SYNTH, P969
   Venugopala K. N., 2016, CHEM BIOL DRUG DES, P1
   WORLD HEALTH ORGANIZATION, 2009, DENGUE: GUIDELINES FOR DIAGNOSIS, TREATMENT, PREVENTION AND CONTROL, P3
   Yang L, 2011, CANCER SCI, V102, P870, DOI 10.1111/j.1349-7006.2011.01874.x
   Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855
NR 35
TC 6
Z9 7
U1 2
U2 18
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0048-3575
EI 1095-9939
J9 PESTIC BIOCHEM PHYS
JI Pest. Biochem. Physiol.
PD JAN
PY 2018
VL 144
BP 64
EP 70
DI 10.1016/j.pestbp.2017.11.006
PG 7
WC Biochemistry & Molecular Biology; Entomology; Physiology
SC Biochemistry & Molecular Biology; Entomology; Physiology
GA FY0YA
UT WOS:000426537400009
PM 29463410
DA 2020-07-08
ER

PT J
AU Sharma, S
   Tyagi, A
   Ramachandra, S
   Bhuyan, L
   Dash, KC
   Raghuvanshi, M
AF Sharma, Swati
   Tyagi, Apurva
   Ramachandra, Sujatha
   Bhuyan, Lipsa
   Dash, Kailash Chandra
   Raghuvanshi, Malvika
TI Knowledge, Attitudes, and Practices among Health-Care Providers
   Regarding Zika Virus Infection
SO JOURNAL OF INTERNATIONAL SOCIETY OF PREVENTIVE AND COMMUNITY DENTISTRY
LA English
DT Article
DE Attitude; health-care providers; knowledge; practice; Zika virus
ID NEEDLESTICK INJURIES; AWARENESS; NURSES
AB Aims and Objectives: Zika virus (ZIKV) is a mosquito-borne flavivirus that was first identified in Uganda in 1947 in monkeys. The study was designed to assess the knowledge, attitude, and practices regarding ZIKV infection among rural health-care providers in Aligarh district, Uttar Pradesh, India.
   Materials and Methods: A total of 600 health-care providers were selected through stratified random sampling in an interventional survey. A self-structured, closed-ended questionnaire was administered to each participant in two phases to record their demographic, professional characteristics, knowledge, attitude, and practices regarding ZIKV.
   Results: Out of 600 health-care workers contacted, 585 (97.5%) agreed to participate in the survey. Multivariable linear regression analysis was carried out to assess the association of participant's professional characteristics with their knowledge, attitude, and practices.
   Conclusion: It showed that there was a wide gap between the level of awareness, knowledge, and practice among the different categories of health-care providers about the ZIKV. This study revealed that there was a very high probability of the risk of transmission of ZIKAV through health-care settings and hence health-care personnel must strictly adhere to Universal Precautions to prevent it.
C1 [Sharma, Swati] Sharda Univ, Sch Dent Sci, Dept Publ Hlth Dent, Greater Noida, Uttar Pradesh, India.
   [Tyagi, Apurva] Divine Multi Special Hosp, Dept Dent, Mathura, Uttar Pradesh, India.
   [Ramachandra, Sujatha; Bhuyan, Lipsa; Dash, Kailash Chandra; Raghuvanshi, Malvika] Kalinga Inst Dent Sci, Dept Oral Pathol & Microbiol, Bhubaneswar, Odisha, India.
RP Tyagi, A (corresponding author), MPH Texilla Amer Univ, Georgetown, Guyana.
EM drapurvatyagi@gmail.com
CR Abdullah M., 2011, INT J INFECT CONTROL, V7, P1
   Alam M, 2002, ANN SAUDI MED, V22, P396, DOI 10.5144/0256-4947.2002.396
   Alfaro-Toloza P, 2015, LANCET INFECT DIS, V15, P510, DOI 10.1016/S1473-3099(15)70160-X
   [Anonymous], ZIK VIR
   Aung MH, 2015, MED J, V57, P8
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Bhardwaj A, 2014, MALAYS ORTHOP J, V8, P6, DOI 10.5704/MOJ.1407.009
   Boseley S., 2020, GUARDIAN
   Ebrahimi H, 2007, J RES HEALTH SCI, V7, P56
   Fazekas B, 2015, J HOSP INFECT, V90, P260, DOI 10.1016/j.jhin.2015.03.007
   George B, 2014, HLTH SCI, V1, P1
   Grenoble R, 2016, WHO DECLARES PUBLIC
   Gupta Nidhi, 2015, Niger Med J, V56, P138, DOI 10.4103/0300-1652.153405
   Guruprasad Yadavalli, 2011, Natl J Maxillofac Surg, V2, P152, DOI 10.4103/0975-5950.94470
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Joob B, 2015, ANN TROP MED PUBLIC, V8, P145, DOI 10.4103/1755-6783.162402
   Kamate SK, 2010, J INFECT DEV COUNTR, V4, P7, DOI 10.3855/jidc.501
   Lisk Clifford, 2015, Acute Med, V14, P47
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Patavegar BN, 2015, INT J HLTH SCI RES, V5, P1
   Prabhu A, 2014, WORKPLACE HEALTH SAF, V62, P243, DOI 10.3928/21650799-20140514-06
   Schilling S, 2009, J CLIN VIROL, V45, P163, DOI 10.1016/j.jcv.2009.04.001
   Valerio L., 2015, OPEN J PREV MED, V56, P138
NR 23
TC 1
Z9 1
U1 3
U2 6
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 2231-0762
EI 2250-1002
J9 J INT SOC PREV COMMU
JI J. Int. Soc. Prev. Community Dent.
PD JAN-FEB
PY 2018
VL 8
IS 1
BP 41
EP 47
DI 10.4103/jispcd.JISPCD_371_17
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA FX8JS
UT WOS:000426338900007
PM 29629328
DA 2020-07-08
ER

PT J
AU Soriano-Arandes, A
   Rivero-Calle, I
   Nastouli, E
   Espiau, M
   Frick, MA
   Alarcon, A
   Martinon-Torres, F
AF Soriano-Arandes, Antoni
   Rivero-Calle, Irene
   Nastouli, Eleni
   Espiau, Maria
   Frick, M. A.
   Alarcon, Ana
   Martinon-Torres, Federico
TI What we know and what we don't know about perinatal Zika virus
   infection: a systematic review
SO EXPERT REVIEW OF ANTI-INFECTIVE THERAPY
LA English
DT Review
DE Arbovirus infection; maternal-fetal infection transmission; teratogen;
   Zika virus
ID GUILLAIN-BARRE-SYNDROME; NEURAL PROGENITORS; ANTIVIRAL ACTIVITY;
   BIRTH-DEFECTS; CASE SERIES; BRAZIL; BRAIN; INFANTS; VACCINE;
   TRANSMISSION
AB Introduction: Zika virus (ZIKV) infection has caused the most challenging worldwide infectious epidemic outbreak in recent months. ZIKV causes microcephaly and other congenital malformations. There is a need to perform updated systematic reviews on ZIKV infection periodically because this epidemic is bringing up new evidence with extraordinary speed.Areas covered: Evidence related to ZIKV infection in the gestational, perinatal, and early infant periods covering epidemiology, virology, pathogenesis, risk factors, time of infection during pregnancy, newborn symptoms, treatment, and vaccines. To this end, a search was performed using terms [Zika'] AND [Perinatal Infection'] OR [Congenital Infection'] in the PubMed (R) international electronic database. Out of a total of 1,538 articles published until 30 November 2017, we finally assessed 106 articles articles that were relevant to the research areas included in this study.Expert commentary: ZIKV is a new teratogenic/neurotropic virus affecting fetuses. Many challenges are still far from being solved regarding the epidemiology, case definition, clinical and laboratory diagnosis, and preventive measures. An approach using omics' and new biomarkers for diagnosis, and a ZIKV-vaccine for treatment, might finally give us the tools to solve these challenges.
C1 [Soriano-Arandes, Antoni; Espiau, Maria; Frick, M. A.] Hosp Univ Vall dHebron, Pediat Infect Dis & Immunodeficiencies Unit, Barcelona, Spain.
   [Rivero-Calle, Irene; Martinon-Torres, Federico] Complejo Hosp Univ Santiago de Compostela, Dept Pediat, Translat Pediat & Infect Dis, Santiago De Compostela, Spain.
   [Nastouli, Eleni] Univ Coll London Hosp NHS Fdn Trust, Dept Virol, London, England.
   [Alarcon, Ana] Hosp Univ St Joan de Deu, Dept Neonatol, Barcelona, Spain.
RP Martinon-Torres, F (corresponding author), Hosp Clin Univ Santiago de Compostela, Translat Pediat & Infect Dis Pediat Clin, Infectol & Traslac, Santiago De Compostela 15706, Spain.
EM federico.martinon.torres@sergas.es
RI Martinon-Torres, Federico/E-4982-2016; Soriano-Arandes,
   Antoni/G-6851-2013; Arandes, Antonio Soriano/Q-3348-2016
OI Martinon-Torres, Federico/0000-0002-9023-581X; Arandes, Antonio
   Soriano/0000-0001-9613-7228; Espiau, Maria/0000-0001-9697-7649; Rivero
   Calle, Irene/0000-0002-3678-9264
FU European Union's Horizon 2020 Research and Innovation program
   (ZIKAction) [734857]
FX This work was partially supported by the European Union's Horizon 2020
   Research and Innovation program (ZIKAction, grant agreement no. 734857).
   Call for research: SC1-PM-22-2016: Addressing the urgent research gaps
   against the Zika virus and other emerging threats in Latin America.
CR ABBASI J, 2016, JAMA J AM MED ASSOC, V316, P1249
   Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Albuquerque MDPM, 2016, EMERG INFECT DIS, V22, P1090, DOI [10.32032/eid2206.160062, 10.3201/eid2206.160062]
   Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Barzon L, 2017, EXPERT OPIN BIOL TH, V17, P1185, DOI 10.1080/14712598.2017.1346081
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brent C, 2016, MMWR-MORBID MORTAL W, V65, P36
   Carroll T, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006537
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cavalcanti DD, 2017, PLOS ONE, V12, pe0175065, DOI DOI 10.1371/JOURNAL.PONE.0175065.ECOLLECTION2017
   Cavalcanti MG, 2017, INT J INFECT DIS, V57, P70, DOI 10.1016/j.ijid.2017.01.042
   Chua A, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005269
   Cohen J, 2016, SCIENCE, V351, P543, DOI 10.1126/science.351.6273.543
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   del Campo M, 2017, AM J MED GENET A, V173, P841, DOI 10.1002/ajmg.a.38170
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Durbin AP, 2016, TRENDS IMMUNOL, V37, P635, DOI 10.1016/j.it.2016.08.006
   Ekins Sean, 2016, F1000Res, V5, P275
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Fernandez-Garcia MD, 2009, CELL HOST MICROBE, V5, P318, DOI 10.1016/j.chom.2009.04.001
   Ferreira AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09797-8
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Frank C, 2016, EUROPEAN COMMUNICABL, V2016, P21, DOI DOI 10.2807/1560-7917
   Frontera JA, 2016, NEW ENGL J MED, V375, P1581, DOI 10.1056/NEJMe1611840
   Gallian P, 2017, BLOOD, V129, P263, DOI 10.1182/blood-2016-09-737981
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gaskell KM, 2017, EMERG INFECT DIS, V23, P137, DOI 10.3201/eid2301.161300
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Halai UA, 2017, CLIN INFECT DIS, V65, P877, DOI 10.1093/cid/cix472
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Julander JG, 2017, ANTIVIR RES, V137, P14, DOI 10.1016/j.antiviral.2016.11.003
   Krow-Lucal ER, 2017, EMERG INFECT DIS, V23, P1260, DOI 10.3201/eid2308.170479
   Krow-Lucal ER, 2017, EMERG INFECT DIS, V23, P841, DOI 10.3201/eid2305.161715
   Lanteri MC, 2016, TRANSFUSION, V56, P1907, DOI 10.1111/trf.13677
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Leal MC, 2017, EMERG INFECT DIS, V23, P1253, DOI 10.3201/eid2308.170354
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Li CF, 2017, EBIOMEDICINE, V24, P189, DOI 10.1016/j.ebiom.2017.09.034
   Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Lustig Y, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.26.30269
   Meertens L, 2016, CELL REP, V18, P1
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moher D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2535
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Mor G, 2017, NAT REV IMMUNOL, V17, P469, DOI 10.1038/nri.2017.64
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Mulkey SB, 2018, PEDIATR NEUROL, V78, P75, DOI 10.1016/j.pediatrneurol.2017.10.012
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Musso D, 2017, CLIN MICROBIOL INFEC, V23, DOI 10.1016/j.cmi.2017.07.006
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Mysorekar IU, 2016, NEW ENGL J MED, V375, P481, DOI 10.1056/NEJMcibr1605445
   Newman CM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00246-8
   NIH, PHAS 2 ZIK VACC TRIA
   NIH, 2016, NIH BEG TEST INV ZIK
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Oh Y, 2017, NAT NEUROSCI, V20, P1209, DOI 10.1038/nn.4612
   Oliveira DBL, 2016, NEW ENGL J MED, V375, P1202, DOI 10.1056/NEJMc1607583
   Pacheco O, 2016, N ENGL J MED, P374
   Pan American Health Organization / World Health Organization Zika Epidemiological Update, 2017, ZIK EP UPD 25 AUG 20
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Pires de Mello CP, 2017, ANTIMICROB AGENTS CH, V62
   Pitts JD, 2017, ANTIVIR RES, V147, P124, DOI 10.1016/j.antiviral.2017.10.014
   Rodo C, 2018, CLIN MICROBIOL INFEC, V24, DOI 10.1016/j.cmi.2017.09.022
   Schaub B, 2017, LANCET INFECT DIS, V17, P520, DOI [10.1016/S1473-3099(17)30102-0, 10.1016/s1473-3099(17)30102-0]
   Schuler-Faccini L, 2016, CLIN PHARMACOL THER, V100, P28, DOI 10.1002/cpt.386
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Snyder B, 2018, J MED VIROL, V90, P8, DOI 10.1002/jmv.24932
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Stone M, 2017, TRANSFUSION, V57, P734, DOI 10.1111/trf.14031
   Suy A, 2016, NEW ENGL J MED, V375, P2611, DOI 10.1056/NEJMc1607580
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   US Food and Drug Administration, 2016, REC DON SCREEN DEF P
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Villamil-Gomez WE, 2016, INT J INFECT DIS, V51, P135, DOI 10.1016/j.ijid.2016.07.017
   Vouga M, 2016, PRENATAL DIAG, V36, P799, DOI 10.1002/pd.4880
   Wang CX, 2017, BIOCHEM BIOPH RES CO, V493, P1555, DOI 10.1016/j.bbrc.2017.10.016
   Wang JQ, 2017, CELL, V171, P229, DOI 10.1016/j.cell.2017.09.002
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Yu YF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15672
   Zhang B, 2017, NAT MED, V23, P548, DOI 10.1038/nm.4302
NR 104
TC 9
Z9 9
U1 1
U2 13
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1478-7210
EI 1744-8336
J9 EXPERT REV ANTI-INFE
JI Expert Rev. Anti-Infect. Ther.
PY 2018
VL 16
IS 3
BP 243
EP 254
DI 10.1080/14787210.2018.1438265
PG 12
WC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
SC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
GA FX5QQ
UT WOS:000426135100007
PM 29415586
DA 2020-07-08
ER

PT J
AU Janssens, S
   Schotsaert, M
   Karnik, R
   Balasubramaniam, V
   Dejosez, M
   Meissner, A
   Garcia-Sastrer, A
   Zwaka, TP
AF Janssens, Syvie
   Schotsaert, Michael
   Karnik, Rahul
   Balasubramaniam, Vinod
   Dejosez, Marion
   Meissner, Alexander
   Garcia-Sastrer, Adolfo
   Zwaka, Thomas P.
TI Zika Virus Alters DNA Methylation of Neural Genes in an Organoid Model
   of the Developing Human Brain
SO MSYSTEMS
LA English
DT Article
DE DNA methylation; Zika virus; astrocytes; brain disorders; microcephaly;
   neurons
ID STEM-CELL MODELS; CEREBRAL ORGANOIDS; INFECTION; DISEASE; ENHANCEMENT
AB Zika virus (ZIKV) infection during early pregnancy can cause microcephaly and associated defects at birth, but whether it can induce neurologic sequelae that appear later in life remains unclear. Using a model of the developing brain based on embryonic stem cell-derived brain organoids, we studied the impact of ZIKV infection on the DNA methylation pattern across the entire genome in selected neural cell types. The virus unexpectedly alters the DNA methylome of neural progenitors, astrocytes, and differentiated neurons at genes that have been implicated in the pathogenesis of a number of brain disorders, most prominently mental retardation and schizophrenia. Our results suggest that ZIKV infection during fetal development could lead to a spectrum of delayed-onset neuropsychiatric complications. IMPORTANCE Scientific research on human neural stem cells and cerebral organoids has confirmed the congenital neurotropic and neurodestructive nature of the Zika virus. However, the extent to which prenatal ZIKV infection is associated with more subtle brain alterations, such as epigenetic changes, remains ill defined. Here, we address the question of whether ZIKV infection induces DNA methylation changes with the potential to cause brain disorders later in life.
C1 [Janssens, Syvie; Dejosez, Marion; Zwaka, Thomas P.] Icahn Sch Med Mt Sinai, Huffington Ctr Cell Based Res Parkinsons Dis, Black Family Stem Cell Inst, Dept Cell Dev & Regenerat Biol, New York, NY 10029 USA.
   [Schotsaert, Michael; Balasubramaniam, Vinod; Garcia-Sastrer, Adolfo] Icahn Sch Med Mt Sinai, Global Hlth & Emerging Pathogens Inst, Dept Microbiol, New York, NY 10029 USA.
   [Schotsaert, Michael; Balasubramaniam, Vinod; Garcia-Sastrer, Adolfo] Icahn Sch Med Mt Sinai, Dept Med, Div Infect Dis, New York, NY 10029 USA.
   [Karnik, Rahul; Meissner, Alexander] Harvard Univ, Dept Stem Cell & Regenerat Biol, Harvard Stem Cell Inst, Cambridge, MA 02138 USA.
   [Karnik, Rahul; Meissner, Alexander] Broad Inst MIT & Harvard, Cambridge, MA USA.
   [Balasubramaniam, Vinod] Monash Univ Malaysia, Jeffrey Cheah Sch Med & Hlth Sci, Bandar Sunway, Selangor, Malaysia.
RP Zwaka, TP (corresponding author), Icahn Sch Med Mt Sinai, Huffington Ctr Cell Based Res Parkinsons Dis, Black Family Stem Cell Inst, Dept Cell Dev & Regenerat Biol, New York, NY 10029 USA.; Garcia-Sastrer, A (corresponding author), Icahn Sch Med Mt Sinai, Global Hlth & Emerging Pathogens Inst, Dept Microbiol, New York, NY 10029 USA.; Garcia-Sastrer, A (corresponding author), Icahn Sch Med Mt Sinai, Dept Med, Div Infect Dis, New York, NY 10029 USA.
EM adolfo.garcia-sastre@mssm.edu; thomaszwaka@mssm.edu
FU Huffington Foundation; NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [NIH/NIAID
   U19AI118610, R21AI129486, R01DA036898, 1R01HD078679]; New York Stem Cell
   Foundation; Belgian American Educational Foundation
FX This work was supported by the Huffington Foundation (T.P.Z.); NIH
   grants NIH/NIAID U19AI118610 (A.G.-S.), R21AI129486 (A.G.-S.),
   R01DA036898 (A.M.), and 1R01HD078679 (A.M.); the New York Stem Cell
   Foundation (A.M.); and the Belgian American Educational Foundation
   (fellowships to both S.J. and M.S.). A.M. is a New York Stem Cell
   Foundation Robertson Investigator.
CR Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Bauer-Mehren A, 2010, BIOINFORMATICS, V26, P2924, DOI 10.1093/bioinformatics/btq538
   BergerSweeney J, 1997, BEHAV BRAIN RES, V86, P121, DOI 10.1016/S0166-4328(96)02251-6
   Boyle P, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R92, 10.1186/gb-2012-13-10-r92]
   Camp JG, 2015, P NATL ACAD SCI USA, V112, P15672, DOI 10.1073/pnas.1520760112
   Correa-Oliveira GE, 2017, REV BRAS PSIQUIATR, V39, P381, DOI 10.1590/1516-4446-2017-2308
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Fernandez AF, 2010, ONCOGENE, V29, P1405, DOI 10.1038/onc.2009.517
   Galanter JM, 2017, ELIFE, V6, DOI 10.7554/eLife.20532
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Gutierrez-Sacristan A, 2015, BIOINFORMATICS, V31, P3075, DOI 10.1093/bioinformatics/btv301
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Halstead SB, 2017, EMERG INFECT DIS, V23, P569, DOI 10.3201/eid2304.161879
   Kapogiannis BG, 2017, JAMA PEDIATR, V171, P478, DOI 10.1001/jamapediatrics.2017.0002
   Kelava I, 2016, CELL STEM CELL, V18, P736, DOI 10.1016/j.stem.2016.05.022
   Khandaker GM, 2013, PSYCHOL MED, V43, P239, DOI 10.1017/S0033291712000736
   Koyuncu OO, 2013, CELL HOST MICROBE, V13, P379, DOI 10.1016/j.chom.2013.03.010
   Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248
   Lancaster MA, 2014, NAT PROTOC, V9, P2329, DOI 10.1038/nprot.2014.158
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Laurent LC, 2010, NAT METHODS, V7, P6, DOI 10.1038/nmeth0110-06
   Ludlow M, 2016, ACTA NEUROPATHOL, V131, P159, DOI 10.1007/s00401-015-1511-3
   Luo CY, 2016, CELL REP, V17, P3369, DOI 10.1016/j.celrep.2016.12.001
   Ming GL, 2016, CELL STEM CELL, V19, P690, DOI 10.1016/j.stem.2016.11.014
   Molofsky AV, 2012, GENE DEV, V26, P891, DOI 10.1101/gad.188326.112
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Nutt C, 2017, LANCET, V389, P1595, DOI 10.1016/S0140-6736(17)31051-6
   Ploeger A, 2010, BIOL PSYCHIAT, V67, P602, DOI 10.1016/j.biopsych.2009.10.010
   Portales-Casamar E, 2016, EPIGENET CHROMATIN, V9, DOI 10.1186/s13072-016-0074-4
   Possas C, 2016, EPIDEMIOL HEALTH, V38, DOI 10.4178/epih.e2016023
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Richetto J, 2017, BIOL PSYCHIAT, V81, P265, DOI 10.1016/j.biopsych.2016.08.010
   Sariol CA, 2017, TRENDS MICROBIOL
   Simonin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005821
   Sun DQ, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r38
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Wei H, 2010, BBA-GENE REGUL MECH, V1799, P296, DOI 10.1016/j.bbagrm.2009.08.007
   Xi YP, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S58
   Yu GC, 2015, BIOINFORMATICS, V31, P608, DOI 10.1093/bioinformatics/btu684
   Yuan SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017540
   Zucker J, 2017, EMERG INFECT DIS, V23, P1047, DOI 10.3201/eid2306.162029
NR 47
TC 8
Z9 8
U1 1
U2 4
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2379-5077
J9 MSYSTEMS
JI mSystems
PD JAN-FEB
PY 2018
VL 3
IS 1
AR UNSP e00210-17
DI 10.1128/mSystems.00210-17
PG 12
WC Microbiology
SC Microbiology
GA FX6DS
UT WOS:000426173900013
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Harapan, H
   Alleta, A
   Anwar, S
   Setiawan, AM
   Maulana, R
   Wahyuniati, N
   Ramadana, MR
   Ikram, I
   Haryanto, S
   Jamil, KF
   Kuch, U
   Rodriguez-Morales, AJ
AF Harapan, Harapan
   Alleta, Alma
   Anwar, Samsul
   Setiawan, Abdul M.
   Maulana, Reza
   Wahyuniati, Nur
   Ramadana, Muhammad R.
   Ikram, Ikram
   Haryanto, Sotianingsih
   Jamil, Kurnia F.
   Kuch, Ulrich
   Rodriguez-Morales, Alfonso J.
TI Attitudes towards Zika virus infection among medical doctors in Aceh
   province, Indonesia
SO JOURNAL OF INFECTION AND PUBLIC HEALTH
LA English
DT Article
DE Zika virus; Zika fever; Attitude; Healthcare worker; Indonesia
ID HEALTH-CARE STUDENTS; WORKERS KNOWLEDGE; CHIKUNGUNYA VIRUS; ASSOCIATION;
   COLOMBIA; AMERICA; CITIES; FEVER
AB Zika virus (ZIKV) infection, a public health emergency of international concern, has recently been confirmed in Indonesia. However, to date, there has been no study to assess how prepared healthcare workers in Indonesia are to confront this emerging infectious disease. The aim of this study was to assess the attitudes of medical doctors in Indonesia towards ZIKV infection and its associated explanatory variables. A cross-sectional self-administered online survey was conducted from 3 May to 3 June 2016 in Aceh province, Indonesia. A pre-tested questionnaire was used to collect data on doctors' attitudes towards ZIKV infection and a range of explanatory variables (basic demographic data, professional characteristics, workplace characteristics and facilities, and medical experience related to ZIKV infection). Associations between attitude and explanatory variables were assessed using multiple-step logistic regression. We received 631 responses, 424 (67.19%) of which were included in the final analysis. Approximately 64% (271) of doctors had a poor attitude towards ZIKV infection. Experience considering ZIKV infection as a differential diagnosis and attendance at a national conference was associated with a good attitude, with odds ratios (OR) of 3.93 (95% confidence interval [CI]: 1.15-13.49) and 1.69 (95% CI: 1.03-2.76), respectively. Unexpectedly, doctors who had attended an international conference and those working at places that had molecular diagnostic (polymerase chain reaction based testing) facilities had lower odds of having a good attitude (OR: 0.35 [95% CI: 0.15-0.84] and 0.42 [95% CI: 0.19-0.95], respectively). In conclusion, the attitude towards ZIKV infection is relatively poor among doctors in Aceh. Therefore, strategies for enhancing their capacity to respond to ZIKV infection are needed. The survey concept and tools were well accepted by the participants of this study, suggesting that this rapid assessment could be rolled out across the Indonesian archipelago and elsewhere to identify and regionally differentiate unmet needs of disease and outbreak preparedness. (C) 2017 The Authors. Published by Elsevier Limited on behalf of King Saud Bin Abdulaziz University for Health Sciences. This is an open access article under the CC BY-NC-ND license
C1 [Harapan, Harapan; Alleta, Alma; Maulana, Reza; Wahyuniati, Nur; Ramadana, Muhammad R.; Ikram, Ikram; Jamil, Kurnia F.] Syiah Kuala Univ, Sch Med, Med Res Unit, Jl T Tanoeh Abe, Darussalam 23111, Banda Aceh, Indonesia.
   [Harapan, Harapan] Syiah Kuala Univ, Sch Med, Trop Dis Ctr, Banda Aceh, Indonesia.
   [Harapan, Harapan] Syiah Kuala Univ, Sch Med, Dept Microbiol, Banda Aceh, Indonesia.
   [Alleta, Alma] Syiah Kuala Univ, Sch Med, Dept Family Med, Banda Aceh, Indonesia.
   [Anwar, Samsul] Syiah Kuala Univ, Fac Math & Nat Sci, Dept Stat, Banda Aceh, Indonesia.
   [Setiawan, Abdul M.] State Islamic Univ Maulana Malik Ibrahim, Fac Med & Hlth Sci, Dept Microbiol, Malang, Indonesia.
   [Haryanto, Sotianingsih] Jambi Univ, Fac Med & Hlth Sci, Dept Clin Pathol, Jambi, Indonesia.
   [Jamil, Kurnia F.] Syiah Kuala Univ, Sch Med, Dept Internal Med, Banda Aceh, Indonesia.
   [Kuch, Ulrich] Goethe Univ, Inst Occupat Med Social Med & Environm Med, Dept Trop Med & Publ Hlth, Frankfurt, Germany.
   [Rodriguez-Morales, Alfonso J.] Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Res Incubator & Grp, Pereira, Risaralda, Colombia.
   [Rodriguez-Morales, Alfonso J.] IPS Imagenes Diagnost SA, Res Grp Med & Diagnost Images GRIMEID, Pereira, Risaralda, Colombia.
RP Harapan, H (corresponding author), Syiah Kuala Univ, Sch Med, Med Res Unit, Jl T Tanoeh Abe, Darussalam 23111, Banda Aceh, Indonesia.
EM harapan@unsyiah.ac.id
RI Harapan, Harapan/I-8741-2016; AJ, Rodriguez-Morales/R-9765-2016
OI Harapan, Harapan/0000-0001-7630-8413; AJ,
   Rodriguez-Morales/0000-0001-9773-2192; Setiawan, abdul
   Malik/0000-0002-6913-2007
CR Bonett DG, 2000, PSYCHOMETRIKA, V65, P23, DOI 10.1007/BF02294183
   BURNKRANT RE, 1991, ADV CONSUM RES, V18, P28
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Gardner LM, 2016, LANCET INFECT DIS, V16, P522, DOI 10.1016/S1473-3099(16)00176-6
   Gupta Nidhi, 2016, Niger Postgrad Med J, V23, P33, DOI 10.4103/1117-1936.180179
   Harapan H, 2017, ASIAN PAC J TROP MED, V10, P182, DOI 10.1016/j.apjtm.2017.01.018
   Hennessey M., 2015, CTR DIS CONTROL PREV, V65, P55, DOI DOI 10.15585/MMWR.MM6503E1
   Iqbal MZ, 2016, VALUE HEALTH, V19, pA484, DOI 10.1016/j.jval.2016.09.798
   Karyanti MR, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-412
   Kosasih H, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002483
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Laras K, 2005, T ROY SOC TROP MED H, V99, P128, DOI 10.1016/j.trstmh.2004.03.013
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Betancourt-Trejos ML, 2016, TRAVEL MED INFECT DI, V14, P283, DOI 10.1016/j.tmaid.2016.03.017
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Maha MS, 2015, EMERG INFECT DIS, V21, P379, DOI 10.3201/eid2102.141121
   Martinez-Pulgarin DF, 2016, TRAVEL MED INFECT DI, V14, P55, DOI 10.1016/j.tmaid.2015.07.005
   Ministry of Health of Indonesia, 2016, PROF KES IND 2015
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Perkasa A, 2016, EMERG INFECT DIS, V22, P924, DOI 10.3201/eid2205.151915
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Sabogal-Roman JA, 2016, TRAVEL MED INFECT DI, V14, P52, DOI 10.1016/j.tmaid.2015.12.003
   Samarasekera U, 2016, LANCET, V387, P521, DOI 10.1016/S0140-6736(16)00257-9
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   World Health Organization, 2016, KNOWL ATT PRACT SURV
   World Health Organization, 2016, SIT REP ZIK VIR MICR
NR 34
TC 12
Z9 12
U1 0
U2 1
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 1876-0341
EI 1876-035X
J9 J INFECT PUBLIC HEAL
JI J. Infect. Public Health
PD JAN-FEB
PY 2018
VL 11
IS 1
BP 99
EP 104
DI 10.1016/j.jiph.2017.06.013
PG 6
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA FX2HJ
UT WOS:000425880000019
PM 28736184
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Jaramillo-Martinez, GA
   Vasquez-Serna, H
   Chavarro-Ordonez, R
   Rojas-Gomez, OF
   Jimenez-Canizales, CE
   Rodriguez-Morales, AJ
AF Jaramillo-Martinez, Guillermo A.
   Vasquez-Serna, Heriberto
   Chavarro-Ordonez, Ruthdy
   Rojas-Gomez, Oscar F.
   Jimenez-Canizales, Carlos E.
   Rodriguez-Morales, Alfonso J.
TI Ibague Saludable: A novel tool of Information and Communication
   Technologies for surveillance, prevention and control of dengue,
   chikungunya, Zika and other vector-borne diseases in Colombia
SO JOURNAL OF INFECTION AND PUBLIC HEALTH
LA English
DT Letter
C1 [Jaramillo-Martinez, Guillermo A.] Municipal Ibague, Ibague, Tolima, Colombia.
   [Jaramillo-Martinez, Guillermo A.; Vasquez-Serna, Heriberto; Chavarro-Ordonez, Ruthdy; Jimenez-Canizales, Carlos E.] Secretary Hlth Ibague, Ibague, Tolima, Colombia.
   [Jaramillo-Martinez, Guillermo A.; Vasquez-Serna, Heriberto; Chavarro-Ordonez, Ruthdy; Rojas-Gomez, Oscar F.] Ibague Saludable Res Grp, Ibague, Tolima, Colombia.
   [Vasquez-Serna, Heriberto; Jimenez-Canizales, Carlos E.; Rodriguez-Morales, Alfonso J.] Colombian Collaborat Network Zika & Other Arbovir, Pereira, Risaralda, Colombia.
   [Rojas-Gomez, Oscar F.] ESE Hosp San Francisco, Ibague, Tolima, Colombia.
   [Jimenez-Canizales, Carlos E.] Univ Surcolombiana, Internal Med, Neiva, Huila, Colombia.
   [Jimenez-Canizales, Carlos E.; Rodriguez-Morales, Alfonso J.] Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Res Grp, Pereira, Colombia.
   [Jimenez-Canizales, Carlos E.; Rodriguez-Morales, Alfonso J.] Univ Tecnol Pereira, Fac Hlth Sci, Infect & Immun Res Grp, Pereira, Colombia.
RP Rodriguez-Morales, AJ (corresponding author), Univ Tecnol Pereira, Fac Hlth Sci, Bldg 14,Carrera 27 10-02 Barrio Alamos, Pereira 660003, Risaralda, Colombia.
EM ajrodriguezmmd@gmail.com
RI AJ, Rodriguez-Morales/R-9765-2016; Jimenez-Canizales, Carlos
   Eduardo/AAR-7264-2020
OI AJ, Rodriguez-Morales/0000-0001-9773-2192; Jimenez-Canizales, Carlos
   Eduardo/0000-0001-7728-1523
FU Secretary of Health of Ibague, Tolima, Colombia
FX Secretary of Health of Ibague, Tolima, Colombia.
CR Brasil LM, 2015, BIOMED ENG ONLINE, V14, DOI 10.1186/s12938-015-0052-2
   Cardona-Ospina JA, 2015, T ROY SOC TROP MED H, V109, P793, DOI 10.1093/trstmh/trv094
   Instituto Nacional de Salud, 2016, EP WEEK 45
   Nagpal BN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166768
   Rodriguez-Morales Alfonso J, 2016, F1000Res, V5, P568, DOI 10.12688/f1000research.8436.1
   Siddiqui TR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005129
   Zamora Antón, 2015, Rev. perú. med. exp. salud publica, V32, P397
NR 7
TC 3
Z9 3
U1 0
U2 1
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 1876-0341
EI 1876-035X
J9 J INFECT PUBLIC HEAL
JI J. Infect. Public Health
PD JAN-FEB
PY 2018
VL 11
IS 1
BP 145
EP 146
DI 10.1016/j.jiph.2017.03.001
PG 2
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA FX2HJ
UT WOS:000425880000033
PM 28434775
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Duehr, J
   Lee, S
   Singh, G
   Foster, GA
   Krysztof, D
   Stramer, SL
   Gonzalez, MCB
   Menichetti, E
   Geretschlager, R
   Gabriel, C
   Simon, V
   Lim, JK
   Krammer, F
AF Duehr, James
   Lee, Silviana
   Singh, Gursewak
   Foster, Gregory A.
   Krysztof, David
   Stramer, Susan L.
   Gonzalez, Maria C. Bermudez
   Menichetti, Eva
   Geretschlaeger, Robert
   Gabriel, Christian
   Simon, Viviana
   Lim, Jean K.
   Krammer, Florian
TI Tick-Borne Encephalitis Virus Vaccine-Induced Human Antibodies Mediate
   Negligible Enhancement of Zika Virus Infection&IT In Vitro&IT and in a
   Mouse Model
SO MSPHERE
LA English
DT Article
DE ADE; TBEV; Zika; antibody-dependent enhancement; tick-borne encephalitis
   virus
ID WEST-NILE-VIRUS; DENGUE VIRUS; MONOCLONAL-ANTIBODIES; DEPENDENT
   ENHANCEMENT; PATHOGENESIS; EPIDEMIOLOGY; IMMUNITY; DISEASE
AB Recent reports in the scientific literature have suggested that anti-dengue virus (DENV) and anti-West Nile virus (WNV) immunity exacerbates Zika virus (ZIKV) pathogenesis in vitro and in vivo in mouse models. Large populations of immune individuals exist for a related flavivirus (tick-borne encephalitis virus [TBEV]), due to large-scale vaccination campaigns and endemic circulation throughout most of northern Europe and the southern Russian Federation. As a result, the question of whether anti-TBEV immunity can affect Zika virus pathogenesis is a pertinent one. For this study, we obtained 50 serum samples from individuals vaccinated with the TBEV vaccine FSME-IMMUN (Central European/Neudorfl strain) and evaluated their enhancement capacity in vitro using K562 human myeloid cells expressing CD32 and in vivo using a mouse model of ZIKV pathogenesis. Among the 50 TBEV vaccinee samples evaluated, 29 had detectable reactivity against ZIKV envelope (E) protein by enzyme-linked immunosorbent assay (ELISA), and 36 showed enhancement of ZIKV infection in vitro. A pool of the most highly reacting and enhanced samples resulted in no significant change in the morbidity/mortality of ZIKV disease in immunocompromised Stat2(-/-) mice. Our results suggest that humoral immunity against TBEV is unlikely to enhance Zika virus pathogenesis in humans. No clinical reports indicating that TBEV vaccinees experiencing enhanced ZIKV disease have been published so far, and though the epidemiological data are sparse, our findings suggest that there is little reason for concern. This study also displays a clear relationship between the phylogenetic distance between two flaviviruses and their capacity for pathogenic enhancement.
   IMPORTANCE The relationship between serial infections of two different serotypes of dengue virus and more severe disease courses is well-documented in the literature, driven by so-called antibody-dependent enhancement (ADE). Recently, studies have shown the possibility of ADE in cells exposed to anti-DENV human plasma and then infected with ZIKV and also in mouse models of ZIKV pathogenesis after passive transfer of anti-DENV human plasma. In this study, we evaluated the extent to which this phenomenon occurs using sera from individuals immunized against tick-borne encephalitis virus (TBEV). This is highly relevant, since large proportions of the European population are vaccinated against TBEV or otherwise seropositive.
C1 [Duehr, James; Lee, Silviana; Singh, Gursewak; Gonzalez, Maria C. Bermudez; Simon, Viviana; Lim, Jean K.; Krammer, Florian] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.
   [Duehr, James] Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, New York, NY 10029 USA.
   [Lee, Silviana] NYU, Grad Sch Arts & Sci, New York, NY USA.
   [Foster, Gregory A.; Krysztof, David; Stramer, Susan L.] Amer Red Cross, Gaithersburg, MD USA.
   [Gonzalez, Maria C. Bermudez; Simon, Viviana] Icahn Sch Med Mt Sinai, Global Hlth Emerging Pathogens Inst, New York, NY 10029 USA.
   [Menichetti, Eva; Geretschlaeger, Robert] Blood Serv Vienna Lower Austria & Burgenland, Austrian Red Cross, Vienna, Austria.
   [Gabriel, Christian] Ludwig Boltzmann Inst Expt & Clin Traumatol, Graz, Austria.
   [Gabriel, Christian] Inst Expt Transfus Med, Altenberg, Austria.
   [Simon, Viviana] Icahn Sch Med Mt Sinai, Dept Med, Divs Infect Dis, New York, NY 10029 USA.
RP Lim, JK; Krammer, F (corresponding author), Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.
EM jean.lim@mssm.edu; florian.krammer@mssm.edu
RI Krammer, Florian/H-3237-2019; Gabriel, Christian/A-1689-2014
OI Krammer, Florian/0000-0003-4121-776X; Gabriel,
   Christian/0000-0003-2043-9320; Duehr, James/0000-0003-2077-6685; Lee,
   Silviana/0000-0002-5847-5725
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [5T32AI007647-18]; NIAIDUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R21 AI130299]
FX J.D. was funded through NIH training fellowship 5T32AI007647-18. This
   project was financially supported by NIAID grant R21 AI130299 to J.K.L.
   and by institutional seed funding to F.K.
CR [Anonymous], 2017, EPID B, V17, P149
   [Anonymous], 2000, EUR C MIN TRANSP
   Atif M, 2016, INFECTION, V44, P695, DOI 10.1007/s15010-016-0935-6
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Terzian ACB, 2017, CLIN INFECT DIS, V65, P1260, DOI 10.1093/cid/cix558
   Bogovic P, 2015, WORLD J CLIN CASES, V3, P430, DOI 10.12998/wjcc.v3.i5.430
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Deng YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016059
   Ecker M, 1999, J GEN VIROL, V80, P179, DOI 10.1099/0022-1317-80-1-179
   HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268
   HALSTEAD SB, 1980, AM J TROP MED HYG, V29, P638, DOI 10.4269/ajtmh.1980.29.638
   Harrison SC, 2016, NAT IMMUNOL, V17, P1010, DOI 10.1038/ni.3539
   Heinz FX, 2004, ARCH VIROL, P201
   HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830, DOI 10.4269/ajtmh.1982.31.830
   HOLZMANN H, 1992, VACCINE, V10, P345, DOI 10.1016/0264-410X(92)90376-U
   Jelinek T, 2012, WIEN MED WOCHENSCHR, V162, P248, DOI 10.1007/s10354-012-0112-1
   JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275
   KLIKS SC, 1988, AM J TROP MED HYG, V38, P411, DOI 10.4269/ajtmh.1988.38.411
   Kunz C, 2003, VACCINE, V21, pS50, DOI 10.1016/S0264-410X(02)00813-7
   KUNZ C, 1976, ZBL BAKT-INT J MED M, V234, P141
   Lehrer Axel T, 2011, J Bioterror Biodef, V2011, P3
   McAuley AJ, 2017, NPJ VACCINES, V2, DOI 10.1038/s41541-017-0009-5
   Nachbagauer R, 2017, NAT IMMUNOL, V18, P464, DOI 10.1038/ni.3684
   Nybakken GE, 2006, J VIROL, V80, P11467, DOI 10.1128/JVI.01125-06
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Paul L., 2016, BIORXIV
   Schuler M, 2014, EUROSURVEILLANCE, V19, P39, DOI 10.2807/1560-7917.ES2014.19.13.20756
   Stramer SL, 2005, NEW ENGL J MED, V353, P451, DOI 10.1056/NEJMoa044333
   Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215
   Who Publication, 2011, Vaccine, V29, P8769, DOI 10.1016/j.vaccine.2011.07.024
   Willis E, 2017, VIROLOGY, V508, P1, DOI 10.1016/j.virol.2017.04.031
NR 31
TC 6
Z9 6
U1 0
U2 6
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2379-5042
J9 MSPHERE
JI mSphere
PD JAN-FEB
PY 2018
VL 3
IS 1
AR e00011-18
DI 10.1128/mSphereDirect.00011-18
PG 10
WC Microbiology
SC Microbiology
GA FW4IX
UT WOS:000425277500001
PM 29435494
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Moreira-Soto, A
   Carneiro, ID
   Fischer, C
   Feldmann, M
   Kummerer, BM
   Silva, NS
   Santos, UG
   Souza, BFDD
   Liborio, FD
   Valenca-Montenegro, MM
   Laroque, PD
   da Fontoura, FR
   Oliveira, AVD
   Drosten, C
   de Lamballerie, X
   Franke, CR
   Drexler, JF
AF Moreira-Soto, Andres
   Carneiro, Ianei de Oliveira
   Fischer, Carlo
   Feldmann, Marie
   Kuemmerer, Beate M.
   Silva, Nama Santos
   Santos, Uilton Goes
   de Carvalho Dominguez Souza, Breno Frederico
   Liborio, Fernanda de Azevedo
   Valenca-Montenegro, Monica Mafra
   Laroque, Plautino de Oliveira
   da Fontoura, Fernanda Rosa
   Dantas Oliveira, Alberto Vinicius
   Drosten, Christian
   de Lamballerie, Xavier
   Franke, Carlos Roberto
   Drexler, Jan Felix
TI Limited Evidence for Infection of Urban and Peri-urban Nonhuman Primates
   with Zika and Chikungunya Viruses in Brazil
SO MSPHERE
LA English
DT Article
DE alphavirus; chikungunya virus; flavivirus; Zika virus; nonhuman primates
ID CROSS-REACTIVITY; ALOUATTA-CARAYA; STATE; TRANSMISSION; CIRCULATION;
   ANTIBODIES; VECTORS; VIREMIA; MONKEY; DENGUE
AB Chikungunya virus (CHIKV) and Zika virus (ZIKV) emerged in the Americas in 2013. Limited antigenic variability of CHIKV and ZIKV may restrict urban transmission cycles due to population protective immunity. In Africa, sylvatic transmission cycles involving nonhuman primates (NHP) are known for CHIKV and ZIKV, causing cyclic reemergence in humans. To evaluate whether sylvatic cycles can be expected in Latin America, we tested 207 NHP collected between 2012 and 2017 in urban and pen-urban settings in Brazil for infection with ZIKV and CHIKV. No animal tested positive for viral RNA in genus-specific and species-specific reverse transcription-PCR (RT-PCR) assays. In contrast, six animals (2.9%) from the families Atelidae, Callitrichidae, and Cebidae showed ZIKV-specific antibodies and 11 (5.3%) showed CHIKVspecific antibodies in plaque reduction neutralization tests (PRNT). Reactivity was monotypic against either ZIKV or CHIKV in all cases, opposing unspecific virucidal activity of sera. PRNT endpoint titers were low at 1:40 in all NHP, and positive specimens did not correspond to the likely dispersal route and time of introduction of both arboviruses. All antibody-positive samples were therefore tested against the NHP-associated yellow fever virus (YFV) and Mayaro virus (MAYV) and against the human-associated dengue virus (DENV) by PRNT. Two ZIKV-positive samples were simultaneously DENV positive and two CHIKV-positive samples were simultaneously MAW positive, at titers of 1:40 to 1:160. This suggested cross-reactive antibodies against heterologous alphaviruses and flaviviruses in 24% of ZIKV-positive/CHIKVpositive sera. In sum, low seroprevalence, invariably low antibody titers, and the distribution of positive specimens call into question the capability of ZIKV and CHIKV to infect New World NHP and establish sylvatic transmission cycles.
   IMPORTANCE Since 2013, Zika virus (ZIKV) and chikungunya virus (CHIKV) have infected millions of people in the Americas via urban transmission cycles. Nonhuman primates (NHP) are involved in sylvatic transmission cycles maintaining ZIKV and CHIKV in the Old World. We tested NHP sampled during 2012 to 2017 in urban and peri-urban areas severely affected by ZIKV and CHIKV in Brazil. Seroprevalence and antibody titers were low for both viruses. Additionally, we found evidence for infection by heterologous viruses eliciting cross-reactive antibodies. Our data suggest that urban or peri-urban NHP are not easily infected by ZIKV and CHIKV despite intense local transmission. These data may imply that the ZIKV and CHIKV outbreaks in the Americas cannot be sustained in urban or peri-urban NHP once human population immunity limits urban transmission cycles. Investigation of diverse animals is urgently required to determine the fate of the ZIKV and CHIKV outbreaks in the Americas.
C1 [Moreira-Soto, Andres; Feldmann, Marie; Kuemmerer, Beate M.] Univ Bonn, Inst Virol, Med Ctr, Bonn, Germany.
   [Moreira-Soto, Andres; Carneiro, Ianei de Oliveira; Fischer, Carlo; Drosten, Christian; Drexler, Jan Felix] Charite, Berlin, Germany.
   [Moreira-Soto, Andres; Carneiro, Ianei de Oliveira; Fischer, Carlo; Drosten, Christian; Drexler, Jan Felix] Free Univ Berlin, Berlin, Germany.
   [Moreira-Soto, Andres; Carneiro, Ianei de Oliveira; Fischer, Carlo; Drosten, Christian; Drexler, Jan Felix] Humboldt Univ, Berlin, Germany.
   [Moreira-Soto, Andres; Carneiro, Ianei de Oliveira; Fischer, Carlo; Drosten, Christian; Drexler, Jan Felix] Inst Virol, Berlin Inst Hlth, Berlin, Germany.
   [Carneiro, Ianei de Oliveira; Silva, Nama Santos; de Carvalho Dominguez Souza, Breno Frederico; Franke, Carlos Roberto] Univ Fed Bahia, Salvador, BA, Brazil.
   [Santos, Uilton Goes] Univ Fed Reconcavo Bahia, Cruz Das Almas, Brazil.
   [Liborio, Fernanda de Azevedo] Wild Anim Triage Ctr, Salvador, BA, Brazil.
   [Valenca-Montenegro, Monica Mafra; Laroque, Plautino de Oliveira] Natl Ctr Res & Conservat Brazilian Primates, Joao Pessoa, Paraiba, Brazil.
   [da Fontoura, Fernanda Rosa] Brasilia Zoo Fdn, Brasilia, DF, Brazil.
   [Dantas Oliveira, Alberto Vinicius] Zoobot Pk Getulio Vargas, Salvador, BA, Brazil.
   [Drosten, Christian; Drexler, Jan Felix] German Ctr Infect Res DZIF, Tubingen, Germany.
   [de Lamballerie, Xavier] Aix Marseille Univ, IRD 190, UMR Emergence Pathol Virales EPV, Inserm 1207,EHESP,IHU Mediterranee Infect, Marseille, France.
RP Drexler, JF (corresponding author), Charite, Berlin, Germany.; Drexler, JF (corresponding author), Free Univ Berlin, Berlin, Germany.; Drexler, JF (corresponding author), Humboldt Univ, Berlin, Germany.; Drexler, JF (corresponding author), Inst Virol, Berlin Inst Hlth, Berlin, Germany.; Drexler, JF (corresponding author), German Ctr Infect Res DZIF, Tubingen, Germany.
EM felix.drexler@charite.de
OI Fischer, Carlo/0000-0001-9163-2406; de oliveira carneiro,
   ianei/0000-0003-0375-8506; Drexler, Jan Felix/0000-0002-3509-0232
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; European Union's Horizon research and innovation program
   through the ZIKAlliance project [734548]
FX I.D.O.C. was supported by a scholarship from the Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES). This work was
   supported by the European Union's Horizon 2020 research and innovation
   program through the ZIKAlliance project (grant agreement no. 734548).
CR Althouse BM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005055
   Althouse BM, 2016, BIORXIV
   Apandi Y, 2009, J GEN MOL VIROL, P35
   Ayllon T, 2017, EMERG INFECT DIS, V23, P1411, DOI 10.3201/eid2308.162007
   Barzon L., 2016, EUROSURVEILLANCE, V21, P2016, DOI DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Batista PM, 2013, REV SOC BRAS MED TRO, V46, P684, DOI 10.1590/0037-8682-0181-2013
   Bicca-Marques JC, 2008, PRIMATES, V49, P246, DOI 10.1007/s10329-008-0091-4
   Bond M, 2015, NATURE, V520, P538, DOI 10.1038/nature14120
   Bosco-Lauth AM, 2016, AM J TROP MED HYG, V94, P504, DOI 10.4269/ajtmh.15-0696
   Buechler CR, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00392-16
   Bueno MG, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005073
   Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X
   Chen CI, 2010, AM J TROP MED HYG, V83, P1249, DOI 10.4269/ajtmh.2010.10-0290
   Chevillon C, 2008, TRENDS MICROBIOL, V16, P80, DOI 10.1016/j.tim.2007.12.003
   CHIU CY, 2017, SCI REP, V7
   Corman VM, 2016, B WORLD HEALTH ORGAN, V94, P880, DOI 10.2471/BLT.16.175950
   Davis N C, 1930, J Exp Med, V52, P405
   Diallo D, 2013, T ROY SOC TROP MED H, V107, P200, DOI 10.1093/trstmh/trs095
   Diallo M, 1999, AM J TROP MED HYG, V60, P281, DOI 10.4269/ajtmh.1999.60.281
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   do Nascimento Rafaela Almeida, 2013, Neotropical Biology and Conservation, V8, P79, DOI 10.4013/nbc.2013.82.03
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Eastwood G, 2017, AM J TROP MED HYG, V97, P1399, DOI 10.4269/ajtmh.17-0126
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Favoretto S, 2016, BIORXIV
   Faye O, 2014, PLOS NEGL TROP DIS, V8
   Gaffigan T, 2015, SYSTEMATIC CATALOG C
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Grywna K, 2010, J CLIN MICROBIOL, V48, P3386, DOI 10.1128/JCM.00317-10
   Hassing RJ, 2010, EUROSURVEILLANCE, V15, P22
   Higgs S, 2015, VECTOR-BORNE ZOONOT, V15, P231, DOI 10.1089/vbz.2014.1745
   Hopkins ME, 2007, DIVERS DISTRIB, V13, P561, DOI 10.1111/j.1472-4642.2007.00364.x
   Johnston R.E., 1996, FIELDS VIROLOGY, P843
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Lourenco-de-Oliveira R, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005698
   Mackay IM, 2016, MICROBES INFECT, V18, P724, DOI 10.1016/j.micinf.2016.10.007
   MARCHETTE N J, 1978, Southeast Asian Journal of Tropical Medicine and Public Health, V9, P317
   Mayer SV, 2017, ACTA TROP, V166, P155, DOI 10.1016/j.actatropica.2016.11.020
   Moreira-Soto Andres, 2017, J Infect Dis, V216, P1501, DOI 10.1093/infdis/jix539
   Moreno ES, 2013, REV INST MED TROP SP, V55, P45, DOI 10.1590/S0036-46652013000100008
   Moureau G, 2007, VECTOR-BORNE ZOONOT, V7, P467, DOI 10.1089/vbz.2007.0206
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Netto EM, 2017, MBIO, V8, DOI [10.1128/mBio.01390-17, 10.1128/mbio.01390-17]
   Panning M, 2009, EMERG INFECT DIS, V15, P469, DOI 10.3201/eid1503.081104
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Ragan IK, 2017, VECTOR-BORNE ZOONOT, V17, P161, DOI 10.1089/vbz.2016.2099
   Sahadeo N, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004199
   Springer MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049521
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Suy A, 2016, NEW ENGL J MED, V375, P2611, DOI 10.1056/NEJMc1607580
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Van Kerkhove MD, 2016, LANCET GLOB HEALTH, V4, pE911, DOI 10.1016/S2214-109X(16)30255-8
   Vanchiere JA, 2017, AM J TROP MED HYG, V27, P17
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
NR 54
TC 10
Z9 10
U1 0
U2 11
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2379-5042
J9 MSPHERE
JI mSphere
PD JAN-FEB
PY 2018
VL 3
IS 1
AR e00523-17
DI 10.1128/mSphere.00523-17
PG 10
WC Microbiology
SC Microbiology
GA FW4IX
UT WOS:000425277500024
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU To, A
   Medina, LO
   Mfuh, KO
   Lieberman, MM
   Wong, TAS
   Namekar, M
   Nakano, E
   Lai, CY
   Kumar, M
   Nerurkar, VR
   Lehrer, AT
AF To, Albert
   Medina, Liana O.
   Mfuh, Kenji O.
   Lieberman, Michael M.
   Wong, Teri Ann S.
   Namekar, Madhuri
   Nakano, Eileen
   Lai, Chih-Yun
   Kumar, Mukesh
   Nerurkar, Vivek R.
   Lehrer, Axel T.
TI Recombinant Zika Virus Subunits Are Immunogenic and Efficacious in Mice
SO MSPHERE
LA English
DT Article
DE recombinant; subunit; vaccine; Zika virus
ID JAPANESE ENCEPHALITIS-VIRUS; WEST-NILE; DENGUE VIRUS; PROTECTIVE
   EFFICACY; NEUTRALIZING ANTIBODIES; MONOCLONAL-ANTIBODIES;
   CROSS-REACTIVITY; DNA VACCINE; IN-VITRO; INFECTION
AB Following the 2015 Zika virus (ZIKV) outbreaks in the South Pacific, Caribbean, and Americas, ZIKV has emerged as a serious threat due to its association with infantile microcephaly and other neurologic disorders. Despite an international effort to develop a safe and effective vaccine to combat congenital Zika syndrome and ZIKV infection, only DNA and mRNA vaccines encoding the precursor membrane (prM) and envelope (E) proteins, an inactivated-ZIKV vaccine, and a measles virus-based ZIKV vaccine are currently in phase I or II (prM/E DNA) clinical trials. A ZIKV vaccine based on a nonreplicating, recombinant subunit platform offers a higher safety profile than other ZIKV vaccine candidates but is still highly immunogenic, inducing high virus-neutralizing antibody titers. Here, we describe the production and purification of Drosophila melanogaster 52 insect cell-derived, soluble ZIKV E protein and evaluate its immunogenicity and efficacy in three different mouse strains. As expected, significant virus-specific antibody titers were observed when using formulations containing clinically relevant adjuvants. Immunized mice challenged with live virus demonstrate inhibition of virus replication. Importantly, plaque reduction neutralization tests (PRNTs) indicate the high-titer production of neutralizing antibodies, a correlate of protection in the defense against ZIKV infection. ZIKV challenge of immunocompetent mice led to full protection against viremia with two doses of adjuvanted vaccine candidates. These data demonstrate a proof of concept and establish recombinant subunit immunogens as an effective vaccine candidate against ZIKV infection. IMPORTANCE The recent outbreaks of Zika virus (ZIKV) infection in French Polynesia, the Caribbean, and the Americas have highlighted the severe neuropathological sequelae that such an infection may cause. The development of a safe, effective ZIKV vaccine is critical for several reasons: (i) the difficulty in diagnosing an active infection due to common nonspecific symptoms, (ii) the lack of a specific antiviral therapy, and (iii) the potentially devastating pathological effects of in utero infection. Moreover, a vaccine with an excellent safety profile, such as a nonreplicating, noninfectious vaccine, would be ideal for high-risk people (e.g., pregnant women, immunocompromised patients, and elderly individuals). This report describes the development of a recombinant subunit protein vaccine candidate derived from stably transformed insect cells expressing the ZIKV envelope protein in vitro, the primary antigen to which effective virus-neutralizing antibodies are engendered by immunized animals for several other flaviviruses; the vaccine candidate elicits effective virus-neutralizing antibodies against ZIKV and provides protection against ZIKV infection in mice.
C1 [To, Albert; Medina, Liana O.; Mfuh, Kenji O.; Lieberman, Michael M.; Wong, Teri Ann S.; Namekar, Madhuri; Nakano, Eileen; Lai, Chih-Yun; Kumar, Mukesh; Nerurkar, Vivek R.; Lehrer, Axel T.] Univ Hawaii, John A Burns Sch Med, Dept Trop Med Med Microbiol & Pharmacol, Honolulu, HI 96822 USA.
   [Namekar, Madhuri; Nakano, Eileen; Kumar, Mukesh; Nerurkar, Vivek R.; Lehrer, Axel T.] Univ Hawaii, John A Burns Sch Med, Pacific Ctr Emerging Infect Dis Res, Honolulu, HI 96822 USA.
RP Lehrer, AT (corresponding author), Univ Hawaii, John A Burns Sch Med, Dept Trop Med Med Microbiol & Pharmacol, Honolulu, HI 96822 USA.; Lehrer, AT (corresponding author), Univ Hawaii, John A Burns Sch Med, Pacific Ctr Emerging Infect Dis Res, Honolulu, HI 96822 USA.
EM lehrer@hawall.edu
RI amsalu, ribka/G-8780-2019; Kumar, Mukesh/N-8814-2015; Nerurkar, Vivek
   R/F-5533-2011
OI Kumar, Mukesh/0000-0003-0970-4875; 
FU Pacific Center for Emerging Infectious Diseases Research (COBRE grant)
   [P30GM114737]; National Institute of General Medical Sciences
   (NIGMS)United States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS); Global Infectious Diseases Training Program,
   Fogarty International Center, NIH [D437W009074]
FX Funding for this project was provided in part by the Pacific Center for
   Emerging Infectious Diseases Research (COBRE grant P30GM114737), by the
   National Institute of General Medical Sciences (NIGMS), and by
   institutional funds. K.O.M. was supported by a grant (D437W009074) from
   the Global Infectious Diseases Training Program, Fogarty International
   Center, NIH.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Blom AG, 2004, VACCINE, V23, P743, DOI 10.1016/j.vaccine.2004.07.021
   Boigard H, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005608
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Castanha PMS, 2017, J INFECT DIS, V215, P781, DOI 10.1093/infdis/jiw638
   Clements DE, 2010, VACCINE, V28, P2705, DOI 10.1016/j.vaccine.2010.01.022
   Coller BAG, 2011, VACCINE, V29, P7267, DOI 10.1016/j.vaccine.2011.07.021
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Davis BS, 2001, J VIROL, V75, P4040, DOI 10.1128/JVI.75.9.4040-4047.2001
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   FAGBAMI A H, 1986, African Journal of Medicine and Medical Sciences, V15, P103
   FAGBAMI AH, 1987, CYTOBIOS, V49, P49
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Govindarajan D, 2015, VACCINE, V33, P4105, DOI 10.1016/j.vaccine.2015.06.067
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Gupta AK, 2011, ACTA VIROL, V55, P165, DOI 10.4149/av_2011_02_165
   Gupta AK, 2008, ACTA VIROL, V52, P219
   Gupta AK, 2003, ACTA VIROL, V47, P141
   Jarvi SI, 2008, VACCINE, V26, P5338, DOI 10.1016/j.vaccine.2008.08.011
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kawiecki AB, 2016, J INFECT DIS, V214, P1357, DOI 10.1093/infdis/jiw377
   Khan M, 2012, VIRUS RES, V167, P236, DOI 10.1016/j.virusres.2012.05.004
   Kim E, 2016, EBIOMEDICINE, V13, P315, DOI 10.1016/j.ebiom.2016.09.028
   Kreil TR, 1998, J VIROL, V72, P3076, DOI 10.1128/JVI.72.4.3076-3081.1998
   Kumar M, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0750-4
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lehrer AT, 2017, VACCINE
   Li C, 2016, J NANOMATER, V2016, P10, DOI DOI 10.3389/FPLS.2016.01356
   Lieberman MM, 2007, VACCINE, V25, P414, DOI 10.1016/j.vaccine.2006.08.018
   Lieberman MM, 2009, CLIN VACCINE IMMUNOL, V16, P1332, DOI 10.1128/CVI.00119-09
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Manoff SB, 2015, VACCINE, V33, P7126, DOI 10.1016/j.vaccine.2015.09.101
   Markoff L, 2000, VACCINE, V18, P26, DOI 10.1016/S0264-410X(00)00038-4
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100
   Namekar M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045851
   Oehler E, 2014, EURO SURVEILL, V19
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   SMITHBURN KC, 1954, AM J TROP MED HYG, V3, P9, DOI 10.4269/ajtmh.1954.3.9
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Van Hoeven N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149610
   Verma S, 2009, VIROLOGY, V385, P425, DOI 10.1016/j.virol.2008.11.047
   Willis E, 2017, VIROLOGY, V508, P1, DOI 10.1016/j.virol.2017.04.031
   Wong SJ, 2004, J CLIN MICROBIOL, V42, P65, DOI 10.1128/JCM.42.1.65-72.2004
   Yang M, 2017, VACCINE, V35, P4287, DOI 10.1016/j.vaccine.2017.04.052
   Zent O, 2003, VACCINE, V21, P738, DOI 10.1016/S0264-410X(02)00592-3
NR 58
TC 16
Z9 16
U1 0
U2 3
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2379-5042
J9 MSPHERE
JI mSphere
PD JAN-FEB
PY 2018
VL 3
IS 1
AR e00576-17
DI 10.1128/mSphere.00576-17
PG 16
WC Microbiology
SC Microbiology
GA FW4IX
UT WOS:000425277500037
PM 29359186
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Espinosa, D
   Mendy, J
   Manayani, D
   Vang, L
   Wang, CL
   Richard, T
   Guenther, B
   Aruri, J
   Avanzini, J
   Garduno, F
   Farness, P
   Gurwith, M
   Smith, J
   Harris, E
   Alexander, J
AF Espinosa, Diego
   Mendy, Jason
   Manayani, Darly
   Vang, Lo
   Wang, Chunling
   Richard, Tiffany
   Guenther, Ben
   Aruri, Jayavani
   Avanzini, Jenny
   Garduno, Fermin
   Farness, Peggy
   Gurwith, Marc
   Smith, Jon
   Harris, Eva
   Alexander, Jeff
TI Passive Transfer of Immune Sera Induced by a Zika Virus-Like Particle
   Vaccine Protects AG129 Mice Against Lethal Zika Virus Challenge
SO EBIOMEDICINE
LA English
DT Article
DE Zika virus; Virus-like particle vaccine; Correlates of protection;
   Passive transfer; Vaccine development
ID JAPANESE ENCEPHALITIS-VIRUS; NEUTRALIZING ANTIBODIES; SEXUAL
   TRANSMISSION; ARBOVIRUS INFECTION; STRUCTURAL BASIS; FUSION-LOOP;
   EFFICACY; BRAZIL; FEVER; IMMUNIZATION
AB Zika virus (ZIKV) poses a serious public health threat due to its association with birth defects in developing fetuses and Guillain-Barre Syndrome in adults. We are developing a ZIKV vaccine based on virus-like particles (VLPs) generated in transiently transfected HEK293 cells. The genetic construct consists of the prMand envelope structural protein genes of ZIKV placed downstream from a heterologous signal sequence. To better understand the humoral responses and correlates of protection (CoP) induced by the VLP vaccine, we evaluated VLP immunogenicity with and without alum in immune-competent mice (C57Bl/6 x Balb/c) and observed efficient induction of neutralizing antibody as well as a dose-sparing effect of alum. To assess the efficacy of the immune sera, we performed passive transfer experiments in AG129 mice. Mice that received the immune sera prior to ZIKV infection demonstrated significantly reduced viral replication as measured by viral RNA levels in the blood and remained healthy, whereas control mice succumbed to infection. The results underscore the protective effect of the antibody responses elicited by this ZIKV VLP vaccine candidate. These studieswill help define optimal vaccine formulations, contribute to translational efforts in developing a vaccine for clinical development, and assist in the definition of immunologic CoP. (c) 2017 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license.
C1 [Mendy, Jason; Manayani, Darly; Vang, Lo; Richard, Tiffany; Guenther, Ben; Aruri, Jayavani; Avanzini, Jenny; Garduno, Fermin; Farness, Peggy; Gurwith, Marc; Smith, Jon; Alexander, Jeff] PaxVax, San Diego, CA 92121 USA.
   [Espinosa, Diego; Wang, Chunling; Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
RP Alexander, J (corresponding author), PaxVax, San Diego, CA 92121 USA.; Harris, E (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
EM jalexander@paxvax.com
OI Espinosa, Diego A./0000-0002-4364-5031
FU PaxVax
FX This study was internally funded by PaxVax. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Akahata W, 2010, NAT MED, V16, P334, DOI 10.1038/nm.2105
   Allison SL, 2003, J VIROL, V77, P11357, DOI 10.1128/JVI.77.21.11357-11366.2003
   Ansar V, 2015, PRIMARY CARE, V42, P189, DOI 10.1016/j.pop.2015.01.001
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Belmusto-Worn VE, 2005, AM J TROP MED HYG, V72, P189, DOI 10.4269/ajtmh.2005.72.189
   Ben-Nathan D, 2003, J INFECT DIS, V188, P5, DOI 10.1086/376870
   Besnard M, 2014, EURO SURVEILL, V19
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Boigard H, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005608
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Cherrier MV, 2009, EMBO J, V28, P3269, DOI 10.1038/emboj.2009.245
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Diamond MS, 2003, J VIROL, V77, P2578, DOI 10.1128/JVI.77.4.2578-2586.2003
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Engle MJ, 2003, J VIROL, V77, P12941, DOI 10.1128/JVI.77.24.12941-12949.2003
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   HAMMON WMD, 1973, AM J TROP MED HYG, V22, P524, DOI 10.4269/ajtmh.1973.22.524
   Hasan SS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14722
   Hastings AK, 2017, YALE J BIOL MED, V90, P325
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hennessey M., 2015, CTR DIS CONTROL PREV, V65, P55, DOI DOI 10.15585/MMWR.MM6503E1
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Hombach J, 2005, VACCINE, V23, P5205, DOI [10.1016/j.vaccine.2005.07.002, 10.1016/j.vaccine.2004.11.040]
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Julander JG, 2011, VACCINE, V29, P6008, DOI 10.1016/j.vaccine.2011.06.034
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kreil TR, 1998, J VIROL, V72, P3076, DOI 10.1128/JVI.72.4.3076-3081.1998
   Kreil TR, 1997, CLIN EXP IMMUNOL, V110, P358, DOI 10.1046/j.1365-2249.1997.4311446.x
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   LUBINIECKI AS, 1973, AM J TROP MED HYG, V22, P535, DOI 10.4269/ajtmh.1973.22.535
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Markoff L, 2000, VACCINE, V18, P26, DOI 10.1016/S0264-410X(00)00038-4
   Marrs C, 2016, AM J PERINAT, V33, P625, DOI 10.1055/s-0036-1580089
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Mattia K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027252
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Orozco S, 2012, J GEN VIROL, V93, P2152, DOI 10.1099/vir.0.045088-0
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Pierson TC, 2012, CURR OPIN VIROL, V2, P168, DOI 10.1016/j.coviro.2012.02.011
   Plotkin S.A., 2013, VACCINES
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shan C, 2017, EBIOMEDICINE, V17, P157, DOI 10.1016/j.ebiom.2017.03.006
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Stiasny K, 2006, J VIROL, V80, P9557, DOI 10.1128/JVI.00080-06
   Sumathy K, 2017, SCI REP-UK, V7, DOI 10.1038/srep46375
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tesh RB, 2002, EMERG INFECT DIS, V8, P1392, DOI 10.3201/eid0812.020229
   Van Gessel Y, 2011, VACCINE, V29, P5925, DOI 10.1016/j.vaccine.2011.06.062
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Vogel G, 2016, SCIENCE, V351, P110, DOI 10.1126/science.351.6269.110
   Vogt MR, 2011, J VIROL, V85, P11567, DOI 10.1128/JVI.05859-11
   Wang JQ, 2017, CELL, V171, P229, DOI 10.1016/j.cell.2017.09.002
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 72
TC 15
Z9 16
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2352-3964
J9 EBIOMEDICINE
JI EBioMedicine
PD JAN
PY 2018
VL 27
BP 61
EP 70
DI 10.1016/j.ebiom.2017.12.010
PG 10
WC Medicine, General & Internal; Medicine, Research & Experimental
SC General & Internal Medicine; Research & Experimental Medicine
GA FX2FR
UT WOS:000425875400011
PM 29269041
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Coghlan, A
   Hoad, VC
   Seed, CR
   Flower, RLP
   Harley, RJ
   Herbert, D
   Faddy, HM
AF Coghlan, A.
   Hoad, V. C.
   Seed, C. R.
   Flower, R. L. P.
   Harley, R. J.
   Herbert, D.
   Faddy, H. M.
TI Emerging infectious disease outbreaks: estimating disease risk in
   Australian blood donors travelling overseas
SO VOX SANGUINIS
LA English
DT Article
DE blood safety; donor deferral; emerging infectious disease; EUFRAT;
   international travel; modelling; risk; transfusion-transmitted infection
ID ZIKA VIRUS; TRANSFUSION TRANSMISSION; DENGUE; EPIDEMIOLOGY;
   INACTIVATION; CHIKUNGUNYA; ULTRAVIOLET; EXPERIENCE; THREAT; SAFETY
AB Background and ObjectivesInternational travel assists spread of infectious pathogens. Australians regularly travel to South-eastern Asia and the isles of the South Pacific, where they may become infected with infectious agents, such as dengue (DENV), chikungunya (CHIKV) and Zika (ZIKV) viruses that pose a potential risk to transfusion safety. In Australia, donors are temporarily restricted from donating for fresh component manufacture following travel to many countries, including those in this study. We aimed to estimate the unmitigated transfusion-transmission (TT) risk from donors travelling internationally to areas affected by emerging infectious diseases.
   Materials and MethodsWe used the European Up-Front Risk Assessment Tool, with travel and notification data, to estimate the TT risk from donors travelling to areas affected by disease outbreaks: Fiji (DENV), Bali (DENV), Phuket (DENV), Indonesia (CHIKV) and French Polynesia (ZIKV).
   ResultsWe predict minimal risk from travel, with the annual unmitigated risk of an infected component being released varying from 1 in 143 million to <1 in one billion and the risk of severe consequences ranging from 1 in 130 million to <1 in one billion.
   ConclusionThe predicted unmitigated likelihood of infection in blood components manufactured from donors travelling to the above-mentioned areas was very low, with the possibility of severe consequences in a transfusion recipient even smaller. Given the increasing demand for plasma products in Australia, the current strategy of restricting donors returning from select infectious disease outbreak areas to source plasma collection provides a simple and effective risk management approach.
C1 [Coghlan, A.; Harley, R. J.; Faddy, H. M.] Australian Red Cross Blood Serv, Res & Dev, Brisbane, Qld, Australia.
   [Coghlan, A.; Faddy, H. M.] Univ Queensland, Sch Med, Brisbane, Qld, Australia.
   [Hoad, V. C.; Seed, C. R.] Australian Red Cross Blood Serv, Med Serv, Perth, WA, Australia.
   [Harley, R. J.] Australian Red Cross Blood Serv, Med Serv, Brisbane, Qld, Australia.
   [Herbert, D.] Australian Red Cross Blood Serv, Med Serv, Melbourne, Vic, Australia.
RP Faddy, HM (corresponding author), Australian Red Cross Blood Serv, Res & Dev, 44 Musk Ave, Kelvin Grove, Qld 4059, Australia.
EM hfaddy@redcrossblood.org.au
RI Flower, Robert/N-3680-2017
OI Seed, Clive/0000-0002-0234-4507; Faddy, Helen/0000-0002-3446-8248
CR Appassakij H, 2016, TRANSFUSION, V56, P2100, DOI 10.1111/trf.13675
   Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Australian Bureau of Statistics, 2013, AUSTR DEM STAT JUN 2
   Australian Bureau of Statistics, 2014, INT MOV 2013 14
   Australian Bureau of Statistics, 2010, AUSTR SOC TRENDS HOL
   Australian Bureau of Statistics, 2014, AUSTR DEM STAT JUN 2
   Australian Bureau of Statistics, 2014, AUSTR DEM STAT DEC 2
   Bureau of Epidemiology Ministry of Public Health Thailand, 2013, 506 MIN PUBL HLTH TH
   Busch MP, 2003, JAMA-J AM MED ASSOC, V289, P959, DOI 10.1001/jama.289.8.959
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Dodd RY, 2014, TRANSFUSION, V54, P1693, DOI 10.1111/trf.12705
   Dodd RY, 2012, BRIT J HAEMATOL, V159, P135, DOI 10.1111/bjh.12031
   Faddy HM, 2016, TRANSFUSION, V56, P1548, DOI 10.1111/trf.13519
   Faddy HM, 2013, EMERG INFECT DIS, V19, P787, DOI 10.3201/eid1905.121664
   Farrugia A, 2009, BLOOD REV, V23, P123, DOI 10.1016/j.blre.2008.10.004
   Gibbons CL, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-147
   Kementerian Kesehatan Republik Indonesia, 2014, PROF KES IND TAH 201
   KIMBALL AM, 2005, GLOBALIZATION HLTH, V1, P1
   Knope K, 2013, COMMUN DIS INTELL, V37, pE55
   Kosasih H, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004390
   Lanteri MC, 2016, TRANSFUSION, V56, P1907, DOI 10.1111/trf.13677
   Lanteri MC, 2012, TRANSFUSION, V52, P1634, DOI 10.1111/j.1537-2995.2012.03747.x
   Lieshout-Krikke R, 2016, VOX SANG, V111, P43
   Lieshout-Krikke RW, 2013, VOX SANG, V104, P12, DOI 10.1111/j.1423-0410.2012.01631.x
   Lieshout-Krikke RW, 2015, TRANSFUSION, V55, P79, DOI 10.1111/trf.12783
   Lucky T, 2014, THE KIRBY I, P5
   Mapako T, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1452-z
   Marks DC, 2014, ISBT SCI SER, V9, P44, DOI 10.1111/voxs.12085
   Morens DM, 2008, LANCET INFECT DIS, V8, P710, DOI 10.1016/S1473-3099(08)70256-1
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   National Statistical Office: Population Census 2010 Bangkok, 2011, POP CENS 2010 BANGK
   Oei W, 2016, VOX SANG, V110, P301, DOI 10.1111/vox.12370
   Oei W, 2014, TRANSFUSION, V54, P1705, DOI 10.1111/trf.12539
   Oei W, 2013, TRANSFUSION, V53, P1421, DOI 10.1111/j.1537-2995.2012.03941.x
   Petersen LR, 2010, VOX SANG, V98, P495, DOI 10.1111/j.1423-0410.2009.01286.x
   Polizzotto MN, 2008, TRANSFUSION, V48, P55, DOI 10.1111/j.1537-2995.2007.01482.x
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Sabino EC, 2016, J INFECT DIS, V213, P694, DOI 10.1093/infdis/jiv326
   Seed CR, 2016, VOX SANG, V110, P317, DOI 10.1111/vox.12372
   Stramer SL, 2009, TRANSFUSION, V49, p1S, DOI 10.1111/j.1537-2995.2009.02279.x
   The World Bank, 2014, TOT POP NUMB PEOPL
   Viennet E, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-379
   World Health Organisation, 2014, DENG SIT UPD 447
   Xie YW, 2008, TRANSFUSION, V48, P1342, DOI 10.1111/j.1537-2995.2008.01647.x
NR 45
TC 0
Z9 0
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0042-9007
EI 1423-0410
J9 VOX SANG
JI Vox Sang.
PD JAN
PY 2018
VL 113
IS 1
BP 21
EP 30
DI 10.1111/vox.12571
PG 10
WC Hematology
SC Hematology
GA FX3BS
UT WOS:000425945300004
PM 29052242
OA Bronze
DA 2020-07-08
ER

PT J
AU Lowe, R
   Barcellos, C
   Brasil, P
   Cruz, OG
   Honorio, NA
   Kuper, H
   Carvalho, MS
AF Lowe, Rachel
   Barcellos, Christovam
   Brasil, Patricia
   Cruz, Oswaldo G.
   Honorio, Nildimar Alves
   Kuper, Hannah
   Carvalho, Marilia Sa
TI The Zika Virus Epidemic in Brazil: From Discovery to Future Implications
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Review
DE Zika virus; microcephaly; Congenital Zika Syndrome; epidemiology;
   surveillance; vector control; socio-economic impact
ID AEDES-ALBOPICTUS DIPTERA; RIO-DE-JANEIRO; INTELLECTUAL DISABILITIES;
   AEGYPTI; DENGUE; TRANSMISSION; INFECTION; CHIKUNGUNYA; AMERICA;
   INDIVIDUALS
AB The first confirmed case of Zika virus infection in the Americas was reported in Northeast Brazil in May 2015, although phylogenetic studies indicate virus introduction as early as 2013. Zika rapidly spread across Brazil and to more than 50 other countries and territories on the American continent. The Aedesaegypti mosquito is thought to be the principal vector responsible for the widespread transmission of the virus. However, sexual transmission has also been reported. The explosively emerging epidemic has had diverse impacts on population health, coinciding with cases of Guillain-Barre Syndrome and an unexpected epidemic of newborns with microcephaly and other neurological impairments. This led to Brazil declaring a national public health emergency in November 2015, followed by a similar decision by the World Health Organization three months later. While dengue virus serotypes took several decades to spread across Brazil, the Zika virus epidemic diffused within months, extending beyond the area of permanent dengue transmission, which is bound by a climatic barrier in the south and low population density areas in the north. This rapid spread was probably due to a combination of factors, including a massive susceptible population, climatic conditions conducive for the mosquito vector, alternative non-vector transmission, and a highly mobile population. The epidemic has since subsided, but many unanswered questions remain. In this article, we provide an overview of the discovery of Zika virus in Brazil, including its emergence and spread, epidemiological surveillance, vector and non-vector transmission routes, clinical complications, and socio-economic impacts. We discuss gaps in the knowledge and the challenges ahead to anticipate, prevent, and control emerging and re-emerging epidemics of arboviruses in Brazil and worldwide.
C1 [Lowe, Rachel] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, Keppel St, London WC1E 7HT, England.
   [Lowe, Rachel] London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, Keppel St, London WC1E 7HT, England.
   [Lowe, Rachel] Barcelona Inst Global Hlth ISGLOBAL, Doctor Aiguader 88, Barcelona 08003, Spain.
   [Barcellos, Christovam] Oswaldo Cruz Fdn Fiocruz, Inst Hlth Commun & Informat, Ave Brasil 4365, BR-21045900 Rio De Janeiro, Brazil.
   [Brasil, Patricia] Oswaldo Cruz Fdn Fiocruz, Inst Nacl Infectol Evandro Chagas, Ave Brasil 4365, BR-21045900 Rio De Janeiro, Brazil.
   [Cruz, Oswaldo G.; Carvalho, Marilia Sa] Oswaldo Cruz Fdn Fiocruz, Sci Computat Program, Ave Brasil 4365, BR-21045900 Rio De Janeiro, Brazil.
   [Honorio, Nildimar Alves] Inst Oswaldo Cruz Fiocruz, Lab Mosquitos Transmissores Hematozoarios, Ave Brasil 4365, BR-21045900 Rio De Janeiro, Brazil.
   [Honorio, Nildimar Alves] Fiocruz MS, Nucleo Operac Sentinela Mosquitos Vetores Nosmove, Ave Brasil 4365, BR-21045900 Rio De Janeiro, Brazil.
   [Kuper, Hannah] London Sch Hyg & Trop Med, Int Ctr Evidence Disabil, Keppel St, London WC1E 7HT, England.
RP Lowe, R (corresponding author), London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, Keppel St, London WC1E 7HT, England.; Lowe, R (corresponding author), London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, Keppel St, London WC1E 7HT, England.; Lowe, R (corresponding author), Barcelona Inst Global Hlth ISGLOBAL, Doctor Aiguader 88, Barcelona 08003, Spain.
EM rachel.lowe@lshtm.ac.uk; xris@fiocruz.br;
   patricia.brasil@ini.fiocruz.br; oswaldo.cruz@fiocruz.br;
   honorio@ioc.fiocruz.br; hannah.kuper@lshtm.ac.uk;
   marilia.carvalho@fiocruz.br
RI CARVALHO, MARILIA/AAD-8283-2020; Barcellos, Christovam/G-6856-2012
OI CARVALHO, MARILIA/0000-0002-9566-0284; Barcellos,
   Christovam/0000-0002-1161-2753; Lowe, Rachel/0000-0003-3939-7343
FU Royal Society Dorothy Hodgkin FellowshipRoyal Society of London;
   Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq)
   [306087/2014-6, 200716/2015-8]; Departamento de Ciencia e Tecnologia do
   Ministerio da Saude do Brasil [DECIT/25000.072811/2016-17]; Coordenacao
   de Aperfeicoamento de Pessoal de Nivel SuperiorCAPES
   [CAPES/88887.116627/2016-01]; European Union under ZIKAlliance grant
   [734548]; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do
   Rio de Janeiro [E-26/010.001610/2016, E-26/2014-203577]; Fundo Nacional
   de Saude (TED) [90/2016]; Wellcome; DfID; European Union under ZikaPLAN
   grant [734584]
FX R.L. was funded by a Royal Society Dorothy Hodgkin Fellowship; C.B. was
   funded by the Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (http://www.cnpq.br/, grant#306087/2014-6); P.B. was funded
   by the Departamento de Ciencia e Tecnologia (DECIT/25000.072811/2016-17)
   do Ministerio da Saude do Brasil and grants from the Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES/88887.116627/2016-01) and the European Union's Horizon 2020
   research and innovation programme under ZIKAlliance grant agreement
   number 734548; N.A.H. was funded by the Fundacao Carlos Chagas Filho de
   Amparo a Pesquisa do Estado do Rio de Janeiro
   (http://www.faperj.br/grant#E-26/010.001610/2016) and the Fundo Nacional
   de Saude (TED No. 90/2016 (FNS); H.K. was supported by funding from
   Wellcome and DfID to work on Zika, and has received funding from the
   European Union's Horizon 2020 research and innovation programme, under
   ZikaPLAN grant agreement number 734584.; M.S.C. was funded by the
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (http://www.cnpq.br/, grant#200716/2015-8) and the Fundacao Carlos
   Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro
   (http://www.faperj.br/, grant#E-26/2014-203577). R.L. is grateful to
   Kathleen O'Reilly, Oliver Brady, Adam Kucharski, and members of ZikaPlan
   and ZikaAlliance for interesting discussions and insights about Zika.
   P.B. acknowledges the London School of Hygiene & Tropical Medicine. The
   authors are grateful to the Brazilian Ministry of Health for the RESP
   and SINAN data.
CR Abad-Franch F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002213
   Abad-Franch F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003702
   Agarwal A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002990
   Aiken ARA, 2016, NEW ENGL J MED, V375, P396, DOI 10.1056/NEJMc1605389
   Aliota MT, 2017, ANTIVIR RES, V144, P223, DOI 10.1016/j.antiviral.2017.06.001
   Althouse BM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005055
   Amraoui F, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.35.30333
   Asher J., 2017, BIORXIV, DOI [10.1101/187591, DOI 10.1101/187591]
   Ayllon T, 2017, EMERG INFECT DIS, V23, P1411, DOI 10.3201/eid2308.162007
   Ayres C, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.86
   Banks LM, 2013, EC COSTS EXCLUSION G
   Barcellos C, 2016, EMERG INFECT DIS, V22, P1894, DOI 10.3201/eid2211.160901
   Barcellos C, 2014, TROP MED INT HEALTH, V19, P159, DOI 10.1111/tmi.12227
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Baum P, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00064416
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Braks MAH, 2003, J MED ENTOMOL, V40, P785, DOI 10.1603/0022-2585-40.6.785
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Campos SS, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2543-4
   Carvalho DO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003864
   Carvalho DO, 2014, ACTA TROP, V132, pS170, DOI 10.1016/j.actatropica.2013.09.023
   Carvalho MS, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005632
   Cavalcanti MG, 2017, INT J INFECT DIS, V57, P70, DOI 10.1016/j.ijid.2017.01.042
   CDC, ZIK VIR HLTH EFF RIS
   Centers for Disease Control and Prevention (CDC), CONG ZIK SYNDR OTH B
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Codeco CT, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003475
   Coelho FC, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00317
   Coeli CM, 2015, CAD SAUDE PUBLICA, V31, P1349, DOI 10.1590/0102-311XED010715
   Colon-Gonzalez FJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006007
   CORNET M, 1979, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V17, P149
   Costa-da-Silva AL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171951
   Darney BG, 2017, OBSTET GYNECOL, V129, P638, DOI [10.1097/AOG.0000000000001914, 10.1097/aog.0000000000001914]
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   De Castro CatAo R., 2011, HYGIEA, V7, P173
   Lima-Camara Tamara Nunes de, 2006, Cad. Saúde Pública, V22, P2079, DOI 10.1590/S0102-311X2006001000013
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   de Souza WV, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00017216
   Di Luca M, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.18.30223
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   Diniz D, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00046316
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Favoretto S, 2016, BIORXIV, DOI [10.1101/049395, DOI 10.1101/049395]
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Fernandes RS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004993
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Goertz GP, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005654
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Griffith GM, 2014, J APPL RES INTELLECT, V27, P401, DOI 10.1111/jar.12073
   Guedes DRD, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.59
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   Hall-Mendelin S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004959
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Honorio NA, 2009, J MED ENTOMOL, V46, P1001, DOI 10.1603/033.046.0505
   Huang YJS, 2017, INSECTS, V8, DOI 10.3390/insects8010021
   Huang YJS, 2016, VECTOR-BORNE ZOONOT, V16, P673, DOI 10.1089/vbz.2016.2058
   Human Rights Watch, NEGL UNPR IMP ZIK OU
   Jones L, 2012, LANCET, V380, P899, DOI 10.1016/S0140-6736(12)60692-8
   Karwowski MP, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2016-0621
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   King DA, 2006, SCIENCE, V313, P1392, DOI 10.1126/science.1129134
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kuper H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144926
   Kuper H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107300
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Lopez-Camelo JS, 2015, ECLAMC FINAL DOCUMEN
   Lounibos LP, 2016, J INFECT DIS, V214, pS453, DOI 10.1093/infdis/jiw285
   Lounibos LP, 2002, ANNU REV ENTOMOL, V47, P233, DOI 10.1146/annurev.ento.47.091201.145206
   Lowe R, 2017, LANCET PLANET HEALTH, V1, pE142, DOI 10.1016/S2542-5196(17)30064-5
   Lowe R, 2016, ELIFE, V5, DOI 10.7554/eLife.11285
   Lowe R, 2014, LANCET INFECT DIS, V14, P619, DOI 10.1016/S1473-3099(14)70781-9
   Maciel-de-Freitas R, 2012, MEM I OSWALDO CRUZ, V107, P828, DOI 10.1590/S0074-02762012000600021
   Mallet HP, 2015, BISES B INFORM SANIT, V13, P1
   Marteleto LJ, 2017, POPUL DEV REV, V43, P199, DOI 10.1111/padr.12074
   Ministerio da Saude, 2015, PROT VIG RESP OC MIC
   Ministerio da Saude, DECL FIM EM NAC ZIK
   Ministerio da Saude, DENG CHIK ZIK
   Ministerio da Saude, 2015, B EPIDEMIOL, V46, P1
   Ministerio da Saude Brasil, 2016, PROT AT SAUD RESP OC
   Ministerio da Saude (Brazil), 2016, PROT VIG RESP OC MIC
   [Ministerio da Saude do Brasil Secretaria devigilanciaem Saude], 2016, B EPIDEMIOLOGICO, V47, P1
   Ministerio da Saude Secretaria de Vigilancia em Saude, 2017, B EPIDEMIOL, V48, P1, DOI DOI 10.5588/IJTLD.11.0170
   Mirza Nabila, 2013, Online J Public Health Inform, V5, P210, DOI 10.5210/ojphi.v5i2.4703
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Munoz AG, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01291
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Muturi EJ, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0667-y
   Nam SJ, 2017, J MENT HEALTH, V26, P50, DOI 10.1080/09638237.2016.1276538
   Netto EM, 2017, MBIO, V8, DOI [10.1128/mBio.01390-17, 10.1128/mbio.01390-17]
   Nuckols JT, 2015, J MED ENTOMOL, V52, P447, DOI 10.1093/jme/tjv017
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Officer Alana, 2011, WORLD REP DIS
   PAHO/WHO, ZIKAEPIDEMIOLOGICAL
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Pan American Health Organization, 2016, PAHO STAT ZIK VIR TR
   Paz-Bailey G., 2017, NEW ENGL J MED, DOI [10. 1056/NEJMoa1613108 28195756, DOI 10.1056/NEJM0A161310828195756]
   Pereira-Silva JW, 2018, MEM I OSWALDO CRUZ, V113, P56, DOI 10.1590/0074-02760170329
   Perkins TA, 2017, P NATL ACAD SCI USA, V114, P5558, DOI 10.1073/pnas.1705969114
   Perkins TA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.126, 10.1038/nmicrobiol.2016.126]
   Possas C, 2017, MEM I OSWALDO CRUZ, V112, P319, DOI 10.1590/0074-02760160510
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Regis LN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067682
   Reis-Castro L, 2012, CROAT MED J, V53, P635, DOI 10.3325/cmj.2012.53.635
   Roundy CM, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.85
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   Smartt CT, 2017, J MED ENTOMOL, V54, P1085, DOI 10.1093/jme/tjx058
   Sotelo JR, 2017, EMERG INFECT DIS, V23, P854, DOI 10.3201/eid2305.161538
   Tauil Pedro Luiz, 2002, Cad. Saúde Pública, V18, P867, DOI 10.1590/S0102-311X2002000300030
   Teixeira MG, 2016, AM J PUBLIC HEALTH, V106, P601, DOI 10.2105/AJPH.2016.303113
   Thangamani S, 2016, AM J TROP MED HYG, V95, P1169, DOI 10.4269/ajtmh.16-0448
   UN General Assembly, CONV RIGHTS PERS DIS
   UNDP, SOC IMP ASS ZIK VIR
   Vazeille M, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000706
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Vorou R, 2016, INT J INFECT DIS, V48, P85, DOI 10.1016/j.ijid.2016.05.014
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   WHO, WHO DIR SUMM OUTC EM
   World Health Organisation, INF FEED AR ZIK VIR
   World Health Organization, 2016, 5 M EM COMM INT HLTH
   World Health Organization, 2004, PYR DRINK WAT BACKGR
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114
NR 129
TC 58
Z9 60
U1 2
U2 14
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD JAN
PY 2018
VL 15
IS 1
AR 96
DI 10.3390/ijerph15010096
PG 18
WC Environmental Sciences; Public, Environmental & Occupational Health
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA FU8QZ
UT WOS:000424121200096
PM 29315224
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Sun, HY
   Chen, Q
   Lai, HF
AF Sun, Haiyan
   Chen, Qiang
   Lai, Huafang
TI Development of Antibody Therapeutics against Flaviviruses
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Review
DE flavivirus; antibody; monoclonal antibody (mAb); therapeutics;
   plant-made antibody; antibody-dependent enhancement (ADE); West Nile
   virus (WNV); Dengue virus (DENV); Zika virus (ZIKV); plant-made
   pharmaceuticals (PMP)
ID WEST-NILE-VIRUS; HUMAN MONOCLONAL-ANTIBODIES; FC-GAMMA-RECEPTOR;
   DEPENDENT CELLULAR CYTOTOXICITY; NEUTRALIZING HUMAN-ANTIBODIES;
   RESPIRATORY SYNCYTIAL VIRUS; CROSS-REACTIVE ANTIBODIES; DNA REPLICON
   SYSTEM; DENGUE VIRUS; ZIKA VIRUS
AB Recent outbreaks of Zika virus (ZIKV) highlight the urgent need to develop efficacious interventions against flaviviruses, many of which cause devastating epidemics around the world. Monoclonal antibodies (mAb) have been at the forefront of treatment for cancer and a wide array of other diseases due to their specificity and potency. While mammalian cell-produced mAbs have shown promise as therapeutic candidates against several flaviviruses, their eventual approval for human application still faces several challenges including their potential risk of predisposing treated patients to more severe secondary infection by a heterologous flavivirus through antibody-dependent enhancement (ADE). The high cost associated with mAb production in mammalian cell cultures also poses a challenge for the feasible application of these drugs to the developing world where the majority of flavivirus infection occurs. Here, we review the current therapeutic mAb candidates against various flaviviruses including West Nile (WNV), Dengue virus (DENV), and ZIKV. The progress of using plants for developing safer and more economical mAb therapeutics against flaviviruses is discussed within the context of their expression, characterization, downstream processing, neutralization, and in vivo efficacy. The progress of using plant glycoengineering to address ADE, the major impediment of flavivirus therapeutic development, is highlighted. These advancements suggest that plant-based systems are excellent alternatives for addressing the remaining challenges of mAb therapeutic development against flavivirus and may facilitate the eventual commercialization of these drug candidates.
C1 [Sun, Haiyan; Chen, Qiang; Lai, Huafang] Arizona State Univ, Biodesign Inst, Sch Life Sci, 1001 S McAllister Ave, Tempe, AZ 85287 USA.
RP Chen, Q (corresponding author), Arizona State Univ, Biodesign Inst, Sch Life Sci, 1001 S McAllister Ave, Tempe, AZ 85287 USA.
EM haiyan.sun@asu.edu; qiang.chen.4@asu.edu; Huafang.lai@asu.edu
OI chen, qiang/0000-0003-1498-7013
FU NIH-NIAIDUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [U01 AI075549, R21/R33AI101329]; Biodesign
   Seed Fund
FX We appreciate the contributions by Junyun He, Ming Yang, Jonathan
   Hurtado, Collin Jugler, Adrian Esqueda, Sean Madden, Yousif Youhana,
   Allen Ramollari, and other current and former members of the Chen
   laboratory for research cited in this review. We also thank Collin
   Jugler for the critical reading of the manuscript. We appreciate the
   assistance of Jonathan Hurtado in preparing the figures. Research in the
   authors' laboratory was supported in part by NIH-NIAID grants U01
   AI075549 and R21/R33AI101329 to Qiang Chen and a Biodesign Seed Fund.
CR Attar N., 2016, NAT REV MICROBIOL, V14, P62, DOI DOI 10.1038/NRMICR0.2015.28
   Austin SK, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002930
   Balsitis SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000790
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   Bendandi M, 2010, ANN ONCOL, V21, P2420, DOI 10.1093/annonc/mdq256
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Blitvich BJ, 2015, VIRUSES-BASEL, V7, P1927, DOI 10.3390/v7041927
   Boado RJ, 2007, BIOTECHNOL BIOENG, V96, P381, DOI 10.1002/bit.21120
   Brady MT, 2014, PEDIATRICS, V134, pE620, DOI 10.1542/peds.2014-1666
   Cai H., 2017, MOJ IMMUNOL, V5, p[145, 00145], DOI [10.15406/moji.2017.05.00145, DOI 10.15406/MOJI.2017.05.00145]
   Calzolari M, 2016, INFECT GENET EVOL, V40, P381, DOI 10.1016/j.meegid.2015.07.032
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Casadevall A, 2004, NAT REV MICROBIOL, V2, P695, DOI 10.1038/nrmicro974
   Castanha PMS, 2017, J INFECT DIS, V215, P781, DOI 10.1093/infdis/jiw638
   Chan KR, 2015, EXPERT REV ANTI-INFE, V13, P1351, DOI 10.1586/14787210.2015.1079127
   Chen Q., 2016, F1000RESEARCH, V5, DOI [10. 12688/f1000research. 8010. 1 27274814, DOI 10.12688/F1000RESEARCH.8010.127274814]
   Chen Q., 2008, BIOL ENG, V1, P291, DOI DOI 10.13031/201326854
   Chen Q., 2015, DRUG TARGET REV, V2, P41
   Chen Q., 2011, EUROPEAN BIOPHARM RE, V2, P64
   Chen Q, 2016, P NATL ACAD SCI USA, V113, P9404, DOI 10.1073/pnas.1610803113
   Chen Q, 2014, CABI BIOTECH SER, P42, DOI 10.1079/9781780643434.0042
   Chen Q, 2014, BIOMED RES INT, DOI 10.1155/2014/418064
   Chen Q, 2011, TRANSGENIC HORTICULTURAL CROPS: CHALLENGES AND OPPORTUNITIES, P83
   Chen Q, 2011, HUM VACCINES, V7, P331, DOI 10.4161/hv.7.3.14262
   Chung KM, 2006, J VIROL, V80, P1340, DOI 10.1128/JVI.80.3.1340-1351.2006
   Cockburn JJB, 2012, STRUCTURE, V20, P303, DOI 10.1016/j.str.2012.01.001
   Collins MH, 2017, CLIN THER, V39, P1519, DOI 10.1016/j.clinthera.2017.07.001
   Costin JM, 2013, J VIROL, V87, P52, DOI 10.1128/JVI.02273-12
   Crill WD, 2004, J VIROL, V78, P13975, DOI 10.1128/JVI.78.24.13975-13986.2004
   Czuczman MS, 1999, J CLIN ONCOL, V17, P268, DOI 10.1200/JCO.1999.17.1.268
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   de Alwis R, 2012, P NATL ACAD SCI USA, V109, P7439, DOI 10.1073/pnas.1200566109
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181
   Deng YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016059
   Dent M, 2016, J GEN VIROL, V97, P3280, DOI 10.1099/jgv.0.000635
   Diamond MS, 2009, ANTIVIR RES, V83, P214, DOI 10.1016/j.antiviral.2009.05.006
   Edeling MA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004072
   Fernandez E, 2017, NAT IMMUNOL, V18, P1261, DOI 10.1038/ni.3849
   Fibriansah G, 2015, SCIENCE, V349, P88, DOI 10.1126/science.aaa8651
   Fibriansah G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7341
   Fibriansah G, 2014, EMBO MOL MED, V6, P358, DOI 10.1002/emmm.201303404
   Gallichotte EN, 2015, MBIO, V6, DOI 10.1128/mBio.01461-15
   Garcia G, 2006, J CLIN VIROL, V37, P53, DOI 10.1016/j.jcv.2006.04.010
   Garraud O, 2016, TRANSFUS CLIN BIOL, V23, P39, DOI 10.1016/j.tracli.2015.12.003
   Gerold G, 2017, MOL CELL PROTEOMICS, V16, pS75, DOI 10.1074/mcp.R116.065649
   Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4
   HALSTEAD SB, 1973, NATURE-NEW BIOL, V243, P24
   HALSTEAD SB, 1979, J INFECT DIS, V140, P527, DOI 10.1093/infdis/140.4.527
   Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0
   Halstead SB, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.AID-0022-2014
   Hasan SS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14722
   Haslwanter D, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006643
   He JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093541
   Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106
   Hezareh M, 2001, J VIROL, V75, P12161, DOI 10.1128/JVI.75.24.12161-12168.2001
   Holbrook MR, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9050097
   Houde D, 2010, MOL CELL PROTEOMICS, V9, P1716, DOI 10.1074/mcp.M900540-MCP200
   Huang K, 2010, J VIROL, V84, P8132, DOI 10.1128/JVI.02699-09
   Huang Z, 2010, BIOTECHNOL BIOENG, V106, P9, DOI 10.1002/bit.22652
   Huang Z, 2009, BIOTECHNOL BIOENG, V103, P706, DOI 10.1002/bit.22299
   Hudis CA, 2007, NEW ENGL J MED, V357, P39, DOI 10.1056/NEJMra043186
   Huisman W, 2009, VACCINE, V27, P505, DOI 10.1016/j.vaccine.2008.10.087
   Hurtado J., PLANT PRODUCED UNPUB
   Jefferis R, 2005, BIOTECHNOL PROGR, V21, P11, DOI 10.1021/bp040016j
   Jiang XR, 2011, NAT REV DRUG DISCOV, V10, P101, DOI 10.1038/nrd3365
   Johnson S, 1997, J INFECT DIS, V176, P1215, DOI 10.1086/514115
   Junglen S, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00375-16, 10.1128/msphere.00375-16]
   KAUFMAN BM, 1989, AM J TROP MED HYG, V41, P576, DOI 10.4269/ajtmh.1989.41.576
   Kaufmann B, 2010, P NATL ACAD SCI USA, V107, P18950, DOI 10.1073/pnas.1011036107
   Kaufmann B, 2006, P NATL ACAD SCI USA, V103, P12400, DOI 10.1073/pnas.0603488103
   Kayser V, 2011, BIOTECHNOL J, V6, P38, DOI 10.1002/biot.201000091
   Kimura H, 2007, CANCER SCI, V98, P1275, DOI 10.1111/j.1349-7006.2007.00510.x
   Klimyuk V, 2014, CURR TOP MICROBIOL, V375, P127, DOI 10.1007/82_2012_212
   KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0
   Kraemer MUG, 2017, LANCET INFECT DIS, V17, P330, DOI [10.1016/S1473-3099(16)30513-8, 10.1016/s1473-3099(16)30513-8]
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005
   Lai CY, 2008, J VIROL, V82, P6631, DOI 10.1128/JVI.00316-08
   Lai HF, 2014, PLANT BIOTECHNOL J, V12, P1098, DOI 10.1111/pbi.12217
   Lai HF, 2012, PLANT CELL REP, V31, P573, DOI 10.1007/s00299-011-1196-6
   Lai HF, 2012, PLANT BIOTECHNOL J, V10, P95, DOI 10.1111/j.1467-7652.2011.00649.x
   Lai HF, 2010, P NATL ACAD SCI USA, V107, P2419, DOI 10.1073/pnas.0914503107
   Laoprasopwattana K, 2007, J INFECT DIS, V195, P1108, DOI 10.1086/512860
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lee W.S., 2007, CURR OPIN HIV AIDS, DOI [10. 1097/COH. 0000000000000439 29194123, DOI 10.1097/COH.000000000000043929194123]
   Lewis S., 2017, P C RETR OPP INF CRO, p449LB
   Lico C, 2008, J CELL PHYSIOL, V216, P366, DOI 10.1002/jcp.21423
   LIN B, 1994, VIROLOGY, V202, P885, DOI 10.1006/viro.1994.1410
   Lok SM, 2008, NAT STRUCT MOL BIOL, V15, P312, DOI 10.1038/nsmb.1382
   Lok SM, 2001, J MED VIROL, V65, P315, DOI 10.1002/jmv.2036
   Loos A, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00523
   Low JGH, 2017, J INFECT DIS, V215, pS96, DOI 10.1093/infdis/jiw423
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P152, DOI 10.2450/2015.0131-15
   Mehlhop E, 2007, CELL HOST MICROBE, V2, P417, DOI 10.1016/j.chom.2007.09.015
   Mehlhop E, 2009, CELL HOST MICROBE, V6, P381, DOI 10.1016/j.chom.2009.09.003
   Mellor JD, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-1
   Messer WB, 2016, J VIROL, V90, P5090, DOI 10.1128/JVI.00155-16
   Mlera L, 2014, PATHOG DIS, V71, P135, DOI 10.1111/2049-632X.12178
   Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   MORENS DM, 1994, CLIN INFECT DIS, V19, P500, DOI 10.1093/clinids/19.3.500
   Mukhopadhyay S, 2003, SCIENCE, V302, P248, DOI 10.1126/science.1089316
   Murphy BR, 2011, ANNU REV IMMUNOL, V29, P587, DOI 10.1146/annurev-immunol-031210-101315
   Murray K, 2010, J INFECT DIS, V201, P2, DOI 10.1086/648731
   Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440
   Musolino A, 2008, J CLIN ONCOL, V26, P1789, DOI 10.1200/JCO.2007.14.8957
   Nandi S, 2016, MABS-AUSTIN, V8, P1456, DOI 10.1080/19420862.2016.1227901
   Nybakken GE, 2005, NATURE, V437, P764, DOI 10.1038/nature03956
   Nybakken GE, 2006, J VIROL, V80, P11467, DOI 10.1128/JVI.01125-06
   Olinger GG, 2012, P NATL ACAD SCI USA, V109, P18030, DOI 10.1073/pnas.1213709109
   Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240
   Oliphant T, 2007, J VIROL, V81, P11828, DOI 10.1128/JVI.00643-07
   Oliphant T, 2006, J VIROL, V80, P12149, DOI 10.1128/JVI.01732-06
   Olson WC, 2009, CURR OPIN HIV AIDS, V4, P104, DOI 10.1097/COH.0b013e3283224015
   Pang T, 2016, LANCET INFECT DIS, V16, P880, DOI 10.1016/S1473-3099(16)30167-0
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   Perera-Lecoin Manuel, 2013, Viruses, V6, P69, DOI 10.3390/v6010069
   Peyret H, 2015, PLANT BIOTECHNOL J, V13, P1121, DOI 10.1111/pbi.12412
   Phoolcharoen W, 2011, P NATL ACAD SCI USA, V108, P20695, DOI 10.1073/pnas.1117715108
   Phoolcharoen W, 2011, PLANT BIOTECHNOL J, V9, P807, DOI 10.1111/j.1467-7652.2011.00593.x
   Pierson TC, 2008, CELL HOST MICROBE, V4, P229, DOI 10.1016/j.chom.2008.08.004
   Pierson Theodore C., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000665
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Qiu XG, 2014, NATURE, V514, P47, DOI 10.1038/nature13777
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   RicoHesse R, 1997, VIROLOGY, V230, P244, DOI 10.1006/viro.1997.8504
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Robinson LN, 2015, CELL, V162, P493, DOI 10.1016/j.cell.2015.06.057
   Rothman AL, 2004, J CLIN INVEST, V113, P946, DOI [10.1172/JCI200421512, 10.1172/JCI21512]
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   Sahr F, 2017, J INFECTION, V74, P302, DOI 10.1016/j.jinf.2016.11.009
   Samarasekera U, 2016, LANCET, V387, P521, DOI 10.1016/S0140-6736(16)00257-9
   Santi L, 2008, VACCINE, V26, P1846, DOI 10.1016/j.vaccine.2008.01.053
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Scott AM, 2012, NAT REV CANCER, V12, P278, DOI 10.1038/nrc3236
   Screaton G, 2015, NAT REV IMMUNOL, V15, P745, DOI 10.1038/nri3916
   Shaaltiel Y, 2016, NAT BIOTECHNOL, V34, P706, DOI 10.1038/nbt.3556
   Shrestha B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000823
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Smith SA, 2013, MBIO, V4, DOI 10.1128/mBio.00873-13
   Sparrow E, 2017, B WORLD HEALTH ORGAN, V95, P235, DOI [10.2471/BLT.16.178061, 10.2471/blt.16.178061]
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Stiasny K, 2006, J VIROL, V80, P9557, DOI 10.1128/JVI.00080-06
   Strasser R, 2014, CURR OPIN BIOTECH, V30, P95, DOI 10.1016/j.copbio.2014.06.008
   Sukupolvi-Petty S, 2010, J VIROL, V84, P9227, DOI 10.1128/JVI.01087-10
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Takada A, 2003, REV MED VIROL, V13, P387, DOI 10.1002/rmv.405
   Tanwar Jyoti, 2014, Interdiscip Perspect Infect Dis, V2014, P541340, DOI 10.1155/2014/541340
   Taylor A, 2015, IMMUNOL REV, V268, P340, DOI 10.1111/imr.12367
   Teoh EP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003888
   Tharakaraman K, 2013, P NATL ACAD SCI USA, V110, pE1555, DOI 10.1073/pnas.1303645110
   Throsby M, 2006, J VIROL, V80, P6982, DOI 10.1128/JVI.00551-06
   Thullier P, 2001, J GEN VIROL, V82, P1885, DOI 10.1099/0022-1317-82-8-1885
   Tuse D, 2014, BIOMED RES INT, DOI 10.1155/2014/256135
   Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019
   VanBlargan LA, 2016, MICROBIOL MOL BIOL R, V80, DOI 10.1128/MMBR.00024-15
   Vogt MR, 2011, J VIROL, V85, P11567, DOI 10.1128/JVI.05859-11
   Vogt MR, 2009, J VIROL, V83, P6494, DOI 10.1128/JVI.00286-09
   Wahala WMPB, 2009, VIROLOGY, V392, P103, DOI 10.1016/j.virol.2009.06.037
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Weiner GJ, 2010, SEMIN HEMATOL, V47, P115, DOI 10.1053/j.seminhematol.2010.01.011
   Wilder-Smith A, 2008, MED CLIN N AM, V92, P1377, DOI 10.1016/j.mcna.2008.07.002
   Williams KL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003157
   Wines BD, 2000, J IMMUNOL, V164, P5313, DOI 10.4049/jimmunol.164.10.5313
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Wong YH, 2017, J VIROL, V91, DOI [10.1128/JVI.00406-17, 10.1128/jvi.00406-17]
   Yamamoto BJ, 2016, ANTIMICROB AGENTS CH, V60, P5787, DOI 10.1128/AAC.00972-16
   Yang M., MONOCLONAL ANT UNPUB
   Yang Z, 2015, NAT BIOTECHNOL, V33, P842, DOI 10.1038/nbt.3280
   Zeitlin L, 2011, P NATL ACAD SCI USA, V108, P20690, DOI 10.1073/pnas.1108360108
   Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
   Zheng K, 2011, MABS-AUSTIN, V3, P568, DOI 10.4161/mabs.3.6.17922
   Zhou XH, 2008, ONCOLOGIST, V13, P954, DOI 10.1634/theoncologist.2008-0089
NR 180
TC 13
Z9 14
U1 0
U2 4
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD JAN
PY 2018
VL 19
IS 1
AR 54
DI 10.3390/ijms19010054
PG 26
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA FV2OI
UT WOS:000424407200052
PM 29295568
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Aguiar, YPC
   Cavalcanti, AFC
   de Alencar, CRB
   Melo, ASD
   Cavalcanti, SDLB
   Cavalcanti, AL
AF Costa Aguiar, Yeska Paola
   Cabral Cavalcanti, Alidianne Fabia
   Barros de Alencar, Catarina Ribeiro
   de Oliveira Melo, Adriana Suely
   Lins Bezerra Cavalcanti, Sergio d'Avila
   Cavalcanti, Alessandro Leite
TI Chronology of the First Deciduous Tooth Eruption in Brazilian Children
   with Microcephaly Associated with Zika Virus: A Longitudinal Study
SO PESQUISA BRASILEIRA EM ODONTOPEDIATRIA E CLINICA INTEGRADA
LA English
DT Article
DE Tooth Eruption; Tooth, Deciduous; Microcephaly; Zika Virus Infection
ID DENTAL-CARIES; PRIMARY TEETH; INFECTION; INFANTS; BIRTH; BORN; LIFE
AB Objective: To analyze the chronology of first deciduous tooth eruption in children with microcephaly associated with presumed or confirmed Zika virus. Material and Methods: A longitudinal study was developed with 74 children of both sexes. Data on prematurity, gestational age (in weeks), anthropometric characteristics at birth [length (cm), weight (g) and cephalic perimeter (cm)] and dental eruption (chronological age and corrected age for prematurity in months) were collected and presented through descriptive statistics. Data was analyzed using the Statistical Package for Social Sciences. Results: The majority of children were female (54.1%) and 14.9% were born premature. The mean gestational age was 38.2 (+/- 1.9) weeks, while length, weight and cephalic perimeter at birth were 45.6 (+/- 3.1) cm, 2750 (+/- 526.6) and 30 (+/- 2.3) cm, respectively. The eruption of the first tooth occurred on average at 12.3 (+/- 3.0) months of chronological age and at 11.1 (+/- 2.3) months of corrected age. The first erupted teeth were the lower deciduous central incisors (82.4%). The mean age for dental eruption in males was 12.5 months (+/- 3.0) and in females 12.0 months (+/- 3.1) among full-term children. For premature infants, the mean corrected age of dental eruption was 11.5 months (+/- 3.4) for boys and 11 months (+/- 1.7) for girls. Conclusion: In this group of children with microcephaly, the first tooth to erupt was the lower central incisor around the first year of life. Girls had lower average eruption time when compared to boys in both chronological age and age corrected for prematurity.
C1 [Costa Aguiar, Yeska Paola; Cabral Cavalcanti, Alidianne Fabia] State Univ Paraiba, Sch Dent, Postgrad Program Dent, Campina Grande, PB, Brazil.
   [Barros de Alencar, Catarina Ribeiro; Lins Bezerra Cavalcanti, Sergio d'Avila; Cavalcanti, Alessandro Leite] State Univ Paraiba, Sch Dent, Campina Grande 3, PB, Brazil.
   [de Oliveira Melo, Adriana Suely] Univ Fed Campina Grande, Fac Med, Campina Grande, PB, Brazil.
RP Aguiar, YPC (corresponding author), Univ Estadual Paraiba, Programa Posgrad Odontol, Ave Baraunas,351 Bodocongo, BR-58429500 Campina Grande, PB, Brazil.
EM yeskapaola@gmail.com
RI Cavalcanti, Alessandro Leite/I-4286-2019; Alencar,
   Catarina/AAQ-5347-2020; Melo, Adriana S O/H-5650-2016; d'Avila,
   Sergio/I-9093-2014
OI Cavalcanti, Alessandro Leite/0000-0003-3572-3332; d'Avila,
   Sergio/0000-0002-7836-896X
FU Coordination of Improvement of Higher Education Personnel (CAPES)CAPES;
   CAPESCAPES; CNPq (National Council for Scientific and Technological
   Development)National Council for Scientific and Technological
   Development (CNPq) [302850/2016-3]
FX YPC Aguiar thanks to the Coordination of Improvement of Higher Education
   Personnel (CAPES) for a doctoral fellowship. CRB Alencar thanks CAPES
   for a post-doctoral fellowship. AL Cavalcanti thanks CNPq (National
   Council for Scientific and Technological Development) for a research
   productivity fellowship (Proc. No. 302850/2016-3).
CR Affan AA, 2014, BRAZ DENT SCI, V17, P67
   Alghadir AH, 2017, AFR HEALTH SCI, V17, P133, DOI 10.4314/ahs.v17i1.17
   [Anonymous], PRET BIRTH
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Brasil. Secretaria de Vigilancia em Saude. Ministerio da Saude, B EPIDEMIOLOGICO
   Torres LB, 2015, EUR J PAEDIATR DENT, V16, P301
   Xavier AFC, 2015, PESQUI BRAS ODONTOPE, V15, P279, DOI 10.4034/PBOCI.2015.151.30
   Cavalcanti AL, 2017, CONTEMP CLIN DENT, V8, P345, DOI 10.4103/0976-237X.214553
   Charlier C, 2017, LANCET CHILD ADOLESC, V1, P134, DOI 10.1016/S2352-4642(17)30021-4
   de Castinho LS, 2017, PESQUI BRAS ODONTOPE, V17, DOI 10.4034/PBOCI.2017.171.23
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   Ferreira L, 2015, PESQUI BRAS ODONTOPE, V15, P361, DOI 10.4034/PBOCI.2015.151.38
   Hartwig AD, 2016, PESQUI BRAS ODONTOPE, V16, P59, DOI 10.4034/PBOCI.2016.161.07
   Kapogiannis BG, 2017, JAMA PEDIATR, V171, P478, DOI 10.1001/jamapediatrics.2017.0002
   Khalifa AM, 2014, EGYPT PEDIATR ASSO, V62, P41, DOI 10.1016/j.epag.2014.04.001
   Lam CU, 2016, CLIN ORAL INVEST, V20, P1871, DOI 10.1007/s00784-015-1670-6
   Leal MC, 2017, EMERG INFECT DIS, V23, P1253, DOI 10.3201/eid2308.170354
   Lopes LC, 2016, PESQUI BRAS ODONTOPE, V16, P289, DOI 10.4034/PBOCI.2016.161.30
   Lynch RJM, 2013, INT DENT J, V63, P3, DOI 10.1111/idj.12076
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Millichap J Gordon, 2016, Pediatr Neurol Briefs, V30, P8, DOI 10.15844/pedneurbriefs-30-1-7
   F. Neto Pedro Garcia, 2014, Rev. paul. pediatr., V32, P17, DOI 10.1590/S0103-05822014000100004
   Oziegbe EO, 2008, J CLIN PEDIATR DENT, V32, P341, DOI 10.17796/jcpd.32.4.9571r10781044217
   Oznurhan F, 2016, PEDIATR DENT J, V26, P1, DOI 10.1016/j.pdj.2015.09.002
   Rezende KMPEC, 2010, PESQUI BRAS ODONTOPE, V10, P61, DOI 10.4034/1519.0501.2010.0101.0010
   Sahin F, 2008, INT J PAEDIATR DENT, V18, P262, DOI 10.1111/j.1365-263X.2007.00893.x
   Sajjadian N, 2010, PEDIATR NEONATOL, V51, P235, DOI 10.1016/S1875-9572(10)60044-7
   Thomson WM, 2018, PESQUI BRAS ODONTOPE, V18, DOI 10.4034/PBOCI.2018.181.ed1
   Valinoti AC, 2016, OPEN DENT J, V10, P420, DOI 10.2174/1874210601610010420
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Dadalto ECV, 2017, PESQUI BRAS ODONTOPE, V17, DOI 10.4034/PBOCI.2017.171.42
   Wang LP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07264-y
   Westra SJ, 2017, LANCET CHILD ADOLESC, V1, P6, DOI 10.1016/S2352-4642(17)30002-0
   Xavier AFC, 2013, BMC ORAL HEALTH, V13, DOI 10.1186/1472-6831-13-71
   Zadzinska E, 2016, ANN HUM BIOL, V43, P25, DOI 10.3109/03014460.2015.1006140
NR 35
TC 5
Z9 5
U1 1
U2 2
PU ASSOC APOIO PESQUISA & SAUDE BUCAL-APESB
PI JOAO PESSOA
PA AGENCIA CIDADE UNIV, UNIV FEDERAL PARAIBA, CAMPUS I, JOAO PESSOA, PB
   58051-970, BRAZIL
SN 1519-0501
EI 1983-4632
J9 PESQUI BRAS ODONTOPE
JI Pesqui. Bras. Odontopediatria Clin. Integr.
PY 2018
VL 18
IS 1
AR e3982
DI 10.4034/PBOCI.2018.181.16
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA FX2JC
UT WOS:000425884700030
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Wahid, B
   Ali, A
   Waqar, M
   Idrees, M
AF Wahid, Braira
   Ali, Amjad
   Waqar, Muhammad
   Idrees, Muhammad
TI An updated systematic review of Zika virus-linked complications
SO ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE
LA English
DT Review
DE Zika virus; Microcephaly; Guillain-Barre syndrome; Acute myelitis;
   Meningoencephalitis; hydrancephaly/hydrops fetalis; Myasthenia gravis
ID GUILLAIN-BARRE-SYNDROME; BIRTH-DEFECTS SURVEILLANCE; CASE SERIES;
   INFECTION; BRAZIL; EPIDEMIOLOGY; ACTIVATION; PATHOLOGY; BRAIN; RISK
AB Objective: To determine the breadth of Zika virus (ZIKV)-associated brain anomalies in neonates and adults. Methods: Systematic review was conducted according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement using electronic databases ScienceDirect, Pubmed, Medline, Scopus, and Global Health Library. Only those research articles, case studies, case-control studies, case-cohort studies, cross-sectional studies, and organizational survey reports were included in the study that reported any fetal outcomes for pregnant women who had infected with ZIKV during the gestational period and ZIKV-related neurological complications in adults as well. Results: Out of total 72 retrieved articles, 50 met the inclusion criteria. We estimated a significant increase in incidence of neural abnormalities such as Guillain-Barre syndrome and microcephaly in the regions that are experiencing ZIKV outbreaks. Other neurological malformations found in ZIKV patients include hydrancephaly/hydrops fetalis, myasthenia gravis, meningoencephalitis and myelitis. Conclusion: Our systematic analysis provides the broad spectrum of neurological malformations in ZIKV infected patients and these data further support the causal link of ZIKV with neurological disorders.
C1 [Wahid, Braira; Ali, Amjad; Waqar, Muhammad; Idrees, Muhammad] Univ Punjab, Ctr Appl Mol Biol, 87 West Canal Bank Rd Thokar Niaz Baig, Lahore 53700, Pakistan.
   [Wahid, Braira; Waqar, Muhammad; Idrees, Muhammad] Genome Ctr Mol Based Diagnost & Res Ctr, Abdalian Cooperat Soc, Cl-25,Block B Al Sudais Plaza, Lahore, Pakistan.
   [Idrees, Muhammad] Hazara Univ, Mansehra, Pakistan.
RP Ali, A (corresponding author), Univ Punjab, Ctr Appl Mol Biol, 87 West Canal Bank Rd Thokar Niaz Baig, Lahore 53700, Pakistan.
EM brairawahid@gmail.com; amjad.camb@pu.edu.pk
RI Idrees, Muhammad/K-6032-2012
OI Idrees, Muhammad/0000-0002-3081-7631
CR Acevedo Nathalie, 2017, Front Microbiol, V8, P42, DOI 10.3389/fmicb.2017.00042
   Arias A, 2017, J CRIT CARE, V37, P19, DOI 10.1016/j.jcrc.2016.08.016
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Blazquez Ana-Belen, 2016, World J Virol, V5, P135
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Calvet GA, 2016, J CLIN VIROL, V74, P1, DOI 10.1016/j.jcv.2015.11.014
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Carod-Artal FJ, 2016, REV NEUROLOGIA, V62, P317, DOI 10.33588/rn.6207.2016152
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Cumberworth SL, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0450-8
   Cunha AJ, 2016, B WHO, V94
   da Silva SR, 2016, J MED VIROL, V88, P1291, DOI 10.1002/jmv.24563
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   de Oliveira CS, 2016, J PEDIAT-BRAZIL, V92, P103, DOI 10.1016/j.jped.2016.02.003
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   Department of Defense, ARM FORC HLTH SURV B
   do Rosario MS, 2016, AM J TROP MED HYG, V95, P1157, DOI 10.4269/ajtmh.16-0306
   Duijster JW, 2016, INFECTION, V44, P797, DOI 10.1007/s15010-016-0906-y
   European Centre for Disease Prevention and Control, EP UPD COMPL POT LIN
   Fabrizius RG, 2016, AM J TROP MED HYG, V95, P1161, DOI 10.4269/ajtmh.16-0397
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hall NB, 2017, MMWR-MORBID MORTAL W, V66, P835, DOI 10.15585/mmwr.mm6631a5
   Hurtado-Villa P, 2017, PEDIATR INFECT DIS J, V36, P1017, DOI [10.1097/INF.0000000000001670, 10.1097/inf.0000000000001670]
   Jaenisch T, 2017, B WORLD HEALTH ORGAN, V95, P191, DOI [10.2471/BLT.16.178608, 10.2471/blt.16.178608]
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kassavetis P, 2016, NEUROLOGY, V87, P336, DOI 10.1212/WNL.0000000000002759
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Korzeniewski K, 2016, INT MARIT HEALTH, V67, P31, DOI 10.5603/IMH.2016.0007
   Langerak T, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00233
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Mehrjardi MZ, 2016, JPN J RADIOL, V34, P765, DOI 10.1007/s11604-016-0588-5
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Molko N, 2017, NEUROLOGY, V88, P1097, DOI 10.1212/WNL.0000000000003697
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Oehler E, 2015, EUROSURVEILLANCE, V20, P13, DOI 10.2807/1560-7917.ES.2015.20.48.30079
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Oh Y, 2017, NAT NEUROSCI, V20, P1209, DOI 10.1038/nn.4612
   PAN Americna Health Organization, ZIK EP UPD
   Fontes CAP, 2016, NEURORADIOLOGY, V58, P837, DOI 10.1007/s00234-016-1687-9
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Reyna-Villasmil E, 2016, MED CLIN-BARCELONA, V146, P331, DOI 10.1016/j.medcli.2016.02.002
   Roze B, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.9.30154
   Santos VS, 2017, AM J TROP MED HYG, V97, P151, DOI 10.4269/ajtmh.16-1021
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Schwartzmann PV, 2017, MAYO CLIN PROC, V92, P460, DOI 10.1016/j.mayocp.2016.12.019
   Silva ACSE, 2016, NEUROPSYCH DIS TREAT, V12, P1747, DOI 10.2147/NDT.S113037
   Soares CN, 2016, J CLIN VIROL, V83, P63, DOI 10.1016/j.jcv.2016.08.297
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Teng Y, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00327
   Tetro JA, 2016, MICROBES INFECT, V18, P167, DOI 10.1016/j.micinf.2015.12.010
   Tricarico PM, 2017, BIOCHEM BIOPH RES CO, V492, P597, DOI 10.1016/j.bbrc.2017.01.158
   van den Berg B, 2016, Ned Tijdschr Geneeskd, V160, pD155
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Watrin L, 2016, MEDICINE, V95, P3257
   World Health Organization, GUILL BARR SYNDR SAL
   World Health Organization, ZIK VIR MICR GUILL B
   World Health Organization, GUILL BARR SYNDR COL
   Yoon KJ, 2017, CELL STEM CELL, V21, P349, DOI 10.1016/j.stem.2017.07.014
   Zambrano H, 2016, AM J TROP MED HYG, V95, P894, DOI 10.4269/ajtmh.16-0323
   Zhu Z, 2017, J EXP MED, V214, P2843, DOI 10.1084/jem.20171093
NR 69
TC 2
Z9 2
U1 0
U2 4
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 1995-7645
EI 2352-4146
J9 ASIAN PAC J TROP MED
JI Asian Pac. J. Trop. Med.
PD JAN
PY 2018
VL 11
IS 1
BP 1
EP 8
DI 10.4103/1995-7645.223527
PG 8
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FW7MH
UT WOS:000425507300001
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Eng, MW
   Clemons, A
   Hill, C
   Engel, R
   Severson, DW
   Behura, SK
AF Eng, Matthew W.
   Clemons, Anthony
   Hill, Casey
   Engel, Roberta
   Severson, David W.
   Behura, Susanta K.
TI Multifaceted functional implications of an endogenously expressed tRNA
   fragment in the vector mosquito Aedes aegypti
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID GENES; MICRORNAS; MIDGUT; SUSCEPTIBILITY; IDENTIFICATION; TRANSCRIPTOME;
   BIOGENESIS; ROLES; TRFS
AB The mosquito Aedes aegypti is the primary vector of human arboviral diseases caused by dengue, chikungunya and Zika viruses. Many studies have shown the potential roles of small RNA molecules such as microRNA, small interfering RNA and PIWI-interacting RNA in vector mosquitoes. The function of tRNA fragments (tRF), the newly discovered class of small RNAs, in mosquitoes is not known. In this study, we show that specific tRFs are expressed in significantly differential manner between males and females of Ae. aegypti strains. Specific tRFs also show differential response during developmental transition from larvae to adults, as well as after blood feeding of adult females. The expression pattern of tRFs upon blood feeding varied depending upon if the blood contained dengue virus, and also if the females were treated with antibiotic prior to feeding to cleanse of the gut bacteria. Our findings show that a single tRF derived from the precursor sequences of a tRNA-Gly was differentially expressed between males and females, developmental transitions and also upon blood feeding by females of two laboratory strains that vary in midgut susceptibility to dengue virus infection. The multifaceted functional implications of this specific tRF suggest that biogenesis of small regulatory molecules from a tRNA can have wide ranging effects on key aspects of Ae. aegypti vector biology.
C1 [Behura, Susanta K.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.
   Univ Notre Dame, Eck Inst Global Hlth, Notre Dame, IN 46556 USA.
   [Behura, Susanta K.] Univ Missouri, Div Anim Sci, Columbia, MO 65211 USA.
RP Behura, SK (corresponding author), Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.; Behura, SK (corresponding author), Univ Missouri, Div Anim Sci, Columbia, MO 65211 USA.
EM behuras@missouri.edu
FU University of Notre Dame; Fogarty International CenterUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH Fogarty International Center (FIC); National Institute of
   Allergy and Infectious Diseases at the National Institutes of
   HealthUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R03-TW008138, R01-AI059342]
FX This work was supported in part by a Faculty Initiation Grant to SKB
   from the University of Notre Dame (http://research.nd.edu) and grants
   from Fogarty International Center and National Institute of Allergy and
   Infectious Diseases at the National Institutes of Health
   (https//grants.nih.gov/) (R03-TW008138, R01-AI059342) to DWS. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Abe Takashi, 2014, Front Genet, V5, P114, DOI 10.3389/fgene.2014.00114
   Akbari OS, 2013, G3-GENES GENOM GENET, V3, P1493, DOI 10.1534/g3.113.006742
   Anderson P, 2014, FEBS LETT, V588, P4297, DOI 10.1016/j.febslet.2014.09.001
   Asgari S, 2014, VIRUSES-BASEL, V6, P3514, DOI 10.3390/v6093514
   Bakowska-Zywicka K, 2016, FEMS YEAST RES, V16, DOI 10.1093/femsyr/fow077
   Behura SK, 2011, INSECT MOL BIOL, V20, P177, DOI 10.1111/j.1365-2583.2010.01055.x
   Behura SK, 2010, INSECT MOL BIOL, V19, P49, DOI 10.1111/j.1365-2583.2009.00933.x
   Behura SK, 2007, INSECT BIOCHEM MOLEC, V37, P3, DOI 10.1016/j.ibmb.2006.10.006
   Behura SK, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001385
   Behura SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021504
   Blenkiron C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122203
   Bouzid M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005176
   Bronkhorst AW, 2014, CURR OPIN VIROL, V7, P19, DOI 10.1016/j.coviro.2014.03.010
   Bryant B, 2010, P NATL ACAD SCI USA, V107, P22391, DOI 10.1073/pnas.1016230107
   Clemons Anthony, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.emo141
   Gebetsberger J, 2016, RNA BIOL, V28, P1
   Goddard J, 2016, AM J MED, V129, P1149, DOI 10.1016/j.amjmed.2016.07.021
   Harker BW, 2013, BMC DEV BIOL, V13, DOI 10.1186/1471-213X-13-29
   Hill CL, 2014, ACTA TROP, V140, P151, DOI 10.1016/j.actatropica.2014.07.015
   Hussain M, 2013, INSECT BIOCHEM MOLEC, V43, P146, DOI 10.1016/j.ibmb.2012.11.005
   Ivanov P, 2015, MOL THER, V23, P1557, DOI 10.1038/mt.2015.161
   Jarrous N, 2007, NUCLEIC ACIDS RES, V35, P3519, DOI 10.1093/nar/gkm071
   Kanai Akio, 2015, Life-Basel, V5, P321, DOI 10.3390/life5010321
   Karaiskos Spyros, 2016, F1000Res, V5, DOI 10.12688/f1000research.10116.1
   Karaiskos S, 2015, BIOL DIRECT, V10, DOI 10.1186/s13062-015-0081-6
   Keam SP, 2017, J PROTEOME RES, V16, P413, DOI 10.1021/acs.jproteome.6b00267
   Keam Simon P., 2015, Life-Basel, V5, P1638, DOI 10.3390/life5041638
   Kumar P, 2016, TRENDS BIOCHEM SCI, V41, P679, DOI 10.1016/j.tibs.2016.05.004
   Lalaouna D, 2015, TRANSCR-AUSTIN, V6, P74, DOI 10.1080/21541264.2015.1093064
   Lee YS, 2009, GENE DEV, V23, P2639, DOI 10.1101/gad.1837609
   Li Q, 2016, SCI REP-UK, V6, DOI 10.1038/srep20850
   Li ZH, 2012, NUCLEIC ACIDS RES, V40, P6787, DOI 10.1093/nar/gks307
   Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214
   Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955
   Lucas KJ, 2013, TRENDS PARASITOL, V29, P295, DOI 10.1016/j.pt.2013.04.003
   Meyer PE, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-461
   Miesen P, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006017
   Miesen P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004452
   Mongelli V, 2016, ANNU REV VIROL, V3, P573, DOI 10.1146/annurev-virology-110615-042447
   Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878
   Nie ZM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-661
   Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122
   Sakkas H, 2016, J VECTOR DIS, V53, P305
   Schiffer S, 2002, EMBO J, V21, P2769, DOI 10.1093/emboj/21.11.2769
   Schneider JR, 2007, MED VET ENTOMOL, V21, P370, DOI 10.1111/j.1365-2915.2007.00699.x
   Severson DW, 2016, INSECTS, V7, DOI 10.3390/insects7040058
   Sharma U, 2016, SCIENCE, V351, P391, DOI 10.1126/science.aad6780
   Shigematsu M, 2014, J MOL BIOL MOL IMAGI, V1, P8
   Su JX, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-1966-2
   THATHY V, 1994, J PARASITOL, V80, P705, DOI 10.2307/3283249
   Toure AM, 2000, J MED ENTOMOL, V37, P246, DOI 10.1603/0022-2585-37.2.246
   Wang QR, 2013, MOL THER, V21, P368, DOI 10.1038/mt.2012.237
   Zhou XB, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku310
NR 53
TC 2
Z9 2
U1 2
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JAN
PY 2018
VL 12
IS 1
AR e0006186
DI 10.1371/journal.pntd.0006186
PG 16
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA FU7HJ
UT WOS:000424022700047
PM 29364883
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Fritzell, C
   Raude, J
   Kazanji, M
   Flamand, C
AF Fritzell, Camille
   Raude, Jocelyn
   Kazanji, Mirdad
   Flamand, Claude
TI Emerging trends of Zika apprehension in an epidemic setting
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID MAD-COW-DISEASE; RISK PERCEPTION; VIRUS; TRANSMISSION; ISLAND
AB Background
   French Guiana is a territory that has a decades-long history of dengue outbreaks and more recently, in 2014, a chikungunya outbreak. Zika virus (ZIKV) emerged in late 2015 and subsequently led to an important outbreak.
   Methodology/Principal findings
   A cross-sectional phone survey was conducted among the general population during the outbreak in June 2016 with a total of 1,129 individuals interviewed to assess perceptions, knowledge and behaviors regarding zika infection. The population seemed aware of zika, and perceived the infection as a more serious health threat than other common mosquito-borne diseases. Furthermore, both the perceptions and behaviors related to zika and its prevention were found to vary considerably among different social groups, geographic areas and gender; less educated female participants were found to perceive the disease as more worrisome and were less likely to adopt protective behaviors. Moreover, female population has been particularly responsive to awareness campaigns and rapidly understood the extent of risks associated with ZIKV infection.
   Conclusions/Significance
   These results revealed that ZIKV appeared at the time of the survey as a new health threat that concerns the public more than chikungunya and dengue fever with differences observed among subgroups of population. These results have implications for the development of multifaceted infection control programs, including strategies for prevention and awareness, helping the population to develop an accurate perception of the threat they are facing and encouraging behavior changes.
C1 [Fritzell, Camille; Kazanji, Mirdad; Flamand, Claude] Pasteur Inst French Guiana, Cayenne, France.
   [Raude, Jocelyn] Univ Aix Marseille, IRD 190, INSERM 1207, EHESP,UMR Emergence Pathol Virales, Marseille, France.
   [Raude, Jocelyn] Univ La Reunion, UMR Proc Infect Milieu Insulaire Trop, INSERM 1187, CNRS 9192,IRD 249, St Denis, Reunion, France.
RP Fritzell, C (corresponding author), Pasteur Inst French Guiana, Cayenne, France.
EM cfritzell@pasteur-cayenne.fr
OI Flamand, Claude/0000-0002-8064-445X
FU Regional Health Agency of French Guiana; European Union's Horizon
   research and innovation program under ZIKAlliance grant [734548];
   Pasteur Institut Department of International Affairs
FX This study was supported by the Regional Health Agency of French Guiana
   and the European Unions Horizon 2020 research and innovation program
   under ZIKAlliance grant agreement No 734548. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript. CF also acknowledges funding from the
   doctoral grant Calmette and Yersin allocated by the Pasteur Institut
   Department of International Affairs.
CR [Anonymous], 2013, SPAD DAT MIN V 8 0 S
   Brug J, 2009, INT J BEHAV MED, V16, P3, DOI 10.1007/s12529-008-9000-x
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   DOUGLAS M, 1990, SOCIOL REV, V38, P445, DOI 10.1111/j.1467-954X.1990.tb00919.x
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Flamand C, 2017, EUROSURVEILLANCE, V22, P23, DOI 10.2807/1560-7917.ES.2017.22.44.17-00102
   Fritzell C, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005081
   Hills SL, 2016, MMWR MORB MORTAL WKL, V65
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101
   Joffe H, 2011, PUBLIC UNDERST SCI, V20, P446, DOI 10.1177/0963662510391604
   Kahan, 2007, J EMPIR LEGAL STUD, V4, P465, DOI DOI 10.1111/J.1740-1461.2007.00097.X
   Loewenstein GF, 2001, PSYCHOL BULL, V127, P267, DOI 10.1037//0033-2909.127.2.267
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Petrie KJ, 1997, PERCEPTIONS HLTH ILL
   QGIS Development Team, 2009, QGIS GEOGR INF SYST
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Raude J, 2005, J RISK RES, V8, P663, DOI 10.1080/13669870500194825
   Raude J, 2009, EUR J EPIDEMIOL, V24, P339, DOI 10.1007/s10654-009-9351-x
   Rothman AJ, 1997, PSYCHOL BULL, V121, P3, DOI 10.1037/0033-2909.121.1.3
   Setbon M, 2005, RISK ANAL, V25, P813, DOI 10.1111/j.1539-6924.2005.00634.x
   Setbon M, 2008, POPULATION, V63, P555, DOI 10.3917/popu.803.0555
   SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507
   Smith RD, 2006, SOC SCI MED, V63, P3113, DOI 10.1016/j.socscimed.2006.08.004
   Stata, 2011, STAT STAT SOFTW REL
   Tavernise S, 2016, NY TIMES
   Van Bortel W, 2014, EURO SURVEILL B EUR, V19
   Vogel G, 2016, SCIENCE, V352, P1375, DOI 10.1126/science.352.6292.1375
   Washer P, 2006, SOC SCI MED, V62, P457, DOI 10.1016/j.socscimed.2005.06.001
   Weinman J, 1996, PSYCHOL HEALTH, V11, P431, DOI 10.1080/08870449608400270
   Weinstein ND, 2007, HEALTH PSYCHOL, V26, P146, DOI 10.1037/0278-6133.26.2.146
   World Health Organization, 2016, ZIK STRAT RESP PLAB
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 36
TC 3
Z9 3
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JAN
PY 2018
VL 12
IS 1
AR e0006167
DI 10.1371/journal.pntd.0006167
PG 14
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA FU7HJ
UT WOS:000424022700035
PM 29370170
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Gardner, LM
   Bota, A
   Gangavarapu, K
   Kraemer, MUG
   Grubaugh, ND
AF Gardner, Lauren M.
   Bota, Andras
   Gangavarapu, Karthik
   Kraemer, Moritz U. G.
   Grubaugh, Nathan D.
TI Inferring the risk factors behind the geographical spread and
   transmission of Zika in the Americas
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID VIRUS; INFECTION; EPIDEMIOLOGY; OUTBREAK
AB Background
   An unprecedented Zika virus epidemic occurred in the Americas during 2015-2016. The size of the epidemic in conjunction with newly recognized health risks associated with the virus attracted significant attention across the research community. Our study complements several recent studies which have mapped epidemiological elements of Zika, by introducing a newly proposed methodology to simultaneously estimate the contribution of various risk factors for geographic spread resulting in local transmission and to compute the risk of spread (or re-introductions) between each pair of regions. The focus of our analysis is on the Americas, where the set of regions includes all countries, overseas territories, and the states of the US.
   Methodology/Principal findings
   We present a novel application of the Generalized Inverse Infection Model (GIIM). The GIIM model uses real observations from the outbreak and seeks to estimate the risk factors driving transmission. The observations are derived from the dates of reported local transmission of Zika virus in each region, the network structure is defined by the passenger air travel movements between all pairs of regions, and the risk factors considered include regional socioeconomic factors, vector habitat suitability, travel volumes, and epidemiological data. The GIIM relies on a multi-agent based optimization method to estimate the parameters, and utilizes a data driven stochastic-dynamic epidemic model for evaluation. As expected, we found that mosquito abundance, incidence rate at the origin region, and human population density are risk factors for Zika virus transmission and spread. Surprisingly, air passenger volume was less impactful, and the most significant factor was (a negative relationship with) the regional gross domestic product (GDP) per capita.
   Conclusions/Significance
   Our model generates country level exportation and importation risk profiles over the course of the epidemic and provides quantitative estimates for the likelihood of introduced Zika virus resulting in local transmission, between all origin-destination travel pairs in the Americas. Our findings indicate that local vector control, rather than travel restrictions, will be more effective at reducing the risks of Zika virus transmission and establishment. Moreover, the inverse relationship between Zika virus transmission and GDP suggests that Zika cases are more likely to occur in regions where people cannot afford to protect themselves from mosquitoes. The modeling framework is not specific for Zika virus, and could easily be employed for other vector-borne pathogens with sufficient epidemiological and entomological data.
C1 [Gardner, Lauren M.; Bota, Andras] UNSW Sydney, Sch Civil & Environm Engn, Sydney, NSW, Australia.
   [Gangavarapu, Karthik; Grubaugh, Nathan D.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.
   [Kraemer, Moritz U. G.] Univ Oxford, Dept Zool, Oxford, England.
   [Kraemer, Moritz U. G.] Boston Childrens Hosp, Boston, MA USA.
   [Kraemer, Moritz U. G.] Harvard Med Sch, Boston, MA USA.
RP Gardner, LM (corresponding author), UNSW Sydney, Sch Civil & Environm Engn, Sydney, NSW, Australia.
EM l.gardner@unsw.edu.au
OI Gardner, Lauren/0000-0003-1083-3850; Grubaugh,
   Nathan/0000-0003-2031-1933
FU National Health and Medical Research CouncilNational Health and Medical
   Research Council of Australia [APP1082524]; NIHUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USA
   [5T32AI007244-33]; National Institute of Child Health and Human
   DevelopmentUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National
   Institute of Child Health & Human Development (NICHD) [T32HD040128];
   National Library of Medicine of the National Institutes of HealthUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Library of Medicine (NLM) [R01LM010812,
   R01LM011965]
FX AB is funded by the National Health and Medical Research Council
   (https://www.nhmrc.gov.au/), project grant (No. APP1082524). NDG is
   supported by NIH (https://www.nih.gov/) training grant 5T32AI007244-33.
   MUGK acknowledges funding from a Training Grant from the National
   Institute of Child Health and Human Development
   (https://www.nichd.nih.gov/) T32HD040128, and the National Library of
   Medicine of the National Institutes of Health (https://www.nlm.nih.gov/)
   (R01LM010812, R01LM011965). The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Ajelli M, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005851
   Bank W. International Comparison Program database, 2016, INT COMP PROGR DAT P
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Besnard M, 2016, EURO SURVEILL, V21
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Bota A, GEN FRAMEWORK ESTIMA
   Bota A, 2014, ACSIS-ANN COMPUT SCI, V2, P75
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Dinh L, 2016, THEOR BIOL MED MODEL, V13, DOI 10.1186/s12976-016-0046-1
   Driggers RW, NEW ENGLAND J MED
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2016, SCIENCE
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gardner L, 2017, PLOS NEGLECT TROP D, V11, P1
   Gardner L, 2013, NETW SPAT EC, V13
   Gardner L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072129
   Gardner LM, 2016, LANCET INFECT DIS, V16, P522, DOI 10.1016/S1473-3099(16)00176-6
   Gardner LM, 2014, NAT HAZARDS REV, V15, DOI 10.1061/(ASCE)NH.1527-6996.0000135
   Gardner LM, 2012, J TROPICAL MED, V2012
   Gonzalez C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000585
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Grubaugh ND, 2016, UK F1000RES, V5, P2046
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Hills S, 2016, MMWR MORB MORTAL WKL
   Ho ZJM, 2017, LANCET INFECT DIS, V17, P813, DOI 10.1016/S1473-3099(17)30249-9
   Hsieh YH, 2017, PEERJ, V5, DOI 10.7717/peerj.3015
   Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kennedy J, 2006, IEEE T SYST MAN CY C, V36, P515, DOI 10.1109/TSMCC.2006.875410
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Manore CA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005255
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i212
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Moffett A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000824
   Monaghan A, 2016, PLOS CURRENTS OUTBRE
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nah K, 2016, PEERJ, V4, DOI 10.7717/peerj.1904
   Netto EM, 2017, MBIO, V8, DOI [10.1128/mBio.01390-17, 10.1128/mbio.01390-17]
   Nowakowski A, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/4956063
   Ogden NH, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-1977-z
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   PAHO, 2015, EP AL INCR MICR NE B
   PAHO, COUNTR TERR AUT TRAN
   PAHO, 2017, PLISA HLTH IND PLATF
   Pan American Health Organization (PAHO), 2017, REG ZIK EP UPD AM MA
   Rey D, 2016, NETW SPAT ECON, V16, P687, DOI 10.1007/s11067-015-9294-6
   Sarkar S, 2016, PALGR COMMUN, V2, DOI 10.1057/palcomms.2016.60
   Sarkar S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000836
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Snyder RE, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005287
   WHO, 2015, WHO WORLD HLTH STAT
   Wilder-Smith A, 2008, MED CLIN N AM, V92, P1377, DOI 10.1016/j.mcna.2008.07.002
   World Health Organization. Fifth meeting of the Emergency Committee under the International Health Regulations, 2005, 5 M EM COMM INT HLTH
   World Health Organization (WHO), 2016, ZIK VIR TECHN REP
   World Health Organization (WHO), 2016, ZIK VIR VECT RISK SP
   World Health Organization (WHO), 2016, WHO SIT REP ZIK VIR
   WorldBank, 2016, INT COMP PROGR DAT G
   Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114
NR 62
TC 13
Z9 13
U1 0
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JAN
PY 2018
VL 12
IS 1
AR e0006194
DI 10.1371/journal.pntd.0006194
PG 25
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA FU7HJ
UT WOS:000424022700052
PM 29346387
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Hotez, PJ
AF Hotez, Peter J.
TI The rise of neglected tropical diseases in the "new Texas"
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Review
ID WEST NILE VIRUS; AUTOCHTHONOUS CHAGAS-DISEASE; TYPHUS GROUP
   RICKETTSIOSIS; UNITED-STATES; CUTANEOUS LEISHMANIASIS; BLOOD-DONORS;
   USA; INFECTION; EXPOSURE; HOUSTON
AB Within the last five years, the State of Texas has experienced either transmission or outbreaks of Ebola, chikungunya, West Nile, and Zika virus infections. Autochthonous transmission of neglected parasitic and bacterial diseases has also become increasingly reported. The rise of such emerging and neglected tropical diseases (NTDs) has not occurred by accident but instead reflects rapidly evolving changes and shifts in a "new" Texas beset by modern and globalizing forces that include rapid expansions in population together with urbanization and human migrations, altered transportation patterns, climate change, steeply declining vaccination rates, and a new paradigm of poverty known as "blue marble health." Summarized here are the major NTDs now affecting Texas. In addition to the vector-borne viral diseases highlighted above, there also is a high level of parasitic infections, including Chagas disease, trichomoniasis, and possibly leishmaniasis and toxocariasis, as well as typhus-group rickettsiosis, a vector-borne bacterial infection. I also highlight some of the key shifts in emerging and neglected disease patterns, partly due to an altered and evolving economic and ecological landscape in the new Texas, and provide some preliminary disease burden estimates for the major prevalent and incident NTDs.
C1 [Hotez, Peter J.] Texas Childrens Hosp, Baylor Coll Med, Natl Sch Trop Med, Ctr Vaccine Dev,Dept Pediat, Houston, TX 77030 USA.
   [Hotez, Peter J.] Texas Childrens Hosp, Baylor Coll Med, Natl Sch Trop Med, Ctr Vaccine Dev,Dept Mol Virol & Microbiol, Houston, TX 77030 USA.
   [Hotez, Peter J.] Baylor Univ, Dept Biol, Waco, TX 76798 USA.
   [Hotez, Peter J.] Rice Univ, James A Baker Inst Publ Policy 3, Houston, TX 77005 USA.
   [Hotez, Peter J.] Texas A&M Univ, Bush Sch Govt & Publ Serv, Scowcroft Inst Int Affairs, College Stn, TX 77843 USA.
RP Hotez, PJ (corresponding author), Texas Childrens Hosp, Baylor Coll Med, Natl Sch Trop Med, Ctr Vaccine Dev,Dept Pediat, Houston, TX 77030 USA.; Hotez, PJ (corresponding author), Texas Childrens Hosp, Baylor Coll Med, Natl Sch Trop Med, Ctr Vaccine Dev,Dept Mol Virol & Microbiol, Houston, TX 77030 USA.; Hotez, PJ (corresponding author), Baylor Univ, Dept Biol, Waco, TX 76798 USA.; Hotez, PJ (corresponding author), Rice Univ, James A Baker Inst Publ Policy 3, Houston, TX 77005 USA.; Hotez, PJ (corresponding author), Texas A&M Univ, Bush Sch Govt & Publ Serv, Scowcroft Inst Int Affairs, College Stn, TX 77843 USA.
EM hotez@bcm.edu
CR Adalja AA, 2012, EMERG INFECT DIS, V18, P608, DOI 10.3201/eid1804.110968
   Andrus J, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002021
   Barry MA, 2014, AM J TROP MED HYG, V91, P345, DOI 10.4269/ajtmh.14-0124
   Beasley DWC, 2013, ANTIVIR RES, V99, P1, DOI 10.1016/j.antiviral.2013.04.015
   Blanton LS, 2016, AM J TROP MED HYG, V95, P457, DOI 10.4269/ajtmh.16-0197
   Bouri N, 2012, PUBLIC HEALTH REP, V127, P259, DOI 10.1177/003335491212700305
   Cervantes DT, 2015, EMERG INFECT DIS, V21, P681, DOI 10.3201/eid2104.141178
   Chowdhury FZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092187
   Clarke CF, 2013, AM J TROP MED HYG, V88, P157, DOI 10.4269/ajtmh.2012.11-0717
   Curtis-Robles R, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004235
   Department of State Health Services, TEX POP 2020 PROJ
   Duggal NK, 2013, AM J TROP MED HYG, V89, P205, DOI 10.4269/ajtmh.13-0140
   Erickson T, 2017, EMERG INFECT DIS, V23, P2068, DOI 10.3201/eid2312.170631
   Esteve-Gassent M. D., 2014, FRONT PUBLIC HEALTH, V2, P1, DOI DOI 10.3389/FPUBH.2014.00177
   Feeding Texas, POV INC LARG TEX CIT
   Garcia MN, 2016, EPIDEMIOL INFECT, V144, P1010, DOI 10.1017/S0950268814002234
   Garcia MN, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003981
   Garcia MN, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0815-4
   Garcia MN, 2015, AM J TROP MED HYG, V92, P325, DOI 10.4269/ajtmh.14-0238
   Garcia MN, 2015, MICROBES INFECT, V17, P163, DOI 10.1016/j.micinf.2014.12.003
   Garcia MN, 2015, AM J CARDIOL, V115, P113, DOI 10.1016/j.amjcard.2014.09.050
   Garcia MN, 2014, VIRAL IMMUNOL, V27, P327, DOI 10.1089/vim.2014.0035
   Garcia MN, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-311
   Gardner WS, 2016, POLITIFACT TEXAS GRE
   Hallmark CJ, 2016, SEX TRANSM DIS, V43, P549, DOI 10.1097/OLQ.0000000000000488
   Hasbun R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148898
   Hotez PJ, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002153
   Hotez PJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0003895
   Hotez PJ, 2014, JAMA PSYCHIAT, V71, P1099, DOI 10.1001/jamapsychiatry.2014.1045
   Hotez Peter J., 2012, NY TIMES
   HOTEZ PJ, 2012, PLOS NEGLECT TROP D, V6
   Hotez PJ, 2016, BLUE MARBLE HLTH INN
   Infoplease, SOC CULT RAC ETHN IM
   Knust B, 2013, EMERG INFECT DIS, V19, P1934, DOI 10.3201/eid1912.131217
   Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35
   Lee RM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003116
   Mann BR, 2013, EMERG INFECT DIS, V19, P1418, DOI 10.3201/eid1909.130377
   Manne JM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002488
   Manne-Goehler J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005033
   Mayes BC, 2013, JAVMA-J AM VET MED A, V243, P1129, DOI 10.2460/javma.243.8.1129
   Migration Policy Institute, DAT HUB STAT IMM DAT
   Monaghan AJ, 2016, PLOS CURR, V16, P8
   Morrison JS, 2016, COMMENTARY
   Murray KO, 2017, EMERG INFECT DIS, V23, P645, DOI 10.3201/eid2304.160958
   Murray KO, 2013, VECTOR-BORNE ZOONOT, V13, P835, DOI 10.1089/vbz.2013.1413
   Murray KO, 2013, EMERG INFECT DIS, V19, P1836, DOI 10.3201/eid1911.130768
   Nolan MS, 2013, EMERG INFECT DIS, V19, P137, DOI 10.3201/eid1901.121135
   Nolan MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040374
   Raghavan RK, 2015, VECTOR-BORNE ZOONOT, V15, P602, DOI 10.1089/vbz.2014.1754
   Risky Business, SE REP COM HEAT HIGH
   Ruktanonchai DJ, 2014, AM J TROP MED HYG, V91, P240, DOI 10.4269/ajtmh.14-0072
   Sarkar S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000836
   Serpa JA, 2012, PATHOG GLOB HEALTH, V106, P256, DOI 10.1179/2047773212Y.0000000028
   Stemmer SM, 2012, J LOW GENIT TRACT DI, V16, P352, DOI 10.1097/LGT.0b013e31824b9be2
   Suburban States, CURR POP DEM STAT TE
   Szonyi B, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2286-0
   Texas Department of State Health Services, CYCL
   Texas Department of State Health Services, DAT
   Texas Department of State Health Services, AM
   Texas Department of State Health Services, INFECTIOUS DISEASE C
   Texas Department of State Health Services, CRYPT
   Texas Department of State Health Services, TEXAS STD SURVEILLAN
   Truman RW, 2011, NEW ENGL J MED, V364, P1626, DOI 10.1056/NEJMoa1010536
   US Census Bureau, 2016, 5 NAT 11 FAST GROW C
   Vitek CJ, 2014, J MED ENTOMOL, V51, P1019, DOI 10.1603/ME13005
   Wallace RM, 2014, MMWR-MORBID MORTAL W, V63, P446
   Weatherhead JE, 2015, AM J TROP MED HYG, V92, P1006, DOI 10.4269/ajtmh.14-0616
   Webber BJ, 2014, MMWR-MORBID MORTAL W, V63, P749
   Won KY, 2008, AM J TROP MED HYG, V79, P552, DOI 10.4269/ajtmh.2008.79.552
   Wozniak EJ, 2015, J PARASITOL, V101, P520, DOI 10.1645/15-748
   Yasukawa K, 2014, AM J TROP MED HYG, V91, P84, DOI 10.4269/ajtmh.14-0058
NR 71
TC 12
Z9 12
U1 2
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JAN
PY 2018
VL 12
IS 1
AR e0005581
DI 10.1371/journal.pntd.0005581
PG 15
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA FU7HJ
UT WOS:000424022700003
PM 29346369
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Perez, D
   van der Stuyft, P
   Toledo, ME
   Ceballos, E
   Fabre, F
   Lefevre, P
AF Perez, Dennis
   van der Stuyft, Patrick
   Eugenia Toledo, Maria
   Ceballos, Enrique
   Fabre, Francisco
   Lefevre, Pierre
TI Insecticide treated curtains and residual insecticide treatment to
   control Aedes aegypti: An acceptability study in Santiago de Cuba
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID DENGUE VACCINE; INCREMENTAL COST; VECTOR CONTROL; EPIDEMIC; RECOMBINANT;
   LESSONS; COVERS; ZIKA
AB Background
   Within the context of a field trial conducted by the Cuban vector control program (AaCP), we assessed acceptability of insecticide-treated curtains (ITCs) and residual insecticide treatment (RIT) with deltamethrin by the community. We also assessed the potential influence of interviewees' risk perceptions for getting dengue and disease severity.
   Methodology/principal findings
   We embedded a qualitative study using in-depth interviews in a cluster randomized trial (CRT) testing the effectiveness of ITCs and RIT in Santiago de Cuba. In-depth interviews (N = 38) were conducted four and twelve months after deployment of the tools with people who accepted the tools, who stopped using them and who did not accept the tools. Data analysis was deductive. Main reasons for accepting ITCs at the start of the trial were perceived efficacy and not being harmful to health. Constraints linked to manufacturer instructions were the main reason for not using ITCs. People stopped using the ITCs due to perceived allergy, toxicity and low efficacy. Few heads of households refused RIT despite the noting reasons for rejection, such as allergy, health hazard and toxicity. Positive opinions of the vector control program influenced acceptability of both tools. However, frequent insecticide fogging as part of routine AaCP vector control actions diminished perceived efficacy of both tools and, therefore, acceptability. Fifty percent of interviewees did feel at risk for getting dengue and considered dengue a severe disease. However, this did not appear to influence acceptability of ITCs or RIT.
   Conclusion/significance
   Acceptability of ITCs and RIT was linked to acceptability of AaCP routine vector control activities. However, uptake and use were not always an indication of acceptability. Factors leading to acceptability may be best identified using qualitative methods, but more research is needed on the concept of acceptability and its measurement.
C1 [Perez, Dennis; Eugenia Toledo, Maria] Inst Trop Med Pedro Kouri, Dept Epidemiol, Havana, Cuba.
   [van der Stuyft, Patrick; Lefevre, Pierre] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium.
   [van der Stuyft, Patrick] Univ Ghent, Dept Publ Hlth, Ghent, Belgium.
   [Ceballos, Enrique] Polyclin Armando Garcia, Dept Vector Control, Santiago De Cuba, Cuba.
   [Fabre, Francisco] Prov Surveillance & Vector Control Unit, Dept Vector Control, Santiago De Cuba, Cuba.
RP Perez, D (corresponding author), Inst Trop Med Pedro Kouri, Dept Epidemiol, Havana, Cuba.
EM dennis@ipk.sld.cu
OI Perez Chacon, Dennis/0000-0003-2993-933X
FU Cuban Ministry of Health; Institute of Tropical Medicine 'Pedro Kouri'
   (Havana City, Cuba); Institute of Tropical Medicine (Antwerp, Belgium);
   Belgium Directorate-General for Development Cooperation
FX This research was funded by the Cuban Ministry of Health and through a
   framework agreement between the Institute of Tropical Medicine 'Pedro
   Kouri' (Havana City, Cuba), the Institute of Tropical Medicine (Antwerp,
   Belgium) and the Belgium Directorate-General for Development
   Cooperation. The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Ajayi IO, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-6
   Alphey L, 2010, VECTOR-BORNE ZOONOT, V10, P295, DOI 10.1089/vbz.2009.0014
   Atkinson JA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-298
   Baly A, 2016, REV SOC BRAS MED TRO, V49, P418, DOI 10.1590/0037-8682-0368-2015
   Baly A, 2016, TROP MED INT HEALTH, V21, P597, DOI 10.1111/tmi.12693
   Benelli G, 2017, ACTA TROP, V174, P91, DOI 10.1016/j.actatropica.2017.06.028
   Binka FN, 1997, TROP MED INT HEALTH, V2, P499, DOI 10.1046/j.1365-3156.1997.d01-299.x
   Bisset Lazcano J. A., 2016, Revista Cubana de Medicina Tropical, V68, P82
   Caprara A, 2016, GLOB HEALTH PROMOT, V23, P3, DOI 10.1177/1757975916673964
   Castex M, 2008, REV CUBA MED TROP, V60, P92
   Castro M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081875
   Che-Mendoza A, 2015, T ROY SOC TROP MED H, V109, P106, DOI 10.1093/trstmh/tru189
   Coller BAG, 2011, CURR OPIN IMMUNOL, V23, P391, DOI 10.1016/j.coi.2011.03.005
   Creswell J, 2011, DESIGN CONDUCTING MI
   de Valdez MRW, 2011, P NATL ACAD SCI USA, V108, P4772, DOI 10.1073/pnas.1019295108
   Denzin Norman, 2005, SAGE HDB QUALITATIVE
   Toledo ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119373
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Guzman M, 2009, LANCET, V14
   Guzman M. G., 2006, Giornale Italiano di Medicina Tropicale, V11, P1
   Guzman MG, 2006, REV PANAM SALUD PUBL, V19, P282, DOI 10.1590/S1020-49892006000400014
   Guzman MG, 2002, LANCET INFECT DIS, V2, P33, DOI 10.1016/S1473-3099(01)00171-2
   Halstead SB, 2012, LANCET, V380, P1535, DOI 10.1016/S0140-6736(12)61510-4
   Jones CH, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-846
   Kouri G, 1998, EMERG INFECT DIS, V4, P89
   KOURI GP, 1989, B WORLD HEALTH ORGAN, V67, P375
   Kroeger A, 2006, BMJ-BRIT MED J, V332, P1247, DOI 10.1136/bmj.332.7552.1247
   Martin J, 2016, ACTA VIROL, V60, P3, DOI 10.4149/av_2016_01_3
   McMeniman CJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000748
   Messenger LA, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-358
   MINSAP, 2013, PIOGR NAC VIG LUCH A
   Munguambe K, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-344
   Paz-Soldan VA, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3191-x
   Paz-Soldan VA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004409
   Peters D.H., 2013, IMPLEMENTATION RES H
   Proctor E, 2011, ADM POLICY MENT HLTH, V38, P65, DOI 10.1007/s10488-010-0319-7
   Rizzo N, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-931
   Rodríguez María Magdalena, 2010, Rev Cubana Med Trop, V62, P217
   Romani MET, 2007, SOC SCI MED, V64, P976, DOI 10.1016/j.socscimed.2006.10.033
   Rubardt M, 1999, HEALTH POLICY PLANN, V14, P313, DOI 10.1093/heapol/14.4.313
   Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7
   Severy LJ, 2005, AIDS BEHAV, V9, P121, DOI 10.1007/s10461-005-1687-y
   Stoddard ST, 2013, P NATL ACAD SCI USA, V110, P994, DOI 10.1073/pnas.1213349110
   Suarez MR, 2005, SOC SCI MED, V61, P495, DOI 10.1016/j.socscimed.2004.11.069
   Thomas SJ, 2011, HUM VACCINES, V7, P674, DOI 10.4161/hv.7.6.14985
   Toledo ME, 2011, TROP MED INT HEALTH, V16, P744, DOI 10.1111/j.1365-3156.2011.02762.x
   Valdés G Luis, 2002, Rev Cubana Med Trop, V54, P220
   Vanlerberghe V, 2011, TROP MED INT HEALTH, V16, P162, DOI 10.1111/j.1365-3156.2010.02668.x
   Vanlerberghe V, 2010, TROP MED INT HEALTH, V15, P1067, DOI 10.1111/j.1365-3156.2010.02582.x
   Vanlerberghe V, 2013, AM J TROP MED HYG, V89, P93, DOI 10.4269/ajtmh.13-0015
   Vanlerberghe V, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000994
   Villa R, 2016, CLIN TER, V167, P7, DOI 10.7417/CT.2016.1907
   WHO, 2ND RES SPRAYING OP
   World Health Organization, 2009, DENG GUID DIAGN TREA
   World Health Organization (WHO), 2012, DENG SEV DENG
NR 55
TC 0
Z9 0
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JAN
PY 2018
VL 12
IS 1
AR e0006115
DI 10.1371/journal.pntd.0006115
PG 20
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA FU7HJ
UT WOS:000424022700015
PM 29293501
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ramasamy, V
   Arora, U
   Shukla, R
   Poddar, A
   Shanmugam, RK
   White, LJ
   Mattocks, MM
   Raut, R
   Perween, A
   Tyagi, P
   de Silva, AM
   Bhaumik, SK
   Kaja, MK
   Villinger, F
   Ahmed, R
   Johnston, RE
   Swaminathan, S
   Khanna, N
AF Ramasamy, Viswanathan
   Arora, Upasana
   Shukla, Rahul
   Poddar, Ankur
   Shanmugam, Rajgokul K.
   White, Laura J.
   Mattocks, Melissa M.
   Raut, Rajendra
   Perween, Ashiya
   Tyagi, Poornima
   de Silva, Aravinda M.
   Bhaumik, Siddhartha K.
   Kaja, Murali Krishna
   Villinger, Francois
   Ahmed, Rafi
   Johnston, Robert E.
   Swaminathan, Sathyamangalam
   Khanna, Navin
TI A tetravalent virus-like particle vaccine designed to display domain III
   of dengue envelope proteins induces multi-serotype neutralizing
   antibodies in mice and macaques which confer protection against antibody
   dependent enhancement in AG129 mice
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID B SURFACE-ANTIGEN; PLASMODIUM-FALCIPARUM MALARIA; PICHIA-PASTORIS;
   HIGH-LEVEL; MONOCLONAL-ANTIBODIES; ZIKA VIRUS; INFECTION; TYPE-2;
   GLYCOPROTEIN; PURIFICATION
AB Background
   Dengue is one of the fastest spreading vector-borne diseases, caused by four antigenically distinct dengue viruses (DENVs). Antibodies against DENVs are responsible for both protection as well as pathogenesis. A vaccine that is safe for and efficacious in all people irrespective of their age and domicile is still an unmet need. It is becoming increasingly apparent that vaccine design must eliminate epitopes implicated in the induction of infection-enhancing antibodies.
   Methodology/principal
   findings We report a Pichia pastoris-expressed dengue immunogen, DSV4, based on DENV envelope protein domain III (EDIII), which contains well-characterized serotype-specific and cross-reactive epitopes. In natural infection, < 10% of the total neutralizing antibody response is EDIII-directed. Yet, this is a functionally relevant domain which interacts with the host cell surface receptor. DSV4 was designed by in-frame fusion of EDIII of all four DENV serotypes and hepatitis B surface (S) antigen and co-expressed with unfused S antigen to form mosaic virus-like particles (VLPs). These VLPs displayed EDIIIs of all four DENV serotypes based on probing with a battery of serotype-specific anti-EDIII monoclonal antibodies. The DSV4 VLPs were highly immunogenic, inducing potent and durable neutralizing antibodies against all four DENV serotypes encompassing multiple genotypes, in mice and macaques. DSV4-induced murine antibodies suppressed viremia in AG129 mice and conferred protection against lethal DENV-4 virus challenge. Further, neither murine nor macaque anti-DSV4 antibodies promoted mortality or inflammatory cytokine production when passively transferred and tested in an in vivo dengue disease enhancement model of AG129 mice.
   Conclusions/significance
   Directing the immune response to a non-immunodominant but functionally relevant serotype-specific dengue epitope of the four DENV serotypes, displayed on a VLP platform, can help minimize the risk of inducing disease-enhancing antibodies while eliciting effective tetravalent seroconversion. DSV4 has a significant potential to emerge as a safe, efficacious and inexpensive subunit dengue vaccine candidate.
C1 [Ramasamy, Viswanathan; Arora, Upasana; Shukla, Rahul; Poddar, Ankur; Shanmugam, Rajgokul K.; Raut, Rajendra; Perween, Ashiya; Tyagi, Poornima; Swaminathan, Sathyamangalam; Khanna, Navin] Int Ctr Genet Engn & Biotechnol, Mol Med Div, Recombinant Gene Prod Grp, New Delhi, India.
   [White, Laura J.; Mattocks, Melissa M.; Johnston, Robert E.] Global Vaccines Inc, 801 Capitola Dr,Ste 11, Durham, NC USA.
   [Raut, Rajendra; de Silva, Aravinda M.] Univ N Carolina, Sch Med, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.
   [Bhaumik, Siddhartha K.; Kaja, Murali Krishna; Khanna, Navin] Emory Univ, Sch Med, Dept Pediat, Div Infect Dis, Atlanta, GA 30322 USA.
   [Kaja, Murali Krishna] ICGEB, Emory Vaccine Ctr, New Delhi, India.
   [Kaja, Murali Krishna; Villinger, Francois; Ahmed, Rafi] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA USA.
   [Khanna, Navin] NCR Biotech Sci Cluster, Translat Hlth Sci & Technol Inst, Faridabad, India.
   [White, Laura J.; Mattocks, Melissa M.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA.
   [Villinger, Francois] Univ Louisiana Lafayette, New Iberia Res Ctr, New Iberia, LA USA.
RP Swaminathan, S (corresponding author), Int Ctr Genet Engn & Biotechnol, Mol Med Div, Recombinant Gene Prod Grp, New Delhi, India.
EM swami@icgeb.res.in; navinkhanna5@gmail.com
OI Swaminathan, Sathyamangalam/0000-0002-4388-2248; Shukla,
   Rahul/0000-0002-4320-9512; RAUT, RAJENDRA/0000-0003-0719-930X
FU Wellcome Trust, UKWellcome Trust [ND/WTL/14/012]; Sun Pharmaceuticals
   India, Limited [ND/SPI/16/027]; Department of Biotechnology, Government
   of IndiaDepartment of Biotechnology (DBT) India [ND/DBT/14/015];
   National Institutes of Health, USAUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [ICIDR
   1U01AI115651]; International CEntre for Genetic Engineering and
   Biotechnology
FX The work was supported by grants from Wellcome Trust, UK (Grant No.
   ND/WTL/14/012), Sun Pharmaceuticals India, Limited (Grant No.
   ND/SPI/16/027), Department of Biotechnology, Government of India (Grant
   No. ND/DBT/14/015), National Institutes of Health, USA (Grant No. ICIDR
   1U01AI115651) and internal core funding from International CEntre for
   Genetic Engineering and Biotechnology to NK. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Batra G, 2010, J BIOSCI BIOENG, V110, P408, DOI 10.1016/j.jbiosc.2010.05.001
   Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brien JD, 2010, J VIROL, V84, P10630, DOI 10.1128/JVI.01190-10
   Campos JLS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181734
   Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   Casares S, 2010, VACCINE, V28, P4880, DOI 10.1016/j.vaccine.2010.05.033
   Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866
   Crill WD, 2001, J VIROL, V75, P7769, DOI 10.1128/JVI.75.16.7769-7773.2001
   de Alwis R, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004386
   de Alwis R, 2012, P NATL ACAD SCI USA, V109, P7439, DOI 10.1073/pnas.1200566109
   de Alwis R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001188
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181
   Etemad B, 2008, AM J TROP MED HYG, V79, P353, DOI 10.4269/ajtmh.2008.79.353
   Ferguson NM, 2016, SCIENCE, V353, P1033, DOI 10.1126/science.aaf9590
   Fibriansah G, 2015, SCIENCE, V349, P88, DOI 10.1126/science.aaa8651
   Fibriansah G, 2014, EMBO MOL MED, V6, P358, DOI 10.1002/emmm.201303404
   Goncalvez AP, 2002, VIROLOGY, V303, P110, DOI 10.1006/viro.2002.1686
   Gromowski GD, 2007, VIROLOGY, V366, P349, DOI 10.1016/j.virol.2007.05.042
   Gurramkonda C, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-13
   Guy B, 2016, NAT REV MICROBIOL, V14, P45, DOI 10.1038/nrmicro.2015.2
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4
   Halstead SB, 2016, VACCINE, V34, P1643, DOI 10.1016/j.vaccine.2016.02.004
   HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830, DOI 10.4269/ajtmh.1982.31.830
   Holmes EC, 2003, INFECT GENET EVOL, V3, P19, DOI 10.1016/S1567-1348(03)00004-2
   Jaiswal S, 2004, PROTEIN EXPRES PURIF, V33, P80, DOI 10.1016/j.pep.2003.09.009
   Katzelnick LC, 2016, P NATL ACAD SCI USA, V113, P728, DOI 10.1073/pnas.1522136113
   Khetarpal N, 2013, J NANOBIOTECHNOL, V11, DOI 10.1186/1477-3155-11-15
   Kraus AA, 2007, J CLIN MICROBIOL, V45, P3777, DOI 10.1128/JCM.00827-07
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Lambeth CR, 2005, J CLIN MICROBIOL, V43, P3267, DOI 10.1128/JCM.43.7.3267-3272.2005
   Lindenbach B., 2013, FIELDS VIROLOGY, V1, P712
   Mani S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064595
   Milligan GN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125476
   Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Patil A, 2012, J CHROMATOGR B, V898, P7, DOI 10.1016/j.jchromb.2012.03.041
   RICOHESSE R, 1990, VIROLOGY, V174, P479, DOI 10.1016/0042-6822(90)90102-W
   Robinson LN, 2015, CELL, V162, P493, DOI 10.1016/j.cell.2015.06.057
   Rodenhuis-Zybert IA, 2011, J VIROL, V85, P11800, DOI 10.1128/JVI.05237-11
   Shrestha B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000823
   Smith DP, 2013, MBIO, V4, DOI 10.1128/mBio.00133-12
   Smith SA, 2012, J VIROL, V86, P2665, DOI 10.1128/JVI.06335-11
   Stoute JA, 1997, NEW ENGL J MED, V336, P86, DOI 10.1056/NEJM199701093360202
   Sukupolvi-Petty S, 2007, J VIROL, V81, P12816, DOI 10.1128/JVI.00432-07
   Sukupolvi-Petty S, 2013, J VIROL, V87, P8826, DOI 10.1128/JVI.01314-13
   Sukupolvi-Petty S, 2010, J VIROL, V84, P9227, DOI 10.1128/JVI.01087-10
   Swaminathan S, 2010, EXPERT OPIN THER PAT, V20, P819, DOI 10.1517/13543771003767476
   Teoh EP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003888
   Tripathi L, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01005
   Vassileva A, 2001, PROTEIN EXPRES PURIF, V21, P71, DOI 10.1006/prep.2000.1335
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   Voorham JMD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029957
   Wahala WMPB, 2009, VIROLOGY, V392, P103, DOI 10.1016/j.virol.2009.06.037
   Wahala WMPB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000821
   Watanabe S, 2015, J VIROL, V89, P5847, DOI 10.1128/JVI.00216-15
   Wilby KJ, 2012, ANN PHARMACOTHER, V46, P384, DOI [10.1345/aph.1AQ0634, 10.1345/aph.1AQ634, 10.1345/aph.1Q634]
   Zellweger RM, 2010, CELL HOST MICROBE, V7, P128, DOI 10.1016/j.chom.2010.01.004
   Zust R, 2014, J VIROL, V88, P7276, DOI 10.1128/JVI.03827-13
NR 62
TC 24
Z9 25
U1 1
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JAN
PY 2018
VL 12
IS 1
AR e0006191
DI 10.1371/journal.pntd.0006191
PG 26
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA FU7HJ
UT WOS:000424022700049
PM 29309412
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT S
AU Bartholomay, LC
   Michel, K
AF Bartholomay, Lyric C.
   Michel, Kristin
BE Berenbaum, MR
TI Mosquito Immunobiology: The Intersection of Vector Health and Vector
   Competence
SO ANNUAL REVIEW OF ENTOMOLOGY, VOL 63
SE Annual Review of Entomology
LA English
DT Review; Book Chapter
DE mosquito; holobiont; melanization; phagocytosis; innate immunity;
   host-pathogen interactions
ID FUNGUS BEAUVERIA-BASSIANA; COMPLEMENT-LIKE PROTEIN; ANOPHELES-GAMBIAE
   DIPTERA; INNATE IMMUNE-RESPONSE; AEDES-AEGYPTI; CULEX-PIPIENS;
   PLASMODIUM-BERGHEI; ZIKA VIRUS; TRANSOVARIAL TRANSMISSION;
   ULTRASTRUCTURAL-CHANGES
AB As holometabolous insects that occupy distinct aquatic and terrestrial environments in larval and adult stages and utilize hematophagy for nutrient acquisition, mosquitoes are subjected to a wide variety of symbiotic interactions. Indeed, mosquitoes play host to endosymbiotic, entomopathogenic, and mosquito-borne organisms, including protozoa, viruses, bacteria, fungi, fungal-like organisms, and metazoans, all of which trigger and shape innate infection-response capacity. Depending on the infection or interaction, the mosquito may employ, for example, cellular and humoral immune effectors for septic infections in the hemocoel, humoral infection responses in the midgut lumen, and RNA interference and programmed cell death for intracellular pathogens. These responses often function in concert, regardless of the infection type, and provide a robust front to combat infection. Mosquito-borne pathogens and entomopathogens overcome these immune responses, employing avoidance or suppression strategies. Burgeoning methodologies are capitalizing on this concerted deployment of immune responses to control mosquito-borne disease.
C1 [Bartholomay, Lyric C.] Univ Wisconsin Madison, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA.
   [Michel, Kristin] Kansas State Univ, Div Biol, Manhattan, KS 66506 USA.
RP Bartholomay, LC (corresponding author), Univ Wisconsin Madison, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA.
EM lyric.bartholomay@wisc.edu; kmichel@ksu.edu
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R21 AI117204, R01 AI095842]
CR Adelman ZN, 2001, INSECT MOL BIOL, V10, P265, DOI 10.1046/j.1365-2583.2001.00267.x
   Ahmed A, 1999, P NATL ACAD SCI USA, V96, P14795, DOI 10.1073/pnas.96.26.14795
   Ahmed AM, 2006, MICROBES INFECT, V8, P308, DOI 10.1016/j.micinf.2005.06.026
   Akorli J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157529
   Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   Aliota MT, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000666
   Andreadis TG, 2005, FOLIA PARASIT, V52, P23, DOI 10.14411/fp.2005.004
   Barletta ABF, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2040-9
   Barros FSM, 2006, J INVERTEBR PATHOL, V91, P199, DOI 10.1016/j.jip.2006.01.001
   Bartholomay LC, 2004, INSECT MOL BIOL, V13, P125, DOI 10.1111/j.0962-1075.2004.00467.x
   Bartholomay LC, 2003, MOL BIOCHEM PARASIT, V130, P43, DOI 10.1016/S0166-6851(03)00143-9
   Bartholomay LC, 2010, SCIENCE, V330, P88, DOI 10.1126/science.1193162
   Baton LA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-257
   Baxter RHG, 2007, P NATL ACAD SCI USA, V104, P11615, DOI 10.1073/pnas.0704967104
   Becnel JJ, 2005, FOLIA PARASIT, V52, P41, DOI 10.14411/fp.2005.006
   Becnel JJ, 2003, J INVERTEBR PATHOL, V83, P181, DOI 10.1016/S0022-2011(03)00058-2
   Becnel JJ, 2001, J GEN VIROL, V82, P275, DOI 10.1099/0022-1317-82-2-275
   BEERNTSEN BT, 1989, J PARASITOL, V75, P76, DOI 10.2307/3282940
   Bhattacharya T, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006427
   Bian GW, 2013, SCIENCE, V340, P748, DOI 10.1126/science.1236192
   Blandin S, 2004, CELL, V116, P661, DOI 10.1016/S0092-8674(04)00173-4
   Blandin S, 2002, EMBO REP, V3, P852, DOI 10.1093/embo-reports/kvf180
   Blandin SA, 2008, CELL HOST MICROBE, V3, P364, DOI 10.1016/j.chom.2008.05.007
   Blandin SA, 2007, IMMUNOL REV, V219, P8, DOI 10.1111/j.1600-065X.2007.00553.x
   Blandin SA, 2009, SCIENCE, V326, P147, DOI 10.1126/science.1175241
   Blanford S, 2005, SCIENCE, V308, P1638, DOI 10.1126/science.1108423
   Blanford S, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-365
   Boete C, 2004, P ROY SOC B-BIOL SCI, V271, P1611, DOI 10.1098/rspb.2004.2762
   Bolling BG, 2015, VIRUSES-BASEL, V7, P4911, DOI 10.3390/v7092851
   BREY PT, 1988, CELL TISSUE RES, V253, P245, DOI 10.1007/BF00221760
   Bryant WB, 2016, DEV COMP IMMUNOL, V55, P119, DOI 10.1016/j.dci.2015.10.020
   Bryant WB, 2014, J EXP BIOL, V217, P1238, DOI 10.1242/jeb.094573
   Caragata EP, 2016, TRENDS PARASITOL, V32, P207, DOI 10.1016/j.pt.2015.10.011
   Carissimo G, 2015, P NATL ACAD SCI USA, V112, pE176, DOI 10.1073/pnas.1412984112
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Castillo JC, 2006, INSECT BIOCHEM MOLEC, V36, P891, DOI 10.1016/j.ibmb.2006.08.010
   Castillo J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002274
   Castillo JC, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aal1505
   Cator LJ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0711
   Cerenius L, 2008, TRENDS IMMUNOL, V29, P263, DOI 10.1016/j.it.2008.02.009
   CHAPMAN HC, 1974, ANNU REV ENTOMOL, V19, P33, DOI 10.1146/annurev.en.19.010174.000341
   CHARLES JF, 1983, ANN INST PASTEUR MIC, VA134, P197, DOI 10.1016/S0769-2609(83)80081-7
   CHEN CC, 1995, EXP PARASITOL, V81, P72, DOI 10.1006/expr.1995.1094
   CHEN CC, 1987, J PARASITOL, V73, P418, DOI 10.2307/3282101
   CHRISTENSEN BM, 1981, T ROY SOC TROP MED H, V75, P439, DOI 10.1016/0035-9203(81)90116-4
   Christensen BM, 2005, TRENDS PARASITOL, V21, P192, DOI 10.1016/j.pt.2005.02.007
   CHRISTENSEN BM, 1989, J PARASITOL, V75, P119, DOI 10.2307/3282948
   CHRISTENSEN BM, 1986, J PARASITOL, V72, P220, DOI 10.2307/3281595
   Christophides GK, 2002, SCIENCE, V298, P159, DOI 10.1126/science.1077136
   CLARK TB, 1968, J INVERTEBR PATHOL, V11, P1, DOI 10.1016/0022-2011(68)90047-5
   CLARK TB, 1976, J INVERTEBR PATHOL, V28, P341, DOI 10.1016/0022-2011(76)90009-4
   Clayton AM, 2014, J INNATE IMMUN, V6, P169, DOI 10.1159/000353602
   Clem RJ, 2016, J GEN VIROL, V97, P1033, DOI 10.1099/jgv.0.000429
   Coggins SA, 2012, DEV COMP IMMUNOL, V37, P390, DOI 10.1016/j.dci.2012.01.005
   COLLINS FH, 1986, SCIENCE, V234, P607, DOI 10.1126/science.3532325
   Daniels CW., 1898, P R SOC LONDON, V64, P44354
   DeMaio J, 1996, AM J TROP MED HYG, V54, P219, DOI 10.4269/ajtmh.1996.54.219
   Dennison NJ, 2014, CURR OPIN INSECT SCI, V3, P6, DOI 10.1016/j.cois.2014.07.004
   Dong SZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep24729
   Dong YM, 2012, INSECT BIOCHEM MOLEC, V42, P126, DOI 10.1016/j.ibmb.2011.11.005
   Dong YM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000423
   Eldering M, 2016, SCI REP-UK, V6, DOI 10.1038/srep20440
   Eng MW, 2016, INSECT BIOCHEM MOLEC, V76, P70, DOI 10.1016/j.ibmb.2016.07.004
   Erickson SM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002433
   FEDERICI BA, 1995, J AM MOSQUITO CONTR, V11, P260
   Flatt T, 2008, J EXP BIOL, V211, P2712, DOI 10.1242/jeb.014878
   Foy BD, 2004, INSECT MOL BIOL, V13, P89, DOI 10.1111/j.1365-2583.2004.00464.x
   Fraiture M, 2009, CELL HOST MICROBE, V5, P273, DOI 10.1016/j.chom.2009.01.005
   Franz AWE, 2015, VIRUSES-BASEL, V7, P3741, DOI 10.3390/v7072795
   Garver LS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000335
   Girard YA, 2005, J MED ENTOMOL, V42, P429, DOI 10.1603/0022-2585(2005)042[0429:USOWNV]2.0.CO;2
   Girard YA, 2007, AM J TROP MED HYG, V76, P118, DOI 10.4269/ajtmh.2007.76.118
   Goic B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12410
   GOLKAR L, 1993, J INVERTEBR PATHOL, V62, P1, DOI 10.1006/jipa.1993.1066
   Gouagna LC, 2004, TROP MED INT HEALTH, V9, P937, DOI 10.1111/j.1365-3156.2004.01300.x
   GRASSMICK RA, 1973, J INVERTEBR PATHOL, V22, P86, DOI 10.1016/0022-2011(73)90015-3
   Gusmao DS, 2010, ACTA TROP, V115, P275, DOI 10.1016/j.actatropica.2010.04.011
   Habtewold T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000070
   Han YS, 2000, EMBO J, V19, P6030, DOI 10.1093/emboj/19.22.6030
   HARDY JL, 1983, ANNU REV ENTOMOL, V28, P229, DOI 10.1146/annurev.en.28.010183.001305
   Hauck ES, 2013, MICROBES INFECT, V15, P775, DOI 10.1016/j.micinf.2013.05.006
   Hegde S, 2015, CURR OPIN VIROL, V15, P97, DOI 10.1016/j.coviro.2015.08.011
   Hillyer JF, 2005, J HISTOCHEM CYTOCHEM, V53, P689, DOI 10.1369/jhc.4A6564.2005
   Hillyer JF, 2002, HISTOCHEM CELL BIOL, V117, P431, DOI 10.1007/s00418-002-0408-0
   Hillyer JF, 2007, INT J PARASITOL, V37, P673, DOI 10.1016/j.ijpara.2006.12.007
   Hillyer JF, 2014, CURR OPIN INSECT SCI, V3, P14, DOI 10.1016/j.cois.2014.07.002
   Hillyer JF, 2010, DEV COMP IMMUNOL, V34, P141, DOI 10.1016/j.dci.2009.08.014
   Hoa NT, 2003, INSECT BIOCHEM MOLEC, V33, P949, DOI 10.1016/S0965-1748(03)00101-2
   Hopwood JA, 2001, J EXP BIOL, V204, P2773
   Horne KM, 2014, VIRUSES-BASEL, V6, P4373, DOI 10.3390/v6114373
   Horton AA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-574
   Hurd H, 2006, PARASITOLOGY, V132, pS33, DOI 10.1017/S0031182006000849
   Hurd H, 2005, EVOLUTION, V59, P2560, DOI 10.1111/j.0014-3820.2005.tb00969.x
   Joshi D, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00366
   Jupatanakul N, 2014, VIRUSES-BASEL, V6, P4294, DOI 10.3390/v6114294
   Keene KM, 2004, P NATL ACAD SCI USA, V101, P17240, DOI 10.1073/pnas.0406983101
   Kelly EM, 2012, J GEN VIROL, V93, P2419, DOI 10.1099/vir.0.042846-0
   Kerwin JL, 2007, J AM MOSQUITO CONTR, V23, P50, DOI 10.2987/8756-971X(2007)23[50:OLG]2.0.CO;2
   Kim W, 2004, J MED ENTOMOL, V41, P447, DOI 10.1603/0022-2585-41.3.447
   King JG, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-55
   King JG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003058
   Kittayapong P, 1999, AM J TROP MED HYG, V61, P612, DOI 10.4269/ajtmh.1999.61.612
   Kokoza V, 2010, P NATL ACAD SCI USA, V107, P8111, DOI 10.1073/pnas.1003056107
   Kumar S, 2004, J BIOL CHEM, V279, P53475, DOI 10.1074/jbc.M409905200
   Lai SC, 2002, J MED ENTOMOL, V39, P266, DOI 10.1603/0022-2585-39.2.266
   Levashina EA, 2001, CELL, V104, P709, DOI 10.1016/S0092-8674(01)00267-7
   LINLEY JR, 1968, J INVERTEBR PATHOL, V12, P7, DOI 10.1016/0022-2011(68)90237-1
   Liu B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003137
   Lombardo F, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1359-y
   Lombardo F, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003145
   Lowenberger CA, 1999, INSECT MOL BIOL, V8, P107, DOI 10.1046/j.1365-2583.1999.810107.x
   Lowenberger CA, 1999, EXP PARASITOL, V91, P59, DOI 10.1006/expr.1999.4350
   Lowenberger CA, 1996, EXP PARASITOL, V83, P191, DOI 10.1006/expr.1996.0066
   Michel K, 2006, P NATL ACAD SCI USA, V103, P16858, DOI 10.1073/pnas.0608033103
   Miesen P, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006017
   Moita LF, 2005, IMMUNITY, V23, P65, DOI 10.1016/j.immuni.2005.05.006
   Molina-Cruz A, 2013, SCIENCE, V340, P984, DOI 10.1126/science.1235264
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Muller HM, 1999, J BIOL CHEM, V274, P11727, DOI 10.1074/jbc.274.17.11727
   Muturi EJ, 2016, MOL ECOL, V25, P4075, DOI 10.1111/mec.13741
   Myles KM, 2008, P NATL ACAD SCI USA, V105, P19938, DOI 10.1073/pnas.0803408105
   Nappi A, 2009, ADV PARASIT, V70, P99, DOI 10.1016/S0065-308X(09)70004-1
   Nappi AJ, 2005, INSECT BIOCHEM MOLEC, V35, P443, DOI 10.1016/j.ibmb.2005.01.014
   Neafsey DE, 2015, SCIENCE, V347, DOI 10.1126/science.1258522
   Ocampo CB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061187
   Oliveira GD, 2012, SCIENCE, V335, P856, DOI 10.1126/science.1209678
   Olson KE, 2015, CURR OPIN VIROL, V15, P119, DOI 10.1016/j.coviro.2015.10.001
   Orfano AS, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1451-y
   Osta MA, 2004, SCIENCE, V303, P2030, DOI 10.1126/science.1091789
   Oviedo MN, 2008, INSECT MOL BIOL, V17, P61, DOI 10.1111/j.1365-2583.2008.00779.x
   Paily KP, 2000, MED VET ENTOMOL, V14, P426, DOI 10.1046/j.1365-2915.2000.00263.x
   PALMER CA, 1986, J INVERTEBR PATHOL, V48, P310, DOI 10.1016/0022-2011(86)90059-5
   Pan XL, 2012, P NATL ACAD SCI USA, V109, pE23, DOI 10.1073/pnas.1116932108
   Parikh GR, 2009, J GEN VIROL, V90, P292, DOI 10.1099/vir.0.005116-0
   Pinto SB, 2008, CELL MICROBIOL, V10, P891, DOI 10.1111/j.1462-5822.2007.01091.x
   Pinto SB, 2009, P NATL ACAD SCI USA, V106, P21270, DOI 10.1073/pnas.0909463106
   Edward EG, 2007, J AM MOSQUITO CONTR, V23, P58, DOI 10.2987/8756-971X(2007)23[58:MN]2.0.CO;2
   PORTER CH, 1985, J AM MOSQUITO CONTR, V1, P238
   Povelones M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003623
   Povelones M, 2009, SCIENCE, V324, P258, DOI 10.1126/science.1171400
   POWERS AM, 1994, VIRUS RES, V32, P57, DOI 10.1016/0168-1702(94)90061-2
   Ramirez JL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001561
   Richman AM, 1996, INSECT MOL BIOL, V5, P203, DOI 10.1111/j.1365-2583.1996.tb00055.x
   Riehle MM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003672
   Rodrigues J, 2010, SCIENCE, V329, P1353, DOI 10.1126/science.1190689
   Saiyasombat R, 2011, J MED ENTOMOL, V48, P1031, DOI 10.1603/ME11043
   Sang RC, 2003, ARCH VIROL, V148, P1085, DOI 10.1007/s00705-003-0018-8
   Scholte EJ, 2004, J INSECT SCI, V4, DOI 10.1093/jis/4.1.19
   Shahabuddin M, 1998, EXP PARASITOL, V89, P103, DOI 10.1006/expr.1998.4212
   Shaw WR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11772
   Shelly S, 2009, IMMUNITY, V30, P588, DOI 10.1016/j.immuni.2009.02.009
   Shin SW, 2006, J BIOL CHEM, V281, P39388, DOI 10.1074/jbc.M608912200
   Shin SW, 2005, J BIOL CHEM, V280, P16499, DOI 10.1074/jbc.M500711200
   Shoulkamy MA, 2001, MYCOPATHOLOGIA, V149, P99, DOI 10.1023/A:1007299217926
   Sinden RE, 2001, TRENDS PARASITOL, V17, P209, DOI 10.1016/S1471-4922(01)01928-6
   Thangamani S, 2016, AM J TROP MED HYG, V95, P1169, DOI 10.4269/ajtmh.16-0448
   Vaidyanathan R, 2006, APOPTOSIS, V11, P1643, DOI 10.1007/s10495-006-8783-y
   Valero-Jimenez CA, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-479
   Vasilakis N, 2015, CURR OPIN VIROL, V15, P69, DOI 10.1016/j.coviro.2015.08.007
   VERNICK KD, 1995, EXP PARASITOL, V80, P583, DOI 10.1006/expr.1995.1074
   Vlachou D, 2005, CURR BIOL, V15, P1185, DOI 10.1016/j.cub.2005.06.044
   Vlachou D, 2004, CELL MICROBIOL, V6, P671, DOI 10.1111/j.1462-5822.2004.00394.x
   Wang H, 2012, J VIROL, V86, P6546, DOI 10.1128/JVI.00125-12
   Wang YH, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004931
   Ward TW, 2001, INSECT MOL BIOL, V10, P397, DOI 10.1046/j.0962-1075.2001.00276.x
   Warr E, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-37
   WASHBURN JO, 1989, J MED ENTOMOL, V26, P173, DOI 10.1093/jmedent/26.3.173
   Waterhouse RM, 2007, SCIENCE, V316, P1738, DOI 10.1126/science.1139862
   WATTS DM, 1973, SCIENCE, V182, P1140, DOI 10.1126/science.182.4117.1140
   WEAVER SC, 1988, J VIROL, V62, P2083, DOI 10.1128/JVI.62.6.2083-2090.1988
   Whitten MMA, 2006, PARASITE IMMUNOL, V28, P121, DOI 10.1111/j.1365-3024.2006.00804.x
   Xu XJ, 2005, MOL BIOCHEM PARASIT, V142, P76, DOI 10.1016/j.molbiopara.2005.02.013
   Yassine H, 2014, J INNATE IMMUN, V6, P806, DOI 10.1159/000363296
   Yassine H, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003029
   Zhang Q, 2017, INSECT SCI, V24, P714, DOI 10.1111/1744-7917.12401
   Zouache K, 2012, MOL ECOL, V21, P2297, DOI 10.1111/j.1365-294X.2012.05526.x
NR 176
TC 22
Z9 23
U1 8
U2 35
PU ANNUAL REVIEWS
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0897 USA
SN 0066-4170
EI 1545-4487
BN 978-0-8243-0163-7
J9 ANNU REV ENTOMOL
JI Annu. Rev. Entomol.
PY 2018
VL 63
BP 145
EP 167
DI 10.1146/annurev-ento-010715-023530
PG 23
WC Entomology
SC Entomology
GA BJ3ZM
UT WOS:000424633700010
PM 29324042
DA 2020-07-08
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Zika vaccine candidate promising in Phase 1 trials
SO HUMAN VACCINES & IMMUNOTHERAPEUTICS
LA English
DT News Item
CR Modjarrad K, 2018, LANCET, V391, P563, DOI 10.1016/S0140-6736(17)33106-9
NR 1
TC 0
Z9 0
U1 0
U2 0
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 2164-5515
EI 2164-554X
J9 HUM VACC IMMUNOTHER
JI Human Vaccines Immunother.
PY 2018
VL 14
IS 2
BP 247
EP 247
PG 1
WC Biotechnology & Applied Microbiology; Immunology
SC Biotechnology & Applied Microbiology; Immunology
GA FV7JU
UT WOS:000424760400005
DA 2020-07-08
ER

PT J
AU Ozawa, H
   Tajima, S
   Nakayama, E
   Kato, K
   Yamashita, A
   Sekizuka, T
   Kuroda, M
   Usuku, S
AF Ozawa, Hiroki
   Tajima, Shigeru
   Nakayama, Eri
   Kato, Kengo
   Yamashita, Akifumi
   Sekizuka, Tsuyoshi
   Kuroda, Makoto
   Usuku, Shuzo
TI Isolation and Complete Genome Sequencing of Zika Virus Imported from the
   Dominican Republic to Japan
SO JAPANESE JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
AB Zika virus (ZIKV) infection has been documented within Central and South America, Asia, and Africa. Here we report the isolation of virus from a patient infected with ZIKV returning to Japan from the Dominican Republic. The ZIKV strain was imaged by electron microscopy and its complete genome sequence was analyzed. Phylogenetic analysis and molecular characterization revealed that the strain was of Asian lineage, and carried 2 unique mutations in its NS5 region. These mutations are characteristic of strains that originated in the Dominican Republic and the USA in 2016.
C1 [Ozawa, Hiroki; Usuku, Shuzo] Yokohama City Inst Publ Hlth, Dept Microbiol Testing & Res, Kanazawa Ku, Tomiokahigashi 2-7-1, Yokohama, Kanagawa 2360051, Japan.
   [Tajima, Shigeru; Nakayama, Eri] Dept Virol 1, 1-23-1 Toyama, Tokyo 1628640, Japan.
   [Kato, Kengo; Yamashita, Akifumi; Sekizuka, Tsuyoshi; Kuroda, Makoto] Natl Inst Infect Dis, Pathogen Genom Ctr, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628640, Japan.
RP Ozawa, H (corresponding author), Yokohama City Inst Publ Hlth, Kanazawa Ku, Tomiokahigashi 2-7-1, Yokohama, Kanagawa 2360051, Japan.
EM ozawa@city.yokohama.jp
OI Sekizuka, Tsuyoshi/0000-0002-1302-5472; Shigeru,
   Tajima/0000-0002-1981-9062
FU Yokohama Municipal Citizen's Hospital
FX This work was supported by Yokohama Municipal Citizen's Hospital. We
   thank Dr. Natsuo Tachikawa and Dr. Yohei Sakamoto for their help with
   sample collection.
CR Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Guyatt KJ, 2001, J VIROL METHODS, V92, P37, DOI 10.1016/S0166-0934(00)00270-6
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Taira M, 2017, JPN J INFECT DIS, V70, P586, DOI 10.7883/yoken.JJID.2017.042
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   Yamashita A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00032
NR 13
TC 1
Z9 3
U1 0
U2 0
PU NATL INST INFECTIOUS DISEASES
PI TOKYO
PA JPN J INFECT DIS ED OFF NATL INST INFECTIOUS DISEASES TOYAMA 1-23-1,
   SHINJUKU-KU, TOKYO, 162-8640, JAPAN
SN 1344-6304
EI 1884-2836
J9 JPN J INFECT DIS
JI Jpn. J. Infect. Dis.
PD JAN
PY 2018
VL 71
IS 1
BP 72
EP 74
DI 10.7883/yoken.JJID.2017.256
PG 3
WC Infectious Diseases
SC Infectious Diseases
GA FV8TB
UT WOS:000424858600014
PM 29279447
OA Bronze
DA 2020-07-08
ER

PT J
AU Ingle, H
   Peterson, ST
   Baldridge, MT
AF Ingle, Harshad
   Peterson, Stefan T.
   Baldridge, Megan T.
TI Distinct Effects of Type I and III Interferons on Enteric Viruses
SO VIRUSES-BASEL
LA English
DT Review
DE norovirus; rotavirus; reovirus; interferon; microbiota; immunity
ID INTESTINAL EPITHELIAL-CELLS; INNATE IMMUNE-RESPONSE; MURINE NOROVIRUS
   INFECTION; IFN-LAMBDA; STIMULATED GENES; ZIKA VIRUS; ROTAVIRUS
   INFECTION; VIRAL-INFECTION; ADENOVIRUS INFECTIONS; ANTIVIRAL PROTECTION
AB Interferons (IFNs) are key host cytokines in the innate immune response to viral infection, and recent work has identified unique roles for IFN subtypes in regulating different aspects of infection. Currently emerging is a common theme that type III IFNs are critical in localized control of infection at mucosal barrier sites, while type I IFNs are important for broad systemic control of infections. The intestine is a particular site of interest for exploring these effects, as in addition to being the port of entry for a multitude of pathogens, it is a complex tissue with a variety of cell types as well as the presence of the intestinal microbiota. Here we focus on the roles of type I and III IFNs in control of enteric viruses, discussing what is known about signaling downstream from these cytokines, including induction of specific IFN-stimulated genes. We review viral strategies to evade IFN responses, effects of IFNs on the intestine, interactions between IFNs and the microbiota, and briefly discuss the role of IFNs in controlling viral infections at other barrier sites. Enhanced understanding of the coordinate roles of IFNs in control of viral infections may facilitate development of antiviral therapeutic strategies; here we highlight potential avenues for future exploration.
C1 [Ingle, Harshad; Peterson, Stefan T.; Baldridge, Megan T.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.
RP Baldridge, MT (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.
EM hingle@wustl.edu; speterson22@wustl.edu; mbaldridge@wustl.edu
RI Baldridge, Megan/T-7274-2019
OI Baldridge, Megan/0000-0002-7030-6131; Ingle, Harshad/0000-0002-5439-8013
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [K22 AI12784601]; DDRCC grant [P30
   DK052574]; Global Probiotics Council's Young Investigator Grant for
   Probiotics Research
FX Support for this work was provided by NIH grant K22 AI12784601, DDRCC
   grant P30 DK052574, and the Global Probiotics Council's Young
   Investigator Grant for Probiotics Research.
CR Abe K, 2007, P NATL ACAD SCI USA, V104, P17022, DOI 10.1073/pnas.0708469104
   Abt MC, 2012, IMMUNITY, V37, P158, DOI 10.1016/j.immuni.2012.04.011
   Alsharifi M, 2008, IMMUNOL CELL BIOL, V86, P239, DOI 10.1038/sj.icb.7100159
   Anafu AA, 2013, J BIOL CHEM, V288, P17261, DOI 10.1074/jbc.M112.438515
   Angel J, 1999, J INTERF CYTOK RES, V19, P655, DOI 10.1089/107999099313802
   Ank N, 2006, J VIROL, V80, P4501, DOI 10.1128/JVI.80.9.4501-4509.2006
   Au-Yeung Nancy, 2013, JAKSTAT, V2, pe23931, DOI 10.4161/jkst.23931
   Bagchi P, 2013, VIROLOGY, V444, P41, DOI 10.1016/j.virol.2013.07.003
   Bailey CC, 2014, ANNU REV VIROL, V1, P261, DOI 10.1146/annurev-virology-031413-085537
   Baldridge MT, 2017, J VIROL, V91, DOI 10.1128/JVI.02079-16
   Baldridge MT, 2016, TRENDS MOL MED, V22, P1047, DOI 10.1016/j.molmed.2016.10.003
   Baldridge MT, 2015, SCIENCE, V347, P266, DOI 10.1126/science.1258025
   Barro M, 2005, P NATL ACAD SCI USA, V102, P4114, DOI 10.1073/pnas.0408376102
   Barro M, 2007, J VIROL, V81, P4473, DOI 10.1128/JVI.02498-06
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Beachboard DC, 2016, CURR OPIN MICROBIOL, V32, P113, DOI 10.1016/j.mib.2016.05.015
   Berger AK, 2017, J VIROL, V91, DOI 10.1128/JVI.02404-16
   Best SM, 2017, CELL HOST MICROBE, V22, P427, DOI 10.1016/j.chom.2017.09.010
   Bhushal S, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00671
   Blumer T, 2017, J BIOL CHEM, V292, P17928, DOI 10.1074/jbc.M117.788877
   Bolen CR, 2014, HEPATOLOGY, V59, P1262, DOI 10.1002/hep.26657
   Bouziat R, 2017, SCIENCE, V356, P44, DOI 10.1126/science.aah5298
   Brand S, 2005, AM J PHYSIOL-GASTR L, V289, pG960, DOI 10.1152/ajpgi.00126.2005
   Broggi A, 2017, NAT IMMUNOL, V18, P1084, DOI 10.1038/ni.3821
   Cannon MJ, 2010, REV MED VIROL, V20, P202, DOI 10.1002/rmv.655
   Chen GY, 2011, J IMMUNOL, V186, P7187, DOI 10.4049/jimmunol.1100412
   Chen JL, 2017, CELL REP, V21, P1588, DOI 10.1016/j.celrep.2017.10.059
   Chen SY, 2017, SCI REP-UK, V7, DOI 10.1038/srep46130
   Chiriac MT, 2017, GASTROENTEROLOGY, V153, P123, DOI 10.1053/j.gastro.2017.03.015
   Coccia EM, 2004, EUR J IMMUNOL, V34, P796, DOI 10.1002/eji.200324610
   Cooper RJ, 2000, EPIDEMIOL INFECT, V125, P333, DOI 10.1017/S0950268899004550
   Corry J, 2017, P NATL ACAD SCI USA, V114, P9433, DOI 10.1073/pnas.1707513114
   Davidson S, 2016, EMBO MOL MED, V8, P1099, DOI 10.15252/emmm.201606413
   de Weerd NA, 2017, J BIOL CHEM, V292, P7554, DOI 10.1074/jbc.M116.773788
   de Weerd NA, 2013, NAT IMMUNOL, V14, P901, DOI 10.1038/ni.2667
   de Weerd NA, 2012, IMMUNOL CELL BIOL, V90, P483, DOI 10.1038/icb.2012.9
   Diebold SS, 2003, NATURE, V424, P324, DOI 10.1038/nature01783
   Douam F., 2017, MBIO, V8, DOI [10. 1128/mBio. 00819-17 28811340, DOI 10.1128/MBI0.00819-1728811340]
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dumoutier L, 2004, J BIOL CHEM, V279, P32269, DOI 10.1074/jbc.M404789200
   Durbin RK, 2013, IMMUNOL REV, V255, P25, DOI 10.1111/imr.12101
   Echavarria M, 2008, CLIN MICROBIOL REV, V21, P704, DOI 10.1128/CMR.00052-07
   Egli A, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.51
   Emmott E, 2017, MOL CELL PROTEOMICS, V16, pS215, DOI 10.1074/mcp.M116.062448
   Espinosa V., 2017, SCI IMMUNOL, V2, DOI [10. 1126/sciimmunol. aan5357 28986419, DOI 10.1126/SCIIMMUN0L.AAN535728986419]
   Everitt AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080723
   Fan JB, 2015, P NATL ACAD SCI USA, V112, P14313, DOI 10.1073/pnas.1505690112
   Feeley EM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002337
   Feng N, 2008, J VIROL, V82, P7578, DOI 10.1128/JVI.00391-08
   Fischer JC, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag2513
   FOX JP, 1969, AM J EPIDEMIOL, V89, P25, DOI 10.1093/oxfordjournals.aje.a120913
   Galani IE, 2017, IMMUNITY, V46, P875, DOI 10.1016/j.immuni.2017.04.025
   Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133
   Grau KR, 2017, NAT MICROBIOL, V2, P1586, DOI 10.1038/s41564-017-0057-7
   Harris V, 2018, GUT MICROBES, V9, P93, DOI 10.1080/19490976.2017.1376162
   Harris VC, 2017, J INFECT DIS, V215, P34, DOI 10.1093/infdis/jiw518
   Helbig KJ, 2014, J MOL BIOL, V426, P1210, DOI 10.1016/j.jmb.2013.10.019
   Hemann EA, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01707
   Hernandez PP, 2015, NAT IMMUNOL, V16, P698, DOI 10.1038/ni.3180
   Hickman D., 2014, MBIO, V5, DOI [10. 1128/mBio. 01032-13 24595373, DOI 10.1128/MBI0.01032-1324595373]
   Holloway G, 2014, J GEN VIROL, V95, P1723, DOI 10.1099/vir.0.064063-0
   Holm CK, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10680
   Holm CK, 2012, NAT IMMUNOL, V13, P737, DOI 10.1038/ni.2350
   Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234
   Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108
   ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048
   Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581
   Jaitin DA, 2006, MOL CELL BIOL, V26, P1888, DOI 10.1128/MCB.26.5.1888-1897.2006
   Jewell NA, 2010, J VIROL, V84, P11515, DOI 10.1128/JVI.01703-09
   Jilg N, 2014, HEPATOLOGY, V59, P1250, DOI 10.1002/hep.26653
   Johansson C, 2007, J EXP MED, V204, P1349, DOI 10.1084/jem.20061587
   Jones MK, 2014, SCIENCE, V346, P755, DOI 10.1126/science.1257147
   Kahan SM, 2011, VIROLOGY, V421, P202, DOI 10.1016/j.virol.2011.09.030
   Karst SM, 2003, SCIENCE, V299, P1575, DOI 10.1126/science.1077905
   Katakura K, 2005, J CLIN INVEST, V115, P695, DOI 10.1172/JCI200522996
   Katlinskaya YV, 2016, MOL CELL BIOL, V36, P1124, DOI 10.1128/MCB.00988-15
   Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010
   Kernbauer E, 2014, NATURE, V516, P94, DOI 10.1038/nature13960
   Ketscher L, 2015, P NATL ACAD SCI USA, V112, P1577, DOI 10.1073/pnas.1412881112
   Kim MJ, 2008, J VIROL, V82, P1474, DOI 10.1128/JVI.01650-07
   Kisseleva T, 2002, GENE, V285, P1, DOI 10.1016/S0378-1119(02)00398-0
   Kosulin K, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2015.12.013
   Kotenko SV, 2017, J BIOL CHEM, V292, P7295, DOI 10.1074/jbc.R117.777102
   Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875
   Kotredes KP, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00410
   Kuss SK, 2011, SCIENCE, V334, P249, DOI 10.1126/science.1211057
   Lam E, 2014, J VIROL, V88, P974, DOI 10.1128/JVI.02702-13
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2015, IMMUNITY, V43, P15, DOI 10.1016/j.immuni.2015.07.001
   Lazear HM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4304
   Lee S, 2017, CELL HOST MICROBE, V22, P449, DOI 10.1016/j.chom.2017.08.021
   Lee S, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00749
   LENGYEL P, 1982, ANNU REV BIOCHEM, V51, P251, DOI 10.1146/annurev.bi.51.070182.001343
   Li J., 2013, MBIO, V4, DOI [10. 1128/mBio. 00385-13 23781071, DOI 10.1128/MBI0.00385-1323781071]
   Li L, 2017, ANTIVIR RES, V140, P76, DOI 10.1016/j.antiviral.2017.01.012
   Li YZ, 2016, P NATL ACAD SCI USA, V113, P2241, DOI 10.1073/pnas.1519657113
   Lienenklaus S, 2009, J IMMUNOL, V183, P3229, DOI 10.4049/jimmunol.0804277
   Lin JD, 2016, PLOS PATHOG, V12, DOI [10.1371/journal.ppat.1005600, 10.1371/journal.ppat.1005726]
   Lind K, 2016, J GEN VIROL, V97, P1368, DOI 10.1099/jgv.0.000443
   Liu B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133800
   Lloyd-Price J, 2017, NATURE, V550, P61, DOI 10.1038/nature23889
   Mahlakoiv T, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004782
   Marchiando AM, 2010, ANNU REV PATHOL-MECH, V5, P119, DOI 10.1146/annurev.pathol.4.110807.092135
   McFadden N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002413
   McFarlane AJ, 2017, J ALLERGY CLIN IMMUN, V140, P1068, DOI 10.1016/j.jaci.2017.01.016
   McNab F, 2015, NAT REV IMMUNOL, V15, P87, DOI 10.1038/nri3787
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mordstein M, 2010, J VIROL, V84, P5670, DOI 10.1128/JVI.00272-10
   Morelli M., 2015, MBIO, V6, DOI [10. 1128/mBio. 02490-14 25626907, DOI 10.1128/MBI0.02490-1425626907]
   Morelli M, 2015, VIROLOGY, V479, P75, DOI 10.1016/j.virol.2015.01.006
   Muir AJ, 2010, HEPATOLOGY, V52, P822, DOI 10.1002/hep.23743
   Nandi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092126
   Nelson AM, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-7
   Nelson AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048224
   Nice TJ, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005684
   Nice TJ, 2015, SCIENCE, V347, P269, DOI 10.1126/science.1258100
   Nice TJ, 2013, J VIROL, V87, P327, DOI 10.1128/JVI.01864-12
   Novatt H, 2016, J INTERF CYTOK RES, V36, P589, DOI 10.1089/jir.2016.0031
   Odendall C, 2014, NAT IMMUNOL, V15, P717, DOI 10.1038/ni.2915
   Okabayashi T, 2011, VIRUS RES, V160, P360, DOI 10.1016/j.virusres.2011.07.011
   Onoguchi K, 2007, J BIOL CHEM, V282, P7576, DOI 10.1074/jbc.M608618200
   Pervolaraki K, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00459
   Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x
   Pestka S, 2007, J BIOL CHEM, V282, P20047, DOI 10.1074/jbc.R700004200
   Peterson LW, 2014, NAT REV IMMUNOL, V14, P141, DOI 10.1038/nri3608
   Pinto AK, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004086
   Planet P.J., 2016, MBIO, V7, DOI [10. 1128/mBio. 01939-15 26861017, DOI 10.1128/MBI0.01939-1526861017]
   Pott J, 2011, P NATL ACAD SCI USA, V108, P7944, DOI 10.1073/pnas.1100552108
   Pulit-Penaloza JA, 2012, VIROLOGY, V425, P82, DOI 10.1016/j.virol.2012.01.006
   Pulverer JE, 2010, J VIROL, V84, P8626, DOI 10.1128/JVI.00303-10
   Qin L, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-526
   Ramanan P, 2013, INFECT CHEMOTHER, V45, P260, DOI 10.3947/ic.2013.45.3.260
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rauch I, 2015, MOL CELL BIOL, V35, P2332, DOI 10.1128/MCB.01498-14
   Rauch I, 2014, EUR J IMMUNOL, V44, P2749, DOI 10.1002/eji.201344401
   Reid E, 2016, J IMMUNOL, V196, P4214, DOI 10.4049/jimmunol.1600049
   Ritchie KJ, 2004, NAT MED, V10, P1374, DOI 10.1038/nm1133
   Rivero-Calle I, 2016, J INFECTION, V72, pS98, DOI 10.1016/j.jinf.2016.04.029
   Robb RJ, 2011, BLOOD, V118, P3399, DOI 10.1182/blood-2010-12-325746
   Rocha-Pereira J, 2018, ANTIVIR RES, V149, P7, DOI 10.1016/j.antiviral.2017.10.017
   Rodriguez MR, 2014, J VIROL, V88, P9277, DOI 10.1128/JVI.01422-14
   Roy S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024859
   Saito M, 2014, CLIN INFECT DIS, V58, P483, DOI 10.1093/cid/cit763
   Samuel MA, 2005, J VIROL, V79, P13350, DOI 10.1128/JVI.79.21.13350-13361.2005
   Sanchez-Tacuba L, 2015, J VIROL, V89, P12145, DOI 10.1128/JVI.01874-15
   Saxena K, 2017, P NATL ACAD SCI USA, V114, pE570, DOI 10.1073/pnas.1615422114
   Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200
   Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231
   Schoenborn JR, 2007, ADV IMMUNOL, V96, P41, DOI 10.1016/S0065-2776(07)96002-2
   Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907
   Selvakumar TA, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01302
   Sen A., 2017, J VIROL, DOI [10. 1128/JVI. 01394-17 29070687, DOI 10.1128/JVI.01394-1729070687]
   Sen A, 2014, J VIROL, V88, P41, DOI 10.1128/JVI.01501-13
   Sen A, 2012, P NATL ACAD SCI USA, V109, P20667, DOI 10.1073/pnas.1212188109
   Seo JY, 2011, SCIENCE, V332, P1093, DOI 10.1126/science.1202007
   Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873
   Sherwood V, 2007, J GEN VIROL, V88, P71, DOI 10.1099/vir.0.82445-0
   Sherwood V, 2012, J GEN VIROL, V93, P618, DOI 10.1099/vir.0.037556-0
   Shi Y, 2014, NAT REV MICROBIOL, V12, P822, DOI 10.1038/nrmicro3362
   Silverman RH, 2014, J INTERF CYTOK RES, V34, P455, DOI 10.1089/jir.2014.0007
   Sommereyns C., 2008, PLOS PATHOG, V4, DOI [10. 1371/journal. ppat. 1000017 18369468, DOI 10.1371/J0URNAL.PPAT.100001718369468]
   Stanifer ML, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11469-6
   Stawowczyk M, 2011, J BIOL CHEM, V286, P7257, DOI 10.1074/jbc.M110.207068
   Steed AL, 2017, SCIENCE, V357, P498, DOI 10.1126/science.aam5336
   Steinberg C, 2009, EUR J IMMUNOL, V39, P1007, DOI 10.1002/eji.200838814
   Sun LL, 2015, CELL HOST MICROBE, V17, P85, DOI 10.1016/j.chom.2014.11.004
   Suthar MS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003168
   Swiecki M, 2017, MUCOSAL IMMUNOL, V10, P936, DOI 10.1038/mi.2016.99
   Tartour K, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006610
   Terenzi F, 2005, VIROLOGY, V340, P116, DOI 10.1016/j.virol.2005.06.011
   Thackray LB, 2012, J VIROL, V86, P13515, DOI 10.1128/JVI.01824-12
   Thompson D.G., 2010, OXFORD TXB MED, P2201
   Tian JK, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/705367
   Tissera MS, 2017, HUM VACC IMMUNOTHER, V13, P921, DOI 10.1080/21645515.2016.1252493
   Tomov VT, 2017, IMMUNITY, V47, P723, DOI 10.1016/j.immuni.2017.09.017
   Tropini C, 2017, CELL HOST MICROBE, V21, P433, DOI 10.1016/j.chom.2017.03.010
   Tschurtschenthaler M, 2014, GUT, V63, P1921, DOI 10.1136/gutjnl-2013-305863
   Uchiyama R, 2014, J INFECT DIS, V210, P171, DOI 10.1093/infdis/jiu037
   Voigt EA, 2015, J INTERF CYTOK RES, V35, P734, DOI 10.1089/jir.2015.0008
   Wack A, 2015, NAT IMMUNOL, V16, P802, DOI 10.1038/ni.3212
   Wang PH, 2015, SCIENCE, V350, P826, DOI 10.1126/science.aab3145
   Wang XY, 2007, CELL HOST MICROBE, V2, P96, DOI 10.1016/j.chom.2007.06.009
   Warren CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096579
   Winkler CW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07099-7
   Wobus CE, 2004, PLOS BIOL, V2, P2076, DOI 10.1371/journal.pbio.0020432
   Yang JY, 2016, IMMUNITY, V44, P889, DOI 10.1016/j.immuni.2016.03.009
   Yu QJ, 2015, CELL REP, V11, P785, DOI 10.1016/j.celrep.2015.03.069
   Zhang R, 2013, P NATL ACAD SCI USA, V110, P13114, DOI 10.1073/pnas.1306917110
   Zhao C, 2005, P NATL ACAD SCI USA, V102, P10200, DOI 10.1073/pnas.0504754102
   Zhou ZL, 2007, J VIROL, V81, P7749, DOI 10.1128/JVI.02438-06
   Zhu S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003592
NR 192
TC 10
Z9 10
U1 0
U2 16
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD JAN
PY 2018
VL 10
IS 1
AR 46
DI 10.3390/v10010046
PG 23
WC Virology
SC Virology
GA FV2RE
UT WOS:000424414900045
PM 29361691
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Tan, CH
   Tan, LK
   Hapuarachchi, HC
   Lai, YL
   Wong, PSJ
   Yap, G
   Mak, KW
   Wong, WY
   Leo, YS
   Wong, MC
   Ng, LC
AF Tan, Cheong Huat
   Tan, Li Kiang
   Hapuarachchi, Hapuarachchige Chanditha
   Lai, Yee Ling
   Wong, Pei Sze Jeslyn
   Yap, Grace
   Mak, Keng Wai
   Wong, Wing Yan
   Leo, Yee Sin
   Wong, Mei Chun
   Ng, Lee Ching
TI Viral and Antibody Kinetics, and Mosquito Infectivity of an Imported
   Case of Zika Fever Due to Asian Genotype (American Strain) in Singapore
SO VIRUSES-BASEL
LA English
DT Article
DE Zika virus; antibody; mosquito
ID AEDES-AEGYPTI MOSQUITOS; VIRUS; TRANSMISSION; BLOOD
AB We report a case of a Singaporean who acquired Zika virus (ZIKV) during a visit to Cuba. The infection was confirmed using molecular and serological methods. This report highlights potential drawbacks of using IgG serology for diagnosis of flavivirus infections in endemic regions. The low viremia detected during the early phase of this case resulted in low mosquito infectivity rates, suggesting the possibility of ZIKV transmission prior to clinical onset. The report also emphasizes the challenges of public health interventions for Zika fever and the importance of sustaining a low vector population to reduce the risk of arbovirus transmission in vulnerable regions.
C1 [Tan, Cheong Huat; Tan, Li Kiang; Hapuarachchi, Hapuarachchige Chanditha; Lai, Yee Ling; Wong, Pei Sze Jeslyn; Yap, Grace; Mak, Keng Wai; Wong, Wing Yan; Ng, Lee Ching] Environm Hlth Inst, Singapore 138667, Singapore.
   [Leo, Yee Sin] Tan Tock Seng Hosp, 11 Jalan Tan Tock Seng, Singapore 308433, Singapore.
   [Wong, Mei Chun] CMC Wong Binjai Clin, 15 Binjai Pk, Singapore 589824, Singapore.
   [Ng, Lee Ching] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore.
RP Ng, LC (corresponding author), Environm Hlth Inst, Singapore 138667, Singapore.; Ng, LC (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore.
EM Tan_cheong_huat@nea.gov.sg; Tan_li_kiang@nea.gov.sg;
   Chanditha_Hapuarachchi@nea.gov.sg; Lai_Yee_Ling@nea.gov.sg;
   Jeslyn_Wong@nea.gov.sg; Grace_Yap@nea.gov.sg; Mak_Keng_Wai@nea.gov.sg;
   Wong_Wing_yan@nea.gov.sg; Yee_Sin_Leo@ttsh.com.sg;
   cmcWongBinjaiClinic@hotmail.sg; Ng_Lee_Ching@nea.gov.sg
OI Hapuarachchi, Hapuarachchige Chanditha/0000-0001-7079-8538
FU National Environment Agency (NEA), Singapore
FX This study was supported by the National Environment Agency (NEA),
   Singapore. We thank Derek Ho, Director-General for Public Health, NEA
   for approval to publish the study.
CR Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Caminade C, 2017, P NATL ACAD SCI USA, V114, P119, DOI 10.1073/pnas.1614303114
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Ciota AT, 2017, EMERG INFECT DIS, V23, P880, DOI 10.3201/eid2305.162041
   Dasgupta S, 2016, MMWR-MORBID MORTAL W, V65, P395, DOI 10.15585/mmwr.mm6515e1
   Gardner L, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005487
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   Hills SL, 2017, J INFECT DIS, V216, pS868, DOI 10.1093/infdis/jix434
   Ho ZJM, 2017, LANCET INFECT DIS, V17, P813, DOI 10.1016/S1473-3099(17)30249-9
   Ikejezie J, 2017, MMWR-MORBID MORTAL W, V66, P329, DOI 10.15585/mmwr.mm6612a4
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Low SL, 2015, AM J TROP MED HYG, V93, P40, DOI 10.4269/ajtmh.14-0671
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Ministry of Health Singapore, WEEKL INF DIS B
   Mittal R, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00486
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Pompon J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01282-6
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Roundy CM, 2017, EMERG INFECT DIS, V23, P625, DOI 10.3201/eid2304.161484
   Tan CH, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1469-6
   Yap G, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001046
NR 23
TC 4
Z9 4
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD JAN
PY 2018
VL 10
IS 1
AR 44
DI 10.3390/v10010044
PG 7
WC Virology
SC Virology
GA FV2RE
UT WOS:000424414900043
PM 29346272
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Sutan, R
   Yeong, ML
   Mahdy, ZA
   Shuhaila, A
   Rohana, J
   Ishak, S
   Shamsuddin, K
   Ismail, A
   Idris, IB
   Sulong, S
AF Sutan, Rosnah
   Yeong, May Luu
   Mahdy, Zaleha Abdullah
   Shuhaila, Ahmad
   Rohana, Jaafar
   Ishak, Shareena
   Shamsuddin, Khadijah
   Ismail, Aniza
   Idris, Idayu Badillah
   Sulong, Saperi
TI Trend of head circumference as a predictor of microcephaly among term
   infants born at a regional center in Malaysia between 2011-2015
SO RESEARCH AND REPORTS IN NEONATOLOGY
LA English
DT Article
DE SGA; perinatal; growth chart; IUGR; birth parameter; occipito-frontal
ID WORLD-HEALTH-ORGANIZATION; ZIKA VIRUS-INFECTION; GROWTH STANDARDS;
   ANTHROPOMETRIC MEASUREMENTS; BIRTH-WEIGHT; CHILDREN; NEWBORNS; SIZE;
   INTELLIGENCE; APPROPRIATE
AB Introduction: The aim of this study was to determine the trend of head circumference as predictor of microcephaly among term infants born in a teaching hospital in Malaysia from 2011 to 2015.
   Methodology: This was a cross-sectional study using data from the electronic birth census. The independent variables were mothers' age and height, parity, birth weight and birth length. All term newborns, both alive and stillbirth, with 37-41 completed gestational weeks, and a birth weight of at least 500 g was extracted from the census.
   Results: A total of 26,503 newborns fulfilled the inclusion criteria (13,655 males, 12,840 females). The mean head circumferences for male and female newborns were 32.93 cm (+/- SD 1.32) and 32.56 cm (+/- SD 1.31). The average head circumference for Malaysian newborns was found to be smaller than the World Health Organization Standard Growth Chart for Term Infant. A total of 17.6% (n=4,669) of the total samples were observed to have microcephaly. Among them, 73.2% (n=3,419) were non-proportionate microcephaly with normal birth weight of 2.5kg and above. Bivariate analyses showed that all independent variables were significant predictors of microcephaly. Both simple and multiple logistic regressions demonstrated that low birth weight was the most significant predictors for microcephaly (adjusted OR 12.14, 95% CI 10.80, 13.65).
   Conclusion: There is an increasing trend of microcephaly across the years and the low birth weight was noted as the main predictor of microcephaly. Future studies are needed to determine the possible cause of increasing microcephaly by controlling for birth weight and gestational age of the neonates.
C1 [Sutan, Rosnah; Yeong, May Luu; Shamsuddin, Khadijah; Ismail, Aniza; Idris, Idayu Badillah] Univ Kebangsaan Malaysia, Med Ctr, Dept Community Hlth, Kuala Lumpur, Malaysia.
   [Mahdy, Zaleha Abdullah; Shuhaila, Ahmad] Univ Kebangsaan Malaysia, Med Ctr, Dept Obstet & Gynecol, Kuala Lumpur, Malaysia.
   [Rohana, Jaafar; Ishak, Shareena] Univ Kebangsaan Malaysia, Dept Pediat, Kuala Lumpur, Malaysia.
   [Sulong, Saperi] Univ Kebangsaan Malaysia, Dept Med Records, Kuala Lumpur, Malaysia.
RP Sutan, R (corresponding author), Univ Kebangsaan Malaysia, Med Ctr, Dept Community Hlth, Fac Med, Jalan Yaacob Latif, Kuala Lumpur 56000, Malaysia.
EM rosnah_sutan@yahoo.com
RI Ismail, Aniza/AAA-9721-2020; Mahdy, Zaleha Abdullah/B-4061-2009; sutan,
   rosnah/F-4732-2017
OI Mahdy, Zaleha Abdullah/0000-0003-0856-0697; sutan,
   rosnah/0000-0001-9956-4727
CR Allanson JE, 2009, AM J MED GENET A, V149A, P6, DOI 10.1002/ajmg.a.32612
   Aris IM, 2014, ANN ACAD MED SINGAP, V43, P439
   Bartholomeusz HH, 2002, NEUROPEDIATRICS, V33, P239, DOI 10.1055/s-2002-36735
   Berg B., 2014, ENCY NEUROLOGICAL SC, P3
   Boo N. Y., 1994, Singapore Medical Journal, V35, P163
   Brantsaeter AL, 2012, BRIT J NUTR, V107, P436, DOI 10.1017/S0007114511003047
   Broekman BFP, 2009, PEDIATRICS, V123, pE1011, DOI 10.1542/peds.2008-3344
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Cole TJ, 1996, HORM RES, V45, P18, DOI 10.1159/000184843
   de Onis Mercedes, 2004, Food Nutr Bull, V25, pS15
   Division of Family Health Development, 2013, PER CAR MAN
   Dwipoerwantoro PG, 2015, J PEDIATR GASTR NUTR, V61, P248, DOI 10.1097/MPG.0000000000000770
   Elmali F, 2012, PEDIATR NEUROL, V46, P307, DOI 10.1016/j.pediatrneurol.2012.02.016
   Eriksen HLF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079200
   Fok TF, 2003, ARCH DIS CHILD-FETAL, V88, P229, DOI 10.1136/fn.88.3.F229
   Gale CR, 2006, PEDIATRICS, V118, P1486, DOI 10.1542/peds.2005-2629
   Grummer-Strawn Laurence M., 2010, Morbidity and Mortality Weekly Report, V59, P1
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Gundacker C, 2010, SCI TOTAL ENVIRON, V408, P5744, DOI 10.1016/j.scitotenv.2010.07.079
   Hernandez-Avila M, 2002, ARCH ENVIRON HEALTH, V57, P482, DOI 10.1080/00039890209601441
   Hui LL, 2008, ARCH DIS CHILD, V93, P561, DOI 10.1136/adc.2007.119826
   Ingvarsson RF, 2007, ACTA PAEDIATR, V96, P383, DOI 10.1111/j.1651-2227.2007.00103.x
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Johnson DE, 2003, DOES SIZE MATTER IS
   Kallen K, 2001, EUR J PUBLIC HEALTH, V11, P329, DOI 10.1093/eurpub/11.3.329
   Kirchengast S, 2003, AM J HUM BIOL, V15, P220, DOI 10.1002/ajhb.10139
   Lira PIC, 2010, DEV MED CHILD NEUROL, V52, P40, DOI 10.1111/j.1469-8749.2009.03353.x
   McKeague IW, 2015, BIOL PSYCHIAT, V77, P833, DOI 10.1016/j.biopsych.2014.08.008
   MOH, 2013, CHID HOM REC
   National Healthcare Group Polyclinics, 2015, CHILD HLTH SERV IMM
   NEGGERS Y, 1995, OBSTET GYNECOL, V85, P192, DOI 10.1016/0029-7844(94)00364-J
   SELLS CJ, 1977, PEDIATRICS, V59, P262
   Shajari H, 2006, ACTA MED IRANICA, V44, P400
   Tanaka H, 2013, ACTA PAEDIATR, V102, P739, DOI 10.1111/apa.12262
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Telatar B, 2009, SAUDI MED J, V30, P409
   Thame M, 1997, EUR J CLIN NUTR, V51, P134, DOI 10.1038/sj.ejcn.1600357
   Von der Hagen M, 2014, DEV MED CHILD NEUROL, V56, P732, DOI 10.1111/dmcn.12425
   Wardlaw T. M, 2004, LOW BIRTHW COUNTR RE
   WHO, CHILD GROWTH STAND
   WHO Multicentre Growth Reference Study Group, 2006, WHO CHILD GROWTH STA
NR 41
TC 0
Z9 0
U1 0
U2 0
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
EI 1179-9935
J9 RES REP NEONATOL
JI Res. Rep. Neonatol.
PY 2018
VL 8
BP 9
EP 17
DI 10.2147/RRN.S140889
PG 9
WC Pediatrics
SC Pediatrics
GA FV2UC
UT WOS:000424422500001
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Cairns, DM
   Boorgu, DSSK
   Levin, M
   Kaplan, DL
AF Cairns, Dana M.
   Boorgu, Devi Sai Sri Kavya
   Levin, Michael
   Kaplan, David L.
TI Niclosamide rescues microcephaly in a humanized in vivo model of Zika
   infection using human induced neural stem cells
SO BIOLOGY OPEN
LA English
DT Article
DE Zika virus; Chick embryo; Neural stem cells; Microcephaly
ID VIRUS-INFECTION; CHICK; PROGENITORS; DYSFUNCTION; EXPRESSION;
   PROTECTION; CYTOKINES; SYSTEM; MOUSE
AB Zika virus (ZIKV) is a mosquito-transmitted flavivirus with a causative link to microcephaly, a condition resulting in reduced cranial size and brain abnormalities. Despite recent progress, there is a current lack of in vivo models that permit the study of systemic virus on human neurons in a developing organism that replicates the pathophysiology of human disease. Furthermore, no treatment to date has been reported to reduce ZIKV-induced microcephaly. We tested the effects of ZIKV on human induced neural stem cells (hiNSCs) in vitro and found that infected hiNSCs secrete inflammatory cytokines, display altered differentiation, and become apoptotic. We also utilized this in vitro system to assess the therapeutic effects of niclosamide, an FDA-approved anthelminthic, and found that it decreases ZIKV production, partially restores differentiation, and prevents apoptosis in hiNSCs. We intracranially injected hiNSCs into developing chicks, subjected them to systemic ZIKV infection via the chorioallantoic membrane (CAM), a tissue similar in structure and function to the mammalian placenta, and found that humanized ZIKV-infected embryos developed severe microcephaly including smaller crania, decreased forebrain volume and enlarged ventricles. Lastly, we utilized this humanized model to show that CAM-delivery of niclosamide can partially rescue ZIKV-induced microcephaly and attenuate infection of hiNSCs in vivo.
   This article has an associated First Person interview with the first author of the paper.
C1 [Cairns, Dana M.; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Boorgu, Devi Sai Sri Kavya; Levin, Michael] Tufts Univ, Dept Biol, Medford, MA 02155 USA.
   [Levin, Michael; Kaplan, David L.] Tufts Univ, Allen Discovery Ctr, Medford, MA 02155 USA.
RP Kaplan, DL (corresponding author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.; Kaplan, DL (corresponding author), Tufts Univ, Allen Discovery Ctr, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
RI Levin, Michael/A-5918-2011
OI Levin, Michael/0000-0001-7292-8084; Cairns, Dana/0000-0003-0574-8395
FU Allen Discovery Center program through The Paul G. Allen Frontiers Group
   [12171]; National Institutes of Health (NIH)United States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA
   [R01NS092847, P41EB002520]
FX This research was supported by the Allen Discovery Center program
   through The Paul G. Allen Frontiers Group (12171) as well as the
   National Institutes of Health (NIH) (R01NS092847 and P41EB002520).
CR Bayless NL, 2016, CELL HOST MICROBE, V20, P423, DOI 10.1016/j.chom.2016.09.006
   Bjornstad S, 2015, J PHARMACOL EXP THER, V355, P386, DOI 10.1124/jpet.115.227025
   Cairns DM, 2016, STEM CELL REP, V7, P557, DOI 10.1016/j.stemcr.2016.07.017
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Chai QQ, 2015, J VIROL, V89, P870, DOI 10.1128/JVI.02154-14
   Coghlan S, 2012, NEUROSCI BIOBEHAV R, V36, P2044, DOI 10.1016/j.neubiorev.2012.07.005
   Cordeiro CN, 2015, OBSTET GYNECOL SURV, V70, P644, DOI 10.1097/OGX.0000000000000236
   Crespo R, 2009, AVIAN DIS, V53, P608, DOI 10.1637/8829-040209-ResNote.1
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Gabriel E, 2017, CELL STEM CELL, V20, P397, DOI 10.1016/j.stem.2016.12.005
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Goodfellow FT, 2016, STEM CELLS DEV, V25, P1691, DOI 10.1089/scd.2016.0231
   Hayes WJ, 1991, HDB PESTICIDE TOXICO
   Kain KH, 2014, DEV DYNAM, V243, P216, DOI 10.1002/dvdy.24093
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   LEVY MILTON, 1940, JOUR BIOL CHEM, V136, P415
   Li CF, 2017, IMMUNITY, V46, P446, DOI 10.1016/j.immuni.2017.02.012
   Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Liu SF, 2016, CIRC RES, V119, P1183, DOI [10.1161/CIRCRESAHA.116.309866, 10.1161/circresaha.116.309866]
   LUNDGREN P, 1995, INT J DEV NEUROSCI, V13, P463, DOI 10.1016/0736-5748(95)00010-E
   Mackenzie F, 2012, DEVELOPMENT, V139, P1371, DOI 10.1242/dev.072348
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Muthumani K, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.21
   Ojeda AF, 2013, GENE EXPR PATTERNS, V13, P303, DOI 10.1016/j.gep.2013.05.006
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [DOI 10.1001/JAMA0PHTHALM0L.2016.0267, 10.1001/jamaophthalmol.2016.0267]
   Ramamoorthi K, 2011, TRENDS MOL MED, V17, P452, DOI 10.1016/j.molmed.2011.03.003
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   SCHNEIDER BF, 1979, TERATOLOGY, V19, P273, DOI 10.1002/tera.1420190302
   Shao Q, 2016, DEVELOPMENT, V143, P4127, DOI 10.1242/dev.143768
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Vermillion MS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14575
   WAY HJ, 1976, J GEN VIROL, V30, P123, DOI 10.1099/0022-1317-30-1-123
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yuri B, 2012, FRONT PSYCHIATRY, V3, P1
   Zhou Z, 2015, BMC DEV BIOL, V15, DOI 10.1186/s12861-015-0077-6
NR 44
TC 13
Z9 14
U1 0
U2 3
PU COMPANY BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING, STATION RD, HISTON, CAMBRIDGE CB24 9LF, ENGLAND
SN 2046-6390
J9 BIOL OPEN
JI Biol. Open
PD JAN
PY 2018
VL 7
IS 1
AR UNSP bio031807
DI 10.1242/bio.031807
PG 11
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA FU8CX
UT WOS:000424081100030
PM 29378701
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI mAbs Against Zika Show Promise
SO BIOPHARM INTERNATIONAL
LA English
DT Editorial Material
CR Magnani DM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan8184
NR 1
TC 0
Z9 0
U1 0
U2 0
PU ADVANSTAR COMMUNICATIONS INC
PI DULUTH
PA 131 W 1ST STREET, DULUTH, MN 55802 USA
SN 1542-166X
EI 1939-1862
J9 BIOPHARM INT
JI Biopharm. Int.
PD JAN
PY 2018
VL 31
IS 1
BP 6
EP 6
PG 1
WC Biotechnology & Applied Microbiology; Pharmacology & Pharmacy
SC Biotechnology & Applied Microbiology; Pharmacology & Pharmacy
GA FU7WM
UT WOS:000424063400003
DA 2020-07-08
ER

PT J
AU Angelidou, A
   Michael, Z
   Hotz, A
   Friedman, K
   Emani, S
   LaRovere, K
   Christou, H
AF Angelidou, Asimenia
   Michael, Zoe
   Hotz, Arda
   Friedman, Kevin
   Emani, Sitaram
   LaRovere, Kerri
   Christou, Helen
TI Is There More to Zika? Complex Cardiac Disease in a Case of Congenital
   Zika Syndrome
SO NEONATOLOGY
LA English
DT Article
DE Hypoplastic left heart syndrome; Microcephaly; Polymicrogyria; Staged
   palliation; Tropism
ID VIRUS-INFECTION; BIRTH-DEFECTS; INVOLVEMENT; OUTCOMES; INFANTS
AB The epidemic of Zika virus (ZIKV) has resulted in a surge of newborns with microcephaly and brain abnormalities. In this report, we describe the first case, to our knowledge, of congenital Zika syndrome with concomitant critical congenital heart disease. The mother had a confirmed ZIKV infection in the first trimester of pregnancy. Fetal ultrasonography at 31 weeks of gestation revealed cerebral cortical calcifications and hypoplastic left heart syndrome. The severity of brain involvement was assessed by postnatal magnetic resonance imaging and echocardiogram, and palliative surgery was performed. The ethical dimensions of this infant's clinical management are discussed. ZIKV is known to affect neural progenitor cells, but whether it could have a tropism for other tissues remains unclear. (c) 2017 S. Karger AG, Basel
C1 [Angelidou, Asimenia; Christou, Helen] Boston Childrens Hosp, Div Newborn Med, 300 Longwood Ave,Enders 9, Boston, MA 02115 USA.
   [Angelidou, Asimenia; Michael, Zoe; Hotz, Arda; Friedman, Kevin; Emani, Sitaram; LaRovere, Kerri; Christou, Helen] Harvard Med Sch, Boston, MA USA.
   [Michael, Zoe; Christou, Helen] Brigham & Womens Hosp, Dept Pediat Newborn Med, Boston, MA 02115 USA.
   [Hotz, Arda] Boston Childrens Hosp, Dept Med, Boston, MA 02115 USA.
   [Friedman, Kevin] Boston Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA.
   [Emani, Sitaram] Boston Childrens Hosp, Dept Cardiovasc Surg, Boston, MA 02115 USA.
   [LaRovere, Kerri] Boston Childrens Hosp, Dept Neurol, Boston, MA 02115 USA.
RP Angelidou, A (corresponding author), Boston Childrens Hosp, Div Newborn Med, 300 Longwood Ave,Enders 9, Boston, MA 02115 USA.
EM asimenia.angelidou@childrens.harvard.edu
RI Michael, Zoe/A-4108-2017
OI Michael, Zoe/0000-0001-7318-0215
CR Aletti M, 2017, CLIN INFECT DIS, V64, P678, DOI 10.1093/cid/ciw802
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cavalcanti DD, 2017, PLOS ONE, V12, pe0175065, DOI DOI 10.1371/JOURNAL.PONE.0175065.ECOLLECTION2017
   Centers for Disease Control and Prevention. National Notifiable Disease Surveillance System, 2016, ZIK VIR DIS ZIK VIR
   Chan JFW, 2016, EBIOMEDICINE, V14, P112, DOI 10.1016/j.ebiom.2016.11.017
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Freitas BDP, 2017, OPHTHALMOLOGY, V124, P407, DOI 10.1016/j.ophtha.2016.10.004
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Krittanawong C, 2016, INT J CARDIOL, V221, P859, DOI 10.1016/j.ijcard.2016.06.293
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Marino BS, 2012, CIRCULATION, V126, P1143, DOI 10.1161/CIR.0b013e318265ee8a
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Miranda CH, 2013, CLIN INFECT DIS, V57, P812, DOI 10.1093/cid/cit403
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [DOI 10.1001/JAMA0PHTHALM0L.2016.0267, 10.1001/jamaophthalmol.2016.0267]
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   WHO, 2017, ZIK SIT REP
   [World Health Organization Pan American Health Organization], 2017, ZIK SUSP CONF CAS RE
   World Health Organization. Fifth meeting of the Emergency Committee under the International Health Regulations, 2005, 5 M EM COMM INT HLTH
NR 25
TC 6
Z9 6
U1 0
U2 4
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1661-7800
EI 1661-7819
J9 NEONATOLOGY
JI Neonatology
PY 2018
VL 113
IS 2
BP 177
EP 182
DI 10.1159/000484656
PG 6
WC Pediatrics
SC Pediatrics
GA FU7FB
UT WOS:000424016500012
PM 29248924
DA 2020-07-08
ER

PT J
AU De, P
   Aher, RB
   Roy, K
AF De, Priyanka
   Aher, Rahul B.
   Roy, Kunal
TI Chemometric modeling of larvicidal activity of plant derived compounds
   against zika virus vector Aedes aegypti: application of ETA indices
SO RSC ADVANCES
LA English
DT Article
ID PUBLIC-HEALTH; DIPTERA; VALIDATION; REGRESSION; TOXICITY
AB Dengue, zika and chikungunya have severe public health concerns in several countries. Human modification of the natural environment continues to create habitats in which mosquitoes, vectors of a wide variety of human and animal pathogens, thrive, which can bring about an enormous negative impact on public health if not controlled properly. Quantitative structure-activity relationship (QSAR) modeling has been applied in this work with the aim of exploring features contributing to promising larvicidal properties against the vector Aedes aegypti (Diptera: Culicidae). A dataset of 61 plant derived compounds reported in previous literature was used in this present study. A genetic algorithm (GA) was used for QSAR model development employing the "Double Cross Validation" (DCV) tool available at http://teqip.jdvu.ac.in/QSAR_Tools/. The DCV tool removes any bias in descriptor selection from a fixed composition of a training set and often provides an optimum solution in terms of predictivity. Simple topological descriptors, the "Extended Topochemical Atom" (ETA) indices developed by the present authors' group, were used for model development. These descriptors do not require pretreatment of molecular structures by conformational analysis or energy minimization before model development, thus saving computational time and resources. They also avoid ambiguities with respect to the existence of compounds in various conformational states leading to the loss of predictive capability in QSAR models. A number of models were generated from GA, and further, the descriptors appearing in the best model obtained from GA were subjected to partial least squares (PLS) regression to obtain the final robust model. The developed model was validated extensively using different validation metrics to check the reliability and predictivity of the model for enhancing confidence in QSAR predictions. Based on the insights obtained from the PLS model, we can conclude that the presence of hydrogen bond acceptor atoms, the presence of multiple bonds as well as sufficient lipophilicity and a limited polar surface area play crucial roles in regulating the activity of the compounds.
C1 [De, Priyanka; Aher, Rahul B.; Roy, Kunal] Jadavpur Univ, Dept Pharmaceut Technol, Drug Theoret & Cheminformat Lab, Kolkata 700032, India.
RP Roy, K (corresponding author), Jadavpur Univ, Dept Pharmaceut Technol, Drug Theoret & Cheminformat Lab, Kolkata 700032, India.
EM kunalroy_in@yahoo.com
RI Roy, Kunal/S-5381-2019; Roy, Kunal/B-1673-2009
OI Roy, Kunal/0000-0003-4486-8074; Roy, Kunal/0000-0003-4486-8074
FU All India Council for Technical Education, New Delhi; UGC, New Delhi
   under UPE-II scheme
FX PD is thankful to All India Council for Technical Education, New Delhi
   for providing an MPharm scholarship. KR thanks the UGC, New Delhi
   providing financial assistance under UPE-II scheme.
CR Akarachantachote N, 2014, INT J PURE APPL MATH, V94, P307, DOI DOI 10.12732/IJPAM.V94I3.2
   Barbosa JDF, 2012, PEST MANAG SCI, V68, P1478, DOI 10.1002/ps.3331
   Baumann D, 2014, J CHEMINFORMATICS, V6, DOI 10.1186/s13321-014-0047-1
   Carrasco H, 2012, MOLECULES, V17, P1002, DOI 10.3390/molecules17011002
   Chai T, 2014, GEOSCI MODEL DEV, V7, P1247, DOI 10.5194/gmd-7-1247-2014
   Chirico N, 2012, J CHEM INF MODEL, V52, P2044, DOI 10.1021/ci300084j
   Gadaleta D., 2016, INT J QUANT STRUCT P, V1, P45, DOI DOI 10.4018/IJQSPR.2016010102
   Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8
   Jackson JE, 2005, USERS GUIDE PRINCIPA
   Katritzky AR, 2008, P NATL ACAD SCI USA, V105, P7359, DOI 10.1073/pnas.0800571105
   Kim JeongKyu, 2005, Entomological Research, V35, P117, DOI 10.1111/j.1748-5967.2005.tb00146.x
   Leardi R, 2001, J CHEMOMETR, V15, P559, DOI 10.1002/cem.651
   Leo A., 1995, EXPLORING QSAR FUNDA
   Licciardi S, 2006, MED VET ENTOMOL, V20, P288, DOI 10.1111/j.1365-2915.2006.00630.x
   Murugan K, 2007, BIORESOURCE TECHNOL, V98, P198, DOI 10.1016/j.biortech.2005.12.009
   Park HS, 2009, EXPERT SYST APPL, V36, P3336, DOI 10.1016/j.eswa.2008.01.039
   POPE PT, 1972, TECHNOMETRICS, V14, P327, DOI 10.2307/1267425
   RICE PJ, 1994, J ECON ENTOMOL, V87, P1172, DOI 10.1093/jee/87.5.1172
   Rose RI, 2001, EMERG INFECT DIS, V7, P17, DOI 10.3201/eid0701.010103
   Roy K, 2004, J CHEM INF COMP SCI, V44, P559, DOI 10.1021/ci0342066
   Roy K, 2011, SAR QSAR ENVIRON RES, V22, P451, DOI 10.1080/1062936X.2011.569900
   Roy K., 2015, QUANTITATIVE STRUCTU, P48
   Roy K, 2012, ADVANCED METHODS AND APPLICATIONS IN CHEMOINFORMATICS: RESEARCH PROGRESS AND NEW APPLICATIONS, P380, DOI 10.4018/978-1-60960-860-6.ch017
   Roy K, 2016, CHEMOMETR INTELL LAB, V152, P18, DOI 10.1016/j.chemolab.2016.01.008
   Roy K, 2010, CURR PHARM DESIGN, V16, P2625, DOI 10.2174/138161210792389270
   Rucker C, 2007, J CHEM INF MODEL, V47, P2345, DOI 10.1021/ci700157b
   Saavedra LM, 2018, SCI TOTAL ENVIRON, V610, P937, DOI 10.1016/j.scitotenv.2017.08.119
   Santos SRL, 2011, CHEMOSPHERE, V84, P150, DOI 10.1016/j.chemosphere.2011.02.018
   Santos SRL, 2010, VECTOR-BORNE ZOONOT, V10, P1049, DOI 10.1089/vbz.2009.0158
   Scotti L, 2014, MED CHEM, V10, P201, DOI 10.2174/15734064113099990005
   Simca-P U., 2002, 10 0 INFO UMETRICS C
   Tapondjou AL, 2005, J STORED PROD RES, V41, P91, DOI 10.1016/j.jspr.2004.01.004
   TOPLISS JG, 1979, J MED CHEM, V22, P1238, DOI 10.1021/jm00196a017
   Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1
   Yap CW, 2011, J COMPUT CHEM, V32, P1466, DOI 10.1002/jcc.21707
NR 35
TC 4
Z9 4
U1 0
U2 3
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2018
VL 8
IS 9
BP 4662
EP 4670
DI 10.1039/c7ra13159c
PG 9
WC Chemistry, Multidisciplinary
SC Chemistry
GA FU5MQ
UT WOS:000423898000018
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Zika vaccine candidate advances to clinical trials
SO HUMAN VACCINES & IMMUNOTHERAPEUTICS
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 0
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 2164-5515
EI 2164-554X
J9 HUM VACC IMMUNOTHER
JI Human Vaccines Immunother.
PY 2018
VL 14
IS 1
BP 10
EP 10
PG 1
WC Biotechnology & Applied Microbiology; Immunology
SC Biotechnology & Applied Microbiology; Immunology
GA FT9OC
UT WOS:000423480400011
DA 2020-07-08
ER

PT J
AU Aagaard, K
   Seferovic, M
   Hamilton, M
   Hu, M
   Gorchakov, R
   Murray, K
   Suter, M
AF Aagaard, Kjersti
   Seferovic, Maxim
   Hamilton, Mark
   Hu, Min
   Gorchakov, Rodion
   Murray, Kristy
   Suter, Melissa
TI Identifying zika virus (ZIKV)-silenced gene targets in the placenta at a
   transcriptome-wide scale using AGO-clip sequencing technology
SO AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT 38th Annual Meeting and Pregnancy Meeting of the
   Society-for-Maternal-Fetal-Medicine
CY JAN 29-FEB 03, 2018
CL Dallas, TX
SP Soc Maternal Fetal Med
C1 [Aagaard, Kjersti; Seferovic, Maxim; Hamilton, Mark; Hu, Min; Gorchakov, Rodion; Murray, Kristy; Suter, Melissa] Baylor Coll Med, Houston, TX 77030 USA.
NR 0
TC 0
Z9 0
U1 1
U2 4
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9378
EI 1097-6868
J9 AM J OBSTET GYNECOL
JI Am. J. Obstet. Gynecol.
PD JAN
PY 2018
VL 218
IS 1
SU S
MA 22
BP S18
EP S19
PG 2
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA FT2CT
UT WOS:000422946900023
DA 2020-07-08
ER

PT J
AU Combs, A
   Fishman, A
   Lee, S
   Pandipati, S
   Mallory, K
AF Combs, Andrew
   Fishman, Alan
   Lee, Sarah
   Pandipati, Santosh
   Mallory, Kimberly
TI Small fetal head circumference in the Zika virus era: Sensitivity
   depends on choice of reference values
SO AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT 38th Annual Meeting and Pregnancy Meeting of the
   Society-for-Maternal-Fetal-Medicine
CY JAN 29-FEB 03, 2018
CL Dallas, TX
SP Soc Maternal Fetal Med
C1 [Combs, Andrew; Fishman, Alan; Lee, Sarah; Pandipati, Santosh; Mallory, Kimberly] Obstetrix Med Grp, Campbell, CA USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9378
EI 1097-6868
J9 AM J OBSTET GYNECOL
JI Am. J. Obstet. Gynecol.
PD JAN
PY 2018
VL 218
IS 1
SU S
MA 443
BP S268
EP S268
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA FT2CT
UT WOS:000422946900443
DA 2020-07-08
ER

PT J
AU Seferovic, MD
   Valentine, G
   Meyer, K
   Harnish, JM
   Suter, M
   Prince, A
   Gorchakov, R
   Berry, R
   Fowler, S
   Swennes, A
   Murray, K
   Aagaard, K
AF Seferovic, Maxim D.
   Valentine, Gregory
   Meyer, Kristen
   Harnish, J. Michael
   Suter, Melissa
   Prince, Amanda
   Gorchakov, Rodion
   Berry, Rebecca
   Fowler, Stephanie
   Swennes, Alton
   Murray, Kristy
   Aagaard, Kjersti
TI Commensal microbes confer protection against Zika virus infection in a
   murine gnotobiotic model of congenital Zika syndrome
SO AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT 38th Annual Meeting and Pregnancy Meeting of the
   Society-for-Maternal-Fetal-Medicine
CY JAN 29-FEB 03, 2018
CL Dallas, TX
SP Soc Maternal Fetal Med
C1 [Seferovic, Maxim D.; Valentine, Gregory; Meyer, Kristen; Harnish, J. Michael; Suter, Melissa; Prince, Amanda; Gorchakov, Rodion; Berry, Rebecca; Fowler, Stephanie; Swennes, Alton; Murray, Kristy; Aagaard, Kjersti] Baylor Coll Med, Houston, TX 77030 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9378
EI 1097-6868
J9 AM J OBSTET GYNECOL
JI Am. J. Obstet. Gynecol.
PD JAN
PY 2018
VL 218
IS 1
SU S
MA 270
BP S172
EP S173
PG 2
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA FT2CT
UT WOS:000422946900271
DA 2020-07-08
ER

PT J
AU Turley, M
   Valentine, G
   Seferovic, M
   Rac, M
   Eppes, C
   Major, A
   Castro, E
   Sanchez, B
   Dunn, J
   Versalovic, J
   Cortes, MS
   Stout, T
   Harrison, G
   Belfort, M
   Aagaard, K
AF Turley, Michelle
   Valentine, Gregory
   Seferovic, Maxim
   Rac, Martha
   Eppes, Carey
   Major, Angela
   Castro, Eumenia
   Sanchez, Brianna
   Dunn, James
   Versalovic, James
   Cortes, Magdalena Sanz
   Stout, Timothy
   Harrison, Gail
   Belfort, Michael
   Aagaard, Kjersti
TI Importance of placental testing in congenital zika virus (zikv)
   infection and fetal malformation syndrome
SO AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT 38th Annual Meeting and Pregnancy Meeting of the
   Society-for-Maternal-Fetal-Medicine
CY JAN 29-FEB 03, 2018
CL Dallas, TX
SP Soc Maternal Fetal Med
C1 [Turley, Michelle; Valentine, Gregory; Seferovic, Maxim; Rac, Martha; Eppes, Carey; Major, Angela; Castro, Eumenia; Dunn, James; Versalovic, James; Cortes, Magdalena Sanz; Stout, Timothy; Harrison, Gail; Belfort, Michael; Aagaard, Kjersti] Baylor Coll Med, Houston, TX 77030 USA.
   [Sanchez, Brianna] Univ Texas El Paso, El Paso, TX 79968 USA.
NR 0
TC 0
Z9 0
U1 2
U2 3
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9378
EI 1097-6868
J9 AM J OBSTET GYNECOL
JI Am. J. Obstet. Gynecol.
PD JAN
PY 2018
VL 218
IS 1
SU S
MA 73
BP S54
EP S55
PG 2
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA FT2CT
UT WOS:000422946900074
DA 2020-07-08
ER

PT J
AU Valentine, G
   Seferovic, M
   Murray, K
   Gorchakov, R
   Suter, M
   Swennes, A
   Sanchez, B
   Fowler, S
   Aagaard, K
AF Valentine, Gregory
   Seferovic, Maxim
   Murray, Kristy
   Gorchakov, Rodion
   Suter, Melissa
   Swennes, Alton
   Sanchez, Brianna
   Fowler, Stephanie
   Aagaard, Kjersti
TI Timing of Zika virus (ZIKV) infection is associated with differences in
   brain weight and microcephaly in a murine model, but not infant moribund
   mortality
SO AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT 38th Annual Meeting and Pregnancy Meeting of the
   Society-for-Maternal-Fetal-Medicine
CY JAN 29-FEB 03, 2018
CL Dallas, TX
SP Soc Maternal Fetal Med
C1 [Valentine, Gregory; Seferovic, Maxim; Murray, Kristy; Gorchakov, Rodion; Suter, Melissa; Swennes, Alton; Fowler, Stephanie; Aagaard, Kjersti] Baylor Coll Med, Houston, TX 77030 USA.
   [Sanchez, Brianna] Univ Texas El Paso, Houston, TX USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9378
EI 1097-6868
J9 AM J OBSTET GYNECOL
JI Am. J. Obstet. Gynecol.
PD JAN
PY 2018
VL 218
IS 1
SU S
MA 277
BP S176
EP S177
PG 2
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA FT2CT
UT WOS:000422946900278
DA 2020-07-08
ER

PT J
AU Brenciaglia, M
   Noel, TP
   Fields, PJ
   Bidaisee, S
   Myers, TE
   Nelson, WM
   Venkateswaran, N
   Venkateswaran, K
   Parameswaran, N
   Bahadoor, A
   Yearwood, K
   Mapp-Alexander, V
   Mitchell, G
   LaBeaud, AD
   Macpherson, CNL
AF Brenciaglia, Marco
   Noel, Trevor P.
   Fields, Paul J.
   Bidaisee, Satesh
   Myers, Todde E.
   Nelson, William M.
   Venkateswaran, Neeraja
   Venkateswaran, Kodumudi
   Parameswaran, Nishanth
   Bahadoor, Avi
   Yearwood, Katherine
   Mapp-Alexander, Veronica
   Mitchell, George
   LaBeaud, A. Desiree
   Macpherson, Calum N. L.
TI Clinical, Serological, and Molecular Observations from a Case Series
   Study during the Asian Lineage Zika Virus Outbreak in Grenada during
   2016
SO CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY
LA English
DT Article
ID GUILLAIN-BARRE-SYNDROME; ARBOVIRAL DISEASES; DENGUE; CHIKUNGUNYA;
   TRANSMISSION; COINFECTION; INFECTION
AB This paper describes the spatial and temporal distribution of cases, demographic characteristics of patients, and clinical manifestations of Zika virus (ZIKV) during the 2016 outbreak in Grenada. The first reported case was recorded in St. Andrew Parish in April, and the last reported case was seen in November, with peak transmission occurring in the last week of June, based on test results. Data were collected from a total of 514 patients, of whom 207 (40%) tested positive for ZIKV. No evidence was found that testing positive for ZIKV infection was related to age, gender, or pregnancy status. Clinical presentation with rash (OR. 2.4, 95% CI. 1.5 to 3.7) or with lymphadenopathy (OR. 1.7, 95% CI. 1.0 to 2.9) were the only reported symptoms consistent with testing positive for ZIKV infection. During the Zika outbreak, the infection rate was 20 clinical cases per 10,000 in the population compared to 41 cases per 10,000 during the chikungunya outbreak in Grenada in 2014 and 17 cases per 10,000 during the dengue outbreak in 2001-2002. Even though the country has employed vector control programs, with no apparent decrease in infection rates, it appears that new abatement approaches are needed to minimize morbidity in future arbovirus outbreaks.
C1 [Brenciaglia, Marco; Noel, Trevor P.; Fields, Paul J.; Bidaisee, Satesh; Bahadoor, Avi; Yearwood, Katherine; Mapp-Alexander, Veronica; Macpherson, Calum N. L.] St Georges Univ, Sch Med, True Blue Campus, St Georges, Grenada.
   [Brenciaglia, Marco; Noel, Trevor P.; Fields, Paul J.; Bidaisee, Satesh; Macpherson, Calum N. L.] Windward Islands Res & Educ Fdn, St Georges, Grenada.
   [Myers, Todde E.] Naval Med Res Ctr, Silver Spring, MD 20910 USA.
   [Nelson, William M.; Venkateswaran, Neeraja] Tetracore Inc, Rockville, MD 20850 USA.
   [Venkateswaran, Kodumudi; Parameswaran, Nishanth] Omni Array Biotechnol LLC, Rockville, MD 20850 USA.
   [Mitchell, George] Minist Hlth, Minist Complex, St Georges, Grenada.
   [LaBeaud, A. Desiree] Stanford Univ, Stanford, CA 94305 USA.
RP Fields, PJ (corresponding author), St Georges Univ, Sch Med, True Blue Campus, St Georges, Grenada.; Fields, PJ (corresponding author), Windward Islands Res & Educ Fdn, St Georges, Grenada.
EM pfields@sgu.edu
FU Armed Forces Health Surveillance Center, Maryland, USA
FX The WINDREF Zika Research Team thanks the Grenada Ministry of Health for
   its partnership in this study and also expresses appreciation to Tracy
   Fecteau and Patricia Valencia in the molecular biology laboratory at
   Tetracore, Inc., for testing the samples. This research was a
   bio-surveillance study conducted in collaboration with the Naval
   Infectious Diseases Diagnostic Laboratory (NIDDL), who received funding
   from the Armed Forces Health Surveillance Center, Maryland, USA.
CR Ansar V, 2015, PRIMARY CARE, V42, P189, DOI 10.1016/j.pop.2015.01.001
   Ballenger-Browning KK, 2009, TROP MED INT HEALTH, V14, P1542, DOI 10.1111/j.1365-3156.2009.02396.x
   Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003
   Brown JE, 2014, EVOLUTION, V68, P514, DOI 10.1111/evo.12281
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   CDC, 2017, DENG 2016
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   European Centre for Disease Prevention and Control, 2016, ZIK VIR DIS EP POT A
   Furuya-Kanamori L, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1417-2
   Mourao MPG, 2015, REV SOC BRAS MED TRO, V48, P20, DOI 10.1590/0037-8682-0133-2013
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Imperato PJ, 2016, J COMMUN HEALTH, V41, P674, DOI 10.1007/s10900-016-0177-7
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Macpherson C, 2016, AM J TROP MED HYG, V95, P890, DOI 10.4269/ajtmh.16-0122
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   McCormack J. P., 1999, THESIS
   Ministry of Finance, 2011, CENS REP GREN CARR P
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Nedjadi T, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0444-8
   PAHO/WHO, 2016, ZIK EP REP ST VINC G
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Panagos A, 2005, REV PANAM SALUD PUBL, V17, P225
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Pastula DM, 2016, J NEUROVIROL, V22, P257, DOI 10.1007/s13365-016-0428-5
   Peper SM, 2016, J GEN INTERN MED, V31, P576, DOI 10.1007/s11606-015-3459-3
   Pessoa R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003201
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Posen HJ, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2016-000087
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P177, DOI 10.1016/j.tmaid.2016.05.004
   Schioler KL, 2009, AM J TROP MED HYG, V81, P280, DOI 10.4269/ajtmh.2009.81.280
   Sejvar JJ, 2011, NEUROEPIDEMIOLOGY, V36, P123, DOI 10.1159/000324710
   Semenza JC, 2009, LANCET INFECT DIS, V9, P365, DOI 10.1016/S1473-3099(09)70104-5
   Sivanthan M., 2006, THESIS
   van den Berg B, 2014, NAT REV NEUROL, V10, P469, DOI 10.1038/nrneurol.2014.121
   van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Venkateswaran N., 2017, J IMMUNOL, V198, P81
   Watrin L, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003257
   Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 48
TC 2
Z9 2
U1 0
U2 1
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1712-9532
EI 1918-1493
J9 CAN J INFECT DIS MED
JI Can. J. Infect. Dis. Med. Microbiol.
PY 2018
VL 2018
AR 4635647
DI 10.1155/2018/4635647
PG 9
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA FU3XZ
UT WOS:000423786900001
PM 29623138
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Adhikari, EH
   McKiever, M
   Nelson, DB
   Johnson, KA
   Stocks, ME
   Rogers, VL
   Roberts, SW
   McIntire, DD
   Casey, BM
AF Adhikari, Emily H.
   McKiever, Monique
   Nelson, David B.
   Johnson, Kathryn A.
   Stocks, Meredith E.
   Rogers, Vanessa L.
   Roberts, Scott W.
   McIntire, Donald D.
   Casey, Brian M.
TI Neonatal surveillance among asymptomatic Zika-exposed infants through 6
   months of life.
SO AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT 38th Annual Pregnancy Meeting of the Society-for-Maternal-Fetal-Medicine
   (SMFM)
CY JAN 29-FEB 03, 2018
CL Dallas, TX
SP Soc Maternal Fetal Med
C1 [Adhikari, Emily H.; McKiever, Monique; Nelson, David B.; Johnson, Kathryn A.; Rogers, Vanessa L.; Roberts, Scott W.; McIntire, Donald D.; Casey, Brian M.] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA.
   [Stocks, Meredith E.] Dallas Cty Hlth & Human Serv, Dallas, TX USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9378
EI 1097-6868
J9 AM J OBSTET GYNECOL
JI Am. J. Obstet. Gynecol.
PD JAN
PY 2018
VL 218
IS 1
SU S
MA 860
BP S512
EP S513
PG 2
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA FU1NL
UT WOS:000423616600359
DA 2020-07-08
ER

PT J
AU Adhikari, EH
   Rodriguez, AN
   Nelson, DB
   Rogers, VL
   Roberts, SW
   McIntire, DD
   Casey, BM
AF Adhikari, Emily H.
   Rodriguez, A. Noel
   Nelson, David B.
   Rogers, Vanessa L.
   Roberts, Scott W.
   McIntire, Donald D.
   Casey, Brian M.
TI Increasing numbers of false positive Zika tests during pregnancy
SO AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT 38th Annual Pregnancy Meeting of the Society-for-Maternal-Fetal-Medicine
   (SMFM)
CY JAN 29-FEB 03, 2018
CL Dallas, TX
SP Soc Maternal Fetal Med
C1 [Adhikari, Emily H.; Rodriguez, A. Noel; Nelson, David B.; Rogers, Vanessa L.; Roberts, Scott W.; McIntire, Donald D.; Casey, Brian M.] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9378
EI 1097-6868
J9 AM J OBSTET GYNECOL
JI Am. J. Obstet. Gynecol.
PD JAN
PY 2018
VL 218
IS 1
SU S
MA 861
BP S513
EP S513
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA FU1NL
UT WOS:000423616600360
DA 2020-07-08
ER

PT J
AU Chandrasekaran, N
   Marotta, M
   Taldone, S
   Koru-Sengul, T
   Curry, CL
AF Chandrasekaran, Neeraja
   Marotta, Mabel
   Taldone, Sabrina
   Koru-Sengul, Tulay
   Curry, Christine L.
TI Knowledge and Perceptions of Zika in Pregnancy
SO AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT 38th Annual Pregnancy Meeting of the Society-for-Maternal-Fetal-Medicine
   (SMFM)
CY JAN 29-FEB 03, 2018
CL Dallas, TX
SP Soc Maternal Fetal Med
C1 [Chandrasekaran, Neeraja; Marotta, Mabel; Taldone, Sabrina; Koru-Sengul, Tulay; Curry, Christine L.] Univ Miami, Miller Sch Med, Miami, FL USA.
   [Chandrasekaran, Neeraja] Morehouse Sch Med, Atlanta, GA 30310 USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9378
EI 1097-6868
J9 AM J OBSTET GYNECOL
JI Am. J. Obstet. Gynecol.
PD JAN
PY 2018
VL 218
IS 1
SU S
MA 939
BP S555
EP S556
PG 2
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA FU1NL
UT WOS:000423616600438
DA 2020-07-08
ER

PT J
AU Eppes, CS
   Rac, M
   Dempster, C
   Allen, S
   Deal, S
   Muldrew, K
   Dunn, J
   Versalovic, J
   Belfort, M
   Aagaard, K
AF Eppes, Catherine S.
   Rac, Martha
   Dempster, Carrie
   Allen, Stephanie
   Deal, Stephanie
   Muldrew, Kenneth
   Dunn, Jim
   Versalovic, Jim
   Belfort, Michael
   Aagaard, Kjersti
TI Prevalence of ZIKV between different demographic groups within the same
   geographic region
SO AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT 38th Annual Pregnancy Meeting of the Society-for-Maternal-Fetal-Medicine
   (SMFM)
CY JAN 29-FEB 03, 2018
CL Dallas, TX
SP Soc Maternal Fetal Med
C1 [Eppes, Catherine S.; Rac, Martha; Dempster, Carrie; Allen, Stephanie; Deal, Stephanie; Muldrew, Kenneth; Dunn, Jim; Versalovic, Jim; Belfort, Michael; Aagaard, Kjersti] Baylor Coll Med, Houston, TX 77030 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9378
EI 1097-6868
J9 AM J OBSTET GYNECOL
JI Am. J. Obstet. Gynecol.
PD JAN
PY 2018
VL 218
IS 1
SU S
MA 872
BP S520
EP S520
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA FU1NL
UT WOS:000423616600371
DA 2020-07-08
ER

PT J
AU Esquivel, M
   Avaad-Portari, E
   Vasconcelos, ZC
   Moreira, ME
   Gaw, SL
AF Esquivel, Mikaela
   Avaad-Portari, Elyzabeth
   Vasconcelos, Zilton C.
   Moreira, Maria E.
   Gaw, Stephanie L.
TI Vertical transmission and placental pathology of twin pregnancies from
   Zika virus infected mothers
SO AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT 38th Annual Pregnancy Meeting of the Society-for-Maternal-Fetal-Medicine
   (SMFM)
CY JAN 29-FEB 03, 2018
CL Dallas, TX
SP Soc Maternal Fetal Med
C1 [Esquivel, Mikaela; Gaw, Stephanie L.] Univ Calif San Francisco, San Francisco, CA 94143 USA.
   [Esquivel, Mikaela] Harvard Univ, Cambridge, MA 02138 USA.
   [Avaad-Portari, Elyzabeth; Vasconcelos, Zilton C.; Moreira, Maria E.] Fiocruz Inst, Inst Fernades Figueira, Rio De Janeiro, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9378
EI 1097-6868
J9 AM J OBSTET GYNECOL
JI Am. J. Obstet. Gynecol.
PD JAN
PY 2018
VL 218
IS 1
SU S
MA 873
BP S520
EP S520
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA FU1NL
UT WOS:000423616600372
DA 2020-07-08
ER

PT J
AU Maykin, M
   Avaad-Portari, E
   Esquivel, M
   Pereira, JP
   Fisher, SJ
   Moreira, ME
   Nielsen-Saines, K
   Brasil, P
   Gaw, SL
AF Maykin, Melanie
   Avaad-Portari, Elyzabeth
   Esquivel, Mikaela
   Pereira, Jose Paulo, Jr.
   Fisher, Susan J.
   Moreira, Maria E.
   Nielsen-Saines, Karin
   Brasil, Patricia
   Gaw, Stephanie L.
TI Placental Histopathologic Findings in Zika-infected Pregnancies
SO AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT 38th Annual Pregnancy Meeting of the Society-for-Maternal-Fetal-Medicine
   (SMFM)
CY JAN 29-FEB 03, 2018
CL Dallas, TX
SP Soc Maternal Fetal Med
C1 [Maykin, Melanie; Esquivel, Mikaela; Fisher, Susan J.; Gaw, Stephanie L.] Univ Calif San Francisco, San Francisco, CA 94143 USA.
   [Avaad-Portari, Elyzabeth; Pereira, Jose Paulo, Jr.; Moreira, Maria E.] Fiocruz Inst, Inst Fernandes Figueira, Rio De Janeiro, Brazil.
   [Esquivel, Mikaela] Harvard Univ, Boston, MA 02115 USA.
   [Nielsen-Saines, Karin] Univ Calif Los Angeles, Los Angeles, CA USA.
   [Brasil, Patricia] Fiocruz Inst, Rio De Janeiro, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9378
EI 1097-6868
J9 AM J OBSTET GYNECOL
JI Am. J. Obstet. Gynecol.
PD JAN
PY 2018
VL 218
IS 1
SU S
MA 874
BP S520
EP S521
PG 2
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA FU1NL
UT WOS:000423616600373
DA 2020-07-08
ER

PT J
AU Seferovic, MD
   San Martin, CS
   Tamhankar, M
   Li, T
   Hu, M
   Blackman, M
   Martyn, C
   Sunshine, S
   Suter, M
   Tardif, S
   Chiu, C
   Patterson, J
   Aagaard, K
AF Seferovic, Maxim D.
   San Martin, Claudia Sanchez
   Tamhankar, Manasi
   Li, Tony
   Hu, Min
   Blackman, Marcia
   Martyn, Calla
   Sunshine, Sara
   Suter, Melissa
   Tardif, Suzette
   Chiu, Charles
   Patterson, Jean
   Aagaard, Kjersti
TI Primary Placental Trophoblasts from Primate Species are Permissive for
   Zika Virus (ZIKV) Replication
SO AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT 38th Annual Pregnancy Meeting of the Society-for-Maternal-Fetal-Medicine
   (SMFM)
CY JAN 29-FEB 03, 2018
CL Dallas, TX
SP Soc Maternal Fetal Med
C1 [Seferovic, Maxim D.; Hu, Min; Suter, Melissa; Aagaard, Kjersti] Baylor Coll Med, Houston, TX 77030 USA.
   [San Martin, Claudia Sanchez; Li, Tony; Martyn, Calla; Sunshine, Sara; Chiu, Charles] Univ Calif San Francisco, San Francisco, CA 94143 USA.
   [Tamhankar, Manasi; Blackman, Marcia; Patterson, Jean] Texas Biomed Res Ctr, San Antonio, TX USA.
   [Blackman, Marcia] Southwest Natl Primate Res Ctr, San Antonio, TX USA.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9378
EI 1097-6868
J9 AM J OBSTET GYNECOL
JI Am. J. Obstet. Gynecol.
PD JAN
PY 2018
VL 218
IS 1
SU S
MA 871
BP S519
EP S519
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA FU1NL
UT WOS:000423616600370
DA 2020-07-08
ER

PT J
AU Tardif, S
   Patterson, J
   Tamhankar, M
   Seferovic, M
   Castro, E
   San Martin, CS
   Suter, M
   Aagaard, K
   Rutherford, J
   Chiu, C
AF Tardif, Suzette
   Patterson, Jean
   Tamhankar, Manasi
   Seferovic, Maxim
   Castro, Eumenia
   San Martin, Claudia Sanchez
   Suter, Melissa
   Aagaard, Kjersti
   Rutherford, Julienne
   Chiu, Charles
TI Congenital Zika Virus (ZIKV) Infection in Marmoset New World Primates
SO AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT 38th Annual Pregnancy Meeting of the Society-for-Maternal-Fetal-Medicine
   (SMFM)
CY JAN 29-FEB 03, 2018
CL Dallas, TX
SP Soc Maternal Fetal Med
C1 [Tardif, Suzette] Southwest Natl Primate Res Ctr, San Antonio, TX USA.
   [Patterson, Jean; Tamhankar, Manasi] Texas Biomed Res Ctr, San Antonio, TX USA.
   [Seferovic, Maxim; Castro, Eumenia; Suter, Melissa; Aagaard, Kjersti] Baylor Coll Med, Houston, TX 77030 USA.
   [San Martin, Claudia Sanchez; Chiu, Charles] Univ Calif San Francisco, San Francisco, CA 94143 USA.
   [Rutherford, Julienne] Univ Illinois, Chicago, IL USA.
NR 0
TC 0
Z9 0
U1 0
U2 4
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9378
EI 1097-6868
J9 AM J OBSTET GYNECOL
JI Am. J. Obstet. Gynecol.
PD JAN
PY 2018
VL 218
IS 1
SU S
MA 868
BP S517
EP S517
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA FU1NL
UT WOS:000423616600367
DA 2020-07-08
ER

PT J
AU Villazana-Kretzer, D
   Schmiedecke, S
   Napolitano, PG
   Stencel-Baerenwald, J
   Gale, M
   Ieronimakis, N
AF Villazana-Kretzer, Diana
   Schmiedecke, Stacey
   Napolitano, Peter G.
   Stencel-Baerenwald, Jennifer
   Gale, Michael
   Ieronimakis, Nicholas
TI Zika virus can infect term human placentas devoid of the maternal
   inflammatory response
SO AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT 38th Annual Pregnancy Meeting of the Society-for-Maternal-Fetal-Medicine
   (SMFM)
CY JAN 29-FEB 03, 2018
CL Dallas, TX
SP Soc Maternal Fetal Med
C1 [Villazana-Kretzer, Diana; Schmiedecke, Stacey; Napolitano, Peter G.; Stencel-Baerenwald, Jennifer; Ieronimakis, Nicholas] Madigan Army Med Ctr, Tacoma, WA 98431 USA.
   [Gale, Michael] Univ Washington, Settle, WA USA.
NR 0
TC 0
Z9 0
U1 1
U2 2
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9378
EI 1097-6868
J9 AM J OBSTET GYNECOL
JI Am. J. Obstet. Gynecol.
PD JAN
PY 2018
VL 218
IS 1
SU S
MA 869
BP S517
EP S518
PG 2
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA FU1NL
UT WOS:000423616600368
DA 2020-07-08
ER

PT J
AU Cannalire, R
   Tarantino, D
   Astolfi, A
   Barreca, ML
   Sabatini, S
   Massari, S
   Tabarrini, O
   Milani, M
   Querat, G
   Mastrangelo, E
   Manfroni, G
   Cecchetti, V
AF Cannalire, Rolando
   Tarantino, Delia
   Astolfi, Andrea
   Barreca, Maria Letizia
   Sabatini, Stefano
   Massari, Serena
   Tabarrini, Oriana
   Milani, Mario
   Querat, Gilles
   Mastrangelo, Eloise
   Manfroni, Giuseppe
   Cecchetti, Violetta
TI Functionalized 2,1-benzothiazine 2,2-dioxides as new inhibitors of
   Dengue NS5 RNA-dependent RNA polymerase
SO EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
LA English
DT Article
DE DENV NS5 RdRp inhibitors; 2,1-benzothiazine 2,2-dioxides; Flavivirus
   polymerase; Antivirals; Molecular docking
ID DRUG DISCOVERY; VIRUS INHIBITORS; PROTEIN; DERIVATIVES; IDENTIFICATION;
   SCAFFOLD; PROGRESS; TARGET
AB Over recent years, many RNA viruses have been "re-discovered", including life-threatening flaviviruses, such as Dengue, Zika, and several encephalitis viruses. Since no specific inhibitors are currently available to treat these infections, there is a pressing need for new therapeutics. Among the flaviviral proteins, NS5 RNA-dependent RNA polymerase (RdRp) represents a validated target being essential for viral replication and it has no human analog. To date, few NS5 RdRp inhibitor chemotypes have been reported and no inhibitors are currently in clinical development. In this context, after an in vitro screening against Dengue 3 NS5 RdRp of our in-house HCV NS5B inhibitors focused library, we found that 2,1-benzothiazine 2,2-dioxides are promising non-nucleoside inhibitors of flaviviral RdRp with compounds 8 and 10 showing IC50 of 0.6 and 0.9 mu M, respectively. Preliminary structure-activity relationships indicated a key role for the C-4 benzoyl group and the importance of a properly functionalized C-6 phenoxy moiety to modulate potency. Compound 8 acts as non-competitive inhibitor and its proposed pose in the so-called N pocket of the RdRp thumb domain allowed to explain the key contribution of the benzoyl and the phenoxy moieties for the ligand binding. (C) 2017 Elsevier Masson SAS. All rights reserved.
C1 [Cannalire, Rolando; Astolfi, Andrea; Barreca, Maria Letizia; Sabatini, Stefano; Massari, Serena; Tabarrini, Oriana; Manfroni, Giuseppe; Cecchetti, Violetta] Univ Perugia, Dipartimento Sci Farmaceut, Via Liceo, I-06123 Perugia, Italy.
   [Tarantino, Delia; Milani, Mario; Mastrangelo, Eloise] Univ Milan, Dipartimento Biosci, Via Celoria 26, I-20133 Milan, Italy.
   [Tarantino, Delia; Milani, Mario; Mastrangelo, Eloise] CNR, Ist Biofis, IBF, Via Celoria 26, I-20133 Milan, Italy.
   [Querat, Gilles] Aix Marseille Univ, Inserm 1207, UMR Emergence Pathol Virales, EHESP,IRD 190, 27 Bd Jean Moulin, F-13005 Marseille, France.
   [Querat, Gilles] Publ Hosp Marseille, Fdn IHU Mediterranee Infect, Fac Med, AP HM, 27 Bd Jean Moulin, F-13005 Marseille, France.
RP Manfroni, G (corresponding author), Univ Perugia, Dipartimento Sci Farmaceut, Via Liceo, I-06123 Perugia, Italy.; Mastrangelo, E (corresponding author), Univ Milan, Dipartimento Biosci, Via Celoria 26, I-20133 Milan, Italy.
EM eloise.mastrangelo@unimi.it; giuseppe.manfroni@unipg.it
RI Querat, Gilles/E-9577-2014; Cannalire, Rolando/AAD-8206-2020; Milani,
   Mario/B-6446-2015
OI Querat, Gilles/0000-0003-1897-8210; Milani, Mario/0000-0001-6098-3991;
   Mastrangelo, Eloise/0000-0002-5968-8386; Barreca, Maria
   Letizia/0000-0003-3530-5042; Sabatini, Stefano/0000-0003-0971-3536;
   Cecchetti, Violetta/0000-0001-8558-7004; Manfroni,
   Giuseppe/0000-0003-0207-3927
FU Italian Government Project SIR [RBSI14C78S]
FX This work has been realized thanks to the Italian Government Project
   SIR; grant number: RBSI14C78S.
CR [Anonymous], 2016, LEADIT V 2 2 0 SEESA
   [Anonymous], 2016, MOKA VERS 2 6 6
   Benmansour F, 2016, EUR J MED CHEM, V109, P146, DOI 10.1016/j.ejmech.2015.12.046
   Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235
   Bollati M, 2010, ANTIVIR RES, V87, P125, DOI 10.1016/j.antiviral.2009.11.009
   Cheema MA, 2007, CHEM PHYS, V336, P157, DOI 10.1016/j.chemphys.2007.06.006
   Galiano Vicente, 2016, Drug Des Devel Ther, V10, P3163
   Guy B, 2016, ANNU REV MED, V67, P387, DOI 10.1146/annurev-med-091014-090848
   Guzman MG, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.55
   Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3
   Halstead SB, 2016, VACCINE, V34, P1643, DOI 10.1016/j.vaccine.2016.02.004
   Harder E, 2016, J CHEM THEORY COMPUT, V12, P281, DOI 10.1021/acs.jctc.5b00864
   Harmata M, 2007, ORG LETT, V9, P4701, DOI 10.1021/ol701863y
   Hong XC, 2008, PROG HET CH, V19, P1
   Lim SP, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005737
   Lim SP, 2015, ANTIVIR RES, V119, P57, DOI 10.1016/j.antiviral.2015.04.010
   Lim SP, 2013, ANTIVIR RES, V100, P500, DOI 10.1016/j.antiviral.2013.09.013
   LOMBARDINO JG, 1972, J HETEROCYCLIC CHEM, V9, P315, DOI 10.1002/jhet.5570090221
   Malet H, 2008, ANTIVIR RES, V80, P23, DOI 10.1016/j.antiviral.2008.06.007
   Manfroni G, 2014, J MED CHEM, V57, P3247, DOI 10.1021/jm401688h
   Manfroni G, 2014, J MED CHEM, V57, P1952, DOI 10.1021/jm401362f
   Manfroni G, 2012, BIOORGAN MED CHEM, V20, P866, DOI 10.1016/j.bmc.2011.11.061
   Manfroni G, 2011, ARKIVOC, P165, DOI 10.3998/ark.5550190.0012.912
   Manvar D, 2016, BIOCHEM BIOPH RES CO, V469, P743, DOI 10.1016/j.bbrc.2015.12.042
   McGovern SL, 2002, J MED CHEM, V45, P1712, DOI 10.1021/jm010533y
   Nagar S, 2012, DRUG METAB DISPOS, V40, P1649, DOI 10.1124/dmd.112.046599
   Oliver A. B., 1975, SYNTH STUTTG, V5, P321
   Protein-Preparation-Wizard, 2016, SCHRODINGER RELEASE
   Rarey M, 1996, J MOL BIOL, V261, P470, DOI 10.1006/jmbi.1996.0477
   Schneider N, 2013, J COMPUT AID MOL DES, V27, P15, DOI 10.1007/s10822-012-9626-2
   Sterling T, 2015, J CHEM INF MODEL, V55, P2324, DOI 10.1021/acs.jcim.5b00559
   Tarantino D, 2016, ANTIVIR RES, V134, P226, DOI 10.1016/j.antiviral.2016.09.007
   Tverdokhlebov AV, 2008, SYNTHESIS-STUTTGART, P2701, DOI 10.1055/s-2008-1067214
   Venkatesham A, 2017, EUR J MED CHEM, V126, P101, DOI 10.1016/j.ejmech.2016.10.008
   World Hlth Org, 2017, VACCINE, V35, P1200, DOI 10.1016/j.vaccine.2016.10.070
   Xu HT, 2016, ANTIMICROB AGENTS CH, V60, P600, DOI 10.1128/AAC.02203-15
   Yap TL, 2007, J VIROL, V81, P4753, DOI 10.1128/JVI.02283-06
   Yin Z, 2009, J MED CHEM, V52, P7934, DOI 10.1021/jm901044z
   Yin Z, 2009, P NATL ACAD SCI USA, V106, P20435, DOI 10.1073/pnas.0907010106
NR 39
TC 8
Z9 8
U1 3
U2 13
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI ISSY-LES-MOULINEAUX
PA 65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE
SN 0223-5234
EI 1768-3254
J9 EUR J MED CHEM
JI Eur. J. Med. Chem.
PD JAN 1
PY 2018
VL 143
BP 1667
EP 1676
DI 10.1016/j.ejmech.2017.10.064
PG 10
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA FU1WY
UT WOS:000423641400043
PM 29137867
DA 2020-07-08
ER

PT J
AU Devillers, J
AF Devillers, J.
TI Repurposing drugs for use against Zika virus infection
SO SAR AND QSAR IN ENVIRONMENTAL RESEARCH
LA English
DT Article
DE Zika virus; drug repurposing; mosquito-borne disease; antiviral drug;
   Aedes sp
ID NEGLECTED DISEASES; INHIBITORS; SURAMIN; IDENTIFICATION; TRANSMISSION;
   REPLICATION; DERIVATIVES; AMERICA; MODELS; QSAR
AB Zika virus (ZIKV) is a mosquito-borne flavivirus for which there are no vaccines or specific therapeutics. To find drugs active on the virus is a complex, expensive and time-consuming process. The prospect of drug repurposing, which consists of finding new indications for existing drugs, is an interesting alternative to expedite drug development for specific diseases. In theory, drug repurposing is also able to respond much more rapidly to a crisis than a classical drug discovery process. Consequently, the methodology is attractive for vector-borne diseases that can emerge or re-emerge worldwide with the risk to become pandemic quickly. Different drugs, showing various structures, have been repurposed to be used against ZIKV infection. They are reviewed in this study and the conditions for their potential use in practice are discussed.
C1 [Devillers, J.] CTIS, Rillieux La Pape, France.
RP Devillers, J (corresponding author), CTIS, Rillieux La Pape, France.
EM j.devillers@ctis.fr
CR Alam A, 2017, BIOMED PHARMACOTHER, V91, P1152, DOI 10.1016/j.biopha.2017.05.045
   Albulescu IC, 2017, ANTIVIR RES, V143, P230, DOI 10.1016/j.antiviral.2017.04.016
   Albulescu IC, 2015, ANTIVIR RES, V121, P39, DOI 10.1016/j.antiviral.2015.06.013
   Aliota MT, 2017, ANTIVIR RES, V144, P223, DOI 10.1016/j.antiviral.2017.06.001
   Barbosa-Lima G, 2017, EUR J MED CHEM, V127, P434, DOI 10.1016/j.ejmech.2017.01.007
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Basavannacharya C, 2014, BIOCHEM BIOPH RES CO, V453, P539, DOI 10.1016/j.bbrc.2014.09.113
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   BRES P, 1970, B WORLD HEALTH ORGAN, V43, P223
   Byler KG, 2016, J MOL GRAPH MODEL, V69, P78, DOI 10.1016/j.jmgm.2016.08.011
   Cao R.Y., 2017, PEDIAT DRUG NITAZOXA, P1, DOI [10.1093/ofid/ofx009, DOI 10.1093/OFID/0FX009]
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cavalla D, 2013, DRUG DISCOV TODAY, V18, P523, DOI 10.1016/j.drudis.2012.12.009
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   Devillers J, 2015, SAR QSAR ENVIRON RES, V26, P263, DOI 10.1080/1062936X.2015.1026571
   Devillers J, 2014, SAR QSAR ENVIRON RES, V25, P805, DOI 10.1080/1062936X.2014.958291
   Devillers J., 2018, COMPUTATIONAL DESIGN
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Doucet JP, 2017, SAR QSAR ENVIRON RES, V28, P451, DOI [10.1080/1062936X.2017.1328855, 10.1080/1062936x.2017.1328855]
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Ekins S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005023
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fernando S, 2016, MOL BIOTECHNOL, V58, P801, DOI 10.1007/s12033-016-9979-1
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Ghofrani HA, 2006, NAT REV DRUG DISCOV, V5, P689, DOI 10.1038/nrd2030
   Greenstone G., 2011, BRIT COLUMB MED J, V53, P230
   Gupta S., 2015, SCI REP, V5, P1
   Gyawali N, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0132-y
   Hawking F, 1978, Adv Pharmacol Chemother, V15, P289, DOI 10.1016/S1054-3589(08)60486-X
   Hou X, 2016, SAR QSAR ENVIRON RES, V27, P101, DOI 10.1080/1062936X.2015.1134652
   Kincaid E, 2016, NAT MED, V22, P824, DOI 10.1038/nm0816-824
   Knehans T, 2011, J COMPUT AID MOL DES, V25, P263, DOI 10.1007/s10822-011-9418-0
   Knox JE, 2006, J MED CHEM, V49, P6585, DOI 10.1021/jm0607606
   Kumar SP, 2015, SAR QSAR ENVIRON RES, V26, P61, DOI 10.1080/1062936X.2014.984628
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Nok AJ, 2003, PARASITOL RES, V90, P71, DOI 10.1007/s00436-002-0799-9
   Oehler E, 2013, EUROSURVEILLANCE, V19, P20720
   Oprea TI, 2015, ASSAY DRUG DEV TECHN, V13, P299, DOI 10.1089/adt.2015.29011.tiodrrr
   Pedrique B, 2013, LANCET GLOB HEALTH, V1, pE371, DOI 10.1016/S2214-109X(13)70078-0
   Posen HJ, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2016-000087
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rossignol JF, 2014, ANTIVIR RES, V110, P94, DOI 10.1016/j.antiviral.2014.07.014
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
   Shawan M. M. A. K., 2015, NAT SCI, V13, P37, DOI DOI 10.1017/CBO9781107415324.004
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Trouiller P, 2002, LANCET, V359, P2188, DOI 10.1016/S0140-6736(02)09096-7
   Vyas VK, 2016, SAR QSAR ENVIRON RES, V27, P427, DOI 10.1080/1062936X.2016.1189959
   Wang P, 2017, SAR QSAR ENVIRON RES, V28, P341, DOI 10.1080/1062936X.2017.1320585
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 53
TC 8
Z9 8
U1 0
U2 6
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1062-936X
EI 1029-046X
J9 SAR QSAR ENVIRON RES
JI SAR QSAR Environ. Res.
PY 2018
VL 29
IS 2
BP 103
EP 115
DI 10.1080/1062936X.2017.1411642
PG 13
WC Chemistry, Multidisciplinary; Computer Science, Interdisciplinary
   Applications; Environmental Sciences; Mathematical & Computational
   Biology; Toxicology
SC Chemistry; Computer Science; Environmental Sciences & Ecology;
   Mathematical & Computational Biology; Toxicology
GA FU1OX
UT WOS:000423620400002
PM 29299939
DA 2020-07-08
ER

PT J
AU Perez-Molina, JA
   Chamorro-Tojeiro, S
AF Perez-Molina, Jose A.
   Chamorro-Tojeiro, Sandra
TI Zika virus: An emerging player in the global scenario
SO ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
LA English
DT Editorial Material
ID MALE SEXUAL TRANSMISSION; INFECTION; INFANTS; BIRTH
C1 [Perez-Molina, Jose A.; Chamorro-Tojeiro, Sandra] Hosp Univ Ramon y Cajal, IRYCIS, Infect Dis Dept, Natl Referral Ctr Trop Dis, Madrid, Spain.
RP Perez-Molina, JA (corresponding author), Hosp Univ Ramon y Cajal, IRYCIS, Infect Dis Dept, Natl Referral Ctr Trop Dis, Madrid, Spain.
EM jperezm@salud.madrid.org
OI Perez-Molina, Jose Antonio/0000-0001-8735-4124
CR Carvalho FD, 2017, NEOTROP ENTOMOL, V46, P243, DOI 10.1007/s13744-017-0520-4
   Collantes F, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1262-y
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   ECDC, 2017, ZIK VIR DIS EP
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Septfons A, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.32.30315
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
   Tang H., 2016, STEM CELLS, V18, P587
   Tebas P, 2017, N ENGL J MED
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   van den Hurk AF, 2017, LANCET INFECT DIS, V17, P1014, DOI 10.1016/S1473-3099(17)30518-2
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Visseaux B, 2016, LANCET INFECT DIS, V16, P1220, DOI 10.1016/S1473-3099(16)30387-5
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   World Health Organization, 2016, WHOZIKVLAB161
   Yuan L, 2017, SCIENCE
   Yung CF, 2016, CLIN INFECT DIS, V63, P708, DOI 10.1093/cid/ciw355
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
NR 30
TC 0
Z9 0
U1 0
U2 1
PU EDICIONES DOYMA S A
PI BARCELONA
PA TRAV DE GRACIA 17-21, 08021 BARCELONA, SPAIN
SN 0213-005X
EI 1578-1852
J9 ENFERM INFEC MICR CL
JI Enferm. Infec. Microbiol. Clin.
PD JAN
PY 2018
VL 36
IS 1
BP 1
EP 3
DI 10.1016/j.eimc.2017.11.005
PG 3
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA FT2ZT
UT WOS:000423015300001
PM 29183802
DA 2020-07-08
ER

PT J
AU Joob, B
   Wiwanitkit, V
AF Joob, Beuy
   Wiwanitkit, Viroj
TI Long term persistence of Zika virus after the onset of symptoms
SO ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
LA English
DT Letter
C1 [Joob, Beuy] Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Hainan, Peoples R China.
RP Joob, B (corresponding author), Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
EM beuyjoob@hotmail.com
CR Atkinson B, 2017, EMERG INFECT DIS, V23, P611, DOI 10.3201/eid2304.161692
   Souto IO, 2018, ENFERM INFEC MICR CL, V36, P21, DOI 10.1016/j.eimc.2016.10.009
   Wiwanitkit S., 2016, Asian Pacific Journal of Tropical Disease, V6, P757, DOI 10.1016/S2222-1808(16)61124-6
   Wiwanitkit S, 2016, ANN TROP MED PUBLIC, V9, DOI 10.4103/1755-6783.193955
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P499, DOI 10.1016/j.apjtm.2016.03.036
NR 5
TC 0
Z9 0
U1 0
U2 1
PU EDICIONES DOYMA S A
PI BARCELONA
PA TRAV DE GRACIA 17-21, 08021 BARCELONA, SPAIN
SN 0213-005X
EI 1578-1852
J9 ENFERM INFEC MICR CL
JI Enferm. Infec. Microbiol. Clin.
PD JAN
PY 2018
VL 36
IS 1
BP 65
EP 65
DI 10.1016/j.eimc.2016.12.012
PG 1
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA FT2ZT
UT WOS:000423015300016
PM 28242036
DA 2020-07-08
ER

PT J
AU Yoldi, MJM
AF Martinez Yoldi, Miguel J.
TI Reply to the letter: Long term persistence of Zika virus after the onset
   of symptoms
SO ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
LA English
DT Letter
C1 [Martinez Yoldi, Miguel J.] Hosp Clin Barcelona, Serv Microbiol, Barcelona, Spain.
RP Yoldi, MJM (corresponding author), Hosp Clin Barcelona, Serv Microbiol, Barcelona, Spain.
EM myoldi@clinic.ub.es
CR Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
NR 1
TC 0
Z9 0
U1 0
U2 0
PU EDICIONES DOYMA S A
PI BARCELONA
PA TRAV DE GRACIA 17-21, 08021 BARCELONA, SPAIN
SN 0213-005X
EI 1578-1852
J9 ENFERM INFEC MICR CL
JI Enferm. Infec. Microbiol. Clin.
PD JAN
PY 2018
VL 36
IS 1
BP 65
EP 66
DI 10.1016/j.eimc.2017.07.009
PG 2
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA FT2ZT
UT WOS:000423015300017
PM 28969937
DA 2020-07-08
ER

PT J
AU Mulkey, SB
   Vezina, G
   Bulas, DI
   Khademian, Z
   Blask, A
   Kousa, Y
   Cristante, C
   Pesacreta, L
   du Plessis, AJ
   DeBiasi, RL
AF Mulkey, Sarah B.
   Vezina, Gilbert
   Bulas, Dorothy I.
   Khademian, Zarir
   Blask, Anna
   Kousa, Youssef
   Cristante, Caitlin
   Pesacreta, Lindsay
   du Plessis, Adre J.
   DeBiasi, Roberta L.
TI Neuroimaging Findings in Normocephalic Newborns With Intrauterine Zika
   Virus Exposure
SO PEDIATRIC NEUROLOGY
LA English
DT Article
DE congenital Zika syndrome; cranial nerve; perinatal infarct; magnetic
   resonance imaging; Guillain-Barre syndrome; congenital infection; virus;
   peripheral neuropathy
ID CYTOMEGALOVIRUS-INFECTION; BIRTH-DEFECTS; INFANTS; VASCULOPATHY;
   PREGNANCY; SPECTRUM; FETUSES; STROKE; ROOT; MRI
AB BACKGROUND: Congenital Zika infection can result in a spectrum of neurological abnormalities in the newborn. Newborns exposed to Zika virus in utero often have neuroimaging as part of their clinical evaluation. METHODS: Through the Congenital Zika Program at Children's National Health System in Washington DC, we performed fetal or neonatal neuroimaging, including magnetic resonance imaging and ultrasound, on over 70 fetuses or neonates with intrauterine Zika exposure. Novel findings on neonatal brain magnetic resonance imaging were observed in two instances. RESULTS: Gadolinium-contrast magnetic resonance imaging showed enhancement of multiple cranial nerves at three days of age on one infant. Another infant underwent magnetic resonance imaging at 16 days of age and was shown to have a chronic ischemic cerebral infarction. This infant had previously normal fetal magnetic resonance imaging. CONCLUSION: Cranial nerve enhancement and cerebral infarction may be among the expanding list of neurological findings in congenital Zika infection. Postnatal brain magnetic resonance imaging should be considered for newborns exposed to Zika virus in utero.
C1 [Mulkey, Sarah B.; Bulas, Dorothy I.; Cristante, Caitlin; Pesacreta, Lindsay; du Plessis, Adre J.] Childrens Natl Hlth Syst, Div Fetal & Transit Med, 111 Michigan Ave NW, Washington, DC 20010 USA.
   [Mulkey, Sarah B.; du Plessis, Adre J.; DeBiasi, Roberta L.] George Washington Univ, Sch Med & Hlth Sci, Dept Pediat, Washington, DC 20052 USA.
   [Mulkey, Sarah B.; du Plessis, Adre J.] George Washington Univ, Sch Med & Hlth Sci, Dept Neurol, Washington, DC 20052 USA.
   [Vezina, Gilbert; Bulas, Dorothy I.; Khademian, Zarir; Blask, Anna] Childrens Natl Hlth Syst, Div Radiol, Washington, DC 20010 USA.
   [Kousa, Youssef] Childrens Natl Hlth Syst, Div Neurol, Washington, DC 20010 USA.
   [DeBiasi, Roberta L.] Childrens Natl Hlth Syst, Div Infect Dis, Washington, DC 20010 USA.
   [DeBiasi, Roberta L.] George Washington Univ, Sch Med & Hlth Sci, Dept Microbiol Immunol & Trop Med, Washington, DC 20052 USA.
RP Mulkey, SB (corresponding author), Childrens Natl Hlth Syst, Div Fetal & Transit Med, 111 Michigan Ave NW, Washington, DC 20010 USA.
EM sbmulkey@childrensnational.org
RI Youssef A Kousa/AAR-3064-2020
OI Youssef A Kousa/0000-0001-6049-8144; Mulkey, Sarah/0000-0002-8084-526X
FU Thrasher Research Fund
FX Neurodevelopmental testing was supported by the Thrasher Research Fund
   (PI: Mulkey).
CR Aragao MFVV, 2017, AM J NEURORADIOL, V38, P1427, DOI 10.3174/ajnr.A5216
   Aragao MFVV, 2017, AM J NEURORADIOL, V38, P1045, DOI 10.3174/ajnr.A5125
   Bhargava R, 2013, MAGN RESON INSIGHTS, V6, P95, DOI 10.4137/MRI.S12561
   Centers for Disease Control and Prevention, 2017, LONG TERM FOLL UP CA
   Centers for Disease Control and Prevention, 2017, CONG ZIK VIR INF EV
   Centers for Disease Control and Prevention National Center for Health Statistics, 2010, WHO GROWTH STAND AR
   Chabrier S, 2011, THROMB RES, V127, P13, DOI 10.1016/j.thromres.2010.10.003
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   del Campo M, 2017, AM J MED GENET A, V173, P841, DOI 10.1002/ajmg.a.38170
   Giannattasio A, 2017, J CLIN VIROL, V91, P31, DOI 10.1016/j.jcv.2017.04.006
   Goodman Alyson B, 2016, MMWR Morb Mortal Wkly Rep, V65, P1082, DOI 10.15585/mmwr.mm6539e2
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Iwasenko JM, 2011, J INFECT DIS, V203, P1526, DOI 10.1093/infdis/jir121
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Mulkey SB, 2010, PEDIATR NEUROL, V43, P263, DOI 10.1016/j.pediatrneurol.2010.05.011
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Schwartz DA, 2017, ARCH GYNECOL OBSTET, V295, P1361, DOI 10.1007/s00404-017-4361-5
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Wu YW, 2005, SEMIN NEUROL, V25, P424, DOI 10.1055/s-2005-923536
NR 20
TC 11
Z9 11
U1 1
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0887-8994
EI 1873-5150
J9 PEDIATR NEUROL
JI Pediatr. Neurol.
PD JAN
PY 2018
VL 78
BP 75
EP 78
DI 10.1016/j.pediatrneurol.2017.10.012
PG 4
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA FT8QX
UT WOS:000423419400012
PM 29167058
DA 2020-07-08
ER

PT J
AU Chakradhar, S
AF Chakradhar, Shraddha
TI Puzzling over privilege: How the immune system protects-and fails-the
   testes
SO NATURE MEDICINE
LA English
DT News Item
ID ZIKA VIRUS
CR Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Griffin BD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15743
   Jenabian MA, 2016, AIDS, V30, P2777, DOI 10.1097/QAD.0000000000001282
   Klein DM, 2017, J BIOCHEM MOL TOXIC, V31, DOI 10.1002/jbt.21911
   MEDAWAR PB, 1948, BRIT J EXP PATHOL, V29, P58
   Mital P, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.110197
   Pendergraft SS, 2017, BIOL REPROD, V96, P720, DOI 10.1095/biolreprod.116.143446
   Ponte R, 2018, J REPROD IMMUNOL, V125, P16, DOI 10.1016/j.jri.2017.10.043
   Routy JP, 2016, INT J TRYPTOPHAN RES, V9, P67, DOI [10.4137/IJTR.S38355, 10.4137/ijtr.s38355]
   Shao C., 2017, NAT COMMUN, V8, P676
   Siemann DN, 2017, J VIROL, V91, DOI 10.1128/JVI.00623-17
   Uraki R, 2017, J INFECT DIS, V215, P1720, DOI 10.1093/infdis/jix204
   Uraki R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602899
   Zeng XK, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.113
   Zhao ST, 2014, CELL MOL IMMUNOL, V11, P428, DOI 10.1038/cmi.2014.38
NR 15
TC 3
Z9 3
U1 0
U2 9
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1078-8956
EI 1546-170X
J9 NAT MED
JI Nat. Med.
PD JAN
PY 2018
VL 24
IS 1
BP 2
EP 5
DI 10.1038/nm0118-2
PG 4
WC Biochemistry & Molecular Biology; Cell Biology; Medicine, Research &
   Experimental
SC Biochemistry & Molecular Biology; Cell Biology; Research & Experimental
   Medicine
GA FT2JB
UT WOS:000422965900002
PM 29315300
DA 2020-07-08
ER

PT J
AU Bollweg, BC
   Silva-Flannery, L
   Spivey, P
   Hale, GL
AF Bollweg, Brigid C.
   Silva-Flannery, Luciana
   Spivey, Pamela
   Hale, Gillian L.
TI Optimization of commercially available Zika virus antibodies for use in
   a laboratory-developed immunohistochemical assay
SO JOURNAL OF PATHOLOGY CLINICAL RESEARCH
LA English
DT Article
DE Zika virus; immunohistochemistry; antibody; pathology; placenta; fetal
   demise; microcephaly
ID CHIKUNGUNYA; INFECTION; PATHOLOGY; BRAZIL; BRAIN
AB Zika virus (ZIKV) infection during pregnancy can cause adverse fetal outcomes and severe irreversible congenital birth defects including microcephaly. Immunohistochemistry (IHC) is a valuable diagnostic tool for detecting ZIKV antigens in tissues from cases of fetal loss in women infected with ZIKV, and for providing insights into disease pathogenesis. As a result, there is increasing demand for commercially available ZIKV antibodies for use in IHC assays. ZIKV antibodies were selected and obtained from commercial sources to include both mouse and rabbit hosts, and a variety of antigenic targets. Pretreatment conditions and antibody concentrations resulting in optimal immunohistochemical staining were determined using ZIKV cell control and polymerase chain reaction (PCR)-confirmed ZIKV case control material (fetal brain tissue). Cross-reactivity of the antibodies against other flaviviruses (dengue virus serogroups 1-4, yellow fever virus, Japanese encephalitis virus, West Nile virus) and chikungunya virus was also evaluated. Immunostaining using the commercially available antibodies was compared to a previously validated ZIKV IHC assay used for primary diagnosis. Four antibodies demonstrated optimal staining similar to the previously validated ZIKV IHC assay. Two of the four antibodies cross-reacted with dengue virus, while the other two antibodies showed no cross-reactivity with dengue, other flaviviruses, or chikungunya virus. Differences in the cross-reactivity profiles could not be entirely explained by the antigenic target. Commercially available ZIKV antibodies can be optimized for use in IHC testing to aid in ZIKV diagnostic testing and an evaluation of tissue tropism.
C1 [Bollweg, Brigid C.; Silva-Flannery, Luciana; Spivey, Pamela; Hale, Gillian L.] Ctr Dis Control & Prevent, Infect Dis Pathol Branch, 1600 Clifton Rd NE,MS G32, Atlanta, GA 30329 USA.
RP Hale, GL (corresponding author), Ctr Dis Control & Prevent, Infect Dis Pathol Branch, 1600 Clifton Rd NE,MS G32, Atlanta, GA 30329 USA.
EM cwx4@cdc.gov
CR Azevedo RSS, 2016, J CLIN VIROL, V85, P56, DOI 10.1016/j.jcv.2016.10.024
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Buchwalow I, 2011, SCI REP-UK, V1, DOI 10.1038/srep00028
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Furuya-Kanamori L, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1417-2
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Jain J, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0543-1
   Kawiecki AB, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0749-x
   Landry ML, 2017, ARCH PATHOL LAB MED, V141, P60, DOI 10.5858/arpa.2016-0406-SA
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Miller MA, 2005, J VET DIAGN INVEST, V17, P461, DOI 10.1177/104063870501700509
   Ramos-Vara JA, 2005, VET PATHOL, V42, P405, DOI 10.1354/vp.42-4-405
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Ritter JM, 2017, ARCH PATHOL LAB MED, V141, P49, DOI 10.5858/arpa.2016-0397-SA
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   Strauss JH, 2001, CELL, V105, P5, DOI 10.1016/S0092-8674(01)00291-4
   Vilches-Moure JG, 2005, J VET DIAGN INVEST, V17, P346, DOI 10.1177/104063870501700407
NR 21
TC 5
Z9 5
U1 0
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
EI 2056-4538
J9 J PATHOL CLIN RES
JI J. Pathol. Clin. Res.
PD JAN
PY 2018
VL 4
IS 1
BP 19
EP 25
DI 10.1002/cjp2.84
PG 7
WC Pathology
SC Pathology
GA FT7OU
UT WOS:000423343200002
PM 29416874
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Lang, BJ
   Idugboe, S
   McManus, K
   Drury, F
   Qureshi, A
   Cator, LJ
AF Lang, Bethan J.
   Idugboe, Stefano
   McManus, Kirelle
   Drury, Florence
   Qureshi, Alima
   Cator, Lauren J.
TI The Effect of Larval Diet on Adult Survival, Swarming Activity and
   Copulation Success in Male Aedes aegypti (Diptera: Culicidae)
SO JOURNAL OF MEDICAL ENTOMOLOGY
LA English
DT Article
DE Aedes aegypti; immature diet; ecology & behavior; mosquito control;
   mating strategy
ID MALE BODY-SIZE; DENGUE VECTOR; MATING SUCCESS; STABILIZING SELECTION;
   ZIKA VIRUS; MOSQUITO; BEHAVIOR; TRANSMISSION; THAILAND; AGE
AB Control of Aedes aegypti (L.) (Diptera: Culicidae) populations is vital for reducing the transmission of several pervasive human diseases. The success of new vector control technologies will be influenced by the fitness of laboratory-reared transgenic males. However, there has been relatively little published data on how rearing practices influence male fitness in Aedes mosquitoes. In the laboratory, the effect of larval food availability on adult male fitness was tested, using a range of different fitness measures. Larval food availability was demonstrated to be positively correlated with adult body size. Larger males survived longer and exhibited greater swarming activity. As a consequence, larger males may have more mating opportunities in the wild. However, we also found that within a swarm larger males did not have an increased likelihood of copulating with a female. The outcome of the mating competition experiments depended on the methodology used to mark the males. These results show that fitness assessment can vary depending on the measure analyzed, and the methodology used to determine it. Continued investigation into these fitness measures and methodologies, and critically, their utility for predicting male performance in the field, will increase the efficiency of vector control programs.
C1 [Lang, Bethan J.; Idugboe, Stefano; McManus, Kirelle; Drury, Florence; Qureshi, Alima; Cator, Lauren J.] Imperial Coll London, Dept Life Sci, Grand Challenges Ecosyst & Environm, Silwood Pk Campus, Ascot SL5 7PY, Berks, England.
   [Idugboe, Stefano] Univ Benin, Dept Anim & Environm Biol, Benin, Nigeria.
RP Cator, LJ (corresponding author), Imperial Coll London, Dept Life Sci, Grand Challenges Ecosyst & Environm, Silwood Pk Campus, Ascot SL5 7PY, Berks, England.
EM l.cator@imperial.ac.uk
OI Drury, Florence/0000-0001-8942-5459
FU BBSRCBiotechnology and Biological Sciences Research Council (BBSRC)
   [BB/N003594/1]
FX We are thankful to the following members of the Cator Lab: Dr. Andy
   Aldersley and Paul Huxley for their constructive comments on the
   manuscript. We further thank Celia Lutrat, Dougal Rees and Olivia Bates
   for their help during the rearing process. B.J.L. would also like to
   thank Olivia Bates, for her help with the mating competition
   experiments. S.I. thanks his sponsor, the National Universities
   Commission (Nigeria) for the monthly stipend he received for the payment
   of his tuition, which made his research possible. We would like to
   acknowledge the BBSRC Funding Standard Award BB/N003594/1 for funding
   our research. B.J.L. conducted the mating competition experiments when
   using the bulb duster method, and led the preparation of the manuscript.
   S.I. conducted the adult survival experiments. K.M. conducted and
   analyzed the swarming activity experiments and F.D. conducted the mating
   competition experiments when using the paint method. L.J.C. participated
   in all experiment designs. A.Q. provided technical support for all
   experiments and dissection assistance for spermathecae checks. B.J.L.,
   L.J.C., and S.I. contributed to preparation of the manuscript.
CR Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   Alphey L, 2010, VECTOR-BORNE ZOONOT, V10, P295, DOI 10.1089/vbz.2009.0014
   Bargielowski I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026086
   Bargielowski IE, 2013, P NATL ACAD SCI USA, V110, P2888, DOI 10.1073/pnas.1219599110
   Bellini R, 2014, ACTA TROP, V132, pS116, DOI 10.1016/j.actatropica.2013.11.022
   Cabrera M, 2007, J AM MOSQUITO CONTR, V23, P1, DOI 10.2987/8756-971X(2007)23[1:AAPMLB]2.0.CO;2
   Carvalho DO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003864
   Cator LJ, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1914-6
   Cator LJ, 2011, J MED ENTOMOL, V48, P941, DOI 10.1603/ME11019
   CLEMENTS A, 1999, BIOL MOSQUITOES
   Clements A. N., 1992, BIOL MOSQUITOES, V2
   Couret J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087468
   Crompton B, 2003, P ROY SOC B-BIOL SCI, V270, P1991, DOI 10.1098/rspb.2003.2477
   Diabate A, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0961-8
   Dickens BL, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-65
   Field A., 2009, DISCOVERING STAT USI
   Garcia GD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160196
   Harris AF, 2012, NAT BIOTECHNOL, V30, P828, DOI 10.1038/nbt.2350
   HARTBERG WK, 1971, B WORLD HEALTH ORGAN, V45, P847
   Helinski MEH, 2012, AM J TROP MED HYG, V86, P635, DOI 10.4269/ajtmh.2012.11-0225
   Helinski MEH, 2011, J MED ENTOMOL, V48, P202, DOI 10.1603/ME10071
   Joubert DA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005434
   Massonnet-Bruneel B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062711
   NASCI RS, 1990, J MED ENTOMOL, V27, P716, DOI 10.1093/jmedent/27.4.716
   Neems RM, 1998, BEHAV ECOL, V9, P279, DOI 10.1093/beheco/9.3.279
   Nghabi KR, 2008, ANIM BEHAV, V76, P105, DOI 10.1016/j.anbehav.2008.01.014
   Okanda F M, 2002, Malar J, V1, P10, DOI 10.1186/1475-2875-1-10
   Oliva CF, 2014, ACTA TROP, V132, pS12, DOI 10.1016/j.actatropica.2013.11.021
   Patil PB, 2015, PEST MANAG SCI, V71, P957, DOI 10.1002/ps.3873
   Peckarsky BL, 2002, BEHAV ECOL SOCIOBIOL, V51, P530, DOI 10.1007/s00265-002-0471-5
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Ponlawat A, 2007, J MED ENTOMOL, V44, P422, DOI 10.1603/0022-2585(2007)44[422:AABSIM]2.0.CO;2
   Ponlawat A, 2009, AM J TROP MED HYG, V80, P395, DOI 10.4269/ajtmh.2009.80.395
   R Core Team, 2014, R LANG ENV STAT COMP
   Sawadogo SP, 2013, J MED ENTOMOL, V50, P285, DOI 10.1603/ME12041
   Smith LB, 2016, PESTIC BIOCHEM PHYS, V133, P1, DOI 10.1016/j.pestbp.2016.03.005
   South SH, 2009, P ROY SOC B-BIOL SCI, V276, P3671, DOI 10.1098/rspb.2009.0991
   Spencer CY, 2005, J AM MOSQUITO CONTR, V21, P177, DOI 10.2987/8756-971X(2005)21[177:FVITDV]2.0.CO;2
   Tolle Michael A, 2009, Curr Probl Pediatr Adolesc Health Care, V39, P97, DOI 10.1016/j.cppeds.2009.01.001
   Tun-Lin W, 2000, MED VET ENTOMOL, V14, P31, DOI 10.1046/j.1365-2915.2000.00207.x
   Yuval B, 1998, ECOL ENTOMOL, V23, P211, DOI 10.1046/j.1365-2311.1998.00118.x
   Yuval B, 2006, ANNU REV ENTOMOL, V51, P413, DOI 10.1146/annurev.ento.51.110104.151058
   YUVAL B, 1993, J INSECT BEHAV, V6, P333, DOI 10.1007/BF01048114
NR 43
TC 2
Z9 2
U1 1
U2 9
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-2585
EI 1938-2928
J9 J MED ENTOMOL
JI J. Med. Entomol.
PD JAN
PY 2018
VL 55
IS 1
BP 29
EP 35
DI 10.1093/jme/tjx187
PG 7
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA FT2LZ
UT WOS:000422975600004
PM 29029298
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Zhao, LM
   Alto, BW
   Smartt, CT
   Shin, D
AF Zhao, Liming
   Alto, Barry W.
   Smartt, Chelsea T.
   Shin, Dongyoung
TI Transcription Profiling for Defensins of Aedes aegypti (Diptera:
   Culicidae) During Development and in Response to Infection With
   Chikungunya and Zika Viruses
SO JOURNAL OF MEDICAL ENTOMOLOGY
LA English
DT Article
DE mosquito; arbovirus infection; developmental regulation; gene expression
ID INDUCIBLE ANTIBACTERIAL PEPTIDE; INSECT IMMUNITY; VECTOR COMPETENCE;
   ANTIMICROBIAL PEPTIDES; PHORMIA-TERRANOVAE; DENGUE-2 VIRUS;
   INDIAN-OCEAN; MOSQUITO; TRANSMISSION; GENE
AB Aedes aegypti (L.) is a vector of chikungunya, dengue, yellow fever and Zika viruses. These viruses encounter a variety of induced defense responses from the innate immune system of the mosquito. We cloned defensin A from Ae. aegypti using laboratory populations originating from Key West and Orlando, Florida. To characterize inducible immune defensin peptides, we examined the defensin A (DefA) and defensin C (DefC) expression through time course studies using quantitative real-time PCR. We observed that ingestion of chikungunya virus (CHIKV) and Zika virus (ZIKV) infected blood triggered early upregulated expression of DefA and DefC at 3 h after blood feeding. At 10-d post infection, there was significant downregulation of DefA and DefC in CHIKV-infected females and significant upregulation of DefA and DefC in ZIKV-infected females compared with control mosquitoes fed uninfected blood. Our studies demonstrate that the relative activity of DefA and DefC changed depending on whether Ae. aegypti was infected with CHIKV or ZIKV, suggesting differences in antiviral defense responses. In addition, we also examined DefA and DefC gene expression during the different developmental stages. Significant qualitative and quantitative differences were found in DefA and DefC transcripts between Key West and Orlando strains. We found that adult males consistently had higher expression than adult females of different ages. Together, these data show that members of the Ae. aegypti defensin gene family play a role in both Zika and chikungunya antiviral response.
C1 [Zhao, Liming; Alto, Barry W.; Smartt, Chelsea T.; Shin, Dongyoung] Univ Florida, Florida Med Entomol Lab, 200 9th St South East, Vero Beach, FL 32962 USA.
RP Zhao, LM (corresponding author), Univ Florida, Florida Med Entomol Lab, 200 9th St South East, Vero Beach, FL 32962 USA.
EM lmzhao@ufl.edu
FU Florida Department of Agriculture and Consumer Services; Florida
   Department of Agriculture and Consumer Services [020190, 020180, 021803]
FX We sincerely thank Melissa Williams, Ayse Civana, Bradley Eastmond,
   Tanise Stenn, Daniel Velez, and Keenan Wiggins of the Florida Medical
   Entomology Laboratory, University of Florida, Vero Beach, for their
   excellent technical support. The isolate of Zika virus was graciously
   provided by the Centers for Disease Control and Prevention. The Indian
   Ocean lineage of Chikungunya virus was kindly provided by Robert Tesh
   (World Reference Center for Emerging Viruses and Arboviruses, through
   the University of Texas Medical Branch in Galveston, Texas) to the
   UF-FMEL. We thank Catherine Pruszynski of Florida Keys Mosquito Control
   District for providing us with Aedes aegypti from Key West, FL. We thank
   Mosquito and Fly Research Unit, Center for Medical, Agricultural and
   Veterinary Entomology, ARS-USDA for providing us with Ae. aegypti from
   Orlando, FL. Funding for this work was provided by Florida Department of
   Agriculture and Consumer Services. Funding for this work was provided by
   Florida Department of Agriculture and Consumer Services: Contract Number
   020190 to Dr. J. Rey, Contract Number 020180 to Dr. W. Tabachnick and
   Contract number 021803 to Drs. L. Zhao and B. Alto.
CR Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004677
   Alphey L, 2002, SCIENCE, V298, P119, DOI 10.1126/science.1078278
   Antonova Y, 2009, INSECT BIOCHEM MOLEC, V39, P303, DOI 10.1016/j.ibmb.2009.01.007
   Bargielowski IE, 2013, P NATL ACAD SCI USA, V110, P2888, DOI 10.1073/pnas.1219599110
   Bargielowski IE, 2016, INSECT SCI, V23, P162, DOI 10.1111/1744-7917.12291
   Barthel A, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0562-3
   Bartholomay LC, 2003, MOL BIOCHEM PARASIT, V130, P43, DOI 10.1016/S0166-6851(03)00143-9
   Bennett KE, 2002, AM J TROP MED HYG, V67, P85, DOI 10.4269/ajtmh.2002.67.85
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bonizzoni M, 2012, G3-GENES GENOM GENET, V2, P103, DOI 10.1534/g3.111.001107
   Bosio CF, 1998, AM J TROP MED HYG, V59, P965, DOI 10.4269/ajtmh.1998.59.965
   BULET P, 1991, J BIOL CHEM, V266, P24520
   BULET P, 1995, BIOCHEMISTRY-US, V34, P7394, DOI 10.1021/bi00022a012
   Caglioti C, 2013, NEW MICROBIOL, V36, P211
   CHALK R, 1994, INSECT BIOCHEM MOLEC, V24, P403, DOI 10.1016/0965-1748(94)90033-7
   Cheng L L, 2001, J Insect Sci, V1, P10
   Chretien JP, 2007, AM J TROP MED HYG, V76, P405, DOI 10.4269/ajtmh.2007.76.405
   Coggins SA, 2012, DEV COMP IMMUNOL, V37, P390, DOI 10.1016/j.dci.2012.01.005
   Desjardins CA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8121
   DIMARCQ JL, 1988, EUR J BIOCHEM, V171, P17, DOI 10.1111/j.1432-1033.1988.tb13752.x
   Dubrulle M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005895
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Estep A, 2015, AMCA 81ST ANNUAL MEE
   FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x
   Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180
   Gasque P, 2016, J INFECT DIS, V214, pS446, DOI 10.1093/infdis/jiw362
   Hall-Mendelin S, 2010, P NATL ACAD SCI USA, V107, P11255, DOI 10.1073/pnas.1002040107
   James AA, 2005, TRENDS PARASITOL, V21, P64, DOI 10.1016/j.pt.2004.11.004
   Kim CH, 2013, J INSECT PHYSIOL, V59, P604, DOI 10.1016/j.jinsphys.2013.03.010
   Kokoza V, 2010, P NATL ACAD SCI USA, V107, P8111, DOI 10.1073/pnas.1003056107
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msv279, 10.1093/molbev/msw054]
   LAMBERT J, 1989, P NATL ACAD SCI USA, V86, P262, DOI 10.1073/pnas.86.1.262
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Lanciotti RS, 2014, EMERG INFECT DIS, V20, P1400, DOI 10.3201/eid2008.140268
   Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9
   Cuevas EL, 2016, MMWR-MORBID MORTAL W, V65, P1409, DOI 10.15585/mmwr.mm6549e1
   Lowenberger CA, 1999, EXP PARASITOL, V91, P59, DOI 10.1006/expr.1999.4350
   Monaghan Andrew J, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.50dfc7f46798675fc63e7d7da563da76
   Mylonakis E, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0290
   NEI M, 2000, MOLECULAR EVOLUTION
   Njenga MK, 2008, J GEN VIROL, V89, P2754, DOI 10.1099/vir.0.2008/005413-0
   Pan XL, 2012, P NATL ACAD SCI USA, V109, pE23, DOI 10.1073/pnas.1116932108
   Parola P, 2006, EMERG INFECT DIS, V12, P1493, DOI 10.3201/eid1210.060610
   Pinto-Diaz CA, 2017, AUTOIMMUN REV, V16, P327, DOI 10.1016/j.autrev.2017.02.002
   Powers AM, 2016, J INFECT DIS, V214, pS449, DOI 10.1093/infdis/jiw382
   Pridgeon JW, 2008, J MED ENTOMOL, V45, P1071, DOI 10.1603/0022-2585(2008)45[1071:DAEROA]2.0.CO;2
   Roa B, 2016, BRATISL MED J, V117, P332, DOI 10.4149/BLL_2016_066
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
   Scheiner M., 2001, DESIGN ANAL ECOLOGIC, P99
   Solomon T, 2016, LANCET INFECT DIS, V16, P402, DOI 10.1016/S1473-3099(16)00125-0
   TABACHNICK WJ, 1985, AM J TROP MED HYG, V34, P1219, DOI 10.4269/ajtmh.1985.34.1219
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   Thomma BPHJ, 2002, PLANTA, V216, P193, DOI 10.1007/s00425-002-0902-6
   Trivers R., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226
   Tsetsarkin KA, 2016, CURR OPIN VIROL, V16, P143, DOI 10.1016/j.coviro.2016.02.007
   Vega-Rua A, 2014, J VIROL, V88, P6294, DOI 10.1128/JVI.00370-14
   Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a
   Zhao LM, 2008, J MED ENTOMOL, V45, P401, DOI 10.1603/0022-2585(2008)45[401:CCGAPE]2.0.CO;2
   Zhao LM, 2009, J MED ENTOMOL, V46, P1361, DOI 10.1603/033.046.0615
   Zhao XL, 2001, INSECT BIOCHEM MOLEC, V31, P481, DOI 10.1016/S0965-1748(00)00155-7
   Zouache K, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1078
NR 62
TC 7
Z9 7
U1 1
U2 17
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-2585
EI 1938-2928
J9 J MED ENTOMOL
JI J. Med. Entomol.
PD JAN
PY 2018
VL 55
IS 1
BP 78
EP 89
DI 10.1093/jme/tjx174
PG 12
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA FT2LZ
UT WOS:000422975600010
PM 28968775
DA 2020-07-08
ER

PT J
AU Kim, CR
   Counotte, M
   Bernstein, K
   Deal, C
   Mayaud, P
   Low, N
   Broutet, N
AF Kim, Caron R.
   Counotte, Michel
   Bernstein, Kyle
   Deal, Carolyn
   Mayaud, Philippe
   Low, Nicola
   Broutet, Nathalie
CA Sexual Transmission Zika Virus Exp
TI Investigating the sexual transmission of Zika virus
SO LANCET GLOBAL HEALTH
LA English
DT Editorial Material
C1 [Kim, Caron R.; Broutet, Nathalie] WHO, Dept Reprod Hlth & Res, World Bank Special Programme Res Dev & Res Traini, UNDP,UNFPA,UNICEF, CH-1211 Geneva, Switzerland.
   [Counotte, Michel; Low, Nicola] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland.
   [Bernstein, Kyle] Ctr Dis Control & Prevent, Div Sexually Transmitted Dis Prevent, Atlanta, GA USA.
   [Deal, Carolyn] NIAID, Rockville, MD USA.
   [Mayaud, Philippe] London Sch Hyg & Trop Med, London, England.
RP Kim, CR (corresponding author), WHO, Dept Reprod Hlth & Res, World Bank Special Programme Res Dev & Res Traini, UNDP,UNFPA,UNICEF, CH-1211 Geneva, Switzerland.
EM kimca@who.int
RI Counotte, Michel Jacques/K-6735-2019
OI Counotte, Michel Jacques/0000-0003-1039-6873
FU World Health OrganizationWorld Health Organization [001]; Intramural CDC
   HHS [CC999999]
CR Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Low N, 2017, STI HIV WORLD C JOIN
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Paz-Bailey G, 2017, N ENGL J MED
   Perera-Lecoin M, 2014, VIRUSES-BASEL, V6, P69, DOI 10.3390/v6010069
NR 6
TC 19
Z9 19
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2214-109X
J9 LANCET GLOB HEALTH
JI Lancet Glob. Health
PD JAN
PY 2018
VL 6
IS 1
BP E24
EP E25
PG 2
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FT3MW
UT WOS:000423052200013
PM 29241605
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Mina, M
   Guterman, L
   Omer, S
AF Mina, Michael
   Guterman, Lauren
   Omer, Saad
TI Zika in the United States: Dynamics, Transmission, and Strategies for
   Control
SO AMERICAN JOURNAL OF CLINICAL PATHOLOGY
LA English
DT Meeting Abstract
CT 52nd Annual Meeting of the American-Society-of-Clinical-Pathologists
   (ASCP)/Academy-of-Clinical-Laboratory-Physicians-and-Scientists (ACLPS)
CY JUN 15-17, 2017
CL New Haven, CT
SP Amer Soc Clin Pathologists, Acad Clin Lab Phys & Scientists
C1 [Mina, Michael] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA USA.
   [Guterman, Lauren; Omer, Saad] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0002-9173
EI 1943-7722
J9 AM J CLIN PATHOL
JI Am. J. Clin. Pathol.
PD JAN
PY 2018
VL 149
SU 1
MA 74
BP S202
EP S202
PG 1
WC Pathology
SC Pathology
GA FT1ZS
UT WOS:000422938200443
DA 2020-07-08
ER

PT J
AU Joob, B
   Wiwanitkit, V
AF Joob, Beuy
   Wiwanitkit, Viroj
TI Incidence of Guillain-Barre syndrome among Zika virus infected cases: a
   report from Thailand
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA English
DT Editorial Material
C1 [Joob, Beuy] Sanitat Med Acad Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Hainan, Peoples R China.
RP Joob, B (corresponding author), Sanitat Med Acad Ctr, Bangkok, Thailand.
EM beuyjoob@hotmail.com
CR Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035
   European Centre for Disease Prevention and Control, 2014, RAP RISK ASS ZIK VIR
   Wiwanitkit V, 2016, ARQ NEURO-PSIQUIAT, V74, P692, DOI 10.1590/0004-282X20160089
NR 3
TC 5
Z9 7
U1 0
U2 0
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
EI 1678-4227
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD JAN
PY 2018
VL 76
IS 1
BP 63
EP 63
DI 10.1590/0004-282X20170173
PG 1
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA FT1ZX
UT WOS:000422938800015
PM 29364400
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Salomao, JFM
AF Salomao, Jose Francisco M.
TI The congenital Zika virus infection: still a puzzle
SO CHILDS NERVOUS SYSTEM
LA English
DT Article
DE Congenital Zika virus infection; Microcephaly; ZIKV outbreak
AB As a new disease, some features of the congenital Zika virus infection are not yet fully understood. The current Brazilian outbreak brought up an unexpected increase in the number of microcephaly cases as this strain is essentially neurotropic and associated with devastating effects on the developing central nervous system.
   This focus session aims to discuss the several issues related to the epidemiology, diagnosis, clinical features, and treatment of the congenital Zika virus infection.
C1 [Salomao, Jose Francisco M.] Oswaldo Cruz Fdn IFF Fiocruz, Fernandes Figueira Inst, Rio De Janeiro, Brazil.
RP Salomao, JFM (corresponding author), Oswaldo Cruz Fdn IFF Fiocruz, Fernandes Figueira Inst, Rio De Janeiro, Brazil.
EM jfsalomao@terra.com.br
OI Manganelli Salomao, Jose Francisco/0000-0001-7301-9130
CR CDC, ZIK VIR CAS COUNTS U
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Juca E, 2017, CHILDS NERV SYST
   Mehrjardi MZ., 2017, VIROLOGY AUCKL, V8
   Steele RW, 2016, CLIN PEDIATR, V55, P698, DOI 10.1177/0009922816638660
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   WHO Media centre, MICR FACT SHEET
NR 7
TC 0
Z9 0
U1 0
U2 4
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0256-7040
EI 1433-0350
J9 CHILD NERV SYST
JI Childs Nerv. Syst.
PD JAN
PY 2018
VL 34
IS 1
BP 61
EP 62
DI 10.1007/s00381-017-3647-z
PG 2
WC Clinical Neurology; Pediatrics; Surgery
SC Neurosciences & Neurology; Pediatrics; Surgery
GA FS7GQ
UT WOS:000419966300013
PM 29101612
DA 2020-07-08
ER

PT J
AU Pone, MVD
   Pone, SM
   Zin, AA
   Mendes, PHB
   Aibe, MS
   de Aguiar, EB
   da Silva, TDG
AF da Silva Pone, Marcos Vinicius
   Pone, Sheila Moura
   Zin, Andrea Araujo
   Barros Mendes, Pedro Henrique
   Aibe, Mitsue Senra
   de Aguiar, Elisa Barroso
   Gomes da Silva, Tallita de Oliveira
TI Zika virus infection in children: epidemiology and clinical
   manifestations
SO CHILDS NERVOUS SYSTEM
LA English
DT Article
DE Zika virus; Epidemiology; Signs and symptoms; Congenital abnormalities;
   Arthrogryposis; Eye diseases
ID OPHTHALMIC MANIFESTATIONS; BIRTH-DEFECTS; BRAZIL; INFANTS; TRANSMISSION;
   SPECTRUM; AMERICA; UPDATE; STATES
AB The purpose of this review is to comprehensively review Congenital Zika Syndrome in regard to their epidemiology and clinical manifestations.
   This subject review of congenital Zika syndrome was composed after conducting a thorough review of the available literature on this topic using PubMed and other primary sources.
   The first epidemic of Zika virus infection in Brazil was followed by an unexpected sharp increase in the incidence of infants born with microcephaly and the description of a new disease, the congenital Zika syndrome. This review focuses on the epidemiological and clinical aspects of Zika infection in children. We conducted a brief historical account of the virus description in 1947, the rare cases of Zika infection occurring up to 2007, and the first epidemics in the Pacific between 2007 and 2014. We also discussed the isolation of the virus in Brazil in 2015 and its spread in the Americas, the microcephaly outbreak in Brazil and its association with Zika virus, and the current epidemiological panorama. We address the known clinical spectrum of Zika virus infection in the pediatric population, including manifestations of acute infection and congenital Zika syndrome, with emphasis on cranial, ophthalmic, and orthopedic abnormalities.
   While much has been learned about congenital Zika syndrome, the full spectrum of this infection is not yet known. This review is based on current, limited data about Zika virus infection. As more information becomes available, we will have a more accurate picture of this new disease.
C1 [da Silva Pone, Marcos Vinicius; Pone, Sheila Moura; Aibe, Mitsue Senra; de Aguiar, Elisa Barroso; Gomes da Silva, Tallita de Oliveira] Oswaldo Cruz Fdn FIOCRUZ, Natl Inst Women Children & Adolescents Hlth Ferna, Pediat Infect Dis Unit, Ave Rui Barbosa 716, BR-22250020 Rio De Janeiro, Brazil.
   [Zin, Andrea Araujo] Oswaldo Cruz Fdn FIOCRUZ, Natl Inst Women Children & Adolescents Hlth Ferna, Clin Res Unit, Ave Rui Barbosa 716, BR-22250020 Rio De Janeiro, Brazil.
   [Barros Mendes, Pedro Henrique] Oswaldo Cruz Fdn FIOCRUZ, Natl Inst Women Children & Adolescents Hlth Ferna, Orthoped Unit, Ave Rui Barbosa 716, BR-22250020 Rio De Janeiro, Brazil.
RP Pone, MVD (corresponding author), Oswaldo Cruz Fdn FIOCRUZ, Natl Inst Women Children & Adolescents Hlth Ferna, Pediat Infect Dis Unit, Ave Rui Barbosa 716, BR-22250020 Rio De Janeiro, Brazil.
EM marcosvpone@gmail.com
RI da Silva Pone, Marcos Vinicius/N-1285-2019
OI da Silva Pone, Marcos Vinicius/0000-0002-5152-2242; Moura Pone,
   Sheila/0000-0002-6246-8915
CR Atif M, 2016, INFECTION, V44, P695, DOI 10.1007/s15010-016-0935-6
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Besnard M, 2017, EMERG INFECT DIS, V23, P1421, DOI 10.3201/eid2308.170198
   Brasil Ministerio da Saude Secretaria de Atencao a Saude, 2016, PORT AT SAUD RESP OC
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cerbino-Neto J, 2016, EMERG INFECT DIS, V22, P1318, DOI 10.3201/eid2207.160375
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Rocha NACF, 2017, INFANT BEHAV DEV, V49, P70, DOI 10.1016/j.infbeh.2017.07.002
   Culjat M, 2016, CLIN INFECT DIS, V63, P805, DOI 10.1093/cid/ciw324
   de Oliveira CS, 2016, J PEDIAT-BRAZIL, V92, P103, DOI 10.1016/j.jped.2016.02.003
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Freitas BDP, 2017, OPHTHALMOLOGY, V124, P407, DOI 10.1016/j.ophtha.2016.10.004
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Horovitz DDG, 2016, NEUROLOGY, V87, P118, DOI 10.1212/WNL.0000000000002814
   GONZALEZ MTG, 1977, AM J TROP MED HYG, V26, P792, DOI 10.4269/ajtmh.1977.26.792
   Goodman Alyson B, 2016, MMWR Morb Mortal Wkly Rep, V65, P1082, DOI 10.15585/mmwr.mm6539e2
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hurtado-Villa P, 2017, PEDIATR INFECT DIS J, V36, P1017, DOI [10.1097/INF.0000000000001670, 10.1097/inf.0000000000001670]
   Ikejezie J, 2017, AM J TRANSPLANT, V17, P1681, DOI 10.1111/ajt.14333
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Karwowski MP, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2016-0621
   Klase ZA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004877
   Leal MC, 2017, EMERG INFECT DIS, V23, P1253, DOI 10.3201/eid2308.170354
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   McCarthy M, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4235
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Meneses JD, 2017, CLIN INFECT DIS, V64, P1302, DOI 10.1093/cid/cix166
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Ministerio da Saude Secretaria de Vigilancia em Saude, 2017, B EPIDEMIOL, V48, P1, DOI DOI 10.5588/IJTLD.11.0170
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Oliveira WK, LANCET
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Parrott J, 2002, J PEDIATR ORTHOPED, V22, P660, DOI 10.1097/01.BPO.0000023144.69745.67
   Posen HJ, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2016-000087
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rathore Mobeen H, 2017, Adv Pediatr, V64, P27, DOI 10.1016/j.yapd.2017.04.002
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Rodriguez-Morales AJ, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0128-2
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Wilder-Smith Annelies, 2017, Lancet Infect Dis, V17, pe101, DOI 10.1016/S1473-3099(16)30518-7
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
   World Health Organization, 2017, SIT REP ZIK VIR MICR
   Yepez JB, 2017, JAMA OPHTHALMOL, V135, P440, DOI 10.1001/jamaophthalmol.2017.0561
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zin AA, 2017, JAMA PEDIATR, V171, P847, DOI 10.1001/jamapediatrics.2017.1474
NR 60
TC 6
Z9 6
U1 0
U2 11
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0256-7040
EI 1433-0350
J9 CHILD NERV SYST
JI Childs Nerv. Syst.
PD JAN
PY 2018
VL 34
IS 1
BP 63
EP 71
DI 10.1007/s00381-017-3635-3
PG 9
WC Clinical Neurology; Pediatrics; Surgery
SC Neurosciences & Neurology; Pediatrics; Surgery
GA FS7GQ
UT WOS:000419966300014
PM 29110197
DA 2020-07-08
ER

PT J
AU Saad, T
   PennaeCosta, AA
   de Goes, FV
   de Freitas, M
   de Almeida, JV
   Ignez, LJD
   Amancio, AP
   Alvim, RJ
   Kramberger, LAA
AF Saad, Tania
   PennaeCosta, Alessandra Augusta
   de Goes, Fernanda Veiga
   de Freitas, Marcela
   de Almeida, Julia Valeriano
   de Santa Ignez, Lucio Jose
   Amancio, Ana Paula
   Alvim, Renata Joviano
   Antunes Kramberger, Ludmilla Athayde
TI Neurological manifestations of congenital Zika virus infection
SO CHILDS NERVOUS SYSTEM
LA English
DT Article
DE Zika virus; Congenital Zika virus syndrome; Microcephaly; Neurological
   manifestations
ID GROWTH; BRAIN
AB In 2015, it was observed a rise in the number of microcephalic newborns associated with a history of non-specific febrile sickness and rash during pregnancy in Brazil. Since then, microcephaly has emerged as a public health concern. A few months after, the causal relation between congenital microcephaly and the Zika virus was discovered. Zika virus, an arbovirus, is a new TORCH member that leads to congenital infection through vertical transmission and harms the developing brain, disrupting synaptogenesis, and causing other central nervous system lesions.
   The purpose of this article is to report the congenital Zika syndrome (CZS) and to emphasize the need for follow-up of the affected children to better know the evolutionary history of this new agent and to optimize the provision of healthcare and improve the quality of life of these patients.
   We review the most relevant literature about clinical manifestations and neuroimaging findings related to neurotropism of Zika virus to characterize the congenital Zika syndrome and suggest the systematization of some exams and procedures to evaluate children exposed to ZIKV with or without microcephaly, according to the author's own experience.
   Vertical ZIKV infection can cause a wide spectrum of neurological manifestations that go beyond microcephaly, and even the non-microcephalic child should be followed during the first years of life, because infection may be asymptomatic or lead to neuropsicomotor delay, epilepsy, and visual abnormalities. The appropriate prospective multidisciplinary follow-up of these patients aims to understand the natural history of this new agent and to provide a better development and quality of life for them and their families.
C1 [Saad, Tania; PennaeCosta, Alessandra Augusta; de Goes, Fernanda Veiga; de Freitas, Marcela; de Almeida, Julia Valeriano; de Santa Ignez, Lucio Jose; Amancio, Ana Paula; Alvim, Renata Joviano; Antunes Kramberger, Ludmilla Athayde] Fiocruz MS, Natl Inst Women Children & Adolescents Hlth Ferna, Div Pediat Neurol, 716 Rui Barbosa Ave, BR-22250020 Rio De Janeiro, Brazil.
   [Saad, Tania] Univ Estacio Sa, Rio De Janeiro, Brazil.
RP Saad, T (corresponding author), Fiocruz MS, Natl Inst Women Children & Adolescents Hlth Ferna, Div Pediat Neurol, 716 Rui Barbosa Ave, BR-22250020 Rio De Janeiro, Brazil.; Saad, T (corresponding author), Univ Estacio Sa, Rio De Janeiro, Brazil.
EM tsaadmd@gmail.com
CR [Anonymous], BAYL SCAL INF TODDL
   Brasil MdSd, 2017, OR INT VIG AT SAUD A
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   European Centre for Disease Prevention and Control, 2014, RAP RISK ASS ZIK VIR
   Horovitz DDG, 2016, NEUROLOGY, V87, P118, DOI 10.1212/WNL.0000000000002814
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Klase ZA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004877
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Ministerio da Saude, 2015, B EPIDEMIOL, V46, P1
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moore CM, 2016, JAMA PEDIAT, V2016, pE1, DOI DOI 10.1001/JAMAPEDIA
   Moriceau S, 2005, DEV PSYCHOBIOL, V47, P230, DOI 10.1002/dev.20093
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   WHO, 2016, ZIK SIT REP NEUR SYN
   Woods CG, 2013, ARCH DIS CHILD, V98, P707, DOI 10.1136/archdischild-2012-302882
   Zin AA, 2017, JAMA PEDIATR, V171, P847, DOI 10.1001/jamapediatrics.2017.1474
NR 23
TC 16
Z9 16
U1 2
U2 6
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0256-7040
EI 1433-0350
J9 CHILD NERV SYST
JI Childs Nerv. Syst.
PD JAN
PY 2018
VL 34
IS 1
BP 73
EP 78
DI 10.1007/s00381-017-3634-4
PG 6
WC Clinical Neurology; Pediatrics; Surgery
SC Neurosciences & Neurology; Pediatrics; Surgery
GA FS7GQ
UT WOS:000419966300015
PM 29127595
DA 2020-07-08
ER

PT J
AU de Vasconcelos, ZFM
   Azevedo, RC
   Thompson, N
   Gomes, L
   Guida, L
   Moreira, MEL
AF Meira de Vasconcelos, Zilton Farias
   Azevedo, Renata Campos
   Thompson, Nathalia
   Gomes, Leonardo
   Guida, Leticia
   Lopes Moreira, Maria Elisabeth
TI Challenges for molecular and serological ZIKV infection confirmation
SO CHILDS NERVOUS SYSTEM
LA English
DT Article
DE ZIKV; Arboviruses; RT-PCR; Serology; PRNT; Vertical transmission;
   Microcephaly
ID FEMALE GENITAL-TRACT; SEXUAL TRANSMISSION; VIRUS-INFECTION; DENGUE;
   BRAZIL; ASSOCIATION; CHIKUNGUNYA; OUTBREAK; SALIVA
AB Zika Virus (ZIKV), member of Flaviviridae family and Flavivirus genus, has recently emerged as international public health emergency after its association with neonatal microcephaly cases. Clinical diagnosis hindrance involves symptom similarities produced by other arbovirus infections, therefore laboratory confirmation is of paramount importance.
   The most reliable test available is based on ZIKV RNA detection from body fluid samples. However, short viremia window periods and asymptomatic infections diminish the success rate for RT-PCR positivity. Beyond molecular detection, all serology tests in areas where other Flavivirus circulates proved to be a difficult task due to the broad range of cross-reactivity, especially with dengue pre-exposed individuals.
   Altogether, lack of serological diagnostic tools brings limitations to any retrospective evaluation. Those studies are central in the context of congenital infection that could occur asymptomatically and mask prevalence and risk rates.
C1 [Meira de Vasconcelos, Zilton Farias; Thompson, Nathalia; Gomes, Leonardo; Guida, Leticia; Lopes Moreira, Maria Elisabeth] Fiocruz MS, Fernandes Figueira Inst, Avenida Rui Barbosa 716, BR-22250020 Rio De Janeiro, Brazil.
   [Azevedo, Renata Campos] Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Rio De Janeiro, Brazil.
RP de Vasconcelos, ZFM (corresponding author), Fiocruz MS, Fernandes Figueira Inst, Avenida Rui Barbosa 716, BR-22250020 Rio De Janeiro, Brazil.
EM zvasconcelos@iff.fiocruz.br
RI Azevedo, Renata/V-3130-2019; Vasconcelos, Zilton/AAD-5784-2019
OI Vasconcelos, Zilton/0000-0002-2193-2224
FU Fernandes Figueira Institute Research Program (Programa de Incentivo a
   Pesquisa II); Rio de Janeiro State Research Grant (Fundacao de Amparo a
   Pesquisa do Estado do Rio de Janeiro) [E-26/201.840/2017]; National
   Research Grant (Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico) [441098/2016-9]; CAPES/FIOCRUZ fellowship (Plano Brasil sem
   Miseria)
FX This work was supported by Fernandes Figueira Institute Research Program
   (Programa de Incentivo a Pesquisa II), Rio de Janeiro State Research
   Grant (Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro-grant
   E-26/201.840/2017), National Research Grant (Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico-grant 441098/2016-9), and
   CAPES/FIOCRUZ fellowship (Plano Brasil sem Miseria).
CR Alcon-LePoder S, 2006, Novartis Found Symp, V277, P233, DOI 10.1002/0470058005.ch17
   ALCONLEPODER S, 2006, NOVART FDN SYMP, V277, P247
   Ambrose JH, 2017, J TROP MED-US, V2017, DOI 10.1155/2017/8072491
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Barreto-Vieira DF, 2016, MEM I OSWALDO CRUZ, V111, P532, DOI 10.1590/0074-02760160104
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Brown WC, 2016, NAT STRUCT MOL BIOL, V23, P865, DOI 10.1038/nsmb.3268
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Colt S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005528
   Culjat M, 2016, CLIN INFECT DIS, V63, P805, DOI 10.1093/cid/ciw324
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   deMFreire CC, 2015, BIORXIV
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Gould EA, 2003, ADV VIRUS RES, V59, P277, DOI 10.1016/S0065-3527(03)59008-X
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Halstead SB, 2017, EMERG INFECT DIS, V23, P569, DOI 10.3201/eid2304.161879
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Landry ML, 2017, ARCH PATHOL LAB MED, V141, P60, DOI 10.5858/arpa.2016-0406-SA
   Lee E, 2010, J VIROL, V84, P5171, DOI 10.1128/JVI.01900-09
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Logan IS, 2016, ZOOL RES, V37, P110, DOI 10.13918/j.issn.2095-8137.2016.2.110
   Longdon B, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004395
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Oom AL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05980-z
   Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Roze B, 2016, EUROSURVEILLANCE, P21, DOI DOI 10.28707/1560-7917.ES.2016.21.9.30154
   Safronetz D, 2017, EMERG INFECT DIS, V23, P1577, DOI 10.3201/eid2309.162043
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Slavov SN, 2016, BRAZ J MED BIOL RES, V49, DOI 10.1590/1414-431X20165420
   Sumita LM, 2016, REV INST MED TROP SP, V58, DOI [10.1590/s1678-9946201658089, 10.1590/S1678-9946201658089]
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Visseaux B, 2016, LANCET INFECT DIS, V16, P1220, DOI 10.1016/S1473-3099(16)30387-5
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Weltman JK, 2016, J MED MICROB DIAGN
   Xu MY, 2016, J VIROL METHODS, V236, P93, DOI 10.1016/j.jviromet.2016.07.014
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 60
TC 10
Z9 10
U1 2
U2 5
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0256-7040
EI 1433-0350
J9 CHILD NERV SYST
JI Childs Nerv. Syst.
PD JAN
PY 2018
VL 34
IS 1
BP 79
EP 84
DI 10.1007/s00381-017-3641-5
PG 6
WC Clinical Neurology; Pediatrics; Surgery
SC Neurosciences & Neurology; Pediatrics; Surgery
GA FS7GQ
UT WOS:000419966300016
PM 29110196
DA 2020-07-08
ER

PT J
AU de Souza, AS
   de Oliveira-Szjenfeld, PS
   Melo, ASD
   de Souza, LAM
   Batista, AGM
   Tovar-Moll, F
AF de Souza, Andrea Silveira
   de Oliveira-Szjenfeld, Patricia Soares
   de Oliveira Melo, Adriana Suely
   Moreira de Souza, Luis Alberto
   Medeiros Batista, Alba Gean
   Tovar-Moll, Fernanda
TI Imaging findings in congenital Zika virus infection syndrome: an update
SO CHILDS NERVOUS SYSTEM
LA English
DT Article
DE Zika; ZIKV; Microcephaly; Congenital malformation; Brain calcifications;
   Ventriculomegaly; Arthrogryposis
ID BRAIN MRI; BRAZIL; SPECTRUM; FETUSES; PREGNANCY; PATHOLOGY; RISK
AB Background Zika virus (ZIKV) is a neurotropic and neurotoxic RNA Flavivirus prompt to cause severe fetal brain dysmorphisms during pregnancy, a period of rapid and critical central nervous system development. Awide range of clinicoradiological findings of congenital ZIKV infections were reported in the literature, such as microcephaly, overlapping sutures, cortical migrational and corpus callosum abnormalities, intracranial calcifications, ventriculomegaly, brain stem and cerebellar malformations, spinal cord involvement, and joint contractures. ZIKV is also related to other severe neurological manifestations in grown-up individuals such as Guillain-Barre syndrome and encephalomyelitis.
   Our purpose is to review the radiological central nervous system abnormalities of congenital ZIKV infection syndrome on different imaging modalities.
C1 [de Souza, Andrea Silveira; Moreira de Souza, Luis Alberto; Tovar-Moll, Fernanda] DOr Inst Res & Educ IDOR, Rua Diniz Cordeiro 30, BR-22281100 Botafogo, RJ, Brazil.
   [de Oliveira-Szjenfeld, Patricia Soares] Univ Fed Sao Paulo, Dept Diagnost Imaging, Sao Paulo, Brazil.
   [de Oliveira-Szjenfeld, Patricia Soares] Univ Fed Sao Paulo, Fdn Inst Educ & Res Diagnost Imaging FIDI, Sao Paulo, Brazil.
   [de Oliveira Melo, Adriana Suely; Medeiros Batista, Alba Gean] Res Inst Prof Amorim Neto IPESQ, Campina Grande, PB, Brazil.
   [de Oliveira Melo, Adriana Suely] UNIFACISA, Campina Grande, PB, Brazil.
   [Medeiros Batista, Alba Gean] Hosp Pedro I, Campina Grande, PB, Brazil.
   [Tovar-Moll, Fernanda] Fed Univ Rio De Janeiro UFRJ, Rio De Janeiro, Brazil.
RP Tovar-Moll, F (corresponding author), DOr Inst Res & Educ IDOR, Rua Diniz Cordeiro 30, BR-22281100 Botafogo, RJ, Brazil.; Tovar-Moll, F (corresponding author), Fed Univ Rio De Janeiro UFRJ, Rio De Janeiro, Brazil.
EM fernanda.tovarmoll@idor.org
RI Melo, Adriana S O/H-5650-2016; de Souza, Andrea Silveira/AAL-1976-2020
OI de Souza, Andrea Silveira/0000-0002-1553-2312
FU Brazilian Council for Development of Science and Technology
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [440909/2016-3]; CAPES FoundationCAPES; Brazilian Ministry of
   Education [88887.116625/2016-01]; Rio de Janeiro Foundation for the
   Support of Science (FAPERJ)Carlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ) [E-26/201.319/2016];
   D'Or Institute for Research and Education (IDOR, PNeuro)
FX This work was funded by different grants from the Brazilian Council for
   Development of Science and Technology (CNPq, Ref: 440909/2016-3), the
   CAPES Foundation, the Brazilian Ministry of Education (Ref.
   88887.116625/2016-01), the Rio de Janeiro Foundation for the Support of
   Science (FAPERJ, Ref: E-26/201.319/2016), and intramural grants from the
   D'Or Institute for Research and Education (IDOR, PNeuro).
CR Aragao MFVV, 2017, AM J NEURORADIOL, V38, P1045, DOI 10.3174/ajnr.A5125
   Aragao MFVV, 2017, ZIKA FOCUS POSTNATAL
   Barkovich AJ, 2012, BRAIN, V135, P1348, DOI 10.1093/brain/aws019
   Barkovich AJ, 1999, AM J NEURORADIOL, V20, P1814
   Bhat Venkatraman, 2014, Indian J Radiol Imaging, V24, P389, DOI 10.4103/0971-3026.143901
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Carvalho NS, 2017, AM J REPROD IMMUNOL, V77
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   Corona-Rivera JR, 2001, EUR J PEDIATR, V160, P664, DOI 10.1007/s004310100813
   Carvalho FHC, 2017, PRENATAL DIAG, V37, P207, DOI 10.1002/pd.4985
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   del Campo M, 2017, AM J MED GENET A, V173, P841, DOI 10.1002/ajmg.a.38170
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Eppes C, 2017, AM J OBSTET GYNECOL, V216, P209, DOI 10.1016/j.ajog.2017.01.020
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Garcez PP, 2017, SCI REP-UK, V7, DOI 10.1038/srep40780
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Guillemette-Artur P, 2016, PEDIATR RADIOL, V46, P1032, DOI 10.1007/s00247-016-3619-6
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kowalczyk B, 2016, ARCH MED SCI, V12, P10, DOI 10.5114/aoms.2016.57578
   Leyser M, 2017, JAMA NEUROL, V74, P610, DOI 10.1001/jamaneurol.2017.0048
   Li HD, 2016, NEURON, V92, P949, DOI 10.1016/j.neuron.2016.11.031
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Mehrjardi MZ, 2016, JPN J RADIOL, V34, P765, DOI 10.1007/s11604-016-0588-5
   Meneses JD, 2017, CLIN INFECT DIS, V64, P1302, DOI 10.1093/cid/cix166
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Sarno M, 2016, ULTRASOUND OBSTET GY
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schaub B, 2017, LANCET CHILD ADOLESC, V1, P45, DOI 10.1016/S2352-4642(17)30001-9
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Schwartz DA, 2017, ARCH GYNECOL OBSTET, V295, P1361, DOI 10.1007/s00404-017-4361-5
   Schwartz DA, 2017, ARCH PATHOL LAB MED, V141, P18, DOI [10.5858/arpa.2016-04, 10.5858/arpa.2016-0429-ED]
   Shastry Siri, 2016, Emerg Med Clin North Am, V34, pe25, DOI 10.1016/j.emc.2016.04.001
   Ticconi C, 2016, PATHOG GLOB HEALTH, V110, P262, DOI 10.1080/20477724.2016.1234804
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   World Health Organization, 2016, ZIK SIT REP ZIK POT
   Zacharias N, 2017, AJP REP, V7, P68, DOI 10.1055/s-0037-1601890
NR 44
TC 9
Z9 9
U1 0
U2 2
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0256-7040
EI 1433-0350
J9 CHILD NERV SYST
JI Childs Nerv. Syst.
PD JAN
PY 2018
VL 34
IS 1
BP 85
EP 93
DI 10.1007/s00381-017-3637-1
PG 9
WC Clinical Neurology; Pediatrics; Surgery
SC Neurosciences & Neurology; Pediatrics; Surgery
GA FS7GQ
UT WOS:000419966300017
PM 29181810
DA 2020-07-08
ER

PT J
AU Chimelli, L
   Avvad-Portari, E
AF Chimelli, L.
   Avvad-Portari, E.
TI Congenital Zika virus infection: a neuropathological review
SO CHILDS NERVOUS SYSTEM
LA English
DT Article
DE Congenital Zika virus infection; Neuropathology; Microcephaly;
   Ventriculomegaly; Calcifications; Migration disturbances
AB Background A relationship between Zika virus (ZikV) infection in pregnancy and the occurrence of microcephaly was established during the Zika outbreak in Brazil (2015-2016). Neuropathological findings in congenital Zika syndrome helped to understand its pathogenetic mechanisms. Results The most relevant postmortem findings in the central nervous system (CNS) of fetuses and neonates infected with ZikV early in gestation are microcephaly with ex-vacuo ventriculomegaly and large head circumference associated with obstructive hydrocephalus due to severe midbrain and aqueduct distortion. Babies with severe brain lesions are born with arthrogryposis. Histologically, there is extensive destruction of the hemispheric parenchyma, calcifications, various disturbances of neuronal migration, reactive gliosis, microglial hyperplasia and occasional perivascular cuffs of lymphocytes, also in the meninges. Hypoplastic lesions secondary to the lack of descending nerve fibers include small basis pontis, pyramids and spinal corticospinal tracts. Cerebellar hypoplasia is also common. Severe nerve motor nerve cell loss is observed in the anterior horn of the spinal cord. Conclusion A spectrum of neuropathological changes, from severe microcephaly to obstructive hydrocephalus was observed. The severity of the lesions is directly related to the gestational age, the most severe occurring when the mother is infected in the first trimester. Infection of progenitor cells at the germinal matrix was demonstrated. The lack of spinal motor neurons is responsible for fetal acynesia and consequent arthrogryposis.
C1 [Chimelli, L.] State Inst Brain Paulo Niemeyer, Lab Neuropathol, Rio De Janeiro, Brazil.
   [Chimelli, L.] Fed Univ Rio De Janeiro UFRJ, Rio De Janeiro, Brazil.
   [Avvad-Portari, E.] Oswaldo Cruz Fdn Fiocruz, Fernandes Figueira Inst, Rio De Janeiro, Brazil.
   [Avvad-Portari, E.] State Univ Rio De Janeiro UERJ, Rio De Janeiro, Brazil.
RP Avvad-Portari, E (corresponding author), Oswaldo Cruz Fdn Fiocruz, Fernandes Figueira Inst, Rio De Janeiro, Brazil.; Avvad-Portari, E (corresponding author), State Univ Rio De Janeiro UERJ, Rio De Janeiro, Brazil.
EM bethavvad@gmail.com
CR Acosta-Reyes J, 2017, EMERG INFECT DIS, V23, P982, DOI 10.3201/eid2306.161702
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Sousa AQ, 2017, EMERG INFECT DIS, V23, P1164, DOI 10.3201/eid2307.162019
NR 9
TC 10
Z9 11
U1 1
U2 5
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0256-7040
EI 1433-0350
J9 CHILD NERV SYST
JI Childs Nerv. Syst.
PD JAN
PY 2018
VL 34
IS 1
BP 95
EP 99
DI 10.1007/s00381-017-3651-3
PG 5
WC Clinical Neurology; Pediatrics; Surgery
SC Neurosciences & Neurology; Pediatrics; Surgery
GA FS7GQ
UT WOS:000419966300018
PM 29167994
DA 2020-07-08
ER

PT J
AU Juca, E
   Pessoa, A
   Ribeiro, E
   Menezes, R
   Kerbage, S
   Lopes, T
   Cavalcanti, LP
AF Juca, Eduardo
   Pessoa, Andre
   Ribeiro, Erlane
   Menezes, Rafaela
   Kerbage, Saile
   Lopes, Thayse
   Cavalcanti, Luciano Pamplona
TI Hydrocephalus associated to congenital Zika syndrome: does shunting
   improve clinical features?
SO CHILDS NERVOUS SYSTEM
LA English
DT Article
DE Zika virus; Microcephaly; Hydrocephalus; Ventriculoperitoneal shunt
ID VIRUS-INFECTION; BRAZIL; SPECTRUM; BRAIN
AB Congenital Zika syndrome (CZS) is a new entity with little information about its course and natural history. It is known that prenatal infection by Zika virus is associated to disrupted nervous system development, leading to typical neurological disabilities and deformities. Some children present progressive ventriculomegaly and hydrocephalus associated to aggravation of seizures and neurological impairment. The aim of this study is to evaluate the development of hydrocephalus and the impact of ventriculoperitoneal shunt insertion in the clinical condition of these children.
   Data was obtained from chart review, direct interviews with patients' parents, direct neurological examination, and analysis of pre- and postoperative neuroimages.
   A group of 115 patients had CZS diagnosis from November 2015 to July 2017. Among them, 21 (18.3%) patients had ventricular enlargement noted on follow-up CT scans. Six children (28.6%) underwent a ventriculoperitoneal shunt and all had some improvement after surgery concerning either waking time during the day and better interaction. Overall improvement was also noted in seizures. Spasticity decrease and more cervical control were also achieved. In two out of six cases, a slight increase in parenchymal length could be noted on the CT scans.
   This series points out the possibility of hypertensive hydrocephalus development in CZS patients. Affected children may benefit from VP shunt insertion. These findings suggest a dual pathology association: fetal brain disruption and primary cortical malformation by the virus itself and hypertensive hydrocephalus. This is already seen in some cases of congenital rubella, toxoplasmosis, or cytomegalovirus-associated hydrocephalus.
C1 [Juca, Eduardo] Univ Fortaleza UNIFOR, Fortaleza, Ceara, Brazil.
   [Juca, Eduardo; Pessoa, Andre; Ribeiro, Erlane; Kerbage, Saile] Hosp Infantil Albert Sabin, Fortaleza, Ceara, Brazil.
   [Juca, Eduardo; Ribeiro, Erlane; Menezes, Rafaela; Lopes, Thayse] Ctr Univ Christus, Fortaleza, Ceara, Brazil.
   [Pessoa, Andre] Univ Estadual Ceara UECE, Fortaleza, Ceara, Brazil.
   [Cavalcanti, Luciano Pamplona] Univ Fed Ceara, Fortaleza, Ceara, Brazil.
RP Juca, E (corresponding author), Univ Fortaleza UNIFOR, Fortaleza, Ceara, Brazil.; Juca, E (corresponding author), Hosp Infantil Albert Sabin, Fortaleza, Ceara, Brazil.; Juca, E (corresponding author), Ctr Univ Christus, Fortaleza, Ceara, Brazil.
EM eduardojuca@gmail.com
RI Juca, Eduardo/AAF-7029-2019; Cavalcanti, Luciano/N-4391-2015
OI Juca, Eduardo/0000-0003-3269-2577; Cavalcanti,
   Luciano/0000-0002-3440-1182; Soares Barros de Menezes,
   Rafaela/0000-0002-7115-4010
CR Alves LV, 2016, REV BRAS SAUDE MATER, V16, P33
   Bale J F Jr, 1985, Pediatr Neurol, V1, P42, DOI 10.1016/0887-8994(85)90008-6
   Bale JF, 2009, CLIN PERINATOL, V36, P639, DOI 10.1016/j.clp.2009.06.005
   Cavalcanti LP, 2017, REV MED UFC, V57, P30
   Cavalheiro S, 2016, CHILD NERV SYST, V32, P1057, DOI 10.1007/s00381-016-3074-6
   del Campo M, 2017, AM J MED GENET A, V173, P841, DOI 10.1002/ajmg.a.38170
   FITZ CR, 1992, AM J NEURORADIOL, V13, P551
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   Hutson SL, 2015, CLIN INFECT DIS, V61, P1831, DOI 10.1093/cid/civ720
   Jones J, 2003, AM FAM PHYS
   KAISER G, 1985, Z KINDERCHIR, V40, P10
   Malinger G, 2003, AM J NEURORADIOL, V24, P28
   Moore C., 2016, J FAMILY VIOLENCE, P1
   Moorthy RK, 2011, NEUROL INDIA, V59, P848, DOI 10.4103/0028-3886.91364
   Nishiyama K, 2015, NEUROL MED-CHIR, V55, P611, DOI 10.2176/nmc.ra.2014-0433
   Olagnier D, 2016, DNA CELL BIOL, V35, P367, DOI 10.1089/dna.2016.3404
   Pastula DM, 2017, JAMA NEUROL
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Ribeiro EM, 2017, J VENOM ANIM TOXINS, V23, DOI 10.1186/s40409-017-0107-x
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Toma AK, 2015, SURGERY, V33, P384
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Venkataramana NK, 2011, J PEDIATR NEUROSCI, V6, P11, DOI 10.4103/1817-1745.85704
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   Vercosa I, 2017, J AM ASS PEDIAT OPHT
   Younger DS, 2016, NEUROL CLIN, V34, P1049, DOI 10.1016/j.ncl.2016.06.008
NR 26
TC 5
Z9 5
U1 0
U2 5
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0256-7040
EI 1433-0350
J9 CHILD NERV SYST
JI Childs Nerv. Syst.
PD JAN
PY 2018
VL 34
IS 1
BP 101
EP 106
DI 10.1007/s00381-017-3636-2
PG 6
WC Clinical Neurology; Pediatrics; Surgery
SC Neurosciences & Neurology; Pediatrics; Surgery
GA FS7GQ
UT WOS:000419966300019
PM 29086073
DA 2020-07-08
ER

PT J
AU McGrath, EL
   Gao, JL
   Wu, P
AF McGrath, Erica L.
   Gao, Junling
   Wu, Ping
TI Proliferation and differentiation of human fetal brain neural stem cells
   in vitro
SO JOURNAL OF NEURORESTORATOLOGY
LA English
DT Article
DE neural stem cell; proliferation; differentiation; neuron; astrocyte
ID ZIKA VIRUS-INFECTION; PROGENITOR CELLS; NEURONS; RESCUE; RAT
AB Primary human fetal brain neural stem cells (hNSCs) are a unique non-genetically modified model system to study molecular mechanisms underlying human neural development, to model human diseases, and to screen drugs or validate new treatments. They may also be used for cell transplantation to treat various neurological diseases. This protocol details our methods that can be used to expand hNSCs in culture as well as how to differentiate them into various neuronal lineages and astrocytes.
C1 [McGrath, Erica L.; Gao, Junling; Wu, Ping] Univ Texas Med Branch, Dept Neurosci & Cell Biol, Res Bldg 17,Room 4-212 B,301 Univ Blvd, Galveston, TX 77555 USA.
   [Wu, Ping] Capital Med Univ, Beijing Inst Brain Disorders, Beijing, Peoples R China.
RP Wu, P (corresponding author), Univ Texas Med Branch, Dept Neurosci & Cell Biol, Res Bldg 17,Room 4-212 B,301 Univ Blvd, Galveston, TX 77555 USA.
EM piwu@utmb.edu
FU John S Dunn Foundation; TIRR Foundation; Coalition for Brain Injury
   Research; Moody Project
FX This work was supported by funds from the John S Dunn Foundation, TIRR
   Foundation, the Coalition for Brain Injury Research, and the Moody
   Project to PW.
CR Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Gao JL, 2006, EXP NEUROL, V201, P281, DOI 10.1016/j.expneurol.2006.04.039
   Gao JL, 2016, CELL TRANSPLANT, V25, P1863, DOI 10.3727/096368916X691150
   Jakel RJ, 2004, NAT REV GENET, V5, P136, DOI 10.1038/nrg1268
   Lee Y, 2012, COLD SPRING HARB PER, V2
   Lopez-Garcia I, BR J PHARM
   Lyczek A, 2017, EXP NEUROL, V291, P74, DOI 10.1016/j.expneurol.2017.02.005
   McGrath EL, 2017, STEM CELL REP, V8, P715, DOI 10.1016/j.stemcr.2017.01.008
   Mertens J, 2016, NAT REV NEUROSCI, V17, P424, DOI 10.1038/nrn.2016.46
   Mich JK, 2014, ELIFE, V3, DOI 10.7554/eLife.02669
   Nam H, 2015, WORLD J STEM CELLS, V7, P126, DOI 10.4252/wjsc.v7.i1.126
   Reekmans K, 2012, STEM CELL REV REP, V8, P262, DOI 10.1007/s12015-011-9266-2
   Sandrock RW, 2010, REGEN MED, V5, P381, DOI 10.2217/RME.10.24
   Svendsen CN, 1998, J NEUROSCI METH, V85, P141, DOI 10.1016/S0165-0270(98)00126-5
   Tarasenko YI, 2007, J NEUROSCI RES, V85, P47, DOI 10.1002/jnr.21098
   Thonhoff JR, 2009, CURR STEM CELL RES T, V4, P178, DOI 10.2174/157488809789057392
   Windrem MS, 2008, CELL STEM CELL, V2, P553, DOI 10.1016/j.stem.2008.03.020
   Wu P, 2002, NAT NEUROSCI, V5, P1271, DOI 10.1038/nn974
NR 18
TC 5
Z9 5
U1 0
U2 6
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 2324-2426
J9 J NEURORESTORATOLOGY
JI J. NEURORESSTORATOLOGY
PY 2018
VL 6
BP 19
EP 27
DI 10.2147/JN.S148794
PG 9
WC Clinical Neurology
SC Neurosciences & Neurology
GA FS8NE
UT WOS:000422668300001
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Graham, BS
   Sullivan, NJ
AF Graham, Barney S.
   Sullivan, Nancy J.
TI Emerging viral diseases from a vaccinology perspective: preparing for
   the next pandemic
SO NATURE IMMUNOLOGY
LA English
DT Review
ID TICK-BORNE ENCEPHALITIS; NEUTRALIZING HUMAN-ANTIBODIES; HUMAN
   MONOCLONAL-ANTIBODIES; EBOLA-VIRUS INFECTION; ZIKA VIRUS; FUSION
   GLYCOPROTEIN; PROTECTIVE EFFICACY; STRUCTURAL BASIS; YELLOW-FEVER;
   DOUBLE-BLIND
AB Emerging infectious diseases will continue to threaten public health and are sustained by global commerce, travel and disruption of ecological systems. Most pandemic threats are caused by viruses from either zoonotic sources or vector-borne sources. Developing better ways to anticipate and manage the ongoing microbial challenge will be critical for achieving the United Nations Sustainable Development Goals and, conversely, each such goal will affect the ability to control infectious diseases. Here we discuss how technology can be applied effectively to better prepare for and respond to new viral diseases with a focus on new paradigms for vaccine development.
C1 [Graham, Barney S.; Sullivan, Nancy J.] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
RP Graham, BS (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
EM bgraham@nih.gov; nsullivan@nih.gov
RI Graham, Barney S./AAC-5898-2019
OI Graham, Barney S./0000-0001-8112-0853
FU National Institute of Allergy and Infectious DiseasesUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
FX We thank J. Mascola, K. Kelley, T. Pierson and K. Morabito for editorial
   comments, and A. Fauci, H. Achincloss, J. Gall, K. Modjarrad, S. Plotkin
   and C. Cassetti for discussions. Supported by the National Institute of
   Allergy and Infectious Diseases (intramural funding).
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Andrews S. F., 2017, COLD SPRING HARB PER
   Bahl K, 2017, MOL THER, V25, P1316, DOI 10.1016/j.ymthe.2017.03.035
   Bailey AL, 2016, J VIROL, V90, P630, DOI 10.1128/JVI.01433-15
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Buck CB, 2004, J VIROL, V78, P751, DOI 10.1128/JVI.78.2.751-757.2004
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P97
   de Alwis R, 2012, P NATL ACAD SCI USA, V109, P7439, DOI 10.1073/pnas.1200566109
   De Santis O, 2016, LANCET INFECT DIS, V16, P311, DOI 10.1016/S1473-3099(15)00486-7
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P600, DOI 10.1016/0035-9203(52)90021-7
   Didierlaurent AM, 2017, EXPERT REV VACCINES, V16, P55, DOI 10.1080/14760584.2016.1213632
   Dormitzer PR, 2015, CURR TOP MICROBIOL, V386, P237, DOI 10.1007/82_2014_399
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Durbin AP, 2011, VACCINE, V29, P7242, DOI 10.1016/j.vaccine.2011.07.023
   Effio CL, 2015, BIOTECHNOL J, V10, P715, DOI 10.1002/biot.201400392
   Ewer K, 2016, NEW ENGL J MED, V374, P1635, DOI 10.1056/NEJMoa1411627
   Fauci AS, 2012, NEW ENGL J MED, V366, P454, DOI 10.1056/NEJMra1108296
   Furman D, 2015, VACCINE, V33, P5271, DOI 10.1016/j.vaccine.2015.06.117
   Gilbert SC, 2017, VACCINE, V35, P4461, DOI 10.1016/j.vaccine.2017.04.085
   Gilman MSA, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aaj1879
   Graham BS, 2013, IMMUNOL REV, V255, P230, DOI 10.1111/imr.12098
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Guy B, 2011, VACCINE, V29, P7229, DOI 10.1016/j.vaccine.2011.06.094
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Hahn BH, 2000, SCIENCE, V287, P607, DOI 10.1126/science.287.5453.607
   Halstead SB, 2011, EXPERT REV VACCINES, V10, P355, DOI [10.1586/erv.11.7, 10.1586/ERV.11.7]
   Heinz FX, 2012, J CLIN VIROL, V55, P289, DOI 10.1016/j.jcv.2012.08.024
   Huttner A, 2015, LANCET INFECT DIS, V15, P1156, DOI 10.1016/S1473-3099(15)00154-1
   Jardine J, 2013, SCIENCE, V340, P711, DOI 10.1126/science.1234150
   Joyce MG, 2016, CELL, V166, P609, DOI 10.1016/j.cell.2016.06.043
   Joyce MG, 2013, J VIROL, V87, P2294, DOI 10.1128/JVI.02717-12
   Julander JG, 2011, VACCINE, V29, P6008, DOI 10.1016/j.vaccine.2011.06.034
   Kanekiyo M, 2013, NATURE, V499, P102, DOI 10.1038/nature12202
   Kaufmann B, 2010, P NATL ACAD SCI USA, V107, P18950, DOI 10.1073/pnas.1011036107
   King NP, 2014, NATURE, V510, P103, DOI 10.1038/nature13404
   King NP, 2012, SCIENCE, V336, P1171, DOI 10.1126/science.1219364
   Kreil TR, 1997, CLIN EXP IMMUNOL, V110, P358, DOI 10.1046/j.1365-2249.1997.4311446.x
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Ledgerwood JE, 2017, NEW ENGL J MED, V376, P928, DOI [10.1056/NEJMoa1410863, 10.1056/nejmoa1410863]
   Ledgerwood JE, 2009, HUM VACCINES, V5, P623, DOI 10.4161/hv.8627
   Li L, 2008, SCIENCE, V319, P1830, DOI 10.1126/science.1153263
   Li YX, 2011, J VIROL, V85, P8954, DOI 10.1128/JVI.00754-11
   Martin JE, 2006, CLIN VACCINE IMMUNOL, V13, P1267, DOI 10.1128/CVI.00162-06
   McLellan JS, 2013, SCIENCE, V340, P1113, DOI 10.1126/science.1234914
   McLellan JS, 2011, J VIROL, V85, P7788, DOI 10.1128/JVI.00555-11
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Muhlebach M. D., 2017, VIRUS GENES
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Muthumani K, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.21
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Peiris JSM, 2003, NEW ENGL J MED, V349, P2431, DOI 10.1056/NEJMra032498
   Pierson TC, 2016, CELL, V167, P625, DOI 10.1016/j.cell.2016.09.020
   Plotkin S. A., 2017, HUM VACCIN IMMUNOTHE
   Plotkin SA, 2015, NEW ENGL J MED, V373, P297, DOI 10.1056/NEJMp1506820
   Prausnitz MR, 2017, ANNU REV CHEM BIOMOL, V8, P177, DOI 10.1146/annurev-chembioeng-060816-101514
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   Richner JM, 2017, CELL, V169, P176, DOI 10.1016/j.cell.2017.03.016
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Schmaljohn C. S., 2017, HUM VACCIN IMMUNOTHE
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Slaoui Moncef, 2015, Nat Rev Drug Discov, V14, P452, DOI 10.1038/nrd4669
   Smit R, 2015, EXPERT REV VACCINES, V14, P737, DOI 10.1586/14760584.2015.985661
   Stanley DA, 2014, NAT MED, V20, P1126, DOI 10.1038/nm.3702
   Staples JE, 2008, JAMA-J AM MED ASSOC, V300, P960, DOI 10.1001/jama.300.8.960
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Sullivan NJ, 2011, NAT MED, V17, P1128, DOI 10.1038/nm.2447
   Sullivan NJ, 2000, NATURE, V408, P605, DOI 10.1038/35046108
   Sumathy K, 2017, SCI REP-UK, V7, DOI 10.1038/srep46375
   Tauber E, 2007, LANCET, V370, P1847, DOI 10.1016/S0140-6736(07)61780-2
   Tian M, 2016, CELL, V166, P1471, DOI 10.1016/j.cell.2016.07.029
   Ulmer JB, 2016, CURR OPIN IMMUNOL, V41, P18, DOI 10.1016/j.coi.2016.05.008
   Ungchusak K, 2005, NEW ENGL J MED, V352, P333, DOI 10.1056/NEJMoa044021
   US Food & Drug Administration, 2016, EM US AUTH
   Van Gessel Y, 2011, VACCINE, V29, P5925, DOI 10.1016/j.vaccine.2011.06.062
   Villar RF, 2016, SCI REP-UK, V6, DOI 10.1038/srep36298
   Volz A, 2017, ADV VIRUS RES, V97, P187, DOI 10.1016/bs.aivir.2016.07.001
   Voss JE, 2010, NATURE, V468, P709, DOI 10.1038/nature09555
   Whitehead SS, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005584
   WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0
   World Health Organization, 2004, CAUS SPEC MORT MORB, P47
   World Health Organization, 2004, GLOB BURD DIS 2004 4
   Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890
   Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532
   Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659
   Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514
   Yassine HM, 2015, NAT MED, V21, P1065, DOI 10.1038/nm.3927
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
   Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819
   Zhou Y, 2015, CURR OPIN IMMUNOL, V35, P131, DOI 10.1016/j.coi.2015.06.006
NR 95
TC 13
Z9 14
U1 2
U2 18
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1529-2908
EI 1529-2916
J9 NAT IMMUNOL
JI Nat. Immunol.
PD JAN
PY 2018
VL 19
IS 1
BP 20
EP 28
DI 10.1038/s41590-017-0007-9
PG 9
WC Immunology
SC Immunology
GA FS4MA
UT WOS:000419765300010
PM 29199281
OA Green Published
DA 2020-07-08
ER

PT J
AU de Mello, CPP
   Tao, X
   Kim, TH
   Bulitta, JB
   Rodriquez, JL
   Pomeroy, JJ
   Brown, AN
AF de Mello, Camilly P. Pires
   Tao, Xun
   Kim, Tae Hwan
   Bulitta, Jurgen B.
   Rodriquez, Jaime L.
   Pomeroy, Justin J.
   Brown, Ashley N.
TI Zika Virus Replication Is Substantially Inhibited by Novel Favipiravir
   and Interferon Alpha Combination Regimens
SO ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
LA English
DT Article
DE combination therapy; favipiravir; Zika virus; antiviral agents;
   interferon alpha; mechanism-based modeling; ribavirin
ID IN-VITRO; INFECTION; RIBAVIRIN; T-705; PHARMACOKINETICS; COMPOUND;
   DISEASE; MODEL
AB Zika virus (ZIKV) is a major public health concern due to its overwhelming spread into the Americas. Currently, there are neither licensed vaccines nor antiviral therapies available for the treatment of ZIKV. We aimed to identify and rationally optimize effective therapeutic regimens for ZIKV by evaluating the antiviral potentials of the approved broad-spectrum antiviral agents favipiravir (FAV), interferon alpha (IFN), and ribavirin (RBV) as single agents and in combinations. For these studies, Vero cells were infected with ZIKV in the presence of increasing concentrations of FAV, IFN, or/and RBV for 4 days. Supernatants were harvested daily, and the viral burden was quantified by a plaque assay on Vero cells. The time course of the viral burden during treatment in vitro was characterized by a novel translational, mechanism-based model, which was subsequently used to rationally optimize combination dosage regimens. The combination regimen of FAV plus IFN provided the greatest extent of viral inhibition without cytotoxicity, reducing the viral burden by 4.4 log(10) PFU/ml at concentrations of 250 mu M FAV and 100 IU/ml IFN. Importantly, these concentrations are achievable in humans. The translational, mechanism-based model yielded unbiased and reasonably precise curve fits. Simulations with the model predicted that clinically relevant regimens of FAV plus IFN would markedly reduce viral burdens in humans, resulting in at least a 10,000-fold reduction in the amount of the virus during the first 4 days of treatment. These findings highlight the substantial promise of rationally optimized combination dosage regimens of FAV plus IFN, which should be further investigated to combat ZIKV.
C1 [de Mello, Camilly P. Pires; Rodriquez, Jaime L.; Pomeroy, Justin J.; Brown, Ashley N.] Univ Florida, Coll Med, Dept Med, Inst Therapeut Innovat, Orlando, FL 32816 USA.
   [Tao, Xun; Kim, Tae Hwan; Bulitta, Jurgen B.] Univ Florida, Dept Pharmaceut, Coll Pharm, Ctr Pharmacometr & Syst Pharmacol, Orlando, FL USA.
RP Brown, AN (corresponding author), Univ Florida, Coll Med, Dept Med, Inst Therapeut Innovat, Orlando, FL 32816 USA.
EM Ashley.Brown@medicine.ufl.edu
RI Bulitta, Jurgen B/P-3355-2018
OI Bulitta, Jurgen B/0000-0001-7352-3097
FU Florida Department of Health, Biomedical Research Program [7ZK30]
FX This work was supported by grant 7ZK30 from the Florida Department of
   Health, Biomedical Research Program. The funders had no role in study
   design, data collection and interpretation, or the decision to submit
   the work for publication. We declare no competing interests.
CR Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Beal SL, 2001, J PHARMACOKINET PHAR, V28, P481, DOI 10.1023/A:1012299115260
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Brown AN, 2011, ANTIMICROB AGENTS CH, V55, P1747, DOI 10.1128/AAC.01629-10
   Bulitta JB, 2013, ANTIMICROB AGENTS CH, V57, P498, DOI 10.1128/AAC.01354-12
   Bulitta JB, 2011, AAPS J, V13, P201, DOI 10.1208/s12248-011-9257-x
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chakraborty A, 2002, J PHARM SCI-US, V91, P1334, DOI 10.1002/jps.3000
   Crotty S, 2000, NAT MED, V6, P1375
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   Detje CN, 2009, J IMMUNOL, V182, P2297, DOI 10.4049/jimmunol.0800596
   Furuta Y, 2002, ANTIMICROB AGENTS CH, V46, P977, DOI 10.1128/AAC.46.4.977-981.2002
   Gallegos KM, 2016, J INFECT DIS, V214, P1192, DOI 10.1093/infdis/jiw358
   GUTTERMAN JU, 1982, ANN INTERN MED, V96, P549, DOI 10.7326/0003-4819-96-5-549
   Julander JG, 2009, ANTIMICROB AGENTS CH, V53, P202, DOI 10.1128/AAC.01074-08
   Ku JH, 1999, BJU INT, V84, P839
   Maag D, 2001, J BIOL CHEM, V276, P46094, DOI 10.1074/jbc.C100349200
   Madelain V, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.01305-16, 10.1128/aac.01305-16]
   Matheron S, 2016, CLIN INFECT DIS, V63, DOI 10.1093/cid/ciw509
   Mentre F, 2015, LANCET INFECT DIS, V15, P150, DOI 10.1016/S1473-3099(14)71047-3
   Morrey JD, 2008, ANTIVIR RES, V80, P377, DOI 10.1016/j.antiviral.2008.07.009
   Nagata T, 2015, DISASTER MED PUBLIC, V9, P79, DOI 10.1017/dmp.2014.151
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Pharmaceuticals and Medical Devices Agency, 2014, REV REP REP DEL RES
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Nguyen THT, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005389
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
NR 28
TC 8
Z9 8
U1 0
U2 4
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0066-4804
EI 1098-6596
J9 ANTIMICROB AGENTS CH
JI Antimicrob. Agents Chemother.
PD JAN
PY 2018
VL 62
IS 1
AR e01983- 17
DI 10.1128/AAC.01983-17
PG 12
WC Microbiology; Pharmacology & Pharmacy
SC Microbiology; Pharmacology & Pharmacy
GA FQ7TJ
UT WOS:000418565300059
PM 29109164
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Lai, LL
   Rouphael, N
   Xu, YX
   Natrajan, MS
   Beck, A
   Hart, M
   Feldhammer, M
   Feldpausch, A
   Hill, C
   Wu, H
   Fairley, JK
   Lankford-Turner, P
   Kasher, N
   Rago, P
   Hu, YJ
   Edupuganti, S
   Patel, SM
   Murray, KO
   Mulligan, MJ
AF Lai, Lilin
   Rouphael, Nadine
   Xu, Yongxian
   Natrajan, Muktha S.
   Beck, Allison
   Hart, Mari
   Feldhammer, Matthew
   Feldpausch, Amanda
   Hill, Charles
   Wu, Henry
   Fairley, Jessica K.
   Lankford-Turner, Pamela
   Kasher, Nicole
   Rago, Patrick
   Hu, Yi-Juan
   Edupuganti, Srilatha
   Patel, Shital M.
   Murray, Kristy O.
   Mulligan, Mark J.
CA Emory Zika Patient Study Team
TI Innate, T-, and B-Cell Responses in Acute Human Zika Patients
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE Zika; immunity; pregnancy; viral persistence; flavivirus
ID DENGUE VIRUS-INFECTION; PROLONGED DETECTION; WHOLE-BLOOD; VACCINE;
   ACTIVATION; IMMUNITY; DISEASE; EBOLA
AB Background. There is an urgent need for studies of viral persistence and immunity during human Zika infections to inform planning and conduct of vaccine clinical trials.
   Methods. In 5 returned US travelers with acute symptomatic Zika infection, clinical features, viral RNA levels, and immune responses were characterized.
   Results. Two pregnant, flavivirus-experienced patients had viral RNA persist in plasma for > 44 and > 26 days. Three days after symptom onset, transient increases in proinflammatory monocytes began followed at 5 days by transient decreases in myeloid dendritic cells. Anti-Zika virus immunoglobulin M was detected at day 7 after symptom onset, persisted beyond 103 days, and remained equivocal through day 172. Zika virus-specific plasmablasts and neutralizing antibodies developed quickly; dengue virus-specific plasmablasts and neutralizing antibodies at high titers developed only in flavivirus-experienced patients. Zika virus-and dengue virus-specific memory B cells developed in both flavivirus-naive and -experienced patients. CD4+ T cells were moderately activated and produced antiviral cytokines after stimulation with Zika virus C, prM, E, and NS5 peptides in 4/4 patients. In contrast, CD8+ T cells were massively activated, but virus-specific cells that produced cytokines were present in only 2/4 patients assessed.
   Conclusions. Acute infections with Zika virus modulated antigen-presenting cell populations early. Flavivirus-experienced patients quickly recalled cross-reactive MBCs to secrete antibodies. Dengue virus-naive patients made little dengue-specific antibody but developed MBCs that cross-reacted against dengue virus. Zika virus-specific functional CD4+ T cells were readily detected, but few CD8+ T cells specific for the tested peptides were found.
C1 [Lai, Lilin; Rouphael, Nadine; Xu, Yongxian; Natrajan, Muktha S.; Beck, Allison; Hart, Mari; Lankford-Turner, Pamela; Kasher, Nicole; Edupuganti, Srilatha; Mulligan, Mark J.] Emory Univ, Sch Med, Dept Med, Hope Clin Emory Vaccine Ctr,Div Infect Dis, Decatur, GA 30033 USA.
   [Feldhammer, Matthew; Hill, Charles; Rago, Patrick] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA.
   [Feldpausch, Amanda] Georgia Dept Publ Hlth, Atlanta, GA USA.
   [Wu, Henry; Fairley, Jessica K.] Emory Univ, Sch Med, Dept Med, Emory TravelWell Ctr,Div Infect Dis, Atlanta, GA 30322 USA.
   [Hu, Yi-Juan] Emory Univ, Rollins Sch Publ Hlth, Dept Biostat & Bioinformat, Atlanta, GA 30322 USA.
   [Patel, Shital M.] Texas Childrens Hosp, Baylor Coll Med, Dept Med, Sect Infect Dis, Houston, TX 77030 USA.
   [Patel, Shital M.] Texas Childrens Hosp, Baylor Coll Med, Dept Mol Virol, Sect Infect Dis, Houston, TX 77030 USA.
   [Patel, Shital M.] Texas Childrens Hosp, Baylor Coll Med, Dept Microbiol, Sect Infect Dis, Houston, TX 77030 USA.
   [Murray, Kristy O.] Texas Childrens Hosp, Baylor Coll Med, Pediat Trop Med, Houston, TX 77030 USA.
RP Mulligan, MJ (corresponding author), Hope Clin Emory Vaccine Ctr, Div Infect Dis, 500 Irvin Court,Suite 200, Decatur, GA 30030 USA.
EM mark.mulligan@emory.edu
RI amsalu, ribka/G-8780-2019; Fairley, Jessica K/W-2777-2019; Mulligan,
   Mark/V-9275-2019
OI Lai, Lilin/0000-0002-9528-6990; Natrajan, Muktha/0000-0003-1854-0382
FU Emory University School of Medicine; Emory Vaccine Center; Georgia
   Research Alliance; National Institutes of Health (NIH), National
   Institute of Allergy and Infectious Diseases (NIAID), Division of
   Microbiology and Infectious Diseases (DMID) [HHSN272201300018I]; 
   [AI115651]
FX This work was supported by the Emory University School of Medicine;
   Emory Vaccine Center; Georgia Research Alliance; and the National
   Institutes of Health (NIH), National Institute of Allergy and Infectious
   Diseases (NIAID), Division of Microbiology and Infectious Diseases
   (DMID; contract HHSN272201300018I) and by a supplemental award to
   NIH/NIAID/DMID (grant AI115651).
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Aletti M, 2017, CLIN INFECT DIS, V64, P678, DOI 10.1093/cid/ciw802
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Centers for Disease Control and Prevention, 2016, ZIK MAC ELISA INSTR
   Centers for Disease Control and Prevention National Center for Emerging and Zoonotic Infectious Diseases Division of Vector-Borne Diseases., ZIK VIR REP SURV
   Chandele A, 2016, J VIROL, V90, P11259, DOI 10.1128/JVI.01424-16
   Cohen J, 2016, SCIENCE, V351, P543, DOI 10.1126/science.351.6273.543
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Edupuganti S, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx133
   Edupuganti S, 2013, AM J TROP MED HYG, V88, P172, DOI 10.4269/ajtmh.2012.12-0179
   Feroldi E, 2017, J INFECT DIS, V215, P221, DOI 10.1093/infdis/jiw533
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Kwissa M, 2014, CELL HOST MICROBE, V16, P115, DOI 10.1016/j.chom.2014.06.001
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanteri MC, 2014, TRANSFUSION, V54, P3232, DOI 10.1111/trf.12764
   Lechner F, 2000, J EXP MED, V191, P1499, DOI 10.1084/jem.191.9.1499
   Lipsitch M, 2016, SCIENCE, V353, P1094, DOI 10.1126/science.aai8126
   Lustig Y, 2016, EURO SURVEILL, V21
   McElroy AK, 2015, P NATL ACAD SCI USA, V112, P4719, DOI 10.1073/pnas.1502619112
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Ndhlovu ZM, 2015, IMMUNITY, V43, P591, DOI 10.1016/j.immuni.2015.08.012
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Osterholm MT, 2016, SCIENCE, V353, P1073, DOI 10.1126/science.aai9078
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Pierson TC, 2016, CELL, V167, P625, DOI 10.1016/j.cell.2016.09.020
   POLAND JD, 1981, B WORLD HEALTH ORGAN, V59, P895
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rios M, 2007, CLIN INFECT DIS, V45, P181, DOI 10.1086/518850
   Rivino L, 2013, J VIROL, V87, P2693, DOI 10.1128/JVI.02675-12
   Schmid MA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00647
   Turtle L, 2016, J EXP MED, V213, P1331, DOI 10.1084/jem.20151517
   Waggoner JJ, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx103
NR 40
TC 23
Z9 23
U1 0
U2 6
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD JAN 1
PY 2018
VL 66
IS 1
BP 1
EP +
DI 10.1093/cid/cix732
PG 10
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA FS2ZO
UT WOS:000419648300001
PM 29020226
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Bandyopadhyay, D
   Qureshi, A
   Ashish, K
   Hajra, A
   Chakraborty, S
AF Bandyopadhyay, Dhrubajyoti
   Qureshi, Arshna
   Ashish, Kumar
   Hajra, Adrija
   Chakraborty, Sandipan
TI Effect of ZIKA virus on adult eyes
SO EUROPEAN JOURNAL OF INTERNAL MEDICINE
LA English
DT Letter
C1 [Bandyopadhyay, Dhrubajyoti] Mt Sinai St Lukes Roosevelt, Dept Internal Med, New York, NY 10025 USA.
   [Qureshi, Arshna] Lady Hardinge Med Coll & Hosp, Dept Med, New Delhi, India.
   [Ashish, Kumar] RG Kar Med Coll & Hosp, Kolkata, India.
   [Hajra, Adrija] IPGMER, Dept Internal Med, Kolkata, India.
   [Chakraborty, Sandipan] Interfaith Med Ctr, Dept Internal Med, New York, NY USA.
RP Bandyopadhyay, D (corresponding author), Mt Sinai St Lukes Roosevelt, Dept Internal Med, New York, NY 10025 USA.
EM dhrubajyoti.bandyopadhyay@mountsinai.org; arshna.q@gmail.com;
   drkumarashish89@gmail.com; adrija847@gmail.com;
   schakraborty@interfaithmedical.com
RI Bandyopadhyay, Dhrubajyoti/AAQ-5622-2020; Hajra, Adrija/AAM-5736-2020
OI Bandyopadhyay, Dhrubajyoti/0000-0002-0709-4324; 
CR Bandyopadhyay D, 2017, EUR J INTERN MED
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Hajra A, 2016, NEUROL INDIA, V64, P1102, DOI 10.4103/0028-3886.190249
   Kenny Walter, NEW RES SHOWS ZIKA C
   Kodati S, 2017, LANCET, V389, P125, DOI 10.1016/S0140-6736(16)32518-1
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Parke DW, 2016, OPHTHALMOLOGY, V123, P2432, DOI 10.1016/j.ophtha.2016.06.039
   Singh PK, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92340
NR 8
TC 2
Z9 2
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0953-6205
EI 1879-0828
J9 EUR J INTERN MED
JI Eur. J. Intern. Med.
PD JAN
PY 2018
VL 47
BP E18
EP E19
DI 10.1016/j.ejim.2017.06.016
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA FS0OB
UT WOS:000419472300009
PM 28641808
DA 2020-07-08
ER

PT J
AU Wiwanitkit, V
AF Wiwanitkit, Viroj
TI Eye problem in Zika virus infection
SO EUROPEAN JOURNAL OF INTERNAL MEDICINE
LA English
DT Letter
DE Eye; Zika virus; Infection
C1 [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Hainan, Peoples R China.
   [Wiwanitkit, Viroj] Patil Univ, Navi Mumbai, India.
   [Wiwanitkit, Viroj] Univ Nis, Fac Med, Nish, Serbia.
   [Wiwanitkit, Viroj] Joseph Ayobabalola Univ, Ilara Mokin, Nigeria.
   [Wiwanitkit, Viroj] Wiwanitkit House, Bangkok, Thailand.
RP Wiwanitkit, V (corresponding author), Hainan Med Univ, Haikou, Hainan, Peoples R China.; Wiwanitkit, V (corresponding author), Patil Univ, Navi Mumbai, India.; Wiwanitkit, V (corresponding author), Univ Nis, Fac Med, Nish, Serbia.; Wiwanitkit, V (corresponding author), Joseph Ayobabalola Univ, Ilara Mokin, Nigeria.; Wiwanitkit, V (corresponding author), Wiwanitkit House, Bangkok, Thailand.
EM wviroj@pioneer.netserv.chula.ac.th
CR Bandyopadhyay D, 2017, EUR J INTERN MED, V44, pE9, DOI 10.1016/j.ejim.2017.05.022
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P499, DOI 10.1016/j.apjtm.2016.03.036
   Wiwanitkit V, 2016, ARQ BRAS OFTALMOL, V79, P280, DOI 10.5935/0004-2749.20160081
NR 3
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0953-6205
EI 1879-0828
J9 EUR J INTERN MED
JI Eur. J. Intern. Med.
PD JAN
PY 2018
VL 47
BP E17
EP E17
DI 10.1016/j.ejim.2017.06.007
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA FS0OB
UT WOS:000419472300008
PM 28610843
DA 2020-07-08
ER

PT J
AU Tran, A
   Theel, ES
AF Tran, Anthony
   Theel, Elitza S.
TI The role of serologic testing for Zika virus infection
SO REVIEWS IN MEDICAL MICROBIOLOGY
LA English
DT Article
DE antibody; ELISA; IgM; nonstructural protein 1; plaque reduction
   neutralization test; serology; Zika virus
ID LINKED IMMUNOSORBENT ASSAYS; DENGUE VIRUS; CROSS-REACTIVITY; INTERIM
   GUIDANCE; IGM; FLAVIVIRUSES; IMMUNOASSAY; SPECIFICITY; PERSISTENCE;
   ANTIBODIES
AB Direct detection of Zika virus (ZIKV) nucleic acid with nucleic acid tests is definitive laboratory evidence of infection. Initial studies suggest that the ZIKV viremic period is limited, leading the Centers for Disease Control and Prevention to recommend that nucleic acid tests be utilized only up to 14 days postsymptom onset in serum and urine. The host immune response to flaviviruses, including to ZIKV, primarily targets the viral envelope (E) protein, which has three main domains (ED I-III). Recent studies suggest that neutralizing antibodies against the EDIII domain are relatively specific and potentially able to discriminate between ZIKV and dengue virus, which share 29% amino acid homology at that region. Comparatively, neutralizing antibodies to EDI and EDII, with amino acid homologies of 35 and 51% between these two viruses, respectively, are highly cross-reactive and likely responsible for the nonspecific reactions observed in the respective serologic assays.
   The current article describes the humoral immune response to ZIKV, reviews serologic assays for detection of antibodies to ZIKV, discusses performance characteristics of commercially available tests, and summarizes the strengths and limitations of currently available serologic methods. Assays examined in the review include the Centers for Disease Control and Prevention Zika IgM antibody capture ELISA, InBios ZIKV Detect IgM Capture ELISA, DiaSorin, LIAISON XL Zika Capture IgM Assay, Euroimmun anti-ZIKV IgM ELISA, and plaque reduction neutralization tests. Despite the availability of multiple diagnostic tests, there remains a need for modified and novel testing strategies, including the potential use of multiple enzyme immunoassays either in parallel or sequentially and IgG in addition to IgM determination. Copyright (C) 2018 Wolters Kluwer Health, Inc. All rights reserved.
C1 [Tran, Anthony] Dist Columbia Dept Forens Sci, Div Publ Hlth Lab, 401 E St SW, Washington, DC 20024 USA.
   [Theel, Elitza S.] Mayo Clin, Div Clin Microbiol, Dept Lab Med & Pathol, Rochester, MN USA.
RP Tran, A (corresponding author), Dist Columbia Dept Forens Sci, Div Publ Hlth Lab, 401 E St SW, Washington, DC 20024 USA.
EM anthony.tran@dc.gov
CR Anderson NW, 2014, DIAGN MICR INFEC DIS, V79, P194, DOI 10.1016/j.diagmicrobio.2014.02.001
   APHL, 2016, APHL RISK ASS BEST P
   Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Busch MP, 2008, J INFECT DIS, V198, P984, DOI 10.1086/591467
   CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37
   CDC, 2016, REV DIAGN TEST ZIK C
   CDC, 2017, CDCHAN00402
   CDC, 2017, DIAGN TEST CHIK VIR
   CDC, 2016, ZIK MAC ELISA INSTR
   Cordeiro MT, 2016, J INFECT DIS, V214, P1897, DOI 10.1093/infdis/jiw477
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   DiaSorin, 2017, LIAISON XL ZIK CAPT
   FDA, 2017, EM US AUTH
   Granger D, 2017, J CLIN MICROBIOL, V55, P2127, DOI [10.1128/JCM.00580-17, 10.1128/jcm.00580-17]
   HALSTEAD SB, 1983, AM J TROP MED HYG, V32, P154, DOI 10.4269/ajtmh.1983.32.154
   Huang YJS, 2015, VECTOR-BORNE ZOONOT, V15, P674, DOI 10.1089/vbz.2015.1795
   Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203
   Immunization VaB, 2007, WHO WHO GUIDELINES, P1
   InBios, 2016, ZIKV DET IGM CAPT EL
   Johnson BW, 2005, VECTOR-BORNE ZOONOT, V5, P137, DOI 10.1089/vbz.2005.5.137
   Kadkhoda K, 2017, DIAGN MICR INFEC DIS, V88, P233, DOI 10.1016/j.diagmicrobio.2017.04.002
   Keasey SL, 2017, CLIN VACCINE IMMUNOL, V24, DOI 10.1128/CVI.00036-17
   L'Huillier AG, 2017, J CLIN MICROBIOL, V55, P2462, DOI 10.1128/JCM.00442-17
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lustig Y, 2017, J CLIN MICROBIOL, V55, P1894, DOI 10.1128/JCM.00346-17
   NIH; CDC, 2009, 21112 CDC HHS NIH
   Oduyebo T, 2017, MMWR-MORBID MORTAL W, V66, P781, DOI 10.15585/mmwr.mm6629e1
   Paz-Bailey G, 2017, N ENGL J MED
   POLAND JD, 1981, B WORLD HEALTH ORGAN, V59, P895
   Prince HE, 2011, CLIN VACCINE IMMUNOL, V18, P2183, DOI 10.1128/CVI.05425-11
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Screaton G, 2015, NAT REV IMMUNOL, V15, P745, DOI 10.1038/nri3916
   Shan C, 2017, J CLIN MICROBIOL, V55, P3028, DOI [10.1128/JCM.00975-17, 10.1128/jcm.00975-17]
   Steinhagen K, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Wong SJ, 2017, EBIOMEDICINE, V16, P136, DOI 10.1016/j.ebiom.2017.01.008
NR 38
TC 0
Z9 0
U1 1
U2 7
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0954-139X
EI 1473-5601
J9 REV MED MICROBIOL
JI Rev. Med. Microbiol.
PD JAN
PY 2018
VL 29
IS 1
BP 1
EP 7
DI 10.1097/MRM.0000000000000122
PG 7
WC Microbiology
SC Microbiology
GA FR9ZA
UT WOS:000419432200001
DA 2020-07-08
ER

PT J
AU St George, K
   Pinsky, BA
AF St George, Kirsten
   Pinsky, Benjamin A.
TI Molecular diagnosis of Zika virus infections
SO REVIEWS IN MEDICAL MICROBIOLOGY
LA English
DT Article
DE emergency use authorization; laboratory developed test; viral load
ID TIME RT-PCR; REVERSE TRANSCRIPTION-PCR; DENGUE VIRUS; CHIKUNGUNYA VIRUS;
   SINGLE-REACTION; WHOLE-BLOOD; CASE SERIES; PAN-DENGUE; ASSAY; RNA
AB The association between Zika virus (ZIKV) infection and serious complications, such as microcephaly in infants and Guillain-Barre syndrome in adults, necessitates the availability of accurate diagnostic tests. Molecular testing for ZIKV RNA provides the most definitive diagnosis of infection. Since the onset of the ZIKV outbreak in the Americas, numerous commercially available assays and laboratory developed tests have been established for Zika RNA. Laboratories now have a wide variety of options available, and choices depend on their resources and patient needs. Molecular detection of Zika RNA however is complicated by issues such as low viral loads, short periods of positivity in some common specimen types, complex decisions on appropriate specimen selection, and timing of specimen collection. Further, the fact that most patients are asymptomatic during the primary infection makes the timing of specimen collection difficult to calculate, but testing still important for high-risk situations such as pregnant women. Copyright (C) 2018 Wolters Kluwer Health, Inc. All rights reserved.
C1 [St George, Kirsten] New York State Dept Hlth, Viral Dis Lab, Wadsworth Ctr, Albany, NY 12237 USA.
   [St George, Kirsten] SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY USA.
   [Pinsky, Benjamin A.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.
   [Pinsky, Benjamin A.] Stanford Univ, Dept Med, Sch Med, Div Infect Dis & Geog Med, Stanford, CA 94305 USA.
RP St George, K (corresponding author), New York State Dept Hlth, Viral Dis Lab, Wadsworth Ctr, Albany, NY 12237 USA.
EM Kirsten.St.George@health.ny.gov
RI amsalu, ribka/G-8780-2019
OI Pinsky, Benjamin/0000-0001-8751-4810
FU Centers for Disease Control and PreventionUnited States Department of
   Health & Human ServicesCenters for Disease Control & Prevention - USA
   [U50/CCU223671]; ThermoFisher; National Institute of Allergy and
   Infectious DiseasesUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R21AI131689]
FX K.S.G. receives funding for Zika virus surveillance from the Centers for
   Disease Control and Prevention under Cooperative Agreement
   U50/CCU223671, and for Zika genomic investigations from ThermoFisher.
   B.A.P. receives funding for the development of Zika virus diagnostic
   assays from the National Institute of Allergy and Infectious Diseases
   (R21AI131689).
CR Acevedo Nathalie, 2017, Front Microbiol, V8, P42, DOI 10.3389/fmicb.2017.00042
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Chan JFW, 2017, TROP MED INT HEALTH, V22, P594, DOI 10.1111/tmi.12857
   Chotiwan N, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag0538
   Colt S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005528
   Corman VM, 2016, B WORLD HEALTH ORGAN, V94, P880, DOI 10.2471/BLT.16.175950
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Frankel MB, 2017, J VIROL METHODS, V246, P117, DOI 10.1016/j.jviromet.2017.05.002
   Gootenberg JS, 2017, SCIENCE, V356, P438, DOI 10.1126/science.aam9321
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   L'Huillier AG, 2017, J CLIN MICROBIOL, V55, P1576, DOI 10.1128/JCM.02153-16
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lustig Y, 2016, EURO SURVEILL, V21
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Musso D, 2017, CLIN MICROBIOL INFEC, V23, DOI 10.1016/j.cmi.2017.07.006
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Pabbaraju K, 2016, J CLIN VIROL, V83, P66, DOI 10.1016/j.jcv.2016.09.001
   Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059
   Paz-Bailey G, 2017, NEW ENGL J MED, DOI [10.1056/NEJMoa1613108, DOI 10.1056/NEJM0A1613108]
   Pessoa R, 2016, EURO SURVEILL, V21
   Pyke Alyssa T, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.4635a54dbffba2156fb2fd76dc49f65e
   Reagan-Steiner S, 2017, MMWR-MORBID MORTAL W, V66, P636, DOI 10.15585/mmwr.mm6624a3
   Ren P, 2017, J CLIN MICROBIOL, V55, P2198, DOI 10.1128/jcm.00603-17
   Ritter JM, 2017, ARCH PATHOL LAB MED, V141, P49, DOI 10.5858/arpa.2016-0397-SA
   Rossini G, 2017, J INFECTION, V75, P242, DOI 10.1016/j.jinf.2017.05.021
   Schaub B, 2017, LANCET INFECT DIS, V17, P520, DOI [10.1016/S1473-3099(17)30102-0, 10.1016/s1473-3099(17)30102-0]
   Smith DE, 2016, NEUROL-CLIN PRACT, V6, P515, DOI 10.1212/CPJ.0000000000000307
   Song JZ, 2016, ANAL CHEM, V88, P7289, DOI 10.1021/acs.analchem.6b01632
   St George K, 2017, J CLIN MICROBIOL, V55, P535, DOI 10.1128/JCM.01232-16
   Stone M, 2017, TRANSFUSION, V57, P734, DOI 10.1111/trf.14031
   Tappe D, 2013, EURO SURVEILL, V19
   Tian B, 2016, BIOSENS BIOELECTRON, V86, P420, DOI 10.1016/j.bios.2016.06.085
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   Waggoner JJ, 2016, EMERG INFECT DIS, V22, P1295, DOI 10.3201/eid2207.160326
   Waggoner JJ, 2016, J CLIN VIROL, V78, P57, DOI 10.1016/j.jcv.2016.01.007
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Waggoner JJ, 2015, DIAGN MICR INFEC DIS, V81, P105, DOI 10.1016/j.diagmicrobio.2014.10.001
   Waggoner JJ, 2014, J CLIN MICROBIOL, V52, P1801, DOI 10.1128/JCM.00013-14
   Waggoner JJ, 2013, J CLIN MICROBIOL, V51, P3418, DOI 10.1128/JCM.01359-13
   Waggoner JJ, 2013, J CLIN MICROBIOL, V51, P2172, DOI 10.1128/JCM.00548-13
   Waggoner JJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002116
   Wang X, 2016, J VIROL METHODS, V238, P86, DOI 10.1016/j.jviromet.2016.10.010
   Xu MY, 2016, J VIROL METHODS, V236, P93, DOI 10.1016/j.jviromet.2016.07.014
   Zambrano H, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12630
   Zambrano H, 2016, AM J TROP MED HYG, V95, P894, DOI 10.4269/ajtmh.16-0323
NR 51
TC 2
Z9 2
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0954-139X
EI 1473-5601
J9 REV MED MICROBIOL
JI Rev. Med. Microbiol.
PD JAN
PY 2018
VL 29
IS 1
BP 8
EP 16
DI 10.1097/MRM.0000000000000125
PG 9
WC Microbiology
SC Microbiology
GA FR9ZA
UT WOS:000419432200002
DA 2020-07-08
ER

PT J
AU Mletzko, J
   Schildgen, O
AF Mletzko, Judith
   Schildgen, Oliver
TI Absence of Zika virus in abortion and placental tissue in a German
   cohort
SO REVIEWS IN MEDICAL MICROBIOLOGY
LA English
DT Article
DE abort; absence in Germany; placenta; Zika virus
ID FEVER; DNA
AB In this study, we verified the hypothesis that the Zika virus (ZIKV) so far solely occurs as an imported zoonosis and is not yet circulating in a cohort in Germany. We have tested tissue specimens from abortions and placentas collected from 300 patients treated at the gynecology department of our hospital. Not surprisingly, although control specimens tested positive for ZIKV by reverse transcription-PCR, none of the tissue specimens contained viral RNA, thus supporting the hypothesis that ZIKV spread is limited to tropical and subtropical areas. Copyright (C) 2018Wolters Kluwer Health, Inc. All rights reserved.
C1 [Mletzko, Judith; Schildgen, Oliver] Klinikum Privaten Univ Witten Herdecke Sitz Koln, Kliniken Stadt Koln gGmbH, Inst Pathol, Cologne, Germany.
RP Schildgen, O (corresponding author), Klinikum Privaten Univ Witten Herdecke Sitz Koln, Kliniken Stadt Koln gGmbH, Inst Pathol, Fachvirol GfV, Ostmerheimer Str 200, D-51109 Cologne, Germany.
EM schildgeno@kliniken-koeln.de
RI Schildgen, Oliver/D-5327-2014
OI Schildgen, Oliver/0000-0003-4297-9627
CR [Anonymous], 2016, Nurs Stand, V31, P66
   [Anonymous], 2015, Wkly Epidemiol Rec, V90, P609
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   DICK GWA, 1953, T ROY SOC TROP MED H, V47, P13, DOI 10.1016/0035-9203(53)90021-2
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Frank C, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.23.30252
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Heitmann A, 2017, EURO SURVEILL, V22
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kaur J, 2014, FUTURE VIROL, V9, P715, DOI 10.2217/FVL.14.59
   Korner RW, 2011, EMERG INFECT DIS, V17, P2303, DOI 10.3201/eid1712.110574
   Lusebrink J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019457
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Oehler E, 2014, EUROSURVEILLANCE, V19, P4
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230
   Schildgen O, 2007, J CLIN VIROL, V38, P366, DOI 10.1016/j.jcv.2007.01.004
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   Windisch W, 2013, J CLIN VIROL, V58, P325, DOI 10.1016/j.jcv.2013.05.020
NR 26
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0954-139X
EI 1473-5601
J9 REV MED MICROBIOL
JI Rev. Med. Microbiol.
PD JAN
PY 2018
VL 29
IS 1
BP 17
EP 19
DI 10.1097/MRM.0000000000000121
PG 3
WC Microbiology
SC Microbiology
GA FR9ZA
UT WOS:000419432200003
DA 2020-07-08
ER

PT J
AU Groner, A
   Broumis, C
   Fang, R
   Nowak, T
   Popp, B
   Schafer, W
   Roth, NJ
AF Groener, Albrecht
   Broumis, Connie
   Fang, Randel
   Nowak, Thomas
   Popp, Birgit
   Schaefer, Wolfram
   Roth, Nathan J.
TI Effective inactivation of a wide range of viruses by pasteurization
SO TRANSFUSION
LA English
DT Article
ID FACTOR-VIII CONCENTRATE; HUMAN SERUM-ALBUMIN; HEPATITIS-E VIRUS; PLASMA
   PRODUCTS; MEDICINAL PRODUCTS; HEAT INACTIVATION; PARVOVIRUS B19; ZIKA
   VIRUS; SAFETY; MANUFACTURE
AB BACKGROUNDCareful selection and testing of plasma reduces the risk of blood-borne viruses in the starting material for plasma-derived products. Furthermore, effective measures such as pasteurization at 60 degrees C for 10 hours have been implemented in the manufacturing process of therapeutic plasma proteins such as human albumin, coagulation factors, immunoglobulins, and enzyme inhibitors to inactivate blood-borne viruses of concern. A comprehensive compilation of the virus reduction capacity of pasteurization is presented including the effect of stabilizers used to protect the therapeutic protein from modifications during heat treatment.
   STUDY DESIGN AND METHODSThe virus inactivation kinetics of pasteurization for a broad range of viruses were evaluated in the relevant intermediates from more than 15 different plasma manufacturing processes. Studies were carried out under the routine manufacturing target variables, such as temperature and product-specific stabilizer composition. Additional studies were also performed under robustness conditions, that is, outside production specifications.
   RESULTSThe data demonstrate that pasteurization inactivates a wide range of enveloped and nonenveloped viruses of diverse physicochemical characteristics. After a maximum of 6 hours' incubation, no residual infectivity could be detected for the majority of enveloped viruses. Effective inactivation of a range of nonenveloped viruses, with the exception of nonhuman parvoviruses, was documented.
   CONCLUSIONPasteurization is a very robust and reliable virus inactivation method with a broad effectiveness against known blood-borne pathogens and emerging or potentially emerging viruses. Pasteurization has proven itself to be a highly effective step, in combination with other complementary safety measures, toward assuring the virus safety of final product.
C1 [Groener, Albrecht; Nowak, Thomas; Popp, Birgit; Schaefer, Wolfram] CSL Behring GmbH, Global Pathogen Safety, Marburg, Germany.
   [Broumis, Connie; Fang, Randel] CSL Behring Australia Pty Ltd, Global Pathogen Safety, Broadmeadows, Vic, Australia.
   [Roth, Nathan J.] CSL Behring AG, Global Pathogen Safety, Bern, Switzerland.
RP Roth, NJ (corresponding author), CSL Behring, Wankdorfstr 10, CH-3014 Bern, Switzerland.
EM nathan.roth@cslbehring.com
RI Roth, Nathan J/K-3894-2013
CR Adcock WL, 1998, BIOTECHNOL APPL BIOC, V28, P85
   [Anonymous], 2011, EMACHMPBWP3606422010
   [Anonymous], 1996, CPMPBWP26895 EUR AG
   [Anonymous], 2011, EMACHMPBWP7062712010
   [Anonymous], 2016, EMACHMPBWP5485242008
   [Anonymous], 2015, EMA WORKSH VIR SAF P
   [Anonymous], 2015, EMACHMPBWP7230092014
   [Anonymous], 1991, VIR VAL STUD DES CON
   BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183
   Blumel J, 2017, TRANSFUSION, V57, P790, DOI 10.1111/trf.13873
   Blumel J, 2002, TRANSFUSION, V42, P1011, DOI 10.1046/j.1537-2995.2002.00158.x
   Boschetti N, 2004, TRANSFUSION, V44, P1079, DOI 10.1111/j.1537-2995.2004.03420.x
   CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562
   Dichtelmueller HO, 2011, TRANSFUSION, V51, P1412, DOI 10.1111/j.1537-2995.2010.03003.x
   Dichtelmuller HO, 2009, TRANSFUSION, V49, P1931, DOI 10.1111/j.1537-2995.2009.02222.x
   ENCK RE, 1979, TRANSFUSION, V19, P32, DOI 10.1046/j.1537-2995.1979.19179160263.x
   Farcet MR, 2016, TRANSFUSION, V56, P383, DOI 10.1111/trf.13343
   Farcet MR, 2012, TRANSFUSION, V52, P181, DOI 10.1111/j.1537-2995.2011.03251.x
   GALLO RC, 1984, SCIENCE, V224, P500, DOI 10.1126/science.6200936
   GELLIS SS, 1948, J CLIN INVEST, V27, P239, DOI 10.1172/JCI101939
   Groner A, 2014, THROMB RES, V134, pS10, DOI 10.1016/j.thromres.2013.10.013
   Hattori S, 2007, VOX SANG, V92, P121, DOI 10.1111/j.1423-0410.2006.00879.x
   HILFENHAUS J, 1985, P SOC EXP BIOL MED, V178, P580
   LEVINE PH, 1977, BLOOD, V50, P1
   Leydold SM, 2012, TRANSFUSION, V52, P2122, DOI 10.1111/j.1537-2995.2012.03565.x
   Mauler R, 1987, Dev Biol Stand, V67, P337
   NOWAK T, 1992, J MED VIROL, V36, P209, DOI 10.1002/jmv.1890360311
   Roth NJ, 2017, TRANSFUSION, V57, P720, DOI 10.1111/trf.14038
   Sawyer WA, 1944, AM J HYG, V39, P337, DOI 10.1093/oxfordjournals.aje.a118911
   SCHIMPF K, 1987, NEW ENGL J MED, V316, P918, DOI 10.1056/NEJM198704093161505
   SCHIMPF K, 1989, NEW ENGL J MED, V321, P1148, DOI 10.1056/NEJM198910263211702
   Solomon C, 2015, THROMB HAEMOSTASIS, V113, P759, DOI 10.1160/TH14-06-0514
   Yunoki M, 2008, VOX SANG, V95, P94, DOI 10.1111/j.1423-0410.2008.01078.x
   Yunoki M, 2013, TRANSFUSION, V53, P2103, DOI 10.1111/trf.12259
NR 34
TC 7
Z9 8
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD JAN
PY 2018
VL 58
IS 1
BP 41
EP 51
DI 10.1111/trf.14390
PG 11
WC Hematology
SC Hematology
GA FS1AW
UT WOS:000419507100009
PM 29148053
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Hindawi, SI
   Hashem, AM
   Damanhouri, GA
   El-Kafrawy, SA
   Tolah, AM
   Hassan, AM
   Azhar, EI
AF Hindawi, Salwa I.
   Hashem, Anwar M.
   Damanhouri, Ghazi A.
   El-Kafrawy, Sherif A.
   Tolah, Ahmed M.
   Hassan, Ahmed M.
   Azhar, Esam I.
TI Inactivation of Middle East respiratory syndrome-coronavirus in human
   plasma using amotosalen and ultraviolet A light
SO TRANSFUSION
LA English
DT Article
ID BLOOD-TRANSFUSION SAFETY; MERS-COV; PATHOGEN INACTIVATION; ZIKA VIRUS;
   COMPONENTS; INFECTION; PLATELET; TRANSMISSION; REPLICATION; DISEASES
AB BACKGROUNDMiddle East respiratory syndrome-coronavirus (MERS-CoV) is a novel zoonotic pathogen. Although the potential for MERS-CoV transmission through blood transfusion is not clear, MERS-CoV was recognized as a pathogen of concern for the safety of the blood supply especially after its detection in whole blood, serum, and plasma of infected individuals. Here we investigated the efficacy of amotosalen and ultraviolet A light (UVA) to inactivate MERS-CoV in fresh-frozen plasma (FFP).
   STUDY DESIGN AND METHODSPooled FFP units were spiked with a recent clinical MERS-CoV isolate. Infectious and genomic viral titers were determined in plasma before and after inactivation with amotosalen/UVA treatment by plaque assay and reverse transcription-quantitative polymerase chain reaction, respectively. In addition, residual replicating or live virus after inactivation was examined by passaging in the permissive Vero E6 cells.
   RESULTSThe mean MERS-CoV infectious titer in pretreatment samples was 4.670.25 log plaque-forming units (pfu)/mL, which was reduced to undetectable levels after inactivation with amotosalen/UVA demonstrating a mean log reduction of more than 4.67 +/- 0.25 pfu/mL. Furthermore, inoculation of inactivated plasma on Vero E6 cells did not result in any cytopathic effect (CPE) even after 7 days of incubation and three consecutive passages, nor the detection of MERS RNA compared to pretreatment samples which showed complete CPE within 2 to 3 days postinoculation and log viral RNA titer ranging from 9.48 to 10.22 copies/mL in all three passages.
   CONCLUSIONOur data show that amotosalen/UVA treatment is a potent and effective way to inactivate MERS-CoV infectious particles in FFP to undetectable levels and to minimize the risk of any possible transfusion-related MERS-CoV transmission.
C1 [Hindawi, Salwa I.] King Abdulaziz Univ, King Abdulaziz Univ Hosp, Blood Transfus Serv, Jeddah, Saudi Arabia.
   [Hindawi, Salwa I.; Damanhouri, Ghazi A.] King Abdulaziz Univ, Dept Med, Fac Med, Jeddah, Saudi Arabia.
   [Hashem, Anwar M.; El-Kafrawy, Sherif A.; Tolah, Ahmed M.; Hassan, Ahmed M.; Azhar, Esam I.] King Abdulaziz Univ, Special Infect Agents Unit, King Fahd Med Res Ctr, POB 128442, Jeddah 21589, Saudi Arabia.
   [Hashem, Anwar M.] King Abdulaziz Univ, Dept Med Microbiol & Parasitol, Fac Med, Jeddah, Saudi Arabia.
   [Azhar, Esam I.] King Abdulaziz Univ, Fac Appl Med Sci, Dept Med Lab Technol, Jeddah, Saudi Arabia.
   [El-Kafrawy, Sherif A.] Menoufiya Univ, Natl Liver Inst, Clin Pathol Dept, Shibin Al Kawm, Egypt.
RP Azhar, EI (corresponding author), King Abdulaziz Univ, Special Infect Agents Unit, King Fahd Med Res Ctr, POB 128442, Jeddah 21589, Saudi Arabia.
EM eazhar@kau.edu.sa
RI Damanhouri, Ghazi/Q-7901-2019; Hassan, Ahmed/AAB-7241-2019
OI Azhar, Esam/0000-0002-1736-181X
FU Cerus Corporation
FX This study was partially funded by Cerus Corporation. The support was in
   the form of supplies and reagents needed for the study.
CR Al-amri SS, 2017, SCI REP-UK, V7, DOI 10.1038/srep44875
   ALAGAILI AN, 2014, MBIO, V5, DOI DOI 10.1128/MBIO.00884-14
   Almekhlafi GA, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1303-8
   Alraddadi BM, 2016, EMERG INFECT DIS, V22, P49, DOI 10.3201/eid2201.151340
   [Anonymous], 2014, STATISTICS
   Arabi YM, 2017, NEW ENGL J MED, V376, P584, DOI 10.1056/NEJMsr1408795
   Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Azhar EI, 2014, NEW ENGL J MED, V370, P2499, DOI 10.1056/NEJMoa1401505
   Berger A, 2004, J CLIN VIROL, V29, P13, DOI 10.1016/j.jcv.2003.09.011
   Bloch EM, 2012, TRANSFUS MED REV, V26, P164, DOI 10.1016/j.tmrv.2011.07.006
   Bost V, 2015, VOX SANG, V109, P414, DOI 10.1111/vox.12300
   Cazenave JP, 2010, TRANSFUSION, V50, P1210, DOI 10.1111/j.1537-2995.2009.02579.x
   Chu H, 2016, J INFECT DIS, V213, P904, DOI 10.1093/infdis/jiv380
   Chu H, 2014, VIROLOGY, V454, P197, DOI 10.1016/j.virol.2014.02.018
   Coleman CM, 2015, CURR PROTOC MICROBIO, V37
   Corman VM, 2012, EUROSURVEILLANCE, V17, P2
   Corman VM, 2012, EUROSURVEILLANCE, V17, P3
   Corman VM, 2016, CLIN INFECT DIS, V62, P477, DOI 10.1093/cid/civ951
   Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747
   European Directorate for the Quality of Medicines and Healthcare, 2013, GUIDE PREPARATION US
   Hemida MG, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.23.20828
   Irsch J, 2011, TRANSFUS MED HEMOTH, V38, P19, DOI 10.1159/000323937
   Keil SD, 2016, TRANSFUSION, V56, P2948, DOI 10.1111/trf.13860
   Kim SY, 2016, EMERG INFECT DIS, V22, P1813, DOI 10.3201/eid2210.160218
   Laffoon B., 2010, Morbidity and Mortality Weekly Report, V59, P1335
   Lessler J, 2016, AM J EPIDEMIOL, V183, P657, DOI 10.1093/aje/kwv452
   Mackay IM, 2015, VIRUS RES, V202, P60, DOI 10.1016/j.virusres.2015.01.021
   Memish ZA, 2014, INT J INFECT DIS, V29, P307, DOI 10.1016/j.ijid.2014.10.002
   Min CK, 2016, SCI REP-UK, V6, DOI 10.1038/srep25359
   Mintz PD, 2006, TRANSFUSION, V46, P1693, DOI 10.1111/j.1537-2995.2006.00959.x
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Moustafa A, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006292
   Muller MA, 2014, EMERG INFECT DIS, V20, P2093, DOI 10.3201/eid2012.141026
   Musso D, 2014, TRANSFUSION, V54, P2924, DOI 10.1111/trf.12713
   Paty MC, 2013, TRANSFUS CLIN BIOL, V20, P165, DOI 10.1016/j.tracli.2013.03.008
   Pinna D, 2005, TRANSFUSION MED, V15, P269, DOI 10.1111/j.0958-7578.2005.00588.x
   Sabir JSM, 2016, SCIENCE, V351, P81, DOI 10.1126/science.aac8608
   Schlenke P, 2014, TRANSFUS MED HEMOTH, V41, P309, DOI 10.1159/000365646
   Shalhoub S, 2015, J ANTIMICROB CHEMOTH, V70, P2129, DOI 10.1093/jac/dkv085
   Shehata MM, 2016, FRONT MED-PRC, V10, P120, DOI 10.1007/s11684-016-0430-6
   Stramer SL, 2014, ISBT SCI SER, V9, P30, DOI 10.1111/voxs.12070
   Tessema B, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-111
   Torane VP, 2008, INDIAN J MED MICROBI, V26, P284, DOI 10.4103/0255-0857.42071
   WHO, 2017, MIDDL E RESP SYNDR C
   Woolhouse MEJ, 2005, TRENDS ECOL EVOL, V20, P238, DOI 10.1016/j.tree.2005.02.009
   Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721
   Zhou J, 2014, J INFECT DIS, V209, P1331, DOI 10.1093/infdis/jit504
NR 47
TC 6
Z9 6
U1 2
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD JAN
PY 2018
VL 58
IS 1
BP 52
EP 59
DI 10.1111/trf.14422
PG 8
WC Hematology
SC Hematology
GA FS1AW
UT WOS:000419507100010
PM 29239484
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Stephen, P
   Lin, SX
AF Stephen, Preyesh
   Lin, Sheng-Xiang
TI RNA-dependent RNA polymerase: Addressing Zika outbreak by a
   phylogeny-based drug target study
SO CHEMICAL BIOLOGY & DRUG DESIGN
LA English
DT Article
DE flavivirus; methyltransferase; microcephaly; molecular modeling;
   non-structural protein 5; phylogeny analysis; RNA-dependent RNA
   polymerase; structure-based drug designing; Zika virus
ID VIRUS-INFECTION; CRYSTAL-STRUCTURE; NS5 PROTEIN; INHIBITORS;
   REPLICATION; DISCOVERY; IDENTIFICATION; PREDICTION; REVEALS; DOCKING
AB Since the first major outbreak of Zika virus (ZIKV) in 2007, ZIKV is spreading explosively through South and Central America, and recent reports in highly populated developing countries alarm the possibility of a more catastrophic outbreak. ZIKV infection in pregnant women leads to embryonic microcephaly and Guillain-Barre syndrome in adults. At present, there is limited understanding of the infectious mechanism, and no approved therapy has been reported. Despite the withdrawal of public health emergency, the WHO still considers the ZIKV as a highly significant and long-term public health challenge that the situation has to be addressed rapidly. Non-structural protein 5 is essential for capping and replication of viral RNA and comprises a methyltransferase and RNA-dependent RNA polymerase (RdRp) domain. We used molecular modeling to obtain the structure of ZIKV RdRp, and by molecular docking and phylogeny analysis, we here demonstrate the potential sites for drug screening. Two metal binding sites and an NS3-interacting region in ZIKV RdRp are demonstrated as potential drug screening sites. The docked structures reveal a remarkable degree of conservation at the substrate binding site and the potential drug screening sites. A phylogeny-based approach is provided for an emergency preparedness, where similar class of ligands could target phylogenetically related proteins.
C1 [Stephen, Preyesh; Lin, Sheng-Xiang] Laval Univ, CHU Res Ctr, Lab Mol Endocrinol, Quebec City, PQ, Canada.
RP Lin, SX (corresponding author), Laval Univ, CHU Res Ctr, Lab Mol Endocrinol, Quebec City, PQ, Canada.
EM sxlin@crchul.ulaval.ca
RI Stephen, Preyesh/L-1010-2019
OI Stephen, Preyesh/0000-0003-2889-2701; Lin,
   Sheng-Xiang/0000-0001-9149-375X
CR Bollati M, 2010, ANTIVIR RES, V87, P125, DOI 10.1016/j.antiviral.2009.11.009
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chung KY, 2010, VIROLOGY, V402, P52, DOI 10.1016/j.virol.2010.03.011
   Coutard B, 2017, J VIROL, V91, DOI 10.1128/JVI.02202-16
   Duan WQ, 2017, EMBO J, V36, P919, DOI 10.15252/embj.201696241
   Dubey S, 2007, EUR J MED CHEM, V42, P1159, DOI 10.1016/j.ejmech.2007.01.024
   DuBois RM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002830
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   GeneOne Life Science I, 2016, STUD GLS 5700 HLTH V
   Goodfellow FT, 2016, STEM CELLS DEV, V25, P1691, DOI 10.1089/scd.2016.0231
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Hall BG, 2013, MOL BIOL EVOL, V30, P1229, DOI 10.1093/molbev/mst012
   Hasan SS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14722
   Javier C., 2016, CELL REP, V16, P6
   Levy R, 2009, PROTEINS, V76, P365, DOI 10.1002/prot.22352
   Lim SP, 2015, ANTIVIR RES, V119, P57, DOI 10.1016/j.antiviral.2015.04.010
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Malet H, 2008, ANTIVIR RES, V80, P23, DOI 10.1016/j.antiviral.2008.06.007
   Ng KKS, 2004, J BIOL CHEM, V279, P16638, DOI 10.1074/jbc.M400584200
   Nguyen NM, 2013, J INFECT DIS, V207, P1442, DOI 10.1093/infdis/jis470
   Nulf CJ, 2004, NUCLEIC ACIDS RES, V32, P3792, DOI 10.1093/nar/gkh706
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Papageorgiou L, 2016, MOL BIOSYST, V12, P2080, DOI 10.1039/c5mb00706b
   Pierce BG, 2014, BIOINFORMATICS, V30, P1771, DOI 10.1093/bioinformatics/btu097
   Powdrill MH, 2010, VIRUSES-BASEL, V2, P2169, DOI 10.3390/v2102169
   SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Scaturro P, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005277
   Shao Q, 2016, DEVELOPMENT, V143, P4127, DOI 10.1242/dev.143768
   Sharp TM, 2016, CLIN INFECT DIS, V63, P1198, DOI 10.1093/cid/ciw476
   Smith TM, 2015, J BIOMOL SCREEN, V20, P153, DOI 10.1177/1087057114551141
   Stahla-Beek HJ, 2012, J VIROL, V86, P8730, DOI 10.1128/JVI.00384-12
   STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498
   Stephen P, 2016, J AM CHEM SOC, V138, P16212, DOI 10.1021/jacs.6b10399
   Strafela P, 2017, ARCH PATHOL LAB MED, V141, P73, DOI 10.5858/arpa.2016-0341-SA
   Tay MYF, 2015, J BIOL CHEM, V290, P2379, DOI 10.1074/jbc.M114.607341
   Tian HL, 2016, PROTEIN CELL, V7, P450, DOI 10.1007/s13238-016-0275-4
   Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206
   Xu HT, 2016, ANTIMICROB AGENTS CH, V60, P600, DOI 10.1128/AAC.02203-15
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Zhao BY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14762
   Zhao YQ, 2015, J VIROL, V89, P10717, DOI 10.1128/JVI.01239-15
   Zou G, 2011, J BIOL CHEM, V286, P14362, DOI 10.1074/jbc.M110.214189
NR 44
TC 1
Z9 1
U1 0
U2 10
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1747-0277
EI 1747-0285
J9 CHEM BIOL DRUG DES
JI Chem. Biol. Drug Des.
PD JAN
PY 2018
VL 91
IS 1
BP 322
EP 327
DI 10.1111/cbdd.13054
PG 6
WC Biochemistry & Molecular Biology; Chemistry, Medicinal
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
GA FR1CO
UT WOS:000418803800030
PM 28636772
DA 2020-07-08
ER

PT J
AU Shiu, C
   Starker, R
   Kwal, J
   Bartlett, M
   Crane, A
   Greissman, S
   Gunaratne, N
   Lardy, M
   Picon, M
   Rodriguez, P
   Gonzalez, I
   Curry, CL
AF Shiu, Colette
   Starker, Rebecca
   Kwal, Jaclyn
   Bartlett, Michelle
   Crane, Anise
   Greissman, Samantha
   Gunaratne, Naiomi
   Lardy, Meghan
   Picon, Michelle
   Rodriguez, Patricia
   Gonzalez, Ivan
   Curry, Christine L.
TI Zika Virus Testing and Outcomes during Pregnancy, Florida, USA, 2016
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID UPDATE INTERIM GUIDANCE; UNITED-STATES; EXPOSURE; ABORTION; WOMEN
AB Zika virus infection during pregnancy can lead to congenital Zika syndrome. Implementation of screening programs and interpretation of test results can be particularly challenging during ongoing local mosquitoborne transmission. We conducted a retrospective chart review of 2,327 pregnant women screened for Zika virus in Miami-Dade County, Florida, USA, during 2016. Of these, 86 had laboratory evidence of Zika virus infection; we describe 2 infants with probable congenital Zika syndrome. Delays in receipt of laboratory test results (median 42 days) occurred during the first month of local transmission. Odds of screening positive for Zika virus were higher for women without health insurance or who did not speak English. Our findings indicate the increase in screening for Zika virus can overwhelm hospital and public health systems, resulting in delayed receipt of results of screening and confirmatory tests and the potential to miss cases or delay diagnoses.
C1 [Shiu, Colette; Starker, Rebecca; Kwal, Jaclyn; Bartlett, Michelle; Crane, Anise; Greissman, Samantha; Gunaratne, Naiomi; Lardy, Meghan; Picon, Michelle; Rodriguez, Patricia; Gonzalez, Ivan; Curry, Christine L.] Univ Miami, Miller Sch Med, Miami, FL 33136 USA.
   [Rodriguez, Patricia; Gonzalez, Ivan; Curry, Christine L.] Jackson Mem Hosp, Miami, FL 33136 USA.
RP Curry, CL (corresponding author), Holtz Childrens Hosp, 1611 NW 12th Ave,7007L, Miami, FL 33136 USA.
EM clcurry@gmail.com
CR Aiken ARA, 2016, NEW ENGL J MED, V375, P396, DOI 10.1056/NEJMc1605389
   Blanchard K, 2017, LANCET, V389, P1603, DOI 10.1016/S0140-6736(17)31010-3
   Centers for Disease Control and Prevention, 2017, FACT SHEET HEALTHC P
   Centers for Disease Control and Prevention, ZIK VIR EV TEST CONG
   Centers for Disease Control and Prevention, ZIK VIR HEALTHC PROV
   Centers for Disease Control and Prevention, PROL IGM ANT RESP PE
   Centers for Disease Control and Prevention, US ZIK PREGN REG
   Felix AC, 2017, J MED VIROL, V89, P1477, DOI 10.1002/jmv.24789
   Florida Department of Health, LIV BIRTHS FLOR VIT
   Gelber SE, 2017, BJOG-INT J OBSTET GY, V124, P550, DOI 10.1111/1471-0528.14388
   Granger D, 2017, J CLIN MICROBIOL, V55, P2127, DOI [10.1128/JCM.00580-17, 10.1128/jcm.00580-17]
   Lucey D, 2017, JAMA-J AM MED ASSOC, V317, P1368, DOI 10.1001/jama.2017.1553
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   Oduyebo T, 2017, MMWR-MORBID MORTAL W, V66, P781, DOI 10.15585/mmwr.mm6629e1
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Zhao ZY, 2017, INVEST OPHTH VIS SCI, V58, P4355, DOI 10.1167/iovs.17-22016
NR 20
TC 8
Z9 8
U1 0
U2 6
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD JAN
PY 2018
VL 24
IS 1
BP 1
EP 8
DI 10.3201/eid2401.170979
PG 8
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA FR2SW
UT WOS:000418918500001
PM 29260671
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Cheng, VCC
   Sridhar, S
   Wong, SC
   Wong, SCY
   Chan, JFW
   Yip, CCY
   Chau, CH
   Au, TWK
   Hwang, YY
   Yau, CSW
   Lo, JYC
   Lee, CK
   Yuen, KY
AF Cheng, Vincent C. C.
   Sridhar, Siddharth
   Wong, Shuk-Ching
   Wong, Sally C. Y.
   Chan, Jasper F. W.
   Yip, Cyril C. Y.
   Chau, Chi-Hung
   Au, Timmy W. K.
   Hwang, Yu-Yan
   Yau, Carol S. W.
   Lo, Janice Y. C.
   Lee, Cheuk-Kwong
   Yuen, Kwok-Yung
TI Japanese Encephalitis Virus Transmitted Via Blood Transfusion, Hong
   Kong, China
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID WEST-NILE-VIRUS; ZIKA VIRUS; UNITED-STATES; DENGUE; TRANSMISSION;
   INFECTION; OUTBREAK; FEVER; DONOR; ALIGNMENT
AB Japanese encephalitis virus (JEV) is a mosquitoborne virus endemic to China and Southeast Asia that causes severe encephalitis in <1% of infected persons. Transmission of JEV via blood transfusion has not been reported. We report transmission of JEV via blood donation products from an asymptomatic viremic donor to 2 immunocompromised recipients. One recipient on high-dose immunosuppressive drugs received JEV-positive packed red blood cells after a double lung transplant; severe encephalitis and a poor clinical outcome resulted. JEV RNA was detected in serum, cerebrospinal fluid, and bronchoalveolar lavage fluid specimens. The second recipient had leukemia and received platelets after undergoing chemotherapy. This patient was asymptomatic; JEV infection was confirmed in this person by IgMseroconversion. This study illustrates that, consistent with other pathogenic flaviviruses, JEV can be transmitted via blood products. Targeted donor screening and pathogen reduction technologies could be used to prevent transfusion-transmitted JEV infection in highly JEV-endemic areas.
C1 [Cheng, Vincent C. C.; Sridhar, Siddharth] Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China.
   [Wong, Shuk-Ching; Chan, Jasper F. W.; Yip, Cyril C. Y.; Yuen, Kwok-Yung] Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China.
   [Cheng, Vincent C. C.; Wong, Shuk-Ching; Au, Timmy W. K.; Hwang, Yu-Yan] Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China.
   [Chau, Chi-Hung] Grantham Hosp, Hong Kong, Hong Kong, Peoples R China.
   [Yau, Carol S. W.; Lo, Janice Y. C.] Ctr Hlth Protect, Hong Kong, Hong Kong, Peoples R China.
   [Lee, Cheuk-Kwong] Hong Kong Red Cross Blood Transfus Serv, Hong Kong, Hong Kong, Peoples R China.
RP Yuen, KY (corresponding author), Univ Hong Kong, Carol Yu Ctr Infect, Univ Pathol Bldg,Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.
EM kyyuen@hku.hk
RI Chan, Jasper F. W./D-8007-2013; Sridhar, Siddharth/J-4061-2019
OI Chan, Jasper F. W./0000-0001-6336-6657; Sridhar,
   Siddharth/0000-0002-2022-8307; Yuen, Kwok-yung/0000-0002-2083-1552
FU Consultancy Service for Enhancing Laboratory Surveillance of Emerging
   Infectious Diseases of the Department of Health, Hong Kong Special
   Administrative Region; Collaborative Innovation Center for Diagnosis and
   Treatment of Infectious Diseases, the Ministry of Education of
   ChinaMinistry of Education, China
FX This work was supported in part by donations from Michael Tong,
   Providence Foundation Ltd (in memory of the late Lui Hac Minh), and the
   Hong Kong Hainan Commercial Association and by funding from the
   Consultancy Service for Enhancing Laboratory Surveillance of Emerging
   Infectious Diseases of the Department of Health, Hong Kong Special
   Administrative Region, and the Collaborative Innovation Center for
   Diagnosis and Treatment of Infectious Diseases, the Ministry of
   Education of China.
CR ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Busch MP, 2006, EMERG INFECT DIS, V12, P395, DOI 10.3201/eid1203.051287
   Busch MP, 2005, NEW ENGL J MED, V353, P460, DOI 10.1056/NEJMoa044029
   Cadar D, 2017, EUROSURVEILLANCE, V22, P9, DOI [10.2807/1560-7917.es.2017.22.14.30501, 10.2807/1560-7917.ES.2017.22.14.30501]
   Campbell GL, 2011, B WORLD HEALTH ORGAN, V89, P766, DOI 10.2471/BLT.10.085233
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Chan JFW, 2017, ANTIVIR RES, V141, P29, DOI 10.1016/j.antiviral.2017.02.002
   Chan JFW, 2015, CURR OPIN VIROL, V10, P63, DOI 10.1016/j.coviro.2015.01.006
   Chen SP, 2012, EPIDEMIOL INFECT, V140, P1637, DOI 10.1017/S095026881100255X
   Cheng VCC, 2001, PERITON DIALYSIS INT, V21, P296
   Cheng VCC, 2016, CLIN INFECT DIS, V62, P714, DOI 10.1093/cid/civ1006
   Cheng VCC, 2009, J CLIN MICROBIOL, V47, P2834, DOI 10.1128/JCM.00908-09
   Cheng VCC, 2012, CHINESE MED J-PEKING, V125, P4283, DOI 10.3760/cma.j.issn.0366-6999.2012.23.022
   Chuang Vivien W. M., 2008, Hong Kong Medical Journal, V14, P170
   Drew VJ, 2017, BLOOD TRANSFUS
   Dunstan RA, 2008, AUST NZ J PUBL HEAL, V32, P354, DOI 10.1111/j.1753-6405.2008.00254.x
   Ellingson KD, 2017, TRANSFUSION, V57, P1625, DOI 10.1111/trf.14164
   Faddy HM, 2016, VOX SANG, V111, P235, DOI 10.1111/vox.12414
   Faddy HM, 2013, EMERG INFECT DIS, V19, P787, DOI 10.3201/eid1905.121664
   Food and Environmental Hygiene Department Hong Kong, 2017, DISTR CUL TRIT JE VE
   Fryk JJ, 2017, TRANSFUSION, V57, P2677, DOI 10.1111/trf.14256
   Iwamoto M, 2003, NEW ENGL J MED, V348, P2196, DOI 10.1056/NEJMoa022987
   Jain N, 2007, TRANSPL INT, V20, P800, DOI 10.1111/j.1432-2277.2007.00514.x
   KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581
   Levi ME, 2013, CURR INFECT DIS REP, V15, P478, DOI 10.1007/s11908-013-0367-8
   Lord JS, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004074
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Pealer LN, 2003, NEW ENGL J MED, V349, P1236, DOI 10.1056/NEJMoa030969
   Petersen LR, 2010, VOX SANG, V98, P495, DOI 10.1111/j.1423-0410.2009.01286.x
   Scaramozzino N, 2001, J CLIN MICROBIOL, V39, P1922, DOI 10.1128/JCM.39.5.1922-1927.2001
   Schlenke P, 2014, TRANSFUS MED HEMOTH, V41, P309, DOI 10.1159/000365646
   Simmons G, 2016, EMERG INFECT DIS, V22, P1221, DOI 10.3201/eid2207.160116
   Tambyah PA, 2008, NEW ENGL J MED, V359, P1526, DOI 10.1056/NEJMc0708673
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   To KKW, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003318
   WAHLBERG P, 1989, J INTERN MED, V225, P173, DOI 10.1111/j.1365-2796.1989.tb00059.x
   Wilder-Smith A, 2009, EMERG INFECT DIS, V15, P8, DOI 10.3201/eid1501.071097
   Yang L, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.57
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 40
TC 11
Z9 12
U1 0
U2 3
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD JAN
PY 2018
VL 24
IS 1
BP 49
EP 57
DI 10.3201/eid2401.171297
PG 9
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA FR2SW
UT WOS:000418918500007
PM 29043965
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Dirlikov, E
   Torres, JV
   Martines, RB
   Reagan-Steiner, S
   Perez, GV
   Rivera, A
   Major, C
   Matos, D
   Munoz-Jordan, J
   Shieh, WJ
   Zaki, SR
   Sharp, TM
AF Dirlikov, Emilio
   Torres, Jose V.
   Martines, Roosecelis Brasil
   Reagan-Steiner, Sarah
   Perez, George Venero
   Rivera, Aidsa
   Major, Chelsea
   Matos, Desiree
   Munoz-Jordan, Jorge
   Shieh, Wun-Ju
   Zaki, Sherif R.
   Sharp, Tyler M.
TI Postmortem Findings in Patient with Guillain-Barre Syndrome and Zika
   Virus Infection
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID PUERTO-RICO; CASE SERIES; COLOMBIA
AB Postmortem examination results of a patient with Guillain-Barre syndrome and confirmed Zika virus infection revealed demyelination of the sciatic and cranial IV nerves, providing evidence of the acute demyelinating inflammatory polyneuropathy Guillain-Barre syndrome variant. Lack of evidence of Zika virus in nervous tissue suggests that pathophysiology was antibody mediated without neurotropism.
C1 [Dirlikov, Emilio; Martines, Roosecelis Brasil; Reagan-Steiner, Sarah; Major, Chelsea; Shieh, Wun-Ju; Zaki, Sherif R.] Ctr Dis Control & Prevent, 1600 Clifton Rd NE,Mailstop E22, Atlanta, GA 30329 USA.
   [Torres, Jose V.] Puerto Rico Inst Forens Sci, San Juan, PR USA.
   [Perez, George Venero] Hermanos Melendez Hosp, Bayamon, PR USA.
   [Rivera, Aidsa; Major, Chelsea; Matos, Desiree; Munoz-Jordan, Jorge; Sharp, Tyler M.] Ctr Dis Control & Prevent, San Juan, PR USA.
   [Sharp, Tyler M.] US Publ Hlth Serv Commissioned Corps, Rockville, MD USA.
RP Dirlikov, E (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd NE,Mailstop E22, Atlanta, GA 30329 USA.
EM klt9@cdc.gov
OI Dirlikov, Emilio/0000-0003-4631-2643
CR Arias A, 2017, J CRIT CARE, V37, P19, DOI 10.1016/j.jcrc.2016.08.016
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Dirlikov E, 2017, JAMA-J AM MED ASSOC, V318, P1498, DOI 10.1001/jama.2017.11483
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P910, DOI 10.15585/mmwr.mm6534e1
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Gerardin P, 2017, NEUROLOGY, V88, P1874, DOI 10.1212/WNL.0000000000003927
   HUND EF, 1993, CRIT CARE MED, V21, P433, DOI 10.1097/00003246-199303000-00023
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Paz-Bailey G, 2017, N ENGL J MED
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Salinas JL, 2017, J NEUROL SCI, V377, P102, DOI 10.1016/j.jns.2017.04.006
   Sejvar JJ, 2011, VACCINE, V29, P599, DOI 10.1016/j.vaccine.2010.06.003
   Tomashek KM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005025
   Uncini A, 2017, J NEUROL NEUROSUR PS, V88, P266, DOI 10.1136/jnnp-2016-314310
   Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1
NR 15
TC 10
Z9 14
U1 0
U2 3
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD JAN
PY 2018
VL 24
IS 1
BP 114
EP 117
DI 10.3201/eid2401.171331
PG 4
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA FR2SW
UT WOS:000418918500015
PM 29261094
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Eggo, RM
   Kucharski, AJ
AF Eggo, Rosalind M.
   Kucharski, Adam J.
TI Expected Duration of Adverse Pregnancy Outcomes after Zika Epidemic
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID VIRUS-INFECTION; INFANTS; BRAZIL; BIRTH; RISK
AB Evidence is increasing that Zika virus-related adverse outcomes can occur throughout pregnancy. Mathematical modeling analysis using reported outcome data suggests that surveillance for these outcomes should begin as soon as an outbreak is detected and should continue for 40 weeks after the outbreak ends.
C1 [Eggo, Rosalind M.; Kucharski, Adam J.] London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.
RP Eggo, RM (corresponding author), London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.
EM r.eggo@lshtm.ac.uk
OI Eggo, Rosalind M/0000-0002-0362-6717
FU Medical Research CouncilMedical Research Council UK (MRC) [MR/K021524/1]
CR [Anonymous], 2016, N Engl J Med, V375, P498, DOI 10.1056/NEJMx160025
   de Brito CAA, 2016, REV SOC BRAS MED TRO, V49, P553, DOI 10.1590/0037-8682-0245-2016
   Aragao MFVV, 2017, AM J NEURORADIOL, V38, P1427, DOI 10.3174/ajnr.A5216
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   de Oliveira WK, 2017, NEW ENGL J MED, V376, P1591, DOI 10.1056/NEJMc1608612
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Martinez ME, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002520
   Pacheco O, 2016, NEW ENGL J MED
   Reefhuis J, 2016, EMERG INFECT DIS, V22, P828, DOI 10.3201/eid2205.160290
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
NR 16
TC 1
Z9 1
U1 0
U2 1
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD JAN
PY 2018
VL 24
IS 1
BP 127
EP 130
DI 10.3201/eid2401.170482
PG 4
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA FR2SW
UT WOS:000418918500018
PM 29058664
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Barbosa, CM
   Di Paola, N
   Cunha, MP
   Rodrigues-Jesus, MJ
   Araujo, DB
   Silveira, VB
   Leal, FB
   Mesquita, FS
   Botosso, VF
   Zanotto, PMA
   Durigon, EL
   Silva, MV
   Oliveira, DBL
AF Barbosa, Carla M.
   Di Paola, Nicholas
   Cunha, Marielton P.
   Rodrigues-Jesus, Monica J.
   Araujo, Danielle B.
   Silveira, Vanessa B.
   Leal, Fabyano B.
   Mesquita, Flavio S.
   Botosso, Viviane F.
   Zanotto, Paolo M. A.
   Durigon, Edison L.
   Silva, Marcos V.
   Oliveira, Danielle B. L.
TI Yellow Fever Virus RNA in Urine and Semen of Convalescent Patient,
   Brazil
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID ZIKA VIRUS; INFECTION
AB Yellow fever virus RNA is usually detected in blood of infected humans. We detected virus RNA in urine and semen samples from a convalescent patient. A complete virus genome was sequenced for an isolate from a urine sample. This virus had a South American I genotype and unique synapomorphic changes.
C1 [Barbosa, Carla M.; Di Paola, Nicholas; Cunha, Marielton P.; Rodrigues-Jesus, Monica J.; Araujo, Danielle B.; Silveira, Vanessa B.; Leal, Fabyano B.; Mesquita, Flavio S.; Zanotto, Paolo M. A.; Durigon, Edison L.; Oliveira, Danielle B. L.] Univ Sao Paulo, Sao Paulo, Brazil.
   [Botosso, Viviane F.] Butantan Inst, Sao Paulo, Brazil.
   [Silva, Marcos V.] Inst Infectol Emilio Ribas, Sao Paulo, Brazil.
   [Silva, Marcos V.] Pontifical Catholic Univ, Sao Paulo, Brazil.
RP Oliveira, DBL (corresponding author), Univ Sao Paulo, Dept Microbiol, Inst Ciencias Biomed 2, Av Prof Lineu Preste 1374, BR-05580900 Sao Paulo, Brazil.
EM danibruna@gmail.com
RI de A. Zanotto, Paolo M./B-9286-2019; Botosso, Viviane/I-5591-2014;
   Oliveira, Danielle BL/H-8030-2015; Araujo, Danielle B/M-9540-2013;
   Barbosa, Carla Meneguin/AAA-8413-2019; Silveira, Vanessa/AAJ-9535-2020
OI de A. Zanotto, Paolo M./0000-0002-8167-0625; Botosso,
   Viviane/0000-0002-7876-3687; Oliveira, Danielle BL/0000-0002-3452-1336;
   Barbosa, Carla Meneguin/0000-0002-7329-202X; Mesquita,
   Flavio/0000-0002-4200-7943; Oliveira, Danielle/0000-0002-0534-0886;
   Rodrigues de Jesus, Monica Josiane/0000-0002-5434-1674
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2016/08727-5,
   2014/17766-9]; Conselho Nacional de Pesquisa (CNPq)National Council for
   Scientific and Technological Development (CNPq) [441105/2016-5];
   FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2013/22136-1, 2016/08204-2, 2014/21141-4, 2016/10161-0]; CNPqNational
   Council for Scientific and Technological Development (CNPq)
   [88887.141172/2017-00]; Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior//Newton Fund [99999.005126/2015/00]
FX This study was supported by Fundacao de Amparo a Pesquisa do Estado de
   Sao Paulo (FAPESP) projects 2016/08727-5 and 2014/17766-9 and Conselho
   Nacional de Pesquisa (CNPq) project 441105/2016-5. N.D. was supported by
   a fellowship from FAPESP (2013/22136-1), M.P.C. was supported by a
   fellowship from FAPESP (2016/08204-2), M.J.R.-J. was supported by a
   fellowship from FAPESP (2014/21141-4), V.B.S. was supported by a
   fellowship from FAPESP (2016/10161-0), and C.M.B. was supported by a
   fellowship from CNPq (88887.141172/2017-00) and the Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior//Newton Fund (Institutional
   links 99999.005126/2015/00).
CR Andries AC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004100
   Barzon L, 2013, J INFECT DIS, V208, P1086, DOI 10.1093/infdis/jit290
   Beasley DWC, 2015, ANTIVIR RES, V115, P48, DOI 10.1016/j.antiviral.2014.12.010
   Bryant JE, 2007, PLOS PATHOG, V3, P668, DOI 10.1371/journal.ppat.0030075
   Diallo D, 2014, AM J TROP MED HYG, V90, P1003, DOI 10.4269/ajtmh.13-0404
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Johnson N, 2010, VECTOR-BORNE ZOONOT, V10, P665, DOI 10.1089/vbz.2009.0210
   Oliveira DBL, 2016, NEW ENGL J MED, V375, P1202, DOI 10.1056/NEJMc1607583
   Pan American Health Organization/ World Health Organization, 2017, EP UPD YELL FEV
   Reuskena CB, 2017, J CLIN MICROBIOL
NR 10
TC 23
Z9 23
U1 0
U2 2
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD JAN
PY 2018
VL 24
IS 1
BP 176
EP 178
DI 10.3201/eid2401.171310
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA FR2SW
UT WOS:000418918500036
PM 29058663
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Fernandez-Carballo, BL
   McBeth, C
   McGuiness, I
   Kalashnikov, M
   Baum, C
   Borros, S
   Sharon, A
   Sauer-Budge, AF
AF Leticia Fernandez-Carballo, B.
   McBeth, Christine
   McGuiness, Ian
   Kalashnikov, Maxim
   Baum, Christoph
   Borros, Salvador
   Sharon, Andre
   Sauer-Budge, Alexis F.
TI Continuous-flow, microfluidic, qRT-PCR system for RNA virus detection
SO ANALYTICAL AND BIOANALYTICAL CHEMISTRY
LA English
DT Article
DE Lab on a chip; Quantitative reverse transcription polymerase chain
   reaction; RNA-based virus detection; Infectious diseases; Point of care;
   Ebola virus
ID REVERSE-TRANSCRIPTION-PCR; OF-CARE DIAGNOSTICS; HEMORRHAGIC-FEVER;
   DEVICES; DNA; INFECTIONS
AB One of the main challenges in the diagnosis of infectious diseases is the need for rapid and accurate detection of the causative pathogen in any setting. Rapid diagnosis is key to avoiding the spread of the disease, to allow proper clinical decisions to be made in terms of patient treatment, and to mitigate the rise of drug-resistant pathogens. In the last decade, significant interest has been devoted to the development of point-of-care reverse transcription polymerase chain reaction (PCR) platforms for the detection of RNA-based viral pathogens. We present the development of a microfluidic, real-time, fluorescence-based, continuous-flow reverse transcription PCR system. The system incorporates a disposable microfluidic chip designed to be produced industrially with cost-effective roll-to-roll embossing methods. The chip has a long microfluidic channel that directs the PCR solution through areas heated to different temperatures. The solution first travels through a reverse transcription zone where RNA is converted to complementary DNA, which is later amplified and detected in real time as it travels through the thermal cycling area. As a proof of concept, the system was tested for Ebola virus detection. Two different master mixes were tested, and the limit of detection of the system was determined, as was the maximum speed at which amplification occurred. Our results and the versatility of our system suggest its promise for the detection of other RNA-based viruses such as Zika virus or chikungunya virus, which constitute global health threats worldwide.
C1 [Leticia Fernandez-Carballo, B.; McBeth, Christine; McGuiness, Ian; Kalashnikov, Maxim; Sharon, Andre; Sauer-Budge, Alexis F.] Fraunhofer USA Ctr Mfg Innovat, 15 St Marys St, Brookline, MA 02446 USA.
   [Leticia Fernandez-Carballo, B.; Borros, Salvador] Univ Ramon Llull, Inst Quim Sarria, Grp Engn Mat GEMAT, Via Augusta 390, Barcelona 08017, Spain.
   [Baum, Christoph] Fraunhofer Inst Prod Technol, Steinbachstr 17, D-52074 Aachen, Germany.
   [Sharon, Andre] Boston Univ, Dept Mech Engn, 110 Cummington Mall, Boston, MA 02215 USA.
   [Sauer-Budge, Alexis F.] Boston Univ, Dept Biomed Engn, 44 Cummington Mall, Boston, MA 02215 USA.
RP Sauer-Budge, AF (corresponding author), Fraunhofer USA Ctr Mfg Innovat, 15 St Marys St, Brookline, MA 02446 USA.; Sauer-Budge, AF (corresponding author), Boston Univ, Dept Biomed Engn, 44 Cummington Mall, Boston, MA 02215 USA.
EM asauerbudge@fraunhofer.org
RI Sauer-Budge, Alexis/L-2286-2019
OI Sauer-Budge, Alexis/0000-0001-5961-5286
FU international research project ML2 - Multilayer MicroLab [318088];
   European CommissionEuropean Commission Joint Research Centre
FX The work presented is based on activities related to the international
   research project ML<SUP>2</SUP> - Multilayer MicroLab (grant agreement
   no. 318088). The ML2 project was funded by the European Commission
   within the Seventh Framework Programme. The authors thank Affymetrix
   Inc. for providing the custom-made master mix. Dolomite Microfluidics is
   gratefully acknowledged for providing microfluidic connectors.
CR Ahmad F, 2012, ANAL CHIM ACTA, V733, P1, DOI 10.1016/j.aca.2012.04.031
   Asiello PJ, 2011, LAB CHIP, V11, P1420, DOI 10.1039/c0lc00666a
   Beer NR, 2008, ANAL CHEM, V80, P1854, DOI 10.1021/ac800048k
   Bissonnette L, 2010, CLIN MICROBIOL INFEC, V16, P1044, DOI 10.1111/j.1469-0691.2010.03282.x
   Center for Disease Control and Prevention, 2015, EB VIR DIS
   Chatterjee A, 2010, ANAL CHEM, V82, P4344, DOI 10.1021/ac100063f
   Chin CD, 2007, LAB CHIP, V7, P41, DOI 10.1039/b611455e
   Crump J, 2011, BMJ-BRIT MED J, V343, P18
   Crump JA, 2013, PLOS NEGLECT TROP D, P7
   Dittrich S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161721
   Drancourt M, 2016, CLIN MICROBIOL REV, V29, P429, DOI 10.1128/CMR.00090-15
   Epigem, 2016, UV EMB
   Felbel J, 2008, ENG LIFE SCI, V8, P68, DOI 10.1002/elsc.200720222
   Fernandez-Carballo BL, 2016, BIOMED MICRODEVICES, V18, DOI 10.1007/s10544-016-0060-4
   Foundation for Innovative New Diagnostics, 2014, SIT REV EB DIAGN OPP
   Hanafiah KM, 2013, BIOMARK MED, V7, P333, DOI [10.2217/bmm.13.57, 10.2217/BMM.13.57]
   Hartung R, 2009, BIOMED MICRODEVICES, V11, P685, DOI 10.1007/s10544-008-9280-6
   Jun SR, 2015, FEMS MICROBIOL REV, V39, P764, DOI 10.1093/femsre/fuv031
   Kaler KVIS, 2014, SENSORS-BASEL, V14, P23283, DOI 10.3390/s141223283
   Kapasi AJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160278
   Kreuels B, 2014, NEW ENGL J MED, V371, P2394, DOI 10.1056/NEJMoa1411677
   Li YY, 2011, MICROFLUID NANOFLUID, V10, P367, DOI 10.1007/s10404-010-0675-3
   Niemz A, 2011, TRENDS BIOTECHNOL, V29, P240, DOI 10.1016/j.tibtech.2011.01.007
   Nouvellet P, 2015, NATURE, V528, pS109, DOI 10.1038/nature16041
   Obeid PJ, 2003, ANAL CHIM ACTA, V494, P1, DOI 10.1016/S0003-2670(03)00898-5
   Pai NP, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001306
   Park S, 2011, BIOTECHNOL ADV, V29, P830, DOI 10.1016/j.biotechadv.2011.06.017
   Peeling RW, 2010, CLIN MICROBIOL INFEC, V16, P1062, DOI 10.1111/j.1469-0691.2010.03279.x
   Prakash R, 2015, MICROMACHINES-BASEL, V6, P63, DOI 10.3390/mi6010063
   Ren KN, 2013, ACCOUNTS CHEM RES, V46, P2396, DOI 10.1021/ar300314s
   Sauer-Budge AF, 2009, LAB CHIP, V9, P2803, DOI 10.1039/b904854e
   Silva RM, 2015, BIOINFORMATICS, V31, P2421, DOI 10.1093/bioinformatics/btv189
   St John Andrew, 2014, Clin Biochem Rev, V35, P155
   SVG Optronics, 2016, R2R UV NAN
   Tang YW, 2012, EMERG MICROBES INFEC, V1, DOI 10.1038/emi.2012.15
   Towner JS, 2007, J INFECT DIS, V196, pS205, DOI 10.1086/520601
   Towner JS, 2004, J VIROL, V78, P4330, DOI 10.1128/JVI.78.8.4330-4341.2004
   Trombley AR, 2010, AM J TROP MED HYG, V82, P954, DOI 10.4269/ajtmh.2010.09-0636
   Ventola C Lee, 2015, P T, V40, P277
   Wallow TI, 2007, LAB CHIP, V7, P1825, DOI 10.1039/b710175a
   Weidmann M, 2004, J CLIN VIROL, V30, P94, DOI 10.1016/j.jcv.2003.09.004
   World Health Organization, 2016, EB VIR DIS, P2016
   World Health Organization, 2014, LAB DIAGN EB VIR DIS
   World Health Organization (WHO), 2016, ANT RES
   Yamanaka K, 2011, ANALYST, V136, P2064, DOI 10.1039/c1an15066a
   Yan L, 2014, MOL BIOSYST, V10, P970, DOI 10.1039/c3mb70304e
   Zhang CS, 2006, BIOTECHNOL ADV, V24, P243, DOI 10.1016/j.biotechadv.2005.10.002
NR 47
TC 6
Z9 6
U1 7
U2 39
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1618-2642
EI 1618-2650
J9 ANAL BIOANAL CHEM
JI Anal. Bioanal. Chem.
PD JAN
PY 2018
VL 410
IS 1
BP 33
EP 43
DI 10.1007/s00216-017-0689-8
PG 11
WC Biochemical Research Methods; Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA FR5PD
UT WOS:000419117600007
PM 29116351
DA 2020-07-08
ER

PT J
AU Javed, F
   Manzoor, KN
   Ali, M
   Haq, IU
   Khan, AA
   Zaib, A
   Manzoor, S
AF Javed, Farakh
   Manzoor, Khanzadi N.
   Ali, Mubashar
   Haq, Irshad U.
   Khan, Abid A.
   Zaib, Assad
   Manzoor, Sobia
TI Zika virus: what we need to know?
SO JOURNAL OF BASIC MICROBIOLOGY
LA English
DT Review
DE Aedes aegypti; genetic variability; non-structural proteins; Zika virus
ID BORNE ENCEPHALITIS-VIRUS; WEST-NILE-VIRUS; DENGUE VIRUS; YELLOW-FEVER;
   SUBCELLULAR-LOCALIZATION; GENOMIC CHARACTERIZATION; INTERIM GUIDELINES;
   UNITED-STATES; STEM-CELLS; INFECTION
AB Zika virus is one of the emerging viruses and is of significant threat to human health globally. It is a mosquito borne flavivirus similar to dengue, yellow fever, and West Nile viruses. It was reported about 5 decades ago and then it spreads to different parts of the world. Large outbreaks were reported on Yap Islands in 2007. Now it has gained wide attention globally by health communities. Major vector for virus transmission is Aedes aegypti mosquito. ZIKV infection is mostly asymptomatic but it is also responsible to cause mild influenza like illness to serious manifestations. There is no specific anti-viral treatment is available for ZIKV infection. The virus disseminates very fast due to which it possesses a serious threat especially in those areas where there is lack of specific immunity against virus. Little knowledge is available on its transmission and pathogenicity. Although virus was discovered years ago but its genomic structure is not clearly understood yet. In this review we focus on the current knowledge of epidemiology of ZIKV, its transmission, its structural biology, different aspects of diagnosis and diagnostic challenges as well as highlighted appropriates antiviral drugs and vaccines regarding treatment.
C1 [Javed, Farakh; Manzoor, Khanzadi N.; Ali, Mubashar; Haq, Irshad U.] Univ Haripur, Dept Microbiol, Haripur, Pakistan.
   [Zaib, Assad] Univ Haripur, Dept Med Lab Technol, Haripur, Pakistan.
   [Khan, Abid A.] COMSATS Inst Informat Technol, Dept Biosci, Islamabad, Pakistan.
   [Manzoor, Sobia] Natl Univ Sci & Technol, Atta Ur Rehman Sch Appl Biosci, Islamabad, Pakistan.
RP Javed, F (corresponding author), Univ Haripur, Dept Microbiol, Haripur, Pakistan.
EM farukhbbt@gmail.com
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Adams MJ, 2015, ARCH VIROL, V160, P1375, DOI 10.1007/s00705-015-2376-4
   Adcock RS, 2017, ANTIVIR RES, V138, P47, DOI 10.1016/j.antiviral.2016.11.018
   Alam A, 2017, BIOMED PHARMACOTHER, V91, P1152, DOI 10.1016/j.biopha.2017.05.045
   Alawieh A, 2014, INT J INFECT DIS, V29, P115, DOI 10.1016/j.ijid.2014.04.023
   Albulescu IC, 2017, ANTIVIR RES, V143, P230, DOI 10.1016/j.antiviral.2017.04.016
   Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   ALLISON SL, 1995, J VIROL, V69, P5816, DOI 10.1128/JVI.69.9.5816-5820.1995
   Althouse BM, 2015, AM J TROP MED HYG, V92, P88, DOI 10.4269/ajtmh.13-0617
   AMBERG SM, 1994, J VIROL, V68, P3794, DOI 10.1128/JVI.68.6.3794-3802.1994
   Baba SS, 1999, COMP IMMUNOL MICROB, V22, P71, DOI 10.1016/S0147-9571(98)00003-4
   Balasubramanian A, 2017, ANTIVIR RES, V137, P141, DOI 10.1016/j.antiviral.2016.11.015
   Barreyro FJ, 2015, LIVER INT, V35, P953, DOI 10.1111/liv.12570
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   BRES P, 1970, B WORLD HEALTH ORGAN, V43, P223
   Bruenn JA, 2003, NUCLEIC ACIDS RES, V31, P1821, DOI 10.1093/nar/gkg277
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   BUCKLEY A, 1988, J GEN VIROL, V69, P1913, DOI 10.1099/0022-1317-69-8-1913
   Bugl H, 2000, MOL CELL, V6, P349, DOI 10.1016/S1097-2765(00)00035-6
   Butcher SJ, 2001, NATURE, V410, P235, DOI 10.1038/35065653
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao RY, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx009
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Caragata EP, 2016, MICROB CELL, V3, P293, DOI 10.15698/mic2016.07.513
   CHAMBERS TJ, 1989, VIROLOGY, V169, P100, DOI 10.1016/0042-6822(89)90045-7
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chan JFW, 2013, TRENDS MICROBIOL, V21, P544, DOI 10.1016/j.tim.2013.05.005
   Ching S, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1017-0
   Chotiwan N, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag0538
   Coffey LL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171148
   Contreras D, 2016, JOVE-J VIS EXP, P114
   Costa VV, 2017, MBIO, V8, P1
   Crabtree MB, 2005, ARCH VIROL, V150, P771, DOI 10.1007/s00705-004-0430-8
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   Delatte H, 2009, J MED ENTOMOL, V46, P33, DOI 10.1603/033.046.0105
   Derraik JG, 2015, AUST NZ J PUBL HEAL, V39, P5, DOI 10.1111/1753-6405.12302
   Diamond MS, 2003, VIRAL IMMUNOL, V16, P259, DOI 10.1089/088282403322396082
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Doller A, 2007, J AM SOC NEPHROL, V18, P581, DOI 10.1681/ASN.2006060568
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Eboigbodin KE, 2016, DIAGN MICR INFEC DIS, V86, P369, DOI 10.1016/j.diagmicrobio.2016.08.027
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Fernandez E, 2017, CURR OPIN VIROL, V23, P59, DOI 10.1016/j.coviro.2017.03.006
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Fu KW, 2016, AM J INFECT CONTROL, V44, P1700, DOI 10.1016/j.ajic.2016.04.253
   Fung Isaac Chun-Hai, 2017, Disaster Med Public Health Prep, V11, P656, DOI 10.1017/dmp.2017.23
   Goebel S, 2016, J VIROL METHODS, V238, P13, DOI 10.1016/j.jviromet.2016.09.015
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hamer DH, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0571-z
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Hercik K, 2017, ARCH VIROL, V162, P2091, DOI 10.1007/s00705-017-3345-x
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Jiang Wen-Ling, 2005, Di Yi Jun Yi Da Xue Xue Bao, V25, P454
   Jurado KA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88461
   Kindhauser MK, 2016, BULL WORLD HEALTH OR, V94, p86C
   Kok WM, 2016, EXPERT OPIN DRUG DIS, V11, P433, DOI 10.1517/17460441.2016.1160887
   Kouznetsova J, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.88
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Landry ML, 2017, ARCH PATHOL LAB MED, V141, P60, DOI 10.5858/arpa.2016-0406-SA
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   LENNARD L, 1992, EUR J CLIN PHARMACOL, V43, P329, DOI 10.1007/BF02220605
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Lim SK, 2017, INFECT CHEMOTHER, V49, P91, DOI 10.3947/ic.2017.49.2.91
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Liu WJ, 2006, J VIROL, V80, P2396, DOI 10.1128/JVI.80.5.2396-2404.2006
   Liu WJ, 2005, J VIROL, V79, P1934, DOI 10.1128/JVI.79.3.1934-1942.2005
   LOBIGS M, 1993, P NATL ACAD SCI USA, V90, P6218, DOI 10.1073/pnas.90.13.6218
   Lowes L, 2016, J PEDIATR REHAB MED, V9, P65, DOI 10.3233/PRM-160362
   Lu G, 2017, ANTIMICROB AGENTS CH, V61, P1
   Ma LX, 2004, P NATL ACAD SCI USA, V101, P3414, DOI 10.1073/pnas.0305892101
   Mackenzie JM, 1998, VIROLOGY, V245, P203, DOI 10.1006/viro.1998.9156
   Mackenzie JM, 1996, VIROLOGY, V220, P232, DOI 10.1006/viro.1996.0307
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   MASON PW, 1989, VIROLOGY, V169, P354, DOI 10.1016/0042-6822(89)90161-X
   Mastrangelo E, 2012, J ANTIMICROB CHEMOTH, V67, P1884, DOI 10.1093/jac/dks147
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miller S, 2006, J BIOL CHEM, V281, P8854, DOI 10.1074/jbc.M512697200
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mourya DT, 2016, INDIAN J MED RES, V143, P553, DOI 10.4103/0971-5916.187103
   Munjal A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01469
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Muthumani K, 2017, CANCER IMMUNOL IMMUN, P1
   NEI M, 1986, MOL BIOL EVOL, V3, P418
   Nover A, 1965, Albrecht Von Graefes Arch Klin Exp Ophthalmol, V168, P388, DOI 10.1007/BF02629855
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Oehler E, 2014, EUROSURVEILLANCE, V19, P4
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Parida MM, 2002, J ETHNOPHARMACOL, V79, P273, DOI 10.1016/S0378-8741(01)00395-6
   PARTON RG, 1995, SCIENCE, V269, P1398, DOI 10.1126/science.7660120
   Pavlasek I, 1996, VET MED-CZECH, V41, P361
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Petersen LR, 2016, NEW ENGL J MED, V375, P294, DOI 10.1056/NEJMc1606769
   PRYOR MJ, 1994, J GEN VIROL, V75, P1183, DOI 10.1099/0022-1317-75-5-1183
   Rainey MM, 2010, GENETICS, V185, P1221, DOI 10.1534/genetics.110.117846
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   Reznik SE, 2017, INT J INFECT DIS, V55, P29, DOI 10.1016/j.ijid.2016.12.011
   Richner JM, 2017, CELL, V169, P176, DOI 10.1016/j.cell.2017.03.016
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Saiz JC, 2017, ANTIMICROB AGENTS CH, V61, P1
   SALUZZO JF, 1982, B SOC PATHOL EXOT, V75, P262
   Saxena Shailendra K., 2016, VirusDisease, V27, P111, DOI 10.1007/s13337-016-0307-y
   Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231
   Sharma M, 2017, AM J INFECT CONTROL, V45, P301, DOI 10.1016/j.ajic.2016.08.022
   Shiryaev SA, 2017, ANTIVIR RES, V143, P218, DOI 10.1016/j.antiviral.2017.04.015
   Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140
   Silverman JA, 2003, ANTIMICROB AGENTS CH, V47, P2538, DOI 10.1128/AAC.47.8.2538-2544.2003
   SMITHBURN KC, 1954, J IMMUNOL, V72, P248
   SMITHBURN KC, 1954, AM J TROP MED HYG, V3, P9, DOI 10.4269/ajtmh.1954.3.9
   Sriwilaijaroen N, 2012, ANTIVIR RES, V94, P139, DOI 10.1016/j.antiviral.2012.02.013
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Tang LIC, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-3
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Varghese FS, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.02227-16, 10.1128/aac.02227-16]
   Wang SH, 2004, J GEN VIROL, V85, P2307, DOI 10.1099/vir.0.80067-0
   Weaver SC, 2013, TRENDS MICROBIOL, V21, P360, DOI 10.1016/j.tim.2013.03.003
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310, DOI 10.4269/ajtmh.2001.64.310
   Xu X, 2016, PLOS CURR, V8, P1
   Ye Q, 2016, INFECT GENET EVOL, V43, P43, DOI 10.1016/j.meegid.2016.05.004
   Young PR, 2000, J CLIN MICROBIOL, V38, P1053, DOI 10.1128/JCM.38.3.1053-1057.2000
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhang S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13679
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 151
TC 7
Z9 8
U1 0
U2 26
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0233-111X
EI 1521-4028
J9 J BASIC MICROB
JI J. Basic Microbiol.
PD JAN
PY 2018
VL 58
IS 1
BP 3
EP 16
DI 10.1002/jobm.201700398
PG 14
WC Microbiology
SC Microbiology
GA FR5SE
UT WOS:000419125700001
PM 29131357
OA Bronze
DA 2020-07-08
ER

PT J
AU Lindsey, NP
   Staples, JE
   Powell, K
   Rabe, IB
   Fischer, M
   Powers, AM
   Kosoy, OI
   Mossel, EC
   Munoz-Jordan, JL
   Beltran, M
   Hancock, WT
   Toews, KAE
   Ellis, EM
   Ellis, BR
   Panella, AJ
   Basile, AJ
   Calvert, AE
   Laven, J
   Goodman, CH
   Gould, CV
   Martin, SW
   Thomas, JD
   Villanueva, J
   Mataia, ML
   Sciulli, R
   Gose, R
   Whelen, AC
   Hills, SL
AF Lindsey, Nicole P.
   Staples, J. Erin
   Powell, Krista
   Rabe, Ingrid B.
   Fischer, Marc
   Powers, Ann M.
   Kosoy, Olga I.
   Mossel, Eric C.
   Munoz-Jordan, Jorge L.
   Beltran, Manuela
   Hancock, W. Thane
   Toews, Karrie-Ann E.
   Ellis, Esther M.
   Ellis, Brett R.
   Panella, Amanda J.
   Basile, Alison J.
   Calvert, Amanda E.
   Laven, Janeen
   Goodman, Christin H.
   Gould, Carolyn V.
   Martin, Stacey W.
   Thomas, Jennifer D.
   Villanueva, Julie
   Mataia, Mary L.
   Sciulli, Rebecca
   Gose, Remedios
   Whelen, A. Christian
   Hills, Susan L.
TI Ability To Serologically Confirm Recent Zika Virus Infection in Areas
   with Varying Past Incidence of Dengue Virus Infection in the United
   States and US Territories in 2016
SO JOURNAL OF CLINICAL MICROBIOLOGY
LA English
DT Article
DE confirmatory; serologic; Zika virus
ID MICRONESIA; GUIDELINES; OUTBREAK; ISLAND
AB Cross-reactivity within flavivirus antibody assays, produced by shared epitopes in the envelope proteins, can complicate the serological diagnosis of Zika virus (ZIKAV) infection. We assessed the utility of the plaque reduction neutralization test (PRNT) to confirm recent ZIKAV infections and rule out misleading positive immunoglobulin M (IgM) results in areas with various levels of past dengue virus (DENV) infection incidence. We reviewed PRNT results of sera collected for diagnosis of ZIKAV infection from 1 January through 31 August 2016 with positive ZIKAV IgM results, and ZIKAV and DENV PRNTs were performed. PRNT result interpretations included ZIKAV, unspecified flavivirus, DENV infection, or negative. For this analysis, ZIKAV IgM was considered false positive for samples interpreted as a DENV infection or negative. In U.S. states, 208 (27%) of 759 IgM-positive results were confirmed to be ZIKAV compared to 11 (21%) of 52 in the U.S. Virgin Islands (USVI), 15 (15%) of 103 in American Samoa, and 13 (11%) of 123 in Puerto Rico. In American Samoa and Puerto Rico, more than 80% of IgM-positive results were unspecified flavivirus infections. The false-positivity rate was 27% in U. S. states, 18% in the USVI, 2% in American Samoa, and 6% in Puerto Rico. In U.S. states, the PRNT provided a virus-specific diagnosis or ruled out infection in the majority of IgM-positive samples. Almost a third of ZIKAV IgM-positive results were not confirmed; therefore, providers and patients must understand that IgM results are preliminary. In territories with historically higher rates of DENV transmission, the PRNT usually could not differentiate between ZIKAV and DENV infections.
C1 [Lindsey, Nicole P.; Staples, J. Erin; Rabe, Ingrid B.; Fischer, Marc; Powers, Ann M.; Kosoy, Olga I.; Mossel, Eric C.; Panella, Amanda J.; Basile, Alison J.; Calvert, Amanda E.; Laven, Janeen; Goodman, Christin H.; Gould, Carolyn V.; Martin, Stacey W.; Hills, Susan L.] Ctr Dis Control & Prevent, Div Vector Borne Dis, Natl Ctr Emerging & Zoonot Infect Dis, Ft Collins, CO 80521 USA.
   [Munoz-Jordan, Jorge L.; Beltran, Manuela] Ctr Dis Control & Prevent, Div Vector Borne Dis, Natl Ctr Emerging & Zoonot Infect Dis, San Juan, PR USA.
   [Powell, Krista] Ctr Dis Control & Prevent, Div TB Eliminat, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA USA.
   [Hancock, W. Thane; Toews, Karrie-Ann E.] Ctr Dis Control & Prevent, Div State & Local Readiness, Off Publ Hlth Preparedness & Response, Atlanta, GA USA.
   [Ellis, Esther M.; Ellis, Brett R.] US Virgin Isl Dept Hlth, Christiansted, VI USA.
   [Thomas, Jennifer D.; Villanueva, Julie] Ctr Dis Control & Prevent, Div Preparedness & Emerging Infect, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA.
   [Mataia, Mary L.] American Samoa Dept Hlth, Fagaalu, American Samoa, Samoa.
   [Sciulli, Rebecca; Gose, Remedios; Whelen, A. Christian] Hawaii Dept Hlth, State Labs Div, Pearl City, HI USA.
RP Lindsey, NP (corresponding author), Ctr Dis Control & Prevent, Div Vector Borne Dis, Natl Ctr Emerging & Zoonot Infect Dis, Ft Collins, CO 80521 USA.
EM frd3@cdc.gov
CR Association of Public Health Laboratories, 2016, UPD DIAGN TEST ZIK C
   Centers for Disease Control and Prevention, 2016, GUID US LAB TEST ZIK
   Centers for Disease Control and Prevention, 2016, REV DIAGN TEST ZIK C
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Food and Drug Administration, 2016, ZIK VIR EM AUTH
   HALSTEAD SB, 1983, AM J TROP MED HYG, V32, P154, DOI 10.4269/ajtmh.1983.32.154
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   LINDSEY HS, 1976, J CLIN MICROBIOL, V4, P503
   Martin DA, 2000, J CLIN MICROBIOL, V38, P1823, DOI 10.1128/JCM.38.5.1823-1826.2000
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Petersen LR, 2012, TRANSFUSION, V52, P1647, DOI 10.1111/j.1537-2995.2011.03529.x
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Roehrig JT, 2008, VIRAL IMMUNOL, V21, P123, DOI 10.1089/vim.2008.0007
   Tomashek KM, 2009, AM J TROP MED HYG, V81, P467, DOI 10.4269/ajtmh.2009.81.467
   Woods CR, 2013, J PEDIATR INFECT DIS, V2, P87, DOI 10.1093/jpids/pis133
   World Health Organization, 2009, DENG GUID DIAGN TREA
NR 19
TC 17
Z9 17
U1 0
U2 0
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0095-1137
EI 1098-660X
J9 J CLIN MICROBIOL
JI J. Clin. Microbiol.
PD JAN
PY 2018
VL 56
IS 1
AR UNSP e01115-17
DI 10.1128/JCM.01115-17
PG 6
WC Microbiology
SC Microbiology
GA FR4RM
UT WOS:000419053400008
PM 29093104
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Gerardin, P
   Ramos, RC
   Jungmann, P
   de Oliveira, JRM
   Amara, A
   Gressens, P
AF Gerardin, Patrick
   Ramos, Regina Coeli
   Jungmann, Patricia
   Mendes de Oliveira, Joao Ricardo
   Amara, Ali
   Gressens, Pierre
TI Zika epidemic: a step towards understanding the infectious causes of
   microcephaly?
SO LANCET INFECTIOUS DISEASES
LA English
DT Editorial Material
ID NEURAL PROGENITORS; ACTIVATION; CELLS
C1 [Gerardin, Patrick] CHU Reunion, INSERM CIC 1410, F-97448 St Pierre, Reunion, France.
   [Gerardin, Patrick] Univ Reunion, CNRS 9192, INSERM U1187, IRD 249,UM 134 PIMIT,Cyclotron Reunion Ocean Indi, St Clotilde, Reunion, France.
   [Ramos, Regina Coeli] Oswaldo Cruz Univ Hosp, Recife, PE, Brazil.
   [Jungmann, Patricia] Univ Pernambuco, Recife, PE, Brazil.
   [Mendes de Oliveira, Joao Ricardo] Univ Fed Pernambuco, Recife, PE, Brazil.
   [Amara, Ali] Univ Paris Diderot, Sorbonne Paris Cite, Hop St Louis,CNRS 7212, Inst Univ Hematol,UMRS Pathol & Virol Mol,INSERM, Paris, France.
   [Gressens, Pierre] Univ Paris Diderot, Sorbonne Paris Cite, INSERM, PROTECT, Paris, France.
   [Gressens, Pierre] Kings Coll London, St Thomas Hosp, Ctr Developing Brain, Kings Hlth Partners,Dept Div Imaging Sci & Biomed, London, England.
RP Gerardin, P (corresponding author), CHU Reunion, INSERM CIC 1410, F-97448 St Pierre, Reunion, France.; Gerardin, P (corresponding author), Univ Reunion, CNRS 9192, INSERM U1187, IRD 249,UM 134 PIMIT,Cyclotron Reunion Ocean Indi, St Clotilde, Reunion, France.
EM patrick.gerardin@chu-reunion.fr
RI gressens, pierre/M-7557-2017
OI gressens, pierre/0000-0002-0909-4221; AMARA, Ali/0000-0002-0283-1815
CR Aldo P, 2016, AM J REPROD IMMUNOL, V76, P348, DOI 10.1111/aji.12578
   Amara A, 2015, NAT REV MICROBIOL, V13, P461, DOI 10.1038/nrmicro3469
   Barkovich AJ, 2012, BRAIN, V135, P1348, DOI 10.1093/brain/aws019
   Chavali PL, 2017, SCIENCE, V357, P83, DOI 10.1126/science.aam9243
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   del Campo M, 2017, AM J MED GENET A, V173, P841, DOI 10.1002/ajmg.a.38170
   Devakumar D, 2018, LANCET INFECT DIS, V18, pE1, DOI [10.1016/S1473-3099(17)30398-5, 10.1016/s1473-3099(17)30398-5]
   El Ghouzzi V, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.266
   Gerardin P, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4850
   Kawasaki H, 2015, AM J PATHOL, V185, P1304, DOI 10.1016/j.ajpath.2015.01.032
   Luo MH, 2010, J VIROL, V84, P3528, DOI 10.1128/JVI.02161-09
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Passemard S, 2013, HAND CLINIC, V111, P129, DOI 10.1016/B978-0-444-52891-9.00013-0
   Puschnik AS, 2017, NAT REV MICROBIOL, V15, P351, DOI 10.1038/nrmicro.2017.29
   Russo FB, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12744
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Vanderver A, 2015, J CHILD NEUROL, V30, P1343, DOI 10.1177/0883073814562252
   Wilcox DR, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005449
NR 19
TC 1
Z9 1
U1 0
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD JAN
PY 2018
VL 18
IS 1
BP 15
EP 16
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA FQ8VG
UT WOS:000418640700013
PM 29303729
OA Bronze
DA 2020-07-08
ER

PT J
AU Bayer, A
   Lennemann, NJ
   Ouyang, YS
   Sadovsky, E
   Sheridan, MA
   Roberts, RM
   Coyne, CB
   Sadovsky, Y
AF Bayer, Avraham
   Lennemann, Nicholas J.
   Ouyang, Yingshi
   Sadovsky, Elena
   Sheridan, Megan A.
   Roberts, R. Michael
   Coyne, Carolyn B.
   Sadovsky, Yoel
TI Chromosome 19 microRNAs exert antiviral activity independent from type
   III interferon signaling
SO PLACENTA
LA English
DT Article
DE Placenta; Trophoblast C19MC; IFN lambda-1; ZIKV
ID HUMAN PLACENTAL TROPHOBLASTS; ZIKA VIRUS; VIRAL-INFECTIONS; C19MC
   MICRORNAS; PATHOLOGY; CELLS; EXPRESSION; PROLIFERATION; TISSUE
AB Introduction: Cultured primary human trophoblasts (PHT), derived from term placentas, are relatively resistant to infection by diverse viruses. The resistance can be conferred to non-trophoblastic cells by pre-exposing them to medium that was conditioned by PHT cells. This antiviral effect is mediated, at least in part, by microRNAs (miRNA) expressed from the chromosome 19 microRNA cluster (C19MC). Recently we showed that PHT cells and cells pre-exposed to PHT medium are also resistant to infection by Zika virus (ZIKV), an effect mediated by the constitutive release of the type III interferons (IFN) IFN lambda-1 and IFN lambda-2 in trophoblastic medium. We hypothesized that trophoblastic C19MC miRNA are active against ZIKV, and assessed the interaction of this pathway with IFN lambda-1 mediated resistance.
   Methods: Term PHT cells were cultured using standard techniques. An osteosarcoma cell line (U2OS) was used as non-trophoblastic cells, which were infected with either ZIKV or vesicular stomatitis virus (VSV). Trophoblastic extracellular vesicles (EVs) were produced by gradient ultracentrifugation. RT-qPCR was used to determine viral infection, cellular or medium miRNA levels and the expression of interferon-stimulated genes.
   Results: We showed that C19MC miRNA attenuate infection of U2OS cells by ZIKV, and that C19MC miRNA or exosomes that contain C19MC miRNA did not influence the type III IFN pathway. Similarly, cell exposure to recombinant IFN lambda-1 had no effect on miRNA expression, and these pathways did not exhibit synergistic interaction.
   Discussion: PHT cells exert antiviral activity by at least two independent mechanisms, mediated by C19MC miRNA and by type III IFNs. (c) 2017 Elsevier Ltd. All rights reserved.
C1 [Bayer, Avraham; Ouyang, Yingshi; Sadovsky, Elena; Coyne, Carolyn B.; Sadovsky, Yoel] Univ Pittsburgh, Magee Womens Res Inst, Pittsburgh, PA 15213 USA.
   [Bayer, Avraham; Ouyang, Yingshi; Coyne, Carolyn B.; Sadovsky, Yoel] Univ Pittsburgh, Dept Obstet & Gynaecol, Reprod Sci, Pittsburgh, PA 15213 USA.
   [Lennemann, Nicholas J.; Coyne, Carolyn B.] Univ Pittsburgh, Dept Pediat, Pittsburgh, PA 15219 USA.
   [Sheridan, Megan A.; Roberts, R. Michael] Univ Missouri, Div Anim Sci, Columbia, MO 65211 USA.
   [Sheridan, Megan A.; Roberts, R. Michael] Univ Missouri, Bond Life Sci Ctr, Columbia, MO 65211 USA.
   [Sheridan, Megan A.; Roberts, R. Michael] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA.
   [Coyne, Carolyn B.; Sadovsky, Yoel] Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA 15219 USA.
RP Sadovsky, Y (corresponding author), Magee Womens Res Inst, 204 Craft Ave, Pittsburgh, PA 15213 USA.
EM ysadovsky@mwri.magee.edu
OI Sadovsky, Yoel/0000-0003-2969-6737; Roberts, R.
   Michael/0000-0002-0008-6559; Sheridan, Megan/0000-0002-6878-7976
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01HD075665, F32AI122456,
   R21HD071707]; Richard King Mellon Foundation [8069]; Twenty-Five Club of
   Magee-Womens Hospital; Margaret Ritchie R. Battle Family Charitable
   Fund; Burroughs Wellcome Investigators in the Pathogenesis of Infectious
   Disease Awards [1011050]
FX We thank Judy Ziegler and Tiffany Coon for technical assistance, Lori
   Rideout for assistance in manuscript preparation, and Bruce Campbell for
   editing. This project was supported by NIH R01HD075665 (C.B.C. and
   Y.S.), F32AI122456 (N.J.L.), R21HD071707 (to Y.S), the Richard King
   Mellon Foundation #8069 (Y.S.), the Twenty-Five Club of Magee-Womens
   Hospital and The Margaret Ritchie R. Battle Family Charitable Fund. In
   addition, C.B.C. is supported by Burroughs Wellcome Investigators in the
   Pathogenesis of Infectious Disease Awards #1011050.
CR Aagaard KM, 2017, SCI REP-UK, V7, DOI 10.1038/srep41389
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Bayer A, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.07.060
   Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Bortolin-Cavaille ML, 2009, NUCLEIC ACIDS RES, V37, P3464, DOI 10.1093/nar/gkp205
   Chang GJ, 2017, FASEB J, V31, P2760, DOI 10.1096/fj.201601146R
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Delorme-Axford E, 2014, ANNU REV VIROL, V1, P133, DOI 10.1146/annurev-virology-031413-085524
   Delorme-Axford E, 2013, P NATL ACAD SCI USA, V110, P12048, DOI 10.1073/pnas.1304718110
   Donker RB, 2012, MOL HUM REPROD, V18, P417, DOI 10.1093/molehr/gas013
   El Costa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35296
   Jurado KA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88461
   KLIMAN HJ, 1986, ENDOCRINOLOGY, V118, P1567, DOI 10.1210/endo-118-4-1567
   Lee CQE, 2016, STEM CELL REP, V6, P257, DOI 10.1016/j.stemcr.2016.01.006
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Mouillet JF, 2010, FASEB J, V24, P2030, DOI 10.1096/fj.09-149724
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Noguer-Dance M, 2010, HUM MOL GENET, V19, P3566, DOI 10.1093/hmg/ddq272
   Ouyang YS, 2016, PLACENTA, V47, P86, DOI 10.1016/j.placenta.2016.09.008
   Payne AF, 2006, J VIROL METHODS, V134, P183, DOI 10.1016/j.jviromet.2006.01.003
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Racicot K, 2017, J CLIN INVEST, V127, P1591, DOI 10.1172/JCI87490
   Ritter JM, 2017, ARCH PATHOL LAB MED, V141, P49, DOI 10.5858/arpa.2016-0397-SA
   Roberts RM, 2016, REPRODUCTION, V152, pR179, DOI 10.1530/REP-16-0325
   Rosenberg AZ, 2017, ARCH PATHOL LAB MED, V141, P43, DOI 10.5858/arpa.2016-0401-OA
   Sadovsky Y., 2015, PERSPECT MED, V5
   Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907
   Schwartz DA, 2017, ARCH GYNECOL OBSTET, V295, P1361, DOI 10.1007/s00404-017-4361-5
   Sheridan MA, 2017, P NATL ACAD SCI USA, V114, pE1587, DOI 10.1073/pnas.1616097114
   Siddharthan V, 2017, VIROLOGY, V507, P89, DOI 10.1016/j.virol.2017.04.013
   Silasi M, 2015, AM J REPROD IMMUNOL, V73, P199, DOI 10.1111/aji.12355
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898
   Vermillion MS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14575
   Weisblum Y, 2011, J VIROL, V85, P13204, DOI 10.1128/JVI.05749-11
   Yabe S, 2016, P NATL ACAD SCI USA, V113, pE2598, DOI 10.1073/pnas.1601630113
NR 41
TC 7
Z9 8
U1 0
U2 4
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
EI 1532-3102
J9 PLACENTA
JI Placenta
PD JAN
PY 2018
VL 61
BP 33
EP 38
DI 10.1016/j.placenta.2017.11.004
PG 6
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA FQ8FO
UT WOS:000418598500005
PM 29277269
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Joob, B
   Wiwanitkit, V
AF Joob, B.
   Wiwanitkit, V.
TI Re: 'Public sentiment and discourse about Zika virus on Instagram'
SO PUBLIC HEALTH
LA English
DT Letter
C1 [Joob, B.] Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
   [Wiwanitkit, V.] Dr DY Patil Univ, Navi Mumbai, India.
RP Joob, B (corresponding author), Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
EM beuyjoob@hotmail.com
CR Garg N, 2015, NEPHROLOGY, V20, P315, DOI 10.1111/nep.12397
   Seltzer EK, 2017, PUBLIC HEALTH, V150, P170, DOI 10.1016/j.puhe.2017.07.015
   Tin SS, 2014, J AM DENT ASSOC, V145, P1108, DOI 10.1016/S0002-8177(14)60232-4
NR 3
TC 0
Z9 0
U1 1
U2 10
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0033-3506
EI 1476-5616
J9 PUBLIC HEALTH
JI Public Health
PD JAN
PY 2018
VL 154
BP 186
EP 186
DI 10.1016/j.puhe.2017.10.026
PG 1
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FQ7SV
UT WOS:000418563900028
PM 29212611
DA 2020-07-08
ER

PT J
AU Seltzer, EK
AF Seltzer, E. K.
TI Re: Letter to the Editor of Public Health in response to 'Public
   sentiment and discourse about Zika virus on Instagram'
SO PUBLIC HEALTH
LA English
DT Letter
C1 [Seltzer, E. K.] Univ Penn, Penn Med Ctr Digital Hlth, Philadelphia, PA 19104 USA.
RP Seltzer, EK (corresponding author), MPH 3400 Civ Ctr Blvd,Floor 14-154, Philadelphia, PA 19104 USA.
EM Emily.seltzer@uphs.upenn.edu
OI Seltzer, Emily/0000-0002-9879-4739
CR Gubrium AC, 2014, AM J PUBLIC HEALTH, V104, P1606, DOI 10.2105/AJPH.2013.301310
   Luckerson V., 2014, TIME MAGAZINE, P8
   Patel N, 2017, MOJ PUBLIC HLTH, V6
   Seltzer EK, 2017, PUBLIC HEALTH, V150, P170, DOI 10.1016/j.puhe.2017.07.015
NR 4
TC 0
Z9 0
U1 1
U2 6
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0033-3506
EI 1476-5616
J9 PUBLIC HEALTH
JI Public Health
PD JAN
PY 2018
VL 154
BP 187
EP 187
DI 10.1016/j.puhe.2017.10.025
PG 1
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FQ7SV
UT WOS:000418563900029
PM 29212612
DA 2020-07-08
ER

PT J
AU Soares, TS
   Gonzalez, BLR
   Torquato, RJS
   Lemos, FJA
   Costa-da-Silva, AL
   Guimaraes, MDC
   Tanaka, AS
AF Soares, Tatiane Sanches
   Rodriguez Gonzalez, Boris Luis
   Soares Torquato, Ricardo Jose
   Alves Lemos, Francisco Jose
   Costa-da-Silva, Andre L.
   Capurro Guimaraes, Margareth de Lara
   Tanaka, Aparecida Sadae
TI Functional characterization of a serine protease inhibitor modulated in
   the infection of the Aedes aegypti with dengue virus
SO BIOCHIMIE
LA English
DT Article
DE Mosquito; Serine protease inhibitor; Aedes aegypti; Pacisfastin;
   Trypsin; Dengue virus (DENV)
ID CRAB PORTUNUS-TRITUBERCULATUS; SCHISTOCERCA-GREGARIA; DIGESTIVE ENZYMES;
   GENE-EXPRESSION; DESERT LOCUST; MOSQUITO; MIDGUT; TRYPSIN; CLONING;
   IDENTIFICATION
AB During feeding with blood meal, female Aedes aegypti can transmit infectious agents, such as dengue, yellow fever, chikungunya and Zika viruses. Dengue virus causes human mortality in tropical regions of the world, and there is no specific treatment or vaccine with maximum efficiency being used for these infections. In the vector-virus interaction, the production of several molecules is modulated by both mosquitoes and invading agents. However, little information is available about these molecules in the Ae. aegypti mosquito during dengue infection. Inhibitors of the pacifastin family have been described to participate in the immune response of insects and Pac2 is the only gene of this family present in Ae. aegypti being then chosen for investigation. Pac2 was expressed in E. coli, purified and analyzed by mass spectrometry and SDS-PAGE. The Pac2 transcript was detected by qPCR, and its protein levels were assessed by Western blotting. The inhibitory activity of Pac2 was measured using its K-i, IC50 and zymography. Mosquito infections with DENV were introduced with the Brazilian ACS-46 DENV-2 strain propagated in C6/36 cells. In the present work, we showed that it is possibly involved in the interaction of the mosquitoes with the dengue virus. The Pac2 transcript was detected in larvae and in both the salivary gland and midgut of Ae. aegypti females, while the native protein was identified in females 3 h post-blood meal. Pac2 is a strong inhibitor of trypsin-like and thrombin-like proteases, which are present in 4th instar larvae midgut and females 24 h after blood meal. During DENV infection, up regulation of Pac2 expression occurs in the salivary gland and midgut. Pac2 is the first Pacifastin inhibitor member described in mosquitoes. Our results suggest that Pac2 acts on mosquito serine proteases, mainly the trypsin-like type, and is under transcriptional control by virus infection signals to allow its survival in the vector or by the mosquito as a defense mechanism against virus infection. (C) 2017 Elsevier B.V. and Societe Francaise de Biochimie et Biologie Moleculaire (SFBBM). All rights reserved.
C1 [Soares, Tatiane Sanches; Rodriguez Gonzalez, Boris Luis; Soares Torquato, Ricardo Jose; Tanaka, Aparecida Sadae] Univ Fed Sao Paulo, Escola Paulista Med, Dept Bioquim, Rua 3 Maio 100, BR-04044020 Sao Paulo, SP, Brazil.
   [Alves Lemos, Francisco Jose] Univ Estadual Norte Fluminense, Lab Biotecnol, Rio De Janeiro, RJ, Brazil.
   [Costa-da-Silva, Andre L.; Capurro Guimaraes, Margareth de Lara] Univ Sao Paulo, Inst Ciencias Biomed, Sao Paulo, SP, Brazil.
RP Tanaka, AS (corresponding author), Univ Fed Sao Paulo, Escola Paulista Med, Dept Bioquim, Rua 3 Maio 100, BR-04044020 Sao Paulo, SP, Brazil.
EM tanaka.bioq@epm.br
RI Tanaka, Aparecida S/L-8754-2017; Costa-Da-Silva, Andre Luis/J-8913-2019;
   Torquato, Ricardo JS/D-7945-2018
OI Tanaka, Aparecida S/0000-0001-9407-805X; Costa-Da-Silva, Andre
   Luis/0000-0002-7615-7376; 
FU Fundacaode Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2012/03657-8,
   2012/15191-3]; Conselho Nacional de Desenvolvimento Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [308780/2013-2, 313073/2013-9]; CAPES/Brazil (Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior)CAPES; INCTeEntomologia
   Molecular [465678/2014-9]
FX This work was supported by Fundacaode Amparo a Pesquisa do Estado de Sao
   Paulo (FAPESP) (2012/03657-8, 2012/15191-3), Conselho Nacional de
   Desenvolvimento Tecnologico (CNPq - 308780/2013-2, 313073/2013-9),
   CAPES/Brazil (Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior) and INCTeEntomologia Molecular (465678/2014-9). AT is a
   research fellow of the CNPq. We thank Dr. Maria A. Juliano from the
   Department of Biophysics, UNIFESP, for performing the Mass Spectrometry
   analysis.
CR [Anonymous], 2016, WEEKLY EPIDEMIOLOGIC, P349
   Bader O, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-116
   Bartholomay LC, 2007, INSECT MOL BIOL, V16, P761, DOI 10.1111/j.1365-2583.2007.00773.x
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   BIETH JG, 1980, CLIN RES PROC, V16, P183
   Brackney DE, 2008, AM J TROP MED HYG, V79, P267, DOI 10.4269/ajtmh.2008.79.267
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   Breugelmans B, 2009, INSECT BIOCHEM MOLEC, V39, P430, DOI 10.1016/j.ibmb.2009.03.005
   Colpitts TM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002189
   Conway MJ, 2014, J VIROL, V88, P164, DOI 10.1128/JVI.02235-13
   Das Suchismita, 2007, J Vis Exp, P220, DOI 10.3791/220
   de Marco R, 2010, PEPTIDES, V31, P1280, DOI 10.1016/j.peptides.2010.03.033
   Gubb D, 2010, BIOCHIMIE, V92, P1749, DOI 10.1016/j.biochi.2010.09.004
   Gulley MM, 2013, J INSECT PHYSIOL, V59, P138, DOI 10.1016/j.jinsphys.2012.08.015
   Hamdaoui A, 1998, FEBS LETT, V422, P74, DOI 10.1016/S0014-5793(97)01585-8
   HOUK EJ, 1985, VIRUS RES, V2, P123, DOI 10.1016/0168-1702(85)90243-6
   LAEMMLI UK, 1973, J MOL BIOL, V80, P575, DOI 10.1016/0022-2836(73)90198-8
   Laskowski M, 2000, BBA-PROTEIN STRUCT M, V1477, P324, DOI 10.1016/S0167-4838(99)00284-8
   Liu Y, 2015, FISH SHELLFISH IMMUN, V43, P36, DOI 10.1016/j.fsi.2014.12.017
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Londono-Renteria B, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005202
   Molina-Cruz A, 2005, AM J TROP MED HYG, V72, P631, DOI 10.4269/ajtmh.2005.72.631
   MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3
   Noonin C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015728
   Noriega FG, 1996, INSECT BIOCHEM MOLEC, V26, P119, DOI 10.1016/0965-1748(95)00068-2
   Romano CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011811
   Salazar MI, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-9
   Sangsuriya P, 2016, DEV COMP IMMUNOL, V54, P32, DOI 10.1016/j.dci.2015.08.003
   Saraiva RG, 2016, DEV COMP IMMUNOL, V64, P53, DOI 10.1016/j.dci.2016.01.015
   Sim S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002631
   Simonet G, 2005, BIOCHEM J, V388, P281, DOI 10.1042/BJ20041414
   Soares TS, 2016, VET PARASITOL, V219, P44, DOI 10.1016/j.vetpar.2016.01.021
   Soares TS, 2015, BIOCHIMIE, V112, P41, DOI 10.1016/j.biochi.2015.02.014
   Soares TS, 2011, GENE, V489, P70, DOI 10.1016/j.gene.2011.08.018
   Soares TS, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1127-4
   Soares TS, 2013, INSECT BIOCHEM MOLEC, V43, P9, DOI 10.1016/j.ibmb.2012.10.007
   Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107
   Wang SY, 2012, FISH SHELLFISH IMMUN, V32, P331, DOI 10.1016/j.fsi.2011.11.025
   WHITFIELD SG, 1973, VIROLOGY, V56, P70, DOI 10.1016/0042-6822(73)90288-2
   World Health Organization (WHO), 2016, DENG SEV DENG
   Xi ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000098
NR 41
TC 6
Z9 6
U1 1
U2 27
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI PARIS
PA 23 RUE LINOIS, 75724 PARIS, FRANCE
SN 0300-9084
EI 1638-6183
J9 BIOCHIMIE
JI Biochimie
PD JAN
PY 2018
VL 144
BP 160
EP 168
DI 10.1016/j.biochi.2017.11.005
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA FQ6TH
UT WOS:000418496400018
PM 29133118
DA 2020-07-08
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Preliminary Safety and Immunogenicity of Anti-Zika Virus Vaccine
SO CLINICAL PHARMACOLOGY & THERAPEUTICS
LA English
DT Editorial Material
CR TEBAS, 2017, NEW ENGL J MED, DOI DOI 10.1056/NEJMOA1708120
NR 1
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0009-9236
EI 1532-6535
J9 CLIN PHARMACOL THER
JI Clin. Pharmacol. Ther.
PD JAN
PY 2018
VL 103
IS 1
BP 13
EP 13
PG 1
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA FQ4UX
UT WOS:000418354800003
DA 2020-07-08
ER

PT J
AU Resiere, D
   Ferge, JL
   Fabre, J
   Raad, M
   Aitsatou, S
   Inamo, J
   Cabie, A
   Megarbane, B
   Mehdaoui, H
AF Resiere, Dabor
   Ferge, Jean Louis
   Fabre, Julien
   Raad, Mathieu
   Aitsatou, Signate
   Inamo, Jocelyn
   Cabie, Andre
   Megarbane, Bruno
   Mehdaoui, Hossein
TI Cardiovascular complications in patients with Zika virus-induced
   Guillain-Barre syndrome
SO JOURNAL OF CLINICAL VIROLOGY
LA English
DT Letter
C1 [Resiere, Dabor; Ferge, Jean Louis; Raad, Mathieu; Mehdaoui, Hossein] Univ Hosp Martinique, Intens Care Unit, Fort De France, Martinique, France.
   [Fabre, Julien; Inamo, Jocelyn] Univ Hosp Martinique, Dept Cardiovasc Med, Fort De France, Martinique, France.
   [Aitsatou, Signate] Univ Hosp Martinique, Dept Neurol, Fort De France, Martinique, France.
   [Cabie, Andre] Univ Hosp Martinique, Dept Infect & Trop Dis, Fort De France, Martinique, France.
   [Megarbane, Bruno] Paris Diderot Univ, Lariboisiere Hosp, Dept Med Crict Care Med, Paris, France.
RP Resiere, D (corresponding author), Univ Hosp Martinique, Intens Care Unit, Fort De France, Martinique, France.
EM Dabor.RESIERE@chu-martinique.fr
RI Mehdaoui, Hossein/A-2466-2019
OI Mehdaoui, Hossein/0000-0001-8647-5215; Cabie, Andre/0000-0003-0117-3061
CR Burakgazi Ahmet Z, 2016, J Clin Neuromuscul Dis, V17, P120, DOI 10.1097/CND.0000000000000106
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Krittanawong C, 2016, INT J CARDIOL, V221, P859, DOI 10.1016/j.ijcard.2016.06.293
   Roze B, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.9.30154
   2016, CIRE ANTILLES GUYANE, V4, P1
NR 5
TC 5
Z9 5
U1 0
U2 2
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1386-6532
EI 1873-5967
J9 J CLIN VIROL
JI J. Clin. Virol.
PD JAN
PY 2018
VL 98
BP 8
EP 9
DI 10.1016/j.jcv.2017.11.002
PG 2
WC Virology
SC Virology
GA FQ6ZY
UT WOS:000418513800003
PM 29175232
DA 2020-07-08
ER

PT J
AU Wang, BH
   Liang, YB
   Lu, YNA
   Zhang, L
   Li, YP
   Song, YZ
   Qin, CF
   Luo, ZX
   Xia, ZQ
   Qin, WH
   Xia, XS
AF Wang, Binghui
   Liang, Yuebo
   Lu, Yunnan
   Zhang, Li
   Li, Yaping
   Song, Yuzhu
   Qin, Chengfeng
   Luo, Zhongxin
   Xia, Zhiqing
   Qin, Weihong
   Xia, Xueshan
TI The importation of the phylogenetic-transition state of Zika virus to
   China in 2014
SO JOURNAL OF INFECTION
LA English
DT Letter
C1 [Wang, Binghui; Zhang, Li; Song, Yuzhu; Xia, Xueshan] Kunming Univ Sci & Technol, Fac Life Sci & Technol, Kunming, Yunnan, Peoples R China.
   [Liang, Yuebo; Lu, Yunnan; Li, Yaping; Qin, Weihong] Care Ctr Int Travel Hlth Yunnan, Kunming, Yunnan, Peoples R China.
   [Qin, Chengfeng] Beijing Inst Microbiol & Epidemiol, Dept Virol, Beijing, Peoples R China.
   [Luo, Zhongxin] Puer Quarantine & Inspect Serv, Puer, Yunnan, Peoples R China.
   [Xia, Zhiqing] Brighton Coll, 1 Eastern Rd, Brighton, E Sussex, England.
RP Xia, XS (corresponding author), Kunming Univ Sci & Technol, Fac Life Sci & Technol, Kunming, Yunnan, Peoples R China.; Qin, WH (corresponding author), Care Ctr Int Travel Hlth Yunnan, Kunming, Yunnan, Peoples R China.
EM qinwh19@sina.com; oliverxia2000@aliyun.com
RI Qin, Cheng-Feng/I-6839-2019
OI Qin, Cheng-Feng/0000-0002-0632-2807
FU National Natural Science Foundation of China (NFSC)National Natural
   Science Foundation of China [81460509]; Yunnan provincial innovation
   team project [2015HC030]; Science and technology project [2016RA014]
FX This work was supported by the National Natural Science Foundation of
   China (NFSC) (81460509), Yunnan provincial innovation team project
   (2015HC030) and Science and technology project (2016RA014).
CR Deng YQ, 2016, SCI CHINA LIFE SCI, V59, P428, DOI 10.1007/s11427-016-5043-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Hennessey M., 2015, CTR DIS CONTROL PREV, V65, P55, DOI DOI 10.15585/MMWR.MM6503E1
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Li JD, 2016, EMERG INFECT DIS, V22, P1133, DOI 10.3201/eid2206.160273
   Pettersson JHO, 2016, MBIO, V7, DOI [10.1128/mBio.01239-16, 10.1128/mbio.01239-16]
   Sun J, 2017, J INFECT
   Zhang YJ, 2016, PROTEIN CELL, V7, P461, DOI 10.1007/s13238-016-0274-5
NR 9
TC 6
Z9 6
U1 0
U2 4
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0163-4453
EI 1532-2742
J9 J INFECTION
JI J. Infect.
PD JAN
PY 2018
VL 76
IS 1
BP 106
EP 109
DI 10.1016/j.jinf.2017.09.002
PG 5
WC Infectious Diseases
SC Infectious Diseases
GA FQ6SO
UT WOS:000418494500015
PM 28889967
OA Bronze
DA 2020-07-08
ER

PT S
AU Lima, TFM
   Beltrame, JPF
   Niquini, CR
   Barbosa, BG
   Davis, CA
AF Melo Lima, Tiago Franca
   Ferreira Beltrame, Joao Paulo
   Niquini, Carlos Ramos
   Barbosa, Breno Goncalves
   Davis, Clodoveu Augusto, Jr.
BE Clua, E
   Roque, L
   Lugmayr, A
   Tuomi, P
TI Design of a Mixed-Reality Serious Game to Tackle a Public Health Problem
SO ENTERTAINMENT COMPUTING - ICEC 2018
SE Lecture Notes in Computer Science
LA English
DT Proceedings Paper
CT 17th IFIP TC 14 International Conference on n Entertainment Computation
   (IFIP-ICEC) held at the 24th IFIP World Computer Congress (WCC)
CY SEP 17-20, 2018
CL Poznan, POLAND
SP Int Federat Informat Proc, Int Federat Informat Proc Tech Comm 14
DE Serious games; Dengue; Aedes aegypti; Awareness; Education; Public
   health; Gamification
AB Despite the emergence of several game-based initiatives in health, aiming to train students and professionals and to support patients rehabilitation, some public health problems remains neglected. Mosquito-borne diseases are a global public health concern. Education and awareness of population are an important intervention strategy and should be part of public health policies, given that individuals behavior may affect the transmission dynamics of diseases. For instance, improper storage of water can become a breeding site for the Aedes aegypti mosquito, the vector of dengue, zika, chikungunya and urban yellow fever viruses. Most of Aedes foci are in or near people's homes and the control of mosquitoes population is essential to prevent these diseases. We believe that games are a powerful tool and can be used to support awareness and behavioral changes regarding public health issues. This paper presents the current development stage of a serious game designed to support actions based on education and engagement of population aimed at vector surveillance and control. A mix of a 2D game with augmented and virtual reality modules and the real world itself will provide the proper environment to offer fun with the purpose of helping to deal with this complex problem. The development is based on agile principles, with short cycles involving activities of conception, design, construction and evaluation. Some partial results are game design, prototypes and demos. Future work includes designing and conducting an experimental study to evaluate effectiveness and efficiency regarding knowledge acquiring and behavioral changes.
C1 [Melo Lima, Tiago Franca; Ferreira Beltrame, Joao Paulo; Niquini, Carlos Ramos; Barbosa, Breno Goncalves] Fed Univ Ouro Preto UFOP, Joao Monlevade, MG, Brazil.
   [Melo Lima, Tiago Franca; Davis, Clodoveu Augusto, Jr.] Univ Fed Minas Gerais, Comp Sci Dept, Belo Horizonte, MG, Brazil.
RP Lima, TFM (corresponding author), Fed Univ Ouro Preto UFOP, Joao Monlevade, MG, Brazil.; Lima, TFM (corresponding author), Univ Fed Minas Gerais, Comp Sci Dept, Belo Horizonte, MG, Brazil.
EM tiagolima@decsi.ufop.br; clodoveu@dcc.ufmg.br
RI Davis, Clodoveu/N-5659-2016
OI Davis, Clodoveu/0000-0002-7327-848X
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); FAPEMIGMinas Gerais State Research Foundation (FAPEMIG); IFIP
   Digital Equity Committee; UFOP
FX The authors acknowledge the support from CNPq, FAPEMIG, IFIP Digital
   Equity Committee and UFOP.
CR Claro L., 2006, DENGUE B, V30
   Connolly TM, 2012, COMPUT EDUC, V59, P661, DOI 10.1016/j.compedu.2012.03.004
   Deterding S, 2011, P 15 INT AC MINDTREK, V15, P9, DOI DOI 10.1145/2181037.2181040
   Dominguez A, 2013, COMPUT EDUC, V63, P380, DOI 10.1016/j.compedu.2012.12.020
   Dondlinger M. J., 2007, J APPL ED TECHNOL, V4, P21, DOI DOI 10.1108/10748120410540463
   Lima T., 2017, 2017 IEEE 5 INT C SE, P1, DOI DOI 10.1109/SEGAH.2017.7939294
   Luna J, 2004, DENGUE B
   Madeira Newton G., 2002, Rev. Soc. Bras. Med. Trop., V35, P221, DOI 10.1590/S0037-86822002000300004
   Michael D. R., 2005, SERIOUS GAMES GAMES
   Padmanabha H, 2010, ECOHEALTH, V7, P78, DOI 10.1007/s10393-010-0301-6
   Pai HH, 2006, J ENVIRON HEALTH, V68, P35
   Prensky M., 2006, DONT BOTHER ME MOM I
NR 12
TC 0
Z9 0
U1 1
U2 1
PU SPRINGER INTERNATIONAL PUBLISHING AG
PI CHAM
PA GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND
SN 0302-9743
EI 1611-3349
BN 978-3-319-99426-0; 978-3-319-99425-3
J9 LECT NOTES COMPUT SC
PY 2018
VL 11112
BP 305
EP 309
DI 10.1007/978-3-319-99426-0_35
PG 5
WC Computer Science, Cybernetics; Computer Science, Interdisciplinary
   Applications; Computer Science, Software Engineering; Computer Science,
   Theory & Methods
SC Computer Science
GA BO3EW
UT WOS:000510152700035
DA 2020-07-08
ER

PT J
AU Olawoyin, O
   Kribs, C
AF Olawoyin, Omomayowa
   Kribs, Christopher
TI Effects of multiple transmission pathways on Zika dynamics
SO INFECTIOUS DISEASE MODELLING
LA English
DT Article
DE Zika virus; Secondary transmission pathways; Epidemic growth rate;
   Control strategies; Basic reproductive number estimate
AB Although the Zika virus is transmitted to humans primarily through the bite of infected female Aedes aegypti mosquitoes, it can also be sexually and vertically transmitted within both populations. In this study, we develop a new mathematical model of the Zika virus which incorporates sexual transmission in humans and mosquitos, vertical transmission in mosquitos, and mosquito to human transmission through bites. Analysis of this deterministic model shows that the secondary transmission routes of Zika increase the basic reproductive number (R-0) of the virus by 5%, shift the peak time of an outbreak to occur 10% sooner, increase the initial growth of an epidemic, and have important consequences for control strategies and estimates of R-0. Furthermore, sensitivity analysis show that the basic reproductive number is most sensitive to the mosquito biting rate and transmission probability parameters and reveal that the dynamics of juvenile mosquito stages greatly impact the peak time of an outbreak. These discoveries deepen our understanding of the complex transmission routes of ZIKV and the consequences that they may hold for public health officials. (C) 2018 The Authors. Production and hosting by Elsevier B.V. on behalf of KeAi Communications Co., Ltd.
C1 [Olawoyin, Omomayowa; Kribs, Christopher] Univ Texas Arlington, Dept Math, 411 South Nedderman Dr,Box 19408, Arlington, TX 76019 USA.
RP Olawoyin, O (corresponding author), Univ Texas Arlington, Dept Math, 411 South Nedderman Dr,Box 19408, Arlington, TX 76019 USA.
EM omomayowa.olawoyin@mavs.uta.edu
FU National Science Foundation Graduate Research Fellowship ProgramNational
   Science Foundation (NSF) [1261006320]
FX The authors would like to thank Dr. Alun Lloyd for reviewing this work
   and providing valuable feedback. This material is based upon work
   supported by the National Science Foundation Graduate Research
   Fellowship Program under Grant No. 1261006320. Any opinions, findings,
   and conclusions or recommendations expressed in this material are those
   of the authors and do not necessarily reflect the views of the National
   Science Foundation.
CR Arriola L., 2009, MATH STAT ESTIMATION, P195
   Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Baca-Carrasco D, 2016, B MATH BIOL, V78, P2228, DOI 10.1007/s11538-016-0219-4
   Bewick S., 2016, BIORXIV
   Byttebier B, 2014, J MED ENTOMOL, V51, P97, DOI 10.1603/ME13066
   Ciota AT, 2017, EMERG INFECT DIS, V23, P880, DOI 10.3201/eid2305.162041
   Dawes BE, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.7
   DIEKMANN O, 1990, J MATH BIOL, V28, P365
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duong V, 2015, P NATL ACAD SCI USA, V112, P14688, DOI 10.1073/pnas.1508114112
   Esteva L, 2005, MATH BIOSCI, V198, P132, DOI 10.1016/j.mbs.2005.06.004
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   FOCKS DA, 1981, AM J TROP MED HYG, V30, P1329, DOI 10.4269/ajtmh.1981.30.1329
   Freour T., 2016, EURO SURVEILLANCE, V21
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Hamel R, 2016, MICROBES INFECT, V18, DOI 10.1016/j.micinf.2016.03.009
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Lloyd AL, 2001, P ROY SOC B-BIOL SCI, V268, P847, DOI 10.1098/rspb.2000.1572
   Lloyd AL, 2009, MATH STAT ESTIMATION, P123, DOI DOI 10.1007/978-90-481-2313-1_6
   Manore C, SIAM NEWS
   Manore CA, 2014, J THEOR BIOL, V356, P174, DOI 10.1016/j.jtbi.2014.04.033
   Maxian O, 2017, EPIDEMICS-NETH, V21, P48, DOI 10.1016/j.epidem.2017.06.003
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nowak MA, 1997, J VIROL, V71, P7518, DOI 10.1128/JVI.71.10.7518-7525.1997
   P. A. H. O. & W. H. Organization, 2015, ZIK SUSP CONF CAS RE
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Ritchie SA, 2013, J MED ENTOMOL, V50, P624, DOI 10.1603/ME12201
   ROSEN L, 1987, AM J TROP MED HYG, V37, P398
   Shutt DP, 2017, EPIDEMICS-NETH, V21, P63, DOI 10.1016/j.epidem.2017.06.005
   Thangamani S, 2016, AM J TROP MED HYG, V95, P1169, DOI 10.4269/ajtmh.16-0448
   THOMPSON WH, 1978, AM J TROP MED HYG, V27, P187, DOI 10.4269/ajtmh.1978.27.187
   Towers S, 2016, EPIDEMICS-NETH, V17, P50, DOI 10.1016/j.epidem.2016.10.003
   Wearing HJ, 2005, PLOS MED, V2, P621, DOI 10.1371/journal.pmed.0020174
   Williams CR, 2013, MED VET ENTOMOL, V27, P313, DOI 10.1111/j.1365-2915.2012.01051.x
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Yang HM, 2009, EPIDEMIOL INFECT, V137, P1188, DOI 10.1017/S0950268809002040
NR 36
TC 3
Z9 3
U1 0
U2 0
PU KEAI PUBLISHING LTD
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING, DONGHENG DISTRICT 100717,
   PEOPLES R CHINA
EI 2468-0427
J9 INFECT DIS MODEL
JI Infect. Dis. Model.
PY 2018
VL 3
BP 331
EP 344
DI 10.1016/j.idm.2018.11.003
PG 14
WC Mathematical & Computational Biology; Infectious Diseases
SC Mathematical & Computational Biology; Infectious Diseases
GA VJ0TG
UT WOS:000528697600024
PM 30839920
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Pan, XL
   Pike, A
   Joshi, D
   Bian, GW
   McFadden, MJ
   Lu, P
   Liang, X
   Zhang, FR
   Raikhel, AS
   Xi, ZY
AF Pan, Xiaoling
   Pike, Andrew
   Joshi, Deepak
   Bian, Guowu
   McFadden, Michael J.
   Lu, Peng
   Liang, Xiao
   Zhang, Fengrui
   Raikhel, Alexander S.
   Xi, Zhiyong
TI The bacterium Wolbachia exploits host innate immunity to establish a
   symbiotic relationship with the dengue vector mosquito Aedes aegypti
SO ISME JOURNAL
LA English
DT Article
ID LIFE-SHORTENING WOLBACHIA; JAK-STAT PATHWAY; ANOPHELES-GAMBIAE;
   OXIDATIVE STRESS; DROSOPHILA; INFECTION; PLASMODIUM; ACTIVATION;
   POPULATIONS; DYNAMICS
AB A host's immune system plays a central role in shaping the composition of the microbiota and, in return, resident microbes influence immune responses. Symbiotic associations of the maternally transmitted bacterium Wolbachia occur with a wide range of arthropods. It is, however, absent from the dengue and Zika vector mosquito Aedes aegypti in nature. When Wolbachia is artificially forced to form symbiosis with this new mosquito host, it boosts the basal immune response and enhances the mosquito's resistance to pathogens, including dengue, Zika virus and malaria parasites. The mechanisms involved in establishing a symbiotic relationship between Wolbachia and A. aegypti, and the long-term outcomes of this interaction, are not well understood. Here, we have demonstrated that both the immune deficiency (IMD) and Toll pathways are activated by the Wolbachia strain wAlbB upon its introduction into A. aegypti. Silencing the Toll and IMD pathways via RNA interference reduces the wAlbB load. Notably, wAlbB induces peptidoglycan recognition protein (PGRP)-LE expression in the carcass of A. aegypti, and its silencing results in a reduction of symbiont load. Using transgenic mosquitoes with stage-specific induction of the IMD and Toll pathways, we have shown that elevated wAlbB infection in these mosquitoes is maintained via maternal transmission. These results indicate that host innate immunity is utilized to establish and promote host-microbial symbiosis. Our results will facilitate a long-term projection of the stability of the Wolbachia-A. aegypti mosquito system that is being developed to control dengue and Zika virus transmission to humans.
C1 [Pan, Xiaoling; Pike, Andrew; Joshi, Deepak; Bian, Guowu; McFadden, Michael J.; Lu, Peng; Liang, Xiao; Zhang, Fengrui; Xi, Zhiyong] Michigan State Univ, Dept Microbiol & Mol Genet, 293 Farm Lane,Room 314,Giltner Hall, E Lansing, MI 48824 USA.
   [Pan, Xiaoling] Hunan Normal Univ, Sch Med, Changsha 410013, Hunan, Peoples R China.
   [Raikhel, Alexander S.] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA.
   [Raikhel, Alexander S.] Univ Calif Riverside, Inst Integrat Mol Biol, Riverside, CA 92521 USA.
   [Xi, Zhiyong] Sun Yat Sen Univ Michigan State Univ Joint Ctr Ve, Guangzhou 510080, Guangdong, Peoples R China.
RP Xi, ZY (corresponding author), Michigan State Univ, Dept Microbiol & Mol Genet, 293 Farm Lane,Room 314,Giltner Hall, E Lansing, MI 48824 USA.
EM xizy@msu.edu
OI McFadden, Michael/0000-0003-0303-6968
FU National Institutes of Health/National Institute of Allergy and
   Infectious DiseaseUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R01AI080597]; United States
   Agency for International Development (USAID) Combating Zika and Future
   Threats programUnited States Agency for International Development
   (USAID); Guangdong Innovative Research Team Program [2011S009]
FX this work was supported by the National Institutes of Health/National
   Institute of Allergy and Infectious Disease R01AI080597, the United
   States Agency for International Development (USAID) Combating Zika and
   Future Threats program, and Guangdong Innovative Research Team Program
   (No. 2011S009). The funders had no role in study design, data collection
   and interpretation, or the decision to submit the work for publication.
CR Antonova Y, 2009, INSECT BIOCHEM MOLEC, V39, P303, DOI 10.1016/j.ibmb.2009.01.007
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bian G, 2005, P NATL ACAD SCI USA, V102, P13568, DOI 10.1073/pnas.0502815102
   Bian GW, 2013, SCIENCE, V340, P748, DOI 10.1126/science.1236192
   Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833
   Bourtzis K, 2000, INSECT MOL BIOL, V9, P635, DOI 10.1046/j.1365-2583.2000.00224.x
   Bourtzis K, 2014, ACTA TROP, V132, pS150, DOI 10.1016/j.actatropica.2013.11.004
   Brelsfoard CL, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000129
   Brennan LJ, 2012, INSECT MOL BIOL, V21, P510, DOI 10.1111/j.1365-2583.2012.01155.x
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Chu HT, 2013, NAT IMMUNOL, V14, P668, DOI 10.1038/ni.2635
   Dimopoulos G, 2003, CELL MICROBIOL, V5, P3, DOI 10.1046/j.1462-5822.2003.00252.x
   Dobson SL, 2003, TRENDS PARASITOL, V19, P128, DOI 10.1016/S1471-4922(03)00002-3
   Dong YM, 2006, PLOS PATHOG, V2, P513, DOI 10.1371/journal.ppat.0020052
   Frolet C, 2006, IMMUNITY, V25, P677, DOI 10.1016/j.immuni.2006.08.019
   Herren JK, 2011, CELL MICROBIOL, V13, P1385, DOI 10.1111/j.1462-5822.2011.01627.x
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490
   Jaenike J, 2010, SCIENCE, V329, P212, DOI 10.1126/science.1188235
   Kambris Z, 2009, SCIENCE, V326, P134, DOI 10.1126/science.1177531
   Kaneko T, 2006, NAT IMMUNOL, V7, P715, DOI 10.1038/ni1356
   Kittayapong P, 2000, J MED ENTOMOL, V37, P340, DOI 10.1603/0022-2585(2000)037[0340:DADOWI]2.0.CO;2
   Kremer N, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-S1-S7
   Kumar S, 2010, SCIENCE, V327, P1644, DOI 10.1126/science.1184008
   Lu P, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001754
   McMeniman CJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000748
   McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326
   Meister S, 2005, P NATL ACAD SCI USA, V102, P11420, DOI 10.1073/pnas.0504950102
   Molloy JC, 2015, VIRUSES-BASEL, V7, P4624, DOI 10.3390/v7082836
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Nyholm SV, 2012, NAT REV MICROBIOL, V10, P815, DOI 10.1038/nrmicro2894
   Oliver KM, 2008, P R SOC B, V275, P293, DOI 10.1098/rspb.2007.1192
   Pan XL, 2012, P NATL ACAD SCI USA, V109, pE23, DOI 10.1073/pnas.1116932108
   Paradkar PN, 2012, P NATL ACAD SCI USA, V109, P18915, DOI 10.1073/pnas.1205231109
   Rances E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002548
   Ricci I, 2002, J MED ENTOMOL, V39, P562, DOI 10.1603/0022-2585-39.4.562
   Rio RVM, 2006, P ROY SOC B-BIOL SCI, V273, P805, DOI 10.1098/rspb.2005.3399
   Shin SW, 2005, J BIOL CHEM, V280, P16499, DOI 10.1074/jbc.M500711200
   Souza-Neto JA, 2009, P NATL ACAD SCI USA, V106, P17841, DOI 10.1073/pnas.0905006106
   Terradas G, 2017, SCI REP-UK, V7, DOI 10.1038/srep43847
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Wang MC, 2003, DEV CELL, V5, P811, DOI 10.1016/S1534-5807(03)00323-X
   Waterhouse RM, 2007, SCIENCE, V316, P1738, DOI 10.1126/science.1139862
   Weiss BL, 2008, P NATL ACAD SCI USA, V105, P15088, DOI 10.1073/pnas.0805666105
   Werren JH, 2008, NAT REV MICROBIOL, V6, P741, DOI 10.1038/nrmicro1969
   Wong ZS, 2015, APPL ENVIRON MICROB, V81, P3001, DOI 10.1128/AEM.03847-14
   Xi ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000098
   Xi ZY, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-1
   Xi ZY, 2005, SCIENCE, V310, P326, DOI 10.1126/science.1117607
   Yano T, 2008, NAT IMMUNOL, V9, P908, DOI 10.1038/ni.1634
   Ye YXH, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002362
   Zhao HW, 2011, J BIOL CHEM, V286, P6211, DOI 10.1074/jbc.M110.181206
   Zou Z, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002394
NR 53
TC 29
Z9 29
U1 3
U2 45
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1751-7362
EI 1751-7370
J9 ISME J
JI ISME J.
PD JAN
PY 2018
VL 12
IS 1
BP 277
EP 288
DI 10.1038/ismej.2017.174
PG 12
WC Ecology; Microbiology
SC Environmental Sciences & Ecology; Microbiology
GA FQ3YB
UT WOS:000418293300022
PM 29099491
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Farhadloo, M
   Winneg, K
   Chan, MPS
   Jamieson, KH
   Albarracin, D
AF Farhadloo, Mohsen
   Winneg, Kenneth
   Chan, Man-Pui Sally
   Jamieson, Kathleen Hall
   Albarracin, Dolores
TI Associations of Topics of Discussion on Twitter With Survey Measures of
   Attitudes, Knowledge, and Behaviors Related to Zika: Probabilistic Study
   in the United States
SO JMIR PUBLIC HEALTH AND SURVEILLANCE
LA English
DT Article
DE Zika; Twitter; topic modeling; public policy; public health
AB Background: Recent outbreaks of Zika virus around the world led to increased discussions about this issue on social media platforms such as Twitter. These discussions may provide useful information about attitudes, knowledge, and behaviors of the population regarding issues that are important for public policy.
   Objective: We sought to identify the associations of the topics of discussions on Twitter and survey measures of Zika-related attitudes, knowledge, and behaviors, not solely based upon the volume of such discussions but by analyzing the content of conversations using probabilistic techniques.
   Methods: Using probabilistic topic modeling with US county and week as the unit of analysis, we analyzed the content of Twitter online communications to identify topics related to the reported attitudes, knowledge, and behaviors captured in a national representative survey (N=33,193) of the US adult population over 33 weeks.
   Results: Our analyses revealed topics related to "congress funding for Zika," "microcephaly," "Zika-related travel discussions," "insect repellent," "blood transfusion technology," and "Zika in Miami" were associated with our survey measures of attitudes, knowledge, and behaviors observed over the period of the study.
   Conclusions: Our results demonstrated that it is possible to uncover topics of discussions from Twitter communications that are associated with the Zika-related attitudes, knowledge, and behaviors of populations over time. Social media data can be used as a complementary source of information alongside traditional data sources to gauge the patterns of attitudes, knowledge, and behaviors in a population.
C1 [Farhadloo, Mohsen; Chan, Man-Pui Sally; Albarracin, Dolores] Univ Illinois, 603 E Daniel St, Champaign, IL 61820 USA.
   [Farhadloo, Mohsen; Winneg, Kenneth; Jamieson, Kathleen Hall] Univ Penn, Annenberg Publ Policy Ctr, Philadelphia, PA 19104 USA.
RP Farhadloo, M (corresponding author), Univ Illinois, 603 E Daniel St, Champaign, IL 61820 USA.
EM mfarhad@illinois.edu
OI Winneg, Kenneth/0000-0003-1871-3570; Chan, Man-pui
   Sally/0000-0003-2984-0487
FU Science of Science Communication endowment of the Annenberg Public
   Policy Center of the University of Pennsylvania; National Institutes of
   HealthUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA
FX This study was funded by the Science of Science Communication endowment
   of the Annenberg Public Policy Center of the University of Pennsylvania
   and the National Institutes of Health.
CR Ajzen I, 1985, ACTION CONTROL COGNI, DOI DOI 10.1007/978-3-642-69746-3_2
   Ajzen I., 2012, OXFORD HDB PERSONALI
   Albarracin D, 1998, J APPL SOC PSYCHOL, V28, P657, DOI 10.1111/j.1559-1816.1998.tb01725.x
   [Anonymous], 2017, ASSESSING REPRESENTA
   Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993
   Centers for Disease Control and Prevention, 2017, AR RISK ZIK
   Chan MS, 2018, SOCIAL PSYCHOL RES M
   De Choudhury M, 2013, ICWSM, P1
   Fang AJ, 2015, SIGIR 2015: PROCEEDINGS OF THE 38TH INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P791, DOI 10.1145/2766462.2767833
   Farhadloo M, 2016, STUD COMPUT INTELL, V639, P1, DOI 10.1007/978-3-319-30319-2_1
   Fishbein M, 1975, INTRO THEORY RES
   Ireland ME, 2016, AIDS BEHAV, V20, P1256, DOI 10.1007/s10461-015-1252-2
   Keeter S, 2006, PUBLIC OPIN QUART, V70, P759, DOI 10.1093/poq/nfl035
   Kumar S, 2013, TWITTER DATA ANAL
   Maio G. R., 2010, PSYCHOL ATTITUDES AT
   Schwartz HA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073791
   Van Durme B., 2012, P 2012 JOINT C EMP M, P48
   Volkova S, 2015, PROCEEDINGS OF THE TWENTY-NINTH AAAI CONFERENCE ON ARTIFICIAL INTELLIGENCE, P4296
   Wyer RS, 2005, HANDBOOK OF ATTITUDES, P273
   Zamal FA, 2012, 6 INT AAAI C WEBL SO
   Zhao WNX, 2011, LECT NOTES COMPUT SC, V6611, P338, DOI 10.1007/978-3-642-20161-5_34
NR 21
TC 8
Z9 8
U1 1
U2 2
PU JMIR PUBLICATIONS, INC
PI TORONTO
PA 130 QUEENS QUAY E, STE 1102, TORONTO, ON M5A 0P6, CANADA
SN 2369-2960
J9 JMIR PUBLIC HLTH SUR
JI JMIR Public Health Surveill.
PD JAN-MAR
PY 2018
VL 4
IS 1
BP 57
EP 67
AR UNSP e16
DI 10.2196/publichealth.8186
PG 11
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA VJ0RN
UT WOS:000526815300005
PM 29426815
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT B
AU Hagen, L
   Scharf, R
   Neely, S
   Keller, T
AF Hagen, Loni
   Scharf, Ryan
   Neely, Stephen
   Keller, Thomas
GP ACM
BE Zuiderwijk, A
   Hinnant, CC
TI Government Social Media Communications during Zika Health Crisis
SO PROCEEDINGS OF THE 19TH ANNUAL INTERNATIONAL CONFERENCE ON DIGITAL
   GOVERNMENT RESEARCH (DGO 2018): GOVERNANCE IN THE DATA AGE
LA English
DT Proceedings Paper
CT 19th Annual International Conference on Digital Government Research
   (Dgo) - Governance in the Data Age
CY MAY 30-JUN 01, 2018
CL Delft Univ Technol, Delft, NETHERLANDS
SP Digital Govt Soc, Emerald Publishing, IOS Press, 4TU, Ctr Res Data
HO Delft Univ Technol
DE Social media; e-government; crisis communications; emergency management;
   local government; content analysis; Twitter
ID LOCAL-GOVERNMENTS; TWITTER; MODEL
AB While the expectation for public officials and government agencies to adopt social media is high, significant questions remain regarding how these tools can be most effectively leveraged to facilitate government communication efforts under crisis conditions. These questions are more puzzling for local governments where unsupportive culture and a lack of resources tend to discourage active use of social media. In an effort to address these issues, this article examines the use of Twitter by federal, state, and local government actors during the 2015-2016 Zika virus outbreak in the United States. We learned that local governments have smaller network sizes. Federal level agencies frequently use Twitter for information provision, using URLs and images while leveraging large network sizes. Elected office holders, in general, managed large networks, and leveraged their popularity during the crisis. This analysis will be of interest to both scholars and practitioners in the areas of emergency management, public administration, and political science, as it helps to deepen our understanding of how government agencies and political leaders engage with the public during times of crisis, and how social media usage differs across various levels of government.
C1 [Hagen, Loni; Neely, Stephen; Keller, Thomas] Univ S Florida, 4202 E Fowler Ave,CIS 1040, Tampa, FL 33620 USA.
RP Hagen, L (corresponding author), Univ S Florida, 4202 E Fowler Ave,CIS 1040, Tampa, FL 33620 USA.
EM lonihagen@usf.edu; ryan.scharf@gmail.com; srneely@usf.edu;
   tekeller@usf.edu
FU National Research Foundation of Korea - Korean GovernmentNational
   Research Foundation of KoreaKorean Government [NRF-2017S1A3A2066084]
FX This work was partially supported by the National Research Foundation of
   Korea Grant funded by the Korean Government (NRF-2017S1A3A2066084).
CR American Red Cross, 2012, SOC MED DIS EM
   [Anonymous], 2016, ZIKA SPRAYING KILLS
   [Anonymous], 2017, DAILY FLORIDA ZIKA V
   Bertot JC, 2010, GOV INFORM Q, V27, P264, DOI 10.1016/j.giq.2010.03.001
   Boyd W, 2010, FEEM SER ECON ENVIR, P1
   Bright J., 2017, ARXIV171007087CS
   Canel M.J., 2012, SAGE HDB POLITICAL C, P85
   Cha M., 2010, ICWSM, V10, P30, DOI DOI 10.1016/J.IPM.2016.04.003
   Conrado SP, 2016, J DECIS SYST, V25, P171, DOI 10.1080/12460125.2016.1187396
   Crudele L., 2016, BLUEPRINT CRISIS COM
   DePaula N, 2018, GOV INFORM Q, V35, P98, DOI 10.1016/j.giq.2017.10.003
   Enyeart M.A., 2011, SOCIAL MEDIA MUNICIP
   Fisher Liu B, 2007, J PUBLIC RELAT RES, V19, P377, DOI DOI 10.1080/10627260701402473
   Fung ICH, 2014, LANCET, V384, P2207, DOI 10.1016/S0140-6736(14)62418-1
   Gao X, 2017, GOV INFORM Q, V34, P627, DOI 10.1016/j.giq.2017.09.005
   Graham M., 2013, PUBLIC RELAT J, V7, P1
   Graham MW, 2015, PUBLIC RELAT REV, V41, P386, DOI 10.1016/j.pubrev.2015.02.001
   Graham T, 2013, INFORM COMMUN SOC, V16, P692, DOI 10.1080/1369118X.2013.785581
   Greenwood S., 2016, SOCIAL MEDIA UPDATE
   Guskin E, 2012, HURRICANE SANDY TWIT
   Hagen L, 2018, SOC SCI COMPUT REV, V36, P523, DOI 10.1177/0894439317721985
   Hughes AL, 2012, J HOMEL SECUR EMERG, V9
   Jin Y, 2014, COMMUN RES, V41, P74, DOI 10.1177/0093650211423918
   Latonero M., 2011, INT J INFORM SYSTEMS, V3, P1, DOI DOI 10.4018/JISCRM.2011100101
   Lee G, 2012, GOV INFORM Q, V29, P492, DOI 10.1016/j.giq.2012.06.001
   LEE M, 2002, J PUBLIC AFFAIRS, V2, P33, DOI DOI 10.1002/PA.92
   LEE MW, 2009, J PUBLIC AFFAIRS ED, P515
   Leston-Bandeira Cristina, 2013, Information Polity, V18, P281, DOI 10.3233/IP-130316
   Li YY, 2016, LECT NOTES COMPUT SC, V9865, P112, DOI 10.1007/978-3-319-45835-9_10
   Madden M., 2011, 65 ONLINE ADULTUSE
   McGregor SC, 2017, J INF TECHNOL POLITI, V14, P154, DOI 10.1080/19331681.2017.1308289
   McNutt John, 2008, CURRENTS, V7, P1
   McNutt K, 2014, CAN PUBLIC ADMIN, V57, P49, DOI 10.1111/capa.12058
   Meijer A, 2013, GOV INFORM Q, V30, P343, DOI 10.1016/j.giq.2013.05.023
   Merchant RM, 2011, NEW ENGL J MED, V365, P289, DOI 10.1056/NEJMp1103591
   Mergel Ines, 2012, Information Polity, V17, P281, DOI 10.3233/IP-2012-000281
   Mergel I, 2017, ROUTL HANDBK, P168
   Mossberger K, 2013, GOV INFORM Q, V30, P351, DOI 10.1016/j.giq.2013.05.016
   Nelson L. D., 2009, ELECT NEWS, V3, P176, DOI DOI 10.1080/19312430903300046
   Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103
   Norris DF, 2013, LECT NOTES COMPUT SC, V8075, P37, DOI 10.1007/978-3-642-40346-0_4
   Palen L, 2007, CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1 AND 2, P727
   Perrin A., 2015, SOCIAL MEDIA USAGE 2
   Porter L, 2010, PUBLIC RELAT REV, V36, P127, DOI 10.1016/j.pubrev.2009.08.014
   Smith A., 2011, 22 ONLINE AM USED SO
   Stelter B., 2012, NY TIMES
   Stewart MC, 2016, COMPUT HUM BEHAV, V54, P639, DOI 10.1016/j.chb.2015.07.009
   Thackeray R, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-242
   Waters RD, 2011, J PUBLIC AFF, V11, P353, DOI 10.1002/pa.385
   Yoon J., WORK PROGR USE MULTI
   Yoon J, 2016, INFORM RES, V21
   Yun GW, 2016, INT J MED INFORM, V91, P67, DOI 10.1016/j.ijmedinf.2016.04.009
   Zavattaro S.M., 2016, SOCIAL MEDIA GOVT TH
   Zhao X., 2013, SEMANTIC WEB WEB SCI, P55, DOI DOI 10.1007/978-1-4614-6880-6_5
NR 54
TC 0
Z9 0
U1 6
U2 6
PU ASSOC COMPUTING MACHINERY
PI NEW YORK
PA 1515 BROADWAY, NEW YORK, NY 10036-9998 USA
BN 978-1-4503-6526-0
PY 2018
BP 93
EP 102
DI 10.1145/3209281.3209364
PG 10
WC Computer Science, Information Systems; Computer Science,
   Interdisciplinary Applications; Public Administration
SC Computer Science; Public Administration
GA BO3SF
UT WOS:000511427500012
DA 2020-07-08
ER

PT B
AU Gui, XN
   Kou, YB
   Pine, K
   Ladaw, E
   Kim, H
   Suzuki-Gill, E
   Chen, YN
AF Gui, Xinning
   Kou, Yubo
   Pine, Kathleen
   Ladaw, Elisa
   Kim, Harold
   Suzuki-Gill, Eli
   Chen, Yunan
GP ACM
TI Multidimensional Risk Communication: Public Discourse on Risks during an
   Emerging Epidemic
SO PROCEEDINGS OF THE 2018 CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING
   SYSTEMS (CHI 2018)
LA English
DT Proceedings Paper
CT CHI Conference on Human Factors in Computing Systems (CHI)
CY APR 21-26, 2018
CL Montreal, CANADA
SP Assoc Comp Machinery, ACM SIGCHI
DE Crisis informatics; public health crisis; Zika virus; biological crisis;
   public participation; social media; emerging epidemic; risk perception;
   risk communication
ID ZIKA VIRUS; SOCIAL AMPLIFICATION; PERCEPTION; DIFFUSION
AB Crisis informatics has examined how institutions and individuals seek, communicate, and curate information in response to crises. The public's communication and perception of risks on social media remain understudied. In this study, we report a qualitative analysis of public perceptions of risks and risk management measures on Reddit during the Zika crisis, an emerging epidemic associated with high uncertainty regarding pathology, epidemiology, and broad consequences. We found two types of perceived risks: ones directly caused by the Zika virus, and ones potentially introduced by authorities' risk management measures. Risk perceptions unfolded along multiple dimensions beyond the imminent and personal level. Reddit users discussed in a speculative way to foresee various risks in the long nun or at larger geographical scales. We discuss the multidimensionality and speculative nature of risk perception on social media, and derive implications for crisis informatics research and public health research and practice.
C1 [Gui, Xinning; Ladaw, Elisa; Kim, Harold; Suzuki-Gill, Eli; Chen, Yunan] Univ Calif Irvine, Irvine, CA 92697 USA.
   [Kou, Yubo] Purdue Univ, W Lafayette, IN 47907 USA.
   [Pine, Kathleen] Arizona State Univ, Phoenix, AZ USA.
RP Gui, XN (corresponding author), Univ Calif Irvine, Irvine, CA 92697 USA.
EM guix@uci.edu; kou2@purdue.edu; khpine@asu.edu; yunanc@uci.edu;
   eladaw@uci.edu; kimho@uci.edu; esuzukig@uci.edu
OI Kou, Yubo/0000-0002-4255-3725
CR Adam Barbara, 2000, RISK SOC CRITICAL IS, P240
   Alexa, 2017, DEM COMP
   [Anonymous], 2017, ZIK VIR COUNTR CLASS
   Bennett P, 2010, RISK COMMUNICATION P
   Berger Sam, 2010, HARVARD LAW POLICY R, V2, P295
   Broniatowski DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083672
   Bucher Hans-Juergen, 2002, 1 MONDAY, V7, DOI [10.5210/fm.v7i4.943, DOI 10.5210/FM.V7I4.943]
   Carroll A, 2017, NY TIMES
   CDC, ZIK VIR DIS
   Centers for Disease Control and Prevention (CDC), 2005, MMWR Morb Mortal Wkly Rep, V54, P961
   Centers for Disease Control & Prevention (CDC), 2017, TRANSM RISKS
   Centers for Disease Control & Prevention (CDC), 2017, SYMPT TEST TREATM
   Charles-Smith LE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139701
   Chou WYS, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1249
   Corbin J, 2015, BASICS QUALITATIVE R
   Culotta A., 2010, P 1 WORKSH SOC MED A, P115, DOI DOI 10.1145/1964858.1964874
   Dehghani M, 2017, BEHAV RES METHODS, V49, P538, DOI 10.3758/s13428-016-0722-4
   Ding H., 2010, CHINA MEDIA RESEARCH, V6, P80
   Dogan AC, 2017, J MATERN-FETAL NEO M, V30, P386, DOI 10.3109/14767058.2016.1174210
   Dunne A., 2013, SPECULATIVE EVERYTHI
   Elsden C, 2017, PROCEEDINGS OF THE 2017 ACM SIGCHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS (CHI'17), P5386, DOI 10.1145/3025453.3025503
   FISCHHOFF B, 1993, ANNU REV PUBL HEALTH, V14, P183, DOI 10.1146/annurev.pu.14.050193.001151
   Fischhoff B., 2009, Oxford textbook of public health, Volume 2: the methods of public health, P940
   FISCHHOFF B, 1985, ISSUES SCI TECHNOL, V2, P83
   Goggins Sean P, 2012, P ACM 2012 C COMP SU, P57, DOI [10.1145/2145204.2145218, DOI 10.1145/2145204.2145218]
   Green LW, 2009, ANNU REV PUBL HEALTH, V30, P151, DOI 10.1146/annurev.publhealth.031308.100049
   Gui XN, 2017, PROCEEDINGS OF THE 2017 ACM SIGCHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS (CHI'17), P4520, DOI 10.1145/3025453.3025891
   Gui Xinning, 2017, P AMIA 2017 ANN S
   Hadi TA, 2016, DISASTER MED PUBLIC, V10, P775, DOI 10.1017/dmp.2016.39
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Heverin T, 2012, J AM SOC INF SCI TEC, V63, P34, DOI 10.1002/asi.21685
   Huang YLL, 2015, PROCEEDINGS OF THE 2015 ACM INTERNATIONAL CONFERENCE ON COMPUTER-SUPPORTED COOPERATIVE WORK AND SOCIAL COMPUTING (CSCW'15), P969, DOI 10.1145/2675133.2675202
   Hughes A.L., 2014, P 32 ANN ACM C HUM F, P1505, DOI [10.1145/2556288.2557227, DOI 10.1145/2556288.2557227]
   Hughes AL, 2009, INT J EMERG MANAG, V6, P248, DOI 10.1504/IJEM.2009.031564
   Hyams KC, 2002, J HEALTH POLIT POLIC, V27, P273, DOI 10.1215/03616878-27-2-273
   Irwin A., 1995, CITIZEN SCI STUDY PE
   JOHNSON BB, 1995, RISK ANAL, V15, P485, DOI 10.1111/j.1539-6924.1995.tb00341.x
   KASPERSON RE, 1988, RISK ANAL, V8, P177, DOI 10.1111/j.1539-6924.1988.tb01168.x
   Kogan M, 2015, PROCEEDINGS OF THE 2015 ACM INTERNATIONAL CONFERENCE ON COMPUTER-SUPPORTED COOPERATIVE WORK AND SOCIAL COMPUTING (CSCW'15), P981, DOI 10.1145/2675133.2675218
   Kou Yubo, 2017, P ACM HUM COMP INT
   Krippendorff K, 2004, CONTENT ANAL INTRO I
   Leavitt Alex, 2014, P SIGCHI C HUM FACT, P1495, DOI DOI 10.1145/2556288.2557140
   Lindley J., 2014, ETHN PRAX IND C P WI, V2014, P237, DOI DOI 10.1111/1559-8918.01030
   LUPTON D, 1993, INT J HEALTH SERV, V23, P425, DOI 10.2190/16AY-E2GC-DFLD-51X2
   Lupton D., 1999, RISK SOCIOCULTURAL T, P1, DOI DOI 10.1017/CBO9780511520778
   Macias W, 2009, J COMPUT-MEDIAT COMM, V15, P1, DOI 10.1111/j.1083-6101.2009.01490.x
   Maunder RG, 2006, EMERG INFECT DIS, V12, P1924
   Moorhead SA, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.1933
   Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759
   Morgan M. G., 2002, RISK COMMUNICATION M
   Munro Robert, 2012, P SPRING S ASS ADV A, P52
   *NAT RES COUNC, 1989, IMPR RISK COMM
   National Research Council (US), 1989, IMPR RISK COMM, DOI [10.17226/1189, DOI 10.17226/1189]
   Ngai JC, 2010, RESPIROLOGY, V15, P543, DOI 10.1111/j.1440-1843.2010.01720.x
   NIH: National Institute of Allergy and Infectious Diseases, EB LONG TERM HLTH EF
   Plotnick Linda, 2016, J HOMEL SECUR EMERG, V13, P2
   Plough Alonzo, SCI TECHNOL, V12, P4, DOI [10.2307/689375, DOI 10.2307/689375]
   Qu Y, 2011, CSCW 2011 MARCH 19 2, P25, DOI DOI 10.1145/1958824.1958830
   Ratanacharoensiri A, 2017, J RES PHARM PRACT, V6, P1, DOI 10.4103/2279-042X.200984
   RENN O, 1992, J SOC ISSUES, V48, P137, DOI 10.1111/j.1540-4560.1992.tb01949.x
   Renn O., 2008, RISK GOVERNANCE COPI
   Reuter C, 2016, INT J HUM-COMPUT ST, V95, P96, DOI 10.1016/j.ijhcs.2016.03.005
   Reynolds B, 2005, J HEALTH COMMUN, V10, P43, DOI 10.1080/10810730590904571
   Rogers GO, 1997, RISK ANAL, V17, P745, DOI 10.1111/j.1539-6924.1997.tb01280.x
   San Y., 2013, SOCIAL MEDIA EMERGEN
   SANDELOWSKI M, 1995, RES NURS HEALTH, V18, P179, DOI 10.1002/nur.4770180211
   Sandman P., 1987, EPA J, V13, P21, DOI DOI 10.1177/0893318988002002006
   Sarcevic Aleksandra, 2012, P ACM 2012 C COMP SU, P47, DOI DOI 10.1145/2145204.2145217
   Shklovski I, 2008, CSCW: 2008 ACM CONFERENCE ON COMPUTER SUPPORTED COOPERATIVE WORK, CONFERENCE PROCEEDINGS, P127
   Signorini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019467
   SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507
   Slovic P, 1982, RISK ANAL, V2, P83, DOI DOI 10.1111/J.1539-6924.1982.TB01369.X
   Slovic P, 2000, PERCEPTION RISK, P220
   Slovic Paul, 1986, RISK EVALUATION MANA, P3, DOI DOI 10.1007/978-1-4613-2103-3
   Starbird K, 2011, 29TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, P1071
   Starbird K, 2012, CHANDOS INF PROF SER, P43
   Starbird K, 2010, 2010 ACM CONFERENCE ON COMPUTER SUPPORTED COOPERATIVE WORK, P241
   Tierney KJ, 1999, SOCIOL FORUM, V14, P215, DOI 10.1023/A:1021414628203
   Vanya M, 2017, REV MED MICROBIOL, V28, P75, DOI 10.1097/MRM.0000000000000096
   Vieweg S, 2010, CHI2010: PROCEEDINGS OF THE 28TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P1079, DOI 10.1145/1753326.1753486
   Villa R, 2016, CLIN TER, V167, P7, DOI 10.7417/CT.2016.1907
   WHO, 2017, ZIK VIR COMPL 2016 P
   WILDAVSKY A, 1990, DAEDALUS, V119, P41
   World Health Organization, 2016, ZIK VIR COMPL
   World Health Organization, 2016, ZIK VIR
   World Health Organization, 2016, WORLD HLTH ORG
   World Health Organization(WHO), 2003, CLIMATE CHANGE HUMAN
NR 87
TC 1
Z9 1
U1 2
U2 2
PU ASSOC COMPUTING MACHINERY
PI NEW YORK
PA 1515 BROADWAY, NEW YORK, NY 10036-9998 USA
BN 978-1-4503-5620-6
PY 2018
DI 10.1145/3173574.3173788
PG 14
WC Computer Science, Cybernetics; Computer Science, Information Systems
SC Computer Science
GA BO2ZO
UT WOS:000509673102058
DA 2020-07-08
ER

PT J
AU Joob, B
   Wiwanitkit, V
AF Joob, Beuy
   Wiwanitkit, Viroj
TI Targets and Receptor of Sexual Transmission of Zika Virus
SO APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
LA English
DT Letter
C1 [Joob, Beuy] Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Haikou Shi, Hainan Sheng, Peoples R China.
RP Joob, B (corresponding author), Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
CR Bagasra O, 2017, APPL IMMUNOHISTO M M, V25, P679, DOI 10.1097/PAI.0000000000000580
   Hashira S, 2000, PEDIATR INT, V42, P337, DOI 10.1046/j.1442-200x.2000.01245.x
   Wiwanitkit V, 2005, AUST NZ J OBSTET GYN, V45, P539, DOI 10.1111/j.1479-828X.2005.00500.x
   Wiwanitkit V, 2006, Clin Exp Obstet Gynecol, V33, P213
NR 4
TC 0
Z9 0
U1 0
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1541-2016
EI 1533-4058
J9 APPL IMMUNOHISTO M M
JI Appl. Immunohistochem.
PD JAN
PY 2018
VL 26
IS 1
BP E14
EP E14
DI 10.1097/PAI.0000000000000617
PG 1
WC Anatomy & Morphology; Medical Laboratory Technology; Pathology
SC Anatomy & Morphology; Medical Laboratory Technology; Pathology
GA FQ1PN
UT WOS:000418130200003
PM 29206717
DA 2020-07-08
ER

PT J
AU Cabral, GB
   Ferreira, JLD
   de Souza, RP
   Cunha, MS
   Luchs, A
   Figueiredo, CA
   Brigido, LFD
AF Cabral, Gabriela Bastos
   de Paula Ferreira, Joao Leandro
   de Souza, Renato Pereira
   Cunha, Mariana Sequetin
   Luchs, Adriana
   Figueiredo, Cristina Adelaide
   de Macedo Brigido, Luis Fernando
TI Simple protocol for population (Sanger) sequencing for Zika virus
   genomic regions
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE Zika virus; Sanger sequencing; PCR; phylogeny
ID RT-PCR; AMERICA; BRAZIL
AB BACKGROUND A number of Zika virus (ZIKV) sequences were obtained using Next-generation sequencing (NGS), a methodology widely applied in genetic diversity studies and virome discovery. However Sanger method is still a robust, affordable, rapid and specific tool to obtain valuable sequences.
   OBJECTIVE The aim of this study was to develop a simple and robust Sanger sequencing protocol targeting ZIKV relevant genetic regions, as envelope protein and nonstructural protein 5 (NS5). In addition, phylogenetic analysis of the ZIKV strains obtained using the present protocol and their comparison with previously published NGS sequences were also carried out.
   METHODS Six Vero cells isolates from serum and one urine sample were available to develop the procedure. Primer sets were designed in order to conduct a nested RT-PCR and a Sanger sequencing protocols. Bayesian analysis was used to infer phylogenetic relationships.
   FINDINGS Seven complete ZIKV envelope protein (1,571 kb) and six partial NS5 (0,798 Kb) were obtained using the protocol, with no amplification of NS5 gene from urine sample. Two NS5 sequences presented ambiguities at positions 495 and 196. Nucleotide analysis of a Sanger sequence and consensus sequence of previously NGS study revealed 100% identity. ZIKV strains described here clustered within the Asian lineage.
   MAIN CONCLUSIONS The present study provided a simple and low-cost Sanger protocol to sequence relevant genes of the ZIKV genome. The identity of Sanger generated sequences with published consensus NGS support the use of Sanger method for ZIKV population studies. The regions evaluated were able to provide robust phylogenetic signals and may be used to conduct molecular epidemiological studies and monitor viral evolution.
C1 [Cabral, Gabriela Bastos; de Paula Ferreira, Joao Leandro; de Macedo Brigido, Luis Fernando] Adolfo Lutz Inst, Ctr Virol, Lab Retrovirus, Nucleo Doencas Sanguineas & Sexuais, Sao Paulo, SP, Brazil.
   [de Souza, Renato Pereira; Cunha, Mariana Sequetin] Adolfo Lutz Inst, Ctr Virol, Nucleo Transmissao Vetorial, Sao Paulo, SP, Brazil.
   [Luchs, Adriana] Adolfo Lutz Inst, Ctr Virol, Nucleo Doencas Enter, Sao Paulo, SP, Brazil.
   [Figueiredo, Cristina Adelaide] Adolfo Lutz Inst, Ctr Virol, Nucleo Doencas Resp, Sao Paulo, SP, Brazil.
RP Brigido, LFD (corresponding author), Adolfo Lutz Inst, Ctr Virol, Lab Retrovirus, Nucleo Doencas Sanguineas & Sexuais, Sao Paulo, SP, Brazil.
EM lubrigido@gmail.com
RI Brigido, Luis F M/C-2155-2011
OI Brigido, Luis F M/0000-0002-1022-7837; Pereira de Souza,
   Renato/0000-0003-1315-7085
FU Adolfo Lutz Instute, FINEP [0219/2016]; FAPESPFundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP) [194417/2013]
FX Adolfo Lutz Instute, FINEP (grant no. 0219/2016), FAPESP (grant no.
   194417/2013).
CR Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Behura SK, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2468-x
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Ciota AT, 2007, VIROLOGY, V357, P165, DOI 10.1016/j.virol.2006.08.005
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005048
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Goode Triona, 2002, Methods Mol Biol, V193, P65
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Gu SH, 2017, VIRUS GENES, V53, P918, DOI 10.1007/s11262-017-1500-9
   GUBLER DJ, 1984, AM J TROP MED HYG, V33, P158, DOI 10.4269/ajtmh.1984.33.158
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Leguia M, 2017, J VIROL METHODS, V248, P77, DOI 10.1016/j.jviromet.2017.06.005
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Shankar A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01761
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   van Boheemen S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02652-w
NR 22
TC 3
Z9 3
U1 0
U2 0
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD JAN
PY 2018
VL 113
IS 1
BP 38
EP 44
DI 10.1590/0074-02760170248
PG 7
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA FO8XA
UT WOS:000417170300007
PM 29185594
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Pereira-Silva, JW
   do Nascimento, VA
   Belchior, HCM
   Almeida, JF
   Pessoa, FAC
   Naveca, FG
   Rios-Velasquez, CM
AF Pereira-Silva, Jordam William
   do Nascimento, Valdinete Alves
   Matos Belchior, Heliana Christy
   Almeida, Jessica Feijo
   Costa Pessoa, Felipe Arley
   Naveca, Felipe Gomes
   Rios-Velasquez, Claudia Maria
TI First evidence of Zika virus venereal transmission in Aedes aegypti
   mosquitoes
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE Zika virus; sexual transmission; mosquito vectors; mating; Flavivirus
ID VERTICAL TRANSMISSION; SEXUAL TRANSMISSION; DIPTERA-CULICIDAE;
   CHIKUNGUNYA-VIRUS; INFECTION; BRAZIL; EPIDEMIC; AMERICA
AB BACKGROUND Aedes aegypti is considered the main Zika virus (ZIKV) vector, and is thought to be responsible for the 20152016 outbreak in Brazil. Zika positive Ae. aegypti males collected in the field suggest that vertical and/or venereal transmission of ZIKV may occur.
   OBJECTIVES In this study, we aimed to demonstrate that venereal transmission of ZIKV by Ae. aegypti can occur under laboratory conditions.
   METHODS Ae. aegypti collected in the city of Manaus, confirmed as negative for Zika, Dengue and Chikungunya virus by reverse transcription real-time polymerase chain reaction (RT-qPCR) (AaM3V-strain), were reared under laboratory conditions and used for the experiments. The ZIKV used in this study was isolated from a patient presenting with symptoms; ZIKV was confirmed by RT-qPCR. Experiment 1: virgin male mosquitoes of AaM3V-strain were intrathoracically inoculated with a ZIKV suspension; four days after injection, they were transferred to a cage containing virgin females of AaM3V-strain and left to copulate for five days. Experiment 2: virgin female mosquitoes of AaM3V-strain were orally infected with a ZIKV suspension by blood feeding membrane assay; nine days after blood feeding, they were placed in cages with Ae. aegypti AaM3V-virgin males and left to copulate for four days. After copulation, all mosquitoes were individually evaluated for viral infection by RT-qPCR.
   FINDINGS The mean infection rate in Experiment 1 and Experiment 2 was 45% and 35%, respectively. In both experiments, cycle threshold values ranged from 13 to 35, indicating the presence of viral genomes.
   MAIN CONCLUSION Ae. aegypti males intrathoracically inoculated with a ZIKV suspension are infected and can transmit the virus to uninfected females by mating. Moreover, Ae. aegypti females orally infected with a ZIKV suspension can transmit the virus to uninfected males by copulation. This study shows that ZIKV infection of Ae. aegypti mosquitoes occurs not only during blood feeding, but also during copulation.
C1 [Pereira-Silva, Jordam William; do Nascimento, Valdinete Alves; Matos Belchior, Heliana Christy; Almeida, Jessica Feijo; Costa Pessoa, Felipe Arley; Naveca, Felipe Gomes; Rios-Velasquez, Claudia Maria] Fundacao Oswaldo Cruz Fiocruz, Inst Leonidas & Maria Deane, Lab Ecol Doencas Transmissiveis Amazonia, Manaus, Amazonas, Brazil.
   [Pereira-Silva, Jordam William; Almeida, Jessica Feijo] Fundacao Oswaldo Cruz Fiocruz, Inst Leonidas & Maria Deane, Programa Posgrad Condicoes Vida & Situacoes Saude, Manaus, Amazonas, Brazil.
RP Rios-Velasquez, CM (corresponding author), Fundacao Oswaldo Cruz Fiocruz, Inst Leonidas & Maria Deane, Lab Ecol Doencas Transmissiveis Amazonia, Manaus, Amazonas, Brazil.
EM claudia.rios@fiocruz.br
RI Naveca, Felipe/H-1130-2012
OI Naveca, Felipe/0000-0002-2888-1060; FEIJO, JESSICA/0000-0002-7288-9799;
   Nascimento, Valdinete/0000-0002-7786-4718
FU FAPEAM/FIOCRUZ; CNPqNational Council for Scientific and Technological
   Development (CNPq) [440856/2016-7]; CAPESCAPES [88881.130825/2016-01,
   88887.130823/2016-00]; FAPEAM; CNPqNational Council for Scientific and
   Technological Development (CNPq); ILMD/FIOCRUZAM (PAT-Program)
FX FAPEAM/FIOCRUZ (call 001/2014 PROEP), CNPq (grant 440856/2016-7), CAPES
   [grants 88881.130825/2016-01 and 88887.130823/2016-00 (call MCTIC/FNDCT
   - CNPq/MEC - CAPES/MS - Decit 14/2016 - Prevencao e Combate ao virus
   Zika)].; JWPS and HCMB received scholarship from FAPEAM; JFA received
   scholarship from CNPq; VAN received scholarship from ILMD/FIOCRUZAM
   (PAT-Program).
CR [Anonymous], 2016, ZIK VIR MICR GUILL B
   Azevedo RSS, 2016, J CLIN VIROL, V85, P56, DOI 10.1016/j.jcv.2016.10.024
   Burkhalter KL, 2017, EMERG INFECT DIS, V23, P680, DOI 10.3201/eid2304.161772
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Ciota AT, 2017, EMERG INFECT DIS, V23, P880, DOI 10.3201/eid2305.162041
   Costa-da-Silva AL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171951
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Fernandes RS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004993
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Guedes DRD, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.59
   Gurukumar KR, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-10
   Haddow AD, 2017, EMERG INFECT DIS, V23, P1274, DOI 10.3201/eid2308.170036
   Hastings AK, 2017, YALE J BIOL MED, V90, P325
   Ikejezie J, 2017, MMWR-MORBID MORTAL W, V66, P329, DOI 10.15585/mmwr.mm6612a4
   KIRYA BG, 1977, T ROY SOC TROP MED H, V71, P254, DOI 10.1016/0035-9203(77)90020-7
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   LEA AO, 1968, J INSECT PHYSIOL, V14, P305, DOI 10.1016/0022-1910(68)90072-3
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Mavale M, 2010, AM J TROP MED HYG, V83, P1242, DOI 10.4269/ajtmh.2010.09-0577
   Medina Freddy, 2012, Curr Protoc Microbiol, VChapter 15, DOI 10.1002/9780471729259.mc15d02s27
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   MS/ SVS-Ministerio da Saude/ Secretaria de Vigilancia em Saude, 2017, MON CAS DENG FEBR CH, V4
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Naveca FG, 2017, MEM I OSWALDO CRUZ, V112, P510, DOI 10.1590/0074-02760160062
   Nunes ML, 2016, J PEDIAT-BRAZIL, V92, P230, DOI 10.1016/j.jped.2016.02.009
   Pang X, 2001, BMC Microbiol, V1, P18, DOI 10.1186/1471-2180-1-18
   ROSEN L, 1974, AM J TROP MED HYG, V23, P1153, DOI 10.4269/ajtmh.1974.23.1153
   Salazar MI, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-9
   Smartt CT, 2017, J MED ENTOMOL, V54, P1085, DOI 10.1093/jme/tjx058
   Thangamani S, 2016, AM J TROP MED HYG, V95, P1169, DOI 10.4269/ajtmh.16-0448
   Vasconcelos PFC, 2016, VECTOR-BORNE ZOONOT, V16, P295, DOI 10.1089/vbz.2016.1952
   World Health Organization. Fifth meeting of the Emergency Committee under the International Health Regulations, 2005, 5 M EM COMM INT HLTH
NR 34
TC 9
Z9 9
U1 0
U2 6
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD JAN
PY 2018
VL 113
IS 1
BP 56
EP 61
DI 10.1590/0074-02760170329
PG 6
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA FO8XA
UT WOS:000417170300009
PM 29185595
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Palanisamy, N
   Akaberi, D
   Lennerstrand, J
AF Palanisamy, Navaneethan
   Akaberi, Dario
   Lennerstrand, Johan
TI Protein backbone flexibility pattern is evolutionarily conserved in the
   Flaviviridae family: A case of NS3 protease in Flavivirus and
   Hepacivirus
SO MOLECULAR PHYLOGENETICS AND EVOLUTION
LA English
DT Article
DE Flaviviridae; Protein C alpha fluctuation; Viral evolution; Zika virus
   (ZIKV); Hepatitis C virus (HCV)
ID VIRUS-INFECTION; ZIKA VIRUS; SERVER; FLUCTUATIONS; SIMULATION
AB Viruses belonging to the Flaviviridae family have been an important health concern for humans, animals and birds alike. No specific treatment is available yet for many of the viral infections caused by the members of this family. Lack of specific drugs against these viruses is mainly due to lack of protein structure information. It has been known that protein backbone fluctuation pattern is highly conserved in protein pairs with similar folds, in spite of the lack of sequence similarity. We hypothesized that this concept should also hold true for proteins (especially enzymes) of viruses included in different genera of the Flaviviridae family, as we know that the sequence similarity between them is low. Using available NS3 protease crystal structures of the Flaviviridae family, our preliminary results have shown that the C alpha (i.e. backbone) fluctuation patterns are highly similar between Flaviviruses and a Hepacivirus (i.e. hepatitis C virus, HCV). This has to be validated further experimentally.
C1 [Palanisamy, Navaneethan] Heidelberg Univ, BioQuant, Mol & Cellular Engn Grp, Heidelberg, Germany.
   [Palanisamy, Navaneethan] Heidelberg Univ, Hartmut Hoffmann Berling Int Grad Sch Mol & Cellu, Heidelberg, Germany.
   [Akaberi, Dario; Lennerstrand, Johan] Uppsala Univ, Sect Clin Microbiol, Dept Med Sci, Uppsala, Sweden.
RP Palanisamy, N (corresponding author), Mol & Cellular Engn Grp, Neuenheimer Feld 267 BioQuant, D-69120 Heidelberg, Germany.
EM navaneethan.palanisamy@bioquant.uni-heidelberg.de
RI Navaneethan, Palanisamy/AAL-1462-2020
OI Navaneethan, Palanisamy/0000-0003-0369-2316
CR Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Campanella JJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-29
   Cui S, 2011, J MOL BIOL, V408, P449, DOI 10.1016/j.jmb.2011.03.007
   Danielsson Axel, 2014, Infection Ecology & Epidemiology, V4, P22251, DOI 10.3402/iee.v4.22251
   Fraser JS, 2011, P NATL ACAD SCI USA, V108, P16247, DOI 10.1073/pnas.1111325108
   Gagne D, 2013, FEBS J, V280, P5596, DOI 10.1111/febs.12371
   Gelly JC, 2011, NUCLEIC ACIDS RES, V39, pW18, DOI 10.1093/nar/gkr333
   Gupta G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134823
   Jamroz M, 2013, NUCLEIC ACIDS RES, V41, pW427, DOI 10.1093/nar/gkt332
   Keskin O, 2000, BIOPHYS J, V78, P2093, DOI 10.1016/S0006-3495(00)76756-7
   Kosloff M, 2008, PROTEINS, V71, P891, DOI 10.1002/prot.21770
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msv279, 10.1093/molbev/msw054]
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Maguid S, 2006, J MOL EVOL, V63, P448, DOI 10.1007/s00239-005-0209-x
   Magyar C, 2005, NUCLEIC ACIDS RES, V33, pW303, DOI 10.1093/nar/gki409
   Ode H, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00258
   Petruzziello A, 2016, WORLD J GASTROENTERO, V22, P7824, DOI 10.3748/wjg.v22.i34.7824
   Pijlman GP, 2008, CELL HOST MICROBE, V4, P579, DOI 10.1016/j.chom.2008.10.007
   Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055
   Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   Simmonds P, 2017, J GEN VIROL, V98, P2, DOI 10.1099/jgv.0.000672
   Suhre K, 2004, NUCLEIC ACIDS RES, V32, pW610, DOI 10.1093/nar/gkh368
NR 24
TC 4
Z9 4
U1 0
U2 7
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1055-7903
EI 1095-9513
J9 MOL PHYLOGENET EVOL
JI Mol. Phylogenet. Evol.
PD JAN
PY 2018
VL 118
BP 58
EP 63
DI 10.1016/j.ympev.2017.09.015
PG 6
WC Biochemistry & Molecular Biology; Evolutionary Biology; Genetics &
   Heredity
SC Biochemistry & Molecular Biology; Evolutionary Biology; Genetics &
   Heredity
GA FO9RC
UT WOS:000417227900007
PM 28951254
DA 2020-07-08
ER

PT J
AU Snyder, B
   Goebel, S
   Koide, F
   Ptak, R
   Kalkeri, R
AF Snyder, Beth
   Goebel, Scott
   Koide, Fusataka
   Ptak, Roger
   Kalkeri, Raj
TI Synergistic antiviral activity of Sofosbuvir and type-I interferons
   (alpha and beta) against Zika virus
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE IFN-alpha; IFN-beta; Sofosbuvir; synergy; type-I IFN; Zika virus
ID DRUG; INFECTION; EFFICACY
AB Zika virus (ZIKV) is transmitted by mosquitoes and causes Dengue-like illness, neurological symptoms such as Guillain-Barre Syndrome and microcephaly in children born to infected pregnant mothers. Recently, the World Health Organization (WHO) declared ZIKV infection as a Global Health Emergency. However, there are no known prophylactic or therapeutic measures against this virus. As a proof of concept toward combination therapeutic strategy against ZIKV, combinations of host-targeted (Interferon- and Interferon-) and direct acting (Sofosbuvir) antivirals were evaluated in a hepatic cell line (Huh7) using a Cytoprotection (CP) assay. The combination of these antivirals resulted in synergistic inhibition of ZIKV infection in the in vitro CP assay. Additional testing in a ZIKV yield assay demonstrated that combination treatment of these antivirals conferred >2-log reduction in the release of viral RNA. Measurement of ZIKV proteins in the cells infected with multiple ZIKV strains isolated from different geographical regions (Americas, Asia, and Africa) using an immunofluorescence assay confirmed the effective antiviral activity of this combination against ZIKV. These results demonstrate the in vitro proof of concept (POC) for using a combination approach utilizing the strengths of both virus and host-targeted antivirals. These results suggest the effectiveness of the combination strategy in combating ZIKV, in the in vitro systems. Further evaluation of such combination therapies in vivo might provide an impetus for the development of effective ZIKV therapeutic strategies.
C1 [Snyder, Beth; Goebel, Scott; Koide, Fusataka; Ptak, Roger; Kalkeri, Raj] Southern Res, Dept Infect Dis Res, Drug Dev, Frederick, MD USA.
RP Kalkeri, R (corresponding author), Southern Res, Vitro Antiviral Drug Dev, 431 Aviat Way, Frederick, MD 21701 USA.
EM rkalkeri@southernresearch.org
RI amsalu, ribka/G-8780-2019
FU Southern Research
FX Southern Research
CR Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Contreras D, 2016, JOVE-J VIS EXP, DOI 10.3791/54767
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Fernando S, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1656-2
   Fontanges T, 2007, GASTROEN CLIN BIOL, V31, P566, DOI 10.1016/S0399-8320(07)89432-2
   Garcia-Garcia Idrian, 2010, BMC Pharmacology, V10, P15, DOI 10.1186/1471-2210-10-15
   Goebel S, 2016, J VIROL METHODS, V238, P13, DOI 10.1016/j.jviromet.2016.09.015
   Hamel R, 2016, MICROBES INFECT, V18, DOI 10.1016/j.micinf.2016.03.009
   Lindqvist R, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0748-7
   Lucchese G, 2016, AUTOIMMUN REV, V15, P801, DOI 10.1016/j.autrev.2016.03.020
   Mawson AR, 2016, BIORESEARCH OPEN ACC, V5, P171, DOI 10.1089/biores.2016.0004
   Meier KC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000614
   Nogueira ML, 2017, AM J TRANSPLANT, V17, DOI 10.1111/ajt.14047
   Nunes ML, 2016, J PEDIAT-BRAZIL, V92, P230, DOI 10.1016/j.jped.2016.02.009
   Pinto EF, 2016, CURR NEUROPHARMACOL, V14, P743, DOI 10.2174/1570159X14666160106155129
   PRICHARD MN, 1990, ANTIVIR RES, V14, P181, DOI 10.1016/0166-3542(90)90001-N
   Ptak RG, 2008, ANTIMICROB AGENTS CH, V52, P1302, DOI 10.1128/AAC.01324-07
   Reznik SE, 2017, INT J INFECT DIS, V55, P29, DOI 10.1016/j.ijid.2016.12.011
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
   Sacramento CQ, 2016, CLINICALLY APPROVED
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Xu HT, 2017, J ANTIMICROB CHEMOTH, V72, P727, DOI 10.1093/jac/dkw514
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Zalesak M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063959
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 26
TC 8
Z9 9
U1 0
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD JAN
PY 2018
VL 90
IS 1
BP 8
EP 12
DI 10.1002/jmv.24932
PG 5
WC Virology
SC Virology
GA FM8XM
UT WOS:000415375600003
PM 28851097
OA Bronze
DA 2020-07-08
ER

PT J
AU Elfiky, AA
   Elshemey, WM
AF Elfiky, Abdo A.
   Elshemey, Wael M.
TI Molecular dynamics simulation revealed binding of nucleotide inhibitors
   to ZIKV polymerase over 444 nanoseconds
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE guanosine inhibitors; molecular docking; molecular dynamics simulation;
   polymerase; protein-ligand docking; Zika virus
ID DEPENDENT RNA-POLYMERASES; VIRUS OUTBREAK; SOFOSBUVIR; DOCKING; IDX-184;
   DRUGS; WATER; NS5
AB In the year 2015, new Zika virus (ZIKV) broke out in Brazil and spread away in more than 80 countries. Scientists directed their efforts toward viral polymerase in attempt to find inhibitors that might interfere with its function. In this study, molecular dynamics simulation (MDS) was performed over 444ns for a ZIKV polymerase model. Molecular docking (MD) was then performed every 10ns during the MDS course to ensure the binding of small molecules to the polymerase over the entire time of the simulation. MD revealed the binding ability of four suggested guanosine inhibitors (GIs); (Guanosine substituted with OH and SH (phenyl) oxidanyl in the 2 carbon of the ribose ring). The GIs were compared to guanosine triphosphate (GTP) and five anti-hepatitis C virus drugs (either approved or under clinical trials). The mode of binding and the binding performance of GIs to ZIKV polymerase were found to be the same as GTP. Hence, these compounds were capable of competing GTP for the active site. Moreover, GIs bound to ZIKV active site more tightly compared to ribavirin, the wide-range antiviral drug.
C1 [Elfiky, Abdo A.; Elshemey, Wael M.] Cairo Univ, Fac Sci, Dept Biophys, Giza, Egypt.
   [Elfiky, Abdo A.] Abdus Salam Int Ctr Theoret Phys ICTP, Dept Quantitat Life Sci, Trieste, Italy.
RP Elfiky, AA (corresponding author), Cairo Univ, Fac Sci, Dept Biophys, Giza, Egypt.; Elfiky, AA (corresponding author), Abdus Salam Int Ctr Theoret Phys ICTP, Dept Quantitat Life Sci, Trieste, Italy.
EM abdo@sci.cu.edu.eg
RI Mohamed, Abdo/H-3595-2019
OI Mohamed, Abdo/0000-0003-4600-6240
FU Cyprus Institute of Science [pro15b114s1]
FX MDS was carried out on Cy-Tera supercomputer facility of Cyprus
   Institute of Science under the production run of the project
   "pro15b114s1." Ali Hassanali is appreciated for his valuable discussions
   and efforts that without it this work would have not been possible. Alaa
   M. Ismail, Wissam A. Gawad, Ahmed A. Ezat, Ahmed Gameel, Mahmoud
   Abdelmohsen, and Mostafa Shaban are appreciated for their helpful
   support and discussions.
CR Asselah T, 2014, J HEPATOL, V61, P435, DOI 10.1016/j.jhep.2014.04.042
   Asselah T, 2014, EXPERT OPIN PHARMACO, V15, P121, DOI 10.1517/14656566.2014.857656
   BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913
   Bellissent-Funel MC, 2016, CHEM REV, V116, P7673, DOI 10.1021/acs.chemrev.5b00664
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Durham E, 2009, J MOL MODEL, V15, P1093, DOI 10.1007/s00894-009-0454-9
   Elfiky A.A., 2016, SOFTWARE TECHNIQUES, P197
   Elfiky AA, 2017, FUTURE VIRO IN PRESS
   Elfiky AA, 2016, MED CHEM RES, V90:, P1
   Elfiky AA, 2017, FUTURE VIROL, V12, P339, DOI 10.2217/fvl-2017-0027
   Elfiky AA, 2017, J MED VIROL, V89, P1040, DOI 10.1002/jmv.24736
   Elfiky AA, 2016, J MED VIROL, V88, P2044, DOI 10.1002/jmv.24678
   Elfiky AA, 2016, MED CHEM RES, V25, P1005, DOI 10.1007/s00044-016-1533-y
   Elfiky AA, 2015, J COMPUT THEOR NANOS, V12, P376, DOI 10.1166/jctn.2015.3739
   Elfiky AA, 2013, PROTEIN J, V32, P75, DOI 10.1007/s10930-013-9462-9
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Ferrer-Orta C, 2015, VIRUSES-BASEL, V7, P4438, DOI 10.3390/v7082829
   Ganesan A, 2017, EXPERT OPIN DRUG DIS, V12, P407, DOI 10.1080/17460441.2017.1291628
   Haddow AJW, 1964, B WID HLTH ORG, V31, P69
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   Ibrahim M, 2012, MED CHEM, V8, P826, DOI 10.2174/157340612802084144
   Ibrahim M, 2010, SPECTROCHIM ACTA A, V75, P702, DOI 10.1016/j.saa.2009.11.042
   Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Leach A, 2001, MOL MODELLING PRINCI, P353
   LII JH, 1989, J AM CHEM SOC, V111, P8576, DOI 10.1021/ja00205a003
   Ma YH, 2017, VIRUS RES, V232, P34, DOI [10.1016/j.virusres.2017.01.021, 10.1016/j.virusres.2017.01.020]
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2017, J MED VIROL, V89, P1505, DOI 10.1002/jmv.24735
   NCBI, 2017, NATIONAL CENTER OF B
   Noorbatcha Ibrahim Ali, 2010, American Journal of Applied Sciences, V7, P823, DOI 10.3844/ajassp.2010.823.828
   Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289
   Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316
   Sacramento CQ, 2016, BIORXIV, V7, P1
   Saleh NA, 2015, J COMPUT THEOR NANOS, V12, P371, DOI 10.1166/jctn.2015.3738
   Saleh NA, 2015, SPECTROCHIM ACTA A, V136, P1523, DOI 10.1016/j.saa.2014.10.045
   Saleh NA, 2014, J COMPUT THEOR NANOS, V11, P544, DOI 10.1166/jctn.2014.3392
   Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75
   Summers KL, 2012, BIOCHEM BIOPH RES CO, V425, P485, DOI 10.1016/j.bbrc.2012.07.141
   Tauro LB, 2017, J MED VIROL, V89, P1, DOI 10.1002/jmv.24696
   Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334
   Upadhyay AK, 2017, ACTA CRYSTALLOGR F, V73, P116, DOI 10.1107/S2053230X17001601
   van Dijk ADJ, 2006, BIOINFORMATICS, V22, P2340, DOI 10.1093/bioinformatics/btl395
   Wang BX, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14763
   WHO, 2016, ZIK STRAT RES FRAM J
   Zumla A, 2016, INT J INFECT DIS, V45, P92, DOI 10.1016/j.ijid.2016.02.1007
NR 50
TC 9
Z9 9
U1 0
U2 18
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD JAN
PY 2018
VL 90
IS 1
BP 13
EP 18
DI 10.1002/jmv.24934
PG 6
WC Virology
SC Virology
GA FM8XM
UT WOS:000415375600004
PM 28922464
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Cevallos, V
   Ponce, P
   Waggoner, JJ
   Pinsky, BA
   Coloma, J
   Quiroga, C
   Morales, D
   Cardenas, MJ
AF Cevallos, Varsovia
   Ponce, Patricio
   Waggoner, Jesse J.
   Pinsky, Benjamin A.
   Coloma, Josefina
   Quiroga, Cristina
   Morales, Diego
   Cardenas, Maria Jose
TI Zika and Chikungunya virus detection in naturally infected Aedes aegypti
   in Ecuador
SO ACTA TROPICA
LA English
DT Article
DE Chikungunya; Zika; Aedes aegypti; Ecuador
ID DENGUE; MOSQUITOS; STATE; SURVEILLANCE; TRANSMISSION; WORLDWIDE; SPREAD;
   BRAZIL; RATES; PCR
AB The wide and rapid spread of Chikungunya (CHIKV) and Zika (ZIKV) viruses represent a global public health problem, especially for tropical and subtropical environments. The early detection of CHIKV and ZIKV in mosquitoes may help to understand the dynamics of the diseases in high-risk areas, and to design data based epidemiological surveillance to activate the preparedness and response of the public health system and vector control programs. This study was done to detect ZIKV and CHIKV viruses in naturally infected fed female Aedes aegypti (L.) mosquitoes from active epidemic urban areas in Ecuador. Pools (n = 193; 22 pools) and individuals (n = 22) of field collected Ae. aegypti mosquitoes from high-risk arboviruses infection sites in Ecuador were analyzed for the presence of CHIKV and ZIKV using RT-PCR. Phylogenetic analysis demonstrated that both ZIKV and CHIKV viruses circulating in Ecuador correspond to the Asian lineages. Minimum infection rate (MIR) of CHIKV for Esmeraldas city was 2.3% and the maximum likelihood estimation (MLE) was 3.3%. The minimum infection rate (MIR) of ZIKV for Portoviejo city was 5.3% and for Manta city was 2.1%. Maximum likelihood estimation (MLE) for Portoviejo city was 6.9% and 2.6% for Manta city. Detection of arboviruses and infection rates in the arthropod vectors may help to predict an outbreak and serve as a warning tool in surveillance programs.
C1 [Cevallos, Varsovia; Quiroga, Cristina; Morales, Diego; Cardenas, Maria Jose] Ctr Invest & Referencia Nacl Vectores, Inst Nacl Invest Salud Publ, Quito, Ecuador.
   [Ponce, Patricio] Univ Cent Ecuador, Fac Biol, Inst Biomed, Quito, Ecuador.
   [Ponce, Patricio] Univ Yachay Tech, Escuela Biol, Urcuqui 100119, Ecuador.
   [Waggoner, Jesse J.] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA USA.
   [Pinsky, Benjamin A.] Stanford Univ, Sch Med, Dept Med, Div Infect Dis & Geog Med, Stanford, CA 94305 USA.
   [Pinsky, Benjamin A.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA.
   [Coloma, Josefina] Univ Calif Berkeley, Sch Publ Hlth & Vaccinol, Berkeley, CA 94720 USA.
RP Cevallos, V (corresponding author), Ctr Invest Referencia Nacl Vectores, Iquique N14285 & Yaguachi, Quito, Ecuador.
EM vcevallos@inspi.gob.ec
OI Pinsky, Benjamin/0000-0001-8751-4810; Morales, Diego/0000-0002-3663-1782
FU Secretary of Higher Education, Science, Technology and Innovation
   (SENESCYT) [PIC-12-INH-002]
FX We thank the Secretary of Higher Education, Science, Technology and
   Innovation (SENESCYT) for providing funds to do this research. Grant
   PIC-12-INH-002.
CR Bernard KA, 2001, EMERG INFECT DIS, V7, P679
   Bustamante DM, 2010, AM J TROP MED HYG, V82, P1172, DOI 10.4269/ajtmh.2010.09-0323
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Condotta SA, 2004, VECTOR-BORNE ZOONOT, V4, P198, DOI 10.1089/vbz.2004.4.198
   Costa-da-Silva AL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005630
   da Costa CA, 2009, REV SOC BRAS MED TRO, V42, P677, DOI 10.1590/S0037-86822009000600013
   Day JF, 2001, ANNU REV ENTOMOL, V46, P111, DOI 10.1146/annurev.ento.46.1.111
   de Oliveira RL, 2003, AM J TROP MED HYG, V69, P105, DOI 10.4269/ajtmh.2003.69.105
   Enfissi A., 2016, LANCET
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Gallian P, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005254
   Gould E. A., 2009, T R SOC TROP MED HYG
   Gu WD, 2008, T ROY SOC TROP MED H, V102, P817, DOI 10.1016/j.trstmh.2008.03.019
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Lau SM, 2015, TROP MED INT HEALTH, V20, P1271, DOI 10.1111/tmi.12555
   Manore CA, 2014, J THEOR BIOL, V356, P174, DOI 10.1016/j.jtbi.2014.04.033
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Marquez S., 2017, GENOME ANNOUNCEMENTS, V5
   Ministerio de Salud Publics, 2017, GAC EP ECUAD SIVE AL
   Mourya DT, 2001, ACTA VIROL, V45, P305
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Pacheco O, 2016, N ENGL J MED
   Patricio Ponce, 2017, J MED ENTOM IN PRESS
   Patterson J, 2016, WEST J EMERG MED, V17, P671, DOI 10.5811/westjem.2016.9.30904
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rodas JD, 2016, AM J TROP MED HYG, V95, P639, DOI 10.4269/ajtmh.16-0091
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Rueda LM, 2004, ZOOTAXA, P1, DOI 10.11646/zootaxa.589.1.1
   Shen S, 2016, VIROL SIN, V31, P118, DOI 10.1007/s12250-016-3774-9
   Souza T. M. A., 2017, PLOS CURR
   Stapleford KA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004402
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Vorou R, 2016, INT J INFECT DIS, V48, P85, DOI 10.1016/j.ijid.2016.05.014
   Waggoner JJ, 2016, EMERG INFECT DIS, V22, P1295, DOI 10.3201/eid2207.160326
   Weaver SC, 2015, ANTIVIR RES, V120, P32, DOI 10.1016/j.antiviral.2015.04.016
   Yactayo S, 2016, J INFECT DIS, V214, pS441, DOI 10.1093/infdis/jiw390
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhang W, 2012, REV FAC NAC SALUD PU, V30, P328
NR 40
TC 10
Z9 10
U1 0
U2 29
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD JAN
PY 2018
VL 177
BP 74
EP 80
DI 10.1016/j.actatropica.2017.09.029
PG 7
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA FN1VN
UT WOS:000415779400011
PM 28982578
DA 2020-07-08
ER

PT J
AU Saavedra, LM
   Romanelli, GP
   Rozo, CE
   Duchowicz, PR
AF Saavedra, Laura M.
   Romanelli, Gustavo P.
   Rozo, Ciro E.
   Duchowicz, Pablo R.
TI The quantitative structure-insecticidal activity relationships from
   plant derived compounds against chikungunya and zika Aedes aegypti
   (Diptera:Culicidae) vector
SO SCIENCE OF THE TOTAL ENVIRONMENT
LA English
DT Article
DE Insecticidal activity; Chikungunya; Zika; Aedes aegypti; QSAR theory;
   MLR analysis
ID MOSQUITO REPELLENTS; QSAR; DERIVATIVES; QSPR; PREDICTION; ALGORITHM;
   QSPR/QSAR; DIPTERA; SEARCH; LARVAE
AB The insecticidal activity of a series of 62 plant derived molecules against the chikungunya, dengue and zika vector, the Aedes aegypti (Diptera: Culicidae) mosquito, is subjected to a Quantitative Structure-Activity Relationships (QSAR) analysis. The ReplacementMethod (RM) variable subset selection technique based on Multivariable Linear Regression (MLR) proves to be successful for exploring 4885 molecular descriptors calculated with Dragon 6. The predictive capability of the obtained models is confirmed through an external test set of compounds, Leave-One-Out (LOO) cross-validation and Y-Randomization. The present study constitutes a first necessary computational step for designing less toxic insecticides. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Saavedra, Laura M.; Duchowicz, Pablo R.] UNLP, CONICET, Inst Invest Fisquim Teor & Aplicadas INIFTA, Diag 113 & 64,CC 16 Sucursal 4, RA-1900 La Plata, Buenos Aires, Argentina.
   [Romanelli, Gustavo P.] UNLP, CONICET, Fac Ciencias Exactas,Dept Quim, Ctr Invest & Desarrollo Ciencias Aplicadas Dr JJ, Calle 47 257,B1900AIK, La Plata, Buenos Aires, Argentina.
   [Romanelli, Gustavo P.] Univ Nacl La Plata, Fac Ciencias Agr & Forestales, Ctr Invest Sanidad Vegetal CISaV, Catedra Quim Organ, Calles 60 & 119 S-N,B1904AAN, La Plata, Buenos Aires, Argentina.
   [Rozo, Ciro E.] Univ Santo Tomas, GIADS, Secc Bucaramanga, Carrera 18 9-27, Bucaramanga 680011, Colombia.
RP Saavedra, LM; Duchowicz, PR (corresponding author), UNLP, CONICET, Inst Invest Fisquim Teor & Aplicadas INIFTA, Diag 113 & 64,CC 16 Sucursal 4, RA-1900 La Plata, Buenos Aires, Argentina.
EM laurasaa0913@gmail.com
FU National Research Council of Argentina (CONICET)Consejo Nacional de
   Investigaciones Cientificas y Tecnicas (CONICET) [PIP11220130100311];
   Patrimonio Autonomo Fondo Nacional de Financiamiento para la Ciencia, la
   Tecnologia y la Innovacion, Francisco Jose de Caldas
   [RC-0572-2012Bio-Red-CENIVAM]
FX PRD acknowledges the financial support from the National Research
   Council of Argentina (CONICET) PIP11220130100311 project. PRD and GPR
   are members of the scientific researcher career of CONICET. CER
   acknowledges the contributions from "Patrimonio Autonomo Fondo Nacional
   de Financiamiento para la Ciencia, la Tecnologia y la Innovacion,
   Francisco Jose de Caldas" contract RC-0572-2012Bio-Red-CENIVAM.
CR [Anonymous], MATL 7 0
   Barbosa JDF, 2012, PEST MANAG SCI, V68, P1478, DOI 10.1002/ps.3331
   Bhattacharjee AK, 2005, QSAR COMB SCI, V24, P593, DOI 10.1002/qsar.200430914
   Carrasco H, 2012, MOLECULES, V17, P1002, DOI 10.3390/molecules17011002
   Ceferino Toloza A., 2006, Journal of Medical Entomology, V43, P889, DOI 10.1603/0022-2585(2006)43[889:FARPOE]2.0.CO;2
   Duchowicz PR, 2008, BIOORGAN MED CHEM, V16, P7944, DOI 10.1016/j.bmc.2008.07.067
   Duchowicz PR, 2012, CURR DRUG SAF, V7, P282, DOI 10.2174/157488612804096623
   Duchowicz PR, 2006, MATCH-COMMUN MATH CO, V55, P179
   Duchowicz PR, 2005, CHEM PHYS LETT, V412, P376, DOI 10.1016/j.cplett.2005.07.016
   Environment Protection Agency- EPA, 1980, U E P A N N DIETH M, V1, P12
   Gillij YG, 2008, BIORESOURCE TECHNOL, V99, P2507, DOI 10.1016/j.biortech.2007.04.066
   Golbraikh A, 2003, J COMPUT AID MOL DES, V17, P241, DOI 10.1023/A:1025386326946
   Ibezim E, 2012, CHEMOMETR INTELL LAB, V110, P81, DOI 10.1016/j.chemolab.2011.10.002
   Katritzky AR, 2008, P NATL ACAD SCI USA, V105, P7359, DOI 10.1073/pnas.0800571105
   KATRITZKY AR, 1995, CHEM SOC REV, V24, P279, DOI 10.1039/cs9952400279
   Leo A., 1995, EXPLORING QSAR FUNDA
   National Pesticide Information Center- NPIC; Oregon State University, 1999, DDT TECHN FACT SHEET
   Ocampo CB, 2011, ACTA TROP, V118, P37, DOI 10.1016/j.actatropica.2011.01.007
   Putz MV, 2013, CURR ORG CHEM, V17, P2845, DOI 10.2174/13852728113179990130
   Putz MV, 2013, STRUCT CHEM, V24, P1873, DOI 10.1007/s11224-013-0249-6
   RICE PJ, 1994, PESTIC SCI, V41, P195, DOI 10.1002/ps.2780410305
   Rojas C, 2015, J CHROMATOGR A, V1422, P277, DOI 10.1016/j.chroma.2015.10.028
   Rucker C, 2007, J CHEM INF MODEL, V47, P2345, DOI 10.1021/ci700157b
   Santos SRL, 2011, CHEMOSPHERE, V84, P150, DOI 10.1016/j.chemosphere.2011.02.018
   Santos SRL, 2010, VECTOR-BORNE ZOONOT, V10, P1049, DOI 10.1089/vbz.2009.0158
   Scotti L, 2014, MED CHEM, V10, P201, DOI 10.2174/15734064113099990005
   Song J, 2013, BIOORG MED CHEM LETT, V23, P1245, DOI 10.1016/j.bmcl.2013.01.015
   Talete srl, DRAG SOFTW MOL DESCR
   WHO, 2006, PEST THEIR APPL CONT
   WHO, 2009, BACKGR DOC DEV WHO G
   World Health Organization (WHO), NUMB REP CAS CHIK FE
   World Health Organization (WHO), EM PREP RESP ZIK VIR
   Xiao Y, 2012, WIRES DATA MIN KNOWL, V2, P209, DOI 10.1002/widm.1049
   Zhou LG, 2012, STUD NAT PROD CHEM, V37, P67, DOI 10.1016/B978-0-444-59514-0.00003-1
NR 34
TC 5
Z9 5
U1 3
U2 47
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0048-9697
EI 1879-1026
J9 SCI TOTAL ENVIRON
JI Sci. Total Environ.
PD JAN 1
PY 2018
VL 610
BP 937
EP 943
DI 10.1016/j.scitotenv.2017.08.119
PG 7
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA FI3VI
UT WOS:000411897700095
PM 28830053
DA 2020-07-08
ER

PT J
AU Rick, AM
   Domek, G
   Cunningham, M
   Olson, D
   Lamb, MM
   Jimenez-Zambrano, A
   Heinrichs, G
   Berman, S
   Asturias, EJ
AF Rick, Anne-Marie
   Domek, Gretchen
   Cunningham, Maureen
   Olson, Daniel
   Lamb, Molly M.
   Jimenez-Zambrano, Andrea
   Heinrichs, Gretchen
   Berman, Stephen
   Asturias, Edwin J.
TI High Background Congenital Microcephaly in Rural Guatemala: Implications
   for Neonatal Congenital Zika Virus Infection Screening
SO GLOBAL HEALTH-SCIENCE AND PRACTICE
LA English
DT Article
ID BRAZIL
AB Background: Congenital microcephaly is the result of a disturbance in early brain development and can have multiple etiologies. Establishing background prevalence of microcephaly in Zika virus (ZIKV)-affected areas is important for improving identification of ZIKV-affected newborns. However, to date, there is limited consistent guidance for the accurate identification of microcephaly in infants of unknown gestational age, a common concern in low-and middle-income countries.
   Methods: Occipital frontal head circumference (OFC) obtained from infants (0-13 days) of unknown gestational age at enrollment in a pregnancy registry in rural Guatemala from August 2014 to March 2016 were retrospectively reviewed. Trained community health nurses recorded anthropometry in an online database. In April 2015, ZIKV was identified in this population. Gestational age was approximated in 2 ways: presumed term and estimated using z-score of zero for height on modified Fenton growth curves. After which, z-scores for OFC and weight were obtained. Microcephaly and microcephaly background prevalence were estimated using 7 established microcephaly case definitions from national and international organizations and 3 proposed definitions using Fenton growth curves. Independent associations with microcephaly and OFC, including relationship with date of birth, were assessed with prevalence ratios and linear regression.
   Results: For 296 infants, the mean OFC was 33.1 cm (range, 29.5 to 37 cm) and the mean OFC z-score was -0.68. Depending on case definition, 13 to 125 infants were classified as having microcephaly (background prevalence 439 to 4,223 per 10,000 live births), and 1 to 9 infants were classified as having severe microcephaly (< -3 standard deviation [SD]) (34 to 304 per 10,000 live births). Five (1.7%) infants met all the microcephaly case definitions. Weight <=-1 SD (prevalence rate [PR], 3.77; 95% confidence interval [CI]: 1.6 to 8.8; P=.002) and small for gestational age (PR, 4.68; 95% CI, 1.8 to 12.3; P=.002) were associated with microcephaly. Date of birth was not associated with OFC z-score or OFC after adjusting for gestational age and gender.
   Conclusions: Estimated background microcephaly is high in rural Guatemala compared with reported rates in Latin America prior to ZIKV epidemic, which has important implications for neonatal screening programs for congenital ZIKV infection. Fenton growth curves offer a standardized approach to the identification of microcephaly in infants of unknown gestational age.
C1 [Rick, Anne-Marie; Domek, Gretchen; Cunningham, Maureen; Berman, Stephen] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO 80045 USA.
   [Rick, Anne-Marie; Domek, Gretchen; Cunningham, Maureen; Olson, Daniel; Lamb, Molly M.; Jimenez-Zambrano, Andrea; Berman, Stephen; Asturias, Edwin J.] Colorado Sch Publ Hlth, Ctr Global Hlth, Aurora, CO 80045 USA.
   [Olson, Daniel; Lamb, Molly M.; Asturias, Edwin J.] Colorado Sch Publ Hlth, Dept Epidemiol, Aurora, CO USA.
   [Olson, Daniel; Asturias, Edwin J.] Univ Colorado, Sch Med, Pediat Infect Dis, Aurora, CO USA.
   [Heinrichs, Gretchen] Univ Colorado, Sch Med, Dept Obstet & Gynecol, Aurora, CO USA.
RP Rick, AM (corresponding author), Univ Colorado, Sch Med, Dept Pediat, Aurora, CO 80045 USA.; Rick, AM (corresponding author), Colorado Sch Publ Hlth, Ctr Global Hlth, Aurora, CO 80045 USA.
EM anne-marie.rick@ucdenver.edu
RI ; Asturias, Edwin/D-9842-2016
OI Rick, Anne-Marie/0000-0002-8166-1198; Asturias,
   Edwin/0000-0002-1275-0787
FU Jose Fernando Bolanos Menendez Foundation; Center for Global Health at
   the University of Colorado
FX Jose Fernando Bolanos Menendez Foundation and the Center for Global
   Health at the University of Colorado.
CR Departamento de Epidemiologia, 2016, SEM EP 29 MAY 4 JUN
   Estudio Colaborativo Latino Americano de Malformaciones Congenitas (ECLAMC), 2015, DOC ECLAMC FIN RES C
   Estudio Colaborativo Latino Americano de Malformaciones Congenitas (ECLAMC), 2015, MICR ECLAMC BRAS
   Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-59
   Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-92
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Gisore P, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-15
   MARTORELL R, 1995, J NUTR, V125, pS1060
   Ministerio da Saude, 2015, EM SAUD PUBL IMP INT
   Ministerio da Saude Secretaria de Vigilancia em Saude, 2016, EM SAUD PUBL IMP INT
   Ministerio de Salud Publica y Asistencia Social (MSPAS) Instituto Nacional de Estadistica (INE), 2015, 6 ENC NAC SAL MAT IN
   MORENO MT, 1994, PEDIATR INFECT DIS J, V13, P516, DOI 10.1097/00006454-199406000-00010
   Olson DAE, 2016, ZIKA VIRUS CHI UNPUB
   Pan American Health Organization (PAHO), 2016, LIN PREL VIG MICR RE
   Pan American Health Organization (PAHO), 2015, IMPL PUBL HLTH AM
   de Araujo JSS, 2016, B WORLD HEALTH ORGAN, V94, P835, DOI 10.2471/BLT.16.170639
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   WHO, 2016, SCREEN ASS MAN NEON
NR 18
TC 3
Z9 3
U1 0
U2 2
PU US AGENCY INT DEVELOPMENT-USAID
PI BALTIMORE
PA US AGENCY INT DEVELOPMENT-USAID, BALTIMORE, MD 00000 USA
SN 2169-575X
J9 GLOB HEALTH-SCI PRAC
JI Glob. Health
PD DEC 28
PY 2017
VL 5
IS 4
BP 686
EP 696
DI 10.9745/GHSP-D-17-00116
PG 11
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FU6HW
UT WOS:000423953500015
PM 29284702
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Terradas, G
   Allen, SL
   Chenoweth, SF
   McGraw, EA
AF Terradas, Gerard
   Allen, Scott L.
   Chenoweth, Stephen F.
   McGraw, Elizabeth A.
TI Family level variation in Wolbachia-mediated dengue virus blocking in
   Aedes aegypti
SO PARASITES & VECTORS
LA English
DT Article
DE Aedes; Genetic variation; Wolbachia; Dengue virus; Evolution
ID LIFE-SHORTENING WOLBACHIA; QUANTITATIVE TRAIT LOCI; VECTOR COMPETENCE;
   COMPARATIVE SUSCEPTIBILITY; GENE-EXPRESSION; INFECTION; HOST;
   POPULATIONS; ESTABLISHMENT; STRAIN
AB Background: The mosquito vector Aedes aegypti is responsible for transmitting a range of arboviruses including dengue (DENV) and Zika (ZIKV). The global reach of these viruses is increasing due to an expansion of the mosquito's geographic range and increasing urbanization and human travel. Vector control remains the primary means for limiting these diseases. Wolbachia pipientis is an endosymbiotic bacterium of insects that has the ability to block the replication of pathogens, including flaviviruses such as DENV or ZIKV, inside the body of the vector. A strain of Wolbachia called wMel is currently being released into wild mosquito populations to test its potential to limit virus transmission to humans. The mechanism that underpins the virus blocking effect, however, remains elusive.
   Methods: We used a modified full-sib breeding design in conjunction with vector competence assays in wildtype and wMel-infected Aedes aegypti collected from the field. All individuals were injected with DENV-2 intrathoracically at 5-6 days of age. Tissues were dissected 7 days post-infection to allow quantification of DENV and Wolbachia loads.
   Results: We show the first evidence of family level variation in Wolbachia-mediated blocking in mosquitoes. This variation may stem from either genetic contributions from themosquito and Wolbachia genomes or environmental influences on Wolbachia. In these families, we also tested for correlations between strength of blocking and expression level for several insect immunity genes with possible roles in blocking, identifying two genes of interest (AGO2 and SCP-2).
   Conclusions: In this study we show variation in Wolbachia-mediated DENV blocking in Aedes aegypti that may arise from genetic contributions and environmental influences on the mosquito-Wolbachia association. This suggests that Wolbachiamediated blocking may have the ability to evolve through time or be expressed differentially across environments. The long-term efficacy of Wolbachia in the field will be dependent on the stability of blocking. Understanding the mechanism of blocking will be necessary for successful development of strategies that counter the emergence of evolved resistance or variation in its expression under diverse field conditions.
C1 [Terradas, Gerard; McGraw, Elizabeth A.] Monash Univ, Sch Biol Sci, Melbourne, Vic, Australia.
   [Allen, Scott L.; Chenoweth, Stephen F.] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia.
RP McGraw, EA (corresponding author), Monash Univ, Sch Biol Sci, Melbourne, Vic, Australia.
EM eam7@psu.edu
RI Chenoweth, Steve/A-7211-2012
OI Chenoweth, Steve/0000-0002-8303-9159; Terradas,
   Gerard/0000-0003-4285-4007; Allen, Scott/0000-0003-3933-0632
FU National Health and Medical Research Council of AustraliaNational Health
   and Medical Research Council of Australia [APP1103804]
FX The work was funded by the National Health and Medical Research Council
   of Australia (grant number: APP1103804) to EAM.
CR Amuzu HE, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005145
   Andrews ES, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003075
   Axford JK, 2016, AM J TROP MED HYG, V94, P507, DOI 10.4269/ajtmh.15-0608
   Bennett KE, 2005, GENETICS, V170, P185, DOI 10.1534/genetics.104.035634
   Bennett KE, 2002, AM J TROP MED HYG, V67, P85, DOI 10.4269/ajtmh.2002.67.85
   Bhattacharya T, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006427
   Bian GW, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002250
   Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833
   Bosio CF, 2000, GENETICS, V156, P687
   Caragata EP, 2014, MICROB ECOL, V67, P205, DOI 10.1007/s00248-013-0339-4
   Caragata EP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003459
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Carrington LB, 2010, P ROY SOC B-BIOL SCI, V277, P2059, DOI 10.1098/rspb.2010.0166
   Cho KO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022703
   Chrostek E, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003896
   Colpitts TM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002189
   Cook PE, 2006, P NATL ACAD SCI USA, V103, P18060, DOI 10.1073/pnas.0604875103
   de Abreu LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098966
   Diallo M, 2008, T ROY SOC TROP MED H, V102, P493, DOI 10.1016/j.trstmh.2008.02.010
   Dickson LB, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003153
   Dobson SL, 2001, J MED ENTOMOL, V38, P844, DOI 10.1603/0022-2585-38.6.844
   Falconer D. S., 1996, INTRO QUANTITATIVE G
   Fansiri T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003621
   Fenn K, 2006, TRENDS PARASITOL, V22, P60, DOI 10.1016/j.pt.2005.12.012
   Ferguson NM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010370
   Frentiu FD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002688
   Frentiu FD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013398
   Fu Q, 2015, J MED ENTOMOL, V52, P1124, DOI 10.1093/jme/tjv101
   GUBLER DJ, 1979, B WORLD HEALTH ORGAN, V57, P931
   Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418
   Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Hoffmann AA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003115
   Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670
   Hussain M, 2011, P NATL ACAD SCI USA, V108, P9250, DOI 10.1073/pnas.1105469108
   Ishmael N, 2009, MICROBIOL-SGM, V155, P2211, DOI 10.1099/mic.0.027581-0
   Johnson KN, 2015, VIRUSES-BASEL, V7, P5705, DOI 10.3390/v7112903
   Joubert DA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005434
   Kambris Z, 2009, SCIENCE, V326, P134, DOI 10.1126/science.1177531
   Kent BN, 2010, TRENDS MICROBIOL, V18, P173, DOI 10.1016/j.tim.2009.12.011
   Kingsolver MB, 2013, J MOL BIOL, V425, P4921, DOI 10.1016/j.jmb.2013.10.006
   Koella JC, 2003, AM NAT, V161, P698, DOI 10.1086/374202
   Lambrechts L, 2015, LANCET INFECT DIS, V15, P862, DOI 10.1016/S1473-3099(15)00091-2
   Lambrechts L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-160
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lu P, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001754
   McGraw EA, 2002, P NATL ACAD SCI USA, V99, P2918, DOI 10.1073/pnas.052466499
   McGraw EA, 2013, NAT REV MICROBIOL, V11, P181, DOI 10.1038/nrmicro2968
   McMeniman CJ, 2008, APPL ENVIRON MICROB, V74, P6963, DOI 10.1128/AEM.01038-08
   McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326
   Molloy JC, 2016, APPL ENVIRON MICROB, V82, P3109, DOI 10.1128/AEM.00275-16
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Newton ILG, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004798
   Osborne SE, 2012, APPL ENVIRON MICROB, V78, P6922, DOI 10.1128/AEM.01727-12
   Osborne SE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000656
   Pan XL, 2012, P NATL ACAD SCI USA, V109, pE23, DOI 10.1073/pnas.1116932108
   Pichon S, 2009, BIOCHEM BIOPH RES CO, V385, P557, DOI 10.1016/j.bbrc.2009.05.118
   Rainey SM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005536
   Ramos-Castaneda J, 2008, INTERVIROLOGY, V51, P335, DOI 10.1159/000175639
   Rances E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002548
   Salazar MI, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-9
   SAXTON AM, 2004, GENETIC ANAL COMPLEX
   Sylvestre G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059933
   Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002
   Terradas G, 2017, CURR OPIN INSECT SCI, V22, P37, DOI 10.1016/j.cois.2017.05.005
   Terradas G, 2017, SCI REP-UK, V7, DOI 10.1038/srep43847
   Nguyen TH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1174-x
   van den Hurk AF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001892
   Vavre F, 1999, MOL BIOL EVOL, V16, P1711, DOI 10.1093/oxfordjournals.molbev.a026084
   Voronin D, 2012, P NATL ACAD SCI USA, V109, pE1638, DOI 10.1073/pnas.1203519109
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Webster CL, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002210
   Weeks AR, 2007, PLOS BIOL, V5, P997, DOI 10.1371/journal.pbio.0050114
   White PM, 2017, GENETICS, V205, P1473, DOI 10.1534/genetics.116.198903
   Whitehorn J, 2015, J INFECT DIS, V212, P1182, DOI 10.1093/infdis/jiv173
   Wong ZS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025430
   Woolfit M, 2013, GENOME BIOL EVOL, V5, P2189, DOI 10.1093/gbe/evt169
   Xi ZY, 2005, SCIENCE, V310, P326, DOI 10.1126/science.1117607
   Ye YXH, 2016, EVOLUTION, V70, P2459, DOI 10.1111/evo.13039
   Ye YXH, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003894
   Ye YXH, 2014, AM J TROP MED HYG, V90, P422, DOI 10.4269/ajtmh.13-0186
   Ye YXH, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002362
   Ye YXH, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000385
   Yeap HL, 2011, GENETICS, V187, P583, DOI 10.1534/genetics.110.122390
   YEN JH, 1973, J INVERTEBR PATHOL, V22, P242, DOI 10.1016/0022-2011(73)90141-9
   Zhang GM, 2016, J GEN VIROL, V97, P3427, DOI 10.1099/jgv.0.000653
   Zhang GM, 2013, P NATL ACAD SCI USA, V110, P10276, DOI 10.1073/pnas.1303603110
   Zug R, 2015, BIOL REV, V90, P89, DOI 10.1111/brv.12098
NR 88
TC 4
Z9 4
U1 1
U2 15
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD DEC 28
PY 2017
VL 10
AR 622
DI 10.1186/s13071-017-2589-3
PG 12
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA FR7FY
UT WOS:000419234300001
PM 29282144
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Jun, SR
   Wassenaar, TM
   Wanchai, V
   Patumcharoenpol, P
   Nookaew, I
   Ussery, DW
AF Jun, Se-Ran
   Wassenaar, Trudy M.
   Wanchai, Visanu
   Patumcharoenpol, Preecha
   Nookaew, Intawat
   Ussery, David W.
TI Suggested mechanisms for Zika virus causing microcephaly: what do the
   genomes tell us?
SO BMC BIOINFORMATICS
LA English
DT Article; Proceedings Paper
CT 14th Annual Conference of the
   MidSouth-Computational-Biology-and-Bioinformatics-Society (MCBIOS)
CY MAR 23-25, 2017
CL Univ Arkansas, Little Rock, AR
SP MidSouth Computat Biol & Bioinformat Soc, Univ Arkansas Med Sci, Natl Ctr Toxicol Res
HO Univ Arkansas
DE Zika virus; Comparative genomics; Positive selection; Phosphorylation;
   Microcephaly
ID NEURAL STEM-CELLS; PHYLOGENETIC ANALYSIS; INFECTION; ALIGNMENT;
   SEQUENCE; DENGUE; EVOLUTION; RESPONSES; AXL
AB Background: Zika virus (ZIKV) is an emerging human pathogen. Since its arrival in the Western hemisphere, from Africa via Asia, it has become a serious threat to pregnant women, causing microcephaly and other neuropathies in developing fetuses. The mechanisms behind these teratogenic effects are unknown, although epidemiological evidence suggests that microcephaly is not associated with the original, African lineage of ZIKV. The sequences of 196 published ZIKV genomes were used to assess whether recently proposed mechanistic explanations for microcephaly are supported by molecular level changes that may have increased its virulence since the virus left Africa. For this we performed phylogenetic, recombination, adaptive evolution and tetramer frequency analyses, and compared protein sequences for the presence of protease cleavage sites, Pfam domains, glycosylation sites, signal peptides, trans-membrane protein domains, and phosphorylation sites.
   Results: Recombination events within or between Asian and Brazilian lineages were not observed, and likewise there were no differences in protease cleavage, glycosylation sites, signal peptides or trans-membrane domains between African and Brazilian strains. The frequency of Retinoic Acid Response Element (RARE) sequences was increased in Brazilian strains. Genetic adaptation was also apparent by tetramer signatures that had undergone major changes in the past but has stabilized in the Brazilian lineage despite subsequent geographic spread, suggesting the viral population presently propagates in the same host species in various regions. Evidence for selection pressure was recognized for several amino acid sites in the Brazilian lineage compared to the African lineage, mainly in nonstructural proteins, especially protein NS4B. A number of these positively selected mutations resulted in an increased potential to be phosphorylated in the Brazilian lineage compared to the African linage, which may have increased their potential to interfere with neural fetal development.
   Conclusions: ZIKV seems to have adapted to a limited number of hosts, including humans, during which its virulence increased. Its protein NS4B, together with NS4A, has recently been shown to inhibit Akt-mTOR signaling in human fetal neural stem cells, a key pathway for brain development. We hypothesize that positive selection of novel phosphorylation sites in the protein NS4B of the Brazilian lineage could interfere with phosphorylation of Akt and mTOR, impairing Akt-mTOR signaling and this may result in an increased risk for developmental neuropathies.
C1 [Jun, Se-Ran; Wanchai, Visanu; Patumcharoenpol, Preecha; Nookaew, Intawat; Ussery, David W.] Univ Arkansas Med Sci, Dept Biomed Informat, Little Rock, AR 72205 USA.
   [Wassenaar, Trudy M.] Mol Microbiol & Genom Consultants, Zotzenheim, Germany.
RP Jun, SR; Ussery, DW (corresponding author), Univ Arkansas Med Sci, Dept Biomed Informat, Little Rock, AR 72205 USA.
EM sjun@uams.edu; dwussery@uams.edu
RI amsalu, ribka/G-8780-2019; Ussery, David/J-2026-2019; Wanchai,
   Visanu/AAR-9992-2020
OI Ussery, David/0000-0003-3632-5512; Wanchai, Visanu/0000-0003-2243-3838
FU UAMS
FX No funding was obtained for this study. The publication cost of this
   article is funded by the start-up funds from UAMS.
CR Abascal F, 2010, NUCLEIC ACIDS RES, V38, pW7, DOI 10.1093/nar/gkq291
   Akiyama BM, 2016, SCIENCE, V354, P1148, DOI 10.1126/science.aah3963
   Alam A, 2016, IMMUNOLOGY, V149, P386, DOI 10.1111/imm.12656
   Armstrong Najealicka, 2017, World J Virol, V6, P1, DOI 10.5501/wjv.v6.i1.1
   Basu R, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0623-2
   Besnard M, 2014, EURO SURVEILL, V19
   Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310
   Butt AM, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.106
   Cragan JD, 2017, MMWR-MORBID MORTAL W, V66, P19, DOI 10.15585/mmwr.mm6608a4
   Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Drummond A, 2003, ADV PARASIT, V54, P331, DOI 10.1016/S0065-308X(03)54008-8
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Faizan MI, 2016, INTERVIROLOGY, V59, P152, DOI 10.1159/000452950
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344
   Gabriel E, 2017, CELL STEM CELL, V20, P397, DOI 10.1016/j.stem.2016.12.005
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Gupta Ramneek, 2002, Pac Symp Biocomput, P310
   Hamel R, 2017, INFECT GENET EVOL, V49, P134, DOI 10.1016/j.meegid.2017.01.015
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Han JF, 2016, J INFECTION, V73, P87, DOI 10.1016/j.jinf.2016.04.011
   Jun SR, 2010, P NATL ACAD SCI USA, V107, P133, DOI 10.1073/pnas.0913033107
   Keasey SL, 2017, CLIN VACCINE IMMUNOL, V24, DOI 10.1128/CVI.00036-17
   Kochakarn T, 2016, ASIAN PAC J TROP MED, V9, P1026, DOI 10.1016/j.apjtm.2016.10.002
   Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315
   Kumar A, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00403
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Liu SF, 2016, CIRC RES, V119, P1183, DOI [10.1161/CIRCRESAHA.116.309866, 10.1161/circresaha.116.309866]
   Martin DP, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev003
   McGrath EL, 2017, STEM CELL REP, V8, P715, DOI 10.1016/j.stemcr.2017.01.008
   Mirza MU, 2016, SCI REP-UK, V6, DOI 10.1038/srep37313
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nayak S, 2016, SEMIN REPROD MED, V34, P266, DOI 10.1055/s-0036-1592071
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701
   Pettersson JHO, 2016, MBIO, V7, DOI [10.1128/mBio.01239-16, 10.1128/mbio.01239-16]
   Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490
   Pride DT, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-8
   Ramaiah A, 2017, INFECT GENET EVOL, V51, P74, DOI 10.1016/j.meegid.2017.03.012
   Rivino L, 2017, IMMUNOLOGY, V150, P146, DOI 10.1111/imm.12681
   Sironi M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004978
   Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033
   Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
   Valencia A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151001
   Vellozzi C, 2014, CLIN INFECT DIS, V58, P1149, DOI 10.1093/cid/ciu005
   Verma R, 2014, J NEUROL SCI, V346, P26, DOI 10.1016/j.jns.2014.08.044
   Wang DP, 2017, SCI REP-UK, V7, DOI 10.1038/srep42580
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Weaver SC, 2017, MBIO, V8, DOI 10.1128/mBio.02063-16
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36
   Winkler CW, 2017, J IMMUNOL, V198, P3526, DOI 10.4049/jimmunol.1601949
   Wong SJ, 2017, EBIOMEDICINE, V16, P136, DOI 10.1016/j.ebiom.2017.01.008
   Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555
   Yin YX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.100
NR 60
TC 10
Z9 10
U1 3
U2 19
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2105
J9 BMC BIOINFORMATICS
JI BMC Bioinformatics
PD DEC 28
PY 2017
VL 18
SU 14
AR 471
DI 10.1186/s12859-017-1894-3
PG 12
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Mathematical & Computational Biology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Mathematical & Computational Biology
GA FR1VA
UT WOS:000418854400008
PM 29297281
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Pathak, N
   Lai, ML
   Chen, WY
   Hsieh, BW
   Yu, GY
   Yang, JM
AF Pathak, Nikhil
   Lai, Mei-Ling
   Chen, Wen-Yu
   Hsieh, Betty-Wu
   Yu, Guann-Yi
   Yang, Jinn-Moon
TI Pharmacophore anchor models of flaviviral NS3 proteases lead to drug
   repurposing for DENV infection
SO BMC BIOINFORMATICS
LA English
DT Article; Proceedings Paper
CT 16th International Conference on Bioinformatics (InCoB) - Bioinformatics
CY SEP 20-22, 2017
CL Shenzhen, PEOPLES R CHINA
DE Flaviviral NS3 proteases; DENV NS3 protease; Pharmacophore anchor
   models; Core and specific anchors; Integrated anchor-based virtual
   screening
ID ZIKA VIRUS; DENGUE; DISCOVERY; ENCEPHALITIS; ASUNAPREVIR; RESISTANCE;
   INHIBITOR; TARGETS
AB Background: Viruses of the flaviviridae family are responsible for some of the major infectious viral diseases around the world and there is an urgent need for drug development for these diseases. Most of the virtual screening methods in flaviviral drug discovery suffer from a low hit rate, strain-specific efficacy differences, and susceptibility to resistance. It is because they often fail to capture the key pharmacological features of the target active site critical for protein function inhibition. So in our current work, for the flaviviral NS3 protease, we summarized the pharmacophore features at the protease active site as anchors (subsite-moiety interactions).
   Results: For each of the four flaviviral NS3 proteases (i.e., HCV, DENV, WNV, and JEV), the anchors were obtained and summarized into 'Pharmacophore anchor (PA) models'. To capture the conserved pharmacophore anchors across these proteases, were merged the four PA models. We identified five consensus core anchors (CEH1, CH3, CH7, CV1, CV3) in all PA models, represented as the "Core pharmacophore anchor (CPA) model" and also identified specific anchors unique to the PA models. Our PA/CPA models complied with 89 known NS3 protease inhibitors. Furthermore, we proposed an integrated anchor-based screening method using the anchors from our models for discovering inhibitors. This method was applied on the DENV NS3 protease to screen FDA drugs discovering boceprevir, telaprevir and asunaprevir as promising anti-DENV candidates. Experimental testing against DV2-NGC virus by in-vitro plaque assays showed that asunaprevir and telaprevir inhibited viral replication with EC50 values of 10.4 mu M & 24.5 mu M respectively. The structure-anchor-activity relationships (SAAR) showed that our PA/CPA model anchors explained the observed in-vitro activities of the candidates. Also, we observed that the CEH1 anchor engagement was critical for the activities of telaprevir and asunaprevir while the extent of inhibitor anchor occupation guided their efficacies.
   Conclusion: These results validate our NS3 protease PA/CPA models, anchors and the integrated anchor-based screening method to be useful in inhibitor discovery and lead optimization, thus accelerating flaviviral drug discovery.
C1 [Pathak, Nikhil; Yang, Jinn-Moon] Acad Sinica, Inst Informat Sci, ITIGP Bioinformat, Taipei 115, Taiwan.
   [Pathak, Nikhil] Natl Tsing Hua Univ, Inst Struct Biol & Bioinformat, Hsinchu 30013, Taiwan.
   [Lai, Mei-Ling; Yu, Guann-Yi] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Zhunan 35053, Taiwan.
   [Chen, Wen-Yu; Hsieh, Betty-Wu] Natl Taiwan Univ, Coll Med, Grad Inst Immunol, Taipei 10617, Taiwan.
   [Pathak, Nikhil; Yang, Jinn-Moon] Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu 30050, Taiwan.
   [Yang, Jinn-Moon] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu 30050, Taiwan.
RP Yang, JM (corresponding author), Acad Sinica, Inst Informat Sci, ITIGP Bioinformat, Taipei 115, Taiwan.; Yang, JM (corresponding author), Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu 30050, Taiwan.; Yang, JM (corresponding author), Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu 30050, Taiwan.
EM moon@faculty.nctu.edu.tw
RI Yu, Guann-Yi/O-5139-2019
OI Yu, Guann-Yi/0000-0002-0580-8282
FU National Science CouncilNational Science Council of Taiwan; Ministry of
   Education; National Health Research InstitutesNational Health Research
   Institutes, JapanNational Health Research Institutes - Taiwan
   [NHRI-EX105-10504PI]; 'Centre for Bioinformatics Research of Aiming for
   the Top University Program' of the National Chiao Tung University;
   Ministry of Education, TaiwanMinistry of Education, Taiwan; Taiwan
   Protein Project [MOST105-0210-01-12-01, MOST106-0210-01-15-04]
FX The research work and the publication was funded by National Science
   Council, and partly supported by Ministry of Education and National
   Health Research Institutes [NHRI-EX105-10504PI]; 'Centre for
   Bioinformatics Research of Aiming for the Top University Program' of the
   National Chiao Tung University and Ministry of Education, Taiwan. This
   work was also partially supported by the Taiwan Protein Project
   (MOST105-0210-01-12-01 and MOST106-0210-01-15-04).
CR Ascione A, 2012, THER ADV CHRONIC DIS, V3, P113, DOI 10.1177/2040622312441496
   Beasley DWC, 2015, ANTIVIR RES, V115, P48, DOI 10.1016/j.antiviral.2014.12.010
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bollati M, 2010, ANTIVIR RES, V87, P125, DOI 10.1016/j.antiviral.2009.11.009
   Borchardt RA, 2016, JAAPA-J AM ACAD PHYS, V29, P48, DOI 10.1097/01.JAA.0000481413.11539.b1
   Brecher Matthew, 2013, Virologica Sinica, V28, P326, DOI 10.1007/s12250-013-3390-x
   Cabarcas-Montalvo M, 2016, EUR J MED CHEM, V110, P87, DOI 10.1016/j.ejmech.2015.12.030
   Chen YF, 2010, NUCLEIC ACIDS RES, V38, pW424, DOI 10.1093/nar/gkq480
   Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073
   Ferenci P, 2015, NAT REV GASTRO HEPAT, V12, P10, DOI 10.1038/nrgastro.2014.198
   Geiss BJ, 2009, FUTURE MED CHEM, V1, P327, DOI 10.4155/FMC.09.27
   Gentile I, 2014, THER CLIN RISK MANAG, V10, P493, DOI 10.2147/TCRM.S66731
   Gubler D.J., 2006, NOVART FDN SYMP, V277, P16, DOI DOI 10.1002/0470058005.CH2
   Gubler Duane J, 2006, Novartis Found Symp, V277, P3, DOI 10.1002/0470058005.ch2
   Hilgenfeldt EG, 2015, WORLD J HEPATOL, V7, P1953, DOI 10.4254/wjh.v7.i15.1953
   Hsu KC, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003127
   Hsu KC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032142
   Hsu KC, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S33
   Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277
   Ishikawa T, 2015, EXPERT OPIN THER TAR, V19, P1379, DOI 10.1517/14728222.2015.1065817
   Jesudian AB, 2013, CLIN LIVER DIS, V17, P47, DOI 10.1016/j.cld.2012.09.010
   Kleinschmidt-DeMasters BK, 2015, BRAIN PATHOL, V25, P625, DOI 10.1111/bpa.12280
   Knox J, 2012, MED J AUSTRALIA, V196, P322, DOI 10.5694/mja11.11026
   Lim SP, 2013, ANTIVIR RES, V100, P500, DOI 10.1016/j.antiviral.2013.09.013
   Liu TQ, 2007, NUCLEIC ACIDS RES, V35, pD198, DOI 10.1093/nar/gkl999
   Lorenz IC, 2006, NATURE, V442, P831, DOI 10.1038/nature04975
   Luo DH, 2015, ANTIVIR RES, V118, P148, DOI 10.1016/j.antiviral.2015.03.014
   Nabel GJ, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf4548
   Nedjadi T, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0444-8
   Noble CG, 2012, J VIROL, V86, P438, DOI 10.1128/JVI.06225-11
   Ong CW, 2016, INTERN MED J, V46, P525, DOI 10.1111/imj.13059
   Poulsen A, 2014, CURR PHARM DESIGN, V20, P3422, DOI 10.2174/13816128113199990633
   Ranjit S, 2011, PEDIATR CRIT CARE ME, V12, P90, DOI 10.1097/PCC.0b013e3181e911a7
   Romano KP, 2010, P NATL ACAD SCI USA, V107, P20986, DOI 10.1073/pnas.1006370107
   Sampath A, 2009, ANTIVIR RES, V81, P6, DOI 10.1016/j.antiviral.2008.08.004
   Shindyalov IN, 1998, PROTEIN ENG, V11, P739, DOI 10.1093/protein/11.9.739
   Shiryaev SA, 2010, FUTURE VIROL, V5, P593, DOI 10.2217/FVL.10.39
   Soumana DI, 2014, ACS CHEM BIOL, V9, P2485, DOI 10.1021/cb5006118
   Talwani R, 2012, DRUG TODAY, V48, P219, DOI 10.1358/dot.2012.48.3.1740457
   Tomlinson SM, 2009, ANTIVIR RES, V82, P110, DOI 10.1016/j.antiviral.2009.02.190
   Vicente CR, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1668-y
   Weinert T, 2015, NAT METHODS, V12, P131, DOI 10.1038/nmeth.3211
   Yang JM, 2004, PROTEINS, V55, P288, DOI 10.1002/prot.20035
   Zhang XQ, 2016, ACTA PHARM SIN B, V6, P26, DOI 10.1016/j.apsb.2015.09.008
NR 44
TC 3
Z9 3
U1 0
U2 11
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2105
J9 BMC BIOINFORMATICS
JI BMC Bioinformatics
PD DEC 28
PY 2017
VL 18
SU 16
AR 548
DI 10.1186/s12859-017-1957-5
PG 13
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Mathematical & Computational Biology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Mathematical & Computational Biology
GA FR1VI
UT WOS:000418855300004
PM 29297305
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Lannes, N
   Eppler, E
   Etemad, S
   Yotovski, P
   Filgueira, L
AF Lannes, Nils
   Eppler, Elisabeth
   Etemad, Samar
   Yotovski, Peter
   Filgueira, Luis
TI Microglia at center stage: a comprehensive review about the versatile
   and unique residential macrophages of the central nervous system
SO ONCOTARGET
LA English
DT Review
DE microglia; neuroinflammation; neurodegeneration; virus infection; brain
   cancer
ID IN-VIVO; HIPPOCAMPAL NEUROGENESIS; NEURODEGENERATIVE DISEASES; ADULT
   NEUROGENESIS; TRAUMATIC BRAIN; MOUSE MODEL; ZIKA VIRUS; TRANSCRIPTOME
   SIGNATURE; ACTIVATED MICROGLIA; NEUROVASCULAR UNIT
AB Microglia cells are the unique residential macrophages of the central nervous system (CNS). They have a special origin, as they derive from the embryonic yolk sac and enter the developing CNS at a very early stage. They play an important role during CNS development and adult homeostasis. They have a major contribution to adult neurogenesis and neuroinflammation. Thus, they participate in the pathogenesis of neurodegenerative diseases and contribute to aging. They play an important role in sustaining and breaking the blood-brain barrier. As innate immune cells, they contribute substantially to the immune response against infectious agents affecting the CNS. They play also a major role in the growth of tumours of the CNS. Microglia are consequently the key cell population linking the nervous and the immune system. This review covers all different aspects of microglia biology and pathology in a comprehensive way.
C1 [Lannes, Nils; Yotovski, Peter; Filgueira, Luis] Univ Fribourg, Dept Med, Anat, CH-1700 Fribourg, Switzerland.
   [Eppler, Elisabeth] Univ Basel, Dept BioMed, Pestalozzistr Zo, CH-4056 Basel, Switzerland.
   [Etemad, Samar] Univ Queensland, Ctr Clin Res, Bldg 71-218 RBWH Herston, Brisbane, Qld 4029, Australia.
RP Filgueira, L (corresponding author), Univ Fribourg, Dept Med, Anat, CH-1700 Fribourg, Switzerland.
EM luis.filgueira@unifr.ch
OI Filgueira, Luis/0000-0002-2266-6650
CR Abou-El-Ardat K, 2017, NEURO-ONCOLOGY, V19, P546, DOI 10.1093/neuonc/now231
   Aguzzi A, 2013, SCIENCE, V339, P156, DOI 10.1126/science.1227901
   Ahmed Z, 2007, J HISTOCHEM CYTOCHEM, V55, P687, DOI 10.1369/jhc.6A7156.2007
   Aniol VA, 2016, NEUROCHEM J+, V10, P1, DOI 10.1134/S1819712415040030
   Anttila JE, 2017, PROG NEURO-PSYCHOPH, V79, P3, DOI 10.1016/j.pnpbp.2016.07.003
   Arcuri C, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00191
   Arnoux I, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/689404
   Ascoli BM, 2016, AUST NZ J PSYCHIAT, V50, P618, DOI 10.1177/0004867416642846
   Asheuer M, 2004, P NATL ACAD SCI USA, V101, P3557, DOI 10.1073/pnas.0306431101
   Askew K, 2017, CELL REP, V18, P391, DOI 10.1016/j.celrep.2016.12.041
   Astell KR, 2017, METHOD CELL BIOL, V138, P593, DOI 10.1016/bs.mcb.2016.10.001
   Atallah N, 2014, ROM J MORPHOL EMBRYO, V55, P745
   Bardehle S, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00354
   Barichello T, 2016, MOL NEUROBIOL, V53, P1770, DOI 10.1007/s12035-015-9107-4
   Barr CM, 2015, NEUROSCI LETT, V588, P196, DOI 10.1016/j.neulet.2015.01.023
   Bayerl SH, 2016, GLIA, V64, P1210, DOI 10.1002/glia.22994
   Beins E, 2016, GLIA, V64, P1007, DOI 10.1002/glia.22979
   Benedek G, 2017, J NEUROIMMUNOL, V310, P51, DOI 10.1016/j.jneuroim.2017.06.007
   Benedek G, 2016, J NEUROIMMUNOL, V293, P45, DOI 10.1016/j.jneuroim.2016.02.009
   Bergon A, 2015, SCHIZOPHR RES, V168, P434, DOI 10.1016/j.schres.2015.08.010
   Beutner C, 2013, GLIA, V61, P1429, DOI 10.1002/glia.22524
   Bhatt RS, 2015, IMMUNOBIOLOGY, V220, P1170, DOI 10.1016/j.imbio.2015.06.002
   Biber K, 2014, GLIA, V62, P841, DOI 10.1002/glia.22654
   Bickford PC, 2017, EXP GERONTOL, V94, P4, DOI 10.1016/j.exger.2017.01.027
   Bieber K, 2015, IMMUNOBIOLOGY, V220, P215, DOI 10.1016/j.imbio.2014.10.025
   Biedermann SV, 2016, HORM BEHAV, V86, P45, DOI 10.1016/j.yhbeh.2016.09.007
   Biesecker KR, 2016, J NEUROSCI, V36, P9435, DOI 10.1523/JNEUROSCI.1782-16.2016
   Bisht K, 2016, GLIA, V64, P826, DOI 10.1002/glia.22966
   Blanchette M, 2015, MECH DEVELOP, V138, P8, DOI 10.1016/j.mod.2015.07.007
   Bodea LG, 2014, J NEUROSCI, V34, P8546, DOI 10.1523/JNEUROSCI.5002-13.2014
   Bowyer JF, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0526-6
   Brandenburg S, 2016, ACTA NEUROPATHOL, V131, P365, DOI 10.1007/s00401-015-1529-6
   Brawek B, 2017, CELL CALCIUM, V64, P109, DOI 10.1016/j.ceca.2017.02.011
   Brehin AC, 2008, J IMMUNOL, V180, P6760, DOI 10.4049/jimmunol.180.10.6760
   Brites D, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00117
   Brown GC, 2015, BRAIN RES, V1628, P288, DOI 10.1016/j.brainres.2015.08.031
   Brown GC, 2014, NAT REV NEUROSCI, V15, P209, DOI 10.1038/nrn3710
   Burguillos M.A., 2015, CELL REP
   Buschert J, 2016, PROG NEURO-PSYCHOPH, V67, P10, DOI 10.1016/j.pnpbp.2016.01.005
   Cai W, 2017, AGEING RES REV, V34, P77, DOI 10.1016/j.arr.2016.09.006
   Carpenter JE, 2016, J VIROL, V90, P379, DOI 10.1128/JVI.02389-15
   da Fonseca ACC, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00362
   Casano AM, 2016, CELL REP, V16, P897, DOI 10.1016/j.celrep.2016.06.033
   Casano AM, 2015, DEV CELL, V32, P469, DOI 10.1016/j.devcel.2015.01.018
   Chang AL, 2016, CANCER RES, V76, P5671, DOI 10.1158/0008-5472.CAN-16-0144
   Chang CF, 2017, NEUROBIOL DIS, V103, P54, DOI 10.1016/j.nbd.2017.03.016
   Chang KC, 2016, BIOCHEM BIOPH RES CO, V473, P565, DOI 10.1016/j.bbrc.2016.03.122
   Cheng ZQ, 2016, JOURNAL PRACT, V10, P744, DOI [10.1111/jnc.13062, 10.1080/17512786.2015.1063079]
   Cherry JD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-98
   Chesnokova V, 2016, BRAIN BEHAV IMMUN, V58, P1, DOI 10.1016/j.bbi.2016.01.017
   Chhor V, 2017, BRAIN BEHAV IMMUN, V63, P197, DOI 10.1016/j.bbi.2016.11.001
   Chinnery HR, 2017, PFLUG ARCH EUR J PHY, V469, P501, DOI 10.1007/s00424-017-1947-5
   Claude J, 2013, J NEUROSCI, V33, P18270, DOI 10.1523/JNEUROSCI.2211-13.2013
   Claypoole LD, 2017, BRAIN BEHAV IMMUN, V59, P135, DOI 10.1016/j.bbi.2016.08.017
   Colton CA, 2009, J NEUROIMMUNE PHARM, V4, P399, DOI 10.1007/s11481-009-9164-4
   Daneman R, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020412
   Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513
   Das A, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1728-5
   Das Sarma J, 2014, J NEUROVIROL, V20, P122, DOI 10.1007/s13365-013-0188-4
   David S, 2015, NEUROSCIENCE, V307, P311, DOI 10.1016/j.neuroscience.2015.08.064
   de Cossio LF, 2017, BRAIN BEHAV IMMUN, V63, P88, DOI 10.1016/j.bbi.2016.09.028
   De Luca SN, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0578-7
   De Lucia C, 2016, BRAIN BEHAV IMMUN, V55, P179, DOI 10.1016/j.bbi.2015.11.001
   Dejda A, 2016, INVEST OPHTH VIS SCI, V57, P1530, DOI 10.1167/iovs.15-18598
   del Rio-Hortega P, 1939, LANCET, V1, P1023
   Dello Russo C, 2017, CURR CANCER DRUG TAR, V17, P267, DOI 10.2174/1568009616666160813191240
   Derecki NC, 2012, NATURE, V484, P105, DOI 10.1038/nature10907
   Doens D, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-48
   Doorn KJ, 2015, FRONT CELL NEUROSCI, V9, DOI [10.3339/fncel.2015.00084, 10.3389/fncel.2015.00084]
   Douvaras P, 2017, STEM CELL REP, V8, P1516, DOI 10.1016/j.stemcr.2017.04.023
   Ellert-Miklaszewska A, 2016, ONCOGENE, V35, P6366, DOI 10.1038/onc.2016.55
   Elmore MRP, 2014, NEURON, V82, P380, DOI 10.1016/j.neuron.2014.02.040
   Erny D, 2015, NAT NEUROSCI, V18, P965, DOI 10.1038/nn.4030
   Etemad S, 2012, J NEUROSCI METH, V209, P79, DOI 10.1016/j.jneumeth.2012.05.025
   Eyo UB, 2017, GLIA, V65, P5, DOI 10.1002/glia.23006
   Fonseca RS, 2016, STEM CELLS DEV, V25, P542, DOI 10.1089/scd.2015.0319
   Fricker M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-196
   Frost JL, 2016, TRENDS CELL BIOL, V26, P587, DOI 10.1016/j.tcb.2016.02.006
   Fu RY, 2014, MOL NEUROBIOL, V49, P1422, DOI 10.1007/s12035-013-8620-6
   Fumagalli S, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00081
   Furman D, 2017, NAT MED, V23, P174, DOI 10.1038/nm.4267
   Furr SR, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00201
   Gajardo-Gomez R, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00086
   Gao WW, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00281
   Gao ZW, 2013, MOL NEUROBIOL, V48, P690, DOI 10.1007/s12035-013-8460-4
   Garcia-Mesa Y, 2017, J NEUROVIROL, V23, P47, DOI 10.1007/s13365-016-0499-3
   Gelosa P, 2014, J CEREBR BLOOD F MET, V34, P979, DOI 10.1038/jcbfm.2014.45
   Gemma C, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00229
   Ghoochani A, 2016, ONCOTARGET, V7, P1838, DOI 10.18632/oncotarget.6550
   Giannoni P, 2016, NEUROBIOL DIS, V88, P107, DOI 10.1016/j.nbd.2016.01.001
   Gieryng A, 2016, WSPOLCZESNA ONKOL, V20, P345, DOI 10.5114/wo.2016.64592
   Gimeno-Bayon J, 2014, J NEUROSCI RES, V92, P723, DOI 10.1002/jnr.23356
   Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637
   Gitik M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-24
   Gnann JW, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0568-7
   Goldmann T, 2016, NAT IMMUNOL, V17, P797, DOI 10.1038/ni.3423
   Gordon S, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0392-4
   Gosselin D, 2017, SCIENCE, V356, DOI 10.1126/science.aal3222
   Grabert K, 2016, NAT NEUROSCI, V19, P504, DOI 10.1038/nn.4222
   Grace PM, 2014, NAT REV IMMUNOL, V14, P217, DOI 10.1038/nri3621
   Grauwet K, 2016, NAT IMMUNOL, V17, P1240, DOI 10.1038/ni.3586
   Greter M, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00249
   Greter M, 2012, IMMUNITY, V37, P1050, DOI 10.1016/j.immuni.2012.11.001
   Grier BD, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00178
   Gu R, 2017, NEUROCHEM RES, V42, P1478, DOI 10.1007/s11064-017-2204-1
   Guo YJ, 2015, LIFE SCI, V127, P12, DOI 10.1016/j.lfs.2015.01.036
   Guruswamy R, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030496
   Gyoneva S, 2014, GLIA, V62, P1345, DOI 10.1002/glia.22686
   Hadas S, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-166
   Haenseler W, 2017, STEM CELL REP, V8, P1727, DOI 10.1016/j.stemcr.2017.05.017
   Hanamsagar R, 2012, TRENDS IMMUNOL, V33, P333, DOI 10.1016/j.it.2012.03.001
   Hattori Y, 2015, J NEUROSCI, V35, P3915, DOI 10.1523/JNEUROSCI.3970-14.2015
   Heiman A, 2014, BRAIN BEHAV IMMUN, V42, P232, DOI 10.1016/j.bbi.2014.06.203
   Hellwig S, 2016, BRAIN BEHAV IMMUN, V55, P126, DOI 10.1016/j.bbi.2015.11.008
   Heneka MT, 2015, NAT IMMUNOL, V16, P229, DOI 10.1038/ni.3102
   Herz J, 2017, IMMUNITY, V46, P943, DOI 10.1016/j.immuni.2017.06.007
   Hilla AM, 2017, J NEUROSCI, V37, P6113, DOI 10.1523/JNEUROSCI.0584-17.2017
   Hines DJ, 2009, GLIA, V57, P1610, DOI 10.1002/glia.20874
   Hirasawa T, 2005, J NEUROSCI RES, V81, P357, DOI 10.1002/jnr.20480
   Hirbec HE, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00227
   Hoeffel G, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00486
   Hoeffel G, 2015, IMMUNITY, V42, P665, DOI 10.1016/j.immuni.2015.03.011
   Holtman IR, 2017, GLIA, V65, P460, DOI 10.1002/glia.23104
   Hoogland ICM, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0332-6
   Hooper C, 2009, FEBS LETT, V583, P3461, DOI 10.1016/j.febslet.2009.09.049
   Horgusluoglu E, 2017, AM J MED GENET B, V174, P93, DOI 10.1002/ajmg.b.32429
   Horng S, 2017, J CLIN INVEST, V127, P3136, DOI 10.1172/JCI91301
   Hutchinson AJ, 2009, NEUROCHEM INT, V54, P439, DOI 10.1016/j.neuint.2009.01.018
   Hwang JS, 2016, J NEUROIMMUNOL, V298, P165, DOI 10.1016/j.jneuroim.2016.08.001
   Imai Y, 1996, BIOCHEM BIOPH RES CO, V224, P855, DOI 10.1006/bbrc.1996.1112
   Inta D, 2017, SCHIZOPHRENIA BULL, V43, P493, DOI 10.1093/schbul/sbw088
   Jhan MK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00182-z
   Jin N, 2017, MOL NEUROBIOL, V54, P4094, DOI 10.1007/s12035-016-9960-9
   Joers V, 2017, PROG NEUROBIOL, V155, P57, DOI 10.1016/j.pneurobio.2016.04.006
   Kemmerling N, 2017, GLIA, V65, P1103, DOI 10.1002/glia.23147
   Kierdorf K, 2013, NAT NEUROSCI, V16, P273, DOI 10.1038/nn.3318
   Kim E, 2016, NEUROTHERAPEUTICS, V13, P702, DOI 10.1007/s13311-016-0463-1
   Klein B, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00169
   Kleinberger G, 2017, EMBO J, V36, P1837, DOI 10.15252/embj.201796516
   Kober DL, 2017, J MOL BIOL, V429, P1607, DOI 10.1016/j.jmb.2017.04.004
   Koellhoffer EC, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040769
   Koguchi K, 2003, J NEUROSCI RES, V74, P898, DOI 10.1002/jnr.10829
   Kopatz J, 2013, GLIA, V61, P1122, DOI 10.1002/glia.22501
   Lake EMR, 2017, J MAGN RESON IMAGING, V46, P505, DOI 10.1002/jmri.25541
   Lake EMR, 2017, NEUROIMAGE, V146, P869, DOI 10.1016/j.neuroimage.2016.09.016
   Lannes N, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0931-5
   Lannes N, 2017, VIROL J, V14, DOI 10.1186/s12985-016-0675-3
   Lee JK, 2009, J NEUROIMMUNE PHARM, V4, P419, DOI 10.1007/s11481-009-9176-0
   Lee JH, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0575-x
   Lehmann ML, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0672-x
   Lehnardt S, 2010, GLIA, V58, P253, DOI 10.1002/glia.20928
   Lelekov-Boissard T, 2009, PHILOS T R SOC A, V367, P4699, DOI 10.1098/rsta.2009.0184
   Leone C, 2006, GLIA, V54, P183, DOI 10.1002/glia.20372
   Leyns CEG, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0192-x
   Li B, 2009, J INNATE IMMUN, V1, P570, DOI 10.1159/000235563
   Li F, 2015, J VIROL, V89, P5602, DOI 10.1128/JVI.00143-15
   Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029
   Lim DA, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a018820
   Linnartz-Gerlach B, 2014, NEUROSCIENCE, V275, P113, DOI 10.1016/j.neuroscience.2014.05.061
   Linnartz-Gerlach B, 2014, GLYCOBIOLOGY, V24, P794, DOI 10.1093/glycob/cwu044
   Lively S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-75
   Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018
   Lopes RS, 2016, J BIOSCIENCES, V41, P381, DOI 10.1007/s12038-016-9621-1
   Lou NH, 2016, P NATL ACAD SCI USA, V113, P1074, DOI 10.1073/pnas.1520398113
   Lum FM, 2017, CLIN INFECT DIS, V64, P914, DOI 10.1093/cid/ciw878
   Luo C, 2017, NEUROPSYCH DIS TREAT, V13, P1661, DOI 10.2147/NDT.S140634
   Luo C, 2016, GLIA, V64, P1508, DOI 10.1002/glia.23018
   Lyman M, 2014, NEUROSCI RES, V79, P1, DOI 10.1016/j.neures.2013.10.004
   Lyons DA, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020586
   Ma YB, 2017, MOL NEUROBIOL, V54, P3717, DOI 10.1007/s12035-016-9939-6
   Macht VA, 2016, NEUROSCI BIOBEHAV R, V71, P267, DOI 10.1016/j.neubiorev.2016.08.039
   Madry C, 2015, J BIOL CHEM, V290, P12443, DOI 10.1074/jbc.R115.637157
   Maggi R, 2015, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00440
   Masuch A, 2016, GLIA, V64, P76, DOI 10.1002/glia.22904
   Masuda T, 2016, ACS CHEM NEUROSCI, V7, P428, DOI 10.1021/acschemneuro.5b00317
   Mathiisen TM, 2010, GLIA, V58, P1094, DOI 10.1002/glia.20990
   Matsuda T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7514
   Mattei D, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.80
   Maurya SK, 2017, J CHEM NEUROANAT, V82, P60, DOI 10.1016/j.jchemneu.2017.05.002
   Mayhew J, 2015, J NEUROENDOCRINOL, V27, P498, DOI 10.1111/jne.12273
   Maysami S, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0359-8
   Mazaheri F, 2017, EMBO REP, V18, P1186, DOI 10.15252/embr.201743922
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Melief J, 2016, GLIA, V64, P1857, DOI 10.1002/glia.23023
   Melief J, 2012, GLIA, V60, P1506, DOI 10.1002/glia.22370
   Michels M, 2017, J NEUROIMMUNOL, V303, P90, DOI 10.1016/j.jneuroim.2016.12.015
   Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015
   Miner JJ, 2016, CURR OPIN IMMUNOL, V38, P18, DOI 10.1016/j.coi.2015.10.008
   Minocha S, 2017, SCI REP-UK, V7, DOI 10.1038/srep43093
   Mitrasinovic OM, 2005, J NEUROSCI, V25, P4442, DOI 10.1523/JNEUROSCI.0514-05.2005
   Miyata M, 2016, BRAIN RES, V1649, P90, DOI 10.1016/j.brainres.2016.08.023
   Miyauchi JT, 2016, TRANSL CANCER RES, V5, pS648, DOI 10.21037/tcr.2016.10.16
   Mizee MR, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0418-8
   Moritz C, 2015, NEUROSCI LETT, V591, P13, DOI 10.1016/j.neulet.2015.02.004
   Morocoima A, 2012, PARASITOL RES, V111, P2099, DOI 10.1007/s00436-012-3057-9
   Mosher KI, 2014, BIOCHEM PHARMACOL, V88, P594, DOI 10.1016/j.bcp.2014.01.008
   Mosser CA, 2017, PROG NEUROBIOL, V149-150, P1, DOI 10.1016/j.pneurobio.2017.01.002
   Mracsko E, 2014, STROKE, V45, P2107, DOI 10.1161/STROKEAHA.114.005801
   Muccigrosso MM, 2016, BRAIN BEHAV IMMUN, V54, P95, DOI 10.1016/j.bbi.2016.01.009
   Sheridan GK, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130181
   Naaldijk YM, 2016, BIOL CHEM, V397, P283, DOI 10.1515/hsz-2015-0257
   Nakagawa Y, 2015, PHARMACOL THERAPEUT, V154, P21, DOI 10.1016/j.pharmthera.2015.06.010
   Napoli I, 2009, GLIA, V57, P1660, DOI 10.1002/glia.20878
   Nayak D, 2014, ANNU REV IMMUNOL, V32, P367, DOI 10.1146/annurev-immunol-032713-120240
   Nelson LH, 2017, BRAIN BEHAV IMMUN, V64, P11, DOI 10.1016/j.bbi.2017.03.010
   Neniskyte U, 2016, INT J BIOCHEM CELL B, V81, P346, DOI 10.1016/j.biocel.2016.06.005
   Neumann J, 2015, ACTA NEUROPATHOL, V129, P259, DOI 10.1007/s00401-014-1355-2
   Nishimura C, 2016, JOVE-J VIS EXP, DOI 10.3791/53582
   Nissen JC, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030561
   Nistico R, 2017, MOL BRAIN, V10, DOI 10.1186/s13041-017-0308-9
   Noristani HN, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00090
   Novoselov VV, 2015, EXP MOL PATHOL, V99, P575, DOI 10.1016/j.yexmp.2015.09.014
   O'Sullivan SA, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0659-7
   Ohgidani M, 2014, SCI REP-UK, V4, DOI 10.1038/srep04957
   Olah M, 2012, GLIA, V60, P96, DOI 10.1002/glia.21251
   Orihuela R, 2016, BRIT J PHARMACOL, V173, P649, DOI 10.1111/bph.13139
   Owens R, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00056
   Pang Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164403
   Paolicelli RC, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00129
   Parisi C, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/2989548
   Peferoen L, 2013, GLIA, V61, pS164
   Pena-Altamira E, 2016, EXPERT OPIN THER TAR, V20, P627, DOI 10.1517/14728222.2016.1121237
   Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989
   Petrik D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072819
   Pflugrad H, 2016, J VIRAL HEPATITIS, V23, P348, DOI 10.1111/jvh.12496
   Pinheiro MAL, 2016, BBA-MOL BASIS DIS, V1862, P461, DOI 10.1016/j.bbadis.2015.10.018
   Pistikova A, 2017, PHYSIOL RES, V66, P441, DOI 10.33549/physiolres.933627
   Poniatowski LA, 2017, MOL NEUROBIOL, V54, P2167, DOI 10.1007/s12035-016-9787-4
   Ponomarev ED, 2005, J IMMUNOL METHODS, V300, P32, DOI 10.1016/j.jim.2005.02.011
   Poon CC, 2017, BRAIN, V140, P1548, DOI 10.1093/brain/aww355
   Prinz M, 2011, NAT NEUROSCI, V14, P1227, DOI 10.1038/nn.2923
   Qi FF, 2016, BRAIN BEHAV IMMUN, V53, P72, DOI 10.1016/j.bbi.2015.11.006
   Raj D, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00206
   Ransohoff RM, 2016, NAT NEUROSCI, V19, P987, DOI 10.1038/nn.4338
   Ransohoff RM, 2015, NEUROTHERAPEUTICS, V12, P896, DOI 10.1007/s13311-015-0385-3
   Rao VR, 2014, AIDS RES THER, V11, DOI 10.1186/1742-6405-11-13
   Reus GZ, 2015, NEUROSCIENCE, V300, P141, DOI 10.1016/j.neuroscience.2015.05.018
   Riquier AJ, 2017, NEUROSCIENCE, V355, P36, DOI 10.1016/j.neuroscience.2017.04.037
   Rosenberg GA, 2017, CLIN SCI, V131, P425, DOI 10.1042/CS20160604
   Rossi F, 2015, CELL REP, V11, P1008, DOI 10.1016/j.celrep.2015.04.028
   Safaiyan S, 2016, NAT NEUROSCI, V19, P995, DOI 10.1038/nn.4325
   Saijo K, 2013, GLIA, V61, P104, DOI 10.1002/glia.22423
   Sakuma R, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0523-9
   Salimi K, 2002, NEUROSCI RES, V43, P221, DOI 10.1016/S0168-0102(02)00036-6
   Salter MW, 2014, CELL, V158, P15, DOI 10.1016/j.cell.2014.06.008
   Santos CC, 2017, TOXICOL IN VITRO, V42, P54, DOI 10.1016/j.tiv.2017.04.004
   Sato K, 2015, GLIA, V63, P1394, DOI 10.1002/glia.22858
   Schafer DP, 2013, J NEUROCHEM, V125, P65
   Schafer DP, 2016, ELIFE, V5, DOI 10.7554/eLife.15224
   Schafer DP, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020545
   Schlachetzki JCM, 2009, CURR ALZHEIMER RES, V6, P554, DOI 10.2174/156720509790147179
   Schreuder L, 2017, BRAIN BEHAV IMMUN, V62, P362, DOI 10.1016/j.bbi.2017.01.010
   Seifert HA, 2017, CELL IMMUNOL, V318, P49, DOI 10.1016/j.cellimm.2017.06.003
   Sellner S, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0374-8
   Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001
   Seong KJ, 2016, KOREAN J PHYSIOL PHA, V20, P41, DOI 10.4196/kjpp.2016.20.1.41
   Shao Q, 2016, DEVELOPMENT, V143, P4127, DOI 10.1242/dev.143768
   Shaw AC, 2013, NAT REV IMMUNOL, V13, P875, DOI 10.1038/nri3547
   Sherwin E, 2016, CURR OPIN GASTROEN, V32, P96, DOI 10.1097/MOG.0000000000000244
   Shigemoto-Mogami Y, 2014, J NEUROSCI, V34, P2231, DOI 10.1523/JNEUROSCI.1619-13.2014
   Sieger D, 2013, GLIA, V61, P3, DOI 10.1002/glia.22385
   Sierra A, 2014, NEURAL PLAST, V2014, DOI 10.1155/2014/610343
   Sierra A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00006
   Smith AM, 2014, TRENDS NEUROSCI, V37, P125, DOI 10.1016/j.tins.2013.12.001
   Smolders SMT, 2017, GLIA, V65, P1072, DOI 10.1002/glia.23145
   Solary E, 2014, J LEUKOCYTE BIOL, V95, P3, DOI 10.1189/jlb.0813466
   Sousa C, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00198
   Spangenberg EE, 2017, BRAIN BEHAV IMMUN, V61, P1, DOI 10.1016/j.bbi.2016.07.003
   Spittau B, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00194
   Squarzoni P, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00248
   Squarzoni P, 2014, CELL REP, V8, P1271, DOI 10.1016/j.celrep.2014.07.042
   Stankovic ND, 2016, ACTA NEUROPATHOL, V131, P347, DOI 10.1007/s00401-015-1524-y
   Staszewski O, 2014, CELL TISSUE RES, V356, P609, DOI 10.1007/s00441-014-1815-y
   Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036
   Strecker JK, 2017, NEUROCHEM INT, V107, P117, DOI 10.1016/j.neuint.2016.11.006
   Sun R, 2016, MOL PAIN, V12, DOI 10.1177/1744806916679166
   Svahn AJ, 2016, DEV NEUROBIOL, V76, P507, DOI 10.1002/dneu.22328
   Svahn AJ, 2013, DEV NEUROBIOL, V73, P60, DOI 10.1002/dneu.22039
   Swinnen N, 2013, GLIA, V61, P150, DOI 10.1002/glia.22421
   Takata K, 2017, IMMUNITY, V47, P183, DOI 10.1016/j.immuni.2017.06.017
   Talia DM, 2016, ARTERIOSCL THROM VAS, V36, P1186, DOI 10.1161/ATVBAHA.115.307080
   Tang Y, 2016, MOL NEUROBIOL, V53, P1181, DOI 10.1007/s12035-014-9070-5
   Tauber SC, 2016, HIV MED, V17, P143, DOI 10.1111/hiv.12288
   Tay TL, 2016, CURR OPIN NEUROBIOL, V39, P30, DOI 10.1016/j.conb.2016.04.003
   Teo JD, 2017, BRAIN BEHAV IMMUN, V63, P186, DOI 10.1016/j.bbi.2016.10.010
   Terry RL, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-270
   Tonchev AB, 2008, J NEUROIMMUNOL, V205, P20, DOI 10.1016/j.jneuroim.2008.07.016
   Tso FY, 2017, J INFECT DIS, V215, P1898, DOI 10.1093/infdis/jiw545
   Tu J, 2015, J MOL NEUROSCI, V56, P509, DOI 10.1007/s12031-015-0553-2
   Tay TL, 2017, J PHYSIOL-LONDON, V595, P1929, DOI 10.1113/JP272134
   Valero J, 2016, ACS CHEM NEUROSCI, V7, P442, DOI 10.1021/acschemneuro.6b00009
   VanRyzin JW, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0297-16.2016
   Varvel NH, 2016, P NATL ACAD SCI USA, V113, pE5665, DOI 10.1073/pnas.1604263113
   Vecino E, 2016, PROG RETIN EYE RES, V51, P1, DOI 10.1016/j.preteyeres.2015.06.003
   Vinet J, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-27
   Wake H, 2009, J NEUROSCI, V29, P3974, DOI 10.1523/JNEUROSCI.4363-08.2009
   Walker FR, 2014, BRAIN BEHAV IMMUN, V37, P1, DOI 10.1016/j.bbi.2013.12.010
   Walls JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002853
   Wang CY, 2016, MOL NEUROBIOL, V53, P6774, DOI 10.1007/s12035-015-9600-9
   Wang HT, 2017, NEUROTOX RES, V31, P505, DOI 10.1007/s12640-016-9696-3
   Weinstein JR, 2005, J NEUROCHEM, V95, P1177, DOI 10.1111/j.1471-4159.2005.03499.x
   Weissleder C, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00274
   Werneburg S, 2016, GLIA, V64, P1314, DOI 10.1002/glia.23004
   Wijesundera KK, 2014, EXP MOL PATHOL, V96, P382, DOI 10.1016/j.yexmp.2014.04.003
   Wolf G, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00191
   Wu R, 2017, MOL BRAIN, V10, DOI 10.1186/s13041-017-0296-9
   Wu XL, 2016, J NEUROIMMUNE PHARM, V11, P572, DOI 10.1007/s11481-016-9654-0
   Xavier ALR, 2015, J NEUROSCI, V35, P11848, DOI 10.1523/JNEUROSCI.1217-15.2015
   Xiong XY, 2016, PROG NEUROBIOL, V142, P23, DOI 10.1016/j.pneurobio.2016.05.001
   Xu HZ, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/5405104
   Xu J, 2016, DEV CELL, V38, P214, DOI 10.1016/j.devcel.2016.06.018
   Yadav A, 2009, J NEUROIMMUNE PHARM, V4, P430, DOI 10.1007/s11481-009-9174-2
   Yang JH, 2016, BRAIN RES BULL, V120, P25, DOI 10.1016/j.brainresbull.2015.10.012
   Yang LY, 2017, NAT PROD RES, V31, P487, DOI 10.1080/14786419.2016.1190719
   Yip PK, 2017, SCI REP-UK, V7, DOI 10.1038/srep41689
   Yirmiya R, 2015, TRENDS NEUROSCI, V38, P637, DOI 10.1016/j.tins.2015.08.001
   Yu T, 2017, BLOOD, V129, P509, DOI 10.1182/blood-2016-07-727651
   Yun SI, 2017, J MICROBIOL, V55, P204, DOI 10.1007/s12275-017-7063-6
   Zabel MK, 2013, AGEING RES REV, V12, P749, DOI 10.1016/j.arr.2013.02.001
   Zhang HW, 2016, ONCOTARGET, V7, P50099, DOI 10.18632/oncotarget.10318
   Zhang JM, 2003, EXP NEUROL, V183, P469, DOI 10.1016/S0014-4886(03)00222-X
   Zhong L, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00204
NR 322
TC 29
Z9 31
U1 1
U2 21
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
EI 1949-2553
J9 ONCOTARGET
JI Oncotarget
PD DEC 26
PY 2017
VL 8
IS 69
BP 114393
EP 114413
DI 10.18632/oncotarget.23106
PG 21
WC Oncology; Cell Biology
SC Oncology; Cell Biology
GA FS1WV
UT WOS:000419570400084
PM 29371994
OA Other Gold, Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Geiser, DL
   Patel, N
   Patel, P
   Bhakta, J
   Velasquez, LS
   Winzerling, JJ
AF Geiser, Dawn L.
   Patel, Naren
   Patel, Pritesh
   Bhakta, Janki
   Velasquez, Lissette S.
   Winzerling, Joy J.
TI Description of a Second Ferritin Light Chain Homologue From the Yellow
   Fever Mosquito (Diptera: Culicidae)
SO JOURNAL OF INSECT SCIENCE
LA English
DT Article
DE CCL-125 cell; development; ferritin; iron; mosquito
ID AEDES-AEGYPTI; PROTEIN NANOCAGE; BLOOD MEAL; IRON; INSECT; CELLS;
   IDENTIFICATION; LOCALIZATION; DROSOPHILA; RESOLUTION
AB Ferritin is required for iron storage in vertebrates and for iron transport and storage in invertebrates, specifically insects. Classical ferritins consist of 24 subunits configured as a polyhedron wherein iron is held. The 24 subunits include light and heavy chains, each with specific functions. Several homologues of the light and heavy chains have been sequenced and studied in insects. In addition to iron transport and storage, ferritin has a role in dietary iron absorption, and functions as a protective agent preventing iron overload, decreasing oxidative stress, and reducing infection in these animals. The expression profile and regulation of a second ferritin light chain homologue (LCH2) in Aedes aegypti [Linnaeus (Diptera: Culicidae), yellow fever mosquito] was characterized in cells, animal developmental stages, and tissues post bloodmeal (PBM) by real-time PCR and immunoblot. Two previously studied ferritin subunits from Ae. aegypti, HCH and LCH1, along with LCH2 were immunoprecipitated and analyzed by mass spectrometry. The three Ae. aegypti ferritin subunits, HCH, LCH1, and LCH2, have different expression profiles and regulation with iron exposure, developmental stage, and tissue response PBM. Ae. aegypti expresses multiple and unique ferritin light chain subunits. Ae. aegypti, the vector for Zika, Dengue, and yellow fever, requires iron for oogenesis that is transported and stored in ferritin; this vector expresses a second light chain ferritin subunit homologue unlike any other species in which ferritin has been studied to date.
C1 [Geiser, Dawn L.; Patel, Naren; Patel, Pritesh; Bhakta, Janki; Velasquez, Lissette S.; Winzerling, Joy J.] Univ Arizona, Coll Agr & Life Sci, Dept Nutr Sci, Tucson, AZ 85721 USA.
RP Geiser, DL (corresponding author), Univ Arizona, Coll Agr & Life Sci, Dept Nutr Sci, Tucson, AZ 85721 USA.
EM dlgeiser@email.arizona.edu
RI Geiser, Dawn L/J-9923-2012
OI Geiser, Dawn L/0000-0002-6004-8407
FU Agricultural Experiment Station; College of Agriculture and Life
   Sciences; Undergraduate Biology Research Program; Honors College at the
   University of Arizona; NIEHSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Environmental Health Sciences (NIEHS) [ES06694]; NIH/NCIUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Cancer Institute (NCI) [CA023074]; BIO5 Institute of
   the University of Arizona; NIH/NCRRUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Center for Research Resources (NCRR) [1S10 RR028868-01]
FX We would like to thank Edwin A. Kohlhepp, Dr. Cynthia L. David, and Dr.
   Linda A. Breci for their technical expertise. This work was supported by
   funds from the Agricultural Experiment Station, the College of
   Agriculture and Life Sciences, the Undergraduate Biology Research
   Program, and the Honors College at the University of Arizona. We would
   like to recognize that the mass spectrometry data were acquired by the
   Arizona Proteomics Consortium supported by NIEHS grant ES06694 to the
   SWEHSC, NIH/NCI grant CA023074 to the UA Cancer Center and by the BIO5
   Institute of the University of Arizona. The Thermo Fisher LTQ Orbitrap
   Velos mass spectrometer was provided by grant 1S10 RR028868-01 from
   NIH/NCRR. All authors declare there are no relationships, financial or
   otherwise, that may pose a conflict of interest.
CR Acland A, 2014, NUCLEIC ACIDS RES, V42, pD7, DOI 10.1093/nar/gkt1146
   Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185
   ANDREWS SC, 1992, J INORG BIOCHEM, V47, P161, DOI 10.1016/0162-0134(92)84062-R
   Ausubel F. M., 1998, CURRENT PROTOCOLS MO
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   CLEMENTS AN, 1984, PHYSIOL ENTOMOL, V9, P1, DOI 10.1111/j.1365-3032.1984.tb00675.x
   COLLIN O, 1988, BIOL CELL, V63, P297, DOI 10.1016/0248-4900(88)90120-7
   Corby-Harris V, 2010, PLOS PATHOG, V6, DOI [10.1371/journal.ppat.1001003, 10.1371/annotation/738ac91f-8c41-4bf5-9a39-bddf0b777a89]
   DICKEY LF, 1987, J BIOL CHEM, V262, P7901
   Dunkov B, 2006, INSECT BIOCHEM MOLEC, V36, P300, DOI 10.1016/j.ibmb.2006.01.007
   Dunkov B. C., 1995, INSECT BIOCH PHYSL, V29, P293, DOI [10.1002/arch.9402903077655055, DOI 10.1002/ARCH.9402903077655055]
   Dunkov Boris C, 2002, J Insect Sci, V2, P7
   Gallois B, 1997, J BIOL INORG CHEM, V2, P360, DOI 10.1007/s007750050143
   Gambling L, 2011, SEMIN CELL DEV BIOL, V22, P637, DOI 10.1016/j.semcdb.2011.08.011
   Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI DOI 10.1385/1-59259-890-0:571
   Geiser DL, 2015, J INSECT SCI, V15, DOI 10.1093/jisesa/iev049
   Geiser DL, 2013, INSECT SCI, V20, P601, DOI 10.1111/j.1744-7917.2012.01581.x
   Geiser DL, 2009, COMP BIOCHEM PHYS B, V152, P352, DOI 10.1016/j.cbpb.2009.01.002
   Geiser DL, 2006, INSECT BIOCHEM MOLEC, V36, P177, DOI 10.1016/j.ibmb.2005.12.001
   Geiser DL, 2003, EUR J BIOCHEM, V270, P3667, DOI 10.1046/j.1432-1033.2003.03709.x
   Giorgi A, 2008, ARCH BIOCHEM BIOPHYS, V478, P69, DOI 10.1016/j.abb.2008.06.022
   Gonzales KK, 2015, PEERJ, V3, DOI 10.7717/peerj.938
   Hamburger AE, 2005, J MOL BIOL, V349, P558, DOI 10.1016/j.jmb.2005.03.074
   Hempstead PD, 1997, J MOL BIOL, V268, P424, DOI 10.1006/jmbi.1997.0970
   Huan P, 2014, GENE, V546, P80, DOI 10.1016/j.gene.2014.05.027
   Huang WH, 2003, DNA SEQUENCE, V14, P211, DOI 10.1080/1042517031000098810
   KOGAN PH, 1990, J MED ENTOMOL, V27, P709, DOI 10.1093/jmedent/27.4.709
   Lee JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103729
   Lipinski P, 2013, CELL MOL LIFE SCI, V70, P23, DOI 10.1007/s00018-012-1018-1
   MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9
   McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376
   Missirlis F, 2006, P NATL ACAD SCI USA, V103, P5893, DOI 10.1073/pnas.0601471103
   NICHOL H, 1990, TISSUE CELL, V22, P767, DOI 10.1016/0040-8166(90)90042-8
   Patton SM, 2005, J CELL SCI, V118, P4365, DOI 10.1242/jcs.02570
   Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   Pham D.Q.D., 2000, SILICO BIOL, V2, pS31
   Pham DQD, 2010, BBA-GEN SUBJECTS, V1800, P824, DOI 10.1016/j.bbagen.2010.03.004
   Pham DQD, 2005, INSECT MOL BIOL, V14, P263, DOI 10.1111/j.1365-2583.2005.00556.x
   Pham DQD, 2005, INSECT MOL BIOL, V14, P223, DOI 10.1111/j.1365-2583.2004.00550.x
   Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75
   Theil EC, 2016, ACCOUNTS CHEM RES, V49, P784, DOI 10.1021/ar500469e
   Theil EC, 2013, INORG CHEM, V52, P12223, DOI 10.1021/ic400484n
   Tosha T, 2012, J BIOL CHEM, V287, P13016, DOI 10.1074/jbc.M111.332734
   TRIKHA J, 1994, PROTEINS, V18, P107, DOI 10.1002/prot.340180204
   You XL, 2015, MOL IMMUNOL, V67, P642, DOI 10.1016/j.molimm.2015.07.020
   Zhang YY, 2013, FISH SHELLFISH IMMUN, V34, P1178, DOI 10.1016/j.fsi.2013.01.023
   Zhou GL, 2007, J INSECT PHYSIOL, V53, P1169, DOI 10.1016/j.jinsphys.2007.06.009
   Zhou GL, 2009, INSECT BIOCHEM MOLEC, V39, P234, DOI 10.1016/j.ibmb.2008.12.004
NR 49
TC 2
Z9 2
U1 0
U2 3
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1536-2442
EI 2250-2645
J9 J INSECT SCI
JI J Insect Sci.
PD DEC 23
PY 2017
VL 17
IS 6
AR 123
DI 10.1093/jisesa/iex096
PG 11
WC Entomology
SC Entomology
GA FR2QZ
UT WOS:000418913200003
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Papa, MP
   Meuren, LM
   Coelho, SVA
   Lucas, CGD
   Mustafa, YM
   Matassoli, FL
   Silveira, PP
   Frost, PS
   Pezzuto, P
   Ribeiro, MR
   Tanuri, A
   Nogueira, ML
   Campanati, L
   Bozza, MT
   Neto, HAP
   Pimentel-Coelho, PM
   Figueiredo, CP
   de Aguiar, RS
   de Arruda, LB
AF Papa, Michelle P.
   Meuren, Lana M.
   Coelho, Sharton V. A.
   de Oliveira Lucas, Carolina G.
   Mustafa, Yasmin M.
   Matassoli, Flavio Lemos
   Silveira, Paola P.
   Frost, Paula S.
   Pezzuto, Paula
   Ribeiro, Milene R.
   Tanuri, Amilcar
   Nogueira, Mauricio L.
   Campanati, Loraine
   Bozza, Marcelo T.
   Paula Neto, Heitor A.
   Pimentel-Coelho, Pedro M.
   Figueiredo, Claudia P.
   de Aguiar, Renato S.
   de Arruda, Luciana B.
TI Zika Virus Infects, Activates, and Crosses Brain Microvascular
   Endothelial Cells, without Barrier Disruption
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE Zika virus; endothelial cells; blood brain barrier; transcytosis; mouse
   experimental model
ID JAPANESE ENCEPHALITIS-VIRUS; IN-VITRO; NERVOUS-SYSTEM; MODEL;
   TRANSCYTOSIS; ENDOCYTOSIS; INTEGRITY; TRANSPORT; PROTEINS; COMPLEX
AB Zika virus (ZIKV) has been associated to central nervous system (CNS) harm, and virus was detected in the brain and cerebrospinal fluids of microcephaly and meningoencephalitis cases. However, the mechanism by which the virus reaches the CNS is unclear. Here, we addressed the effects of ZIKV replication in human brain microvascular endothelial cells (HBMECs), as an in vitro model of blood brain barrier (BBB), and evaluated virus extravasation and BBB integrity in an in vivo mouse experimental model. HBMECs were productively infected by African and Brazilian ZIKV strains (ZIKV(MR766) and ZIKV(PE243)), which induce increased production of type I and type III IFN, inflammatory cytokines and chemokines. Infection with ZIKV(MR766) promoted earlier cellular death, in comparison to ZIKV(PE243), but infection with either strain did not result in enhanced endothelial permeability. Despite the maintenance of endothelial integrity, infectious virus particles crossed the monolayer by endocytosis/exocytosis-dependent replication pathway or by transcytosis. Remarkably, both viruses' strains infected IFNAR deficient mice, with high viral load being detected in the brains, without BBB disruption, which was only detected at later time points after infection. These data suggest that ZIKV infects and activates endothelial cells, and might reach the CNS through basolateral release, transcytosis or transinfection processes. These findings further improve the current knowledge regarding ZIKV dissemination pathways.
C1 [Papa, Michelle P.; Meuren, Lana M.; Coelho, Sharton V. A.; de Oliveira Lucas, Carolina G.; Mustafa, Yasmin M.; Matassoli, Flavio Lemos; de Arruda, Luciana B.] Univ Fed Rio de Janeiro, Inst Microbiol Paulo Goes, Dept Virol, Rio De Janeiro, Brazil.
   [de Oliveira Lucas, Carolina G.; Bozza, Marcelo T.] Univ Fed Rio de Janeiro, Inst Microbiol Paulo Goes, Dept Imunol, Rio De Janeiro, Brazil.
   [Silveira, Paola P.; Pezzuto, Paula; Tanuri, Amilcar; de Aguiar, Renato S.] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Rio De Janeiro, Brazil.
   [Frost, Paula S.; Figueiredo, Claudia P.] Univ Fed Rio de Janeiro, Fac Farm, Nucleo Neurociencias, Rio De Janeiro, Brazil.
   [Ribeiro, Milene R.; Nogueira, Mauricio L.] Fac Med Sao Jose Do Rio Preto, Lab Pesquisas Virol, Sao Jose Do Rio Preto, Brazil.
   [Campanati, Loraine] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Rio De Janeiro, Brazil.
   [Paula Neto, Heitor A.] Univ Fed Rio de Janeiro, Fac Farm, Dept Biotecnol Farmaceut, Lab Alvos Mol, Rio De Janeiro, Brazil.
   [Pimentel-Coelho, Pedro M.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil.
RP de Arruda, LB (corresponding author), Univ Fed Rio de Janeiro, Inst Microbiol Paulo Goes, Dept Virol, Rio De Janeiro, Brazil.
EM arruda@micro.ufrj.br
RI Pimentel-Coelho, Pedro M/K-1994-2015; Pimentel-Coelho, Pedro
   Moreno/AAM-9106-2020; Figueiredo, Claudia P/F-8424-2012; Nogueira,
   Mauricio L/B-7599-2012; Arruda, Luciana B/N-9086-2013; Campanati,
   Loraine/V-2632-2018; Aguiar, Renato S/G-3542-2015
OI Pimentel-Coelho, Pedro M/0000-0002-2414-3386; Pimentel-Coelho, Pedro
   Moreno/0000-0002-2414-3386; Nogueira, Mauricio L/0000-0003-1102-2419;
   Campanati, Loraine/0000-0001-9172-1951; Aguiar, Renato
   S/0000-0001-5180-3717; Figueiredo, Claudia/0000-0001-9467-9891; da Silva
   Frost, Paula/0000-0002-3814-999X
FU CAPESCAPES; CAPES/PVE-Program; CNPqNational Council for Scientific and
   Technological Development (CNPq); FAPERJ-Rede ZIKA; FINEPCiencia
   Tecnologia e Inovacao (FINEP); FAPERJCarlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ); FAPESPFundacao
   de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2013/21719-3]
FX This work was supported by CAPES, CAPES/PVE-Program, CNPq, FAPERJ-Rede
   ZIKA, and FINEP. MP was the recipient of a CNPq fellowship. LM and CL
   were the recipient of a CAPES fellowship. SC was the recipient of a
   FAPERJ fellowship. MN is supported by a FAPESP grant #2013/21719-3. MN
   and MB are a CNPq Fellowship recipient.
CR Coelho SVA, 2017, J VIROL METHODS, V246, P65, DOI 10.1016/j.jviromet.2017.04.011
   Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Bramley JC, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00206-17
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Chang CY, 2015, GLIA, V63, P1915, DOI 10.1002/glia.22857
   Chanthick C, 2016, SCI REP-UK, V6, DOI 10.1038/srep31855
   Chen CJ, 2014, J VIROL, V88, P1150, DOI 10.1128/JVI.02738-13
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   da Conceicao TM, 2013, VIROLOGY, V435, P281, DOI 10.1016/j.virol.2012.09.038
   Daniels BP, 2015, CLIN PHARMACOL THER, V97, P372, DOI 10.1002/cpt.75
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Diefenbach RJ, 2008, REV MED VIROL, V18, P35, DOI 10.1002/rmv.560
   Dohgu S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039565
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Finke S, 2005, VIRUS RES, V111, P120, DOI 10.1016/j.virusres.2005.04.004
   FUJIWARA T, 1988, J BIOL CHEM, V263, P18545
   Galliez RM, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw203
   Harmon B, 2012, J VIROL, V86, P12954, DOI 10.1128/JVI.02242-12
   JANZER RC, 1987, NATURE, V325, P253, DOI 10.1038/325253a0
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Liou ML, 1998, CELL TISSUE RES, V293, P389, DOI 10.1007/s004410051130
   Lucey D, 2017, JAMA-J AM MED ASSOC, V317, P1368, DOI 10.1001/jama.2017.1553
   Luethy LN, 2016, VIROLOGY, V487, P1, DOI 10.1016/j.virol.2015.09.019
   Mahad D, 2006, BRAIN, V129, P212, DOI 10.1093/brain/awh655
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Miner JJ, 2016, CURR OPIN IMMUNOL, V38, P18, DOI 10.1016/j.coi.2015.10.008
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Mladinich MC, 2017, MBIO, V8, DOI [10.1128/mBio.00952-17, 10.1128/mbio.00952-17]
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Morrey JD, 2008, J GEN VIROL, V89, P467, DOI 10.1099/vir.0.83345-0
   Nikolskaia OV, 2006, J CLIN INVEST, V116, P2739, DOI [10.1172/JC127798, 10.1172/JCI27798.]
   Racaniello VR, 2006, VIROLOGY, V344, P9, DOI 10.1016/j.virol.2005.09.015
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reis PA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003099
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Roach T, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0824-7
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Salinas S, 2010, NAT REV MICROBIOL, V8, P645, DOI 10.1038/nrmicro2395
   Samuel MA, 2007, P NATL ACAD SCI USA, V104, P17140, DOI 10.1073/pnas.0705837104
   Saunders NR, 2015, FRONT NEUROSCI-SWITZ, V9, DOI [10.3389/fnins.2015.00385, 10.3339/fnins.2015.00385]
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Singh PK, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92340
   Srinivasan B, 2015, JALA-J LAB AUTOM, V20, P107, DOI 10.1177/2211068214561025
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Tugizov SM, 2013, J VIROL, V87, P8179, DOI 10.1128/JVI.00443-13
   Velandia-Romero ML, 2012, J NEUROVIROL, V18, P374, DOI 10.1007/s13365-012-0117-y
   Verma S, 2009, VIROLOGY, V385, P425, DOI 10.1016/j.virol.2008.11.047
   Vermillion MS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14575
   Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 62
TC 29
Z9 31
U1 1
U2 9
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD DEC 22
PY 2017
VL 8
AR 2557
DI 10.3389/fmicb.2017.02557
PG 17
WC Microbiology
SC Microbiology
GA FQ8DF
UT WOS:000418592400001
PM 29312238
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU da Silva, MB
   Da Cunha, AM
   Santos, RCR
   Valentini, A
   Caetano, EWS
   Freire, VN
AF Bezerra da Silva, M.
   Da Cunha, A. M.
   Santos, R. C. R.
   Valentini, A.
   Caetano, E. W. S.
   Freire, V. N.
TI Changing the gap type of solid state boric acid by heating: a
   dispersion-corrected density functional study of alpha-, beta-, and
   gamma-metaboric acid polymorphs
SO NEW JOURNAL OF CHEMISTRY
LA English
DT Article
ID ELECTRONIC-STRUCTURE; OPTICAL-PROPERTIES; CRYSTAL STRUCTURE; ZIKA VIRUS;
   MOLECULES; MALARIA; CASTEP; WATER
AB The metaboric acid alpha-, beta-, and gamma-polymorphs were investigated using density functional theory (DFT) calculations by employing the generalized gradient approximation improved using the Tkatchenko-Scheffler scheme to take into account dispersive interactions. The structural, electronic, and optical properties of these polymorphs were thus obtained, with unit cell deviations Delta a, Delta b, and Delta c (in comparison with X-ray data) as small as -0.08, -0.09, and -0.06 angstrom for alpha-(BOH)(3)O-3, 0.00, 0.06, and -0.09 angstrom for beta-(BOH)(3)O-3, and 0.01, 0.01, and 0.01 angstrom for gamma-(BOH)(3)O-3. The layered a-MA polymorph is predicted by our simulations to have a direct gap of 6.26 eV, which is close to the values found recently for the boric acid triclinic (H3BO3-2A, 6.25 eV) and trigonal (H3BO3-3T, 6.28 eV) indirect gap systems. As the alpha-MA structure can be obtained by heating up the H3BO3-2A crystal above 100 degrees C, we have an interesting result that a change in temperature can modify the nature of the band gap of boric acid in the solid state from indirect to direct. van der Waals interactions between the metaboric acid alpha-(BOH)(3)O-3 planes (distance of about 3.1 +/- 0.01 angstrom) are a relevant aspect determining its energy gap, while its direct or indirect character depends on the crystal structure and molecular components. On the other hand, the polymeric monoclinic beta-(BOH)(3)O-3 has an indirect gap of 6.56 eV, while the covalent cubic gamma-(BOH)(3)O-3 has a direct gap of 7.28 eV. Finally, the complex dielectric function and optical absorption considering polarized light along the 001, 010, 100 crystal planes and polycrystalline samples (POLY) of the three metaboric acid polymorphs were obtained.
C1 [Bezerra da Silva, M.; Freire, V. N.] Univ Fed Ceara, Dept Fis, Caixa Postal 6030, BR-60440900 Fortaleza, CE, Brazil.
   [Da Cunha, A. M.; Santos, R. C. R.; Valentini, A.; Freire, V. N.] Univ Fed Ceara, Dept Quim Analit & Fis Quim, BR-60440554 Fortaleza, CE, Brazil.
   [Caetano, E. W. S.] DEMEL, Inst Fed Educ Ciencia & Tecnol Ceara, Campus Fortaleza, BR-60040531 Fortaleza, CE, Brazil.
RP Caetano, EWS (corresponding author), DEMEL, Inst Fed Educ Ciencia & Tecnol Ceara, Campus Fortaleza, BR-60040531 Fortaleza, CE, Brazil.
EM ewcaetano@gmail.com
RI Freire, Valder/D-1136-2013; Caetano, Ewerton WS/A-2284-2015; Valentini,
   Antoninho/N-1358-2018; BEZERRA DA SILVA, MAURICELIO/M-8997-2017; Santos,
   Regina C. R./N-1418-2018
OI Freire, Valder/0000-0001-7867-3908; Caetano, Ewerton
   WS/0000-0002-1021-6927; Valentini, Antoninho/0000-0002-7019-6155;
   BEZERRA DA SILVA, MAURICELIO/0000-0001-7941-3956; Santos, Regina C.
   R./0000-0002-6943-366X
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [304781/2016-9, 140898/2016-6]; FUNCAP [PR2-0101-00006.01.00/15]
FX V. N. F. and A. Valentini are senior researchers from the Brazilian
   National Research Council (CNPq), and would like to acknowledge the
   financial support received during the development of this work. E. W. S.
   C. and M. B. da Silva received financial support from CNPq projects
   304781/2016-9 and 140898/2016-6, respectively. The authors also want to
   thank financial support received from the FUNCAP project
   PR2-0101-00006.01.00/15.
CR Benelli G, 2016, PARASITOL RES, V115, P1747, DOI 10.1007/s00436-016-4971-z
   Beran GJO, 2016, CHEM REV, V116, P5567, DOI 10.1021/acs.chemrev.5b00648
   Berland K, 2015, REP PROG PHYS, V78, DOI 10.1088/0034-4885/78/6/066501
   da Silva MB, 2016, CRYST GROWTH DES, V16, P6631, DOI 10.1021/acs.cgd.6b01297
   Bhami LC, 2015, J VECTOR DIS, V52, P147
   Caetano EWS, 2005, AIP CONF PROC, V772, P1095
   CEPERLEY DM, 1980, PHYS REV LETT, V45, P566, DOI 10.1103/PhysRevLett.45.566
   Clark SJ, 2005, Z KRISTALLOGR, V220, P567, DOI 10.1524/zkri.220.5.567.65075
   Costa SN, 2013, CRYST GROWTH DES, V13, P2793, DOI 10.1021/cg400111w
   da Silva JG, 2013, CHEM PHYS LETT, V587, P20, DOI 10.1016/j.cplett.2013.09.051
   Delley B, 2000, J CHEM PHYS, V113, P7756, DOI 10.1063/1.1316015
   DORSET DL, 1992, ACTA CRYSTALLOGR A, V48, P568, DOI 10.1107/S0108767392002344
   Elango M, 2005, J PHYS CHEM A, V109, P8587, DOI 10.1021/jp053382+
   Enyashin AN, 2005, CHEM PHYS LETT, V411, P186, DOI 10.1016/j.cplett.2005.05.120
   Farfan-Garcia ED, 2016, TOXICOL LETT, V258, P115, DOI 10.1016/j.toxlet.2016.06.018
   Flores MZS, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.115104
   Freyhardt CC, 2000, ACTA CRYSTALLOGR C, V56, P276, DOI 10.1107/S0108270199016042
   Gao SP, 2012, COMP MATER SCI, V61, P266, DOI 10.1016/j.commatsci.2012.04.039
   Gao WL, 2014, INORG CHEM, V53, P2364, DOI 10.1021/ic403175w
   Grimme S, 2016, CHEM REV, V116, P5105, DOI 10.1021/acs.chemrev.5b00533
   HOHENBERG P, 1964, PHYS REV B, V136, pB864, DOI 10.1103/PhysRev.136.B864
   Hoja J, 2017, WIRES COMPUT MOL SCI, V7, DOI 10.1002/wcms.1294
   Jones RO, 2015, REV MOD PHYS, V87, P897, DOI 10.1103/RevModPhys.87.897
   Klimes J, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4754130
   KOHN W, 1965, PHYS REV, V140, P1133, DOI 10.1103/PhysRev.140.A1133
   LIN JS, 1993, PHYS REV B, V47, P4174, DOI 10.1103/PhysRevB.47.4174
   Maia FF, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3584680
   MONKHORST HJ, 1976, PHYS REV B, V13, P5188, DOI 10.1103/PhysRevB.13.5188
   Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nielsen FH, 2014, J TRACE ELEM MED BIO, V28, P383, DOI 10.1016/j.jtemb.2014.06.023
   Novoselov KS, 2005, P NATL ACAD SCI USA, V102, P10451, DOI 10.1073/pnas.0502848102
   Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865
   PERDEW JP, 1981, PHYS REV B, V23, P5048, DOI 10.1103/PhysRevB.23.5048
   PETERS CR, 1964, ACTA CRYSTALLOGR, V17, P229, DOI 10.1107/S0365110X64000597
   Pfrommer BG, 1997, J COMPUT PHYS, V131, P233, DOI 10.1006/jcph.1996.5612
   Qualls WA, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0819-8
   Segall MD, 2002, J PHYS-CONDENS MAT, V14, P2717, DOI 10.1088/0953-8984/14/11/301
   Shuvalov R. R., 2003, ACTA CRYSTALLOGR C, V59
   Silva AM, 2015, J PHYS CHEM A, V119, P11791, DOI 10.1021/acs.jpca.5b08784
   Silva AM, 2013, CRYST GROWTH DES, V13, P4844, DOI 10.1021/cg401016v
   Silva AM, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.195201
   Tkatchenko A, 2015, ADV FUNCT MATER, V25, P2054, DOI 10.1002/adfm.201403029
   Tkatchenko A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.073005
   ZACHARIASEN WH, 1963, ACTA CRYSTALLOGR, V16, P385, DOI 10.1107/S0365110X6300102X
   ZACHARIASEN WH, 1963, ACTA CRYSTALLOGR, V16, P380, DOI 10.1107/S0365110X63001018
   Zanatta G, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4869179
NR 47
TC 1
Z9 1
U1 0
U2 15
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1144-0546
EI 1369-9261
J9 NEW J CHEM
JI New J. Chem.
PD DEC 21
PY 2017
VL 41
IS 24
BP 15533
EP 15544
DI 10.1039/c7nj02945d
PG 12
WC Chemistry, Multidisciplinary
SC Chemistry
GA FO7MF
UT WOS:000417058800092
DA 2020-07-08
ER

PT J
AU Piltch-Loeb, R
   Abramson, DM
   Merdjanoff, AA
AF Piltch-Loeb, Rachael
   Abramson, David M.
   Merdjanoff, Alexis A.
TI Risk salience of a novel virus: US population risk perception,
   knowledge, and receptivity to public health interventions regarding the
   Zika virus prior to local transmission
SO PLOS ONE
LA English
DT Article
ID MODEL; SARS; BEHAVIORS; COMMUNICATION; NETHERLANDS
AB Background
   As the incidence of Zika infection accelerated in Central and South American countries from November 2015 through April 2016, U.S. public health officials developed vector control and risk communication strategies to address mosquito-borne and sexual modes of transmission. This study reports upon U.S. perceptions of the Zika virus prior to domestic transmission, and analyzes the association of socio-economic, political, knowledge and risk factors with population receptivity to selected behavioral, environmental, and clinical intervention strategies.
   Methods
   A representative sample of 1,233 U.S. residents was drawn from address-based telephone and mobile phone lists, including an oversample of 208 women of child-bearing age living in five U.S. southern states. Data were collected between April and June, 2016, and weighted to represent U.S. population distributions.
   Results
   Overall, 78% of the U.S. population was aware of Zika prior to domestic transmission. Those unaware of the novel virus were more likely to be younger, lower income, and of Hispanic ethnicity. Among those aware of Zika, over half would delay pregnancy for a year or more in response to public health warnings; approximately one third agreed with a possible vector-control strategy of targeted indoor spraying by the government; and nearly two-thirds agreed that the government should make pregnancy-termination services available to women who learn their fetus had a Zika-related birth defect. Receptivity to these public health interventions varied by age, risk perception, and knowledge of the virus.
   Conclusion
   Risk salience and population receptivity to public health interventions targeting a novel virus can be conditioned on pre-existing characteristics in the event of an emerging infectious disease. Risk communicators should consider targeted strategies to encourage adoption of behavioral, environmental, and clinical interventions.
C1 [Piltch-Loeb, Rachael; Abramson, David M.; Merdjanoff, Alexis A.] NYU, Coll Global Publ Hlth, New York, NY 10003 USA.
RP Piltch-Loeb, R (corresponding author), NYU, Coll Global Publ Hlth, New York, NY 10003 USA.
EM Rpl5@nyu.edu
FU National Science Foundation RAPID grant [1638545]; NSF RAPID grant
   [1638545]
FX This work was supported by National Science Foundation RAPID grant
   1638545, Abramson Pl.; Funding acknowledgment: NSF RAPID grant 1638545
CR AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T
   ArboNET, 2017, ZIK CAS US
   Brug J, 2004, EMERG INFECT DIS, V10, P1486, DOI 10.3201/eid1008.040283
   Brug J, 2004, EMERG INFECT DIS, P10
   Brug J, 2009, RISK PERCRPTIONS BEH
   Covello VT, 2001, J URBAN HEALTH, V78, P382, DOI 10.1093/jurban/78.2.382
   FISCHHOFF B, 1978, POLICY SCI, V9, P127, DOI 10.1007/BF00143739
   Griffin RJ, 1999, ENVIRON RES, V80, pS230, DOI 10.1006/enrs.1998.3940
   Gursky E., 2003, BIOSECUR BIOTERROR, V1, P97
   Ho SS, 2013, J HEALTH COMMUN, V18, P773, DOI 10.1080/10810730.2012.743624
   Ibuka Y, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-296
   Jiang XY, 2009, INT J BEHAV MED, V16, P58, DOI 10.1007/s12529-008-9005-5
   Jones JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008032
   KASPERSON RE, 1988, RISK ANAL, V8, P177, DOI 10.1111/j.1539-6924.1988.tb01168.x
   Lindell MK, 2012, RISK ANAL, V32, P616, DOI 10.1111/j.1539-6924.2011.01647.x
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Oster AM, 2016, MMWR-MORBID MORTAL W, P65
   Rojek AM, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0760-x
   ROSENSTOCK IM, 1974, HEALTH EDUC QUART, V2, P354, DOI 10.1177/109019817400200405
   Rudisill C, 2013, J RISK RES, V16, P959, DOI 10.1080/13669877.2012.761271
   Seale H, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-99
   Shartzer A, 2016, WOMEN REPRODUCTIVE A
   Simeone RM, 2016, MMWR-MORBID MORTAL W, P65
   SLOVIC P, 1979, ENVIRONMENT, V21, P14, DOI 10.1080/00139157.1979.9933091
   Slovic P., 1992, PERCEPTION RISK REFL
   Smith RD, 2006, SOC SCI MED, V63, P3113, DOI 10.1016/j.socscimed.2006.08.004
   Wenzel RP, 2003, NEW ENGL J MED, V348, P1947, DOI 10.1056/NEJMp030072
   WITTE K, 1992, COMMUN MONOGR, V59, P329, DOI 10.1080/03637759209376276
   Zhang YG, 2009, ASIA-PAC POWER ENERG, P1371
NR 30
TC 9
Z9 9
U1 2
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 21
PY 2017
VL 12
IS 12
AR e0188666
DI 10.1371/journal.pone.0188666
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FQ8BI
UT WOS:000418587400012
PM 29267308
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Carossino, M
   Li, YQ
   Lee, PYA
   Tsai, CF
   Chou, PH
   Williams, D
   Skillman, A
   Cook, RF
   Brown, G
   Chang, HFG
   Wang, HTT
   Balasuriya, UBR
AF Carossino, Mariano
   Li, Yanqiu
   Lee, Pei-Yu A.
   Tsai, Chuan-Fu
   Chou, Pin-Hsing
   Williams, Dennis
   Skillman, Ashley
   Cook, R. Frank
   Brown, Grayson
   Chang, Hsiao-Fen G.
   Wang, Hwa-Tang T.
   Balasuriya, Udeni B. R.
TI Evaluation of a field-deployable reverse transcription-insulated
   isothermal PCR for rapid and sensitive on-site detection of Zika virus
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Zika virus; Insulated isothermal PCR; iiPCR; POCKIT; Point-of-need assay
ID OF-NEED DIAGNOSIS; TIME RT-PCR; AEDES-AEGYPTI; SEXUAL TRANSMISSION;
   MOLECULAR-DETECTION; IIPCR ASSAY; PUERTO-RICO; INFECTION; SEMEN;
   PHYLOGENY
AB Background: The recent emergence of Zika virus (ZIKV) in Brazil and its precipitous expansion throughout the Americas has highlighted the urgent need for a rapid and reliable on-site diagnostic assay suitable for viral detection. Such point-ofneed (PON), low-cost diagnostics are essential for ZIKV control in vulnerable areas with limited resources.
   Methods: We developed and evaluated a ZIKV-specific field-deployable RT-iiPCR reagent set targeting the E gene for rapid detection of ZIKV in ZIKV-spiked human and mosquito specimens, and compared its performance to the Center for Disease Control and Prevention (CDC) and Pan American Health Organization (PAHO) RT-qPCR assays targeting the E and NS2B genes, respectively.
   Results: These assays demonstrated exclusive specificity for ZIKV (African and Asian lineages), had limits of detection ranging from 10 to 100 in vitro transcribed RNA copies/mu l and detection endpoints at 10 plaque forming units/ml of infectious tissue culture fluid. Analysis of human whole blood, plasma, serum, semen, urine, and mosquito pool samples spiked with ZIKV showed an agreement of 90% (k = 0.80), 92% (k = 0.82), 95% (k = 0.86), 92% (k = 0.81), 90% (k = 0.79), and 100% (k = 1), respectively, between the RT-iiPCR assay and composite results from the reference RT-qPCR assays. Overall, the concurrence between the ZIKV RT-iiPCR and the reference RT-qPCR assays was 92% (k = 0.83).
   Conclusions: The ZIKV RT-iiPCR has a performance comparable to the reference CDC and PAHO RT-qPCR assays but provides much faster results (similar to 1.5 h) with a field-deployable system that can be utilized as a PON diagnostic with the potential to significantly improve the quality of the health care system in vulnerable areas.
C1 [Carossino, Mariano; Li, Yanqiu; Skillman, Ashley; Cook, R. Frank; Balasuriya, Udeni B. R.] Univ Kentucky, Coll Agr Food & Environm, Maxwell H Gluck Equine Res Ctr, Dept Vet Sci, Lexington, KY 40506 USA.
   [Lee, Pei-Yu A.; Tsai, Chuan-Fu; Chou, Pin-Hsing; Chang, Hsiao-Fen G.; Wang, Hwa-Tang T.] GeneReach USA, Lexington, MA USA.
   [Williams, Dennis] Univ Kentucky, Kentucky Blood Ctr, Med Ctr, Chandler Hosp, Lexington, KY USA.
   [Brown, Grayson] Univ Kentucky, Coll Agr Food & Environm, Dept Entomol, Lexington, KY USA.
RP Balasuriya, UBR (corresponding author), Univ Kentucky, Coll Agr Food & Environm, Maxwell H Gluck Equine Res Ctr, Dept Vet Sci, Lexington, KY 40506 USA.
EM ubalasuriya@uky.edu
FU College of Agriculture, Food and Environment (CAFE), University of
   Kentucky, Lexington, KY, USA [1013172620]; Maxwell H. Gluck Equine
   Research Center (GERC), Department of Veterinary Science, University of
   Kentucky, Lexington, KY, USA [1215389410]
FX This study was funded by the College of Agriculture, Food and
   Environment (CAFE; grant number 1013172620) and the Maxwell H. Gluck
   Equine Research Center (GERC), Department of Veterinary Science (grant
   number 1215389410), University of Kentucky, Lexington, KY, USA.
CR Abd El Wahed A, 2017, PLOS CURRENTS OUTBRE
   Acevedo Nathalie, 2017, Front Microbiol, V8, P42, DOI 10.3389/fmicb.2017.00042
   Ambagala A, 2015, TRANSBOUND EMERG DIS
   Ambagala A., 2016, TRANSBOUND EMERG DIS
   [Anonymous], 2015, Wkly Epidemiol Rec, V90, P609
   Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Balasuriya UBR, 2017, J VIROL METHODS, V241, P58, DOI 10.1016/j.jviromet.2016.12.010
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Barzon L., 2016, EUROSURVEILLANCE, V21, P2016, DOI DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Besnard M, 2014, EURO SURVEILL, V19
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Bustin Stephen A, 2004, J Biomol Tech, V15, P155
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Carossino M, 2016, J VIROL METHODS, V234, P7, DOI 10.1016/j.jviromet.2016.02.015
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chang HFG, 2012, BIOTECHNOL J, V7, P662, DOI 10.1002/biot.201100453
   Charrel RN, 2016, B WORLD HEALTH ORGAN, V94, P574, DOI 10.2471/BLT.16.171207
   Chua KH, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1183-z
   Corman VM, 2016, B WORLD HEALTH ORGAN, V94, P880, DOI 10.2471/BLT.16.175950
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Eboigbodin KE, 2016, DIAGN MICR INFEC DIS, V86, P369, DOI 10.1016/j.diagmicrobio.2016.08.027
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Fleige Simone, 2006, Molecular Aspects of Medicine, V27, P126, DOI 10.1016/j.mam.2005.12.003
   Froeschl G, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2123-9
   Galel SA, 2017, TRANSFUSION
   Go YY, 2017, J MOL DIAGN, V19, P817, DOI 10.1016/j.jmoldx.2017.06.007
   Go YY, 2016, J CLIN MICROBIOL, V54, P1528, DOI 10.1128/JCM.00225-16
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hennessey M., 2015, CTR DIS CONTROL PREV, V65, P55, DOI DOI 10.15585/MMWR.MM6503E1
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Jimenez A, 2017, MED REV, V31, P1, DOI DOI 10.1016/J.TMRV.2016.08.001
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Kuehnert MJ, 2016, MMWR-MORBID MORTAL W, V65, P627, DOI 10.15585/mmwr.mm6524e2
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Landry ML, 2017, ARCH PATHOL LAB MED, V141, P60, DOI 10.5858/arpa.2016-0406-SA
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Matheron S, 2016, CLIN INFECT DIS, V63, DOI 10.1093/cid/ciw509
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1180
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Musso D., 2014, EURO SURVEILL, V19
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nicastri E., 2016, EURO SURVEILL, V21
   Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059
   Paz-Bailey G, 2017, N ENGL J MED
   Petersen LR, 2016, NEW ENGL J MED, V375, P294, DOI 10.1056/NEJMc1606769
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Schrader C, 2012, J APPL MICROBIOL, V113, P1014, DOI 10.1111/j.1365-2672.2012.05384.x
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Soltan MA, 2016, J VIROL METHODS, V235, P99, DOI 10.1016/j.jviromet.2016.05.006
   Song JZ, 2016, ANAL CHEM, V88, P7289, DOI 10.1021/acs.analchem.6b01632
   Tetro JA, 2016, MICROBES INFECT, V18, P167, DOI 10.1016/j.micinf.2015.12.010
   Thangamani S, 2016, AM J TROP MED HYG, V95, P1169, DOI 10.4269/ajtmh.16-0448
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   Tsai YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090545
   Tsai YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045278
   Tsai YL, 2012, J VIROL METHODS, V181, P134, DOI 10.1016/j.jviromet.2012.01.017
   Waggoner JJ, 2016, EMERG INFECT DIS, V22, P1295, DOI 10.3201/eid2207.160326
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Wilkes RP, 2015, J VIROL METHODS, V220, P35, DOI 10.1016/j.jviromet.2015.04.007
   Wilkes RP, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0213-8
   Wilkes RP, 2015, J VET DIAGN INVEST, V27, P510, DOI 10.1177/1040638715593597
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Xu MY, 2016, J VIROL METHODS, V236, P93, DOI 10.1016/j.jviromet.2016.07.014
   Ye Q, 2016, INFECT GENET EVOL, V43, P43, DOI 10.1016/j.meegid.2016.05.004
   Zambrano H, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12630
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhang JQ, 2016, J VIROL METHODS, V234, P34, DOI 10.1016/j.jviromet.2016.03.016
NR 85
TC 10
Z9 10
U1 0
U2 13
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD DEC 19
PY 2017
VL 17
AR 778
DI 10.1186/s12879-017-2852-4
PG 15
WC Infectious Diseases
SC Infectious Diseases
GA FR2BR
UT WOS:000418872500001
PM 29258444
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ndenga, BA
   Mutuku, FM
   Ngugi, HN
   Mbakaya, JO
   Aswani, P
   Musunzaji, PS
   Vulule, J
   Mukoko, D
   Kitron, U
   LaBeaud, AD
AF Ndenga, Bryson Alberto
   Mutuku, Francis Maluki
   Ngugi, Harun Njenga
   Mbakaya, Joel Omari
   Aswani, Peter
   Musunzaji, Peter Siema
   Vulule, John
   Mukoko, Dunstan
   Kitron, Uriel
   LaBeaud, Angelle Desiree
TI Characteristics of Aedes aegypti adult mosquitoes in rural and urban
   areas of western and coastal Kenya
SO PLOS ONE
LA English
DT Article
ID LANDING PERIODICITY; DENGUE; DIPTERA; HUMANS; VIRUS; TRANSMISSION;
   ALBOPICTUS; DIVERSITY; ABUNDANCE; TRINIDAD
AB Aedes aegypti is the main vector for yellow fever, dengue, chikungunya and Zika viruses. Recent outbreaks of dengue and chikungunya have been reported in Kenya. Presence and abundance of this vector is associated with the risk for the occurrence and transmission of these diseases. This study aimed to characterize the presence and abundance of Ae. aegypti adult mosquitoes from rural and urban sites in western and coastal regions of Kenya. Presence and abundance of Ae. aegypti adult mosquitoes were determined indoors and outdoors in two western (urban Kisumu and rural Chulaimbo) and two coastal (urban Ukunda and rural Msambweni) sites in Kenya. Sampling was performed using quarterly human landing catches, monthly Prokopack automated aspirators and monthly Biogents-sentinel traps. A total of 2,229 adult Ae. aegypti mosquitoes were collected: 785 (35.2%) by human landing catches, 459 (20.6%) by Prokopack aspiration and 985 (44.2%) by Biogents-sentinel traps. About three times as many Ae. aegypti mosquitoes were collected in urban than rural sites (1,650 versus 579). Comparable numbers were collected in western (1,196) and coastal (1,033) sites. Over 80% were collected outdoors through human landing catches and Prokopack aspiration. The probability of collecting Ae. aegypti mosquitoes by human landing catches was significantly higher in the afternoon than morning hours (P<0.001), outdoors than indoors (P<0.001) and in urban than rural sites (P = 0.008). Significantly more Ae. aegypti mosquitoes were collected using Prokopack aspiration outdoors than indoors (P<0.001) and in urban than rural areas (P<0.001). Significantly more mosquitoes were collected using Biogents-sentinel traps in urban than rural areas (P = 0.008) and in western than coastal sites (P = 0.006). The probability of exposure to Ae. aegypti bites was highest in urban areas, outdoors and in the afternoon hours. These characteristics have major implications for the possible transmission of arboviral diseases and for the planning of surveillance and control programs.
C1 [Ndenga, Bryson Alberto; Mbakaya, Joel Omari; Aswani, Peter] Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Kisumu, Kenya.
   [Mutuku, Francis Maluki] Tech Univ Mombasa, Dept Environm & Hlth Sci, Mombasa, Kenya.
   [Ngugi, Harun Njenga] Chuka Univ, Dept Biol Sci, Chuka, Kenya.
   [Ngugi, Harun Njenga] Univ Nairobi, Dept Zool, Nairobi, Kenya.
   [Musunzaji, Peter Siema] Minist Hlth, Vector Borne Dis Control Unit, Msambweni, Kenya.
   [Vulule, John] Kenya Govt Med Res Ctr, Ctr Infect & Parasit Dis Control Res, Busia, Kenya.
   [Mukoko, Dunstan] Minist Hlth, Vector Borne Dis Control Unit, Nairobi, Kenya.
   [Kitron, Uriel] Emory Univ, Dept Environm Sci, Atlanta, GA 30322 USA.
   [LaBeaud, Angelle Desiree] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA.
RP Ndenga, BA (corresponding author), Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Kisumu, Kenya.
EM bndenga@yahoo.com
FU National Institutes of Health, USAUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [RO1 AI102918]
FX This study was funded by a program award RO1 AI102918 from the National
   Institutes of Health, USA to Dr. Angelle Desiree LaBeaud. The funder had
   no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Akhwale W., 2013, E AFR PUBLIC HLTH LA, V7, P1
   Bhat M. A., 2014, International Journal of Current Microbiology and Applied Sciences, V3, P253
   Blaylock JM, 2011, TRAVEL MED INFECT DI, V9, P246, DOI 10.1016/j.tmaid.2011.06.005
   Bos R, 1988, PARASIT TODAY, V4
   CDC, 2016, MOSQ BIT PREV US
   CHADEE DD, 1988, MED VET ENTOMOL, V2, P189, DOI 10.1111/j.1365-2915.1988.tb00071.x
   Chadee DD, 2000, J VECTOR ECOL, V25, P158
   Chen B, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13070712
   Chepkorir E, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-435
   Cigarroa-Toledo N, 2016, EMERG INFECT DIS, V22, P1804, DOI 10.3201/eid2210.152087
   Ferreira DAD, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2025-8
   Edman JD, 1998, J MED ENTOMOL, V35, P578, DOI 10.1093/jmedent/35.4.578
   Ellis EM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003733
   Farraudiere L, 2017, REV PANAM SALUD PUBL, V41
   Favaro EA, 2006, J VECTOR ECOL, V31, P285, DOI 10.3376/1081-1710(2006)31[285:PSOASA]2.0.CO;2
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Freire M. E., 2014, 7 GROWTH DIAL
   Getachew D, 2015, INTERDISCIP PERSPECT
   Gillett J. D., 1972, COMMON AFRICAN MOSQU
   GOUCK H. K., 1962, FLORIDA ENTOMOL, V45, P93, DOI 10.2307/3492224
   Harburguer L, 2011, J MED ENTOMOL, V48, P577, DOI 10.1603/ME10074
   Harrington LC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003048
   Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209
   Harrington LC, 2001, J MED ENTOMOL, V38, P411, DOI 10.1603/0022-2585-38.3.411
   Hertz JT, 2016, PATHOG GLOB HEALTH, V110, P108, DOI 10.1080/20477724.2016.1182719
   Heydari N, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14020196
   Higa Yukiko, 2015, Tropical Medicine and Health, V43, P107, DOI 10.2149/tmh.2014-29
   Higa Yukiko, 2011, Tropical Medicine and Health, V39, P17, DOI 10.2149/tmh.2011-S04
   Huang Y, 2004, SUBGENUS STEGOMYIA A
   Konongoi L, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0641-0
   Kraemer M, 2015, ECOL EPID GLOB HLTH
   LaBeaud A, 2015, PLOS NEGL TROP DIS, V9
   Leisnham P, 2014, PLOS ONE, V9
   Lounibos LP, 2016, J INFECT DIS, V214, pS453, DOI 10.1093/infdis/jiw285
   Lutomiah J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004981
   Lutomiah J, 2013, J VECTOR ECOL, V38, P134, DOI 10.1111/j.1948-7134.2013.12019.x
   McBride CS, 2014, NATURE, V515, P222, DOI 10.1038/nature13964
   Moore M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002175
   Mwangangi JM, 2012, PARASITOL RES, V110, P61, DOI 10.1007/s00436-011-2449-6
   Ngugi HN, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2271-9
   Ochieng C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132645
   Orsborne J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152805
   Ponlawat A, 2005, J MED ENTOMOL, V42, P844, DOI 10.1603/0022-2585(2005)042[0844:BFPOAA]2.0.CO;2
   Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395
   Saifur RGM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030919
   Sanga B, 2017, STANDARD NEWSPAPER
   Siriyasatien P, 2010, SE ASIAN J TROP MED, V41, P43
   STRAUSS W. G., 1965, MOSQUITO NEWS, V25, P272
   Sutherland LJ, 2011, AM J TROP MED HYG, V85, P158, DOI 10.4269/ajtmh.2011.10-0203
   Thonnon J, 1998, AM J TROP MED HYG, V59, P108, DOI 10.4269/ajtmh.1998.59.108
   United Nations, 2014, WORLD URB PROSP 2014
   Vazquez-Prokopec GM, 2009, J MED ENTOMOL, V46, P1256, DOI 10.1603/033.046.0602
   Vu DM, 2017, AM J TROP MED HYG, V96, P141, DOI 10.4269/ajtmh.16-0562
   Waggoner J, 2017, MALARIA CHIKUNGUNYA
   Wan-Norafikah O, 2012, SAINS MALAYS, V41, P1309
   Webb CM, 2012, BRIT J SOC WORK, V42, P1235, DOI 10.1093/bjsw/bcr144
   World Health Organization (WHO), 2016, DIS OUTBREAK NE 0208
   Yalwala S, 2015, J VECTOR ECOL, V40, P301, DOI 10.1111/jvec.12168
NR 58
TC 7
Z9 8
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 19
PY 2017
VL 12
IS 12
AR e0189971
DI 10.1371/journal.pone.0189971
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FQ7PP
UT WOS:000418554900045
PM 29261766
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ali, M
   Miller, K
   Folz, R
   Johnson, BR
   Kiarie, J
AF Ali, Moazzam
   Miller, Kelsey
   Folz, Rachel
   Johnson, Brooke Ronald, Jr.
   Kiarie, James
TI Study protocol on establishment of sentinel sites network for
   contraceptive and abortion trends, needs and utilization of services in
   Zika virus affected countries (vol 14, 19, 2017)
SO REPRODUCTIVE HEALTH
LA English
DT Correction
C1 [Ali, Moazzam; Miller, Kelsey; Folz, Rachel; Johnson, Brooke Ronald, Jr.; Kiarie, James] WHO, Dept Reprod Hlth & Res, Ave Appia 20, CH-1211 Geneva 27, Switzerland.
RP Ali, M (corresponding author), WHO, Dept Reprod Hlth & Res, Ave Appia 20, CH-1211 Geneva 27, Switzerland.
EM alimoa@who.int
OI kiarie, james/0000-0003-4180-7858
FU World Health OrganizationWorld Health Organization [001]
CR Ali M, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0282-9
NR 1
TC 1
Z9 1
U1 0
U2 2
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1742-4755
J9 REPROD HEALTH
JI Reprod. Health
PD DEC 19
PY 2017
VL 14
AR 177
DI 10.1186/s12978-017-0432-0
PG 1
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FQ9KA
UT WOS:000418679800001
PM 29258544
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Sun, XM
   Hua, S
   Chen, HR
   Ouyang, ZY
   Einkauf, K
   Tse, S
   Ard, K
   Ciaranello, A
   Yawetz, S
   Sax, P
   Rosenberg, ES
   Lichterfeld, M
   Yu, XG
AF Sun, Xiaoming
   Hua, Stephane
   Chen, Hsiao-Rong
   Ouyang, Zhengyu
   Einkauf, Kevin
   Tse, Samantha
   Ard, Kevin
   Ciaranello, Andrea
   Yawetz, Sigal
   Sax, Paul
   Rosenberg, Eric S.
   Lichterfeld, Mathias
   Yu, Xu G.
TI Transcriptional Changes during Naturally Acquired Zika Virus Infection
   Render Dendritic Cells Highly Conducive to Viral Replication
SO CELL REPORTS
LA English
DT Article
ID FATTY-ACID SYNTHASE; WEST NILE VIRUS; IDENTIFICATION; MONOCYTES;
   EFFECTORS; PRODUCTS; PROTEINS; TARGET; GENES; SITES
AB Although dendritic cells are among the human cell population best equipped for cell-intrinsic antiviral immune defense, they seem highly susceptible to infection with the Zika virus (ZIKV). Using highly purified myeloid dendritic cells isolated from individuals with naturally acquired acute infection, we here show that ZIKV induces profound perturbations of transcriptional signatures relative to healthy donors. Interestingly, we noted a remarkable downregulation of antiviral interferon-stimulated genes and innate immune sensors, suggesting that ZIKV can actively suppress interferon-dependent immune responses. In contrast, several host factors known to support ZIKV infection were strongly upregulated during natural ZIKV infection; these transcripts included AXL, the main entry receptor for ZIKV; SOCS3, a negative regulator of ISG expression; and IDO-1, a recognized inducer of regulatory T cell responses. Thus, during in vivo infection, ZIKV can transform the transcriptome of dendritic cells in favor of the virus to render these cells highly conducive to ZIKV infection.
C1 [Sun, Xiaoming; Hua, Stephane; Chen, Hsiao-Rong; Ouyang, Zhengyu; Einkauf, Kevin; Tse, Samantha; Lichterfeld, Mathias; Yu, Xu G.] Massachusetts Gen Hosp, MIT & Harvard, Ragon Inst MGH, Boston, MA 02114 USA.
   [Yawetz, Sigal; Sax, Paul; Lichterfeld, Mathias; Yu, Xu G.] Brigham & Womens Hosp, Infect Dis Div, 75 Francis St, Boston, MA 02115 USA.
   [Ard, Kevin; Ciaranello, Andrea; Rosenberg, Eric S.] Massachusetts Gen Hosp, Infect Dis Div, Boston, MA 02114 USA.
RP Yu, XG (corresponding author), Massachusetts Gen Hosp, MIT & Harvard, Ragon Inst MGH, Boston, MA 02114 USA.; Yu, XG (corresponding author), Brigham & Womens Hosp, Infect Dis Div, 75 Francis St, Boston, MA 02115 USA.
EM xyu@mgh.harvard.edu
RI Sun, Xiaoming/H-9656-2019; HUA, Stephane/I-6690-2019; Lichterfeld,
   Mathias/B-2042-2008
OI Sun, Xiaoming/0000-0001-6266-6869; HUA, Stephane/0000-0002-2244-5663;
   Lichterfeld, Mathias/0000-0001-9865-8350; Einkauf,
   Kevin/0000-0001-7123-1293; Tse, Samantha/0000-0002-9493-4538
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [HL134539, AI089339, HL121890,
   HL126554, AI116228, AI087452]; Ragon Institute of MGH, MIT and Harvard
FX X.G.Y. is supported by NIH (grants HL134539, AI089339, HL121890,
   HL126554, AI116228, and AI087452) and by the Ragon Institute of MGH, MIT
   and Harvard.
CR Aoki T, 2009, MOL BIOL CELL, V20, P2639, DOI 10.1091/mbc.E08-11-1104
   Bailey CC, 2014, ANNU REV VIROL, V1, P261, DOI 10.1146/annurev-virology-031413-085537
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Bhattacharyya S, 2013, CELL HOST MICROBE, V14, P136, DOI 10.1016/j.chom.2013.07.005
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Calvet GA, 2016, CURR OPIN INFECT DIS, V29, P459, DOI 10.1097/QCO.0000000000000301
   Carow B, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00058
   Chammard TB, 2017, EMERG INFECT DIS, V23, P696, DOI 10.3201/eid2304.161967
   Chaudhary V, 2017, J VIROL, V91, DOI 10.1128/JVI.00163-17
   Clarke P, 2014, MBIO, V5, DOI 10.1128/mBio.00902-14
   Cunha Antonio Jose Ledo Alves da, 2017, Pediatr Infect Dis J, V36, P528, DOI 10.1097/INF.0000000000001486
   Foo SS, 2017, NAT MICROBIOL, V2, P1558, DOI 10.1038/s41564-017-0016-3
   Frumence E, 2016, VIROLOGY, V493, P217, DOI 10.1016/j.virol.2016.03.006
   Gorman MJ, 2016, J VIROL, V90, P8212, DOI 10.1128/JVI.00581-16
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Heaton NS, 2010, P NATL ACAD SCI USA, V107, P17345, DOI 10.1073/pnas.1010811107
   Itsui Y, 2006, J VIRAL HEPATITIS, V13, P690, DOI 10.1111/j.1365-2893.2006.00732.x
   Jiang D, 2010, J VIROL, V84, P8332, DOI 10.1128/JVI.02199-09
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457
   Metz P, 2012, HEPATOLOGY, V56, P2082, DOI 10.1002/hep.25908
   Michlmayr D, 2017, NAT MICROBIOL, V2, P1462, DOI 10.1038/s41564-017-0035-0
   Monel B, 2017, EMBO J, V36, P1653, DOI 10.15252/embj.201695597
   Nair S., 2012, CURR PROTOC IMMUNOL, V7
   Nascimento OJM, 2017, CURR OPIN NEUROL, V30, P500, DOI 10.1097/WCO.0000000000000471
   Olagnier D, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004566
   Panchaud A, 2016, CLIN MICROBIOL REV, V29, P659, DOI 10.1128/CMR.00014-16
   Perera-Lecoin Manuel, 2013, Viruses, V6, P69, DOI 10.3390/v6010069
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Richard AS, 2017, P NATL ACAD SCI USA, V114, P2024, DOI 10.1073/pnas.1620558114
   Richter MKS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098785
   Rolfe AJ, 2016, CELL BIOSCI, V6, DOI 10.1186/s13578-016-0110-x
   Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034
   SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Savidis G, 2016, CELL REP, V15, P2323, DOI 10.1016/j.celrep.2016.05.074
   Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907
   Sztul E, 2009, FEBS LETT, V583, P3770, DOI 10.1016/j.febslet.2009.10.083
   Tang WC, 2014, J VIROL, V88, P6793, DOI 10.1128/JVI.00045-14
   Thurner B, 1999, J IMMUNOL METHODS, V223, P1, DOI 10.1016/S0022-1759(98)00208-7
   Tongluan N, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0685-9
   Trombetta J.J., 2014, CURR PROTOC MOL BIOL, V107
   Wu Y, 2017, CELL DISCOV, V3
   Zhao H, 2012, J HEPATOL, V56, P326, DOI 10.1016/j.jhep.2011.07.026
NR 49
TC 24
Z9 24
U1 1
U2 10
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 2211-1247
J9 CELL REP
JI Cell Reports
PD DEC 19
PY 2017
VL 21
IS 12
BP 3471
EP 3482
DI 10.1016/j.celrep.2017.11.087
PG 12
WC Cell Biology
SC Cell Biology
GA FQ6NP
UT WOS:000418481600015
PM 29262327
OA DOAJ Gold, Green Accepted
DA 2020-07-08
ER

PT J
AU Hamid, PH
   Prastowo, J
   Ghiffari, A
   Taubert, A
   Hermosilla, C
AF Hamid, Penny Humaidah
   Prastowo, Joko
   Ghiffari, Ahmad
   Taubert, Anja
   Hermosilla, Carlos
TI Aedes aegypti resistance development to commonly used insecticides in
   Jakarta, Indonesia
SO PLOS ONE
LA English
DT Article
ID SODIUM-CHANNEL GENE; KNOCKDOWN RESISTANCE; ZIKA VIRUS; CROSS-RESISTANCE;
   MOLECULAR-BASIS; DENGUE; MUTATIONS; F1534C; EVOLUTION; MALARIA
AB Aedes aegypti is the primary vector of various relevant arthropod-borne viral infectious diseases worldwide. The mosquito control is still mainly performed by using insecticides but their effectiveness is increasingly questioned nowadays. We here conducted a study on Ae. aegypti resistance development towards several commonly used insecticides in the capital city of Jakarta, Indonesia. In order to achieve this goal, Ae. aegypti eggs from Jakarta were collected with ovitraps and hatched in the insectary of the Gadjah Mada University, Indonesia. The F0 generations were used for WHO resistance tests and knockdown resistance (kdr) assays. Presented results clearly showed that there was resistance development of Ae. aegypti populations to the here tested pyrethroid insecticides (i.e. permethrin). Observed mortalities were less than 90% with highest resistance against 0.75% permethrin concentrations. Furthermore, a significant association of V1016G gene mutations with resistance phenotypes to 0.75% permethrin was observed. Nevertheless, the F1534C mutation did not show a significant correlation to resistance development. In conclusion, our results show that populations of Ae. aegypti mosquitoes within the city of Jakarta have developed resistance against several routinely used pyrethroid insecticides in local performed control programs. Thus, the regular verification/assessment of resistance development status will hopefully help in the future to assist local public health authorities in their mosquito control programs by recommending and managing the rotation of different routinely used insecticides with diverse effector mechanisms in order to delay Ae. aegypti resistance development.
C1 [Hamid, Penny Humaidah; Prastowo, Joko] Univ Gadjah Mada, Dept Parasitol, Karangmalang, Yogyakarta, Indonesia.
   [Ghiffari, Ahmad] Univ Muhammadiyah, Fac Med, Palembang, Indonesia.
   [Taubert, Anja; Hermosilla, Carlos] Justus Liebig Univ Giessen, Inst Parasitol, Biomed Res Ctr Seltersberg, Giessen, Germany.
RP Hamid, PH (corresponding author), Univ Gadjah Mada, Dept Parasitol, Karangmalang, Yogyakarta, Indonesia.
EM penny_hamid@ugm.ac.id
RI Ghiffari, Ahmad/O-3562-2018; Ghiffari, Ahmad/AAO-1409-2020
OI Ghiffari, Ahmad/0000-0003-1518-2364; 
FU Direktorat Jenderal Pendidikan Tinggi Indonesia (DIKTI)-INSINAS
   [226/SP2H/LT/DRPM/III/2016]
FX This work was supported by the Direktorat Jenderal Pendidikan Tinggi
   Indonesia (DIKTI)-INSINAS research grant No. 226/SP2H/LT/DRPM/III/2016
   (simlitabmas.ristekdikti.go.id). The funder had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Acosta EG, 2016, EXPERT REV VACCINES, V15, P467, DOI 10.1586/14760584.2016.1121814
   Alagarasu K, 2016, VACCINE, V34, P2759, DOI 10.1016/j.vaccine.2016.04.070
   Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x
   Alvarez LC, 2015, PEST MANAG SCI, V71, P863, DOI 10.1002/ps.3846
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   Linss JGB, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-25
   Brengues C, 2003, MED VET ENTOMOL, V17, P87, DOI 10.1046/j.1365-2915.2003.00412.x
   Brown JE, 2014, EVOLUTION, V68, P514, DOI 10.1111/evo.12281
   Central Bureau of Statistic Republic of Indonesia, 2013, IND POP PROJ
   Delatte H, 2011, INFECT GENET EVOL, V11, P1769, DOI 10.1016/j.meegid.2011.07.016
   Du YZ, 2013, P NATL ACAD SCI USA, V110, P11785, DOI 10.1073/pnas.1305118110
   Duong V, 2017, INT J INFECT DIS, V54, P121, DOI 10.1016/j.ijid.2016.11.420
   Grisales N, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002438
   Hamid PH, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2215-4
   Hammond A, 2016, NAT BIOTECHNOL, V34, P78, DOI 10.1038/nbt.3439
   Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018
   Hirata K, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003085
   Hu HM, 2016, HUM VACC IMMUNOTHER, V12, P1678, DOI 10.1080/21645515.2016.1143576
   Ishak IH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0797-2
   Katanami Y, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/tax031
   Kotsakiozi P, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005653
   Kushwah RBS, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003332
   Li CX, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0933-z
   Liu-Helmersson J, 2016, EBIOMEDICINE, V7, P267, DOI 10.1016/j.ebiom.2016.03.046
   Liu-Helmersson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089783
   Ministry of Health Republic of Indonesia, 2015, DEM BERD BIAS MUL ME
   Ministry of Health Republic of Indonesia, 2016, CEG ZIK KKP SOET LAK
   Ministry of Health Republic of Indonesia, 2016, SIT DBD
   Naqqash MN, 2016, PARASITOL RES, V115, P1363, DOI 10.1007/s00436-015-4898-9
   Olanratmanee P, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001913
   Paul A, 2006, J MED ENTOMOL, V43, P55, DOI 10.1603/0022-2585(2006)043[0055:EONIFC]2.0.CO;2
   Plernsub S, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1713-0
   Rivero A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001000
   Sayono S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150577
   Smith LB, 2016, PESTIC BIOCHEM PHYS, V133, P1, DOI 10.1016/j.pestbp.2016.03.005
   Stenhouse SA, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-253
   Sujitha V, 2015, PARASITOL RES, V114, P3315, DOI 10.1007/s00436-015-4556-2
   Tabachnick WJ, 2013, INT J ENV RES PUB HE, V10, P249, DOI 10.3390/ijerph10010249
   Tikar SN, 2009, PARASITOL RES, V105, P57, DOI 10.1007/s00436-009-1362-8
   WHO, 2006, PEST THEIR APPL CONT
   WHO, 2013, TEST PROC INREMO
   Wuliandari JR, 2015, INSECTS, V6, P658, DOI 10.3390/insects6030658
   Yanola J, 2011, TROP MED INT HEALTH, V16, P501, DOI 10.1111/j.1365-3156.2011.02725.x
   Zammarchi L, 2015, EUROSURVEILLANCE, V20, P14
NR 46
TC 13
Z9 13
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 18
PY 2017
VL 12
IS 12
AR e0189680
DI 10.1371/journal.pone.0189680
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FQ5HM
UT WOS:000418389500047
PM 29253003
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Yeh, SC
   Pompon, J
AF Yeh, Shih-Chia
   Pompon, Julien
TI Flaviviruses Produce a Subgenomic Flaviviral RNA That Enhances Mosquito
   Transmission
SO DNA AND CELL BIOLOGY
LA English
DT Article
DE flavivirus; mosquitoes; sfRNA; innate immunity; Xrn1; transmission
ID WEST NILE VIRUS; DENGUE VIRUS; ZIKA VIRUS; INTERFERENCE; CELLS;
   PSEUDOKNOT; ACTIVATION; EXPRESSION; INFECTION; REVEALS
AB Mosquito-borne flaviviruses (MBFVs) are a global public health burden. MBFVs have several unique 3UTR structures that inhibit the host RNA decay machinery to produce subgenomic flaviviral RNAs (sfRNAs). Number of sfRNA species and their relative quantities are dependent on the 3UTR tertiary structures and can vary between tissues. Two recent in vivo studies demonstrated that sfRNA enhances mosquito transmission, resulting in increased infection rate of saliva. Transmission efficiency is determined by the immune response. First evidence points to sfRNA interference with the Toll and RNAi immune pathways. However, a more complex picture that includes flexibility in sfRNA production and interaction with immune-related proteins remains to be explored.
C1 [Yeh, Shih-Chia; Pompon, Julien] Duke Natl Univ Singapore, Programme Emerging Infect Dis, Med Sch, 8 Coll Rd, Singapore 169857, Singapore.
   [Pompon, Julien] Univ Montpellier, CNRS, MIVEGEC, IRD, Montpellier, France.
RP Pompon, J (corresponding author), Duke Natl Univ Singapore, Programme Emerging Infect Dis, Med Sch, 8 Coll Rd, Singapore 169857, Singapore.
EM julien.pompon@duke-nus.edu.sg
FU National Medical Research Council of Singapore as an NIG [NMRC/
   BNIG/2032/2015]; National Medical Research Council of Singapore a CBRG
   [NMRC/CBRG/0074/2014]; Ministry of Education [MOE2015-T3-1-003]
FX This work was supported by two grants from the National Medical Research
   Council of Singapore as an NIG (NMRC/ BNIG/2032/2015) and a CBRG
   (NMRC/CBRG/0074/2014) awarded to J.P., and a Ministry of Education Tier3
   grant (MOE2015-T3-1-003) partially awarded to J.P. We thank Drs.
   Guillaume Marti and Kuo-Chieh Liao for critical review of an earlier
   draft.
CR Akiyama BM, 2016, SCIENCE, V354, P1148, DOI 10.1126/science.aah3963
   Brackney DE, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000856
   Brackney DE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000502
   Brierley I, 2007, NAT REV MICROBIOL, V5, P598, DOI 10.1038/nrmicro1704
   Chapman EG, 2014, ELIFE, V3, DOI 10.7554/eLife.01892
   Chapman EG, 2014, SCIENCE, V344, P307, DOI 10.1126/science.1250897
   Ciota AT, 2017, CURR OPIN INSECT SCI, V22, P28, DOI 10.1016/j.cois.2017.05.002
   Conway MJ, 2014, J VIROL, V88, P164, DOI 10.1128/JVI.02235-13
   Filomatori CV, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006265
   Franz AWE, 2015, VIRUSES-BASEL, V7, P3741, DOI 10.3390/v7072795
   Franz AWE, 2006, P NATL ACAD SCI USA, V103, P4198, DOI 10.1073/pnas.0600479103
   Funk A, 2010, J VIROL, V84, P11407, DOI 10.1128/JVI.01159-10
   Goertz GP, 2016, J VIROL, V90, P10145, DOI 10.1128/JVI.00930-16
   Goertz G.P., 2017, VIRUS RES, V31, P15
   Gritsun TS, 2007, ADV VIRUS RES, V69, P203, DOI 10.1016/S0065-3527(06)69005-2
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8
   Jobling B., 1987, ANATOMICAL DRAWINGS
   Kieft JS, 2015, RNA BIOL, V12, P1169, DOI 10.1080/15476286.2015.1094599
   Liu R, 2010, BIOCHEM BIOPH RES CO, V391, P1099, DOI 10.1016/j.bbrc.2009.12.030
   Manokaran G, 2015, SCIENCE, V350, P217, DOI 10.1126/science.aab3369
   Mendenhall IH, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005667
   Moon SL, 2015, VIROLOGY, V485, P322, DOI 10.1016/j.virol.2015.08.009
   Nagarajan V.K., 2013, BIOCH BIOPHYS ACTA, V19
   Ng WC, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9060137
   Olson KE, 2015, CURR OPIN VIROL, V15, P119, DOI 10.1016/j.coviro.2015.10.001
   Paradkar PN, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002823
   Paradkar PN, 2012, P NATL ACAD SCI USA, V109, P18915, DOI 10.1073/pnas.1205231109
   Pijlman GP, 2008, CELL HOST MICROBE, V4, P579, DOI 10.1016/j.chom.2008.10.007
   Pompon J, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006535
   Pompon J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01282-6
   Ramirez JL, 2010, DEV COMP IMMUNOL, V34, P625, DOI 10.1016/j.dci.2010.01.006
   Reperant LA, 2017, VACCINE, V35, P4470, DOI 10.1016/j.vaccine.2017.04.082
   Roby JA, 2014, VIRUSES-BASEL, V6, P404, DOI 10.3390/v6020404
   Salazar MI, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-9
   Sanchez-Vargas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000299
   Schnettler E, 2012, J VIROL, V86, P13486, DOI 10.1128/JVI.01104-12
   Silva PAGC, 2010, J VIROL, V84, P11395, DOI 10.1128/JVI.01047-10
   Sim S, 2014, VIRUSES-BASEL, V6, P4479, DOI 10.3390/v6114479
   Sim S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002295
   Souza-Neto JA, 2009, P NATL ACAD SCI USA, V106, P17841, DOI 10.1073/pnas.0905006106
   Tuno N, 2017, J MED ENTOMOL, V54, P8, DOI 10.1093/jme/tjw165
   Villordo SM, 2016, TRENDS MICROBIOL, V24, P270, DOI 10.1016/j.tim.2016.01.002
   Villordo SM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004604
   Ward AM, 2011, RNA BIOL, V8, P1173, DOI 10.4161/rna.8.6.17836
   Xi ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000098
   Zou Z, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002394
NR 47
TC 5
Z9 5
U1 1
U2 1
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1044-5498
EI 1557-7430
J9 DNA CELL BIOL
JI DNA Cell Biol.
PD MAR
PY 2018
VL 37
IS 3
BP 154
EP 159
DI 10.1089/dna.2017.4059
EA DEC 2017
PG 6
WC Biochemistry & Molecular Biology; Cell Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Cell Biology; Genetics & Heredity
GA GC4FT
UT WOS:000418124300001
PM 29251994
DA 2020-07-08
ER

PT J
AU Pigott, DM
   Deshpande, A
   Letourneau, I
   Morozoff, C
   Reiner, RC
   Kraemer, MUG
   Brent, SE
   Bogoch, II
   Khan, K
   Biehl, MH
   Burstein, R
   Earl, L
   Fullman, N
   Messina, JP
   Mylne, AQN
   Moyes, CL
   Shearer, FM
   Bhatt, S
   Brady, OJ
   Gething, PW
   Weiss, DJ
   Tatem, AJ
   Caley, L
   De Groeve, T
   Vernaccini, L
   Golding, N
   Horby, P
   Kuhn, JH
   Laney, SJ
   Ng, E
   Piot, P
   Sankoh, O
   Murray, CJL
   Hay, SI
AF Pigott, David M.
   Deshpande, Aniruddha
   Letourneau, Ian
   Morozoff, Chloe
   Reiner, Robert C., Jr.
   Kraemer, Moritz U. G.
   Brent, Shannon E.
   Bogoch, Isaac I.
   Khan, Kamran
   Biehl, Molly H.
   Burstein, Roy
   Earl, Lucas
   Fullman, Nancy
   Messina, Jane P.
   Mylne, Adrian Q. N.
   Moyes, Catherine L.
   Shearer, Freya M.
   Bhatt, Samir
   Brady, Oliver J.
   Gething, Peter W.
   Weiss, Daniel J.
   Tatem, Andrew J.
   Caley, Luke
   De Groeve, Tom
   Vernaccini, Luca
   Golding, Nick
   Horby, Peter
   Kuhn, Jens H.
   Laney, Sandra J.
   Ng, Edmond
   Piot, Peter
   Sankoh, Osman
   Murray, Christopher J. L.
   Hay, Simon I.
TI Local, national, and regional viral haemorrhagic fever pandemic
   potential in Africa: a multistage analysis
SO LANCET
LA English
DT Article
ID EMERGING INFECTIOUS-DISEASES; ZOONOTIC NICHE; VIRUS-DISEASE; LASSA
   FEVER; EBOLA; PREDICTION; SCIENCE; REFORMS; MODELS; HEALTH
AB Background Predicting when and where pathogens will emerge is difficult, yet, as shown by the recent Ebola and Zika epidemics, effective and timely responses are key. It is therefore crucial to transition from reactive to proactive responses for these pathogens. To better identify priorities for outbreak mitigation and prevention, we developed a cohesive framework combining disparate methods and data sources, and assessed subnational pandemic potential for four viral haemorrhagic fevers in Africa, Crimean-Congo haemorrhagic fever, Ebola virus disease, Lassa fever, and Marburg virus disease.
   Methods In this multistage analysis, we quantified three stages underlying the potential of widespread viral haemorrhagic fever epidemics. Environmental suitability maps were used to define stage 1, index-case potential, which assesses populations at risk of infection due to spillover from zoonotic hosts or vectors, identifying where index cases could present. Stage 2, outbreak potential, iterates upon an existing framework, the Index for Risk Management, to measure potential for secondary spread in people within specific communities. For stage 3, epidemic potential, we combined local and international scale connectivity assessments with stage 2 to evaluate possible spread of local outbreaks nationally, regionally, and internationally.
   Findings We found epidemic potential to vary within Africa, with regions where viral haemorrhagic fever outbreaks have previously occurred (eg, western Africa) and areas currently considered non-endemic (eg, Cameroon and Ethiopia) both ranking highly. Tracking transitions between stages showed how an index case can escalate into a widespread epidemic in the absence of intervention (eg, Nigeria and Guinea). Our analysis showed Chad, Somalia, and South Sudan to be highly susceptible to any outbreak at subnational levels.
   Interpretation Our analysis provides a unified assessment of potential epidemic trajectories, with the aim of allowing national and international agencies to pre-emptively evaluate needs and target resources. Within each country, our framework identifies at-risk subnational locations in which to improve surveillance, diagnostic capabilities, and health systems in parallel with the design of policies for optimal responses at each stage. In conjunction with pandemic preparedness activities, assessments such as ours can identify regions where needs and provisions do not align, and thus should be targeted for future strengthening and support.
C1 [Pigott, David M.; Deshpande, Aniruddha; Letourneau, Ian; Morozoff, Chloe; Reiner, Robert C., Jr.; Biehl, Molly H.; Burstein, Roy; Earl, Lucas; Fullman, Nancy; Murray, Christopher J. L.; Hay, Simon I.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA.
   [Kraemer, Moritz U. G.] Univ Oxford, Dept Zool, Oxford, England.
   [Messina, Jane P.] Univ Oxford, Sch Geog & Environm, Oxford, England.
   [Messina, Jane P.] Univ Oxford, Sch Interdisciplinary Area Studies, Oxford, England.
   [Moyes, Catherine L.; Gething, Peter W.; Weiss, Daniel J.; Hay, Simon I.] Univ Oxford, Big Data Inst, Li Ka Shing Ctr Hlth Informat & Discovery, Oxford, England.
   [Horby, Peter] Univ Oxford, Ctr Trop Med & Global Hlth, Nuffield Dept Med, Oxford, England.
   [Kraemer, Moritz U. G.] Harvard Univ, Harvard Med Sch, Boston, MA 02115 USA.
   [Kraemer, Moritz U. G.] Boston Childrens Hosp, Boston, MA USA.
   [Brent, Shannon E.; Khan, Kamran] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada.
   [Bogoch, Isaac I.] Toronto Gen Hosp, Div Gen Internal Med, Toronto, ON, Canada.
   [Bogoch, Isaac I.] Toronto Gen Hosp, Div Infect Dis, Toronto, ON, Canada.
   [Bogoch, Isaac I.] Univ Toronto, Dept Med, Toronto, ON, Canada.
   [Mylne, Adrian Q. N.] Univ Warwick, Warwick Med Sch, Coventry, W Midlands, England.
   [Bhatt, Samir] Imperial Coll London, Dept Infect Dis Epidemiol, London, England.
   [Brady, Oliver J.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.
   [Piot, Peter] London Sch Hyg & Trop Med, Directors Off, London, England.
   [Tatem, Andrew J.] Univ Southampton, Dept Geog & Environm, WorldPop, Southampton, Hants, England.
   [Tatem, Andrew J.] Flowminder Fdn, Stockholm, Sweden.
   [Caley, Luke] Start Network, London, England.
   [De Groeve, Tom; Vernaccini, Luca] European Commiss, Joint Res Ctr, Ispra, Italy.
   [Golding, Nick] Univ Melbourne, Sch BioSci, Appl Ecol Grp, Parkville, Vic, Australia.
   [Kuhn, Jens H.] NIAID, Integrated Res Facil Ft Detrick, Div Clin Res, NIH, Frederick, MD USA.
   [Laney, Sandra J.] SJL Global Consulting, Seattle, WA USA.
   [Sankoh, Osman] INDEPTH Network, Accra, Ghana.
RP Hay, SI (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA.
EM sihay@uw.edu
RI Kuhn, Jens H./B-7615-2011; Hay, Simon I/F-8967-2015; Ng,
   Edmond/L-5871-2019
OI Kuhn, Jens H./0000-0002-7800-6045; Hay, Simon I/0000-0002-0611-7272;
   Horby, Peter/0000-0002-9822-1586; Gething, Peter/0000-0001-6759-5449;
   Bhatt, Samir/0000-0002-0891-4611; Moyes, Catherine/0000-0002-8028-4079
FU Paul G Allen Family Foundation; Bill & Melinda Gates FoundationGates
   Foundation; Wellcome TrustWellcome Trust; UK Department for
   International Development
FX Paul G Allen Family Foundation, Bill & Melinda Gates Foundation,
   Wellcome Trust, UK Department for International Development.
CR Agua-Agum J, 2016, NEW ENGL J MED, V375, P587, DOI 10.1056/NEJMsr1513109
   Bannister B, 2010, BRIT MED BULL, V95, P193, DOI 10.1093/bmb/ldq022
   Bhatt S, 2015, ELIFE, V4, DOI 10.7554/eLife.09672
   Bloom DE, 2017, P NATL ACAD SCI USA, V114, P4055, DOI 10.1073/pnas.1701410114
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Bogoch II, 2015, LANCET, V385, P29, DOI 10.1016/S0140-6736(14)61828-6
   Borchert M, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-357
   BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x
   Camacho A., 2015, PLOS CURR OUTBREAKS, V7, P1, DOI DOI 10.1371/CURRENTS.OUTBREAKS.406AE55E83EC0B5193E3085
   Cantor SB, 1999, J CLIN EPIDEMIOL, V52, P885, DOI 10.1016/S0895-4356(99)00075-X
   De Groeve T., 2014, INDEX RISK MANAGEMEN
   Dieleman JL, 2016, LANCET, V387, P2536, DOI 10.1016/S0140-6736(16)30168-4
   Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x
   Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159
   [Event Data Project Armed Conflict Location], 2016, ARM CONFL LOC EV DAT
   Fa JE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161703
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Food and Agricultural Organization of the United Nations, 2008, GLOB ADM UN LAYERS G
   Forouzanfar MH, 2016, LANCET, V388, P1659, DOI 10.1016/S0140-6736(16)31679-8
   Golding N, 2017, LANCET
   Hay SI, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0250
   Hayman DTS, 2012, EMERG INFECT DIS, V18, P1207, DOI 10.3201/eid1807.111654
   Index for Risk Management, 2015, US INFORM ASS CRIS D
   Institute for Health Metrics and Evaluation, 2015, GLOB ED ATT 1970 201
   Institute for Health Metrics and Evaluation, 2016, FIN GLOB HLTH 2015 D
   Jean N, 2016, SCIENCE, V353, P790, DOI 10.1126/science.aaf7894
   Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536
   Kassebaum NJ, 2016, LANCET, V388, P1603, DOI 10.1016/S0140-6736(16)31460-X
   Kieny MP, 2015, LANCET, V385, P91, DOI 10.1016/S0140-6736(14)62479-X
   Kraemer MUG, 2016, TRENDS PARASITOL, V32, P19, DOI 10.1016/j.pt.2015.09.006
   Kramer AM, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160294
   Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x
   Lo Iacono G, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004957
   Marty R, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2016-000129
   Merler S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005093
   Messina JP, 2015, T ROY SOC TROP MED H, V109, P503, DOI 10.1093/trstmh/trv050
   Messina JP, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.16
   Moon S, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j280
   Moon S, 2015, LANCET, V386, P2204, DOI 10.1016/S0140-6736(15)00946-0
   Moore Melinda, 2017, Rand Health Q, V6, P5
   Morozoff C, 2016, EMERG INFECT DIS, V22
   Moss R, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005018
   Mylne A, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.42
   Mylne AQN, 2015, T ROY SOC TROP MED H, V109, P483, DOI 10.1093/trstmh/trv047
   Nelson A., 2008, ESTIMATED TRAVEL TIM
   Paez-Espino D, 2016, NATURE, V536, P425, DOI 10.1038/nature19094
   Paruolo P, 2013, J R STAT SOC A STAT, V176, P609, DOI 10.1111/j.1467-985X.2012.01059.x
   Pigott DM, 2016, ELIFE, V5, DOI 10.7554/eLife.16412
   Pigott DM, 2015, T ROY SOC TROP MED H, V109, P366, DOI 10.1093/trstmh/trv024
   Pigott DM, 2014, ELIFE, V3, DOI [10.7554/eLife.02851, 10.7554/eLife.04395]
   Piot P, 2014, SCIENCE, V345, P1221, DOI 10.1126/science.1260695
   Pullan RL, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001626
   Raleigh C, 2010, J PEACE RES, V47, P651, DOI 10.1177/0022343310378914
   Redding DW, 2016, METHODS ECOL EVOL, V7, P646, DOI 10.1111/2041-210X.12549
   Russell CA, 2014, ELIFE, V3, DOI 10.7554/eLife.03883
   Saltelli A, 2002, J AM STAT ASSOC, V97, P702, DOI 10.1198/016214502388618447
   Sands P, 2016, NEW ENGL J MED, V374, P1281, DOI 10.1056/NEJMsr1600236
   SEDAC, GLOB RUR URB MAPP PR
   Skrip LA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004802
   Stevens GA, 2016, LANCET, V388, pE19, DOI 10.1016/S0140-6736(16)30388-9
   Tatem AJ, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.4
   The World Bank, 2015, INT US PER 100 PEOPL
   Transparency International, 2016, 2015 CORR PERC IND
   Vaz RG, 2016, J INFECT DIS, V213, pS140, DOI 10.1093/infdis/jiv581
   Vos T, 2016, LANCET, V388, P1545, DOI 10.1016/S0140-6736(16)31678-6
   WHO, 2016, WHO UNICEF REV NAT I
   WHO, 2016, HLTH EXP RAT COUNTR
   Woldehanna S, 2015, SOC SCI MED, V129, P87, DOI 10.1016/j.socscimed.2014.10.059
   World Bank, 2015, ACC EL POP
   World Bank, 2015, WORLDW GOV IND WGI P
   World Bank, 2015, MOB CELL SUBSCR PER
   WorldPop Project, 2015, GRIDD POP SURF AFR
NR 72
TC 28
Z9 29
U1 1
U2 17
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD DEC 16
PY 2017
VL 390
IS 10113
BP 2662
EP 2672
DI 10.1016/S0140-6736(17)32092-5
PG 11
WC Medicine, General & Internal
SC General & Internal Medicine
GA FQ1FF
UT WOS:000418101000027
PM 29031848
OA Green Published, Green Accepted, Other Gold
DA 2020-07-08
ER

PT J
AU Landais, A
   Cesaire, A
   Fernandez, M
   Breurec, S
   Herrmann, C
   Delion, F
   Desprez, P
AF Landais, Anne
   Cesaire, Audrey
   Fernandez, Manuel
   Breurec, Sebastien
   Herrmann, Cecile
   Delion, Frederique
   Desprez, Philippe
TI ZIKA vasculitis: A new cause of stroke in children?
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Letter
DE Zika virus infection; Vasculitis; Ischemic stroke; Child
AB Viral infectious vasculitis is a cause of stroke in children. Zika virus infection is often asymptomatic. Neurological complications have however been reported: Guillain-Barre, ADEM, meningoencephalitis, myelitis, microcephaly in the fetus of infected mothers. We discuss the case of a child presenting acute infection with ZIKV that was associated with a stroke. A 10-months-old boy without medical history presented after 2 days of fever and cutaneous rash, conjunctivitis on day 5, a right hemiparesis on day 6. Brain MRI found an ischemic stroke in the left superficial MCA territory with distal occlusion of left Ml portion of the MCA. Specific real-time reverse PCR detected Zika virus in serum. There are no known cases of cerebral infarction associated with Zika infection. However, cases of cerebral infarcts associated with dengue vasculitis have rarely been described. It has been recently showed that there is a tropism of the Zika virus for endothelial cells. This could be responsible for stroke, possibly particularly in young children.
C1 [Landais, Anne] Univ Hosp Pointe A Pitre, Neurol Dept, Route Chauvel, F-97139 Pointe a Pitre, Guadeloupe, France.
   [Cesaire, Audrey; Delion, Frederique; Desprez, Philippe] Univ Hosp Pointe A Pitre, Paediat Dept, F-97139 Pointe a Pitre, Guadeloupe, France.
   [Fernandez, Manuel] Univ Hosp Pointe A Pitre, Radiol Dept, F-97139 Pointe a Pitre, Guadeloupe, France.
   [Breurec, Sebastien; Herrmann, Cecile] Univ Hosp Pointe A Pitre, Lab Microbiol, F-97139 Pointe a Pitre, Guadeloupe, France.
   [Breurec, Sebastien] Inst Pasteur Guadeloupe, Pointe a Pitre, Guadeloupe, France.
   [Breurec, Sebastien] Univ Antilles, Pointe a Pitre, Guadeloupe, France.
RP Landais, A (corresponding author), Univ Hosp Pointe A Pitre, Neurol Dept, Route Chauvel, F-97139 Pointe a Pitre, Guadeloupe, France.
EM anne.landais@chu-guadeloupe.fr
CR Chen Wei-Hsi, 2006, J Infect, V52, pe87, DOI 10.1016/j.jinf.2005.06.003
   Liu S., 2016, CIRC RES
   Mathew S, 2010, J STROKE CEREBROVASC, V19, P253, DOI 10.1016/j.jstrokecerebrovasdis.2009.05.003
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Nanda SK, 2014, PEDIATR NEUROL, V51, P570, DOI 10.1016/j.pediatrneurol.2014.06.019
   Niemeyer B, 2017, EUR NEUROL, V77, P45, DOI 10.1159/000453396
   Oehler E, 2014, EURO SURVEILL, V19
NR 7
TC 11
Z9 12
U1 0
U2 5
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0022-510X
EI 1878-5883
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD DEC 15
PY 2017
VL 383
BP 211
EP 213
DI 10.1016/j.jns.2017.10.045
PG 3
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA FT9UQ
UT WOS:000423498200044
PM 29122294
DA 2020-07-08
ER

PT J
AU Medina, MT
   Medina-Montoya, M
AF Medina, Marco T.
   Medina-Montoya, Marco
TI New spectrum of the neurologic consequences of Zika
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Editorial Material
DE Zika; Neurologic complications; Childhood; Arterial ischemic stroke
ID ARTERIAL ISCHEMIC-STROKE; VIRUS-INFECTION
AB Zika virus infection represents a new neuropathological agent with association to a wide spectrum of neurological complications: a) Congenital Zika Syndrome by affecting the neural stem cells of the human fetal brain; b) Guillain-Barre Syndrome by an autoimmune response against peripheral myelin and/or axonal components or probable direct inflammatory reaction; c) Encephalitis/meningoencephalitis and myelitis by a direct viral inflammatory process on the central nervous system; d) Sensory neuropathy by infecting directly the peripheral neurons and causing substantial cell death and pathogenic transcriptional dysregulation; e) Acute Disseminated Encephalomyelitis and optic neuropathy; f) Seizures and Epilepsy and g) childhood arterial ischemic stroke by probable inflammatory reaction and endothelial injury.
C1 [Medina, Marco T.] WFN Zika Working Grp, London, England.
   [Medina, Marco T.; Medina-Montoya, Marco] Natl Autonomous Univ Honduras, Fac Med Sci, Tegucigalpa, Honduras.
RP Medina, MT (corresponding author), Natl Autonomous Univ Honduras, Fac Med Sci, Tegucigalpa, Honduras.
EM marcotmedina@yahoo.com
OI Medina, Marco Tulio/0000-0003-0469-054X
CR Asadi-Pooya AA, 2016, SEIZURE-EUR J EPILEP, V43, P13, DOI 10.1016/j.seizure.2016.10.011
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Elkind MSV, 2016, CIRCULATION, V133, P732, DOI 10.1161/CIRCULATIONAHA.115.018595
   Freitas BD, 2017, CURR OPIN OPHTHALMOL, V28, P595, DOI 10.1097/ICU.0000000000000420
   Fullerton HJ, 2017, STROKE, V48, P2875, DOI 10.1161/STROKEAHA.117.018272
   Landais A., 2017, J NEUROL SCI
   McGrath EL, 2017, STEM CELL REP, V8, P715, DOI 10.1016/j.stemcr.2017.01.008
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Medina MT, 2016, J NEUROL SCI, V369, P271, DOI 10.1016/j.jns.2016.08.044
   Mladinich MC, 2017, MBIO, V8, DOI [10.1128/mBio.00952-17, 10.1128/mbio.00952-17]
   Nanda SK, 2014, PEDIATR NEUROL, V51, P570, DOI 10.1016/j.pediatrneurol.2014.06.019
   Niemeyer B, 2017, EUR NEUROL, V77, P45, DOI 10.1159/000453396
   Oh Y, 2017, NAT NEUROSCI, V20, P1209, DOI 10.1038/nn.4612
   Thomas SL, 2014, CLIN INFECT DIS, V58, P61, DOI 10.1093/cid/cit659
NR 15
TC 9
Z9 9
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-510X
EI 1878-5883
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD DEC 15
PY 2017
VL 383
BP 214
EP 215
DI 10.1016/j.jns.2017.10.046
PG 2
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA FT9UQ
UT WOS:000423498200045
PM 29108750
DA 2020-07-08
ER

PT J
AU Boppana, SB
   Britt, WJ
   Fowler, K
   Hutto, SC
   James, SH
   Kimberlin, DW
   Poole, C
   Ross, SA
   Whitley, RJ
AF Boppana, Suresh B.
   Britt, William J.
   Fowler, Karen
   Hutto, S. Cecelia
   James, Scott H.
   Kimberlin, David W.
   Poole, Claudette
   Ross, Shannon A.
   Whitley, Richard J.
TI Pathogenesis of Non-Zika Congenital Viral Infections
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Zika; congenital infections; rubella; hepatitis B; neonatal herpes
   simplex infection
ID HERPES-SIMPLEX-VIRUS; HEPATITIS-B-VIRUS; SENSORINEURAL HEARING-LOSS;
   PRIMARY CYTOMEGALOVIRUS-INFECTION; NEONATAL HERPES; LONG-TERM;
   PREEXISTING IMMUNITY; RECURRENT INFECTION; NATURAL-HISTORY; CMV
   INFECTION
AB A widespread epidemic of Zika virus (ZIKV) infection was reported in 2015 from South and Central America and the Caribbean. Although the full spectrum of ZIKV infection of the newborn has yet to be determined, other maternal viral infections resulting in transmission to the fetus provide instructive lessons that can be applied to the prospective evaluation of individuals with ZIKV infection. This review focuses on those other congenital infections, including rubella, congenital cytomegalovirus, human immunodeficiency virus, hepatitis B virus, and neonatal herpes simplex virus, from which lessons for the evaluation of ZIKV in the newborn can be applied.
C1 [Boppana, Suresh B.; Britt, William J.; Fowler, Karen; Hutto, S. Cecelia; James, Scott H.; Kimberlin, David W.; Poole, Claudette; Ross, Shannon A.; Whitley, Richard J.] Univ Alabama Birmingham, Div Pediat Infect Dis, Birmingham, AL 35233 USA.
RP Whitley, RJ (corresponding author), Univ Alabama Birmingham, Div Pediat Infect Dis, Birmingham, AL 35233 USA.
EM rwhitley@peds.uab.edu
FU National Institute of Allergy and Infectious Diseases (NIAID), part of
   the National Institutes of Health (NIH)
FX This article is part of a supplement sponsored by the National Institute
   of Allergy and Infectious Diseases (NIAID), part of the National
   Institutes of Health (NIH).
CR Ahlfors K, 1999, SCAND J INFECT DIS, V31, P443, DOI 10.1080/00365549950163969
   AHLFORS K, 1984, SCAND J INFECT DIS, V16, P129, DOI 10.3109/00365548409087131
   Alarcon A, 2013, J PEDIATR-US, V163, P828, DOI 10.1016/j.jpeds.2013.03.014
   ALFORD CA, 1981, CLIN PERINATOL, V8, P397
   Ancora G, 2007, J PEDIATR-US, V150, P157, DOI 10.1016/j.jpeds.2006.11.032
   [Anonymous], 2016, ZIK VIR MICR GUILL B
   Aragao MFVV, 2017, AM J NEURORADIOL, V38, P1045, DOI 10.3174/ajnr.A5125
   BARKOVICH AJ, 1994, AM J NEURORADIOL, V15, P703
   BELMAN AL, 1993, ANN NY ACAD SCI, V693, P107, DOI 10.1111/j.1749-6632.1993.tb26260.x
   Bhimma R, 2003, ARCH PEDIAT ADOL MED, V157, P1025, DOI 10.1001/archpedi.157.10.1025
   BOESCH C, 1989, PEDIATR RADIOL, V19, P91, DOI 10.1007/BF02387893
   BOND WW, 1981, LANCET, V1, P550
   BOPPANA S B, 1992, Pediatric Research, V31, p158A
   Boppana SB, 1999, PEDIATRICS, V104, P55, DOI 10.1542/peds.104.1.55
   Boppana SB, 1997, PEDIATRICS, V99, P409, DOI 10.1542/peds.99.3.409
   BOPPANA SB, 1992, PEDIATR INFECT DIS J, V11, P93, DOI 10.1097/00006454-199202000-00007
   Brasil P, 2016, LANCET INFECT DIS, V16, P1307, DOI 10.1016/S1473-3099(16)30372-3
   Britt WJ, 2011, INFECT DIS FETUS NEW, P706
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Capretti MG, 2014, BRAIN DEV-JPN, V36, P203, DOI 10.1016/j.braindev.2013.04.001
   Centers for Disease Control and Prevention, 2017, HIV PREGN WOM INF CH
   Chisari FV, 2010, PATHOL BIOL, V58, P258, DOI 10.1016/j.patbio.2009.11.001
   CONBOY TJ, 1987, J PEDIATR-US, V111, P343, DOI 10.1016/S0022-3476(87)80451-1
   Custer B, 2004, J CLIN GASTROENTEROL, V38, pS158, DOI 10.1097/00004836-200411003-00008
   Dahle A J, 2000, J Am Acad Audiol, V11, P283
   Dar L, 2008, PEDIATR INFECT DIS J, V27, P841, DOI 10.1097/INF.0b013e3181723d55
   De Santis M, 2006, REPROD TOXICOL, V21, P390, DOI 10.1016/j.reprotox.2005.01.014
   de Vries JJC, 2013, REV MED VIROL, V23, P241, DOI 10.1002/rmv.1744
   DEMMLER GJ, 1991, REV INFECT DIS, V13, P315, DOI 10.1093/clinids/13.2.315
   Dickover RE, 1996, JAMA-J AM MED ASSOC, V275, P599, DOI 10.1001/jama.275.8.599
   Dreher AM, 2014, J PEDIATR-US, V164, P855, DOI 10.1016/j.jpeds.2013.12.007
   Dunn DT, 2003, LANCET, V362, P1605
   EPSTEIN LG, 1986, PEDIATRICS, V78, P678
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS ZIK VIR
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fowler Karen B., 1996, Pediatric Research, V39, p171A
   Fowler KB, 2006, J CLIN VIROL, V35, P226, DOI 10.1016/j.jcv.2005.09.016
   FOWLER KB, 1993, J INFECT DIS, V168, P552, DOI 10.1093/infdis/168.3.552
   FOWLER KB, 1992, NEW ENGL J MED, V326, P663, DOI 10.1056/NEJM199203053261003
   Fowler KB, 1997, J PEDIATR-US, V130, P624, DOI 10.1016/S0022-3476(97)70248-8
   Gaytant MA, 2003, EUR J PEDIATR, V162, P248, DOI 10.1007/s00431-002-1115-3
   Grant GB, 2015, MMWR-MORBID MORTAL W, V64, P1052, DOI 10.15585/mmwr.mm6437a5
   Grosse SD, 2009, J CLIN VIROL, V46, pS32, DOI 10.1016/j.jcv.2009.08.019
   HARRIS S, 1984, EAR HEARING, V5, P352, DOI 10.1097/00003446-198411000-00006
   HAYWARD JC, 1991, J CHILD NEUROL, V6, P109, DOI 10.1177/088307389100600203
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Highleyman L., INFANT ZIKA INFECT M
   Hou Jinlin, 2005, Int J Med Sci, V2, P50
   James SH, 2014, J PEDIATR INFECT DIS, V3, pS19, DOI 10.1093/jpids/piu050
   James SH, 2015, INFECT DIS CLIN N AM, V29, P391, DOI 10.1016/j.idc.2015.05.001
   James SH, 2015, CLIN PERINATOL, V42, P47, DOI 10.1016/j.clp.2014.10.005
   Joint United Nations Programme on HIV/AIDS, 2013, 2013 PROGR REP GLOB
   KANE M, 1995, VACCINE, V13, pS47
   Kenneson A, 2007, REV MED VIROL, V17, P253, DOI 10.1002/rmv.535
   Kimberlin DW, 2011, NEW ENGL J MED, V365, P1284, DOI 10.1056/NEJMoa1003509
   Kimberlin DW, 2001, PEDIATRICS, V108, P230, DOI 10.1542/peds.108.2.230
   Kimberlin DW, 2001, PEDIATRICS, V108, P223, DOI 10.1542/peds.108.2.223
   Kylat RI, 2006, EUR J PEDIATR, V165, P773, DOI 10.1007/s00431-006-0172-6
   Maartens G, 2014, LANCET, V384, P258, DOI 10.1016/S0140-6736(14)60164-1
   Manicklal S, 2013, CLIN MICROBIOL REV, V26, P86, DOI 10.1128/CMR.00062-12
   MILLER E, 1982, LANCET, V2, P781
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Morgan-Capner P, 1991, CDR (Lond Engl Rev), V1, pR57
   MORRIS DJ, 1994, PEDIATR INFECT DIS J, V13, P61, DOI 10.1097/00006454-199401000-00013
   Morton CC, 2006, NEW ENGL J MED, V354, P2151, DOI 10.1056/NEJMra050700
   Mussi-Pinhata MM, 2009, CLIN INFECT DIS, V49, P522, DOI 10.1086/600882
   Noyola DE, 2001, J PEDIATR-US, V138, P325, DOI 10.1067/mpd.2001.112061
   OXTOBY MJ, 1990, PEDIATR INFECT DIS J, V9, P609
   Pan CQ, 2016, NEW ENGL J MED, V374, P2324, DOI 10.1056/NEJMoa1508660
   PASS RF, 1991, PEDIATR ANN, V20, P419, DOI 10.3928/0090-4481-19910801-07
   PECKHAM CS, 1983, LANCET, V1, P1352
   Penazzato M, 2017, JAIDS-J ACQ IMM DEF, V75, pS59, DOI [10.1097/qai.0000000000001333, 10.1097/QAI.0000000000001333]
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pinninti SG, 2016, PEDIATR INFECT DIS J, V35, P924, DOI 10.1097/INF.0000000000001194
   Pinninti SG, 2014, CLIN PERINATOL, V41, P945, DOI 10.1016/j.clp.2014.08.012
   Pinninti SG, 2013, AM J PERINAT, V30, P113, DOI 10.1055/s-0032-1332802
   Plotkin SA, 2006, CLIN INFECT DIS, V43, pS164, DOI 10.1086/505950
   PREECE PM, 1983, ARCH DIS CHILD, V58, P970, DOI 10.1136/adc.58.12.970
   PREECE PM, 1986, J EPIDEMIOL COMMUN H, V40, P205, DOI 10.1136/jech.40.3.205
   Ramjee G, 2013, AIDS RES THER, V10, DOI 10.1186/1742-6405-10-30
   Reef SE, 2011, J INFECT DIS, V204, pS24, DOI 10.1093/infdis/jir155
   Rivera LB, 2002, PEDIATRICS, V110, P762, DOI 10.1542/peds.110.4.762
   Ross SA, 2006, J PEDIATR-US, V148, P332, DOI 10.1016/j.jpeds.2005.09.003
   Schillie S, 2015, PEDIATRICS, V135, pE1141, DOI 10.1542/peds.2014-3213
   SCHOPFER K, 1978, ARCH DIS CHILD, V53, P536, DOI 10.1136/adc.53.7.536
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   SCOTT GB, 1989, NEW ENGL J MED, V321, P1791, DOI 10.1056/NEJM198912283212604
   SHAPIRO CN, 1993, PEDIATR INFECT DIS J, V12, P433, DOI 10.1097/00006454-199305000-00036
   Simon V, 2006, LANCET, V368, P489, DOI 10.1016/S0140-6736(06)69157-5
   STAGNO S, 1986, JAMA-J AM MED ASSOC, V256, P1904, DOI 10.1001/jama.256.14.1904
   STAGNO S, 1977, NEW ENGL J MED, V296, P1254, DOI 10.1056/NEJM197706022962203
   STAGNO S, 1982, Clinical Obstetrics and Gynecology, V25, P563, DOI 10.1097/00003081-198209000-00014
   STEVENS CE, 1987, JAMA-J AM MED ASSOC, V257, P2612, DOI 10.1001/jama.257.19.2612
   Townsend CL, 2013, CLIN INFECT DIS, V56, P1232, DOI 10.1093/cid/cit018
   WALMUS BF, 1988, J INFECT DIS, V157, P172, DOI 10.1093/infdis/157.1.172
   Wang CB, 2011, CLIN INFECT DIS, V52, pE11, DOI 10.1093/cid/ciq085
   WHITE NH, 1989, J INFECT DIS, V159, P1013, DOI 10.1093/infdis/159.6.1013
   Whitley RJ, 2017, CLIN VIROLOGY, P415
   WILLIAMSON WD, 1990, AM J DIS CHILD, V144, P1365, DOI 10.1001/archpedi.1990.02150360091031
   WILLIAMSON WD, 1992, PEDIATRICS, V90, P862
   WILLIAMSON WD, 1982, AM J DIS CHILD, V136, P902, DOI 10.1001/archpedi.1982.03970460032007
   YOW MD, 1988, AM J OBSTET GYNECOL, V158, P1189, DOI 10.1016/0002-9378(88)90252-9
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 103
TC 2
Z9 2
U1 0
U2 5
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD DEC 15
PY 2017
VL 216
SU 10
BP S912
EP S918
DI 10.1093/infdis/jix431
PG 7
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA FQ3DY
UT WOS:000418238500009
PM 29267912
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Durbin, AP
   Whitehead, SS
AF Durbin, Anna P.
   Whitehead, Stephen S.
TI Zika Vaccines: Role for Controlled Human Infection
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE controlled human infection model (CHIM); Zika vaccines; Zika virus
ID GUILLAIN-BARRE-SYNDROME; HUMAN CHALLENGE MODEL; MALARIA-NAIVE ADULTS;
   CIRCUMSPOROZOITE PROTEIN VACCINE; PLASMODIUM-FALCIPARUM MALARIA; MALE
   SEXUAL TRANSMISSION; PHASE 2A TRIAL; VIRUS CHALLENGE; EFFICACY;
   IMMUNIZATION
AB Zika virus (ZIKV), a previously little known arbovirus, caused an unprecedented outbreak in Latin America and the Caribbean throughout 2015 and 2016. The virus has been associated with the congenital Zika syndrome (CZS), which can occur with maternal ZIKV infection during any trimester and can result from asymptomatic infection. There is concern that even low levels of viremia can result in CZS, meaning an effective vaccine will need to induce very high levels of protection. Controlled human infection models (CHIMs), in which subjects are infected with a pathogen of interest, have been used to down-select vaccine candidates and have provided efficacy data in support of vaccine licensure.
   A ZIKV CHIM could be instrumental in determining which of the many ZIKV vaccine candidates provides the highest degree of protection and should be advanced in clinical development. The development of a ZIKV CHIM is not without challenges. The ZIKV, unlike other flaviviruses, is sexually and mosquito-transmitted, and an increase in the incidence of Guillain-Barr, syndrome was reported in some countries during the ZIKV outbreak. These obstacles can be overcome with thoughtful study design to ensure maximal risk mitigation. If successful, a ZIKV CHIM could de-risk and accelerate ZIKV vaccine development.
C1 [Durbin, Anna P.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA.
   [Whitehead, Stephen S.] NIAID, Infect Dis Lab, NIH, Bethesda, MD 20892 USA.
RP Durbin, AP (corresponding author), 624 N Broadway,Room 251, Baltimore, MD 21205 USA.
EM adurbin1@jhu.edu
RI Whitehead, Stephen/AAG-2787-2019
FU National Institutes of Allergy and Infectious Diseases Intramural
   Research Program, National Institutes of Health, NIH
   [HHSN272200900010C]; Laboratory of Infectious Diseases, National
   Institute of Allergy and Infectious Diseases, National Institutes of
   Health; National Institute of Allergy and Infectious Diseases (NIAID),
   part of the National Institutes of Health (NIH)
FX This work was supported by a contract with the National Institutes of
   Allergy and Infectious Diseases Intramural Research Program, National
   Institutes of Health, NIH (contract HHSN272200900010C; to A. P. D.) and
   by the Laboratory of Infectious Diseases, National Institute of Allergy
   and Infectious Diseases, National Institutes of Health (S. S. W. is a
   senior staff scientist).; This work is part of a supplement sponsored by
   the National Institute of Allergy and Infectious Diseases (NIAID), part
   of the National Institutes of Health (NIH).
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   [Anonymous], CAS COUNTS US
   Atmar RL, 2011, NEW ENGL J MED, V365, P2178, DOI 10.1056/NEJMoa1101245
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brooks RB, 2016, MMWR-MORBID MORTAL W, V65, P915, DOI 10.15585/mmwr.mm6534e2
   Chen WH, 2016, CLIN INFECT DIS, V62, P1329, DOI 10.1093/cid/ciw145
   Chroni E, 2004, EUR J NEUROL, V11, P383, DOI 10.1111/j.1468-1331.2004.00799.x
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Darsley MJ, 2012, CLIN VACCINE IMMUNOL, V19, P1921, DOI 10.1128/CVI.00364-12
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   DeVincenzo JP, 2014, NEW ENGL J MED, V371, P711, DOI 10.1056/NEJMoa1401184
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P910, DOI 10.15585/mmwr.mm6534e1
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Epstein JE, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.89154
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Harro C, 2011, CLIN VACCINE IMMUNOL, V18, P1719, DOI 10.1128/CVI.05194-11
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hughes RA, 2006, ARCH INTERN MED, V166, P1301, DOI 10.1001/archinte.166.12.1301
   Joguet G, 2017, LANCET INFECT DIS, V17, P1200, DOI 10.1016/S1473-3099(17)30444-9
   Kester KE, 2001, J INFECT DIS, V183, P640, DOI 10.1086/318534
   Kester KE, 2008, VACCINE, V26, P2191, DOI 10.1016/j.vaccine.2008.02.048
   Kester KE, 2007, VACCINE, V25, P5359, DOI 10.1016/j.vaccine.2007.05.005
   Kester KE, 2009, J INFECT DIS, V200, P337, DOI 10.1086/600120
   Kim YI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113100
   Kirkpatrick BD, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1517
   Larsen CP, 2015, VACCINE, V33, P7075, DOI 10.1016/j.vaccine.2015.09.052
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Pan-American Health Organization/World Health Organization, 2017, ZIK EP REP BRAZ
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Porter CK, 2013, EPIDEMIOL INFECT, V141, P223, DOI 10.1017/S0950268812001677
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Russell K, 2017, CLIN INFECT DIS, V64, P211, DOI 10.1093/cid/ciw692
   Seder RA, 2013, SCIENCE, V341, P1359, DOI 10.1126/science.1241800
   Stoute JA, 1997, NEW ENGL J MED, V336, P86, DOI 10.1056/NEJM199701093360202
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Taylor DN, 2006, CLIN INFECT DIS, V42, P1283, DOI 10.1086/503039
   Van Koningsveld R, 2000, NEUROLOGY, V54, P620, DOI 10.1212/WNL.54.3.620
   Vannice KS, 2019, VACCINE, V37, P7443, DOI 10.1016/j.vaccine.2016.10.034
   WHO, 2017, WHO VACC PIP TRACK
NR 47
TC 5
Z9 5
U1 0
U2 5
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD DEC 15
PY 2017
VL 216
SU 10
BP S971
EP S975
DI 10.1093/infdis/jix491
PG 5
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA FQ3DY
UT WOS:000418238500017
PM 29267920
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Erbelding, E
   Cassetti, C
AF Erbelding, Emily
   Cassetti, Cristina
TI Zika Virus and Future Research Directions
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE priorities; research directions; Zika
ID EPIDEMIOLOGY; INFECTION
AB There was a dramatic upsurge in research activity after the recognition of Zika virus (ZIKV) transmission in South America in 2015 and its causal relationship to devastating anomalies in newborn infants. Progress in this area required a community of arbovirologists poised to refocus their research efforts and rapidly characterize the features of ZIKV transmission and infection through diverse multidisciplinary collaborations. Significant gaps remain in our knowledge of the natural history of ZIKV infection, its effects on neurodevelopment, modes and risk of transmission, and its interrelationship with other arbovirus infections. Development of effective countermeasures, such as therapeutics and an effective vaccine, are also research priorities. Lessons learned from our research response to ZIKV may help public health officials plan for the next emerging infectious disease threat.
   The last 18 months have witnessed one of the most rapid and coordinated research responses against an emerging disease to date. Zika virus, a pathogen that has been known since 1947 but poorly studied until recently because it was believed to only cause a mild infection, has rapidly become the object of intense investigation by the international research community since the link between infection and severe congenital disease was announced by Brazilian authorities in November 2015. According to PubMed, the total number of ZIKV-related publications skyrocketed from 117 in 2015 to 3253 in August of 2017. This supplement summarizes the tremendous progress that has been made since 2015 to elucidate the biology of this virus, its various disease manifestations in humans and animals, the diverse routes by which it is transmitted, and the role of various mosquito vectors in the recent outbreaks. In addition, several efforts have been initiated to develop new diagnostics, therapeutics, vaccines, and vector control strategies to better detect, treat, and prevent this important infection. There are 3 factors that contributed to the rapid progress in ZIKV research: (1) the availability of dedicated funding for ZIKV research; (2) the prior existence of both flavivirologists and maternal-child health researchers who were poised to tackle this new public health challenge; and (3) the high level of coordination and collaboration between different research agencies worldwide.
   Despite the significant progress, many significant questions remain to be addressed to accelerate the development of effective ZIKV countermeasures and increase our preparedness against this significant public health threat. Some of the most pressing scientific gaps that need to be addressed to advance the field are summarized below.
C1 [Erbelding, Emily] NIAID, Div Microbiol & Infect Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
   [Cassetti, Cristina] Div Microbiol & Infect Dis, Virol Branch, Bethesda, MD USA.
RP Cassetti, C (corresponding author), NIAID, NIH, 5601 Fishers Lane, Bethesda, MD 20892 USA.
EM ccassetti@niaid.nih.gov
FU National Institute of Allergy and Infectious Diseases (NIAID), part of
   the National Institutes of Health (NIH)
FX This work is part of a supplement sponsored by the National Institute of
   Allergy and Infectious Diseases (NIAID), part of the National Institutes
   of Health (NIH).
CR Barzon L., 2016, EUROSURVEILLANCE, V21, P2016, DOI DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Cromwell EA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005429
   Durbin AP, 2017, J INFECT DIS, V216, pS971, DOI 10.1093/infdis/jix491
   Eisen L, 2014, J MED ENTOMOL, V51, P496, DOI 10.1603/ME13214
   Erguler K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174293
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Hills SL, 2017, J INFECT DIS, V216, pS868, DOI 10.1093/infdis/jix434
   James SH, 2016, CURR OPIN PEDIATR, V28, P81, DOI 10.1097/MOP.0000000000000305
   Johansson MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104915
   Julander JG, 2017, J INFECT DIS, V216, pS919, DOI 10.1093/infdis/jix465
   Kauffman EB, 2017, J INFECT DIS, V216, pS976, DOI 10.1093/infdis/jix405
   Keegan LT, 2017, J INFECT DIS, V216, pS884, DOI 10.1093/infdis/jix437
   Manore CA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005255
   Maxian O, 2017, EPIDEMICS-NETH, V21, P48, DOI 10.1016/j.epidem.2017.06.003
   Morabito KM, 2017, J INFECT DIS, V216, pS957, DOI 10.1093/infdis/jix464
   Mordecai EA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005568
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Munoz LS, 2017, J INFECT DIS, V216, pS897, DOI 10.1093/infdis/jix511
   Musso D, 2017, CLIN MICROBIOL INFEC, V23, DOI 10.1016/j.cmi.2017.07.006
   Osuna CE, 2017, J INFECT DIS, V216, pS928, DOI 10.1093/infdis/jix540
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
NR 22
TC 4
Z9 4
U1 0
U2 10
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD DEC 15
PY 2017
VL 216
SU 10
BP S991
EP S994
DI 10.1093/infdis/jix492
PG 4
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA FQ3DY
UT WOS:000418238500019
PM 29267921
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Gruber, MF
   Farizo, KM
   Pratt, RD
   Fink, DL
   Finn, TM
   Krause, PR
   Borio, LL
   Marks, PW
AF Gruber, Marion F.
   Farizo, Karen M.
   Pratt, R. Douglas
   Fink, Doran L.
   Finn, Theresa M.
   Krause, Philip R.
   Borio, Lucian L.
   Marks, Peter W.
TI Clinical Development Strategies and Considerations for Zika Vaccine
   Licensure
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE US FDA; Zika; clinical development; licensure pathways; vaccine
ID VIRUS
AB The Zika outbreak that began in 2015 has spread from Brazil to countries across the Western Hemisphere including the United States, presenting global public health challenges that call for the expedited development and availability of preventive vaccines to protect against Zika virus disease. While the general principles guiding the nonclinical and clinical development for Zika vaccines are the same as those of other preventive vaccines, unique considerations apply, in particular if development occurs during a public health emergency. Furthermore, incomplete information about the pathogenesis of Zika virus disease and the mechanism by which candidate preventive vaccines potentially may confer protection presents additional challenges to their clinical development. Nevertheless, definition of clinical development strategies to enable sound regulatory assessment, with a goal toward licensure is critical for these products. This article will provide an overview of the regulatory considerations for the clinical development and licensure of Zika vaccine candidates including a discussion of clinical study designs, approaches to demonstrate vaccine effectiveness, and regulatory pathways to licensure.
C1 [Gruber, Marion F.; Farizo, Karen M.; Pratt, R. Douglas; Fink, Doran L.; Finn, Theresa M.; Krause, Philip R.] US FDA, Off Vaccines Res & Review, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA.
   [Borio, Lucian L.] US FDA, Off Commissioner, Silver Spring, MD 20993 USA.
   [Marks, Peter W.] US FDA, Ctr Biol Evaluat & Res, 10903 New Hampshire Ave,Bldg 71,Rm 3230, Silver Spring, MD 20993 USA.
RP Gruber, MF (corresponding author), US FDA, Ctr Biol Evaluat & Res, 10903 New Hampshire Ave,Bldg 71,Rm 3230, Silver Spring, MD 20993 USA.
EM marion.gruber@fda.hhs.gov
FU National Institute of Allergy and Infectious Diseases (NIAID), part of
   the National Institutes of Health (NIH)
FX This work is part of a supplement sponsored by the National Institute of
   Allergy and Infectious Diseases (NIAID), part of the National Institutes
   of Health (NIH).
CR Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chattopadhyay R, 2017, VACCINE, V35, P2767, DOI 10.1016/j.vaccine.2017.03.072
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Marston HD, 2016, NEW ENGL J MED, V375, P1209, DOI 10.1056/NEJMp1607762
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   National Institute of Allergy and Infectious Diseases, ETH CONS ZIK VIR HUM
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Roberts JN, 2015, VACCINE, V33, P966, DOI 10.1016/j.vaccine.2014.12.068
   Thomas SJ, 2016, NEW ENGL J MED, V375, P1212, DOI 10.1056/NEJMp1609300
   U.S. Food and Drug Administration, 2015, GUID IND PROD DEV AN
   US Food and Drug Administration, 2006, GUID IND EST OP CLIN
   US Food and Drug Administration, 2016, GUID IND EXP ACC INV
   US Food and Drug Administration, 2017, GUID IND EM US AUTH
   US Food and Drug Administration, 2011, GUID IND GEN PRINC D
NR 15
TC 5
Z9 5
U1 0
U2 0
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD DEC 15
PY 2017
VL 216
SU 10
BP S964
EP S970
DI 10.1093/infdis/jix433
PG 7
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA FQ3DY
UT WOS:000418238500016
PM 29267913
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Gubler, DJ
   Vasilakis, N
   Musso, D
AF Gubler, Duane J.
   Vasilakis, Nikos
   Musso, Didier
TI History and Emergence of Zika Virus
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Aedes aegypti; GBS; microcephaly; mosquito; Zika
ID AEDES-AEGYPTI MOSQUITOS; GUILLAIN-BARRE-SYNDROME; WEST-NILE-VIRUS;
   HEMAGGLUTINATION-INHIBITION; SEXUAL TRANSMISSION; FRENCH-POLYNESIA;
   FEDERATED STATES; DENGUE VIRUS; YAP STATE; INFECTION
AB Zika virus was discovered in East Africa in 1947 by the Rockefeller Foundation during investigations on the ecology of yellow fever. Although it was subsequently shown to have widespread distribution in Africa and Asia, it was not known to cause epidemics until 2007. This paper describes the history of the virus discovery, emergence and evolution as an epidemic virus, and the its evolving clinical spectrum.
C1 [Gubler, Duane J.] Duke NUS Med Sch, Emerging Infect Dis Programme, Singapore 169857, Singapore.
   [Vasilakis, Nikos] Univ Texas Med Branch, Dept Pathol, Ctr Biodef & Emerging Infect Dis, Ctr Trop Dis,Inst Human Infect & Immun, Galveston, TX 77555 USA.
   [Musso, Didier] Inst Louis Malarde Papeete, Unit Emerging Infect Dis, Tahiti, French Polynesi, France.
RP Gubler, DJ (corresponding author), Duke NUS Med Sch, Emerging Infect Dis Programme, Singapore 169857, Singapore.
EM duane.gubler@duke-nus.edu.sg
RI Musso, Didier/P-7809-2016; Musso, Didier/AAO-8178-2020
OI Musso, Didier/0000-0002-9226-0971; Musso, Didier/0000-0002-9226-0971
FU Duke-NUS Medical School (Singapore)National University of Singapore;
   National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R24AI120942,
   U01AI115577]; National Institute of Allergy and Infectious Diseases
   (NIAID), part of the National Institutes of Health (NIH)
FX This work was partially funded by Duke-NUS Medical School (Singapore)
   and by National Institutes of Health Grants R24AI120942 and U01AI115577
   (to University of Texas).; This work is part of a supplement sponsored
   by the National Institute of Allergy and Infectious Diseases (NIAID),
   part of the National Institutes of Health (NIH).
CR de Brito CAA, 2016, REV SOC BRAS MED TRO, V49, P537, DOI 10.1590/0037-8682-0328-2016
   Araujo AQC, 2016, BRAIN, V139, P2122, DOI 10.1093/brain/aww158
   Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   Ayllon T, 2017, EMERG INFECT DIS, V23, P1411, DOI 10.3201/eid2308.162007
   Azar SR, 2017, AM J TROP MED HYG, V97, P330, DOI 10.4269/ajtmh.16-0969
   Baud D, 2017, LANCET
   Bautista LE, 2016, LANCET, V387, P2599, DOI 10.1016/S0140-6736(16)30844-3
   Bennett SN, 2010, MOL BIOL EVOL, V27, P811, DOI 10.1093/molbev/msp285
   Bennett SN, 2003, MOL BIOL EVOL, V20, P1650, DOI 10.1093/molbev/msg182
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Besnard M, 2014, EURO SURVEILL, V19
   BOORMAN JPT, 1968, T ROY SOC TROP MED H, V62, P269, DOI 10.1016/0035-9203(68)90168-5
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Brizzi K, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0561-1
   Butt AM, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.106
   CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chen RB, 2011, VIRUSES-BASEL, V3, P1562, DOI 10.3390/v3091562
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Chu DT, 2017, EUR J CLIN MICROBIOL, DOI [10.1007/s10096-017-3038-8, DOI 10.1007/S10096-017-3038-8]
   CLARKE DH, 1958, AM J TROP MED HYG, V7, P561, DOI 10.4269/ajtmh.1958.7.561
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   del Campo M, 2017, AM J MED GENET A, V173, P841, DOI 10.1002/ajmg.a.38170
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Durand Mark A, 2005, Pac Health Dialog, V12, P99
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fontanet A, 2016, LANCET, V387, P2600, DOI 10.1016/S0140-6736(16)30773-5
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gerardin P, 2008, PLOS MED, V5, P413, DOI 10.1371/journal.pmed.0050060
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Herrera BB, 2017, J INFECT DIS, V215, P1546, DOI 10.1093/infdis/jix182
   Karabatsos N., 1985, INT CATALOGUE ARBOVI
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Kuno Goro, 2003, Adv Virus Res, V61, P3, DOI 10.1016/S0065-3527(03)61001-8
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   LEE VH, 1984, MOSQ NEWS, V44, P184
   Levi JE, 2016, J INFECT DIS, V213, P689, DOI 10.1093/infdis/jiv322
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mallet H. P., 2016, Bulletin Epidemiologique Hebdomadaire, P367
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Messer WB, 2003, EMERG INFECT DIS, V9, P800
   METTLER NE, 1971, APPL MICROBIOL, V22, P377, DOI 10.1128/AEM.22.3.377-379.1971
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D., 2014, EURO SURVEILL, V19
   Musso D, 2017, LANCET INFE IN PRESS
   Musso D, 2017, LANCET INFECT DIS, V17, P255, DOI 10.1016/S1473-3099(17)30070-1
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nash D, 2001, NEW ENGL J MED, V344, P1807, DOI 10.1056/NEJM200106143442401
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Oehler E, 2014, EURO SURVEILL, V19
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Ramaiah A, 2017, INFECT GENET EVOL, V51, P74, DOI 10.1016/j.meegid.2017.03.012
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Richard V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005024
   Roundy CM, 2017, EMERG INFECT DIS, V23, P625, DOI 10.3201/eid2304.161484
   RUDNICK A, 1986, I MED RES MALAYS B, V23, P51
   Russell PK, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004589
   Savage HM, 1998, AM J TROP MED HYG, V58, P519, DOI 10.4269/ajtmh.1998.58.519
   Schwartz DA, 2017, ARCH PATHOL LAB MED, V141, P18, DOI [10.5858/arpa.2016-04, 10.5858/arpa.2016-0429-ED]
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   SMITH C E G, 1958, Trans R Soc Trop Med Hyg, V52, P237
   Steel A, 2010, VIROLOGY, V405, P505, DOI 10.1016/j.virol.2010.05.033
   Stramer SL, 2005, NEW ENGL J MED, V353, P451, DOI 10.1056/NEJMoa044333
   Tan PC, 2008, OBSTET GYNECOL, V111, P1111, DOI 10.1097/AOG.0b013e31816a49fc
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Tsetsarkin KA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5084
   Tsetsarkin KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002412
   Valencia A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151001
   Vasilakis N, 2017, CURR OPIN VIROL, V22, P30, DOI 10.1016/j.coviro.2016.11.007
   Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   Wikan N, 2017, ASIAN PAC J TROP MED, V10, P1, DOI 10.1016/j.apjtm.2016.11.013
   Wikan N, 2017, LANCET INFECT DIS, V17, P15, DOI 10.1016/S1473-3099(16)30525-4
   World Health Organization, 2009, DENG GUID DIAGN TREA
   World Health Organization, 2017, SIT REP ZIK VIR MICR
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 99
TC 29
Z9 30
U1 0
U2 23
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD DEC 15
PY 2017
VL 216
SU 10
BP S860
EP S867
DI 10.1093/infdis/jix451
PG 8
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA FQ3DY
UT WOS:000418238500002
PM 29267917
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Hills, SL
   Fischer, M
   Petersen, LR
AF Hills, Susan L.
   Fischer, Marc
   Petersen, Lyle R.
TI Epidemiology of Zika Virus Infection
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Zika; epidemiology; arbovirus; emerging disease; Africa; Asia; Pacific;
   Americas
ID PUERTO-RICO; BORNE TRANSMISSION; UNITED-STATES; OUTBREAK; CAMBODIA;
   AMERICA; ISLAND
AB Long known to be endemic in Africa and Southeast Asia and a rare cause of acute febrile illness, Zika virus (ZIKAV) arose from obscurity when an Asian genotype ZIKAV caused an outbreak of mild febrile illness in 2007 in Yap State, Federated States of Micronesia. Subsequent viral spread in the Pacific led to a large outbreak in French Polynesia commencing in 2013. After its recognition in the Americas through March 2017, the Pan American Health Organization has received reports of > 750000 suspected and laboratory-confirmed cases of autochthonous ZIKAV transmission. Outbreaks in most countries in the Americas peaked in early to mid-2016. Increased surveillance in several Southeast Asian counties has led to increased case recognition, including an outbreak in Singapore, and the first reports of birth defects linked to ZIKAV in the region. As of April 2017, the World Health Organization reported 84 countries or territories with current or previous ZIKAV transmission.
C1 [Hills, Susan L.; Fischer, Marc; Petersen, Lyle R.] Ctr Dis Control & Prevent, Div Vector Borne Dis, Natl Ctr Emerging & Zoonot Infect Dis, Ft Collins, CO 80521 USA.
RP Hills, SL (corresponding author), Ctr Dis Control & Prevent, Div Vector Borne Dis, 3156 Rampart Rd, Ft Collins, CO 80521 USA.
EM shills@cdc.gov
FU CDCUnited States Department of Health & Human ServicesCenters for
   Disease Control & Prevention - USA; National Institute of Allergy and
   Infectious Diseases (NIAID), part of the National Institutes of Health
   (NIH)
FX This work was supported by the CDC.; This work is part of a supplement
   sponsored by the National Institute of Allergy and Infectious Diseases
   (NIAID), part of the National Institutes of Health (NIH).
CR Adams L, 2016, MMWR-MORBID MORTAL W, V65, P774, DOI 10.15585/mmwr.mm6530e1
   Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   [Anonymous], 2017, ZIK VIR COUNTR CLASS
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Chevalier MS, 2017, EMERG INFECT DIS, V23, P790, DOI 10.3201/eid2305.161873
   Council of State and Territorial Epidemiologists, ZIK VIR DIS CONG ZIK
   Council of State and Territorial Epidemiologists, ZIK VIR DIS ZIK VIR
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duong V, 2017, EMERG INFECT DIS, V23, P296, DOI 10.3201/eid2302.161432
   Duong V, 2017, INT J INFECT DIS, V54, P121, DOI 10.1016/j.ijid.2016.11.420
   Fabrizius RG, 2016, AM J TROP MED HYG, V95, P1161, DOI 10.4269/ajtmh.16-0397
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Florida Health, ZIK VIR
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Hancock WT, 2017, MMWR-MORBID MORTAL W, V66, P299, DOI 10.15585/mmwr.mm6611a5
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Hennessey MJ, 2016, AM J TROP MED HYG, V95, P212, DOI 10.4269/ajtmh.16-0049
   Herrera BB, 2017, J INFECT DIS, V215, P1546, DOI 10.1093/infdis/jix182
   Ikejezie J, 2017, MMWR-MORBID MORTAL W, V66, P329, DOI 10.15585/mmwr.mm6612a4
   Institut Pasteur du Laos, ARB SURV
   Korhonen EM, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.2.30107
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lednicky J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004687
   Leo YS, 2016, LANCET INFECT DIS, V16, P1317, DOI 10.1016/S1473-3099(16)30448-0
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Mallet HP, 2015, BILAN EPIDEMIE VIRUS
   Maurer-Stroh S, EURO SURVEILL, V2016, P21
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Ministerio da Saude, 2015, EV SAUD PUBL REL AOS
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983
   National Environment Agency, ZIK CAS CLUST
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Pan American Health Organization, ZIK SUSP CONF CAS RE
   Pan American Health Organization, ZIK EP REP MEX
   Pan American Health Organization, EP AL NEUR SYNDR CON
   Pan American Health Organization WHO, 2017, ZIK EP UPD
   Pan-American Health Organization/World Health Organization, 2017, ZIK EP REP BRAZ
   Petersen LR, 2016, NEW ENGL J MED, V375, P294, DOI 10.1056/NEJMc1606769
   Roze B, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.9.30154
   Russell K, 2017, CLIN INFECT DIS, V64, P211, DOI 10.1093/cid/ciw692
   Sharp TM, 2016, CLIN INFECT DIS, V63, P1198, DOI 10.1093/cid/ciw476
   Simmons G, 2016, EMERG INFECT DIS, V22, P1221, DOI 10.3201/eid2207.160116
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Tappe D, EURO SURVEILL, V2014, P19
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   WHO, 2016, DIS OUTBREAK NE 0208
   WHO, WHO DIR GEN SUMM OUT
   World Health Organization, 2017, SIT REP ZIK VIR MICR
   World Health Organization, 2015, ZIK VIR INF CAP VERD
   World Health Organization, 2016, COUNTR TERR SHOW HIS
   World Health Organization, 2016, SIT REP ZIK VIR MICR
   World Health Organization. Fifth meeting of the Emergency Committee under the International Health Regulations, 2005, 5 M EM COMM INT HLTH
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 68
TC 33
Z9 34
U1 1
U2 11
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD DEC 15
PY 2017
VL 216
SU 10
BP S868
EP S874
DI 10.1093/infdis/jix434
PG 7
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA FQ3DY
UT WOS:000418238500003
PM 29267914
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Kauffman, EB
   Kramer, LD
AF Kauffman, Elizabeth B.
   Kramer, Laura D.
TI Zika Virus Mosquito Vectors: Competence, Biology, and Vector Control
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Zika; Flavivirus; Aedes aegypti; Aedes albopictus; vector competence
ID AEDES-ALBOPICTUS DIPTERA; DESICCATION SURVIVAL-TIME;
   NINO-SOUTHERN-OSCILLATION; HOST-FEEDING PATTERNS; CHIKUNGUNYA VIRUS;
   CULEX-QUINQUEFASCIATUS; AEGYPTI MOSQUITOS; NORTH-AMERICA; YELLOW-FEVER;
   VERTICAL TRANSMISSION
AB Zika virus (ZIKV) (Flaviviridae, Flavivirus) has become one of the most medically important mosquito-borne viruses because of its ability to cause microcephaly in utero and Guillain-Barr, syndrome in adults. This virus emerged from its sylvatic cycle in Africa to cause an outbreak in Yap, Federated States of Micronesia in 2007, French Polynesia in 2014, and most recently South America in 2015. The rapid expansion of ZIKV in the Americas largely has been due to the biology and behavior of its vector, Aedes aegypti. Other arboviruses transmitted by Ae. aegypti include the 2 flaviviruses dengue virus and yellow fever virus and the alphavirus chikungunya virus, which are also (re)emerging viruses in the Americas. This mosquito vector is highly domesticated, living in close association with humans in urban households. Its eggs are desiccation resistant, and the larvae develop rapidly in subtropical and tropical environments. Climate warming is facilitating range expansion of Ae. aegypti, adding to the threat this mosquito poses to human health, especially in light of the difficulty controlling it. Aedes albopictus, another highly invasive arbovirus vector that has only been implicated in one country (Gabon), is an important vector of ZIKV, but because of its wide geographic distribution may become a more important vector in the future. This article discusses the historical background of ZIKV and the biology and ecology of these 2 vectors.
C1 [Kauffman, Elizabeth B.; Kramer, Laura D.] SUNY Albany, Arbovirus Lab, Wadsworth Ctr, New York State Dept Hlth, Albany, NY 12222 USA.
   [Kramer, Laura D.] SUNY Albany, Sch Publ Hlth, Albany, NY USA.
RP Kramer, LD (corresponding author), SUNY Albany, New York State Dept Hlth, Wadsworth Ctr, POB 22002, Albany, NY 12201 USA.
EM laura.kramer@health.ny.gov
FU New York State Department of Health; National Institute of Allergy and
   Infectious Diseases (NIAID), part of the National Institutes of Health
   (NIH)
FX This work was supported by the New York State Department of Health.;
   This work is part of a supplement sponsored by the National Institute of
   Allergy and Infectious Diseases (NIAID), part of the National Institutes
   of Health (NIH).
CR Aliota MT, 2016, EMERG INFECT DIS, V22, P1857, DOI 10.3201/eid2210.161082
   Amraoui F, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.35.30333
   Bargielowski IE, 2015, INFECT GENET EVOL, V36, P456, DOI 10.1016/j.meegid.2015.08.016
   Bargielowski IE, 2016, INSECT SCI, V23, P162, DOI 10.1111/1744-7917.12291
   Belinato TA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130719
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Boccolini D, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.35.30328
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Braks MAH, 2014, ANN ENTOMOL SOC AM, V9, P130
   Bueno MG, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005073
   Burke R, 2010, MED VET ENTOMOL, V24, P117, DOI 10.1111/j.1365-2915.2010.00864.x
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Caragata EP, 2016, TRENDS PARASITOL, V32, P207, DOI 10.1016/j.pt.2015.10.011
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Caron M, 2012, CLIN INFECT DIS, V55, pE45, DOI 10.1093/cid/cis530
   Carvalho DO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003864
   Carvalho FD, 2017, NEOTROP ENTOMOL, V46, P243, DOI 10.1007/s13744-017-0520-4
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Ciota AT, 2017, EMERG INFECT DIS, V23, P1110, DOI 10.3201/eid2307.161633
   Ciota AT, 2017, EMERG INFECT DIS, V23, P880, DOI 10.3201/eid2305.162041
   Cornet M, 1979, ENTOMOL MED PARASITO, V17, P47
   Di Luca M, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.18.30223
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dodson BL, 2017, PEERJ, V5, DOI 10.7717/peerj.3096
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dyer O, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j707
   ECDC, AED ALB
   Eisen L, 2014, J MED ENTOMOL, V51, P496, DOI 10.1603/ME13214
   Enserink M, 2008, SCIENCE, V320, P864, DOI 10.1126/science.320.5878.864
   Equihua M, 2017, ACTA TROP, V166, P316, DOI 10.1016/j.actatropica.2016.11.014
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Faraji A, 2016, J MED ENTOMOL, V53, P1029, DOI 10.1093/jme/tjw096
   Faraji A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003037
   Faull KJ, 2016, J VECTOR ECOL, V41, P55, DOI 10.1111/jvec.12194
   Fernandes RS, 2017, MEM I OSWALDO CRUZ, V112, P577, DOI 10.1590/0074-02760170145
   Fernandes RS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004993
   Fonseca DM, 2006, AM J TROP MED HYG, V74, P284, DOI 10.4269/ajtmh.2006.74.284
   Gaunt MW, 2001, J GEN VIROL, V82, P1867, DOI 10.1099/0022-1317-82-8-1867
   Grandadam M, 2011, EMERG INFECT DIS, V17, P910, DOI 10.3201/eid1705.101873
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   Guedes DRD, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.59
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   HADDOW A. J., 1964, BULL WORLD HEALTH ORGAN, V31, P57
   Hahn MB, 2016, J MED ENTOMOL, V53, P1169, DOI 10.1093/jme/tjw072
   Hales S, 1996, LANCET, V348, P1664, DOI 10.1016/S0140-6736(05)65737-6
   Hall-Mendelin S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004959
   HANSON SM, 1995, J AM MOSQUITO CONTR, V11, P35
   Harris AF, 2012, NAT BIOTECHNOL, V30, P828, DOI 10.1038/nbt.2350
   Hart CE, 2017, EMERG INFECT DIS, V23, P559, DOI 10.3201/eid2303.161636
   HAWLEY WA, 1987, SCIENCE, V236, P1114, DOI 10.1126/science.3576225
   Heitmann A, 2017, EUROSURVEILLANCE, V22, P4, DOI 10.2807/1560-7917.ES.2017.22.2.30437
   Hoffmann AA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003115
   Hopp MJ, 2001, CLIMATIC CHANGE, V48, P441, DOI 10.1023/A:1010717502442
   Huang YJS, 2016, VECTOR-BORNE ZOONOT, V16, P673, DOI 10.1089/vbz.2016.2058
   Hufbauer RA, 2012, EVOL APPL, V5, P89, DOI 10.1111/j.1752-4571.2011.00211.x
   Juliano SA, 2002, OECOLOGIA, V130, P458, DOI 10.1007/s004420100811
   Juliano SA, 1998, ECOLOGY, V79, P255, DOI 10.1890/0012-9658(1998)079[0255:SIARAM]2.0.CO;2
   Juliano SA, 2016, BIOLOGICAL INVASIONS AND ANIMAL BEHAVIOUR, P245
   Kenney JL, 2017, AM J TROP MED HYG, V96, P1235, DOI 10.4269/ajtmh.16-0865
   Klassen W, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P39, DOI 10.1007/1-4020-4051-2_2
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   LACEY LA, 1986, ANNU REV ENTOMOL, V31, P265, DOI 10.1146/annurev.en.31.010186.001405
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Lo Presti A, 2012, INFECT GENET EVOL, V12, P392, DOI 10.1016/j.meegid.2011.12.015
   Lourenco-de-Oliveira R, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005511
   Lozano-Fuentes S, 2012, AM J TROP MED HYG, V87, P902, DOI 10.4269/ajtmh.2012.12-0244
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Marcombe S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101992
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   MILLER BR, 1989, TROP MED PARASITOL, V40, P396
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Moyes CL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005625
   Mulla M. S., 1990, Bacterial control of mosquitoes & black flies: biochemistry, genetics & applications of Bacillus thuringiensis israelensis and Bacillus sphaericus., P134
   Mulla MS, 1986, FUNDAMENTAL APPLIED, P494
   MULLA MS, 1985, INTEGRATED MOSQUITO, V2, P227
   NICHOLLS N, 1993, LANCET, V342, P1284, DOI 10.1016/0140-6736(93)92368-4
   Ogoma SB, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-287
   Oxitec, OX SCI
   (PAHO/ WHO) Pan American Health Organization/ World Health Organization, 2016, ZIK EP UPD 21 APR 20
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   Paupy C, 2012, VECTOR-BORNE ZOONOT, V12, P167, DOI 10.1089/vbz.2011.0736
   Ponlawat A, 2005, J MED ENTOMOL, V42, P844, DOI 10.1603/0022-2585(2005)042[0844:BFPOAA]2.0.CO;2
   Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Richard V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005024
   Richards SL, 2006, J MED ENTOMOL, V43, P543, DOI 10.1603/0022-2585(2006)43[543:HPOAAD]2.0.CO;2
   Ritchie SA, 2014, DENGUE AND DENGUE HEMORRHAGIC FEVER, 2ND EDITION, P455, DOI 10.1079/9781845939649.0455
   Rose RI, 2001, EMERG INFECT DIS, V7, P17, DOI 10.3201/eid0701.010103
   Roundy CM, 2017, EMERG INFECT DIS, V23, P625, DOI 10.3201/eid2304.161484
   Russell BM, 2002, J MED ENTOMOL, V39, P143, DOI 10.1603/0022-2585-39.1.143
   Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263
   Severo OP, 1955, YELL FEV S COMM CJ F, V1955
   De Majo MS, 2017, J MED ENTOMOL, V54, P106, DOI 10.1093/jme/tjw131
   SOPER FL, 1963, AM J PUBLIC HEALTH N, V53, P7, DOI 10.2105/AJPH.53.1.7
   SOTA T, 1992, OECOLOGIA, V90, P353, DOI 10.1007/BF00317691
   SUNY Levin Institute, INCR GLOB TRAV
   Suwanchaichinda C, 2002, ARCH INSECT BIOCHEM, V49, P71, DOI 10.1002/arch.10009
   Tan CH, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005496
   Thangamani S, 2016, AM J TROP MED HYG, V95, P1169, DOI 10.4269/ajtmh.16-0448
   Thomas DD, 2000, SCIENCE, V287, P2474, DOI 10.1126/science.287.5462.2474
   Tripet F, 2011, AM J TROP MED HYG, V85, P265, DOI 10.4269/ajtmh.2011.10-0677
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Tsetsarkin KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006835
   UNWTO, 2016, UNWTO ANN REP 2016
   Valerio L, 2010, VECTOR-BORNE ZOONOT, V10, P291, DOI 10.1089/vbz.2009.0007
   Vasilakis N, 2010, J VIROL, V84, P3726, DOI 10.1128/JVI.02640-09
   Vythilingam I, 2005, J AM MOSQUITO CONTR, V21, P296, DOI 10.2987/8756-971X(2005)21[296:LAFEOT]2.0.CO;2
   Vythilingam I, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01452
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   Werren JH, 2008, NAT REV MICROBIOL, V6, P741, DOI 10.1038/nrmicro1969
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Wyss JH, 2000, ANN NY ACAD SCI, V916, P186, DOI 10.1111/j.1749-6632.2000.tb05289.x
NR 117
TC 25
Z9 26
U1 4
U2 33
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD DEC 15
PY 2017
VL 216
SU 10
BP S976
EP S990
DI 10.1093/infdis/jix405
PG 15
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA FQ3DY
UT WOS:000418238500018
PM 29267910
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Keegan, LT
   Lessler, J
   Johansson, MA
AF Keegan, Lindsay T.
   Lessler, Justin
   Johansson, Michael A.
TI Quantifying Zika: Advancing the Epidemiology of Zika With Quantitative
   Models
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Zika; mathematical modeling; epidemiology
ID GUILLAIN-BARRE-SYNDROME; VIRUS-INFECTION; REPRODUCTION NUMBER;
   FRENCH-POLYNESIA; MOSQUITO-BORNE; GLOBAL RISK; TRANSMISSION; COLOMBIA;
   OUTBREAK; PREGNANCY
AB When Zika virus (ZIKV) emerged in the Americas, little was known about its biology, pathogenesis, and transmission potential, and the scope of the epidemic was largely hidden, owing to generally mild infections and no established surveillance systems. Surges in congenital defects and Guillain-Barr, syndrome alerted the world to the danger of ZIKV. In the context of limited data, quantitative models were critical in reducing uncertainties and guiding the global ZIKV response. Here, we review some of the models used to assess the risk of ZIKV-associated severe outcomes, the potential speed and size of ZIKV epidemics, and the geographic distribution of ZIKV risk. These models provide important insights and highlight significant unresolved questions related to ZIKV and other emerging pathogens.
C1 [Keegan, Lindsay T.; Lessler, Justin] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA.
   [Johansson, Michael A.] Ctr Dis Control & Prevent, Div Vector Borne Dis, San Juan, PR USA.
   [Johansson, Michael A.] TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA.
RP Johansson, MA (corresponding author), 1324 Calle Canada, San Juan, PR 00920 USA.
EM mjohans-son@cdc.gov
OI Johansson, Michael/0000-0002-5090-7722; Keegan,
   Lindsay/0000-0002-8526-3007
FU National Institute of Allergy and Infectious DiseasesUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01 AI102939]; National Institute of Allergy and Infectious Diseases
   (NIAID), part of the National Institutes of Health (NIH)
FX This work was supported by the National Institute of Allergy and
   Infectious Diseases (grant R01 AI102939 to L. T. K. and J. L.).; This
   work is part of a supplement sponsored by the National Institute of
   Allergy and Infectious Diseases (NIAID), part of the National Institutes
   of Health (NIH).
CR Alfaro-Murillo JA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004743
   Andronico A, 2017, AM J EPIDEMIOL, V186, P1194, DOI 10.1093/aje/kwx008
   Aubry M, 2015, 64 ANN M AM SOC TROP
   Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, N ENGL J MED
   Caminade C, 2017, P NATL ACAD SCI USA, V114, P119, DOI 10.1073/pnas.1614303114
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cardoso CW, 2015, OUTBREAK EXANTHEMATO
   Carlson CJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004968
   Castillo-Chavez C., 2002, MATH APPROACHES EMER
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Centers for Disease Control and Prevention, ZIK VIR CAS COUNTS U
   Champagne C, 2016, ELIFE, V5, DOI [10.7554/eLife.19874.001, 10.7554/eLife.19874]
   Chan M., 2016, WHO DIRECTOR GEN SUM
   Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023
   Colombia Ministry of Health, 2015, MINSALUD CONF 1 NEUV
   de Oliveira WK, 2017, NEW ENGL J MED, V376, P1591, DOI 10.1056/NEJMc1608612
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dinh L, 2016, THEOR BIOL MED MODEL, V13, DOI 10.1186/s12976-016-0046-1
   Dirlikov E, 2017, EMERG INFECT DIS, V23, P134, DOI 10.3201/eid2301.161290
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Ellington SR, 2016, JAMA PEDIATR, V170, P940, DOI 10.1001/jamapediatrics.2016.2974
   European Centre for Disease Prevention and Control, 2017, RAP RISK ASS ZIK VIR, P13
   Ferguson N. M., 2016, SCIENCE
   Funk S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005173
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Gardner LM, 2016, LANCET INFECT DIS, V16, P522, DOI 10.1016/S1473-3099(16)00176-6
   Hsieh YH, 2017, PEERJ, V5, DOI 10.7717/peerj.3015
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Lipsitch M, 2011, BIOSECUR BIOTERROR, V9, P89, DOI 10.1089/bsp.2011.0007
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Majumder Maimuna S, 2016, JMIR Public Health Surveill, V2, pe30, DOI 10.2196/publichealth.5814
   Manore CA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005255
   Massad E., 2016, GLOB HLTH ACTION, V9
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Monaghan A. J., 2016, PLOS CURRENTS, V8
   Mordecai EA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005568
   Ndeffo-Mbah ML, 2016, ANN INTERN MED, V165, P551, DOI 10.7326/M16-0919
   Nishiura H, 2016, TRAVEL MED INFECT DI, V14, P274, DOI 10.1016/j.tmaid.2016.03.016
   Nishiura H, 2016, EPIDEMICS-NETH, V15, P66, DOI 10.1016/j.epidem.2016.03.001
   Nishiura H, 2016, INT J INFECT DIS, V45, P95, DOI 10.1016/j.ijid.2016.02.017
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Ogden NH, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-1977-z
   Paploski IAD, 2016, EMERG INFECT DIS, V22, P1438, DOI 10.3201/eid2208.160496
   Perkins TA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.126, 10.1038/nmicrobiol.2016.126]
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Rocklov J, 2016, EBIOMEDICINE, V9, P250, DOI 10.1016/j.ebiom.2016.06.009
   Rojas DP, 2016, EUROSURVEILLANCE, V21, P26, DOI 10.2807/1560-7917.ES.2016.21.28.30283
   Saad-Roy CM, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-2076-z
   Samy AM, 2016, MEM I OSWALDO CRUZ, V111, P559, DOI 10.1590/0074-02760160149
   Santos J, 2017, ACTA TROP, V168, P80, DOI 10.1016/j.actatropica.2017.01.015
   Sejvar JJ, 2011, NEUROEPIDEMIOLOGY, V36, P123, DOI 10.1159/000324710
   Towers S, 2016, EPIDEMICS-NETH, V17, P50, DOI 10.1016/j.epidem.2016.10.003
   Villela DA, 2017, EPIDEMIOL INFECT, P1
   Walker WL, 2016, MMWR-MORBID MORTAL W, V65, P983, DOI 10.15585/mmwr.mm6536e5
   Yakob L, 2016, LANCET INFECT DIS, V16, P1100, DOI 10.1016/S1473-3099(16)30324-3
   Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhang Q, 2017, P NATL ACAD SCI
   Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114
NR 69
TC 7
Z9 7
U1 0
U2 9
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD DEC 15
PY 2017
VL 216
SU 10
BP S884
EP S890
DI 10.1093/infdis/jix437
PG 7
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA FQ3DY
UT WOS:000418238500005
PM 29267915
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Morabito, KM
   Graham, BS
AF Morabito, Kaitlyn M.
   Graham, Barney S.
TI Zika Virus Vaccine Development
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Zika virus; vaccine development; DNA; mRNA; whole-inactivated;
   live-attenuated; chimeric
ID TETRAVALENT DENGUE VACCINE; TICK-BORNE ENCEPHALITIS; MESSENGER-RNA
   VACCINES; WEST NILE VIRUS; PROTECTIVE EFFICACY; STRUCTURAL BASIS;
   YELLOW-FEVER; FUSION-LOOP; PHASE-III; INFECTION
AB The emergence of Zika virus in Brazil and its association with microcephaly and Guillain-Barr, syndrome led to accelerated vaccine development efforts. Based on prior flavivirus vaccine development programs, knowledge of flavivirus particle structure, definition of E dimers as the key antigenic target, and deep understanding of neutralizing mechanisms, multiple vaccine strategies have advanced to the stage of clinical evaluation with unprecedented speed. These include nucleic acid (DNA and messenger RNA), whole-inactivated virus, live-attenuated or chimeric virus, and protein or viruslike particle vaccines. Within a year from the declaration by the World Health Organization of Zika virus as a Public Health Emergency of International Concern, multiple vaccine candidates entered clinical trials, now totaling 7 products with an additional 40-plus candidate vaccines in preclinical development. The rapid progress in vaccine development demonstrates the capacity of governments, public health organizations, and the scientific community to respond to pandemic threats when sufficient prior knowledge exists, emergency funding is made available, and interagency cooperation is achieved and serves as a paradigm for preparing for future emerging infectious diseases.
C1 [Morabito, Kaitlyn M.; Graham, Barney S.] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
RP Graham, BS (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
EM bgraham@nih.gov
RI Graham, Barney S./AAC-5898-2019
OI Graham, Barney S./0000-0001-8112-0853; Morabito,
   Kaitlyn/0000-0002-4849-4690
FU NIAIDUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID); National Institute of Allergy and
   Infectious Diseases (NIAID), part of the National Institutes of Health
   (NIH)
FX This work was supported by the NIAID (intramural funding to K. M. M. and
   B. S. G.).; This work is part of a supplement sponsored by the National
   Institute of Allergy and Infectious Diseases (NIAID), part of the
   National Institutes of Health (NIH).
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cherrier MV, 2009, EMBO J, V28, P3269, DOI 10.1038/emboj.2009.245
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   de Alwis R, 2012, P NATL ACAD SCI USA, V109, P7439, DOI 10.1073/pnas.1200566109
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Deering RP, 2014, EXPERT OPIN DRUG DEL, V11, P885, DOI 10.1517/17425247.2014.901308
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P600, DOI 10.1016/0035-9203(52)90021-7
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Durbin AP, 2011, VACCINE, V29, P7242, DOI 10.1016/j.vaccine.2011.07.023
   Ferlenghi I, 2001, MOL CELL, V7, P593, DOI 10.1016/S1097-2765(01)00206-4
   Flipse J, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003749
   Guy B, 2011, VACCINE, V29, P7229, DOI 10.1016/j.vaccine.2011.06.094
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Halstead SB, 2011, EXPERT REV VACCINES, V10, P355, DOI [10.1586/erv.11.7, 10.1586/ERV.11.7]
   Heinz FX, 2012, VACCINE, V30, P4301, DOI 10.1016/j.vaccine.2011.09.114
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Julander JG, 2011, VACCINE, V29, P6008, DOI 10.1016/j.vaccine.2011.06.034
   Kaufmann B, 2010, P NATL ACAD SCI USA, V107, P18950, DOI 10.1073/pnas.1011036107
   Kreil TR, 1997, CLIN EXP IMMUNOL, V110, P358, DOI 10.1046/j.1365-2249.1997.4311446.x
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Muthumani K, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.21
   Netland J, 2013, VIRUSES-BASEL, V5, P2573, DOI 10.3390/v5102573
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Osorio JE, 2016, EXPERT REV VACCINES, V15, P497, DOI 10.1586/14760584.2016.1128328
   Osorio JE, 2014, LANCET INFECT DIS, V14, P830, DOI 10.1016/S1473-3099(14)70811-4
   Papania MJ, 2014, JAMA PEDIATR, V168, P148, DOI 10.1001/jamapediatrics.2013.4342
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Richner JM, 2017, CELL, V169, P176, DOI 10.1016/j.cell.2017.03.016
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Rivino L, 2017, IMMUNOLOGY, V150, P146, DOI 10.1111/imm.12681
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   Sahin U, 2014, NAT REV DRUG DISCOV, V13, P759, DOI 10.1038/nrd4278
   Shan C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00737-8
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Smit R, 2015, EXPERT REV VACCINES, V14, P737, DOI 10.1586/14760584.2015.985661
   Staples JE, 2008, JAMA-J AM MED ASSOC, V300, P960, DOI 10.1001/jama.300.8.960
   Sumathy K, 2017, SCI REP-UK, V7, DOI 10.1038/srep46375
   Tauber E, 2007, LANCET, V370, P1847, DOI 10.1016/S0140-6736(07)61780-2
   Van Gessel Y, 2011, VACCINE, V29, P5925, DOI 10.1016/j.vaccine.2011.06.062
   Vogt MR, 2011, J VIROL, V85, P11567, DOI 10.1128/JVI.05859-11
   Weissman D, 2015, EXPERT REV VACCINES, V14, P265, DOI 10.1586/14760584.2015.973859
   Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36
   Whitehead SS, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005584
   Winkler CW, 2017, J IMMUNOL, V198, P3526, DOI 10.4049/jimmunol.1601949
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 55
TC 13
Z9 13
U1 1
U2 12
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD DEC 15
PY 2017
VL 216
SU 10
BP S957
EP S963
DI 10.1093/infdis/jix464
PG 7
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA FQ3DY
UT WOS:000418238500015
PM 29267918
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Morens, DM
   Fauci, AS
AF Morens, David M.
   Fauci, Anthony S.
TI Pandemic Zika: A Formidable Challenge to Medicine and Public Health
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE epidemic; flavivirus; pandemic; Zika; Zika virus
ID VIRUS; PATHOGENESIS; ENHANCEMENT; INFECTION
C1 [Morens, David M.; Fauci, Anthony S.] NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
RP Morens, DM (corresponding author), Bldg 31,Rm 7A-03,31 Ctr Dr, Bethesda, MD 20982 USA.
EM dm270q@nih.gov
FU National Institute of Allergy and Infectious Diseases (NIAID), part of
   the National Institutes of Health (NIH)
FX This work is part of a supplement sponsored by the National Institute of
   Allergy and Infectious Diseases (NIAID), part of the National Institutes
   of Health (NIH).
CR Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Durbin AP, 2017, J INFECT DIS, V216, pS971, DOI 10.1093/infdis/jix491
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fauci AS, 2012, NEW ENGL J MED, V366, P454, DOI 10.1056/NEJMra1108296
   Gregory CJ, 2017, J INFECT DIS, V216, pS875, DOI 10.1093/infdis/jix396
   Gruber MF, 2017, J INFECT DIS, V216, pS964, DOI 10.1093/infdis/jix433
   Gubler DJ, 2017, J INFECT DIS, V216, pS860, DOI 10.1093/infdis/jix451
   Hills SL, 2017, J INFECT DIS, V216, pS868, DOI 10.1093/infdis/jix434
   Julander JG, 2017, J INFECT DIS, V216, pS919, DOI 10.1093/infdis/jix465
   Kauffman EB, 2017, J INFECT DIS, V216, pS976, DOI 10.1093/infdis/jix405
   Keegan LT, 2017, J INFECT DIS, V216, pS884, DOI 10.1093/infdis/jix437
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Morabito KM, 2017, J INFECT DIS, V216, pS957, DOI 10.1093/infdis/jix464
   Morens DM, 2016, J INFECT DIS, V214, pS434, DOI 10.1093/infdis/jiw291
   MORENS DM, 1994, CLIN INFECT DIS, V19, P500, DOI 10.1093/clinids/19.3.500
   Munoz LS, 2017, J INFECT DIS, V216, pS897, DOI 10.1093/infdis/jix511
   Munoz-Jordan JL, 2017, J INFECT DIS, V216, pS951, DOI 10.1093/infdis/jix502
   Osuna CE, 2017, J INFECT DIS, V216, pS928, DOI 10.1093/infdis/jix540
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Pompon J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01282-6
   Priyamvada L, 2017, J INFECT DIS, V216, pS906, DOI 10.1093/infdis/jix513
   Sirohi D, 2017, J INFECT DIS, V216, pS935, DOI 10.1093/infdis/jix515
   Virchow R., 1879, GESAMMELTE ABH, VXI, P96
   Whitley R, 2017, J INFECT DIS, V216, pS912
   Xie XP, 2017, J INFECT DIS, V216, pS945, DOI 10.1093/infdis/jix406
   Zorrilla CD, 2017, J INFECT DIS, V216, pS891, DOI 10.1093/infdis/jix448
NR 27
TC 8
Z9 8
U1 1
U2 4
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD DEC 15
PY 2017
VL 216
SU 10
BP S857
EP S859
DI 10.1093/infdis/jix383
PG 3
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA FQ3DY
UT WOS:000418238500001
PM 29267908
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Munoz, LS
   Parra, B
   Pardo, CA
AF Munoz, Laura S.
   Parra, Beatriz
   Pardo, Carlos A.
CA Neuroviruses Emerging Amer Study
TI Neurological Implications of Zika Virus Infection in Adults
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Zika virus; Guillain-Barre syndrome; neurological disease; adult
   population
ID GUILLAIN-BARRE-SYNDROME; CROSS-REACTIVITY; DENGUE VIRUS; PATHOGENESIS;
   AMERICA; POLYNEURITIS; TRANSMISSION; MICRONESIA; SPREAD
AB The 2015-2016 epidemic of Zika virus (ZIKV) in the Americas and the Caribbean was associated with an unprecedented burden of neurological disease among adults. Clinically, Guillain-Barre syndrome (GBS) predominated among regions affected by the ZIKV epidemic, but the spectrum of neurological disease in the adults appears broader as cases of encephalopathy, encephalitis, meningitis, myelitis, and seizures have also been reported. A para-infectious temporal profile of ZIKV-associated GBS (ZIKV-GBS) has been described in clinical studies, which may suggest a direct viral neuropathic effect. However, ZIKV neuropathogenesis has not yet been fully understood. Mechanisms for ZIKV-GBS and other neurological syndromes have been hypothesized, such as adaptive viral genetic changes, immunological interactions with other circulating flaviviruses, and host and factors. This review summarizes the current evidence on ZIKV-associated neurological complications in the adults.
C1 [Munoz, Laura S.; Pardo, Carlos A.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21287 USA.
   [Parra, Beatriz] Univ Valle, Dept Microbiol, Sch Med, Cali, Colombia.
RP Pardo, CA (corresponding author), Johns Hopkins Univ, Sch Med, 600 North Wolfe St,627 Pathol Bldg, Baltimore, MD 21287 USA.
EM cpardov1@jhmi.edu
RI Pardo, Carlos A./A-5192-2008
OI Pardo, Carlos A./0000-0002-4128-5335; Munoz Arcos, Laura
   Sofia/0000-0002-0229-9056
FU Bart McLean Fund for Neuroimmunology Research; Johns Hopkins Project
   Restore; European Union Zika Plan; National Institute of Allergy and
   Infectious Diseases (NIAID), part of the National Institutes of Health
   (NIH)
FX This work was supported by the Bart McLean Fund for Neuroimmunology
   Research and the Johns Hopkins Project Restore. The Neuroviruses
   Emerging in the Americas Study is supported in part by the European
   Union Zika Plan.; This work is part of a supplement sponsored by the
   National Institute of Allergy and Infectious Diseases (NIAID), part of
   the National Institutes of Health (NIH).
CR Anaya JM, 2017, J AUTOIMMUN, V77, P123, DOI 10.1016/j.jaut.2016.12.007
   Arias A, 2017, J CRIT CARE, V37, P19, DOI 10.1016/j.jcrc.2016.08.016
   ASBURY AK, 1990, ANN NEUROL, V27, pS21, DOI 10.1002/ana.410270707
   ASBURY AK, 1969, MEDICINE, V48, P173, DOI 10.1097/00005792-196905000-00001
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Colombian National Institute of Health, B EPIDEMIOLOGICO SEM
   Cox Bryan D., 2015, Antiviral Chemistry & Chemotherapy, V24, P118, DOI 10.1177/2040206616653873
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dick GW, 1952, T R SOC TROP MED HYG, V46, P11
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P910, DOI 10.15585/mmwr.mm6534e1
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   da Silva IRF, 2017, JAMA NEUROL, V74, P1190, DOI 10.1001/jamaneurol.2017.1703
   Galliez RM, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw203
   Hadden RDM, 1998, ANN NEUROL, V44, P780, DOI 10.1002/ana.410440512
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Halstead SB, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.AID-0022-2014
   Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9
   Kassavetis P, 2016, NEUROLOGY, V87, P336, DOI 10.1212/WNL.0000000000002759
   Knipe DM, 2013, FIELDS VIROLOGY, V6
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   McCracken MK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006487
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Medina MT, 2016, J NEUROL SCI, V369, P271, DOI 10.1016/j.jns.2016.08.044
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nascimento OJM, 2017, NEUROLOGY, V88, P2330, DOI 10.1212/WNL.0000000000004026
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Oh Y, 2017, NAT NEUROSCI, V20, P1209, DOI 10.1038/nn.4612
   Pan American Health Organization (PAHO), 2016, EP UPD NEUR SYNDR CO
   Fontes CAP, 2016, NEURORADIOLOGY, V58, P837, DOI 10.1007/s00234-016-1687-9
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Reyna-Villasmil E, 2016, MED CLIN-BARCELONA, V146, P331, DOI 10.1016/j.medcli.2016.02.002
   Roth W, 2017, NEUROL-NEUROIMMUNOL, V4, DOI 10.1212/NXI.0000000000000349
   Roze B, 2016, EUROSURVEILLANCE, V21, P5, DOI 10.2807/1560-7917.ES.2016.21.16.30205
   Roze B, ZIKA VIRUS DETECTION
   Sironi M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004978
   Situation report Zika virus microcephaly Guillain Barre syndrome, SIT REP ZIK VIR MICR
   Siu R, 2016, NEUROLOGY, V87, P1623, DOI 10.1212/WNL.0000000000003038
   Soares CN, 2016, J CLIN VIROL, V83, P63, DOI 10.1016/j.jcv.2016.08.297
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Tsunoda Ikuo, 2016, Acta Med Kinki Univ, V41, P37
   Sebastian UU, 2017, J CRIT CARE, V42, P275, DOI 10.1016/j.jcrc.2017.07.038
   Uncini A, 2017, J NEUROL NEUROSUR PS, V88, P266, DOI 10.1136/jnnp-2016-314310
   van den Berg B, 2016, Ned Tijdschr Geneeskd, V160, pD155
   van den Berg B, 2014, NAT REV NEUROL, V10, P469, DOI 10.1038/nrneurol.2014.121
   Vorou R, 2016, INT J INFECT DIS, V48, P85, DOI 10.1016/j.ijid.2016.05.014
   Watrin L, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003257
   Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1
   World Health Organization, GUILL BARR SYNDR SAL
   World Health Organization, GUILL BARR SYNDR COL
   World Health Organization, GUILL BARR SYNDR BRA
NR 63
TC 19
Z9 20
U1 0
U2 6
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD DEC 15
PY 2017
VL 216
SU 10
BP S897
EP S905
DI 10.1093/infdis/jix511
PG 9
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA FQ3DY
UT WOS:000418238500007
PM 29267923
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Munoz-Jordan, JL
AF Munoz-Jordan, Jorge L.
TI Diagnosis of Zika Virus Infections: Challenges and Opportunities
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Zika; diagnosis; arbovirus; ZIKV
ID UPDATE INTERIM GUIDANCE; GUILLAIN-BARRE-SYNDROME; REVERSE
   TRANSCRIPTION-PCR; LINKED-IMMUNOSORBENT-ASSAY; SEXUAL TRANSMISSION;
   UNITED-STATES; REAL-TIME; MICRONEUTRALIZATION TEST; NEUTRALIZING
   ANTIBODIES; PROLONGED DETECTION
AB Accurate diagnosis of Zika virus (ZIKV) infections has become a pressing need for the effective prevention and control of the epidemic. The findings that ZIKV infections are associated with birth defects and neurologic disease, and that the virus can be sexually transmitted, accentuate the need for accurate diagnostic testing for different applications
   new to the arbovirus field. Antibody response to related flaviviruses has long been known to be cross-reactive, and antibody detection of ZIKV is nonspecific in populations previously exposed to any of the four dengue viruses or West Nile virus, or vaccinated against yellow fever virus. Therefore, the diagnosis of ZIKV infections has increasingly depended on detection by nucleic acid tests. During the recent epidemic, tests authorized for emergency use have been utilized by public health laboratories and the commercial sector, but a more dependable and responsive diagnostic testing has yet to be developed.
C1 [Munoz-Jordan, Jorge L.] Ctr Dis Control & Prevent, Div Vector Borne Dis, 1324 Canada St, San Juan, PR 00920 USA.
RP Munoz-Jordan, JL (corresponding author), Ctr Dis Control & Prevent, Div Vector Borne Dis, 1324 Canada St, San Juan, PR 00920 USA.
EM CKQ2@CDC.GOV
FU National Institute of Allergy and Infectious Diseases (NIAID), part of
   the National Institutes of Health (NIH)
FX This work is part of a supplement sponsored by the National Institute of
   Allergy and Infectious Diseases (NIAID), part of the National Institutes
   of Health (NIH).
CR Acevedo Nathalie, 2017, Front Microbiol, V8, P42, DOI 10.3389/fmicb.2017.00042
   Allwinn R, 2002, MED MICROBIOL IMMUN, V190, P199, DOI 10.1007/s00430-001-0107-9
   [Anonymous], 2017, Am J Transplant, V17, P572, DOI 10.1111/ajt.14179
   [Anonymous], 2016, MMWR-MORBID MORTAL W, V65, P474, DOI 10.15585/mmwr.mm6518e1
   Atkinson B, 2017, EMERG INFECT DIS, V23, P611, DOI 10.3201/eid2304.161692
   Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Brooks JT, 2016, MMWR-MORBID MORTAL W, V65, P745, DOI 10.15585/mmwr.mm6529e2
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009
   Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Dirlikov E, 2017, EMERG INFECT DIS, V23, P134, DOI 10.3201/eid2301.161290
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P451, DOI 10.15585/mmwr.mm6517e2
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Eppes C, 2017, AM J OBSTET GYNECOL, V216, P209, DOI 10.1016/j.ajog.2017.01.020
   Fourcade C, 2016, J CLIN VIROL, V82, P1, DOI 10.1016/j.jcv.2016.06.011
   Frank C, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.23.30252
   Frankel MB, 2017, J VIROL METHODS, V246, P117, DOI 10.1016/j.jviromet.2017.05.002
   Freour T, SEXUAL TRANSMISSION
   Gallichotte EN, 2015, MBIO, V6, DOI 10.1128/mBio.01461-15
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Granger D, 2017, J CLIN MICROBIOL, V55, P2127, DOI [10.1128/JCM.00580-17, 10.1128/jcm.00580-17]
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Kuehnert MJ, 2016, MMWR-MORBID MORTAL W, V65, P627, DOI 10.15585/mmwr.mm6524e2
   L'Huillier AG, 2017, J CLIN MICROBIOL, V55, P1576, DOI 10.1128/JCM.02153-16
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Argolo AFLDE, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1867-6
   Lustig Y, 2017, J CLIN MICROBIOL, V55, P1894, DOI 10.1128/JCM.00346-17
   Maistriau M, 2017, VIRUS RES, V237, P1, DOI 10.1016/j.virusres.2017.05.004
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P894, DOI 10.1016/S1473-3099(16)30153-0
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   Miller E, 2017, J NEUROL SCI, V375, P367, DOI 10.1016/j.jns.2017.02.029
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Muller WJ, 2017, JAMA-J AM MED ASSOC, V317, P35, DOI 10.1001/jama.2016.18632
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nourollahpour Shiadeh M, 2017, J MATERN-FETAL NEO M, V30, P562, DOI 10.1080/14767058.2016.1177820
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Oladapo OT, 2016, LANCET GLOB HEALTH, V4, pE510, DOI 10.1016/S2214-109X(16)30098-5
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P323, DOI 10.15585/mmwr.mm6512e3
   Pabbaraju K, 2016, J CLIN VIROL, V83, P66, DOI 10.1016/j.jcv.2016.09.001
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Peeling RW, 2010, NAT REV MICROBIOL, pS30, DOI 10.1038/nrmicro2459
   Pessoa R, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.30.30302
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Rao R, 2017, OBSTET GYNECOL, V129, P1098, DOI 10.1097/AOG.0000000000002049
   Rather IA, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00305
   Relich RF, 2017, CLIN LAB MED, V37, P253, DOI 10.1016/j.cll.2017.01.002
   Reusken C, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.23.30251
   Russell K, 2017, CLIN INFECT DIS, V64, P211, DOI 10.1093/cid/ciw692
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2
   Safronetz D, 2017, EMERG INFECT DIS, V23, P1577, DOI 10.3201/eid2309.162043
   Shan C, 2017, EBIOMEDICINE, V17, P157, DOI 10.1016/j.ebiom.2017.03.006
   Smith DW, 2016, LANCET, V387, P1486, DOI 10.1016/S0140-6736(16)00564-X
   Soares CN, 2016, J CLIN VIROL, V83, P63, DOI 10.1016/j.jcv.2016.08.297
   Sotelo JR, 2017, EMERG INFECT DIS, V23, P854, DOI 10.3201/eid2305.161538
   St George K, 2017, J CLIN MICROBIOL, V55, P535, DOI 10.1128/JCM.01232-16
   Stone M, 2017, TRANSFUSION, V57, P734, DOI 10.1111/trf.14031
   Tan SK, 2017, J VIROL METHODS, V248, P66, DOI 10.1016/j.jviromet.2017.04.018
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Vorndam V, 2002, AM J TROP MED HYG, V66, P208, DOI 10.4269/ajtmh.2002.66.208
   Waggoner JJ, 2016, EMERG INFECT DIS, V22, P1295, DOI 10.3201/eid2207.160326
   Wahala WMPB, 2011, VIRUSES-BASEL, V3, P2374, DOI 10.3390/v3122374
   Welch RJ, 2014, J VIROL METHODS, V195, P247, DOI 10.1016/j.jviromet.2013.10.019
   Wong SJ, 2017, EBIOMEDICINE, V16, P136, DOI 10.1016/j.ebiom.2017.01.008
   Zambrano H, 2016, AM J TROP MED HYG, V95, P894, DOI 10.4269/ajtmh.16-0323
NR 74
TC 11
Z9 11
U1 2
U2 6
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD DEC 15
PY 2017
VL 216
SU 10
BP S951
EP S956
DI 10.1093/infdis/jix502
PG 6
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA FQ3DY
UT WOS:000418238500014
PM 29267922
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Priyamvada, L
   Suthar, MS
   Ahmed, R
   Wrammert, J
AF Priyamvada, Lalita
   Suthar, Mehul S.
   Ahmed, Rafi
   Wrammert, Jens
TI Humoral Immune Responses Against Zika Virus Infection and the Importance
   of Preexisting Flavivirus Immunity
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Zika virus; dengue virus; flavivirus; antibody; antibody-dependent
   enhancement; humoral immunity
ID ANTIBODY-DEPENDENT ENHANCEMENT; DENGUE HEMORRHAGIC-FEVER; NEUTRALIZING
   ANTIBODIES; MEDIATED ENHANCEMENT; MATERNAL ANTIBODY; CROSS-REACTIVITY;
   STRUCTURAL BASIS; PATHOGENESIS; DISEASE; POTENT
AB The recent emergence of Zika virus (ZIKV) in the western hemisphere has been linked to Guillain-Barre syndrome, congenital microcephaly, and devastating ophthalmologic and neurologic developmental abnormalities. The vast geographic spread and adverse disease outcomes of the 2015-2016 epidemic have elevated ZIKV from a previously understudied virus to one of substantial public health interest worldwide. Recent efforts to dissect immunological responses to ZIKV have provided significant insights into the functional quality and antigenic targets of ZIKV-induced B-cell responses. Several groups have demonstrated immunological cross-reactivity between ZIKV and other flaviviruses and have identified antibodies capable of both cross-neutralization, as well as antibody-dependent enhancement (ADE) of ZIKV infection. However, the impact of preexisting flavivirus immunity on ZIKV pathogenesis, the generation of protective responses, and in utero transmission of ZIKV infection remain unclear. Given the widespread endemicity of DENV in the areas most effected by the current ZIKV outbreak, the possibility of ADE is especially concerning and may pose unique challenges to the development and deployment of safe and immunogenic ZIKV vaccines. Here, we review current literature pertaining to ZIKV-induced B-cell responses and humoral cross-reactivity and discuss relevant considerations for the development of vaccines and therapeutics against ZIKV.
C1 [Priyamvada, Lalita; Suthar, Mehul S.; Wrammert, Jens] Emory Univ, Sch Med, Dept Pediat, Div Infect Dis, Atlanta, GA 30322 USA.
   [Priyamvada, Lalita; Suthar, Mehul S.; Ahmed, Rafi; Wrammert, Jens] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA.
   [Ahmed, Rafi] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.
RP Wrammert, J (corresponding author), Emory Univ, Dept Pediat, Emory Vaccine Ctr, 1760 Haygood Dr, Atlanta, GA 30322 USA.
EM jwramme@emory.edu
RI Priyamvada, Lalita/J-6252-2019
OI Priyamvada, Lalita/0000-0002-0479-0164
FU National Institute of Allergy and Infectious Diseases (NIAID), part of
   the National Institutes of Health (NIH)
FX This work is part of a supplement sponsored by the National Institute of
   Allergy and Infectious Diseases (NIAID), part of the National Institutes
   of Health (NIH).
CR Andrade DV, 2018, VIRUS RES, V254, P27, DOI 10.1016/j.virusres.2017.06.019
   Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114
   Balsitis SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000790
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   Cao B, 2017, J INTERF CYTOK RES, V37, P287, DOI 10.1089/jir.2017.0011
   Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181
   Deng YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016059
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Durbin A, 2017, EXPERT REV VACCINES, V16, P781, DOI 10.1080/14760584.2017.1345309
   ENDERS G, 1994, LANCET, V343, P1548, DOI 10.1016/S0140-6736(94)92943-2
   FAGBAMI AH, 1987, CYTOBIOS, V49, P49
   Fernandez E, 2017, CURR OPIN VIROL, V23, P59, DOI 10.1016/j.coviro.2017.03.006
   FISCHER DB, 1970, YALE J BIOL MED, V42, P329
   Gomez JMM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004536
   Goncalvez AP, 2007, P NATL ACAD SCI USA, V104, P9422, DOI 10.1073/pnas.0703498104
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4
   HALSTEAD SB, 1977, NATURE, V265, P739, DOI 10.1038/265739a0
   Hasan SS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14722
   KLIKS SC, 1988, AM J TROP MED HYG, V38, P411, DOI 10.4269/ajtmh.1988.38.411
   Koren G, 2002, J CLIN PHARMACOL, V42, P267, DOI 10.1177/00912700222011283
   Lai L., 2017, CLIN INFECT DIS, DOI [10.1093/cid/cix732, DOI 10.1093/CID/CIX732]
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Liao HX, 2011, J EXP MED, V208, P2237, DOI 10.1084/jem.20110363
   Magnani DM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005655
   McArthur MA, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9060143
   McCracken MK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006487
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Negishi H, 1998, J Perinatol, V18, P466
   Nigro G, 2005, NEW ENGL J MED, V353, P1350, DOI 10.1056/NEJMoa043337
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   PEIRIS JSM, 1979, NATURE, V282, P509, DOI 10.1038/282509a0
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Priyamvada L, 2016, J VIROL, V90, P5574, DOI 10.1128/JVI.03203-15
   Revello MG, 2014, NEW ENGL J MED, V370, P1316, DOI 10.1056/NEJMoa1310214
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Rogers TF, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan6809
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Simmons CP, 2007, J INFECT DIS, V196, P416, DOI 10.1086/519170
   Smith SA, 2012, J VIROL, V86, P2665, DOI 10.1128/JVI.06335-11
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Stiasny K, 2006, J VIROL, V80, P9557, DOI 10.1128/JVI.00080-06
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Tran NBC, 2009, J INFECT DIS, V200, P1893, DOI 10.1086/648407
   Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Williams KL, 2012, VIROLOGY, V429, P12, DOI 10.1016/j.virol.2012.03.003
   Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890
   Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352
   Yu L, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93042
   Zellweger RM, 2010, CELL HOST MICROBE, V7, P128, DOI 10.1016/j.chom.2010.01.004
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 61
TC 16
Z9 16
U1 0
U2 4
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD DEC 15
PY 2017
VL 216
SU 10
BP S906
EP S911
DI 10.1093/infdis/jix513
PG 6
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA FQ3DY
UT WOS:000418238500008
PM 29267924
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Sirohi, D
   Kuhn, RJ
AF Sirohi, Devika
   Kuhn, Richard J.
TI Zika Virus Structure, Maturation, and Receptors
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE cryo-EM; maturation; neutralizing antibodies; receptors; Zika virus
ID WEST-NILE-VIRUS; ENVELOPE PROTEIN GLYCOSYLATION; MALE SEXUAL
   TRANSMISSION; PR-M CLEAVAGE; DENGUE-VIRUS; HIGHLY POTENT;
   PHOSPHATIDYLSERINE RECEPTORS; TYROSINE KINASES; DENDRITIC CELLS;
   HUMAN-ANTIBODY
AB The emergence of Zika virus (ZIKV) as a major public health threat has focused research on understanding virus biology and developing a suite of strategies for disease intervention. Recent advances in cryoelectron microscopy have accelerated structure-function studies of flaviviruses and of ZIKV in particular. Structures of the mature and immature ZIKV have demonstrated its similarity with other known flaviviruses such as dengue and West Nile viruses. However, ZIKV's unique pathobiology demands an explanation of how its structure, although similar to its flavivirus relatives, is sufficiently unique to address questions of receptor specificity, transmission, and antigenicity. Progress in defining the immunodominant epitopes and how neutralizing antibodies bind to them will provide great insight as vaccines progress through clinical trials. Identification of host receptors will substantially illuminate the interesting ZIKV tropism and provide insights into pathogenesis. Although the answers to all of these questions are not yet available, rapid progress in combining structural biology with other techniques is revealing the similarities and the differences in virion structure and function between ZIKV and related flaviviruses.This review article describes the structure of mature and immature ZIKV in the context of related flaviviruses and provides insights into the antibody interactions and receptor usage of the virus.
C1 [Sirohi, Devika; Kuhn, Richard J.] Purdue Univ, Dept Biol Sci, Purdue Inst Inflammat Immunol & Infect Dis, W Lafayette, IN 47907 USA.
RP Kuhn, RJ (corresponding author), Purdue Univ, 240 South Martin Jischke Dr, W Lafayette, IN 47907 USA.
EM kuhnr@purdue.edu
RI Sirohi, Devika/I-7136-2019
OI Sirohi, Devika/0000-0001-8601-6211
FU National Institute of Allergy and Infectious Diseases of the National
   Institutes of Health (NIH)United States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R01AI073755]; NIHUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [NIGMS P41-GM103311]; National Institute of Allergy and Infectious
   Diseases (NIAID), part of the National Institutes of Health (NIH)
FX This work was funded by the National Institute of Allergy and Infectious
   Diseases of the National Institutes of Health (NIH) (R01AI073755; to R.
   J. K.). Chimera package was used for creating molecular graphics of
   ZIKV. Chimera development by the Resource for Biocomputing,
   Visualization, and Informatics at the University of California, San
   Francisco is funded by the NIH (NIGMS P41-GM103311).; This work is part
   of a supplement sponsored by the National Institute of Allergy and
   Infectious Diseases (NIAID), part of the National Institutes of Health
   (NIH).
CR Amara A, 2015, NAT REV MICROBIOL, V13, P461, DOI 10.1038/nrmicro3469
   Amraoui F, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.35.30333
   Azar SR, 2017, AM J TROP MED HYG, V97, P330, DOI 10.4269/ajtmh.16-0969
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Beasley DWC, 2005, J VIROL, V79, P8339, DOI 10.1128/JVI.79.13.8339-8347.2005
   Bhattacharyya S, 2013, CELL HOST MICROBE, V14, P136, DOI 10.1016/j.chom.2013.07.005
   Chavali PL, 2017, SCIENCE, V357, P83, DOI 10.1126/science.aam9243
   Che PL, 2013, VIROLOGY, V446, P303, DOI 10.1016/j.virol.2013.08.009
   Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866
   Chu JJH, 2004, J BIOL CHEM, V279, P54533, DOI 10.1074/jbc.M410208200
   Ciota AT, 2017, EMERG INFECT DIS, V23, P1110, DOI 10.3201/eid2307.161633
   Cortese M, 2017, CELL REP, V18, P2113, DOI 10.1016/j.celrep.2017.02.014
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Cruz-Oliveira C, 2015, FEMS MICROBIOL REV, V39, P155, DOI 10.1093/femsre/fuu004
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Das S, 2009, VIROLOGY, V385, P47, DOI 10.1016/j.virol.2008.10.025
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Davis CW, 2006, J BIOL CHEM, V281, P37183, DOI 10.1074/jbc.M605429200
   Davis CW, 2006, J VIROL, V80, P1290, DOI 10.1128/JVI.80.3.1290-1301.2006
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181
   Dowd KA, 2011, VIROLOGY, V411, P306, DOI 10.1016/j.virol.2010.12.020
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Fibriansah G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7341
   Fibriansah G, 2013, J VIROL, V87, P7585, DOI 10.1128/JVI.00757-13
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Freeman GJ, 2010, IMMUNOL REV, V235, P172, DOI 10.1111/j.0105-2896.2010.00903.x
   Gao F, 2010, BIOCHEM BIOPH RES CO, V391, P952, DOI 10.1016/j.bbrc.2009.11.172
   Goo L, 2016, MBIO, V7, DOI [10.1128/mBio.01396-16, 10.1128/mbio.01396-16]
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Graham DK, 2014, NAT REV CANCER, V14, P769, DOI 10.1038/nrc3847
   Gromowski GD, 2015, J VIROL, V89, P6328, DOI 10.1128/JVI.00219-15
   Hall-Mendelin S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004959
   HALSTEAD SB, 1976, P SOC EXP BIOL MED, V151, P136, DOI 10.3181/00379727-151-39160
   HALSTEAD SB, 1980, AM J TROP MED HYG, V29, P638, DOI 10.4269/ajtmh.1980.29.638
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hasan SS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14722
   Hastings AK, 2017, CELL REP, V19, P558, DOI 10.1016/j.celrep.2017.03.058
   HSIEH P, 1984, J BIOL CHEM, V259, P2375
   Jarvis DL, 2003, VIROLOGY, V310, P1, DOI 10.1016/S0042-6822(03)00120-X
   Junjhon J, 2008, J VIROL, V82, P10776, DOI 10.1128/JVI.01180-08
   Junjhon J, 2010, J VIROL, V84, P8353, DOI 10.1128/JVI.00696-10
   Keelapang P, 2004, J VIROL, V78, P2367, DOI 10.1128/JVI.78.5.2367-2381.2004
   Kim SY, 2017, BIOCHEMISTRY-US, V56, P1151, DOI 10.1021/acs.biochem.6b01056
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kostyuchenko VA, 2014, J VIROL, V88, P477, DOI 10.1128/JVI.02641-13
   Kostyuchenko VA, 2013, J VIROL, V87, P7700, DOI 10.1128/JVI.00197-13
   Kuhn RJ, 2015, VIROLOGY, V479, P508, DOI 10.1016/j.virol.2015.03.025
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Lemke G, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009076
   Li L, 2008, SCIENCE, V319, P1830, DOI 10.1126/science.1153263
   Linger RMA, 2008, ADV CANCER RES, V100, P35, DOI 10.1016/S0065-230X(08)00002-X
   Liu WZ, 2015, BIOINFORMATICS, V31, P3359, DOI 10.1093/bioinformatics/btv362
   Lok SM, 2008, NAT STRUCT MOL BIOL, V15, P312, DOI 10.1038/nsmb.1382
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Matheron S, 2016, CLIN INFECT DIS, V63, DOI 10.1093/cid/ciw509
   Medigeshi GR, 2008, J VIROL, V82, P5212, DOI 10.1128/JVI.00008-08
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Miller JL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040017
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Miner JJ, 2015, NAT MED, V21, P1464, DOI 10.1038/nm.3974
   Mukhopadhyay S, 2003, SCIENCE, V302, P248, DOI 10.1126/science.1089316
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Navarro-Sanchez E, 2003, EMBO REP, V4, P723, DOI 10.1038/sj.embor.embor866
   Nelson S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000060
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Perera-Lecoin Manuel, 2013, Viruses, V6, P69, DOI 10.3390/v6010069
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Pierson TC, 2008, CELL HOST MICROBE, V4, P229, DOI 10.1016/j.chom.2008.08.004
   Pierson TC, 2012, CURR OPIN VIROL, V2, P168, DOI 10.1016/j.coviro.2012.02.011
   Pierson Theodore C., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000665
   Plevka P, 2011, EMBO REP, V12, P602, DOI 10.1038/embor.2011.75
   Pokidysheva E, 2006, CELL, V124, P485, DOI 10.1016/j.cell.2005.11.042
   Prasad VM, 2017, NAT STRUCT MOL BIOL, V24, P184, DOI 10.1038/nsmb.3352
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Richard AS, 2017, P NATL ACAD SCI USA, V114, P2024, DOI 10.1073/pnas.1620558114
   Richard V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005024
   Rossignol ED, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12740
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Sheng ZY, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00272
   Shirato K, 2004, J GEN VIROL, V85, P3637, DOI 10.1099/vir.0.80247-0
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Tang WW, 2016, CELL REP, V17, P3091, DOI 10.1016/j.celrep.2016.11.070
   Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840
   Thangamani S, 2016, AM J TROP MED HYG, V95, P1169, DOI 10.4269/ajtmh.16-0448
   Thongtan T, 2012, J MED VIROL, V84, P615, DOI 10.1002/jmv.23248
   Uraki R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602899
   Valle JRD, 2005, J VIROL, V79, P4557, DOI 10.1128/JVI.79.8.4557-4567.2005
   Wang XX, 2017, NAT COMMUN, V8, DOI [10.1038/s41467-017-00024-6, 10.1038/s41467-017-01822-8]
   Watterson D, 2012, J GEN VIROL, V93, P72, DOI 10.1099/vir.0.037317-0
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   Xie XP, 2017, MBIO, V8, DOI [10.1128/mBio.02134-16, 10.1128/mbio.02134-16]
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Yu IM, 2009, J VIROL, V83, P12101, DOI 10.1128/JVI.01637-09
   Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264
   Zhang S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13679
   Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463
   Zhang XZ, 2013, P NATL ACAD SCI USA, V110, P6795, DOI 10.1073/pnas.1304300110
   Zhang Y, 2003, EMBO J, V22, P2604, DOI 10.1093/emboj/cdg270
NR 104
TC 35
Z9 36
U1 1
U2 24
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD DEC 15
PY 2017
VL 216
SU 10
BP S935
EP S944
DI 10.1093/infdis/jix515
PG 10
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA FQ3DY
UT WOS:000418238500012
PM 29267925
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Zorrilla, CD
   Garcia, IG
   Fragoso, LG
   De La Vega, A
AF Zorrilla, Carmen D.
   Garcia Garcia, Ines
   Garcia Fragoso, Lourdes
   De La Vega, Alberto
TI Zika Virus Infection in Pregnancy: Maternal, Fetal, and Neonatal
   Considerations
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Zika in pregnancy; pregnancy; ZIKV
ID BIRTH-DEFECTS; UNITED-STATES; INFANTS
AB An infection with the Zika virus (ZIKV) is usually mild, with nonspecific symptoms and most often asymptomatic. However, because of its causal relationship with severe congenital malformations, the ZIKV epidemic became an imperative for mobilization, renewed strategies for vector control, and biomedical research. A congenital Zika syndrome (CZS) has been characterized with 5 distinctive features that focus on brain development abnormalities (including microcephaly and brain calcifications), retinal manifestations, and defects on extremities including congenital contractures and hypertonia. The CZS could be just "the tip of the iceberg", pending the documentation of a spectrum of disease that could manifest later in life, from mild dysfunction to severe disease. It will be a matter of time for neurodevelopmental abnormalities, learning disabilities, and other unknown but yet-to-be-described outcomes to be associated with intrauterine ZIKV infection. In addition, ZIKV infection during pregnancy has been associated with other adverse outcomes. Reports mostly include ZIKV-affected pregnancies, and it will be difficult to clearly establish causality without appropriate control groups. We are summarizing some of the known or reported consequences of such infection during pregnancy. Women of reproductive age and particularly pregnant women are the most vulnerable to the adverse consequences of the ZIKV epidemic. Vector control programs need to be expanded to curtail new infections. Research is needed to develop safe and effective treatments, a preventive or therapeutic vaccine, and specific and sensitive tests and to diagnose and identify correlates of long-term immunity. Vaccines and treatments should be safe to be used in pregnancy. To do nothing would allow thousands of pregnant women to expose their fetuses to an infection that causes birth defects and other problems. Prenatal diagnosis technology development is necessary to be able to predict or diagnose adverse fetal outcomes related to ZIKV. Moreover, these tests should be used in a manner similar to the testing/screening method for neural tube defects and common chromosomal anomalies during prenatal care.
C1 [Zorrilla, Carmen D.; De La Vega, Alberto] Univ Puerto Rico, Sch Med, Dept Obstet & Gynecol, San Juan, PR 00936 USA.
   [Garcia Garcia, Ines; Garcia Fragoso, Lourdes] Univ Puerto Rico, Sch Med, Dept Pediat, San Juan, PR 00936 USA.
RP Zorrilla, CD (corresponding author), UPR Sch Med, Obstet & Gynecol, POB 365067, San Juan, PR 00936 USA.; Zorrilla, CD (corresponding author), Maternal Infant Studies Ctr CEMI, SJ ZIP, IUPR CTU, CEMI,MI HMHR, POB 365067, San Juan, PR 00936 USA.
EM carmen.zorrilla@upr.edu
FU National Institute of Allergy and Infectious Diseases, National
   Institutes of Health (NIH)United States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [5UM1AI069415-12]; Integrated
   University of Puerto Rico Clinical Trials Unit; Eunice Kennedy Shriver
   National Institute of Child Health and Human Development, NIHUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child
   Health & Human Development (NICHD) [3U01HD052102-12S1]; National
   Institute of Allergy and Infectious Diseases (NIAID), part of the
   National Institutes of Health (NIH)
FX C. D. Z. received funds from the National Institute of Allergy and
   Infectious Diseases, National Institutes of Health (NIH) (Grant
   5UM1AI069415-12), Integrated University of Puerto Rico Clinical Trials
   Unit, and the Eunice Kennedy Shriver National Institute of Child Health
   and Human Development, NIH (Grant 3U01HD052102-12S1; for the Zika in
   Infants and Pregnancy [ZIP] study).r This work is part of a supplement
   sponsored by the National Institute of Allergy and Infectious Diseases
   (NIAID), part of the National Institutes of Health (NIH).
CR American College of Obstetricianand Gynecologist Committee, 2016, PRACTICE B, P1
   [Anonymous], 2016, Wkly Epidemiol Rec, V91, P73
   [Anonymous], 2004, PEDIATRICS, V114, P1377
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   De Santis M, 2006, REPROD TOXICOL, V21, P390, DOI 10.1016/j.reprotox.2005.01.014
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duby JC, 2006, PEDIATRICS, V118, P405, DOI 10.1542/peds.2006-1231
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Leal MC, 2015, HEARING LOSS INFANTS
   Lin HZ, 2017, SINGAP MED J, V58, P171, DOI 10.11622/smedj.2017026
   Lissauer D, 2016, BJOG-INT J OBSTET GY, V123, P1258, DOI 10.1111/1471-0528.14071
   Mai CT, 2013, BIRTH DEFECTS RES A, V97, P709, DOI 10.1002/bdra.23198
   Mallet HP, 2015, BISES B INFORM SANIT, V13, P1
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i855
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Moore KL, 2015, DEV HUMAN CLIN ORIEN
   Muller WJ, 2017, JAMA-J AM MED ASSOC, V317, P35, DOI 10.1001/jama.2016.18632
   Mysorekar IU, 2016, NEW ENGL J MED, V375, P481, DOI 10.1056/NEJMcibr1605445
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Pacheco Oscar, 2016, N Engl J Med, DOI 10.1056/NEJMoa1604037
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Petersen E, 2016, MMWR-MORBID MORTAL W, V65, P1070
   Polifka JE, 2002, CAN MED ASSOC J, V167, P265
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reyna-Villasmil E, 2016, MED CLIN-BARCELONA, V146, P331, DOI 10.1016/j.medcli.2016.02.002
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   Suy A, 2016, NEW ENGL J MED, V375, P2611, DOI 10.1056/NEJMc1607580
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   WHO, 2016, ZIK VIR FACT SHEET
   World Health Organization, 2016, 1 M INT HLTH REG 200
   Yuan S, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00062
NR 46
TC 13
Z9 13
U1 0
U2 13
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD DEC 15
PY 2017
VL 216
SU 10
BP S891
EP S896
DI 10.1093/infdis/jix448
PG 6
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA FQ3DY
UT WOS:000418238500006
PM 29267916
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Hernandez, JM
   Podbilewicz, B
AF Hernandez, Javier M.
   Podbilewicz, Benjamin
TI The hallmarks of cell-cell fusion
SO DEVELOPMENT
LA English
DT Review
DE Fertilization; Fusogen; Gamete fusion; Mating; Organogenesis; Cell-cell
   fusion; Syncytin; Fusexins; EFF-1; HAP2; GCS1; AFF-1; Myomaker;
   Myomixer; Myomerger; Minion; Placenta; Muscle; Virus-cell fusion;
   Tick-borne encephalitis; Zika; Influenza; Dengue viruses; SNAREs;
   Hemifusion; Pore formation
ID VIRAL MEMBRANE-FUSION; SPERM-EGG FUSION; INFLUENZA-VIRUS HEMAGGLUTININ;
   ENDOGENOUS-RETROVIRUS-FAMILY; MYOBLAST FUSION; CAENORHABDITIS-ELEGANS;
   C-ELEGANS; CHLAMYDOMONAS-REINHARDTII; MAMMALIAN FERTILIZATION;
   ENVELOPE-PROTEIN
AB Cell-cell fusion is essential for fertilization and organ development. Dedicated proteins known as fusogens are responsible for mediating membrane fusion. However, until recently, these proteins either remained unidentified or were poorly understood at the mechanistic level. Here, we review how fusogens surmount multiple energy barriers to mediate cell-cell fusion. We describe how early preparatory steps bring membranes to a distance of similar to 10 nm, while fusogens act in the final approach between membranes. The mechanical force exerted by cell fusogens and the accompanying lipidic rearrangements constitute the hallmarks of cell-cell fusion. Finally, we discuss the relationship between viral and eukaryotic fusogens, highlight a classification scheme regrouping a superfamily of fusogens called Fusexins, and propose new questions and avenues of enquiry.
C1 [Hernandez, Javier M.] Max Planck Inst Mol Physiol, Dept Struct Biochem, D-44227 Dortmund, Germany.
   [Podbilewicz, Benjamin] Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel.
RP Hernandez, JM (corresponding author), Max Planck Inst Mol Physiol, Dept Struct Biochem, D-44227 Dortmund, Germany.; Podbilewicz, B (corresponding author), Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel.
EM matias.hernandez@mpi-dortmund.mpg.de; podbilew@technion.ac.il
OI Hernandez, Matias/0000-0001-5266-9708; Podbilewicz,
   Benjamin/0000-0002-0411-4182
FU Israel Science Foundation (ISF)Israel Science Foundation [443/12,
   257/17]; United States - Israel Binational Science Foundation
   (BSF)US-Israel Binational Science Foundation [213-151]; Ministry of
   Science, Technology and Space [3-13022]; Adelis Brain Research Award
   from the Adelis Foundation; European Research CouncilEuropean Research
   Council (ERC) [ELEGANSFUSION 268843]; Max Planck Society
   (Max-Planck-Gesellschaft)
FX Research in the B.P. lab is supported by the Israel Science Foundation
   (ISF; grants 443/12 and 257/17), the United States - Israel Binational
   Science Foundation (BSF; grant 213-151), the Ministry of Science,
   Technology and Space (grant 3-13022), the Adelis Brain Research Award
   from the Adelis Foundation, and the European Research Council (Advanced
   Grant ELEGANSFUSION 268843). Research in the J.M.H. lab is supported by
   the Max Planck Society (Max-Planck-Gesellschaft).
CR Abdus-Saboor I, 2011, DEVELOPMENT, V138, P3545, DOI 10.1242/dev.068148
   Abmayr SM, 2012, DEVELOPMENT, V139, P641, DOI 10.1242/dev.068353
   Aguilar PS, 2013, TRENDS GENET, V29, P427, DOI 10.1016/j.tig.2013.01.011
   Avinoam O, 2011, CURR TOP MEMBR, V68, P209, DOI 10.1016/B978-0-12-385891-7.00009-X
   Avinoam O, 2011, SCIENCE, V332, P589, DOI 10.1126/science.1202333
   Aydin H, 2016, NATURE, V534, P562, DOI 10.1038/nature18595
   Bi P, 2017, SCIENCE, V356, P323, DOI 10.1126/science.aam9361
   Bianchi E, 2014, NATURE, V508, P483, DOI 10.1038/nature13203
   Blaise S, 2003, P NATL ACAD SCI USA, V100, P13013, DOI 10.1073/pnas.2132646100
   BLOBEL CP, 1992, NATURE, V356, P248, DOI 10.1038/356248a0
   Blond JL, 2000, J VIROL, V74, P3321, DOI 10.1128/JVI.74.7.3321-3329.2000
   Blond JL, 1999, J VIROL, V73, P1175, DOI 10.1128/JVI.73.2.1175-1185.1999
   Bolze PA, 2016, PLACENTA, V39, P116, DOI 10.1016/j.placenta.2016.01.011
   Borges F, 2008, PLANT PHYSIOL, V148, P1168, DOI 10.1104/pp.108.125229
   Bour BA, 2000, GENE DEV, V14, P1498
   BUCHANAN MJ, 1989, J CELL BIOL, V108, P199, DOI 10.1083/jcb.108.1.199
   BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0
   Calder LJ, 2016, NAT STRUCT MOL BIOL, V23, P853, DOI 10.1038/nsmb.3271
   Carmena A, 2002, DEV BIOL, V244, P226, DOI 10.1006/dbio.2002.0606
   CARR CM, 1993, CELL, V73, P823, DOI 10.1016/0092-8674(93)90260-W
   Cassata G, 2005, DEVELOPMENT, V132, P739, DOI 10.1242/dev.01638
   Chen J, 1999, P NATL ACAD SCI USA, V96, P8967, DOI 10.1073/pnas.96.16.8967
   CHERNOMORDIK LV, 1986, DOKL AKAD NAUK SSSR+, V288, P1009
   Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504
   Chernomordik LV, 1998, J CELL BIOL, V140, P1369, DOI 10.1083/jcb.140.6.1369
   Chernomordik LV, 2005, CELL, V123, P375, DOI 10.1016/j.cell.2005.10.015
   Chiorazzi M, 2013, P NATL ACAD SCI USA, V110, P3943, DOI 10.1073/pnas.1217271110
   Chlanda P, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.50, 10.1038/nmicrobiol.2016.50]
   Cho CH, 2000, DEV BIOL, V222, P289, DOI 10.1006/dbio.2000.9703
   Ciglar L, 2014, DEVELOPMENT, V141, P2633, DOI 10.1242/dev.101956
   Cole ES, 2014, CURR BIOL, V24, P2168, DOI 10.1016/j.cub.2014.07.064
   Cornelis G, 2015, P NATL ACAD SCI USA, V112, pE487, DOI 10.1073/pnas.1417000112
   Costin JM, 2013, J VIROL, V87, P52, DOI 10.1128/JVI.02273-12
   CROSS JC, 1994, SCIENCE, V266, P1508, DOI 10.1126/science.7985020
   Cui L, 2016, CELL ADHES MIGR, V10, P39, DOI 10.1080/19336918.2015.1093720
   Dalpe G, 2005, DEVELOPMENT, V132, P1387, DOI 10.1242/dev.01694
   Dalton P, 2007, FEBS J, V274, P2715, DOI 10.1111/j.1742-4658.2007.05806.x
   del Campo JJ, 2005, CURR BIOL, V15, P413, DOI 10.1016/j.cub.2005.01.054
   Delos SE, 2000, J VIROL, V74, P1686, DOI 10.1128/JVI.74.4.1686-1693.2000
   DETMERS PA, 1983, J CELL BIOL, V97, P522, DOI 10.1083/jcb.97.2.522
   Dhanyasi N, 2015, J CELL BIOL, V211, P191, DOI 10.1083/jcb.201503005
   Doberstein SK, 1997, J CELL BIOL, V136, P1249, DOI 10.1083/jcb.136.6.1249
   Doms RW, 2017, CELL, V168, P755, DOI 10.1016/j.cell.2017.02.012
   Donaldson SH, 2011, P NATL ACAD SCI USA, V108, P15699, DOI 10.1073/pnas.1112411108
   Dottermusch-Heidel C, 2012, DEV BIOL, V368, P18, DOI 10.1016/j.ydbio.2012.04.031
   Dupressoir A, 2005, P NATL ACAD SCI USA, V102, P725, DOI 10.1073/pnas.0406509102
   Dupressoir A, 2011, P NATL ACAD SCI USA, V108, pE1164, DOI 10.1073/pnas.1112304108
   Escobar-Restrepo Juan M, 2014, Worm, V3, pe965605, DOI 10.4161/21624046.2014.965605
   Esnault C, 2008, P NATL ACAD SCI USA, V105, P17532, DOI 10.1073/pnas.0807413105
   Esnault C, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003400
   Fedry J, 2017, CELL, V168, P904, DOI 10.1016/j.cell.2017.01.024
   Ferris PJ, 2005, PLANT CELL, V17, P597, DOI 10.1105/tpc.104.028035
   Ferris PJ, 1996, MOL BIOL CELL, V7, P1235
   Frame IG, 2001, GENE, V263, P219, DOI 10.1016/S0378-1119(00)00567-9
   Galletta BJ, 2004, MECH DEVELOP, V121, P1455, DOI 10.1016/j.mod.2004.08.001
   Gamage DG, 2017, J BIOL CHEM, V292, P17272, DOI 10.1074/jbc.M117.811372
   Gattegno T, 2007, MOL BIOL CELL, V18, P1153, DOI 10.1091/mbc.E06-09-0855
   Ghosh-Roy A, 2010, DEV DYNAM, V239, P1460, DOI 10.1002/dvdy.22253
   Gildor B, 2009, EMBO REP, V10, P1043, DOI 10.1038/embor.2009.129
   Goh Q, 2017, ELIFE, V6, DOI 10.7554/eLife.20007
   Gong R, 2005, BIOCHEM BIOPH RES CO, V331, P1193, DOI 10.1016/j.bbrc.2005.04.032
   GOODENOUGH UW, 1982, J CELL BIOL, V92, P378, DOI 10.1083/jcb.92.2.378
   Gregory SM, 2011, P NATL ACAD SCI USA, V108, P11211, DOI 10.1073/pnas.1104760108
   Hannah BP, 2007, J VIROL, V81, P4858, DOI 10.1128/JVI.02755-06
   Haralalka S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114126
   Haralalka S, 2011, DEVELOPMENT, V138, P1551, DOI 10.1242/dev.057653
   Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456
   Hernandez JM, 2012, SCIENCE, V336, P1581, DOI 10.1126/science.1221976
   Hirai M, 2008, CURR BIOL, V18, P607, DOI 10.1016/j.cub.2008.03.045
   HUNNICUTT GR, 1990, J CELL BIOL, V111, P1605, DOI 10.1083/jcb.111.4.1605
   Inoue N, 2005, NATURE, V434, P234, DOI 10.1038/nature03362
   Jin P, 2011, DEV CELL, V20, P623, DOI 10.1016/j.devcel.2011.04.007
   Johnson MA, 2004, GENETICS, V168, P971, DOI 10.1534/genetics.104.029447
   Kato K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12198
   KEMBLE GW, 1994, CELL, V76, P383, DOI 10.1016/0092-8674(94)90344-1
   Kesper DA, 2007, DEV DYNAM, V236, P404, DOI 10.1002/dvdy.21035
   Kielian M, 2006, NAT REV MICROBIOL, V4, P67, DOI 10.1038/nrmicro1326
   Kielian M, 1996, J CELL BIOL, V134, P863, DOI 10.1083/jcb.134.4.863
   Kim JH, 2015, CURR OPIN GENET DEV, V32, P162, DOI 10.1016/j.gde.2015.03.006
   Kim JH, 2015, DEV CELL, V32, P561, DOI 10.1016/j.devcel.2015.01.005
   Kim S, 2007, DEV CELL, V12, P571, DOI 10.1016/j.devcel.2007.02.019
   Koh K, 2004, DEV BIOL, V267, P252, DOI 10.1016/j.ydbio.2003.11.014
   Kolotuev I, 2004, DEV BIOL, V266, P322, DOI 10.1016/j.ydbio.2003.10.029
   Kolotuev I, 2008, DEV BIOL, V313, P142, DOI 10.1016/j.ydbio.2007.10.010
   Kontani K, 2005, DEV CELL, V8, P787, DOI 10.1016/j.devcel.2005.02.018
   Koonin EV, 2015, ANN NY ACAD SCI, V1341, P10, DOI 10.1111/nyas.12728
   Koonin EV, 2013, CURR OPIN VIROL, V3, P546, DOI 10.1016/j.coviro.2013.06.008
   KOZLOV MM, 1989, EUR BIOPHYS J BIOPHY, V17, P121
   KOZLOV MM, 1983, BIOFIZIKA+, V28, P242
   Kravtsov V, 2017, DEVELOPMENT, V144, P2364, DOI 10.1242/dev.150037
   Larsson LI, 2007, THESCIENTIFICWORLDJO, V7, P1193, DOI 10.1100/tsw.2007.212
   Larsson LI, 2007, HUM PATHOL, V38, P726, DOI 10.1016/j.humpath.2006.10.018
   LEIKIN SL, 1987, J THEOR BIOL, V129, P411, DOI 10.1016/S0022-5193(87)80021-8
   Leikina E, 2000, MOL BIOL CELL, V11, P2359, DOI 10.1091/mbc.11.7.2359
   Lenard A, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002126
   LENEVEU DM, 1976, NATURE, V259, P601, DOI 10.1038/259601a0
   Li YL, 2007, BIOPHYS J, V93, P2178, DOI 10.1529/biophysj.106.101220
   Liang CY, 2010, BIOL REPROD, V83, P387, DOI 10.1095/biolreprod.110.083915
   Lin H, 2007, GENETICS, V176, P913, DOI 10.1534/genetics.106.066167
   Liu YJ, 2008, GENE DEV, V22, P1051, DOI 10.1101/gad.1656508
   Lu XB, 2005, J BIOL CHEM, V280, P30538, DOI 10.1074/jbc.M506862200
   Martens S, 2008, NAT REV MOL CELL BIO, V9, P543, DOI 10.1038/nrm2417
   Massarwa R, 2007, DEV CELL, V12, P557, DOI 10.1016/j.devcel.2007.01.016
   Melikyan GB, 2000, MOL BIOL CELL, V11, P3765, DOI 10.1091/mbc.11.11.3765
   MELIKYAN GB, 1995, J CELL BIOL, V131, P679, DOI 10.1083/jcb.131.3.679
   Mi S, 2000, NATURE, V403, P785
   Millay DP, 2016, P NATL ACAD SCI USA, V113, P2116, DOI 10.1073/pnas.1600101113
   Millay DP, 2014, GENE DEV, V28, P1641, DOI 10.1101/gad.247205.114
   Millay DP, 2013, NATURE, V499, P301, DOI 10.1038/nature12343
   Misamore MJ, 2003, MOL BIOL CELL, V14, P2530, DOI 10.1091/mbc.E02-12-0790
   Mitani Y, 2017, FASEB J, V31, P400, DOI 10.1096/fj.201600945R
   Modis Y, 2014, CURR OPIN VIROL, V5, P34, DOI 10.1016/j.coviro.2014.01.009
   Mohler WA, 2002, DEV CELL, V2, P355, DOI 10.1016/S1534-5807(02)00129-6
   Moiseeva YM, 2017, RUSS J DEV BIOL+, V48, P117, DOI 10.1134/S1062360417020096
   Moller AMJ, 2017, J CELL PHYSIOL, V232, P1396, DOI 10.1002/jcp.25633
   Mori T, 2006, NAT CELL BIOL, V8, P64, DOI 10.1038/ncb1345
   Mori T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015957
   MUGA A, 1994, BIOCHEMISTRY-US, V33, P4444, DOI 10.1021/bi00181a002
   Myers TR, 2005, DEV CELL, V8, P117, DOI 10.1016/j.devcel.2004.11.015
   Nakaya Y, 2015, VIRUSES-BASEL, V7, P2928, DOI 10.3390/v7062753
   Nasir A, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500527
   Neumann B, 2015, NATURE, V517, P219, DOI 10.1038/nature14102
   Nishimura K, 2016, CURR BIOL, V26, pR661, DOI 10.1016/j.cub.2016.06.028
   NUSSBAUM O, 1987, J VIROL, V61, P2245, DOI 10.1128/JVI.61.7.2245-2252.1987
   Onel SF, 2014, J NEUROGENET, V28, P302, DOI 10.3109/01677063.2014.936014
   Onel SF, 2011, CELL FUSIONS: REGULATION AND CONTROL, P139, DOI 10.1007/978-90-481-9772-9_6
   Ohto U, 2016, NATURE, V534, P566, DOI 10.1038/nature18596
   Okamoto M, 2016, DEV BIOL, V415, P6, DOI 10.1016/j.ydbio.2016.05.018
   Oren-Suissa M, 2007, TRENDS CELL BIOL, V17, P537, DOI 10.1016/j.tcb.2007.09.004
   Oren-Suissa M, 2017, GENETICS, V206, P215, DOI 10.1534/genetics.116.196386
   Oren-Suissa M, 2010, SCIENCE, V328, P1285, DOI 10.1126/science.1189095
   Orias E, 2014, CURR BIOL, V24, pR831, DOI 10.1016/j.cub.2014.08.004
   Pan JM, 2002, MOL BIOL CELL, V13, P1417, DOI 10.1091/mbc.01-11-0531
   Peng XX, 2007, J BIOL CHEM, V282, P381, DOI 10.1074/jbc.M606353200
   Perez-Vargas J, 2014, CELL, V157, P407, DOI 10.1016/j.cell.2014.02.020
   Pinello JF, 2017, CURR BIOL, V27, P651, DOI 10.1016/j.cub.2017.01.049
   PODBILEWICZ B, 1994, DEV BIOL, V161, P408, DOI 10.1006/dbio.1994.1041
   Podbilewicz B, 2000, NEMATOLOGY, V2, P99, DOI 10.1163/156854100508818
   Podbilewicz B, 2006, DEV CELL, V11, P471, DOI 10.1016/j.devcel.2006.09.004
   Podbilewicz B, 2014, ANNU REV CELL DEV BI, V30, P111, DOI 10.1146/annurev-cellbio-101512-122422
   Potgens AJG, 2004, HUM REPROD UPDATE, V10, P487, DOI 10.1093/humupd/dmh039
   Powell GT, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001216
   Procko C, 2011, DEVELOPMENT, V138, P1371, DOI 10.1242/dev.058305
   Qiao H, 1999, MOL BIOL CELL, V10, P2759, DOI 10.1091/mbc.10.8.2759
   Quinn ME, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15665
   Radzvilavicius AL, 2016, J THEOR BIOL, V404, P160, DOI 10.1016/j.jtbi.2016.05.037
   Raj I, 2017, CELL, V169, P1315, DOI 10.1016/j.cell.2017.05.033
   Rasmussen JP, 2008, DEV CELL, V14, P559, DOI 10.1016/j.devcel.2008.01.019
   Redelsperger F, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006289
   Reese C, 2005, NATURE, V436, P410, DOI 10.1038/nature03722
   Reese C, 2005, J CELL BIOL, V171, P981, DOI 10.1083/jcb.200510018
   Renard M, 2005, J MOL BIOL, V352, P1029, DOI 10.1016/j.jmb.2005.07.058
   Rizo J, 2006, P NATL ACAD SCI USA, V103, P19611, DOI 10.1073/pnas.0609841103
   Ruebner M, 2012, J CELL BIOCHEM, V113, P2383, DOI 10.1002/jcb.24110
   Ruiz-Gomez M, 2000, CELL, V102, P189, DOI 10.1016/S0092-8674(00)00024-6
   SAITO T, 1991, CURR GENET, V19, P65, DOI 10.1007/BF00326284
   Sapir A, 2007, DEV CELL, V12, P683, DOI 10.1016/j.devcel.2007.03.003
   Schejter ED, 2016, SEMIN CELL DEV BIOL, V60, P112, DOI 10.1016/j.semcdb.2016.07.016
   Schmid T, 2015, CURR OPIN GENET DEV, V32, P1, DOI 10.1016/j.gde.2015.01.006
   Sens KL, 2010, J CELL BIOL, V191, P1013, DOI 10.1083/jcb.201006006
   Sharma-Kishore R, 1999, DEVELOPMENT, V126, P691
   Shemer G, 2004, CURR BIOL, V14, P1587, DOI 10.1016/j.cub.2004.07.059
   Shemer G, 2002, GENE DEV, V16, P3136, DOI 10.1101/gad.251202
   Shibukawa Y, 2010, MOL BIOL CELL, V21, P3973, DOI 10.1091/mbc.E10-03-0261
   Shilagardi K, 2013, SCIENCE, V340, P359, DOI 10.1126/science.1234781
   Shinn-Thomas JH, 2011, INT REV CEL MOL BIO, V289, P149, DOI 10.1016/B978-0-12-386039-2.00005-5
   Shmulevitz M, 2000, EMBO J, V19, P902, DOI 10.1093/emboj/19.5.902
   Smurova K., 2016, SMALL GTPASES, V8, P177
   Smurova K, 2016, CELL REP, V14, P1517, DOI 10.1016/j.celrep.2016.01.027
   Soe K, 2011, BONE, V48, P837, DOI 10.1016/j.bone.2010.11.011
   Speijer D, 2015, P NATL ACAD SCI USA, V112, P8827, DOI 10.1073/pnas.1501725112
   Steele RE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007680
   STEGMANN T, 1989, ANNU REV BIOPHYS BIO, V18, P187, DOI 10.1146/annurev.bb.18.060189.001155
   Stein A, 2009, NATURE, V460, P525, DOI 10.1038/nature08156
   Steinberg F, 2010, J BIOL CHEM, V285, P37704, DOI 10.1074/jbc.M110.140517
   Steinberg F, 2010, J BIOL CHEM, V285, P2193, DOI 10.1074/jbc.M109.058248
   STEINHAUER DA, 1995, J VIROL, V69, P6643, DOI 10.1128/JVI.69.11.6643-6651.1995
   Stiasny K, 1996, J VIROL, V70, P8142, DOI 10.1128/JVI.70.11.8142-8147.1996
   Stone CE, 2009, DEV BIOL, V329, P201, DOI 10.1016/j.ydbio.2009.02.030
   TRUEHEART J, 1989, P NATL ACAD SCI USA, V86, P9916, DOI 10.1073/pnas.86.24.9916
   Valansi C, 2017, J CELL BIOL, V216, P571, DOI 10.1083/jcb.201610093
   von Besser K, 2006, DEVELOPMENT, V133, P4761, DOI 10.1242/dev.02683
   Wang Q, 2006, CELL, V125, P549, DOI 10.1016/j.cell.2006.02.044
   Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X
   Weinstein N., 2016, ORGANOGENETIC GENE N, P9
   WEIS WI, 1990, J MOL BIOL, V212, P737, DOI 10.1016/0022-2836(90)90234-D
   WHITE J, 1982, NATURE, V300, P658, DOI 10.1038/300658a0
   White JM, 2008, CRIT REV BIOCHEM MOL, V43, P189, DOI [10.1080/10409230802058320, 10.1080/10409230802058320 ]
   White JM, 2007, DEV CELL, V12, P667, DOI 10.1016/j.devcel.2007.04.009
   WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0
   Wong JL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000882
   Wong JL, 2010, TRENDS CELL BIOL, V20, P134, DOI 10.1016/j.tcb.2009.12.007
   Yang YH, 2017, DEV CELL, V41, P107, DOI 10.1016/j.devcel.2017.03.006
   Yochem J, 1998, GENETICS, V149, P1323
   Yu CC, 2002, J BIOL CHEM, V277, P50062, DOI 10.1074/jbc.M209316200
   Zeev-Ben-Mordehai T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4912
   Zhang Q, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15664
   Zhang WB, 2017, DEV BIOL, V423, P24, DOI 10.1016/j.ydbio.2017.01.019
   Zhuang L, 2017, ARCH BIOCHEM BIOPHYS, V625, P54, DOI 10.1016/j.abb.2017.06.002
   Zhuang L, 2015, BBA-MOL CELL RES, V1853, P2273, DOI 10.1016/j.bbamcr.2015.05.027
   Zito F, 2016, EUR J CELL BIOL, V95, P552, DOI 10.1016/j.ejcb.2016.09.002
NR 201
TC 35
Z9 37
U1 3
U2 26
PU COMPANY OF BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL,
   CAMBS, ENGLAND
SN 0950-1991
EI 1477-9129
J9 DEVELOPMENT
JI Development
PD DEC 15
PY 2017
VL 144
IS 24
BP 4481
EP 4495
DI 10.1242/dev.155523
PG 15
WC Developmental Biology
SC Developmental Biology
GA FQ1PU
UT WOS:000418130900003
PM 29254991
OA Bronze
DA 2020-07-08
ER

PT J
AU Satterfield-Nash, A
   Kotzky, K
   Allen, J
   Bertolli, J
   Moore, CA
   Pereira, IO
   Pessoa, A
   Melo, F
   Santelli, ACFES
   Boyle, CA
   Peacock, G
AF Satterfield-Nash, Ashley
   Kotzky, Kim
   Allen, Jacob
   Bertolli, Jeanne
   Moore, Cynthia A.
   Pereira, Isabela Ornelas
   Pessoa, Andre
   Melo, Flavio
   Faria e Silva Santelli, Ana Carolina
   Boyle, Coleen A.
   Peacock, Georgina
TI Health and Development at Age 19-24 Months of 19 Children Who Were Born
   with Microcephaly and Laboratory Evidence of Congenital Zika Virus
   Infection During the 2015 Zika Virus Outbreak - Brazil, 2017
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
ID DIAGNOSIS; INFANTS
C1 [Satterfield-Nash, Ashley; Kotzky, Kim] Oak Ridge Inst Sci & Educ, Oak Ridge, TN 37830 USA.
   [Allen, Jacob] Eagle Global Sci, San Antonio, TX USA.
   [Bertolli, Jeanne; Moore, Cynthia A.; Boyle, Coleen A.; Peacock, Georgina] CDC, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA.
   [Pereira, Isabela Ornelas] Minist Hlth Brazil, Fortaleza, Ceara, Brazil.
   [Pessoa, Andre] Hosp Infantil Albert Sabin, Fortaleza, Ceara, Brazil.
   [Melo, Flavio] Hosp Reg Guarabira Governo Estado Paraiba, Guarabira, Paraiba, Brazil.
   [Faria e Silva Santelli, Ana Carolina] CDC Brazil, Ctr Global Hlth, Rio De Janeiro, Brazil.
RP Satterfield-Nash, A (corresponding author), Oak Ridge Inst Sci & Educ, Oak Ridge, TN 37830 USA.
EM yev6@cdc.gov
RI Nash, Ashley/Y-2026-2019
OI Kotzky, Kim/0000-0002-5114-4552
CR Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   Douglass LM, 2016, PEDIATR NEUROL, V54, P64, DOI 10.1016/j.pediatrneurol.2015.09.016
   International Fetal and Newborn Growth Consortium for the 21st Century, 2017, STAND NEWB REF VER P
   Martin DA, 2000, J CLIN MICROBIOL, V38, P1823, DOI 10.1128/JCM.38.5.1823-1826.2000
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Pan American Health Organization, 2016, TIM EM ZIK VIR AM
   Romeo DM, 2016, DEV MED CHILD NEUROL, V58, P240, DOI 10.1111/dmcn.12876
   Secretaria de Vigilancia em Saude Ministerio da Saude, 2017, INT MON CHANG GROWTH
   World Health Organization, 2017, CHILD GROWTH STAND H
NR 10
TC 54
Z9 57
U1 0
U2 6
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD DEC 15
PY 2017
VL 66
IS 49
BP 1347
EP 1351
PG 5
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FQ0SO
UT WOS:000418067200002
PM 29240727
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Campos, SS
   Fernandes, RS
   dos Santos, AAC
   de Miranda, RM
   Telleria, EL
   Ferreira-de-Brito, A
   de Castro, MG
   Failloux, AB
   Bonaldo, MC
   Lourenco-de-Oliveira, R
AF Campos, Stephanie Silva
   Fernandes, Rosilainy Surubi
   Cunha dos Santos, Alexandre Araujo
   de Miranda, Rafaella Moraes
   Telleria, Erich Loza
   Ferreira-de-Brito, Anielly
   de Castro, Marcia Goncalves
   Failloux, Anna-Bella
   Bonaldo, Myrna C.
   Lourenco-de-Oliveira, Ricardo
TI Zika virus can be venereally transmitted between Aedes aegypti
   mosquitoes
SO PARASITES & VECTORS
LA English
DT Article
DE Zika virus; Aedes aegypti; Venereal transmission
ID ENCEPHALITIS-VIRUS; TRANSMISSION; ALBOPICTUS; CULICIDAE; AMERICA;
   DIPTERA; BRAZIL
AB Background: Alternative transmission routes have been described for Zika virus (ZIKV). Here, we assessed for the first time the venereal transmission of ZIKV between Aedes aegypti under laboratory conditions.
   Results: Orally-infected mosquito females were able to transmit the virus to males venereally, and males inoculated intrathoracically were capable of infecting females during mating. The genome of venereally-transmitted virus recovered from males was identical to that of ZIKV ingested by mated females.
   Conclusion: We conclude that venereal transmission between Aedes mosquitoes might contribute to Zika virus maintenance in nature.
C1 [Campos, Stephanie Silva; Fernandes, Rosilainy Surubi; de Miranda, Rafaella Moraes; Ferreira-de-Brito, Anielly; de Castro, Marcia Goncalves; Lourenco-de-Oliveira, Ricardo] Fiocruz MS, Inst Oswaldo Cruz, Lab Mosquitos Transmissores Hematozoarios, Rio De Janeiro, Brazil.
   [Cunha dos Santos, Alexandre Araujo; Bonaldo, Myrna C.] Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Mol Flavivirus, Rio De Janeiro, Brazil.
   [Telleria, Erich Loza] Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Mol Parasitos & Vetores, Rio De Janeiro, Brazil.
   [Failloux, Anna-Bella] Inst Pasteur, Arboviruses & Insect Vectors, Paris, France.
RP Lourenco-de-Oliveira, R (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Mosquitos Transmissores Hematozoarios, Rio De Janeiro, Brazil.
EM lourenco@ioc.fiocruz.br
RI Telleria, Erich L/F-1580-2015
OI Telleria, Erich L/0000-0003-0006-0057; Lourenco-de-Oliveira,
   Ricardo/0000-0003-0423-5694
FU European Union's Horizon research and innovation programme (ZIKAlliance)
   [734,548]; CAPES-COFECUB Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior [799/14]; Fundacao Carlos Chagas Filho de Amparo a
   Pesquisa do Estado do Rio de JaneiroCarlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ)
   [E-26/102.351/2013, E-26/201.335/2016]; Conselho Nacional
   Desenvolvimento Cientifico e TecnologicoNational Council for Scientific
   and Technological Development (CNPq) [309,577/2013-6]; National Institut
   of Health [1UO1 AI115595-01]
FX This work was supported by the European Union's Horizon 2020 research
   and innovation programme (ZIKAlliance grant 734,548), CAPES-COFECUB
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (grant
   799/14), Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do
   Rio de Janeiro (grants E-26/102.351/2013 and E-26/201.335/2016),
   Conselho Nacional Desenvolvimento Cientifico e Tecnologico (grant
   309,577/2013-6) and National Institut of Health (grant 1UO1
   AI115595-01). The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Aliota MT, 2017, ANTIVIR RES, V144, P223, DOI 10.1016/j.antiviral.2017.06.001
   Barzon L., 2016, EUROSURVEILLANCE, V21, P2016, DOI DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Campos S. E., 2017, THESIS
   Ciota AT, 2017, EMERG INFECT DIS, V23, P880, DOI 10.3201/eid2305.162041
   Consoli R.A.G.B., 1998, PRINCIPAIS MOSQUITOS
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005048
   Fernandes RS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004993
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Higgs S., 2004, BIOL DIS VECTORS
   Mavale MS, 2006, AM J TROP MED HYG, V75, P1151, DOI 10.4269/ajtmh.2006.75.1151
   Mavale M, 2010, AM J TROP MED HYG, V83, P1242, DOI 10.4269/ajtmh.2010.09-0577
   Mourya DT, 1999, INDIAN J MED RES, V109, P202
   Possas C, 2017, MEM I OSWALDO CRUZ, V112, P319, DOI 10.1590/0074-02760160510
   ROSEN L, 1987, AM J TROP MED HYG, V37, P398
   Samy AM, 2016, MEM I OSWALDO CRUZ, V111, P559, DOI 10.1590/0074-02760160149
   Septfons A, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.32.30315
   SHROYER DA, 1990, J MED ENTOMOL, V27, P334, DOI 10.1093/jmedent/27.3.334
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
NR 20
TC 7
Z9 7
U1 1
U2 4
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD DEC 15
PY 2017
VL 10
AR 605
DI 10.1186/s13071-017-2543-4
PG 4
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA FQ0KH
UT WOS:000418044300001
PM 29246237
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Gregory, CJ
   Oduyebo, T
   Brault, AC
   Brooks, JT
   Chung, KW
   Hills, S
   Kuehnert, MJ
   Mead, P
   Meaney-Delman, D
   Rabe, I
   Staples, E
   Petersen, LR
AF Gregory, Christopher J.
   Oduyebo, Titilope
   Brault, Aaron C.
   Brooks, John T.
   Chung, Koo-Whang
   Hills, Susan
   Kuehnert, Matthew J.
   Mead, Paul
   Meaney-Delman, Dana
   Rabe, Ingrid
   Staples, Erin
   Petersen, Lyle R.
TI Modes of Transmission of Zika Virus
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Zika virus; transmission modes; Aedes mosquitoes; pathogenesis
ID WEST-NILE-VIRUS; MALE SEXUAL TRANSMISSION; AEDES-AEGYPTI; PLACENTAL
   TROPHOBLASTS; VERTICAL TRANSMISSION; UNITED-STATES; YELLOW-FEVER;
   PUERTO-RICO; INFECTION; DENGUE
AB For > 60 years, Zika virus (ZIKV) has been recognized as an arthropod-borne virus with Aedes species mosquitoes as the primary vector. However in the past 10 years, multiple alternative routes of ZIKV transmission have been identified. We review the available data on vector and non-vector-borne modes of transmission and interventions undertaken, to date, to reduce the risk of human infection through these routes. Although much has been learned during the outbreak in the Americas on the underlying mechanisms and pathogenesis of non-vector-borne ZIKV infections, significant gaps remain in our understanding of the relative incidence of, and risk from, these modes compared to mosquito transmission. Additional research is urgently needed on the risk, pathogenesis, and effectiveness of measures to mitigate non-vector-borne ZIKV transmission.
C1 [Gregory, Christopher J.; Brault, Aaron C.; Hills, Susan; Mead, Paul; Rabe, Ingrid; Staples, Erin; Petersen, Lyle R.] Ctr Dis Control & Prevent, Div Vector Borne Dis, 3156 Rampart Rd, Ft Collins, CO 80521 USA.
   [Oduyebo, Titilope] Ctr Dis Control & Prevent, Div Reprod Hlth, Atlanta, GA USA.
   [Brooks, John T.] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA USA.
   [Chung, Koo-Whang; Kuehnert, Matthew J.] Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Atlanta, GA USA.
   [Meaney-Delman, Dana] Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA.
RP Gregory, CJ (corresponding author), Ctr Dis Control & Prevent, Div Vector Borne Dis, 3156 Rampart Rd, Ft Collins, CO 80521 USA.
EM hgk4@cdc.gov
FU CDCUnited States Department of Health & Human ServicesCenters for
   Disease Control & Prevention - USA; National Institute of Allergy and
   Infectious Diseases (NIAID), part of the National Institutes of Health
   (NIH)
FX This work was conducted by CDC employees in the course of their usual
   duties without additional funding support.; This work is part of a
   supplement sponsored by the National Institute of Allergy and Infectious
   Diseases (NIAID), part of the National Institutes of Health (NIH).
CR Aagaard KM, 2017, SCI REP-UK, V7, DOI 10.1038/srep41389
   Abbasi M, 2003, J INFECT DIS, V188, P608, DOI 10.1086/377132
   Adams L, 2016, MMWR-MORBID MORTAL W, V65, P774, DOI 10.15585/mmwr.mm6530e1
   Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227
   Alleghany County Health Department, HLTH DEP REP 4 CONF
   Althouse BM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005055
   Althouse BM, 2015, AM J TROP MED HYG, V92, P88, DOI 10.4269/ajtmh.13-0617
   Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6
   Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Barzon L., 2016, EUROSURVEILLANCE, V21, P2016, DOI DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Blau DM, 2013, EMERG INFECT DIS, V19, P1518, DOI 10.3201/eid1909.130365
   Blohm GM, 2017, GENOME ANNOUNC, P5
   Boccolini D, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.35.30328
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brent C, 2016, MMWR-MORBID MORTAL W, V65, P981, DOI 10.15585/mmwr.mm6536e4
   Brooks RB, 2016, MMWR-MORBID MORTAL W, V65, P915, DOI 10.15585/mmwr.mm6534e2
   Buechler CR, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00392-16
   Burton GJ, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0066
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao B, 2017, J INTERF CYTOK RES, V37, P287, DOI 10.1089/jir.2017.0011
   Cavalcanti MG, 2017, INT J INFECT DIS, V57, P70, DOI 10.1016/j.ijid.2017.01.042
   Centers for Disease Control and Prevention, LAB SAF WORK ZIK VIR
   Centers for Disease Control and Prevention, 2017, CAS COUNTS US
   Cheeran MCJ, 2009, CLIN MICROBIOL REV, V22, P99, DOI 10.1128/CMR.00023-08
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Ciota AT, 2017, EMERG INFECT DIS, V23, P1110, DOI 10.3201/eid2307.161633
   Ciota AT, 2017, EMERG INFECT DIS, V23, P880, DOI 10.3201/eid2305.162041
   Couto A. Mallmann, 2010, Morbidity and Mortality Weekly Report, V59, P130
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   de Carvalho NS, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12616
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Di Luca M, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.18.30223
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dodson BL, 2017, PEERJ, V5, DOI 10.7717/peerj.3096
   Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Fernandes RS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004993
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Food and Drug Administration, REV REC RED RISK ZIK
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Galel SA, 2017, TRANSFUSION, V57, P762, DOI 10.1111/trf.14029
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   Haddow AD, 2017, EMERG INFECT DIS, V23, P1274, DOI 10.3201/eid2308.170036
   Hahn MB, 2016, J MED ENTOMOL, V53, P1169, DOI 10.1093/jme/tjw072
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Heitmann A, 2017, EUROSURVEILLANCE, V22, P4, DOI 10.2807/1560-7917.ES.2017.22.2.30437
   Herrera BB, 2017, J INFECT DIS, V215, P1546, DOI 10.1093/infdis/jix182
   Hinckley AF, 2007, PEDIATRICS, V119, pE666, DOI 10.1542/peds.2006-2107
   Huang YJS, 2016, VECTOR-BORNE ZOONOT, V16, P673, DOI 10.1089/vbz.2016.2058
   Jang HC, 2016, J KOREAN MED SCI, V31, P1173, DOI 10.3346/jkms.2016.31.7.1173
   KOKERNOT RH, 1965, T ROY SOC TROP MED H, V59, P563, DOI 10.1016/0035-9203(65)90159-8
   Kuehnert MJ, 2016, MMWR-MORBID MORTAL W, V65, P627, DOI 10.15585/mmwr.mm6524e2
   Laughhunn A, 2017, TRANSFUSION, V57, P779, DOI 10.1111/trf.13993
   Leal Walter S, 2016, F1000Res, V5, P2546
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Li CX, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.8
   Liu ZZ, 2017, EMERG INFECT DIS, V23, P1085, DOI 10.3201/eid2307.161528
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Nicastri E, 2016, EMERG INFECT DIS, V22, P2228, DOI 10.3201/eid2212.161280
   Nogueira ML, 2017, AM J TRANSPLANT, V17, DOI 10.1111/ajt.14047
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Organ Procurement and Transplantation Network, GUID ZIK VIR
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Pealer LN, 2003, NEW ENGL J MED, V349, P1236, DOI 10.1056/NEJMoa030969
   Penot P, 2017, EUROSURVEILLANCE, V22, P8, DOI 10.2807/1560-7917.ES.2017.22.3.30444
   Petersen LR, 2016, NEW ENGL J MED, V375, P294, DOI 10.1056/NEJMc1606769
   Pierce A, 2008, MOL ENDOCRINOL, V22, P2481, DOI 10.1210/me.2008-0169
   Pompon J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01282-6
   Prisant N, 2017, CLIN INFECT DIS, V64, P107, DOI 10.1093/cid/ciw669
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Radke EG, 2012, EMERG INFECT DIS, V18, P135, DOI 10.3201/eid1801.110130
   Ragan IK, 2017, VECTOR-BORNE ZOONOT, V17, P161, DOI 10.1089/vbz.2016.2099
   Reiter P, 2003, EMERG INFECT DIS, V9, P86
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Ritter JM, 2017, ARCH PATHOL LAB MED, V141, P49, DOI 10.5858/arpa.2016-0397-SA
   Rosenberg AZ, 2017, ARCH PATHOL LAB MED, V141, P43, DOI 10.5858/arpa.2016-0401-OA
   Roundy CM, 2017, EMERG INFECT DIS, V23, P625, DOI 10.3201/eid2304.161484
   Roze B, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.9.30154
   SCHERER WF, 1980, AM J TROP MED HYG, V29, P1359
   Schwartzmann PV, 2017, MAYO CLIN PROC, V92, P460, DOI 10.1016/j.mayocp.2016.12.019
   Simoni MK, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12613
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Sotelo JR, 2017, EMERG INFECT DIS, V23, P854, DOI 10.3201/eid2305.161538
   Sun JF, 2016, JAMA OPHTHALMOL, V134, P1330, DOI 10.1001/jamaophthalmol.2016.3417
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tang WW, 2016, CELL REP, V17, P3091, DOI 10.1016/j.celrep.2016.11.070
   Thangamani S, 2016, AM J TROP MED HYG, V95, P1169, DOI 10.4269/ajtmh.16-0448
   Thomas DL, 2016, EMERG INFECT DIS, V22, P1002, DOI 10.3201/eid2206.152000
   United Network for Organ Sharing, GUID ORG DON TRANSPL
   US Food and Drug Administration, DON SCREEN REC RED R
   Ventura LO, 2017, J AAPOS, V21, P295, DOI 10.1016/j.jaapos.2017.04.003
   Vermillion MS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14575
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   WHO Guidelines Approved by the Guidelines Review Committee, 2016, GUID INF FEED AR ZIK
   Winston DJ, 2014, TRANSPLANTATION, V97, P881, DOI 10.1097/TP.0000000000000024
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Yakob L, 2016, LANCET INFECT DIS, V16, P1100, DOI 10.1016/S1473-3099(16)30324-3
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
NR 129
TC 32
Z9 32
U1 0
U2 17
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD DEC 15
PY 2017
VL 216
SU 10
BP S875
EP S883
DI 10.1093/infdis/jix396
PG 9
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA FQ3DY
UT WOS:000418238500004
PM 29267909
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Julander, JG
   Siddharthan, V
AF Julander, Justin G.
   Siddharthan, Venkatraman
TI Small-Animal Models of Zika Virus
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Zika virus; rodent; congenital; flavivirus
ID WEST-NILE-VIRUS; ADENOSINE NUCLEOSIDE INHIBITOR; MALE SEXUAL
   TRANSMISSION; MOUSE MODEL; DENGUE-VIRUS; PLACENTAL PATHOLOGY;
   ENCEPHALITIS-VIRUS; VIRAL-INFECTION; YELLOW-FEVER; MICE
AB Zika virus (ZIKV) infection can result in serious consequences, including severe congenital manifestations, persistent infection in the testes, and neurologic sequelae. After a pandemic emergence, the virus has spread to much of North and South America and has been introduced to many countries outside of ZIKV-endemic areas as infected travelers return to their home countries. Rodent models have been important in gaining a better understanding of the wide range of disease etiologies associated with ZIKV infection and for the initial phase of developing countermeasures to prevent or treat viral infections. We discuss herein the advantages and disadvantages of small-animal models that have been developed to replicate various aspects of disease associated with ZIKV infection.
C1 [Julander, Justin G.; Siddharthan, Venkatraman] Utah State Univ, Inst Antiviral Res, ADVS Dept, Logan, UT 84322 USA.
RP Julander, JG (corresponding author), Utah State Univ, Inst Antiviral Res, ADVS Dept, Logan, UT 84322 USA.
EM justin.julander@usu.edu
FU National Institute of Allergy and Infectious Diseases (NIAID), part of
   the National Institutes of Health (NIH)
FX This work is part of a supplement sponsored by the National Institute of
   Allergy and Infectious Diseases (NIAID), part of the National Institutes
   of Health (NIH).
CR Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   Balsitis SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000790
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   Betancourt D, 2017, J IMMUNOL, V198, P3023, DOI 10.4049/jimmunol.1602180
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Chan JFW, 2016, EBIOMEDICINE, V14, P112, DOI 10.1016/j.ebiom.2016.11.017
   Costa F, 2016, ANN INTERN MED, V164, P689, DOI 10.7326/M16-0332
   CROSS JC, 1994, SCIENCE, V266, P1508, DOI 10.1126/science.7985020
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Deng YQ, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw175
   Diamond MS, 2008, IMMUNOL REV, V225, P212, DOI 10.1111/j.1600-065X.2008.00676.x
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   ENDERS AC, 1965, AM J ANAT, V116, P29, DOI 10.1002/aja.1001160103
   Fernandes NCCA, 2017, EXP TOXICOL PATHOL, V69, P63, DOI 10.1016/j.etp.2016.11.004
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Georgiades P, 2002, PLACENTA, V23, P3, DOI 10.1053/plac.2001.0738
   Goodfellow FT, 2016, STEM CELLS DEV, V25, P1691, DOI 10.1089/scd.2016.0231
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Halai UA, 2017, CLIN INFECT DIS, V65, P877, DOI 10.1093/cid/cix472
   Halstead S.B., 2015, F1000RESEARCH, V4, pF1000, DOI DOI 10.12688/F1000RESEARCH.7024.1
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Julander JG, 2006, VIROLOGY, V347, P175, DOI 10.1016/j.virol.2005.11.040
   Julander JG, 2005, ANTIVIR RES, V65, P79, DOI 10.1016/j.antiviral.2004.10.005
   Julander JG, 2008, ANTIVIR RES, V78, P230, DOI 10.1016/j.antiviral.2008.01.007
   Julander JG, 2017, ANTIVIR RES, V137, P14, DOI 10.1016/j.antiviral.2016.11.003
   Julander JG, 2014, ANTIMICROB AGENTS CH, V58, P6607, DOI 10.1128/AAC.03368-14
   Kumar M, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0750-4
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li CF, 2017, IMMUNITY, V46, P446, DOI 10.1016/j.immuni.2017.02.012
   Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Manangeeswaran M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006004
   MATHUR A, 1981, INFECT IMMUN, V34, P26, DOI 10.1128/IAI.34.1.26-29.1981
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Monath TP, 2012, EXPERT REV VACCINES, V11, P427, DOI [10.1586/erv.12.6, 10.1586/ERV.12.6]
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nelson J, 2015, ANTIVIR RES, V122, P39, DOI 10.1016/j.antiviral.2015.07.008
   Olsen DB, 2004, ANTIMICROB AGENTS CH, V48, P3944, DOI 10.1128/AAC.48.10.3944-3953.2004
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Priyamvada L, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.42
   REAGAN R L, 1955, Tex Rep Biol Med, V13, P934
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Rosenberg AZ, 2017, ARCH PATHOL LAB MED, V141, P43, DOI 10.5858/arpa.2016-0401-OA
   Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Roundy CM, 2017, EMERG INFECT DIS, V23, P625, DOI 10.3201/eid2304.161484
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Schwartz DA, 2017, ARCH GYNECOL OBSTET, V295, P1361, DOI 10.1007/s00404-017-4361-5
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Sheridan MA, 2017, P NATL ACAD SCI USA, V114, pE1587, DOI 10.1073/pnas.1616097114
   Siddharthan V, 2017, VIROLOGY, V507, P89, DOI 10.1016/j.virol.2017.04.013
   Siddharthan V, 2009, J VIROL, V83, P4251, DOI 10.1128/JVI.00017-09
   Simoni MK, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12613
   Singh PK, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92340
   Smith DR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005296
   Sukupolvi-Petty S, 2007, J VIROL, V81, P12816, DOI 10.1128/JVI.00432-07
   Sumathy K, 2017, SCI REP-UK, V7, DOI 10.1038/srep46375
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Tang WW, 2016, CELL REP, V17, P3091, DOI 10.1016/j.celrep.2016.11.070
   Taylor R, 2016, J INFECT PUBLIC HEAL, V9, P220, DOI 10.1016/j.jiph.2016.04.002
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Uraki R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602899
   Vermillion MS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14575
   Victora CG, 2017, LANCET, V389, P152, DOI 10.1016/S0140-6736(17)30015-6
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Warren TK, 2014, NATURE, V508, P402, DOI 10.1038/nature13027
   WAY HJ, 1976, J GEN VIROL, V30, P123, DOI 10.1099/0022-1317-30-1-123
   Widman DG, 2017, MBIO, V8, DOI [10.1128/mBio.02014-16, 10.1128/mbio.02014-16]
   Winkler AM, 2015, CURR OPIN HEMATOL, V22, P521, DOI 10.1097/MOH.0000000000000191
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Xavier-Neto J, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005363
   Yin Z, 2009, P NATL ACAD SCI USA, V106, P20435, DOI 10.1073/pnas.0907010106
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zellweger RM, 2010, CELL HOST MICROBE, V7, P128, DOI 10.1016/j.chom.2010.01.004
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 88
TC 10
Z9 10
U1 0
U2 5
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD DEC 15
PY 2017
VL 216
SU 10
BP S919
EP S927
DI 10.1093/infdis/jix465
PG 9
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA FQ3DY
UT WOS:000418238500010
PM 29267919
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Osuna, CE
   Whitney, JB
AF Osuna, Christa E.
   Whitney, James B.
TI Nonhuman Primate Models of Zika Virus Infection, Immunity, and
   Therapeutic Development
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Zika virus; nonhuman primates; animal models; therapeutics; viral
   persistence
ID ANTIBODY-DEPENDENT ENHANCEMENT; SMALL-MOLECULE INHIBITORS; MALE SEXUAL
   TRANSMISSION; DENGUE VIRUS; PROTECTIVE EFFICACY; NUCLEOSIDE ANALOG;
   YELLOW-FEVER; VIRAL LOAD; VACCINE; RHESUS
AB Zika virus is a re-emerging flavivirus transmitted primarily by arthropod vectors. The recent devastating outbreak of Zika virus in Brazil was preceded by the slow global encroachment of this virus over many decades. To date, significant research efforts are underway to understand the spread and the unique pathogenesis of this virus; with the intent to rapidly develop vaccines and therapeutics. Several model systems have emerged to study Zika. This review will focus on the use of nonhuman primates to model Zika infection.
C1 [Osuna, Christa E.; Whitney, James B.] Harvard Med Sch, Ctr Virol & Vaccine Res, Beth Israel Deaconess Med Ctr, Boston, MA USA.
   [Whitney, James B.] MIT, Massachusetts Gen Hosp, Ragon Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
   [Whitney, James B.] Harvard Univ, Cambridge, MA 02138 USA.
RP Whitney, JB (corresponding author), Beth Israel Deaconess Med Ctr, E CLS Rm 1039,330 Brookline Ave, Boston, MA 02215 USA.
EM jwhitne2@bidmc.harvard.edu
OI Osuna, Christa/0000-0003-2761-2456
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [AI127089]; National
   Institute of Allergy and Infectious Diseases (NIAID), part of the
   National Institutes of Health (NIH)
FX This work was supported by the National Institutes of Health (award
   number AI127089 to J. B. W.).; This work is part of a supplement
   sponsored by the National Institute of Allergy and Infectious Diseases
   (NIAID), part of the National Institutes of Health (NIH).
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005168
   Althouse BM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005055
   Andrade DV, 2018, VIRUS RES, V254, P27, DOI 10.1016/j.virusres.2017.06.019
   Arck PC, 2013, NAT MED, V19, P548, DOI 10.1038/nm.3160
   Atkinson B, 2017, EMERG INFECT DIS, V23, P611, DOI 10.3201/eid2304.161692
   Azevedo RSS, 2016, J CLIN VIROL, V85, P56, DOI 10.1016/j.jcv.2016.10.024
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Terzian ACB, 2017, CLIN INFECT DIS, V65, P1260, DOI 10.1093/cid/cix558
   Betancourt D, 2017, J IMMUNOL, V198, P3023, DOI 10.4049/jimmunol.1602180
   Bethell DB, 1998, J INFECT DIS, V177, P778, DOI 10.1086/517807
   Blanc M, 2013, IMMUNITY, V38, P106, DOI 10.1016/j.immuni.2012.11.004
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Boigard H, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005608
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Bueno MG, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005073
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Cao B, 2017, J EXP MED, V214, P2303, DOI 10.1084/jem.20170957
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Carroll T, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006537
   Castanha PMS, 2017, J INFECT DIS, V215, P781, DOI 10.1093/infdis/jiw638
   Coffey LL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171148
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Durbin AP, 2016, SEMIN REPROD MED, V34, P299, DOI 10.1055/s-0036-1592070
   El Costa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35296
   European Centre for Disease Prevention and Control, 2014, ZIK VIR INF OUTBR FR
   European Centre for Disease Prevention and Control, 2017, CURR ZIK VIR TRANSM
   Foo SS, 2017, NAT MICROBIOL, V2, P1558, DOI 10.1038/s41564-017-0016-3
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Garg H, 2017, J VIROL, V91, DOI 10.1128/JVI.00834-17
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grigsby PL, 2016, SEMIN REPROD MED, V34, P11, DOI 10.1055/s-0035-1570031
   Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3
   Haddow AD, 2017, EMERG INFECT DIS, V23, P1274, DOI 10.3201/eid2308.170036
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Han JF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10595-5
   Harrower J, 2016, EMERG INFECT DIS, V22, P1855, DOI 10.3201/eid2210.160951
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Julander JG, 2017, ANTIVIR RES, V137, P14, DOI 10.1016/j.antiviral.2016.11.003
   Julander JG, 2014, ANTIMICROB AGENTS CH, V58, P6607, DOI 10.1128/AAC.03368-14
   Kim E, 2016, EBIOMEDICINE, V13, P315, DOI 10.1016/j.ebiom.2016.09.028
   Koide F, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02028
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lee H, 2017, ANTIVIR RES, V139, P49, DOI 10.1016/j.antiviral.2016.12.016
   Li CF, 2017, IMMUNITY, V46, P446, DOI 10.1016/j.immuni.2017.02.012
   Li HD, 2016, NEURON, V92, P949, DOI 10.1016/j.neuron.2016.11.031
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   Liu SY, 2013, IMMUNITY, V38, P92, DOI 10.1016/j.immuni.2012.11.005
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Meinhardt A, 2017, NAT REV UROL, V14, P135, DOI 10.1038/nrurol.2016.265
   Meltzer E, 2016, AM J MED, V129, P1126, DOI 10.1016/j.amjmed.2016.04.034
   Michlmayr D, 2017, NAT MICROBIOL
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Muthumani K, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.21
   Mysorekar IU, 2016, NEW ENGL J MED, V375, P481, DOI 10.1056/NEJMcibr1605445
   Newman CM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00246-8
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Souto IO, 2018, ENFERM INFEC MICR CL, V36, P21, DOI 10.1016/j.eimc.2016.10.009
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Reusken C, 2016, EURO SURVEILL, V21
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   Richner JM, 2017, CELL, V169, P176, DOI 10.1016/j.cell.2017.03.016
   Rothman AL, 2010, CURR TOP MICROBIOL, V338, P83, DOI 10.1007/978-3-642-02215-9_7
   Russell K, 2017, CLIN INFECT DIS, V64, P211, DOI 10.1093/cid/ciw692
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Silveira ELV, 2017, J IMMUNOL, V199, P1003, DOI 10.4049/jimmunol.1700256
   Sumathy K, 2017, SCI REP-UK, V7, DOI 10.1038/srep46375
   Suthar MS, 2013, NAT REV MICROBIOL, V11, P115, DOI 10.1038/nrmicro2950
   Taylor R, 2016, J INFECT PUBLIC HEAL, V9, P220, DOI 10.1016/j.jiph.2016.04.002
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Warren TK, 2014, NATURE, V508, P402, DOI 10.1038/nature13027
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 100
TC 12
Z9 13
U1 0
U2 3
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD DEC 15
PY 2017
VL 216
SU 10
BP S928
EP S934
DI 10.1093/infdis/jix540
PG 7
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA FQ3DY
UT WOS:000418238500011
PM 29267926
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Xie, XP
   Zou, J
   Shan, C
   Shi, PY
AF Xie, Xuping
   Zou, Jing
   Shan, Chao
   Shi, Pei-Yong
TI Small Molecules and Antibodies for Zika Therapy
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Zika; therapeutics; drug discovery
ID DENGUE VIRUS; SEXUAL TRANSMISSION; MEMBRANE ASSOCIATION; NS2B-NS3
   PROTEASE; CRYSTAL-STRUCTURE; RHESUS-MONKEYS; DOUBLE-BLIND; INFECTION;
   PROTECTION; VACCINE
AB Zika virus (ZIKV) infection during pregnancy can cause devastating congenital abnormities or fetal demise. Zika virus infection could also cause Guillain-Barr, syndrome in adults. Mosquito control, vaccine, and therapeutics are 3 potential, effective means to prevent ZIKV infection. Here we review the current status of ZIKV drug discovery. Both small molecule inhibitors and therapeutic antibodies have been identified, some of which have shown promising efficacy in mouse models. Most inhibitors were identified through screening US Food and Drug Administration-approved drugs and clinical trial compounds; however, none of them were potent enough to justify a ZIKV clinical trial. Such a repurposing approach has also been pursued for dengue therapy, with several compounds tested in clinical trials showing no clinical benefits. Because pregnant women are the main target population for ZIKV treatment, therapeutic candidates could be developed through a 2-stage path. The first stage should demonstrate safety and efficacy in nonpregnant patients. Once efficacy has been demonstrated in nonpregnant patients, the candidates should be rapidly advanced to stage 2 for safety and efficacy evaluation in pregnant patients. The 2-stage developmental path is supported by previous results from trials with other viral infections that showed that treatment of pregnant women with antiviral drugs or hyperimmunoglobulins significantly reduced congenital abnormalities in neonates.
C1 [Xie, Xuping; Zou, Jing; Shan, Chao; Shi, Pei-Yong] Univ Texas Med Branch, Dept Biochem & Mol Biol, 5-136 Med Res Bldg,301 Univ Blvd, Galveston, TX 77550 USA.
   [Shi, Pei-Yong] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77550 USA.
   [Shi, Pei-Yong] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77550 USA.
RP Shi, PY (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, 5-136 Med Res Bldg,301 Univ Blvd, Galveston, TX 77550 USA.
EM peshi@UTMB.edu
RI amsalu, ribka/G-8780-2019; Xie, Xuping/AAD-7406-2019
FU University of Texas Medical Branch (UTMB) startup award; University of
   Texas STARs Award; US Centers for Disease Control and Prevention grant
   for the Western Gulf Center of Excellence for Vector-Borne Diseases; Pan
   American Health Organization grant [SCON2016-01353]; Kleberg Foundation
   award; UTMB Clinical and Translational Science Award [UL1TR-001439];
   National Institute of Allergy and Infectious Diseases (NIAID), part of
   the National Institutes of Health (NIH)
FX This work was partially supported by a University of Texas Medical
   Branch (UTMB) startup award, a University of Texas STARs Award, a US
   Centers for Disease Control and Prevention grant for the Western Gulf
   Center of Excellence for Vector-Borne Diseases, a Pan American Health
   Organization grant (SCON2016-01353), a Kleberg Foundation award, and a
   UTMB Clinical and Translational Science Award (UL1TR-001439 to P.-Y.
   S.); This work is part of a supplement sponsored by the National
   Institute of Allergy and Infectious Diseases (NIAID), part of the
   National Institutes of Health (NIH).
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Abel S, 2009, ANTIVIR THER, V14, P607
   Adcock RS, 2017, ANTIVIR RES, V138, P47, DOI 10.1016/j.antiviral.2016.11.018
   Aliota MT, 2017, ANTIVIR RES, V144, P223, DOI 10.1016/j.antiviral.2017.06.001
   Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6
   Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   Balasubramanian A, 2017, ANTIVIR RES, V137, P141, DOI 10.1016/j.antiviral.2016.11.015
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Barouch DH, 2017, IMMUNITY, V46, P176, DOI 10.1016/j.immuni.2017.02.005
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Barzon L., 2016, EUROSURVEILLANCE, V21, P2016, DOI DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Betancourt D, 2017, J IMMUNOL, V198, P3023, DOI 10.4049/jimmunol.1602180
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brown WC, 2016, NAT STRUCT MOL BIOL, V23, P865, DOI 10.1038/nsmb.3268
   Brucker MC, 2017, J MIDWIFERY WOM HEAL, V62, P308, DOI 10.1111/jmwh.12611
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chen YL, 2015, ANTIVIR RES, V122, P12, DOI 10.1016/j.antiviral.2015.07.010
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Cooksley W Graham E, 2004, MedGenMed, V6, P16
   Cooper ER, 2002, J ACQ IMMUN DEF SYND, V29, P484, DOI 10.1097/00126334-200204150-00009
   De Clercq E, 2016, CLIN MICROBIOL REV, V29, P695, DOI 10.1128/CMR.00102-15
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Deng YQ, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw175
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Dudley DM, 2016, BIORXIV, DOI [10.1101/046334, DOI 10.1101/046334]
   Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   Godoy AS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14764
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   HALSTEAD SB, 1979, J INFECT DIS, V140, P527, DOI 10.1093/infdis/140.4.527
   Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106
   Hollier LM, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004946.pub2
   Jain R, 2016, NAT STRUCT MOL BIOL, V23, P752, DOI 10.1038/nsmb.3258
   JANEWAY CA, 1945, B NEW YORK ACAD MED, V21, P202
   Juckstock J, 2015, PHARMACOLOGY, V95, P209, DOI 10.1159/000381626
   Julander JG, 2017, ANTIVIR RES, V137, P14, DOI 10.1016/j.antiviral.2016.11.003
   Kimberlin DW, 2003, J PEDIATR-US, V143, P16, DOI 10.1016/S0022-3476(03)00192-6
   Kirkpatrick BD, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1517
   Koren G, 2002, J CLIN PHARMACOL, V42, P267, DOI 10.1177/00912700222011283
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kuehnert MJ, 2016, MMWR-MORBID MORTAL W, V65, P627, DOI 10.15585/mmwr.mm6524e2
   Lai CJ, 2007, J VIROL, V81, P12766, DOI 10.1128/JVI.01420-07
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   Low JG, 2014, LANCET INFECT DIS, V14, P706, DOI 10.1016/S1473-3099(14)70730-3
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nguyen NM, 2013, J INFECT DIS, V207, P1442, DOI 10.1093/infdis/jis470
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Ordman CW, 1944, J CLIN INVEST, V23, P541, DOI 10.1172/JCI101519
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Parke DW, 2016, OPHTHALMOLOGY, V123, P2432, DOI 10.1016/j.ophtha.2016.06.039
   Phoo WW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13410
   Probst P, 2017, VACCINE, V35, P1964, DOI 10.1016/j.vaccine.2017.01.053
   Pryke KM, 2017, MBIO, V8, DOI [10.1128/mBio.00452-17, 10.1128/mbio.00452-17]
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Robbie GJ, 2013, ANTIMICROB AGENTS CH, V57, P6147, DOI 10.1128/AAC.01285-13
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Roundy CM, 2017, EMERG INFECT DIS, V23, P625, DOI 10.3201/eid2304.161484
   Russell K, 2017, CLIN INFECT DIS, V64, P211, DOI 10.1093/cid/ciw692
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Schwarz MC, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00246-16
   Shan C, 2017, J CLIN MICROBIOL
   Shan C, 2017, NATURE COMM IN PRESS
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Shan C, 2017, METHODS MOL BIOL, V1602, P47, DOI 10.1007/978-1-4939-6964-7_4
   Shan C, 2017, EBIOMEDICINE, V17, P157, DOI 10.1016/j.ebiom.2017.03.006
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Shan C, 2016, ACS INFECT DIS, V2, P170, DOI 10.1021/acsinfecdis.6b00030
   Shepherd J, 2000, Health Technol Assess, V4, P1
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Tam DTH, 2012, CLIN INFECT DIS, V55, P1216, DOI 10.1093/cid/cis655
   Terzian ACB, 2017, CLIN INFECT DIS IN P
   Thangamani S, 2016, AM J TROP MED HYG, V95, P1169, DOI 10.4269/ajtmh.16-0448
   Tong X, 2014, J INFECT DIS, V209, P668, DOI 10.1093/infdis/jit562
   Tricou Vianney, 2010, PLoS Negl Trop Dis, V4, pe785, DOI 10.1371/journal.pntd.0000785
   Tsetsarkin KA, 2016, MBIO, V7, DOI 10.1128/mBio.01114-16
   van Leeuwen E, 2014, NEW ENGL J MED, V370, P2543, DOI 10.1056/NEJMc1405377
   Wang BX, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14763
   Wang QY, 2011, J VIROL, V85, P6548, DOI 10.1128/JVI.02510-10
   Wang TT, 2017, SCIENCE, V355, P395, DOI 10.1126/science.aai8128
   Weger-Lucarelli J, 2017, J VIROL, V91, DOI 10.1128/JVI.01765-16
   Whitehorn J, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-203
   Widman DG, 2017, MBIO, V8, DOI [10.1128/mBio.02014-16, 10.1128/mbio.02014-16]
   Xie XP, 2017, MBIO, V8, DOI [10.1128/mBio.02134-16, 10.1128/mbio.02134-16]
   Xie XP, 2016, EBIOMEDICINE, V12, P156, DOI 10.1016/j.ebiom.2016.09.013
   Xie XP, 2016, CELL HOST MICROBE, V19, P566, DOI 10.1016/j.chom.2016.04.019
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Xu XY, 2016, EMBO J, V35, P2170, DOI 10.15252/embj.201695290
   Yin Z, 2009, P NATL ACAD SCI USA, V106, P20435, DOI 10.1073/pnas.0907010106
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zhao BY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14762
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
   Zou G, 2012, ANTIVIR RES, V95, P216, DOI 10.1016/j.antiviral.2012.06.010
NR 109
TC 13
Z9 15
U1 0
U2 5
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD DEC 15
PY 2017
VL 216
SU 10
BP S945
EP S950
DI 10.1093/infdis/jix406
PG 6
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA FQ3DY
UT WOS:000418238500013
PM 29267911
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Souza, GK
   Schuquel, ITA
   Moura, VM
   Belloto, AC
   Chiavelli, LUR
   Ruiz, ALTG
   Shiozawa, L
   de Carvalho, JE
   Garcia, FP
   Kaplum, V
   Rodrigues, JHD
   Scariot, DB
   Delvecchio, R
   Machado-Ferreira, E
   Santana, R
   Soares, CAG
   Nakamura, CV
   Santin, SMD
   Pomini, AM
AF Souza, Gredson Keiff
   Albrecht Schuquel, Ivania Teresinha
   Moura, Vagner Marques
   Belloto, Andrezza Correia
   Rovigatti Chiavelli, Lucas Ulisses
   Tasca Gois Ruiz, Ana Lucia
   Shiozawa, Larissa
   de Carvalho, Joao Ernesto
   Garcia, Francielle Pelegrin
   Kaplum, Vanessa
   da Silva Rodrigues, Jean Henrique
   Scariot, Debora Botura
   Delvecchio, Rodrigo
   Machado-Ferreira, Erik
   Santana, Renato
   Gomes Soares, Carlos Augusto
   Nakamura, Celso Vataru
   de Oliveira Santin, Silvana Maria
   Pomini, Armando Mateus
TI X-ray structure of O-methyl-acrocol and anti-cancer, anti-parasitic,
   anti-bacterial and anti-Zika virus evaluations of the Brazilian palm
   tree Acrocomia totai
SO INDUSTRIAL CROPS AND PRODUCTS
LA English
DT Article
DE Triterpenes; Anti-proliferative; Antimicrobial; Anti-protozoal; Zika
   virus
ID QUINOXALINE DERIVATIVES; ANTIMICROBIAL ACTIVITY; BIODIESEL PRODUCTION;
   CANCER CELLS; ACULEATA; OIL; PICEATANNOL; ETHANOLYSIS; INFECTION;
   PROLIFERATION
AB Acrocomia totai Mart ("macauba") is a palm tree native from Brazil, whose potential for biodiesel production has been widely explored. In spite of the industrial interest in the oil from the nuts, little is known about the potential applications of other parts of the plant, especially in the pharmacological area. A phytochemical study of the plant thorns led to the identification of a new compound 3-(R)-methoxy-21-(R)-H-hop-22(29)-en-30-ol 1, two known triterpenes 2-3, four steroids 4-7 and a stilbene, piceatannol 8. The structures were elucidated by spectroscopic analyses, including 1D and 2D NMR and low and high resolution mass spectrometry. Compound 1 was purified as crystals, which allowed the determination of the absolute configuration of the asymmetric carbons by analysis of the X-ray diffraction spectrum. Biological tests were performed with crude extract (CE), fractions and isolated compound. The assays showed activity for CE against lung carcinoma (GI(50) 59.2 mu g mL(-1)). The ethyl acetate fraction (EAF) showed efficacy against many tumor cell lines, and the tests showed the most prominent activity for breast cancer (GI(50) 10.4 mu g mL(-1)), glioma (GI(50) 77.3 mu g mL(-1)), uterine cervix (SiHa) HPV 16 (IC50 39.8 mu g mL(-1)), (HeLa) HPV 18 (IC50 12.0 pg mL(-1)) and Caco-2 (IC50 40.0 mu g mL(-1)) and showed bacteriostatic action against Staphylococcus aureus (MIC 50 mu g mL(-1)). Piceatannol 8 isolated from EAF showed activity against the protozoan which causes leishmaniosis (IC50 58.4 mu g mL(-1)). For Ttypanosorna cruzi, the methanol fraction (EC50 15.5 mu g mL(-1)), CE (20.5 mu g(-1)), and HEF (43.8 mu g mL(-1)) were the most active, being highly selective for the protozoan and less toxic against Vero cells. The compound 8 was further tested against Zika virus MR 766 strain on MOI 2, however the assays showed no inhibition against virus infection.
C1 [Souza, Gredson Keiff; Albrecht Schuquel, Ivania Teresinha; Moura, Vagner Marques; Belloto, Andrezza Correia; Rovigatti Chiavelli, Lucas Ulisses; de Oliveira Santin, Silvana Maria; Pomini, Armando Mateus] Univ Estadual Maringa, Dept Chem, Maringa, Parana, Brazil.
   [Tasca Gois Ruiz, Ana Lucia; Shiozawa, Larissa; de Carvalho, Joao Ernesto] Univ Estadual Campinas, CPQBA, Div Pharmacol & Toxicol, Sao Paulo, Brazil.
   [de Carvalho, Joao Ernesto] Univ Estadual Campinas, Fac Pharmaceut Sci, Sao Paulo, Brazil.
   [Garcia, Francielle Pelegrin; Kaplum, Vanessa; da Silva Rodrigues, Jean Henrique; Scariot, Debora Botura; Nakamura, Celso Vataru] Univ Estadual Maringa, Dept Basic Hlth Sci, Maringa, Parana, Brazil.
   [Delvecchio, Rodrigo; Machado-Ferreira, Erik; Santana, Renato; Gomes Soares, Carlos Augusto] Univ Fed Rio de Janeiro, Dept Genet, Inst Biol, Rio De Janeiro, Brazil.
RP Pomini, AM (corresponding author), Univ Estadual Maringa, Dept Chem, Maringa, Parana, Brazil.
EM ampomini@uem.br
RI de Oliveira Santin, Silvana Maria/AAD-8707-2019; Garcia, Francielle
   Pelegrin/L-7691-2018; Ruiz, Ana Lucia Tasca Gois/C-2249-2012; Soares,
   Carlos A G/H-9464-2016; Souza, Gredson Keiff/G-2558-2016; Pomini,
   Armando M/P-1277-2018; Nakamura, Celso Vataru/AAA-5620-2019; Aguiar,
   Renato S/G-3542-2015
OI Garcia, Francielle Pelegrin/0000-0001-8966-9154; Ruiz, Ana Lucia Tasca
   Gois/0000-0002-0844-8702; Soares, Carlos A G/0000-0001-9058-9266; Souza,
   Gredson Keiff/0000-0001-9724-1131; Aguiar, Renato S/0000-0001-5180-3717
FU CAPES (Coordenacho de Aperfeicoamento de Pessoal de Nivel
   Superior)CAPES; CNPQ (Conselho Nacional de Desenvolvimento Cientffico e
   Tecnologico)National Council for Scientific and Technological
   Development (CNPq); Fundacao AraucariaFundacao Araucaria
FX Authors are thankful for financial support and fellowships provided by
   CAPES (Coordenacho de Aperfeicoamento de Pessoal de Nivel Superior),
   CNPQ (Conselho Nacional de Desenvolvimento Cientffico e Tecnologico) and
   Fundacao Araucaria. We are also very much appreciative of Prof. Anita J.
   Marsaioli (Unicamp) for her assistance.
CR Abad-Franch F, 2015, ACTA TROP, V151, P126, DOI 10.1016/j.actatropica.2015.07.005
   Abreu AG, 2012, GENET MOL BIOL, V35, P119, DOI 10.1590/S1415-47572012005000002
   Aguieiras ECG, 2014, FUEL, V135, P315, DOI 10.1016/j.fuel.2014.06.069
   AKIHISA T, 1992, CHEM PHARM BULL, V40, P789, DOI 10.1248/cpb.40.789
   Passos CLA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141778
   ANDREWS NW, 1982, J PROTOZOOL, V29, P264, DOI 10.1111/j.1550-7408.1982.tb04024.x
   Basso RC, 2013, ENERG FUEL, V27, P5907, DOI 10.1021/ef401102e
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   BRENER Z., 1962, REV INST MED TROP SAO PAULO, V4, P389
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Carey F.A., 2011, ORGANIC CHEM, P89
   Carvalho AKF, 2013, IND CROP PROD, V50, P485, DOI 10.1016/j.indcrop.2013.07.040
   Cogo J, 2015, EUR J MED CHEM, V90, P107, DOI 10.1016/j.ejmech.2014.11.018
   Costa GM, 2016, J MYCOL MED, V26, P217, DOI 10.1016/j.mycmed.2016.03.002
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   del Rey B, 1999, BIOORG MED CHEM LETT, V9, P2711, DOI 10.1016/S0960-894X(99)00453-9
   del Rio JC, 2016, IND CROP PROD, V84, P294, DOI 10.1016/j.indcrop.2016.02.018
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   Duarte N, 2008, PHYTOTHER RES, V22, P455, DOI 10.1002/ptr.2334
   Evaristo AB, 2016, IND CROP PROD, V85, P63, DOI 10.1016/j.indcrop.2016.02.052
   Ferreira MJU, 2011, NUTS AND SEEDS IN HEALTH AND DISEASE PREVENTION, P453, DOI 10.1016/B978-0-12-375688-6.10054-4
   FERRIGNI NR, 1984, J NAT PROD, V47, P347, DOI 10.1021/np50032a019
   Galotta ALQ, 2005, QUIM NOVA, V28, P610, DOI 10.1590/S0100-40422005000400011
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   GASPAR EMM, 1993, PHYTOCHEMISTRY, V34, P523, DOI 10.1016/0031-9422(93)80039-U
   GOULART MOF, 1993, QUIM NOVA, V16, P95
   Heliawati L., 2015, Journal of Applied Pharmaceutical Science, V5, P110
   HUI WH, 1976, PHYTOCHEMISTRY, V15, P1741
   Iha OK, 2014, IND CROP PROD, V62, P318, DOI 10.1016/j.indcrop.2014.09.003
   INPA. Instituto Nacional de Pesquisas da Amazonia, 2015, TECN INP DES FERR CO
   Kaplum V, 2016, ANTIMICROB AGENTS CH, V60, P3433, DOI 10.1128/AAC.02582-15
   Kim EJ, 2009, J MED FOOD, V12, P943, DOI 10.1089/jmf.2008.1341
   Kuo PL, 2008, MOL NUTR FOOD RES, V52, P408, DOI 10.1002/mnfr.200700252
   Lazarin-Bidoia D, 2016, ANTIMICROB AGENTS CH, V60, P890, DOI 10.1128/AAC.01360-15
   Lima EBC, 2015, BRAZ J MED BIOL RES, V48, P953, DOI 10.1590/1414-431X20154773
   Magosso MF, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15027816
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Michelin S, 2015, RENEW ENERG, V76, P388, DOI 10.1016/j.renene.2014.11.067
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Moura-Costa GF, 2012, J ETHNOPHARMACOL, V143, P631, DOI 10.1016/j.jep.2012.07.016
   NAKAJIMA K, 1978, CHEM PHARM BULL, V26, P3050
   National Committee for Clinical Laboratory Standards, 2006, M7A7 CLSI NCCLS
   Navarro-Diaz HJ, 2014, J SUPERCRIT FLUID, V93, P130, DOI 10.1016/j.supflu.2013.11.008
   Ohmoto T., 1969, CHEM COMMUN, V60, P601
   Oliveira A.I.T., 2016, SCI WORLD J
   PAUPTIT RA, 1984, AUST J CHEM, V37, P1341, DOI 10.1071/CH9841341
   Peng W, 2015, J ETHNOPHARMACOL, V164, P340, DOI 10.1016/j.jep.2015.02.010
   da Silva BP, 2009, CARBOHYD POLYM, V75, P380, DOI 10.1016/j.carbpol.2008.09.031
   Perez S, 1997, Pharm Acta Helv, V72, P105
   Prado RG, 2016, ENERG FUEL, V30, P6662, DOI 10.1021/acs.energyfuels.6b00005
   Silva GCR, 2013, J FOOD PROCESS ENG, V36, P134, DOI 10.1111/j.1745-4530.2011.00657.x
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rodriguez MF, 2005, J ARCHAEOL SCI, V32, P1534, DOI 10.1016/j.jas.2005.04.016
   ROWAN DD, 1992, PHYTOCHEMISTRY, V31, P702, DOI 10.1016/0031-9422(92)90066-Y
   SABBIR A, 2016, ASIAN PAC J TROP DIS, V6, P925, DOI DOI 10.1016/S2222-1808(16)61157-X
   Sakande J, 2011, Pak J Biol Sci, V14, P578, DOI 10.3923/pjbs.2011.578.583
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Santana NDS, 2016, ARCH GYNECOL OBSTET, V294, P797, DOI 10.1007/s00404-016-4097-7
   Silva LN, 2016, BIOENERG RES, V9, P864, DOI 10.1007/s12155-016-9740-4
   Silva RR, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-107
   Singla R.K., 2012, WEBMED CENT PHARM SC, V3
   Dias FBS, 2011, INFECT GENET EVOL, V11, P869, DOI 10.1016/j.meegid.2011.02.008
   Tauchen J, 2016, REV BRAS FARMACOGN, V26, P728, DOI 10.1016/j.bjp.2016.03.016
   Tolomeo M, 2013, EXP PARASITOL, V133, P37, DOI 10.1016/j.exppara.2012.10.006
   Traesel GK, 2015, GENET MOL RES, V14, P585, DOI 10.4238/2015.January.26.13
   Traesel GK, 2014, FOOD CHEM TOXICOL, V74, P320, DOI 10.1016/j.fct.2014.10.026
   Vaughan J.S, 1960, 4744 NPG, P81
   Yim N, 2010, BIOORG MED CHEM LETT, V20, P1165, DOI 10.1016/j.bmcl.2009.12.020
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 69
TC 5
Z9 5
U1 1
U2 30
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0926-6690
EI 1872-633X
J9 IND CROP PROD
JI Ind. Crop. Prod.
PD DEC 15
PY 2017
VL 109
BP 483
EP 492
DI 10.1016/j.indcrop.2017.08.066
PG 10
WC Agricultural Engineering; Agronomy
SC Agriculture
GA FL0DA
UT WOS:000413880300060
DA 2020-07-08
ER

PT J
AU Faden, RR
   Krubiner, CB
   Lyerly, AD
   Little, MO
   August, A
   Beigi, RH
   Durbin, AP
   Karron, RA
   Kass, NE
   Luna, F
   Palacios, R
   Precioso, AR
   Saenz, C
   Sheffield, JS
   Thome, B
AF Faden, Ruth R.
   Krubiner, Carleigh B.
   Lyerly, Anne D.
   Little, Margaret O.
   August, Allison
   Beigi, Richard H.
   Durbin, Anna P.
   Karron, Ruth A.
   Kass, Nancy E.
   Luna, Florencia
   Palacios, Ricardo
   Precioso, Alexander Roberto
   Saenz, Carla
   Sheffield, Jeanne S.
   Thome, Beatriz
CA Ethics Working Grp ZIKV Res & Pre
TI Ethics, pregnancy, and ZIKV vaccine research & development
SO VACCINE
LA English
DT Editorial Material
C1 [Faden, Ruth R.; Krubiner, Carleigh B.; Kass, Nancy E.] Johns Hopkins Berman Inst Bioeth, Baltimore, MD 21205 USA.
   [Lyerly, Anne D.] Univ N Carolina, Ctr Bioeth, Chapel Hill, NC 27515 USA.
   [Little, Margaret O.] Georgetown Univ, Kennedy Inst Eth, Washington, DC 20057 USA.
   [August, Allison] Valera Tx, Cambridge, MA USA.
   [Beigi, Richard H.] Univ Pittsburgh, Magee Womens Hosp, Med Ctr, Pittsburgh, PA 15260 USA.
   [Durbin, Anna P.; Karron, Ruth A.; Kass, Nancy E.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA.
   [Luna, Florencia] Fac Latinoamer Ciencias Sociales FLACSO, Buenos Aires, DF, Argentina.
   [Palacios, Ricardo; Precioso, Alexander Roberto; Ethics Working Grp ZIKV Res & Pre] Butantan Inst, Stio Paulo, Brazil.
   [Sheffield, Jeanne S.] Pan Amer Hlth Org, Washington, DC USA.
   [Thome, Beatriz] Johns Hopkins Med Dept Gynecol & Obstet, Baltimore, MD USA.
RP Krubiner, CB (corresponding author), Johns Hopkins Berman Inst Bioeth, Baltimore, MD 21205 USA.
EM ckrubiner@jhu.edu
RI Palacios, Ricardo/B-7248-2018; Palacios, Ricardo/AAN-7606-2020; thome,
   beatriz C/B-7337-2018; Precioso, Alexander Roberto/A-9712-2013
OI Palacios, Ricardo/0000-0002-1410-8579; Palacios,
   Ricardo/0000-0002-1410-8579; thome, beatriz C/0000-0002-3941-3756;
   Precioso, Alexander Roberto/0000-0001-8657-9292
FU Wellcome TrustWellcome Trust [203160/Z/16/4]
FX This work was supported by a grant from the Wellcome Trust
   [203160/Z/16/4]. We gratefully acknowledge the support from our research
   staff, especially Elana Jaffe and Marisha Wickremsinhe. We are also
   grateful to the many colleagues and experts who offered their time,
   insights, and feedback on this work.
CR Adam MP, 2011, AM J MED GENET C, V157C, P175, DOI 10.1002/ajmg.c.30313
   Barouch DH, 2017, IMMUNITY, V46, P176, DOI 10.1016/j.immuni.2017.02.005
   Black S, 2009, LANCET, V374, P2115, DOI 10.1016/S0140-6736(09)61877-8
   Faden RR, 2017, PREGNANT WO IN PRESS
   Mastroianni A, 2001, HASTINGS CENT REP, V31, P21, DOI 10.2307/3527551
   Mastroianni AC, 2017, HASTINGS CENT REP, V47, P38, DOI 10.1002/hast.706
   Restrepo-Mendez MC, 2016, B WORLD HEALTH ORGAN, V94, P794, DOI 10.2471/BLT.15.162172
   van der Zande ISE, 2016, RES ETHICS FORUM, V3, P65, DOI 10.1007/978-3-319-26512-4_5
   WHO Global Vaccine Advisory Committee on Vaccine Safety, 2014, SAF IMM PREGN REV EV
   Wilson RJ, 2015, VACCINE, V33, P6420, DOI 10.1016/j.vaccine.2015.08.046
NR 10
TC 2
Z9 2
U1 1
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD DEC 14
PY 2017
VL 35
IS 49
BP 6819
EP 6822
DI 10.1016/j.vaccine.2017.09.065
PN B
PG 4
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA FR3QD
UT WOS:000418980300001
PM 29056425
DA 2020-07-08
ER

PT J
AU Nanni, A
   Meredith, S
   Gati, S
   Holm, K
   Harmon, T
   Ginsberg, A
AF Nanni, Angeline
   Meredith, Stefanie
   Gati, Stephanie
   Holm, Karin
   Harmon, Tom
   Ginsberg, Ann
TI Strengthening global vaccine access for adolescents and adults
SO VACCINE
LA English
DT Review
DE Adolescent and adult immunization; Pediatric immunization; Vaccine;
   Vaccine introduction; Global immunization policies; Research agenda for
   adolescent and adult immunization; Vaccine delivery; TB; HIV; Ebola
   vaccine; Zika; HPV; STIs
ID COUNTRIES
AB Global immunization efforts to date have heavily focused on infants and children, with noted success on public health. Healthy adolescents and adults contribute to the economic growth and development of countries but efforts to ensure vaccine coverage for these groups receive inadequate global attention and resources. Emerging epidemics for a number of infectious diseases including Ebola, Zika, dengue, malaria and the continuing epidemics of tuberculosis and several sexually transmitted infections, including HIV, HPV and Hepatitis B, have high incidence and prevalence in adolescents and adults. New vaccines under development for these diseases and under-used vaccines such as for human papilloma virus will have the greatest health and economic impact in these populations.
   Global consensus, political will, policies, global and country infrastructure, and financing mechanisms are needed to accelerate access for the billions of adolescents and adults living under the threat of devastating infectious disease outbreaks and epidemics, especially in lower income countries. The global health community and countries cannot afford to delay planning for implementation of adolescent and adult vaccine programs that will potentially save millions of lives and strengthen global and national economies. The article examines this next challenge and suggests a research agenda and a framework for action to galvanize global and national policy decision-makers to begin preparations for future immunization challenges. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Nanni, Angeline; Gati, Stephanie; Ginsberg, Ann] Aeras, 1405 Res Blvd, Rockville, MD 20850 USA.
   [Meredith, Stefanie] Global Hlth Consulting, 8 Rue St Jean, CH-1260 Nyon, Switzerland.
   [Harmon, Tom] 410 Madison St NE 2, Minneapolis, MN 55413 USA.
   [Holm, Karin] Council Int Org Med Sci, Case Postale 2100, CH-1211 Geneva, Switzerland.
RP Nanni, A (corresponding author), Aeras, 1405 Res Blvd, Rockville, MD 20850 USA.
EM angeline.nanni@verizon.net; stefanie@globalhealthconsulting.net;
   stephanie.b.gati@gmail.com; holmk@cioms.ch; thomas.harmon@gmail.com;
   aginsberg@aeras.org
RI Holm, Karin R/P-8795-2018
OI Holm, Karin R/0000-0003-4816-4445
FU Aeras
FX We are grateful to colleagues who contributed to discussion at the
   Aeras-sponsored event, Planning for Adult Vaccination in Middle and
   Low-Income Countries, HIV, TB, and Malaria Workshop, September 4-5,
   2013. (Available at
   www.aeras.org/blog/planning-for-adult-vaccination-in-middle-and-low-inco
   me-countries-hiv-tb-an.)
CR Aeras Foundation, 2013, TB VACC RES DEV BUS
   [Anonymous], 2014, B WORLD HEALTH ORGAN, V92, P314, DOI 10.2471/BLT.14.020514
   Brenzel L, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P389
   Brooks A, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-683
   Bruni L, 2016, LANCET GLOB HEALTH, V4, pE453, DOI 10.1016/S2214-109X(16)30099-7
   Castillo-Solorzano C, 2011, J INFECT DIS, V204, pS571, DOI 10.1093/infdis/jir472
   Djingarey MH, 2015, CLIN INFECT DIS, V61, pS434, DOI 10.1093/cid/civ551
   Excler J-L, VACCINE, V33, pd4
   Gavi Alliance, 2016, HPV VACC LESS LEARN
   Gavi the Vaccine Alliance, 2017, HUM PAP VACC SUPP GA
   Ginsburg O, 2016, LANCET GLOB HEALTH, V4, pE428, DOI 10.1016/S2214-109X(16)30107-3
   Gottlieb SL, 2016, VACCINE, V34, P2939, DOI 10.1016/j.vaccine.2016.03.111
   Harmon TM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146387
   Harris RC, 2016, HUM VACCIN IMMUNOTHE
   Hayden EC, 2016, NATURE NEWS
   Hutubessy R, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-136
   Kaufmann SHE, 2017, INT J INFECT DIS, V56, P263, DOI 10.1016/j.ijid.2016.10.018
   Knight GM, 2014, P NATL ACAD SCI USA, V111, P15520, DOI 10.1073/pnas.1404386111
   Piot P, 2014, SCIENCE, V345, P1221, DOI 10.1126/science.1260695
   Tota JE, 2011, PREV MED, V53, pS12, DOI 10.1016/j.ypmed.2011.08.017
   UNAIDS. HIV prevention among adolescent girls and young women, 2016, HIV PREV AD GIRLS YO, P10
   UNICEF, 2014, EXP IMM COV
   United Nations Development Programme, 2017, SOC IMP ASS ZIK VIR
   White R, 2015, IND EFF INF FORC TB
   WHO, 2013, GLOB VACC ACT PLAN 2
   WHO UNICEF World Bank, 2009, STATE WORLD VACCINES
   World Health Organisation, 2014, GLOB IMM DAT
   World Health Organization, 2016, WHO PARTN GLOB LEARN
   World Health Organization, 2000, WOM MENT HLTH EV BAS, P31
   World Health Organization, 2016, WHO REC ROUT IMM SUM
   World Health Organization (WHO), 2016, GUID INTR HPV VACC N
NR 31
TC 2
Z9 3
U1 0
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD DEC 14
PY 2017
VL 35
IS 49
BP 6823
EP 6827
DI 10.1016/j.vaccine.2017.10.023
PN B
PG 5
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA FR3QD
UT WOS:000418980300002
PM 29122384
DA 2020-07-08
ER

PT J
AU Hunt, A
   Banner, N
   Littler, K
AF Hunt, Adrienne
   Banner, Natalie
   Littler, Katherine
TI The global forum on bioethics in research meeting, "ethics of research
   in pregnancy": emerging consensus themes and outputs
SO REPRODUCTIVE HEALTH
LA English
DT Article; Proceedings Paper
CT Global-Forum-on-Bioethics-in-Research (GFBR) Ethics of Research in
   Pregnancy Meeting
CY NOV 03-04, 2016
CL Buenos Aires, ARGENTINA
SP Global Forum Bioeth Res
DE International research ethics; Global forum on bioethics in research;
   Pregnancy
AB Research during pregnancy is affected by multiple ethical challenges which have not received sufficient international attention and consideration from the bioethics, clinical, and policymaking communities working together. Unresolved ethical questions about research in pregnancy have significant detrimental impacts on maternal and newborn health, in part because they inhibit an evidence base being developed on the efficacy and safety of medicines and health interventions for pregnant women. These problems are compounded in low-and middle-income country (LMIC) settings due to variability in regulatory provisions, the burden of maternal morbidity and mortality, and many social and cultural conventions that impact on pregnant women's ability to participate in research. Research in pregnancy was chosen as a topic for the 2016 Global Forum on Bioethics in Research (GFBR) meeting, and its timeliness was all the more apparent given the 2016 Zika outbreak, which has deeply affected the Latin American region. The meeting's emerging consensus themes and outputs epitomized the core aims of the GFBR-to give voice to LMIC perspectives as a priority in dialogue about global health research ethics and to promote collaboration. In this instance, the GFBR meeting catalyzed a strong, unified drive to push researchers and policymakers to include pregnant women in research by default: given the complex nature of the topic, this is a significant achievement in addressing an important question of social justice.
C1 [Hunt, Adrienne; Banner, Natalie; Littler, Katherine] Wellcome Trust Res Labs, Policy Dept, London, England.
RP Hunt, A (corresponding author), Wellcome Trust Res Labs, Policy Dept, London, England.
EM a.hunt@wellcome.ac.uk
FU Wellcome TrustWellcome Trust; Bill & Melinda Gates FoundationGates
   Foundation; UK's MRC; US National Institutes of HealthUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA
FX The GFBR is sponsored by the Wellcome Trust, the Bill & Melinda Gates
   Foundation, the UK's MRC, and the US National Institutes of Health. The
   publication cost of this article was funded by the Wellcome Trust.
CR Angell M, 1997, NEW ENGL J MED, V337, P847, DOI 10.1056/NEJM199709183371209
   Global Forum on Bioethics in Research, 2016, GFBR 2015 M REP EM E
   Global Forum on Bioethics in Research, 2017, GFBR 2016 M REP ETH
   Littler K, 2014, S AFRICAN J BIOETHIC, V7, P5
   Pan American Health Organization, 2016, ZIK ETH CONS ETH GUI
   Saenz C, 2017, REV PANAM SALUD PUBL, V41, pe13
NR 6
TC 1
Z9 1
U1 0
U2 1
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1742-4755
J9 REPROD HEALTH
JI Reprod. Health
PD DEC 14
PY 2017
VL 14
SU 3
AR 158
DI 10.1186/s12978-017-0431-1
PG 4
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FQ0YA
UT WOS:000418082100013
PM 29297364
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Dupont-Rouzeyrol, M
   Diancourt, L
   Calvez, E
   Vandenbogaert, M
   O'Connor, O
   Teissier, A
   Pol, M
   Aubry, M
   Faye, O
   Tou, D
   Cao-Lormeau, VM
   Caro, V
AF Dupont-Rouzeyrol, Myrielle
   Diancourt, Laure
   Calvez, Elodie
   Vandenbogaert, Mathias
   O'Connor, Olivia
   Teissier, Anita
   Pol, Morgane
   Aubry, Maite
   Faye, Oumar
   Tou, Douglas
   Cao-Lormeau, Van-Mai
   Caro, Valerie
TI Zika virus evolution on the edges of the Pacific ocean
SO EMERGING MICROBES & INFECTIONS
LA English
DT Letter
ID INTRODUCTIONS
C1 [Dupont-Rouzeyrol, Myrielle; Calvez, Elodie; O'Connor, Olivia; Pol, Morgane] Inst Pasteur Nouvelle Caledonie, Reseau Int Inst Pasteur, URE Dengue & Arboviroses, F-98845 Noumea, New Caledonia, France.
   [Diancourt, Laure; Vandenbogaert, Mathias; Caro, Valerie] Inst Pasteur, Environm & Infect Risks Unit, Lab Urgent Response Biol Threats, F-75724 Paris, France.
   [Teissier, Anita; Aubry, Maite; Cao-Lormeau, Van-Mai] Inst Louis Malarde, F-98713 Papeete, French Polynesi, France.
   [Faye, Oumar] Inst Pasteur, Dakar 16000, Senegal.
   [Tou, Douglas] Minist Hlth, Rarotonga Hosp Lab, TE MARAE ORA, Rarotonga, Cook Islands.
RP Dupont-Rouzeyrol, M (corresponding author), Inst Pasteur Nouvelle Caledonie, Reseau Int Inst Pasteur, URE Dengue & Arboviroses, F-98845 Noumea, New Caledonia, France.
EM mdupont@pasteur.nc
RI Cao-Lormeau, Van-Mai/H-4879-2018; Faye, Oumar/T-7168-2019
OI Cao-Lormeau, Van-Mai/0000-0001-5606-7480; O'CONNOR,
   Olivia/0000-0002-8108-8408; Vandenbogaert, Mathias/0000-0002-3073-9688;
   Aubry, Maite/0000-0002-9913-5794
FU Action Concertees Inter Pasteuriennes [ACIP A-15-2014]; French
   Government's Investissement d'Avenir Programme (Labex Integrative
   Biology of Emerging Infectious Diseases, IBEID)French National Research
   Agency (ANR) [ANR-10-LABX-62-IBEID]; French Ministry for Foreign and
   International Affairs [063-14_2014, 121-15_2016, 030-16_2016]; European
   Union's Horizon Research and Innovation Programme under ZIKAlliance
   [734548]
FX This work was partially supported by the Action Concertees Inter
   Pasteuriennes (ZikAe project, ACIP A-15-2014), by the French
   Government's Investissement d'Avenir Programme (Labex Integrative
   Biology of Emerging Infectious Diseases, IBEID, grant number
   ANR-10-LABX-62-IBEID), by the French Ministry for Foreign and
   International Affairs (ISID-Pacific program, Pacific Funds, grant no.
   063-14_2014/no. 121-15_2016/no. 030-16_2016) and by the European Union's
   Horizon 2020 Research and Innovation Programme under ZIKAlliance Grant
   Agreement no. 734548. We thank Charlotte Baliere, Meriadeg Le Gouil and
   Etienne Simon-Loriere from Institut Pasteur, Paris, for discussions,
   Mathieu Boimard from Life Technologies sequencing support.
CR A-Nuegoonpipat A, 2004, VIROLOGY, V329, P505, DOI 10.1016/j.virol.2004.08.029
   Aubry M, 2015, EMERG INFECT DIS, V21, P724, DOI 10.3201/eid2104.141741
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1034, DOI 10.3201/eid2006.131413
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Dupont-Rouzeyrol M, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-61
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Li DS, 2010, EMERG INFECT DIS, V16, P123, DOI 10.3201/eid1601.091275
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Pettersson JHO, 2016, MBIO, V7, DOI [10.1128/mBio.01239-16, 10.1128/mbio.01239-16]
   Shi WF, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.68
NR 15
TC 9
Z9 9
U1 0
U2 0
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
EI 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD DEC 13
PY 2017
VL 6
AR e111
DI 10.1038/emi.2017.102
PG 3
WC Immunology; Microbiology
SC Immunology; Microbiology
GA FQ6CZ
UT WOS:000418452600001
PM 29235552
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Abbink, P
   Larocca, RA
   Visitsunthorn, K
   Boyd, M
   De la Barrera, RA
   Gromowski, GD
   Kirilova, M
   Peterson, R
   Li, ZF
   Nanayakkara, O
   Nityanandam, R
   Mercado, NB
   Borducchi, EN
   Chandrashekar, A
   Jetton, D
   Mojta, S
   Gandhi, P
   LeSuer, J
   Khatiwada, S
   Lewis, MG
   Modjarrad, K
   Jarman, RG
   Eckels, KH
   Thomas, SJ
   Michael, NL
   Barouch, DH
AF Abbink, Peter
   Larocca, Rafael A.
   Visitsunthorn, Kittipos
   Boyd, Michael
   De la Barrera, Rafael A.
   Gromowski, Gregory D.
   Kirilova, Marinela
   Peterson, Rebecca
   Li, Zhenfeng
   Nanayakkara, Ovini
   Nityanandam, Ramya
   Mercado, Noe B.
   Borducchi, Erica N.
   Chandrashekar, Abishek
   Jetton, David
   Mojta, Shanell
   Gandhi, Priya
   LeSuer, Jake
   Khatiwada, Shreeya
   Lewis, Mark G.
   Modjarrad, Kayvon
   Jarman, Richard G.
   Eckels, Kenneth H.
   Thomas, Stephen J.
   Michael, Nelson L.
   Barouch, Dan H.
TI Durability and correlates of vaccine protection against Zika virus in
   rhesus monkeys
SO SCIENCE TRANSLATIONAL MEDICINE
LA English
DT Article
ID CROSS-REACTIVITY; DENGUE VIRUS; INFECTION; CHALLENGE; IMMUNITY;
   PATHOGENESIS; ENHANCEMENT; EFFICACY; MACAQUES; MODEL
AB An effective Zika virus (ZIKV) vaccine will require long-term durable protection. Several ZIKV vaccine candidates have demonstrated protective efficacy in nonhuman primates, but these studies have typically involved ZIKV challenge shortly after vaccination at peak immunity. We show that a single immunization with an adenovirus vector-based vaccine, as well as two immunizations with a purified inactivated virus vaccine, afforded robust protection against ZIKV challenge in rhesus monkeys at 1 year after vaccination. In contrast, two immunizations with an optimized DNA vaccine, which provided complete protection at peak immunity, resulted in reduced protective efficacy at 1 year that was associated with declining neutralizing antibody titers to subprotective levels. These data define a microneutralization log titer of 2.0 to 2.1 as the threshold required for durable protection against ZIKV challenge in this model. Moreover, our findings demonstrate that protection against ZIKV challenge in rhesus monkeys is possible for at least 1 year with a single-shot vaccine.
C1 [Abbink, Peter; Larocca, Rafael A.; Visitsunthorn, Kittipos; Boyd, Michael; Kirilova, Marinela; Peterson, Rebecca; Li, Zhenfeng; Nanayakkara, Ovini; Nityanandam, Ramya; Mercado, Noe B.; Borducchi, Erica N.; Chandrashekar, Abishek; Jetton, David; Mojta, Shanell; Gandhi, Priya; LeSuer, Jake; Khatiwada, Shreeya; Barouch, Dan H.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA.
   [De la Barrera, Rafael A.; Gromowski, Gregory D.; Modjarrad, Kayvon; Jarman, Richard G.; Eckels, Kenneth H.; Thomas, Stephen J.; Michael, Nelson L.] Walter Reed Army Inst Res, Silver Spring, MD 20910 USA.
   [Lewis, Mark G.] Bioqual Inc, Rockville, MD 20852 USA.
   [Barouch, Dan H.] MIT, Ragon Inst Massachusetts Gen Hosp, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
   [Barouch, Dan H.] Harvard, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
RP Barouch, DH (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA.; Barouch, DH (corresponding author), MIT, Ragon Inst Massachusetts Gen Hosp, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Barouch, DH (corresponding author), Harvard, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
EM dbarouch@bidmc.harvard.edu
RI Chandrashekar, Abishek/P-2610-2019; Visitsunthorn, Kittipos/N-1062-2018;
   Barouch, Dan/Y-3918-2019
OI Chandrashekar, Abishek/0000-0001-7821-5552; Visitsunthorn,
   Kittipos/0000-0002-1811-9267; LeSuer, Jake/0000-0001-7669-1619; Jetton,
   David/0000-0002-1615-9986; Abbink, Peter/0000-0003-1978-088X
FU U.S. Military Research and Materiel Command; U.S. Military HIV Research
   Program; Henry M. Jackson Foundation [W81XWH-11-2-0174]; NIHUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA [AI095985, AI096040, AI124377]; Ragon Institute of
   Massachusetts General Hospital, Massachusetts Institute of Technology,
   and Harvard
FX We acknowledge support from the U.S. Military Research and Materiel
   Command and the U.S. Military HIV Research Program through its
   cooperative agreement with the Henry M. Jackson Foundation
   (W81XWH-11-2-0174); the NIH (AI095985, AI096040, and AI124377); and the
   Ragon Institute of Massachusetts General Hospital, Massachusetts
   Institute of Technology, and Harvard. The views expressed in this
   manuscript are those of the authors and do not represent the official
   views of the Department of the Army or the Department of Defense.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Barouch DH, 2017, IMMUNITY, V46, P176, DOI 10.1016/j.immuni.2017.02.005
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Durbin A, 2017, EXPERT REV VACCINES, V16, P781, DOI 10.1080/14760584.2017.1345309
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fernandez E, 2017, CURR OPIN VIROL, V23, P59, DOI 10.1016/j.coviro.2017.03.006
   Griffin BD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15743
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Hombach J, 2005, VACCINE, V23, P5205, DOI [10.1016/j.vaccine.2005.07.002, 10.1016/j.vaccine.2004.11.040]
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kim E, 2016, EBIOMEDICINE, V13, P315, DOI 10.1016/j.ebiom.2016.09.028
   Kreil TR, 1997, CLIN EXP IMMUNOL, V110, P358, DOI 10.1046/j.1365-2249.1997.4311446.x
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   MASON RA, 1973, APPL MICROBIOL, V25, P539, DOI 10.1128/AEM.25.4.539-544.1973
   McCracken MK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006487
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Sumathy K, 2017, SCI REP-UK, V7, DOI 10.1038/srep46375
NR 32
TC 41
Z9 42
U1 0
U2 8
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 1946-6234
EI 1946-6242
J9 SCI TRANSL MED
JI Sci. Transl. Med.
PD DEC 13
PY 2017
VL 9
IS 420
AR eaao4163
DI 10.1126/scitranslmed.aao4163
PG 7
WC Cell Biology; Medicine, Research & Experimental
SC Cell Biology; Research & Experimental Medicine
GA FP8PQ
UT WOS:000417908400005
PM 29237759
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Wilder-Smith, A
   Preet, R
   Renhorn, KE
   Ximenes, RA
   Rodrigues, LC
   Solomon, T
   Neyts, J
   Lambrechts, L
   Willison, HJ
   Peeling, R
   Falconar, AK
   Precioso, AR
   Logan, J
   Lang, T
   Endtz, HP
   Massad, E
AF Wilder-Smith, A.
   Preet, R.
   Renhorn, K. E.
   Ximenes, R. A.
   Rodrigues, L. C.
   Solomon, T.
   Neyts, J.
   Lambrechts, L.
   Willison, H. J.
   Peeling, R.
   Falconar, A. K.
   Precioso, A. R.
   Logan, J.
   Lang, T.
   Endtz, H. P.
   Massad, E.
TI ZikaPLAN: Zika Preparedness Latin American Network
SO GLOBAL HEALTH ACTION
LA English
DT Article
DE Zika; congenital Zika syndrome; public health emergency; epidemic
   preparedness; research capacity building network; collaboration;
   European Commission
ID GUILLAIN-BARRE-SYNDROME; VIRUS-INFECTION; DENGUE VIRUS; INFANTS; BRAZIL;
   RISK; IMPORTATIONS; OUTBREAK
AB The ongoing Zika virus (ZIKV) outbreak in Latin America, the Caribbean, and the Pacific Islands has underlined the need for a coordinated research network across the whole region that can respond rapidly to address the current knowledge gaps in Zika and enhance research preparedness beyond Zika. The European Union under its Horizon 2020 Research and Innovation Programme awarded three research consortia to respond to this need. Here we present the ZikaPLAN (Zika Preparedness Latin American Network) consortium. ZikaPLAN combines the strengths of 25 partners in Latin America, North America, Africa, Asia, and various centers in Europe. We will conduct clinical studies to estimate the risk and further define the full spectrum and risk factors of congenital Zika virus syndrome (including neurodevelopmental milestones in the first 3 years of life), delineate neurological complications associated with ZIKV due to direct neuroinvasion and immune-mediated responses in older children and adults, and strengthen surveillance for birth defects and Guillain-Barre Syndrome. Laboratory-based research to unravel neurotropism and investigate the role of sexual transmission, determinants of severe disease, and viral fitness will underpin the clinical studies. Social messaging and engagement with affected communities, as well as development of wearable repellent technologies against Aedes mosquitoes will enhance the impact. Burden of disease studies, data-driven vector control, and vaccine modeling as well as risk assessments on geographic spread of ZIKV will form the foundation for evidence-informed policies. While addressing the research gaps around ZIKV, we will engage in capacity building in laboratory and clinical research, collaborate with existing and new networks to share knowledge, and work with international organizations to tackle regulatory and other bottlenecks and refine research priorities. In this way, we can leverage the ZIKV response toward building a long-term emerging infectious diseases response capacity in the region to address future challenges.
C1 [Wilder-Smith, A.; Preet, R.; Renhorn, K. E.] Umea Univ, Dept Publ Hlth & Clin Med, Unit Epidemiol & Global Hlth, Umea, Sweden.
   [Ximenes, R. A.; Rodrigues, L. C.] Univ Pernambuco, Inst Apoio Fundacao, Recife, PE, Brazil.
   [Rodrigues, L. C.; Peeling, R.; Falconar, A. K.; Logan, J.] London Sch Hyg & Trop Med, London, England.
   [Solomon, T.] Univ Liverpool, Inst Infect & Global Hlth, Liverpool, Merseyside, England.
   [Neyts, J.] Katholieke Univ Leuven, Rega Inst Med Res, Dept Microbiol & Immunol, Leuven, Belgium.
   [Lambrechts, L.] Inst Pasteur, CNRS, Insect Virus Interact Grp, Dept Genomes & Genet,Unite Rech Associee 3012, Paris 15, France.
   [Willison, H. J.] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland.
   [Falconar, A. K.] Fdn Univ Norte, Dept Med, Barranquilla, Colombia.
   [Precioso, A. R.] Inst Butantan, Sao Paulo, SP, Brazil.
   [Logan, J.] Univ Oxford, Global Hlth Network, Oxford, England.
   [Endtz, H. P.] Fdn Merieux, Lyon, France.
   [Endtz, H. P.] Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands.
   [Massad, E.] Univ Sao Paulo, Fundacao Apoio, Sao Paulo, Brazil.
RP Wilder-Smith, A (corresponding author), Umea Univ, Dept Publ Hlth & Clin Med, Unit Epidemiol & Global Hlth, Umea, Sweden.
EM awilder-smith@ntu.edu.sg
RI Precioso, Alexander Roberto/A-9712-2013; Massad, Eduardo/B-1169-2012;
   Neyts, Johan/U-8267-2017; Lambrechts, Louis/A-2057-2010
OI Precioso, Alexander Roberto/0000-0001-8657-9292; Massad,
   Eduardo/0000-0002-7200-2916; Neyts, Johan/0000-0002-0033-7514; Willison,
   Hugh/0000-0002-5997-1683; Preet, Raman Kaur/0000-0002-4371-5941;
   Renhorn, Karl-Erik/0000-0003-1855-8902; Lambrechts,
   Louis/0000-0001-5958-2138; Solomon, Tom/0000-0001-7266-6547
FU European Union's Horizon research and innovation programme [734584]
FX The project, ZikaPLAN, is funded by European Union's Horizon 2020
   research and innovation programme under Grant Agreement No. 734584.
CR Azevedo RSS, 2016, J CLIN VIROL, V85, P56, DOI 10.1016/j.jcv.2016.10.024
   Brunoni D, 2016, CIENC SAUDE COLETIVA, V21, P3296, DOI 10.1590/1413-812320152110.16832016
   Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990
   Vieira MADES, 2017, REV INST MED TROP SP, V59, DOI [10.1590/s1678-9946201759022, 10.1590/S1678-9946201759022]
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   de Magalhaes-Barbosa MC, 2017, TRAVEL MED INFECT DI, V16, P52, DOI 10.1016/j.tmaid.2017.03.009
   de Magalhaes-Barbosa MC, 2016, TRAVEL MED INFECT DI, V14, P458, DOI 10.1016/j.tmaid.2016.09.006
   de Sa TH, 2016, LANCET GLOB HEALTH, V4, pE603, DOI 10.1016/S2214-109X(16)30174-7
   do Rosario MS, 2016, AM J TROP MED HYG, V95, P1157, DOI 10.4269/ajtmh.16-0306
   Furtado T, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003225
   Lang T, 2015, NATURE, V524, P29, DOI 10.1038/524029a
   Leal MC, 2017, EMERG INFECT DIS, V23, P1253, DOI 10.3201/eid2308.170354
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Liu-Helmersson J, 2016, EBIOMEDICINE, V7, P267, DOI 10.1016/j.ebiom.2016.03.046
   Liu-Helmersson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089783
   Lopez LF, 2016, B MATH BIOL, V78, P185, DOI 10.1007/s11538-015-0135-z
   Massad E, 2017, EPIDEMIOL INFECT, V145, P2303, DOI 10.1017/S0950268817001200
   Massad E, 2013, EPIDEMIOL INFECT, V141, P412, DOI 10.1017/S0950268812000507
   Massad E, 2016, LANCET, V388, P658, DOI 10.1016/S0140-6736(16)31228-4
   Massad E, 2016, LANCET, V388, P25, DOI 10.1016/S0140-6736(16)30842-X
   Massad E, 2016, GLOBAL HEALTH ACTION, V9, P1, DOI 10.3402/gha.v9.31669
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Munoz LS, 2016, SEMIN REPROD MED, V34, P273, DOI 10.1055/s-0036-1592066
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Quam MB, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw059
   Quam MB, 2015, J TRAVEL MED, V22, P186, DOI 10.1111/jtm.12192
   Rocklov J, 2016, EBIOMEDICINE, V9, P250, DOI 10.1016/j.ebiom.2016.06.009
   Souza AD, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00064615
   Wilder-Smith A, 2012, GLOB HLTH ACTION, V5
   Wilder-Smith A, 2017, LANCET INFECT DIS, V17, P1109, DOI 10.1016/S1473-3099(17)30494-2
   Yakob L, 2016, LANCET INFECT DIS, V16, P1100, DOI 10.1016/S1473-3099(16)30324-3
NR 32
TC 12
Z9 12
U1 0
U2 11
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
EI 1654-9880
J9 GLOBAL HEALTH ACTION
JI Glob. Health Action
PD DEC 13
PY 2017
VL 10
IS 1
AR 1398485
DI 10.1080/16549716.2017.1398485
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FS3BL
UT WOS:000419653800001
PM 29235414
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Dudley, DM
   Newman, CM
   Lalli, J
   Stewart, LM
   Koenig, MR
   Weiler, AM
   Semler, MR
   Barry, GL
   Zarbock, KR
   Mohns, MS
   Breitbach, ME
   Schultz-Darken, N
   Peterson, E
   Newton, W
   Mohr, EL
   Capuano, S
   Osorio, JE
   O'Connor, SL
   O'Connor, DH
   Friedrich, TC
   Aliota, MT
AF Dudley, Dawn M.
   Newman, Christina M.
   Lalli, Joseph
   Stewart, Laurel M.
   Koenig, Michelle R.
   Weiler, Andrea M.
   Semler, Matthew R.
   Barry, Gabrielle L.
   Zarbock, Katie R.
   Mohns, Mariel S.
   Breitbach, Meghan E.
   Schultz-Darken, Nancy
   Peterson, Eric
   Newton, Wendy
   Mohr, Emma L.
   Capuano, Saverio, III
   Osorio, Jorge E.
   O'Connor, Shelby L.
   O'Connor, David H.
   Friedrich, Thomas C.
   Aliota, Matthew T.
TI Infection via mosquito bite alters Zika virus tissue tropism and
   replication kinetics in rhesus macaques
SO NATURE COMMUNICATIONS
LA English
DT Article
ID GUILLAIN-BARRE-SYNDROME; AEDES-AEGYPTI; DENGUE VIRUS; ARBOVIRUS
   INFECTION; TRANSMISSION; VECTOR; HOST; STRAIN; SALIVA; BLOOD
AB Mouse and nonhuman primate models now serve as useful platforms to study Zika virus (ZIKV) pathogenesis, candidate therapies, and vaccines, but they rely on needle inoculation of virus: the effects of mosquito-borne infection on disease outcome have not been explored in these models. Here we show that infection via mosquito bite delays ZIKV replication to peak viral loads in rhesus macaques. Importantly, in mosquito-infected animals ZIKV tissue distribution was limited to hemolymphatic tissues, female reproductive tract tissues, kidney, and liver, potentially emulating key features of human ZIKV infections, most of which are characterized by mild or asymptomatic disease. Furthermore, deep sequencing analysis reveals that ZIKV populations in mosquito-infected monkeys show greater sequence heterogeneity and lower overall diversity than in needle-inoculated animals. This newly developed system will be valuable for studying ZIKV disease because it more closely mimics human infection by mosquito bite than needle-based inoculations.
C1 [Dudley, Dawn M.; Newman, Christina M.; Stewart, Laurel M.; Koenig, Michelle R.; Semler, Matthew R.; Zarbock, Katie R.; Mohns, Mariel S.; Breitbach, Meghan E.; O'Connor, Shelby L.; O'Connor, David H.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Pathol & Lab Med, 3170 UW Med Fdn Centennial Bldg,1685 Highland Ave, Madison, WI 53705 USA.
   [Lalli, Joseph; Osorio, Jorge E.; Friedrich, Thomas C.; Aliota, Matthew T.] Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, 1656 Linden Dr, Madison, WI 53706 USA.
   [Weiler, Andrea M.; Barry, Gabrielle L.; Schultz-Darken, Nancy; Peterson, Eric; Newton, Wendy; Capuano, Saverio, III; O'Connor, Shelby L.; O'Connor, David H.; Friedrich, Thomas C.] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, 1220 Capitol Ct, Madison, WI 53715 USA.
   [Mohr, Emma L.] Univ Wisconsin, Dept Pediat, Ctr Clin Sci, 600 Highland Ave, Madison, WI 53792 USA.
RP Aliota, MT (corresponding author), Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, 1656 Linden Dr, Madison, WI 53706 USA.
EM mtaliota@wisc.edu
OI Aliota, Matthew/0000-0002-6902-9149
FU Research Facilities Improvement ProgramUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Center for Research Resources (NCRR) [RR15459-01, RR020141-01];
    [DHHS/PHS/NIH R21AI131454];  [DHHS/PHS/NIH R01AI116382];  [P51OD011106]
FX The authors acknowledge Jens Kuhn and Jiro Wada for preparing
   silhouettes of macaques used in figures. We thank the Veterinary, Animal
   Care, Scientific Protocol Implementation, and the Pathology staff at the
   Wisconsin National Primate Research Center (WNPRC) for their
   contribution to this study. We also thank Emma Walker for assistance
   with the mouse experiments. Funding for this project came from
   DHHS/PHS/NIH R21AI131454 to M.T.A. and DHHS/PHS/NIH R01AI116382 to
   D.H.O. and from P51OD011106 awarded to the WNPRC, Madison, WI. This
   research was conducted in part at a facility that constructed with
   support from Research Facilities Improvement Program Grants RR15459-01
   and RR020141-01. The publication's contents are solely the
   responsibility of the authors and do not necessarily represent the
   official views of the NCRR or NIH.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005168
   Aliota MT, 2016, EMERG INFECT DIS, V22, P1857, DOI 10.3201/eid2210.161082
   Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004677
   Althouse BM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005055
   Araujo AQC, 2016, BRAIN, V139, P2122, DOI 10.1093/brain/aww158
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   CHRISTENSEN BM, 1984, T AM MICROSC SOC, V103, P423, DOI 10.2307/3226478
   Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695
   Ciota AT, 2017, EMERG INFECT DIS, V23, P1110, DOI 10.3201/eid2307.161633
   Coffey LL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171148
   Conway MJ, 2014, J VIROL, V88, P164, DOI 10.1128/JVI.02235-13
   Cox J, 2012, J VIROL, V86, P7637, DOI 10.1128/JVI.00534-12
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Dzul-Manzanilla F, 2016, T ROY SOC TROP MED H, V110, P141, DOI 10.1093/trstmh/trv106
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fontaine A, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-187
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Grubaugh ND, 2016, CELL HOST MICROBE, V19, P481, DOI 10.1016/j.chom.2016.03.002
   GUBLER DJ, 1976, AM J TROP MED HYG, V25, P146, DOI 10.4269/ajtmh.1976.25.146
   Halai UA, 2017, CLIN INFECT DIS, V65, P877, DOI 10.1093/cid/cix472
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Kofler R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015925
   Koide F, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02028
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Leitner WW, 2012, EUR J IMMUNOL, V42, P3110, DOI 10.1002/eji.201270102
   Leitner WW, 2011, EUR J IMMUNOL, V41, P3396, DOI 10.1002/eji.201190075
   Lequime S, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006111
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   MILLER BR, 1989, TROP MED PARASITOL, V40, P396
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Musso D, 2017, J MED VIROL, V89, P1505, DOI 10.1002/jmv.24735
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Osorio JE, 1996, AM J TROP MED HYG, V54, P338, DOI 10.4269/ajtmh.1996.54.338
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Peters NC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000484
   Pingen M, 2017, TRENDS PARASITOL, V33, P645, DOI 10.1016/j.pt.2017.04.003
   Pingen M, 2016, IMMUNITY, V44, P1455, DOI 10.1016/j.immuni.2016.06.002
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   R Development Core Team, 2016, R LANG ENV STAT COMP
   RIBEIRO JMC, 1987, ANNU REV ENTOMOL, V32, P463, DOI 10.1146/annurev.en.32.010187.002335
   Rogers ME, 2004, NATURE, V430, P463, DOI 10.1038/nature02675
   Satya RV, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1073
   Schmid MA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005676
   Schneider BS, 2008, T ROY SOC TROP MED H, V102, P400, DOI 10.1016/j.trstmh.2008.01.024
   Schneider BS, 2006, VIRAL IMMUNOL, V19, P74, DOI 10.1089/vim.2006.19.74
   Sheehy SH, 2012, MOL THER, V20, P2355, DOI 10.1038/mt.2012.223
   Smith DR, 2006, EMERG INFECT DIS, V12, P1190, DOI 10.3201/eid1708.050841
   Styer LM, 2007, PLOS PATHOG, V3, P1262, DOI 10.1371/journal.ppat.0030132
   Styer LM, 2011, J VIROL, V85, P1517, DOI 10.1128/JVI.01112-10
   Thangamani S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012137
   Vanderberg J, 2007, AM J PATHOL, V171, P1405, DOI 10.2353/ajpath.2007.070661
   Villamil-Gomez WE, 2017, TRAVEL MED INFECT DI, V16, P62, DOI 10.1016/j.tmaid.2017.03.012
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
NR 59
TC 34
Z9 34
U1 0
U2 8
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD DEC 13
PY 2017
VL 8
AR 2096
DI 10.1038/s41467-017-02222-8
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FP8HV
UT WOS:000417884500002
PM 29235456
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Puschnik, AS
   Marceau, CD
   Ooi, YS
   Majzoub, K
   Rinis, N
   Contessa, JN
   Carette, JE
AF Puschnik, Andreas S.
   Marceau, Caleb D.
   Ooi, Yaw Shin
   Majzoub, Karim
   Rinis, Natalie
   Contessa, Joseph N.
   Carette, Jan E.
TI A Small-Molecule Oligosaccharyltransferase Inhibitor with Pan-flaviviral
   Activity
SO CELL REPORTS
LA English
DT Article
ID ZIKA VIRUS-INFECTION; N-GLYCOSYLATION; OXIDOREDUCTASE ACTIVITY; SCREEN;
   IDENTIFICATION; DEFINES
AB The mosquito-borne flaviviruses include important human pathogens such as dengue, Zika, West Nile, and yellow fever viruses, which pose a serious threat for global health. Recent genetic screens identified endoplasmic reticulum (ER)-membrane multiprotein complexes, including the oligosaccharyltransferase (OST) complex, as critical flavivirus host factors. Here, we show that a chemical modulator of the OST complex termed NGI-1 has promising antiviral activity against flavivirus infections. We demonstrate that NGI-1 blocks viral RNA replication and that antiviral activity does not depend on inhibition of the N-glycosylation function of the OST. Viral mutants adapted to replicate in cells deficient of the OST complex showed resistance to NGI-1 treatment, reinforcing the on-target activity of NGI-1. Lastly, we show that NGI-1 also has strong antiviral activity in primary and disease-relevant cell types. This study provides an example for advancing from the identification of genetic determinants of infection to a host-directed antiviral compound with broad activity against flaviviruses.
C1 [Puschnik, Andreas S.; Marceau, Caleb D.; Ooi, Yaw Shin; Majzoub, Karim; Carette, Jan E.] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA.
   [Rinis, Natalie; Contessa, Joseph N.] Yale Sch Med, Dept Therapeut Radiol, New Haven, CT 06511 USA.
   [Contessa, Joseph N.] Yale Sch Med, Dept Pharmacol, New Haven, CT 06511 USA.
RP Carette, JE (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA.
EM carette@stanford.edu
OI Ooi, Yaw Shin/0000-0001-9014-1365; Carette, Jan/0000-0002-5187-8070;
   Majzoub, Karim/0000-0001-7345-6840
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [DP2 AI104557, U19 AI109662,
   RO1CA172391]; David and Lucile Packard FoundationThe David & Lucile
   Packard Foundation; Stanford graduate fellowshipStanford University;
   Boehringer Ingelheim FondsBoehringer Ingelheim; NSF-GFRP
FX The work was funded in part by the NIH (grants DP2 AI104557 and U19
   AI109662 to J.E.C. and RO1CA172391 to J.N.C.), the David and Lucile
   Packard Foundation (J.E.C.), a Stanford graduate fellowship (A.S.P.),
   Boehringer Ingelheim Fonds (A.S.P.), and the NSF-GFRP (C.D.M.).
CR Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Chen YL, 2015, ANTIVIR RES, V122, P12, DOI 10.1016/j.antiviral.2015.07.010
   Cherepanova NA, 2014, J CELL BIOL, V206, P525, DOI 10.1083/jcb.201404083
   Estoppey D, 2017, CELL REP, V19, P451, DOI 10.1016/j.celrep.2017.03.071
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   HEIFETZ A, 1979, BIOCHEMISTRY-US, V18, P2186, DOI 10.1021/bi00578a008
   Kaufmann S.H.E, 2017, NAT REV DRUG DISCOV
   Lin DL, 2017, MBIO, V8, DOI [10.1128/mBio.00939-17, 10.1128/mbio.00939-17]
   Lopez-Sambrooks C, 2016, NAT CHEM BIOL, V12, P1023, DOI 10.1038/nchembio.2194
   Ma HM, 2015, CELL REP, V12, P673, DOI 10.1016/j.celrep.2015.06.049
   Marceau CD, 2016, NATURE, V535, P159, DOI 10.1038/nature18631
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   OhAinle M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003084
   Puschnik AS, 2017, NAT REV MICROBIOL, V15, P351, DOI 10.1038/nrmicro.2017.29
   Rausch K, 2017, CELL REP, V18, P804, DOI 10.1016/j.celrep.2016.12.068
   Ruiz-Canada C, 2009, CELL, V136, P272, DOI 10.1016/j.cell.2008.11.047
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Schulz BL, 2009, P NATL ACAD SCI USA, V106, P11061, DOI 10.1073/pnas.0812515106
   Sevier CS, 2002, NAT REV MOL CELL BIO, V3, P836, DOI 10.1038/nrm954
   Shrimal S, 2015, SEMIN CELL DEV BIOL, V41, P71, DOI 10.1016/j.semcdb.2014.11.005
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Wu SJL, 2000, NAT MED, V6, P816, DOI 10.1038/77553
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625
NR 25
TC 27
Z9 27
U1 1
U2 5
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 2211-1247
J9 CELL REP
JI Cell Reports
PD DEC 12
PY 2017
VL 21
IS 11
BP 3032
EP 3039
DI 10.1016/j.celrep.2017.11.054
PG 8
WC Cell Biology
SC Cell Biology
GA FP7VY
UT WOS:000417849000004
PM 29241533
OA DOAJ Gold, Green Accepted
DA 2020-07-08
ER

PT J
AU Blackman, MA
   Kim, IJ
   Lin, JS
   Thomas, SJ
AF Blackman, Marcia A.
   Kim, In-Jeong
   Lin, Jr-Shiuan
   Thomas, Stephen J.
TI Challenges of Vaccine Development for Zika Virus
SO VIRAL IMMUNOLOGY
LA English
DT Review
DE Zika virus; vaccine; mosquito-borne
ID ANTIBODY-DEPENDENT ENHANCEMENT; DENGUE VIRUS; NEUTRALIZING ANTIBODIES;
   CROSS-REACTIVITY; STRUCTURAL BASIS; INFECTION; RHESUS; PROTECTION;
   DISEASE; IMMUNOPATHOLOGY
AB The emergence of outbreaks of Zika virus (ZIKV) in Brazil in 2015 was associated with devastating effects on fetal development and prompted a world health emergency and multiple efforts to generate an effective vaccine against infection. There are now more than 40 vaccine candidates in preclinical development and six in clinical trials. Despite similarities with other flaviviruses to which successful vaccines have been developed, such as yellow fever virus and Japanese Encephalitis virus, there are unique challenges to the development and clinical trials of a vaccine for ZIKV.
C1 [Blackman, Marcia A.; Kim, In-Jeong; Lin, Jr-Shiuan] Trudeau Inst, 154 Algonquin Ave, Saranac Lake, NY 12983 USA.
   [Thomas, Stephen J.] SUNY Upstate Med Univ, Div Infect Dis, Syracuse, NY 13210 USA.
RP Blackman, MA (corresponding author), Trudeau Inst, 154 Algonquin Ave, Saranac Lake, NY 12983 USA.
EM mblackman@trudeauinstitute.org
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   [Anonymous], 2017, WHO SITUATION REPORT
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Barouch DH, 2017, IMMUNITY, V46, P176, DOI 10.1016/j.immuni.2017.02.005
   Barzon L, 2017, EXPERT OPIN BIOL TH, V17, P1185, DOI 10.1080/14712598.2017.1346081
   Betancourt D, 2017, J IMMUNOL, V198, P3023, DOI 10.4049/jimmunol.1602180
   Boigard H, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005608
   BURKE DS, 1988, AM J TROP MED HYG, V38, P172, DOI 10.4269/ajtmh.1988.38.172
   Campos JLS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181734
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Castanha PMS, 2017, J INFECT DIS, V215, P781, DOI 10.1093/infdis/jiw638
   Chamberlain AT, 2017, SCIENCE, V358, P452, DOI 10.1126/science.aao4219
   Charles Anu Susan, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.4ab8bc87c945eb41cd8a49e127082620
   Cohen J, 2017, SCIENCE, V357, P631, DOI 10.1126/science.357.6352.631
   Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990
   Cui LY, 2017, EBIOMEDICINE, V20, P193, DOI 10.1016/j.ebiom.2017.04.029
   Culshaw A, 2017, CURR OPIN IMMUNOL, V48, P1, DOI 10.1016/j.coi.2017.07.001
   De Carvalho NS, 2016, BRAZ J INFECT DIS, V20, P282, DOI 10.1016/j.bjid.2016.02.006
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Durbin AP, 2016, SEMIN REPROD MED, V34, P299, DOI 10.1055/s-0036-1592070
   Faden R, 2017, VACCINE, DOI [10.1016/j.vaccine.2017.09.065, DOI 10.1016/J.VACCINE.2017.09.065]
   Fan YC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004167
   Fernandez E, 2017, NAT IMMUNOL, V18, P1261, DOI 10.1038/ni.3849
   Firbas C, 2015, HUM VACC IMMUNOTHER, V11, P411, DOI 10.4161/21645515.2014.983412
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gibbons RV, 2007, AM J TROP MED HYG, V77, P910, DOI 10.4269/ajtmh.2007.77.910
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Griffin BD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15743
   Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4
   HALSTEAD SB, 1979, J INFECT DIS, V140, P527, DOI 10.1093/infdis/140.4.527
   HALSTEAD SB, 1977, J EXP MED, V146, P201, DOI 10.1084/jem.146.1.201
   Halstead SB, 2017, LANCET INFECT DIS, V17, pE378, DOI 10.1016/S1473-3099(17)30362-6
   Halstead SB, 2017, EMERG INFECT DIS, V23, P569, DOI 10.3201/eid2304.161879
   Halstead SB, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.AID-0022-2014
   HEINZ FX, 1984, J GEN VIROL, V65, P1921, DOI 10.1099/0022-1317-65-11-1921
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Huang HR, 2017, J VIROL, V91, DOI [10.1128/JVI.00900-17, 10.1128/jvi.00900-17]
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kam YW, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92428
   Kawiecki AB, 2016, J INFECT DIS, V214, P1357, DOI 10.1093/infdis/jiw377
   KLIKS SC, 1989, AM J TROP MED HYG, V40, P444, DOI 10.4269/ajtmh.1989.40.444
   Lagunas-Rangel FA, 2017, J VIRUS ERAD, V3, P124
   Laoprasopwattana K, 2005, J INFECT DIS, V192, P510, DOI 10.1086/431520
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lehrer Axel T, 2011, J Bioterror Biodef, V2011, P3
   Lima NS, 2017, TRENDS IMMUNOL, V38, P594, DOI 10.1016/j.it.2017.05.004
   Lindenbach Brett D., 2007, FIELDS VIROLOGY, P1101
   Londono-Renteria B, 2017, J GEN VIROL, V98, P1702, DOI 10.1099/jgv.0.000833
   Mahalingam S, 2017, LANCET INFECT DIS, V17, P686, DOI 10.1016/S1473-3099(17)30340-7
   Marston HD, 2016, NEW ENGL J MED, V375, P1209, DOI 10.1056/NEJMp1607762
   McArthur MA, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9060143
   McArthur Monica A, 2011, J Bioterror Biodef, VS1, P2
   McCracken MK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006487
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Moi ML, 2010, J VIROL METHODS, V163, P205, DOI 10.1016/j.jviromet.2009.09.018
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Morrison C, 2016, NAT REV DRUG DISCOV, V15, P521, DOI 10.1038/nrd.2016.159
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Pan American Health Organization WHO, 2017, ZIK EP UPD
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Pardy RD, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006184
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   Pierson TC, 2012, CURR OPIN VIROL, V2, P168, DOI 10.1016/j.coviro.2012.02.011
   Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   RUSSELL PK, 1967, JPN J MED SCI BIOL, VS 20, P103
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Screaton G, 2015, NAT REV IMMUNOL, V15, P745, DOI 10.1038/nri3916
   Shah SK, 2017, ETHICAL CONSIDERATIO
   Solomon IH, 2016, J NEUROINFECT DIS, V7, P220
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Thomas SJ, 2017, NEW ENGL J MED, V376, P1883, DOI 10.1056/NEJMcibr1701402
   Thomas SJ, 2016, NEW ENGL J MED, V375, P1212, DOI 10.1056/NEJMp1609300
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Wang JQ, 2017, CELL, V171, P229, DOI 10.1016/j.cell.2017.09.002
   Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36
   Wilson RJ, 2015, VACCINE, V33, P6420, DOI 10.1016/j.vaccine.2015.08.046
   Winkler CW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07099-7
   Yang M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08247-9
   Yu L, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93042
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
   Zou J, 2017, EBIOMEDICINE, V20, P11, DOI 10.1016/j.ebiom.2017.05.005
NR 101
TC 5
Z9 5
U1 2
U2 2
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 0882-8245
EI 1557-8976
J9 VIRAL IMMUNOL
JI Viral Immunol.
PD MAR
PY 2018
VL 31
IS 2
BP 117
EP 123
DI 10.1089/vim.2017.0145
EA DEC 2017
PG 7
WC Immunology; Virology
SC Immunology; Virology
GA GC8TL
UT WOS:000417598000001
PM 29227202
DA 2020-07-08
ER

PT J
AU Mittal, R
   Nguyen, D
   Debs, LH
   Patel, AP
   Liu, G
   Jhaveri, VM
   Kay, SIS
   Mittal, J
   Bandstra, ES
   Younis, RT
   Chapagain, P
   Jayaweera, DT
   Liu, XZ
AF Mittal, Rahul
   Desiree Nguyen
   Debs, Luca H.
   Patel, Amit P.
   Liu, George
   Jhaveri, Vasanti M.
   Kay, Sae-In S.
   Mittal, Jeenu
   Bandstra, Emmalee S.
   Younis, Ramzi T.
   Chapagain, Prem
   Jayaweera, Dushyantha T.
   Liu, Xue Zhong
TI Zika Virus: An Emerging Global Health Threat
SO FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY
LA English
DT Review
DE Zika virus; pathogenesis; animal models of Zika virus; Zika virus
   proteins
ID MALE SEXUAL TRANSMISSION; PREGNANT-WOMEN; HEARING-LOSS; INFECTION;
   BRAZIL; FETAL; INFANTS; MODEL; BRAIN; EMERGENCE
AB Zika virus (ZIKV) is an emerging healthcare threat. The presence of the mosquito Aedes species across South and Central America in combination with complementary climates have incited an epidemic of locally transmitted cases of ZIKV infection in Brazil. As one of the most significant current public health concerns in the Americas, ZIKV epidemic has been a cause of alarm due to its known and unknown complications. At this point, there has been a clear association between ZIKV infection and severe clinical manifestations in both adults and neonates, including but not limited to neurological deficits such as Guillain-Barre syndrome (GBS) and microcephaly, respectively. The gravity of the fetal anomalies linked to ZIKV vertical transmission from the mother has prompted a discussion on whether to include ZIKV as a formal member of the TORCH [Toxoplasma gondii, other, rubella virus, cytomegalovirus (CMV), and herpes] family of pathogens known to breach placental barriers and cause congenital disease in the fetus. The mechanisms of these complex phenotypes have yet to be fully described. As such, diagnostic tools are limited and no effective modalities are available to treat ZIKV. This article will review the recent advancements in understanding the pathogenesis of ZIKV infection as well as diagnostic tests available to detect the infection. Due to the increase in incidence of ZIKV infections, there is an immediate need to develop new diagnostic tools and novel preventive as well as therapeutic modalities based on understanding the molecular mechanisms underlying the disease.
C1 [Mittal, Rahul; Desiree Nguyen; Debs, Luca H.; Patel, Amit P.; Liu, George; Jhaveri, Vasanti M.; Mittal, Jeenu; Younis, Ramzi T.; Liu, Xue Zhong] Univ Miami, Miller Sch Med, Dept Otolaryngol, Miami, FL 33136 USA.
   [Kay, Sae-In S.] Nova Southeastern Univ, Dept Surg, Div Otorhinolaryngol, Dr Kiran C Patel Coll Osteopath Med, Ft Lauderdale, FL 33314 USA.
   [Bandstra, Emmalee S.; Younis, Ramzi T.; Liu, Xue Zhong] Univ Miami, Miller Sch Med, Dept Pediat, Div Neonatol, Miami, FL 33136 USA.
   [Younis, Ramzi T.; Liu, Xue Zhong] Univ Miami, Miller Sch Med, Dept Pediat, Miami, FL 33136 USA.
   [Chapagain, Prem] Florida Int Univ, Dept Phys, Miami, FL 33199 USA.
   [Chapagain, Prem] Florida Int Univ, Biomol Sci Inst, Miami, FL 33199 USA.
   [Jayaweera, Dushyantha T.] Univ Miami, Miller Sch Med, Dept Med, Miami, FL 33136 USA.
RP Mittal, R; Liu, XZ (corresponding author), Univ Miami, Miller Sch Med, Dept Otolaryngol, Miami, FL 33136 USA.; Liu, XZ (corresponding author), Univ Miami, Miller Sch Med, Dept Pediat, Div Neonatol, Miami, FL 33136 USA.; Liu, XZ (corresponding author), Univ Miami, Miller Sch Med, Dept Pediat, Miami, FL 33136 USA.
EM r.mittal11@med.miami.edu; xliu@med.miami.edu
FU Florida Department of Health [7ZK20, 7ZK080]
FX XL and RY are recipients of a grant 7ZK20 from the Florida Department of
   Health. EB is a recipient of a grant 7ZK080 from the Florida Department
   of Health.
CR Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Akey DL, 2014, SCIENCE, V343, P881, DOI 10.1126/science.1247749
   Al-Qahtani AA, 2016, J INFECT DEV COUNTR, V10, P201, DOI 10.3855/jidc.8350
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   Aman MJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004702
   Anderson KB, 2016, ANN INTERN MED, V165, P175, DOI 10.7326/M16-0617
   Aragao MFVV, 2017, AM J NEURORADIOL, V38, P1045, DOI 10.3174/ajnr.A5125
   Araujo AQC, 2016, BRAIN, V139, P2122, DOI 10.1093/brain/aww158
   Arias A, 2017, J CRIT CARE, V37, P19, DOI 10.1016/j.jcrc.2016.08.016
   Arzuza-Ortega L, 2016, EMERG INFECT DIS, V22, P925, DOI 10.3201/eid2205.151934
   Asadi-Pooya AA, 2016, SEIZURE-EUR J EPILEP, V43, P13, DOI 10.1016/j.seizure.2016.10.011
   Bachiller-Luque P, 2016, ENFERM INFEC MICR CL, V34, P243, DOI 10.1016/j.eimc.2016.02.012
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Becker R, 2016, NAT MED, V22, P225, DOI 10.1038/nm0316-225
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Blazquez Ana-Belen, 2016, World J Virol, V5, P135
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brecher M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130062
   Burton GJ, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.07.050
   Calotta NA, 2017, ANN PLAS SURG, V78, P467, DOI 10.1097/SAP.0000000000000988
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Charrel RN, 2016, B WORLD HEALTH ORGAN, V94, P574, DOI 10.2471/BLT.16.171207
   Chen HL, 2016, J CHIN MED ASSOC, V79, P174, DOI 10.1016/j.jcma.2016.03.001
   Cosano-Quero A, 2018, ACTAS DERMO-SIFILOGR, V109, pE13, DOI 10.1016/j.ad.2017.02.021
   Carvalho MDCG, 2017, CLIN NEUROPHYSIOL, V128, P204, DOI 10.1016/j.clinph.2016.11.004
   Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990
   Cox Bryan D., 2015, Antiviral Chemistry & Chemotherapy, V24, P118, DOI 10.1177/2040206616653873
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Cunha Antonio Jose Ledo Alves da, 2017, Pediatr Infect Dis J, V36, P528, DOI 10.1097/INF.0000000000001486
   da Silva SR, 2016, J MED VIROL, V88, P1657, DOI 10.1002/jmv.24582
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   de Oliveira WK, 2017, NEW ENGL J MED, V376, P1591, DOI 10.1056/NEJMc1608612
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Demir T, 2016, FOLIA MICROBIOL, V61, P523, DOI 10.1007/s12223-016-0467-6
   Derrington SM, 2016, JAMA DERMATOL, V152, P691, DOI 10.1001/jamadermatol.2016.1433
   Deseda CC, 2017, CURR OPIN PEDIATR, V29, P97, DOI 10.1097/MOP.0000000000000442
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   Dowall SD, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005704
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Edupuganti S, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx133
   Ekins Sean, 2016, F1000Res, V5, P150, DOI 10.12688/f1000research.8013.1
   Fajardo A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2015.01667
   Farahnik B, 2016, J AM ACAD DERMATOL, V74, P1286, DOI 10.1016/j.jaad.2016.02.1232
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Fernandez MP, 2017, JAMA OPHTHALMOL, V135, P1163, DOI 10.1001/jamaophthalmol.2017.3595
   da Silva IRF, 2017, JAMA NEUROL, V74, P1190, DOI 10.1001/jamaneurol.2017.1703
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Freitas BD, 2017, CURR OPIN OPHTHALMOL, V28, P595, DOI 10.1097/ICU.0000000000000420
   Freitas BDP, 2017, OPHTHALMOLOGY, V124, P407, DOI 10.1016/j.ophtha.2016.10.004
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Frumence E, 2016, VIROLOGY, V493, P217, DOI 10.1016/j.virol.2016.03.006
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Gallian P, 2017, BLOOD, V129, P263, DOI 10.1182/blood-2016-09-737981
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Garza-Gonzlez E, 2017, BRAZ J INFECT DIS, V21, P554, DOI 10.1016/j.bjid.2017.04.008
   Goodfellow FT, 2016, STEM CELLS DEV, V25, P1691, DOI 10.1089/scd.2016.0231
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Grossi-Soyster EN, 2017, CURR OPIN PEDIATR, V29, P102, DOI 10.1097/MOP.0000000000000449
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Hajra A, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12607
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   He A, 2017, AM J CLIN DERMATOL, V18, P231, DOI 10.1007/s40257-016-0243-z
   Imperato PJ, 2016, J COMMUN HEALTH, V41, P674, DOI 10.1007/s10900-016-0177-7
   Ioannou P, 2017, IDCases, V8, P92, DOI 10.1016/j.idcr.2017.04.019
   Jamil Z, 2016, ASIAN PAC J TROP MED, V9, P606, DOI 10.1016/j.apjtm.2016.05.020
   Joo K, 2017, VET IMMUNOL IMMUNOP, V183, P1, DOI 10.1016/j.vetimm.2016.10.015
   Joob B, 2017, J FORMOS MED ASSOC, V116, P406, DOI 10.1016/j.jfma.2016.07.011
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Kumar M, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0750-4
   Kurosaki Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13836-9
   LaMonica BE, 2012, CURR OPIN NEUROBIOL, V22, P747, DOI 10.1016/j.conb.2012.03.006
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Leal MC, 2017, EMERG INFECT DIS, V23, P1253, DOI 10.3201/eid2308.170354
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Lessler J, 2016, B WORLD HEALTH ORGAN, V94, P841, DOI 10.2471/BLT.16.174540
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017
   Liu SQ, 2018, J MED VIROL, V90, P389, DOI 10.1002/jmv.24970
   Lucchese G, 2016, AUTOIMMUN REV, V15, P801, DOI 10.1016/j.autrev.2016.03.020
   Luo DH, 2015, ANTIVIR RES, V118, P148, DOI 10.1016/j.antiviral.2015.03.014
   MacMicking JD, 2012, NAT REV IMMUNOL, V12, P367, DOI 10.1038/nri3210
   Maeda A, 2013, VET J, V195, P33, DOI 10.1016/j.tvjl.2012.08.019
   Mallet HP, 2015, BISES B INFORM SANIT, V13, P1
   Marquezan MC, 2018, SURV OPHTHALMOL, V63, P166, DOI 10.1016/j.survophthal.2017.06.001
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Mayor S, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1362
   McCarthy M, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4235
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Moi ML, 2017, LANCET INFECT DIS, V17, P805, DOI 10.1016/S1473-3099(17)30412-7
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Mittal R, 2018, JAMA OTOLARYNGOL, V144, P3, DOI 10.1001/jamaoto.2017.1798
   Mlacker S, 2016, INT J DERMATOL, V55, P1369, DOI 10.1111/ijd.13399
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moghadas SM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05013-9
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Mor G, 2016, AM J REPROD IMMUNOL, V75, P421, DOI 10.1111/aji.12505
   Moshfeghi DM, 2016, JAMA OPHTHALMOL, V134, P945, DOI 10.1001/jamaophthalmol.2016.1303
   Murray JS, 2017, J SPEC PEDIATR NURS, V22, DOI 10.1111/jspn.12164
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nascimento OJM, 2017, CURR OPIN NEUROL, V30, P500, DOI 10.1097/WCO.0000000000000471
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Nielsen-Saines K, 2012, PEDIATRICS, V129, pE1525, DOI 10.1542/peds.2011-2340
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Olschlager S, 2017, AM J TROP MED HYG, V97, P1070, DOI 10.4269/ajtmh.17-0268
   Ozkurt Z, 2017, EURASIAN J MED, V49, P142, DOI 10.5152/eurasianjmed.2017.17147
   Pacheco Oscar, 2016, N Engl J Med, DOI 10.1056/NEJMoa1604037
   Panchaud A, 2016, CLIN MICROBIOL REV, V29, P659, DOI 10.1128/CMR.00014-16
   Perera R, 2008, ANTIVIR RES, V80, P11, DOI 10.1016/j.antiviral.2008.05.004
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Pougnet L, 2016, ANN BIOL CLIN-PARIS, V74, P712, DOI 10.1684/abc.2016.1196
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [DOI 10.1001/JAMA0PHTHALM0L.2016.0267, 10.1001/jamaophthalmol.2016.0267]
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reagan-Steiner S, 2017, MMWR-MORBID MORTAL W, V66, P636, DOI 10.15585/mmwr.mm6624a3
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Roberts RM, 2016, REPRODUCTION, V152, pR179, DOI 10.1530/REP-16-0325
   Rose AS, 2015, NUCLEIC ACIDS RES, V43, pW576, DOI 10.1093/nar/gkv402
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Roze B, 2016, EUROSURVEILLANCE, V21, P5, DOI 10.2807/1560-7917.ES.2016.21.16.30205
   Sacramento C. Q., 2016, BIORXIV, V2016, DOI [10.1101/061671, DOI 10.1101/061671]
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Savino W, 2017, GERONTOLOGY, V63, P210, DOI 10.1159/000453579
   Shiose S, 2011, J BIOL CHEM, V286, P15543, DOI 10.1074/jbc.M111.228551
   Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140
   Sironi M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004978
   Sokal A, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/taw066
   Sousa AQ, 2017, EMERG INFECT DIS, V23, P1164, DOI 10.3201/eid2307.162019
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   Tebas Pablo, 2017, N Engl J Med, DOI 10.1056/NEJMoa1708120
   Tyler KL, 2017, JAMA NEUROL, V74, P1169, DOI 10.1001/jamaneurol.2017.1471
   Sebastian UU, 2017, J CRIT CARE, V42, P275, DOI 10.1016/j.jcrc.2017.07.038
   van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P1420, DOI 10.1001/jamaophthalmol.2016.4283
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Ventura LO, 2017, J AAPOS, V21, P295, DOI 10.1016/j.jaapos.2017.04.003
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Vest KG, 2016, DISASTER MED PUBLIC, V10, P707, DOI 10.1017/dmp.2016.43
   Waddell LA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156376
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Werner H, 2016, ULTRASOUND OBST GYN, V47, P657, DOI 10.1002/uog.15901
   Wiwanitkit V, 2017, BRAZ J OTORHINOLAR, V83, P239, DOI 10.1016/j.bjorl.2016.08.007
   World Health Organization (WHO), 2017, ZIK STRAT RESP FRAM
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yaddanapudi K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026766
   Yepez JB, 2017, JAMA OPHTHALMOL, V135, P440, DOI 10.1001/jamaophthalmol.2017.0561
   Yoon D, 2017, J KOREAN MED SCI, V32, P1440, DOI 10.3346/jkms.2017.32.9.1440
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zammarchi L, 2016, MEDITERR J HEMATOL I, V8, DOI 10.4084/MJHID.2016.056
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhang S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13679
   Zmurko J, 2015, REV MED VIROL, V25, P205, DOI 10.1002/rmv.1835
NR 181
TC 19
Z9 19
U1 0
U2 9
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2235-2988
J9 FRONT CELL INFECT MI
JI Front. Cell. Infect. Microbiol.
PD DEC 8
PY 2017
VL 7
AR 486
DI 10.3389/fcimb.2017.00486
PG 19
WC Immunology; Microbiology
SC Immunology; Microbiology
GA FP2UH
UT WOS:000417474100001
PM 29276699
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Khaiboullina, S
   Uppal, T
   Sarkar, R
   Kletenkov, K
   St Jeor, S
   Rizvanov, A
   Verma, S
   Gorzalski, A
AF Khaiboullina, Svetlana
   Uppal, Timsy
   Sarkar, Rupa
   Kletenkov, Konstantin
   St Jeor, Stephen
   Rizvanov, Albert
   Verma, Subhash
   Gorzalski, Andrew
TI Zika Virus Infection Activates Proinflammatory Cytokines and Triggers
   Monocyte Differentiation
SO BLOOD
LA English
DT Meeting Abstract
CT 59th Annual Meeting of the American-Society-of-Hematology (ASH)
CY DEC 09-12, 2017
CL Atlanta, GA
RI Rizvanov, Albert/H-4486-2013
OI Rizvanov, Albert/0000-0002-9427-5739
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC HEMATOLOGY
PI WASHINGTON
PA 2021 L ST NW, SUITE 900, WASHINGTON, DC 20036 USA
SN 0006-4971
EI 1528-0020
J9 BLOOD
JI Blood
PD DEC 7
PY 2017
VL 130
SU 1
MA 2290
PG 3
WC Hematology
SC Hematology
GA GG1DF
UT WOS:000432419405344
DA 2020-07-08
ER

EF